PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Baek, AE; Kanthi, Y; Sutton, NR; Liao, H; Pinsky, DJ				Baek, Amy E.; Kanthi, Yogendra; Sutton, Nadia R.; Liao, Hui; Pinsky, David J.			Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3)	FASEB JOURNAL			English	Article						vascular homeostasis; endothelium; cAMP	CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ENDOTHELIAL-CELLS; INTERMITTENT CLAUDICATION; PLATELET-AGGREGATION; EXTRACELLULAR ATP; ADENOSINE UPTAKE; CILOSTAZOL; INHIBITION; MILRINONE; DIPHOSPHOHYDROLASE	The ectoenzyme CD39 suppresses thrombosis and inflammation by suppressing ATP and ADP to AMP. However, mechanisms of CD39 transcriptional and post-translational regulation are not well known. Here we show that CD39 levels are modulated by inhibition of phosphodiesterase 3 (PDE3). RAW macrophages and human umbilical vein endothelial cells (HUVECs) were treated with the PDE3 inhibitors cilostazol and milrinone, then analyzed using qRT-PCR, immunoprecipitation/Western blot, immunofluorescent staining, radio-thin-layer chromatography, a malachite green assay, and ELISA. HUVECs expressed elevated CD39 protein (2-fold [P<0.05] for cilostazol and 2.5-fold [P<0.01] for milrinone), while macrophage CD39 mRNA and protein were both elevated after PDE3 inhibition. HUVEC ATPase activity increased by 25% with cilostazol and milrinone treatment (P<0.05 and P<0.01, respectively), as did ADPase activity (47% and 61%, P<0.001). There was also a dose-dependent elevation of soluble CD39 after treatment with 8-Br-cAMP, with maximal elevation of 60% more CD39 present compared to controls (1 mM, P<0.001). Protein harvested after 8-Br-cAMP treatment showed that ubiquitination of CD39 was decreased by 43% compared to controls. A DMSO or PBS vehicle control was included for each experiment based on solubility of cilostazol, milrinone, and 8-Br-cAMP. These results indicate that PDE3 inhibition regulates endothelial CD39 at a post-translational level.Baek, A. E., Kanthi, Y., Sutton, N. R., Liao, H., Pinsky, D. J. Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3).	[Baek, Amy E.; Pinsky, David J.] Univ Michigan, Med Ctr, Div Cardiovasc Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Kanthi, Yogendra; Sutton, Nadia R.; Liao, Hui; Pinsky, David J.] Univ Michigan, Med Ctr, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Baek, AE (corresponding author), 7240 Med Sci Res Bldg 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	abaek@umich.edu	liao, hui/GSE-5758-2022	Kanthi, MD, Yogendra/0000-0002-5660-5194; Sutton, Nadia/0000-0002-0968-3085	Taubman Medical Research Institute of the University of Michigan; U.S. National Institutes of Health Multidisciplinary Cardiovascular Research Training [T32 HL007853]; American Heart Association; Ruth professorship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	Taubman Medical Research Institute of the University of Michigan; U.S. National Institutes of Health Multidisciplinary Cardiovascular Research Training; American Heart Association(American Heart Association); Ruth professorship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Taubman Medical Research Institute of the University of Michigan (D.J.P.), a Ruth professorship (D.J.P.), U.S. National Institutes of Health Multidisciplinary Cardiovascular Research Training grant T32 HL007853 (D.J.P., N.S., Y.K.), and an American Heart Association predoctoral fellowship (A.E.B.).	Adelstein R S, 1980, Ann N Y Acad Sci, V356, P142, DOI 10.1111/j.1749-6632.1980.tb29607.x; ANDERSON JL, 1987, J AM COLL CARDIOL, V9, P711, DOI 10.1016/S0735-1097(87)80223-1; Ansermot N, 2010, ARCH INTERN MED, V170, P529, DOI 10.1001/archinternmed.2010.26; Atabakhsh E, 2009, MOL CANCER RES, V7, P1962, DOI 10.1158/1541-7786.MCR-09-0098; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bramer SL, 1999, CLIN PHARMACOKINET, V37, P1, DOI 10.2165/00003088-199937002-00001; Bruno O, 2011, BRIT J PHARMACOL, V164, P2054, DOI 10.1111/j.1476-5381.2011.01524.x; Cone J, 1999, J CARDIOVASC PHARM, V34, P497, DOI 10.1097/00005344-199910000-00004; Dawson DL, 1998, CIRCULATION, V98, P678, DOI 10.1161/01.CIR.98.7.678; Dindyal Shiva, 2009, Recent Pat Cardiovasc Drug Discov, V4, P6; Elkind MSV, 2010, STROKE, V41, pS3, DOI 10.1161/STROKEAHA.110.594945; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Essler M, 2000, J IMMUNOL, V164, P6543, DOI 10.4049/jimmunol.164.12.6543; Fujiwara Y, 2011, J TOXICOL SCI, V36, P155, DOI 10.2131/jts.36.155; Goncalves DAP, 2009, ENDOCRINOLOGY, V150, P5395, DOI 10.1210/en.2009-0428; Gorcideski EZ, 2009, CIRC-HEART FAIL, V2, P320, DOI 10.1161/CIRCHEARTFAILURE.108.839076; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; KIMURA Y, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1144; KOGA S, 1995, AM J PHYSIOL-CELL PH, V268, pC1104, DOI 10.1152/ajpcell.1995.268.5.C1104; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; Lira EC, 2011, MUSCLE NERVE, V44, P371, DOI 10.1002/mus.22066; Liu YG, 2000, J CARDIOVASC PHARM, V36, P351, DOI 10.1097/00005344-200009000-00011; Liu YG, 2001, CARDIOVASC DRUG REV, V19, P369, DOI 10.1111/j.1527-3466.2001.tb00076.x; Marcus AJ, 2005, SEMIN THROMB HEMOST, V31, P234, DOI 10.1055/s-2005-869528; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; Minami N, 1997, LIFE SCI, V61, pPL383, DOI 10.1016/S0024-3205(97)00986-7; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Netherton SJ, 2005, MOL PHARMACOL, V67, P263, DOI 10.1124/mol.104.004853; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Rosen RC, 2003, AM J CARDIOL, V92, p9M, DOI 10.1016/S0002-9149(03)00824-5; Schror K, 2002, DIABETES OBES METAB, V4, pS14, DOI 10.1046/j.1463-1326.2002.0040s2s14.x; Stull J T, 1980, Adv Cyclic Nucleotide Res, V13, P39; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Wang L, 2012, MOL CELL BIOCHEM, V359, P83, DOI 10.1007/s11010-011-1002-3; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Wu Y, 2006, BIOCHEM J, V396, P23, DOI 10.1042/BJ20051568; Yano M, 2000, AM J PHYSIOL-HEART C, V279, pH1898, DOI 10.1152/ajpheart.2000.279.4.H1898; Zhang W, 2002, MOL PHARMACOL, V62, P514, DOI 10.1124/mol.62.3.514; Zhong XT, 2001, J BIOL CHEM, V276, P41518, DOI 10.1074/jbc.M104415200	45	19	19	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4419	4428		10.1096/fj.13-234625	http://dx.doi.org/10.1096/fj.13-234625			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23901069	Green Published, Green Submitted			2022-12-25	WOS:000329937500010
J	Versari, S; Longinotti, G; Barenghi, L; Maier, JAM; Bradamante, S				Versari, Silvia; Longinotti, Giulia; Barenghi, Livia; Maier, Jeanette Anne Marie; Bradamante, Silvia			The challenging environment on board the International Space Station affects endothelial cell function by triggering oxidative stress through thioredoxin interacting protein overexpression: the ESA-SPHINX experiment	FASEB JOURNAL			English	Article						microgravity; spaceflight; microarray; human umbilical vein endothelial cells; focal adhesion	GENE-EXPRESSION; DISTURBED FLOW; SHEAR-STRESS; MICROGRAVITY; GENOMICS; GROWTH; CYTOSKELETON; MECHANISMS; MICRORNAS; COMPLEX	Exposure to microgravity generates alterations that are similar to those involved in age-related diseases, such as cardiovascular deconditioning, bone loss, muscle atrophy, and immune response impairment. Endothelial dysfunction is the common denominator. To shed light on the underlying mechanism, we participated in the Progress 40P mission with Spaceflight of Human Umbilical Vein Endothelial Cells (HUVECs): an Integrated Experiment (SPHINX), which consisted of 12 in-flight and 12 ground-based control modules and lasted 10 d. Postflight microarray analysis revealed 1023 significantly modulated genes, the majority of which are involved in cell adhesion, oxidative phosphorylation, stress responses, cell cycle, and apoptosis. Thioredoxin-interacting protein was the most up-regulated (33-fold), heat-shock proteins 70 and 90 the most down-regulated (5.6-fold). Ion channels (TPCN1, KCNG2, KCNJ14, KCNG1, KCNT1, TRPM1, CLCN4, CLCA2), mitochondrial oxidative phosphorylation, and focal adhesion were widely affected. Cytokine detection in the culture media indicated significant increased secretion of interleukin-1 and interleukin-1. Nitric oxide was found not modulated. Our data suggest that in cultured HUVECs, microgravity affects the same molecular machinery responsible for sensing alterations of flow and generates a prooxidative environment that activates inflammatory responses, alters endothelial behavior, and promotes senescence.Versari, S., Longinotti, G., Barenghi, L., Maier, J. A. M., Bradamante, S. The challenging environment on board the International Space Station affects endothelial cell function by triggering oxidative stress through thioredoxin-interacting protein overexpression: the ESA-SPHINX experiment.	[Versari, Silvia; Longinotti, Giulia; Barenghi, Livia; Bradamante, Silvia] CNR, ISTM, I-20133 Milan, Italy; [Maier, Jeanette Anne Marie] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie Molecolari (ISTM-CNR); University of Milan	Bradamante, S (corresponding author), CNR, ISTM, Via Golgi 19, I-20133 Milan, Italy.	silvia.bradamante@istm.cnr.it	Maier, Jeanette Anne Marie/H-4820-2012	Maier, Jeanette Anne Marie/0000-0002-6326-9221; Barenghi, Livia/0000-0001-7493-5798	ESA-ESTEC [4200014651]; Italian Space Agency (ASI) [I/048/10/0]	ESA-ESTEC(European Space Agency); Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI))	The authors thank the European Space Research and Technology Centre (ESTEC) Life Science Instrumentation Laboratory, User Support Operation Centre (USOC; Zurich, Switzerland); Thales Alenia Space (Turin, Italy); Kayser Italia (Livorno, Italy); S. P. Korolyov Rocket and Space Corp. Energia (Moscow, Russia); and European Space Agency (ESA) Office (Moscow, Russia) for technical and logistic support. This work was supported by the ESA-ESTEC (contract 4200014651) and by the Italian Space Agency (ASI; contract I/048/10/0).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernardini D, 2005, BBA-MOL CELL RES, V1745, P265, DOI 10.1016/j.bbamcr.2005.06.013; Biggar KK, 2011, J MOL CELL BIOL, V3, P167, DOI 10.1093/jmcb/mjq045; Biolo G, 2003, CURR OPIN CLIN NUTR, V6, P31, DOI 10.1097/00075197-200301000-00006; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boonstra J., 2011, LAB SCI SPACE DATA, P107; Silvia B, 2010, BBA-MOL CELL RES, V1803, P1376, DOI 10.1016/j.bbamcr.2010.07.007; Buravkova L, 2005, ACTA ASTRONAUT, V57, P67, DOI 10.1016/j.actaastro.2005.03.012; Buravkova LB, 2001, ACTA ASTRONAUT, V48, P647, DOI 10.1016/S0094-5765(01)00023-6; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Carlsson Sofia I M, 2002, J Gravit Physiol, V9, pP273; Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Collins C, 2011, EXP GERONTOL, V46, P185, DOI 10.1016/j.exger.2010.09.010; Cotrupi Sabrina, 2004, J Gravit Physiol, V11, pP173; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dikalov SI, 2012, ANTIOXID REDOX SIGNA; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Dunn LL, 2010, ARTERIOSCL THROM VAS, V30, P2089, DOI 10.1161/ATVBAHA.110.209643; Griffoni C, 2011, J CELL BIOCHEM, V112, P265, DOI 10.1002/jcb.22921; Grosse J, 2012, FASEB J, V26, P639, DOI 10.1096/fj.11-194886; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hsiai T. K, 2010, HEMODYNAMICS MECHANO, P1; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Infanger M, 2007, J CELL BIOCHEM, V101, P1439, DOI 10.1002/jcb.21261; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001; Klein-Nulend J, 2003, ADV SPACE RES-SERIES, V32, P1551, DOI 10.1016/S0273-1177(03)90395-4; Kliche K, 2011, PFLUG ARCH EUR J PHY, V462, P209, DOI 10.1007/s00424-011-0929-2; Lanave C, 2004, GENE, V333, P71, DOI 10.1016/j.gene.2004.02.017; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DS, 2011, J R SOC INTERFACE, V8, P1379, DOI 10.1098/rsif.2011.0177; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Mariotti M, 2009, MICROGRAVITY SCI TEC, V21, P141, DOI 10.1007/s12217-008-9066-8; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Morbidelli L, 2005, BIOCHEM BIOPH RES CO, V334, P491, DOI 10.1016/j.bbrc.2005.06.124; Muid S., 2010, GRAVIT SPACE BIOL S, V23, pS1; Ng MKC, 2007, ARTERIOSCL THROM VAS, V27, P106, DOI 10.1161/01.ATV.0000251517.98396.4a; Nichols HL, 2006, PHYSIOL GENOMICS, V26, P163, DOI 10.1152/physiolgenomics.00323.2005; Pedersen SF, 2011, J AM SOC NEPHROL, V22, P1587, DOI 10.1681/ASN.2010121284; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Sanford GL, 2002, IN VITRO CELL DEV-AN, V38, P493; Santarpia L, 2010, ENDOCR-RELAT CANCER, V17, pF51, DOI 10.1677/ERC-09-0222; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Sukharev S, 2012, J CELL SCI, V125, P3075, DOI 10.1242/jcs.092353; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tomasini R, 2005, ONCOGENE, V24, P8093, DOI 10.1038/sj.onc.1208951; Tretter L, 2004, NEUROCHEM RES, V29, P569, DOI 10.1023/B:NERE.0000014827.94562.4b; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; van Raam BJ, 2012, BBA-PROTEINS PROTEOM, V1824, P113, DOI 10.1016/j.bbapap.2011.06.005; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Vecchione A, 2010, ENDOCR-RELAT CANCER, V17, pF37, DOI 10.1677/ERC-09-0163; Vernikos J, 1996, BIOESSAYS, V18, P1029, DOI 10.1002/bies.950181215; Vernikos J, 2010, GERONTOLOGY, V56, P157, DOI 10.1159/000252852; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Walther I, 1996, J BIOTECHNOL, V47, P113, DOI 10.1016/0168-1656(96)01375-2; Wang E, 1999, FASEB J, V13, pS167; Wang XQ, 2012, CIRC RES, V110, P560, DOI 10.1161/CIRCRESAHA.111.256362; World C, 2011, ARTERIOSCL THROM VAS, V31, P1890, DOI 10.1161/ATVBAHA.111.226340; Wu MZ, 2011, AGEING RES REV, V10, P1, DOI 10.1016/j.arr.2009.11.002; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Yoshioka J, 2004, CIRCULATION, V109, P2581, DOI 10.1161/01.CIR.0000129771.32215.44; Zschauer TC, 2011, ARTERIOSCL THROM VAS, V31, P650, DOI 10.1161/ATVBAHA.110.218982	70	88	92	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4466	4475		10.1096/fj.13-229195	http://dx.doi.org/10.1096/fj.13-229195			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23913861				2022-12-25	WOS:000329937500014
J	Dalal, S; Ragheb, DRT; Schubot, FD; Klemba, M				Dalal, Seema; Ragheb, Daniel R. T.; Schubot, Florian D.; Klemba, Michael			A Naturally Variable Residue in the S1 Subsite of M1 Family Aminopeptidases Modulates Catalytic Properties and Promotes Functional Specialization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR HEMOGLOBIN CATABOLISM; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; ACTIVE-SITE; M1-FAMILY AMINOPEPTIDASE; CRYSTAL-STRUCTURE; TRIMS PRECURSORS; STRUCTURAL BASIS; DISTINCT ROLES	M1 family metallo-aminopeptidases fulfill a wide range of critical and in some cases medically relevant roles in humans and human pathogens. The specificity of M1-aminopeptidases is dominated by the interaction of the well defined S1 subsite with the side chain of the first (P1) residue of the substrate and can vary widely. Extensive natural variation occurs at one of the residues that contributes to formation of the cylindrical S1 subsite. We investigated whether this natural variation contributes to diversity in S1 subsite specificity. Effects of 11 substitutions of the S1 subsite residue valine 459 in the Plasmodium falciparum aminopeptidase PfA-M1 and of three substitutions of the homologous residue methionine 260 in Escherichia coli aminopeptidase N were characterized. Many of these substitutions altered steady-state kinetic parameters for dipeptide hydrolysis and remodeled S1 subsite specificity. The most dramatic change in specificity resulted from substitution with proline, which collapsed S1 subsite specificity such that only substrates with P1-Arg, -Lys, or -Met were appreciably hydrolyzed. The structure of PfA-M1 V459P revealed that the proline substitution induced a local conformational change in the polypeptide backbone that resulted in a narrowed S1 subsite. The restricted specificity and active site backbone conformation of PfA-M1 V459P mirrored those of endoplasmic reticulum aminopeptidase 2, a human enzyme with proline in the variable S1 subsite position. Our results provide compelling evidence that changes in the variable residue in the S1 subsite of M1-aminopeptidases have facilitated the evolution of new specificities and ultimately novel functions for this important class of enzymes.	[Dalal, Seema; Ragheb, Daniel R. T.; Klemba, Michael] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Schubot, Florian D.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Klemba, M (corresponding author), Virginia Tech, 306 Engel Hall, Blacksburg, VA 24061 USA.	klemba@vt.edu		Schubot, Florian/0000-0002-7403-4735	National Institutes of Health [AI077638]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077638 (to M.K.).	Addlagatta A, 2008, BIOCHEMISTRY-US, V47, P5303, DOI 10.1021/bi7022333; Addlagatta A, 2006, P NATL ACAD SCI USA, V103, P13339, DOI 10.1073/pnas.0606167103; Azimzadeh O, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-189; Bhosale M, 2013, MICROBIOL RES, V168, P56, DOI 10.1016/j.micres.2012.06.003; Birtley JR, 2012, BIOCHEMISTRY-US, V51, P286, DOI 10.1021/bi201230p; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Dalal S, 2012, MOL BIOCHEM PARASIT, V183, P70, DOI 10.1016/j.molbiopara.2012.02.003; Drag M, 2010, J BIOL CHEM, V285, P3310, DOI 10.1074/jbc.M109.060418; Evnouchidou I, 2009, CURR PHARM DESIGN, V15, P3656, DOI 10.2174/138161209789271816; FERSHT A, 1985, ENZYME STRUCTURE MEC, P311; Flipo M, 2007, J MED CHEM, V50, P1322, DOI 10.1021/jm061169b; Fournie-Zaluski MC, 2009, ACTA CRYSTALLOGR D, V65, P814, DOI 10.1107/S090744490901779X; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Harbut MB, 2011, P NATL ACAD SCI USA, V108, pE526, DOI 10.1073/pnas.1105601108; Haroon N, 2010, NAT REV RHEUMATOL, V6, P461, DOI 10.1038/nrrheum.2010.85; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Niven GW, 1995, APPL MICROBIOL BIOT, V44, P100, DOI [10.1007/BF00164487, 10.1007/s002530050526]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, J BIOL CHEM, V283, P30010, DOI 10.1074/jbc.M804650200; Ragheb D, 2011, J BIOL CHEM, V286, P27255, DOI 10.1074/jbc.M111.225318; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Tholander F, 2008, CHEM BIOL, V15, P920, DOI 10.1016/j.chembiol.2008.07.018; Thompson MW, 2009, PROTEIN PEPTIDE LETT, V16, P1256, DOI 10.2174/092986609789071199; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zervoudi E, 2011, BIOCHEM J, V435, P411, DOI 10.1042/BJ20102049; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	36	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26004	26012		10.1074/jbc.M113.465625	http://dx.doi.org/10.1074/jbc.M113.465625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897806	Green Published, hybrid			2022-12-25	WOS:000330623300031
J	Pugazhenthi, S; Zhang, Y; Bouchard, R; Mahaffey, G				Pugazhenthi, Subbiah; Zhang, Yuji; Bouchard, Ron; Mahaffey, Gregory			Induction of an Inflammatory Loop by Interleukin-1 beta and Tumor Necrosis Factor-alpha Involves NF-kappa B and STAT-1 in Differentiated Human Neuroprogenitor Cells	PLOS ONE			English	Article							NEURAL STEM-CELLS; ALZHEIMERS-DISEASE; DOWN-REGULATION; NETWORK MOTIFS; EXPRESSION; PROTEIN; BRAIN; CHEMOKINES; CYTOKINES; DEATH	Proinflammatory cytokines secreted from microglia are known to induce a secondary immune response in astrocytes leading to an inflammatory loop. Cytokines also interfere with neurogenesis during aging and in neurodegenerative diseases. The present study examined the mechanism of induction of inflammatory mediators at the transcriptional level in human differentiated neuroprogenitor cells (NPCs). Interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) induced the expression of cytokines and chemokines in differentiated human NPCs as shown by an immune pathway-specific array. Network motif (NM) analysis of these genes revealed 118 three-node NMs, suggesting complex interactions between inflammatory mediators and transcription factors. Immunofluorescent staining showed increases in the levels of IL-8 and CXCL10 proteins in neurons and glial cells. Findings from Taqman low density array suggested the synergistic actions of IL-1 beta and TNF-alpha in the induction of a majority of inflammatory genes by a mechanism involving NF-kB and STAT-1. Nuclear localization of these transcription factors in differentiated NPCs was observed following exposure to IL-1 alpha and TNF-alpha. Further studies on CXCL10, a chemokine known to be elevated in the Alzheimer's brain, showed that TNF-alpha is a stronger inducer of CXCL10 promoter when compared to IL-1 beta. The synergy between these cytokines was lost when ISRE or kB elements in CXCL10 promoter were mutated. Our findings suggest that the activation of inflammatory pathways in neurons and astrocytes through transcription factors including NF-kB and STAT-1 play important roles in neuroglial interactions and in sustaining the vicious cycle of inflammatory response.	[Pugazhenthi, Subbiah; Bouchard, Ron; Mahaffey, Gregory] Vet Affairs Med Ctr, Endocrinol Sect, Denver, CO USA; [Pugazhenthi, Subbiah; Bouchard, Ron] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Zhang, Yuji] Mayo Clin, Rochester, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Mayo Clinic	Pugazhenthi, S (corresponding author), Vet Affairs Med Ctr, Endocrinol Sect, Denver, CO USA.	subbiah.pugazhenthi@ucdenver.edu		Zhang, Yuji/0000-0002-5429-6762	Veterans Administration [NEUD-004-07F]; Veterans Affairs [I01BX001837] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review grant (NEUD-004-07F) from the Veterans Administration (to SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Bhat NR, 2010, J NEUROCHEM, V115, P551, DOI 10.1111/j.1471-4159.2010.06978.x; Bottai D, 2003, J HEMATOTH STEM CELL, V12, P655, DOI 10.1089/15258160360732687; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Christen U, 2004, AUTOIMMUNITY, V37, P273, DOI 10.1080/08916930410001713124; de Haas AH, 2007, MOL NEUROBIOL, V36, P137, DOI 10.1007/s12035-007-0036-8; Duan RS, 2008, NEUROCHEM RES, V33, P1085, DOI 10.1007/s11064-007-9554-z; Galli R, 2003, CIRC RES, V92, P598, DOI 10.1161/01.RES.0000065580.02404.F4; Glaser J, 2006, J NEUROSCI RES, V84, P724, DOI 10.1002/jnr.20982; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hindlycke H, 2012, BIOCHEM BIOPH RES CO, V418, P845, DOI 10.1016/j.bbrc.2012.01.130; Jambal P, 2003, J BIOL CHEM, V278, P23055, DOI 10.1074/jbc.M212450200; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Majumder S, 1998, J IMMUNOL, V161, P4736; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; MURPHY PG, 1995, J NEUROSCI, V15, P5130; Nichol KE, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-13; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Pugazhenthi S, 2006, FREE RADICAL BIO MED, V40, P21, DOI 10.1016/j.freeradbiomed.2005.08.023; Pugazhenthi S, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-60; Pugazhenthi S, 2011, J VIROL, V85, P6678, DOI 10.1128/JVI.00445-11; Pugazhenthi U, 2010, DIABETOLOGIA, V53, P2357, DOI 10.1007/s00125-010-1849-y; Ray B, 2009, CURR OPIN PHARMACOL, V9, P434, DOI 10.1016/j.coph.2009.06.012; Ryan DA, 2010, J NEUROSCI METH, V190, P171, DOI 10.1016/j.jneumeth.2010.05.001; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shen Q, 2006, BRAIN RES, V1086, P9, DOI 10.1016/j.brainres.2006.02.116; Sheng WS, 2005, J LEUKOCYTE BIOL, V78, P1233, DOI 10.1189/jlb.0405221; Smale ST, 2012, CURR OPIN IMMUNOL, V24, P51, DOI 10.1016/j.coi.2011.12.008; Tenner AJ, 2001, NEUROBIOL AGING, V22, P849, DOI 10.1016/S0197-4580(01)00301-3; Tong LQ, 2008, NEUROBIOL AGING, V29, P1380, DOI 10.1016/j.neurobiolaging.2007.02.027; van Weering HRJ, 2011, HIPPOCAMPUS, V21, P220, DOI 10.1002/hipo.20742; Velmurugan K, 2012, J NEUROCHEM, V123, P919, DOI 10.1111/jnc.12036; Velmurugan K, 2012, ENDOCRINOLOGY, V153, P1116, DOI 10.1210/en.2011-1895; Vukic V, 2009, NEUROBIOL DIS, V34, P95, DOI 10.1016/j.nbd.2008.12.007; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Zhang YJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-203	48	60	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69585	10.1371/journal.pone.0069585	http://dx.doi.org/10.1371/journal.pone.0069585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922745	Green Submitted, Green Published, gold			2022-12-25	WOS:000323369700047
J	Tian, M; Lv, Y; Zhai, C; Zhu, HT; Yu, L; Wang, B				Tian, Min; Lv, Yi; Zhai, Chao; Zhu, Haitao; Yu, Liang; Wang, Bo			Alternative Immunomodulatory Strategies for Xenotransplantation: CD80/CD86-CTLA4 Pathway-Modified Immature Dendritic Cells Promote Xenograft Survival	PLOS ONE			English	Article							REGULATORY T-CELLS; ISLET XENOGRAFTS; PORCINE ISLETS; TOLERANCE; PIG; RESPONSES; EXPRESSION; INDUCTION; REJECTION; CAPACITY	Background: Xenotransplantation is a promising approach to circumventing the current organ shortage. However, T-cell-dependent anti-xenoresponses are a major challenge to successful xenografts. Given the advantages of the use of CTLA4-Ig in the survival of allografts, the purpose of the study was to investigate the therapeutic potential of CTLA4-IgG4 modified immature dendritic cells (imDCs) in the prevention of islets xenograft rejection. Methods: CTLA4-IgG4 was constructed by the fusion of the extracellular regions of porcine CTLA4 to human the hIgG4 Fc region. The imDCs were induced and cultured from porcine peripheral blood mononuclear cells (PBMC). The CTLA4-IgG4 modified imDCs were delivered via the portal vein to the liver of diabetic mice (insulin-dependent diabetes mellitus) before islet xenografting, and mCTLA4-Ig was administered intravenously after xenotransplantation. Results: The xenograft survival of mice receiving unmodified imDCs was approximately 30 days. However, following administration of CTLA4-IgG4 modified imDCs before grafting and mCTLA4-Ig after grafting, xenografts survived for more than 100 days. Flow cytometric analysis showed that the CD4(+)CD25(+)Foxp3(+) Treg population was increased in spleens. The efficacy of donor CTLA4-IgG4 modified imDCs correlated partially with the amplification of Tregs. Conclusions: These results confirm that selective inhibition of the direct and indirect pathways of T-cell activation by donor CTLA4-IgG4 modified imDCs and receptor CTLA4-Ig is a highly effective strategy to promote survival of xenografts.	[Tian, Min; Lv, Yi; Zhai, Chao; Zhu, Haitao; Yu, Liang; Wang, Bo] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Coll Med, Xian 710049, Peoples R China	Xi'an Jiaotong University	Wang, B (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Coll Med, Xian 710049, Peoples R China.	bobwang75@126.com	zhu, HAITAO/GVL-0589-2022		National Natural Science Foundation [30700772]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The work has funding source supporting from National Natural Science Foundation (30700772). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005; Ellis JH, 1996, J IMMUNOL, V156, P2700; Ezzelarab M, 2011, SEMIN IMMUNOL, V23, P252, DOI 10.1016/j.smim.2011.06.007; Graves SS, 2009, TRANSPLANTATION, V88, P317, DOI 10.1097/TP.0b013e3181ae3285; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Hubert P, 2007, J LEUKOCYTE BIOL, V82, P781, DOI 10.1189/jlb.1106694; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Jung ID, 2010, BIOCHEM PHARMACOL, V80, P491, DOI 10.1016/j.bcp.2010.04.025; Kim HI, 2009, XENOTRANSPLANTATION, V16, P11, DOI 10.1111/j.1399-3089.2008.00504.x; Koulmanda M, 2004, XENOTRANSPLANTATION, V11, P525, DOI 10.1111/j.1399-3089.2004.00174.x; Lin YJ, 2008, TRANSPLANTATION, V86, P1452, DOI 10.1097/TP.0b013e318188acb0; Lob S, 2009, INT REV IMMUNOL, V28, P185, DOI 10.1080/08830180902989119; Lutz MB, 2009, EUR J IMMUNOL, V39, P2325, DOI 10.1002/eji.200939548; Maestri M, 2008, J SURG RES, V150, P100, DOI 10.1016/j.jss.2008.01.028; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Min T, 2010, TRANSPL P, V42, P1825, DOI 10.1016/j.transproceed.2010.01.068; Mirenda V, 2005, DIABETES, V54, P1048, DOI 10.2337/diabetes.54.4.1048; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; MOSES RD, 1990, J EXP MED, V172, P567, DOI 10.1084/jem.172.2.567; Nasreen M, 2010, EUR J IMMUNOL, V40, P2016, DOI 10.1002/eji.200940085; Nishimura T, 2010, XENOTRANSPLANTATION, V17, P313, DOI 10.1111/j.1399-3089.2010.00599.x; Noguchi H, 2009, TRANSPLANTATION, V87, P1629, DOI 10.1097/TP.0b013e3181a5515c; Ollinger R, 2010, TRANSPL INT, V23, P1071, DOI 10.1111/j.1432-2277.2010.01158.x; Olack BJ, 2001, TRANSPLANT P, V33, P784, DOI 10.1016/S0041-1345(00)02254-5; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Pierson RN, 2009, XENOTRANSPLANTATION, V16, P263, DOI 10.1111/j.1399-3089.2009.00534.x; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Rayat GR, 2003, J ENDOCRINOL, V177, P127, DOI 10.1677/joe.0.1770127; Robert S, 2012, J IMMUNOL, V188, P37; Rossini AA, 1999, PHYSIOL REV, V79, P99, DOI 10.1152/physrev.1999.79.1.99; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Singh NP, 2004, XENOTRANSPLANTATION, V11, P33, DOI 10.1111/j.1399-3089.2004.00079.x; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Sucher R, 2009, J AM COLL SURGEONS, V209, pS56, DOI 10.1016/j.jamcollsurg.2009.06.132; Summerfield A, 2009, DEV COMP IMMUNOL, V33, P299, DOI 10.1016/j.dci.2008.05.005; Tesar BM, 2004, J IMMUNOL, V173, P4377, DOI 10.4049/jimmunol.173.7.4377; Thomson AW, 2010, AM J TRANSPLANT, V10, P214, DOI 10.1111/j.1600-6143.2009.02955.x; Tian Min, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P434; Tonomura N, 2008, XENOTRANSPLANTATION, V15, P129, DOI 10.1111/j.1399-3089.2008.00450.x; Vaughan AN, 2000, J IMMUNOL, V165, P3175, DOI 10.4049/jimmunol.165.6.3175; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Xia JJ, 2010, TRANSPL INT, V23, P1154, DOI 10.1111/j.1432-2277.2010.01106.x; Yang DF, 2008, TRANSPL IMMUNOL, V19, P197, DOI 10.1016/j.trim.2008.05.005; Yonekawa Y, 2005, CELL TRANSPLANT, V14, P757, DOI 10.3727/000000005783982512; Zhai C, 2011, XENOTRANSPLANTATION, V18, P40, DOI 10.1111/j.1399-3089.2011.00627.x	49	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69640	10.1371/journal.pone.0069640	http://dx.doi.org/10.1371/journal.pone.0069640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922766	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700057
J	Viiri, J; Amadio, M; Marchesi, N; Hyttinen, JMT; Kivinen, N; Sironen, R; Rilla, K; Akhtar, S; Provenzani, A; D'Agostino, VG; Govoni, S; Pascale, A; Agostini, H; Petrovski, G; Salminen, A; Kaarniranta, K				Viiri, Johanna; Amadio, Marialaura; Marchesi, Nicoletta; Hyttinen, Juha M. T.; Kivinen, Niko; Sironen, Reijo; Rilla, Kirsi; Akhtar, Saeed; Provenzani, Alessandro; D'Agostino, Vito Giuseppe; Govoni, Stefano; Pascale, Alessia; Agostini, Hansjurgen; Petrovski, Goran; Salminen, Antero; Kaarniranta, Kai			Autophagy Activation Clears ELAVL1/HuR-Mediated Accumulation of SQSTM1/p62 during Proteasomal Inhibition in Human Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							BINDING PROTEIN P62; MACULAR DEGENERATION; ALZHEIMERS-DISEASE; MEDIATED PROTEOLYSIS; OXIDATIVE STRESS; BODY FORMATION; EXPRESSION; KINASE; HUR; DEGRADATION	Age-related macular degeneration (AMD) is the most common reason of visual impairment in the elderly in the Western countries. The degeneration of retinal pigment epithelial cells (RPE) causes secondarily adverse effects on neural retina leading to visual loss. The aging characteristics of the RPE involve lysosomal accumulation of lipofuscin and extracellular protein aggregates called "drusen". Molecular mechanisms behind protein aggregations are weakly understood. There is intriguing evidence suggesting that protein SQSTM1/p62, together with autophagy, has a role in the pathology of different degenerative diseases. It appears that SQSTM1/p62 is a connecting link between autophagy and proteasome mediated proteolysis, and expressed strongly under the exposure to various oxidative stimuli and proteasomal inhibition. ELAVL1/HuR protein is a post-transcriptional factor, which acts mainly as a positive regulator of gene expression by binding to specific mRNAs whose corresponding proteins are fundamental for key cellular functions. We here show that, under proteasomal inhibitor MG-132, ELAVL1/HuR is up-regulated at both mRNA and protein levels, and that this protein binds and post-transcriptionally regulates SQSTM1/p62 mRNA in ARPE-19 cell line. Furthermore, we observed that proteasomal inhibition caused accumulation of SQSTM1/p62 bound irreversibly to perinuclear protein aggregates. The addition of the AMPK activator AICAR was pro-survival and promoted cleansing by autophagy of the former complex, but not of the ELAVL1/HuR accumulation, indeed suggesting that SQSTM1/p62 is decreased through autophagy-mediated degradation, while ELAVL1/HuR through the proteasomal pathway. Interestingly, when compared to human controls, AMD donor samples show strong SQSTM1/p62 rather than ELAVL1/HuR accumulation in the drusen rich macular area suggesting impaired autophagy in the pathology of AMD.	[Viiri, Johanna; Hyttinen, Juha M. T.; Kivinen, Niko; Kaarniranta, Kai] Univ Eastern Finland, Inst Clin Med, Dept Ophthalmol, Kuopio, Finland; [Amadio, Marialaura; Marchesi, Nicoletta; Govoni, Stefano; Pascale, Alessia] Univ Pavia, Pharmacol Sect, Dept Drug Sci, I-27100 Pavia, Italy; [Sironen, Reijo] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Sironen, Reijo] Kuopio Univ Hosp, Dept Clin Pathol, SF-70210 Kuopio, Finland; [Sironen, Reijo] Univ Eastern Finland, Bioctr Kuopio, Kuopio, Finland; [Sironen, Reijo] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Rilla, Kirsi] Univ Eastern Finland, Inst Biomed, Sch Med, Dept Anat, Kuopio, Finland; [Akhtar, Saeed] King Saud Univ, Coll Appl Med Sci, Dept Optometry & Vis Sci, Riyadh, Saudi Arabia; [Provenzani, Alessandro; D'Agostino, Vito Giuseppe] Univ Trento, Ctr Integrat Biol, Lab Genom Screening, Trento, Italy; [Agostini, Hansjurgen] Univ Freiburg, Univ Eye Hosp, Dept Ophthalmol, D-79106 Freiburg, Germany; [Petrovski, Goran] Univ Debrecen, Med & Hlth Sci Ctr, Dept Ophthalmol, H-4012 Debrecen, Hungary; [Petrovski, Goran] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biochem & Mol Biol, Stem Cells & Eye Res Lab, H-4012 Debrecen, Hungary; [Salminen, Antero] Univ Eastern Finland, Inst Clin Med, Dept Neurol, Kuopio, Finland; [Salminen, Antero] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Kaarniranta, Kai] Kuopio Univ Hosp, Dept Ophthalmol, SF-70210 Kuopio, Finland	University of Eastern Finland; University of Pavia; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; King Saud University; University of Trento; University of Freiburg; University of Debrecen; University of Debrecen; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Kaarniranta, K (corresponding author), Univ Eastern Finland, Inst Clin Med, Dept Ophthalmol, Kuopio, Finland.	kai.kaarniranta@uef.fi	D'Agostino, Vito/AAS-4260-2020; Provenzani, Alessandro/I-9211-2012; Govoni, Stefano/K-2965-2015; Akhtar, Saeed/AGY-3605-2022; Marchesi, Nicoletta/GQZ-7428-2022	D'Agostino, Vito/0000-0003-3379-2254; Provenzani, Alessandro/0000-0003-1652-3415; Govoni, Stefano/0000-0002-7243-6837; Marchesi, Nicoletta/0000-0001-6271-1420; Rilla, Kirsi/0000-0002-7862-5727; Hyttinen, Juha/0000-0002-3414-4032; Kaarniranta, Kai/0000-0003-2600-8679; Petrovski, Goran/0000-0003-2905-9252	Kuopio University Hospital EVO grant [5503726]; Academy of Finland; Finnish Cultural Foundation and its North Savo Fund; Finnish Eye Foundation; Evald and Hilda Nissi Foundation; Blind Friends Society	Kuopio University Hospital EVO grant; Academy of Finland(Academy of Finland); Finnish Cultural Foundation and its North Savo Fund(Finnish Cultural Foundation); Finnish Eye Foundation; Evald and Hilda Nissi Foundation; Blind Friends Society	This work was supported by the Kuopio University Hospital EVO grant 5503726, the Academy of Finland, the Finnish Cultural Foundation and its North Savo Fund, the Finnish Eye Foundation, Evald and Hilda Nissi Foundation and Blind Friends Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67; Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Amadio M, 2008, CURR PHARM DESIGN, V14, P2651, DOI 10.2174/138161208786264052; Amadio M, 2009, J ALZHEIMERS DIS, V16, P409, DOI 10.3233/JAD-2009-0967; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bonelli MA, 2004, EXP GERONTOL, V39, P423, DOI 10.1016/j.exger.2003.12.004; Braak H, 2011, J NEURAL TRANSM, V118, P809, DOI 10.1007/s00702-010-0508-2; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Geetha T, 2012, BIOMARKERS, V17, P99, DOI 10.3109/1354750X.2011.653986; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Gordois A, 2012, GLOB PUBLIC HEALTH, V7, P465, DOI 10.1080/17441692.2011.634815; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Ishii T, 1997, BIOCHEM BIOPH RES CO, V232, P33, DOI 10.1006/bbrc.1997.6221; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kaarniranta K, 2013, AUTOPHAGY, V9, P973, DOI 10.4161/auto.24546; Kaarniranta K, 2011, J ALZHEIMERS DIS, V24, P615, DOI 10.3233/JAD-2011-101908; Kaarniranta Kai, 2010, Front Biosci (Elite Ed), V2, P1374; Kaarniranta K, 2009, EXP GERONTOL, V44, P685, DOI 10.1016/j.exger.2009.09.002; Kaarniranta K, 2009, AGEING RES REV, V8, P128, DOI 10.1016/j.arr.2009.01.001; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Krohne TU, 2010, EXP EYE RES, V90, P261, DOI 10.1016/j.exer.2009.10.014; Krohne TU, 2010, INVEST OPHTH VIS SCI, V51, P553, DOI 10.1167/iovs.09-3755; Kurz T, 2009, AUTOPHAGY, V5, P494, DOI 10.4161/auto.5.4.7961; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Kuusisto E, 2001, BIOCHEM BIOPH RES CO, V280, P223, DOI 10.1006/bbrc.2000.4107; Li Y, 2008, EXP GERONTOL, V43, P1114, DOI 10.1016/j.exger.2008.08.052; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nakaso K, 2004, BRAIN RES, V1012, P42, DOI 10.1016/j.brainres.2004.03.029; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Pascale A, 2012, CELL MOL LIFE SCI, V69, P501, DOI 10.1007/s00018-011-0810-7; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Ryhanen T, 2009, J CELL MOL MED, V13, P3616, DOI 10.1111/j.1582-4934.2008.00577.x; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Salminen A, 2012, PROG NEUROBIOL, V96, P87, DOI 10.1016/j.pneurobio.2011.11.005; Salminen A, 2009, TRENDS MOL MED, V15, P217, DOI 10.1016/j.molmed.2009.03.004; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Sambrook J, 1990, MOL CLONING LAB MANU, P125; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Shamsi FA, 2001, INVEST OPHTH VIS SCI, V42, P3041; SIN HP, 2012, ACTA OPHTHALMOL, DOI DOI 10.1111/J.1755-3768.2011.02357.X.EPUB; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Viana R, 2008, BIOCHEM BIOPH RES CO, V369, P964, DOI 10.1016/j.bbrc.2008.02.126; Viiri J, 2010, MOL VIS, V16, P1399; Wang AL, 2009, AUTOPHAGY, V5, P1190, DOI 10.4161/auto.5.8.10087; Wang AL, 2009, AUTOPHAGY, V5, P563, DOI 10.4161/auto.5.4.8163; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	66	123	127	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69563	10.1371/journal.pone.0069563	http://dx.doi.org/10.1371/journal.pone.0069563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922739	gold, Green Submitted, Green Published			2022-12-25	WOS:000323369700043
J	Chaouiya, C; Ourrad, O; Lima, R				Chaouiya, Claudine; Ourrad, Ouerdia; Lima, Ricardo			Majority Rules with Random Tie-Breaking in Boolean Gene Regulatory Networks	PLOS ONE			English	Article							YEAST-CELL-CYCLE; DYNAMICS; SYSTEMS; MODEL; STOCHASTICITY; LIMITATIONS; ROBUSTNESS; CIRCUITS	We consider threshold Boolean gene regulatory networks, where the update function of each gene is described as a majority rule evaluated among the regulators of that gene: it is turned ON when the sum of its regulator contributions is positive (activators contribute positively whereas repressors contribute negatively) and turned OFF when this sum is negative. In case of a tie (when contributions cancel each other out), it is often assumed that the gene keeps it current state. This framework has been successfully used to model cell cycle control in yeast. Moreover, several studies consider stochastic extensions to assess the robustness of such a model. Here, we introduce a novel, natural stochastic extension of the majority rule. It consists in randomly choosing the next value of a gene only in case of a tie. Hence, the resulting model includes deterministic and probabilistic updates. We present variants of the majority rule, including alternate treatments of the tie situation. Impact of these variants on the corresponding dynamical behaviours is discussed. After a thorough study of a class of two-node networks, we illustrate the interest of our stochastic extension using a published cell cycle model. In particular, we demonstrate that steady state analysis can be rigorously performed and can lead to effective predictions; these relate for example to the identification of interactions whose addition would ensure that a specific state is absorbing.	[Chaouiya, Claudine] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Ourrad, Ouerdia] A Mira Univ Bejaia, Theoret Phys Lab, Bejaia, Algeria; [Lima, Ricardo] Dream & Sci Factory, Marseille, France; [Lima, Ricardo] Inst Complex Sci, Lisbon, Portugal	Instituto Gulbenkian de Ciencia; Universite de Bejaia	Chaouiya, C (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	chaouiya@igc.gulbenkian.pt	Chaouiya, Claudine/F-8560-2012	Chaouiya, Claudine/0000-0003-2350-0756	Fundacao de Ciencia e Tecnologia [PTDC/EIA-CCO/099229/2008]; Fundação para a Ciência e a Tecnologia [PTDC/EIA-CCO/099229/2008] Funding Source: FCT	Fundacao de Ciencia e Tecnologia; Fundação para a Ciência e a Tecnologia	This work was partially supported by the Fundacao de Ciencia e Tecnologia (PTDC/EIA-CCO/099229/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alvarez-Buylla ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003626; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Braunewell S, 2007, J THEOR BIOL, V245, P638, DOI 10.1016/j.jtbi.2006.11.012; Coutinho R, 2006, J MATH BIOL, V52, P524, DOI 10.1007/s00285-005-0359-x; dAri R., 1990, BIOL FEEDBACK; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Faure A, 2009, MOL BIOSYST, V5, P1569, DOI [10.1039/b907562n, 10.1039/B907562n]; Faure A, 2009, MOL BIOSYST, V5, P1787, DOI [10.1039/b910101m, 10.1039/B910101m]; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Garg A, 2009, BIOINFORMATICS, V25, pI101, DOI 10.1093/bioinformatics/btp214; Glass L, 2010, CURR OPIN GENET DEV, V20, P644, DOI 10.1016/j.gde.2010.09.005; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Irons DJ, 2009, J THEOR BIOL, V257, P543, DOI 10.1016/j.jtbi.2008.12.028; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kemeny J.G., 1976, MARKOV CHAINS, V6; Lee WB, 2009, FEBS LETT, V583, P927, DOI 10.1016/j.febslet.2009.02.010; LEVIN D. A., 2009, MARKOV CHAINS MIXING; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Murrugarra D, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-5; Remy E, 2008, BIOINFORMATICS, V24, pI220, DOI 10.1093/bioinformatics/btn287; Robert F., 1995, SYSTEMES DYNAMIQUES, V19; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Stoll G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011917; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Zanudo JGT, 2011, INTEL SYST REF LIBR, V11, P113, DOI 10.1007/978-3-642-19621-8_6; Zhang YP, 2006, PHYSICA D, V219, P35, DOI 10.1016/j.physd.2006.05.009	30	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69626	10.1371/journal.pone.0069626	http://dx.doi.org/10.1371/journal.pone.0069626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922761	Green Submitted, Green Published, gold			2022-12-25	WOS:000322838900065
J	Courtney, R; Seymour, J				Courtney, Robert; Seymour, Jamie			Seasonality in Polyps of a Tropical Cubozoan: A latina nr mordens	PLOS ONE			English	Article							CARYBDEA-MARSUPIALIS LINNAEUS; TRIPEDALIA-CYSTOPHORA CUBOZOA; LIFE-HISTORY; RHIZOSTOME MEDUSAE; ASEXUAL REPRODUCTION; CYANEA CNIDARIA; AURELIA-AURITA; JELLYFISH; BEHAVIOR; METAMORPHOSIS	A latina nr mordens have been located in large predictable spawning aggregations near Osprey Reef in the Coral Sea eight to ten days after a full moon; however, polyps have never been located in-situ. The polyp stage contributes to the abundance of medusae through asexual reproduction and metamorphosis, and may influence the periodicity of medusae by metamorphosis of the polyp. To elucidate the relationship between medusae periodicity and polyp ecology, polyps were exposed to thermal and osmotic treatments in order to determine the theoretical environmental limits to their distribution. Maximum fecundity occurred in thermal treatments of 21 to 25 degrees C and the theoretical minimum thermal requirement for population stability was approximately 17 degrees C. Polyps were also exposed to five feeding regimes and fecundity was found to be positively correlated with feeding frequency. Thermal and osmotic variations did not induce metamorphosis in this species, however, reduced food did. The implications of asexual reproduction and cues for metamorphosis in relation to population dynamics of this species are discussed.	[Courtney, Robert] James Cook Univ, Fac Sci & Engn, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Seymour, Jamie] James Cook Univ, Fac Med Hlth & Mol Sci, Sch Publ Hlth Trop Med & Rehabil Sci, Cairns, Qld, Australia; [Seymour, Jamie] James Cook Univ, Cairns, Qld, Australia	James Cook University; James Cook University; James Cook University	Courtney, R (corresponding author), James Cook Univ, Fac Sci & Engn, Sch Marine & Trop Biol, Cairns, Qld, Australia.	Robert.Courtney@my.jcu.edu.au		Courtney, Robert/0000-0002-3914-1551	Lions Foundation of Australia; Queensland Emergency Medical Research Foundation, Brisbane, Queensland	Lions Foundation of Australia; Queensland Emergency Medical Research Foundation, Brisbane, Queensland	The Lions Foundation of Australia provided a grant that partially supported this research. JS acknowledges the financial support of the Queensland Emergency Medical Research Foundation, Brisbane, Queensland. The funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arai M.N., 1997, FUNCTIONAL BIOL SCYP; Arneson A. C., 1976, COELENTERATE ECOLOGY, P227, DOI [10.1007/978-1-4757-9724-4_24, DOI 10.1007/978-1-4757-9724-4_24]; Bigelow R., 1900, MEMOIRS READ BOSTON, V5, P190; BREWER RH, 1991, J EXP MAR BIOL ECOL, V152, P49, DOI 10.1016/0022-0981(91)90134-I; BREWER RH, 1976, BIOL BULL-US, V150, P183, DOI 10.2307/1540467; BREWER RH, 1984, BIOL BULL, V166, P11, DOI 10.2307/1541426; BREWER RH, 1978, ESTUARIES, V1, P120, DOI 10.2307/1351601; Burnett JW, 1996, VENOMOUS POISONOUS M, P98; Cutress C. E., 1973, P ASS ISLAND MARINE, V9, P25; Fischer AB, 2004, HYDROBIOLOGIA, V530, P331, DOI 10.1007/s10750-004-2658-4; Gershwin LA, 2005, ZOOTAXA, P1; Gordon M, 2004, HYDROBIOLOGIA, V530, P339, DOI 10.1007/s10750-004-2655-7; Gordon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031277; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P171, DOI 10.1007/BF00026459; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; HOLST S, 2006, J MAR BIOL ASSOC UK, V151, P863; Holst S, 2010, HYDROBIOLOGIA, V645, P53, DOI 10.1007/s10750-010-0214-y; KIKINGER R, 1992, MAR ECOL-P S Z N I, V13, P333, DOI 10.1111/j.1439-0485.1992.tb00359.x; KING B, 2002, 44 CRC REEF RES CTR; LASKAMEHNERT G, 1985, HELGOLANDER MEERESUN, V39, P129, DOI 10.1007/BF01997447; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Mehnert G, 1984, THESIS RHEINISCHE FR, P1; Purcell JE, 1999, MAR ECOL PROG SER, V180, P187, DOI 10.3354/meps180187; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2007, MAR ECOL PROG SER, V348, P183, DOI 10.3354/meps07056; Stampar SN, 2008, CAH BIOL MAR, V49, P247; Stangl K, 2002, VIE MILIEU, V52, P131; Stanish KD, 1997, TESTING CHLORIDE PEN, P1; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Straehler-Pohl I., 2009, THESIS U HAMBURG, P1; Straehler-Pohl I, 2011, ZOOTAXA, P36; Studebaker J. P., 1972, THESIS U PUERTO RICO, P1; SUGIURA Y, 1966, EMBRYOLOGIA, V9, P105, DOI 10.1111/j.1440-169X.1966.tb00219.x; SUGIURA Y, 1965, BIOL BULL, V128, P493, DOI 10.2307/1539908; SUGIURA Y, 1964, EMBRYOLOGIA, V8, P223, DOI 10.1111/j.1440-169X.1964.tb00200.x; Sugiura Y., 1963, Annotationes Zoologicae Japonenses, V36, P194; Thomas C S, 2001, Hawaii Med J, V60, P100; Toshino Sho, 2013, Plankton & Benthos Research, V8, P1; WERNER B, 1983, HELGOLANDER MEERESUN, V36, P257, DOI 10.1007/BF01983630; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0; Yamaguchi M., 1980, P11	42	11	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69369	10.1371/journal.pone.0069369	http://dx.doi.org/10.1371/journal.pone.0069369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922707	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900039
J	Gao, JH; Wen, SL; Yang, WJ; Lu, YY; Tong, H; Huang, ZY; Liu, ZX; Tang, CW				Gao, Jin-Hang; Wen, Shi-Lei; Yang, Wen-Juan; Lu, Yao-Yao; Tong, Huan; Huang, Zhi-Yin; Liu, Zhang-Xu; Tang, Cheng-Wei			Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis	PLOS ONE			English	Article							EXPERIMENTAL LIVER FIBROSIS; MOLECULAR-MECHANISMS; TARGETS; VEGF; CYCLOOXYGENASE-2; PROLIFERATION; FIBROGENESIS; SORAFENIB; PROLONGS; SURVIVAL	Background: Increased intra-hepatic resistance to portal blood flow is the primary factor leading to portal hypertension in cirrhosis. Up-regulated expression of cyclooxygenase-2 (COX-2) in the cirrhotic liver might be a potential target to ameliorate portal hypertension. Objective: To verify the effect of celecoxib, a selective inhibitor of COX-2, on portal hypertension and the mechanisms behind it. Methods: Cirrhotic liver model of rat was established by peritoneal injection of thiacetamide (TAA). 36 rats were randomly assigned to control, TAA and TAA+celecoxib groups. Portal pressures were measured by introduction of catheters into portal vein. Hepatic fibrosis was assessed by the visible hepatic fibrotic areas and mRNAs for collagen III and alpha-SMA. The neovasculature was determined by hepatic vascular areas, vascular casts and CD31 expression. Expressions of COX-2, vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2) and related signal molecules were quantitated. Results: Compared with TAA group, the portal pressure in TAA+celecoxib group was significantly decreased by 17.8%, p<0.01. Celecoxib treatment greatly reduced the tortuous hepatic portal venules. The data of fibrotic areas, CD31expression, mRNA levels of alpha-SMA and collagen III in TAA+celecoxib group were much lower than those in TAA group, p, 0.01. Furthermore, the up-regulation of hepatic mRNA and protein levels of VEGF, VEGFR-2 and COX-2 induced by TAA was significantly inhibited after celecoxib treatment. The expressions of prostaglandin E2 (PGE2), phosphorylated extracellular signal-regulated kinase (p-ERK), hypoxia-inducible factor-1 alpha (HIF-1 alpha), and c-fos were also down-regulated after celecoxib treatment. Conclusions: Long term administration of celecoxib can efficiently ameliorate portal hypertension in TAA rat model by its dual inhibitory effects on the intrahepatic fibrosis and angiogenesis. The anti-angiogenesis effect afforded by celecoxib may attribute to its modulation on VEGF/VEGFR-2 through the down-regulation of integrated signal pathways involving PGE2-HIF-1 alpha-VEGF and p-ERK-c-fos-VEGFR-2.	[Gao, Jin-Hang; Wen, Shi-Lei; Tang, Cheng-Wei] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Div Peptides Related Human Dis, Chengdu 610064, Peoples R China; [Gao, Jin-Hang; Yang, Wen-Juan; Lu, Yao-Yao; Tong, Huan; Huang, Zhi-Yin; Tang, Cheng-Wei] Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610064, Peoples R China; [Wen, Shi-Lei] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610064, Peoples R China; [Liu, Zhang-Xu] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA 90033 USA	Sichuan University; Sichuan University; Sichuan University; University of Southern California	Tang, CW (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Div Peptides Related Human Dis, Chengdu 610064, Peoples R China.	shcqcdmed@163.com			Natural Science Fund of China [81170413]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This study is supported by Grant #81170413 of Natural Science Fund of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5; Bosch J, 2010, J HEPATOL, V53, P558, DOI 10.1016/j.jhep.2010.03.021; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen HX, 2009, NAT REV CLIN ONCOL, V6, P465, DOI 10.1038/nrclinonc.2009.94; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; Fallowfield JA, 2011, AM J PHYSIOL-GASTR L, V300, pG709, DOI 10.1152/ajpgi.00451.2010; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Giannitrapani L, 2009, ANN NY ACAD SCI, V1155, P293, DOI 10.1111/j.1749-6632.2009.03698.x; Hui AY, 2006, LIVER INT, V26, P125, DOI 10.1111/j.1478-3231.2005.01202.x; Jain RK, 2012, CELL, V149, P1408, DOI 10.1016/j.cell.2012.05.025; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Liu H, 2009, PROSTAG OTH LIPID M, V88, P63, DOI 10.1016/j.prostaglandins.2008.10.002; Maddrey W C, 2000, Am J Ther, V7, P153, DOI 10.1097/00045391-200007030-00003; Masyuk TV, 2003, AM J PATHOL, V162, P1175, DOI 10.1016/S0002-9440(10)63913-2; McCormack PL, 2011, DRUGS, V71, P2457, DOI 10.2165/11208240-000000000-00000; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Paik YH, 2009, GUT, V58, P1517, DOI 10.1136/gut.2008.157420; Patsenker E, 2009, HEPATOLOGY, V50, P1501, DOI 10.1002/hep.23144; Rockey DC, 2008, CLIN LIVER DIS, V12, P939, DOI 10.1016/j.cld.2008.07.011; Sahin M, 2009, ANGIOLOGY, V60, P242, DOI 10.1177/0003319708318378; Samant RS, 2011, ONCOTARGET, V2, P122; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065; Thabut D, 2011, HEPATOLOGY, V54, P573, DOI 10.1002/hep.24427; Thabut D, 2010, J HEPATOL, V53, P976, DOI 10.1016/j.jhep.2010.07.004; Tong H, 2013, J DIGEST DIS, V14, P29, DOI 10.1111/1751-2980.12001; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Van Steenkiste C, 2011, HEPATOLOGY, V53, P1629, DOI 10.1002/hep.24238; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Wang R, 2013, CURR PHARM DESIGN, V19, P115; Xiao ZF, 2007, CELL RES, V17, P73, DOI 10.1038/sj.cr.7310126; Xie Y, 2011, CANCER BIOL THER, V12, P86, DOI 10.4161/cbt.12.1.15730; Yu J, 2009, LIVER INT, V29, P25, DOI 10.1111/j.1478-3231.2008.01760.x	33	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69309	10.1371/journal.pone.0069309	http://dx.doi.org/10.1371/journal.pone.0069309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922700	Green Submitted, Green Published, gold			2022-12-25	WOS:000322838900032
J	Cardoso, T; Teixeira-Pinto, A; Rodrigues, PP; Aragao, I; Costa-Pereira, A; Sarmento, AE				Cardoso, Teresa; Teixeira-Pinto, Armando; Rodrigues, Pedro Pereira; Aragao, Irene; Costa-Pereira, Altamiro; Sarmento, Antonio E.			Predisposition, Insult/Infection, Response and Organ Dysfunction (PIRO): A Pilot Clinical Staging System for Hospital Mortality in Patients with Infection	PLOS ONE			English	Article							SCORE; DEFINITIONS; PNEUMONIA; SEVERITY; MODEL	Purpose: To develop a clinical staging system based on the PIRO concept (Predisposition, Infection, Response and Organ dysfunction) for hospitalized patients with infection. Methods: One year prospective cohort study of all hospitalized patients with infection (n = 1035), admitted into a large tertiary care, university hospital. Variables associated with hospital mortality were selected using logistic regressions. Based on the regression coefficients, a score for each PIRO component was developed and a classification tree was used to stratify patients into four stages of increased risk of hospital mortality. The final clinical staging system was then validated using an independent cohort (n = 186). Results: Factors significantly associated with hospital mortality were . for Predisposition: age, sex, previous antibiotic therapy, chronic hepatic disease, chronic hematologic disease, cancer, atherosclerosis and a Karnofsky index, 70; . for Insult/Infection: type of infection . for Response: abnormal temperature, tachypnea, hyperglycemia and severity of infection and . for Organ dysfunction: hypotension and SOFA score >= 1. The area under the ROC curve (CI95%) for the combined PIRO model as a predictor for mortality was 0.85 (0.82-0.88). Based on the scores for each of the PIRO components and on the cut-offs estimated from the classification tree, patients were stratified into four stages of increased mortality rates: stage I: <= 5%, stage II: 6-20%, stage III: 21-50% and stage IV: >50%. Finally, this new clinical staging system was studied in a validation cohort, which provided similar results (0%, 9%, 31% and 67%, in each stage, respectively). Conclusions: Based on the PIRO concept, a new clinical staging system was developed for hospitalized patients with infection, allowing stratification into four stages of increased mortality, using the different scores obtained in Predisposition, Response, Infection and Organ dysfunction. The proposed system will likely help to define inclusion criteria in clinical trials as well as tailoring individual management plans for patients with infection.	[Cardoso, Teresa] Univ Porto, Hosp Santo Antonio, Intens Care Unit, Unidade Cuidados Intens Polivalente, P-4100 Oporto, Portugal; [Teixeira-Pinto, Armando; Rodrigues, Pedro Pereira; Costa-Pereira, Altamiro] Univ Porto, Fac Med, Ctr Res Hlth Technol & Informat Syst CINTESIS, Dept Hlth Informat & Decis Sci, P-4100 Oporto, Portugal; [Teixeira-Pinto, Armando] Univ Sydney, Fac Med, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Aragao, Irene] Univ Porto, Hosp Santo Antonio, Unidade Cuidados Intens Polivalente, P-4100 Oporto, Portugal; [Sarmento, Antonio E.] Univ Porto, Hosp Sao Joao, Dept Infect Dis, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; University of Sydney; Universidade do Porto; Sao Joao Hospital; Universidade do Porto	Cardoso, T (corresponding author), Univ Porto, Hosp Santo Antonio, Intens Care Unit, Unidade Cuidados Intens Polivalente, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	cardoso.tmc@gmail.com	Teixeira-Pinto, Armando/H-7947-2013; Sarmento, António/M-5235-2013; Costa-Pereira, Altamiro/I-5987-2012; Rodrigues, Pedro Pereira/H-5789-2012; , CINTESIS/C-6631-2014	Teixeira-Pinto, Armando/0000-0002-9389-2516; Sarmento, António/0000-0001-5269-7231; Costa-Pereira, Altamiro/0000-0001-8467-6398; Rodrigues, Pedro Pereira/0000-0001-7867-6682; , CINTESIS/0000-0001-7248-2086	ASSUCIP - Associacao de Apoio a Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal; Teaching and Research Department (Departamento de Formacao, Ensino e Investigacao) of Oporto Hospital Centre; Science and Technology Foundation [PIC/IC/83312/2007]	ASSUCIP - Associacao de Apoio a Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal; Teaching and Research Department (Departamento de Formacao, Ensino e Investigacao) of Oporto Hospital Centre; Science and Technology Foundation	This research was supported by an unrestricted grant from ASSUCIP - Associacao de Apoio a Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal (Intensive Care Unit Support Association). Teresa Cardoso is funded by a PhD research grant from the Teaching and Research Department (Departamento de Formacao, Ensino e Investigacao) of Oporto Hospital Centre. Teixeira-Pinto is funded by a clinical research grant from the Science and Technology Foundation (PIC/IC/83312/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2009, CRIT CARE, V13, DOI 10.1186/cc7881; Angus DC, 2003, CRIT CARE, V7, P248, DOI 10.1186/cc2193; Denoix P. F., 1946, B I NAT HYG, V1, P70; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gini C., 1912, J R STAT SOC, V76, P326; Granja C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053885; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Horan TC, 1997, AM J INFECT CONTROL, V25, P112, DOI 10.1016/S0196-6553(97)90037-7; Howell MD, 2011, CRIT CARE MED, V39, P322, DOI 10.1097/CCM.0b013e3182037a8e; Karnofsky D. A., 1949, EVALUATION CHEMOTHER, P196; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lisboa T, 2008, CHEST, V134, P1208, DOI 10.1378/chest.08-1106; Moreno RP, 2008, INTENS CARE MED, V34, P496, DOI 10.1007/s00134-007-0943-1; Nguyen HB, 2012, J CRIT CARE, V27, P362, DOI 10.1016/j.jcrc.2011.08.013; Rello J, 2009, CRIT CARE MED, V37, P456, DOI 10.1097/CCM.0b013e318194b021; Rubulotta F, 2009, CRIT CARE MED, V37, P1329, DOI 10.1097/CCM.0b013e31819d5db1; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; World Health Organization, 2012, WORLD HLTH STAT 2012	22	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70806	10.1371/journal.pone.0070806	http://dx.doi.org/10.1371/journal.pone.0070806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894684	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900141
J	Jeru, I; Charmion, S; Cochet, E; Copin, B; Duquesnoy, P; Garcia, MTM; Le Borgne, G; Cathebras, P; Gaillat, J; Karabina, S; Dode, C; Lohse, P; Hentgen, V; Amselem, S				Jeru, Isabelle; Charmion, Serge; Cochet, Emmanuelle; Copin, Bruno; Duquesnoy, Philippe; Garcia, Maria Teresa Mitjavila; Le Borgne, Gaelle; Cathebras, Pascal; Gaillat, Jacques; Karabina, Sonia; Dode, Catherine; Lohse, Peter; Hentgen, Veronique; Amselem, Serge			Involvement of the Same TNFR1 Residue in Mendelian and Multifactorial Inflammatory Disorders	PLOS ONE			English	Article							PERIODIC SYNDROME TRAPS; FACTOR RECEPTOR-I; TNFRSF1A MUTATION; CROHNS-DISEASE; WILD-TYPE; R92Q; VARIANTS; GENE; HETEROGENEITY; ASSOCIATION	Objectives: TNFRSF1A is involved in an autosomal dominant autoinflammatory disorder called TNFR-associated periodic syndrome (TRAPS). Most TNFRSF1A mutations are missense changes and, apart from those affecting conserved cysteines, their deleterious effect remains often questionable. This is especially true for the frequent R92Q mutation, which might not be responsible for TRAPS per se but represents a susceptibility factor to multifactorial inflammatory disorders. This study investigates TRAPS pathophysiology in a family exceptional by its size (13 members) and compares the consequences of several mutations affecting arginine 92. Methods: TNFRSF1A screening was performed by PCR-sequencing. Comparison of the 3-dimensional structure and electrostatic properties of wild-type and mutated TNFR1 proteins was performed by in silico homology modeling. TNFR1 expression was assessed by FACS analysis, western blotting and ELISA in lysates and supernatants of HEK293T cells transiently expressing wild-type and mutated TNFR1. Results: A TNFRSF1A heterozygous missense mutation, R92W (c.361C>T), was shown to perfectly segregate with typical TRAPS manifestations within the family investigated (p<5.10(-4)). It was associated with very high disease penetrance (0.9). Prediction of its impact on the protein structure revealed local conformational changes and alterations of the receptor electrostatic properties. R92W also impairs the TNFR1 expression at the cell surface and the levels of soluble receptor. Similar results were obtained with R92P, another mutation previously identified in a very small familial form with incomplete penetrance and variable expressivity. In contrast, TNFR1-R92Q behaves like the wild-type receptor. Conclusions: These data demonstrate the pathogenicity of a mutation affecting arginine 92, a residue whose involvement in inflammatory disorders is deeply debated. Combined with previous reports on arginine 92 mutations, this study discloses an unusual situation in which different amino acid substitutions at the same position in the protein are associated with a clinical spectrum bridging Mendelian to multifactorial conditions.	[Jeru, Isabelle; Copin, Bruno; Duquesnoy, Philippe; Le Borgne, Gaelle; Karabina, Sonia; Amselem, Serge] INSERM, UMR S933, Paris, France; [Jeru, Isabelle; Le Borgne, Gaelle; Karabina, Sonia; Amselem, Serge] Univ Paris 06, UPMC, UMR S933, Paris, France; [Jeru, Isabelle; Cochet, Emmanuelle; Amselem, Serge] Hop Trousseau, AP HP, Serv Genet & Embryol Med, F-75571 Paris, France; [Jeru, Isabelle; Cathebras, Pascal; Karabina, Sonia; Amselem, Serge] CNRS, INSERM, AP HP, UPMC,Dept Hosp Univ Inflammat Immunopathol Biothe, Paris, France; [Charmion, Serge] Ctr Hosp Univ St Etienne, Serv Med Interne, St Etienne, France; [Garcia, Maria Teresa Mitjavila] INSERM, UMR S935, Villejuif, France; [Gaillat, Jacques] Ctr Hosp Reg Annecy, Serv Malad Infect, Pringy, France; [Dode, Catherine] Hop Cochin, AP HP, Serv Biochim & Genet Mol, F-75674 Paris, France; [Lohse, Peter] Univ Munich, Dept Clin Chem Grosshadern, Munich, Germany; [Lohse, Peter] Inst Lab Med & Human Genet, Singen, Germany; [Hentgen, Veronique] Ctr Hosp Versailles, French Reference Ctr Autoinflammatory Dis CeReMAI, Le Chesnay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier Annecy Genevois; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Munich; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay	Jeru, I (corresponding author), INSERM, UMR S933, Paris, France.	isabelle.jeru@trs.aphp.fr	Mitjavila-Garcia, Maria Teresa/L-8909-2018; HENTGEN, Véronique/AAR-1348-2021		Institut national de la sante et de la recherche medicale (INSERM); Universite Pierre et Marie Curie - Paris 6	Institut national de la sante et de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie - Paris 6	This work was supported by grants from the Institut national de la sante et de la recherche medicale (INSERM); and the Universite Pierre et Marie Curie - Paris 6. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganna E, 2004, GENES IMMUN, V5, P289, DOI 10.1038/sj.gene.6364070; Aganna E, 2003, ARTHRITIS RHEUM-US, V48, P2632, DOI 10.1002/art.11215; Aganna E, 2001, EUR J HUM GENET, V9, P63, DOI 10.1038/sj.ejhg.5200573; Aksentijevich I, 2001, AM J HUM GENET, V69, P301, DOI 10.1086/321976; Amoura Z, 2005, ARTHRITIS RHEUM, V52, P608, DOI 10.1002/art.20873; Bachetti T, 2013, ANN RHEUM DIS, V72, P1044, DOI 10.1136/annrheumdis-2012-201952; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Cantarini L, 2009, INT J IMMUNOPATH PH, V22, P1051, DOI 10.1177/039463200902200421; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; D'Osualdo A, 2006, ARTHRITIS RHEUM-US, V54, P998, DOI 10.1002/art.21657; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dieude P, 2007, ANN RHEUM DIS, V66, P1113, DOI 10.1136/ard.2006.060764; Dode C, 2002, ARTHRITIS RHEUM-US, V46, P2181, DOI 10.1002/art.10429; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Goris A, 2011, J NEUROIMMUNOL, V235, P110, DOI 10.1016/j.jneuroim.2011.04.005; Hull KM, 2002, MEDICINE, V81, P349, DOI 10.1097/00005792-200209000-00002; Jenne DE, 2007, ANN RHEUM DIS, V66, P1266, DOI 10.1136/ard.2006.065987; Kumpfel T, 2007, ARTHRITIS RHEUM, V56, P2774, DOI 10.1002/art.22795; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lobito AA, 2006, BLOOD, V108, P1320, DOI 10.1182/blood-2005-11-006783; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Pelagatti MA, 2011, ARTHRITIS RHEUM-US, V63, P1141, DOI 10.1002/art.30237; Poirier O, 2004, EUR J HUM GENET, V12, P213, DOI 10.1038/sj.ejhg.5201143; Ravet N, 2006, ANN RHEUM DIS, V65, P1158, DOI 10.1136/ard.2005.048611; Rebelo SL, 2006, ARTHRITIS RHEUM-US, V54, P2674, DOI 10.1002/art.21964; Shroyer NF, 2001, HUM MOL GENET, V10, P2671, DOI 10.1093/hmg/10.23.2671; Siebert S, 2005, ARTHRITIS RHEUM, V52, P1287, DOI 10.1002/art.20955; Simon A, 2010, P NATL ACAD SCI USA, V107, P9801, DOI 10.1073/pnas.0914118107; Todd I, 2004, IMMUNOLOGY, V113, P65, DOI 10.1111/j.1365-2567.2004.01942.x; Todd I, 2007, ARTHRITIS RHEUM, V56, P2765, DOI 10.1002/art.22740; Touitou I, 2006, ANN RHEUM DIS, V65, P1530, DOI 10.1136/ard.2006.054312; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Wang XJ, 2000, JAMA-J AM MED ASSOC, V284, P1814, DOI 10.1001/jama.284.14.1814; Yousaf N, 2005, ARTHRITIS RHEUM-US, V52, P2906, DOI 10.1002/art.21268	35	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69757	10.1371/journal.pone.0069757	http://dx.doi.org/10.1371/journal.pone.0069757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894535	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900093
J	Ma, LY; Lv, Z; Su, JR; Wang, JJ; Yan, DH; Wei, JJ; Pei, S				Ma, Liyan; Lv, Zhi; Su, Jianrong; Wang, Jianjie; Yan, Donghui; Wei, Jingjuan; Pei, Shuang			Consistent Condom Use Increases the Colonization of Lactobacillus crispatus in the Vagina	PLOS ONE			English	Article							TRANSMITTED-DISEASE ACQUISITION; PEROXIDE-PRODUCING LACTOBACILLI; SIMPLEX-VIRUS TYPE-2; BACTERIAL-VAGINOSIS; HYDROGEN-PEROXIDE; HORMONAL CONTRACEPTION; INTRAUTERINE-DEVICE; MICROBIAL-FLORA; SEXUAL-ACTIVITY; RISK-FACTORS	Background: Non-hormonal contraception methods have been widely used, but their effects on colonization by vaginal lactobacilli remain unclear. Objective: To determine the association between non-hormonal contraception methods and vaginal lactobacilli on women's reproductive health. Methods: The cross-sectional study included 164 healthy women between 18-45 years of age. The subjects were divided into different groups on the basis of the different non-hormonal contraception methods used by them. At the postmenstrual visit (day 21 or 22 of the menstrual cycle), vaginal swabs were collected for determination of Nugent score, quantitative culture and real-time polymerase chain reaction (PCR) of vaginal lactobacilli. The prevalence, colony counts and 16S rRNA gene expression of the Lactobacillus strains were compared between the different groups by Chi-square and ANOVA statistical analysis methods. Results: A Nugent score of 0-3 was more common in the condom group (93.1%) than in the group that used an interuterine device(IUD) (75.4%), (p = 0.005). The prevalence of H2O2-producing Lactobacillus was significantly higher in the condom group (82.3%) than in the IUD group (68.2%), (p = 0.016). There was a significant difference in colony count (mean +/- standard error (SE), log(10)colony forming unit (CFU)/ml) of H2O2-producing Lactobacillus between condom users (7.81 +/- 0.14) and IUD users (6.54 +/- 0.14), (p = 0.000). The 16S rRNA gene expression (mean +/- SE, log(10)copies/ml) of Lactobacillus crispatus was significantly higher in the condom group (8.09 +/- 0.16) than in the IUD group (6.03 +/- 0.18), (p = 0.000). Conclusion: Consistent condom use increases the colonization of Lactobacillus crispatus in the vagina and may protect against both bacterial vaginosis (BV) and human immunodeficiency virus (HIV).	[Ma, Liyan; Lv, Zhi; Su, Jianrong; Yan, Donghui; Wei, Jingjuan; Pei, Shuang] Capital Med Univ, Clin Lab Ctr, Beijing Friendship Hosp, Beijing, Peoples R China; [Wang, Jianjie] Capital Med Univ, Beijing Friendship Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Su, JR (corresponding author), Capital Med Univ, Clin Lab Ctr, Beijing Friendship Hosp, Beijing, Peoples R China.	sujianrong6@126.com			National Natural Science Foundation of China [30972819]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [grant number 30972819]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; AVONTS D, 1990, SEX TRANSM DIS, V17, P23; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; BARBONE F, 1990, AM J OBSTET GYNECOL, V163, P510, DOI 10.1016/0002-9378(90)91186-G; Bolton M, 2008, SEX TRANSM DIS, V35, P214, DOI 10.1097/OLQ.0b013e31815b017a; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Calzolari E, 2000, INT J GYNECOL OBSTET, V70, P341, DOI 10.1016/S0020-7292(00)00217-4; Centre for Disease Control (CDC), 2002, MAL LAT COND SEX TRA; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cherpes TL, 2003, SEX TRANSM DIS, V30, P405, DOI 10.1097/00007435-200305000-00006; Cleland J, 2009, BEST PRACT RES CL OB, V23, P165, DOI 10.1016/j.bpobgyn.2008.11.002; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; De Seta F, 2012, CONTRACEPTION, V86, P526, DOI 10.1016/j.contraception.2012.02.012; do Lago RF, 2003, CONTRACEPTION, V68, P105, DOI 10.1016/S0010-7824(03)00109-4; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gupta K, 2000, J INFECT DIS, V181, P595, DOI 10.1086/315267; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hutchinson KB, 2007, EPIDEMIOLOGY, V18, P702, DOI 10.1097/EDE.0b013e3181567eaa; Kaida A, PLOS ONE, V5; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Munk AC, PLOS ONE, V7; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; O'Hanlon DE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-120; Rifkin SB, 2009, CONTRACEPTION, V80, P63, DOI 10.1016/j.contraception.2009.01.008; Riggs M, 2007, SEX TRANSM DIS, V34, P954, DOI 10.1097/OLQ.0b013e31811ed0e4; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Shlay JC, 2004, SEX TRANSM DIS, V31, P526, DOI 10.1097/01.olq.0000137897.17919.d1; Trussell J, 2007, CHOOSING CONTRACEPTI; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Wiesenfeld HC, 2002, OBSTET GYNECOL, V100, P456, DOI 10.1016/S0029-7844(02)02118-X; Yen S, 2003, OBSTET GYNECOL, V102, P927, DOI 10.1016/S0029-7844(03)00858-5	37	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70716	10.1371/journal.pone.0070716	http://dx.doi.org/10.1371/journal.pone.0070716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894682	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000218
J	Paes, LS; Mantilla, BS; Zimbres, FM; Pral, EMF; de Melo, PD; Tahara, EB; Kowaltowski, AJ; Elias, MC; Silber, AM				Paes, Lisvane Silva; Mantilla, Brian Suarez; Zimbres, Flavia Menezes; Furusho Pral, Elisabeth Mieko; de Melo, Patricia Diogo; Tahara, Erich B.; Kowaltowski, Alicia J.; Elias, Maria Carolina; Silber, Ariel Mariano			Proline Dehydrogenase Regulates Redox State and Respiratory Metabolism in Trypanosoma cruzi	PLOS ONE			English	Article							RAT-LIVER MITOCHONDRIA; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR DIFFERENTIATION; CHAGAS-DISEASE; EXPRESSION; PROTEIN; ACID; GENE; TRANSPORT	Over the past three decades, L-proline has become recognized as an important metabolite for trypanosomatids. It is involved in a number of key processes, including energy metabolism, resistance to oxidative and nutritional stress and osmoregulation. In addition, this amino acid supports critical parasite life cycle processes by acting as an energy source, thus enabling host-cell invasion by the parasite and subsequent parasite differentiation. In this paper, we demonstrate that L-proline is oxidized to D 1-pyrroline-5-carboxylate (P5C) by the enzyme proline dehydrogenase (TcPRODH, E. C. 1.5.99.8) localized in Trypanosoma cruzi mitochondria. When expressed in its active form in Escherichia coli, TcPRODH exhibits a K-m of 16.58 +/- 1.69 mu M and a V-max of 66 +/- 2 nmol/min mg. Furthermore, we demonstrate that TcPRODH is a FAD-dependent dimeric state protein. TcPRODH mRNA and protein expression are strongly upregulated in the intracellular epimastigote, a stage which requires an external supply of proline. In addition, when Saccharomyces cerevisiae null mutants for this gene (PUT1) were complemented with the TcPRODH gene, diminished free intracellular proline levels and an enhanced sensitivity to oxidative stress in comparison to the null mutant were observed, supporting the hypothesis that free proline accumulation constitutes a defense against oxidative imbalance. Finally, we show that proline oxidation increases cytochrome c oxidase activity in mitochondrial vesicles. Overall, these results demonstrate that TcPRODH is involved in proline-dependant cytoprotection during periods of oxidative imbalance and also shed light on the participation of proline in energy metabolism, which drives critical processes of the T. cruzi life cycle.	[Paes, Lisvane Silva; Mantilla, Brian Suarez; Zimbres, Flavia Menezes; Furusho Pral, Elisabeth Mieko; Silber, Ariel Mariano] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [de Melo, Patricia Diogo; Elias, Maria Carolina] Inst Butantan, Ctr Appl Toxinol CAT CEPID, LETA, Sao Paulo, Brazil; [Tahara, Erich B.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo	Silber, AM (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.	asilber@usp.br	Kowaltowski, Alicia J/H-8698-2012; Vieira, Lisvane Paes/AAI-6761-2020; Elias, Maria QB/AAW-9284-2021; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Elias, Maria Carolina/E-9197-2015; Silber, Ariel/O-6951-2015	Vieira, Lisvane Paes/0000-0001-8589-5939; Elias, Maria Carolina/0000-0002-0501-8280; Suarez Mantilla, Brian/0000-0001-7839-1222; Silber, Ariel/0000-0003-4528-4732; Menezes Zimbres, Flavia/0000-0003-3512-1999	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/50631-1]; Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [470272/2011-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant # 11/50631-1 to AMS), Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant # 470272/2011-2 to AMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Alia, 2001, AMINO ACIDS, V21, P195; Almeida-de-Faria M, 1999, EXP PARASITOL, V92, P263, DOI 10.1006/expr.1999.4423; Ayliffe MA, 2005, MOL GENET GENOMICS, V274, P494, DOI 10.1007/s00438-005-0048-x; Banu MN, BIOSCI BIOTECHNOL BI, V74, P2043; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BONTEMPI E, 1989, MOL BIOCHEM PARASIT, V33, P43, DOI 10.1016/0166-6851(89)90040-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220; BRENER Z, 1976, J PROTOZOOL, V23, P147, DOI 10.1111/j.1550-7408.1976.tb05258.x; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; Bursell JDH, 1996, J MEMBRANE BIOL, V154, P131, DOI 10.1007/s002329900138; Caceres AJ, 2003, MOL BIOCHEM PARASIT, V126, P251, DOI 10.1016/S0166-6851(02)00294-3; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; CASTILLO FJ, 1984, PLANT PHYSIOL, V74, P846, DOI 10.1104/pp.74.4.846; CAZZULO JJ, 1994, J BIOENERG BIOMEMBR, V26, P157, DOI 10.1007/BF00763064; Chamond N, 2009, MOL BIOCHEM PARASIT, V165, P170, DOI 10.1016/j.molbiopara.2009.02.002; Chen CB, 2005, P NATL ACAD SCI USA, V102, P3459, DOI 10.1073/pnas.0407960102; Chen CB, 2006, APPL ENVIRON MICROB, V72, P4001, DOI 10.1128/AEM.02428-05; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V14, P83, DOI 10.1016/0166-6851(85)90108-2; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Delwing D, 2003, INT J DEV NEUROSCI, V21, P105, DOI 10.1016/S0736-5748(02)00109-0; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Emanuelsson O, 2001, METHOD CELL BIOL, V65, P175, DOI 10.1016/S0091-679X(01)65011-8; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; HOEK JB, 1980, J BIOL CHEM, V255, P8711; HOMSY JJ, 1989, J PROTOZOOL, V36, P150, DOI 10.1111/j.1550-7408.1989.tb01063.x; Hu CAA, 2007, MOL CELL BIOCHEM, V295, P85, DOI 10.1007/s11010-006-9276-6; JOHNSON AB, 1962, J BIOL CHEM, V237, P1876; JUAN SM, 1977, J PARASITOL, V63, P921, DOI 10.2307/3279910; Kaul S, 2008, AMINO ACIDS, V34, P315, DOI 10.1007/s00726-006-0407-x; Krishnan N, 2006, J BACTERIOL, V188, P1227, DOI 10.1128/JB.188.4.1227-1235.2006; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lee YH, 2003, NAT STRUCT BIOL, V10, P109, DOI 10.1038/nsb885; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magdaleno A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004534; Martins RM, 2009, INFECT IMMUN, V77, P3023, DOI 10.1128/IAI.00138-09; Maxwell SA, 2003, J BIOL CHEM, V278, P9784, DOI 10.1074/jbc.M210012200; Monaghan PJ, 2007, FEBS J, V274, P2070, DOI 10.1111/j.1742-4658.2007.05750.x; Morita Y, 2003, APPL ENVIRON MICROB, V69, P212, DOI 10.1128/AEM.69.1.212-219.2003; Nomura M, 2004, P NATL ACAD SCI USA, V101, P12616, DOI 10.1073/pnas.0403349101; Ostrander EL, 2009, BIOCHEMISTRY-US, V48, P951, DOI 10.1021/bi802094k; Paes LS, 2011, CURR PHARM DESIGN, V17, P2074, DOI 10.2174/138161211796904786; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; Phang JM, 2008, AMINO ACIDS, V35, P681, DOI 10.1007/s00726-008-0063-4; Phang JM, 2008, AMINO ACIDS, V35, P653, DOI 10.1007/s00726-008-0103-0; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Rasmusson AG, 2008, MITOCHONDRION, V8, P47, DOI 10.1016/j.mito.2007.10.004; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Sarkar D, 2009, BIORESOURCE TECHNOL, V100, P5332, DOI 10.1016/j.biortech.2009.03.086; Schagger H, 1996, ELECTROPHORESIS, V17, P709, DOI 10.1002/elps.1150170415; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Silber AM, 2002, J EUKARYOT MICROBIOL, V49, P441, DOI 10.1111/j.1550-7408.2002.tb00225.x; Silber AM, 2009, MOL BIOCHEM PARASIT, V168, P102, DOI 10.1016/j.molbiopara.2009.07.006; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; SIMONDSEN RP, 1982, BIOCHEMISTRY-US, V21, P6366, DOI 10.1021/bi00268a008; Skopelitis DS, 2006, PLANT CELL, V18, P2767, DOI 10.1105/tpc.105.038323; Strecker V, 2010, PROTEOMICS, V10, P3379, DOI 10.1002/pmic.201000343; SYLVESTER D, 1976, COMP BIOCHEM PHYS B, V55, P443, DOI 10.1016/0305-0491(76)90318-7; Takagi H, 2000, FEMS MICROBIOL LETT, V184, P103, DOI 10.1016/S0378-1097(00)00023-9; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; THOMSON JF, 1960, BIOCHIM BIOPHYS ACTA, V44, P72, DOI 10.1016/0006-3002(60)91524-9; Tonelli RR, 2004, CELL MICROBIOL, V6, P733, DOI 10.1111/j.1462-5822.2004.00397.x; TURRENS JF, 1989, BIOCHEM J, V259, P363, DOI 10.1042/bj2590363; Verbruggen N, 1996, P NATL ACAD SCI USA, V93, P8787, DOI 10.1073/pnas.93.16.8787; Wanduragala S, 2010, ARCH BIOCHEM BIOPHYS, V498, P136, DOI 10.1016/j.abb.2010.04.020; White TA, 2007, J BIOL CHEM, V282, P14316, DOI 10.1074/jbc.M700912200; WOOD JM, 1988, J MEMBRANE BIOL, V106, P183, DOI 10.1007/BF01872157	74	45	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69419	10.1371/journal.pone.0069419	http://dx.doi.org/10.1371/journal.pone.0069419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894476	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100059
J	Kong, DC; Zheng, TS; Zhang, M; Wang, DD; Du, SH; Li, X; Fang, JH; Cao, XJ				Kong, Dechao; Zheng, Tiansheng; Zhang, Ming; Wang, Daode; Du, Shihao; Li, Xiang; Fang, Jiahu; Cao, Xiaojian			Static Mechanical Stress Induces Apoptosis in Rat Endplate Chondrocytes through MAPK and Mitochondria-Dependent Caspase Activation Signaling Pathways	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; PROTEIN-KINASE; INTERVERTEBRAL DISC; CELL-DEATH; BAX TRANSLOCATION; TERMINAL KINASE; UP-REGULATION; CYTOCHROME-C; CARTILAGE; P38	Mechanical stress has detrimental effects on cartilaginous endplate chondrocytes due to apoptosis in vivo and in vitro. In this study, we investigated the possible apoptosis signaling pathways induced by mechanical stress in cultured rat cervical endplate chondrocytes. Static mechanical load significantly reduced cell viability in a time-and load-dependent manner, as demonstrated by the Cell Counting Kit-8 (CCK-8) assay. Chondrocyte apoptosis induced by mechanical stress was confirmed by annexin V/propidium iodide (PI) staining and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL). Western blot analysis revealed that static load-induced chondrocyte apoptosis was accompanied by increased phosphorylation of c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase 1/2 (ERK1/2), and p38 mitogen-activated protein kinase (MAPK). The loss of mitochondrial membrane potential (Delta Psi m), increased Cytochrome c release, and activated Caspase-9 and Caspase-3, indicating that the mitochondrial pathway is involved in mechanical stress-induced chondrocyte apoptosis. Treatment with inhibitors of JNK (SP600125), p38 MAPK (SB203580), and ERK (PD98059) prior to mechanical stimulation reversed both the static load-induced chondrocyte apoptosis and the activation of JNK, p38 MAPK, and ERK. Taken together, the data presented in this study demonstrate that mechanical stress induces apoptosis in rat cervical endplate chondrocytes through the MAPK-mediated mitochondrial apoptotic pathway.	[Kong, Dechao; Zheng, Tiansheng; Zhang, Ming; Wang, Daode; Du, Shihao; Li, Xiang; Fang, Jiahu; Cao, Xiaojian] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Fang, JH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, Nanjing, Jiangsu, Peoples R China.	fjh4508@163.com; xiaojiancao@gmail.com		Fang, Jiahu/0000-0001-9521-3719	National Natural Science Foundation of China [81071518, 81171694]; Foundation of Jiangsu Province Public Health Bureau of China [H200906]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT - 015]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Jiangsu Province Public Health Bureau of China; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (No. 81071518, 81171694), the Foundation of Jiangsu Province Public Health Bureau of China (No. H200906), the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (No. IRT - 015), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga K, 2003, SPINE, V28, P1528, DOI 10.1097/00007632-200307150-00010; Ariga K, 2001, SPINE, V26, P2414, DOI 10.1097/00007632-200111150-00004; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen CH, 2013, TOXICOLOGY, V303, P72, DOI 10.1016/j.tox.2012.10.008; Cherng YG, 2008, J ORTHOP RES, V26, P1018, DOI 10.1002/jor.20578; Clancy R, 2001, OSTEOARTHR CARTILAGE, V9, P294, DOI 10.1053/joca.2000.0388; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Geng Y, 1996, J CLIN INVEST, V98, P2425, DOI 10.1172/JCI119056; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Harnois C, 2004, J CELL PHYSIOL, V198, P209, DOI 10.1002/jcp.10399; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Krammer P H, 1999, Adv Immunol, V71, P163; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kuhn K, 2004, OSTEOARTHR CARTILAGE, V12, P1, DOI 10.1016/j.joca.2003.09.015; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LARSSON T, 1991, MATRIX, V11, P388, DOI 10.1016/S0934-8832(11)80193-9; Lee HJ, 2005, TOXICOL APPL PHARM, V203, P124, DOI 10.1016/j.taap.2004.08.004; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005; Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004; Lotz JC, 2000, SPINE, V25, P1477, DOI 10.1097/00007632-200006150-00005; Lucchinetti E, 2002, OSTEOARTHR CARTILAGE, V10, P71, DOI 10.1053/joca.2001.0483; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Murphy KM, 2000, CELL DEATH DIFFER, V7, P102, DOI 10.1038/sj.cdd.4400597; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Petrache I, 1999, AM J PHYSIOL-LUNG C, V277, pL589, DOI 10.1152/ajplung.1999.277.3.L589; Racz B, 2007, BONE, V40, P1536, DOI 10.1016/j.bone.2007.02.011; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Relic B, 2004, J BIOL CHEM, V279, P22399, DOI 10.1074/jbc.M314118200; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Teijido O, 2010, FEBS LETT, V584, P3305, DOI 10.1016/j.febslet.2010.07.002; Tong JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016781; Wang XD, 2001, GENE DEV, V15, P2922; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang XW, 2012, J BIOMED RES, V26, P103, DOI 10.1016/S1674-8301(12)60019-0; Zhou Y, 2007, OSTEOARTHR CARTILAGE, V15, P884, DOI 10.1016/j.joca.2007.02.001	44	63	69	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69403	10.1371/journal.pone.0069403	http://dx.doi.org/10.1371/journal.pone.0069403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894471	Green Published, gold, Green Submitted			2022-12-25	WOS:000322391400058
J	Cipriano, R; Bryson, BL; Miskimen, KLS; Bartel, CA; Hernandez-Sanchez, W; Bruntz, RC; Scott, SA; Lindsley, CW; Brown, HA; Jackson, MW				Cipriano, R.; Bryson, B. L.; Miskimen, K. L. S.; Bartel, C. A.; Hernandez-Sanchez, W.; Bruntz, R. C.; Scott, S. A.; Lindsley, C. W.; Brown, H. A.; Jackson, M. W.			Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B	ONCOGENE			English	Article						FAM83B; EGFR; PLD1; MAPK; mTOR; HMEC transformation	HUMAN BREAST-CANCER; PHOSPHATIDIC-ACID; CELLS; TRANSFORMATION; ACTIVATION; KINASE; SURVIVAL; RAS; RESISTANCE; NUTLIN-3	Despite the progress made in targeted anticancer therapies in recent years, challenges remain. The identification of new potential targets will ensure that the arsenal of cancer therapies continues to expand. FAM83B was recently discovered in a forward genetic screen for novel oncogenes that drive human mammary epithelial cell (HMEC) transformation. We report here that elevated FAM83B expression increases Phospholipase D (PLD) activity, and that suppression of PLD1 activity prevents FAM83B-mediated transformation. The increased PLD activity is engaged by hyperactivation of epidermal growth factor receptor (EGFR), which is regulated by an interaction involving FAM83B and EGFR. Preventing the FAM83B/EGFR interaction by site-directed mutation of lysine 230 of FAM83B suppressed PLD activity and MAPK signaling. Furthermore, ablation of FAM83B expression from breast cancer cells inhibited EGFR phosphorylation and suppressed cell proliferation. We propose that understanding the mechanism of FAM83B-mediated transformation will provide a foundation for future therapies aimed at targeting its function as an intermediary in EGFR, MAPK and mTOR activation.	[Cipriano, R.; Bryson, B. L.; Miskimen, K. L. S.; Bartel, C. A.; Hernandez-Sanchez, W.; Jackson, M. W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Bruntz, R. C.; Scott, S. A.; Brown, H. A.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Vanderbilt Inst Chem Biol,Vanderbilt Ingram Canc, Nashville, TN 37232 USA; [Lindsley, C. W.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA; [Lindsley, C. W.] Vanderbilt Univ, Med Ctr, Dept Chem, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN USA; [Brown, H. A.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Chem Biol, Vanderbilt Ingram Canc Ctr,Dept Chem, Nashville, TN USA; [Brown, H. A.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Chem Biol, Vanderbilt Ingram Canc Ctr,Dept Biochem, Nashville, TN USA; [Jackson, M. W.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Case Western Reserve University	Jackson, MW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Case Comprehens Canc Ctr, 2103 Cornell Rd,WRB 3-134, Cleveland, OH 44106 USA.	mark.w.jackson@case.edu	Bryson, Benjamin L/D-1070-2014	Bryson, Benjamin L/0000-0003-4131-0200; Hernandez-Sanchez, Wilnelly/0000-0003-0723-9738	US National Institutes of Health [R01CA138421, T32CA059366]; Department of Defense Breast Cancer Research Program [BC095847, BC074072]; American Cancer Society [RSG-10-072-01-TBG]; McDonnell Foundation; NIH MLPCN Vanderbilt Specialized Chemistry Center [U54 MH084659]; NATIONAL CANCER INSTITUTE [T32CA059366, P30CA043703, R01CA138421, T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, T32GM007628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084659] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); American Cancer Society(American Cancer Society); McDonnell Foundation; NIH MLPCN Vanderbilt Specialized Chemistry Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Chase Foy for technical help and Damian Junk for helpful discussions. The core facilities provided by the Case Comprehensive Cancer Center (P30 CA43703; Athymic Animal and Xenograft Core Facility; Gene Expression and Genotyping Core Facility; Cytometry and Imaging Microscopy Core Facility; Radiation Resources Core Facility). This work was supported by the US National Institutes of Health (R01CA138421 to MWJ; T32CA059366 to RC and CB), the Department of Defense Breast Cancer Research Program (BC095847 and BC074072 to MWJ), the American Cancer Society (RSG-10-072-01-TBG to MWJ) and the McDonnell Foundation for brain cancer research (HAB) and the NIH MLPCN U54 MH084659 (CWL) Vanderbilt Specialized Chemistry Center for Accelerated Probe Development.	Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carraway H, 2004, BREAST CANCER RES, V6, P219, DOI 10.1186/bcr927; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Cipriano R, 2013, ONCOTARGET, V4, P729, DOI 10.18632/oncotarget.1027; Cipriano R, 2012, J CLIN INVEST, V122, P3197, DOI 10.1172/JCI60517; Cipriano R, 2010, CELL CYCLE, V9, P1373, DOI 10.4161/cc.9.7.11193; Foster D., 2006, CURRENT SIGNAL TRANS; Foster DA, 2003, MOL CANCER RES, V1, P789; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Ghosh S, 1997, BIOCHEM SOC T, V25, P561, DOI 10.1042/bst0250561; Grant S, 2008, J CLIN INVEST, V118, P3003, DOI 10.1172/JCI36898; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Jackson MW, 2004, ONCOGENE, V23, P4477, DOI 10.1038/sj.onc.1207575; Joseph T, 2001, BIOCHEM BIOPH RES CO, V289, P1019, DOI 10.1006/bbrc.2001.6118; Kan CE, 2007, CANCER RES, V67, P9862, DOI 10.1158/0008-5472.CAN-07-0259; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Ladeda V, 2001, BIOCHEM BIOPH RES CO, V283, P854, DOI 10.1006/bbrc.2001.4845; Lee SY, 2012, J CLIN INVEST, V122, P3211, DOI 10.1172/JCI60498; Noh DY, 2000, CANCER LETT, V161, P207, DOI 10.1016/S0304-3835(00)00612-1; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; REICH R, 1995, CLIN EXP METASTAS, V13, P134, DOI 10.1007/BF00133618; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Uchida H, 1999, ANTICANCER RES, V19, P671; Uchida N, 1997, J CANCER RES CLIN, V123, P280, DOI 10.1007/s004320050060; Williger BT, 1999, J BIOL CHEM, V274, P735, DOI 10.1074/jbc.274.2.735; Xie Z, 1998, J BIOL CHEM, V273, P34679, DOI 10.1074/jbc.273.52.34679	39	25	27	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 19	2014	33	25					3298	3306		10.1038/onc.2013.293	http://dx.doi.org/10.1038/onc.2013.293			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK5DA	23912460	Green Accepted			2022-12-25	WOS:000338443400009
J	Vannier, C; Pesty, A; San-Roman, MJ; Schmidt, AA				Vannier, Christian; Pesty, Arlette; San-Roman, Mabel Jouve; Schmidt, Anne A.			The Bin/Amphiphysin/Rvs (BAR) Domain Protein Endophilin B2 Interacts with Plectin and Controls Perinuclear Cytoskeletal Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; MEMBRANE CURVATURE; INTERMEDIATE-FILAMENTS; AMPHIPATHIC HELICES; STRUCTURAL BASIS; SH3 DOMAIN; REGULATES AUTOPHAGY; NUCLEAR-ENVELOPE; FISSION; RECRUITMENT	Proteins of the Bin/amphiphysin/Rvs (BAR) domain superfamily are essential in controlling the shape and dynamics of intracellular membranes. Here, we present evidence for the unconventional function of a member of the endophilin family of BAR and Src homology 3 domain-containing proteins, namely endophilin B2, in the perinuclear organization of intermediate filaments. Using mass spectrometry analysis based on capturing endophilin B2 partners in in situ pre-established complexes in cells, we unravel the interaction of endophilin B2 with plectin 1, a variant of the cytoskeleton linker protein plectin as well as with vimentin. Endophilin B2 directly binds the N-terminal region of plectin 1 via Src homology 3-mediated interaction and vimentin indirectly via plectin-mediated interaction. The relevance of these interactions is strengthened by the selective and drastic reorganization of vimentin around nuclei upon overexpression of endophilin B2 and by the extensive colocalization of both proteins in a meshwork of perinuclear filamentous structures. By generating mutants of the endophilin B2 BAR domain, we show that this phenotype requires the BAR-mediated membrane binding activity of endophilin B2. Plectin 1 or endophilin B2 knockdown using RNA interference disturbed the perinuclear organization of vimentin. Altogether, these data suggest that the endophilin B2-plectin 1 complex functions as a membrane-anchoring device organizing and stabilizing the perinuclear network of vimentin filaments. Finally, we present evidence for the involvement of endophilin B2 and plectin 1 in nuclear positioning in individual cells. This points to the potential importance of the endophilin B2-plectin complex in the biological functions depending on nuclear migration and positioning.	[Vannier, Christian; Pesty, Arlette; San-Roman, Mabel Jouve; Schmidt, Anne A.] Univ Paris Diderot, Inst Jacques Monod, Sorbonne Paris Cite, CNRS,UMR7592, F-75205 Paris 13, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Schmidt, AA (corresponding author), Univ Paris Diderot, Inst Jacques Monod, Sorbonne Paris Cite, CNRS,UMR7592, 15 Rue Helene Brion, F-75205 Paris 13, France.	schmidt.anne@ijm.univ-paris-diderot.fr		Schmidt, Anne/0000-0002-8326-0937; Jouve San Roman, Mabel Juana/0000-0002-3115-4681	CNRS; La Ligue National Contre le Cancer, Comite de Paris	CNRS(Centre National de la Recherche Scientifique (CNRS)); La Ligue National Contre le Cancer, Comite de Paris	This work was supported by CNRS and by a grant from La Ligue National Contre le Cancer, Comite de Paris.	Abrahamsberg C, 2005, P NATL ACAD SCI USA, V102, P18449, DOI 10.1073/pnas.0505380102; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Burgstaller G, 2010, MOL BIOL CELL, V21, P3362, DOI 10.1091/mbc.E10-02-0094; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Dupin I, 2011, INT J BIOCHEM CELL B, V43, P1698, DOI 10.1016/j.biocel.2011.09.004; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Gortat A, 2012, J BIOL CHEM, V287, P4232, DOI 10.1074/jbc.M111.325837; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hijikata T, 2008, J CELL SCI, V121, P2062, DOI 10.1242/jcs.021634; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Kabeche R, 2011, MOL BIOL CELL, V22, P4059, DOI 10.1091/mbc.E11-07-0605; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karotki L, 2011, J CELL BIOL, V195, P889, DOI 10.1083/jcb.201104040; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Kirmse R, 2010, METHOD CELL BIOL, V96, P565, DOI 10.1016/S0091-679X(10)96023-8; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Loll PJ, 2008, ACTA CRYSTALLOGR F, V64, P243, DOI 10.1107/S1744309108007574; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Masuda M, 2010, SEMIN CELL DEV BIOL, V21, P391, DOI 10.1016/j.semcdb.2010.01.010; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Morgan JT, 2011, MOL BIOL CELL, V22, P4324, DOI 10.1091/mbc.E11-04-0287; Niwa T, 2009, CANCER SCI, V100, P2115, DOI 10.1111/j.1349-7006.2009.01282.x; Olivera-Couto A, 2011, MOL BIOL CELL, V22, P2360, DOI 10.1091/mbc.E10-12-1021; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Postel R, 2011, J CELL SCI, V124, P755, DOI 10.1242/jcs.081174; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Ralser M, 2005, HUM MOL GENET, V14, P2893, DOI 10.1093/hmg/ddi321; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rezniczek GA, 2004, METHOD CELL BIOL, V78, P721; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rostovtseva TK, 2009, J BIOL CHEM, V284, P34390, DOI 10.1074/jbc.M109.021873; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Suetsugu S, 2012, TRENDS CELL BIOL, V22, P141, DOI 10.1016/j.tcb.2012.01.001; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Takahashi Y, 2011, AUTOPHAGY, V7, P61, DOI 10.4161/auto.7.1.14015; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Valencia RG, 2013, MOL BIOL CELL, V24, P768, DOI 10.1091/mbc.E12-06-0488; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; VIKSTROM KL, 1992, J CELL BIOL, V118, P121, DOI 10.1083/jcb.118.1.121; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wiche Gerhard, 2011, Bioarchitecture, V1, P14; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	75	11	11	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27619	27637		10.1074/jbc.M113.485482	http://dx.doi.org/10.1074/jbc.M113.485482			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921385	hybrid, Green Published			2022-12-25	WOS:000330597300056
J	Wendel, AA; Cooper, DE; Ilkayeva, OR; Muoio, DM; Coleman, RA				Wendel, Angela A.; Cooper, Daniel E.; Ilkayeva, Olga R.; Muoio, Deborah M.; Coleman, Rosalind A.			Glycerol-3-phosphate Acyltransferase (GPAT)-1, but Not GPAT4, Incorporates Newly Synthesized Fatty Acids into Triacylglycerol and Diminishes Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; INSULIN-RESISTANCE; SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; DEFICIENT MICE; PURIFICATION; METABOLISM; EXPRESSION; IDENTIFICATION; GLYCEROL; ENZYMES	Four glycerol-3-phosphate acyltransferase (GPAT) isoforms, each encoded by a separate gene, catalyze the initial step in glycerolipid synthesis; in liver, the major isoforms are GPAT1 and GPAT4. To determine whether each of these hepatic isoforms performs a unique function in the metabolism of fatty acid, we measured the incorporation of de novo synthesized fatty acid or exogenous fatty acid into complex lipids in primary mouse hepatocytes from control, Gpat1(-/-), and Gpat4(-/-) mice. Although hepatocytes from each genotype incorporated a similar amount of exogenous fatty acid into triacylglycerol (TAG), only control and Gpat4(-/-) hepatocytes were able to incorporate de novo synthesized fatty acid into TAG. When compared with controls, Gpat1(-/-) hepatocytes oxidized twice as much exogenous fatty acid. To confirm these findings and to assess hepatic beta-oxidation metabolites, we measured acylcarnitines in liver from mice after a 24-h fast and after a 24-h fast followed by 48 h of refeeding with a high sucrose diet to promote lipogenesis. Confirming the in vitro findings, the hepatic content of long-chain acylcarnitine in fasted Gpat1(-/-) mice was 3-fold higher than in controls. When compared with control and Gpat4(-/-) mice, after the fasting-refeeding protocol, Gpat1(-/-) hepatic TAG was depleted, and long-chain acylcarnitine content was 3.5-fold higher. Taken together, these data demonstrate that GPAT1, but not GPAT4, is required to incorporate de novo synthesized fatty acids into TAG and to divert them away from oxidation.	[Wendel, Angela A.; Cooper, Daniel E.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Ilkayeva, Olga R.; Muoio, Deborah M.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Ilkayeva, Olga R.; Muoio, Deborah M.] Duke Univ, Dept Med & Pharmacol, Durham, NC 27704 USA; [Ilkayeva, Olga R.; Muoio, Deborah M.] Duke Univ, Dept Canc Biol, Durham, NC 27704 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University	Coleman, RA (corresponding author), Univ N Carolina, Dept Nutr, CB 7461, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Muoio, Debbie Marie/E-1147-2012	Muoio, Deborah/0000-0003-3760-9277	National Institutes of Health [DK56598, DK089312, DK083157, T32HD057824]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089312, F32DK083157, R01DK056598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56598 (to R.A.C.), DK089312 (to D.M.M.), DK083157 (to A.A.W.), and T32HD057824 (to D.E.C.).	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; BREMER J, 1976, MOL CELL BIOCHEM, V12, P113, DOI 10.1007/BF01731557; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Hammond LE, 2002, MOL CELL BIOL, V22, P8204, DOI 10.1128/MCB.22.23.8204-8214.2002; Hammond LE, 2007, EXP MOL PATHOL, V82, P210, DOI 10.1016/j.yexmp.2006.12.004; Harada N, 2007, MOL CELL BIOCHEM, V297, P41, DOI 10.1007/s11010-006-9321-5; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; KELKER HC, 1979, J BIOL CHEM, V254, P5364; Lewin TM, 2008, BBA-MOL CELL BIOL L, V1781, P352, DOI 10.1016/j.bbalip.2008.05.001; Lu BA, 2010, J LIPID RES, V51, P3207, DOI 10.1194/jlr.M007054; McDevitt RM, 2001, AM J CLIN NUTR, V74, P737; MONROY G, 1973, J BIOL CHEM, V248, P2845; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Parks EJ, 2008, J NUTR, V138, P1039, DOI 10.1093/jn/138.6.1039; Pellon-Malson M, 2007, BBA-MOL CELL BIOL L, V1771, P830, DOI 10.1016/j.bbalip.2007.04.001; Qi JS, 2012, J LIPID RES, V53, P1106, DOI 10.1194/jlr.M020156; Timlin MT, 2005, DIABETES, V54, P2694, DOI 10.2337/diabetes.54.9.2694; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; Wendel AA, 2010, DIABETES, V59, P1321, DOI 10.2337/db09-1380; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; YET SF, 1995, BIOCHEMISTRY-US, V34, P7303, DOI 10.1021/bi00022a003; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109	31	62	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27299	27306		10.1074/jbc.M113.485219	http://dx.doi.org/10.1074/jbc.M113.485219			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908354	Green Published, hybrid			2022-12-25	WOS:000330597300026
J	Tominari, S; Nakakura, T; Yasuo, T; Yamanaka, K; Takahashi, Y; Shirasaka, T; Nakayama, T				Tominari, Shinjiro; Nakakura, Takahiro; Yasuo, Toshihiko; Yamanaka, Kyoko; Takahashi, Yoshimitsu; Shirasaka, Takuma; Nakayama, Takeo			Implementation of Mental Health Service Has an Impact on Retention in HIV Care: A Nested Case-Control Study in a Japanese HIV Care Facility	PLOS ONE			English	Article							CD4 CELL COUNTS; CASE-MANAGEMENT; MEDICAL-CARE; STRESS-MANAGEMENT; INFECTED PATIENTS; FOLLOW-UP; MORTALITY; INTERVENTIONS; ASSOCIATIONS; OUTPATIENT	Background: Poor retention in the care of patients with human immunodeficiency virus (HIV) is associated with adverse patient outcomes such as antiretroviral therapy failure and death. Therefore, appropriate case management is required for better patient retention; however, which intervention in case management is important has not been fully investigated. Meanwhile, in Japan, each local government is required to organize mental health services for patients with HIV so that a case manager at an HIV care facility can utilize them, but little is known about the association between implementation of the services and loss to follow-up. Therefore, we investigated that by a nested case-control study. Methods: The target population consisted of all patients with HIV who visited Osaka National Hospital, the largest HIV care facility in western Japan, between 2000 and 2010. Loss to follow-up was defined as not returning for follow-up care more than 1 year after the last visit. Independent variables included patient demographics, characteristics of the disease and treatment, and whether the patients have received mental health services. For each case, three controls were randomly selected and matched. Results: Of the 1620 eligible patients, 88 loss to follow-up cases were identified and 264 controls were matched. Multivariate-adjusted conditional logistic regression revealed that loss to follow-up was less frequent among patients who had received mental health services implemented by their case managers (adjusted odds ratio [95% confidence interval] 0.35 [0.16-0.76]). Loss to follow-up also occurred more frequently in patients who did not receive antiretroviral therapy (adjusted odds ratio [95% confidence interval], 7.51 [3.34-16.9]), who were under 30 years old (2.74 [1.36-5.50]), or who were without jobs (3.38 [1.58-7.23]). Conclusion: Mental health service implementation by case managers has a significant impact on patient retention.	[Tominari, Shinjiro; Takahashi, Yoshimitsu; Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Nakakura, Takahiro; Yasuo, Toshihiko] Osaka Natl Hosp, Natl Hosp Org, Dept Clin Psychol, Osaka, Japan; [Yamanaka, Kyoko] Osaka Prefecture Univ, Sch Humanities & Social Sci, Dept Social Welf, Osaka, Japan; [Shirasaka, Takuma] Osaka Natl Hosp, Natl Hosp Org, AIDS Med Ctr, Osaka, Japan	Kyoto University; Osaka National Hospital; Osaka Metropolitan University; Osaka National Hospital	Tominari, S (corresponding author), Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan.	tominari-s@umin.ac.jp	NAKAYAMA, Takeo/HCH-0537-2022; Takahashi, Yoshimitsu/J-4664-2016; TAKAHASHI, Yoshimitsu/GZB-2656-2022	Takahashi, Yoshimitsu/0000-0003-4073-9945; Nakayama, Takeo/0000-0002-7918-6252	Ministry of Health, Labor and Welfare in Japan	Ministry of Health, Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	Work was supported by grants from the Ministry of Health, Labor and Welfare in Japan and budgets for research of the department of health informatics, Kyoto University School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman JJ, 2002, AIDS CARE, V14, pS109, DOI [10.1080/09540120220149993, 10.1080/09540120220149993a]; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Berger S, 2008, AIDS, V22, P767, DOI 10.1097/QAD.0b013e3282f511dc; Blashill Aaron J, 2011, Curr HIV/AIDS Rep, V8, P215, DOI 10.1007/s11904-011-0089-1; Cunningham WE, 2008, J NATL MED ASSOC, V100, P840, DOI 10.1016/S0027-9684(15)31379-1; Fleishman JA, 2008, HEALTH SERV RES, V43, P76, DOI 10.1111/j.1475-6773.2007.00750.x; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Giordano TP, 2005, AIDS CARE, V17, P773, DOI 10.1080/09540120412331336652; Hessol NA, 2009, J WOMENS HEALTH, V18, P1627, DOI 10.1089/jwh.2008.1337; Higa DH, 2012, CURR HIV-AIDS REP, V9, P313, DOI 10.1007/s11904-012-0136-6; *JAP FDN AIDS PREV, 2011, AIDS INC YEARL REP; Ko NY, 2012, INT J NURS STUD, V49, P656, DOI 10.1016/j.ijnurstu.2012.01.004; Krishnan S, 2011, HIV CLIN TRIALS, V12, P190, DOI [10.1310/HCT1204-190, 10.1310/hct1204-190]; Li L, 2010, AM J PUBLIC HEALTH, V100, P2418, DOI 10.2105/AJPH.2009.185462; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Ndiaye B, 2009, AIDS, V23, P1786, DOI 10.1097/QAD.0b013e32832e3469; Ndiaye B, 2009, ANTIVIR THER, V14, P567; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Robison LS, 2008, AIDS RES HUM RETROV, V24, P1347, DOI 10.1089/aid.2008.0083; Sayles JN, 2009, J GEN INTERN MED, V24, P1101, DOI 10.1007/s11606-009-1068-8; Scott-Sheldon LAJ, 2008, HEALTH PSYCHOL, V27, P129, DOI 10.1037/0278-6133.27.2.129; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Tobias CR, 2007, AIDS PATIENT CARE ST, V21, P426, DOI 10.1089/apc.2006.0138; Tripathi A, 2011, AIDS RES HUM RETROV, V27, P751, DOI [10.1089/aid.2010.0268, 10.1089/AID.2010.0268]; Wilson MG, 2013, AIDS BEHAV, V17, P1612, DOI 10.1007/s10461-012-0283-1; Zhang Y, 2012, JAIDS-J ACQ IMM DEF, V60, P59, DOI 10.1097/QAI.0b013e31824c3d9f	27	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69603	10.1371/journal.pone.0069603	http://dx.doi.org/10.1371/journal.pone.0069603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204MP	23922753	Green Submitted, Green Published, gold			2022-12-25	WOS:000323369700054
J	Bakir, MS; Gruschke, F; Taylor, WR; Haberl, EJ; Sharankou, I; Perka, C; Funk, JF				Bakir, Mustafa Sinan; Gruschke, Franziska; Taylor, William R.; Haberl, Ernst Johannes; Sharankou, Ilya; Perka, Carsten; Funk, Julia F.			Temporal but Not Spatial Variability during Gait Is Reduced after Selective Dorsal Rhizotomy in Children with Cerebral Palsy	PLOS ONE			English	Article							PARKINSONS-DISEASE; MOTOR FUNCTION; FOLLOW-UP; PERFORMANCE; METAANALYSIS; RELIABILITY; PLASTICITY; SPASTICITY; STABILITY; ABILITIES	Introduction: Variability in task output is a ubiquitous characteristic that results from non-continuous motor neuron firing during muscular force generation. However, variability can also be attributed to errors in control and coordination of the motor neurons themselves in diseases such as cerebral palsy (CP). Selective dorsal rhizotomy (SDR), a neurosurgical approach to sever sensory nerve roots, is thought to decrease redundant or excessive afferent signalling to intramedullary neurons. In addition to its demonstrated ability to reduce muscular spasticity, we hypothesised that SDR is able to decrease variability during gait, the most frequent functional motor activity of daily living. Methods: Twelve CP children (aged 6.1 +/- 1.3yrs), who underwent SDR and performed gait analysis pre- and 12 months postoperatively, were compared to a control group of eleven typically developing (TD) children. Coefficients of variability as well as mean values were analysed for: temporal variables of gait, spatial parameters and velocity. Results: Gait parameters of cadence (p = 0.006) and foot progression angle at mid-stance (p = 0.041) changed significantly from pre- to post-SDR. The variability of every temporal parameter was significantly reduced after SDR (p = 0.003-0.049), while it remained generally unchanged for the spatial parameters. Only a small change in gait velocity was observed, but variability in cadence was significantly reduced after SDR (p = 0.015). Almost all parameters changed with a tendency towards normal, but differences between TD and CP children remained in all parameters. Discussion: The results confirm that SDR improves functional gait performance in children with CP. However, almost exclusively, parameters of temporal variability were significantly improved, leading to the conjecture that temporal variability and spatial variability may be governed independently by the motor cortex. As a result, temporal parameters of task performance may be more vulnerable to disruption, but also more responsive to treatment success of interventions such as SDR.	[Bakir, Mustafa Sinan; Gruschke, Franziska; Perka, Carsten; Funk, Julia F.] Charite, Dept Orthopaed, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Bakir, Mustafa Sinan; Gruschke, Franziska; Taylor, William R.; Sharankou, Ilya; Funk, Julia F.] Charite, Ctr Sports Sci & Sports Med Berlin, Julius Wolff Inst, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Taylor, William R.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Haberl, Ernst Johannes] Charite, Dept Paediat Neurosurg, D-13353 Berlin, Germany; [Funk, Julia F.] Charite, Social Paediat Ctr, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Funk, JF (corresponding author), Charite, Dept Orthopaed, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany.	julia.funk@charite.de	Taylor, William R./F-8692-2010; Perka, Carsten/ABG-6505-2021	Taylor, William R./0000-0003-4060-4098; Bakir, Sinan/0000-0002-2448-2150; Perka, Carsten/0000-0002-0993-581X				Abel MF, 2005, J NEUROSURG, V102, P157, DOI 10.3171/jns.2005.102.2.0157; Abel MF, 1996, J PEDIATR ORTHOPED, V16, P753, DOI 10.1097/01241398-199611000-00010; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bruijn SM, 2009, J BIOMECH, V42, P1506, DOI 10.1016/j.jbiomech.2009.03.047; Bruijn SM, 2009, J NEUROSCI METH, V178, P327, DOI 10.1016/j.jneumeth.2008.12.015; Chan SHS, 2008, PEDIATR NEUROL, V39, P22, DOI 10.1016/j.pediatrneurol.2008.03.017; CRAFT S, 1995, PEDIATR NEUROSURG, V23, P68, DOI 10.1159/000120939; Descatoire A., 2009, Annals of Physical and Rehabilitation Medicine, V52, P319, DOI 10.1016/j.rehab.2009.02.004; Engsberg JR, 2006, J NEUROSURG, V105, P8, DOI 10.3171/ped.2006.105.1.8; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011; Farmer JP, 2007, CHILD NERV SYST, V23, P991, DOI 10.1007/s00381-007-0398-2; Gage JR., 2009, IDENTIFICATION TREAT; Galna B, 2013, GAIT POSTURE, V37, P580, DOI 10.1016/j.gaitpost.2012.09.025; Granata KP, 2007, GAIT POSTURE, V26, P329, DOI 10.1016/j.gaitpost.2007.02.002; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hausdorff JM, 2009, MOVEMENT DISORD, V24, P1688, DOI 10.1002/mds.22554; Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040, DOI 10.1152/jappl.1999.86.3.1040; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Hislop H.J., 2007, DANIELS WORTHINGHAMS; HOF AL, 1996, GAIT POSTURE, V4, P222; Johnson DC, 1997, J PEDIATR ORTHOPED, V17, P392, DOI 10.1097/00004694-199705000-00022; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Josenby AL, 2012, DEV MED CHILD NEUROL, V54, P429, DOI 10.1111/j.1469-8749.2012.04258.x; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; Kegelmeyer DA, 2012, GAIT POSTURE; Kurz MJ, 2012, GAIT POSTURE, V36, P600, DOI 10.1016/j.gaitpost.2012.05.029; Kurz MJ, 2012, NEUROIMAGE, V59, P1602, DOI 10.1016/j.neuroimage.2011.08.084; McLaughlin J, 2002, DEV MED CHILD NEUROL, V44, P17, DOI 10.1017/S0012162201001608; MURRAY MP, 1964, J BONE JOINT SURG AM, V46, P335, DOI 10.2106/00004623-196446020-00009; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Oki A, 2010, J NEUROSURG-PEDIATR, V6, P353, DOI 10.3171/2010.7.PEDS09318; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Park Tae Sung, 2006, Neurosurg Focus, V21, pe7; Paul SM, 2007, DEV MED CHILD NEUROL, V49, P542, DOI 10.1111/j.1469-8749.2007.00542.x; PEACOCK WJ, 1991, J NEUROSURG, V74, P380, DOI 10.3171/jns.1991.74.3.0380; Plotnik M, 2009, J NEUROL NEUROSUR PS, V80, P347, DOI 10.1136/jnnp.2008.157362; Portney L., 1993, FDN CLIN RES APPL PR, V3rd; Prosser LA, 2010, GAIT POSTURE, V31, P522, DOI 10.1016/j.gaitpost.2010.03.001; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; Rosano C, 2007, NEUROEPIDEMIOLOGY, V29, P193, DOI 10.1159/000111582; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Russel DJ, 2002, CLIN DEV MED, V159; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Schwartz MH, 2004, J PEDIATR ORTHOPED, V24, P45, DOI 10.1097/01241398-200401000-00009; SINDOU M, 1989, NEUROSURGERY, V24, P655, DOI 10.1227/00006123-198905000-00002; Singh NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048449; Socie MJ, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/645197; Sosnoff JJ, 2006, NEUROSCI LETT, V392, P165, DOI 10.1016/j.neulet.2005.09.010; Suzuki M, 2008, NEUROIMAGE, V39, P600, DOI 10.1016/j.neuroimage.2007.08.044; Taylor WR, 2010, GAIT POSTURE, V32, P231, DOI 10.1016/j.gaitpost.2010.05.005; Thomas SS, 1996, J PEDIATR ORTHOPED, V16, P747, DOI 10.1097/01241398-199611000-00009; Thomas SS, 2004, J PEDIATR ORTHOP B, V13, P358, DOI 10.1097/01202412-200411000-00002; Trost JP, 2008, DEV MED CHILD NEUROL, V50, P765, DOI 10.1111/j.1469-8749.2008.03031.x; van Schie PEM, 2005, CHILD NERV SYST, V21, P451, DOI 10.1007/s00381-004-1105-1	57	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69500	10.1371/journal.pone.0069500	http://dx.doi.org/10.1371/journal.pone.0069500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922724	gold, Green Published, Green Submitted			2022-12-25	WOS:000322838900050
J	Iwaki, J; Kikuchi, K; Mizuguchi, Y; Kawahigashi, Y; Yoshida, H; Uchida, E; Takizawa, T				Iwaki, Jun; Kikuchi, Kunio; Mizuguchi, Yoshiaki; Kawahigashi, Yutaka; Yoshida, Hiroshi; Uchida, Eiji; Takizawa, Toshihiro			MiR-376c Down-Regulation Accelerates EGF-Dependent Migration by Targeting GRB2 in the HuCCT1 Human Intrahepatic Cholangiocarcinoma Cell Line	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HISTONE DEACETYLASE INHIBITION; ACUTE MYELOID-LEUKEMIA; MMP9 EXPRESSION; MICRORNAS; CANCER; PATHWAY; DOMAIN; RAS; INTERNALIZATION	MicroRNA miR-376c was expressed in normal intrahepatic biliary epithelial cells (HIBEpiC), but was significantly suppressed in the HuCCT1 intrahepatic cholangiocarcinoma (ICC) cell line. The biological significance of the down-regulation of miR-376c in HuCCT1 cells is unknown. We hypothesized that miR-376c could function as a tumor suppressor in these cells. To test this hypothesis, we sought the targets of miR-376c, and characterized the effect of its down-regulation on HuCCT1 cells. We performed proteomic analysis of miR-376c-overexpressing HuCCT1 cells to identify candidate targets of miR-376c, and validated these targets by 3'-UTR reporter assay. Transwell migration assays were performed to study the migratory response of HuCCT1 cells to miR-376c overexpression. Furthermore, microarrays were used to identify the signaling that were potentially involved in the miR-376c-modulated migration of HuCCT1. Finally, we assessed epigenetic changes within the potential promoter region of the miR-376c gene in these cells. Proteomic analysis and subsequent validation assays showed that growth factor receptor-bound protein 2 (GRB2) was a direct target of miR-376c. The transwell migration assay revealed that miR-376c significantly reduced epidermal growth factor (EGF)-dependent cell migration in HuCCT1 cells. DNA microarray and subsequent pathway analysis showed that interleukin 1 beta and matrix metallopeptidase 9 were possible participants in EGF-dependent migration of HuCCT1 cells. Bisulfite sequencing showed higher methylation levels of CpG sites upstream of the miR-376c gene in HuCCT1 relative to HIBEpiC cells. Combined treatment with the DNA-demethylating agent 5-aza-2'-deoxycytidine and the histone deacetylase inhibitor trichostatin A significantly upregulated the expression of miR-376c in HuCCT1 cells. We revealed that epigenetic repression of miR-376c accelerated EGF-dependent cell migration through its target GRB2 in HuCCT1 cells. These findings suggest that miR-376c functions as a tumor suppressor. Since metastasis is the major cause of death in ICC, microRNA manipulation could lead to the development of novel anti-cancer therapy strategies for ICC.	[Iwaki, Jun; Kikuchi, Kunio; Takizawa, Toshihiro] Nippon Med Sch, Dept Mol Med & Anat, Tokyo 113, Japan; [Mizuguchi, Yoshiaki; Kawahigashi, Yutaka; Yoshida, Hiroshi; Uchida, Eiji] Nippon Med Sch, Dept Surg Organ Funct & Biol Regulat, Tokyo 113, Japan	Nippon Medical School; Nippon Medical School	Takizawa, T (corresponding author), Nippon Med Sch, Dept Mol Med & Anat, 1-1-5 Sendagi, Tokyo 113, Japan.	t-takizawa@nms.ac.jp			Private University Strategic Research Foundation Support Program from the Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science, Japan; Grants-in-Aid for Scientific Research [23591908] Funding Source: KAKEN	Private University Strategic Research Foundation Support Program from the Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aids for Scientific Research and Private University Strategic Research Foundation Support Program from the Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY PP, 2002, PATHOLOGY LIVER, P711; Atabey N, 2001, J BIOL CHEM, V276, P14308, DOI 10.1074/jbc.M010202200; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; DALY RJ, 1994, ONCOGENE, V9, P2723; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Gay B, 1999, J BIOL CHEM, V274, P23311, DOI 10.1074/jbc.274.33.23311; Giehl K, 2000, ONCOGENE, V19, P2930, DOI 10.1038/sj.onc.1203612; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; Giubellino A, 2007, CANCER RES, V67, P6012, DOI 10.1158/0008-5472.CAN-07-0022; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kawahigashi Yutaka, 2009, Journal of Nippon Medical School, V76, P188; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Malhi H, 2006, J HEPATOL, V45, P856, DOI 10.1016/j.jhep.2006.09.001; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Nakanuma Y., 2010, WHO CLASSIFICATION T, P217; Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991; Patel T, 2006, NAT CLIN PRACT GASTR, V3, P33, DOI 10.1038/ncpgasthep0389; Qin WW, 2012, J ENDOCRINOL, V214, P145, DOI 10.1530/JOE-12-0147; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Shirabe K, 2002, SURGERY, V131, pS159, DOI 10.1067/msy.2002.119498; Sorkin A, 2001, BIOCHEM SOC T, V29, P480, DOI 10.1042/BST0290480; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Verbeek BS, 1997, J PATHOL, V183, P195; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yamazaki T, 2002, J CELL SCI, V115, P1791; Yang F, 2011, NEOPLASIA, V13, P590, DOI 10.1593/neo.11422; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Zhang JS, 2011, MOL BIOL CELL, V22, P2119, DOI 10.1091/mbc.E10-12-0969	54	46	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69496	10.1371/journal.pone.0069496	http://dx.doi.org/10.1371/journal.pone.0069496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922722	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900048
J	Tsai, YC; Lee, YM; Lam, KK; Lin, JF; Wang, JJ; Yen, MH; Cheng, PY				Tsai, Yung-Chieh; Lee, Yen-Mei; Lam, Kwok-Keung; Lin, Jui-Fen; Wang, Jhi-Joung; Yen, Mao-Hsiung; Cheng, Pao-Yun			The Role of Heat Shock Protein 70 in the Protective Effect of YC-1 on beta-Amyloid-Induced Toxicity in Differentiated PC12 Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ACTIVATED NEUTRAL PROTEINASE; SMOOTH-MUSCLE-CELLS; ALZHEIMERS-DISEASE; MOLECULAR CHAPERONES; TAU-PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; GUANYLATE-CYCLASE; PRECURSOR PROTEIN; IN-VITRO	Neurodegenerative brain disorders such as Alzheimer's disease (AD) have been well investigated. However, significant methods for the treatment of the progression of AD are unavailable currently. Heat shock protein 70 (Hsp70) plays important roles in neural protection from stress by assisting cellular protein folding. In this study, we investigated the effect and the molecular mechanism of YC-1, an activator of guanylyl cyclase (GC), on A beta(25-35)-induced cytotoxicity in differentiated PC12 cells. The results of this study showed that A beta(25-35) (10 mu M) significantly increased p25 protein production in a pattern that was consistent with the increase in mu-calpain expression. Moreover, A beta(25-35) significantly increased tau hyperphosphorylation and induced differentiated PC12 cell death. YC-1 (0.5-10 mu M) prevented the cell death induced by A beta(25-35). In addition, YC-1 (1, 10 mu M) significantly blocked A beta(25-35)-induced mu-calpain expression and decreased the formation of p25 and tau hyperphosphorylation. Moreover, YC-1 (5-20 mu M) alone or combined with A beta(25-35) (10 mu M) significantly increased the expression of Hsp70 in differentiated PC12 cells. The neuroprotective effect of YC-1 was significantly attenuated by an Hsp70 inhibitor (quercetin, 50 mu M) or in PC12 cells transfected with an Hsp70 small interfering RNA. However, pretreatment of cells with the GC inhibitor ODQ (10 mu M) did not affect the neuroprotective effect of YC-1 against A beta(25-35) in differentiated PC12 cells. These results suggest that the neuroprotective effect of YC-1 against A beta(25-35)-induced toxicity is mainly mediated by the induction of Hsp70. Thus, YC-1 is a potential agent against AD.	[Tsai, Yung-Chieh] Chi Mei Med Ctr, Dept Obstet & Gynecol, Tainan, Taiwan; [Tsai, Yung-Chieh] Taipei Med Univ, Dept Med, Taipei, Taiwan; [Tsai, Yung-Chieh] Chia Nan Univ Pharm & Sci, Dept Sport Management, Tainan, Taiwan; [Lee, Yen-Mei; Lin, Jui-Fen; Yen, Mao-Hsiung] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Lam, Kwok-Keung] Taipei Med Coll, Dept Pharmacol, Taipei, Taiwan; [Lam, Kwok-Keung] Catholic Mercy Hosp, Dept Anesthesiol, Hsinchu, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Cheng, Pao-Yun] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan	Chi Mei Hospital; Taipei Medical University; Chia Nan University of Pharmacy & Science; National Defense Medical Center; Taipei Medical University; Chi Mei Hospital; China Medical University Taiwan	Yen, MH (corresponding author), Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan.	mhyen@mail.ndmctsgh.edu.tw; pycheng@mail.cmu.edu.tw	Cheng, Pao-Yun/M-1372-2013; Tsai, Yung-Chieh/HGB-4660-2022	Lee, Yen Mei/0000-0002-5855-5346	National Science Council Taiwan [NSC 99-2320-B-039-006]	National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a research grant from the National Science Council (NSC 99-2320-B-039-006) Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Chen M, 2005, BIOCHEM BIOPH RES CO, V330, P714, DOI 10.1016/j.bbrc.2005.03.029; Cheng PY, 2006, FREE RADICAL BIO MED, V40, P1313, DOI 10.1016/j.freeradbiomed.2005.11.024; Di Rosa G, 2002, J MOL NEUROSCI, V19, P135, DOI 10.1007/s12031-002-0024-4; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Fifre A, 2006, J BIOL CHEM, V281, P229, DOI 10.1074/jbc.M507378200; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GREENBERG SM, 1995, NEUROSCI LETT, V198, P52, DOI 10.1016/0304-3940(95)11944-R; Heo HJ, 2000, MOL CELLS, V10, P253; IVERSEN LL, 1995, BIOCHEM J, V311, P1; KIRBY BA, 1994, J NEUROSCI, V14, P5687; KO FN, 1994, BLOOD, V84, P4226, DOI 10.1182/blood.V84.12.4226.bloodjournal84124226; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Leschik J, 2007, J NEUROCHEM, V101, P1303, DOI 10.1111/j.1471-4159.2006.04435.x; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; Liu YN, 2008, SHOCK, V30, P274, DOI 10.1097/shk.0b013e318162c63a; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Morgan C, 2004, PROG NEUROBIOL, V74, P323, DOI 10.1016/j.pneurobio.2004.10.004; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PEREZ N, 1991, MOL BRAIN RES, V11, P249, DOI 10.1016/0169-328X(91)90033-T; Rank KB, 2002, FEBS LETT, V514, P263, DOI 10.1016/S0014-5793(02)02376-1; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rapoport M, 2000, J NEUROCHEM, V74, P125, DOI 10.1046/j.1471-4159.2000.0740125.x; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; Tulis David Anthony, 2004, Curr Med Chem Cardiovasc Hematol Agents, V2, P343, DOI 10.2174/1568016043356200; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Zheng WH, 2002, NEUROSCIENCE, V115, P201, DOI 10.1016/S0306-4522(02)00404-9; Zhou XW, 2006, NEUROBIOL DIS, V22, P657, DOI 10.1016/j.nbd.2006.01.006	42	18	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69320	10.1371/journal.pone.0069320	http://dx.doi.org/10.1371/journal.pone.0069320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922702	gold, Green Published			2022-12-25	WOS:000322838900034
J	Aggarwal, KP; Tandon, S; Naik, PK; Singh, SK; Tandon, C				Aggarwal, Kanu Priya; Tandon, Simran; Naik, Pradeep Kumar; Singh, Shrawan Kumar; Tandon, Chanderdeep			Peeping into Human Renal Calcium Oxalate Stone Matrix: Characterization of Novel Proteins Involved in the Intricate Mechanism of Urolithiasis	PLOS ONE			English	Article							TAMM-HORSFALL GLYCOPROTEIN; UDP-GLUCOSE-GLYCOPROTEIN; ORGANIC MATRIX; CRYSTAL-BINDING; ACTIN-FILAMENT; RIBONUCLEASE B; ANNEXIN-II; KIDNEY; CELLS; OSTEOPONTIN	Background: The increasing number of patients suffering from urolithiasis represents one of the major challenges which nephrologists face worldwide today. For enhancing therapeutic outcomes of this disease, the pathogenic basis for the formation of renal stones is the need of hour. Proteins are found as major component in human renal stone matrix and are considered to have a potential role in crystal-membrane interaction, crystal growth and stone formation but their role in urolithiasis still remains obscure. Methods: Proteins were isolated from the matrix of human CaOx containing kidney stones. Proteins having MW>3 kDa were subjected to anion exchange chromatography followed by molecular-sieve chromatography. The effect of these purified proteins was tested against CaOx nucleation and growth and on oxalate injured Madin-Darby Canine Kidney (MDCK) renal epithelial cells for their activity. Proteins were identified by Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF MS) followed by database search with MASCOT server. In silico molecular interaction studies with CaOx crystals were also investigated. Results: Five proteins were identified from the matrix of calcium oxalate kidney stones by MALDI-TOF MS followed by database search with MASCOT server with the competence to control the stone formation process. Out of which two proteins were promoters, two were inhibitors and one protein had a dual activity of both inhibition and promotion towards CaOx nucleation and growth. Further molecular modelling calculations revealed the mode of interaction of these proteins with CaOx at the molecular level. Conclusions: We identified and characterized Ethanolamine-phosphate cytidylyltransferase, Ras GTPase-activating-like protein, UDP-glucose: glycoprotein glucosyltransferase 2, RIMS-binding protein 3A, Macrophage-capping protein as novel proteins from the matrix of human calcium oxalate stone which play a critical role in kidney stone formation. Thus, these proteins having potential to modulate calcium oxalate crystallization will throw light on understanding and controlling urolithiasis in humans.	[Aggarwal, Kanu Priya; Tandon, Simran; Naik, Pradeep Kumar; Tandon, Chanderdeep] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India; [Singh, Shrawan Kumar] Postgrad Inst Med Educ & Res, Dept Urol, Chandigarh 160012, India	Jaypee University of Information Technology; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Tandon, C (corresponding author), Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India.	chanderdeep.tandon@juit.ac.in	TANDON, simran/AAF-1158-2020; Tandon, Chanderdeep/AAF-1124-2020	Tandon, Chanderdeep/0000-0003-3720-0455; Tandon, Simran/0000-0002-6937-0216; Solan India, Jaypee University of Information Technology/0000-0002-4664-5002	Indian Council of Medical Research (ICMR); Jaypee University of Information Technology, Solan, H.P., India	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Jaypee University of Information Technology, Solan, H.P., India	The authors thank the Indian Council of Medical Research (ICMR) and Jaypee University of Information Technology, Solan, H.P., India for providing funds to carry out this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2010, INT BRAZ J UROL, V36, P480, DOI 10.1590/S1677-55382010000400011; Aggarwal KP, 2013, INT BRAZ J UROL, V39, P128, DOI 10.1590/S1677-5538.IBJU.2013.01.16; Aggarwal KP, 2013, CLIN CHIM ACTA, V415, P181, DOI 10.1016/j.cca.2012.10.040; Aggarwal S, 2000, MOL CELL BIOCHEM, V210, P109, DOI 10.1023/A:1007109120558; Arnold SM, 2000, BIOCHEMISTRY-US, V39, P2149, DOI 10.1021/bi9916473; ASOKAN D, 2004, NEPHRON PHYSIOL, V97, P23; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Bigelow MW, 1997, AM J PHYSIOL, V272, P55; Bladergroen BA, 1997, BBA-LIPID LIPID MET, V1348, P91, DOI 10.1016/S0005-2760(97)00113-6; BOYCE WH, 1968, AM J MED, V45, P673, DOI 10.1016/0002-9343(68)90203-9; BOYCE WH, 1956, J UROLOGY, V76, P213, DOI 10.1016/S0022-5347(17)66686-2; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Brill S, 1996, MOL CELL BIOL, V16, P4869; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; DABIRI GA, 1992, J BIOL CHEM, V267, P16545; DINUBILE MJ, 1995, MOL BIOL CELL, V6, P1659, DOI 10.1091/mbc.6.12.1659; DUSSOL B, 1995, UROL RES, V23, P45, DOI 10.1007/BF00298850; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Govindaraj A, 2002, BJU INT, V90, P336, DOI 10.1046/j.1464-410X.2002.02849.x; Grewal JS, 2005, BIOCHEM J, V387, P609, DOI 10.1042/BJ20041465; Gul A, 2007, UROL RES, V35, P63, DOI 10.1007/s00240-007-0087-3; Hajjar KA, 1998, J BIOL CHEM, V273, P9987, DOI 10.1074/jbc.273.16.9987; HAMMES MS, 1995, KIDNEY INT, V48, P501, DOI 10.1038/ki.1995.320; HENNEQUIN C, 1993, UROL RES, V21, P101, DOI 10.1007/BF01788827; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HESS B, 1992, UROL RES, V20, P83, DOI 10.1007/BF00294343; Houghton P, 2007, METHODS, V42, P377, DOI 10.1016/j.ymeth.2007.01.003; Huang HS, 2002, J UROLOGY, V167, P2584, DOI 10.1016/S0022-5347(05)65042-2; Jaggi M, 2007, UROL RES, V35, P55, DOI 10.1007/s00240-007-0083-7; Jeong BC, 2005, UROL RES, V33, P87, DOI 10.1007/s00240-004-0451-5; Karamustafa F., 2006, FABAD J PHARM SCI, V31, P1; Khan SR, 1997, UROL INT, V59, P59, DOI 10.1159/000283025; Khan SR, 1996, CALCIFIED TISSUE INT, V59, P357, DOI 10.1007/s002239900140; Khan SR, 2002, KIDNEY INT, V62, P2062, DOI 10.1046/j.1523-1755.2002.00676.x; KHAN SR, 1995, UROL RES, V23, P71, DOI 10.1007/BF00307936; KHAN SR, 1990, CALCIFIED TISSUE INT, V46, P116, DOI 10.1007/BF02556095; KOK DJ, 1994, KIDNEY INT, V46, P847, DOI 10.1038/ki.1994.341; Konya E, 2003, EUR UROL, V43, P564, DOI 10.1016/S0302-2838(03)00088-5; Koul H, 1996, KIDNEY INT, V50, P1525, DOI 10.1038/ki.1996.467; Kramer G, 2003, BJU INT, V91, P554, DOI 10.1046/j.1464-410X.2003.04139.x; Kumar V, 2003, J AM SOC NEPHROL, V14, P289, DOI 10.1097/01.ASN.0000046030.24938.0A; Lai Peter C., 2012, Frontiers in Genetics, V3, P61, DOI 10.3389/fgene.2012.00061; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Latha P, 2006, BIOCHEM BIOPH RES CO, V345, P345, DOI 10.1016/j.bbrc.2006.04.086; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Lieske JC, 1999, J AM SOC NEPHROL, V10, pS422; Lieske JC, 1996, AM J PHYSIOL-RENAL, V270, pF192, DOI 10.1152/ajprenal.1996.270.1.F192; LIESKE JC, 1995, AM J PHYSIOL-RENAL, V268, pF604, DOI 10.1152/ajprenal.1995.268.4.F604; LIESKE JC, 1992, AM J PHYSIOL, V262, pF622, DOI 10.1152/ajprenal.1992.262.4.F622; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moriyama MT, 2007, UROL RES, V35, P295, DOI 10.1007/s00240-007-0114-4; NAKAGAWA Y, 1985, J CLIN INVEST, V76, P1455, DOI 10.1172/JCI112124; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Pathak P, 2011, J BIOMED SCI ENG; Pathak P, 2010, INT BRAZ J UROL, V36, P621, DOI 10.1590/S1677-55382010000500013; Pellieux C, 2003, J BIOL CHEM, V278, P29136, DOI 10.1074/jbc.M300598200; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; RYALL RL, 1993, WORLD J UROL, V11, P59; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Selvam R, 1996, MOL CELL BIOCHEM, V156, P93, DOI 10.1007/BF00426330; Semangoen T, 2008, J PROTEOME RES, V7, P2889, DOI 10.1021/pr800113k; Sorokina EA, 2004, J AM SOC NEPHROL, V15, P2057, DOI 10.1097/01.ASN.0000133024.83256.C8; SPICER SS, 1992, J HISTOCHEM CYTOCHEM, V40, P1, DOI 10.1177/40.1.1370305; STEVENS FC, 1983, CAN J BIOCHEM CELL B, V61, P906, DOI 10.1139/o83-115; SUGIMOTO T, 1985, EUR UROL, V11, P334; Sumitra K, 2005, NEPHROL DIAL TRANSPL, V20, P1407, DOI 10.1093/ndt/gfh794; Tandon CD, 1998, J CELL BIOCHEM, V68, P287, DOI 10.1002/(SICI)1097-4644(19980301)68:3<287::AID-JCB1>3.0.CO;2-Q; Tessier DC, 2000, GLYCOBIOLOGY, V10, P403, DOI 10.1093/glycob/10.4.403; Tiselius HG, 1997, UROL RES, V25, P153, DOI 10.1007/BF01037933; Tsujihata M, 2000, J UROLOGY, V164, P1718, DOI 10.1016/S0022-5347(05)67095-4; Umekawa T, 2006, BJU INT, V98, P656, DOI 10.1111/j.1464-410X.2006.06334.x; Verhulst A, 2003, J AM SOC NEPHROL, V14, P107, DOI 10.1097/01.ASN.0000038686.17715.42; Verkoelen CF, 2000, KIDNEY INT, V58, P1045, DOI 10.1046/j.1523-1755.2000.00262.x; Verkoelen CF, 2000, KIDNEY INT, V57, P1072, DOI 10.1046/j.1523-1755.2000.00934.x; WARPEHOSKI MA, 1981, CALCIFIED TISSUE INT, V33, P211, DOI 10.1007/BF02409440; Weichhart T, 2005, WIEN KLIN WOCHENSCHR, V117, P316, DOI 10.1007/s00508-005-0353-8; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; YOUNG CL, 1994, J BIOL CHEM, V269, P13997; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5	84	13	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69916	10.1371/journal.pone.0069916	http://dx.doi.org/10.1371/journal.pone.0069916			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894559	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900100
J	Reitmaier, S; Schmidt, H; Ihler, R; Kocak, T; Graf, N; Ignatius, A; Wilke, HJ				Reitmaier, Sandra; Schmidt, Hendrik; Ihler, Renate; Kocak, Tugrul; Graf, Nicolas; Ignatius, Anita; Wilke, Hans-Joachim			Preliminary Investigations on Intradiscal Pressures during Daily Activities: An In Vivo Study Using the Merino Sheep	PLOS ONE			English	Article							OVINE INTERVERTEBRAL DISC; NUCLEUS PULPOSUS; MODEL; DEGENERATION; SPINE; PUNCTURE; INJURY; MOTION; CELLS; TEARS	Purpose: Currently, no studies exist, which attest the suitability of the ovine intervertebral disc as a biomechanical in vivo model for preclinical tests of new therapeutic strategies of the human disc. By measuring the intradiscal pressure in vivo, the current study attempts to characterize an essential biomechanical parameter to provide a more comprehensive physiological understanding of the ovine intervertebral disc. Methods: Intradiscal pressure (IDP) was measured for 24 hours within the discs L2-L3 and L4-L5 via a piezo-resistive pressure sensor in one merino sheep. The data were divided into an activity and a recovery phase and the corresponding average pressures for both phases were determined. Additionally, IDPs for different static and dynamic activities were analyzed and juxtaposed to human data published previously. After sacrificing the sheep, the forces corresponding to the measured IDPs were examined ex vivo in an axial compression test. Results: The temporal patterns of IDP where pressure decreased during activity and increased during rest were comparable between humans and sheep. However, large differences were observed for different dynamic activities such as standing up or walking. Here, IDPs averaged 3.73 MPa and 1.60 MPa respectively, approximately two to four times higher in the ovine disc compared to human. These IDPs correspond to lower ex vivo derived axial compressive forces for the ovine disc in comparison to the human disc. For activity and rest, average ovine forces were 130 N and 58 N, compared to human forces of 400-600 N and 100 N, respectively. Conclusions: In vivo IDPs were found to be higher in the ovine than in the human disc. In contrast, axial forces derived ex vivo were markedly lower in comparison to humans. Both should be considered in future preclinical tests of intradiscal therapies using the sheep. The techniques used in the current study may serve as a protocol for measuring IDP in a variety of large animal models.	[Reitmaier, Sandra; Schmidt, Hendrik; Ihler, Renate; Graf, Nicolas; Ignatius, Anita; Wilke, Hans-Joachim] Univ Ulm, Inst Orthoped Res & Biomech, Ctr Musculoskeletal Res, D-89069 Ulm, Germany; [Kocak, Tugrul] Univ Ulm, Dept Orthoped Surg, D-89069 Ulm, Germany	Ulm University; Ulm University	Reitmaier, S (corresponding author), Univ Ulm, Inst Orthoped Res & Biomech, Ctr Musculoskeletal Res, D-89069 Ulm, Germany.	sandra.reitmaier@uni-ulm.de	Ignatius, Anita/M-6012-2013; Wilke, Hans-Joachim/M-6440-2014	Ignatius, Anita/0000-0002-4782-1979; Wilke, Hans-Joachim/0000-0001-6007-8844; Schmidt, Hendrik/0000-0003-3300-8685	EU [NMP3-LA-2008-213904]	EU(European Commission)	This work was funded by the EU project Disc regeneration (NMP3-LA-2008-213904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; AHLGREN BD, 1994, SPINE, V19, P948, DOI 10.1097/00007632-199404150-00014; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Baramki HG, 2000, SURG RADIOL ANAT, V22, P25, DOI 10.1007/s00276-000-0025-3; Benz K, 2012, EUR SPINE J, V21, P1758, DOI 10.1007/s00586-012-2443-4; Buttermann GR, 2009, SPINE J, V9, P105, DOI 10.1016/j.spinee.2007.09.006; Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1; Fazzalari NL, 2001, SPINE, V26, P2575, DOI 10.1097/00007632-200112010-00010; Fernando HN, 2011, J ORTHOP RES, V29, P1634, DOI 10.1002/jor.21430; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Galbusera F, 2011, EUR SPINE J, V20, P563, DOI 10.1007/s00586-010-1586-4; Ghosh P, 2012, J NEUROSURG-SPINE, V16, P479, DOI 10.3171/2012.1.SPINE11852; Guder E, 2009, Z ORTHOP UNFALLCHIR, V147, P52, DOI 10.1055/s-2008-1039139; Hauerstock D, 2001, TRANSACTIONS OF THE; Haussler K K, 2001, Equine Vet J Suppl, P160; Hegewald AA, 2008, FRONT BIOSCI-LANDMRK, V13, P1507, DOI 10.2741/2777; Hsieh AH, 2009, SPINE, V34, P998, DOI 10.1097/BRS.0b013e31819c09c4; Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x; Ishihara H, 1996, J APPL PHYSIOL, V80, P839, DOI 10.1152/jappl.1996.80.3.839; Kiefer A, 1997, Eur Spine J, V6, P45, DOI 10.1007/BF01676574; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Ledet EH, 2009, SPINE, V34, P1457, DOI 10.1097/BRS.0b013e3181a48554; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Melrose J, 2012, SPINE, V37, P18, DOI 10.1097/BRS.0b013e31820cd8d5; Melrose J, 2009, EUR SPINE J, V18, P479, DOI 10.1007/s00586-008-0871-y; MOORE RJ, 1992, SPINE, V17, P874, DOI 10.1097/00007632-199208000-00003; Nachemson A, 1970, Scand J Rehabil Med Suppl, V1, P1; Neidlinger-Wilke C, 2006, EUR SPINE J, V15, pS372, DOI 10.1007/s00586-006-0112-1; OSTI OL, 1990, SPINE, V15, P762, DOI 10.1097/00007632-199008010-00005; Reid JE, 2002, CLIN BIOMECH, V17, P312, DOI 10.1016/S0268-0033(02)00009-8; Reitmaier S, 2012, J MECH BEHAV BIOMED; Reitmaier S, 2012, J R SOC INTERFACE, V9, P1869, DOI 10.1098/rsif.2012.0016; Rohlmann A, 2009, J BIOMECH, V42, P1520, DOI 10.1016/j.jbiomech.2009.03.048; Rozumalski A, 2008, GAIT POSTURE, V28, P378, DOI 10.1016/j.gaitpost.2008.05.005; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; Schmidt H, 2013, J MECH BEHAV BIOMED, V17, P229, DOI 10.1016/j.jmbbm.2012.09.010; Sebastine IM, 2007, P ANN INT IEEE EMBS, P6401; Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346; Team R. D. C, 2011, R LANG ENV STAT COMP; Wei A, 2009, INT J BIOL SCI, V5, P388; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wilke HJ, 2003, SPINE, V28, P2585, DOI 10.1097/01.BRS.0000096673.16363.C7; Wilke HJ, 1997, ANAT RECORD, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P; Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009; Wilke HJ, 2001, SPINE, V26, P636, DOI 10.1097/00007632-200103150-00014; Woiciechowsky C., 2012, J TISSUE ENG REGEN M	46	57	59	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69610	10.1371/journal.pone.0069610	http://dx.doi.org/10.1371/journal.pone.0069610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894509	Green Submitted, Green Published, gold			2022-12-25	WOS:000322167900082
J	Sakashita, T; Hamada, N; Kawaguchi, I; Ouchi, NB; Hara, T; Kobayashi, Y; Saito, K				Sakashita, Tetsuya; Hamada, Nobuyuki; Kawaguchi, Isao; Ouchi, Noriyuki B.; Hara, Takamitsu; Kobayashi, Yasuhiko; Saito, Kimiaki			A Framework for Analysis of Abortive Colony Size Distributions Using a Model of Branching Processes in Irradiated Normal Human Fibroblasts	PLOS ONE			English	Article							VIDEO TIME-LAPSE; GENOMIC INSTABILITY; CELLS; SURVIVAL; APOPTOSIS; DELAY	Background: Clonogenicity gives important information about the cellular reproductive potential following ionizing irradiation, but an abortive colony that fails to continue to grow remains poorly characterized. It was recently reported that the fraction of abortive colonies increases with increasing dose. Thus, we set out to investigate the production kinetics of abortive colonies using a model of branching processes. Methodology/Principal Findings: We firstly plotted the experimentally determined colony size distribution of abortive colonies in irradiated normal human fibroblasts, and found the linear relationship on the log-linear or log-log plot. By applying the simple model of branching processes to the linear relationship, we found the persistent reproductive cell death (RCD) over several generations following irradiation. To verify the estimated probability of RCD, abortive colony size distribution (<= 15 cells) and the surviving fraction were simulated by the Monte Carlo computational approach for colony expansion. Parameters estimated from the log-log fit demonstrated the good performance in both simulations than those from the log-linear fit. Radiation-induced RCD, i.e. excess probability, lasted over 16 generations and mainly consisted of two components in the early (<3 generations) and late phases. Intriguingly, the survival curve was sensitive to the excess probability over 5 generations, whereas abortive colony size distribution was robust against it. These results suggest that, whereas short-term RCD is critical to the abortive colony size distribution, long-lasting RCD is important for the dose response of the surviving fraction. Conclusions/Significance: Our present model provides a single framework for understanding the behavior of primary cell colonies in culture following irradiation.	[Sakashita, Tetsuya; Kobayashi, Yasuhiko] Japan Atom Energy Agcy, Microbeam Radiat Biol Grp, Gunma, Japan; [Hamada, Nobuyuki] CRIEPI, Nucl Technol Res Lab, Radiat Safety Res Ctr, Tokyo, Japan; [Kawaguchi, Isao] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Regulatory Sci Res Program, Chiba 260, Japan; [Ouchi, Noriyuki B.] JAEA, Radiat Effect Anal Grp, Ibaraki, Japan; [Hara, Takamitsu] Fukushima Med Univ, Fukushima Global Med Sci Ctr, Adv Clin Res Ctr, Fukushima, Japan; [Saito, Kimiaki] JAEA, Fukushima Environm Safety Ctr, Tokyo, Japan	Japan Atomic Energy Agency; Central Research Institute of Electric Power Industry - Japan; National Institutes for Quantum Science & Technology; Japan Atomic Energy Agency; Fukushima Medical University; Japan Atomic Energy Agency	Sakashita, T (corresponding author), Japan Atom Energy Agcy, Microbeam Radiat Biol Grp, Gunma, Japan.	sakashita.tetsuya@jaea.go.jp; hamada-n@criepi.denken.or.jp		Hamada, Nobuyuki/0000-0003-2518-6131				BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; Benbrahim-Tallaa L, 2009, ENVIRON HEALTH PERSP, V117, P1847, DOI 10.1289/ehp.0900999; CHANG WP, 1992, CARCINOGENESIS, V13, P923, DOI 10.1093/carcin/13.6.923; Chu K, 2004, RADIAT RES, V162, P270, DOI 10.1667/RR3221; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Corral A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066103; Dermody BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024635; ELKIND MM, 1960, RADIAT RES, V13, P556, DOI 10.2307/3570945; Endlich B, 2000, RADIAT RES, V153, P36, DOI 10.1667/0033-7587(2000)153[0036:CVTLMS]2.0.CO;2; Hamada N, 2011, CURR MOL PHARMACOL, V4, P126; Hamada N, 2008, MUTAT RES-FUND MOL M, V637, P190, DOI 10.1016/j.mrfmmm.2007.07.002; Hamada N, 2006, RADIAT RES, V166, P24, DOI 10.1667/RR3579.1; KIEFER J, 1971, J THEOR BIOL, V30, P307, DOI 10.1016/0022-5193(71)90057-9; Klein AM, 2010, P NATL ACAD SCI USA, V107, P270, DOI 10.1073/pnas.0909738107; Lorimore SA, 2003, ONCOGENE, V22, P7058, DOI 10.1038/sj.onc.1207044; MARDER BA, 1993, MOL CELL BIOL, V13, P6667, DOI 10.1128/MCB.13.11.6667; Maruvka YE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026480; Ojima M, 2011, RADIAT RES, V175, P90, DOI 10.1667/RR2223.1; Sasaki H, 2004, J RADIAT RES, V45, P497, DOI 10.1269/jrr.45.497; Sun W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006720; Suzuki K, 2010, MUTAT RES-FUND MOL M, V683, P29, DOI 10.1016/j.mrfmmm.2009.10.003	21	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70291	10.1371/journal.pone.0070291	http://dx.doi.org/10.1371/journal.pone.0070291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894635	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000202
J	Schram, AW; Baas, R; Jansen, PWTC; Riss, A; Tora, L; Vermeulen, M; Timmers, HTM				Schram, Andrea W.; Baas, Roy; Jansen, Pascal W. T. C.; Riss, Anne; Tora, Laszlo; Vermeulen, Michiel; Timmers, H. Th. Marc			A Dual Role for SAGA-Associated Factor 29 (SGF29) in ER Stress Survival by Coordination of Both Histone H3 Acetylation and Histone H3 Lysine-4 Trimethylation	PLOS ONE			English	Article							BOX-BINDING PROTEIN; STRUCTURAL INTEGRITY; CHROMATIN STATE; HAT COMPLEXES; PHD FINGER; RECRUITMENT; TRANSCRIPTION; METHYLATION; ATAC; ACETYLTRANSFERASE	The SGF29 protein binds to tri-methylated lysine-4 of histone H3 (H3K4me3), which is a histone modification associated with active promoters. Human SGF29 is a subunit of the histone acetyltransferase module of the SAGA (Spt-Ada-Gcn5 acetyltransferase) and ATAC (Ada-Two-A-containing 2A) co-activator complexes. Previous work revealed that the SAGA complex is recruited to endoplasmic reticulum (ER) stress target genes and required for their induction. Here, we report the involvement of SGF29 in the survival of human cells from ER stress. SGF29 knockdown results in impaired transcription of the ER stress genes GRP78 and CHOP. Besides histone H3K14 acetylation, we find that SGF29 is also required for the maintenance of H3K4me3 at these genes, which is already present prior to ER stress. Reduced levels of H3K4me3 in the absence of SGF29 correlate with a decreased association of ASH2L, which is a core component of the SET1/MLL complexes, to GFP78 and CHOP. In conclusion, our results suggest that the H3K4me3-binding protein SGF29 plays a central and dual role in the ER stress response. Prior to ER stress, the protein coordinates H3K4me3 levels, thereby maintaining a 'poised' chromatin state on ER stress target gene promoters. Following ER stress induction, SGF29 is required for increased H3K14 acetylation on these genes, which then results in full transcriptional activation, thereby promoting cell survival.	[Schram, Andrea W.; Baas, Roy; Jansen, Pascal W. T. C.; Vermeulen, Michiel; Timmers, H. Th. Marc] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands; [Riss, Anne; Tora, Laszlo] Univ Strasbourg, Inst Genet & Biol, Cellular Signaling & Nucl Dynam Program, Illkirch Graffenstaden, France	Utrecht University; Utrecht University Medical Center; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vermeulen, M (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands.	m.vermeulen-3@umcutrecht.nl; H.T.M.Timmers@umcutrecht.nl	Vermeulen, Michiel/C-8883-2013; Tora, Laszlo/E-9999-2018	Vermeulen, Michiel/0000-0003-0836-6894; Tora, Laszlo/0000-0001-7398-2250; Baas, Roy/0000-0002-3535-3565	Netherlands Organization for Scientific Research (NWO) through a TOP [700.57.302]; Netherlands Proteomics Centre	Netherlands Organization for Scientific Research (NWO) through a TOP(Netherlands Organization for Scientific Research (NWO)); Netherlands Proteomics Centre	This work was supported by the Netherlands Organization for Scientific Research (NWO) through a TOP grant (#700.57.302) to HTMT and by the Netherlands Proteomics Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; DORNER AJ, 1990, J BIOL CHEM, V265, P22029; Eberl HC, 2013, MOL CELL, V49, P368, DOI 10.1016/j.molcel.2012.10.026; Eissenberg JC, 2012, GENE, V496, P69, DOI 10.1016/j.gene.2012.01.003; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Nagy Z, 2010, CELL MOL LIFE SCI, V67, P611, DOI 10.1007/s00018-009-0199-8; Nagy Z, 2009, MOL CELL BIOL, V29, P1649, DOI 10.1128/MCB.01076-08; Raciti M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.167; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Samali Afshin, 2010, Int J Cell Biol, V2010, P830307, DOI 10.1155/2010/830307; Samara NL, 2011, CURR OPIN STRUC BIOL, V21, P767, DOI 10.1016/j.sbi.2011.09.004; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sela D, 2012, J BIOL CHEM, V287, P23035, DOI 10.1074/jbc.M112.369504; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shukla A, 2012, BIOCHEMISTRY-US, V51, P706, DOI 10.1021/bi201708z; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Takahashi YH, 2011, MOL CELL, V42, P118, DOI 10.1016/j.molcel.2011.03.006; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Varier RA, 2010, EMBO J, V29, P3967, DOI 10.1038/emboj.2010.261; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001	47	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70035	10.1371/journal.pone.0070035	http://dx.doi.org/10.1371/journal.pone.0070035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894581	Green Submitted, Green Published, gold			2022-12-25	WOS:000325211000177
J	Baccini, M; Kosatsky, T; Biggeri, A				Baccini, Michela; Kosatsky, Tom; Biggeri, Annibale			Impact of Summer Heat on Urban Population Mortality in Europe during the 1990s: An Evaluation of Years of Life Lost Adjusted for Harvesting	PLOS ONE			English	Article							HIGH AMBIENT-TEMPERATURE; WAVE; DISEASE; DEATHS; FRANCE	Background: Efforts to prevent and respond to heat-related illness would benefit by quantifying the impact of summer heat on acute population mortality. We estimated years of life lost due to heat in 14 European cities during the 1990s accounting for harvesting. Methods: We combined the number of deaths attributable to heat estimated by the PHEWE project with life expectancy derived from population life tables. The degree of harvesting was quantified by comparing the cumulative effect of heat up to lagged day 30 with the immediate effect of heat, by geographical region and age. Next, an evaluation of years of life lost adjusted for harvesting was obtained. Results: Without accounting for harvesting, we estimated more than 23,000 years of life lost per year, 55% of which was among individuals younger than 75. When 30 day mortality displacement was taken into account, the overall impact reduced on average by 75%. Harvesting was more pronounced in North-continental cities than in Mediterranean cities and was stronger among young people than among elderly. Conclusions: High ambient temperatures during summer were responsible for many deaths in European cities during the 1990s, but a large percentage of these deaths likely involved frail persons whose demise was only briefly hastened by heat exposure. Differences in harvesting across regions and classes of age could reflect different proportions of frail individuals in the population or could be indicative of heterogeneous dynamics underlying the entry and exit of individuals from the high-risk pool which is subject to mortality displacement.	[Baccini, Michela; Biggeri, Annibale] Univ Florence, Dept Stat Informat & Applicat G Parenti, Florence, Italy; [Baccini, Michela; Biggeri, Annibale] ISPO Canc Prevent & Res Inst, Biostat Unit, Florence, Italy; [Kosatsky, Tom] WHO, European Ctr Environm & Hlth, Rome, Italy	University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; World Health Organization	Baccini, M (corresponding author), Univ Florence, Dept Stat Informat & Applicat G Parenti, Florence, Italy.	baccini@disia.unifi.it			European Commission, DG Research [QLK4-CT-2001-00152]	European Commission, DG Research(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the European Commission, DG Research, FP5 (contract QLK4-CT-2001-00152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccini M, 2011, J EPIDEMIOL COMMUN H, V65, P64, DOI 10.1136/jech.2008.085639; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basu R, 2011, ENVIRON RES, V111, P1286, DOI 10.1016/j.envres.2011.09.006; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Huang CR, 2011, ENVIRON HEALTH PERSP, V119, P1681, DOI 10.1289/ehp.1103456; Khalaj B, 2010, INT ARCH OCC ENV HEA, V83, P833, DOI 10.1007/s00420-010-0534-2; Klenk J, 2010, AGE AGEING, V39, P245, DOI 10.1093/ageing/afp248; Michelozzi P, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-12; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Rabl A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-25; Rocklov J, 2010, INT J ENV RES PUB HE, V7, P2607, DOI 10.3390/ijerph7062607; ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143; Schwartz J, 2003, REVISED ANAL TIME SE, P219; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Toulemon L, 2008, POP STUD-J DEMOG, V62, P39, DOI 10.1080/00324720701804249; Vandentorren S, 2006, EUR J PUBLIC HEALTH, V16, P583, DOI 10.1093/eurpub/ckl063; Zanobetti A, 2000, Biostatistics, V1, P279, DOI 10.1093/biostatistics/1.3.279	23	43	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69638	10.1371/journal.pone.0069638	http://dx.doi.org/10.1371/journal.pone.0069638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	187PW	23894516	gold, Green Published			2022-12-25	WOS:000322132100074
J	Kaarbo, M; Storm, ML; Qu, S; Waehre, H; Risberg, B; Danielsen, HE; Saatcioglu, F				Kaarbo, Mari; Storm, Margrethe L.; Qu, Su; Waehre, Hakon; Risberg, Bjorn; Danielsen, Havard E.; Saatcioglu, Fahri			TCTP Is an Androgen-Regulated Gene Implicated in Prostate Cancer	PLOS ONE			English	Article							CONTROLLED TUMOR PROTEIN; HISTAMINE-RELEASING-FACTOR; BRONCHIAL EPITHELIAL-CELLS; MOLECULAR-IDENTIFICATION; POTENTIAL ROLE; MESSENGER-RNA; CALCIUM; ACTIVATION; EXPRESSION; GROWTH	TCTP has been implicated in a plethora of important cellular processes related to cell growth, cell cycle progression, malignant transformation and inhibition of apoptosis. In addition to these intracellular functions, TCTP has extracellular functions and plays an important role in immune cells. TCTP expression was previously shown to be deregulated in prostate cancer, but its function in prostate cancer cells is largely unknown. Here we show that TCTP expression is regulated by androgens in LNCaP prostate cancer cells in vitro as well as human prostate cancer xenografts in vivo. Knockdown of TCTP reduced colony formation and increased apoptosis in LNCaP cells, implicating it as an important factor for prostate cancer cell growth. Global gene expression profiling in TCTP knockdown LNCaP cells showed that several interferon regulated genes are regulated by TCTP, suggesting that it may have a role in regulating immune function in prostate cancer. In addition, recombinant TCTP treatment increased colony formation in LNCaP cells suggesting that secreted TCTP may function as a proliferative factor in prostate cancer. These results suggest that TCTP may have a role in prostate cancer development.	[Kaarbo, Mari; Storm, Margrethe L.; Qu, Su; Saatcioglu, Fahri] Univ Oslo, Dept Biosci, Oslo, Norway; [Waehre, Hakon; Risberg, Bjorn; Danielsen, Havard E.; Saatcioglu, Fahri] Oslo Univ Hosp, Inst Med Informat, Oslo, Norway; [Risberg, Bjorn] Oslo Univ Hosp, Div Pathol, Oslo, Norway; [Danielsen, Havard E.] Oslo Univ Hosp, Ctr Canc Biomed, Oslo, Norway; [Danielsen, Havard E.] Univ Oslo, Dept Informat, N-0316 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Saatcioglu, F (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	fahris@ibv.uio.no	Danielsen, Havard/AAK-8489-2020; Danielsen, Havard e/A-7540-2014	Kaarbo, Mari/0000-0003-3983-6545	Norwegian Research Council [193337/V50]; Norwegian Cancer Society [71395-PR-2006-0335]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	This work has been supported by grants from the Norwegian Research Council (Grant # 193337/V50, www.forskningsradet.no) and Norwegian Cancer Society (Grant # 71395-PR-2006-0335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amson R, 2013, TRENDS CELL BIOL, V23, P37, DOI 10.1016/j.tcb.2012.10.002; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Arcuri F, 2004, PROSTATE, V60, P130, DOI 10.1002/pros.20054; Baylot V, 2012, MOL THER, V20, P2244, DOI 10.1038/mt.2012.155; Bommer UA, 2002, RNA, V8, P478, DOI 10.1017/S1355838202022586; Chan THM, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/369384; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Coleman IM, 2006, NEOPLASIA, V8, P862, DOI 10.1593/neo.06328; Duarte CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029653; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Engedal N, 2002, ONCOGENE, V21, P1017, DOI 10.1038/sj.onc.1205167; Fenner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008799; Gnanasekar M, 2009, INT J ONCOL, V34, P1241, DOI 10.3892/ijo_00000252; HAGHIGHAT NG, 1992, MOL BIOCHEM PARASIT, V51, P99, DOI 10.1016/0166-6851(92)90205-X; Heinonen H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-348; Huggins C, 1941, CANCER RES, V1, P293; Jamal K, 2008, EXPERT REV ANTICANC, V8, P957, DOI 10.1586/14737140.8.6.957; Kaarbo M, 2007, BIOESSAYS, V29, P1227, DOI 10.1002/bies.20676; Kang HS, 2001, J IMMUNOL, V166, P6545, DOI 10.4049/jimmunol.166.11.6545; Kim M, 2000, ARCH PHARM RES, V23, P633, DOI 10.1007/BF02975253; LECHNER JF, 1982, IN VITRO CELL DEV B, V18, P633; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MacDonald SM, 2012, J ASTHMA ALLERGY, V5, P51, DOI 10.2147/JAA.S28868; Madigan AA, 2012, GENES IMMUN, V13, P566, DOI 10.1038/gene.2012.40; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Marra E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-129; McConkey DJ, 1997, BIOCHEM BIOPH RES CO, V239, P357, DOI 10.1006/bbrc.1997.7409; Nagabhushan M, 1996, CANCER RES, V56, P3042; Nagano-Ito M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/204960; Nelson PS, 2012, J CLIN ONCOL, V30, P644, DOI 10.1200/JCO.2011.39.1300; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; Sirois I, 2011, CELL DEATH DIFFER, V18, P549, DOI 10.1038/cdd.2010.126; SUSINI L, 2008, CELL DEATH DIFFER; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Vonakis BM, 2001, J ALLERGY CLIN IMMUN, V108, P822, DOI 10.1067/mai.2001.119159; WAINSTEIN MA, 1994, CANCER RES, V54, P6049; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; YENOFSKY R, 1982, P NATL ACAD SCI-BIOL, V79, P5876, DOI 10.1073/pnas.79.19.5876; Yoneda K, 2004, AM J PHYSIOL-LUNG C, V286, pL174, DOI 10.1152/ajplung.00118.2003; Zhang D, 2002, J BIOL CHEM, V277, P37430, DOI 10.1074/jbc.M207413200	42	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69398	10.1371/journal.pone.0069398	http://dx.doi.org/10.1371/journal.pone.0069398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894469	gold, Green Published, Green Submitted			2022-12-25	WOS:000322132100056
J	Lee, J; Hong, YS; Jeong, JH; Yang, EJ; Jhun, JY; Park, MK; Jung, YO; Min, JK; Kim, HY; Park, SH; Cho, ML				Lee, Jennifer; Hong, Yeon Sik; Jeong, Jeong Hee; Yang, Eun Ji; Jhun, Joo Yeon; Park, Mi Kyoung; Jung, Young Ok; Min, Jun Ki; Kim, Ho Youn; Park, Sung Hwan; Cho, Mi-La			Coenzyme Q10 Ameliorates Pain and Cartilage Degradation in a Rat Model of Osteoarthritis by Regulating Nitric Oxide and Inflammatory Cytokines	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; FACTOR-KAPPA-B; MITOCHONDRIAL DYSFUNCTION; ARTICULAR-CARTILAGE; METABOLIC SYNDROME; GENE-EXPRESSION; SYNOVIAL-FLUID; RECEPTOR; CHONDROCYTES; INCREASES	Objective: To investigate the effect of CoenzymeQ10 (CoQ10) on pain severity and cartilage degeneration in an experimental model of rat osteoarthritis (OA). Materials and Methods: OA was induced in rats by intra-articular injection of monosodium iodoacetate (MIA) to the knee. Oral administration of CoQ10 was initiated on day 4 after MIA injection. Pain severity was assessed by measuring secondary tactile allodynia using the von Frey assessment test. The degree of cartilage degradation was determined by measuring cartilage thickness and the amount of proteoglycan. The mankin scoring system was also used. Expressions of matrix metalloproteinase-13 (MMP-13), interleukin-1 beta (IL-1 beta), IL-6, IL-15, inducible nitric oxide synthase (iNOS), nitrotyrosine and receptor for advanced glycation end products (RAGE) were analyzed using immunohistochemistry. Results: Treatment with CoQ10 demonstrated an antinociceptive effect in the OA animal model. The reduction in secondary tactile allodynia was shown by an increased pain withdrawal latency and pain withdrawal threshold. CoQ10 also attenuated cartilage degeneration in the osteoarthritic joints. MMP-13, IL-1b, IL-6, IL-15, iNOS, nitrotyrosine and RAGE expressions were upregulated in OA joints and significantly reduced with CoQ10 treatment. Conclusion: CoQ10 exerts a therapeutic effect on OA via pain suppression and cartilage degeneration by inhibiting inflammatory mediators, which play a vital role in OA pathogenesis.	[Lee, Jennifer; Hong, Yeon Sik; Min, Jun Ki; Kim, Ho Youn; Park, Sung Hwan; Cho, Mi-La] Catholic Univ Korea, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Jeong, Jeong Hee; Yang, Eun Ji; Jhun, Joo Yeon; Park, Mi Kyoung] Catholic Univ Korea, Coll Med, Rheumatism Res Ctr, Seoul, South Korea; [Jung, Young Ok] Hallym Univ, Kang Nam Sacred Heart Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Cho, Mi-La] Catholic Univ Korea, Coll Med, Conversant Res Consortium Immunol Dis, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Hallym University; Catholic University of Korea	Park, SH (corresponding author), Catholic Univ Korea, Dept Internal Med, Div Rheumatol, Seoul, South Korea.	rapark@catholic.ac.kr; iammila@catholic.ac.kr			Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092258]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MEST) [2012049783]	Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by a grant from the Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (grant number A092258), Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (grant number 2012049783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2008, OSTEOARTHR CARTILAGE, V16, pS15, DOI 10.1016/S1063-4584(08)60008-4; Bauerova K, 2010, ACTA BIOCHIM POL, V57, P347; Berenbaum F, 2012, OSTEOARTHR CARTILAGE, V20, pS5, DOI 10.1016/j.joca.2012.02.621; Berenbaum F, 2013, CURR OPIN RHEUMATOL, V25, P114, DOI 10.1097/BOR.0b013e32835a9414; Blanco FJ, 2011, NAT REV RHEUMATOL, V7, P161, DOI 10.1038/nrrheum.2010.213; BULSTRA SK, 1989, CLIN ORTHOP RELAT R, P294; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Cake MA, 2004, OSTEOARTHR CARTILAGE, V12, P974, DOI 10.1016/j.joca.2004.08.012; Chadjichristos C, 2003, J BIOL CHEM, V278, P39762, DOI 10.1074/jbc.M303541200; Cordero MD, 2012, NUTRITION, V28, P1200, DOI 10.1016/j.nut.2012.03.018; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Doss F, 2007, SCAND J RHEUMATOL, V36, P136, DOI 10.1080/03009740701250785; Fuller Bryan, 2006, J Cosmet Dermatol, V5, P30, DOI 10.1111/j.1473-2165.2006.00220.x; Gavriilidis C, 2013, ARTHRITIS RHEUM-US, V65, P378, DOI 10.1002/art.37782; GREEN DE, 1963, BIOCHEM Z, V338, P335; Hirose J, 2011, ACTA HISTOCHEM, V113, P613, DOI 10.1016/j.acthis.2010.06.007; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008; Jiang LP, 2013, J ORTHOP RES, V31, P364, DOI 10.1002/jor.22250; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kunitomo M, 2008, J PHARMACOL SCI, V107, P128, DOI 10.1254/jphs.FP0072365; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lee HK, 2011, DIABETES METAB J, V35, P207, DOI 10.4093/dmj.2011.35.3.207; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Mitchell T, 2012, FREE RADICAL BIO MED, V52, P838, DOI 10.1016/j.freeradbiomed.2011.12.014; Nah SS, 2007, FEBS LETT, V581, P1928, DOI 10.1016/j.febslet.2007.03.090; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Scanzello CR, 2009, OSTEOARTHR CARTILAGE, V17, P1040, DOI 10.1016/j.joca.2009.02.011; Schmelzer C, 2008, BIOFACTORS, V32, P179, DOI 10.1002/biof.5520320121; Steenvoorden MMC, 2006, ARTHRITIS RHEUM-US, V54, P253, DOI 10.1002/art.21523; STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Tsai KL, 2012, J NUTR BIOCHEM, V23, P458, DOI 10.1016/j.jnutbio.2011.01.011; Vaamonde-Garcia C, 2012, ARTHRITIS RHEUM-US, V64, P2927, DOI 10.1002/art.34508; Verzijl N, 2002, ARTHRITIS RHEUM, V46, P114, DOI 10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P; Wang CH, 2013, FEBS J, V280, P1039, DOI 10.1111/febs.12096; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	42	27	31	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69362	10.1371/journal.pone.0069362	http://dx.doi.org/10.1371/journal.pone.0069362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894457	Green Published, gold			2022-12-25	WOS:000322132100055
J	Wang, H; He, ZQ; Zhang, C; Zhang, L; Xu, D				Wang, Han; He, Zhiquan; Zhang, Chao; Zhang, Li; Xu, Dong			Transmembrane Protein Alignment and Fold Recognition Based on Predicted Topology	PLOS ONE			English	Article							HIDDEN-MARKOV-MODEL; NOVO STRUCTURE PREDICTION; BARREL MEMBRANE-PROTEINS; COUPLED RECEPTORS; SOLVENT ACCESSIBILITY; SECONDARY STRUCTURE; DATA-BANK; EVOLUTIONARY INFORMATION; STRUCTURAL ALIGNMENT; SEQUENCE ALIGNMENT	Background: Although Transmembrane Proteins (TMPs) are highly important in various biological processes and pharmaceutical developments, general prediction of TMP structures is still far from satisfactory. Because TMPs have significantly different physicochemical properties from soluble proteins, current protein structure prediction tools for soluble proteins may not work well for TMPs. With the increasing number of experimental TMP structures available, template-based methods have the potential to become broadly applicable for TMP structure prediction. However, the current fold recognition methods for TMPs are not as well developed as they are for soluble proteins. Methodology: We developed a novel TMP Fold Recognition method, TMFR, to recognize TMP folds based on sequence-to-structure pairwise alignment. The method utilizes topology-based features in alignment together with sequence profile and solvent accessibility. It also incorporates a gap penalty that depends on predicted topology structure segments. Given the difference between alpha-helical transmembrane protein (alpha TMP) and beta-strands transmembrane protein (beta TMP), parameters of scoring functions are trained respectively for these two protein categories using 58 alpha TMPs and 17 beta TMPs in a non-redundant training dataset. Results: We compared our method with HHalign, a leading alignment tool using a non-redundant testing dataset including 72 alpha TMPs and 30 beta TMPs. Our method achieved 10% and 9% better accuracies than HHalign in alpha TMPs and beta TMPs, respectively. The raw score generated by TMFR is negatively correlated with the structure similarity between the target and the template, which indicates its effectiveness for fold recognition. The result demonstrates TMFR provides an effective TMP-specific fold recognition and alignment method.	[Wang, Han] NE Normal Univ, Sch Comp Sci & Informat Technol, Changchun, Peoples R China; [Wang, Han; He, Zhiquan; Zhang, Chao; Xu, Dong] Univ Missouri, Dept Comp Sci, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Zhang, Li] Changchun Univ Technol, Sch Comp Sci & Engn, Changchun, Peoples R China	Northeast Normal University - China; University of Missouri System; University of Missouri Columbia; Changchun University of Technology	Xu, D (corresponding author), Univ Missouri, Dept Comp Sci, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA.	xudong@missouri.edu	Wang, Han/GPT-0015-2022; Zhang, Chao/E-6476-2015	Zhang, Chao/0000-0001-8019-7998; wang, han/0000-0002-4302-1886	US National Institutes of Health [R21/R33-GM078601, R01-GM100701]; National Natural Science Foundation of China [61175023, 60973092, 60903097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R33GM078601, R21GM078601, R01GM100701] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is partially supported by US National Institutes of Health Grants R21/R33-GM078601 and R01-GM100701 as well as National Natural Science Foundation of China under Grant No. 61175023, 60973092, 60903097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Bannwarth M, 2002, PROTEIN ENG, V15, P799, DOI 10.1093/protein/15.10.799; Becker OM, 2004, P NATL ACAD SCI USA, V101, P11304, DOI 10.1073/pnas.0401862101; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Chen CP, 2002, PROTEIN SCI, V11, P2774, DOI 10.1110/ps.0214502; Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cserzo M, 2004, BIOINFORMATICS, V20, P136, DOI 10.1093/bioinformatics/btg394; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Giegerich R, 2000, BIOINFORMATICS, V16, P665, DOI 10.1093/bioinformatics/16.8.665; Godzik A, 1996, PROTEIN SCI, V5, P1325, DOI 10.1002/pro.5560050711; Gromiha MM, 2005, NUCLEIC ACIDS RES, V33, pW164, DOI 10.1093/nar/gki367; Hedman M, 2002, PROTEIN SCI, V11, P652, DOI 10.1110/ps.39402; Hill JR, 2013, BIOINFORMATICS, V29, P54, DOI 10.1093/bioinformatics/bts640; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017215; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Ikeda M, 2003, NUCLEIC ACIDS RES, V31, P406, DOI 10.1093/nar/gkg020; Illergard K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-333; Iverson TM, 2002, J BIOL CHEM, V277, P16124, DOI 10.1074/jbc.M200815200; Jayasinghe S, 2001, PROTEIN SCI, V10, P455, DOI 10.1110/ps.43501; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Kahsay RY, 2005, BIOINFORMATICS, V21, P1853, DOI 10.1093/bioinformatics/bti303; Kalani MYS, 2004, P NATL ACAD SCI USA, V101, P3815, DOI 10.1073/pnas.0400100101; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kall L, 2002, FEBS LETT, V532, P415, DOI 10.1016/S0014-5793(02)03730-4; Kelm S, 2010, BIOINFORMATICS, V26, P2833, DOI 10.1093/bioinformatics/btq554; Kim D, 2003, PROTEIN ENG, V16, P641, DOI 10.1093/protein/gzg081; Kim S, 2004, P NATL ACAD SCI USA, V101, P5988, DOI 10.1073/pnas.0308694101; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee J, 2011, PROTEINS, V79, P2403, DOI 10.1002/prot.23059; Liang J, 2011, BIOCH BIOPHYSICA ACT; Liu S, 2007, PROTEINS, V68, P636, DOI 10.1002/prot.21459; Lo A, 2008, J PROTEOME RES, V7, P487, DOI 10.1021/pr0702058; Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Michino M, 2010, PROTEINS, V78, P2189, DOI 10.1002/prot.22731; Murzin AG, 2001, PROTEINS, P76; Ng DP, 2011, BIOCH BIOPHYSICA ACT; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Ou YY, 2010, J COMPUT CHEM, V31, P217, DOI 10.1002/jcc.21281; Phatak M, 2011, CURR PROTEIN PEPT SC, V12, P563, DOI 10.2174/138920311796957603; Punta M, 2007, METHODS, V41, P460, DOI 10.1016/j.ymeth.2006.07.026; Randall A, 2008, BIOINFORMATICS, V24, P513, DOI 10.1093/bioinformatics/btm548; Rost B, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P192; Shacham S, 2004, PROTEINS, V57, P51, DOI 10.1002/prot.20195; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Teichert F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-251; Trabanino RJ, 2004, BIOPHYS J, V86, P1904, DOI 10.1016/S0006-3495(04)74256-3; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Waldispuehl J, 2008, PROTEINS, V71, P1097, DOI 10.1002/prot.21788; Waldispuhl J, 2006, NUCLEIC ACIDS RES, V34, pW189, DOI 10.1093/nar/gkl205; Wang H, 2012, BBA-BIOMEMBRANES, V1818, P2679, DOI 10.1016/j.bbamem.2012.05.030; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Xu Y, 2000, PROTEINS, V40, P343, DOI 10.1002/1097-0134(20000815)40:3<343::AID-PROT10>3.0.CO;2-S; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yuan Z, 2006, J PROTEOME RES, V5, P1063, DOI 10.1021/pr050397b; Zemla A, 2001, PROTEINS, P13; Zemla A, 1999, PROTEINS, P22; Zeth K, 2000, STRUCTURE, V8, P981, DOI 10.1016/S0969-2126(00)00189-1; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013; Zhou HY, 2010, PROTEINS, V78, P2041, DOI 10.1002/prot.22717; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308; Zhou HY, 2003, PROTEIN SCI, V12, P1547, DOI 10.1110/ps.0305103	87	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69744	10.1371/journal.pone.0069744	http://dx.doi.org/10.1371/journal.pone.0069744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894534	Green Published, gold, Green Submitted			2022-12-25	WOS:000322391400069
J	Raina, D; Uchida, Y; Kharbanda, A; Rajabi, H; Panchamoorthy, G; Jin, C; Kharbanda, S; Scaltriti, M; Baselga, J; Kufe, D				Raina, D.; Uchida, Y.; Kharbanda, A.; Rajabi, H.; Panchamoorthy, G.; Jin, C.; Kharbanda, S.; Scaltriti, M.; Baselga, J.; Kufe, D.			Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells	ONCOGENE			English	Article						MUC1; HER2; HER3; trastuzumab; resistance; breast cancer	GROWTH-FACTOR RECEPTOR; KINASE INHIBITOR P27(KIP1); FACTOR-I RECEPTOR; CYCLIN-E; PHOSPHORYLATION; CONTRIBUTES; LAPATINIB; ERBB3; CHEMOTHERAPY; MECHANISM	Patients with HER2-positive breast cancer often exhibit intrinsic or acquired resistance to trastuzumab treatment. The transmembrane mucin 1 (MUC1) oncoprotein is aberrantly overexpressed in breast cancer cells and associates with HER2. The present studies demonstrate that silencing MUC1 C-terminal subunit (MUC1-C) in HER2-overexpressing SKBR3 and BT474 breast cancer cells results in the downregulation of constitutive HER2 activation. Moreover, treatment with the MUC1-C inhibitor, GO-203, was associated with disruption of MUC1-C/HER2 complexes and decreases in tyrosine-phosphorylated HER2 (p-HER2) levels. In studies of trastuzumab-resistant SKBR3R and BT474R cells, we found that the association between MUC1-C and HER2 is markedly increased (B20-fold) as compared with that in sensitive cells. In addition, silencing MUC1-C in the trastuzumab-resistant cells or treatment with GO-203 decreased p-HER2 and AKT activation. Moreover, targeting MUC1-C was associated with the downregulation of phospho-p27 and cyclin E, which confer trastuzumab resistance. Consistent with these results, targeting MUC1-C inhibited the growth and clonogenic survival of both trastuzumab-resistant cells. Our results further demonstrate that silencing MUC1-C reverses resistance to trastuzumab and that the combination of GO-203 and trastuzumab is highly synergistic. These findings indicate that MUC1-C contributes to constitutive activation of the HER2 pathway and that targeting MUC1-C represents a potential approach to abrogate trastuzumab resistance.	[Raina, D.; Panchamoorthy, G.; Kharbanda, S.] Genus Oncol, Boston, MA USA; [Uchida, Y.; Kharbanda, A.; Rajabi, H.; Jin, C.; Kufe, D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Scaltriti, M.; Baselga, J.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Kufe, D (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 450 Brookline Ave,Dana 830, Boston, MA 02215 USA.	donald_kufe@dfci.harvard.edu			National Cancer Institute [CA97098, CA166480]; Susan G Komen for the Cure Grant [SAC110046]; NATIONAL CANCER INSTITUTE [R01CA097098, R01CA166480] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen for the Cure Grant(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants CA97098 and CA166480 awarded by the National Cancer Institute, and by the Susan G Komen for the Cure Grant SAC110046 (MS and JB).	Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Duraisamy S, 2007, INT J ONCOL, V31, P671; Fessler SP, 2009, BREAST CANCER RES TR, V118, P113, DOI 10.1007/s10549-009-0412-3; Guertin AD, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-45; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Huang XP, 2010, CANCER RES, V70, P1204, DOI 10.1158/0008-5472.CAN-09-3321; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Klapper LN, 2000, CANCER RES, V60, P3384; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lee-Hoeflich ST, 2011, CANCER DISCOV, V1, P326, DOI 10.1158/2159-8290.CD-11-0062; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li PF, 2004, J BIOL CHEM, V279, P25260, DOI 10.1074/jbc.M311052200; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 2003, MOL CANCER RES, V1, P765; Mittendorf EA, 2010, ONCOGENE, V29, P3896, DOI 10.1038/onc.2010.151; Mittendorf EA, 2009, CLIN CANCER RES, V15, P7381, DOI 10.1158/1078-0432.CCR-09-1735; Motti ML, 2004, CELL CYCLE, V3, P1074; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2004, CANCER RES, V64, P3981, DOI 10.1158/0008-5472.CAN-03-3900; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2007, MOL CANCER THER, V6, P667, DOI 10.1158/1535-7163.MCT-06-0423; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Scaltriti M, 2011, MOL CANCER THER, V10, P817, DOI 10.1158/1535-7163.MCT-10-0966; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	47	75	82	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 26	2014	33	26					3422	3431		10.1038/onc.2013.308	http://dx.doi.org/10.1038/onc.2013.308			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK9WM	23912457	Green Submitted, Green Accepted			2022-12-25	WOS:000338779300009
J	Wang, J; Ptacek, JB; Kirkegaard, K; Bullitt, E				Wang, Jing; Ptacek, Jennifer B.; Kirkegaard, Karla; Bullitt, Esther			Double-membraned Liposomes Sculpted by Poliovirus 3AB Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION COMPLEX; ENDOPLASMIC-RETICULUM; RNA REPLICATION; POLYMERASE 3D(POL); VIRUS-REPLICATION; VIRAL-PROTEINS; IN-VITRO; ASSOCIATION; ARCHITECTURE; LC3	Infection with many positive-strand RNA viruses dramatically remodels cellular membranes, resulting in the accumulation of double-membraned vesicles that resemble cellular autophagosomes. In this study, a single protein encoded by poliovirus, 3AB, is shown to be sufficient to induce the formation of double-membraned liposomes via the invagination of single-membraned liposomes. Poliovirus 3AB is a 109-amino acid protein with a natively unstructured N-terminal domain. HeLa cells transduced with 3AB protein displayed intracellular membrane disruption; specifically, the formation of cytoplasmic invaginations. The ability of a single viral protein to produce structures of similar topology to cellular autophagosomes should facilitate the understanding of both cellular and viral mechanisms for membrane remodeling.	[Wang, Jing; Bullitt, Esther] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Ptacek, Jennifer B.; Kirkegaard, Karla] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94301 USA	Boston University; Stanford University	Kirkegaard, K (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, 299 Campus Dr,Fairchild D325, Stanford, CA 94301 USA.	karlak@stanford.edu; bullitt@bu.edu		Bullitt, Esther/0000-0003-2447-6209	National Institutes of Health [GM102474]; American Cancer Society; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Director's Pioneer Award (to K. K.) and National Institutes of Health Grant GM102474 (to E. B.). This work was also supported by the American Cancer Society (to J. B. P.).	Belov GA, 2012, J VIROL, V86, P302, DOI 10.1128/JVI.05937-11; Belov GA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000216; BIENZ K, 1992, J VIROL, V66, P2740, DOI 10.1128/JVI.66.5.2740-2747.1992; BIENZ K, 1987, VIROLOGY, V160, P220, DOI 10.1016/0042-6822(87)90063-8; BIENZ K, 1990, J VIROL, V64, P1156, DOI 10.1128/JVI.64.3.1156-1163.1990; Boura E, 2012, STRUCTURE, V20, P874, DOI 10.1016/j.str.2012.03.008; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; Dafforn TR, 2004, EMBO REP, V5, P1046, DOI 10.1038/sj.embor.7400276; DALES S, 1973, BACTERIOL REV, V37, P103, DOI 10.1128/MMBR.37.2.103-135.1973; DALES S, 1965, AM J MED, V38, P699, DOI 10.1016/0002-9343(65)90191-9; Dodd DA, 2001, J VIROL, V75, P8158, DOI 10.1128/JVI.75.17.8158-8165.2001; Doedens JR, 1997, J VIROL, V71, P9054, DOI 10.1128/JVI.71.12.9054-9064.1997; Egger D, 1996, J VIROL, V70, P8675, DOI 10.1128/JVI.70.12.8675-8683.1996; Ehrlich LS, 2011, J MOL BIOL, V413, P347, DOI 10.1016/j.jmb.2011.08.038; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Fujita K, 2007, BIOCHEMISTRY-US, V46, P5185, DOI 10.1021/bi6024758; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; HARRIS KS, 1994, J BIOL CHEM, V269, P27004; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hoekstra D., 1991, MEMBRANE FUSION, P89; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Khan SH, 2012, MOL BIOSYST, V8, P91, DOI 10.1039/c1mb05265a; LAMA J, 1994, J BIOL CHEM, V269, P66; Lanman J, 2008, J STRUCT BIOL, V161, P439, DOI 10.1016/j.jsb.2007.09.009; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MOLLA A, 1994, J BIOL CHEM, V269, P27015; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; O'Donnell V, 2011, VIROLOGY, V410, P142, DOI 10.1016/j.virol.2010.10.042; Pasieka TJ, 2003, J VIROL METHODS, V111, P157, DOI 10.1016/S0166-0934(03)00152-6; Paul AV, 1998, VIROLOGY, V250, P241, DOI 10.1006/viro.1998.9376; PAUL AV, 1994, J BIOL CHEM, V269, P29173; Peker B, 2004, BIOTECHNOL PROGR, V20, P262, DOI 10.1021/bp034182n; PLOTCH SJ, 1995, J VIROL, V69, P7169, DOI 10.1128/JVI.69.11.7169-7179.1995; Prinz WA, 2009, CRIT REV BIOCHEM MOL, V44, P278, DOI 10.1080/10409230903183472; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4; SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Spagnolo JF, 2010, RNA, V16, P382, DOI 10.1261/rna.1955410; Strauss DM, 2003, J MOL BIOL, V330, P225, DOI 10.1016/S0022-2836(03)00577-1; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Takahashi Y, 2009, CELL DEATH DIFFER, V16, P947, DOI 10.1038/cdd.2009.19; Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07; Teterina NL, 2006, J VIROL, V80, P5327, DOI 10.1128/JVI.02684-05; Teterina NL, 2011, J VIROL, V85, P4284, DOI 10.1128/JVI.02398-10; Thaa B, 2011, BIOCHEM J, V437, P389, DOI 10.1042/BJ20110706; Towner JS, 1996, J BIOL CHEM, V271, P26810, DOI 10.1074/jbc.271.43.26810; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Weill CO, 2008, CYTOTECHNOLOGY, V56, P41, DOI 10.1007/s10616-007-9102-3; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Xiang WK, 1995, RNA, V1, P892; Xiang WK, 1998, J VIROL, V72, P6732, DOI 10.1128/JVI.72.8.6732-6741.1998; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	66	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27287	27298		10.1074/jbc.M113.498899	http://dx.doi.org/10.1074/jbc.M113.498899			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908350	hybrid, Green Published			2022-12-25	WOS:000330597300025
J	Deranieh, RM; He, Q; Caruso, JA; Greenberg, ML				Deranieh, Rania M.; He, Quan; Caruso, Joseph A.; Greenberg, Miriam L.			Phosphorylation Regulates myo-Inositol-3-phosphate Synthase A NOVEL REGULATORY MECHANISM OF INOSITOL BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOINOSITOL 1-PHOSPHATE SYNTHASE; YEAST SACCHAROMYCES-CEREVISIAE; INOSITOL-1-PHOSPHATE SYNTHASE; PHOSPHOLIPID BIOSYNTHESIS; CRYSTAL-STRUCTURE; L-MYO-INOSITOL-1-PHOSPHATE SYNTHASE; MAJOR SITES; IDENTIFICATION; ENZYME; GENE	myo-Inositol-3-phosphate synthase (MIPS) plays a crucial role in inositol homeostasis. Transcription of the coding gene INO1 is highly regulated. However, regulation of the enzyme is not well defined. We previously showed that MIPS is indirectly inhibited by valproate, suggesting that the enzyme is post-translationally regulated. Using P-32(i) labeling and phosphoamino acid analysis, we show that yeast MIPS is a phosphoprotein. Mass spectrometry analysis identified five phosphosites, three of which are conserved in the human MIPS. Analysis of phosphorylation-deficient and phosphomimetic site mutants indicated that the three conserved sites in yeast (Ser-184, Ser-296, and Ser-374) and humans (Ser-177, Ser-279, and Ser-357) affect MIPS activity. Both S296A and S296D yeast mutants and S177A and S177D human mutants exhibited decreased enzymatic activity, suggesting that a serine residue is critical at that location. The phosphomimetic mutations S184D (human S279D) and S374D (human S357D) but not the phosphodeficient mutations decreased activity, suggesting that phosphorylation of these two sites is inhibitory. The double mutation S184A/S374A caused an increase in MIPS activity, conferred a growth advantage, and partially rescued sensitivity to valproate. Our findings identify a novel mechanism of regulation of inositol synthesis by phosphorylation of MIPS.	[Deranieh, Rania M.; He, Quan; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Caruso, Joseph A.] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA	Wayne State University; Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu	Caruso, Joseph A./U-8429-2019	Caruso, Joseph A./0000-0003-2900-3996; He, Quan/0000-0001-7706-9960	National Institutes of Health [DK 081367]; Wayne State University Graduate Research Fellowship; Graduate Research Enhancement Funds; National Institutes of Health Center [P30 ES06639, P30 CA22453]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University Graduate Research Fellowship; Graduate Research Enhancement Funds; National Institutes of Health Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 081367 (to M. L. G.). This work was also supported by Wayne State University Graduate Research Fellowship and Graduate Research Enhancement Funds (to R. M. D.). The Wayne State University Proteomics Core Facility is supported by National Institutes of Health Center Grants P30 ES06639 and P30 CA22453.	ADHIKARI J, 1988, INDIAN J BIOCHEM BIO, V25, P408; Azab AN, 2007, MOL MICROBIOL, V63, P1248, DOI 10.1111/j.1365-2958.2007.05591.x; Bachhawat N, 1999, J MOL BIOL, V291, P531, DOI 10.1006/jmbi.1999.2980; BARNETT JEG, 1970, BIOCHEM J, V119, P183, DOI 10.1042/bj1190183; Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chang YF, 2007, J BIOL CHEM, V282, P17613, DOI 10.1074/jbc.M702799200; Chen LJ, 2000, BIOCHEMISTRY-US, V39, P12415, DOI 10.1021/bi001517q; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; CULBERTSON MR, 1975, GENETICS, V80, P23; DEANJOHNSON M, 1989, J BIOL CHEM, V264, P1274; Deranieh RM, 2012, ORG BIOMOL CHEM, V10, P9601, DOI 10.1039/c2ob26577j; Deranieh RM, 2009, BIOCHEM SOC T, V37, P1099, DOI 10.1042/BST0371099; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; GARCIAPEREZ A, 1991, J MEMBRANE BIOL, V119, P1, DOI 10.1007/BF01868535; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Geiger James H., 2006, V39, P157; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Guan GM, 2003, ARCH BIOCHEM BIOPHYS, V417, P251, DOI 10.1016/S0003-9861(03)00388-6; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Jin XS, 2004, J BIOL CHEM, V279, P13889, DOI 10.1074/jbc.M308986200; Jin XS, 2003, ACTA CRYSTALLOGR D, V59, P1154, DOI 10.1107/S0907444903008205; Ju SL, 2004, J BIOL CHEM, V279, P21759, DOI 10.1074/jbc.M312078200; Kniewel Ryan, 2002, Journal of Structural and Functional Genomics, V2, P129, DOI 10.1023/A:1021293408654; LOEWUS MW, 1971, PLANT PHYSIOL, V48, P255, DOI 10.1104/pp.48.3.255; Lohia A, 1999, MOL BIOCHEM PARASIT, V98, P67, DOI 10.1016/S0166-6851(98)00147-9; MAEDA T, 1980, J BIOL CHEM, V255, P8458; McLaurin J, 1998, J MOL BIOL, V278, P183, DOI 10.1006/jmbi.1998.1677; NAHORSKI SR, 1991, TRENDS PHARMACOL SCI, V12, P297, DOI 10.1016/0165-6147(91)90581-C; Neelon K, 2011, BIOPHYS J, V101, P2816, DOI 10.1016/j.bpj.2011.10.038; Norman RA, 2002, STRUCTURE, V10, P393, DOI 10.1016/S0969-2126(02)00718-9; Nunez Lilia R., 2006, V39, P135; Seelan RS, 2009, J BIOL CHEM, V284, P9443, DOI 10.1074/jbc.M900206200; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Shimohama S, 1998, NEUROSCI LETT, V245, P159, DOI 10.1016/S0304-3940(98)00209-2; Stein AJ, 2002, J BIOL CHEM, V277, P9484, DOI 10.1074/jbc.M109371200; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; WHITE MJ, 1991, J BIOL CHEM, V266, P863	41	29	30	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26822	26833		10.1074/jbc.M113.479121	http://dx.doi.org/10.1074/jbc.M113.479121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902760	Green Published, hybrid			2022-12-25	WOS:000330594500048
J	McStay, GP; Su, CH; Thomas, SM; Xu, JT; Tzagoloff, A				McStay, Gavin P.; Su, Chen-Hsien; Thomas, Susan M.; Xu, Jonathan Tong; Tzagoloff, Alexander			Characterization of Assembly Intermediates Containing Subunit 1 of Yeast Cytochrome Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; C-OXIDASE; ATP SYNTHASE; TRANSLATION; GENE; MUTANTS; COX1P; MSS51P	Mitochondrial-encoded Cox1p, one of the three core subunits of yeast cytochrome oxidase (COX), was previously shown to associate with regulatory proteins and nuclear-encoded subunits into five high molecular weight complexes that were proposed to constitute the pathway for biogenesis of the Cox1p assembly module. One of the intermediates (D5) was inferred, but not directly shown to exist. In the present study mitochondria of strains expressing C-terminal-tagged subunits of COX that had not been looked at previously were pulse-labeled and analyzed for the presence of newly translated Cox1p in the immunoprecipitates. These studies revealed that of the eight nuclear-encoded COX subunits, only Cox5ap, Cox6p, and Cox8p are present in the Cox1p module. Both Cox5ap and Cox8p share interfaces with Cox1p in the holoenzyme, whereas Cox6p interacts indirectly through Cox5ap. These results suggest that the subunit contacts in the holoenzyme are probably established during biogenesis of the Cox1p module. To confirm the existence of the largest Cox1p intermediates (D5), which was only inferred previously, radiolabeled Cox1p with a C-terminal tag was expressed in COX-deficient pet111 and pet494 mutants. Pulldown assays confirmed the presence of newly translated Cox1p in D5, which in wild type cannot be demonstrated directly because of its co-migration with COX in the native electrophoresis system used to separate the intermediates. Jointly, the results of these analyses substantiate our previous proposal that COX is assembled from separate assembly modules, each containing one of the mitochondrial-translated core subunits in association with a unique set of nuclear-encoded subunits.	[McStay, Gavin P.; Su, Chen-Hsien; Thomas, Susan M.; Xu, Jonathan Tong; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@columbia.edu	McStay, Gavin/K-9574-2013	McStay, Gavin/0000-0003-1363-8719; Xu, Jonathan/0000-0001-8893-4286	National Institutes of Health [GM 50187]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 50187.	Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2003, J BIOL CHEM, V278, P8881, DOI 10.1074/jbc.M212427200; COSTANZO MC, 1986, MOL CELL BIOL, V6, P3694, DOI 10.1128/MCB.6.11.3694; DOWNIE JA, 1977, J MOL BIOL, V113, P369, DOI 10.1016/0022-2836(77)90147-4; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Glerum DM, 1997, FEBS LETT, V412, P410, DOI 10.1016/S0014-5793(97)00799-0; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; McStay GP, 2013, FEBS LETT, V587, P943, DOI 10.1016/j.febslet.2013.02.022; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; POUTRE CG, 1987, GENETICS, V115, P637; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8236; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	34	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26546	26556		10.1074/jbc.M113.498592	http://dx.doi.org/10.1074/jbc.M113.498592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897805	Green Published, hybrid			2022-12-25	WOS:000330594500021
J	Humanes-Valera, D; Aguilar, J; Foffani, G				Humanes-Valera, Desire; Aguilar, Juan; Foffani, Guglielmo			Reorganization of the Intact Somatosensory Cortex Immediately after Spinal Cord Injury	PLOS ONE			English	Article							PHANTOM-LIMB PAIN; CORTICAL REORGANIZATION; BARREL CORTEX; FUNCTIONAL REORGANIZATION; SYNAPTIC PLASTICITY; SENSORIMOTOR CORTEX; POPULATION ACTIVITY; SLEEP OSCILLATIONS; SENSORY RESPONSES; NEUROPATHIC PAIN	Sensory deafferentation produces extensive reorganization of the corresponding deafferented cortex. Little is known, however, about the role of the adjacent intact cortex in this reorganization. Here we show that a complete thoracic transection of the spinal cord immediately increases the responses of the intact forepaw cortex to forepaw stimuli (above the level of the lesion) in anesthetized rats. These increased forepaw responses were independent of the global changes in cortical state induced by the spinal cord transection described in our previous work (Aguilar et al., J Neurosci 2010), as the responses increased both when the cortex was in a silent state (down-state) or in an active state (up-state). The increased responses in the intact forepaw cortex correlated with increased responses in the deafferented hindpaw cortex, suggesting that they could represent different points of view of the same immediate state-independent functional reorganization of the primary somatosensory cortex after spinal cord injury. Collectively, the results of the present study and of our previous study suggest that both state-dependent and state-independent mechanisms can jointly contribute to cortical reorganization immediately after spinal cord injury.	[Humanes-Valera, Desire; Aguilar, Juan; Foffani, Guglielmo] Hosp Nacl Paraplej, Serv Salud Castilla La Mancha, Toledo, Spain	Hospital Nacional de Paraplejicos	Aguilar, J (corresponding author), Hosp Nacl Paraplej, Serv Salud Castilla La Mancha, Toledo, Spain.	jdaguilar@sescam.jccm.es; gfoffani@sescam.jccm.es	Foffani, Guglielmo/ABD-5897-2020; Aguilar, Juan/N-3850-2019; Aguilar, Juan/Q-2206-2015; Humanes-Valera, Desire/K-1690-2016	Aguilar, Juan/0000-0002-8070-3923; Aguilar, Juan/0000-0002-8070-3923; Humanes-Valera, Desire/0000-0001-8574-9835; Foffani, Guglielmo/0000-0001-7289-6668	International Foundation for Research in Paraplegia [P120]; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (Spain) [PI11/02451]; FEDER	International Foundation for Research in Paraplegia; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); FEDER(European Commission)	This work was supported by International Foundation for Research in Paraplegia (P120) and partly supported by Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III PI11/02451 (Spain), co-funded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2011, J PHYSIOL-LONDON, V589, P4981, DOI 10.1113/jphysiol.2011.214189; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; CALFORD MB, 1988, NATURE, V332, P446, DOI 10.1038/332446a0; Carlton SM, 2009, PAIN, V147, P265, DOI 10.1016/j.pain.2009.09.030; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V542, P567, DOI 10.1113/jphysiol.2002.019059; Castro-Alamancos MA, 2000, J NEUROSCI, V20, P9195; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Chauvette S, 2012, NEURON, V75, P1105, DOI 10.1016/j.neuron.2012.08.034; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DOSTROVSKY JO, 1976, EXP NEUROL, V52, P480, DOI 10.1016/0014-4886(76)90219-3; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Erchova IA, 2002, EUR J NEUROSCI, V15, P744, DOI 10.1046/j.0953-816x.2002.01898.x; Faggin BM, 1997, P NATL ACAD SCI USA, V94, P9428, DOI 10.1073/pnas.94.17.9428; Favero M, 2012, J NEUROPHYSIOL, V108, P1010, DOI 10.1152/jn.00256.2012; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Foffani G, 2011, SPINAL CORD, V49, P822, DOI 10.1038/sc.2011.11; Freund P, 2013, NEUROSCIENTIST, V19, P116, DOI 10.1177/1073858412449192; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Ghosh A, 2012, CEREB CORTEX, V22, P1309, DOI 10.1093/cercor/bhr191; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Green JB, 1998, NEUROLOGY, V50, P1115, DOI 10.1212/WNL.50.4.1115; Gustin SM, 2012, J NEUROSCI, V32, P14874, DOI 10.1523/JNEUROSCI.1733-12.2012; Gwak YS, 2012, EXP NEUROL, V234, P362, DOI 10.1016/j.expneurol.2011.10.010; Gwak YS, 2008, PAIN, V138, P410, DOI 10.1016/j.pain.2008.01.021; Hains BC, 2005, BRAIN, V128, P2359, DOI 10.1093/brain/awh623; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Hirata A, 2011, J NEUROPHYSIOL, V105, P1495, DOI 10.1152/jn.01085.2010; Hirata A, 2009, J NEUROPHYSIOL, V102, P437, DOI 10.1152/jn.00277.2009; Hofstetter CP, 2003, EUR J NEUROSCI, V18, P3061, DOI 10.1111/j.1460-9568.2003.03062.x; Ishizeki J, 2008, ANESTHESIOLOGY, V108, P447, DOI 10.1097/ALN.0b013e318164cfba; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jain N, 1997, NATURE, V386, P495, DOI 10.1038/386495a0; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Kao T, 2011, J NEUROPHYSIOL, V106, P2662, DOI 10.1152/jn.01017.2010; Kao T, 2009, J NEUROSCI, V29, P7549, DOI 10.1523/JNEUROSCI.2474-08.2009; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; LEONG SK, 1987, J ANAT, V154, P15; Levy LM, 2002, ANN NEUROL, V52, P755, DOI 10.1002/ana.10372; Lilja J, 2006, J NEUROSCI, V26, P6330, DOI 10.1523/JNEUROSCI.0626-06.2006; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Masri R, 2009, J NEUROPHYSIOL, V102, P181, DOI 10.1152/jn.00152.2009; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; Moore CI, 2000, P NATL ACAD SCI USA, V97, P14703, DOI 10.1073/pnas.250348997; Morales-Botello ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040174; Moxon KA, 2008, NEUROSCIENCE, V156, P1083, DOI 10.1016/j.neuroscience.2008.08.009; Nagashima K, 2005, ANESTHESIOLOGY, V103, P318, DOI 10.1097/00000542-200508000-00015; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Paxino G., 2007, RAT BRAIN STEREOTAXI; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; Puig MV, 2008, P NATL ACAD SCI USA, V105, P8428, DOI 10.1073/pnas.0712219105; Quiton RL, 2010, J NEUROPHYSIOL, V104, P1717, DOI 10.1152/jn.00161.2010; Reig R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000670; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Salgado H, 2011, CEREB CORTEX, V21, P212, DOI 10.1093/cercor/bhq081; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sceniak MP, 2006, J NEUROPHYSIOL, V95, P3865, DOI 10.1152/jn.01196.2005; Sigler A, 2009, P NATL ACAD SCI USA, V106, P11759, DOI 10.1073/pnas.0812695106; Simoes EL, 2012, J NEUROSCI, V32, P3211, DOI 10.1523/JNEUROSCI.4592-11.2012; Simon W, 2001, ANESTHESIOLOGY, V94, P1058, DOI 10.1097/00000542-200106000-00021; STERIADE M, 1994, TRENDS NEUROSCI, V17, P199; WALL PD, 1971, NATURE, V232, P542, DOI 10.1038/232542a0; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007; Yague JG, 2011, EXP NEUROL, V227, P252, DOI 10.1016/j.expneurol.2010.11.011; Yamahachi H, 2009, NEURON, V64, P719, DOI 10.1016/j.neuron.2009.11.026	77	33	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69655	10.1371/journal.pone.0069655	http://dx.doi.org/10.1371/journal.pone.0069655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922771	gold, Green Published, Green Submitted			2022-12-25	WOS:000323369700061
J	Jiang, QF; Zhou, Z; Wang, LL; Wang, LL; Yue, F; Wang, JJ; Song, LS				Jiang, Qiufen; Zhou, Zhi; Wang, Leilei; Wang, Lingling; Yue, Feng; Wang, Jingjing; Song, Linsheng			A Scallop Nitric Oxide Synthase (NOS) with Structure Similar to Neuronal NOS and Its Involvement in the Immune Defense	PLOS ONE			English	Article							NERVOUS-SYSTEM; MOLECULAR CHARACTERIZATION; CRASSOSTREA-VIRGINICA; GECARCINUS-LATERALIS; EXPRESSION ANALYSIS; SEQUENCE ALIGNMENT; MEMORY FORMATION; CHLAMYS-FARRERI; POND SNAIL; LAND CRAB	Background: Nitric oxide synthase (NOS) is responsible for synthesizing nitric oxide (NO) from L-arginine, and involved in multiple physiological functions. However, its immunological role in mollusc was seldom reported. Methodology: In the present study, an NOS (CfNOS) gene was identified from the scallop Chlamys farreri encoding a polypeptide of 1486 amino acids. Its amino acid sequence shared 50.0 similar to 54.7, 40.7 similar to 47.0 and 42.5 similar to 44.5% similarities with vertebrate neuronal (n), endothelial (e) and inducible (i) NOSs, respectively. CfNOS contained PDZ, oxygenase and reductase domains, which resembled those in nNOS. The CfNOS mRNA transcripts expressed in all embryos and larvae after the 2-cell embryo stage, and were detectable in all tested tissues with the highest level in the gonad, and with the immune tissues hepatopancreas and haemocytes included. Moreover, the immunoreactive area of CfNOS distributed over the haemocyte cytoplasm and cell membrane. After LPS, beta-glucan and PGN stimulation, the expression level of CfNOS mRNA in haemocytes increased significantly at 3 h (4.0-, 4.8- and 2.7-fold, respectively, P < 0.01), and reached the peak at 12 h (15.3- and 27.6-fold for LPS and beta-glucan respectively, P < 0.01) and 24 h (17.3-fold for PGN, P < 0.01). In addition, TNF-alpha also induced the expression of CfNOS, which started to increase at 1 h (5.2-fold, P < 0.05) and peaked at 6 h (19.9-fold, P < 0.01). The catalytic activity of the native CfNOS protein was 30.3 +/- 0.3 U mgprot(-1), and it decreased significantly after the addition of the selective inhibitors of nNOS and iNOS (26.9 +/- 0.4 and 29.3 +/- 0.1 U mgprot(-1), respectively, P < 0.01). Conclusions: These results suggested that CfNOS, with identical structure with nNOS and similar enzymatic characteristics to nNOS and iNOS, played the immunological role of iNOS to be involved in the scallop immune defense against PAMPs and TNF-alpha.	[Jiang, Qiufen; Zhou, Zhi; Wang, Leilei; Wang, Lingling; Yue, Feng; Wang, Jingjing; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Jiang, Qiufen; Wang, Leilei; Yue, Feng; Wang, Jingjing] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, LL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	zhi, zhouzhi/J-8063-2013; Yue, Feng/S-6565-2017		National Science Foundation of China [30925028]; National Basic Research Program (973 Program) [2010CB126404]; National High Technology Research and Development Program (863 Program) from the Chinese Ministry of Science and Technology [2012AA10A401]; Shandong Provincial Natural Science Foundation [JQ201110]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program (863 Program) from the Chinese Ministry of Science and Technology(National High Technology Research and Development Program of China); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This research was supported by grants (No. 30925028 to LS) from National Science Foundation of China, National Basic Research Program (973 Program, No. 2010CB126404) and National High Technology Research and Development Program (863 Program, No. 2012AA10A401) from the Chinese Ministry of Science and Technology, and a grant from Shandong Provincial Natural Science Foundation (No. JQ201110 to LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andreakis N, 2011, MOL BIOL EVOL, V28, P163, DOI 10.1093/molbev/msq179; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Cioni C, 2012, J COMP NEUROL, V520, P364, DOI 10.1002/cne.22729; Cole AG, 2002, J EXP BIOL, V205, P3143; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V26, P625, DOI 10.1016/j.fsi.2008.10.004; Dzhansugurova L. B., 2003, Ontogenez, V34, P306; Figueroa XF, 2001, AM J PHYSIOL-HEART C, V280, pH1222, DOI 10.1152/ajpheart.2001.280.3.H1222; Foley E, 2003, GENE DEV, V17, P115, DOI 10.1101/gad.1018503; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GELPERIN A, 1994, NATURE, V369, P61, DOI 10.1038/369061a0; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Groves JT, 2000, CURR OPIN CHEM BIOL, V4, P687, DOI 10.1016/S1367-5931(00)00146-0; HUGHES TK, 1991, DEV COMP IMMUNOL, V15, P117, DOI 10.1016/0145-305X(91)90002-G; Inada M, 2010, FISH SHELLFISH IMMUN, V28, P701, DOI 10.1016/j.fsi.2010.01.010; Ivanina AV, 2010, J EXP BIOL, V213, P433, DOI 10.1242/jeb.038059; Jeffroy F, 2011, FISH SHELLFISH IMMUN, V31, P1137, DOI 10.1016/j.fsi.2011.10.008; Jiang QF, 2013, FISH SHELLFISH IMMUN, V34, P100, DOI 10.1016/j.fsi.2012.10.011; Katzoff A, 2006, J NEUROPHYSIOL, V96, P1247, DOI 10.1152/jn.00056.2006; Kim HW, 2004, J EXP BIOL, V207, P2845, DOI 10.1242/jeb.01117; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Korneev SA, 2005, J NEUROSCI, V25, P1188, DOI 10.1523/JNEUROSCI.4671-04.2005; Koutsogiannaki S, 2010, ISJ-INVERT SURVIV J, V7, P11; Kuzin B, 1996, CELL, V87, P639, DOI 10.1016/S0092-8674(00)81384-7; Lee SJ, 1998, J BIOL CHEM, V273, P27430, DOI 10.1074/jbc.273.42.27430; Matsuo R, 2009, BIOCHEM BIOPH RES CO, V386, P724, DOI 10.1016/j.bbrc.2009.06.112; McDonald AA, 2011, COMP BIOCHEM PHYS A, V158, P150, DOI 10.1016/j.cbpa.2010.10.013; MONCADA S, 1991, PHARMACOL REV, V43, P109; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; Nappi AJ, 2000, NITRIC OXIDE-BIOL CH, V4, P423, DOI 10.1006/niox.2000.0294; Qureshi AA, 1996, J INVEST DERMATOL, V107, P815, DOI 10.1111/1523-1747.ep12330572; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; Regulski M, 2004, CURR BIOL, V14, pR881, DOI 10.1016/j.cub.2004.09.068; Rodriguez-Ramos T, 2010, FISH SHELLFISH IMMUN, V29, P469, DOI 10.1016/j.fsi.2010.05.013; Roszer T, 2009, CELL TISSUE RES, V336, P325, DOI 10.1007/s00441-009-0764-3; Sadreyev RI, 2000, SOC NEUR ABSTR, V26; Scheinker V, 2005, BIOCHEM BIOPH RES CO, V338, P1204, DOI 10.1016/j.bbrc.2005.10.069; SCHUMAN EM, 1994, ANNU REV NEUROSCI, V17, P153, DOI 10.1146/annurev.neuro.17.1.153; Serfozo Z, 2002, J NEUROCYTOL, V31, P131, DOI 10.1023/A:1023945522690; Shi XW, 2012, DEV COMP IMMUNOL, V37, P270, DOI 10.1016/j.dci.2012.03.008; Smith PK, 1989, MEASUREMENT PROTEIN; Stasiv Y, 2004, GENE DEV, V18, P1812, DOI 10.1101/gad.298004; Tirape A, 2007, DEV COMP IMMUNOL, V31, P859, DOI 10.1016/j.dci.2007.01.005; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225; Villamil L, 2007, DEV COMP IMMUNOL, V31, P968, DOI 10.1016/j.dci.2007.01.006; Wang PH, 2012, DEV COMP IMMUNOL, V36, P39, DOI 10.1016/j.dci.2011.06.002; Yao CL, 2010, FISH SHELLFISH IMMUN, V28, P453, DOI 10.1016/j.fsi.2009.12.002	53	49	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69158	10.1371/journal.pone.0069158	http://dx.doi.org/10.1371/journal.pone.0069158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922688	Green Submitted, gold, Green Published			2022-12-25	WOS:000322838900026
J	Kavitha, CV; Nambiar, M; Narayanaswamy, PB; Thomas, E; Rathore, U; Kumar, CSA; Choudhary, B; Rangappa, KS; Raghavan, SC				Kavitha, Chandagirikoppal V.; Nambiar, Mridula; Narayanaswamy, Pavan B.; Thomas, Elizabeth; Rathore, Ujjwal; Kumar, Channapillekoppalu S. Ananda; Choudhary, Bibha; Rangappa, Kanchugarakoppal S.; Raghavan, Sathees C.			Propyl-2-(8-(3,4-Difluorobenzyl)-2 ',5 '-Dioxo-8-Azaspiro[Bicyclo[3.2.1] Octane-3,4 '-Imidazolidine]-1 '-yl) Acetate Induces Apoptosis in Human Leukemia Cells through Mitochondrial Pathway following Cell Cycle Arrest	PLOS ONE			English	Article							HYDANTOINS; AGENTS; EXPRESSION; P53	Background: Due to the functional defects in apoptosis signaling molecules or deficient activation of apoptosis pathways, leukemia has become an aggressive disease with poor prognosis. Although the majority of leukemia patients initially respond to chemotherapy, relapse is still the leading cause of death. Hence targeting apoptosis pathway would be a promising strategy for the improved treatment of leukemia. Hydantoin derivatives possess a wide range of important biological and pharmacological properties including anticancer properties. Here we investigated the antileukemic activity and mechanism of action of one of the potent azaspiro hydantoin derivative, (ASHD). Materials and Methods: To investigate the antileukemic efficacy of ASHD, we have used MTT assay, cell cycle analysis by FACS, tritiated thymidine incorporation assay, Annexin V staining, JC1 staining and western blot analysis. Results: Results showed that ASHD was approximately 3-fold more potent than the parent compounds in inducing cytotoxicity. Tritiated thymidine assay in conjunction with cell cycle analysis suggests that ASHD inhibited the growth of leukemic cells. The limited effect of ASHD on cell viability of normal cells indicated that it may be specifically directed to cancer cells. Translocation of phosphatidyl serine, activation of caspase 3, caspase 9, PARP, alteration in the ratio of BCL2/BAD protein expression as well as the loss of mitochondrial membrane potential suggests activation of the intrinsic pathway of apoptosis. Conclusion: These results could facilitate the future development of novel hydantoin derivatives as chemotherapeutic agents for leukemia.	[Kavitha, Chandagirikoppal V.; Nambiar, Mridula; Narayanaswamy, Pavan B.; Thomas, Elizabeth; Rathore, Ujjwal; Choudhary, Bibha; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Kumar, Channapillekoppalu S. Ananda; Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; University of Mysore	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in	Thomas, Elizabeth/AAV-3393-2020; Rathore, Ujjwal/AAD-9974-2021	Rathore, Ujjwal/0000-0002-0329-7431; Narayanaswamy, Pavan/0000-0001-5135-0527	Lady Tata Memorial Trust; IISc	Lady Tata Memorial Trust; IISc	This work was supported by Lady Tata Memorial Trust international award for leukemia research, and IISc startup grant for SCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazil CW, 1998, ANNU REV MED, V49, P135; Chiruvella KK, 2008, FEBS LETT, V582, P4066, DOI 10.1016/j.febslet.2008.11.001; COMBER RN, 1992, J MED CHEM, V35, P3567, DOI 10.1021/jm00097a014; Durland-Busbice S, 2002, LEUKEMIA, V16, P2165, DOI 10.1038/sj.leu.2402647; Fiallo MML, 2001, EUR J PHARM SCI, V12, P487, DOI 10.1016/S0928-0987(00)00200-1; Kavitha CV, 2009, BIOCHEM PHARMACOL, V77, P348, DOI 10.1016/j.bcp.2008.10.018; Kumar CSA, 2009, INVEST NEW DRUG, V27, P327, DOI 10.1007/s10637-008-9179-3; Kumar TS, 2010, J BIOL CHEM, V285, P32657, DOI 10.1074/jbc.M110.140350; LUBBERT M, 1988, J EXP MED, V167, P873, DOI 10.1084/jem.167.3.873; Miyato Y, 2004, J RADIAT RES, V45, P189, DOI 10.1269/jrr.45.189; Nefzi A, 2002, J COMB CHEM, V4, P175, DOI 10.1021/cc010064l; Neuzil J, 2007, J BIOENERG BIOMEMBR, V39, P65, DOI 10.1007/s10863-006-9060-z; RODGERS TR, 1977, J MED CHEM, V20, P591, DOI 10.1021/jm00214a031; ROSENFELD C, 1977, EUR J CANCER, V13, P377, DOI 10.1016/0014-2964(77)90085-8; Rudin CM, 1997, ANNU REV MED, V48, P267; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Shahabuddin MS, 2011, INVEST NEW DRUG, V29, P523, DOI 10.1007/s10637-009-9379-5; Shahabuddin MS, 2010, INVEST NEW DRUG, V28, P35, DOI 10.1007/s10637-008-9212-6; Shangary S, 2005, MITOCHONDRIAL DEATH; Somsak L, 2001, J MED CHEM, V44, P2843, DOI 10.1021/jm010892t; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thenmozhiyal JC, 2004, J MED CHEM, V47, P1527, DOI 10.1021/jm030450c; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TOMPKINS JE, 1986, J MED CHEM, V29, P855, DOI 10.1021/jm00155a042; Xie Y, 2003, CANCER-AM CANCER SOC, V97, P2229, DOI 10.1002/cncr.11316	25	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69103	10.1371/journal.pone.0069103	http://dx.doi.org/10.1371/journal.pone.0069103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922684	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000322838900022
J	Kim, JS; Kwon, D; Hwang, ST; Lee, DR; Shim, SH; Kim, HC; Park, H; Kim, W; Han, MK; Lee, SH				Kim, Jin-Su; Kwon, Daekee; Hwang, Seung-Taeh; Lee, Dong Ryul; Shim, Sung Han; Kim, Hee-Chun; Park, Hansoo; Kim, Won; Han, Myung-Kwan; Lee, Soo-Hong			hESC Expansion and Stemness Are Independent of Connexin Forty-Three-Mediated Intercellular Communication between hESCs and hASC Feeder Cells	PLOS ONE			English	Article							FUNCTIONAL GAP-JUNCTIONS; SELF-RENEWAL; UNDIFFERENTIATED GROWTH; HUMAN BLASTOCYSTS; HUMAN PLACENTA; DIFFERENTIATION; CULTURE; LINES; MOUSE; PROPAGATION	Background: Human embryonic stem cells (hESCs) are a promising and powerful source of cells for applications in regenerative medicine, tissue engineering, cell-based therapies, and drug discovery. Many researchers have employed conventional culture techniques using feeder cells to expand hESCs in significant numbers, although feeder-free culture techniques have recently been developed. In regard to stem cell expansion, gap junctional intercellular communication (GJIC) is thought to play an important role in hESC survival and differentiation. Indeed, it has been reported that hESC-hESC communication through connexin 43 (Cx43, one of the major gap junctional proteins) is crucial for the maintenance of hESC stemness during expansion. However, the role of GJIC between hESCs and feeder cells is unclear and has not yet been reported. Methodology/Principal Findings: This study therefore examined whether a direct Cx43-mediated interaction between hESCs and human adipose-derived stem cells (hASCs) influences the maintenance of hESC stemness. Over 10 passages, hESCs cultured on a layer of Cx43-downregulated hASC feeder cells showed normal morphology, proliferation (colony growth), and stemness, as assessed by alkaline phosphatase (AP), OCT4 (POU5F1-Human gene Nomenclature Database), SOX2, and NANOG expression. Conclusions/Significance: These results demonstrate that Cx43-mediated GJIC between hESCs and hASC feeder cells is not an important factor for the conservation of hESC stemness and expansion.	[Kim, Jin-Su; Kwon, Daekee; Hwang, Seung-Taeh; Lee, Soo-Hong] CHA Univ, Dept Biomed Sci, Songnam, South Korea; [Lee, Dong Ryul; Shim, Sung Han] CHA Univ, Dept Biomed Sci, Seoul, South Korea; [Kim, Hee-Chun] Bundang CHA Hosp, Dept Orthopaed, Songnam, South Korea; [Park, Hansoo] Chung Ang Univ, Dept Integrat Engn, Seoul 156756, South Korea; [Kim, Won] Chonbuk Natl Univ, Dept Internal Med, Jeonju, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Dept Microbiol, Jeonju, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Dept Biochem, Jeonju, South Korea	Pochon Cha University; Pochon Cha University; Chung Ang University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Han, MK (corresponding author), Chonbuk Natl Univ, Dept Microbiol, Jeonju, South Korea.	iamtom@jbnu.ac.kr; soohong@cha.ac.krv		Han, Myung-Kwan/0000-0003-1931-8898	Korea Healthcare Technology RD Project [A 091087]	Korea Healthcare Technology RD Project	This work was supported by a grant from the Korea Healthcare Technology R&D Project, administered by the Ministry for Health, Welfare and Family Affairs, Republic of Korea (grant no. A 091087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaci M, 2008, BIOTECHNIQUES, V45, P33, DOI 10.2144/000112810; Amit M, 2011, NAT PROTOC, V6, P572, DOI 10.1038/nprot.2011.325; Archambeault DR, 2010, P NATL ACAD SCI USA, V107, P10526, DOI 10.1073/pnas.1000318107; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Carpenter MK, 2004, DEV DYNAM, V229, P243, DOI 10.1002/dvdy.10431; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Dravid G, 2006, METH MOL B, V331, P91; Escobedo-Lucea C, 2010, METHODS MOL BIOL, V584, P55, DOI 10.1007/978-1-60761-369-5_3; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Galat V, 2011, STEM CELLS DEV; Galat V, 2012, STEM CELLS DEV, V21, P1250, DOI 10.1089/scd.2010.0578; Haku Ken, 2011, Bull Tokyo Dent Coll, V52, P173; Hardy K, 1996, MOL HUM REPROD, V2, P621, DOI 10.1093/molehr/2.8.621; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hentze H, 2007, TRENDS BIOTECHNOL, V25, P24, DOI 10.1016/j.tibtech.2006.10.010; Huettner JE, 2006, STEM CELLS, V24, P1654, DOI 10.1634/stemcells.2005-0003; Hwang ST, 2010, BIOMATERIALS, V31, P8012, DOI 10.1016/j.biomaterials.2010.07.031; Hwang ST, 2009, TISSUE ENG REGEN MED, V6, P1375; Kong SW, 2011, BONE, V48, P298, DOI 10.1016/j.bone.2010.09.029; Krysko DV, 2005, APOPTOSIS, V10, P459, DOI 10.1007/s10495-005-1875-2; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Li D, 2010, J CELL BIOL, V191, P631, DOI 10.1083/jcb.201006094; Li L, 2010, STEM CELLS, V28, P247, DOI 10.1002/stem.289; Liang YJ, 2011, STEM CELLS, V29, P1995, DOI 10.1002/stem.750; Lin TM, 2007, BIOCHEM BIOPH RES CO, V361, P883, DOI 10.1016/j.bbrc.2007.07.116; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Park Y, 2010, STEM CELLS DEV, V19, P1713, DOI 10.1089/scd.2010.0014; Park Y, 2010, CELL REPROGRAM, V12, P315, DOI 10.1089/cell.2009.0113; RAMOSMEJIA V, 2011, STEM CELLS DEV; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Sharovskaya YY, 2012, STEM CELLS DEV; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Todorova MG, 2008, J CELL PHYSIOL, V214, P354, DOI 10.1002/jcp.21203; Trosko JE, 2000, METHODS, V20, P245, DOI 10.1006/meth.1999.0941; Unger C., 2008, CURR PROTOC STEM CEL; Valiunas V, 2004, J PHYSIOL-LONDON, V555, P617, DOI 10.1113/jphysiol.2003.058719; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wong RCB, 2008, STEM CELL REV, V4, P283, DOI 10.1007/s12015-008-9038-9; Wong RCB, 2006, BIOCHEM BIOPH RES CO, V344, P181, DOI 10.1016/j.bbrc.2006.03.127; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu XF, 2011, MECH DEVELOP, V128, P412, DOI 10.1016/j.mod.2011.08.001; Yabut O, 2011, AGING-US, V3, P494, DOI 10.18632/aging.100328	52	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69175	10.1371/journal.pone.0069175	http://dx.doi.org/10.1371/journal.pone.0069175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922689	gold, Green Submitted, Green Published			2022-12-25	WOS:000322838900027
J	Patterson, S; Moran, P; Epel, E; Sinclair, E; Kemeny, ME; Deeks, SG; Bacchetti, P; Acree, M; Epling, L; Kirschbaum, C; Hecht, FM				Patterson, Sarah; Moran, Patricia; Epel, Elissa; Sinclair, Elizabeth; Kemeny, Margaret E.; Deeks, Steven G.; Bacchetti, Peter; Acree, Michael; Epling, Lorrie; Kirschbaum, Clemens; Hecht, Frederick M.			Cortisol Patterns Are Associated with T Cell Activation in HIV	PLOS ONE			English	Article							CD38 ANTIGEN-EXPRESSION; PRIMATE LYMPH-NODES; IMMUNE ACTIVATION; DEPRESSIVE SYMPTOMS; DISEASE PROGRESSION; SHORTER SURVIVAL; HLA-DR; INFECTION; STRESS; MARKER	Objective: The level of T cell activation in untreated HIV disease is strongly and independently associated with risk of immunologic and clinical progression. The factors that influence the level of activation, however, are not fully defined. Since endogenous glucocorticoids are important in regulating inflammation, we sought to determine whether less optimal diurnal cortisol patterns are associated with greater T cell activation. Methods: We studied 128 HIV-infected adults who were not on treatment and had a CD4(+) T cell count above 250 cells/ml. We assessed T cell activation by CD38 expression using flow cytometry, and diurnal cortisol was assessed with salivary measurements. Results: Lower waking cortisol levels correlated with greater T cell immune activation, measured by CD38 mean fluorescent intensity, on CD4(+) T cells (r = -0.26, p = 0.006). Participants with lower waking cortisol also showed a trend toward greater activation on CD8(+) T cells (r = -0.17, p = 0.08). A greater diurnal decline in cortisol, usually considered a healthy pattern, correlated with less CD4(+) (r = 0.24, p = 0.018) and CD8(+) (r = 0.24, p = 0.017) activation. Conclusions: These data suggest that the hypothalamic-pituitary-adrenal (HPA) axis contributes to the regulation of T cell activation in HIV. This may represent an important pathway through which psychological states and the HPA axis influence progression of HIV.	[Patterson, Sarah; Moran, Patricia; Sinclair, Elizabeth; Deeks, Steven G.; Acree, Michael; Epling, Lorrie; Hecht, Frederick M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Epel, Elissa; Kemeny, Margaret E.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kirschbaum, Clemens] Tech Univ Dresden, D-01062 Dresden, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Technische Universitat Dresden	Hecht, FM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	rhecht@php.ucsf.edu	Kirschbaum, Clemens/AAB-1752-2020	Hecht, Frederick/0000-0002-5782-1171	U.S. National Institutes of Health; NCCAM [PO1 AT002024]; NCRR [UL1RR024131]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P01AT002024] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT007827] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the U.S. National Institutes of Health, NCCAM PO1 AT002024 and NCRR UL1RR024131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2001, PSYCHONEUROENDOCRINO, V26, P189, DOI 10.1016/S0306-4530(00)00045-7; Bower JE, 2005, PSYCHONEUROENDOCRINO, V30, P92, DOI 10.1016/j.psyneuen.2004.06.003; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Capitanio JP, 1998, P NATL ACAD SCI USA, V95, P4714, DOI 10.1073/pnas.95.8.4714; Capitanio JP, 1999, BRAIN BEHAV IMMUN, V13, P138, DOI 10.1006/brbi.1998.0540; Cohen S, 2006, PSYCHOSOM MED, V68, P41, DOI 10.1097/01.psy.0000195967.51768.ea; Cole SW, 2008, PSYCHOSOM MED, V70, P562, DOI 10.1097/PSY.0b013e3181773bbd; Cole SW, 2001, P NATL ACAD SCI USA, V98, P12695, DOI 10.1073/pnas.221134198; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deterre P, 1996, J IMMUNOL, V157, P1381; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hajat A, 2010, PSYCHONEUROENDOCRINO; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Iyer SB, 1998, CYTOMETRY, V33, P206, DOI 10.1002/(SICI)1097-0320(19981001)33:2<206::AID-CYTO15>3.0.CO;2-Y; Kemeny ME, 2007, BRAIN BEHAV IMMUN, V21, P1009, DOI 10.1016/j.bbi.2007.07.010; KESTENS L, 1994, CLIN EXP IMMUNOL, V95, P436, DOI 10.1111/j.1365-2249.1994.tb07015.x; Kino T, 1999, J EXP MED, V189, P51, DOI 10.1084/jem.189.1.51; Knight JM, 2010, PSYCHOSOM MED, V72, P855, DOI 10.1097/PSY.0b013e3181f4ab87; Kumari M, 2010, PSYCHOSOM MED, V72, P27, DOI 10.1097/PSY.0b013e3181c85712; Leserman J, 2000, AM J PSYCHIAT, V157, P1221, DOI 10.1176/appi.ajp.157.8.1221; Lindeberg SI, 2008, PSYCHONEUROENDOCRINO, V33, P471, DOI 10.1016/j.psyneuen.2008.01.005; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Liu ZY, 1996, CYTOMETRY, V26, P1; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Miller GE, 2008, BIOL PSYCHIAT, V64, P266, DOI 10.1016/j.biopsych.2008.03.017; Plaeger S, 1999, CLIN IMMUNOL, V90, P238, DOI 10.1006/clim.1998.4646; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Savarino A, 2000, AIDS, V14, P1079, DOI 10.1097/00002030-200006160-00004; Schlotz W, 2004, PSYCHOSOM MED, V66, P207, DOI 10.1097/01.psy.0000116715.78238.56; Sinclair E, 2006, J INFECT DIS, V194, P1537, DOI 10.1086/508997; Sloan EK, 2006, J VIROL, V80, P4326, DOI 10.1128/JVI.80.9.4326-4335.2006; Sloan EK, 2007, J NEUROSCI, V27, P8857, DOI 10.1523/JNEUROSCI.1247-07.2007; UMEDA T, 1981, CLIN CHIM ACTA, V110, P245; WALKER RF, 1978, CLIN CHEM, V24, P1460; WEITZMAN ED, 1971, J CLIN ENDOCR METAB, V33, P14, DOI 10.1210/jcem-33-1-14; Zapanti E, 2008, HORM-INT J ENDOCRINO, V7, P205, DOI 10.14310/horm.2002.1200	40	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e63429	10.1371/journal.pone.0063429	http://dx.doi.org/10.1371/journal.pone.0063429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922644	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900001
J	Pitti, A; Kuniyoshi, Y; Quoy, M; Gaussier, P				Pitti, Alexandre; Kuniyoshi, Yasuo; Quoy, Mathias; Gaussier, Philippe			Modeling the Minimal Newborn's Intersubjective Mind: The Visuotopic-Somatotopic Alignment Hypothesis in the Superior Colliculus	PLOS ONE			English	Article							ORIENTING BEHAVIOR; IMITATION; INTEGRATION; FETAL; SPIKE; PERCEPTION; MECHANISMS; STRATEGIES; PREFERENCE; EMERGENCE	The question whether newborns possess inborn social skills is a long debate in developmental psychology. Fetal behavioral and anatomical observations show evidences for the control of eye movements and facial behaviors during the third trimester of pregnancy whereas specific sub-cortical areas, like the superior colliculus (SC) and the striatum appear to be functionally mature to support these behaviors. These observations suggest that the newborn is potentially mature for developing minimal social skills. In this manuscript, we propose that the mechanism of sensory alignment observed in SC is particularly important for enabling the social skills observed at birth such as facial preference and facial mimicry. In a computational simulation of the maturing superior colliculus connected to a simulated facial tissue of a fetus, we model how the incoming tactile information is used to direct visual attention toward faces. We suggest that the unisensory superficial visual layer (eye-centered) and the deep somatopic layer (face-centered) in SC are combined into an intermediate layer for visuo-tactile integration and that multimodal alignment in this third layer allows newborns to have a sensitivity to configuration of eyes and mouth. We show that the visual and tactile maps align through a Hebbian learning stage and and strengthen their synaptic links from each other into the intermediate layer. It results that the global network produces some emergent properties such as sensitivity toward the spatial configuration of face-like patterns and the detection of eyes and mouth movement.	[Pitti, Alexandre; Quoy, Mathias; Gaussier, Philippe] Univ Cergy Pontoise, ENSEA, UMR CNRS 8051, Dept Comp Sci,ETIS Lab, Cergy Pontoise, France; [Kuniyoshi, Yasuo] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Mechanoinformat, ISI Lab, Tokyo, Japan	CY Cergy Paris Universite; University of Tokyo	Pitti, A (corresponding author), Univ Cergy Pontoise, ENSEA, UMR CNRS 8051, Dept Comp Sci,ETIS Lab, Cergy Pontoise, France.	alexandre.pitti@ensea.fr	Pitti, Alex/GYV-0908-2022	Pitti, Alex/0000-0002-6541-578X	Japan Science and Technology Agency Asada ERATO Synergistic project (Japan); Agence Nationale de la Recherche (France) [INTERACT ANR09-CORD-014]	Japan Science and Technology Agency Asada ERATO Synergistic project (Japan); Agence Nationale de la Recherche (France)(French National Research Agency (ANR))	This study was supported by Japan Science and Technology Agency Asada ERATO Synergistic project (Japan) (http://www.jst.go.jp/EN/) and Agence Nationale de la Recherche project INTERACT ANR09-CORD-014 (France) (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerra F, 2002, DEVELOPMENTAL SCI, V5, P98, DOI 10.1111/1467-7687.00215; Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; Balas B, 2010, DEVELOPMENTAL SCI, V13, P469, DOI 10.1111/j.1467-7687.2009.00901.x; Bednar JA, 2003, NEURAL COMPUT, V15, P1525, DOI 10.1162/089976603321891792; BENEDETTI F, 1995, EUR J NEUROSCI, V7, P1512, DOI 10.1111/j.1460-9568.1995.tb01146.x; Benedetti F, 2006, EUROPEAN J NEUROSCIE, V7, P1942; BOOT PM, 1992, AM J DERMATOPATH, V14, P391, DOI 10.1097/00000372-199210000-00003; Boucenna S., 2010, AUTONOMOUS DEV SOCIA; Boucenna S, 2010, IROS, P1; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Bremner AJ, 2008, TRENDS COGN SCI, V12, P298, DOI 10.1016/j.tics.2008.05.003; Casey M, 2008, P INT JOINT C NEUR N; Crish SD, 2006, NEUROSCIENCE, V139, P1461, DOI 10.1016/j.neuroscience.2005.11.073; Crish SD, 2003, J COMP NEUROL, V464, P415, DOI 10.1002/cne.10791; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; de Schonen S., 1989, EUROPEAN B COGNITIVE, V9, P3; DEVRIES JIP, 1982, EARLY HUM DEV, V7, P301, DOI 10.1016/0378-3782(82)90033-0; DOMINEY PF, 1992, CEREB CORTEX, V2, P153, DOI 10.1093/cercor/2.2.153; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Ferrari PF, 2009, CHILD DEV, V80, P1057, DOI 10.1111/j.1467-8624.2009.01316.x; Ferrell C., 1996, From Animals to Animats 4. Proceedings of the Fourth International Conference on Simulation of Adaptive Behavior, P94; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Glaser C, 2011, IEEE T AUTON MENT DE, V3, P285, DOI 10.1109/TAMD.2011.2138705; Groh JM, 1996, J NEUROPHYSIOL, V75, P439, DOI 10.1152/jn.1996.75.1.439; Heyes C, 2003, PSYCHOL REV, V110, P713, DOI 10.1037/0033-295X.110.4.713; James DK, 2010, INFANT CHILD DEV, V19, P45, DOI 10.1002/icd.653; Johnson MH, 2007, ACTA PAEDIATR, V96, P3, DOI 10.1111/j.1651-2227.2006.00037.x; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Joseph R, 2000, DEV REV, V20, P81, DOI 10.1006/drev.1999.0486; Kadic AS., 2008, DONALD SCHL J ULTRAS, V2, P19, DOI [10.5005/jp-journals-10009-1063, DOI 10.5005/JP-JOURNALS-10009-1063]; Kalesnykas RP, 1996, NEUROSCIENTIST, V2, P284, DOI 10.1177/107385849600200514; King AJ, 2004, CURR BIOL, V14, pR335, DOI 10.1016/j.cub.2004.04.018; Kinjo K, 2008, J ROBOT MECHATRON, V20, P358, DOI 10.20965/jrm.2008.p0358; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kuniyoshi Y, 2003, IEEE INT CONF ROBOT, P3132; Kuniyoshi Y, 2006, BIOL CYBERN, V95, P589, DOI 10.1007/s00422-006-0127-z; Kurjak A., 2005, J PERINAT MED, V31, P496, DOI 10.1515/JPM.2003.076; Lepage JF, 2007, DEVELOPMENTAL SCI, V10, P513, DOI 10.1111/j.1467-7687.2007.00631.x; Lungarella M, 2005, INT C DEVEL LEARN, P25; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Mori Hiroki, 2010, 2010 IEEE 9th International Conference on Development and Learning (ICDL 2010), P82, DOI 10.1109/DEVLRN.2010.5578860; Mori Hiroki, 2007, 7 INT C EP ROB, P93; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Moschovakis AK, 1996, CURR OPIN NEUROBIOL, V6, P811, DOI 10.1016/S0959-4388(96)80032-8; Myowa-Yamakoshi M, 2006, INFANCY, V10, P289, DOI 10.1207/s15327078in1003_5; Nagy E, 2004, INFANT BEHAV DEV, V27, P54, DOI 10.1016/j.infbeh.2003.06.004; Nagy E, 2011, INFANT CHILD DEV, V20, P3, DOI 10.1002/icd.683; Neil PA, 2006, DEVELOPMENTAL SCI, V9, P454, DOI 10.1111/j.1467-7687.2006.00512.x; Nelson CA, 2001, INFANT CHILD DEV, V10, P3, DOI 10.1002/icd.239; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Pavlou A., 2010, P INT JOINT C NEUR N; Pellegrini GL, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016107; Perrault TJ, 2005, J NEUROPHYSIOL, V93, P2575, DOI 10.1152/jn.00926.2004; Piaget J., 1954, CONSTRUCTION REALITY; Pitti A, 2008, EUR PHYS J B, V63, P239, DOI 10.1140/epjb/e2008-00238-2; Pitti A., 2010, 10 INT C EP ROB, P89; Pitti A., 2012, HORIZONS NEUROSCIENC, V6, P247; Pitti A, 2012, IEEE-RAS INT C HUMAN, P297, DOI 10.1109/HUMANOIDS.2012.6651535; Porges SW, 2011, INFANT CHILD DEV, V20, P106, DOI 10.1002/icd.688; Pouget A., 1997, J COGNITIVE NEUROSCI, V3, P1192; Prechtl HFR, 2001, HANDBOOK OF BRAIN AND BEHAVIOUR IN HUMAN DEVELOPMENT, P415; Ray E, 2011, DEVELOPMENTAL SCI, V14, P92, DOI 10.1111/j.1467-7687.2010.00961.x; REDDY V., 2008, INFANTS KNOW MINDS; Rigato S, 2011, INFANT CHILD DEV, V20, P20, DOI 10.1002/icd.684; Rochat P, 2011, CONSCIOUS COGN, V20, P109, DOI 10.1016/j.concog.2010.09.012; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Shibata M, 2012, NEUROREPORT, V23, P373, DOI 10.1097/WNR.0b013e3283520296; Simion F, 1998, J EXP PSYCHOL HUMAN, V24, P1399, DOI 10.1037/0096-1523.24.5.1399; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; SIROSH J, 1994, BIOL CYBERN, V71, P65, DOI 10.1007/BF00198912; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; SPRAGUE JM, 1965, EXP NEUROL, V11, P115, DOI 10.1016/0014-4886(65)90026-9; Stanojevic M., 2008, J ULTRASOUND OBSTET, V2, P64; Stein B., 2010, FRONTIERS INTEGRATIV, V30, P4904; Stein BE, 2010, EUR J NEUROSCI, V31, P1713, DOI 10.1111/j.1460-9568.2010.07206.x; Stein BE, 2009, HEARING RES, V258, P4, DOI 10.1016/j.heares.2009.03.012; STEIN BE, 1984, ANNU REV NEUROSCI, V7, P95, DOI 10.1146/annurev.ne.07.030184.000523; STEIN BE, 1975, SCIENCE, V189, P224, DOI 10.1126/science.1094540; Stein BE., 1993, MERGING SENSES; Streri A, 2000, DEVELOPMENTAL SCI, V3, P319, DOI 10.1111/1467-7687.00126; Takeshita H, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P37, DOI 10.1007/4-431-30248-4_2; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Trevarthen C, 2011, INFANT CHILD DEV, V20, P119, DOI 10.1002/icd.689; Triplett JW, 2012, J NEUROSCI, V32, P5264, DOI 10.1523/JNEUROSCI.0240-12.2012; Tsunozaki M, 2009, AM J DERMATOPATH, V19, P1; Turati C, 2004, CURR DIR PSYCHOL SCI, V13, P5, DOI 10.1111/j.0963-7214.2004.01301002.x; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Van Rullen R, 1998, BIOSYSTEMS, V48, P229, DOI 10.1016/S0303-2647(98)00070-7; VanRullen R, 2002, VISION RES, V42, P2593, DOI 10.1016/S0042-6989(02)00298-5; Wallace M.T., 2004, COGNIT PROCESS, V5, P69, DOI [10.1007/s10339-004-0017-z, DOI 10.1007/S10339-004-0017-Z]; Wallace MT, 2007, J NEUROPHYSIOL, V97, P921, DOI 10.1152/jn.00497.2006; Wallace MT, 2000, J NEUROPHYSIOL, V83, P3578, DOI 10.1152/jn.2000.83.6.3578; Wallace MT, 2001, J NEUROSCI, V21, P8886, DOI 10.1523/JNEUROSCI.21-22-08886.2001; Yamaguchi Y, 2010, PRES VES P, P145	103	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69474	10.1371/journal.pone.0069474	http://dx.doi.org/10.1371/journal.pone.0069474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922718	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900045
J	Zhao, YT; Guo, DG; Hou, SX; Zhong, HB; Yan, J; Zhang, CL; Zhou, Y				Zhao, Yantao; Guo, Dagang; Hou, Shuxun; Zhong, Hongbin; Yan, Jun; Zhang, Chunli; Zhou, Ying			Porous Allograft Bone Scaffolds: Doping with Strontium	PLOS ONE			English	Article							RANELATE; WOMEN; HYDROXYAPATITE; KINETICS; CEMENT; RISK	Strontium (Sr) can promote the process of bone formation. To improve bioactivity, porous allograft bone scaffolds (ABS) were doped with Sr and the mechanical strength and bioactivity of the scaffolds were evaluated. Sr-doped ABS were prepared using the ion exchange method. The density and distribution of Sr in bone scaffolds were investigated by inductively coupled plasma optical emission spectrometry (ICP-OES), X-ray photoelectron spectroscopy (XPS), and energy-dispersive X-ray spectroscopy (EDS). Controlled release of strontium ions was measured and mechanical strength was evaluated by a compressive strength test. The bioactivity of Sr-doped ABS was investigated by a simulated body fluid (SBF) assay, cytotoxicity testing, and an in vivo implantation experiment. The Sr molar concentration [Sr/(Sr+Ca)] in ABS surpassed 5% and Sr was distributed nearly evenly. XPS analyses suggest that Sr combined with oxygen and carbonate radicals. Released Sr ions were detected in the immersion solution at higher concentration than calcium ions until day 30. The compressive strength of the Sr-doped ABS did not change significantly. The bioactivity of Sr-doped material, as measured by the in vitro SBF immersion method, was superior to that of the Sr-free freeze-dried bone and the Sr-doped material did not show cytotoxicity compared with Sr-free culture medium. The rate of bone mineral deposition for Sr-doped ABS was faster than that of the control at 4 weeks (3.28 +/- 0.23 mu m/day vs. 2.60 +/- 0.20 mu m/day; p<0.05). Sr can be evenly doped into porous ABS at relevant concentrations to create highly active bone substitutes.	[Zhao, Yantao; Hou, Shuxun; Zhong, Hongbin; Zhang, Chunli; Zhou, Ying] Chinese Peoples Liberat Army, Affiliated Hosp 1, Gen Hosp, Dept Orthoped, Beijing, Peoples R China; [Guo, Dagang] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China; [Yan, Jun] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Peoples R China	Chinese People's Liberation Army General Hospital; Xi'an Jiaotong University; Air Force Military Medical University	Zhao, YT (corresponding author), Chinese Peoples Liberat Army, Affiliated Hosp 1, Gen Hosp, Dept Orthoped, Beijing, Peoples R China.	Userzyt@qq.com; Userzyt@sina.com		Guo, Dagang/0000-0001-8802-5453	NSFC [81000417, 81201380];  [10KMM33];  [QN201104]	NSFC(National Natural Science Foundation of China (NSFC)); ; 	Kindly thanks for the support of NSFC 81000417, 81201380 and Hospital project 10KMM33, QN201104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenberg P, 1996, ACTA ORTHOP SCAND, V67, P377, DOI 10.3109/17453679609002335; Bakker AD, 2013, BONE, V53, P112, DOI 10.1016/j.bone.2012.11.044; BLAKE GM, 1986, EUR J NUCL MED, V12, P447, DOI 10.1007/BF00254749; Brewer L, 2011, EUR J CLIN PHARMACOL, V67, P321, DOI 10.1007/s00228-011-0999-2; Cazalbou S, 2005, J MATER SCI-MATER M, V16, P405, DOI 10.1007/s10856-005-6979-2; Costain DJ, 2009, INJURY, V40, P1260, DOI 10.1016/j.injury.2009.01.116; Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7; Guo DG, 2009, J BIOMED MATER RES A, V88A, P43, DOI 10.1002/jbm.a.31844; Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032; Jensen J.-E. Beck, 1997, Bone (New York), V20, p104S; Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218; Johal KK, 2002, J MATER SCI-MATER M, V13, P375, DOI 10.1023/A:1014336517741; Kalish Bryan P, 2008, J Oral Implantol, V34, P83, DOI 10.1563/1548-1336(2008)34[83:IOMDBO]2.0.CO;2; Kannan S, 2011, ACTA BIOMATER, V7, P1835, DOI 10.1016/j.actbio.2010.12.009; Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006; Li YF, 2010, BIOMATERIALS, V31, P9006, DOI 10.1016/j.biomaterials.2010.07.112; Linde F, 1988, Eng Med, V17, P23, DOI 10.1243/EMED_JOUR_1988_017_008_02; Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055; Matsunaga K, 2009, J PHYS CHEM B, V113, P3584, DOI 10.1021/jp808713m; MORENO EC, 1990, J BIOL BUCCALE, V18, P195; NEUMAN WF, 1956, J BIOL CHEM, V219, P551; Nielsen SP, 2004, J CLIN DENSITOM, V7, P262, DOI 10.1385/JCD:7:3:262; Panzavolta S, 2008, J BIOMED MATER RES A, V84A, P965, DOI 10.1002/jbm.a.31412; Reginster JY, 2003, DRUG TODAY, V39, P89, DOI 10.1358/dot.2003.39.2.799416; Rodríguez Juliana, 2012, Acta odontol. latinoam., V25, P208; Roschger P, 2010, J BONE MINER RES, V25, P891, DOI 10.1359/jbmr.091028; Roux C, 2006, J BONE MINER RES, V21, P536, DOI 10.1359/JBMR.060101; Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7; Seeman E, 2006, J BONE MINER RES, V21, P1113, DOI 10.1359/JBMR.060404; Takaoka S, 2010, HORM METAB RES, V42, P627, DOI 10.1055/s-0030-1255091; Tsourvakas S, 2009, ACTA ORTHOP BELG, V75, P537; Van der Stok J, 2011, ACTA BIOMATER, V7, P739, DOI 10.1016/j.actbio.2010.07.035; Vestermark MT, 2011, DAN MED BULL, V58; Yan J, 2013, J BIOMED MATER RES A, V101, P2465, DOI 10.1002/jbm.a.34548; Yang GL, 2012, INT J ORAL MAX IMPL, V27, P1332; Yerramshetty JS, 2006, BONE, V39, P1236, DOI 10.1016/j.bone.2006.06.002	38	20	21	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69339	10.1371/journal.pone.0069339	http://dx.doi.org/10.1371/journal.pone.0069339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922703	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900035
J	Jiang, YD; Zhang, QH; Liu, L; Tang, J; Kern, TS; Steinle, JJ				Jiang, Youde; Zhang, Qiuhua; Liu, Li; Tang, Jie; Kern, Timothy S.; Steinle, Jena J.			beta 2-Adrenergic Receptor Knockout Mice Exhibit A Diabetic Retinopathy Phenotype	PLOS ONE			English	Article							RAT RETINA; ADRENERGIC-RECEPTORS; INDUCED APOPTOSIS; MULLER CELLS; EXPRESSION; PHOSPHORYLATION; ALPHA	There is considerable evidence from our lab and others for a functional link between beta-adrenergic receptor and insulin receptor signaling pathways in retina. Furthermore, we hypothesize that this link may contribute to lesions similar to diabetic retinopathy in that the loss of adrenergic input observed in diabetic retinopathy may disrupt normal anti-apoptotic insulin signaling, leading to retinal cell death. Our studies included assessment of neural retina function (ERG), vascular degeneration, and Muller glial cells (which express only beta 1 and beta 2-adrenergic receptor subtypes). In the current study, we produced beta 2-adrenergic receptor knockout mice to examine this deletion on retinal neurons and vasculature, and to identify specific pathways through which beta 2-adrenergic receptor modulates insulin signaling. As predicted from our hypothesis, beta 2-adrenergic receptor knockout mice display certain features similar to diabetic retinopathy. In addition, loss of beta 2-adrenergic input resulted in an increase in TNF alpha, a key inhibitor of insulin receptor signaling. Increased TNF alpha may be associated with insulin-dependent production of the anti-apoptotic factor, Akt. Since the effects occurred in vivo under normal glucose conditions, we postulate that aspects of the diabetic retinopathy phenotype might be triggered by loss of beta 2-adrenergic receptor signaling.	[Jiang, Youde; Zhang, Qiuhua; Steinle, Jena J.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Liu, Li; Steinle, Jena J.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Ophthalmol & Med, Cleveland, OH 44106 USA; [Kern, Timothy S.] Stokes Vet Adm Hosp, Dept Res, Cleveland, OH USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Steinle, JJ (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA.	jsteinl1@uthsc.edu	zhang, qiu/GXG-5600-2022		National Eye Institute [R01EY022045, EY00300]; Juvenile Diabetes Research Foundation [2-2011-597]; Oxnard Foundation; Research to Prevent Blindness Award; NEI [PHS 3P30, EY013080]; Veterans Administration; NATIONAL EYE INSTITUTE [R01EY022045, R01EY000300, R56EY000300, P30EY021721, P30EY013080] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Oxnard Foundation; Research to Prevent Blindness Award(Research to Prevent Blindness (RPB)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Administration(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute Vision Grants R01EY022045 (JJS) and EY00300 (TSK); Juvenile Diabetes Research Foundation Grant (2-2011-597 to JJS); Oxnard Foundation (JJS); Research to Prevent Blindness Award (PI: Barrett Haik); NEI Vision Core Grant: PHS 3P30; EY013080 (PI: Dianna Johnson), and a Merit Grant from the Veterans Administration (TSK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; BURNSTOCK G, 1990, J AUTONOM NERV SYST, V30, pS25, DOI 10.1016/0165-1838(90)90096-2; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Jiang YD, 2010, EXP EYE RES, V91, P171, DOI 10.1016/j.exer.2010.04.014; Jiang YD, 2010, INVEST OPHTH VIS SCI, V51, P2730, DOI 10.1167/iovs.09-4779; Kusner LL, 2004, INVEST OPHTH VIS SCI, V45, P1553, DOI 10.1167/iovs.03-1294; Panjala SR, 2011, MOL VIS, V17, P1822; Steinle JJ, 2009, EXP EYE RES, V88, P1014, DOI 10.1016/j.exer.2008.12.015; Steinle JJ, 2003, J BIOL CHEM, V278, P20681, DOI 10.1074/jbc.M300368200; Steinle JJ, 2002, BRIT J PHARMACOL, V136, P730, DOI 10.1038/sj.bjp.0704771; Walker RJ, 2011, INVEST OPHTHALMOL VI; Walker RJ, 2007, INVEST OPHTH VIS SCI, V48, P5276, DOI 10.1167/iovs.07-0129; Wiley LA, 2005, INVEST OPHTH VIS SCI, V46, P744, DOI 10.1167/iovs.04-1023; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779	15	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70555	10.1371/journal.pone.0070555	http://dx.doi.org/10.1371/journal.pone.0070555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894672	Green Submitted, gold, Green Published			2022-12-25	WOS:000322167900134
J	de la Poza, F; Calvo-Pinilla, E; Lopez-Gil, E; Marin-Lopez, A; Mateos, F; Castillo-Olivares, J; Lorenzo, G; Ortego, J				de la Poza, Francisco; Calvo-Pinilla, Eva; Lopez-Gil, Elena; Marin-Lopez, Alejandro; Mateos, Francisco; Castillo-Olivares, Javier; Lorenzo, Gema; Ortego, Javier			Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(-/-) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus	PLOS ONE			English	Article							RECOMBINANT CANARYPOX VIRUS; OUTER CAPSID PROTEINS; HORSESICKNESS VIRUS; ORAL INFECTION; RESPONSES; VP2; IMMUNIZATION; SUFFICIENT; DEFICIENT; GENES	African horse sickness virus (AHSV) belongs to the genus Orbivirus. We have now engineered naked DNAs and recombinant modified vaccinia virus Ankara (rMVA) expressing VP2 and NS1 proteins from AHSV-4. IFNAR((-/-)) mice inoculated with DNA/rMVA-VP2,-NS1 from AHSV-4 in an heterologous prime-boost vaccination strategy generated significant levels of neutralizing antibodies specific of AHSV-4. In addition, vaccination stimulated specific T cell responses against the virus. The vaccine elicited partial protection against an homologous AHSV-4 infection and induced cross-protection against the heterologous AHSV-9. Similarly, IFNAR((-/-)) mice vaccinated with an homologous prime-boost strategy with rMVA-VP2-NS1 from AHSV-4 developed neutralizing antibodies and protective immunity against AHSV-4. Furthermore, the levels of immunity were very high since none of vaccinated animals presented viraemia when they were challenged against the homologous AHSV-4 and very low levels when they were challenged against the heterologous virus AHSV-9. These data suggest that the immunization with rMVA/rMVA was more efficient in protection against a virulent challenge with AHSV-4 and both strategies, DNA/rMVA and rMVA/rMVA, protected against the infection with AHSV-9. The inclusion of the protein NS1 in the vaccine formulations targeting AHSV generates promising multiserotype vaccines.	[de la Poza, Francisco; Calvo-Pinilla, Eva; Lopez-Gil, Elena; Marin-Lopez, Alejandro; Mateos, Francisco; Lorenzo, Gema; Ortego, Javier] INIA, Ctr Invest Sanidad Anim, Madrid, Spain; [Calvo-Pinilla, Eva; Castillo-Olivares, Javier] Pirbright Inst, Woking, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Ortego, J (corresponding author), INIA, Ctr Invest Sanidad Anim, Madrid, Spain.	ortego@inia.es	Castillo-Olivares, Javier/AAA-8837-2019; Ortego, Javier/M-6810-2019; CALVO-PINILLA, EVA/L-5348-2014; Marín-López, Alejandro/K-6418-2014; Castillo-Olivares, Javier/L-5337-2014; Castillo-Olivares, Javier/AAA-7603-2019; ortego, javier/K-6020-2014	Castillo-Olivares, Javier/0000-0003-3453-8557; Ortego, Javier/0000-0002-4275-7277; CALVO-PINILLA, EVA/0000-0002-4667-4081; Marín-López, Alejandro/0000-0003-2840-1722; Castillo-Olivares, Javier/0000-0003-3453-8557; ortego, javier/0000-0002-4275-7277; Lorenzo, Gema/0000-0003-1869-9051	Comision Interministerial de Ciencia y Tecnologia (CICYT) [AGL2011-23506, AGL2011-22485]; European Union [228394-NADIR]	Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); European Union(European Commission)	This work was supported by grants from the Comision Interministerial de Ciencia y Tecnologia (CICYT) (AGL2011-23506 and AGL2011-22485) and the 228394-NADIR-Integrating Activities 7th European Union program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW M, 1995, VET IMMUNOL IMMUNOP, V47, P311, DOI 10.1016/0165-2427(94)05410-T; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; BURRAGE TG, 1993, VIROLOGY, V196, P799, DOI 10.1006/viro.1993.1537; Calvo-Pinilla E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034735; Calvo-Pinilla E, 2010, J GEN VIROL, V91, P2821, DOI 10.1099/vir.0.024117-0; Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027; Castillo-Olivares J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016503; Chiam R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005997; Du Toit R. M., 1944, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V19, P7; El Garch H, 2012, VET IMMUNOL IMMUNOP, V149, P76, DOI 10.1016/j.vetimm.2012.06.009; Eschbaumer M, 2011, VET MICROBIOL; Franceschi V, 2011, VACCINE, V29, P3074, DOI 10.1016/j.vaccine.2011.01.075; GRUBMAN MJ, 1992, VIROLOGY, V186, P444, DOI 10.1016/0042-6822(92)90009-E; Guthrie AJ, 2009, VACCINE, V27, P4434, DOI 10.1016/j.vaccine.2009.05.044; HOWELL P. G., 1962, ONDERSTEPOORT JOUR VET RES, V29, P139; Jabbar TK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060574; Janardhana V, 1999, RES VET SCI, V67, P213, DOI 10.1053/rvsc.1999.0306; Kyle JL, 2008, VIROLOGY, V380, P296, DOI 10.1016/j.virol.2008.08.008; Ma GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034425; Manole V, 2012, J VIROL, V86, P7858, DOI 10.1128/JVI.00517-12; MartinezTorrecuadrada JL, 1996, J GEN VIROL, V77, P1211, DOI 10.1099/0022-1317-77-6-1211; McINTOSH B. M., 1958, ONDERSTEPOORT JOUR VET RES, V27, P465; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; Mortola E, 2004, J VIROL, V78, P2875, DOI 10.1128/JVI.78.6.2875-2883.2004; Ohka S, 2007, J VIROL, V81, P7902, DOI 10.1128/JVI.02675-06; Pretorius A, 2012, VET IMMUNOL IMMUNOP, V146, P81, DOI 10.1016/j.vetimm.2012.01.016; Roy P, 1996, J GEN VIROL, V77, P2053, DOI 10.1099/0022-1317-77-9-2053; Roy P., 1996, FIELDS VIROLOGY, V1, P1709; Scanlen M, 2002, VACCINE, V20, P1079, DOI 10.1016/S0264-410X(01)00445-5; StoneMarschat MA, 1996, VIROLOGY, V220, P219, DOI 10.1006/viro.1996.0304; VANSTADEN V, 1991, VIROLOGY, V185, P500, DOI 10.1016/0042-6822(91)90808-O; von Teichman BF, 2010, VACCINE, V28, P6505, DOI 10.1016/j.vaccine.2010.06.105; Weyer CT, 2013, EQUINE VET J, V45, P117, DOI 10.1111/j.2042-3306.2012.00590.x	33	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70197	10.1371/journal.pone.0070197	http://dx.doi.org/10.1371/journal.pone.0070197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894615	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000192
J	Jimenez-Alberto, A; Alvarado-Facundo, E; Ribas-Aparicio, RM; Castelan-Vega, JA				Jimenez-Alberto, Alicia; Alvarado-Facundo, Esmeralda; Maria Ribas-Aparicio, Rosa; Castelan-Vega, Juan A.			Analysis of Adaptation Mutants in the Hemagglutinin of the Influenza A(H1N1)pdm09 Virus	PLOS ONE			English	Article							SOLVATED INTERACTION ENERGY; MOLECULAR-DYNAMICS; FORCE-FIELD; BINDING; SPECIFICITY; PROTEINS; BALANCE; BIOLOGY; FUSION; D222G	Hemagglutinin is the major surface glycoprotein of influenza viruses. It participates in the initial steps of viral infection through receptor binding and membrane fusion events. The influenza pandemic of 2009 provided a unique scenario to study virus evolution. We performed molecular dynamics simulations with four hemagglutinin variants that appeared throughout the 2009 influenza A (H1N1) pandemic. We found that variant 1 (S143G, S185T) likely arose to avoid immune recognition. Variant 2 (A134T), and variant 3 (D222E, P297S) had an increased binding affinity for the receptor. Finally, variant 4 (E374K) altered hemagglutinin stability in the vicinity of the fusion peptide. Variants 1 and 4 have become increasingly predominant, while variants 2 and 3 declined as the pandemic progressed. Our results show some of the different strategies that the influenza virus uses to adapt to the human host and provide an example of how selective pressure drives antigenic drift in viral proteins.	[Jimenez-Alberto, Alicia; Alvarado-Facundo, Esmeralda; Maria Ribas-Aparicio, Rosa; Castelan-Vega, Juan A.] Inst Politecn Nacl, Dept Microbiol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Alvarado-Facundo, Esmeralda] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA	Instituto Politecnico Nacional - Mexico; US Food & Drug Administration (FDA)	Castelan-Vega, JA (corresponding author), Inst Politecn Nacl, Dept Microbiol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico.	jcastelv@encb.ipn.mx		Castelan-Vega, Juan/0000-0003-1102-2101	Instituto Politecnico Nacional (IPN), through SIP [20130044, 20131346, 20131349]; COFAA fellowship by the Instituto Politecnico Nacional (IPN)-Mexico; EDI fellowship by the Instituto Politecnico Nacional (IPN)-Mexico; RMR-A of COFAA fellowship by the Instituto Politecnico Nacional (IPN)-Mexico; EDD fellowship by the Instituto Politecnico Nacional (IPN)-Mexico; CONACyT-Mexico; IPN	Instituto Politecnico Nacional (IPN), through SIP; COFAA fellowship by the Instituto Politecnico Nacional (IPN)-Mexico; EDI fellowship by the Instituto Politecnico Nacional (IPN)-Mexico; RMR-A of COFAA fellowship by the Instituto Politecnico Nacional (IPN)-Mexico; EDD fellowship by the Instituto Politecnico Nacional (IPN)-Mexico; CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); IPN	This work was funded by the Instituto Politecnico Nacional (IPN), through SIP grants 20130044, 20131346, and 20131349. AJ-A and JC-V are recipients of COFAA and EDI fellowships, and RMR-A of COFAA and EDD fellowships, all of them granted by the Instituto Politecnico Nacional (IPN)-Mexico. EA-F gives thanks CONACyT-Mexico and IPN for graduate studies fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Case DA, 2012, AMBER 12; Chen GQG, 2012, ACTA MATH SCI, V32, P1; Chen WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038794; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DuBois RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002398; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hess B, 1997, AIDJCC430CO2H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hug Susanna, 2013, Methods Mol Biol, V924, P127, DOI 10.1007/978-1-62703-017-5_6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Jongkon Nipa, 2009, BMC Genomics, V10 Suppl 3, pS24, DOI 10.1186/1471-2164-10-S3-S24; Kao CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031162; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Liechti R, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq004; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Newhouse EI, 2009, J AM CHEM SOC, V131, P17430, DOI 10.1021/ja904052q; O'Donnell CD, 2012, MBIO, V3, DOI 10.1128/mBio.00120-12; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Priyadarzini TRK, 2012, J BIOL CHEM, V287, P34547, DOI 10.1074/jbc.M112.357061; Puzelli S, 2010, EUROSURVEILLANCE, V15, P6; Rykkvin R, 2013, EUROSURVEILLANCE, V18, P3; Sakabe S, 2011, VIRUS RES, V158, P124, DOI 10.1016/j.virusres.2011.03.022; Seyer R, 2012, J INFECT DIS, V205, P262, DOI 10.1093/infdis/jir716; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Xu D, 2009, J MOL BIOL, V387, P465, DOI 10.1016/j.jmb.2009.01.040; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12; Yasugi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030946; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108	41	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70005	10.1371/journal.pone.0070005	http://dx.doi.org/10.1371/journal.pone.0070005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894575	Green Submitted, gold, Green Published			2022-12-25	WOS:000325211000174
J	Richard, G; Meyers, AJ; McLean, MD; Arbabi-Ghahroudi, M; MacKenzie, R; Hall, JC				Richard, Gabrielle; Meyers, Ashley J.; McLean, Michael D.; Arbabi-Ghahroudi, Mehdi; MacKenzie, Roger; Hall, J. Christopher			In Vivo Neutralization of alpha-Cobratoxin with High-Affinity Llama Single-Domain Antibodies (V(H)Hs) and a VHH-Fc Antibody	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; PHAGE DISPLAY LIBRARY; LOCAL TISSUE-DAMAGE; ANTIVENOM DEVELOPMENT; NAJA-KAOUTHIA; SNAKE-VENOM; THAI COBRA; EXPRESSION; FRAGMENT; IGG	Small recombinant antibody fragments (e.g. scFvs and V(H)Hs), which are highly tissue permeable, are being investigated for antivenom production as conventional antivenoms consisting of IgG or F(ab')(2) antibody fragments do not effectively neutralize venom toxins located in deep tissues. However, antivenoms composed entirely of small antibody fragments may have poor therapeutic efficacy due to their short serum half-lives. To increase serum persistence and maintain tissue penetration, we prepared low and high molecular mass antivenom antibodies. Four llama V(H)Hs were isolated from an immune VHH-displayed phage library and were shown to have high affinity, in the low nM range, for alpha-cobratoxin (alpha-Cbtx), the most lethal component of Naja kaouthia venom. Subsequently, our highest affinity VHH (C2) was fused to a human Fc fragment to create a V(H)H2-Fc antibody that would offer prolonged serum persistence. After in planta (Nicotiana benthamiana) expression and purification, we show that our V(H)H2-Fc antibody retained high affinity binding to alpha-Cbtx. Mouse alpha-Cbtx challenge studies showed that our highest affinity V(H)Hs (C2 and C20) and the V(H)H2-Fc antibody effectively neutralized lethality induced by alpha-Cbtx at an antibody: toxin molar ratio as low as ca. 0.75x:1. Further research towards the development of an antivenom therapeutic involving these anti-alpha-Cbtx V(H)Hs and V(H)H2-Fc antibody molecules should involve testing them as a combination, to determine whether they maintain tissue penetration capability and low immunogenicity, and whether they exhibit improved serum persistence and therapeutic efficacy.	[Richard, Gabrielle; Meyers, Ashley J.; McLean, Michael D.; MacKenzie, Roger; Hall, J. Christopher] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Richard, Gabrielle; Arbabi-Ghahroudi, Mehdi; MacKenzie, Roger] Natl Res Council Canada, Human Hlth Therapeut Portfolio, Ottawa, ON, Canada	University of Guelph; National Research Council Canada	Hall, JC (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.	jchall@uoguelph.ca						Arbabi-Ghahroudi M, 2009, METHOD MOL BIOL, V525, pxiii; Arbabi-Ghahroudi Mehdi, 2009, V525, P187, DOI 10.1007/978-1-59745-554-1_10; Baral Toya Nath, 2012, Methods Mol Biol, V911, P257, DOI 10.1007/978-1-61779-968-6_16; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; Canul-Tec JC, 2011, J BIOL CHEM, V286, P20892, DOI 10.1074/jbc.M111.238410; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Chippaux JP, 2006, EPIDEMIOLOGY ENVENOM; Chotwiwatthanakun C, 2001, TOXICON, V39, P1487, DOI 10.1016/S0041-0101(01)00108-8; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; Cook DAN, 2010, TOXICON, V56, P373, DOI 10.1016/j.toxicon.2010.04.005; Cook DAN, 2010, TOXICON, V56, P363, DOI 10.1016/j.toxicon.2010.03.025; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; Cortez-Retamozo V, 2002, INT J CANCER, V98, P456, DOI 10.1002/ijc.10212; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Doyle PJ, 2008, MOL IMMUNOL, V45, P3703, DOI 10.1016/j.molimm.2008.06.005; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Grohs BM, 2010, J AGR FOOD CHEM, V58, P10056, DOI 10.1021/jf102284f; Gutierrez JM, 2003, CLIN PHARMACOKINET, V42, P721, DOI 10.2165/00003088-200342080-00002; Gutierrez JM, 1998, TOXICON, V36, P1529, DOI 10.1016/S0041-0101(98)00145-7; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Harrison RA, 2006, TOXICON, V47, P364, DOI 10.1016/j.toxicon.2005.10.017; Herrera M, 2005, TOXICON, V46, P775, DOI 10.1016/j.toxicon.2005.08.004; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; KABAT EA, 1991, J IMMUNOL, V147, P1709; KARLSSON E, 1972, TOXICON, V10, P217, DOI 10.1016/0041-0101(72)90006-2; Kulkeaw K, 2009, J PROTEOMICS, V72, P270, DOI 10.1016/j.jprot.2008.12.007; Lafaye P, 1997, IMMUNOTECHNOLOGY, V3, P117, DOI 10.1016/S1380-2933(97)00068-7; Lalloo DG, 2003, J TOXICOL-CLIN TOXIC, V41, P277, DOI 10.1081/CLT-120021113; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Makvandi-Nejad S, 2011, J IMMUNOL METHODS, V373, P8, DOI 10.1016/j.jim.2011.07.006; Makvandi-Nejad S, 2010, J IMMUNOL METHODS, V360, P103, DOI 10.1016/j.jim.2010.06.015; Gutierrez JM, 2007, CURR PHARM DESIGN, V13, P2935, DOI 10.2174/138161207782023784; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; McLean MD, 2007, ANTIMICROB AGENTS CH, V51, P3322, DOI 10.1128/AAC.00366-07; Meddeb-Mouelhi F, 2003, TOXICON, V42, P785, DOI 10.1016/j.toxicon.2003.10.021; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Fernandez GP, 2010, TOXICON, V55, P642, DOI 10.1016/j.toxicon.2009.07.031; Pratanaphon R, 1997, VACCINE, V15, P1523, DOI 10.1016/S0264-410X(97)00098-4; Riano-Umbarila L, 2011, J BIOL CHEM, V286, P6143, DOI 10.1074/jbc.M110.189175; Stewart CS, 2007, TOXICON, V49, P699, DOI 10.1016/j.toxicon.2006.11.023; SUNTHORNANDH P, 1992, MOL IMMUNOL, V29, P501, DOI 10.1016/0161-5890(92)90007-K; van der Linden R, 2000, J IMMUNOL METHODS, V240, P185, DOI 10.1016/S0022-1759(00)00188-5; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; Villani ME, 2009, PLANT BIOTECHNOL J, V7, P59, DOI 10.1111/j.1467-7652.2008.00371.x; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Xie XM, 2010, MOL IMMUNOL, V47, P1529, DOI 10.1016/j.molimm.2010.01.016	54	67	71	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69495	10.1371/journal.pone.0069495	http://dx.doi.org/10.1371/journal.pone.0069495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894495	Green Published, gold, Green Submitted			2022-12-25	WOS:000322132100065
J	Saunders, HM; Hughes, VA; Cappai, R; Bottomley, SP				Saunders, Helen M.; Hughes, Victoria A.; Cappai, Roberto; Bottomley, Stephen P.			Conformational Behavior and Aggregation of Ataxin-3 in SDS	PLOS ONE			English	Article							DEUBIQUITINATING ENZYME ATAXIN-3; POLYGLUTAMINE PROTEIN ATAXIN-3; SOLUBLE AMYLOID OLIGOMERS; NON-EXPANDED ATAXIN-3; FIBRIL FORMATION; JOSEPHIN DOMAIN; ALPHA-SYNUCLEIN; HUNTINGTONS-DISEASE; SECONDARY STRUCTURE; LIPID-MEMBRANES	Spinocerebellar ataxia type 3 (SCA3) is one of nine polyglutamine (polyQ) diseases all characterized by the presence of intraneuronal inclusions that contain aggregated protein. Aggregation of ataxin-3, the causative protein of SCA3, has been well characterized in vitro, with both pathogenic and non-pathogenic length ataxin-3 undergoing fibrillogenesis. However, only ataxin-3 containing an expanded polyQ tract leads to SCA3. Therefore other cellular factors, not present in previous in vitro studies, may modulate aggregation during disease. The interactions between fibrillar species and cell membranes have been characterized in a number of amyloid diseases, including Huntington's Disease, and these interactions affect aggregation and toxicity. We have characterized the effects of the membrane mimetic sodium dodecyl sulfate (SDS) on ataxin-3 structure and aggregation, to show that both micellar and non-micellar SDS have differing effects on the two stages of ataxin-3 aggregation. We also demonstrate that fibrillar ataxin-3 binds phospholipids, in particular phosphorylated phosphotidylinositols. These results highlight the effect of intracellular factors on the ataxin-3 misfolding landscape and their implications in SCA3 and polyQ diseases in general are discussed.	[Saunders, Helen M.; Hughes, Victoria A.; Bottomley, Stephen P.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Cappai, Roberto] Univ Melbourne, Dept Pathol & Mol Sci Bio21, Parkville, Vic 3052, Australia; [Cappai, Roberto] Univ Melbourne, Inst Biotechnol, Parkville, Vic 3052, Australia	Monash University; University of Melbourne; University of Melbourne	Bottomley, SP (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	steve.bottomley@monash.edu	Cappai, Roberto/B-3347-2010	Cappai, Roberto/0000-0002-9505-8496	Australian Research Council; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the Australian Research Council and the National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MF, 2006, J MOL BIOL, V364, P1061, DOI 10.1016/j.jmb.2006.09.085; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Bevivino AE, 2001, P NATL ACAD SCI USA, V98, P11955, DOI 10.1073/pnas.211305198; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 2001, J BIOL CHEM, V276, P44889, DOI 10.1074/jbc.M106575200; Chow MKM, 2006, METHOD ENZYMOL, V413, P1, DOI 10.1016/S0076-6879(06)13001-3; Chow MKM, 2004, BIOCHEM BIOPH RES CO, V322, P387, DOI 10.1016/j.bbrc.2004.07.131; Chow MKM, 2004, J BIOL CHEM, V279, P47643, DOI 10.1074/jbc.M405799200; Chow MKM, 2004, J MOL BIOL, V335, P333, DOI 10.1016/j.jmb.2003.08.064; Davis CH, 2009, BIOPHYS J, V96, P785, DOI 10.1016/j.bpj.2008.09.053; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Gales L, 2005, J MOL BIOL, V353, P642, DOI 10.1016/j.jmb.2005.08.061; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Helenius A, 1979, Methods Enzymol, V56, P734; Hirakura Y, 2000, J NEUROSCI RES, V60, P490, DOI 10.1002/(SICI)1097-4547(20000515)60:4<490::AID-JNR7>3.0.CO;2-9; Ignatova Z, 2007, J BIOL CHEM, V282, P36736, DOI 10.1074/jbc.M703682200; Kagan BL, 2001, BRAIN RES BULL, V56, P281, DOI 10.1016/S0361-9230(01)00654-2; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kegel KB, 2009, J NEUROCHEM, V110, P1585, DOI 10.1111/j.1471-4159.2009.06255.x; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Marchal S, 2003, J BIOL CHEM, V278, P31554, DOI 10.1074/jbc.M304205200; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Menon RP, 2006, CELL MOL LIFE SCI, V63, P1677, DOI 10.1007/s00018-006-6097-4; Monoi H, 2000, BIOPHYS J, V78, P2892, DOI 10.1016/S0006-3495(00)76830-5; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Padiath QS, 2005, AM J MED GENET B, V133B, P124, DOI 10.1002/ajmg.b.30088; Pertinhez TA, 2002, FEBS LETT, V529, P193, DOI 10.1016/S0014-5793(02)03333-1; Pozzi C, 2008, NEUROBIOL DIS, V30, P190, DOI 10.1016/j.nbd.2008.01.011; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ricchelli F, 2007, INT J BIOCHEM CELL B, V39, P966, DOI 10.1016/j.biocel.2007.01.012; Robertson AL, 2010, CURR MED CHEM, V17, P3058; Robertson AL, 2011, J MOL BIOL, V413, P879, DOI 10.1016/j.jmb.2011.09.014; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Robertson AL, 2008, BIOPHYS J, V95, P5922, DOI 10.1529/biophysj.108.138487; Saunders HM, 2011, PROTEIN SCI, V20, P1675, DOI 10.1002/pro.698; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Shehi E, 2003, BIOCHEMISTRY-US, V42, P14626, DOI 10.1021/bi0352825; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Suopanki J, 2006, J NEUROCHEM, V96, P870, DOI 10.1111/j.1471-4159.2005.03620.x; Takeyoshi I, 2007, ENCY SURFACE COLLOID, P5251; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Tew DJ, 2008, BIOPHYS J, V94, P2752, DOI 10.1529/biophysj.107.119909; Thakur AK, 2009, NAT STRUCT MOL BIOL; THOMPSON W, 1976, EUR J BIOCHEM, V65, P107, DOI 10.1111/j.1432-1033.1976.tb10394.x; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	64	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69416	10.1371/journal.pone.0069416	http://dx.doi.org/10.1371/journal.pone.0069416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894474	Green Published, gold, Green Submitted			2022-12-25	WOS:000322132100058
J	Ha, J; Kuznetsov, A				Ha, Joon; Kuznetsov, Alexey			Interaction of NMDA Receptor and Pacemaking Mechanisms in the Midbrain Dopaminergic Neuron	PLOS ONE			English	Article							COUPLED-OSCILLATOR MODEL; SUBSTANTIA-NIGRA; FIRING PATTERN; COMPUTATIONAL MODEL; POTASSIUM CHANNELS; CALCIUM-CHANNELS; RAT; DYNAMICS; CONDUCTANCES; FREQUENCY	Dopamine neurotransmission has been found to play a role in addictive behavior and is altered in psychiatric disorders. Dopaminergic (DA) neurons display two functionally distinct modes of electrophysiological activity: low- and high-frequency firing. A puzzling feature of the DA neuron is the following combination of its responses: N-methyl-D-aspartate receptor (NMDAR) activation evokes high-frequency firing, whereas other tonic excitatory stimuli (alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate receptor (AMPAR) activation or applied depolarization) block firing instead. We suggest a new computational model that reproduces this combination of responses and explains recent experimental data. Namely, somatic NMDAR stimulation evokes high-frequency firing and is more effective than distal dendritic stimulation. We further reduce the model to a single compartment and analyze the mechanism of the distinct high-frequency response to NMDAR activation vs. other stimuli. Standard nullcline analysis shows that the mechanism is based on a decrease in the amplitude of calcium oscillations. The analysis confirms that the nonlinear voltage dependence provided by the magnesium block of the NMDAR determine its capacity to elevate the firing frequency. We further predict that the moderate slope of the voltage dependence plays the central role in the frequency elevation. Additionally, we suggest a repolarizing current that sustains calcium-independent firing or firing in the absence of calcium-dependent repolarizing currents. We predict that the ether-a-go-go current (ERG), which has been observed in the DA neuron, is the best fit for this critical role. We show that a calcium-dependent and a calcium-independent oscillatory mechanisms form a structure of interlocked negative feedback loops in the DA neuron. The structure connects research of DA neuron firing with circadian biology and determines common minimal models for investigation of robustness of oscillations, which is critical for normal function of both systems.	[Ha, Joon] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA; [Kuznetsov, Alexey] Purdue Univ Indianapolis, Indiana Univ, Dept Math Sci, Indianapolis, IN USA; [Kuznetsov, Alexey] Purdue Univ Indianapolis, Indiana Univ, Ctr Math Biosci, Indianapolis, IN USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University	Kuznetsov, A (corresponding author), Purdue Univ Indianapolis, Indiana Univ, Dept Math Sci, Indianapolis, IN USA.	alexey@math.iupui.edu			National Science Foundation [DMS-0817717]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022821] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work was supported by the National Science Foundation grant DMS-0817717. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGER BE, 1979, NATURE, V281, P315, DOI 10.1038/281315a0; Amini B, 1999, J NEUROPHYSIOL, V82, P2249, DOI 10.1152/jn.1999.82.5.2249; Blythe SN, 2009, J NEUROSCI, V29, P15531, DOI 10.1523/JNEUROSCI.2961-09.2009; Canavier CC, 2006, J NEUROPHYSIOL, V96, P2549, DOI 10.1152/jn.00704.2006; Canavier CC, 2007, J NEUROPHYSIOL, V98, P3006, DOI 10.1152/jn.00422.2007; Canavier CC, 1999, J COMPUT NEUROSCI, V6, P49, DOI 10.1023/A:1008809000182; CARLSON NR, 1999, FDN PHYSL PSYCHOL; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; CHERGUI K, 1993, EUR J NEUROSCI, V5, P137, DOI 10.1111/j.1460-9568.1993.tb00479.x; Deister CA, 2009, J NEUROSCI, V29, P15888, DOI 10.1523/JNEUROSCI.4053-09.2009; Drion G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002050; Durante P, 2004, J NEUROPHYSIOL, V91, P1450, DOI 10.1152/jn.01015.2003; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; GRACE AA, 1989, J NEUROSCI, V9, P3463; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; HOLMES WR, 1990, J NEUROPHYSIOL, V63, P1148, DOI 10.1152/jn.1990.63.5.1148; JAHR CE, 1990, J NEUROSCI, V10, P3178; Ji H, 2006, NEUROSCIENCE, V140, P623, DOI 10.1016/j.neuroscience.2006.02.020; Ji HF, 2012, EUR J NEUROSCI, V36, P2906, DOI 10.1111/j.1460-9568.2012.08190.x; Johnson SW, 2004, BRAIN RES, V1019, P293, DOI 10.1016/j.brainres.2004.06.022; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; JURASKA JM, 1977, J COMP NEUROL, V172, P585, DOI 10.1002/cne.901720403; Khaliq ZM, 2010, J NEUROSCI, V30, P7401, DOI 10.1523/JNEUROSCI.0143-10.2010; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Komendantov AO, 2004, J NEUROPHYSIOL, V91, P346, DOI 10.1152/jn.00062.2003; Kuznetsov AS, 2006, J NEUROPHYSIOL, V95, P932, DOI 10.1152/jn.00691.2004; Kuznetsova AY, 2010, J COMPUT NEUROSCI, V28, P389, DOI 10.1007/s10827-010-0222-y; Li YX, 1996, NEUROSCIENCE, V71, P397, DOI 10.1016/0306-4522(95)00483-1; Morikawa H, 2003, J NEUROSCI, V23, P149; Nedergaard S, 2004, NEUROSCIENCE, V125, P841, DOI 10.1016/j.neuroscience.2004.02.030; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Nedergaard S, 1993, J NEUROSCI, V48, P423; Oster AM, 2011, J PHYSIOL-PARIS, V105, P53, DOI 10.1016/j.jphysparis.2011.07.012; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Papa M, 2003, J COMP NEUROL, V466, P119, DOI 10.1002/cne.10886; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Putzier I, 2009, J NEUROSCI, V29, P15414, DOI 10.1523/JNEUROSCI.4742-09.2009; Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6; SAH P, 1992, P ROY SOC B-BIOL SCI, V249, P71, DOI 10.1098/rspb.1992.0085; Sanguinetti M, 1990, J GEN PHYSIOL, V96, P196; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SHEPARD PD, 1991, EXP BRAIN RES, V86, P141, DOI 10.1007/BF00231048; SILVA NL, 1990, J NEUROPHYSIOL, V64, P262, DOI 10.1152/jn.1990.64.1.262; Strange PG, 2001, PHARMACOL REV, V53, P119; Tong ZY, 1996, J NEURAL TRANSM, V103, P889, DOI 10.1007/BF01291780; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolfart J, 2002, J NEUROSCI; YUNG WH, 1991, J PHYSIOL-LONDON, V436, P643, DOI 10.1113/jphysiol.1991.sp018571; Zakharov DG, 2012, CHAOS SOLITON FRACT, V45, P640, DOI 10.1016/j.chaos.2012.01.007; Zakharov DG, 2012, JETP LETT, V95, P676	54	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69984	10.1371/journal.pone.0069984	http://dx.doi.org/10.1371/journal.pone.0069984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894569	Green Published, Green Submitted, gold			2022-12-25	WOS:000322391400075
J	Ehmann, DE; Jahic, H; Ross, PL; Gu, RF; Hu, J; Durand-Reville, TF; Lahiri, S; Thresher, J; Livchak, S; Gao, N; Palmer, T; Walkup, GK; Fisher, SL				Ehmann, David E.; Jahic, Haris; Ross, Philip L.; Gu, Rong-Fang; Hu, Jun; Durand-Reville, Thomas F.; Lahiri, Sushmita; Thresher, Jason; Livchak, Stephania; Gao, Ning; Palmer, Tiffany; Walkup, Grant K.; Fisher, Stewart L.			Kinetics of Avibactam Inhibition against Class A, C, and D beta-Lactamases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO ACTIVITY; PSEUDOMONAS-AERUGINOSA; CEFTAZIDIME-AVIBACTAM; NXL104 COMBINATIONS; ENTEROBACTERIACEAE; ANTIBIOTICS; CHALLENGES; POTENT	Avibactam is a non-beta-lactam beta-lactamase inhibitor with a spectrum of activity that includes beta-lactamase enzymes of classes A, C, and selected D examples. In this work acylation and deacylation rates were measured against the clinically important enzymes CTX-M-15, KPC-2, Enterobacter cloacae AmpC, Pseudomonas aeruginosa AmpC, OXA-10, and OXA-48. The efficiency of acylation (k(2)/K-i) varied across the enzyme spectrum, from 1.1 x 10(1) M-1 s(-1) for OXA-10 to 1.0 x 10(5) for CTX-M-15. Inhibition of OXA-10 was shown to follow the covalent reversible mechanism, and the acylated OXA-10 displayed the longest residence time for deacylation, with a half-life of greater than 5 days. Across multiple enzymes, acyl enzyme stability was assessed by mass spectrometry. These inhibited enzyme forms were stable to rearrangement or hydrolysis, with the exception of KPC-2. KPC-2 displayed a slow hydrolytic route that involved fragmentation of the acyl-avibactam complex. The identity of released degradation products was investigated, and a possible mechanism for the slow deacylation from KPC-2 is proposed.	[Ehmann, David E.] AstraZeneca R&D Boston, Infect Innovat Med Unit, Waltham, MA 02451 USA; AstraZeneca R&D Boston, Discovery Sci Innovat Med Unit, Waltham, MA 02451 USA	AstraZeneca; AstraZeneca	Ehmann, DE (corresponding author), AstraZeneca R&D Boston, Infect Innovat Med Unit, 35 Gatehouse Dr, Waltham, MA 02451 USA.	david.ehmann@astrazeneca.com		Gao, Ning/0000-0003-1605-4137				Aktas Z, 2012, INT J ANTIMICROB AG, V39, P86, DOI 10.1016/j.ijantimicag.2011.09.012; Bebrone C, 2010, DRUGS, V70, P651, DOI 10.2165/11318430-000000000-00000; Bethel CR, 2011, ANTIMICROB AGENTS CH, V55, P3465, DOI 10.1128/AAC.00089-11; Bonnefoy A, 2004, J ANTIMICROB CHEMOTH, V54, P410, DOI 10.1093/jac/dkh358; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Bush K, 2012, CURR OPIN PHARMACOL, V12, P527, DOI 10.1016/j.coph.2012.06.003; Bush K, 2011, ANNU REV MICROBIOL, V65, P455, DOI 10.1146/annurev-micro-090110-102911; Bush K, 2010, EXPERT OPIN THER PAT, V20, P1277, DOI 10.1517/13543776.2010.515588; Coleman K, 2011, CURR OPIN MICROBIOL, V14, P550, DOI 10.1016/j.mib.2011.07.026; De Luca F, 2011, P NATL ACAD SCI USA, V108, P18424, DOI 10.1073/pnas.1110530108; Drawz SM, 2011, PROTEIN SCI, V20, P941, DOI 10.1002/pro.612; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dubreuil J, 2012, INT J ANTIMICROB AG, V39, P500, DOI 10.1016/j.ijantimicag.2012.02.013; Ehmann DE, 2012, P NATL ACAD SCI USA, V109, P11663, DOI 10.1073/pnas.1205073109; Fink A. F., 2012, BETA LACTAMASES, P161; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Jencks WP, 1997, ANNU REV BIOCHEM, V66, P1, DOI 10.1146/annurev.biochem.66.1.1; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lahiri SD, 2013, ANTIMICROB AGENTS CH, V57, P2496, DOI 10.1128/AAC.02247-12; Levasseur P, 2012, ANTIMICROB AGENTS CH, V56, P1606, DOI 10.1128/AAC.06064-11; Livermore DM, 2008, J ANTIMICROB CHEMOTH, V62, P1053, DOI 10.1093/jac/dkn320; Livermore DM, 2011, ANTIMICROB AGENTS CH, V55, P390, DOI 10.1128/AAC.00756-10; Miles RW, 1998, BIOCHEMISTRY-US, V37, P8615, DOI 10.1021/bi980658d; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Mushtaq S, 2010, J ANTIMICROB CHEMOTH, V65, P2376, DOI 10.1093/jac/dkq306; Papp-Wallace KM, 2012, ANTIMICROB AGENTS CH, V56, P4428, DOI 10.1128/AAC.05769-11; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Pratt R., 2012, BETA LACTAMASES, P259; Shahid M, 2009, CRIT REV MICROBIOL, V35, P81, DOI 10.1080/10408410902733979; Shlaes DM, 2013, ANN NY ACAD SCI, V1277, P105, DOI 10.1111/nyas.12010; Stachyra T, 2010, ANTIMICROB AGENTS CH, V54, P5132, DOI 10.1128/AAC.00568-10; Stachyra T, 2009, J ANTIMICROB CHEMOTH, V64, P326, DOI 10.1093/jac/dkp197; Walkty A, 2011, ANTIMICROB AGENTS CH, V55, P2992, DOI 10.1128/AAC.01696-10; Xu H, 2012, BIOCHEMISTRY-US, V51, P4551, DOI 10.1021/bi300508r; Zhanel GG, 2013, DRUGS, V73, P159, DOI 10.1007/s40265-013-0013-7	39	255	264	3	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27960	27971		10.1074/jbc.M113.485979	http://dx.doi.org/10.1074/jbc.M113.485979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23913691	hybrid, Green Published			2022-12-25	WOS:000330612800023
J	Yeh, CW; Kao, SH; Cheng, YC; Hsu, LS				Yeh, Chi-Wei; Kao, Shoa-Hsuan; Cheng, Yi-Chuan; Hsu, Li-Sung			Knockdown of Cyclin-dependent Kinase 10 (cdk10) Gene Impairs Neural Progenitor Survival via Modulation of raf1a Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETS2 TRANSCRIPTION FACTOR; PROTEIN-KINASE; CELL-CYCLE; CDC2-RELATED KINASE; ZEBRAFISH; DIFFERENTIATION; IDENTIFICATION; APOPTOSIS; NEURONS; CANCER	In this study, we used zebrafish as an animal model to elucidate the developmental function of cdk10 in vertebrates. In situ hybridization analyses demonstrated that cdk10 is expressed throughout development with a relative enrichment in the brain in the late stages. Similar to its mammalian ortholog, cdk10 can interact with the transcription factor ETS2 and exhibit kinase activity by phosphorylating histone H1. Morpholino-based loss of cdk10 expression caused apoptosis in sox2-positive cells and decreased the expression of subsequent neuronal markers. Acetylated tubulin staining revealed a significant reduction in the number of Rohon-Beard sensory neurons in cdk10 morphants. This result is similar to that demonstrated by decreased islet2 expression in the dorsal regions. Moreover, cdk10 morphants exhibited a marked loss of huC-positive neurons in the telencephalon and throughout the spinal cord axis. The population of retinal ganglion cells was also diminished in cdk10 morphants. These phenotypes were rescued by co-injection of cdk10 mRNA. Interestingly, the knockdown of cdk10 significantly elevated raf1a mRNA expression. Meanwhile, an MEK inhibitor (U0126) recovered sox2 and ngn1 transcript levels in cdk10 morphants. Our findings provide the first functional characterization of cdk10 in vertebrate development and reveal its critical function in neurogenesis by modulation of raf1a expression.	[Yeh, Chi-Wei; Kao, Shoa-Hsuan; Hsu, Li-Sung] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung 40201, Taiwan; [Cheng, Yi-Chuan] Chang Gung Univ, Grad Inst Biomed Sci, Sch Med, Tao Yuan 33302, Taiwan; [Hsu, Li-Sung] Chung Shan Med Univ Hosp, Clin Lab, Taichung 40201, Taiwan	Chung Shan Medical University; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University Hospital	Hsu, LS (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, 110,Sec 1,Jianguo N Rd, Taichung 40201, Taiwan.	lshsu405@yahoo.com.tw			National Science Council (NSC) [NSC-99-2321-B-001-027, 100-2321-B-400-003]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	We thank the Zebrafish Core in Academia Sinica, Institute of Cellular and Organismic Biology, which is supported by National Science Council (NSC) Grant NSC-99-2321-B-001-027, the Taiwan Zebrafish Core Facility for providing the zebrafish AB strain and Tg (huc:gfp), and the National Health Research Institute, which is supported by NSC Grant 100-2321-B-400-003. Upright fluorescence microscopy was performed in the Instrument Center of Chung Shan Medical University, which is supported by the National Science Council, Ministry of Education, and Chung Shan Medical University.	Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Bagella L, 2006, J CELL BIOCHEM, V99, P978, DOI 10.1002/jcb.20981; Bermel C, 2009, MOL CELL NEUROSCI, V42, P427, DOI 10.1016/j.mcn.2009.09.005; BULLRICH F, 1995, CANCER RES, V55, P1199; Chen E, 2004, CURR PHARM BIOTECHNO, V5, P409, DOI 10.2174/1389201043376652; Chen J, 2011, NEUROBIOL DIS, V43, P455, DOI 10.1016/j.nbd.2011.04.019; Chen J, 2009, EUR J NEUROSCI, V29, P287, DOI 10.1111/j.1460-9568.2008.06590.x; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Deacon EM, 2002, J CELL SCI, V115, P983; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grant P, 2001, EUR J BIOCHEM, V268, P1534, DOI 10.1046/j.1432-1033.2001.02025.x; Hahn CM, 2005, NEUROSCIENCE, V134, P449, DOI 10.1016/j.neuroscience.2005.04.020; Hsu LS, 2011, INT J MOL SCI, V12, P3606, DOI 10.3390/ijms12063606; Hsu LS, 2010, DEV DYNAM, V239, P3098, DOI 10.1002/dvdy.22433; Husson H, 2002, BLOOD, V99, P282, DOI 10.1182/blood.V99.1.282; Illanes O, 2006, TOXICOL PATHOL, V34, P243, DOI 10.1080/01926230600713186; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Kanungo J, 2007, NEUROSCI LETT, V412, P233, DOI 10.1016/j.neulet.2006.11.016; Kanungo J, 2006, J NEUROCHEM, V99, P251, DOI 10.1111/j.1471-4159.2006.04114.x; Kanungo J, 2009, BIOCHEM BIOPH RES CO, V386, P263, DOI 10.1016/j.bbrc.2009.06.038; Kasten M, 2001, ONCOGENE, V20, P1832, DOI 10.1038/sj.onc.1204295; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Ko CY, 2011, CELL DEATH DIFFER, V18, P1757, DOI 10.1038/cdd.2011.44; Leman ES, 2009, J CELL BIOCHEM, V108, P1274, DOI 10.1002/jcb.22357; Lesuisse C, 2002, J CEREBR BLOOD F MET, V22, P935, DOI 10.1097/00004647-200208000-00005; Li AM, 2003, INVEST OPHTH VIS SCI, V44, P996, DOI 10.1167/iovs.02-0434; LI S, 1995, CANCER RES, V55, P3992; Liu QY, 2007, CELL RES, V17, P163, DOI 10.1038/sj.cr.7310144; Liu W, 2001, P NATL ACAD SCI USA, V98, P1649, DOI 10.1073/pnas.98.4.1649; Magarinos M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014435; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossler OG, 2004, J NEUROCHEM, V88, P1240, DOI 10.1046/j.1471-4159.2003.02255.x; Sakamoto K, 2011, J OCUL PHARMACOL TH, V27, P419, DOI 10.1089/jop.2010.0141; Tanaka H, 2012, DEV BIOL, V370, P223, DOI 10.1016/j.ydbio.2012.07.032; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M, 1997, SEMIN CELL DEV BIOL, V8, P477, DOI 10.1006/scdb.1997.0173; Yang K, 2013, BRAIN STRUCT FUNCT, V218, P669, DOI 10.1007/s00429-012-0420-7; Yu JH, 2012, ONCOL REP, V27, P1266, DOI 10.3892/or.2011.1617; Zhang L, 2011, ECOTOXICOLOGY, V20, P643, DOI 10.1007/s10646-011-0604-6; Zhong XY, 2012, GENE, V498, P68, DOI 10.1016/j.gene.2012.01.022	47	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27927	27939		10.1074/jbc.M112.420265	http://dx.doi.org/10.1074/jbc.M112.420265			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23902762	Green Published, hybrid			2022-12-25	WOS:000330612800020
J	Berrier, C; Pozza, A; de Lavalette, AD; Chardonnet, S; Mesneau, A; Jaxel, C; le Maire, M; Ghazi, A				Berrier, Catherine; Pozza, Alexandre; de lavalette, Agnes de Lacroix; Chardonnet, Solenne; Mesneau, Agnes; Jaxel, Christine; le Maire, Marc; Ghazi, Alexandre			The Purified Mechanosensitive Channel TREK-1 Is Directly Sensitive to Membrane Tension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVATED CHANNELS; DETERGENT BINDING; CRYSTAL-STRUCTURE; ION CHANNELS; PATCH-CLAMP; YEAST; PURIFICATION; PROTEINS; EXPRESSION	Mechanosensitive channels are detected in all cells and are speculated to play a key role in many functions including osmoregulation, growth, hearing, balance, and touch. In prokaryotic cells, a direct gating of mechanosensitive channels by membrane tension was clearly demonstrated because the purified channels could be functionally reconstituted in a lipid bilayer. No such evidence has been presented yet in the case of mechanosensitive channels from animal cells. TREK-1, a two-pore domain K+ channel, was the first animal mechanosensitive channel identified at the molecular level. It is the target of a large variety of agents such as volatile anesthetics, neuroprotective agents, and antidepressants. We have produced the mouse TREK-1 in yeast, purified it, and reconstituted the protein in giant liposomes amenable to patch clamp recording. The protein exhibited the expected electrophysiological properties in terms of kinetics, selectivity, and pharmacology. Negative pressure (suction) applied through the pipette had no effect on the channel, but positive pressure could completely and reversibly close the channel. Our interpretation of these data is that the intrinsic tension in the lipid bilayer is sufficient to maximally activate the channel, which can be closed upon modification of the tension. These results indicate that TREK-1 is directly sensitive to membrane tension.	[Berrier, Catherine; Chardonnet, Solenne; Mesneau, Agnes; Ghazi, Alexandre] Univ Paris 11, CNRS, UMR 8619, IBBMC, F-91405 Orsay, France; [Pozza, Alexandre; de lavalette, Agnes de Lacroix; Jaxel, Christine; le Maire, Marc] Univ Paris 11, CNRS, UMR 8221, CEA,Inst Biol & Technol Saclay iBitec S, F-91191 Gif Sur Yvette, France; [Pozza, Alexandre; de lavalette, Agnes de Lacroix; Jaxel, Christine; le Maire, Marc] CEA Saclay, F-91191 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Ghazi, A (corresponding author), Univ Paris 11, CNRS, UMR 8619, IBBMC, F-91405 Orsay, France.	alexandre.ghazi@u-psud.fr		JAXEL, CHRISTINE/0000-0002-1387-4458	Agence nationale de la recherche (ANR) [BLAN06-2_135035]	Agence nationale de la recherche (ANR)(French National Research Agency (ANR))	This work was supported by Agence nationale de la recherche (ANR) Grant BLAN06-2_135035.	Ajouz B, 2000, J BIOL CHEM, V275, P1015, DOI 10.1074/jbc.275.2.1015; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; BERRIER C, 1989, FEBS LETT, V259, P27, DOI 10.1016/0014-5793(89)81486-3; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Cardi D, 2010, J BIOL CHEM, V285, P26406, DOI 10.1074/jbc.M109.090340; Cardi D, 2010, METHODS MOL BIOL, V601, P247, DOI 10.1007/978-1-60761-344-2_15; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chemin J, 2007, PFLUG ARCH EUR J PHY, V455, P97, DOI 10.1007/s00424-007-0250-2; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Di Cera E, 2001, ANN NY ACAD SCI, V936, P133; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Ghazi A, 1998, BIOCHIMIE, V80, P357; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; Honore E, 2006, P NATL ACAD SCI USA, V103, P6859, DOI 10.1073/pnas.0600463103; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Hortigon-Vinagre MP, 2011, FREE RADICAL BIO MED, V50, P323, DOI 10.1016/j.freeradbiomed.2010.11.017; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Kang D, 2007, J PHYSIOL-LONDON, V583, P57, DOI 10.1113/jphysiol.2007.136150; Kim D, 2003, TRENDS PHARMACOL SCI, V24, P648, DOI 10.1016/j.tips.2003.10.008; Kloda A, 2001, CELL BIOCHEM BIOPHYS, V34, P349, DOI 10.1385/CBB:34:3:349; Kloda A, 2007, P NATL ACAD SCI USA, V104, P1540, DOI 10.1073/pnas.0609649104; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li XT, 2006, CARDIOVASC RES, V69, P86, DOI 10.1016/j.cardiores.2005.08.018; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Perozo E, 2006, NAT REV MOL CELL BIO, V7, P109, DOI 10.1038/nrm1833; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Thomas D, 2008, NEURON, V58, P859, DOI 10.1016/j.neuron.2008.04.016; Ursell T, 2011, BIOPHYS J, V101, P1913, DOI 10.1016/j.bpj.2011.08.057; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	47	54	54	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27307	27314		10.1074/jbc.M113.478321	http://dx.doi.org/10.1074/jbc.M113.478321			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23897808	Green Published, hybrid			2022-12-25	WOS:000330597300027
J	Ma, SB; Shukla, V; Fang, LL; Gould, KA; Joshi, SS; Lu, RQ				Ma, Shibin; Shukla, Vipul; Fang, Leilei; Gould, Karen A.; Joshi, Shantaram S.; Lu, Runqing			Accelerated Development of Chronic Lymphocytic Leukemia in New Zealand Black Mice Expressing a Low Level of Interferon Regulatory Factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; IRF FAMILY; LOCUS; TCL1; DIFFERENTIATION; RECEPTOR; MOUSE; PHOSPHORYLATION	A recent genome-wide SNP association study identified IRF4 as a major susceptibility gene for chronic lymphocytic leukemia (CLL). Moreover, the SNPs located in the 3' UTR of the IRF4 gene have been linked to a down-regulation of IRF4. However, whether a low level of IRF4 is critical for CLL development remains unclear. New Zealand Black (NZB) mice are a naturally occurring, late-onset mouse model of CLL. To examine the role of a reduced level of IRF4 in CLL development, we generated, through breeding, IRF4 heterozygous mutant mice in the NZB background (NZB IRF4(+/-)). Our results show that CLL development is accelerated dramatically in the NZB IRF4(+/-) mice. The average onset of CLL in NZB mice is 12 months, but CLL cells can be detected in NZB IRF4(+/-) mice at 3 months of age. By 5 months of age, 80% of NZB IRF4(+/-) mice developed CLL. CLL cells are derived from B1 cells in mice. Interestingly, NZB IRF4(+/-) B1 cells exhibit prolonged survival, accelerated self-renewal, and defects in differentiation. Although NZB IRF4(+/-) CLL cells are resistant to apoptosis, high levels of IRF4 inhibit their survival. High levels of IRF4 also reduce the survival of MEC-1 human CLL cells. Our analysis further reveals that high levels of IRF4 suppress Akt activity and can do so without the IRF4 DNA binding domain. Thus, our findings reveal a causal relationship between a low level of IRF4 and the development of CLL and establish IRF4 as a novel regulator in the pathogenesis of CLL.	[Ma, Shibin; Shukla, Vipul; Fang, Leilei; Gould, Karen A.; Joshi, Shantaram S.; Lu, Runqing] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Lu, RQ (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, 985805 Nebraska Med Ctr, Omaha, NE 68198 USA.	Rlu@UNMC.edu	Joshi, Sudhanshu/L-2284-2019; Shukla, Vipul/AAM-6310-2020	Joshi, Sudhanshu/0000-0003-4748-5001; 	National Institutes of Health [AI67891]; Nebraska Health and Human Services [LB506]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI67891 (to R. L.). This work was also supported by Nebraska Health and Human Services Grant LB506 (to R. L.).	Acquaviva J, 2008, BLOOD, V112, P3798, DOI 10.1182/blood-2007-10-117838; Allan JM, 2010, LEUKEMIA, V24, P877, DOI 10.1038/leu.2009.298; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chang CC, 2002, BLOOD, V100, P4671, DOI 10.1182/blood-2002-01-0104; Chiorazzi N, 2005, ANN NY ACAD SCI, V1062, P1, DOI 10.1196/annals.1358.002; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Crowther-Swanepoel D, 2010, HUM MOL GENET, V19, P1840, DOI 10.1093/hmg/ddq044; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De Silva NS, 2012, IMMUNOL REV, V247, P73, DOI 10.1111/j.1600-065X.2012.01113.x; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dighiero G, 2008, LANCET, V371, P1017, DOI 10.1016/S0140-6736(08)60456-0; Enzler T, 2009, BLOOD, V114, P4469, DOI 10.1182/blood-2009-06-230169; Gaidano G, 2012, J CLIN INVEST, V122, P3432, DOI 10.1172/JCI64101; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; HANADA M, 1993, BLOOD, V82, P1820; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Hardy RR, 2006, J IMMUNOL, V177, P2749, DOI 10.4049/jimmunol.177.5.2749; Havelange V, 2011, BLOOD, V118, P2827, DOI 10.1182/blood-2011-04-350579; Herling M, 2006, LEUKEMIA, V20, P280, DOI 10.1038/sj.leu.2404017; Hofbauer SW, 2010, CANCER RES, V70, P7336, DOI 10.1158/0008-5472.CAN-09-4411; Jo SH, 2012, J BIOL CHEM, V287, P1770, DOI 10.1074/jbc.M111.289728; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Lia M, 2012, BLOOD, V119, P2981, DOI 10.1182/blood-2011-09-381814; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Lu RQ, 2008, TRENDS IMMUNOL, V29, P487, DOI 10.1016/j.it.2008.07.006; Ma SB, 2006, J IMMUNOL, V177, P7898, DOI 10.4049/jimmunol.177.11.7898; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Michie AM, 2007, BIOCHEM SOC T, V35, P1009, DOI 10.1042/BST0351009; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Nordgren TM, 2010, OPEN LEUK J, V3, P69; Pathak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022628; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Pepper C, 2008, BLOOD, V112, P3807, DOI 10.1182/blood-2008-05-157131; PHILLIPS JA, 1992, CANCER RES, V52, P437; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Salerno E, 2010, CYTOM PART B-CLIN CY, V78B, pS98, DOI 10.1002/cyto.b.20544; Salerno E, 2009, MOL CANCER THER, V8, P2684, DOI 10.1158/1535-7163.MCT-09-0127; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Yan XJ, 2006, P NATL ACAD SCI USA, V103, P11713, DOI 10.1073/pnas.0604564103	51	13	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26430	26440		10.1074/jbc.M113.475913	http://dx.doi.org/10.1074/jbc.M113.475913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897826	Green Published, hybrid			2022-12-25	WOS:000330594500008
J	Oliver, MB; van der Linden, MPG; Kuntzel, SA; Saad, JS; Nahm, MH				Oliver, Melissa B.; van der Linden, Mark P. G.; Kuentzel, Sharon A.; Saad, Jamil S.; Nahm, Moon H.			Discovery of Streptococcus pneumoniae Serotype 6 Variants with Glycosyltransferases Synthesizing Two Differing Repeating Units	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULAR POLYSACCHARIDE; MONOCLONAL-ANTIBODIES; GENETIC-BASIS; AMINO-ACID; VACCINE; SYSTEM; DONOR; BIOSYNTHESIS; SEROGROUP-6; PREDICTION	Streptococcus pneumoniae is a persistent, opportunistic commensal of the human nasopharynx and is the leading cause of community-acquired pneumonia. It expresses an anti-phagocytic capsular polysaccharide (PS). Genetic variation of the capsular PS synthesis (cps) locus is the molecular basis for structural and antigenic heterogeneity of capsule types (serotypes). Serogroup 6 has four known members (6A-6D) with distinct serologic properties, homologous cps loci, and structurally similar PSs. cps of serotypes 6A/6B have wciN alpha, encoding alpha-1,3-galactosyltransferase, whereas serotypes 6C/6D have wciN beta encoding alpha-1,3-glucosyltransferase. Two atypical serogroup 6 isolates (named 6X11 and 6X12) have been discovered recently in Germany. Flow cytometric studies using monoclonal antibodies show that 6X11 has serologic properties of 6B/6D, whereas 6X12 has 6A/6C. NMR studies of their capsular PSs revealed that 6X11 and 6X12 have two different repeating units with a distribution of similar to 40:60 6B:6D and 75:25 6A:6C PS, respectively. Sequencing of the wciN alpha gene in 6X12 and 6X11 revealed single and double nucleotide substitutions, respectively, resulting in the amino acid changes A150T and D38N. Substitution of alanine with threonine at position 150 in a 6A strain was associated with hybrid serologic and chemical profiles like 6X12. The hybrid serotypes represented by 6X12 and 6X11 strains are now named serotypes 6F and 6G. Single amino acid changes in cps genes encoding glycosyltransferases can alter substrate specificities, permit biosynthesis of heterogeneous capsule repeating units, and result in new hybrid capsule types that may differ in their interaction with the immune system of the host.	[Saad, Jamil S.; Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Oliver, Melissa B.; Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [van der Linden, Mark P. G.; Kuentzel, Sharon A.] Rhein Westfal TH Aachen, Univ Hosp, German Natl Reference Ctr Streptococci, Dept Med Microbiol, D-52074 Aachen, Germany	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; RWTH Aachen University; RWTH Aachen University Hospital	Nahm, MH (corresponding author), Univ Alabama Birmingham, Dept Pathol, BBRB 614,1720 2nd Ave S, Birmingham, AL 35294 USA.	nahm@uab.edu	van der Linden, Mark/B-9305-2009	van der Linden, Mark/0000-0002-6574-4313; Nahm, Moon/0000-0002-6922-1042; Saad, Jamil/0000-0001-9503-6484	National Institutes of Health [R01 AI-31473, P30CA013148]; Robert Koch-Institut; Bundesministerium fur Gesundheit Project [1369-235]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Koch-Institut; Bundesministerium fur Gesundheit Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI-31473 (to M. H. N.) and P30CA013148 (to the University of Alabama at Birmingham Comprehensive Cancer Center). This work was also supported by the Robert Koch-Institut and Bundesministerium fur Gesundheit Project 21369-235.	AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; Batt SL, 2005, J CLIN MICROBIOL, V43, P2656, DOI 10.1128/JCM.43.6.2656-2661.2005; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Bratcher PE, 2009, MICROBIOL-SGM, V155, P576, DOI 10.1099/mic.0.024521-0; Breton C, 1998, J BIOCHEM, V123, P1000; Cai P, 2012, CARBOHYD RES, V351, P98, DOI 10.1016/j.carres.2012.01.017; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Calix JJ, 2012, J BIOL CHEM, V287, P13996, DOI 10.1074/jbc.M112.346924; Chaikuad A, 2011, P NATL ACAD SCI USA, V108, P21028, DOI 10.1073/pnas.1113921108; Claus H, 2009, MOL MICROBIOL, V71, P960, DOI 10.1111/j.1365-2958.2008.06580.x; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elberse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025018; Han WQ, 2012, BIOCHEMISTRY-US, V51, P5804, DOI 10.1021/bi300640b; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hyams C, 2013, INFECT IMMUN, V81, P354, DOI 10.1128/IAI.00862-12; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kong FR, 2005, J MED MICROBIOL, V54, P351, DOI 10.1099/jmm.0.45924-0; Lee H, 2009, CLIN VACCINE IMMUNOL, V16, P376, DOI 10.1128/CVI.00344-08; Lin JS, 2006, J CLIN MICROBIOL, V44, P383, DOI 10.1128/JCM.44.2.383-388.2006; Mavroidi A, 2004, J BACTERIOL, V186, P8181, DOI 10.1128/JB.186.24.8181-8192.2004; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Millard CM, 2012, APPL ENVIRON MICROB, V78, P8219, DOI 10.1128/AEM.02216-12; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Ramakrishnan B, 2007, J MOL BIOL, V365, P570, DOI 10.1016/j.jmb.2006.10.034; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; Sheppard CL, 2010, CLIN VACCINE IMMUNOL, V17, P1820, DOI 10.1128/CVI.00335-10; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Steenhoff AP, 2006, CLIN INFECT DIS, V42, P907, DOI 10.1086/500941; Sun Y, 2001, INFECT IMMUN, V69, P336, DOI 10.1128/IAI.69.1.336-344.2001; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Talaga P, 2001, VACCINE, V19, P2987, DOI 10.1016/S0264-410X(00)00535-1; Trzcinski K, 2003, APPL ENVIRON MICROB, V69, P7364, DOI 10.1128/AEM.69.12.7364-7370.2003; van der Linden M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060848; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wyres KL, 2013, J INFECT DIS, V207, P439, DOI 10.1093/infdis/jis703; Xayarath B, 2007, J BACTERIOL, V189, P3369, DOI 10.1128/JB.01938-06; Yother J, 2004, PNEUMOCCOCUS, P30; Yu J, 2008, J MED MICROBIOL, V57, P171, DOI 10.1099/jmm.0.47549-0; Yu JG, 2011, CLIN VACCINE IMMUNOL, V18, P1900, DOI 10.1128/CVI.05312-11; Yuki N, 2007, J NEUROCHEM, V103, P150, DOI 10.1111/j.1471-4159.2007.04707.x	50	57	60	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25976	25985		10.1074/jbc.M113.480152	http://dx.doi.org/10.1074/jbc.M113.480152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897812	Green Published, hybrid			2022-12-25	WOS:000330623300028
J	Guan, Z; Zhou, Y; Liu, JC; Jiang, XL; Li, SC; Yang, SM; Chen, AL				Guan, Zheng; Zhou, Yu; Liu, Jinchuan; Jiang, Xiaoling; Li, Sicong; Yang, Shuming; Chen, Ailiang			A Simple Method to Extract DNA from Hair Shafts Using Enzymatic Laundry Powder	PLOS ONE			English	Article							MOLECULAR-MASS DNA; MITOCHONDRIAL-DNA; ANCIENT DNA; KERATINISED HAIR; DEGRADED HAIR; SINGLE HAIRS; MUMMIES; NAIL	A simple method to extract DNA from hair shafts was developed by using enzymatic laundry powder at the first step of the process. The whole extraction can be finished in less than 2 hours. The simple extraction reagent proposed here contains only two cheap components: ordinary enzymatic laundry powder and PCR buffer. After extraction, an ultra sensitive fluorescent nucleic acid stain, PicoGreen, was used for quantifying trace amount of double-stranded DNA in the solution extracted. For further validation of DNA extraction, four primers were employed to amplify DNA microsatellite loci. Both fluorescence spectroscopy and PCR results suggested that this method can extract DNA from hair shafts with good efficiency and repeatability. The study will greatly facilitate the use of hair shafts in future for DNA analyses on genome-wide scale.	[Chen, Ailiang] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100193, Peoples R China; Minist Agr, Key Lab Agrofood Qual & Safety, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; Ministry of Agriculture & Rural Affairs	Chen, AL (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100193, Peoples R China.	ailiang.chen@gmail.com	Chen, Ailiang/AAA-6470-2022; Guan, Zheng/L-7701-2018	Guan, Zheng/0000-0001-8617-8114	International Science and Technology Cooperation Program of China [2012DFA31140]; Special Fund for Agro scientific Research in the Public Interest [201203046]	International Science and Technology Cooperation Program of China; Special Fund for Agro scientific Research in the Public Interest	Funding provided by The International Science and Technology Cooperation Program of China (2012DFA31140) http://www.istcp.org.cn/ and the Special Fund for Agro scientific Research in the Public Interest (201203046) http://119.253.58.231/hykj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amory S, 2007, FORENSIC SCI INT, V166, P218, DOI 10.1016/j.forsciint.2006.05.042; Baker LE, 2001, J FORENSIC SCI, V46, P126; Bengtsson CF, 2012, ANN ANAT, V194, P17, DOI 10.1016/j.aanat.2011.03.013; Brandstatter A, 2003, INT J LEGAL MED, V117, P180, DOI 10.1007/s00414-002-0350-7; Capelli Cristian, 2005, V297, P265; Chinese Pharmacopoeia Commission, 2010, PHARM PEOPL REP CHIN, VIII, P61; Cooper A, 2000, SCIENCE, V289, P1139; FAO, 2011, MOL GEN CHAR AN GEN, P68; Gilbert MTR, 2007, AM J PHYS ANTHROPOL, V133, P847, DOI 10.1002/ajpa.20602; Gilbert MTP, 2004, CURR BIOL, V14, pR463, DOI 10.1016/j.cub.2004.06.008; Gilbert MTP, 2006, FORENSIC SCI INT, V156, P208, DOI 10.1016/j.forsciint.2005.02.021; Gilbert MTP, 2006, FORENSIC SCI INT, V156, P201, DOI 10.1016/j.forsciint.2005.02.019; Heywood DM, 2003, J COSMET SCI, V54, P21; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; KALBE J, 1988, BIOL CHEM H-S, V369, P413, DOI 10.1515/bchm3.1988.369.1.413; Linch CA, 2009, J FORENSIC SCI, V54, P346, DOI 10.1111/j.1556-4029.2008.00972.x; McNevin D, 2005, FORENSIC SCI INT, V153, P237, DOI 10.1016/j.forsciint.2005.05.006; McNevin D, 2005, FORENSIC SCI INT, V153, P247, DOI 10.1016/j.forsciint.2005.05.005; Nasiri H, 2005, J CLIN LAB ANAL, V19, P229, DOI 10.1002/jcla.20083; Nozawa H, 1999, Leg Med (Tokyo), V1, P61, DOI 10.1016/S1344-6223(99)80014-5; SCHREIBER A, 1988, FEBS LETT, V230, P209, DOI 10.1016/0014-5793(88)80673-2; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; Steadman DW, 2006, J FORENSIC SCI, V51, P11, DOI 10.1111/j.1556-4029.2005.00001.x; UCHIHI R, 1992, J FORENSIC SCI, V37, P853; WILSON MR, 1995, INT J LEGAL MED, V108, P68, DOI 10.1007/BF01369907	25	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69588	10.1371/journal.pone.0069588	http://dx.doi.org/10.1371/journal.pone.0069588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922747	gold, Green Submitted, Green Published			2022-12-25	WOS:000323369700049
J	Riba, M; Rausa, M; Sorosina, M; Cittaro, D; Manteiga, JMG; Nai, A; Pagani, A; Martinelli-Boneschi, F; Stupka, E; Camaschella, C; Silvestri, L				Riba, Michela; Rausa, Marco; Sorosina, Melissa; Cittaro, Davide; Manteiga, Jose Manuel Garcia; Nai, Antonella; Pagani, Alessia; Martinelli-Boneschi, Filippo; Stupka, Elia; Camaschella, Clara; Silvestri, Laura			A Strong Anti-Inflammatory Signature Revealed by Liver Transcription Profiling of Tmprss6-/- Mice	PLOS ONE			English	Article							MATRIPTASE-2 TMPRSS6; GENE-EXPRESSION; IRON; REGULATOR; INFLAMMATION; FERROPORTIN; DEFICIENCY; ACTIVATION; SMAD4; ATF3	Control of systemic iron homeostasis is interconnected with the inflammatory response through the key iron regulator, the antimicrobial peptide hepcidin. We have previously shown that mice with iron deficiency anemia (IDA)-low hepcidin show a pro-inflammatory response that is blunted in iron deficient-high hepcidin Tmprss6 KO mice. The transcriptional response associated with chronic hepcidin overexpression due to genetic inactivation of Tmprss6 is unknown. By using whole genome transcription profiling of the liver and analysis of spleen immune-related genes we identified several functional pathways differentially expressed in Tmprss6 KO mice, compared to IDA animals and thus irrespective of the iron status. In the effort of defining genes potentially targets of Tmprss6 we analyzed liver gene expression changes according to the genotype and independently of treatment. Tmprss6 inactivation causes down-regulation of liver pathways connected to immune and inflammatory response as well as spleen genes related to macrophage activation and inflammatory cytokines production. The anti-inflammatory status of Tmprss6 KO animals was confirmed by the down-regulation of pathways related to immunity, stress response and intracellular signaling in both liver and spleen after LPS treatment. Opposite to Tmprss6 KO mice, Hfe(-/-) mice are characterized by iron overload with inappropriately low hepcidin levels. Liver expression profiling of Hfe(-/-) deficient versus iron loaded mice show the opposite expression of some of the genes modulated by the loss of Tmprss6. Altogether our results confirm the anti-inflammatory status of Tmprss6 KO mice and identify new potential target pathways/genes of Tmprss6.	[Riba, Michela; Cittaro, Davide; Manteiga, Jose Manuel Garcia; Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Rausa, Marco; Nai, Antonella; Pagani, Alessia; Camaschella, Clara; Silvestri, Laura] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Rausa, Marco; Nai, Antonella; Pagani, Alessia; Camaschella, Clara; Silvestri, Laura] Univ Vita Salute, Milan, Italy; [Sorosina, Melissa; Martinelli-Boneschi, Filippo] Ist Sci San Raffaele, INSPE, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Silvestri, L (corresponding author), Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy.	silvestri.laura@hsr.it	Silvestri, Laura/A-1417-2015; Manteiga, Jose Manuel Garcia/AAN-1954-2020; Sorosina, Melissa/AAN-1980-2020; Pagani, Alessia/AAN-4301-2020; Nai, Antonella/AAB-8749-2019; Cittaro, Davide/K-2405-2018; Riba, Michela/AAG-8955-2019; Camaschella, Clara/A-3289-2015	Silvestri, Laura/0000-0002-8726-9808; Manteiga, Jose Manuel Garcia/0000-0002-5481-040X; Sorosina, Melissa/0000-0003-4376-2550; Pagani, Alessia/0000-0003-2374-4988; Nai, Antonella/0000-0002-0739-5282; Cittaro, Davide/0000-0003-0384-3700; martinelli boneschi, filippo/0000-0002-9955-1368; Stupka, Elia/0000-0003-3154-4011; riba, michela/0000-0003-4857-2027	Telethon [GGP12025]; ERARE; Ricerca Finalizzata Ministero Sanita Rome [RF-2010-2312048]; Association Francaise contre les Myopathies [AFM14137]	Telethon(Fondazione Telethon); ERARE; Ricerca Finalizzata Ministero Sanita Rome; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was partly supported by Telethon Grant GGP12025, ERARE-2009 and Ricerca Finalizzata Ministero Sanita Rome RF-2010-2312048 to CC, and by Association Francaise contre les Myopathies AFM14137 to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Casanovas G, 2012, HAEMATOLOGICA; Corradini E, 2009, GASTROENTEROLOGY, V137, P1489, DOI 10.1053/j.gastro.2009.06.057; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M., 2000, POSTGENOME INFORM; Kanehisa Minoru, 2013, Methods Mol Biol, V939, P263, DOI 10.1007/978-1-62703-107-3_17; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kempf T, 2011, NAT MED, V17, P581, DOI 10.1038/nm.2354; Lakhal S, 2011, J BIOL CHEM, V286, P4090, DOI 10.1074/jbc.M110.173096; Maurer E, 2012, BIOL CHEM, V393, P535, DOI 10.1515/hsz-2011-0221; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Pagani A, 2011, BLOOD, V118, P736, DOI 10.1182/blood-2011-02-337212; Parmigiani G., 2003, ANAL GENE EXPRESSION; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Qin HW, 2005, BLOOD, V106, P3114, DOI 10.1182/blood-2005-02-0759; R Core Team, 2012, R LANG ENV STAT COMP; Rodriguez A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007212; Roy CN, 2004, NAT GENET, V36, P481, DOI 10.1038/ng1350; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Smyth G, 2005, LIMMA LINEAR MODELS; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weiss G, 2005, BEST PRACT RES CL HA, V18, P183, DOI 10.1016/j.beha.2004.09.001; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	39	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69694	10.1371/journal.pone.0069694	http://dx.doi.org/10.1371/journal.pone.0069694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922777	Green Submitted, Green Published, gold			2022-12-25	WOS:000323369700066
J	Staats, M; Erkens, RHJ; van de Vossenberg, B; Wieringa, JJ; Kraaijeveld, K; Stielow, B; Geml, J; Richardson, JE; Bakker, FT				Staats, Martijn; Erkens, Roy H. J.; van de Vossenberg, Bart; Wieringa, Jan J.; Kraaijeveld, Ken; Stielow, Benjamin; Geml, Jozsef; Richardson, James E.; Bakker, Freek T.			Genomic Treasure Troves: Complete Genome Sequencing of Herbarium and Insect Museum Specimens	PLOS ONE			English	Article							DNA EXTRACTION; AMPLIFICATION; PLANT; ENRICHMENT; EVOLUTION; ALIGNMENT; PATTERNS; DAMAGE	Unlocking the vast genomic diversity stored in natural history collections would create unprecedented opportunities for genome-scale evolutionary, phylogenetic, domestication and population genomic studies. Many researchers have been discouraged from using historical specimens in molecular studies because of both generally limited success of DNA extraction and the challenges associated with PCR-amplifying highly degraded DNA. In today's next-generation sequencing (NGS) world, opportunities and prospects for historical DNA have changed dramatically, as most NGS methods are actually designed for taking short fragmented DNA molecules as templates. Here we show that using a standard multiplex and paired-end Illumina sequencing approach, genome-scale sequence data can be generated reliably from dry-preserved plant, fungal and insect specimens collected up to 115 years ago, and with minimal destructive sampling. Using a reference-based assembly approach, we were able to produce the entire nuclear genome of a 43-year-old Arabidopsis thaliana (Brassicaceae) herbarium specimen with high and uniform sequence coverage. Nuclear genome sequences of three fungal specimens of 22-82 years of age (Agaricus bisporus, Laccaria bicolor, Pleurotus ostreatus) were generated with 81.4-97.9% exome coverage. Complete organellar genome sequences were assembled for all specimens. Using de novo assembly we retrieved between 16.2-71.0% of coding sequence regions, and hence remain somewhat cautious about prospects for de novo genome assembly from historical specimens. Non-target sequence contaminations were observed in 2 of our insect museum specimens. We anticipate that future museum genomics projects will perhaps not generate entire genome sequences in all cases (our specimens contained relatively small and low-complexity genomes), but at least generating vital comparative genomic data for testing (phylo)genetic, demographic and genetic hypotheses, that become increasingly more horizontal. Furthermore, NGS of historical DNA enables recovering crucial genetic information from old type specimens that to date have remained mostly unutilized and, thus, opens up a new frontier for taxonomic research as well.	[Staats, Martijn; Wieringa, Jan J.; Bakker, Freek T.] Wageningen Univ, Biosystemat Grp, NL-6700 AP Wageningen, Netherlands; [Erkens, Roy H. J.] Maastricht Univ, Maastricht Sci Program, Maastricht, Netherlands; [Erkens, Roy H. J.] Univ Utrecht, Dept Biol, Ecol & Biodivers Grp, Utrecht, Netherlands; [van de Vossenberg, Bart] Dutch Natl Plant Protect Org, Natl Reference Ctr, Wageningen, Netherlands; [Wieringa, Jan J.] Wageningen Univ, Herbarium Vadense WAG, Netherlands Ctr Biodivers Nat, Sect NHN, NL-6700 AP Wageningen, Netherlands; [Kraaijeveld, Ken] Leiden Univ, Dept Human Genet, Med Ctr, Leiden Genome Technol Ctr, NL-2300 RA Leiden, Netherlands; [Stielow, Benjamin] Cent Bur Schimmelcultures Fungal Biodivers Ctr CB, Utrecht, Netherlands; [Geml, Jozsef] Nat Biodivers Ctr, Sect Natl Herbarium Netherlands, Leiden, Netherlands; [Richardson, James E.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Richardson, James E.] Univ Los Andes, Lab Bot & Sistemat, Bogota, Colombia	Wageningen University & Research; Maastricht University; Utrecht University; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Naturalis Biodiversity Center; Universidad de los Andes (Colombia)	Bakker, FT (corresponding author), Wageningen Univ, Biosystemat Grp, NL-6700 AP Wageningen, Netherlands.	freek.bakker@wur.nl	Richardson, James-Edward/L-2768-2016; Erkens, Roy H.J./B-9961-2008; Wieringa, Jan J./D-9517-2015; Geml, Jozsef/AAW-9993-2020; Geml, Jozsef/C-2223-2018	Richardson, James-Edward/0000-0001-9014-4865; Erkens, Roy H.J./0000-0002-1093-0370; Wieringa, Jan J./0000-0003-0566-372X; Geml, Jozsef/0000-0001-8745-0423; Bakker, Freek T./0000-0003-0227-6687; van de Vossenberg, Bart T.L.H./0000-0003-1205-6119	European Community Research Infrastructures program [226506-CP-CSA-Infra]; Innovational Research Incentives Scheme (VENI) (NWO-ALW, The Netherlands) [863.09.017]	European Community Research Infrastructures program; Innovational Research Incentives Scheme (VENI) (NWO-ALW, The Netherlands)	The work was funded by the European Community Research Infrastructures program under FP7 call 'Synthesis of Systematic Resources', grant number 226506-CP-CSA-Infra. RHJE was supported via the Innovational Research Incentives Scheme (VENI, nr. 863.09.017; NWO-ALW, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Carstens B, 2012, SYST BIOL, V61, P713, DOI 10.1093/sysbio/sys050; Cronn R, 2012, AM J BOT, V99, P291, DOI 10.3732/ajb.1100356; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Delisle F, 2003, J BIOGEOGR, V30, P1033, DOI 10.1046/j.1365-2699.2003.00897.x; Dillon N, 1996, INSECT MOL BIOL, V5, P21, DOI 10.1111/j.1365-2583.1996.tb00036.x; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Erickson DL, 2005, P NATL ACAD SCI USA, V102, P18315, DOI 10.1073/pnas.0509279102; Erkens RHJ, 2008, BLUMEA, V53, P407, DOI 10.3767/000651908X608052; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Grigoriev I. V., 2011, Mycology - An International Journal on Fungal Biology, V2, P192; Groenenberg DSJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-114; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kane N, 2012, AM J BOT, V99, P320, DOI 10.3732/ajb.1100570; Kauserud H, 2012, P NATL ACAD SCI USA, V109, P14488, DOI 10.1073/pnas.1200789109; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Knapp M, 2010, GENES-BASEL, V1, P227, DOI 10.3390/genes1020227; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; Palmer SA, 2012, MOL BIOL EVOL, V29, P2031, DOI 10.1093/molbev/mss070; Poulakakis N, 2008, P NATL ACAD SCI USA, V105, P15464, DOI 10.1073/pnas.0805340105; Primack D, 2004, AM J BOT, V91, P1260, DOI 10.3732/ajb.91.8.1260; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Steele PR, 2012, AM J BOT, V99, P330, DOI 10.3732/ajb.1100491; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Tagliavia M, 2011, ANAL LETT, V44, P1058, DOI 10.1080/00032719.2010.506939; Thompson JF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-217; Wieringa JJ, 2011, PLANT ECOL EVOL, V144, P242, DOI 10.5091/plecevo.2011.588; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	49	148	155	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69189	10.1371/journal.pone.0069189	http://dx.doi.org/10.1371/journal.pone.0069189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922691	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700021
J	Yu, XX; Watts, LM; Manchem, VP; Chakravarty, K; Monia, BP; McCaleb, ML; Bhanot, S				Yu, Xing Xian; Watts, Lynnetta M.; Manchem, Vara Prasad; Chakravarty, Kaushik; Monia, Brett P.; McCaleb, Michael L.; Bhanot, Sanjay			Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-19; INDUCED HEPATIC STEATOSIS; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; DRUG DISCOVERY; EMERGING DRUGS; ACID SYNTHESIS; WEIGHT-LOSS; BILE-ACIDS; SUPPRESSION	Obesity is a primary risk factor for multiple metabolic disorders. Many drugs for the treatment of obesity, which mainly act through CNS as appetite suppressants, have failed during development or been removed from the market due to unacceptable adverse effects. Thus, there are very few efficacious drugs available and remains a great unmet medical need for anti-obesity drugs that increase energy expenditure by acting on peripheral tissues without severe side effects. Here, we report a novel approach involving antisense inhibition of fibroblast growth factor receptor 4 (FGFR4) in peripheral tissues. Treatment of diet-induce obese (DIO) mice with FGFR4 antisense oligonucleotides (ASO) specifically reduced liver FGFR4 expression that not only resulted in decrease in body weight (BW) and adiposity in free-feeding conditions, but also lowered BW and adiposity under caloric restriction. In addition, combination treatment with FGFR4 ASO and rimonabant showed additive reduction in BW and adiposity. FGFR4 ASO treatment increased basal metabolic rate during free-feeding conditions and, more importantly, prevented adaptive decreases of metabolic rate induced by caloric restriction. The treatment increased fatty acid oxidation while decreased lipogenesis in both liver and fat. Mechanistic studies indicated that anti-obesity effect of FGFR4 ASO was mediated at least in part through an induction of plasma FGF15 level resulted from reduction of hepatic FGFR4 expression. The anti-obesity effect was accompanied by improvement in plasma glycemia, whole body insulin sensitivity, plasma lipid levels and liver steatosis. Therefore, FGFR4 could be a potential novel target and antisense reduction of hepatic FGFR4 expression could be an efficacious therapy as an adjunct to diet restriction or to an appetite suppressant for the treatment of obesity and related metabolic disorders.	[Yu, Xing Xian; Manchem, Vara Prasad; Chakravarty, Kaushik; Monia, Brett P.; McCaleb, Michael L.] Isis Pharmaceut Inc, Dept Antisense Drug Discovery, Carlsbad, CA USA; [Watts, Lynnetta M.; Bhanot, Sanjay] Isis Pharmaceut Inc, Dept Clin Dev, Carlsbad, CA USA	Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc	Yu, XX (corresponding author), Isis Pharmaceut Inc, Dept Antisense Drug Discovery, Carlsbad, CA USA.	xyu@isisph.com			Isis Pharmaceuticals, Inc.	Isis Pharmaceuticals, Inc.	Studies described in this report were funded by Isis Pharmaceuticals, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Chakrabarti R, 2009, EXPERT OPIN THER TAR, V13, P195, DOI [10.1517/14728220802637063 , 10.1517/14728220802637063]; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; Christopoulou FD, 2011, J CLIN PHARM THER, V36, P10, DOI 10.1111/j.1365-2710.2010.01164.x; Das SK, 2006, CURR MED CHEM, V13, P1429, DOI 10.2174/092986706776872880; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Harrigan GG, 2006, IDRUGS, V9, P188; Harrigan GG, 2006, IDRUGS, V9, P28; Heal D.J., 2012, NEUROPHARMACOLOGY; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jones SA, 2012, ADV EXP MED BIOL, V728, P171, DOI 10.1007/978-1-4614-0887-1_11; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; MacLean PS, 2011, AM J PHYSIOL-REG I, V301, pR581, DOI 10.1152/ajpregu.00755.2010; Miyata M, 2009, DRUG METAB DISPOS, V37, P338, DOI 10.1124/dmd.108.022590; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pandey SK, 2007, J BIOL CHEM, V282, P14291, DOI 10.1074/jbc.M609626200; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184; Samaha FF, 2009, OBESITY, V17, P220, DOI 10.1038/oby.2008.476; Saris WHM, 2001, OBES RES, V9, p295S, DOI 10.1038/oby.2001.134; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Schoeller DA, 2008, INT J OBESITY, V32, pS72, DOI 10.1038/ijo.2008.241; Shin DJ, 2009, J BIOL CHEM, V284, P11110, DOI 10.1074/jbc.M808747200; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Vetter ML, 2010, NAT REV ENDOCRINOL, V6, P578, DOI 10.1038/nrendo.2010.121; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Wiley JL, 2005, BRIT J PHARMACOL, V145, P293, DOI 10.1038/sj.bjp.0706157; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482; Yu XX, 2008, AM J PHYSIOL-ENDOC M, V295, pE436, DOI 10.1152/ajpendo.00629.2007; Yu XX, 1997, J NUTR, V127, P1814, DOI 10.1093/jn/127.9.1814; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783	42	54	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e66923	10.1371/journal.pone.0066923	http://dx.doi.org/10.1371/journal.pone.0066923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922646	Green Submitted, Green Published, gold			2022-12-25	WOS:000323369700001
J	Wu, JH; Zhu, SH; Yao, GL; Mohammed, MA; Marshall, T				Wu, Jianhua; Zhu, Shihua; Yao, Guiqing Lily; Mohammed, Mohammed A.; Marshall, Tom			Patient Factors Influencing the Prescribing of Lipid Lowering Drugs for Primary Prevention of Cardiovascular Disease in UK General Practice: A National Retrospective Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MULTIVARIATE PREDICTION; EUROPEAN GUIDELINES; HEALTH-CARE; CHOLESTEROL; RISK; HYPERCHOLESTEROLEMIA; UNDERTREATMENT; POPULATION; MANAGEMENT	Background: Guidelines indicate eligibility for lipid lowering drugs, but it is not known to what extent GPs' follow guidelines in routine clinical practice or whether additional clinical factors systematically influence their prescribing decisions. Methods: A retrospective cohort analysis was undertaken using electronic primary care records from 421 UK general practices. At baseline (May 2008) patients were aged 30 to 74 years, free from cardiovascular disease and not taking lipid lowering drugs. The outcome was prescription of a lipid lowering drug within the next two years. The proportions of eligible and ineligible patients prescribed lipid lowering drugs were reported and multivariable logistic regression models were used to investigate associations between age, sex, cardiovascular risk factors and prescribing. Results: Of 365,718 patients with complete data, 13.8% (50,558) were prescribed lipid lowering drugs: 28.5% (21,101/74,137) of those eligible and 10.1% (29,457/291,581) of those ineligible. Only 41.7% (21,101/50,558) of those prescribed lipid lowering drugs were eligible. In multivariable analysis prescribing was most strongly associated with increasing age (OR for age >= 65 years 4.21; 95% CI 4.05-4.39); diabetes (OR 4.49; 95% CI 4.35-4.64); total cholesterol level >= 7 mmol/L (OR 2.20; 95% CI 2.12-2.29); and >= 4 blood pressure measurements in the past year (OR 4.24; 95% CI 4.06-4.42). The predictors were similar in eligible and ineligible patients. Conclusions: Most lipid lowering drugs for primary prevention are prescribed to ineligible patients. There is underuse of lipid lowering drugs in eligible patients.	[Wu, Jianhua] Univ London, Ctr Environm & Prevent Med, Barts & London Sch Med & Dent, London, England; [Zhu, Shihua; Mohammed, Mohammed A.; Marshall, Tom] Univ Birmingham, Sch Publ Hlth & Populat Sci, Birmingham, W Midlands, England; [Yao, Guiqing Lily] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	University of London; Queen Mary University London; University of Birmingham; University of Southampton	Marshall, T (corresponding author), Univ Birmingham, Sch Publ Hlth & Populat Sci, Birmingham, W Midlands, England.	t.p.marshall@bham.ac.uk	Wu, Jianhua/G-1080-2019	Wu, Jianhua/0000-0001-6093-599X; Marshall, Tom/0000-0001-9277-5214	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme(National Institute for Health Research (NIHR))	Tom Marshall, Guiqing Lily Yao and Jianhua Wu were partly funded by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. The views expressed in this publication are not necessarily those of the NIHR, the Department of Health, NHS Partner Trusts, University of Birmingham or the CLAHRC-BBC Management Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abookire SA, 2001, ARCH INTERN MED, V161, P53, DOI 10.1001/archinte.161.1.53; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 2012, PRESCR COST AN ENGL; [Anonymous], 2012, CEG STRAT DAT; Ashworth M, 2007, J PUBLIC HEALTH-UK, V29, P40, DOI 10.1093/pubmed/fdl068; ASSMANN G, 1990, AM J CARDIOL, V65, pF11, DOI 10.1016/0002-9149(90)91248-5; Barham Ann Hiott, 2009, Prev Cardiol, V12, P95, DOI 10.1111/j.1751-7141.2008.00019.x; BLACKBURN H, 1974, NEW ENGL J MED, V290, P1315, DOI 10.1056/NEJM197406062902310; BRAND RJ, 1976, CIRCULATION, V53, P348, DOI 10.1161/01.CIR.53.2.348; Bryan S, 2006, SOC SCI MED, V63, P2698, DOI 10.1016/j.socscimed.2006.07.008; Christian AH, 2006, J GEN INTERN MED, V21, P231, DOI 10.1111/j.1525-1497.2006.00331.x; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Forde I, 2011, ATHEROSCLEROSIS, V215, P223, DOI 10.1016/j.atherosclerosis.2010.12.012; Frohlich J, 1998, CAN J CARDIOL, V14, p17A; Getz L, 2003, BMJ-BRIT MED J, V327, P498, DOI 10.1136/bmj.327.7413.498; Goldstein JL, 1983, METABOLIC BASIS INHE, P672; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gumbs PD, 2006, DRUG AGING, V23, P733, DOI 10.2165/00002512-200623090-00003; HAQ IU, 1995, LANCET, V346, P1467, DOI 10.1016/S0140-6736(95)92477-9; Hippisley-Cox JVY, 2009, TRENDS CONSULTATION; KANNEL WB, 1976, AM J CARDIOL, V38, P46, DOI 10.1016/0002-9149(76)90061-8; KEYS A, 1972, CIRCULATION, V45, P815, DOI 10.1161/01.CIR.45.4.815; Krum H, 2001, MED J AUSTRALIA, V194, pS57; Lopez-Carmona D, 2012, EUR J PREV CARDIOL, V19, P1074, DOI 10.1177/1741826711418166; Ma J, 2005, PLOS MED, V2, P434, DOI 10.1371/journal.pmed.0020123; Macklin J, 2011, SCOT MED J, V56, P33, DOI 10.1258/smj.2010.010016; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Mantel-Teeuwisse AK, 2003, BRIT J CLIN PHARMACO, V55, P389, DOI 10.1046/j.1365-2125.2003.01769.x; Marshall T, 2006, HEART, V92, P1651, DOI 10.1136/hrt.2005.072405; Marston L, 2010, PHARMACOEPIDEM DR S, V19, P618, DOI 10.1002/pds.1934; McBride P, 1998, ARCH INTERN MED, V158, P1238, DOI 10.1001/archinte.158.11.1238; Menotti A, 1975, G Ital Cardiol, V5, P843; Mohammed MA, 2012, MED DECIS MAKING, V32, P498, DOI 10.1177/0272989X12437246; Montgomery AA, 2001, FAM PRACT, V18, P309, DOI 10.1093/fampra/18.3.309; National Institute for Clinical Excellence, 2008, CLIN GUID EV REV LIP; National Institute for Clinical Excellence, 2008, CG71 FAM HYP NICE GU; National Institute for Clinical Excellence, 2008, TYP 2 DIAB CLIN GUID; Ohlsson H, 2009, PHARMACOEPIDEM DR S, V18, P682, DOI 10.1002/pds.1767; PAGE IH, 1970, CIRCULATION, V42, P625, DOI 10.1161/01.CIR.42.4.625; PEDERSEN TR, 1994, LANCET, V344, P1383; Petursson H, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-70; RICHARD JL, 1977, ARCH MAL COEUR VAISS, V70, P531; Roumie CL, 2007, JT COMM J QUAL PATIE, V33, P277, DOI 10.1016/S1553-7250(07)33032-8; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Scottish Intercollegiate Guidelines Network SIGN 97, 2007, RISK EST PREV CARD D; Selmer R, 2009, BRIT J CLIN PHARMACO, V67, P355, DOI 10.1111/j.1365-2125.2008.03360.x; SHEPHERD J, 1987, BRIT MED J, V295, P1245, DOI 10.1136/bmj.295.6608.1245; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Stafford L, 2009, AUST FAM PHYSICIAN, V38, P739; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Tonstad S, 2004, J INTERN MED, V255, P494, DOI 10.1111/j.1365-2796.2004.01315.x; Townsend PP., 1988, HLTH DEPRIVATION INE; van Duijn HJ, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X578025; Verma A, 2012, SOUTH MED J, V105, P329, DOI 10.1097/SMJ.0b013e318259bad3; Weinstein M C, 1978, Ann N Y Acad Sci, V304, P424, DOI 10.1111/j.1749-6632.1978.tb25625.x; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6; WOLFE BMJ, 1990, CAN MED ASSOC J, V142, P1371; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Wood D, 1998, HEART S2, V80	64	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e67611	10.1371/journal.pone.0067611	http://dx.doi.org/10.1371/journal.pone.0067611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922649	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000322838900005
J	Koene, JM; Liew, TS; Montagne-Wajer, K; Schilthuizen, M				Koene, Joris M.; Liew, Thor-Seng; Montagne-Wajer, Kora; Schilthuizen, Menno			A Syringe-Like Love Dart Injects Male Accessory Gland Products in a Tropical Hermaphrodite	PLOS ONE			English	Article							SNAIL HELIX-ASPERSA; SEXUAL SELECTION; COUNTER-ADAPTATION; EVOLUTION; COEVOLUTION; GASTROPODA; APPARATUS; PATERNITY; INSECTS; SYSTEM	Sexual conflict shapes the evolution of many behaviours and processes involved in reproduction. Nearly all evidence supporting this comes from species where the sexes are separated. However, a substantial proportion of animals and most plants are hermaphroditic, and theoretical work predicts that sexual conflict plays an important role even when the sexes are joined within one individual. This seems to have resulted in bizarre mating systems, sophisticated sperm packaging and complex reproductive morphologies. By far the best-known example of such a strategy in hermaphrodites is the shooting of so-called love-darts in land snails. All known love darts carry a gland product on their outside and enter this into the partner's hemolymph by stabbing. Here, we show that species of the snail genus Everettia possess a syringe-like dart that serves as a real injection needle. Their dart is round in cross-section, contains numerous channels, and has perforations along its side. Histology and electron microscopy show that these holes connect to the channels inside the dart and run all the way up to the elaborate mucus glands that are attached to the dart sac. This is the first report on a love dart that is used as a syringe to directly inject the gland product into the partner's hemolymph. Although the exact use and function of this dart remains to be demonstrated, this clearly adds to the complexity of the evolution of reproductive strategies in hermaphrodites in general. Moreover, the perforations on the outside of the love dart resemble features of other injection devices, thus uncovering common design and repeated evolution of such features in animals.	[Koene, Joris M.; Montagne-Wajer, Kora] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Ecol Sci, Amsterdam, Netherlands; [Koene, Joris M.; Liew, Thor-Seng; Schilthuizen, Menno] Naturalis Biodivers Ctr, Leiden, Netherlands; [Liew, Thor-Seng; Schilthuizen, Menno] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Sabah, Malaysia; [Schilthuizen, Menno] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands	Vrije Universiteit Amsterdam; Naturalis Biodiversity Center; Universiti Malaysia Sabah; Leiden University; Leiden University - Excl LUMC	Koene, JM (corresponding author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Ecol Sci, Amsterdam, Netherlands.	joris.koene@falw.vu.nl	Liew, Thor-Seng/I-5032-2016; Koene, Joris M./B-4502-2009; Liew, Thor-Seng/AHC-0363-2022	Liew, Thor-Seng/0000-0002-9437-5924; Koene, Joris M./0000-0001-8188-3439; Liew, Thor-Seng/0000-0002-9437-5924	Research Council for Earth and Life Sciences (ALW-NWO); Royal Netherlands Academy of Arts & Sciences (KNAW); ALW-NWO [819.01.012]; NWO	Research Council for Earth and Life Sciences (ALW-NWO)(Netherlands Organization for Scientific Research (NWO)); Royal Netherlands Academy of Arts & Sciences (KNAW); ALW-NWO(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	JMK's research is supported by the Research Council for Earth and Life Sciences (ALW-NWO) and the Royal Netherlands Academy of Arts & Sciences (KNAW). TSL's work is funded under project 819.01.012 of ALW-NWO. This publication was supported by an Open Access grant of NWO to JMK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1990, J EXP ZOOL, V255, P80, DOI 10.1002/jez.1402550111; Anthes N, 2007, BIOL LETTERS, V3, P121, DOI 10.1098/rsbl.2006.0596; Anthes N, 2010, AM NAT, V176, P249, DOI 10.1086/655218; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; ARNQVIST G, 2005, SEXUAL CONFLICT, P330; Bedhomme S, 2009, BIOL LETTERS, V5, P717, DOI 10.1098/rsbl.2009.0401; Castelin M, 2012, MOL PHYLOGENET EVOL, V64, P21, DOI 10.1016/j.ympev.2012.03.001; CHARNOV EL, 1979, P NATL ACAD SCI USA, V76, P2480, DOI 10.1073/pnas.76.5.2480; Chase R, 2006, P ROY SOC B-BIOL SCI, V273, P1471, DOI 10.1098/rspb.2006.3474; Darwin C., 1871, THE DESCENT OF MAN A; Godwin-Austen H.H., 1891, P ZOOL SOC LOND, V59, P22, DOI [https://doi.org/10.1111/j.1469-7998.1891.tb06805.x, DOI 10.1111/J.1469-7998.1891.TB06805.X]; Greeff JM, 1999, AM NAT, V153, P421, DOI 10.1086/303184; Hoffer JNA, 2012, ANIM BEHAV, V84, P523, DOI 10.1016/j.anbehav.2012.06.002; Hotzy C, 2012, CURR BIOL, V22, P2258, DOI 10.1016/j.cub.2012.10.009; Izumi H, 2011, SENSOR ACTUAT A-PHYS, V165, P115, DOI 10.1016/j.sna.2010.02.010; Koene JM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-25; Koene JM, 2005, BEHAV ECOL SOCIOBIOL, V59, P243, DOI 10.1007/s00265-005-0030-y; Koene JM, 1998, J EXP BIOL, V201, P2313; Koene JM, 1998, J MOLLUS STUD, V64, P75, DOI 10.1093/mollus/64.1.75; Koene JM, 2012, THE OXFORD HANDBOOK; Koene JM, 2006, AM NAT, V168, P553, DOI 10.1086/508028; Kohn AJ, 1999, J MOLLUS STUD, V65, P461, DOI 10.1093/mollus/65.4.461; Landolfa MA, 2001, BEHAV ECOL, V12, P773, DOI 10.1093/beheco/12.6.773; Lange R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043234; LEONARD JL, 1984, AM NAT, V124, P282, DOI 10.1086/284269; Liew TS, 2009, ZOOL J LINN SOC-LOND, V157, P515, DOI 10.1111/j.1096-3642.2009.00526.x; Michiels NK, 2006, INTEGR COMP BIOL, V46, P473, DOI 10.1093/icb/icj043; Michiels NK, 1998, NATURE, V391, P647, DOI 10.1038/35527; Morrow EH, 2003, P ROY SOC B-BIOL SCI, V270, P2377, DOI 10.1098/rspb.2003.2514; Nakadera Y, 2013, CAN J ZOOL, V91, P367, DOI 10.1139/cjz-2012-0272; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PERTOT WJ, 1992, J ENDODONT, V18, P100, DOI 10.1016/S0099-2399(06)81307-5; Preece T, 2009, AM NAT, V173, P632, DOI 10.1086/597377; Reyes-Tur B, 2007, ANIM BIOL, V57, P261, DOI 10.1163/157075607780377974; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rogers DW, 2002, BEHAV ECOL SOCIOBIOL, V52, P289, DOI 10.1007/s00265-002-0519-6; Scharer L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0052; Scharer L, 2012, TRENDS ECOL EVOL, V27, P260, DOI 10.1016/j.tree.2011.12.006; Scharer L, 2011, P NATL ACAD SCI USA, V108, P1490, DOI 10.1073/pnas.1013892108; Schilthuizen M, 2005, TRENDS ECOL EVOL, V20, P581, DOI 10.1016/j.tree.2005.08.014; Zahradnicek O, 2008, MECH DEVELOP, V125, P786, DOI 10.1016/j.mod.2008.06.008	41	11	11	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69968	10.1371/journal.pone.0069968	http://dx.doi.org/10.1371/journal.pone.0069968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894565	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900102
J	Gorovits, R; Moshe, A; Ghanim, M; Czosnek, H				Gorovits, Rena; Moshe, Adi; Ghanim, Murad; Czosnek, Henryk			Recruitment of the Host Plant Heat Shock Protein 70 by Tomato Yellow Leaf Curl Virus Coat Protein Is Required for Virus Infection	PLOS ONE			English	Article							TRIPLE GENE-BLOCK; SUBCELLULAR-LOCALIZATION; BEMISIA-TABACI; CIRCULATIVE TRANSMISSION; REPLICATION PROTEINS; MOLECULAR CHAPERONES; HSP70 CHAPERONES; KDA PROTEIN; GEMINIVIRUS; EXPRESSION	A functional capsid protein (CP) is essential for host plant infection and insect transmission of Tomato yellow leaf curl virus (TYLCV) and other monopartite begomoviruses. We have previously shown that TYLCV CP specifically interacts with the heat shock protein 70 (HSP70) of the virus insect vector, Bemisia tabaci. Here we demonstrate that during the development of tomato plant infection with TYLCV, a significant amount of HSP70 shifts from a soluble form into insoluble aggregates. CP and HSP70 co-localize in these aggregates, first in the cytoplasm, then in the nucleus of cells associated with the vascular system. CP-HSP70 interaction was demonstrated by co-immunopreciptation in cytoplasmic - but not in nuclear extracts from leaf and stem. Inhibition of HSP70 expression by quercetin caused a decrease in the amount of nuclear CP aggregates and a re-localization of a GFP-CP fusion protein from the nucleus to the cytoplasm. HSP70 inactivation resulted in a decrease of TYLCV DNA levels, demonstrating the role of HSP70 in TYLCV multiplication in planta. The current study reveals for the first time the involvement of plant HSP70 in TYLCV CP intracellular movement. As described earlier, nuclear aggregates contained TYLCV DNA-CP complexes and infectious virions. Showing that HSP70 localizes in these large nuclear aggregates infers that these structures operate as nuclear virus factories.	[Gorovits, Rena; Moshe, Adi; Czosnek, Henryk] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; [Ghanim, Murad] Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel	Hebrew University of Jerusalem; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Gorovits, R (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel.	gorovits@agri.huji.ac.il			U.S. Agency for International Development, Middle East Research and Cooperation (MERC) program [GEG-G-00-02-00003-00, M21-037]	U.S. Agency for International Development, Middle East Research and Cooperation (MERC) program(United States Agency for International Development (USAID))	This research was supported by grant from the U.S. Agency for International Development, Middle East Research and Cooperation (MERC) program to H. C. (GEG-G-00-02-00003-00), Project M21-037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diaz-Pendon JA, 2010, MOL PLANT PATHOL, V11, P441, DOI [10.1111/j.1364-3703.2010.00618.x, 10.1111/J.1364-3703.2010.00618.X]; Aoki K, 2002, P NATL ACAD SCI USA, V99, P16342, DOI 10.1073/pnas.252427999; Aparicio F, 2005, PLANT PHYSIOL, V138, P529, DOI 10.1104/pp.104.058958; Aranda M, 1998, VIROLOGY, V243, P261, DOI 10.1006/viro.1998.9032; Aranda MA, 1996, P NATL ACAD SCI USA, V93, P15289, DOI 10.1073/pnas.93.26.15289; Arguello-Astorga G, 2004, J VIROL, V78, P4817, DOI 10.1128/JVI.78.9.4817-4826.2004; Bae MS, 2003, PLANT J, V36, P652, DOI 10.1046/j.1365-313X.2003.01907.x; Bar-Ziv A, 2012, PLANT SIGNAL BEHAV, V7, P983, DOI 10.4161/psb.20935; Bendahmane M, 2007, VIROLOGY, V366, P107, DOI 10.1016/j.virol.2007.03.052; Brown G, 2005, VIROLOGY, V338, P69, DOI 10.1016/j.virol.2005.05.004; Castillo AG, 2003, VIROLOGY, V312, P381, DOI 10.1016/S0042-6822(03)00234-4; Chang BY, 1997, J GEN VIROL, V78, P1175, DOI 10.1099/0022-1317-78-5-1175; Czosnek H, 2007, MANAGEMENT MOL BIOL; DAVIES C, 1993, VIROLOGY, V197, P166, DOI 10.1006/viro.1993.1577; Escaler M, 2000, VIROLOGY, V267, P318, DOI 10.1006/viro.1999.0119; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Ghanim M, 2001, J MORPHOL, V248, P22, DOI 10.1002/jmor.1018; Ghanim M, 2001, PHYTOPATHOLOGY, V91, P188, DOI 10.1094/PHYTO.2001.91.2.188; Glick E, 2008, P NATL ACAD SCI USA, V105, P157, DOI 10.1073/pnas.0709036105; Gotz M, 2012, J VIROL, V86, P13241, DOI 10.1128/JVI.00880-12; Gongora-Castillo E, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-295; Gorovits R, 2007, MOL PLANT MICROBE IN, V20, P1376, DOI 10.1094/MPMI-20-11-1376; Gorovits R, 2013, VIRUS RES, V171, P33, DOI 10.1016/j.virusres.2012.09.017; Gorovits Rena, 2007, P223, DOI 10.1007/978-1-4020-4769-5_13; Gutierrez C, 2000, PLANT MOL BIOL, V43, P763, DOI 10.1023/A:1006462028363; Gutierrez C, 2004, VET MICROBIOL, V98, P111, DOI 10.1016/j.vetmic.2003.10.012; Hanley-Bowdoin L, 2004, MOL PLANT PATHOL, V5, P149, DOI [10.1111/j.1364-3703.2004.00214.x, 10.1111/J.1364-3703.2004.00214.X]; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Havelda Z, 2000, PLANT CELL, V12, P1975, DOI 10.1105/tpc.12.10.1975; Hofer P, 1997, VIROLOGY, V236, P288, DOI 10.1006/viro.1997.8751; Ito J, 2006, J PROTEOME RES, V5, P3459, DOI 10.1021/pr060403j; Ivanovic T, 2007, J BIOL CHEM, V282, P12210, DOI 10.1074/jbc.M610258200; Kanzaki H, 2003, MOL PLANT PATHOL, V4, P383, DOI [10.1046/j.1364-3703.2003.00186.x, 10.1046/J.1364-3703.2003.00186.X]; Kaufer S, 2012, J VIROL, V86, P1079, DOI 10.1128/JVI.02662-10; Krenz B, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00291; Krenz B, 2010, VIROLOGY, V401, P6, DOI 10.1016/j.virol.2010.02.011; Kunik T, 1998, PLANT J, V13, P393, DOI 10.1046/j.1365-313X.1998.00037.x; Lambert C, 2003, P NATL ACAD SCI USA, V100, P5199, DOI 10.1073/pnas.0930813100; Li PP, 2009, J VIROL, V83, P37, DOI 10.1128/JVI.00844-08; Lin BL, 2001, CELL STRESS CHAPERON, V6, P201, DOI 10.1379/1466-1268(2001)006<0201:GAOTHS>2.0.CO;2; Lozano-Duran R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022383; Lozano-Duran R, 2011, PLANT CELL, V23, P1014, DOI 10.1105/tpc.110.080267; Manwell LA, 2007, COMP BIOCHEM PHYS A, V148, P521, DOI 10.1016/j.cbpa.2007.06.422; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Morin S, 1999, VIROLOGY, V256, P75, DOI 10.1006/viro.1999.9631; Moshe A, 2012, METABOLOMICS S, VS1, DOI [10.4172/2153-0769 S1-006, DOI 10.4172/2153-0769]; Moshe A, 2012, VIRUSES-BASEL, V4, P2218, DOI 10.3390/v4102218; Nagy PD, 2011, VIROLOGY, V411, P374, DOI 10.1016/j.virol.2010.12.061; NAVOT N, 1991, VIROLOGY, V185, P151, DOI 10.1016/0042-6822(91)90763-2; Paciorek T, 2006, NAT PROTOC, V1, P104, DOI 10.1038/nprot.2006.16; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Rojas MR, 2001, VIROLOGY, V291, P110, DOI 10.1006/viro.2001.1194; ROULEAU M, 1994, VIROLOGY, V204, P254, DOI 10.1006/viro.1994.1530; Sade D, 2012, PLANT MOL BIOL, V80, P273, DOI 10.1007/s11103-012-9946-6; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Schroda M, 2001, BIOCHEM SOC T, V29, P413, DOI 10.1042/BST0290413; Serva S, 2006, J VIROL, V80, P2162, DOI 10.1128/JVI.80.5.2162-2169.2006; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Soll J, 2002, CURR OPIN PLANT BIOL, V5, P529, DOI 10.1016/S1369-5266(02)00296-0; Tomita Y, 2003, J VIROL, V77, P2990, DOI 10.1128/JVI.77.5.2990-2997.2003; Wang MH, 2004, BRIT J CANCER, V90, P926, DOI 10.1038/sj.bjc.6601583; Wang RYL, 2009, J VIROL, V83, P3276, DOI 10.1128/JVI.02313-08; Weeks SA, 2008, J VIROL, V82, P2004, DOI 10.1128/JVI.02017-07; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; ZEIDAN M, 1991, J GEN VIROL, V72, P2607, DOI 10.1099/0022-1317-72-11-2607; Zrachya A, 2007, TRANSGENIC RES, V16, P385, DOI 10.1007/s11248-006-9042-2; Zrachya A, 2007, VIROLOGY, V358, P159, DOI 10.1016/j.virol.2006.08.016	74	50	55	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70280	10.1371/journal.pone.0070280	http://dx.doi.org/10.1371/journal.pone.0070280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894631	gold, Green Published, Green Submitted			2022-12-25	WOS:000325211000201
J	Menegazzo, L; Albiero, M; Millioni, R; Tolin, S; Arrigoni, G; Poncina, N; Tessari, P; Avogaro, A; Fadini, GP				Menegazzo, Lisa; Albiero, Mattia; Millioni, Renato; Tolin, Serena; Arrigoni, Giorgio; Poncina, Nicol; Tessari, Paolo; Avogaro, Angelo; Fadini, Gian Paolo			Circulating myeloid calcifying cells have antiangiogenic activity via thrombospondin-1 overexpression	FASEB JOURNAL			English	Article						stem cells; atherosclerosis; inflammation; endothelial cells	MIGRATION INHIBITORY FACTOR; ENDOTHELIAL GROWTH-FACTOR; MYOCARDIAL-INFARCTION; TUMOR-GROWTH; MACROPHAGE; NEOVASCULARIZATION; ATHEROSCLEROSIS; ATHEROGENESIS; ANGIOGENESIS; OSTEOGENESIS	Myeloid calcifying cells (MCCs) represent a subpopulation of human monocytes with procalcific potential and are characterized by coexpression of osteocalcin (OC) and bone alkaline phosphatase (BAP). Herein, an in-depth proteomic investigation of MCCs based on fluorescence-activated cell sorting, protein extraction and digestion, isobaric tag for relative and absolute quantitation labeling, fractionation, and analysis on matrix-assisted laser desorption/ionization-time of flight/time of flight and LTQ Orbitrap mass spectrometers identified and quantified more than 700 proteins and revealed pathways activated in OC(+)BAP(+) MCCs compared with those in OC(-)BAP(-) cells. Among proteins referable to angiogenesis, the thrombospondin-1 pathway was markedly up-regulated in MCCs vs. control cells. Up-regulation of the thrombospondin-1 pathway was confirmed by a genome-wide transcriptional analysis. Using in vitro and in vivo angiogenesis assays, we found that freshly isolated MCCs and cultured MCCs display an antiangiogenic function by means of both paracrine activity (conditioned medium) and altered spatial localization in cocultures with endothelial cells. Thrombospondin-1 inhibition by antibody-mediated neutralization or gene knockdown restored the angiogenic activity of OC(+)BAP(+) MCCs toward normal values and abolished the antiangiogenic effects of MCC conditioned medium. These data indicate that circulating MCCs exert antiangiogenic activity by virtue of their overexpression of thrombospondin-1. The study highlights the successful identification and validation of a pathogenic pathway by a gold standard proteomic/transcriptomic analysis of blood cells.Menegazzo, L., Albiero, M., Millioni, R., Tolin, S., Arrigoni, G., Poncina, N., Tessari, P., Avogaro, A., Fadini, G. P. Circulating myeloid calcifying cells have antiangiogenic activity.	[Menegazzo, Lisa; Millioni, Renato; Poncina, Nicol; Tessari, Paolo; Avogaro, Angelo; Fadini, Gian Paolo] Univ Padua, Dept Med, Padua, Italy; [Arrigoni, Giorgio] Univ Padua, Dept Biomed Sci, Padua, Italy; [Menegazzo, Lisa; Albiero, Mattia; Tolin, Serena; Arrigoni, Giorgio; Poncina, Nicol; Avogaro, Angelo; Fadini, Gian Paolo] Venetian Inst Mol Med, Padua, Italy; [Tolin, Serena; Arrigoni, Giorgio] Univ Padua, Prote Ctr, Padua, Italy	University of Padua; University of Padua; Veneto Institute Molecular Medicine; University of Padua	Fadini, GP (corresponding author), Univ Hosp Padova, Div Metab Dis, Dept Med, Via Giustiniani 2, I-35100 Padua, Italy.	gianpaolo.fadini@unipd.it	Fadini, Gian Paolo/M-4575-2019; Albiero, Mattia/AAG-4257-2019; Avogaro, Angelo/S-3808-2016; Millioni, Renato/ABG-1799-2020; Arrigoni, Giorgio/A-3535-2014	Fadini, Gian Paolo/0000-0002-6510-2097; Albiero, Mattia/0000-0003-4142-9738; Arrigoni, Giorgio/0000-0002-4103-2733; AVOGARO, ANGELO/0000-0002-1177-0516	European Foundation for the Study of Diabetes/AstraZeneca Young Investigator Award	European Foundation for the Study of Diabetes/AstraZeneca Young Investigator Award	The authors acknowledge the technical assistance of Stefano Ciciliot (Venetian Institute of Molecular Medicine) for gene silencing and of Silvio Bicciato and Emilia Maria Cristina Mazza (Center for Genome Research, Department of Life Sciences, University of Modena and Reggio Emilia) for analysis of microarray data. This work was supported by a European Foundation for the Study of Diabetes/AstraZeneca Young Investigator Award (to G. P. F). L. M. and M. A. performed research and analyzed data; R. M. and S. T. designed research, performed research, and analyzed data; G. A. designed research and analyzed data; N.P. performed research and analyzed data; P. T. designed research; A. A. designed research and wrote manuscript; and G. P. F. designed research, analyzed data, and wrote manuscript. The authors declare no conflicts of interest.	Bento CF, 2011, DIABETOLOGIA, V54, P1946, DOI 10.1007/s00125-011-2191-8; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Fadini GP, 2012, CIRCULATION, V125, P2772, DOI 10.1161/CIRCULATIONAHA.112.090860; Fadini GP, 2011, CIRC RES, V108, P1112, DOI 10.1161/CIRCRESAHA.110.234088; Gossl M, 2010, JACC-CARDIOVASC IMAG, V3, P32, DOI 10.1016/j.jcmg.2009.10.009; Hellings WE, 2010, CIRCULATION, V121, P1941, DOI 10.1161/CIRCULATIONAHA.109.887497; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Kishuku M, 2009, J IMMUNOL, V183, P8176, DOI 10.4049/jimmunol.0803849; Kocher T, 2009, J PROTEOME RES, V8, P4743, DOI 10.1021/pr900451u; Lawler PR, 2012, COLD SPRING HARB PER, V2; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Shoji T, 2010, LAB INVEST, V90, P637, DOI 10.1038/labinvest.2010.39; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	21	18	19	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4355	4365		10.1096/fj.12-223719	http://dx.doi.org/10.1096/fj.12-223719			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23901071				2022-12-25	WOS:000329937500004
J	Zhang, SF; Zhao, H; Darzynkiewicz, Z; Zhou, PB; Zhang, ZT; Lee, EYC; Lee, MYWT				Zhang, Sufang; Zhao, Hong; Darzynkiewicz, Zbiegniew; Zhou, Pengbo; Zhang, Zhongtao; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.			A Novel Function of CRL4(Cdt2) REGULATION OF THE SUBUNIT STRUCTURE OF DNA POLYMERASE delta IN RESPONSE TO DNA DAMAGE AND DURING THE S PHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; OKAZAKI FRAGMENT MATURATION; UBIQUITIN LIGASE; P12 SUBUNIT; PIP BOX; PCNA; DEGRADATION; REPLICATION; P21; REPAIR	DNA polymerase delta (Pol delta 4) is a heterotetrameric enzyme, whose p12 subunit is degraded in response to DNA damage, leaving behind a trimer (Pol delta 3) with altered enzymatic characteristics that participate in gap filling during DNA repair. We demonstrate that CRL4(Cdt2), a key regulator of cell cycle progression that targets replication licensing factors, also targets the p12 subunit of Pol delta 4 in response to DNA damage and on entry into S phase. Evidence for the involvement of CRL4(Cdt2) included demonstration that p12 possesses a proliferating cell nuclear antigen-interacting protein-degron (PIP-degron) and that knockdown of the components of the CRL4(Cdt2) complex inhibited the degradation of p12 in response to DNA damage. Analysis of p12 levels in synchronized cell populations showed that p12 is partially degraded in S phase and that this is affected by knockdowns of CUL4A or CUL4B. Laser scanning cytometry of overexpressed wild type p12 and a mutant resistant to degradation showed that the reduction in p12 levels during S phase was prevented by mutation of p12. Thus, CRL4(Cdt2) also regulates the subunit composition of Pol delta during the cell cycle. These studies reveal a novel function of CRL4(Cdt2), i.e. the direct regulation of DNA polymerase delta, adding to its known functions in the regulation of the licensing of replication origins and expanding the scope of its overall control of DNA replication. The formation of Pol delta 3 in S phase as a normal aspect of cell cycle progression leads to the novel implications that it is involved in DNA replication as well as DNA repair.	[Zhang, Sufang; Zhang, Zhongtao; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Zhao, Hong; Darzynkiewicz, Zbiegniew] New York Med Coll, Dept Pathol, Brander Canc Res Inst, Valhalla, NY 10595 USA; [Zhou, Pengbo] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	New York Medical College; New York Medical College; Cornell University	Lee, MYWT (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	Marietta_lee@NYMC.edu		Zhang, Sufang/0000-0003-3883-023X; Darzynkiewicz, Zbigniew/0000-0002-2040-7081; zhang, zhongtao/0000-0002-1910-4753	National Institutes of Health [GM31973, ES14737, CA028704, CA098210, CA159925]; NATIONAL CANCER INSTITUTE [R56CA098210, R01CA159925, R01CA098210, R01CA028704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31973 and ES14737 (to M. Y. W. T. L.), CA028704 (to Z. D.), and CA098210 and CA159925 (to P. Z.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Balakrishnan L, 2011, J BIOL CHEM, V286, P6865, DOI 10.1074/jbc.R110.209502; Beattie TR, 2012, EMBO J, V31, P1556, DOI 10.1038/emboj.2012.12; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chea J, 2012, CELL CYCLE, V11, P2885, DOI 10.4161/cc.21280; Chen JJ, 2011, CELL BIOCHEM BIOPHYS, V60, P47, DOI 10.1007/s12013-011-9187-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Galal WC, 2012, CELL CYCLE, V11, P2771, DOI 10.4161/cc.21258; Garg P, 2005, CELL CYCLE, V4, P221; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gibbs E, 1997, J BIOL CHEM, V272, P2373; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hannah J, 2009, DNA REPAIR, V8, P536, DOI 10.1016/j.dnarep.2009.01.011; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jascur T, 2011, J BIOL CHEM, V286, P29531, DOI 10.1074/jbc.M111.221341; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kang YH, 2012, P NATL ACAD SCI USA, V109, P6042, DOI 10.1073/pnas.1203734109; Kerzendorfer C, 2011, MECH AGEING DEV, V132, P366, DOI 10.1016/j.mad.2011.02.003; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kopanja D, 2011, DEV BIOL, V352, P278, DOI 10.1016/j.ydbio.2011.01.028; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee J, 2013, BLOOD, V121, P4082, DOI 10.1182/blood-2012-09-455204; Lee MYWT, 2012, ENVIRON MOL MUTAGEN, V53, P683, DOI 10.1002/em.21743; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Lehmann AR, 2006, DNA REPAIR, V5, P404, DOI 10.1016/j.dnarep.2005.12.005; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Li H, 2006, CELL CYCLE, V5, P428, DOI 10.4161/cc.5.4.2425; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Masuda Y, 2010, J MOL BIOL, V396, P487, DOI 10.1016/j.jmb.2010.01.003; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Rytkonen AK, 2006, FEBS J, V273, P2984, DOI 10.1111/j.1742-4658.2006.05310.x; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sivaprasad U, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-8; Soria G, 2008, J CELL SCI, V121, P3271, DOI 10.1242/jcs.027730; Soria G, 2010, DNA REPAIR, V9, P358, DOI 10.1016/j.dnarep.2009.12.003; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Vaara M, 2012, J BIOL CHEM, V287, P33327, DOI 10.1074/jbc.M112.357996; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Wu SM, 2011, CELL CYCLE, V10, P68, DOI 10.4161/cc.10.1.14363; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; ZENG XR, 1994, J BIOL CHEM, V269, P13748; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhang SF, 2013, J BIOL CHEM, V288, P2941, DOI 10.1074/jbc.M112.423392; Zhang WW, 2011, FEBS LETT, V585, P2786, DOI 10.1016/j.febslet.2011.04.044; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595; Zhao H, 2012, CYTOM PART A, V81A, P45, DOI 10.1002/cyto.a.21172; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048; Zhou YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022224; Zhuang ZH, 2010, BBA-PROTEINS PROTEOM, V1804, P1081, DOI 10.1016/j.bbapap.2009.06.018	80	44	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29550	29561		10.1074/jbc.M113.490466	http://dx.doi.org/10.1074/jbc.M113.490466			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23913683	Green Published, hybrid			2022-12-25	WOS:000330615300031
J	Tinkum, KL; White, LS; Marpegan, L; Herzog, E; Piwnica-Worms, D; Piwnica-Worms, H				Tinkum, Kelsey L.; White, Lynn S.; Marpegan, Luciano; Herzog, Erik; Piwnica-Worms, David; Piwnica-Worms, Helen			Forkhead Box O1 ( FOXO1) Protein, but Not p53, Contributes to Robust Induction of p21 Expression in Fasted Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSCRIPTION; PHOSPHORYLATION; HYPOGLYCEMIA; INSULIN	Reporter mice that enable the activity of the endogenous p21 promoter to be dynamically monitored in real time in vivo and under a variety of experimental conditions revealed ubiquitous p21 expression in mouse organs including the brain. Low light bioluminescence microscopy was employed to localize p21 expression to specific regions of the brain. Interestingly, p21 expression was observed in the paraventricular, arcuate, and dorsomedial nuclei of the hypothalamus, regions that detect nutrient levels in the blood stream and signal metabolic actions throughout the body. These results suggested a link between p21 expression and metabolic regulation. We found that short-term food deprivation (fasting) potently induced p21 expression in tissues involved in metabolic regulation including liver, pancreas and hypothalamic nuclei. Conditional reporter mice were generated that enabled hepatocyte-specific expression of p21 to be monitored in vivo. Bioluminescence imaging demonstrated that fasting induced a 7-fold increase in p21 expression in livers of reporter mice and Western blotting demonstrated an increase in protein levels as well. The ability of fasting to induce p21 expression was found to be independent of p53 but dependent on FOXO1. Finally, occupancy of the endogenous p21 promoter by FOXO1 was observed in the livers of fasted but not fed mice. Thus, fasting promotes loading of FOXO1 onto the p21 promoter to induce p21 expression in hepatocytes.	[Tinkum, Kelsey L.; White, Lynn S.; Piwnica-Worms, David; Piwnica-Worms, Helen] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Tinkum, Kelsey L.; White, Lynn S.; Piwnica-Worms, David; Piwnica-Worms, Helen] Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Tinkum, Kelsey L.; White, Lynn S.; Piwnica-Worms, David; Piwnica-Worms, Helen] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Piwnica-Worms, Helen] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Marpegan, Luciano; Herzog, Erik] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Piwnica-Worms, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Unit 1479, T Boone Pickens Acad Tower,1400 Pressler St, Houston, TX 77030 USA.	dpiwnica-worms@mdanderson.org; hpiwnica-worms@mdanderson.org	Piwnica-Worms, Helen/C-5214-2012	Marpegan, Luciano/0000-0003-3652-9873; Herzog, Erik/0000-0001-7209-5174	NCI Cancer Center [P30 CA91842]; NATIONAL CANCER INSTITUTE [P50CA094056, P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH063140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Jinwu Sun for generating the conditional p21 targeting vector and for screening clones, Catherine Kusmicki for assistance with cloning and Philippe Soriano for providing pBigT plasmid. Anne Brunet is thanked for her generous gift of FOXO1 antibody for ChIP and Ashley Webb is thanked for providing advice on the ChIP protocol. We thank Ron DePinho for providing FOXO1<SUP>f/f</SUP> mice, Shin Imai for providing Albumin-Cre mice, Mike White for performing blastocyst injections, Emily Powell for editorial assistance, Reece Goiffon for statistical assistance, and Clay Semenkovich and Trey Coleman for assistance with metabolic analysis. Finally, we thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital for the use of the Embryonic Stem Cell Core and electroporation services. The Alvin J. Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant (P30 CA91842).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chaya D., 2003, METHOD ENZYMOL, P361; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Estep PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005242; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gross S, 2007, MOL IMAGING, V6, P121, DOI 10.2310/7290.2007.00009; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Marpegan L, 2011, J NEUROSCI, V31, P8342, DOI 10.1523/JNEUROSCI.6537-10.2011; Marshall BA, 1999, J BIOL CHEM, V274, P27426, DOI 10.1074/jbc.274.39.27426; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paxions G., 2001, MOUSE BRAIN STEREOTA, Vsecond; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Tinkum KL, 2011, MOL CELL BIOL, V31, P3759, DOI 10.1128/MCB.05243-11; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527	27	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27999	28008		10.1074/jbc.M113.494328	http://dx.doi.org/10.1074/jbc.M113.494328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23918930	Green Published, hybrid			2022-12-25	WOS:000330612800026
J	Kim, S; Park, S				Kim, Sunmin; Park, SangYoun			Structural Changes during Cysteine Desulfurase CsdA and Sulfur Acceptor CsdE Interactions Provide Insight into the trans-Persulfuration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI COUNTERPART; S CLUSTER BIOGENESIS; NIFS-LIKE PROTEIN; CRYSTAL-STRUCTURE; SULFINATE DESULFINASE; SELENOCYSTEINE LYASE; GENE CLONING; ISCU; SUFS; PURIFICATION	In Escherichia coli, three cysteine desulfurases (IscS, SufS, and CsdA) initiate the delivery of sulfur for various biological processes such as the biogenesis of Fe-S clusters. The sulfur generated as persulfide on a cysteine residue of cysteine desulfurases is further transferred to Fe-S scaffolds (e.g. IscU) or to intermediate cysteine-containing sulfur acceptors (e.g. TusA, SufE, and CsdE) prior to its utilization. Here, we report the structures of CsdA and the CsdA-CsdE complex, which provide insight into the sulfur transfer mediated by the trans-persulfuration reaction. Analysis of the structures indicates that the conformational flexibility of the active cysteine loop in CsdE is essential for accepting the persulfide from the cysteine of CsdA. Additionally, CsdA and CsdE invoke a different binding mode than those of previously reported cysteine desulfurase (IscS) and sulfur acceptors (TusA and IscU). Moreover, the conservation of interaction-mediating residues between CsdA/SufS and CsdE/SufE further suggests that the SufS-SufE interface likely resembles that of CsdA and CsdE.	[Kim, Sunmin; Park, SangYoun] Soongsil Univ, Sch Syst Biomed Sci, Seoul 156743, South Korea	Soongsil University	Park, S (corresponding author), Soongsil Univ, Coll Nat Sci, Sch Syst Biomed Sci, 511 Sangdo Dong, Seoul 156743, South Korea.	psy@ssu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea [2013R1A1A2005276]; Ministry of Education, Science and Technology (MEST); MEST; Pohang University of Science and Technology	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Pohang University of Science and Technology	This work was supported by Basic Science Research Program Grant 2013R1A1A2005276 through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (MEST). Experiments performed at the Pohang Light Source were supported in part by MEST and the Pohang University of Science and Technology.	Adinolfi S, 2004, EUR J BIOCHEM, V271, P2093, DOI 10.1111/j.1432-1033.2004.04112.x; Bolstad HM, 2010, J PROTEOME RES, V9, P5358, DOI 10.1021/pr1006087; Clausen T, 2000, P NATL ACAD SCI USA, V97, P3856, DOI 10.1073/pnas.97.8.3856; Collins R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030581; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goldsmith-Fischman S, 2004, J MOL BIOL, V344, P549, DOI 10.1016/j.jmb.2004.08.074; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Katoh E, 2000, J MOL BIOL, V304, P219, DOI 10.1006/jmbi.2000.4170; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Liu GH, 2005, PROTEIN SCI, V14, P1597, DOI 10.1110/ps.041322705; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Omi R, 2010, J BIOL CHEM, V285, P12133, DOI 10.1074/jbc.M109.084475; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Sendra M, 2007, FEBS LETT, V581, P1362, DOI 10.1016/j.febslet.2007.02.058; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Trotter V, 2009, MOL MICROBIOL, V74, P1527, DOI 10.1111/j.1365-2958.2009.06954.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754	36	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27172	27180		10.1074/jbc.M113.480277	http://dx.doi.org/10.1074/jbc.M113.480277			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23913692	hybrid, Green Published			2022-12-25	WOS:000330597300016
J	Ma, CL; Hagstrom, D; Polley, SG; Subramani, S				Ma, Changle; Hagstrom, Danielle; Polley, Soumi Guha; Subramani, Suresh			Redox-regulated Cargo Binding and Release by the Peroxisomal Targeting Signal Receptor, Pex5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICHIA-PASTORIS; PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; MATRIX; MECHANISM; MEMBRANE; UBIQUITINATION; LOCALIZATION; RECOGNITION; BIOGENESIS	In its role as a mobile receptor for peroxisomal matrix cargo containing a peroxisomal targeting signal called PTS1, the protein Pex5 shuttles between the cytosol and the peroxisome lumen. Pex5 binds PTS1 proteins in the cytosol via its C-terminal tetratricopeptide domains and delivers them to the peroxisome lumen, where the receptor.cargo complex dissociates. The cargo-free receptor is exported to the cytosol for another round of import. How cargo release and receptor recycling are regulated is poorly understood. We found that Pex5 functions as a dimer/oligomer and that its protein interactions with itself (homo-oligomeric) and with Pex8 (hetero-oligomeric) control the binding and release of cargo proteins. These interactions are controlled by a redox-sensitive amino acid, cysteine 10 of Pex5, which is essential for the formation of disulfide bond-linked Pex5 forms, for high affinity cargo binding, and for receptor recycling. Disulfide bond-linked Pex5 showed the highest affinity for PTS1 cargo. Upon reduction of the disulfide bond by dithiothreitol, Pex5 transitioned to a noncovalent dimer, concomitant with the partial release of PTS1 cargo. Additionally, dissipation of the redox balance between the cytosol and the peroxisome lumen caused an import defect. A hetero-oligomeric interaction between the N-terminal domain (amino acids 1-110) of Pex5 and a conserved motif at the C terminus of Pex8 further facilitates cargo release, but only under reducing conditions. This interaction is also important for the release of PTS1 proteins. We suggest a redox-regulated model for Pex5 function during the peroxisomal matrix protein import cycle.	[Ma, Changle; Hagstrom, Danielle; Polley, Soumi Guha; Subramani, Suresh] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Subramani, S (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, Rm 3326 Bonner Hall,9500 Gilman Dr, La Jolla, CA 92093 USA.	ssubramani@ucsd.edu		Ireland, Danielle/0000-0002-9827-1604; Ma, Changle/0000-0003-3360-2799	National Institutes of Health MERIT Award [DK41737]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK041737, R01DK041737, R37DK041737] Funding Source: NIH RePORTER	National Institutes of Health MERIT Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health MERIT Award DK41737 (to S. S.).	Aksam EB, 2008, FREE RADICAL BIO MED, V45, P1115, DOI 10.1016/j.freeradbiomed.2008.07.010; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Ghys K, 2002, BIOCHEM J, V365, P41, DOI 10.1042/BJ20011432; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; Harano T, 2001, BIOCHEM J, V357, P157, DOI 10.1042/0264-6021:3570157; Horiguchi H, 2001, J BIOL CHEM, V276, P14279, DOI 10.1074/jbc.M011661200; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; LIU H, 1995, J BIOL CHEM, V270, P10940, DOI 10.1074/jbc.270.18.10940; Liu XQ, 2013, J BIOL CHEM, V288, P7230, DOI 10.1074/jbc.M112.424911; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Ma C, 2009, MOL BIOL CELL, V20, P3680, DOI 10.1091/mbc.E09-01-0037; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Nashiro C, 2011, TRAFFIC, V12, P774, DOI 10.1111/j.1600-0854.2011.01182.x; Noctor Graham, 2011, Arabidopsis Book, V9, pe0142, DOI 10.1199/tab.0142; Ohdate T, 2012, BBA-MOL CELL BIOL L, V1821, P1295, DOI 10.1016/j.bbalip.2012.05.004; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Pye VE, 2010, J BIOL CHEM, V285, P24078, DOI 10.1074/jbc.M110.106013; Saleem RA, 2006, BBA-MOL CELL RES, V1763, P1541, DOI 10.1016/j.bbamcr.2006.09.005; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Sundaramoorthy R, 2006, J MOL BIOL, V359, P347, DOI 10.1016/j.jmb.2006.03.032; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; Yano T, 2010, MOL CELL BIOL, V30, P3758, DOI 10.1128/MCB.00121-10; Zhang L, 2006, MOL BIOL CELL, V17, P690, DOI 10.1091/mbc.E05-08-0758	39	59	60	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27220	27231		10.1074/jbc.M113.492694	http://dx.doi.org/10.1074/jbc.M113.492694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23902771	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000330597300020
J	Calderon, RH; Garcia-Cerdan, JG; Malnoe, A; Cook, R; Russell, JJ; Gaw, C; Dent, RM; de Vitry, C; Niyogi, KK				Calderon, Robert H.; Garcia-Cerdan, Jose G.; Malnoe, Alizee; Cook, Ron; Russell, James J.; Gaw, Cynthia; Dent, Rachel M.; de Vitry, Catherine; Niyogi, Krishna K.			A Conserved Rubredoxin Is Necessary for Photosystem II Accumulation in Diverse Oxygenic Photoautotrophs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; SYNECHOCOCCUS SP PCC-7002; ARABIDOPSIS-THALIANA; ELECTRON-TRANSFER; CHLAMYDOMONAS-REINHARDTII; CLOSTRIDIUM-PASTEURIANUM; FUNCTIONAL GENOMICS; PYROCOCCUS-FURIOSUS; CRYSTAL-STRUCTURE; NIFE HYDROGENASE	In oxygenic photosynthesis, two photosystems work in tandem to harvest light energy and generate NADPH and ATP. Photosystem II (PSII), theprotein-pigmentcomplexthatuseslightenergyto catalyze the splitting of water, is assembled from its component parts in a tightly regulated process that requires a number of assembly factors. The 2pac mutant of the unicellular green alga Chlamydomonas reinhardtii was isolated and found to have no detectable PSII activity, whereas other components of the photosynthetic electron transport chain, including photosystem I, were still functional. PSII activity was fully restored by complementation with the RBD1 gene, which encodes a small iron-sulfur protein known as a rubredoxin. Phylogenetic evidence supports the hypothesis that this rubredoxin and its orthologs are unique to oxygenic phototrophs and distinct from rubredoxins in Archaea and bacteria (excluding cyanobacteria). Knockouts of the rubredoxin orthologs in the cyanobacterium Synechocystis sp. PCC 6803 and the plant Arabidopsis thaliana were also found to be specifically affected in PSII accumulation. Taken together, our data suggest that this rubredoxin is necessary for normal PSII activity in a diverse set of organisms that perform oxygenic photosynthesis.	[Calderon, Robert H.; Garcia-Cerdan, Jose G.; Malnoe, Alizee; Cook, Ron; Russell, James J.; Gaw, Cynthia; Dent, Rachel M.; Niyogi, Krishna K.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Malnoe, Alizee; Dent, Rachel M.; Niyogi, Krishna K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [de Vitry, Catherine] Univ Paris 06, CNRS, Inst Biol Physicochim, Unite Mixte Rech 7141, F-75005 Paris, France	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Niyogi, KK (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	niyogi@berkeley.edu	Malnoë, Alizée/U-4517-2018	Malnoë, Alizée/0000-0002-8777-3174; Calderon, Robert/0000-0002-7863-9889	Philomathia Foundation; Gordon and Betty Moore Foundation [GBMF3070]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, U.S. Dept. of Energy, FWP [449B]	Philomathia Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, U.S. Dept. of Energy, FWP	This work was supported in part by the Philomathia Foundation and the Gordon and Betty Moore Foundation (through Grant GBMF3070, to K. K. N.).; Supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, U.S. Dept. of Energy, FWP number 449B.	ADMAN E, 1975, P NATL ACAD SCI USA, V72, P4854, DOI 10.1073/pnas.72.12.4854; Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Armbruster U, 2010, PLANT CELL, V22, P3439, DOI 10.1105/tpc.110.077453; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bailleul B, 2010, PHOTOSYNTH RES, V106, P179, DOI 10.1007/s11120-010-9579-z; BENNOUN P, 1986, PLANT MOL BIOL, V6, P151, DOI 10.1007/BF00021484; Boehm M, 2011, J BIOL CHEM, V286, P14812, DOI 10.1074/jbc.M110.207944; Cai WH, 2010, PLANT PHYSIOL, V154, P109, DOI 10.1104/pp.110.159558; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Dismukes GC, 2001, P NATL ACAD SCI USA, V98, P2170, DOI 10.1073/pnas.061514798; Eaton-Rye JJ, 2011, METHODS MOL BIOL, V684, P295, DOI [10.1007/978.1.60761.925.3_22, 10.1007/978-1-60761-925-3_22]; Eriksson Jan, 2000, Molecular Cell Biology Research Communications, V3, P292, DOI 10.1006/mcbr.2000.0227; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Fritsch J, 2011, J BACTERIOL, V193, P2487, DOI 10.1128/JB.01427-10; Fu A, 2007, P NATL ACAD SCI USA, V104, P15947, DOI 10.1073/pnas.0707851104; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagelueken G, 2007, P NATL ACAD SCI USA, V104, P12276, DOI 10.1073/pnas.0702919104; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Karamoko M, 2011, PLANT CELL, V23, P4462, DOI 10.1105/tpc.111.089680; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Komenda J, 2012, CURR OPIN PLANT BIOL, V15, P245, DOI 10.1016/j.pbi.2012.01.017; Kunert A, 2000, J MICROBIOL METH, V41, P185, DOI 10.1016/S0167-7012(00)00162-7; Kurtz DM, 2004, ACCOUNTS CHEM RES, V37, P902, DOI 10.1021/ar0200091; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGALL J, 1988, BIOCHEMISTRY-US, V27, P1636, DOI 10.1021/bi00405a037; Loytynoja A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-579; LOVENBERG W, 1965, P NATL ACAD SCI USA, V54, P193, DOI 10.1073/pnas.54.1.193; Lyska D, 2013, PLANTA, V237, P413, DOI 10.1007/s00425-012-1752-5; Manyani H, 2005, J BACTERIOL, V187, P7018, DOI 10.1128/JB.187.20.7018-7026.2005; Martienssen RA, 1998, P NATL ACAD SCI USA, V95, P2021, DOI 10.1073/pnas.95.5.2021; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Ossenbuhl F, 2004, PLANT CELL, V16, P1790, DOI 10.1105/tpc.023226; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; RAGSDALE SW, 1983, J BACTERIOL, V155, P1224, DOI 10.1128/JB.155.3.1224-1237.1983; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Tan GH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni124; Thorgersen MP, 2012, P NATL ACAD SCI USA, V109, P18547, DOI 10.1073/pnas.1208605109; Tiwari A, 2009, BBA-BIOENERGETICS, V1787, P985, DOI 10.1016/j.bbabio.2009.03.017; Tran PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042196; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wastl J, 2000, J BIOL CHEM, V275, P30058, DOI 10.1074/jbc.M004629200; Wastl J, 2000, FEBS LETT, V471, P191, DOI 10.1016/S0014-5793(00)01399-5; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Xiong J, 2002, ANNU REV PLANT BIOL, V53, P503, DOI 10.1146/annurev.arplant.53.100301.135212; Yeh AP, 2000, BIOCHEMISTRY-US, V39, P2499, DOI 10.1021/bi992428k; Yoon KS, 1999, J BIOL CHEM, V274, P29772, DOI 10.1074/jbc.274.42.29772; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zhang PP, 2012, PLANT CELL, V24, P1952, DOI 10.1105/tpc.111.094417	61	41	41	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26688	26696		10.1074/jbc.M113.487629	http://dx.doi.org/10.1074/jbc.M113.487629			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23900844	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000330594500034
J	Ismail, IH; McDonald, D; Strickfaden, H; Xu, ZZ; Hendzel, MJ				Ismail, Ismail Hassan; McDonald, Darin; Strickfaden, Hilmar; Xu, Zhizhong; Hendzel, Michael J.			A Small Molecule Inhibitor of Polycomb Repressive Complex 1 Inhibits Ubiquitin Signaling at DNA Double-strand Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE RESPONSE; HISTONE UBIQUITYLATION; REPAIR PROTEINS; H2AX PROTEIN; STEM-CELLS; BMI1; PHOSPHORYLATION; RECRUITMENT; LIGASE; CANCER	Polycomb-repressive complex 1 (PRC1)-mediated histone ubiquitylation plays an important role in aberrant gene silencing in human cancers and is a potential target for cancer therapy. Here we show that 2-pyridine-3-yl-methylene-indan-1,3-dione (PRT4165) is a potent inhibitor of PRC1-mediated H2A ubiquitylation in vivo and in vitro. The drug also inhibits the accumulation of all detectable ubiquitin at sites of DNA double-strand breaks (DSBs), the retention of several DNA damage response proteins in foci that form around DSBs, and the repair of the DSBs. In vitro E3 ubiquitin ligase activity assays revealed that PRT4165 inhibits both RNF2 and RING 1A, which are partially redundant paralogues that together account for the E3 ubiquitin ligase activity found in PRC1 complexes, but not RNF8 nor RNF168. Because ubiquitylation is completely inhibited despite the efficient recruitment of RNF8 to DSBs, our results suggest that PRC1-mediated monoubiquitylation is required for subsequent RNF8- and/or RNF168-mediated polyubiquitylation. Our results demonstrate the unique feature of PRT4165 as a novel chromatin-remodeling compound and provide a new tool for the inhibition of ubiquitylation signaling at DNA double-strand breaks.	[Ismail, Ismail Hassan; McDonald, Darin; Strickfaden, Hilmar; Xu, Zhizhong; Hendzel, Michael J.] Univ Alberta, Cross Canc Inst, Dept Oncol, Fac Med & Dent, Edmonton, AB T6G 1Z2, Canada; [Ismail, Ismail Hassan] Cairo Univ, Fac Sci, Dept Biophys, Giza 12613, Egypt	University of Alberta; Egyptian Knowledge Bank (EKB); Cairo University	Hendzel, MJ (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, Fac Med & Dent, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	mhendzel@ualberta.ca	Hendzel, Michael/C-3391-2009; Strickfaden, Hilmar/AAW-3522-2021	Hendzel, Michael/0000-0002-9603-7945; Ismail, Ismail Hassan/0000-0002-5526-6063	Alberta Cancer Foundation; Canadian Institute of Health Research	Alberta Cancer Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Alberta Cancer Foundation and the Canadian Institute of Health Research.	Alchanati I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008104; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chagraoui J, 2011, P NATL ACAD SCI USA, V108, P5284, DOI 10.1073/pnas.1014263108; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P711, DOI 10.1139/O09-057; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Ismail IH, 2012, NUCLEIC ACIDS RES, V40, P5497, DOI 10.1093/nar/gks222; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Nacerddine K, 2012, J CLIN INVEST, V122, P1920, DOI 10.1172/JCI57477; Opeskin K, 1998, J CLIN NEUROSCI, V5, P471, DOI 10.1016/S0967-5868(98)90295-8; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Raaphorst FM, 2000, AM J PATHOL, V157, P709, DOI 10.1016/S0002-9440(10)64583-X; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Sims JJ, 2012, NAT METHODS, V9, P303, DOI [10.1038/NMETH.1888, 10.1038/nmeth.1888]; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Uhrhammer Nancy, 1998, Cancer Research, V58, P3480; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wu CY, 2011, J BIOL CHEM, V286, P30806, DOI 10.1074/jbc.M111.257469	32	58	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26944	26954		10.1074/jbc.M113.461699	http://dx.doi.org/10.1074/jbc.M113.461699			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902761	hybrid, Green Published			2022-12-25	WOS:000330594500059
J	Lauffer, BEL; Mintzer, R; Fong, RN; Mukund, S; Tam, C; Zilberleyb, I; Flicke, B; Ritscher, A; Fedorowicz, G; Vallero, R; Ortwine, DF; Gunzner, J; Modrusan, Z; Neumann, L; Koth, CM; Lupardus, PJ; Kaminker, JS; Heise, CE; Steiner, P				Lauffer, Benjamin E. L.; Mintzer, Robert; Fong, Rina; Mukund, Susmith; Tam, Christine; Zilberleyb, Inna; Flicke, Birgit; Ritscher, Allegra; Fedorowicz, Grazyna; Vallero, Roxanne; Ortwine, Daniel F.; Gunzner, Janet; Modrusan, Zora; Neumann, Lars; Koth, Christopher M.; Lupardus, Patrick J.; Kaminker, Joshua S.; Heise, Christopher E.; Steiner, Pascal			Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; ISOFORM SELECTIVITY; EXPRESSION; CANCER; LEUKEMIA; GENE; GENERATION; INDUCTION; APOPTOSIS; PATTERNS	Histone deacetylases (HDACs) are critical in the control of gene expression, and dysregulation of their activity has been implicated in a broad range of diseases, including cancer, cardiovascular, and neurological diseases. HDAC inhibitors (HDACi) employing different zinc chelating functionalities such as hydroxamic acids and benzamides have shown promising results in cancer therapy. Although it has also been suggested that HDACi with increased isozyme selectivity and potency may broaden their clinical utility and minimize side effects, the translation of this idea to the clinic remains to be investigated. Moreover, a detailed understanding of how HDACi with different pharmacological properties affect biological functions in vitro and in vivo is still missing. Here, we show that a panel of benzamide-containing HDACi are slow tight-binding inhibitors with long residence times unlike the hydroxamate-containing HDACi vorinostat and trichostatin-A. Characterization of changes in H2BK5 and H4K14 acetylation following HDACi treatment in the neuroblastoma cell line SH-SY5Y revealed that the timing and magnitude of histone acetylation mirrored both the association and dissociation kinetic rates of the inhibitors. In contrast, cell viability and microarray gene expression analysis indicated that cell death induction and changes in transcriptional regulation do not correlate with the dissociation kinetic rates of the HDACi. Therefore, our study suggests that determining how the selective and kinetic inhibition properties of HDACi affect cell function will help to evaluate their therapeutic utility.	[Lauffer, Benjamin E. L.; Vallero, Roxanne; Steiner, Pascal] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Mintzer, Robert; Heise, Christopher E.] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Fong, Rina; Mukund, Susmith; Tam, Christine; Zilberleyb, Inna; Koth, Christopher M.; Lupardus, Patrick J.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Modrusan, Zora] Genentech Inc, Labs Microarray, San Francisco, CA 94080 USA; [Ortwine, Daniel F.; Gunzner, Janet] Genentech Inc, Discovery Chem, San Francisco, CA 94080 USA; [Kaminker, Joshua S.] Genentech Inc, Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Flicke, Birgit; Ritscher, Allegra; Neumann, Lars] Proteros Biostruct GmbH, D-82152 Planegg Martinsfried, Germany; [Fedorowicz, Grazyna] CellScape Corp, Newark, CA 94560 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Heise, CE (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	heise.christopher@gene.com; steiner.pascal@gene.com		Koth, Christopher/0000-0003-3939-8856	Department of Energy, Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41GM103393]; NCRR [P41RR001209]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yvonne Franke and Krista Bowman at Genentech for cloning and expression of HDACs. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy, Office of Science, by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by National Institutes of Health Grant P41GM103393 from NIGMS and Grant P41RR001209 from the NCRR. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bertrand P, 2010, EUR J MED CHEM, V45, P2095, DOI 10.1016/j.ejmech.2010.02.030; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Chavan AV, 2010, MINI-REV MED CHEM, V10, P1263; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZX, 2002, CANCER LETT, V188, P127, DOI 10.1016/S0304-3835(02)00322-1; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERICKSON P, 1992, BLOOD, V80, P1825; Govindarajan N, 2011, J ALZHEIMERS DIS, V26, P187, DOI 10.3233/JAD-2011-110080; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guidotti A, 2011, NEUROPHARMACOLOGY, V60, P1007, DOI 10.1016/j.neuropharm.2010.10.021; Halsall J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033453; Hanson J., 2013, PLOS ONE IN PRESS; Hug BA, 2004, ONCOGENE, V23, P4270, DOI 10.1038/sj.onc.1207674; Janssen C, 2010, J NEUROPATH EXP NEUR, V69, P573, DOI 10.1097/NEN.0b013e3181ddd404; Johnson CA, 2002, J BIOL CHEM, V277, P9590, DOI 10.1074/jbc.M107942200; Kattar SD, 2009, BIOORG MED CHEM LETT, V19, P1168, DOI 10.1016/j.bmcl.2008.12.083; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKinsey TA, 2012, ANNU REV PHARMACOL, V52, P303, DOI 10.1146/annurev-pharmtox-010611-134712; Methot JL, 2008, BIOORG MED CHEM LETT, V18, P973, DOI 10.1016/j.bmcl.2007.12.031; Neumann L, 2011, METHOD ENZYMOL, V493, P299, DOI 10.1016/B978-0-12-381274-2.00012-1; Neumann L, 2009, J COMPUT AID MOL DES, V23, P501, DOI 10.1007/s10822-009-9288-x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Rosato RR, 2003, CANCER RES, V63, P3637; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Scuto A, 2008, BLOOD, V111, P5093, DOI 10.1182/blood-2007-10-117762; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Subramanian S, 2010, PHARMACEUTICALS, V3, P2751, DOI 10.3390/ph3092751; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Whitehead L, 2011, BIOORGAN MED CHEM, V19, P4626, DOI 10.1016/j.bmc.2011.06.030; Wiech NL, 2009, CURR TOP MED CHEM, V9, P257, DOI 10.2174/156802609788085241; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	57	267	270	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26926	26943		10.1074/jbc.M113.490706	http://dx.doi.org/10.1074/jbc.M113.490706			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897821	hybrid, Green Published			2022-12-25	WOS:000330594500058
J	Rozeboom, HJ; Yu, SK; Madrid, S; Kalk, KH; Zhang, R; Dijkstra, BW				Rozeboom, Henriette J.; Yu, Shukun; Madrid, Susan; Kalk, Kor H.; Zhang, Ran; Dijkstra, Bauke W.			Crystal Structure of alpha-1,4-Glucan Lyase, a Unique Glycoside Hydrolase Family Member with a Novel Catalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN DEGRADING ENZYME; ALPHA-GLUCOSIDASE; SULFOLOBUS-SOLFATARICUS; EFFICIENT PURIFICATION; SUBSTRATE-SPECIFICITY; MALTASE-GLUCOAMYLASE; STARCH; 1,5-ANHYDRO-D-FRUCTOSE; CLASSIFICATION; XYLOSIDASE	alpha-1,4-Glucan lyase (EC 4.2.2.13) from the red seaweed Gracilariopsis lemaneiformis cleaves alpha-1,4-glucosidic linkages in glycogen, starch, and malto-oligosaccharides, yielding the keto-monosaccharide 1,5-anhydro-D-fructose. The enzyme belongs to glycoside hydrolase family 31 (GH31) but degrades starch via an elimination reaction instead of hydrolysis. The crystal structure shows that the enzyme, like GH31 hydrolases, contains a (beta/alpha)(8)-barrel catalytic domain with B and B' sub-domains, an N-terminal domain N, and the C-terminal domains C and D. The N-terminal domain N of the lyase was found to bind a trisaccharide. Complexes of the enzyme with acarbose and 1-dexoynojirimycin and two different covalent glycosyl-enzyme intermediates obtained with fluorinated sugar analogues show that, like GH31 hydrolases, the aspartic acid residues Asp(553) and Asp(665) are the catalytic nucleophile and acid, respectively. However, as a unique feature, the catalytic nucleophile is in a position to act also as a base that abstracts a proton from the C2 carbon atom of the covalently bound subsite -1 glucosyl residue, thus explaining the unique lyase activity of the enzyme. One Glu to Val mutation in the active site of the homologous alpha-glucosidase from Sulfolobus solfataricus resulted in a shift from hydrolytic to lyase activity, demonstrating that a subtle amino acid difference can promote lyase activity in a GH31 hydrolase.	[Rozeboom, Henriette J.; Kalk, Kor H.; Dijkstra, Bauke W.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands; [Yu, Shukun; Madrid, Susan] Danisco AS, Danisco Innovat, DK-1001 Copenhagen, Denmark; [Zhang, Ran] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of Groningen; University of British Columbia	Yu, SK (corresponding author), Danisco AS, Genencor, Edwin Rahrs Vej 38, DK-8220 Aarhus, Denmark.	shukun.yu@danisco.com; b.w.dijkstra@rug.nl	Dijkstra, Bauke W./H-4308-2019	Dijkstra, Bauke W./0000-0001-9731-6586; Rozeboom, Henriette/0000-0002-1656-6477				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bojsen K, 1999, BBA-PROTEIN STRUCT M, V1430, P396, DOI 10.1016/S0167-4838(99)00017-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cook MW, 2003, FOOD CHEM TOXICOL, V41, P523, DOI 10.1016/S0278-6915(02)00280-6; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst HA, 2005, BIOLOGIA, V60, P149; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Henrissat B, 2008, CURR OPIN STRUC BIOL, V18, P527, DOI 10.1016/j.sbi.2008.09.003; Hirano K, 2000, GLYCOBIOLOGY, V10, P1283, DOI 10.1093/glycob/10.12.1283; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larsbrink J, 2012, J BIOL CHEM, V287, P43288, DOI 10.1074/jbc.M112.416511; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; Lee SS, 2005, BIOLOGIA, V60, P137; Lee SS, 2003, BIOCHEMISTRY-US, V42, P13081, DOI 10.1021/bi035189g; Lee SS, 2002, J AM CHEM SOC, V124, P4948, DOI 10.1021/ja0255610; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; McCarter JD, 1996, J AM CHEM SOC, V118, P241, DOI 10.1021/ja952732a; McCarter JD, 1996, J BIOL CHEM, V271, P6889, DOI 10.1074/jbc.271.12.6889; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakai Hiroyuki I.T., 2006, J APPL GLYCOSCI, V53, P137, DOI [10.5458/jag.53.137, DOI 10.5458/JAG.53.137]; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Okuyama M, 2006, FEBS LETT, V580, P2707, DOI 10.1016/j.febslet.2006.04.025; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Tan KM, 2010, FASEB J, V24, P3939, DOI 10.1096/fj.10-156257; Trincone A, 2001, TETRAHEDRON-ASYMMETR, V12, P2783, DOI 10.1016/S0957-4166(01)00491-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yip VL, 2006, CURR OPIN CHEM BIOL, V10, P147, DOI 10.1016/j.cbpa.2006.02.005; Yoshinaga K, 1999, BBA-GEN SUBJECTS, V1472, P447, DOI 10.1016/S0304-4165(99)00147-6; YU S, 1993, BIOCHIM BIOPHYS ACTA, V1156, P313, DOI 10.1016/0304-4165(93)90049-E; Yu S, 1997, BBA-PROTEIN STRUCT M, V1339, P311, DOI 10.1016/S0167-4838(97)00014-9; Yu SK, 2008, IUBMB LIFE, V60, P798, DOI 10.1002/iub.125; Yu SK, 1999, BBA-PROTEIN STRUCT M, V1433, P1, DOI 10.1016/S0167-4838(99)00152-1; YU SK, 1995, BBA-GEN SUBJECTS, V1244, P1, DOI 10.1016/0304-4165(94)00202-9; Yu SK, 1999, ROY SOC CH, P243; Yu SK, 1997, CARBOHYD RES, V305, P73, DOI 10.1016/S0008-6215(97)00226-7	50	17	17	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26764	26774		10.1074/jbc.M113.485896	http://dx.doi.org/10.1074/jbc.M113.485896			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902768	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000330594500041
J	Xia, HJ; Wang, CY; Chen, WL; Zhang, HL; Chaudhury, L; Zhou, ZM; Liu, R; Chen, CS				Xia, Houjun; Wang, Chunyan; Chen, Wenlin; Zhang, Hailin; Chaudhury, Leena; Zhou, Zhongmei; Liu, Rong; Chen, Ceshi			Kruppel-like Factor 5 Transcription Factor Promotes Microsomal Prostaglandin E-2 Synthase 1 Gene Transcription in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; IN-VIVO; PROGNOSTIC-FACTOR; EPITHELIAL-CELLS; ANGIOTENSIN-II; EXPRESSION; KLF5; PROLIFERATION; TUMORIGENESIS; ACTIVATION	The KLF5 (Kruppel-like factor 5) transcription factor is specifically expressed in a subset of estrogen receptor alpha-negative breast cancers. Although KLF5 promotes breast cancer cell cycle progression, survival, and tumorigenesis, the mechanism by which KLF5 promotes breast cancer is still not entirely understood. Here, we demonstrate that mPGES1, encoding microsomal prostaglandin E-2 synthase 1 (mPGES1), is a KLF5 direct downstream target gene. KLF5 overexpression or knockdown positively altered the levels of mPGES1 mRNA and protein in multiple breast cell lines. 12-O-Tetradecanoylphorbol-13-acetate induced the expression of both KLF5 and mPGES1 in dosage- and time-dependent manners. The induction of KLF5 was essential for 12-O-tetradecanoylphorbol-13-acetate to induce mPGES1 expression. Additionally, KLF5 bound to the mPGES1 gene proximal promoter and activated its transcription. Both KLF5 and mPGES1 promoted prostaglandin E-2 production; regulated p21, p27, and Survivin downstream gene expression; and likewise stimulated cell proliferation. Overexpression of mPGES1 partially rescued the KLF5 knockdown-induced downstream gene expression changes and growth arrest in MCF10A cells. Finally, we demonstrate that the expression of mPGES1 was positively correlated with the estrogen receptor alpha/progesterone receptor/HER2 triple-negative status. These findings suggest that mPGES1 is a target gene of KLF5, making it a new biomarker and a potential therapeutic target for triple-negative breast cancers.	[Xia, Houjun; Wang, Chunyan; Zhang, Hailin; Zhou, Zhongmei; Liu, Rong; Chen, Ceshi] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Xia, Houjun; Wang, Chunyan; Zhang, Hailin; Zhou, Zhongmei; Liu, Rong; Chen, Ceshi] Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Wang, Chunyan] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Wang, Chunyan] Kunming Med Univ, Affiliated Hosp 1, Dept Pathol, Kunming 650031, Yunnan, Peoples R China; [Chen, Wenlin] Kunming Med Univ, Canc Hosp, Kunming 650031, Yunnan, Peoples R China; [Chaudhury, Leena] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming Medical University; Kunming Medical University; Albany Medical College	Chen, CS (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.	chenc@mail.kiz.ac.cn		Xia, Houjun/0000-0003-1045-1465; Chen, Ceshi/0000-0001-6398-3516	Stem Cell and Regenerative Medicine Research Grant from the Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01040406]; National Natural Science Foundation of China [81202110, 81272930, U1132605]; Top Talents Program of Yunnan Province, China [2010CI114]; Science and Technological Key Project of Yunnan Province [2012FB185]; "Western Light" Talents Training Program of the Chinese Academy of Sciences	Stem Cell and Regenerative Medicine Research Grant from the Strategic Priority Research Program of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Talents Program of Yunnan Province, China; Science and Technological Key Project of Yunnan Province; "Western Light" Talents Training Program of the Chinese Academy of Sciences	This work was supported by Stem Cell and Regenerative Medicine Research Grant XDA01040406 from the Strategic Priority Research Program of the Chinese Academy of Sciences; National Natural Science Foundation of China Grants 81202110, 81272930, and U1132605; Grant 2010CI114 from the Top Talents Program of Yunnan Province, China; Grant 2012FB185 from the Science and Technological Key Project of Yunnan Province (to R. L.); and the "Western Light" Talents Training Program of the Chinese Academy of Sciences (to H.X.).	Bafford R, 2006, SURGERY, V140, P289, DOI 10.1016/j.surg.2006.04.004; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Catley MC, 2003, FEBS LETT, V547, P75, DOI 10.1016/S0014-5793(03)00672-0; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Chandrasekharan S, 2005, J LIPID RES, V46, P2636, DOI 10.1194/jlr.M500213-JLR200; Chang SH, 2005, CANCER RES, V65, P4496, DOI 10.1158/0008-5472.CAN-05-0129; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CJ, 2012, PATHOL ONCOL RES, V18, P161, DOI 10.1007/s12253-011-9422-7; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Deckmann K, 2010, BIOCHEM PHARMACOL, V80, P1365, DOI 10.1016/j.bcp.2010.07.032; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Diaz-Munoz MD, 2012, BIOCHEM J, V443, P451, DOI 10.1042/BJ20111052; Guerrero MD, 2009, EUR J PHARMACOL, V620, P112, DOI 10.1016/j.ejphar.2009.08.007; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Donnini S, 2012, ONCOGENE, V31, P3457, DOI 10.1038/onc.2011.503; Ekstrom L, 2003, BBA-GENE STRUCT EXPR, V1627, P79, DOI 10.1016/S0167-4781(03)00077-0; Forsberg L, 2000, FEBS LETT, V471, P78, DOI 10.1016/S0014-5793(00)01367-3; Goldstein BG, 2007, AM J PHYSIOL-GASTR L, V292, pG1784, DOI 10.1152/ajpgi.00541.2006; Hanaka H, 2009, P NATL ACAD SCI USA, V106, P18757, DOI 10.1073/pnas.0910218106; Harris RE, 2000, CANCER RES, V60, P2101; He M, 2009, J BIOCHEM, V146, P683, DOI 10.1093/jb/mvp115; Kamei D, 2003, J BIOL CHEM, V278, P19396, DOI 10.1074/jbc.M213290200; Kawai-Kowase K, 1999, CIRC RES, V85, P787, DOI 10.1161/01.RES.85.9.787; Kim HS, 2012, BREAST CANCER RES TR, V132, P51, DOI 10.1007/s10549-011-1521-3; Koeberle A, 2010, J PHARMACOL EXP THER, V332, P840, DOI 10.1124/jpet.109.160663; Kubatka P, 2003, CANCER LETT, V202, P131, DOI 10.1016/j.canlet.2003.08.006; Liu R, 2011, MOL ENDOCRINOL, V25, P1137, DOI 10.1210/me.2010-0497; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; Lu D, 2012, ONCOGENE, V31, P842, DOI 10.1038/onc.2011.287; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakanishi M, 2008, CANCER RES, V68, P3251, DOI 10.1158/0008-5472.CAN-07-6100; Nakanishi M, 2010, BIOCHIMIE, V92, P660, DOI 10.1016/j.biochi.2010.02.006; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Naraba H, 2002, J BIOL CHEM, V277, P28601, DOI 10.1074/jbc.M203618200; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Park SY, 2012, J CELL BIOCHEM, V113, P3653, DOI 10.1002/jcb.24238; Rorsch F, 2010, J MED CHEM, V53, P911, DOI 10.1021/jm9012505; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Silva E, 2010, J REPROD IMMUNOL, V84, P66, DOI 10.1016/j.jri.2009.10.004; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Sur I, 2002, EUR J CELL BIOL, V81, P323, DOI 10.1078/0171-9335-00257; Takagi K, 2012, ENDOCR-RELAT CANCER, V19, P741, DOI 10.1530/ERC-12-0017; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Walters JN, 2012, BIOCHEM J, V443, P561, DOI 10.1042/BJ20111801; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242; Zheng HQ, 2009, ONCOGENE, V28, P3702, DOI 10.1038/onc.2009.235; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200	54	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26731	26740		10.1074/jbc.M113.483958	http://dx.doi.org/10.1074/jbc.M113.483958			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23913682	Green Published, hybrid			2022-12-25	WOS:000330594500038
J	Kobayashi, M; Debold, EP; Turner, MA; Kobayashi, T				Kobayashi, Minae; Debold, Edward P.; Turner, Matthew A.; Kobayashi, Tomoyoshi			Cardiac Muscle Activation Blunted by a Mutation to the Regulatory Component, Troponin T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTOMYOSIN SUBFRAGMENT-1 ATPASE; RABBIT SKELETAL-MUSCLE; THIN-FILAMENT; TROPOMYOSIN-TROPONIN; ACTIN-FILAMENTS; IN-VITRO; MYOSIN SUBFRAGMENT-1; COOPERATIVE BINDING; ALPHA-TROPOMYOSIN; STRIATED-MUSCLE	The striated muscle thin filament comprises actin, tropomyosin, and troponin. The Tn complex consists of three subunits, troponin C (TnC), troponin I (TnI), and troponin T (TnT). TnT may serve as a bridge between the Ca2+ sensor (TnC) and the actin filament. In the short helix preceding the IT-arm region, H1(T2), there are known dilated cardiomyopathy-linked mutations (among them R205L). Thus we hypothesized that there is an element in this short helix that plays an important role in regulating the muscle contraction, especially in Ca2+ activation. We mutated Arg-205 and several other amino acid residues within and near the H1(T2) helix. Utilizing an alanine replacement method to compare the effects of the mutations, the biochemical and mechanical impact on the actomyosin interaction was assessed by solution ATPase activity assay, an in vitro motility assay, and Ca2+ binding measurements. Ca2+ activation was markedly impaired by a point mutation of the highly conserved basic residue R205A, residing in the short helix H1(T2) of cTnT, whereas the mutations to nearby residues exhibited little effect on function. Interestingly, rigor activation was unchanged between the wild type and R205A TnT. In addition to the reduction in Ca2+ sensitivity observed in Ca2+ binding to the thin filament, myosin S1-ADP binding to the thin filament was significantly affected by the same mutation, which was also supported by a series of S1 concentration-dependent ATPase assays. These suggest that the R205A mutation alters function through reduction in the nature of cooperative binding of S1.	[Kobayashi, Minae; Kobayashi, Tomoyoshi] Univ Illinois, Dept Physiol & Biophys, Cardiovasc Res Ctr, Chicago, IL 60612 USA; [Debold, Edward P.; Turner, Matthew A.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Massachusetts System; University of Massachusetts Amherst	Kobayashi, M (corresponding author), 835 S Wolcott Ave M-C 901, Chicago, IL 60612 USA.	minaek@uic.edu			National Institutes of Health [R01 HL082923, T32 HL007692]; American Heart Association [09SDG2100039]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082923, T32HL007692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL082923 (to T. K.) and T32 HL007692 (to M. K.). This work was also supported by American Heart Association Grant 09SDG2100039 (to E. P. D.).	AMPHLETT GW, 1976, FEBS LETT, V72, P163, DOI 10.1016/0014-5793(76)80836-8; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; CHONG PCS, 1982, J BIOL CHEM, V257, P9152; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Debold EP, 2012, J APPL PHYSIOL, V113, P1413, DOI 10.1152/japplphysiol.00775.2012; Debold EP, 2011, AM J PHYSIOL-REG I, V300, pR1401, DOI 10.1152/ajpregu.00772.2010; EISENBERG E, 1974, J BIOL CHEM, V249, P4742; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gafurov B, 2004, BIOCHEMISTRY-US, V43, P15276, DOI 10.1021/bi048646h; Gafurov B, 2004, BIOPHYS J, V87, P1825, DOI 10.1529/biophysj.104.043364; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gordon AM, 1997, BIOPHYS J, V72, P1295, DOI 10.1016/S0006-3495(97)78776-9; GUTH K, 1987, J BIOL CHEM, V262, P13627; HEELEY DH, 1989, BIOCHEM J, V258, P831, DOI 10.1042/bj2580831; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; Homsher E, 2003, BIOPHYS J, V85, P1046, DOI 10.1016/S0006-3495(03)74543-3; Hooper SL, 2005, PHYSIOL REV, V85, P1001, DOI 10.1152/physrev.00019.2004; Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001; Kad NM, 2005, P NATL ACAD SCI USA, V102, P16990, DOI 10.1073/pnas.0506326102; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kobayashi T, 2009, J BIOL CHEM, V284, P20052, DOI 10.1074/jbc.M109.001396; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; LAMKIN M, 1983, BIOCHEMISTRY-US, V22, P3053, DOI 10.1021/bi00282a005; Landis C, 1999, J BIOL CHEM, V274, P31279, DOI 10.1074/jbc.274.44.31279; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEHMAN W, 1975, J GEN PHYSIOL, V66, P1, DOI 10.1085/jgp.66.1.1; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Manning EP, 2012, J MOL BIOL, V421, P54, DOI 10.1016/j.jmb.2012.05.008; Manning EP, 2012, J BIOL CHEM, V287, P14515, DOI 10.1074/jbc.M111.257436; Manning EP, 2011, BIOCHEMISTRY-US, V50, P7405, DOI 10.1021/bi200506k; Maytum R, 2001, BIOCHEMISTRY-US, V40, P7334, DOI 10.1021/bi010072i; MCKILLOP DFA, 1991, BIOCHEM J, V279, P711, DOI 10.1042/bj2790711; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mijailovich SM, 2012, EUR BIOPHYS J BIOPHY, V41, P1015, DOI 10.1007/s00249-012-0859-8; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; Palm T, 2003, BIOPHYS J, V84, P3181, DOI 10.1016/S0006-3495(03)70042-3; PAN BS, 1989, J BIOL CHEM, V264, P8495; PAN BS, 1987, J BIOL CHEM, V262, P7839; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; Pinto JR, 2008, PFLUG ARCH EUR J PHY, V456, P1177, DOI 10.1007/s00424-008-0480-y; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Robinson P, 2007, FASEB J, V21, P896, DOI 10.1096/fj.06-6899com; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; Sfichi-Duke L, 2010, J MOL CELL CARDIOL, V48, P934, DOI 10.1016/j.yjmcc.2010.01.005; Snook JH, 2008, FREE RADICAL BIO MED, V44, P14, DOI 10.1016/j.freeradbiomed.2007.09.004; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Swartz DR, 1997, BIOPHYS J, V73, P293, DOI 10.1016/S0006-3495(97)78070-6; Sykes BD, 2003, NAT STRUCT BIOL, V10, P588, DOI 10.1038/nsb0803-588; Takeda S, 1997, EUR J BIOCHEM, V246, P611, DOI 10.1111/j.1432-1033.1997.00611.x; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TANOKURA M, 1983, J BIOCHEM, V93, P331, DOI 10.1093/oxfordjournals.jbchem.a134185; TAO T, 1986, BIOCHEMISTRY-US, V25, P7633, DOI 10.1021/bi00371a054; TAWADA Y, 1975, J BIOCHEM, V78, P65; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; WALSH TP, 1985, J MOL BIOL, V182, P265, DOI 10.1016/0022-2836(85)90344-4	67	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26335	26349		10.1074/jbc.M113.494096	http://dx.doi.org/10.1074/jbc.M113.494096			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897817	hybrid, Green Published			2022-12-25	WOS:000330623300062
J	Martinez-Nunez, MA; Poot-Hernandez, AC; Rodriguez-Vazquez, K; Perez-Rueda, E				Alberto Martinez-Nunez, Mario; Cesar Poot-Hernandez, Augusto; Rodriguez-Vazquez, Katya; Perez-Rueda, Ernesto			Increments and Duplication Events of Enzymes and Transcription Factors Influence Metabolic and Regulatory Diversity in Prokaryotes	PLOS ONE			English	Article							COMPARATIVE GENOMICS; SCALING LAWS; GENE; EVOLUTION; DATABASE; PROTEIN; CONSERVATION; BACTERIA; INSIGHTS; IMPACT	In this work, the content of enzymes and DNA-binding transcription factors (TFs) in 794 non-redundant prokaryotic genomes was evaluated. The identification of enzymes was based on annotations deposited in the KEGG database as well as in databases of functional domains (COG and PFAM) and structural domains (Superfamily). For identifications of the TFs, hidden Markov profiles were constructed based on well-known transcriptional regulatory families. From these analyses, we obtained diverse and interesting results, such as the negative rate of incremental changes in the number of detected enzymes with respect to the genome size. On the contrary, for TFs the rate incremented as the complexity of genome increased. This inverse related performance shapes the diversity of metabolic and regulatory networks and impacts the availability of enzymes and TFs. Furthermore, the intersection of the derivatives between enzymes and TFs was identified at 9,659 genes, after this point, the regulatory complexity grows faster than metabolic complexity. In addition, TFs have a low number of duplications, in contrast to the apparent high number of duplications associated with enzymes. Despite the greater number of duplicated enzymes versus TFs, the increment by which duplicates appear is higher in TFs. A lower proportion of enzymes among archaeal genomes (22%) than in the bacterial ones (27%) was also found. This low proportion might be compensated by the interconnection between the metabolic pathways in Archaea. A similar proportion was also found for the archaeal TFs, for which the formation of regulatory complexes has been proposed. Finally, an enrichment of multifunctional enzymes in Bacteria, as a mechanism of ecological adaptation, was detected.	[Alberto Martinez-Nunez, Mario; Rodriguez-Vazquez, Katya] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Dept Ingn Sistemas Computac & Automatizac, Mexico City 04510, DF, Mexico; [Cesar Poot-Hernandez, Augusto; Perez-Rueda, Ernesto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Martinez-Nunez, MA (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Dept Ingn Sistemas Computac & Automatizac, Ciudad Univ, Mexico City 04510, DF, Mexico.	malberto.martinez@iimas.unam.mx; erueda@ibt.unam.mx	RODRIGUEZ-VAZQUEZ, KATYA/D-4418-2017; Rodriguez-Vázquez, Katya/ABF-4715-2020; Martinez-Nuñez, Mario Alberto/AAH-6079-2019; Perez-Rueda, Ernesto/D-7468-2016	RODRIGUEZ-VAZQUEZ, KATYA/0000-0002-9413-2762; Rodriguez-Vázquez, Katya/0000-0002-9413-2762; Martinez-Nuñez, Mario Alberto/0000-0001-8907-2542; Perez-Rueda, Ernesto/0000-0002-6879-0673; Poot-Hernandez, Augusto Cesar/0000-0003-4565-7594	Direccion General Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico [IN-209511, IN-109011]; Consejo Nacional de Ciencia y Tecnologia [155116]	Direccion General Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Support from Direccion General Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico (IN-209511, IN-109011), Consejo Nacional de Ciencia y Tecnologia (155116) and Direccion General Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico Postdoctoral Fellowship to M.A.M-N is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Martin-Fernandez MA, 2009, LECT NOTES COMPUT SC, V5761, P156, DOI 10.1007/978-3-642-04268-3_20; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Baumbach J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-429; Benedict MN, 2012, J BACTERIOL, V194, P855, DOI 10.1128/JB.06040-11; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bratlie MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-588; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Chaban B, 2006, CAN J MICROBIOL, V52, P73, DOI [10.1139/WDS-147, 10.1139/w05-147]; Forterre Patrick, 2009, J Biol, V8, P7, DOI 10.1186/jbiol110; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Grilli J, 2012, NUCLEIC ACIDS RES, V40, P530, DOI 10.1093/nar/gkr711; He Z, 2004, J AM CHEM SOC, V126, P2378, DOI 10.1021/ja0389927; Ikeda M, 2006, APPL MICROBIOL BIOT, V69, P615, DOI 10.1007/s00253-005-0252-y; James TY, 2002, J BASIC MICROB, V42, P91, DOI 10.1002/1521-4028(200205)42:2<91::AID-JOBM91>3.0.CO;2-8; Koonin EV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002173; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Maslov S, 2009, P NATL ACAD SCI USA, V106, P9743, DOI 10.1073/pnas.0903206106; Mazurie A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-59; Meeks JC, 2002, ARCH MICROBIOL, V178, P395, DOI 10.1007/s00203-002-0476-5; Mira A, 2006, TRENDS MICROBIOL, V14, P200, DOI 10.1016/j.tim.2006.03.001; Molina N, 2008, GENOME RES, V18, P148, DOI 10.1101/gr.6759507; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Perez-Rueda E, 2009, MOL BIOSYST, V5, P1494, DOI 10.1039/b907384a; Pitcher DG, 2005, VET J, V170, P300, DOI 10.1016/j.tvjl.2004.08.011; Pushker R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r27; R-programming, 2011, R LANG ENV STAT COMP; Ranea JAG, 2005, TRENDS GENET, V21, P21, DOI 10.1016/j.tig.2004.11.014; Razin S, 2010, BIOLOGICALS, V38, P183, DOI 10.1016/j.biologicals.2009.11.008; Robertson CE, 2005, CURR OPIN MICROBIOL, V8, P638, DOI 10.1016/j.mib.2005.10.003; Schmidt S, 2003, TRENDS BIOCHEM SCI, V28, P336, DOI 10.1016/S0968-0004(03)00114-2; Shakhnovich BE, 2006, GENOME RES, V16, P1529, DOI 10.1101/gr.5346206; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Ullrich A, 2011, ARTIF LIFE, V17, P87, DOI 10.1162/artl_a_00021; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Whitworth DE, 2008, TRENDS MICROBIOL, V16, P512, DOI 10.1016/j.tim.2008.08.001; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	43	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69707	10.1371/journal.pone.0069707	http://dx.doi.org/10.1371/journal.pone.0069707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922780	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700068
J	Bertin, GI; Lavstsen, T; Guillonneau, F; Doritchamou, J; Wang, CW; Jespersen, JS; Ezimegnon, S; Fievet, N; Alao, MJ; Lalya, F; Massougbodji, A; Ndam, NT; Theander, TG; Deloron, P				Bertin, Gwladys I.; Lavstsen, Thomas; Guillonneau, Francois; Doritchamou, Justin; Wang, Christian W.; Jespersen, Jakob S.; Ezimegnon, Sem; Fievet, Nadine; Alao, Maroufou J.; Lalya, Francis; Massougbodji, Achille; Ndam, Nicaise Tuikue; Theander, Thor G.; Deloron, Philippe			Expression of the Domain Cassette 8 Plasmodium falciparum Erythrocyte Membrane Protein 1 Is Associated with Cerebral Malaria in Benin	PLOS ONE			English	Article							BRAIN ENDOTHELIAL-CELLS; VAR GENE-EXPRESSION; INFECTED ERYTHROCYTES; TANZANIAN CHILDREN; ANTIBODIES; ANTIGENS; SURFACE; PARASITE; TRANSCRIPTION; ACQUISITION	Background: Plasmodium falciparum erythrocyte membrane protein-1 (PfEMP-1) is a highly polymorphic adherence receptor expressed on the surface of infected erythrocytes. Based on sequence homology PfEMP-1 variants have been grouped into three major groups A-C, the highly conserved VAR2CSA variants, and semi-conserved types defined by tandem runs of specific domains ("domain cassettes'' (DC)). The PfEMP-1 type expressed determines the adherence phenotype, and is associated with clinical outcome of infection. Methods: Parasite isolates from Beninese children or women presenting with, respectively, CM or PAM were collected along with samples from patients with uncomplicated malaria (UM). We assessed the transcript level of var genes by RT-qPCR and the expression of PfEMP-1 proteins by LC-MS/MS. Results: Var genes encoding DC8 and Group A PfEMP-1 were transcribed more often and at higher levels in cerebral malaria vs. uncomplicated malaria patients. LC-MS/MS identified peptides from group A, DC8 PfEMP-1 more frequently in cerebral malaria than in uncomplicated malaria and pregnancy-associated malaria samples. Conclusion: This is the first study to show association between PfEMP-1 subtype and disease outcome by direct analysis of parasites proteome. The results corroborate that group A and specifically the PfEMP-1 types DC8 are universally associated with cerebral malaria. This is a crucial observation for promoting studies on malaria pathogenesis.	[Bertin, Gwladys I.; Doritchamou, Justin; Fievet, Nadine; Ndam, Nicaise Tuikue; Deloron, Philippe] IRD, Mere & Enfant Face Infect Tropicales UMR216, Paris, France; [Bertin, Gwladys I.; Guillonneau, Francois; Doritchamou, Justin; Fievet, Nadine; Ndam, Nicaise Tuikue; Deloron, Philippe] Univ Paris 05, PRES Paris Sorbonne Cite, Paris, France; [Lavstsen, Thomas; Wang, Christian W.; Jespersen, Jakob S.; Theander, Thor G.] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Lavstsen, Thomas; Wang, Christian W.; Jespersen, Jakob S.; Theander, Thor G.] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Guillonneau, Francois] Univ Paris 05, Prote Facil 3P5, Paris, France; [Doritchamou, Justin; Ezimegnon, Sem; Fievet, Nadine; Massougbodji, Achille; Ndam, Nicaise Tuikue] CERPAGE, Cotonou, Benin; [Alao, Maroufou J.] Mother & Child Hosp HOMEL, Dept Paediat, Cotonou, Benin; [Lalya, Francis] CNHU, Dept Paediat, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Rigshospitalet; University of Copenhagen; UDICE-French Research Universities; Universite Paris Cite	Deloron, P (corresponding author), IRD, Mere & Enfant Face Infect Tropicales UMR216, Paris, France.	philippe.deloron@ird.fr	Theander, Thor/F-6714-2015; Deloron, Philippe/G-6305-2010; Doritchamou, Justin/T-5671-2017	Theander, Thor/0000-0002-3509-7514; Deloron, Philippe/0000-0003-4705-2484; Doritchamou, Justin/0000-0002-4589-7216; Wang, Christian/0000-0003-3140-6989; Lavstsen, Thomas/0000-0002-3044-4249; Schmidt Jespersen, Jakob/0000-0002-4930-5900; Tuikue Ndam, Nicaise/0000-0003-2646-2513; Guillonneau, Francois/0000-0003-1484-4696; Fievet, Nadine/0000-0003-2272-9794; Bertin, Gwladys/0000-0002-2218-9591	IRD; Gr-Ex	IRD; Gr-Ex	The work was supported by IRD and Gr-Ex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akogbeto M, 1995, ANN SOC BELG MED TR, V75, P219; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Coppel RL, 1998, CURR OPIN MICROBIOL, V1, P472, DOI 10.1016/S1369-5274(98)80068-4; Falk N, 2009, J INFECT DIS, V200, P347, DOI 10.1086/600071; Fievet N, 2006, INFECT GENET EVOL, V6, P459, DOI 10.1016/j.meegid.2006.02.006; Fried M, 2007, MOL BIOCHEM PARASIT, V155, P57, DOI 10.1016/j.molbiopara.2007.05.010; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Giha HA, 2000, IMMUNOL LETT, V71, P117, DOI 10.1016/S0165-2478(99)00173-X; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kalmbach Y, 2010, J INFECT DIS, V202, P313, DOI 10.1086/653586; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Miller LH, 2002, MOL BIOCHEM PARASIT, V120, P321, DOI 10.1016/S0166-6851(02)00011-7; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Organization WH, 2000, T R SOC TROP MED HYG, P94; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poullet P, 2007, PROTEOMICS, V7, P2553, DOI 10.1002/pmic.200600784; Rask TS, 2010, PLOS COMPUT BIOL, P6; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Voss TS, 2000, MOL BIOCHEM PARASIT, V107, P103, DOI 10.1016/S0166-6851(00)00176-6; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106	31	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68368	10.1371/journal.pone.0068368	http://dx.doi.org/10.1371/journal.pone.0068368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922654	gold, Green Published, Green Submitted			2022-12-25	WOS:000323369700006
J	Bowen, MT; Kevin, RC; May, M; Staples, LG; Hunt, GE; McGregor, IS				Bowen, Michael T.; Kevin, Richard C.; May, Matthew; Staples, Lauren G.; Hunt, Glenn E.; McGregor, Iain S.			Defensive Aggregation (Huddling) in Rattus Norvegicus toward Predator Odor: Individual Differences, Social Buffering Effects and Neural Correlates	PLOS ONE			English	Article							CONDITIONED FEAR RESPONSES; CAT ODOR; OLFACTORY SYSTEM; PLAY-BEHAVIOR; COPING STYLES; JUVENILE RATS; ANIMAL-MODEL; SELFISH HERD; ADULT RATS; EXPOSURE	Aggregation is a defensive strategy employed by many prey species in response to predatory threat. Our group has characterized defensive aggregation (huddling) in Rattus norvegicus in response to a ball of cat fur. In this situation some rats huddle less, and approach the threatening cue more than others (active vs. passive responders). The present study explored whether active responding is a stable phenotype associated with behaviors outside direct predatory encounters. The neural substrates of active and passive responding under predatory threat were explored using c-Fos immunohistochemistry. Finally, we examined whether the presence of conspecifics during predatory threat biases behavior towards active responding. Active and passive responding styles were found to be stable in individual rats across consecutive group exposures to cat fur, and were predicted by anxiety-like behavior in an open-field emergence test. Active responders displayed less conditioned fear in an environment associated with predatory threat, and had higher post-exposure intake of a weak sucrose solution (a test of "anhedonia''). Active responding was associated with: greater cat fur-induced activation of the accessory olfactory bulb, reflecting greater olfactory stimulation in rats actively approaching the fur; lowered activation of somatosensory cortex, reflecting reduced huddling with conspecifics; and reduced activation in the lateral septum. Social exposure to cat fur promoted active responding relative to individual exposure, and lowered c-Fos expression in the dorsomedial periaqueductal grey, medial caudate putamen and lateral habenula. We conclude that individual differences in anti-predator behavior appear stable traits with active responders having a more resilient phenotype. Social exposure to predatory threat has an acute buffering effect, subtly changing the neural and behavioral response towards threat and encouraging active responding. An association between active responding and lower c-Fos expression in the lateral septum is consistent with previous studies that highlight this region as an important neurobiological substrate of defensive aggregation.	[Bowen, Michael T.; Kevin, Richard C.; May, Matthew; McGregor, Iain S.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Staples, Lauren G.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Hunt, Glenn E.] Univ Sydney, Concord Clin Sch, Discipline Psychiat, Sydney, NSW 2006, Australia	University of Sydney; Macquarie University; University of Sydney	Bowen, MT (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	mbowen@psych.usyd.edu.au; iain.mcgregor@sydney.edu.au	Kevin, Richard/C-1129-2018; Hunt, Glenn/G-5934-2012	Kevin, Richard/0000-0002-4912-4499; mcgregor, iain/0000-0002-9307-7159; Hunt, glenn/0000-0002-8088-9406; Bowen, Michael/0000-0002-8965-4136	Australian Research Council [DP0988609]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council grant to ISM. Grant number DP0988609 (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; BELFIORE E, 1985, CLASSICAL QUART, V35, P349, DOI 10.1017/S0009838800040222; BERARDI A, 2012, COOPERATIVE BREEDING, V23, P645, DOI DOI 10.1515/REVNEURO-2012-0054; Berardi A, 2012, REV NEUROSCIENCE, V23, P645, DOI 10.1515/revneuro-2012-0054; Blacker D, 2005, COMPREHENSIVE TXB PS, P929; Blanchard DC, 2011, NEUROSCI BIOBEHAV R, V35, P991, DOI 10.1016/j.neubiorev.2010.10.016; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P761; Blanchard DC, 2003, NEUROSCI LETT, V345, P145, DOI 10.1016/S0304-3940(03)00415-4; Blanchard RJ, 2001, NEUROSCI BIOBEHAV R, V25, P587, DOI 10.1016/S0149-7634(01)00043-4; BLANCHARD RJ, 1989, J COMP PSYCHOL, V103, P70, DOI 10.1037/0735-7036.103.1.70; BLANCHARD RJ, 1993, PSYCHOPHARMACOLOGY, V110, P245, DOI 10.1007/BF02246981; Bowen MT, 2012, BEHAV PROCESS, V90, P331, DOI 10.1016/j.beproc.2012.03.014; Braida D, 2012, PSYCHOPHARMACOLOGY, P1; Canteras NS, 1997, BRAIN RES BULL, V44, P297, DOI 10.1016/S0361-9230(97)00141-X; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Dielenberg RA, 2004, BEHAV BRAIN RES, V153, P487, DOI 10.1016/j.bbr.2004.01.015; Dielenberg RA, 1999, J COMP PSYCHOL, V113, P376, DOI 10.1037/0735-7036.113.4.376; Dielenberg RA, 2001, BRAIN RES, V897, P228, DOI 10.1016/S0006-8993(01)02227-2; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; DIELENBERG RA, 2004, NEUROSCI LETT, V153, P487, DOI DOI 10.1016/J.BBR.2004.01.015; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Eilam D, 2011, NEUROSCI BIOBEHAV R, V35, P999, DOI 10.1016/j.neubiorev.2010.08.002; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Fryxell John M., 1995, P257; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; Goodson JL, 2009, FRONT NEUROENDOCRIN, V30, P429, DOI 10.1016/j.yfrne.2009.05.007; Goodson JL, 2009, SCIENCE, V325, P862, DOI 10.1126/science.1174929; Gray J. A., 2003, NEUROPSYCHOLOGY ANXI; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hennessy MB, 2009, FRONT NEUROENDOCRIN, V30, P470, DOI 10.1016/j.yfrne.2009.06.001; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Kelly AM, 2011, HORM BEHAV, V60, P12, DOI 10.1016/j.yhbeh.2011.01.012; Kendig MD, 2011, BEHAV BRAIN RES, V225, P405, DOI 10.1016/j.bbr.2011.07.058; Kirkwood R, 1999, EMU, V99, P40, DOI 10.1071/MU99006; Kiyokawa Y, 2005, CHEM SENSES, V30, P513, DOI 10.1093/chemse/bji044; Kiyokawa Y, 2004, BEHAV NEUROSCI, V118, P798, DOI 10.1037/0735-7044.118.4.798; Kiyokawa Y, 2007, EUR J NEUROSCI, V26, P3606, DOI 10.1111/j.1460-9568.2007.05969.x; Kiyokawa Y, 2009, EUR J NEUROSCI, V29, P777, DOI 10.1111/j.1460-9568.2009.06618.x; Kline P., 1999, HDB PSYCHOL TESTING; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korzan WJ, 2007, BRAIN BEHAV EVOLUT, V70, P257, DOI 10.1159/000105489; Landgraf R, 2003, EUR J NEUROSCI, V18, P403, DOI 10.1046/j.1460-9568.2003.02750.x; Landgrag R, 2003, BRAIN RES B, V18, P403; Ledoux JE, 2001, AM J PSYCHIAT, V158, P1953, DOI 10.1176/appi.ajp.158.12.1953; LEDOUX JE, 2001, NEURAL ACTIVATION CA, V158, P1953; Lever C, 2006, REV NEUROSCIENCE, V17, P111; Louvart N, 2005, PSYCHONEUROENDOCRINO, V30, P316, DOI 10.1016/j.psyneuen.2004.09.003; May MD, 2012, PHYSIOL BEHAV, V107, P711, DOI 10.1016/j.physbeh.2012.03.007; McGregor IS, 2004, J NEUROSCI, V24, P4134, DOI 10.1523/JNEUROSCI.0187-04.2004; McGregor IS, 1999, PSYCHOPHARMACOLOGY, V147, P174, DOI 10.1007/s002130051158; Mongeau R, 2003, J NEUROSCI, V23, P3855; Morley KC, 2001, EUR J PHARMACOL, V433, P91, DOI 10.1016/S0014-2999(01)01512-6; Motbey CP, 2012, ADDICT BIOL, V17, P409, DOI 10.1111/j.1369-1600.2011.00384.x; Muris P, 2002, PERS INDIV DIFFER, V32, P337, DOI 10.1016/S0191-8869(01)00027-7; Nafe JP, 1937, AM J PSYCHOL, V49, P645, DOI 10.2307/1416388; Omori A, 2008, METAPHOR SYMBOL, V23, P130, DOI 10.1080/10926480801944277; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Perrot-Sinal TS, 2004, BRAIN RES, V1027, P161, DOI 10.1016/j.brainres.2004.08.056; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Rutz C, 2012, CURR BIOL, V22, P820, DOI 10.1016/j.cub.2012.03.028; Schneider M, 2005, NEUROPSYCHOPHARMACOL, V30, P944, DOI 10.1038/sj.npp.1300634; Schneider M, 2004, PHYSIOL BEHAV, V30, P944; Shentu Y, 2010, STAT MED, V29, P2200, DOI 10.1002/sim.3966; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siegmund A, 2006, ANN NY ACAD SCI, V1071, P324, DOI 10.1196/annals.1364.025; Siviy SM, 2008, NEUROSCI BIOBEHAV R, V32, P1249, DOI 10.1016/j.neubiorev.2008.05.004; Siviy SM, 2008, J COMP PSYCHOL, V122, P1, DOI 10.1037/0735-7036.122.1.1; Staples LG, 2008, NEUROSCIENCE, V151, P937, DOI 10.1016/j.neuroscience.2007.11.039; Staples LG, 2008, NEUROSCI BIOBEHAV R, V32, P1209, DOI 10.1016/j.neubiorev.2008.05.011; Staples LG, 2009, NEUROSCI LETT, V462, P157, DOI 10.1016/j.neulet.2009.06.069; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Wilson JH, 2000, HORM BEHAV, V38, P39, DOI 10.1006/hbeh.2000.1600; WILSON JH, 2000, J COMP PHYSIOL PSYCH, V38, P39; Yoshida K, 2005, NEUROSCIENCE, V133, P1039, DOI 10.1016/j.neuroscience.2005.03.044; YOSHIDA K, 2005, P AUS PHYSL, V133, P1039, DOI DOI 10.1016/J.NEUROSCIENCE.2005.03.044; Zahavi A., 1990, P103, DOI 10.1017/CBO9780511752452.005; Zahavi A, 1997, EUR J NEUROSCI, DOI DOI 10.1111/EJN.12194	81	36	36	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68483	10.1371/journal.pone.0068483	http://dx.doi.org/10.1371/journal.pone.0068483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922655	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700007
J	Zhang, ZJ; Bergquist, R; Chen, DM; Yao, BD; Wang, ZL; Gao, J; Jiang, QW				Zhang, Zhijie; Bergquist, Robert; Chen, Dongmei; Yao, Baodong; Wang, Zengliang; Gao, Jie; Jiang, Qingwu			Identification of Parasite-Host Habitats in Anxiang County, Hunan Province, China Based on Multi-Temporal China-Brazil Earth Resources Satellite (CBERS) Images	PLOS ONE			English	Article							SNAIL ONCOMELANIA-HUPENSIS; REPUBLIC-OF-CHINA; 3 GORGES DAM; SCHISTOSOMIASIS-JAPONICA; MARSHLAND REGIONS; SPATIAL-ANALYSIS; LAKE REGION; RISK; TRANSMISSION; IMPACT	Remote sensing is a promising technique for monitoring the distribution and dynamics of various vector-borne diseases. In this study, we used the multi-temporal CBERS images, obtained free of charge, to predict the habitats of the snail Oncomelania hupensis, the sole intermediate host of schistosomiasis japonica, a snail-borne parasitic disease of considerable public health in China. Areas of suitable snail habitats were identified based on the normalized difference vegetation index (NDVI) and the normalized difference water index (NDWI), and the predictive model was tested against sites (snails present or absent) that were surveyed directly for O. hupensis. The model performed well (sensitivity and specificity were 63.64% and 78.09%, respectively), and with further development, we may provide an accurate, inexpensive tool for the broad-scale monitoring and control of schistosomiasis, and other similar vector-borne diseases.	[Zhang, Zhijie; Yao, Baodong; Wang, Zengliang; Gao, Jie; Jiang, Qingwu] Fudan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Shanghai 200433, Peoples R China; [Zhang, Zhijie; Yao, Baodong; Wang, Zengliang; Gao, Jie; Jiang, Qingwu] Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China; [Zhang, Zhijie; Wang, Zengliang; Gao, Jie; Jiang, Qingwu] Fudan Univ, Sch Publ Hlth, Lab Spatial Anal & Modeling, Shanghai 200433, Peoples R China; [Bergquist, Robert] Ingerod, Brastad, Sweden; [Chen, Dongmei] Queens Univ, Dept Geog, Fac Arts & Sci, Lab Geog Informat & Spatial Anal, Kingston, ON K7L 3N6, Canada	Fudan University; Fudan University; Queens University - Canada	Zhang, ZJ (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Shanghai 200433, Peoples R China.	epistat@gmail.com		Jiang, Qingwu/0000-0001-8921-3317; zhang, zhijie/0000-0002-1276-787X	National Natural Science Foundation of China [81102167, 81172609, J1210041]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20110071120040]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD) [201186]; National ST Major Program [2012ZX10004220, 2008ZX10004-011]; Ecological Environment and Humanities/Social Sciences Interdisciplinary Research Project of Tyndall Center of Fudan University [FTC98503A09]; Key Discipline Construction of Public Health of Shanghai [12GWZX0101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD)(Foundation for the Author of National Excellent Doctoral Dissertation of China); National ST Major Program; Ecological Environment and Humanities/Social Sciences Interdisciplinary Research Project of Tyndall Center of Fudan University; Key Discipline Construction of Public Health of Shanghai	This research was supported by grants awarded to Dr. Zhijie Zhang and Dr. Qingwu Jiang from National Natural Science Foundation of China (grants 81102167, 81172609, and J1210041); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP), (grant 20110071120040); a Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD) (201186), the National S&T Major Program (2012ZX10004220, 2008ZX10004-011), the Ecological Environment and Humanities/Social Sciences Interdisciplinary Research Project of Tyndall Center of Fudan University (FTC98503A09), and the Key Discipline Construction of Public Health of Shanghai (12GWZX0101). The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Feitosa RQ, 2011, PATTERN RECOGN LETT, V32, P927, DOI 10.1016/j.patrec.2010.09.024; Guo JG, 2005, ACTA TROP, V96, P213, DOI 10.1016/j.actatropica.2005.07.029; Hay SI, 1997, T ROY SOC TROP MED H, V91, P105, DOI 10.1016/S0035-9203(97)90186-3; Jensen JR, 2007, REMOTE SENSING ENV E; Lei Zheng-long, 2011, Zhongguo Xuexichongbing Fangzhi Zazhi, V23, P599; Leonardo L. R., 2005, Parassitologia (Rome), V47, P105; Li YS, 2005, ACTA TROP, V96, P266, DOI 10.1016/j.actatropica.2005.07.020; Li Yuan-pei, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P583; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; Lino CD, 2000, ACTA ASTRONAUT, V47, P559; Martins-Bede FT, 2010, MEM I OSWALDO CRUZ, V105, P541, DOI 10.1590/S0074-02762010000400033; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; McManus DP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001053; McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Nihei N, 2009, JPN J INFECT DIS, V62, P125; Peng WX, 2010, PARASITOLOGY, V137, P1099, DOI 10.1017/S003118200999206X; Schowengerdt R. A., 2007, REMOTE SENSING MODEL; SHIH FY, 1994, INFORM SCI-APPL, V1, P97, DOI 10.1016/1069-0115(94)90010-8; Simoonga C, 2009, PARASITOLOGY, V136, P1683, DOI 10.1017/S0031182009006222; Spear R, 1998, ANN GIS, V4, P14; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Wu XH, 2005, ACTA TROP, V96, P276, DOI 10.1016/j.actatropica.2005.07.021; Xu XJ, 2000, ANN TROP MED PARASIT, V94, P333, DOI 10.1080/00034983.2000.11813548; Yang G. J., 2005, Parassitologia (Rome), V47, P127; Yang GJ, 2006, GEOSPATIAL HEALTH, V1, P85, DOI 10.4081/gh.2006.283; Zhang JQ, 2006, SURVEILLANCE SIMULAT; Zhang SJ, 2002, ACTA TROP, V82, P289, DOI 10.1016/S0001-706X(02)00021-9; Zhang ZJ, 2008, ANN TROP MED PARASIT, V102, P541, DOI 10.1179/136485908X311830; Zhang ZJ, 2009, PARASITOLOGY, V136, P737, DOI 10.1017/S0031182009005885; Zhang ZJ, 2012, GEOSPATIAL HEALTH, V6, P205, DOI 10.4081/gh.2012.138; Zhang ZJ, 2008, ACTA TROP, V107, P217, DOI 10.1016/j.actatropica.2008.04.027; Zhang Z, 2008, PARASITOL INT, V57, P121, DOI 10.1016/j.parint.2007.09.008; Zhang ZJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001620; Zhang ZJ, 2009, T ROY SOC TROP MED H, V103, P1045, DOI 10.1016/j.trstmh.2008.11.012; Zhang ZY, 2005, ACTA TROP, V96, P205, DOI 10.1016/j.actatropica.2005.07.027; Zhao A, 2008, CHINESE SCI BULL, V53, P115, DOI 10.1007/s11434-007-0522-4; Zhao GM, 2005, ACTA TROP, V96, P288, DOI 10.1016/j.actatropica.2005.07.023; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188; Zhou XN, 2010, ADV PARASIT, V72, P145, DOI 10.1016/S0065-308X(10)72006-6; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; Zhou XN, 2002, ACTA TROP, V82, P199, DOI 10.1016/S0001-706X(02)00011-6; Zhou YB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-194; Zhou YB, 2011, AM J TROP MED HYG, V85, P83, DOI 10.4269/ajtmh.2011.10-0574; Zhou YB, 2011, T ROY SOC TROP MED H, V105, P189, DOI 10.1016/j.trstmh.2010.12.006; Zhou YB, 2010, MOLLUSCAN RES, V30, P102; Zhu HM, 2008, ECOHEALTH, V5, P137, DOI 10.1007/s10393-008-0168-y	46	9	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69447	10.1371/journal.pone.0069447	http://dx.doi.org/10.1371/journal.pone.0069447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922712	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700030
J	Chen, ML; Su, X; Xiong, W; Liu, JF; Wu, Y; Feng, YQ; Yuan, BF				Chen, Ming-Luan; Su, Xin; Xiong, Wei; Liu, Jiu-Feng; Wu, Yan; Feng, Yu-Qi; Yuan, Bi-Feng			Assessing Gibberellins Oxidase Activity by Anion Exchange/Hydrophobic Polymer Monolithic Capillary Liquid Chromatography-Mass Spectrometry	PLOS ONE			English	Article							SMALL MOLECULES; BIOACTIVE GIBBERELLIN; PLANT-GROWTH; BIOSYNTHESIS; SEPARATION; PHYTOHORMONES; ELONGATION; METABOLISM; COLUMNS; ASSAY	Bioactive gibberellins (GAs) play a key regulatory role in plant growth and development. In the biosynthesis of GAs, GA3-oxidase catalyzes the final step to produce bioactive GAs. Thus, the evaluation of GA3-oxidase activity is critical for elucidating the regulation mechanism of plant growth controlled by GAs. However, assessing catalytic activity of endogenous GA3-oxidase remains challenging. In the current study, we developed a capillary liquid chromatography - mass spectrometry (cLC-MS) method for the sensitive assay of in-vitro recombinant or endogenous GA3-oxidase by analyzing the catalytic substrates and products of GA3-oxidase (GA(1), GA(4), GA(9), GA(20)). An anion exchange/hydrophobic poly([2( methacryloyloxy) ethyl] trimethylammonium-co-divinylbenzene-co-ethylene glycol dimethacrylate)(META-co-DVB-co-EDMA) monolithic column was successfully prepared for the separation of all target GAs. The limits of detection (LODs, Signal/Noise = 3) of GAs were in the range of 0.62-0.90 fmol. We determined the kinetic parameters (K-m) of recombinant GA3-oxidase in Escherichia coli (E. coli) cell lysates, which is consistent with previous reports. Furthermore, by using isotope labeled substrates, we successfully evaluated the activity of endogenous GA3-oxidase that converts GA(9) to GA(4) in four types of plant samples, which is, to the best of our knowledge, the first report for the quantification of the activity of endogenous GA3-oxidase in plant. Taken together, the method developed here provides a good solution for the evaluation of endogenous GA3-oxidase activity in plant, which may promote the in-depth study of the growth regulation mechanism governed by GAs in plant physiology.	[Chen, Ming-Luan; Su, Xin; Liu, Jiu-Feng; Feng, Yu-Qi; Yuan, Bi-Feng] Wuhan Univ, Dept Chem, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China; [Xiong, Wei; Wu, Yan] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Feng, YQ (corresponding author), Wuhan Univ, Dept Chem, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China.	yqfeng@whu.edu.cn; bfyuan@whu.edu.cn	Feng, Yu-Qi/H-1479-2011; Yuan, Bi-Feng/K-5803-2013	Feng, Yu-Qi/0000-0003-1107-5385; Yuan, Bi-Feng/0000-0001-5223-4659	National Basic Research Program of China (973 Program) [2013CB910702, 2012CB720601]; National Natural Science Foundation of China [91217309, 91017013, 31070327, 21205091, 21228501]; Ph.D. Programs Foundation of Ministry of Education of China [20120141120037]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Hubei Province [2011CDB440]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The authors thank the financial support from the National Basic Research Program of China (973 Program) (2013CB910702, 2012CB720601), the National Natural Science Foundation of China (91217309, 91017013, 31070327, 21205091, 21228501), Ph.D. Programs Foundation of Ministry of Education of China (20120141120037), the Fundamental Research Funds for the Central Universities, and the Natural Science Foundation of Hubei Province (2011CDB440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2009, J EXP BOT, V60, P1085, DOI 10.1093/jxb/ern301; ALBONE KS, 1990, PLANT PHYSIOL, V94, P132, DOI 10.1104/pp.94.1.132; Arrua RD, 2012, ANALYST, V137, P5179, DOI 10.1039/c2an35804b; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Brown JF, 2005, IND ENG CHEM RES, V44, P8565, DOI 10.1021/ie048843c; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Chen ML, 2013, CHEM-EUR J, V19, P1035, DOI 10.1002/chem.201203129; Chen ML, 2012, J CHROMATOGR B, V905, P67, DOI 10.1016/j.jchromb.2012.08.005; Chen ML, 2011, J CHROMATOGR B, V879, P938, DOI 10.1016/j.jchromb.2011.03.003; Chhun T, 2007, PLANT CELL, V19, P3876, DOI 10.1105/tpc.107.054759; Dayan J, 2012, PLANT CELL, V24, P66, DOI 10.1105/tpc.111.093096; FRENETTE R, 1994, TETRAHEDRON LETT, V35, P9177, DOI 10.1016/0040-4039(94)88458-7; Fukuda M, 2009, J PLANT PHYSIOL, V166, P2077, DOI 10.1016/j.jplph.2009.06.003; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Horimoto T, 2011, HORTIC ENVIRON BIOTE, V52, P233, DOI 10.1007/s13580-011-0207-4; Hu JH, 2008, PLANT CELL, V20, P320, DOI 10.1105/tpc.107.057752; Kim SG, 2008, PLANT J, V55, P77, DOI 10.1111/j.1365-313X.2008.03493.x; Ko DH, 2010, CLIN CHEM, V56, P764, DOI 10.1373/clinchem.2009.139618; Lange MJP, 2012, J EXP BOT, V63, P2681, DOI 10.1093/jxb/err448; Laverdiere I, 2012, ANAL CHEM, V84, P216, DOI 10.1021/ac202404y; Liu SC, 2013, ANAL BIOANAL CHEM, V405, P1257, DOI 10.1007/s00216-012-6509-2; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Lv YQ, 2012, ANAL CHEM, V84, P8457, DOI 10.1021/ac302438m; Ma QA, 2010, ANAL METHODS-UK, V2, P1333, DOI 10.1039/c0ay00228c; Martin DN, 1997, P NATL ACAD SCI USA, V94, P8907, DOI 10.1073/pnas.94.16.8907; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Nadeau CD, 2011, PLANT PHYSIOL, V156, P897, DOI 10.1104/pp.111.172577; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Ribeiro DM, 2012, J EXP BOT, V63, P2769, DOI 10.1093/jxb/err463; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; Spacil Z, 2011, ANAL CHEM, V83, P4822, DOI 10.1021/ac200417u; Spray CR, 1996, P NATL ACAD SCI USA, V93, P10515, DOI 10.1073/pnas.93.19.10515; Stanelle RD, 2005, J CHROMATOGR A, V1100, P68, DOI 10.1016/j.chroma.2005.09.014; SVEC F, 1992, ANAL CHEM, V64, P820, DOI 10.1021/ac00031a022; Svec F, 2012, J CHROMATOGR A, V1228, P250, DOI 10.1016/j.chroma.2011.07.019; Svec F, 2010, J CHROMATOGR A, V1217, P902, DOI 10.1016/j.chroma.2009.09.073; Urban J, 2010, ANAL CHEM, V82, P1621, DOI 10.1021/ac100008n; Williams J, 1998, LIBR J, V123, P117; Xiao YH, 2010, J PLANT PHYSIOL, V167, P829, DOI 10.1016/j.jplph.2010.01.003; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804	42	4	4	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69629	10.1371/journal.pone.0069629	http://dx.doi.org/10.1371/journal.pone.0069629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922762	Green Submitted, gold, Green Published			2022-12-25	WOS:000322838900066
J	Liu, PF; Chen, SB; Li, X; Qin, L; Huang, K; Wang, LH; Huang, WH; Li, SB; Jia, B; Zhong, M; Pan, GJ; Cai, JL; Pei, DQ				Liu, Pengfei; Chen, Shubin; Li, Xiang; Qin, Li; Huang, Ke; Wang, Lihui; Huang, Wenhao; Li, Shengbiao; Jia, Bei; Zhong, Mei; Pan, Guangjin; Cai, Jinglei; Pei, Duanqing			Low Immunogenicity of Neural Progenitor Cells Differentiated from Induced Pluripotent Stem Cells Derived from Less Immunogenic Somatic Cells	PLOS ONE			English	Article							CD4(+) T-CELLS; UMBILICAL-CORD BLOOD; HUMAN IPS CELLS; NF-KAPPA-B; ESTABLISHED MELANOMA; GENETIC CORRECTION; EPIGENETIC MEMORY; IMMUNE PROPERTIES; PERIPHERAL-BLOOD; GENERATION	The groundbreaking discovery of induced pluripotent stem cells (iPS cells) provides a new source for cell therapy. However, whether the iPS derived functional lineages from different cell origins have different immunogenicity remains unknown. It had been known that the cells isolated from extra-embryonic tissues, such as umbilical cord mesenchymal cells (UMCs), are less immunogenic than other adult lineages such as skin fibroblasts (SFs). In this report, we differentiated iPS cells from human UMCs and SFs into neural progenitor cells (NPCs) and analyzed their immunogenicity. Through co-culture with allologous peripheral blood mononuclear cells (PBMCs), we showed that UMCs were indeed less immunogenic than skin cells to simulate proliferation of PBMCs. Surprisingly, we found that the NPCs differentiated from UMC-iPS cells retained low immunogenicity as the parental UMCs based on the PBMC proliferation assay. In cytotoxic expression assay, reactions in most kinds of immune effector cells showed more perforin and granzyme B expression with SF-NPCs stimulation than that with UMC-NPCs stimulation in PBMC co-culture system, in T cell co-culture system as well. Furthermore, through whole genome expression microarray analysis, we showed that over 70 immune genes, including all members of HLA-I, were expressed at lower levels in NPCs derived from UMC-iPS cells than that from SF-iPS cells. Our results demonstrated a phenomenon that the low immunogenicity of the less immunogenic cells could be retained after cell reprogramming and further differentiation, thus provide a new concept to generate functional lineages with lower immunogenicity for regenerative medicine.	[Liu, Pengfei; Chen, Shubin; Li, Xiang; Huang, Ke; Wang, Lihui; Huang, Wenhao; Li, Shengbiao; Pan, Guangjin; Cai, Jinglei; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Liu, Pengfei] Jilin Univ, Sch Pharmaceut, Dept Regenerat Med, Changchun, Jilin Province, Peoples R China; [Qin, Li] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Ctr Infect & Immun, State Key Lab Resp Dis,Lab Pathogen Biol, Guangzhou 510530, Guangdong, Peoples R China; [Jia, Bei; Zhong, Mei] Southern Med Univ, Nanfang Hosp, Ctr Prenatal & Hereditary Dis Diag, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Jilin University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Southern Medical University - China	Pan, GJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	pan_guangjin@gibh.ac.cn; cai_jinglei@gibh.ac.cn; pei_duanqing@gibh.ac.cn			National Natural Science Foundation of China [31000402]; Ministry of Science and Technology 973 Program [2011CB965204, 2012CB966802]; "Strategic Priority Research Program'' of the Chinese Academy of Sciences [XDA01020401, XDA01020202]; 863 Program [2011AA020109]; Ministry of Science and Technology International Technology Cooperation Program [2012DFH30050]; National S&T Major Special Project on Major New Drug Innovation [2011ZX09102-010-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology 973 Program(National Basic Research Program of China); "Strategic Priority Research Program'' of the Chinese Academy of Sciences(Chinese Academy of Sciences); 863 Program(National High Technology Research and Development Program of China); Ministry of Science and Technology International Technology Cooperation Program; National S&T Major Special Project on Major New Drug Innovation	This work was supported by the grants from National Natural Science Foundation of China (31000402), Ministry of Science and Technology 973 Program (2011CB965204, 2012CB966802), the "Strategic Priority Research Program'' of the Chinese Academy of Sciences (XDA01020401, XDA01020202), 863 Program (2011AA020109), Ministry of Science and Technology International Technology Cooperation Program (2012DFH30050), and National S&T Major Special Project on Major New Drug Innovation (No. 2011ZX09102-010-01).'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; ALMICI C, 1995, HAEMATOLOGICA, V80, P473; ALMICI C, 1995, STEM CELLS, V13, P533, DOI 10.1002/stem.5530130511; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Becker PD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013137; Bonde S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003212; Boyd AS, 2012, STEM CELLS, V30, P797, DOI 10.1002/stem.1066; Boyd AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010965; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Charron D, 2009, J CARDIOVASC TRANSL, V2, P130, DOI 10.1007/s12265-008-9062-9; Daadi MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041120; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fairchild PJ, 2010, NAT REV IMMUNOL, V10, P868, DOI 10.1038/nri2878; Falsini B, 2012, LANCET, V379, P2050, DOI 10.1016/S0140-6736(12)60890-3; Farowski F, 2012, INT J ANTIMICROB AG, V39, P228, DOI 10.1016/j.ijantimicag.2011.11.006; Ghose J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023837; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Huang JH, 2012, LANCET, V379, P2050, DOI 10.1016/S0140-6736(12)60891-5; Jangpatarapongsa K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045971; Kadereit S, 2011, SEMIN IMMUNOPATHOL, V33, P551, DOI 10.1007/s00281-011-0265-9; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Koido S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059280; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee G, 2010, NAT METHODS, V7, P25, DOI [10.1038/NMETH.F.283, 10.1038/nmeth.f.283]; Li B, 2010, CYTOTECHNOLOGY, V62, P509, DOI 10.1007/s10616-010-9311-z; Liskovykh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027345; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Moretta L, 2011, BLOOD, V117, P764, DOI 10.1182/blood-2010-08-264085; Nelson TJ, 2010, NAT REV CARDIOL, V7, P700, DOI 10.1038/nrcardio.2010.159; Niapour A, 2012, CELL TRANSPLANT, V21, P827, DOI 10.3727/096368911X593163; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita K, 2011, CIRC RES, V109, P720, DOI 10.1161/RES.0b013e318232e187; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; Pick M, 2012, STEM CELLS, V30, P2700, DOI 10.1002/stem.1242; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Sindhu STAK, 2003, J VIROL, V77, P1848, DOI 10.1128/JVI.77.3.1848-1855.2003; Strachan T., 2004, HUMAN MOL GENETICS; Suarez-Alvarez B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010192; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takata H, 2004, ACTA MED OKAYAMA, V58, P181; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WAGNER JE, 1995, BLOOD, V86, P512, DOI 10.1182/blood.V86.2.512.bloodjournal862512; WANG L, 2012, PLOS ONE; Wang M, 2009, IMMUNOLOGY, V126, P220, DOI 10.1111/j.1365-2567.2008.02891.x; Wang YX, 2012, CELL RES, V22, P637, DOI 10.1038/cr.2012.23; Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028; Wunderlich S, 2012, CELL REPROGRAM, V14, P471, DOI 10.1089/cell.2012.0041; Xi JY, 2011, STEM CELLS DEV, V20, P821, DOI 10.1089/scd.2010.0398; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yagi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041572; Yang JY, 2010, J BIOL CHEM, V285, P40303, DOI 10.1074/jbc.M110.183392; Zhao QJ, 2009, CYTOTHERAPY, V11, P414, DOI 10.1080/14653240902849754; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou W, 2007, VIRAL IMMUNOL, V20, P379, DOI 10.1089/vim.2007.0030	66	39	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69617	10.1371/journal.pone.0069617	http://dx.doi.org/10.1371/journal.pone.0069617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922758	Green Submitted, Green Published, gold			2022-12-25	WOS:000322838900062
J	Shao, Z; Friedlander, M; Hurst, CG; Cui, ZH; Pei, DT; Evans, LP; Juan, AM; Tahir, H; Duhamel, F; Chen, J; Sapieha, P; Chemtob, S; Joyal, JS; Smith, LEH				Shao, Zhuo; Friedlander, Mollie; Hurst, Christian G.; Cui, Zhenghao; Pei, Dorothy T.; Evans, Lucy P.; Juan, Aimee M.; Tahir, Houda; Duhamel, Francois; Chen, Jing; Sapieha, Przemyslaw; Chemtob, Sylvain; Joyal, Jean-Sebastien; Smith, Lois E. H.			Choroid Sprouting Assay: An Ex Vivo Model of Microvascular Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; PHENOTYPIC HETEROGENEITY; MACULAR DEGENERATION; EXPRESSION; RETINOPATHY; MICROGLIA; CHANNELS; EXPLANT	Angiogenesis of the microvasculature is central to the etiology of many diseases including proliferative retinopathy, age-related macular degeneration and cancer. A mouse model of microvascular angiogenesis would be very valuable and enable access to a wide range of genetically manipulated tissues that closely approximate small blood vessel growth in vivo. Vascular endothelial cells cultured in vitro are widely used, however, isolating pure vascular murine endothelial cells is technically challenging. A microvascular mouse explant model that is robust, quantitative and can be reproduced without difficulty would overcome these limitations. Here we characterized and optimized for reproducibility an organotypic microvascular angiogenesis mouse and rat model from the choroid, a microvascular bed in the posterior of eye. The choroidal tissues from C57BL/6J and 129S6/SvEvTac mice and Sprague Dawley rats were isolated and incubated in Matrigel. Vascular sprouting was comparable between choroid samples obtained from different animals of the same genetic background. The sprouting area, normalized to controls, was highly reproducible between independent experiments. We developed a semi-automated macro in ImageJ software to allow for more efficient quantification of sprouting area. Isolated choroid explants responded to manipulation of the external environment while maintaining the local interactions of endothelial cells with neighboring cells, including pericytes and macrophages as evidenced by immunohistochemistry and fluorescence-activated cell sorting (FACS) analysis. This reproducible ex vivo angiogenesis assay can be used to evaluate angiogenic potential of pharmacologic compounds on microvessels and can take advantage of genetically manipulated mouse tissue for microvascular disease research.	[Shao, Zhuo; Friedlander, Mollie; Hurst, Christian G.; Cui, Zhenghao; Pei, Dorothy T.; Evans, Lucy P.; Juan, Aimee M.; Chen, Jing; Joyal, Jean-Sebastien; Smith, Lois E. H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Ophthalmol, Boston, MA 02114 USA; [Duhamel, Francois; Sapieha, Przemyslaw; Chemtob, Sylvain] Univ Montreal, Dept Ophthalmol, Res Ctr, Hop Maisonneuve Rosemont, Montreal, PQ, Canada; [Tahir, Houda; Duhamel, Francois; Chemtob, Sylvain] CHU St Justine, Res Ctr, Dept Pediat Ophthalmol, Montreal, PQ, Canada; [Tahir, Houda; Duhamel, Francois; Chemtob, Sylvain] CHU St Justine, Res Ctr, Dept Pharmacol, Montreal, PQ, Canada	Harvard University; Boston Children's Hospital; Harvard Medical School; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Smith, LEH (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Ophthalmol, Boston, MA 02114 USA.	Lois.Smith@childrens.harvard.edu		Juan, Aimee/0000-0002-0221-2280; Qian, Mollie/0000-0001-7536-9054	National Institutes of Health (NIH) [EY017017-04S1, EY017017-05]; V. Kann Rasmussen Foundation; Boston Children's Hospital Mental Retardation and Developmental Disabilities Research Center [PO1HD18655]; Research to Prevent Blindness; Alcon Research Institute Award; Lowy Medical Foundation; Canadian Institute of Health Research (CIHR); CIHR Banting & Best PhD Scholarship; Fonds de la Recherche en Sante du Quebec (FRSQ); Boston Children's Hospital Ophthalmology Foundation; Charles H. Hood Foundation; Blind Children's Center; BrightFocus Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022275, R01EY017017] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V. Kann Rasmussen Foundation; Boston Children's Hospital Mental Retardation and Developmental Disabilities Research Center; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Alcon Research Institute Award; Lowy Medical Foundation; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Banting & Best PhD Scholarship(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Boston Children's Hospital Ophthalmology Foundation; Charles H. Hood Foundation; Blind Children's Center; BrightFocus Foundation(BrightFocus Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by funding from National Institutes of Health (NIH) (EY017017-04S1, EY017017-05), V. Kann Rasmussen Foundation, Boston Children's Hospital Mental Retardation and Developmental Disabilities Research Center PO1HD18655, Research to Prevent Blindness Senior Investigator Award, Alcon Research Institute Award and Lowy Medical Foundation (LEHS). ZS is supported by Canadian Institute of Health Research (CIHR) System Biology Training Scholarship and Travel Grant. FD is supported by CIHR Banting & Best PhD Scholarship and Health Professional PhD Scholarship from the Fonds de la Recherche en Sante du Quebec (FRSQ). JC is supported by Boston Children's Hospital Ophthalmology Foundation, Charles H. Hood Foundation Child Health Research Award, Blind Children's Center, and BrightFocus Foundation. PS holds a Canada Research Chair tier II. SC holds a Canada Research chair tier I (Vision science) and the Leopoldine Wolfe Chair in translational research in macular degeneration (U Montreal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Aplin AC, 2006, PHYSIOL GENOMICS, V27, P20, DOI 10.1152/physiolgenomics.00048.2006; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Ayton LN, 2012, CLIN EXPT OPHTHALMOL; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Bildin VN, 2001, EXP BIOL MED, V226, P919, DOI 10.1177/153537020122601007; Browning AC, 2012, BRIT J OPHTHALMOL, V96, P128, DOI 10.1136/bjophthalmol-2011-300572; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; de Lange EC, 2012, CURR PHARM BIOTECHNO; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Go Ronald S, 2003, Methods Mol Med, V85, P59; HIDAYAT AA, 1985, OPHTHALMOLOGY, V92, P512; Jow F, 1999, J MEMBRANE BIOL, V167, P53, DOI 10.1007/s002329900471; Jugdutt BI, 2002, J AM COLL CARDIOL, V39, P1538, DOI 10.1016/S0735-1097(02)01805-3; Kamouchi M, 1997, CELL CALCIUM, V22, P497, DOI 10.1016/S0143-4160(97)90077-4; Kobayashi S, 2004, BIOL PHARM BULL, V27, P1565, DOI 10.1248/bpb.27.1565; Kobayashi S, 2004, BIOL PHARM BULL, V27, P1382, DOI 10.1248/bpb.27.1382; Kobayashi S, 1999, BIOL PHARM BULL, V22, P360, DOI 10.1248/bpb.22.360; Kobayashi S, 1998, JPN J PHARMACOL, V78, P471, DOI 10.1254/jjp.78.471; Kohler R, 2001, CARDIOVASC RES, V51, P160, DOI 10.1016/S0008-6363(01)00281-4; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Marrelli A, 2011, AUTOIMMUN REV, V10, P595, DOI 10.1016/j.autrev.2011.04.020; Nicosia RF, 2011, INT J DEV BIOL, V55, P447, DOI 10.1387/ijdb.103222rn; Pemp B, 2008, CAN J OPHTHALMOL, V43, P295, DOI 10.3129/i08-049; Pons M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016722; Rasmussen JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046087; Ritter MR, 2006, J CLIN INVEST, V116, P3266, DOI 10.1172/JCI29683; Sandow SL, 2009, AM J PHYSIOL-HEART C, V297, pH1, DOI 10.1152/ajpheart.00042.2009; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Shao Z, 2011, INVEST OPHTH VIS SCI, V52, P6238, DOI 10.1167/iovs.10-6742; Stahl A, 2008, FEBS LETT, V582, P3097, DOI 10.1016/j.febslet.2008.08.005; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Zaniolo K, 2011, INVEST OPHTH VIS SCI, V52, P5376, DOI 10.1167/iovs.10-7152; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	43	74	78	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69552	10.1371/journal.pone.0069552	http://dx.doi.org/10.1371/journal.pone.0069552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922736	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900055
J	Yap, KL; Sysa-Shah, P; Bolon, B; Wu, RC; Gao, M; Herlinger, AL; Wang, FY; Faiola, F; Huso, D; Gabrielson, K; Wang, TL; Wang, JL; Shih, IM				Yap, Kai Lee; Sysa-Shah, Polina; Bolon, Brad; Wu, Ren-Chin; Gao, Min; Herlinger, Alice L.; Wang, Fengying; Faiola, Francesco; Huso, David; Gabrielson, Kathleen; Wang, Tian-Li; Wang, Jianlong; Shih, Ie-Ming			Loss of NAC1 Expression Is Associated with Defective Bony Patterning in the Murine Vertebral Axis	PLOS ONE			English	Article							CELL PLURIPOTENCY FACTOR; EMBRYONIC STEM-CELLS; OVARIAN-CANCER; BTB/POZ PROTEIN; MIGRATION; GROWTH; PROLIFERATION; SOMITOGENESIS; TRANSCRIPTION; CONTRIBUTES	NAC1 encoded by NACC1 is a member of the BTB/POZ family of proteins and participates in several pathobiological processes. However, its function during tissue development has not been elucidated. In this study, we compared homozygous null mutant Nacc1(-/-) and wild type Nacc1(+/+) mice to determine the consequences of diminished NAC1 expression. The most remarkable change in Nacc1(-/-) mice was a vertebral patterning defect in which most knockout animals exhibited a morphological transformation of the sixth lumbar vertebra (L6) into a sacral identity; thus, the total number of pre-sacral vertebrae was decreased by one (to 25) in Nacc1(-/-) mice. Heterozygous Nacc1(+/-) mice had an increased tendency to adopt an intermediate phenotype in which L6 underwent partial sacralization. Nacc1(-/-) mice also exhibited non-closure of the dorsal aspects of thoracic vertebrae T10-T12. Chondrocytes from Nacc1(+/+) mice expressed abundant NAC1 while Nacc1(-/-) chondrocytes had undetectable levels. Loss of NAC1 in Nacc1(-/-) mice was associated with significantly reduced chondrocyte migratory potential as well as decreased expression of matrilin-3 and matrilin-4, two cartilage-associated extracellular matrix proteins with roles in the development and homeostasis of cartilage and bone. These data suggest that NAC1 participates in the motility and differentiation of developing chondrocytes and cartilaginous tissues, and its expression is necessary to maintain normal axial patterning of murine skeleton.	[Yap, Kai Lee; Wu, Ren-Chin; Gao, Min; Herlinger, Alice L.; Wang, Fengying; Shih, Ie-Ming] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Sysa-Shah, Polina; Huso, David; Gabrielson, Kathleen] Johns Hopkins Univ, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Bolon, Brad] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Herlinger, Alice L.] Univ Fed Espirito Santo, Hlth Sci Ctr, Biotechnol Program RENORBIO, Vitoria, Brazil; [Faiola, Francesco; Wang, Jianlong] Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Wang, Tian-Li; Shih, Ie-Ming] Johns Hopkins Med Inst, Dept Gynecol, Baltimore, MD 21205 USA; [Wang, Tian-Li; Shih, Ie-Ming] Johns Hopkins Med Inst, Dept Obstet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University System of Ohio; Ohio State University; Universidade Federal do Espirito Santo; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Wang, JL (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	jianlong.wang@mssm.edu; ishih@jhmi.edu	Wang, Jianlong/AAG-9425-2020; Wang, Jianlong/GQR-1191-2022; Faiola, Francesco/Q-4218-2018; Herlinger, Alice L/P-1719-2014; sdsd, shihieih/ABE-6190-2020	Wang, Jianlong/0000-0002-1317-6457; Faiola, Francesco/0000-0002-3512-8253; Herlinger, Alice L/0000-0002-7660-7058; Yap, Kai Lee/0000-0003-4496-5464; Wu, Ren-Chin/0000-0003-1439-0874	NIH/NCI [RO1CA103937, RO1CA148826]; NY state Department of Health (NYSTEM) [C026420]; Black Family Stem Cell Institute; NATIONAL CANCER INSTITUTE [R01CA148826, R01CA103937] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NY state Department of Health (NYSTEM); Black Family Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH/NCI grants RO1CA103937, RO1CA148826 to IMS, and by a grant from NY state Department of Health (NYSTEM#C026420) and a seed fund from the Black Family Stem Cell Institute to JW. ALH is a fellow of CAPES (No. 10417/12-5) from Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestrem C, 1998, J CELL SCI, V111, P1649; Carpenter EM, 1997, DEVELOPMENT, V124, P4505; Cha XY, 1997, J NEUROSCI, V17, P6864; Davidson B, 2011, J CELL MOL MED, V15, P535, DOI [10.1111/j.1582-4934.2010.01019.x, 10.1111/j.1582-4934.2010.01023.x]; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fu P, 2007, J BIOL CHEM, V282, P22298, DOI 10.1074/jbc.M703066200; Gao M, 2012, INT J MOL SCI, V13, P13881, DOI 10.3390/ijms131113881; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hostikka SL, 2009, INT J BIOL SCI, V5, P397; Ishibashi M, 2009, CLIN CANCER RES, V15, P804, DOI 10.1158/1078-0432.CCR-08-2134; Ishikawa M, 2010, INT J ONCOL, V36, P1097, DOI 10.3892/ijo_00000591; Jinawath N, 2009, ONCOGENE, V28, P1941, DOI 10.1038/onc.2009.37; Klatt AR, 2011, INT J BIOCHEM CELL B, V43, P320, DOI 10.1016/j.biocel.2010.12.010; Klatt AR, 2002, MATRIX BIOL, V21, P289, DOI 10.1016/S0945-053X(02)00006-9; Klatt AR, 2001, J BIOL CHEM, V276, P17267, DOI 10.1074/jbc.M100587200; Korutla L, 2002, NEUROSCIENCE, V110, P421, DOI 10.1016/S0306-4522(01)00518-8; Korutla L, 2009, NEUROCHEM INT, V54, P245, DOI 10.1016/j.neuint.2008.12.008; Kragtorp KA, 2006, DEVELOPMENT, V133, P685, DOI 10.1242/dev.02230; Kuo PL, 2012, CARCINOGENESIS; Kusumi K, 2008, ADV EXP MED BIOL, V638, P140; Ma TH, 2009, J BIOL CHEM, V284, P16071, DOI 10.1074/jbc.M109.005041; Mackler SA, 2003, NEUROSCIENCE, V121, P355, DOI 10.1016/S0306-4522(03)00376-2; Mackler S, 2008, BEHAV BRAIN RES, V187, P48, DOI 10.1016/j.bbr.2007.08.036; Mancini C, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-10; MCLAREN A, 1958, J EMBRYOL EXP MORPH, V6, P645; Nagy A, 2009, COLD SPRING HARB PRO, V2009; Nakayama K, 2007, CANCER RES, V67, P8058, DOI 10.1158/0008-5472.CAN-07-1357; Nakayama K, 2006, P NATL ACAD SCI USA, V103, P18739, DOI 10.1073/pnas.0604083103; Nakayama K, 2010, GYNECOL ONCOL, V119, P469, DOI 10.1016/j.ygyno.2010.08.031; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Pickett EA, 2008, DEVELOPMENT, V135, P589, DOI 10.1242/dev.013763; Schymeinsky J, 2011, TRENDS CELL BIOL, V21, P247, DOI 10.1016/j.tcb.2010.12.001; Shih IM, 2011, MODERN PATHOL, V24, P638, DOI 10.1038/modpathol.2010.230; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stead MA, 2009, ACTA CRYSTALLOGR F, V65, P445, DOI 10.1107/S1744309109012214; Tsunoda K, 2011, J INVEST DERMATOL, V131, P1710, DOI 10.1038/jid.2011.110; Vigil D, 2012, CANCER RES, V72, P5338, DOI 10.1158/0008-5472.CAN-11-2373; Wagener R, 1998, FEBS LETT, V436, P123, DOI 10.1016/S0014-5793(98)01111-9; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang Y, 2012, DEV BIOL, V365, P110, DOI 10.1016/j.ydbio.2012.02.013; Yap KL, 2012, CANCER RES, V72, P4085, DOI 10.1158/0008-5472.CAN-12-0302; Yeasmin S, 2011, HUM PATHOL; Yeasmin S, 2008, CLIN CANCER RES, V14, P1686, DOI 10.1158/1078-0432.CCR-07-4085; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200; Zhang Y, 2012, ONCOGENE, V31, P1055, DOI 10.1038/onc.2011.290; Zhang Y, 2012, CANCER RES, V72, P4262, DOI 10.1158/0008-5472.CAN-12-0139	46	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69099	10.1371/journal.pone.0069099	http://dx.doi.org/10.1371/journal.pone.0069099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922682	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900020
J	Cao, HZ; Wu, JH; Wang, Y; Jiang, H; Zhang, T; Liu, X; Xu, YY; Liang, DQ; Gao, P; Sun, YP; Gifford, B; D'Ascenzo, M; Liu, XM; Tellier, LCAM; Yang, F; Tong, X; Chen, D; Zheng, J; Li, WY; Richmond, T; Xu, X; Wang, J; Li, YR				Cao, Hongzhi; Wu, Jinghua; Wang, Yu; Jiang, Hui; Zhang, Tao; Liu, Xiao; Xu, Yinyin; Liang, Dequan; Gao, Peng; Sun, Yepeng; Gifford, Benjamin; D'Ascenzo, Mark; Liu, Xiaomin; Tellier, Laurent C. A. M.; Yang, Fang; Tong, Xin; Chen, Dan; Zheng, Jing; Li, Weiyang; Richmond, Todd; Xu, Xun; Wang, Jun; Li, Yingrui			An Integrated Tool to Study MHC Region: Accurate SNV Detection and HLA Genes Typing in Human MHC Region Using Targeted High-Throughput Sequencing	PLOS ONE			English	Article							FRAMEWORK; PROJECT; MAP	The major histocompatibility complex (MHC) is one of the most variable and gene-dense regions of the human genome. Most studies of the MHC, and associated regions, focus on minor variants and HLA typing, many of which have been demonstrated to be associated with human disease susceptibility and metabolic pathways. However, the detection of variants in the MHC region, and diagnostic HLA typing, still lacks a coherent, standardized, cost effective and high coverage protocol of clinical quality and reliability. In this paper, we presented such a method for the accurate detection of minor variants and HLA types in the human MHC region, using high-throughput, high-coverage sequencing of target regions. A probe set was designed to template upon the 8 annotated human MHC haplotypes, and to encompass the 5 megabases (Mb) of the extended MHC region. We deployed our probes upon three, genetically diverse human samples for probe set evaluation, and sequencing data show that similar to 97% of the MHC region, and over 99% of the genes in MHC region, are covered with sufficient depth and good evenness. 98% of genotypes called by this capture sequencing prove consistent with established HapMap genotypes. We have concurrently developed a one-step pipeline for calling any HLA type referenced in the IMGT/HLA database from this target capture sequencing data, which shows over 96% typing accuracy when deployed at 4 digital resolution. This cost-effective and highly accurate approach for variant detection and HLA typing in the MHC region may lend further insight into immune-mediated diseases studies, and may find clinical utility in transplantation medicine research. This one-step pipeline is released for general evaluation and use by the scientific community.	[Cao, Hongzhi; Wu, Jinghua; Wang, Yu; Jiang, Hui; Zhang, Tao; Liu, Xiao; Xu, Yinyin; Liang, Dequan; Gao, Peng; Sun, Yepeng; Liu, Xiaomin; Tellier, Laurent C. A. M.; Yang, Fang; Tong, Xin; Chen, Dan; Zheng, Jing; Li, Weiyang; Xu, Xun; Wang, Jun; Li, Yingrui] BGI Shenzhen, Sci & Technol Dept, Shenzhen, Peoples R China; [Gifford, Benjamin; D'Ascenzo, Mark; Richmond, Todd] Roche NimbleGen Inc, Madison, WI USA; [Cao, Hongzhi; Jiang, Hui; Liu, Xiao; Tellier, Laurent C. A. M.; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Roche Holding; University of Copenhagen; King Abdulaziz University; Novo Nordisk Foundation; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Sci & Technol Dept, Shenzhen, Peoples R China.	liyr@genomics.cn; wangj@genomics.cn	Li, Yingrui/K-1064-2015; Liu, Xiao/P-2732-2015; Xu, Xun/AAI-6763-2020; Li, Weiyang/GRO-0563-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Liu, Xiao/0000-0002-8073-0534; Xu, Xun/0000-0002-5338-5173; Wang, Jun/0000-0002-2113-5874; Liu, Xiaomin/0000-0003-2155-3627; Zhang, Tao/0000-0003-2765-2802; Wang, Jun/0000-0002-8540-8931; Melchior Tellier, Laurent Christian Asker/0000-0003-3240-4926	National High Technology Research and Development Program of China [2012AA02A201]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The study was supported by the National High Technology Research and Development Program of China (NO. 2012AA02A201), and the funder's website is: http://www.863.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SCI TRANSL MED; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bray RA, 2008, BIOL BLOOD MARROW TR, V14, P45, DOI 10.1016/j.bbmt.2008.06.014; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dunckley Heather, 2012, Methods Mol Biol, V882, P9, DOI 10.1007/978-1-61779-842-9_2; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morishima Y, 2002, BLOOD, V99, P4200, DOI 10.1182/blood.V99.11.4200; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484	22	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69388	10.1371/journal.pone.0069388	http://dx.doi.org/10.1371/journal.pone.0069388			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894464	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900061
J	Kuo, HC; Hsu, YW; Wu, CM; Chen, SHY; Hung, KS; Chang, WP; Yang, KD; Hsieh, KS; Chen, WC; Onouchi, Y; Chang, WC				Kuo, Ho-Chang; Hsu, Yu-Wen; Wu, Chung-Min; Chen, Shawn Hsiang-Yin; Hung, Kuo-Sheng; Chang, Wei-Pin; Yang, Kuender D.; Hsieh, Kai-Sheng; Chen, Wei-Chiao; Onouchi, Yoshihiro; Chang, Wei-Chiao			A Replication Study for Association of ITPKC and CASP3 Two-Locus Analysis in IVIG Unresponsiveness and Coronary Artery Lesion in Kawasaki Disease	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN TREATMENT; GENOME-WIDE ASSOCIATION; TREATMENT FAILURE; GAMMA-GLOBULIN; SUSCEPTIBILITY; LOCUS; POLYMORPHISMS; CHILDREN; THERAPY; YOUNG	Single-nucleotide polymorphisms (SNPs) in inositol 1,4,5-trisphosphate 3-kinase C (ITPKC, rs28493229) and caspase-3 (CASP3, rs113420705) are associated with susceptibility to KD in Japanese and Taiwanese populations. This study was conducted to investigate the involvement of these 2 SNPs in the risk for intravenous immunoglobulin (IVIG) resistance and coronary artery lesion (CAL) in Taiwanese population. A total of 340 KD patients were subjected to assess by the identification of 2-locus genes model. A combinatorial association between ITPKC (rs28493229) and CASP3 (rs113420705) was found in CAL formation (P = 0.0227, OR: 3.06). KD patients with high-risk genotype had a trend of overrepresentation in IVIG resistance compared with individual SNPs. Our findings suggest the existence of genetic factors affecting patients' risk for CAL formation and IVIG responsiveness in a Taiwanese population.	[Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hsu, Yu-Wen; Chen, Shawn Hsiang-Yin; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Wu, Chung-Min] Natl Taipei Univ Technol, Dept Business Management, Taipei 106, Taiwan; [Hung, Kuo-Sheng] Taipei Med Univ, Wan Fang Med Ctr, Ctr Excellence Clin Trial, Taipei, Taiwan; [Hung, Kuo-Sheng] Taipei Med Univ, Wan Fang Med Ctr, Res Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan; [Yang, Kuender D.] Show Chwan Mem Hosp Chang Bing, Dept Med Res, Changhua, Taiwan; [Hsieh, Kai-Sheng] Kaohsiung Vet Gen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chen, Wei-Chiao] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Onouchi, Yoshihiro] RIKEN, Ctr Genom Med, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan; [Hsu, Yu-Wen; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wanfang Hosp, Dept Pharm, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; National Taipei University of Technology; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Kaohsiung Veterans General Hospital; National Cheng Kung University; RIKEN; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw	Kuo, Ho-Chang/AAQ-6644-2020; 吳, 忠敏/HGD-7379-2022	Kuo, Ho-Chang/0000-0002-3295-2984; Chen, Shawn Hsiang-Yin/0000-0001-5535-7152; Hsieh, Kai-Sheng/0000-0002-0294-9872; Chang, Wei-Chiao/0000-0002-8573-5924	National Science Council, Taiwan [NSC101-2628-B038-001-MY2, NSC101-2320-B038-029-MY3, NSC100-2314-B-182A-048-MY3]; Chang Gung Memorial Hospital, Taiwan [CMRPG8A0481]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from the National Science Council, Taiwan (NSC101-2628-B038-001-MY2, NSC101-2320-B038-029-MY3 and NSC100-2314-B-182A-048-MY3). This work was also supported by a grant from Chang Gung Memorial Hospital, Taiwan (CMRPG8A0481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Hinks A, 2009, ARTHRITIS RHEUM, V60, P251, DOI 10.1002/art.24187; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; Kawasaki T, 1967, Arerugi, V16, P178; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Kuo HC, 2010, J CLIN IMMUNOL; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2011, J HUM GENET, V56, P840, DOI 10.1038/jhg.2011.113; Kuo HC, 2011, ACTA PHARMACOL SIN, V32, P1193, DOI 10.1038/aps.2011.93; Kuo HC, 2011, J CLIN IMMUNOL, V31, P650, DOI 10.1007/s10875-011-9524-8; Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370; Kuo HC, 2011, J HUM GENET, V56, P161, DOI 10.1038/jhg.2010.154; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x; Kuo Ho-Chang, 2007, Journal of Microbiology Immunology and Infection, V40, P395; Liang CD, 2009, AM HEART J, V157, P584, DOI 10.1016/j.ahj.2008.11.020; Lin MT, 2011, PEDIATR INFECT DIS J, V30, P148, DOI 10.1097/INF.0b013e3181f43a4e; Newburger JW, 2007, NEW ENGL J MED, V356, P663, DOI 10.1056/NEJMoa061235; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Onouchi Y, 2013, PHARMACOGENOMICS J, V13, P52, DOI 10.1038/tpj.2011.45; Onouchi Y, 2011, PHARMACOGENOMICS J; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Qu HQ, 2009, J IMMUNOL, V183, P5158, DOI 10.4049/jimmunol.0901337; Shimizu C, 2011, CIRC-CARDIOVASC GENE, V4, P16, DOI 10.1161/CIRCGENETICS.110.940858; SHULMAN ST, 1995, PEDIATR CLIN N AM, V42, P1205; Townley RG, 2004, ANN ALLERG ASTHMA IM, V92, P350, DOI 10.1016/S1081-1206(10)61574-8; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Tse SML, 2002, J PEDIATR-US, V140, P450, DOI 10.1067/mpd.2002.122469; Wang CL, 2005, PEDIATR INFECT DIS J, V24, P998, DOI 10.1097/01.inf.0000183786.70519.fa; Wang CL, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.2.e140; Wang CL, 2002, J PEDIATR-US, V141, P560, DOI 10.1067/mpd.2002.127505; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yu HR, 2009, PEDIAT ALLERG IMM-UK, V20, P699, DOI 10.1111/j.1399-3038.2008.00844.x	42	29	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69685	10.1371/journal.pone.0069685	http://dx.doi.org/10.1371/journal.pone.0069685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894522	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900091
J	Schroder, PM; Khattar, M; Deng, RH; Xie, AN; Chen, WH; Stepkowski, SM				Schroder, Paul M.; Khattar, Mithun; Deng, Ronghai; Xie, Aini; Chen, Wenhao; Stepkowski, Stanislaw M.			Transient Combination Therapy Targeting the Immune Synapse Abrogates T Cell Responses and Prolongs Allograft Survival in Mice	PLOS ONE			English	Article							ANTIGEN-1 MONOCLONAL-ANTIBODY; LONG-TERM SURVIVAL; RECEPTOR INTERNALIZATION; RENAL-TRANSPLANTATION; ISLET TRANSPLANTATION; CARDIAC ALLOGRAFTS; MULTICENTER TRIAL; LFA-1; EFALIZUMAB; ACTIVATION	T cells play a major role in allograft rejection, which occurs after T cell activation by the engagement of several functional molecules to form an immune synapse with alloantigen presenting cells. In this study, the immune synapse was targeted using mAbs directed to the TCR beta-chain (TCR beta) and lymphocyte function-associated antigen-1 (LFA1) to induce long-term allograft survival. Evaluation of antigen-specific T cell responses was performed by adoptively transferring CFSE labeled transgenic OT-II cells into wild-type mice and providing OVA peptide by intravenous injection. Graft survival studies were performed in mice by transplanting BALB/c ear skins onto the flanks of C57BL/6 recipients. The anti-TCR beta plus anti-LFA1 mAb combination (but not either mAb alone) abrogated antigen-specific T cell responses invitro and invivo. Transient combination therapy with these agents resulted in significantly prolonged skin allograft survival in mice (51 +/- 10 days; p<0.01) when compared to treatment with either anti-TCRb mAb (24 +/- 5 days) or anti-LFA1 mAb (19 +/- 3 days) alone or no treatment (10 +/- 1 days). When lymphoid tissues from these mice were analyzed at different times post-transplant, only those receiving the combination of anti-TCR beta and anti-LFA1 mAbs demonstrated long-lasting reductions in total T cell numbers, cellular and humoral anti-donor responses, and expression of CD3 on the surface of T cells. These results demonstrate that transient anti-TCR beta and anti-LFA1 mAb combination therapy abrogates antigen-reactive T cell responses with long-lasting effects that significantly prolong allograft survival.	[Schroder, Paul M.; Khattar, Mithun; Deng, Ronghai; Chen, Wenhao; Stepkowski, Stanislaw M.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, Toledo, OH 43606 USA; [Deng, Ronghai] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Aini; Chen, Wenhao] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Xie, Aini] Huazhong Univ Sci & Technol, Dept Cardiovasc Surg, Union Hosp, Wuhan 430074, Peoples R China	University System of Ohio; University of Toledo; Sun Yat Sen University; Baylor College of Medicine; Huazhong University of Science & Technology	Chen, WH (corresponding author), Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	wenhaoc@bcm.edu; Stanislaw.Stepkowski@utoledo.edu	Chen, Wenhao/J-6553-2019; Khattar, Mithun/AAD-4760-2020; Khattar, Mithun/O-4415-2014	Chen, Wenhao/0000-0002-0626-3739; Khattar, Mithun/0000-0002-4355-4623	National Institutes of Health [5RO1AI090244-02]; American Heart Association [11SDG7690000]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the National Institutes of Health (grant number 5RO1AI090244-02) and the American Heart Association (grant number 11SDG7690000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Behrens GMN, 2004, J IMMUNOL, V172, P5420, DOI 10.4049/jimmunol.172.9.5420; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Burrell BE, 2012, AM J TRANSPLANT, V12, P576, DOI 10.1111/j.1600-6143.2011.03879.x; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Crotzer VL, 2004, J EXP MED, V199, P981, DOI 10.1084/jem.20031105; Durrbach A, 2010, NAT REV NEPHROL, V6, P160, DOI 10.1038/nrneph.2009.233; Ferguson R, 2011, AM J TRANSPLANT, V11, P66, DOI 10.1111/j.1600-6143.2010.03338.x; FERRARESSO M, 1994, J IMMUNOL, V153, P3307; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Garrod Kym R, 2008, J Vis Exp, DOI 10.3791/634; GOTOH M, 1994, TRANSPLANTATION, V57, P123; GOUGEON ML, 1985, CELL IMMUNOL, V95, P75, DOI 10.1016/0008-8749(85)90296-5; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hourmant M, 1996, TRANSPLANTATION, V62, P1565, DOI 10.1097/00007890-199612150-00006; Isobe M, 1996, TRANSPLANTATION, V62, P411, DOI 10.1097/00007890-199608150-00019; ISOBE M, 1992, SCIENCE, V255, P1125, DOI 10.1126/science.1347662; Kitchens WH, 2011, IMMUNOTHERAPY-UK, V3, P305, DOI 10.2217/IMT.10.113; KNIGHT RJ, 1994, TRANSPLANTATION, V57, P1581; KNOBLOCH C, 1991, CELL IMMUNOL, V138, P150, DOI 10.1016/0008-8749(91)90140-7; Krieger NR, 1996, J EXP MED, V184, P2013, DOI 10.1084/jem.184.5.2013; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; Lunsford KE, 2005, J IMMUNOL, V175, P7855, DOI 10.4049/jimmunol.175.12.7855; Martinez-Martin N, 2011, IMMUNITY, V35, P208, DOI 10.1016/j.immuni.2011.06.003; Miyahara Y, 2012, AM J TRANSPLANT, V12, P1409, DOI 10.1111/j.1600-6143.2012.04006.x; Nakakura EK, 1996, TRANSPLANTATION, V62, P547, DOI 10.1097/00007890-199609150-00001; Nicolls MR, 2000, J IMMUNOL, V164, P3627, DOI 10.4049/jimmunol.164.7.3627; PAUL LC, 1993, TRANSPLANTATION, V55, P1196; Posselt AM, 2010, AM J TRANSPLANT, V10, P1870, DOI 10.1111/j.1600-6143.2010.03073.x; Reichardt P, 2007, IMMUNOL REV, V218, P165, DOI 10.1111/j.1600-065X.2007.00526.x; Reisman NM, 2011, BLOOD, V118, P5851, DOI 10.1182/blood-2011-04-347252; Schwab N, 2012, NEUROLOGY, V78, P458, DOI 10.1212/WNL.0b013e3182478d4b; Setoguchi K, 2011, AM J TRANSPLANT, V11, P923, DOI 10.1111/j.1600-6143.2011.03492.x; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; Turgeon NA, 2010, AM J TRANSPLANT, V10, P2082, DOI 10.1111/j.1600-6143.2010.03212.x; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; Vincenti F, 2008, AM J TRANSPLANT, V8, P1972, DOI 10.1111/j.1600-6143.2008.02403.x; Vincenti F, 2007, AM J TRANSPLANT, V7, P1770, DOI 10.1111/j.1600-6143.2007.01845.x; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Waid TH, 1997, J HEART LUNG TRANSPL, V16, P913; WAID TH, 1992, TRANSPLANTATION, V53, P80, DOI 10.1097/00007890-199201000-00015; Waid TH, 2009, DRUG DES DEV THER, V3, P205; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Willenborg DO, 1996, J IMMUNOL, V157, P1973; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69397	10.1371/journal.pone.0069397	http://dx.doi.org/10.1371/journal.pone.0069397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894468	gold, Green Submitted, Green Published			2022-12-25	WOS:000322167900064
J	Smits, MLJ; van den Hoven, AF; Rosenbaum, CENM; Zonnenberg, BA; Lam, MGEH; Nijsen, JFW; Koopman, M; van den Bosch, MAAJ				Smits, Maarten L. J.; van den Hoven, Andor F.; Rosenbaum, Charlotte E. N. M.; Zonnenberg, Bernard A.; Lam, Marnix G. E. H.; Nijsen, Johannes F. W.; Koopman, Miriam; van den Bosch, Maurice A. A. J.			Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with Y-90-Microspheres for Unresectable Liver Metastases	PLOS ONE			English	Article							Y-90 MICROSPHERE BRACHYTHERAPY; HEPATIC MALIGNANCIES; COLORECTAL-CANCER; SINGLE-CENTER; TRIAL; CHEMOTHERAPY; DISEASE; TUMORS; RECOMMENDATIONS; EMBOLIZATION	Objective: To investigate clinical and laboratory toxicity in patients with unresectable liver metastases, treated with yttrium-90 radioembolization (Y-90-RE). Methods: Patients with liver metastases treated with Y-90-RE, between February 1st 2009 and March 31st 2012, were included in this study. Clinical toxicity assessment was based on the reporting in patient's charts. Laboratory investigations at baseline and during a four-month follow-up were used to assess laboratory toxicity according to the Common Terminology Criteria for Adverse Events version 4.02. The occurrence of grade 3-4 laboratory toxicity was stratified according to treatment strategy (whole liver treatment in one session versus sequential sessions). Response assessment was performed at the level of target lesions, whole liver and overall response in accordance with RECIST 1.1 at 3- and 6 months post-treatment. Median time to progression (TTP) and overall survival were calculated by Kaplan-Meier analysis. Results: A total of 59 patients, with liver metastases from colorectal cancer (n = 30), neuroendocrine tumors (NET) (n = 6) and other primary tumors (n = 23) were included. Clinical toxicity after Y-90-RE treatment was confined to grade 1-2 events, predominantly post-embolization symptoms. No grade 3-4 clinical toxicity was observed, whereas laboratory toxicity grade 3-4 was observed in 38% of patients. Whole liver treatment in one session was not associated with increased laboratory toxicity. Three-months disease control rates for target lesions, whole liver and overall response were 35%, 21% and 19% respectively. Median TTP was 6.2 months for target lesions, 3.3 months for the whole liver and 3.0 months for overall response. Median overall survival was 8.9 months. Conclusion: The risk of severe complications or grade 3-4 clinical toxicity in patients with liver metastases of various primary tumors undergoing Y-90-RE is low. In contrast, laboratory toxicity grade 3-4 can be expected to occur in more than one-third of patients without any clinical signs of radiation induced liver disease.	[Smits, Maarten L. J.; van den Hoven, Andor F.; Rosenbaum, Charlotte E. N. M.; Zonnenberg, Bernard A.; Lam, Marnix G. E. H.; Nijsen, Johannes F. W.; Koopman, Miriam; van den Bosch, Maurice A. A. J.] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands; [Smits, Maarten L. J.; van den Hoven, Andor F.; Rosenbaum, Charlotte E. N. M.; Zonnenberg, Bernard A.; Lam, Marnix G. E. H.; Nijsen, Johannes F. W.; Koopman, Miriam; van den Bosch, Maurice A. A. J.] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van den Bosch, MAAJ (corresponding author), Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands.	mbosch@umcutrecht.nl	Nijsen, Frank/C-2839-2018	Nijsen, Frank/0000-0001-7625-2253				Arslan N, 2011, VOJNOSANIT PREGL, V68, P341, DOI 10.2298/VSP1104341A; Barentsz MW, 2011, CARDIOVASC INTER RAD, V34, P1074, DOI 10.1007/s00270-010-0088-4; BIERMAN HR, 1951, J NATL CANCER I, V12, P107; Carretero C, 2007, AM J GASTROENTEROL, V102, P1216, DOI 10.1111/j.1572-0241.2007.01172.x; Chua TC, 2011, J CANCER RES CLIN, V137, P865, DOI 10.1007/s00432-010-0948-y; da Silveira EBV, 2002, GASTROINTEST ENDOSC, V55, P432, DOI 10.1067/mge.2002.120879; Dezarn WA, 2011, MED PHYS, V38, P4824, DOI 10.1118/1.3608909; Dudeck O, 2012, CARDIOVASC INTER RAD, V35, P1083, DOI 10.1007/s00270-011-0252-5; Dunfee BL, 2010, J VASC INTERV RADIOL, V21, P90, DOI 10.1016/j.jvir.2009.09.011; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Garin E, 2010, EUR J NUCL MED MOL I, V37, P453, DOI 10.1007/s00259-009-1279-6; Gray B, 2001, ANN ONCOL, V12, P1711, DOI 10.1023/A:1013569329846; Guha C, 2011, SEMIN RADIAT ONCOL, V21, P256, DOI 10.1016/j.semradonc.2011.05.003; Gulec SA, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-15; Heusner TA, 2010, ROFO-FORTSCHR RONTG, V182, P603, DOI 10.1055/s-0029-1245192; Kennedy A, 2007, INT J RADIAT ONCOL, V68, P13, DOI 10.1016/j.ijrobp.2006.11.060; Kennedy AS, 2006, INT J RADIAT ONCOL, V65, P412, DOI 10.1016/j.ijrobp.2005.12.051; Lam MG, 2013, CARDIOVASC INTERVENT; LAWRENCE TS, 1995, INT J RADIAT ONCOL, V31, P1237, DOI 10.1016/0360-3016(94)00418-K; Louie JD, 2009, J VASC INTERV RADIOL, V20, P606, DOI 10.1016/j.jvir.2009.01.021; Piana PM, 2011, J VASC INTERV RADIOL, V22, P1373, DOI 10.1016/j.jvir.2011.06.006; REED GB, 1966, AM J PATHOL, V48, P597; Riaz A, 2009, J VASC INTERV RADIOL, V20, P1121, DOI 10.1016/j.jvir.2009.05.030; Salem R, 2006, J VASC INTERV RADIOL, V17, P1425, DOI 10.1097/01.RVI.0000235779.88652.53; Sato K, 2006, CARDIOVASC INTER RAD, V29, P522, DOI 10.1007/s00270-005-0171-4; Seidensticker R, 2012, CARDIOVASC INTER RAD, V35, P1109, DOI 10.1007/s00270-011-0295-7; Sempoux C, 1997, HEPATOLOGY, V26, P128; Sharma RA, 2008, CLIN ONCOL-UK, V20, P261, DOI 10.1016/j.clon.2007.12.008; Sirtex, 2013, SIR SPHER YTTR 90 RE; Smits MLJ, 2012, LANCET ONCOL, V13, P1025, DOI 10.1016/S1470-2045(12)70334-0; Szyszko T, 2007, NUCL MED COMMUN, V28, P21, DOI 10.1097/MNM.0b013e3280121a8f; Van Hazel G, 2004, J SURG ONCOL, V88, P78, DOI 10.1002/jso.20141; Vente MAD, 2009, EUR RADIOL, V19, P951, DOI 10.1007/s00330-008-1211-7	33	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69448	10.1371/journal.pone.0069448	http://dx.doi.org/10.1371/journal.pone.0069448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894481	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900071
J	Tovey, ER; Willenborg, CM; Crisafulli, DA; Rimmer, J; Marks, GB				Tovey, Euan R.; Willenborg, Christiana M.; Crisafulli, Daniele A.; Rimmer, Janet; Marks, Guy B.			Most Personal Exposure to House Dust Mite Aeroallergen Occurs during the Day	PLOS ONE			English	Article							ALLERGENS DER-I; CAT ALLERGEN; SENSITIZATION; CLASSROOMS; CHILDREN; ASTHMA	Background: The bed is commonly regarded as the main site of house dust mite exposure; however this has not been directly established by continuous measurements. The objective of this study was to determine the pattern of personal exposure to mite aeroallergen over 24 hours. Methods: 12 adults each collected 9 sequential samples (8 during the day, mean 115 mins, and one overnight, mean 514 mins) over 24 hours using a portable air-pump (2L/min) connected to an IOM filter located on the shoulder during the day and on the bed head overnight. Samples were analysed for mite allergen Der p 1 by ELISA. Location and activity were recorded. A mixed model analysis was performed to determine exposure as a function of 14 categories of activity. Results: Personal aeroallergen exposure differed widely over time, both within and between subjects. The highest average exposure (1117 pg/m(3), 95% CI: 289-4314) occurred on public transport and the lowest overnight in bed (45 pg/m(3), 95% CI: 17-17), which contributed only 9.8% (95% CI: 4.4%-15.1%) of total daily exposure. Aeroallergens were not related to bed reservoirs. Conclusion: The study challenges the current paradigm that the bed is the main site of HDM exposure and instead suggests most exposure occurs in association with domestic activity and proximity to other people. Effective mite interventions, designed to improve asthma outcomes, need to first identify and then address the multiple sources of aeroallergen exposure.	[Tovey, Euan R.; Crisafulli, Daniele A.; Rimmer, Janet] Woolcock Inst Med Res, Allergen Grp, Sydney, NSW, Australia; [Tovey, Euan R.; Rimmer, Janet; Marks, Guy B.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Willenborg, Christiana M.] Prince Wales Hosp, Virol Res Lab, Sydney, NSW, Australia; [Marks, Guy B.] Woolcock Inst Med Res, Epidemiol Grp, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney; Woolcock Institute of Medical Research	Tovey, ER (corresponding author), Woolcock Inst Med Res, Allergen Grp, Sydney, NSW, Australia.	euan.tovey@sydney.edu.au	Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053	National Health and Medical Research Council of Australia [571126]; Asthma Foundation of New South Wales, Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Asthma Foundation of New South Wales, Australia	This work was supported by the National Health and Medical Research Council of Australia (571126) www.nhmrc.gov.au and the Asthma Foundation of New South Wales, Australia, http://www.asthmafoundation.org.au/NSW/Home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crisafulli D, 2007, ALLERGY, V62, P1394, DOI 10.1111/j.1398-9995.2007.01533.x; De Lucca SD, 2000, J ALLERGY CLIN IMMUN, V106, P874, DOI 10.1067/mai.2000.110804; Delfino RJ, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-69; Ferro AR, 2004, J EXPO ANAL ENV EPID, V14, pS34, DOI 10.1038/sj.jea.7500356; Glasgow NJ, 2011, ARCH DIS CHILD, V96, P541, DOI 10.1136/adc.2010.189696; Gore R, 2011, CLIN EXP ALLERGY, V41, P1848; Gotzsche PC, 2008, ALLERGY, V63, P646, DOI 10.1111/j.1398-9995.2008.01690.x; Karlsson AS, 2004, J ALLERGY CLIN IMMUN, V113, P1172, DOI 10.1016/j.jaci.2003.12.590; Matsui EC, 2010, ALLERGY, V65, P1414, DOI 10.1111/j.1398-9995.2010.02412.x; O'Rourke SD, 2002, J ALLERGY CLIN IMMUN, V109, pS47, DOI 10.1016/S0091-6749(02)81228-3; Patchett K, 1997, J ALLERGY CLIN IMMUN, V100, P755, DOI 10.1016/S0091-6749(97)70269-0; Rabinovitch N, 2005, J ALLERGY CLIN IMMUN, V116, P1053, DOI 10.1016/j.jaci.2005.08.045; Raja S, 2010, ENVIRON INT, V36, P8, DOI 10.1016/j.envint.2009.09.001; SAKAGUCHI M, 1989, INT ARCH ALLER A IMM, V90, P190, DOI 10.1159/000235022; SAKAGUCHI M, 1992, ALLERGY, V47, P55, DOI 10.1111/j.1398-9995.1992.tb02250.x; Sordillo JE, 2011, J ALLERGY CLIN IMMUN, V127, P1165, DOI 10.1016/j.jaci.2011.01.066; Tovey E, 1999, J ALLERGY CLIN IMMUN, V103, P179, DOI 10.1016/S0091-6749(99)70488-4; TOVEY ER, 1981, AM REV RESPIR DIS, V124, P630; Tovey E, 2012, CURR ALLERGY ASTHM R, V12, P465, DOI 10.1007/s11882-012-0285-0; Tovey ER, 2011, J ALLERGY CLIN IMMUN, V128, P723, DOI 10.1016/j.jaci.2011.07.009	20	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69900	10.1371/journal.pone.0069900	http://dx.doi.org/10.1371/journal.pone.0069900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894558	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900099
J	Filipova, L; Petrusek, A; Matasova, K; Delaunay, C; Grandjean, F				Filipova, Lenka; Petrusek, Adam; Matasova, Klara; Delaunay, Carine; Grandjean, Frederic			Prevalence of the Crayfish Plague Pathogen Aphanomyces astaci in Populations of the Signal Crayfish Pacifastacus leniusculus in France: Evaluating the Threat to Native Crayfish	PLOS ONE			English	Article							NORTH-AMERICAN CRAYFISH; POLYMERASE-CHAIN-REACTION; NOBLE CRAYFISH; PERSISTENT INFECTION; RANDOM AMPLIFICATION; FUNGUS; AGENT; OOMYCETE; IDENTIFICATION; EPIZOOTICS	Aphanomyces astaci, the crayfish plague pathogen, first appeared in Europe in the mid-19th century and is still responsible for mass mortalities of native European crayfish. The spread of this parasite across the continent is especially facilitated by invasive North American crayfish species that serve as its reservoir. In France, multiple cases of native crayfish mortalities have been suggested to be connected with the presence of the signal crayfish Pacifastacus leniusculus, which is highly abundant in the country. It shares similar habitats as the native white-clawed crayfish Austropotamobius pallipes and, when infected, the signal crayfish might therefore easily transmit the pathogen to the native species. We investigated the prevalence of A. astaci in French signal crayfish populations to evaluate the danger they represent to local populations of native crayfish. Over 500 individuals of Pacifastacus leniusculus from 45 French populations were analysed, plus several additional individuals of other non-indigenous crayfish species Orconectes limosus, O. immunis and Procambarus clarkii. Altogether, 20% of analysed signal crayfish tested positive for Aphanomyces astaci, and the pathogen was detected in more than half of the studied populations. Local prevalence varied significantly, ranging from 0% up to 80%, but wide confidence intervals suggest that the number of populations infected by A. astaci may be even higher than our results show. Analysis of several individuals of other introduced species revealed infections among two of these, O. immunis and P. clarkii. Our results confirm that the widespread signal crayfish serves as a key reservoir of Aphanomyces astaci in France and therefore represents a serious danger to native crayfish species, especially the white-clawed crayfish. The prevalence in other non-indigenous crayfish should also be investigated as they likely contribute to pathogen transmission in the country.	[Filipova, Lenka; Petrusek, Adam; Matasova, Klara] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Filipova, Lenka; Delaunay, Carine; Grandjean, Frederic] Univ Poitiers, Lab Ecol & Biol Interact, Equipe Ecol Evolut Symbiose, UMR CNRS 7267, Poitiers, France	Charles University Prague; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Grandjean, F (corresponding author), Univ Poitiers, Lab Ecol & Biol Interact, Equipe Ecol Evolut Symbiose, UMR CNRS 7267, Poitiers, France.	frederic.grandjean@univ-poitiers.fr	grandjean, frederic/H-2017-2012; Petrusek, Adam/A-3510-2008	grandjean, frederic/0000-0002-8494-0985; Petrusek, Adam/0000-0001-5150-4370	French National Agency for Water and Aquatic Environments (ONEMA); Charles University in Prague [SVV 265 207]	French National Agency for Water and Aquatic Environments (ONEMA); Charles University in Prague	This project has been funded by the French National Agency for Water and Aquatic Environments (ONEMA) and the Charles University in Prague (SVV 265 207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman DJ, 1996, REV SCI TECH OIE, V15, P603, DOI 10.20506/rst.15.2.943; ALDERMAN DJ, 1986, J FISH DIS, V9, P367, DOI 10.1111/j.1365-2761.1986.tb01030.x; Arignon JCV, 1999, CRUSTACEAN ISS, V11, P129; Bohman P, 2006, B FR PECHE PISCIC, P1291, DOI 10.1051/kmae:2006026; Bramard M, 2006, B FR PECHE PISCIC, P857, DOI 10.1051/kmae:2006027; Collas M, 2007, BFPP-CONNAISS GEST P, P1, DOI 10.1051/kmae:2007010; Collas M, 2002, ASTACICULTEUR FRANCE, V70, P2; Dieguez-Uribeondo J, 2006, B FR PECHE PISCIC, P1303, DOI 10.1051/kmae:2006036; Dubois J-P, 2003, ASTACICULTEUR FRANCE, V77, P2; Edgerton BF, 2004, CONSERV BIOL, V18, P1466, DOI 10.1111/j.1523-1739.2004.00436.x; Filipova L, 2012, THESIS CHARLES U PRA; Fureder L., 2006, ATLAS CRAYFISH EUROP, V64; Grandjean F, 1997, CR ACAD SCI III-VIE, V320, P551, DOI 10.1016/S0764-4469(97)84710-5; Hochwimmer G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-184; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Holdich David M., 2003, P15; Holdich DM, 2002, B FR PECHE PISCIC, P611, DOI 10.1051/kmae:2002055; HUANG TS, 1994, AQUACULTURE, V126, P1, DOI 10.1016/0044-8486(94)90243-7; Johnsen SI, 2007, BIOL INVASIONS, V9, P939, DOI 10.1007/s10530-007-9092-2; Jussila J, 2011, AQUACULTURE, V321, P17, DOI 10.1016/j.aquaculture.2011.08.026; Kokko H, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012006; Kozubikova E, 2008, AQUACULTURE, V274, P208, DOI 10.1016/j.aquaculture.2007.11.015; Kozubikova E, 2011, DIS AQUAT ORGAN, V97, P113, DOI 10.3354/dao02411; Kozubikova E, 2011, J INVERTEBR PATHOL, V108, P214, DOI 10.1016/j.jip.2011.08.002; Kozubikova E, 2009, CONSERV BIOL, V23, P1204, DOI 10.1111/j.1523-1739.2009.01240.x; Kusar D, 2013, DIS AQUAT ORGAN, V103, P157, DOI 10.3354/dao02567; Machino Y., 1998, ASTACICULTEUR FR, V54, P2; Machino Y, 1999, ASTACICULTEUR FRANCE, V60, P2; Makkonen J, 2012, DIS AQUAT ORGAN, V102, P129, DOI 10.3354/dao02547; Makkonen J, 2010, FRESHW CRAYFISH, V17, P155, DOI [10.5869/fc.2010.v17.155, DOI 10.5869/FC.2010.V17.155]; Makkonen J, 2012, FUNGAL GENET BIOL, V49, P635, DOI 10.1016/j.fgb.2012.05.014; Matasova K, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011029; Neveu A, 1998, ASTACICULTEUR FRANCE, V57, P6; Neveu A, 2002, PACIFASTACUS LENIUSC, P87; Neveu A, 1998, ASTACICULTEUR FRANCE, V57, P2; Neveu A, 2000, ASTACICULTEUR FRANCE, V63, P7; Neveu A, 2002, ASTACICULTEUR FRANCE, V76, P2; Nylund V, 2000, J CRUSTACEAN BIOL, V20, P777, DOI 10.1651/0278-0372(2000)020[0777:TPOCPA]2.0.CO;2; Nylund V., 1983, Freshwater Crayfish, V5, P277; Oidtmann B, 2004, VET MICROBIOL, V100, P269, DOI 10.1016/j.vetmic.2004.01.019; Oidtmann B, 2002, VET MICROBIOL, V85, P183, DOI 10.1016/S0378-1135(01)00505-3; Oidtmann B, 1999, DIS AQUAT ORGAN, V35, P235, DOI 10.3354/dao035235; Oidtmann B, 2006, DIS AQUAT ORGAN, V72, P53, DOI 10.3354/dao072053; Papin JC, 2000, ASTACICULTEUR FRANCE, V63, P11; Parvulescu L, 2012, DIS AQUAT ORGAN, V98, P85, DOI 10.3354/dao02432; Peay Stephanie, 2009, P63; R Core Team, 2021, R LANG ENV STAT COMP; Raveret-Wattel C, 1885, B SOC NAT ACCLIMAT F, V2, P614; Schrimpf A, 2013, FRESHWATER BIOL, V58, P1116, DOI 10.1111/fwb.12112; Schrimpf A, 2013, AQUAT INVASIONS, V8, P103, DOI 10.3391/ai.2013.8.1.12; Schrimpf A, 2012, AQUAT INVASIONS, V7, P503, DOI 10.3391/ai.2012.7.4.007; Skov C, 2009, UDBREDELSE BEKAEMPEL; Skov C, 2011, BIOL INVASIONS, V13, P1269, DOI 10.1007/s10530-010-9901-x; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Stevenson M, 2013, EPIR R PACKAGE ANAL; Strand DA, 2011, DIS AQUAT ORGAN, V95, P9, DOI 10.3354/dao02334; Svoboda J, 2012, DIS AQUAT ORGAN, V98, P255, DOI 10.3354/dao02445; Tuffs S, 2011, VET MICROBIOL, V153, P343, DOI 10.1016/j.vetmic.2011.06.012; Vennerstrom P, 1998, ANN ZOOL FENN, V35, P43; Vigneux E, 1997, B FR PECHE PISCIC, P357, DOI 10.1051/kmae:1997035; Viljamaa-Dirks S, 2013, DIS AQUAT ORGAN, V103, P199, DOI 10.3354/dao02575; Viljamaa-Dirks S, 2011, B EUR ASSOC FISH PAT, V31, P182; Vralstad T, 2011, DIS AQUAT ORGAN, V97, P75, DOI 10.3354/dao02386; Vralstad T, 2009, VET MICROBIOL, V137, P146, DOI 10.1016/j.vetmic.2008.12.022; Westman K, 2001, B FR PECHE PISCIC, P613, DOI 10.1051/kmae:2001008	65	61	61	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70157	10.1371/journal.pone.0070157	http://dx.doi.org/10.1371/journal.pone.0070157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894606	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000189
J	Jiang, XH; Zhang, MG; You, Y; Liu, F				Jiang, Xuhua; Zhang, Mingguang; You, Yan; Liu, Fang			The Production of Somatostatin Interneurons in the Olfactory Bulb Is Regulated by the Transcription Factor Sp8	PLOS ONE			English	Article							EXTERNAL PLEXIFORM LAYER; NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; PERIGLOMERULAR CELLS; GANGLIONIC EMINENCE; ADULT NEUROGENESIS; BRAIN-INJURY; NEURONS; DIFFERENTIATION; SUBPOPULATION	Somatostatin (Som), one of the most concentrated neuropeptides in the brain, is highly expressed in the olfactory bulb (OB). However, the temporal profile by which OB somatostatin-expressing (Som+) interneurons are produced and the molecular mechanisms controlling this profile are totally unknown. In the present study, we found that all the Som+ interneurons in the mouse external plexiform layer (EPL) and the rat glomerular layer (GL) express the transcription factor Sp8. Using the 5-bromo-2'-deoxyuridine (BrdU) birth dating method, combined with immunostaining, we showed that the generation of Som+ interneurons in the mouse and rat OB is confined to the later embryonic and earlier postnatal stages. Within the mouse OB, the production of Som+ interneurons is maximal during late embryogenesis and decreases after birth, whereas the generation of Som+ interneurons is low during embryogenesis and increases gradually after birth in the rat OB. Interestingly, genetic ablation of Sp8 by cre/loxP-based recombination severely reduces the number of Som+ interneurons in the EPL of the mouse OB. Taken together, these results suggest that Sp8 is required for the normal production of Som+ interneurons in the EPL of the mouse OB.	[Jiang, Xuhua; You, Yan; Liu, Fang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Jiang, Xuhua; You, Yan; Liu, Fang] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Zhang, Mingguang] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Liu, F (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China.	fliu1978@fudan.edu.cn			National Natural Science Foundation of China [30900425, 31121061, 30990261]; Shanghai Natural Science Foundation [13ZR1402700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This work was funded by the National Natural Science Foundation of China (30900425; 31121061; 30990261) and Shanghai Natural Science Foundation (13ZR1402700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Cai YQ, 2013, STEM CELLS, V31, P1193, DOI 10.1002/stem.1363; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gutierrez-Mecinas M, 2005, J COMP NEUROL, V489, P467, DOI 10.1002/cne.20649; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Kosaka K, 2007, BRAIN RES, V1167, P42, DOI 10.1016/j.brainres.2007.04.087; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; Lepousez G, 2010, J COMP NEUROL, V518, P1976, DOI 10.1002/cne.22317; Li XS, 2011, J NEUROSCI, V31, P8450, DOI 10.1523/JNEUROSCI.0939-11.2011; Liu F, 2009, J NEUROSCI, V29, P5075, DOI 10.1523/JNEUROSCI.0201-09.2009; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Stenman J, 2003, J NEUROSCI, V23, P167; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; van Praag H M, 2002, Crisis, V23, P77; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Wang YL, 2010, J NEUROSCI, V30, P5334, DOI 10.1523/JNEUROSCI.5963-09.2010; Wei B, 2011, EUR J NEUROSCI, V33, P819, DOI 10.1111/j.1460-9568.2010.07570.x; Yang Z, 2008, J COMP NEUROL, V506, P347, DOI 10.1002/cne.21557; Yang ZG, 2007, DEV NEUROSCI-BASEL, V29, P331, DOI 10.1159/000105474; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	31	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70049	10.1371/journal.pone.0070049	http://dx.doi.org/10.1371/journal.pone.0070049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894587	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000180
J	Lim, CY; Junit, SM; Abdulla, MA; Aziz, AA				Lim, Chor Yin; Junit, Sarni Mat; Abdulla, Mahmood Ameen; Aziz, Azlina Abdul			In Vivo Biochemical and Gene Expression Analyses of the Antioxidant Activities and Hypocholesterolaemic Properties of Tamarindus indica Fruit Pulp Extract	PLOS ONE			English	Article							HDL CHOLESTEROL LEVELS; LDL RECEPTOR; DIETARY-CHOLESTEROL; PLASMA-CHOLESTEROL; COA REDUCTASE; HEART-DISEASE; LEAF EXTRACT; CYTOCHROME-P450; PROTEIN; CANCER	Background: Tamarindus indica (T. indica) is a medicinal plant with many biological activities including anti-diabetic, hypolipidaemic and anti-bacterial activities. A recent study demonstrated the hypolipidaemic effect of T. indica fruit pulp in hamsters. However, the biochemical and molecular mechanisms responsible for these effects have not been fully elucidated. Hence, the aims of this study were to evaluate the antioxidant activities and potential hypocholesterolaemic properties of T. indica, using in vitro and in vivo approaches. Methodology/Principal Findings: The in vitro study demonstrated that T. indica fruit pulp had significant amount of phenolic (244.9 +/- 10.1 mg GAE/extract) and flavonoid (93.9 +/- 2.6 mg RE/g extract) content and possessed antioxidant activities. In the in vivo study, hamsters fed with high-cholesterol diet for ten weeks showed elevated serum triglyceride, total cholesterol, HDL-C and LDL-C levels. Administration of T. indica fruit pulp to hypercholesterolaemic hamsters significantly lowered serum triglyceride, total cholesterol and LDL-C levels but had no effect on the HDL-C level. The lipid-lowering effect was accompanied with significant increase in the expression of Apo A1, Abcg5 and LDL receptor genes and significant decrease in the expression of HMG-CoA reductase and Mtp genes. Administration of T. indica fruit pulp to hypercholesterolaemic hamsters also protected against oxidative damage by increasing hepatic antioxidant enzymes, antioxidant activities and preventing hepatic lipid peroxidation. Conclusion/Significance: It is postulated that tamarind fruit pulp exerts its hypocholesterolaemic effect by increasing cholesterol efflux, enhancing LDL-C uptake and clearance, suppressing triglyceride accumulation and inhibiting cholesterol biosynthesis. T. indica fruit pulp has potential antioxidative effects and is potentially protective against diet-induced hypercholesterolaemia.	[Lim, Chor Yin; Junit, Sarni Mat; Abdulla, Mahmood Ameen; Aziz, Azlina Abdul] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia	Universiti Malaya	Aziz, AA (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	azlina_aziz@um.edu.my	MAT-JUNIT, SARNI/GXW-0277-2022; mat-junit, sarni/J-5838-2015; AZIZ, AZLINA ABDUL/B-8303-2010	AZIZ, AZLINA ABDUL/0000-0002-9210-5066; Mat Junit, Sarni/0000-0002-9813-452X	High Impact Research Grant [H-20001-00-E000009]; University of Malaya [RG458-12HTM]; Postgraduate Research Fund from University of Malaya, Malaysia [PV116-2012A]	High Impact Research Grant; University of Malaya(Universiti Malaya); Postgraduate Research Fund from University of Malaya, Malaysia	This research was financially supported by the High Impact Research Grant (H-20001-00-E000009), University of Malaya Research Grant (RG458-12HTM) and Postgraduate Research Fund (PV116-2012A) from University of Malaya, Malaysia. The funders had no role in the study design, data collection and analysis and preparation of the manuscript.	Alsaif M. A., 2007, IJP - International Journal of Pharmacology, V3, P123; Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187; [Anonymous], CARD DIS; Ben Khaled H, 2012, FOOD RES INT, V45, P60, DOI 10.1016/j.foodres.2011.10.003; Bennett AJ, 1996, FEBS LETT, V394, P247, DOI 10.1016/0014-5793(96)00962-3; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BRINTON EA, 1990, J CLIN INVEST, V85, P144, DOI 10.1172/JCI114405; Bundy R, 2008, PHYTOMEDICINE, V15, P668, DOI 10.1016/j.phymed.2008.03.001; Bursill CA, 2007, ATHEROSCLEROSIS, V193, P86, DOI 10.1016/j.atherosclerosis.2006.08.033; Chong URW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039476; Ciolino HP, 1999, BIOCHEM J, V340, P715, DOI 10.1042/0264-6021:3400715; Cos P, 2002, FREE RADICAL RES, V36, P711, DOI 10.1080/10715760290029182; Daniel Reji Susan, 1998, Indian Journal of Experimental Biology, V36, P902; Davidson MH, 2007, AM J CARDIOL, V99, p3C, DOI 10.1016/j.amjcard.2006.11.016; Doughari J. H., 2006, Tropical Journal of Pharmaceutical Research, V5, P597; Du EZ, 1996, J LIPID RES, V37, P1309; Frishman William H., 1998, American Journal of Medicine, V104, p18S, DOI 10.1016/S0002-9343(98)00184-3; Fruchart JC, 1996, ISRAEL J MED SCI, V32, P498; Gao S, 2010, BIOCHEM BIOPH RES CO, V398, P619, DOI 10.1016/j.bbrc.2010.05.114; Gregg Richard E., 1994, Current Opinion in Lipidology, V5, P81, DOI 10.1097/00041433-199404000-00003; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HAYEK T, 1993, J CLIN INVEST, V91, P1665, DOI 10.1172/JCI116375; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Hoffmann A, 1996, BBA-LIPID LIPID MET, V1299, P95, DOI 10.1016/0005-2760(95)00201-4; HORTON JD, 1993, J CLIN INVEST, V92, P743, DOI 10.1172/JCI116645; Huang XQ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-9; INGEBRITSEN TS, 1979, J BIOL CHEM, V254, P9986; Kahlon TS, 1999, CEREAL CHEM, V76, P772, DOI 10.1094/CCHEM.1999.76.5.772; Katalinic V, 2004, FOOD CHEM, V86, P593, DOI 10.1016/j.foodchem.2003.10.007; Katan MB, 1997, AM J CLIN NUTR, V65, P1542, DOI 10.1093/ajcn/65.5.1542; Kim KT, 2008, FOOD SCI BIOTECHNOL, V17, P1361; Kittichanun C, 2010, J HEALTH RES, V24, P1; LAKSHMANAN M R, 1973, Biochemical and Biophysical Research Communications, V50, P704, DOI 10.1016/0006-291X(73)91301-6; Lee MK, 2002, BIOORGAN MED CHEM, V10, P2239, DOI 10.1016/S0968-0896(02)00059-7; Ling JJ, 2012, FOOD CHEM, V130, P229, DOI 10.1016/j.foodchem.2011.07.039; Liu HY, 2008, FOOD RES INT, V41, P363, DOI 10.1016/j.foodres.2007.12.012; Martinello F, 2006, FOOD CHEM TOXICOL, V44, P810, DOI 10.1016/j.fct.2005.10.011; Masood N, 2011, ASIAN PAC J CANCER P, V12, P377; MENGEL CE, 1966, J CLIN INVEST, V45, P1150, DOI 10.1172/JCI105421; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; Nammi S, 2010, BASIC CLIN PHARMACOL, V106, P389, DOI 10.1111/j.1742-7843.2009.00497.x; Patalay M, 2005, J NUTR, V135, P735, DOI 10.1093/jn/135.4.735; Pitman WA, 1998, ATHEROSCLEROSIS, V138, P43, DOI 10.1016/S0021-9150(97)00302-X; Pushparaj P, 2000, J ETHNOPHARMACOL, V72, P69, DOI 10.1016/S0378-8741(00)00200-2; Quinones L, 2001, CANCER LETT, V174, P35, DOI 10.1016/S0304-3835(01)00686-3; Ramiro-Puig E, 2007, J AGR FOOD CHEM, V55, P6431, DOI 10.1021/jf070487w; Razali N, 2012, FOOD CHEM, V131, P441, DOI 10.1016/j.foodchem.2011.09.001; Razali N, 2010, GENES NUTR, V5, P331, DOI 10.1007/s12263-010-0187-5; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rimbau V, 1999, PHYTOTHER RES, V13, P128, DOI 10.1002/(SICI)1099-1573(199903)13:2&lt;128::AID-PTR399&gt;3.0.CO;2-7; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHOULDERS CC, 1983, NUCLEIC ACIDS RES, V11, P2827, DOI 10.1093/nar/11.9.2827; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; SPADY DK, 1985, J LIPID RES, V26, P465; Sudjaroen Y, 2005, FOOD CHEM TOXICOL, V43, P1673, DOI 10.1016/j.fct.2005.05.013; Surekha D, 2009, Indian J Med Sci, V63, P13, DOI 10.4103/0019-5359.49077; Suzuki K, 2003, CANCER LETT, V195, P177, DOI 10.1016/S0304-3835(03)00182-4; Theriault A, 2000, J LIPID RES, V41, P1969; Uno S, 2004, MOL PHARMACOL, V65, P1225, DOI 10.1124/mol.65.5.1225; WETTERAU JR, 1992, SCIENCE, V258, P999; White DA, 1997, PROSTAG LEUKOTR ESS, V57, P455, DOI 10.1016/S0952-3278(97)90428-2; Wilcox LJ, 2001, J LIPID RES, V42, P725; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wilund KR, 2004, J LIPID RES, V45, P1429, DOI 10.1194/jlr.M400167-JLR200; Yasuda A, 2011, J AGR FOOD CHEM, V59, P1470, DOI 10.1021/jf103820b; Yazdanparast R, 2008, CHEM-BIOL INTERACT, V172, P176, DOI 10.1016/j.cbi.2008.01.006; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zhang AH, 2004, FEBS LETT, V570, P25, DOI 10.1016/j.febslet.2004.06.017; Zhao JC, 1998, WORLD J GASTROENTERO, V4, P337, DOI 10.3748/wjg.v4.i4.337	71	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70058	10.1371/journal.pone.0070058	http://dx.doi.org/10.1371/journal.pone.0070058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894592	gold, Green Submitted, Green Published			2022-12-25	WOS:000325211000182
J	Sahlberg, AS; Ruuska, M; Granfors, K; Penttinen, MA				Sahlberg, Anna S.; Ruuska, Marja; Granfors, Kaisa; Penttinen, Markus A.			Altered Regulation of ELAVL1/HuR in HLA-B27-Expressing U937 Monocytic Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; MESSENGER-RNA; REACTIVE ARTHRITIS; SALMONELLA-ENTERITIDIS; YERSINIA ANTIGENS; B-POCKET; HUR; HLA-B27; EXPRESSION	Objective: To investigate the role of HLA-B27 expression in the regulation of RNA binding protein (RBP) Embryonic Lethal Abnormal Vision (ELAV) L1/Human antigen R (HuR) expression in Salmonella-infected or LPS-stimulated human monocytic cells, since HuR is a critical regulator of the post-transcriptional fate of many genes (e.g. TNF alpha) important in inflammatory response. Methods: U937 monocytic cells were stably transfected with pSV2neo resistant vector (mock), wild type HLA-B27, or mutated HLA-B27 with amino acid substitutions in the B pocket. Cells were differentiated, infected with Salmonella enteritidis or stimulated with lipopolysaccharide. The expression levels of HuR protein and cleavage products (CP1 and CP2) were detected by Western blotting and flow cytometry. Specific inhibitors were used to study the role of PKR and p38 in HuR expression and generation of CPs. TNF alpha and IL-10 secretion after p38 and PKR inhibition were measured by ELISA. Results: Full length HuR is overexpressed and HuR cleavage is disturbed in U937 monocytic cells expressing HLA-B27 heavy chains (HC). Increased full length HuR expression, disturbed cleavage and reduced dependence on PKR after infection correlate with the expression of glutamic acid 45 in the B pocket that is linked to the misfolding of HLA-B27. Conclusion: Results show that the expression of HLA-B27 HCs modulates the intracellular environment of U937 monocyte/macrophages by altering HuR regulation. This phenomenon is at least partly dependent on the misfolding feature of the B27 molecule. Since HuR is an important regulator of multiple genes involved in inflammatory response observations offer an explanation how HLA-B27 may modulate inflammatory response.	[Sahlberg, Anna S.; Ruuska, Marja; Penttinen, Markus A.] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Sahlberg, Anna S.; Ruuska, Marja; Granfors, Kaisa] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland	University of Turku; Finland National Institute for Health & Welfare	Sahlberg, AS (corresponding author), Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland.	anna.sahlberg@utu.fi	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680	Academy of Finland; Sigrid Juselius Foundation; Maud Kuistila Foundation; Finnish Cultural Foundation, Varsinais-Suomi Regional fund	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Maud Kuistila Foundation; Finnish Cultural Foundation, Varsinais-Suomi Regional fund(Finnish Cultural Foundation)	Study was supported by grants from the Academy of Finland (www.aka.fi), the Sigrid Juselius Foundation (www.sigridjuselius.fi), Maud Kuistila Foundation (www.maudkuistilanmuistosaatio.fi) and Finnish Cultural Foundation, Varsinais-Suomi Regional fund (www.skr.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennett RL, 2006, BLOOD, V108, P821, DOI 10.1182/blood-2005-11-006817; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC; Cherry J, 2008, J BIOL CHEM, V283, P30812, DOI 10.1074/jbc.M805659200; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; Colbert RA, 2004, CURR MOL MED, V4, P21, DOI 10.2174/1566524043479293; Dangoria NS, 2002, J BIOL CHEM, V277, P23459, DOI 10.1074/jbc.M110336200; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Dobreva ZG, 2009, IMMUNOPHARM IMMUNOT, V31, P195, DOI 10.1080/08923970802626276; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Ekman P, 2002, INFECT IMMUN, V70, P1609, DOI 10.1128/IAI.70.3.1609-1614.2002; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Gaston JSH, 1999, ARTHRITIS RHEUM, V42, P2239; Ge SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034093; Ge SC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-456; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; GRANFORS K, 1989, NEW ENGL J MED, V320, P216, DOI 10.1056/NEJM198901263200404; Granfors K, 1998, ARTHRITIS RHEUM, V41, P855, DOI 10.1002/1529-0131(199805)41:5<855::AID-ART12>3.0.CO;2-J; GRANFORS K, 1990, LANCET, V335, P685, DOI 10.1016/0140-6736(90)90804-E; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Khan MA, 2002, ANN INTERN MED, V136, P896, DOI 10.7326/0003-4819-136-12-200206180-00011; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Laitio P, 1997, EUR J IMMUNOL, V27, P1331, DOI 10.1002/eji.1830270606; Lin WN, 2011, BRIT J PHARMACOL, V163, P1691, DOI 10.1111/j.1476-5381.2011.01312.x; MAKIIKOLA O, 1992, LANCET, V339, P1096, DOI 10.1016/0140-6736(92)90675-S; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mear JP, 1999, J IMMUNOL, V163, P6665; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Penttinen MA, 2004, ARTHRITIS RHEUM, V50, P2255, DOI 10.1002/art.20336; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Rhee WJ, 2010, P NATL ACAD SCI USA, V107, P6858, DOI 10.1073/pnas.1000444107; Ruuska M, 2012, ARTHRITIS RHEUM-US, V64, P772, DOI 10.1002/art.33391; Sahlberg AS, 2012, SCAND J IMMUNOL, V75, P184, DOI 10.1111/j.1365-3083.2011.02648.x; Sahlberg AS, 2007, ARTHRITIS RHEUM, V56, P2652, DOI 10.1002/art.22746; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; TAUROG JD, 1988, J IMMUNOL, V141, P4020; von Roretz C, J BIOL CHEM, V285, P16806; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; von Roretz C, 2010, J BIOL CHEM, V285, P16806, DOI 10.1074/jbc.M109.087320	46	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e70377	10.1371/journal.pone.0070377	http://dx.doi.org/10.1371/journal.pone.0070377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894643	Green Submitted, Green Published, gold			2022-12-25	WOS:000322132100092
J	Tarrant, J; Cilliers, D; du Preez, LH; Weldon, C				Tarrant, Jeanne; Cilliers, Dirk; du Preez, Louis H.; Weldon, Che			Spatial Assessment of Amphibian Chytrid Fungus (Batrachochytrium dendrobatidis) in South Africa Confirms Endemic and Widespread Infection	PLOS ONE			English	Article							PREDICTING SPECIES DISTRIBUTIONS; SURVEY PROTOCOL; CHYTRIDIOMYCOSIS; PATHOGEN; DISEASE; DECLINES; CONSERVATION; TEMPERATURE; PREVALENCE; MORTALITY	Chytridiomycosis has been identified as a major cause of global amphibian declines. Despite widespread evidence of Batrachochytrium dendrobatidis infection in South African frogs, sampling for this disease has not focused on threatened species, or whether this pathogen poses a disease risk to these species. This study assessed the occurrence of Bd-infection in South African Red List species. In addition, all known records of infection from South Africa were used to model the ecological niche of Bd to provide a better understanding of spatial patterns and associated disease risk. Presence and prevalence of Bd was determined through quantitative real-time PCR of 360 skin swab samples from 17 threatened species from 38 sites across the country. Average prevalence was 14.8% for threatened species, with pathogen load varying considerably between species. MaxEnt was used to model the predicted distribution of Bd based on 683 positive records for South Africa. The resultant probability threshold map indicated that Bd is largely restricted to the wet eastern and coastal regions of South Africa. A lack of observed adverse impacts on wild threatened populations supports the endemic pathogen hypothesis for southern Africa. However, all threatened species occur within the limits of the predicted distribution for Bd, exposing them to potential Bd-associated risk factors. Predicting pathogen distribution patterns and potential impact is increasingly important for prioritising research and guiding management decisions.	[Tarrant, Jeanne; Cilliers, Dirk; du Preez, Louis H.; Weldon, Che] North West Univ, Unit Environm Sci & Management, Potchefstroom, North West Prov, South Africa	North West University - South Africa	Tarrant, J (corresponding author), North West Univ, Unit Environm Sci & Management, Potchefstroom, North West Prov, South Africa.	jeannetarrant@ymail.com		Weldon, Che/0000-0001-6716-0787; Cilliers, Dirk/0000-0001-9777-0463	Green Trust - Project [GT 1489]; National Research Foundation, South Africa	Green Trust - Project; National Research Foundation, South Africa(National Research Foundation - South Africa)	This research (part of JT's PhD) was funded by The Green Trust - Project number GT 1489. Bursary funding was also provided by the National Research Foundation, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2012, BD MAPS; Adams MJ, 2010, ECOL APPL, V20, P289, DOI 10.1890/08-2319.1; Andre SE, 2008, J WILDLIFE DIS, V44, P716, DOI 10.7589/0090-3558-44.3.716; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Bell RC, 2011, ECOHEALTH, V8, P116, DOI 10.1007/s10393-010-0364-4; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Boycott RC, 2004, SI MAB SERIES, V#9, P56; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brem F, 2007, ECOHEALTH; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Burrowes PA, 2004, HERPETOLOGICA, V60, P141, DOI 10.1655/03-50; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Daszak P, 2007, AMPHIBIAN CONSERVATI; DIGIACOMO RF, 1986, J AM VET MED ASSOC, V189, P22; Doherty-Bone TM, 2012, DIS AQUAT O IN PRESS; Du Preez LH, 2009, COMPLETE GUIDE FROGS, P200; Duffus ALJ, 2009, ECOHEALTH, V6, P335, DOI 10.1007/s10393-009-0271-8; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2011, ARCGIS DESKT REL 10; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Forzan MJ, 2010, DIS AQUAT ORGAN, V91, P91, DOI 10.3354/dao02244; Gahl MK, 2012, CONSERV BIOL, V26, P135, DOI 10.1111/j.1523-1739.2011.01801.x; Garner TWJ, 2007, ANIM CONSERV, V10, P418, DOI 10.1111/j.1469-1795.2007.00147.x; Gibson L, 2007, DIVERS DISTRIB, V13, P704, DOI 10.1111/j.1472-4642.2007.00365.x; Goldberg TL, 2007, J WILDLIFE DIS, V43, P521, DOI 10.7589/0090-3558-43.3.521; Goodman P.S., 2000, DETERMINING CONSERVA; Greenbaum Eli, 2008, Herpetological Review, V39, P70; Hernandez PA, 2008, BIODIVERS CONSERV, V17, P1353, DOI 10.1007/s10531-007-9314-z; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; IUCN, 2022, IUCN RED LIST THREAT; Jackson CR, 2011, J NAT CONSERV, V19, P87, DOI 10.1016/j.jnc.2010.06.006; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kielgast J, 2010, ANIM CONSERV, V13, P36, DOI 10.1111/j.1469-1795.2009.00297.x; Kriger KM, 2009, ECOHEALTH, V6, P6, DOI 10.1007/s10393-009-0228-y; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2010, ECOHEALTH, V7, P185, DOI 10.1007/s10393-010-0327-9; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; Measey GJ, 2011, SANBI BIODIVERS SER, P1; Minter L.R., 2004, ATLAS RED DATA BOOK, V9; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; Mittermeier R, 2005, HOTSPOTS REVISITED E; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; OIE Website. World Organisation for Animal Health, INF BATR DENDR; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Penner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056236; Phillips S.J., 2004, 21 INT C MACH LEARN; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pickersgill M, 2004, SI MAB SERIES, V#9, P131; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Roedder Dennis, 2009, Diversity, V1, P52; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Skerratt LF, 2010, DIS AQUAT ORGAN, V92, P117, DOI 10.3354/dao02272; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; South African Frog Re-Assessment Group (SA-FRoG) & IUCN SSC Amphibian Specialist Group, 2010, IUCN 2011; St-Hilaire S, 2009, ECOHEALTH, V6, P16, DOI 10.1007/s10393-009-0227-z; Stabach Jared A., 2009, International Journal of Biodiversity and Conservation, V1, P177; Tinoco BA, 2009, BIRD CONSERV INT, V19, P63, DOI 10.1017/S0959270908007703; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Weldon C, 2011, FUNGAL DIS EMERGING; Weldon C., 2004, FROGLOG, V62, P2; Weldon C, 2007, AFR J HERPETOL, V56, P77, DOI 10.1080/21564574.2007.9635553; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	79	16	17	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69591	10.1371/journal.pone.0069591	http://dx.doi.org/10.1371/journal.pone.0069591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894506	Green Published, gold			2022-12-25	WOS:000322132100070
J	Marsh, AJ; O'Sullivan, O; Hill, C; Ross, RP; Cotter, PD				Marsh, Alan J.; O'Sullivan, Orla; Hill, Colin; Ross, R. Paul; Cotter, Paul D.			Sequencing-Based Analysis of the Bacterial and Fungal Composition of Kefir Grains and Milks from Multiple Sources	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; RIBOSOMAL-RNA GENE; CULTURE-INDEPENDENT METHODS; FERMENTED MILK; MICROBIAL DIVERSITY; CHEMICAL-PROPERTIES; TAIWANESE KEFIR; NEXT-GENERATION; CANDIDA-KEFYR; YEASTS	Kefir is a fermented milk-based beverage to which a number of health-promoting properties have been attributed. The microbes responsible for the fermentation of milk to produce kefir consist of a complex association of bacteria and yeasts, bound within a polysaccharide matrix, known as the kefir grain. The consistency of this microbial population, and that present in the resultant beverage, has been the subject of a number of previous, almost exclusively culture-based, studies which have indicated differences depending on geographical location and culture conditions. However, culture-based identification studies are limited by virtue of only detecting species with the ability to grow on the specific medium used and thus culture-independent, molecular-based techniques offer the potential for a more comprehensive analysis of such communities. Here we describe a detailed investigation of the microbial population, both bacterial and fungal, of kefir, using high-throughput sequencing to analyse 25 kefir milks and associated grains sourced from 8 geographically distinct regions. This is the first occasion that this technology has been employed to investigate the fungal component of these populations or to reveal the microbial composition of such an extensive number of kefir grains or milks. As a result several genera and species not previously identified in kefir were revealed. Our analysis shows that the bacterial populations in kefir are dominated by 2 phyla, the Firmicutes and the Proteobacteria. It was also established that the fungal populations of kefir were dominated by the genera Kazachstania, Kluyveromyces and Naumovozyma, but that a variable sub-dominant population also exists.	[Marsh, Alan J.; O'Sullivan, Orla; Ross, R. Paul; Cotter, Paul D.] TEAGASC, Food Res Ctr, Fermoy, Cork, Ireland; [Marsh, Alan J.; Hill, Colin; Ross, R. Paul; Cotter, Paul D.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Marsh, Alan J.; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland	Teagasc; University College Cork; University College Cork	Hill, C (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	c.hill@ucc.ie; paul.cotter@teagasc.ie	O'Sullivan, Orla/ABE-5980-2020; Hill, Colin/A-5611-2012; Cotter, Paul/AAX-5449-2021; Ross, Paul/A-7584-2015; Cotter, Paul/B-7781-2008; STANTON, CATHERINE/A-9549-2015	O'Sullivan, Orla/0000-0002-4332-1109; Hill, Colin/0000-0002-8527-1445; Cotter, Paul/0000-0002-5465-9068; Ross, Paul/0000-0003-4876-8839; Cotter, Paul/0000-0002-5465-9068; STANTON, CATHERINE/0000-0002-6724-7011	Science Foundation Ireland (SFI), through the Irish Government's National Development Plan; SFI CSET grant APC CSET 2 [07/CE/B1368]	Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland); SFI CSET grant APC CSET 2(Science Foundation Ireland)	The Alimentary Pharmabiotic Centre is a research centre funded by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan. The authors and their work were supported by SFI CSET grant APC CSET 2 grant 07/CE/B1368. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abellana M, 1999, J APPL MICROBIOL, V87, P371, DOI 10.1046/j.1365-2672.1999.00828.x; ANGULO L, 1993, J DAIRY RES, V60, P263, DOI 10.1017/S002202990002759X; Asiegbu FO, 2005, MOL PLANT PATHOL, V6, P395, DOI 10.1111/J.1364-3703.2005.00295.X; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang HJ, 1998, NEW ENGL J MED, V338, P706, DOI 10.1056/NEJM199803123381102; Chen HC, 2008, FOOD MICROBIOL, V25, P492, DOI 10.1016/j.fm.2008.01.003; Chen MJ, 2005, ASIAN AUSTRAL J ANIM, V18, P711, DOI 10.5713/ajas.2005.711; Chen TH, 2009, J DAIRY SCI, V92, P3002, DOI 10.3168/jds.2008-1669; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Miguel MGDP, 2010, FOOD RES INT, V43, P1523, DOI 10.1016/j.foodres.2010.04.031; Desreumaux P, 2011, GASTROENTEROLOGY, V140, pS50; Dobson A, 2011, FEMS MICROBIOL LETT, V320, P56, DOI 10.1111/j.1574-6968.2011.02290.x; ENGEL G, 1986, MILCHWISSENSCHAFT, V41, P418; Etienne-Mesmin L, 2011, APPL ENVIRON MICROB, V77, P1127, DOI 10.1128/AEM.02130-10; Farnworth E. R., 2005, Food Science and Technology Bulletin:  Functional Foods, V2, P1, DOI 10.1616/1476-2137.13938; Foligne B, 2010, WORLD J GASTROENTERO, V16, P2134, DOI 10.3748/wjg.v16.i17.2134; Gadaga TH, 2001, INT J FOOD MICROBIOL, V68, P21, DOI 10.1016/S0168-1605(01)00466-4; Gao J, 2012, J FOOD SCI, V77, pM425, DOI 10.1111/j.1750-3841.2012.02805.x; Garbers IM, 2004, WORLD J MICROB BIOT, V20, P687, DOI 10.1007/s11274-004-2624-3; Garrote GL, 2001, J DAIRY RES, V68, P639, DOI 10.1017/S0022029901005210; Gonzalez-Sanchez F, 2010, INT J DAIRY TECHNOL, V63, P431, DOI 10.1111/j.1471-0307.2010.00604.x; Guzel-Seydim ZB, 2011, CRIT REV FOOD SCI, V51, P261, DOI 10.1080/10408390903579029; Hansen K, 2005, MOL PHYLOGENET EVOL, V36, P1, DOI 10.1016/j.ympev.2005.03.010; Hawksworth DL, 2011, IMA FUNGUS, V2, P155, DOI 10.5598/imafungus.2011.02.02.06; Heras-Vazquez FJL, 2003, FEMS YEAST RES, V3, P3; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Hunter GC, 2009, MOL PLANT PATHOL, V10, P1, DOI 10.1111/j.1364-3703.2008.00516.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ivanova G, 2012, J U CHEM TECHNOL MET, V47, P59; Kesmen Z, 2011, J FOOD SCI, V76, pM276, DOI 10.1111/j.1750-3841.2011.02191.x; Koutinas AA, 2005, BIOTECHNOL BIOENG, V89, P788, DOI 10.1002/bit.20394; Koyanagi T, 2011, LETT APPL MICROBIOL, V53, P635, DOI 10.1111/j.1472-765X.2011.03155.x; Kumura H, 2004, J DAIRY SCI, V87, P4050, DOI 10.3168/jds.S0022-0302(04)73546-8; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kwak HS, 1996, J DAIRY SCI, V79, P937, DOI 10.3168/jds.S0022-0302(96)76444-5; Kwon CS, 2003, FOOD SCI BIOTECHNOL, V12, P476; LARIVIERE JW, 1967, ARCH MIKROBIOL, V59, P269; Latorre-Garcia L, 2007, WORLD J MICROB BIOT, V23, P785, DOI 10.1007/s11274-006-9298-y; Lee BK, 2001, AQUACULT ENG, V25, P111, DOI 10.1016/S0144-8609(01)00075-9; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; Lin CW, 1999, AUST J DAIRY TECHNOL, V54, P14; Listemann H, 1998, MYCOSES, V41, P343, DOI 10.1111/j.1439-0507.1998.tb00349.x; Lopitz-Otsoa Fernando, 2006, Revista Iberoamericana de Micologia, V23, P67; Loretan T, 2003, S AFR J SCI, V99, P92; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Magalhaes KT, 2011, BRAZ J MICROBIOL, V42, P693, DOI [10.1590/S1517-83822011000200034, 10.1590/S1517-838220110002000034]; Mainville I, 2006, SYST APPL MICROBIOL, V29, P59, DOI 10.1016/j.syapm.2005.07.001; MARTINI AV, 1988, MYCOLOGIA, V80, P241, DOI 10.2307/3807799; Masoud W, 2011, INT DAIRY J, V21, P142, DOI 10.1016/j.idairyj.2010.10.007; Miyamoto M, 2010, FOOD SCI TECHNOL RES, V16, P319, DOI 10.3136/fstr.16.319; Montanari G, 1996, J DAIRY RES, V63, P327, DOI 10.1017/S0022029900031836; Motaghi M, 1997, WORLD J MICROB BIOT, V13, P579, DOI 10.1023/A:1018577728412; Park EJ, 2012, FOOD MICROBIOL, V30, P197, DOI 10.1016/j.fm.2011.10.011; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Pintado ME, 1996, INT J FOOD SCI TECH, V31, P15, DOI 10.1111/j.1365-2621.1996.16-316.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quigley L, 2012, J APPL MICROBIOL, V113, P96, DOI 10.1111/j.1365-2672.2012.05294.x; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Rea MC, 1996, J APPL BACTERIOL, V81, P83, DOI 10.1111/j.1365-2672.1996.tb03286.x; Renker C, 2004, FEMS YEAST RES, V4, P597, DOI 10.1016/j.femsyr.2004.01.001; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Sakamoto N, 2011, INT J FOOD MICROBIOL, V144, P352, DOI 10.1016/j.ijfoodmicro.2010.10.017; Santamaria M, 2012, BRIEF BIOINFORM, V13, P682, DOI 10.1093/bib/bbs036; Simova E, 2002, J IND MICROBIOL BIOT, V28, P1, DOI [10.1038/sj/jim/7000186, 10.1038/sj.jim.7000186]; Steels H, 1999, J APPL MICROBIOL, V87, P520, DOI 10.1046/j.1365-2672.1999.00844.x; Tas TK, 2012, INT J DAIRY TECHNOL, V65, P126, DOI 10.1111/j.1471-0307.2011.00733.x; Wang SY, 2008, J DAIRY SCI, V91, P3798, DOI 10.3168/jds.2007-0468; Witthuhn RC, 2005, INT DAIRY J, V15, P383, DOI 10.1016/j.idairyj.2004.07.016; Wyder MT, 1997, FOOD TECHNOL BIOTECH, V35, P299; You SJ, 2006, J ANIM SCI, V84, P310; Yuksekdag ZN, 2004, LEBENSM-WISS TECHNOL, V37, P663, DOI 10.1016/j.lwt.2004.02.004; Zhou JZ, 2009, FOOD MICROBIOL, V26, P770, DOI 10.1016/j.fm.2009.04.009	77	131	136	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69371	10.1371/journal.pone.0069371	http://dx.doi.org/10.1371/journal.pone.0069371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894461	Green Submitted, Green Published, gold			2022-12-25	WOS:000322391400055
J	Zoued, A; Durand, E; Bebeacua, C; Brunet, YR; Douzi, B; Cambillau, C; Cascales, E; Journet, L				Zoued, Abdelrahim; Durand, Eric; Bebeacua, Cecilia; Brunet, Yannick R.; Douzi, Badreddine; Cambillau, Christian; Cascales, Eric; Journet, Laure			TssK Is a Trimeric Cytoplasmic Protein Interacting with Components of Both Phage-like and Membrane Anchoring Complexes of the Type VI Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; ENTEROAGGREGATIVE ESCHERICHIA-COLI; BACTERIAL TYPE VI; PSEUDOMONAS-AERUGINOSA; ELECTRON-MICROSCOPY; INNER MEMBRANE; TAILED PHAGES; APPARATUS; CRITERIA; TUBULES	The Type VI secretion system (T6SS) is a macromolecular machine that mediates bacteria-host or bacteria-bacteria interactions. The T6SS core apparatus assembles from 13 proteins that form two sub-assemblies: a phage-like complex and a trans-envelope complex. The Hcp, VgrG, TssE, and TssB/C subunits are structurally and functionally related to components of the tail of contractile bacteriophages. This phage-like structure is thought to be anchored to the membrane by a trans-envelope complex composed of the TssJ, TssL, and TssM proteins. However, how the two sub-complexes are connected remains unknown. Here we identify TssK, a protein that establishes contacts with the two T6SS sub-complexes through direct interactions with TssL, Hcp, and TssC. TssK is a cytoplasmic protein assembling trimers that display a three-armed shape, as revealed by TEM and SAXS analyses. Fluorescence microscopy experiments further demonstrate the requirement of TssK for sheath assembly. Our results suggest a central role for TssK by linking both complexes during T6SS assembly.	[Zoued, Abdelrahim; Brunet, Yannick R.; Cascales, Eric; Journet, Laure] Aix Marseille Univ, CNRS, UMR 7255, Inst Microbiol Mediterranee,Lab Ingn Syst Macromo, F-13402 Marseille 20, France; [Durand, Eric; Bebeacua, Cecilia; Douzi, Badreddine; Cambillau, Christian] Aix Marseille Univ, CNRS, UMR 6098, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Journet, L (corresponding author), Aix Marseille Univ, CNRS, UMR7255, Lab Ingn Syst Macromol, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	ljournet@imm.cnrs.fr	Durand, Eric/E-6739-2017; Douzi, Badreddine/ABA-4540-2021; CASCALES, ERIC/G-7420-2011; douzi, Badreddine/Z-5707-2019	Durand, Eric/0000-0002-0577-8220; Douzi, Badreddine/0000-0003-3140-4713; CASCALES, ERIC/0000-0003-0611-9179; Journet, Laure/0000-0002-5847-2962; Zoued, Abdelrahim/0000-0002-6973-1755	Centre National de la Recherche Scientifique (CNRS); Aix-Marseille University; Agence Nationale de la Recherche [ANR-10-JCJC-1303-03]; CNRS; Marseille-Nice Genopole; IBiSA; Fondation de la Recherche Medicale [FRM DEQ2011-0421282]; French Ministere de la Recherche; Fondation pour la Recherche Medicale [SPF20101221116]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Marseille-Nice Genopole; IBiSA; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministere de la Recherche(Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by the Centre National de la Recherche Scientifique (CNRS), the Aix-Marseille University, and a grant from the Agence Nationale de la Recherche (ANR-10-JCJC-1303-03) (to E. C.). This work was also supported by the CNRS, the Aix-Marseille University, and by grants from the Marseille-Nice Genopole, IBiSA, and the Fondation de la Recherche Medicale (FRM DEQ2011-0421282) (to C. C.).; Supported by doctoral fellowships from the French Ministere de la Recherche.; Supported by a post-doctoral fellowship from the Fondation pour la Recherche Medicale (SPF20101221116).	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; Aschtgen MS, 2010, VIRULENCE, V1, P535, DOI 10.4161/viru.1.6.13732; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Casabona MG, 2013, PROTEOMICS, V13, P2419, DOI 10.1002/pmic.201200565; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Kanamaru S, 2009, P NATL ACAD SCI USA, V106, P4067, DOI 10.1073/pnas.0901205106; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lin JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067647; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Osipiuk Jerzy, 2011, Journal of Structural and Functional Genomics, V12, P21, DOI 10.1007/s10969-011-9107-1; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2010, METHOD ENZYMOL, V482, P295, DOI 10.1016/S0076-6879(10)82012-9; Sciara G, 2008, J BIOL CHEM, V283, P2716, DOI 10.1074/jbc.M707533200; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	53	80	80	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27031	27041		10.1074/jbc.M113.499772	http://dx.doi.org/10.1074/jbc.M113.499772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921384	hybrid, Green Published			2022-12-25	WOS:000330597300005
J	Krantz, KC; Puchalla, J; Thapa, R; Kobayashi, C; Bisher, M; Viehweg, J; Carr, CM; Rye, HS				Krantz, Kelly C.; Puchalla, Jason; Thapa, Rajan; Kobayashi, Callie; Bisher, Margaret; Viehweg, Julie; Carr, Chavela M.; Rye, Hays S.			Clathrin Coat Disassembly by the Yeast Hsc70/Ssa1p and Auxilin/Swa2p Proteins Observed by Single-particle Burst Analysis Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED ENDOCYTOSIS; UNCOATING ATPASE; BUDDING YEAST; IN-VIVO; VESICLES; MECHANISM; HSC70; DISSOCIATION; CHAPERONE; COMPLEX	The role of clathrin-coated vesicles in receptor-mediated endocytosis is conserved among eukaryotes, and many of the proteins required for clathrin coat assembly and disassembly have orthologs in yeast and mammals. In yeast, dozens of proteins have been identified as regulators of the multistep reaction required for endocytosis, including those that regulate disassembly of the clathrin coat. In mammalian systems, clathrin coat disassembly has been reconstituted using neuronal clathrin baskets mixed with the purified chaperone ATPase 70-kDa heat shock cognate (Hsc70), plus a clathrin-specific co-chaperone, such as the synaptic protein auxilin. Yet, despite previous characterization of the yeast Hsc70 ortholog, Ssa1p, and the auxilin-like ortholog, Swa2p, testing mechanistic models for disassembly of nonneuronal clathrin coats has been limited by the absence of a functional reconstitution assay. Here we use single-particle burst analysis spectroscopy, in combination with fluorescence correlation spectroscopy, to follow the population dynamics of fluorescently tagged yeast clathrin baskets in the presence of purified Ssa1p and Swa2p. An advantage of this combined approach for mechanistic studies is the ability to measure, as a function of time, changes in the number and size of objects from a starting population to the reaction products. Our results indicate that Ssa1p and Swa2p cooperatively disassemble yeast clathrin baskets into fragments larger than the individual triskelia, suggesting that disassembly of clathrin-coated vesicles may proceed through a partially uncoated intermediate.	[Krantz, Kelly C.; Bisher, Margaret; Viehweg, Julie] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Puchalla, Jason] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Thapa, Rajan; Kobayashi, Callie; Carr, Chavela M.; Rye, Hays S.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Princeton University; Princeton University; Texas A&M University System; Texas A&M University College Station	Rye, HS (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	haysrye@tamu.edu		Rye, Hays/0000-0002-9420-3137	National Institutes of Health [R01 GM065421]; Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065421 (to H. S. R.). This work was also supported by and the Beckman Foundation (Beckman Young Investigator) (to H. S. R.).	AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; ALTSTIEL L, 1983, CELL, V32, P921, DOI 10.1016/0092-8674(83)90077-6; Angers CG, 2009, MOL BIOL CELL, V20, P4563, DOI 10.1091/mbc.E09-04-0272; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; BRAELL WA, 1984, J CELL BIOL, V99, P734, DOI 10.1083/jcb.99.2.734; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Ferguson ML, 2006, BIOCHEMISTRY-US, V45, P5916, DOI 10.1021/bi052568w; Fotin A, 2004, NATURE, V432, P649, DOI 10.1038/nature03078; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gall WE, 2000, CURR BIOL, V10, P1349, DOI 10.1016/S0960-9822(00)00771-5; GAO BC, 1991, J BIOL CHEM, V266, P19565; GREENE LE, 1990, J BIOL CHEM, V265, P6682; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; Greener T, 2001, NAT CELL BIOL, V3, P215, DOI 10.1038/35055137; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Jiang RF, 2000, J BIOL CHEM, V275, P8439, DOI 10.1074/jbc.275.12.8439; Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969; Ma YC, 2002, J BIOL CHEM, V277, P49267, DOI 10.1074/jbc.M203695200; Madan D, 2008, J BIOL CHEM, V283, P32003, DOI 10.1074/jbc.M802898200; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Needham PG, 2008, ARCH BIOCHEM BIOPHYS, V478, P167, DOI 10.1016/j.abb.2008.07.023; Nunez D, 2011, TRAFFIC, V12, P1868, DOI 10.1111/j.1600-0854.2011.01273.x; Pfund C, 2001, MOL BIOL CELL, V12, P3773, DOI 10.1091/mbc.12.12.3773; Pishvaee B, 2000, NAT CELL BIOL, V2, P958, DOI 10.1038/35046619; PRASAD K, 1994, J BIOL CHEM, V269, P6931; Puchalla J, 2008, P NATL ACAD SCI USA, V105, P14400, DOI 10.1073/pnas.0805969105; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Rapoport I, 2008, MOL BIOL CELL, V19, P405, DOI 10.1091/mbc.E07-09-0870; Rizzoli SO, 2007, TRAFFIC, V8, P1137, DOI 10.1111/j.1600-0854.2007.00614.x; Rothnie A, 2011, P NATL ACAD SCI USA, V108, P6927, DOI 10.1073/pnas.1018845108; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHMID SL, 1985, J BIOL CHEM, V260, P44; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; Smith CJ, 2004, J MOL BIOL, V336, P461, DOI 10.1016/j.jmb.2003.12.006; Traub LM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001037; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Xing Y, 2010, EMBO J, V29, P655, DOI 10.1038/emboj.2009.383; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012	47	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26721	26730		10.1074/jbc.M113.491753	http://dx.doi.org/10.1074/jbc.M113.491753			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23913685	Green Published, hybrid			2022-12-25	WOS:000330594500037
J	Hicks, DA; Makova, NZ; Gough, M; Parkin, ET; Nalivaeva, NN; Turner, AJ				Hicks, David A.; Makova, Natalia Z.; Gough, Mallory; Parkin, Edward T.; Nalivaeva, Natalia N.; Turner, Anthony J.			The Amyloid Precursor Protein Represses Expression of Acetylcholinesterase in Neuronal Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; COPPER-BINDING DOMAIN; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; SECRETED FORMS; NEURITE OUTGROWTH; GENE-EXPRESSION; ALPHA-SECRETASE; BETA-PEPTIDES; APP	The toxic role of amyloid beta peptides in Alzheimer's disease is well documented. Their generation is via sequential beta- and gamma-secretase cleavage of the membrane-bound amyloid precursor protein (APP). Other APP metabolites include the soluble ectodomains sAPP alpha and sAPP beta and also the amyloid precursor protein intracellular domain (AICD). In this study, we examined whether APP is involved in the regulation of acetylcholinesterase (AChE), which is a key protein of the cholinergic system and has been shown to accelerate amyloid fibril formation and increase their toxicity. Overexpression of the neuronal specific isoform, APP(695), in the neuronal cell lines SN56 and SH-SY5Y substantially decreased levels of AChE mRNA, protein, and catalytic activity. Although similar decreases in mRNA levels were observed of the proline-rich anchor of AChE, PRiMA, no changes were seen in mRNA levels of the related enzyme, butyrylcholinesterase, nor of the high-affinity choline transporter. A gamma-secretase inhibitor did not affect AChE transcript levels or enzyme activity in SN56 (APP(695)) or SH-SY5Y (APP(695)) cells, showing that regulation of AChE by APP does not require the generation of AICD or amyloid beta peptide. Treatment of wildtype SN56 cells with siRNA targeting APP resulted in a significant up-regulation in AChE mRNA levels. Mutagenesis studies suggest that the observed transcriptional repression of AChE is mediated by the E1 region of APP, specifically its copper-binding domain, but not the C-terminal YENTPY motif. In conclusion, AChE is regulated in two neuronal cell lines by APP in a manner independent of the generation of sAPP alpha, sAPP beta, and AICD.	[Hicks, David A.; Makova, Natalia Z.; Nalivaeva, Natalia N.; Turner, Anthony J.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Gough, Mallory; Parkin, Edward T.] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England; [Nalivaeva, Natalia N.] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia	University of Leeds; Lancaster University; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Turner, AJ (corresponding author), Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	a.j.turner@leeds.ac.uk	Nalivaeva, Natalia/K-6522-2018	Nalivaeva, Natalia/0000-0002-7134-3540; Parkin, Edward/0000-0003-3270-3184	UK Biotechnology and Biological Sciences Research Council; UK Medical Research Council; Alzheimer's Research UK; Russian Foundation for Basic Research [FBR 13-04-00388]; Russian Academy of Sciences; Medical Research Council [G0802189] Funding Source: researchfish; MRC [G0802189] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Biotechnology and Biological Sciences Research Council (studentship support to D. A. H.), the UK Medical Research Council, Alzheimer's Research UK, Russian Foundation for Basic Research Grant FBR 13-04-00388, and the Fundamental Sciences to Medicine Programme of the Russian Academy of Sciences.	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Alvarez A, 1997, J MOL BIOL, V272, P348, DOI 10.1006/jmbi.1997.1245; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; BARGER SW, 1995, J NEUROCHEM, V64, P2087; BARGER SW, 1995, BIOCHEM J, V311, P45, DOI 10.1042/bj3110045; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Boncristiano S, 2002, J NEUROSCI, V22, P3234, DOI 10.1523/JNEUROSCI.22-08-03234.2002; Canet-Aviles RM, 2002, MOL BRAIN RES, V102, P62, DOI 10.1016/S0169-328X(02)00184-5; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chang KA, 2010, BMB REP, V43, P656, DOI [10.3858/BMBRep.2010.43.10.656, 10.5483/BMBRep.2010.43.10.656]; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; Clarke NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034747; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Diez M, 2003, NEUROBIOL DIS, V14, P579, DOI 10.1016/j.nbd.2003.08.003; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Furukawa K, 1996, NATURE, V379, P74, DOI 10.1038/379074a0; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halliday AC, 2012, PROTEIN PEPTIDE LETT, V19, P165; HAMMOND DN, 1990, BRAIN RES, V512, P190, DOI 10.1016/0006-8993(90)90626-M; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Henderson Z, 2010, BRAIN RES, V1344, P34, DOI 10.1016/j.brainres.2010.05.022; Hicks D, 2011, J NEUROCHEM, V116, P742, DOI 10.1111/j.1471-4159.2010.07032.x; Hicks DA, 2013, CHEM-BIOL INTERACT, V203, P302, DOI 10.1016/j.cbi.2012.09.019; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Isacson O, 2002, TRENDS NEUROSCI, V25, P79, DOI 10.1016/S0166-2236(02)02037-4; Isbert S, 2012, CELL MOL LIFE SCI, V69, P1353, DOI 10.1007/s00018-011-0882-4; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kong GKW, 2008, EUR BIOPHYS J BIOPHY, V37, P269, DOI 10.1007/s00249-007-0234-3; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Madhusudan A, 2009, EUR J NEUROSCI, V30, P1064, DOI 10.1111/j.1460-9568.2009.06884.x; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Noda Y, 2013, NEUROSCI LETT, V547, P10, DOI 10.1016/j.neulet.2013.04.057; Ohkawara T, 2011, GENE, V475, P1, DOI 10.1016/j.gene.2010.11.014; Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; Rice HC, 2013, BIOCHEMISTRY-US, V52, P3264, DOI 10.1021/bi400165f; Sandbrink R, 1996, ANN NY ACAD SCI, V777, P281, DOI 10.1111/j.1749-6632.1996.tb34433.x; Schettini G, 2010, J NEUROCHEM, V115, P1299, DOI 10.1111/j.1471-4159.2010.07044.x; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Toiber D, 2009, J NEURAL TRANSM, V116, P1435, DOI 10.1007/s00702-009-0249-2; Toiber D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003108; Van Dam D, 2005, NEUROCHEM INT, V46, P409, DOI 10.1016/j.neuint.2004.11.005; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhang XJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00040; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	79	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26039	26051		10.1074/jbc.M113.461269	http://dx.doi.org/10.1074/jbc.M113.461269			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897820	Green Published, hybrid			2022-12-25	WOS:000330623300034
J	Park, YJ; Cho, CS; Emery, P; Kim, WU				Park, Yune-Jung; Cho, Chul-Soo; Emery, Paul; Kim, Wan-Uk			LDL Cholesterolemia as a Novel Risk Factor for Radiographic Progression of Rheumatoid Arthritis: A Single-Center Prospective Study	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; DISEASE-ACTIVITY; PSORIATIC-ARTHRITIS; SYNOVIAL-FLUID; JOINT DAMAGE; LIPID-LEVELS; INFLAMMATION; LEPTIN; SERUM; ASSOCIATION	Dyslipidemia has been implicated in various musculoskeletal diseases, including rheumatoid arthritis (RA). Evidence is emerging that there might be a pathogenic interaction among inflammation, dyslipidemia, and adipokines. We prospectively investigated the association of cumulative lipid levels with radiographic progression of RA. RA patients (n = 242) underwent plasma cholesterol assessment at four visits. Disease activity parameters and X-rays of the hands and feet were also serially monitored in these patients. The cumulative inflammatory burden and lipid levels were estimated by time-integrated values. Serum leptin and adiponectin concentrations were determined by ELISA. When patients were divided into three groups according to time-integrated lipid levels, as expected, patients with LDL cholesterol and/or triglyceride levels in the third tertile had persistently higher ESR and CRP levels. In parallel, a more rapid radiographic progression over two years was observed in patients with higher LDL cholesterol and/or triglyceride levels. In multivariate analysis, time-integrated LDL cholesterol was independently associated with radiographic progression. Particularly, the risk of radiographic progression was 5.6-fold in a subgroup with both LDL cholesterol and triglyceride levels in the third tertile. Moreover, LDL cholesterol synergistically increased the adjusted probability of radiographic progression in patients with high serum leptin levels but not in those without. These results demonstrate that LDL cholesterolemia is a novel serum marker that can be used to predict radiographic progression of RA, which seems to be related to circulatory leptin levels. We suggest that personalized and more aggressive anti-rheumatic therapy is required for dyslipidemic subgroups in RA patients.	[Park, Yune-Jung; Cho, Chul-Soo; Kim, Wan-Uk] Catholic Univ Korea, Dept Internal Med, Div Rheumatol, Sch Med, Seoul, South Korea; [Emery, Paul] Univ Leeds, Div Musculoskeletal Dis, Leeds Inst Rheumat & Musculoskeletal Med, Chapel Allerton Hosp, Leeds, W Yorkshire, England; [Emery, Paul] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England	Catholic University of Korea; Chapel Allerton Hospital; University of Leeds; Leeds Biomedical Research Centre; University of Leeds	Kim, WU (corresponding author), Catholic Univ Korea, Dept Internal Med, Div Rheumatol, Sch Med, Seoul, South Korea.	wan725@catholic.ac.kr	Kim, Wan-Uk/AAO-8502-2020; emery, paul/B-3560-2013	Kim, Wan-Uk/0000-0001-8224-8496	Korea Healthcare Technology R&D Project, the Ministry for Health, Welfare and Family Affairs [A092258]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [R33-2008-000-10064-0, 2009-0080087]; St. Vincent Hospital, Research Institute of Medical Science [SVHR-2012-04]; National Institute for Health Research [NF-SI-0508-10299] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish	Korea Healthcare Technology R&D Project, the Ministry for Health, Welfare and Family Affairs; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); St. Vincent Hospital, Research Institute of Medical Science; National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	This work was supported by grants from the Korea Healthcare Technology R&D Project, the Ministry for Health, Welfare and Family Affairs (No. A092258), the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (R33-2008-000-10064-0 and 2009-0080087), and the St. Vincent Hospital, Research Institute of Medical Science (SVHR-2012-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bokarewa M, 2003, ANN RHEUM DIS, V62, P952, DOI 10.1136/ard.62.10.952; Busso N, 2002, J IMMUNOL, V168, P875, DOI 10.4049/jimmunol.168.2.875; Choy E, 2009, ANN RHEUM DIS, V68, P460, DOI 10.1136/ard.2008.101964; DAWES PT, 1986, ANN RHEUM DIS, V45, P945, DOI 10.1136/ard.45.11.945; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Drossaers-Bakker KW, 2002, ARTHRIT RHEUM-ARTHR, V47, P383, DOI 10.1002/art.10513; Dursunoglu D, 2005, RHEUMATOL INT, V25, P241, DOI 10.1007/s00296-004-0438-0; Ebina K, 2009, CLIN RHEUMATOL, V28, P445, DOI 10.1007/s10067-008-1074-y; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Giles JT, 2011, ANN RHEUM DIS, V70, P1562, DOI 10.1136/ard.2011.150813; Giles JT, 2009, ARTHRIT RHEUM-ARTHR, V61, P1248, DOI 10.1002/art.24789; Gomez R, 2011, NAT REV RHEUMATOL, V7, P528, DOI 10.1038/nrrheum.2011.107; Gremese E, 2012, ARTHRITIS CARE RES H; Hamnvik OPR, 2011, METABOLISM, V60, P987, DOI 10.1016/j.metabol.2010.09.009; Hurt-Camejo E, 2001, ARTHRITIS RHEUM, V44, P2761, DOI 10.1002/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5; James MJ, 1998, LIPIDS, V33, P1115, DOI 10.1007/s11745-998-0313-8; Jick SS, 2009, ANN RHEUM DIS, V68, P546, DOI 10.1136/ard.2008.091967; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Klaasen R, 2011, ARTHRITIS RHEUM-US, V63, P359, DOI 10.1002/art.30136; Klein-Wieringa IR, 2011, ARTHRITIS RHEUM-US, V63, P2567, DOI 10.1002/art.30449; Li WQ, 2012, ANN RHEUM DIS, V71, P1267, DOI 10.1136/annrheumdis-2011-201273; Love TJ, 2012, ANN RHEUM DIS, V71, P1273, DOI 10.1136/annrheumdis-2012-201299; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Myasoedova E, 2011, ANN RHEUM DIS, V70, P482, DOI 10.1136/ard.2010.135871; Park YJ, 2013, CLIN EXP RHEUMATOL, V31, P180; Park YB, 2002, AM J MED, V113, P188, DOI 10.1016/S0002-9343(02)01186-5; Park YJ, 2013, J RHEUMATOL IN PRESS; Popa C, 2007, ANN RHEUM DIS, V66, P1503, DOI 10.1136/ard.2006.066191; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rho YH, 2009, ARTHRITIS RHEUM-US, V60, P1906, DOI 10.1002/art.24626; ROBINSON DR, 1975, ANN NY ACAD SCI, V256, P318, DOI 10.1111/j.1749-6632.1975.tb36058.x; Seven A, 2009, RHEUMATOL INT, V29, P743, DOI 10.1007/s00296-008-0764-8; STRUTHERS GR, 1983, ANN RHEUM DIS, V42, P519, DOI 10.1136/ard.42.5.519; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Symmons DPM, 1997, ARTHRITIS RHEUM, V40, P1955, DOI 10.1002/art.1780401106; Tam LS, 2007, CLIN RHEUMATOL, V26, P1495, DOI 10.1007/s10067-007-0539-8; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; VALENTE AJ, 1980, ANN RHEUM DIS, V39, P490, DOI 10.1136/ard.39.5.490; van der Heijde D, 2000, J RHEUMATOL, V27, P261; van Halm VP, 2007, ANN RHEUM DIS, V66, P184, DOI 10.1136/ard.2006.051672; WILDING P, 1975, CLIN CHIM ACTA, V64, P185, DOI 10.1016/0009-8981(75)90200-4; WINYARD PG, 1993, ANN RHEUM DIS, V52, P677, DOI 10.1136/ard.52.9.677; Xibille-Friedmann D, 2010, ANN RHEUM DIS, V69, P930, DOI 10.1136/ard.2009.111732; Yoo WH, 2004, J RHEUMATOL, V31, P1746	45	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68975	10.1371/journal.pone.0068975	http://dx.doi.org/10.1371/journal.pone.0068975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922673	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700016
J	Baker, MR; Swanson, P; Young, G				Baker, Matthew R.; Swanson, Penny; Young, Graham			Injuries from Non-Retention in Gillnet Fisheries Suppress Reproductive Maturation in Escaped Fish	PLOS ONE			English	Article							TROUT SALMO-GAIRDNERI; ADULT SOCKEYE-SALMON; ONCORHYNCHUS-NERKA; PLASMA-CORTISOL; ACUTE STRESS; IN-VITRO; DISEASE RESISTANCE; PACIFIC SALMON; PHYSIOLOGY; RESPONSES	Exploitation of fisheries resources has unintended consequences, not only in the bycatch and discard of non-target organisms, but also in damage to targeted fish that are injured by gear but not landed (non-retention). Delayed mortality due to non-retention represents lost reproductive potential in exploited stocks, while not contributing to harvest. Our study examined the physiological mechanisms by which delayed mortality occurs and the extent to which injuries related to disentanglement from commercial gear compromise reproductive success in spawning stocks of Pacific salmon (Oncorhynchus spp.). We found evidence for elevated stress in fish injured via non-retention in gillnet fisheries. Plasma cortisol levels correlated with the severity of disentanglement injury and were elevated in fish that developed infections related to disentanglement injuries. We also analyzed sex steroid concentrations in females (estradiol-17 beta and 17,20 beta-dihydroxy-4-pregnen-3-one) to determine whether non-retention impairs reproductive potential in escaped individuals. We demonstrate evidence for delayed or inhibited maturation in fish with disentanglement injuries. These findings have important implications for effective conservation and management of exploited fish stocks and suggest means to improve spawning success in such stocks if retention in commercial fisheries is improved and incidental mortality reduced.	[Baker, Matthew R.; Young, Graham] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Swanson, Penny] NOAA, NW Fisheries Sci Ctr, Fisheries Serv, Seattle, WA USA; [Swanson, Penny; Young, Graham] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Washington State University	Baker, MR (corresponding author), NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA.	Matthew.Baker@noaa.gov	Baker, Matthew/AAB-9186-2020	Baker, Matthew/0000-0002-2501-181X	Gordon and Betty Moore Foundation; National Science Foundation biocomplexity Program; Environmental Protection Agency STAR fellowship	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation biocomplexity Program(National Science Foundation (NSF)); Environmental Protection Agency STAR fellowship(United States Environmental Protection Agency)	Funding for this research was provided by the Gordon and Betty Moore Foundation, the National Science Foundation biocomplexity Program, and the Environmental Protection Agency STAR fellowship (to M.R.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaska Department of Fish & Game, 2001, POL STAT SALM ESC GO; Alaska Department of Fish & Game, 2000, AL SALM SUST FISH PO; Baker MR, 2011, EVOL APPL, V4, P429, DOI 10.1111/j.1752-4571.2010.00154.x; Baker MR, 2009, J APPL ECOL, V46, P752, DOI 10.1111/j.1365-2664.2009.01673.x; Baker MR, 2013, J NATURE CO IN PRESS; Baker MR, ECOL APPL IN PRESS; Baker TT, REV SALMON ESC UNPUB; Barry TP, 1997, GEN COMP ENDOCR, V107, P172, DOI 10.1006/gcen.1997.6910; Barton B.A., 1991, Annual Review of Fish Diseases, V1, P3, DOI 10.1016/0959-8030(91)90019-G; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; BOUCK GR, 1966, T AM FISH SOC, V95, P170, DOI 10.1577/1548-8659(1966)95[170:IOCMOB]2.0.CO;2; Brett J.R., 1995, PHYSL ECOLOGY PACIFI, P3; BRY C, 1985, GEN COMP ENDOCR, V57, P47, DOI 10.1016/0016-6480(85)90199-6; Burgner R. L., 1991, PACIFIC SALMON LIFE; CAMPBELL PM, 1992, BIOL REPROD, V47, P1140, DOI 10.1095/biolreprod47.6.1140; CHOPIN FS, 1995, FISH RES, V21, P315, DOI 10.1016/0165-7836(94)00301-C; Congleton JL, 2006, AQUAC RES, V37, P1146, DOI 10.1111/j.1365-2109.2006.01528.x; Cooke SJ, 2006, CAN J FISH AQUAT SCI, V63, P1469, DOI 10.1139/F06-042; Cooke SJ, 2012, PHILOS T R SOC B, V367, P1757, DOI 10.1098/rstb.2012.0022; Davis KB, 2006, N AM J AQUACULT, V68, P116, DOI 10.1577/A05-007.1; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Donaldson E.M., 1981, P11; Donaldson E.M., 1972, GEN COMP ENDOCRINO S, V3, P254, DOI [10.1016/0016-6480(72)90155-4, DOI 10.1016/0016-6480(72)90155-4]; DONALDSON EM, 1968, GEN COMP ENDOCR, V11, P552, DOI 10.1016/0016-6480(68)90071-3; Ellis A.E., 1981, P147; FAGERLUN.UH, 1967, GEN COMP ENDOCR, V8, P197, DOI 10.1016/0016-6480(67)90066-4; Flores AM, 2012, J COMP PHYSIOL B, V182, P77, DOI 10.1007/s00360-011-0600-4; FOO JTW, 1993, AQUACULTURE, V115, P133, DOI 10.1016/0044-8486(93)90364-5; GAMPERL AK, 1994, REV FISH BIOL FISHER, V4, P215, DOI 10.1007/BF00044129; Gilhousen, 1990, INT PAC SALMON FISH, V26, P1; GOETZ FW, 1983, FISH PHYSIOL, V9, P117; He P., 2010, BEHAV MARINE FISHES; Hendry AP, 1999, CAN J ZOOL, V77, P1663, DOI 10.1139/cjz-77-11-1663; Hinch S.G., 2006, BEHAV PHYSL FISH FIS, V24; Hruska KA, 2007, AM FISH S S, V54, P17; Hruska KA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P663, DOI 10.1086/652411; IDLER DR, 1961, CAN J BIOCHEM PHYS, V39, P1737, DOI 10.1139/o61-191; JALABERT B, 1976, J FISH RES BOARD CAN, V33, P974, DOI 10.1139/f76-124; Kinnison MT, 2003, J EVOLUTION BIOL, V16, P1257, DOI 10.1046/j.1420-9101.2003.00631.x; Kojima T, 2004, FISHERIES SCI, V70, P860, DOI 10.1111/j.1444-2906.2004.00880.x; KORENMAN SG, 1974, J CLIN ENDOCR METAB, V38, P718, DOI 10.1210/jcem-38-4-718; Kubokawa K, 2001, ZOOL SCI, V18, P947, DOI 10.2108/zsj.18.947; Kubokawa K, 1999, AQUACULTURE, V172, P335, DOI 10.1016/S0044-8486(98)00504-3; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; MAULE AG, 1989, J ENDOCRINOL, V120, P135, DOI 10.1677/joe.0.1200135; MAZEAUD MM, 1977, T AM FISH SOC, V106, P201, DOI 10.1577/1548-8659(1977)106&lt;201:PASEOS&gt;2.0.CO;2; McConnachie SH, 2012, HORM BEHAV, V62, P67, DOI 10.1016/j.yhbeh.2012.05.001; NAGAHAMA Y, 1989, FISH PHYSIOL BIOCHEM, V7, P193, DOI 10.1007/BF00004707; NAGAHAMA Y, 1987, DEV GROWTH DIFFER, V29, P1; Pankhurst NW, 2011, GEN COMP ENDOCR, V170, P265, DOI 10.1016/j.ygcen.2010.07.017; Pankhurst N.W., 1997, P73; Pankhurst NW, 1998, FISH PHYSIOL BIOCHEM, V19, P315, DOI 10.1023/A:1007751403189; Pankhurst NW, 2000, GEN COMP ENDOCR, V117, P225, DOI 10.1006/gcen.1999.7401; PICKERING AD, 1989, FISH PHYSIOL BIOCHEM, V7, P253, DOI 10.1007/BF00004714; PLANAS JV, 1993, GEN COMP ENDOCR, V91, P8, DOI 10.1006/gcen.1993.1099; POTTINGER TG, 1995, GEN COMP ENDOCR, V98, P311, DOI 10.1006/gcen.1995.1073; Raby GD, 2011, BIOSCIENCE, V61, P271, DOI 10.1525/bio.2011.61.4.7; Roff Derek A., 1992; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schreck CB, 2010, GEN COMP ENDOCR, V165, P549, DOI 10.1016/j.ygcen.2009.07.004; SCOTT AP, 1982, GEN COMP ENDOCR, V46, P444, DOI 10.1016/0016-6480(82)90098-3; Smirnov AI, 1958, MANUAL REPROD PACIFI; SOWER SA, 1982, GEN COMP ENDOCR, V47, P42, DOI 10.1016/0016-6480(82)90082-X; Summerfelt R.C., 1990, P213; Suuronen P., 2005, FAO FISHERIES TECHNI; Swanson P, 2003, FISH PHYSIOL BIOCHEM, V28, P53, DOI 10.1023/B:FISH.0000030476.73360.07; TRUSCOTT B, 1986, GEN COMP ENDOCR, V62, P99, DOI 10.1016/0016-6480(86)90098-5; Wedemeyer G.A., 1990, P451; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Wingfield JC, 1999, PHYSIOLOGY; WOOD CM, 1983, J FISH BIOL, V22, P189, DOI 10.1111/j.1095-8649.1983.tb04739.x	71	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69615	10.1371/journal.pone.0069615	http://dx.doi.org/10.1371/journal.pone.0069615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894510	gold, Green Submitted, Green Published			2022-12-25	WOS:000322167900083
J	Conson, M; Mazzarella, E; Frolli, A; Esposito, D; Marino, N; Trojano, L; Massagli, A; Gison, G; Aprea, N; Grossi, D				Conson, Massimiliano; Mazzarella, Elisabetta; Frolli, Alessandro; Esposito, Dalila; Marino, Nicoletta; Trojano, Luigi; Massagli, Angelo; Gison, Giovanna; Aprea, Nellantonio; Grossi, Dario			Motor Imagery in Asperger Syndrome: Testing Action Simulation by the Hand Laterality Task	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; MIRROR NEURON SYSTEM; VISUAL PERSPECTIVE-TAKING; PARKINSONS-DISEASE; ALE METAANALYSIS; MENTAL ROTATION; IMITATION; REPRESENTATIONS; IDENTIFICATION; MECHANISMS	Asperger syndrome (AS) is a neurodevelopmental condition within the Autism Spectrum Disorders (ASD) characterized by specific difficulties in social interaction, communication and behavioural control. In recent years, it has been suggested that ASD is related to a dysfunction of action simulation processes, but studies employing imitation or action observation tasks provided mixed results. Here, we addressed action simulation processes in adolescents with AS by means of a motor imagery task, the classical hand laterality task (to decide whether a rotated hand image is left or right); mental rotation of letters was also evaluated. As a specific marker of action simulation in hand rotation, we assessed the so-called biomechanical effect, that is the advantage for judging hand pictures showing physically comfortable versus physically awkward positions. We found the biomechanical effect in typically-developing participants but not in participants with AS. Overall performance on both hand laterality and letter rotation tasks, instead, did not differ in the two groups. These findings demonstrated a specific alteration of motor imagery skills in AS. We suggest that impaired mental simulation and imitation of goal-less movements in ASD could be related to shared cognitive mechanisms.	[Conson, Massimiliano; Marino, Nicoletta; Trojano, Luigi; Grossi, Dario] Univ Naples 2, Dept Psychol, Neuropsychol Lab, Caserta, Italy; [Mazzarella, Elisabetta] Sci Inst Fdn Santa Lucia, Dept Neuromotor Physiol, Rome, Italy; [Frolli, Alessandro] Univ Naples 2, Serv Neuropsychiat, Naples, Italy; [Esposito, Dalila; Massagli, Angelo] Sci Inst IRCCS, Eugenio Medea Reg Branch Ostuni, Brindisi Dept Neurorehabil 2, Brindisi, Italy; [Gison, Giovanna; Aprea, Nellantonio] Ctr Med Riabilitat Pompei Srl, Pompei, Italy	Universita della Campania Vanvitelli; IRCCS Santa Lucia; Universita della Campania Vanvitelli	Conson, M (corresponding author), Univ Naples 2, Dept Psychol, Neuropsychol Lab, Caserta, Italy.	massimiliano.conson@unina2.it	Trojano, Luigi/F-2396-2016; Conson, Massimiliano/AAT-3300-2020	Trojano, Luigi/0000-0002-0328-9642; Conson, Massimiliano/0000-0002-4776-306X; Frolli, Alessandro/0000-0002-2784-2887				American Psychiatric Association (APA), 2002, DSM 4 TR MAN DIAGN S; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Beacher FDCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038355; Buxbaum LJ, 2000, BRAIN COGNITION, V44, P166, DOI 10.1006/brcg.2000.1227; Buxbaum LJ, 2005, COGNITIVE BRAIN RES, V25, P226, DOI 10.1016/j.cogbrainres.2005.05.014; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Conson M, 2008, NEUROPSYCHOLOGIA, V46, P2622, DOI 10.1016/j.neuropsychologia.2008.04.015; Conson M, 2010, BRAIN COGNITION, V73, P189, DOI 10.1016/j.bandc.2010.05.001; COOPER LA, 1975, J EXP PSYCHOL HUMAN, V104, P48, DOI 10.1037/0096-1523.1.1.48; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Dinstein I, 2010, NEURON, V66, P461, DOI 10.1016/j.neuron.2010.03.034; Falter CM, 2008, J AUTISM DEV DISORD, V38, P507, DOI 10.1007/s10803-007-0419-8; Gallese V, 2013, DEV MED CHILD NEUROL, V55, P15, DOI 10.1111/j.1469-8749.2012.04398.x; Gallese V, 2011, TRENDS COGN SCI, V15, P512, DOI 10.1016/j.tics.2011.09.003; Gugliotta M., 2009, 1218 BVN; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Hamilton AFDC, 2008, Q J EXP PSYCHOL, V61, P101, DOI 10.1080/17470210701508798; Hamilton AFD, 2007, NEUROPSYCHOLOGIA, V45, P1859, DOI 10.1016/j.neuropsychologia.2006.11.022; Hamilton AFD, 2009, COGNITION, V113, P37, DOI 10.1016/j.cognition.2009.07.007; Helmich RC, 2007, NEUROPSYCHOLOGIA, V45, P2201, DOI 10.1016/j.neuropsychologia.2007.02.024; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Hobson RP, 2008, J EXP CHILD PSYCHOL, V101, P170, DOI 10.1016/j.jecp.2008.04.007; Hobson RP, 1999, J CHILD PSYCHOL PSYC, V40, P649, DOI 10.1111/1469-7610.00481; Honaga E, 2010, NEUROSCI LETT, V478, P141, DOI 10.1016/j.neulet.2010.05.004; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kessler K, 2012, SPAT COGN COMPUT, V12, P133, DOI 10.1080/13875868.2011.634533; KLIN A, 1995, J CHILD PSYCHOL PSYC, V36, P1127, DOI 10.1111/j.1469-7610.1995.tb01361.x; Kosslyn SM, 2001, NEUROREPORT, V12, P2519, DOI 10.1097/00001756-200108080-00046; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Marsh LE, 2011, NEUROIMAGE, V56, P1511, DOI 10.1016/j.neuroimage.2011.02.003; Mazzarella E, 2013, SOC NEUROSCI-UK, V8, P248, DOI 10.1080/17470919.2012.761160; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Ochipa C, 1997, NEUROLOGY, V49, P474, DOI 10.1212/WNL.49.2.474; Orsini A, 1993, WISC R CONTRIBUTO TA; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; Pelgrims B, 2009, CEREB CORTEX, V19, P2298, DOI 10.1093/cercor/bhn248; Raven J.C., 1954, SPM STANDARD PROGR M; Rogers SJ, 1996, CHILD DEV, V67, P2060, DOI 10.2307/1131609; ROTHI LJG, 1991, COGN NEUROPSYCHOL, V8, P443, DOI 10.1080/02643299108253382; Rumiatil RI, 2005, J COGNITIVE NEUROSCI, V17, P1420, DOI 10.1162/0898929054985374; Schwoebel J, 2004, COGN NEUROPSYCHOL, V21, P285, DOI 10.1080/02643290342000348; SEKIYAMA K, 1982, PERCEPT PSYCHOPHYS, V32, P89, DOI 10.3758/BF03204268; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Soulieres I, 2011, NEUROPSYCHOLOGIA, V49, P848, DOI 10.1016/j.neuropsychologia.2011.01.027; van Nuenen BFL, 2012, J NEUROSCI, V32, P9546, DOI 10.1523/JNEUROSCI.0335-12.2012; Volkmar FR, 2000, KAPLAN SADOCKS COMPR; Wild KS, 2012, J AUTISM DEV DISORD, V42, P1739, DOI 10.1007/s10803-011-1417-4; Williams JHG, 2004, J AUTISM DEV DISORD, V34, P285, DOI 10.1023/B:JADD.0000029551.56735.3a; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013	55	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70734	10.1371/journal.pone.0070734	http://dx.doi.org/10.1371/journal.pone.0070734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228SX	23894683	Green Submitted, Green Published, gold			2022-12-25	WOS:000325211000219
J	Hsu, CS; Huang, CJ; Kao, JH; Lin, HH; Chao, YC; Fan, YC; Tsai, PS				Hsu, Ching-Sheng; Huang, Chun-Jen; Kao, Jia-Horng; Lin, Hans Hsienhong; Chao, You-Chen; Fan, Yen-Chun; Tsai, Pei-Shan			Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; ASIAN-PACIFIC ASSOCIATION; VIRUS-RELATED CIRRHOSIS; RIBAVIRIN THERAPY; HCV INFECTION; ALPHA; MANAGEMENT; TAIWAN; METAANALYSIS; NATIONWIDE	Background: Interferon-based therapy (IBT) has been the standard of care for hepatitis C virus (HCV) infection. However, conflicting results exist regarding the effects of IBT on risk of developing hepatocellular carcinoma (HCC) and cirrhosis-associated complications, and most included highly selected patients. Methods: This 8-year cohort study was based on the Longitudinal Health Insurance Database 2000 (LHID 2000) consisting of 1,000,000 beneficiaries randomly selected from all Taiwan National Health Insurance enrollees in 2000 (>23.7 million). Patients with newly detected HCV infections (n = 11,264) were classified based on treatment and clinical outcomes. IBTs were defined as regimens that included interferon- alfa, pegylated interferon- alfa -2a, or pegylated interferon-alfa -2b for at least 3 months. The Cox proportional hazards models were used to estimate the hazard ratio (HR) and associated confidence interval (CI) of HCC and cirrhosis-associated complications for IBT. Results: The 8-year incidence rate for HCC was 3.9% among patients who received IBT and 5.6% among those who did not. The HCC-free survival rate was significantly higher among patients receiving IBT during the 8-year period than their counterpart (adjusted HR, 0.50; 95% CI, 0.31-0.81; P = .004). Similarly, the event-free survival rates for esophageal variceal bleeding (adjusted HR, 0.45; 95% CI, 0.22-0.91; P = .026), hepatic encephalopathy (adjusted HR, 0.38; 95% CI, 0.21-0.69; P = .001), ascites (adjusted HR, 0.28; 95% CI, 0.14-0.57; P<.001), and cirrhosis (adjusted HR, 0.63; 95% CI, 0.44-0.91; P = .013) were significantly higher among patients who received IBT than those who did not, after adjustment for associated factors. Conclusion: Treatment with interferon may reduce the 8-year risk of HCC and cirrhosis-associated complications in patients with chronic HCV infection.	[Hsu, Ching-Sheng; Lin, Hans Hsienhong; Chao, You-Chen] Buddhist Tzu Chi Gen Hosp, Div Gastroenterol, Dept Internal Med, Taipei Branch, Taipei, Taiwan; [Hsu, Ching-Sheng; Huang, Chun-Jen; Lin, Hans Hsienhong; Chao, You-Chen] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Huang, Chun-Jen; Fan, Yen-Chun] Buddhist Tzu Chi Gen Hosp, Dept Anesthesiol, Taipei Branch, Taipei, Taiwan; [Huang, Chun-Jen] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Kao, Jia-Horng] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Dept Med Res, Taipei 10764, Taiwan; [Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 10764, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ Hosp, Sleep Sci Ctr, Taipei, Taiwan	Buddhist Tzu Chi General Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Taipei Medical University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Tsai, PS (corresponding author), Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei, Taiwan.	ptsai@tmu.edu.tw	Kao, Jia-Horng/AAB-8947-2019; Fan, Yen-Chun/AAG-7183-2021	Kao, Jia-Horng/0000-0002-2442-7952; Chao, You-Chen/0000-0002-8831-2265	Buddhist Tzu Chi General Hospital, Taipei Branch [TCRD-TPE-100-C1-2]; National Science Council, Executive Yuan, Taiwan [NSC 99-2314-B-303-004, NSC 99-2628-B-038-013-MY3]	Buddhist Tzu Chi General Hospital, Taipei Branch; National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants from the Buddhist Tzu Chi General Hospital, Taipei Branch (TCRD-TPE-100-C1-2) and the National Science Council, Executive Yuan, Taiwan (NSC 99-2314-B-303-004 and NSC 99-2628-B-038-013-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa Y, 2000, CANCER, V89, P53, DOI 10.1002/1097-0142(20000701)89:1<53::AID-CNCR8>3.3.CO;2-Y; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; [Anonymous], 2012, UN HLTH COV TAIW; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Benvegnu L, 1998, CANCER-AM CANCER SOC, V83, P901, DOI 10.1002/(SICI)1097-0142(19980901)83:5<901::AID-CNCR15>3.0.CO;2-Z; Bonis PAL, 1997, HEPATOLOGY, V26, P1035, DOI 10.1053/jhep.1997.v26.pm0009328332; Camma C, 2004, HEPATOLOGY, V39, P333, DOI 10.1002/hep.20073; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chen D S, 1995, Princess Takamatsu Symp, V25, P27; CHEN DS, 1990, J INFECT DIS, V162, P817, DOI 10.1093/infdis/162.4.817; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Fattovich G, 1997, J HEPATOL, V27, P201, DOI 10.1016/S0168-8278(97)80302-9; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gramenzi A, 2001, GUT, V48, P843, DOI 10.1136/gut.48.6.843; Hu KQ, 1999, HEPATOLOGY, V29, P1311, DOI 10.1002/hep.510290424; Hung CH, 2006, J VIRAL HEPATITIS, V13, P409, DOI 10.1111/j.1365-2893.2005.00707.x; Hung CH, 2011, ANTIVIR THER, V16, P959, DOI 10.3851/IMP1842; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Imai Y, 1998, ANN INTERN MED, V129, P94, DOI 10.7326/0003-4819-129-2-199807150-00005; Ingiliz P, 2012, J HEPATOL, V56, P49, DOI 10.1016/j.jhep.2011.05.028; Kao JH, 2000, J GASTROEN HEPATOL, V15, pE91, DOI 10.1046/j.1440-1746.2000.02108.x; Lok AS, 2011, GASTROENTEROLOGY, V140, P840, DOI 10.1053/j.gastro.2010.11.050; Manesis EK, 2009, ALIMENT PHARM THER, V29, P1121, DOI 10.1111/j.1365-2036.2009.03974.x; Mazzella G, 1996, J HEPATOL, V24, P141, DOI 10.1016/S0168-8278(96)80022-5; McCaughan GW, 2007, J GASTROEN HEPATOL, V22, P615, DOI 10.1111/j.1440-1746.2007.04883.x; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Okanoue Takeshi, 2005, Clin Gastroenterol Hepatol, V3, pS89, DOI 10.1016/S1542-3565(05)00701-9; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Papatheodoridis GV, 2001, ALIMENT PHARM THER, V15, P689, DOI 10.1046/j.1365-2036.2001.00979.x; Shiffman ML, 2009, GASTROENTEROLOGY, V137, P1986, DOI 10.1053/j.gastro.2009.08.067; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Younossi Z, 2007, HEPATOLOGY, V45, P806, DOI 10.1002/hep.21565; Yu ML, 2007, ONCOLOGY-BASEL, V72, P16, DOI 10.1159/000111703; Yu ML, 2006, ANTIVIR THER, V11, P985; Yu ML, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-27	39	28	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70458	10.1371/journal.pone.0070458	http://dx.doi.org/10.1371/journal.pone.0070458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894660	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000211
J	Bichsel, KJ; Gogia, N; Malouff, T; Pena, Z; Forney, E; Hammiller, B; Watson, P; Hansen, LA				Bichsel, Kyle J.; Gogia, Navdeep; Malouff, Timothy; Pena, Zachary; Forney, Eric; Hammiller, Brianna; Watson, Patrice; Hansen, Laura A.			Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia	PLOS ONE			English	Article							CELL LUNG-CANCER; PHASE-III TRIAL; METASTATIC COLORECTAL-CANCER; INDUCED HAIR LOSS; TRANSGENIC MICE; BREAST-CANCER; EGF RECEPTOR; P53; FOLLICLE; GEFITINIB	Treatment of cancer patients with chemotherapeutics like cyclophosphamide often causes alopecia as a result of premature and aberrant catagen. Because the epidermal growth factor receptor (EGFR) signals anagen hair follicles to enter catagen, we hypothesized that EGFR signaling may be involved in cyclophosphamide-induced alopecia. To test this hypothesis, skin-targeted Egfr mutant mice were generated by crossing floxed Egfr and Keratin 14 promoter-driven Cre recombinase mice. Cyclophosphamide treatment of control mice resulted in alopecia while Egfr mutant skin was resistant to cyclophosphamide-induced alopecia. Egfr mutant skin entered catagen normally, as indicated by dermal papilla condensation and decreased follicular proliferation, but did not progress to telogen as did Egfr wild type follicles. Egfr mutant follicles responded with less proliferation, apoptosis, and fewer p53-positive cells after cyclophosphamide. Treatment of control mice with the EGFR inhibitors erlotinib or gefitinib similarly suppressed alopecia and catagen progression by cyclophosphamide. Secondary analysis of clinical trials utilizing EGFR-targeted therapies and alopecia-inducing chemotherapy also revealed evidence for involvement of EGFR in chemotherapy-induced alopecia. Taken together, our results demonstrated the involvement of EGFR signaling in chemotherapy-induced alopecia, which will help in the design of novel therapeutic regimens to minimize chemotherapy-induced alopecia.	[Bichsel, Kyle J.; Gogia, Navdeep; Malouff, Timothy; Pena, Zachary; Forney, Eric; Hammiller, Brianna; Hansen, Laura A.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Watson, Patrice] Creighton Univ, Sch Med, Dept Preventat Med & Publ Hlth, Omaha, NE USA	Creighton University; Creighton University	Hansen, LA (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	LHansen@creighton.edu			National Institutes of Health [1 R01 ES015585]; State of Nebraska LB595; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Nebraska LB595; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Dr. Hansen's research is funded by the National Institutes of Health (1 R01 ES015585) and the State of Nebraska LB595 (no number). Mr. Gogia received an Alpha Omega Alpha student research fellowship (no number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS CJ, 1961, BMJ-BRIT MED J, V2, P1516, DOI 10.1136/bmj.2.5266.1516; Bitomsky N, 2009, FEBS J, V276, P6074, DOI 10.1111/j.1742-4658.2009.07331.x; Bodo E, 2007, AM J PATHOL, V171, P1153, DOI 10.2353/ajpath.2007.061164; Botchkarev VA, 2000, CANCER RES, V60, P5002; Botchkarev VA, 2003, J INVEST DERM SYMP P, V8, P72, DOI 10.1046/j.1523-1747.2003.12175.x; Botchkarev VA, 1999, FASEB J, V13, P395, DOI 10.1096/fasebj.13.2.395; Frohna P, 2006, J CLIN PHARMACOL, V46, P282, DOI 10.1177/0091270005284193; Graves JE, 2006, J AM ACAD DERMATOL, V55, P349, DOI 10.1016/j.jaad.2005.12.016; Guarneri V, 2008, BREAST CANCER RES TR, V110, P127, DOI 10.1007/s10549-007-9688-3; HANDJISKI BK, 1994, BRIT J DERMATOL, V131, P303, DOI 10.1111/j.1365-2133.1994.tb08515.x; Hansen LA, 1996, INT CONGR SER, V1111, P425; Hansen LA, 1997, AM J PATHOL, V150, P1959; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Hendrix S, 2005, J INVEST DERMATOL, V125, P42, DOI 10.1111/j.0022-202X.2005.23787.x; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; HUSSEIN AM, 1993, SOUTH MED J, V86, P489, DOI 10.1097/00007611-199305000-00001; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Kwon YW, 2002, J BIOL CHEM, V277, P1837, DOI 10.1074/jbc.M105033200; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; Lu JF, 2006, CLIN PHARMACOL THER, V80, P136, DOI 10.1016/j.clpt.2006.04.007; Macquart-Moulin G, 1997, BRIT J CANCER, V76, P1640, DOI 10.1038/bjc.1997.610; Maklad A, 2009, J INVEST DERMATOL, V129, P690, DOI 10.1038/jid.2008.281; Messersmith WA, 2007, CLIN CANCER RES, V13, P4664, DOI 10.1158/1078-0432.CCR-07-0065; Mill P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000748; MILNE DM, 1994, J BIOL CHEM, V269, P9253; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Okines AFC, 2010, J CLIN ONCOL, V28, P3945, DOI 10.1200/JCO.2010.29.2847; PAUS R, 1994, AM J PATHOL, V144, P719; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Rodust PM, 2009, BRIT J DERMATOL, V161, P107, DOI 10.1111/j.1365-2133.2009.09458.x; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Seo MR, 2007, J BIOL CHEM, V282, P24720, DOI 10.1074/jbc.M702343200; Sharov AA, 2004, CANCER RES, V64, P6266, DOI 10.1158/0008-5472.CAN-04-1367; Shimada K, 2003, CARCINOGENESIS, V24, P1067, DOI 10.1093/carcin/bgg058; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Swaisland HC, 2005, CLIN PHARMACOKINET, V44, P1165, DOI 10.2165/00003088-200544110-00004; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656	46	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69368	10.1371/journal.pone.0069368	http://dx.doi.org/10.1371/journal.pone.0069368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894460	Green Published, gold, Green Submitted			2022-12-25	WOS:000322391400054
J	Mustafi, D; Kevany, BM; Genoud, C; Bai, XD; Palczewski, K				Mustafi, Debarshi; Kevany, Brian M.; Genoud, Christel; Bai, Xiaodong; Palczewski, Krzysztof			Photoreceptor phagocytosis is mediated by phosphoinositide signaling	FASEB JOURNAL			English	Article						lincRNA; retina; RNA-Seq; RPE	REV-ERB-ALPHA; ROD OUTER SEGMENTS; CIRCADIAN CLOCK; DIACYLGLYCEROL KINASE; PHOSPHOLIPASE-C; NONCODING RNAS; ROYAL-COLLEGE; GENE; TRANSCRIPTION; EXPRESSION	Circadian oscillations in peripheral tissues, such as the retinal compartment of the eye, are critical to anticipating changing metabolic demands. Circadian shedding of retinal photoreceptor cell discs with subsequent phagocytosis by the neighboring retinal pigmented epithelium (RPE) is essential for removal of toxic metabolites and lifelong survival of these postmitotic neurons. Defects in photoreceptor phagocytosis can lead to severe retinal pathology, but the biochemical mechanisms remain poorly defined. By first documenting a 2.8-fold burst of photoreceptor phagocytosis events in the mouse eye in the morning compared with the afternoon by serial block face imaging, we established time points to assess transcriptional readouts by RNA sequencing (RNA-Seq). We identified 365 oscillating protein-coding transcripts that implicated the phosphoinositide lipid signaling network mediating the discrete steps of photoreceptor phagocytosis. Moreover, examination of overlapping cistromic sites by core clock transcription factors and promoter elements of these effector genes provided a functional basis for the circadian cycling of these transcripts. RNA-Seq also revealed oscillating expression of 16 long intergenic noncoding RNAs and key histone modifying enzymes critical for circadian gene expression. Our phenotypic and genotypic characterization reveals a complex global landscape of overlapping and temporally controlled networks driving the essential circadian process in the eye.Mustafi, D., Kevany, B. M., Genoud, C., Bai, X., Palczewski, K. Photoreceptor phagocytosis is mediated by phosphoinositide signaling.	[Mustafi, Debarshi; Kevany, Brian M.; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bai, Xiaodong] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Genoud, Christel] Friedrich Miescher Inst Biomed Res, Electron Microscopy Facil, Basel, Switzerland	Case Western Reserve University; Case Western Reserve University; Friedrich Miescher Institute for Biomedical Research	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu		Mustafi, Debarshi/0000-0002-9164-7488; genoud, christel/0000-0002-0933-9911	National Eye Institute of the U.S. National Institutes of Health (NIH) [R01-EY-008061, R01-EY-019478, R01-EY-022606, R01-EY-022326, P30-EY-11373]; Research to Prevent Blindness Foundation; Foundation Fighting Blindness, Fight for Sight; Ohio Lions Eye Research Foundation; Maurice E. Muller Foundation of Switzerland; CWRU Medical Scientist Training Program from NIH [T32GM007250]; Visual Sciences Training Program from NIH [T32EY007157]; NATIONAL EYE INSTITUTE [T32EY007157, R01EY019478, R01EY008061, R01EY022606, P30EY011373, R01EY022326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Eye Institute of the U.S. National Institutes of Health (NIH); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness, Fight for Sight; Ohio Lions Eye Research Foundation; Maurice E. Muller Foundation of Switzerland; CWRU Medical Scientist Training Program from NIH; Visual Sciences Training Program from NIH; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Leslie T. Webster, Jr. [Case Western Reserve University (CWRU)] for valuable comments on the manuscript. The authors thank Neil Molyneaux, Simone Edelheit, and Milena Rajak (CWRU) for technical assistance and Dr. Ahmad Khalil (CWRU) for helpful discussions. Research reported in this work was supported by the National Eye Institute of the U.S. National Institutes of Health (NIH) under awards R01-EY-008061, R01-EY-019478, R01-EY-022606, R01-EY-022326, and P30-EY-11373, and the Research to Prevent Blindness Foundation, Foundation Fighting Blindness, Fight for Sight, and the Ohio Lions Eye Research Foundation. D. M. was supported in part by the CWRU Medical Scientist Training Program (T32GM007250) and Visual Sciences Training Program (T32EY007157) training grants from the NIH as well as the Maurice E. Muller Foundation of Switzerland. K. P. is John H. Hord Professor of Pharmacology.	Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; ALLEN LAH, 1995, J EXP MED, V182, P829, DOI 10.1084/jem.182.3.829; Almena M, 2011, TRENDS BIOCHEM SCI, V36, P593, DOI 10.1016/j.tibs.2011.06.005; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Botelho RJ, 2009, J BIOL CHEM, V284, P28522, DOI 10.1074/jbc.M109.009514; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chowers I, 2004, INVEST OPHTH VIS SCI, V45, P2098, DOI 10.1167/iovs.03-0863; Coon SL, 2012, P NATL ACAD SCI USA, V109, P13319, DOI 10.1073/pnas.1207748109; Crandall DL, 2000, J CLIN ENDOCR METAB, V85, P2609, DOI 10.1210/jc.85.7.2609; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Ding L, 1998, J BIOL CHEM, V273, P32746, DOI 10.1074/jbc.273.49.32746; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Hall MO, 1996, INVEST OPHTH VIS SCI, V37, P1473; HETH CA, 1994, INVEST OPHTH VIS SCI, V35, P409; HETH CA, 1995, INVEST OPHTH VIS SCI, V36, P984; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jeon H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-149; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kolko M, 2007, INVEST OPHTH VIS SCI, V48, P1401, DOI 10.1167/iovs.06-0865; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Lee HS, 2003, NAT NEUROSCI, V6, P111, DOI 10.1038/nn1006; Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404; Liu X., 2012, PLOS ONE, V7, DOI rg/10.1371/journal.pone.0040345; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; MOISSEIEV J, 1990, INVEST OPHTH VIS SCI, V31, P1070; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mustafi D, 2013, HUM MOL GENET, V22, P2992, DOI 10.1093/hmg/ddt156; Mustafi D, 2012, J CLIN INVEST, V122, P2989, DOI 10.1172/JCI64427; Mustafi D, 2011, FASEB J, V25, P3157, DOI 10.1096/fj.11-186767; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Park YJ, 2008, P NATL ACAD SCI USA, V105, P11784, DOI 10.1073/pnas.0801394105; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109; Ryeom SW, 1996, J CELL SCI, V109, P387; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; Shelby SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053964; Steinckwich N, 2011, J IMMUNOL, V186, P2182, DOI 10.4049/jimmunol.1001338; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Takeda Y, 2011, NUCLEIC ACIDS RES, V39, P4769, DOI 10.1093/nar/gkq1335; TERMAN JS, 1993, BRAIN RES, V605, P256; Todt JC, 2004, J LEUKOCYTE BIOL, V75, P705, DOI 10.1189/jlb.0903439; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Tovin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003116; Valekunja UK, 2013, P NATL ACAD SCI USA, V110, P1554, DOI 10.1073/pnas.1214168110; van den Bout I, 2007, EXP CELL RES, V313, P1260, DOI 10.1016/j.yexcr.2007.01.005; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	88	33	33	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4585	4595		10.1096/fj.13-237537	http://dx.doi.org/10.1096/fj.13-237537			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23913857	Green Published			2022-12-25	WOS:000329937500024
J	Fan, MY; Krutilina, R; Sun, J; Sethuraman, A; Yang, CH; Wu, ZH; Yue, JM; Pfeffer, LM				Fan, Meiyun; Krutilina, Raisa; Sun, Jing; Sethuraman, Aarti; Yang, Chuan He; Wu, Zhao-hui; Yue, Junming; Pfeffer, Lawrence M.			Comprehensive Analysis of MicroRNA (miRNA) Targets in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; MESSENGER-RNAS; WIDE IDENTIFICATION; ARGONAUTE PROTEINS; CYCLE REGULATION; AUTOPHAGY; METASTASIS; SITES; APOPTOSIS	MicroRNAs (miRNAs) regulate mRNA stability and translation through the action of the RNAi-induced silencing complex. In this study, we systematically identified endogenous miRNA target genes by using AGO2 immunoprecipitation (AGO2-IP) and microarray analyses in two breast cancer cell lines, MCF7 and MDA-MB-231, representing luminal and basal-like breast cancer, respectively. The expression levels of similar to 70% of the AGO2-IP mRNAs were increased by DROSHA or DICER1 knockdown. In addition, integrated analysis of miRNA expression profiles, mRNA-AGO2 interaction, and the 3 '-UTR of mRNAs revealed that >60% of the AGO2-IP mRNAs were putative targets of the 50 most abundantly expressed miRNAs. Together, these results suggested that the majority of the AGO2-associated mRNAs were bona fide miRNA targets. Functional enrichment analysis uncovered that the AGO2-IP mRNAs were involved in regulation of cell cycle, apoptosis, adhesion/migration/invasion, stress responses (e. g. DNA damage and endoplasmic reticulum stress and hypoxia), and cell-cell communication (e.g. Notch and Ephrin signaling pathways). A role of miRNAs in regulating cell migration/invasion and stress response was further defined by examining the impact of DROSHA knockdown on cell behaviors. We demonstrated that DROSHA knockdown enhanced cell migration and invasion, whereas it sensitized cells to cell death induced by suspension culture, glucose depletion, and unfolding protein stress. Data from an orthotopic xenograft model showed that DROSHA knockdown resulted in reduced growth of primary tumors but enhanced lung metastasis. Taken together, these results suggest that miRNAs collectively function to promote survival of tumor cells under stress but suppress cell migration/invasion in breast cancer cells.	Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Ctr Adult Canc Res, Memphis, TN 38163 USA; Univ Tennessee, Hlth Sci Ctr, Dept Lab Med, Ctr Adult Canc Res, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Fan, MY (corresponding author), 19 South Manassas St, Memphis, TN 38163 USA.	mfan2@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA140346, CA133322]; NATIONAL CANCER INSTITUTE [R01CA149251, R01CA133322, R01CA140346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA140346 (to M. F.) and CA133322 (to L. M. P.).	Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hassan MQ, 2010, J CELL BIOCHEM, V110, P817, DOI 10.1002/jcb.22562; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Iwasaki YW, 2013, RNA, V19, P490, DOI 10.1261/rna.036608.112; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nicklas JA, 2003, J FORENSIC SCI, V48, P936; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Valdmanis PN, 2012, NUCLEIC ACIDS RES, V40, P3704, DOI 10.1093/nar/gkr1274; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang BD, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-98; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wang L, 2012, ONCOGENE, V31, P2499, DOI 10.1038/onc.2011.444; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wee EJH, 2012, ONCOGENE, V31, P4182, DOI 10.1038/onc.2011.584; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	66	35	37	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27480	27493		10.1074/jbc.M113.491803	http://dx.doi.org/10.1074/jbc.M113.491803			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921383	Green Published, hybrid			2022-12-25	WOS:000330597300043
J	Kwon, HS; Johnson, TV; Joe, MK; Abu-Asab, M; Zhang, J; Chan, CC; Tomarev, SI				Kwon, Heung Sun; Johnson, Thomas V.; Joe, Myung Kuk; Abu-Asab, Mones; Zhang, Jun; Chan, Chi Chao; Tomarev, Stanislav I.			Myocilin Mediates Myelination in the Peripheral Nervous System through ErbB2/3 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-ANGLE GLAUCOMA; SCHWANN-CELLS; WALLERIAN DEGENERATION; MUTATIONS; GLIOMEDIN; RANVIER; GENE; EXPRESSION; PROTEINS; NODES	The glaucoma-associated gene, myocilin, is expressed in ocular and non-ocular tissues including the peripheral nervous system, but its functions in these tissues remain poorly understood. We demonstrate that in sciatic nerve, myocilin is expressed in Schwann cells with high concentrations at the nodes of Ranvier. There, myocilin interacts with gliomedin, neurofascin, and NrCAM, which are essential for node formation and function. Treatment of isolated dorsal root ganglion cultures with myocilin stimulates clustering of the nodal proteins neurofascin and sodium channel Na(v)1.2. Sciatic nerves of myocilin null mice express reduced levels of several myelin-associated and basal membrane proteins compared with those of wild-type littermates. They also demonstrate reduced myelin sheath thickness and partial disorganization of the nodes. Myocilin signaling through ErbB2/3 receptors may contribute to these observed effects. Myocilin binds to ErbB2/ErbB3, activates these receptors, and affects the downstream PI3K-AKT signaling pathway. These data implicate a role for myocilin in the development and/or maintenance of myelination and nodes of Ranvier in sciatic nerve.	[Kwon, Heung Sun; Johnson, Thomas V.; Joe, Myung Kuk; Tomarev, Stanislav I.] NEI, SRGCB, LRCMB, NIH, Bethesda, MD 20892 USA; [Abu-Asab, Mones; Zhang, Jun; Chan, Chi Chao] NEI, Histol Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Tomarev, SI (corresponding author), NEI, SRGCB, LRCMB, NIH, Bldg 6,Rm 212,6 Ctr Dr, Bethesda, MD 20892 USA.	tomarevs@nei.nih.gov	Johnson, Thomas V/C-9351-2011	Johnson, Thomas V/0000-0002-5372-5457; Abu-Asab, Mones/0000-0002-4047-1232	Intramural Research Program of the NEI, National Institutes of Health; NATIONAL EYE INSTITUTE [ZICEY000461, ZIAEY000222, ZIAEY000318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Intramural Research Program of the NEI, National Institutes of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the NEI, National Institutes of Health.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Agrawal D, 2009, J STRUCT BIOL, V168, P521, DOI 10.1016/j.jsb.2009.06.019; Albrecht DE, 2008, GLIA, V56, P611, DOI 10.1002/glia.20636; Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; Carroll SL, 1997, J NEUROSCI, V17, P1642; Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Cotter L, 2010, SCIENCE, V328, P1415, DOI 10.1126/science.1187735; Davies AM, 1998, CURR BIOL, V8, pR15, DOI 10.1016/S0960-9822(98)70009-0; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Fingert JH, 2002, SURV OPHTHALMOL, V47, P547, DOI 10.1016/S0039-6257(02)00353-3; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Joe MK, 2012, J BIOL CHEM, V287, P13216, DOI 10.1074/jbc.M111.224063; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lam DSC, 2000, INVEST OPHTH VIS SCI, V41, P1386; Lemke G., 2006, SCI STKE 2006, P11; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Malyukova I, 2006, INVEST OPHTH VIS SCI, V47, P206, DOI 10.1167/iovs.05-0220; Mckee KK, 2012, J CELL SCI, V125, P4609, DOI 10.1242/jcs.107995; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Nakagawa M, 2001, GLIA, V35, P101, DOI 10.1002/glia.1075; Ohlmann A, 2003, GLIA, V43, P128, DOI 10.1002/glia.10233; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; PORTER S, 1986, J NEUROSCI, V6, P3070; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V245, P887, DOI 10.1006/bbrc.1998.8541; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; Wiggs JL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1674; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Yang DR, 2005, J CELL BIOL, V168, P655, DOI 10.1083/jcb.200411158; Yu WM, 2005, J NEUROSCI, V25, P4463, DOI 10.1523/JNEUROSCI.5032-04.2005	48	27	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26357	26371		10.1074/jbc.M112.446138	http://dx.doi.org/10.1074/jbc.M112.446138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897819	hybrid, Green Published			2022-12-25	WOS:000330594500002
J	Green, WW; Basilious, A; Dubuc, R; Zielinski, BS				Green, Warren W.; Basilious, Alfred; Dubuc, Rejean; Zielinski, Barbara S.			The Neuroanatomical Organization of Projection Neurons Associated with Different Olfactory Bulb Pathways in the Sea Lamprey, Petromyzon marinus	PLOS ONE			English	Article							SYNAPTIC ORGANIZATION; NERVUS TERMINALIS; CHANNEL CATFISH; MEDIAL REGION; MITRAL CELLS; PHEROMONE; INFORMATION; INHIBITION; LOCOMOTION; MORPHOLOGY	Although there is abundant evidence for segregated processing in the olfactory system across vertebrate taxa, the spatial relationship between the second order projection neurons (PNs) of olfactory subsystems connecting sensory input to higher brain structures is less clear. In the sea lamprey, there is tight coupling between olfaction and locomotion via PNs extending to the posterior tuberculum from the medial region of the olfactory bulb. This medial region receives peripheral input predominantly from the accessory olfactory organ. However, the axons from olfactory sensory neurons residing in the main olfactory epithelium extend to non-medial regions of the olfactory bulb, and the non-medial bulbar PNs extend their axons to the lateral pallium. It is not known if the receptive fields of the PNs in the two output pathways overlap; nor has the morphology of these PNs been investigated. In this study, retrograde labelling was utilized to investigate the PNs belonging to medial and non-medial projections. The dendrites and somata of the medial PNs were confined to medial glomerular neuropil, and dendrites of non-medial PNs did not enter this territory. The cell bodies and dendrites of the non-medial PNs were predominantly located below the glomeruli (frequently deeper in the olfactory bulb). While PNs in both locations contained single or multiple primary dendrites, the somal size was greater for medial than for non-medial PNs. When considered with the evidence-to-date, this study shows different neuroanatomical organization for medial olfactory bulb PNs extending to locomotor control centers and non-medial PNs extending to the lateral pallium in this vertebrate.	[Green, Warren W.; Basilious, Alfred; Zielinski, Barbara S.] Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada; [Dubuc, Rejean] Univ Montreal, Dept Physiol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada; [Dubuc, Rejean] Univ Quebec, Dept Kinanthropol, Grp Rech Activite Phys Adaptee, Montreal, PQ H3C 3P8, Canada	University of Windsor; Universite de Montreal; University of Quebec; University of Quebec Montreal	Zielinski, BS (corresponding author), Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada.	zielin1@uwindsor.ca		Green, Warren/0000-0002-6254-3911	Great Lake Fisheries Commission [8400272]; Natural Sciences and Engineering Research Council of Canada [217435, 46383]; Canadian Institutes of Health Research [15129]; Fonds de la Recherche du Quebec - Sante [5249]	Great Lake Fisheries Commission; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	The authors acknowledge group grant support from the Great Lake Fisheries Commission (Grant 8400272) to BZ and RD; Grant support from the Natural Sciences and Engineering Research Council of Canada (Grant 217435) to RD; Canadian Institutes of Health Research (Grant 15129) to RD; Fonds de la Recherche du Quebec - Sante (Group Grant 5249) to RD; and Natural Sciences and Engineering Research Council of Canada support (Grant 46383) to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO JR, 1988, NEUROSCI RES COMMUN, V3, P113; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Derjean D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000567; DRYER L, 1994, ANAT EMBRYOL, V189, P91; Dubuc R, 2008, BRAIN RES REV, V57, P172, DOI 10.1016/j.brainresrev.2007.07.016; Frontini A, 2003, J COMP NEUROL, V465, P27, DOI 10.1002/cne.10811; Fuller CL, 2006, J COMP NEUROL, V499, P218, DOI 10.1002/cne.21091; Gariepy JF, 2012, P NATL ACAD SCI USA, V109, pE84, DOI 10.1073/pnas.1113002109; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; Hamdani EH, 2003, CHEM SENSES, V28, P181, DOI 10.1093/chemse/28.3.181; Hansen A, 2003, J NEUROSCI, V23, P9328; Hara TJ, 1998, NEUROSCIENCE, V82, P301; Heier P, 1948, ACTA ANAT, V8, P9; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; IWAHORI N, 1987, NEUROSCI RES, V5, P126, DOI 10.1016/0168-0102(87)90029-0; Johnson NS, 2009, P NATL ACAD SCI USA, V106, P1021, DOI 10.1073/pnas.0808530106; KLEEREKOPER H., 1963, PHYSIOL ZOOL, V36, P347; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Li WM, 2002, SCIENCE, V296, P138, DOI 10.1126/science.1067797; Ma MH, 2007, CRIT REV BIOCHEM MOL, V42, P463, DOI 10.1080/10409230701693359; Meisami E, 1998, MICROSC RES TECHNIQ, V43, P476, DOI 10.1002/(SICI)1097-0029(19981215)43:6<476::AID-JEMT2>3.3.CO;2-M; Namiki S, 2011, J COMP NEUROL, V519, P3367, DOI 10.1002/cne.22754; Nikonov AA, 2001, J NEUROPHYSIOL, V86, P1869, DOI 10.1152/jn.2001.86.4.1869; NORTHCUTT RG, 1988, BRAIN BEHAV EVOLUT, V32, P96, DOI 10.1159/000116537; Polenova O.A., 1993, Journal fuer Hirnforschung, V34, P261; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Ren X, 2009, J COMP NEUROL, V516, P105, DOI 10.1002/cne.22100; Ryczko D, 2013, CURR PHARM DES  0121, V21; SATOU M, 1990, PROG NEUROBIOL, V34, P115, DOI 10.1016/0301-0082(90)90004-Z; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Smetana R, 2010, NAT NEUROSCI, V13, P731, DOI 10.1038/nn.2548; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; STRAUSFELD NJ, 1991, VISUAL NEUROSCI, V7, P13, DOI 10.1017/S0952523800010919; Tobet SA, 1996, J COMP NEUROL, V376, P97; Villar-Cervino V, 2011, J COMP NEUROL, V519, P1712, DOI 10.1002/cne.22597; VONBARTHELD CS, 1988, BRAIN BEHAV EVOLUT, V32, P151, DOI 10.1159/000116542; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; YOUSON JH, 1979, CAN J ZOOL, V57, P1808, DOI 10.1139/z79-235; Zielinski BS, 2000, J COMP NEUROL, V420, P324	42	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69525	10.1371/journal.pone.0069525	http://dx.doi.org/10.1371/journal.pone.0069525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922730	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700038
J	Singh, J; Sankar, MM; Kumar, S; Gopinath, K; Singh, N; Mani, K; Singh, S				Singh, Jitendra; Sankar, Manimuthu Mani; Kumar, Sandeep; Gopinath, Krishnamurthy; Singh, Niti; Mani, Kalaivani; Singh, Sarman			Incidence and Prevalence of Tuberculosis among Household Contacts of Pulmonary Tuberculosis Patients in a Peri-Urban Population of South Delhi, India	PLOS ONE			English	Article							RISK-FACTORS; TRANSMISSION; INFECTION; DISEASE	Background: Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the leading causes of mortality and morbidity across all age groups throughout the world, especially in developing countries. Methodology/Principal Findings: In this study, we have included 432 open index cases with their 1608 household contacts in a prospective cohort study conducted from May 2007 to March 2009. The follow-up period was 2 years. All Index cases were diagnosed on the basis of suggestive signs and symptoms and sputum being AFB positive. Among the 432 index patients, 250 (57.9%) were males and 182 (42.1%) females; with mean age of 34 +/- 14.4 yr and 26 +/- 11.1 yr, respectively. Out of 1608 household contacts, 866 (53.9%) were males and 742 (46.1%) females; with mean age of 26.5 +/- 15.8 and 26.5 +/- 16.0 yr, respectively. Of the total 432 households, 304 (70.4%) had <= 4 members and 128 (29.6%) had >= 5 members. The median size of the family was four. Of the 1608 contacts, 1206 were able to provide sputum samples, of whom 83 (6.9%) were found MTB culture positive. Household contacts belonging to adult age group were predominantly (74, 89.2%) infected as compared to the children (9, 10.8%). On screening the contact relationship status with index patients, 52 (62.7%) were first-degree relatives, 18 (34.6%) second-degree relatives and 12 (14.5%) spouses who got infected from their respective index patients. Co-prevalent and incident tuberculosis was found in 52 (4.3%) and 31 (2.6%) contacts, respectively. In incident cases, the diagnosis could be made between 4 to 24 months of follow-up, after their baseline evaluation. Conclusion: Active household contact investigation is a powerful tool to detect and treat tuberculosis at early stages and the only method to control TB in high-TB-burden countries.	[Singh, Jitendra; Sankar, Manimuthu Mani; Kumar, Sandeep; Gopinath, Krishnamurthy; Singh, Sarman] All India Inst Med Sci, Div Clin Microbiol & Mol Med, New Delhi, India; [Singh, Niti] Lala Ram Sarup Inst TB & Resp Dis, New Delhi, India; [Mani, Kalaivani] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, S (corresponding author), All India Inst Med Sci, Div Clin Microbiol & Mol Med, New Delhi, India.	sarman_singh@yahoo.com	KUMAR, SANDEEP/GZA-7182-2022; Singh, Sarman/AAR-8914-2020	Singh, Sarman/0000-0002-0749-9647	Indian Council of Medical Research (ICMR), New Delhi [5/8/5/4/2005-ECD-I]	Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR))	The study was supported by the Indian Council of Medical Research (ICMR), New Delhi (ICMR Sanction Order Number: 5/8/5/4/2005-ECD-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR; Christopher DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010408; Dhingra V.K., 2004, INDIAN J MED, V29, P44; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Enarson D A, 1990, Bull Int Union Tuberc Lung Dis, V65, P73; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Harries AD, 1997, T ROY SOC TROP MED H, V91, P416, DOI 10.1016/S0035-9203(97)90262-5; Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X; HSU KHK, 1963, AM J PUBLIC HEALTH N, V53, P1761, DOI 10.2105/AJPH.53.11.1761; Kent TP, 1985, PUBLIC HLTH MYCOBACT, P31; Kenyon TA, 2002, INT J TUBERC LUNG D, V6, P843; Khatri GR, 2002, NEW ENGL J MED, V347, P1420, DOI 10.1056/NEJMsa020098; KUMAR R, 1984, J EPIDEMIOL COMMUN H, V38, P253, DOI 10.1136/jech.38.3.253; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; NARAIN R, 1966, B WORLD HEALTH ORGAN, V34, P639; National institute for health and clinical excellence, 2006, CG33 NAT I HLTH CLIN, P23; Ormerod P, 2000, THORAX, V55, P887; Ramkrishnan CV, 1961, B WORLD HEALTH ORGAN, V25, P361; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Revised National Tuberculosis Control Programme (RNTCP), 2005, GUID QUAL ASS SMEAR; Sankar MM, 2009, J CLIN MICROBIOL, V47, P4189, DOI 10.1128/JCM.01295-09; Sinfield R, 2006, ANN TROP PAEDIATR, V26, P205, DOI 10.1179/146532806X120291; Singh M, 2005, ARCH DIS CHILD, V90, P624, DOI 10.1136/adc.2003.044255; Singh S, 2007, AIDS, V21, P2345, DOI 10.1097/QAD.0b013e3282f125c9; Singh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040213; Singh S, 2008, ASIAN PAC J TROP MED, V1, P60; Smith R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1291; STRUTHERS E, 1961, AM REV RESPIR DIS, V83, P808; Triasih R, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/301808; Whalen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016137; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033	32	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69730	10.1371/journal.pone.0069730	http://dx.doi.org/10.1371/journal.pone.0069730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922784	Green Submitted, Green Published, gold			2022-12-25	WOS:000322838900075
J	Li, BB; Li, SS; Yin, J; Zhong, J				Li, Binbin; Li, Sisi; Yin, Juan; Zhong, Jiang			Identification and Characterization of the Spodoptera Su(var) 3-9 Histone H3K9 trimethyltransferase and Its Effect in AcMNPV Infection	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LYSINE METHYLTRANSFERASES; GENE-EXPRESSION; HP1; DNA; METHYLATION; INHIBITOR; ACTIVATION; BINDING; CELLS	Histone H3-lysine9 (H3K9) trimethyltransferase gene Su(var) 3-9 was cloned and identified in three Spodoptera insects, Spodoptera frugiperda (S. frugiperda), S. exigua and S. litura. Sequence analysis showed that Spodoptera Su(var) 3-9 is highly conserved evolutionarily. Su(var) 3-9 protein was found to be localized in the nucleus in Sf9 cells, and interact with histone H3, and the heterochromatin protein 1a (HP1a) and HP1b. A dose-dependent enzymatic activity was found at both 27 degrees C and 37 degrees C in vitro, with higher activity at 27 degrees C. Addition of specific inhibitor chaetocin resulted in decreased histone methylation level and host chromatin relaxation. In contrast, overexpression of Su(var) 3-9 caused increased histone methylation level and cellular genome compaction. In AcMNV-infected Sf9 cells, the transcription of Su(var) 3-9 increased at late time of infection, although the mRNA levels of most cellular genes decreased. Pre-treatment of Sf9 cells with chaetocin speeded up viral DNA replication, and increased the transcription level of a variety of virus genes, whereas in Sf9 cells pre-transformed with Su(var) 3-9 expression vector, viral DNA replication slow down slightly. These findings suggest that Su(var) 3-9 might participate in the viral genes expression an genome replication repression during AcMNPV infection. It provided a new insight for the understanding virus-host interaction mechanism.	[Li, Binbin; Li, Sisi; Yin, Juan; Zhong, Jiang] Fudan Univ, Dept Microbiol & Microbial Engn, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University	Zhong, J (corresponding author), Fudan Univ, Dept Microbiol & Microbial Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	jzhong@fudan.edu.cn	Li, Binbin/AAO-5959-2020; 江, 钟/E-3005-2010	Li, Binbin/0000-0002-8572-8003; Li, Sisi/0000-0002-7290-8128; Zhong, Jiang/0000-0003-1801-9642	National Natural Science Foundation of China [31170143]; National Science and Technology Major Project for Drug Discovery [2011ZX09506-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project for Drug Discovery	This work was supported by National Natural Science Foundation of China (31170143) and the National Science and Technology Major Project for Drug Discovery (2011ZX09506-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Boeke J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010042; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Day L, 2007, J VIROL, V81, P6389, DOI 10.1128/JVI.02172-06; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kantor B, 2009, P NATL ACAD SCI USA, V106, P18786, DOI 10.1073/pnas.0905859106; Krauss V, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-18; Krauss V, 2000, GENETICS, V156, P1157; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyupina YV, 2011, VIROLOGY, V421, P34, DOI 10.1016/j.virol.2011.09.010; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Negre V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-322; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; Peng Y, 2007, J BIOTECHNOL, V131, P180, DOI 10.1016/j.jbiotec.2007.06.009; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schotta G, 2003, GENETICA, V117, P149, DOI 10.1023/A:1022923508198; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Spenger A, 2004, PROTEIN EXPRES PURIF, V38, P17, DOI 10.1016/j.pep.2004.08.001; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Wang L, 2006, ARCH VIROL, V151, P2047, DOI 10.1007/s00705-006-0772-5; Wang X, 2010, ANAL BIOCHEM, V396, P322, DOI 10.1016/j.ab.2009.09.033; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; WILSON ME, 1986, VIROLOGY, V151, P315, DOI 10.1016/0042-6822(86)90052-8; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	40	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69442	10.1371/journal.pone.0069442	http://dx.doi.org/10.1371/journal.pone.0069442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894480	Green Submitted, Green Published, gold			2022-12-25	WOS:000322167900070
J	Steffler, F; Sieber, V				Steffler, Fabian; Sieber, Volker			Refolding of a Thermostable Glyceraldehyde Dehydrogenase for Application in Synthetic Cascade Biomanufacturing	PLOS ONE			English	Article							ESCHERICHIA-COLI; ALDEHYDE DEHYDROGENASE; BACILLUS-STEAROTHERMOPHILUS; THERMOPLASMA-ACIDOPHILUM; ALCOHOL-DEHYDROGENASE; PROTEINS; STABILITY; ENZYMES; DECARBOXYLATION; SOLUBILIZATION	The production of chemicals from renewable resources is gaining importance in the light of limited fossil resources. One promising alternative to widespread fermentation based methods used here is Synthetic Cascade Biomanufacturing, the application of minimized biocatalytic reaction cascades in cell free processes. One recent example is the development of the phosphorylation independent conversion of glucose to ethanol and isobutanol using only 6 and 8 enzymes, respectively. A key enzyme for this pathway is aldehyde dehydrogenase from Thermoplasma acidophilum, which catalyzes the highly substrate specific oxidation of D-glyceraldehyde to D-glycerate. In this work the enzyme was recombinantly expressed in Escherichia coli. Using matrix-assisted refolding of inclusion bodies the yield of enzyme production was enhanced 43-fold and thus for the first time the enzyme was provided in substantial amounts. Characterization of structural stability verified correct refolding of the protein. The stability of the enzyme was determined by guanidinium chloride as well as isobutanol induced denaturation to be ca. -8 kJ/mol both at 25 degrees C and 40 degrees C. The aldehyde dehydrogenase is active at high temperatures and in the presence of small amounts of organic solvents. In contrast to previous publications, the enzyme was found to accept NAD(+) as cofactor making it suitable for application in the artificial glycolysis.	[Steffler, Fabian; Sieber, Volker] Tech Univ Munich, Straubing Ctr Sci, Straubing, Germany	Technical University of Munich	Sieber, V (corresponding author), Tech Univ Munich, Straubing Ctr Sci, Straubing, Germany.	sieber@tum.de	Sieber, Volker/D-2006-2013	Sieber, Volker/0000-0001-5458-9330	German Ministry of Education and Science (BMBF) [0315485B]	German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was kindly supported by the German Ministry of Education and Science (BMBF) through grant No. 0315485B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGAR EM, 1985, J BIOTECHNOL, V2, P275, DOI 10.1016/0168-1656(85)90030-6; [Anonymous], 1989, PROTEIN STRUCTURE PR; ARNOLD FH, 1988, PROTEIN ENG, V2, P21, DOI 10.1093/protein/2.1.21; Atsumi S, 2010, MOL SYST BIOL, V6, P11; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brynildsen MP, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.34; CHENAULT HK, 1987, APPL BIOCHEM BIOTECH, V14, P147, DOI 10.1007/BF02798431; Consalvi V, 2000, PROTEIN ENG, V13, P501, DOI 10.1093/protein/13.7.501; Cowan DA, 1997, COMP BIOCHEM PHYS A, V118, P429, DOI 10.1016/S0300-9629(97)00004-2; Dashivets T, 2009, CHEMBIOCHEM, V10, P869, DOI 10.1002/cbic.200800697; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guagliardi A, 1996, INT J BIOCHEM CELL B, V28, P239, DOI 10.1016/1357-2725(95)00138-7; Guterl JK, 2013, ENG LIFE SCI, V13, P4, DOI 10.1002/elsc.201100231; Guterl JK, 2012, CHEMSUSCHEM, V5, P2165, DOI 10.1002/cssc.201200365; HEDRICK JL, 1964, ARCH BIOCHEM BIOPHYS, V105, P261, DOI 10.1016/0003-9861(64)90007-4; Holzinger A, 1996, BIOTECHNIQUES, V20, P804; IMANAKA T, 1993, J FERMENT BIOENG, V76, P161, DOI 10.1016/0922-338X(93)90001-O; Janker-Obermeier I, 2012, IND CROP PROD, V39, P198, DOI 10.1016/j.indcrop.2012.02.022; Jankowski MD, 2008, BIOPHYS J, V95, P1487, DOI 10.1529/biophysj.107.124784; Jung JH, 2006, BIOCHEM J, V397, P131, DOI 10.1042/BJ20051763; Kato T, 2010, EXTREMOPHILES, V14, P33, DOI 10.1007/s00792-009-0285-8; Kaur J, 2006, CRIT REV BIOTECHNOL, V26, P165, DOI 10.1080/07388550600851423; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim S, 2008, PROTEIN EXPRES PURIF, V62, P116, DOI 10.1016/j.pep.2008.06.015; Kolb M, 2012, BIORESOURCE TECHNOL, V104, P298, DOI 10.1016/j.biortech.2011.11.080; Kube J, 2006, EXTREMOPHILES, V10, P221, DOI 10.1007/s00792-005-0490-z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016438; NEUBAUER P, 1995, BIOTECHNOL BIOENG, V47, P139, DOI 10.1002/bit.260470204; Ogawa J, 2002, CURR OPIN BIOTECH, V13, P367, DOI 10.1016/S0958-1669(02)00331-2; Pandey A, 2000, BIOTECHNOL APPL BIOC, V31, P135, DOI 10.1042/BA19990073; Perozich J, 2000, EUR J BIOCHEM, V267, P6197, DOI 10.1046/j.1432-1327.2000.01697.x; Reher M, 2006, FEBS LETT, V580, P1198, DOI 10.1016/j.febslet.2006.01.029; Richter N, 2009, CHEMBIOCHEM, V10, P1888, DOI 10.1002/cbic.200900193; Rodriguez-Zavala JS, 2006, PROTEIN SCI, V15, P1387, DOI 10.1110/ps.052039606; Rohowsky B, 2012, APPLIED ENERGY; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Ruszczycky MW, 2004, BIOORG CHEM, V32, P51, DOI 10.1016/j.bioorg.2003.09.006; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sieber V, 1998, NAT BIOTECHNOL, V16, P955, DOI 10.1038/nbt1098-955; Sorensen HP, 2003, J CHROMATOGR B, V786, P207, DOI 10.1016/S1570-0232(02)00689-X; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu X, 2013, APPLIED AND ENVIRONM; Yamanaka Y, 2002, BIOCHEM BIOPH RES CO, V298, P632, DOI 10.1016/S0006-291X(02)02523-8; Ye XH, 2009, CHEMSUSCHEM, V2, P149, DOI 10.1002/cssc.200900017; YIN SJ, 1989, BIOCHEM GENET, V27, P321, DOI 10.1007/BF00554167; You C, 2012, CELL FREE BIOSYSTEMS, P1; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456; Zhang YHP, 2011, J MATER CHEM, V21, P18877, DOI 10.1039/c1jm12078f	54	8	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70592	10.1371/journal.pone.0070592	http://dx.doi.org/10.1371/journal.pone.0070592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894676	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900137
J	Kumar, BN; Taylor, RW; Pask, GM; Zwiebel, LJ; Newcomb, RD; Christie, DL				Kumar, Brijesh N.; Taylor, Robert W.; Pask, Gregory M.; Zwiebel, Laurence J.; Newcomb, Richard D.; Christie, David L.			A Conserved Aspartic Acid Is Important for Agonist (VUAA1) and Odorant/Tuning Receptor-Dependent Activation of the Insect Odorant Co-Receptor (Orco)	PLOS ONE			English	Article							MOSQUITO ANOPHELES-GAMBIAE; TRANSMEMBRANE DOMAIN; OLFACTORY RECEPTORS; MEMBRANE TOPOLOGY; MOLECULAR-BASIS; ION CHANNELS; SELECTIVITY; SUBUNIT; BLOCK	Insect odorant receptors function as heteromeric odorant-gated cation channels comprising a conventional odorant-sensitive tuning receptor, and a conserved co-receptor (Orco). An Orco agonist, VUAA1, is able to activate both heteromeric and homomeric Orco-containing channels. Very little is known about specific residues in Orco that contribute to cation permeability and gating. We investigated the importance of two conserved Asp residues, one in each of transmembrane domains 5 and 7, for channel function by mutagenesis. Drosophila melanogaster Orco and its substitution mutants were expressed in HEK cells and VUAA1-stimulated channel activity was determined by Ca2+ influx and whole-cell patch clamp electrophysiology. Substitution of D466 in transmembrane 7 with amino acids other than glutamic acid resulted in a substantial reduction in channel activity. The D466E Orco substitution mutant was,2 times more sensitive to VUAA1. The permeability of the D466E Orco mutant to cations was unchanged relative to wild-type Orco. When D466E Orco is co-expressed with a conventional tuning odorant receptor, the heteromeric complex also shows increased sensitivity to an odorant. Thus, the effect of the D466E mutation is not specific to VUAA1 agonism or dependent on homomeric Orco assembly. We suggest the gain-of-activation characteristic of the D466E mutant identifies an amino acid that is likely to be important for activation of both heteromeric and homomeric insect odorant receptor channels.	[Kumar, Brijesh N.; Newcomb, Richard D.; Christie, David L.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Taylor, Robert W.; Pask, Gregory M.; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Chem Biol & Global Hlth, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Program Dev Biol, Nashville, TN USA; [Newcomb, Richard D.] Plant & Food Res, Auckland, New Zealand	University of Auckland; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; New Zealand Institute for Plant & Food Research Ltd	Christie, DL (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	d.christie@auckland.ac.nz	Kumar, Brijesh/GPP-3392-2022; Christie, David L/C-8065-2009; Newcomb, Richard/C-2067-2009	Kumar, Brijesh/0000-0003-0271-3445; Newcomb, Richard/0000-0002-7307-9755; Zwiebel, Laurence/0000-0001-6686-7289	Marsden Fund; Royal Society of New Zealand [PAF-09-01]; US National Institutes of Health (NIAID) [AI056402]; NIDCD through an NRSA [F31 [DC011989]]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011989] Funding Source: NIH RePORTER	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Royal Society of New Zealand(Royal Society of New Zealand); US National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCD through an NRSA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research was supported by grants from the Marsden Fund supported by the Royal Society of New Zealand (PAF-09-01 to RDN) and the US National Institutes of Health (NIAID, AI056402 to LJZ). G. M. P was supported by the NIDCD through an NRSA F31 [DC011989]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bohbot JD, 2011, CHEM SENSES, V36, P149, DOI 10.1093/chemse/bjq105; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605; Dodd JR, 2001, J BIOL CHEM, V276, P46983, DOI 10.1074/jbc.M107137200; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Li TB, 2011, J GEN PHYSIOL, V137, P289, DOI 10.1085/jgp.201010576; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Taylor RW, 2012, ACS CHEM BIOL, V7, P1647, DOI 10.1021/cb300331z; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wicher D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00001; Zhou XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002930	31	26	27	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70218	10.1371/journal.pone.0070218	http://dx.doi.org/10.1371/journal.pone.0070218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894621	gold, Green Published, Green Submitted			2022-12-25	WOS:000325211000196
J	Kolpakova, A; Katz, S; Keren, A; Rojtblat, A; Bengal, E				Kolpakova, Alina; Katz, Sandra; Keren, Aviad; Rojtblat, Adi; Bengal, Eyal			Transcriptional Regulation of Mesoderm Genes by MEF2D during Early Xenopus Development	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; ENHANCER FACTOR 2A; MAP KINASE; GASTRULATION MOVEMENTS; EXPRESSION; INDUCTION; EMBRYOS; ACTIVATION; LAEVIS; HYBRIDIZATION	In Xenopus, specification of the three germ layers is one of the earliest developmental decisions occurring prior to gastrulation. The maternally-expressed vegetally-localized transcription factor VegT has a central role in cell autonomous specification of endoderm and in the generation of mesoderm-inducing signals. Yet, marginally-expressed transcription factors that cooperate with mesoderm-inducing signals are less investigated. Here we report that the transcription factors MEF2A and MEF2D are expressed in the animal hemisphere before mid-blastula transition. At the initiation of zygotic transcription, expression of MEF2D expands into the marginal region that gives rise to mesoderm. Knockdown of MEF2D delayed gastrulation movements, prevented embryo elongation at the subsequent tailbud stage and caused severe defects in axial tissues. At the molecular level, MEF2D knockdown reduced the expression of genes involved in mesoderm formation and patterning. We also report that MEF2D functions with FGF signaling in a positive feedback loop; each augments the expression of the other in the marginal region and both are necessary for mesodermal gene expression. One target of MEF2D is the Nodal-related 1 gene (Xnr1) that mediates some of MEF2D mesodermal activities. Chromatin immunoprecipitation analysis revealed that MEF2D associates with transcriptional regulatory sequences of the Xnr1 gene. Several MEF2 binding sites within the proximal promoter region of Xnr1 were identified by their in vitro association with MEF2D protein. The same promoter region was necessary but not sufficient to mediate MEF2D activity in a reporter gene assay. In sum, our results indicate that the MEF2D protein is a key transcription factor in the marginal zone acting in a positive feedback loop with FGF signaling that promotes mesoderm specification at late blastula stages.	[Kolpakova, Alina; Katz, Sandra; Keren, Aviad; Rojtblat, Adi; Bengal, Eyal] Technion Israel Inst Technol, Rappaport Inst Res Med Sci, Dept Biochem, Fac Med, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Bengal, E (corresponding author), Technion Israel Inst Technol, Rappaport Inst Res Med Sci, Dept Biochem, Fac Med, Haifa, Israel.	bengal@tx.technion.ac.il			Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the Israel Science Foundation, founded by the Israel Academy of Sciences and Humanities, Niedersachsen-Israeli Research Cooperation Program, Rappaport Institute for Medical Research and the Technion Fund for Advancement of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius E, 2000, DEVELOPMENT, V127, P1173; AMAYA E, 1993, DEVELOPMENT, V118, P477; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; CHAMBERS AE, 1994, GENE DEV, V8, P1324, DOI 10.1101/gad.8.11.1324; Clements D, 1999, DEVELOPMENT, V126, P4903; Cox DM, 2003, J BIOL CHEM, V278, P15297, DOI 10.1074/jbc.M211312200; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; della Gaspera B, 2009, DEV BIOL, V328, P392, DOI 10.1016/j.ydbio.2009.01.039; Fletcher G, 2006, MECH DEVELOP, V123, P730, DOI 10.1016/j.mod.2006.07.007; Fletcher RB, 2008, DEV DYNAM, V237, P1243, DOI 10.1002/dvdy.21517; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; GOTOH Y, 1995, EMBO J, V14, P2491, DOI 10.1002/j.1460-2075.1995.tb07246.x; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HARTLEY RS, 1994, DEV BIOL, V163, P521, DOI 10.1006/dbio.1994.1168; HEASMAN J, 1984, CELL, V37, P185, DOI 10.1016/0092-8674(84)90314-3; Heasman J, 2006, SEMIN CELL DEV BIOL, V17, P93, DOI 10.1016/j.semcdb.2005.11.005; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Hyde CE, 2000, DEVELOPMENT, V127, P1221; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; King ML, 2005, BIOL CELL, V97, P19; Kofron M, 1999, DEVELOPMENT, V126, P5759; Lea R, 2009, DEV DYNAM, V238, P1467, DOI 10.1002/dvdy.21913; LEIBHAM D, 1994, MOL CELL BIOL, V14, P686, DOI 10.1128/MCB.14.1.686; Luxardi G, 2010, DEVELOPMENT, V137, P417, DOI 10.1242/dev.039735; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Nentwich O, 2009, DEV BIOL, V336, P313, DOI 10.1016/j.ydbio.2009.09.039; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1977, Current Topics Dev Biol, V11, P115, DOI 10.1016/S0070-2153(08)60744-9; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Osada SI, 2000, DEVELOPMENT, V127, P2503; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Quinn ZA, 2001, NUCLEIC ACIDS RES, V29, P732, DOI 10.1093/nar/29.3.732; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Satoh K, 2007, MOL CELL BIOL, V27, P7623, DOI 10.1128/MCB.01481-07; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Sturla LM, 2005, CANCER RES, V65, P5683, DOI 10.1158/0008-5472.CAN-04-2283; Takahashi S, 2000, DEVELOPMENT, V127, P5319; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; Wylie C, 1996, DEVELOPMENT, V122, P2987; Yang J, 2002, DEVELOPMENT, V129, P5743, DOI 10.1242/dev.00150; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Zetser A, 2001, DEV BIOL, V240, P168, DOI 10.1006/dbio.2001.0465; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	48	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69693	10.1371/journal.pone.0069693	http://dx.doi.org/10.1371/journal.pone.0069693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894525	Green Published, gold, Green Submitted			2022-12-25	WOS:000322391400067
J	Donley, C; McClelland, K; McKeen, HD; Nelson, L; Yakkundi, A; Jithesh, PV; Burrows, J; McClements, L; Valentine, A; Prise, KM; McCarthy, HO; Robson, T				Donley, C.; McClelland, K.; McKeen, H. D.; Nelson, L.; Yakkundi, A.; Jithesh, P. V.; Burrows, J.; McClements, L.; Valentine, A.; Prise, K. M.; McCarthy, H. O.; Robson, T.			Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen	ONCOGENE			English	Article						RBCK1; FKBPL; estrogen receptor; p21; tamoxifen	PROTEIN-KINASE-C; UBIQUITIN LIGASE COMPLEX; ESTROGEN-RECEPTOR-ALPHA; KAPPA-B ACTIVATION; BREAST-CANCER; CELL-PROLIFERATION; BINDING-PROTEIN; DEGRADATION; GENE; TRANSCRIPTION	FKBPL has been implicated in processes associated with cancer, including regulation of tumor growth and angiogenesis with high levels of FKBPL prognosticating for improved patient survival. Understanding how FKBPL levels are controlled within the cell is therefore critical. We have identified a novel role for RBCK1 as an FKBPL-interacting protein, which regulates FKBPL stability at the post-translational level via ubiquitination. Both RBCK1 and FKBPL are upregulated by 17-beta-estradiol and interact within heat shock protein 90 chaperone complexes, together with estrogen receptor-alpha (ER alpha). Furthermore, FKBPL and RBCK1 associate with ER alpha at the promoter of the estrogen responsive gene, pS2, and regulate pS2 levels. MCF-7 clones stably overexpressing RBCK1 were shown to have reduced proliferation and increased levels of FKBPL and p21. Furthermore, these clones were resistant to tamoxifen therapy, suggesting that RBCK1 could be a predictive marker of response to endocrine therapy. RBCK1 knockdown using targeted small interfering RNA resulted in increased proliferation and increased sensitivity to tamoxifen treatment. Moreover, in support of our in vitro data, analysis of mRNA microarray data sets demonstrated that high levels of FKBPL and RBCK1 correlated with increased patient survival, whereas high RBCK1 predicted for a poor response to tamoxifen. Our findings support a role for RBCK1 in the regulation of FKBPL with important implications for estrogen receptor signaling, cell proliferation and response to endocrine therapy.	[Donley, C.; McClelland, K.; McKeen, H. D.; Nelson, L.; Yakkundi, A.; Burrows, J.; McClements, L.; Valentine, A.; McCarthy, H. O.; Robson, T.] Queens Univ Belfast, Sch Pharm, McClay Res Ctr, Belfast BT9 7BL, Antrim, North Ireland; [Jithesh, P. V.] Univ Liverpool, Liverpool Canc Res UK Ctr, Liverpool L69 3BX, Merseyside, England; [Prise, K. M.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast; University of Liverpool; Queens University Belfast	Robson, T (corresponding author), Queens Univ Belfast, Sch Pharm, McClay Res Ctr, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	t.robson@qub.ac.uk	Prise, Kevin/N-7872-2015; Jithesh, Puthen Veettil/O-6262-2019; McClements, Lana/S-9458-2019	Prise, Kevin/0000-0001-6134-7946; Jithesh, Puthen Veettil/0000-0001-7747-0930; McClements, Lana/0000-0002-4911-1014; McCarthy, Helen/0000-0002-1254-3745; Cochrane, Keeva/0000-0001-7961-0474; Robson, Tracy/0000-0003-4262-6872	Department of Employment and Learning, Northern Ireland; Action Cancer, Northern Ireland; Breast Cancer Campaign, United Kingdom; Medical Research Council, United Kingdom; Biotechnology and Biological Sciences Research Council, United Kingdom; Biotechnology and Biological Sciences Research Council [BB/I006958/1] Funding Source: researchfish; Medical Research Council [G1001473] Funding Source: researchfish; BBSRC [BB/I006958/1] Funding Source: UKRI; MRC [G1001473] Funding Source: UKRI	Department of Employment and Learning, Northern Ireland; Action Cancer, Northern Ireland; Breast Cancer Campaign, United Kingdom; Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The financial support for this work was provided by PhD studentships awarded to C Donley and K McClelland from Department of Employment and Learning, Northern Ireland and Action Cancer, Northern Ireland, respectively. HD McKeen was supported by grants from Breast Cancer Campaign, United Kingdom and then the Medical Research Council, United Kingdom and A Yakkundi was supported by a grant from the Biotechnology and Biological Sciences Research Council, United Kingdom. All grants were awarded to T Robson.	Bublik DR, 2010, J BIOL CHEM, V285, P5274, DOI 10.1074/jbc.M109.045948; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Cong YS, 1997, J BIOL CHEM, V272, P16482, DOI 10.1074/jbc.272.26.16482; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09; Gustafsson N, 2010, CANCER RES, V70, P1265, DOI 10.1158/0008-5472.CAN-09-2674; Gustafsson-Sheppard NN, 2012, J MOL ENDOCRINOL, V49, P277; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Inn KS, 2011, MOL CELL, V41, P354, DOI 10.1016/j.molcel.2010.12.029; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Landgraf K, 2010, MOL CELL BIOL, V30, P5764, DOI 10.1128/MCB.01645-09; Li Yue-Ying, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P733; McKeen HD, 2008, ENDOCRINOLOGY, V149, P5724, DOI 10.1210/en.2008-0168; McKeen HD, 2011, BIOCHEM SOC T, V39, P663, DOI 10.1042/BST0390663; McKeen HD, 2010, CANCER RES, V70, P1090, DOI 10.1158/0008-5472.CAN-09-2515; Mullenders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004798; Nakamura M, 2006, BIOCHEM BIOPH RES CO, V351, P340, DOI 10.1016/j.bbrc.2006.09.163; Ni L, 2010, MOL CELL BIOL, V30, P1243, DOI 10.1128/MCB.01891-08; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Robson T, 1999, RADIAT RES, V152, P451, DOI 10.2307/3580140; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; Sunnotel O, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-22; Tian Y, 2007, J BIOL CHEM, V282, P16776, DOI 10.1074/jbc.M701913200; Tokunaga C, 1998, BIOCHEM BIOPH RES CO, V244, P353, DOI 10.1006/bbrc.1998.8270; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Valentine A, 2011, CLIN CANCER RES, V17, P1044, DOI 10.1158/1078-0432.CCR-10-2241; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Yao YL, 2011, CURR OPIN PHARMACOL, V11, P301, DOI 10.1016/j.coph.2011.03.005; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2	36	19	21	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 26	2014	33	26					3441	3450		10.1038/onc.2013.306	http://dx.doi.org/10.1038/onc.2013.306			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK9WM	23912458				2022-12-25	WOS:000338779300011
J	Andrianifahanana, M; Wilkes, MC; Gupta, SK; Rahimi, RA; Repellin, CE; Edens, M; Wittenberger, J; Yin, XQ; Maidl, E; Becker, J; Leof, EB				Andrianifahanana, Mahefatiana; Wilkes, Mark C.; Gupta, Shiv K.; Rahimi, Rod A.; Repellin, Claire E.; Edens, Maryanne; Wittenberger, Joshua; Yin, Xueqian; Maidl, Elizabeth; Becker, Jackson; Leof, Edward B.			Profibrotic TGF beta responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases	FASEB JOURNAL			English	Article						EGF; pulmonary fibrosis	GROWTH-FACTOR-BETA; INDUCED PULMONARY-FIBROSIS; IMATINIB MESYLATE; PHOSPHATIDYLINOSITOL 3-KINASE; MAP KINASE; ACTIVATION; LUNG; MECHANISMS; EXPRESSION; INDUCTION	Transforming growth factor (TGF) has significant profibrotic activity both in vitro and in vivo. This reflects its capacity to stimulate fibrogenic mediators and induce the expression of other profibrotic cytokines such as platelet-derived growth factor (PDGF) and epidermal growth factor (EGF/ErbB) ligands. Here we address both the mechanisms by which TGF induced ErbB ligands and the physiological significance of inhibiting multiple TGF-regulated processes. The data document that ErbB ligand induction requires PDGF receptor (PDGFR) mediation and engages a positive autocrine/paracrine feedback loop via ErbB receptors. Whereas PDGFRs are essential for TGF-stimulated ErbB ligand up-regulation, TGF-specific signals are also required for ErbB receptor activation. Subsequent profibrotic responses are shown to involve the cooperative action of PDGF and ErbB signaling. Moreover, using a murine treatment model of bleomycin-induced pulmonary fibrosis we found that inhibition of TGF/PDGF and ErbB pathways with imatinib plus lapatinib, respectively, not only prevented myofibroblast gene expression to a greater extent than either drug alone, but also essentially stabilized gas exchange (oxygen saturation) as an overall measure of lung function. These observations provide important mechanistic insights into profibrotic TGF signaling and indicate that targeting multiple cytokines represents a possible strategy to ameliorate organ fibrosis dependent on TGF.Andrianifahanana, M., Wilkes, M. C., Gupta, S. K., Rahimi, R. R., Repellin, C. E., Edens, M., Wittenberger, J., Yin, X., Maidl, E., Becker, J., Leof, E. B. Profibrotic TGF responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases.	[Andrianifahanana, Mahefatiana; Wilkes, Mark C.; Gupta, Shiv K.; Edens, Maryanne; Wittenberger, Joshua; Yin, Xueqian; Maidl, Elizabeth; Becker, Jackson; Leof, Edward B.] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Thorac Dis Res Unit,Div Pulm & Crit Care Med, Rochester, MN 55905 USA; [Rahimi, Rod A.] Johns Hopkins Med Ctr, Baltimore, MD USA; [Repellin, Claire E.] Stanford Res Inst, Menlo Pk, CA USA	Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; SRI International; Stanford University	Leof, EB (corresponding author), Mayo Clin, Stabile 858,200 1st St SW, Rochester, MN 55905 USA.	leof.edward@mayo.edu		Wilkes, Mark/0000-0002-9600-6831	U.S. Public Health Service from the National Institute of General Medical Sciences [GM-55816, GM-54200]; Scleroderma Foundation; Mayo Foundation; Fraternal Order of Eagles Cancer Research Fund (Rochester, MN, USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841, R01GM055816, R37GM055816, R01GM054200] Funding Source: NIH RePORTER	U.S. Public Health Service from the National Institute of General Medical Sciences; Scleroderma Foundation; Mayo Foundation; Fraternal Order of Eagles Cancer Research Fund (Rochester, MN, USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Public Health Service grants GM-55816 and GM-54200 from the National Institute of General Medical Sciences, the Scleroderma Foundation, and the Mayo Foundation (to E. B. L.). M. A. received a Fraternal Order of Eagles Cancer Research Fund (Rochester, MN, USA) fellowship grant. The authors declare no conflicts of interest.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Andrianifahanana M, 2010, CANCER RES, V70, P7421, DOI 10.1158/0008-5472.CAN-10-0232; Aono Y, 2005, AM J RESP CRIT CARE, V171, P1279, DOI 10.1164/rccm.200404-531OC; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Beyer C, 2012, CURR OPIN RHEUMATOL, V24, P274, DOI 10.1097/BOR.0b013e3283524b9a; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Cho MC, 2008, BIOCHEM BIOPH RES CO, V377, P832, DOI 10.1016/j.bbrc.2008.10.053; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; DANIEL TO, 1987, J BIOL CHEM, V262, P11893; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Daniels CE, 2010, AM J RESP CRIT CARE, V181, P604, DOI 10.1164/rccm.200906-0964OC; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Distler O., 2010, ARTHRITIS RHEUM S10, V62, P560, DOI DOI 10.1002/ART.28329; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; GOUSTIN AS, 1986, CANCER RES, V46, P1015; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hong M, 2011, J BIOL CHEM, V286, P17841, DOI 10.1074/jbc.M111.233676; Ishii Y, 2006, AM J RESP CRIT CARE, V174, P550, DOI 10.1164/rccm.200509-1534OC; Khanna D, 2011, ARTHRITIS RHEUM-US, V63, P3540, DOI 10.1002/art.30548; Kolosova I, 2011, J CELL PHYSIOL, V226, P1248, DOI 10.1002/jcp.22448; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; Magro L, 2008, BONE MARROW TRANSPL, V42, P757, DOI 10.1038/bmt.2008.252; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; MOSELEY PL, 1986, J CLIN INVEST, V78, P1150, DOI 10.1172/JCI112695; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nakerakanti Sashidhar, 2012, Open Rheumatol J, V6, P156, DOI 10.2174/1874312901206010156; Olivieri A, 2009, BLOOD, V114, P709, DOI 10.1182/blood-2009-02-204156; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Pope J, 2011, ARTHRITIS RHEUM-US, V63, P3547, DOI 10.1002/art.30549; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Rice AB, 1999, AM J PATHOL, V155, P213, DOI 10.1016/S0002-9440(10)65115-2; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; Sivakumar P, 2012, CURR OPIN PULM MED, V18, P462, DOI 10.1097/MCP.0b013e328356800f; Spiera RF, 2011, ANN RHEUM DIS, V70, P1003, DOI 10.1136/ard.2010.143974; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Takahashi M, 2003, CIRCULATION, V108, P2524, DOI 10.1161/01.CIR.0000096482.02567.8C; Taylor LM, 2000, J BIOL CHEM, V275, P16709, DOI 10.1074/jbc.275.22.16709; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Wilkes MC, 2006, J BIOL CHEM, V281, P27846, DOI 10.1074/jbc.M603721200; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xie T, 2011, PHYSIOL GENOMICS, V43, P479, DOI 10.1152/physiolgenomics.00222.2010; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001	60	38	42	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4444	4454		10.1096/fj.12-224907	http://dx.doi.org/10.1096/fj.12-224907			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23913859	Green Published			2022-12-25	WOS:000329937500012
J	Dangel, A; Ackermann, N; Abdel-Hadi, O; Maier, R; Onder, K; Francois, P; Muller, CW; Pane-Farre, J; Engelmann, S; Schrenzel, J; Heesemann, J; Lindermayr, C				Dangel, Alexandra; Ackermann, Nikolaus; Abdel-Hadi, Omar; Maier, Richard; Oender, Kamil; Francois, Patrice; Mueller, Carsten W.; Pane-Farre, Jan; Engelmann, Susanne; Schrenzel, Jacques; Heesemann, Juergen; Lindermayr, Christian			A de novo-designed antimicrobial peptide with activity against multiresistant Staphylococcus aureus acting on RsbW kinase	FASEB JOURNAL			English	Article						sigma B transcription factor; NanoSIMS; DNA binding	SIGMA-FACTOR SIGMA(B); RECOMBINATIONAL CLONING; BIOFILM FORMATION; GENOME SEQUENCE; CELL; VIRULENCE; RESISTANCE; EVOLUTION; MEMBRANE; MICROORGANISMS	Antimicrobial peptides are a promising complement to common antibiotics, development of resistance to which is a growing problem. Here we present a de novo-designed peptide, SP1-1 (RKKRLKLLKRLL-NH2), with antimicrobial activity against multiresistant Staphylococcus aureus (minimal inhibitory concentration: 6.25 M). Elucidation of the mode of action of this peptide revealed a strong interaction with RsbW kinase (K-d: 6.01 +/- 2.73 nM), a serine kinase negatively regulating the activity of the transcription factor sigma B (SigB). SP1-1 binding and functional modulation of RsbW were shown in vitro by a combination of biochemical, molecular, and biophysical methods, which were further genetically evidenced in vivo by analysis of S. aureus sigB deletion mutants. Intracellular localization of the peptide was demonstrated using nanometer-scaled secondary ion mass spectrometry. Moreover, microarray analysis revealed that transcription of numerous genes, involved in cell wall and amino acid metabolism, transport mechanisms, virulence, and pigmentation, is affected. Interestingly, several WalR binding motif containing genes are induced by SP1-1. In sum, the designed peptide SP1-1 seems to have multiple modes of action, including inhibition of a kinase, and therefore might contribute to the development of new antibacterial compounds, giving bacterial kinase inhibition a closer inspection.Dangel, A., Ackermann, N., Abdel-Hadi, O., Maier, R., onder, K., Francois, P., Muller, C. W., Pane-Farre, J., Engelmann, S., Schrenzel, J., Heesemann, J., Lindermayr, C. A de novo-designed antimicrobial peptide with activity against multiresistant Staphylococcus aureus acting on RsbW kinase.	[Dangel, Alexandra; Lindermayr, Christian] Helmholtz Ctr Munich, Inst Biochem Plant Pathol, Neuherberg, Germany; [Ackermann, Nikolaus; Heesemann, Juergen] Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany; [Abdel-Hadi, Omar; Maier, Richard; Oender, Kamil] Paracelsus Med Univ Salzburg, Dept Dermatol, Salzburg, Austria; [Francois, Patrice; Schrenzel, Jacques] Univ Hosp Geneva, Genom Res Lab, Geneva, Switzerland; [Mueller, Carsten W.] Tech Univ Munich, Dept Soil Sci, Freising Weihenstephan, Germany; [Pane-Farre, Jan; Engelmann, Susanne] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Paracelsus Private Medical University; University of Geneva; Technical University of Munich; Ernst Moritz Arndt Universitat Greifswald	Lindermayr, C (corresponding author), Helmholtz Zentrum Munich, Land Str, D-85764 Munich, Germany.	lindermayr@helmholtz-muenchen.de	Lindermayr, Christian/M-7338-2014; Schrenzel, Jacques/AAC-5685-2021; francois, patrice/AAL-5583-2020; Mueller, Carsten W/C-2679-2012; Schrenzel, Jacques/P-8525-2017; Dangel, Alexandra/Y-8811-2019	Lindermayr, Christian/0000-0002-9343-4996; Schrenzel, Jacques/0000-0001-5464-7764; Mueller, Carsten W/0000-0003-4119-0544; Schrenzel, Jacques/0000-0001-5464-7764; Dangel, Alexandra/0000-0001-6737-5681; francois, patrice/0000-0002-0540-750X				Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Andres E, 2012, EUR J CLIN MICROBIOL, V31, P881, DOI 10.1007/s10096-011-1430-8; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Behrens S, 2012, ENVIRON MICROBIOL, V14, P2851, DOI 10.1111/j.1462-2920.2012.02724.x; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Brandner CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-321; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Cameca, 2009, NANOSIMS 50 50L INST; Cebrian G, 2009, J APPL MICROBIOL, V107, P187, DOI 10.1111/j.1365-2672.2009.04194.x; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Chen H, 2011, PLOS ONE, V6; Chen ZJ, 2011, APPL MICROBIOL BIOT, V89, P281, DOI 10.1007/s00253-010-2864-0; COUTO MA, 1993, INFECT IMMUN, V61, P2991, DOI 10.1128/IAI.61.7.2991-2994.1993; Delaune A, 2012, INFECT IMMUN, V80, P3438, DOI 10.1128/IAI.00195-12; Diemond-Hernandez B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-68; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Garcia-Olmedo F, 1998, BIOPOLYMERS, V47, P479, DOI 10.1002/(SICI)1097-0282(1998)47:6<479::AID-BIP6>3.0.CO;2-K; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillaspy A. F., 2007, STAPHYLOCOCCUS AUREU; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Guerquin-Kern JL, 2005, BBA-GEN SUBJECTS, V1724, P228, DOI 10.1016/j.bbagen.2005.05.013; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hecker M, 2009, RES MICROBIOL, V160, P245, DOI 10.1016/j.resmic.2009.03.008; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Kim JY, 2011, AMINO ACIDS, V40, P183, DOI 10.1007/s00726-010-0632-1; King-Scott J, 2011, STRUCTURE, V19, P56, DOI 10.1016/j.str.2010.11.010; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Laverty G, 2011, INT J MOL SCI, V12, P6566, DOI 10.3390/ijms12106566; Livermore DM, 2004, CLIN MICROBIOL INFEC, V10, P1, DOI 10.1111/j.1465-0691.2004.1004.x; Maier RH, 2008, BIOTECHNIQUES, V45, P235, DOI 10.2144/000112897; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2157, DOI 10.1007/s00018-011-0709-3; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1082, DOI 10.1023/B:BIRY.0000046881.29486.51; Miyazaki E, 1999, J BACTERIOL, V181, P2846, DOI 10.1128/JB.181.9.2846-2851.1999; Musat N, 2012, FEMS MICROBIOL REV, V36, P486, DOI 10.1111/j.1574-6976.2011.00303.x; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Otvos L, 2000, BIOCHEMISTRY-US, V39, P14150, DOI 10.1021/bi0012843; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; Pane-Farre J, 2009, J BACTERIOL, V191, P2561, DOI 10.1128/JB.01514-08; Park CB, 1996, BIOCHEM BIOPH RES CO, V218, P408, DOI 10.1006/bbrc.1996.0071; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pietiainen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-429; Scherl A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-296; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Senn MM, 2005, J BACTERIOL, V187, P8006, DOI 10.1128/JB.187.23.8006-8019.2005; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang GS, 2012, ANTIMICROB AGENTS CH, V56, P845, DOI 10.1128/AAC.05637-11; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wilke MH, 2010, EUR J MED RES, V15, P571, DOI 10.1186/2047-783X-15-12-571; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zeng XC, 2012, PEPTIDES, V33, P44, DOI 10.1016/j.peptides.2011.11.012	72	17	18	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4476	4488		10.1096/fj.13-234575	http://dx.doi.org/10.1096/fj.13-234575			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23901070	Green Published			2022-12-25	WOS:000329937500015
J	Prado, GN; Romero, JR; Rivera, A				Prado, Gregory N.; Romero, Jose R.; Rivera, Alicia			Endothelin-1 receptor antagonists regulate cell surface-associated protein disulfide isomerase in sickle cell disease	FASEB JOURNAL			English	Article						erythrocytes; Gardos channel; redox reactions; Berkeley transgenic SCD mice	ERYTHROCYTE DEHYDRATION; THROMBUS FORMATION; PLASMA-MEMBRANE; CL-COTRANSPORT; K+ TRANSPORT; MOUSE MODEL; CHANNEL; ACTIVATION; PHOSPHORYLATION; EXPRESSION	Increased endothelin-1 (ET-1) levels, disordered thiol protein status, and erythrocyte hydration status play important roles in sickle cell disease (SCD) through unresolved mechanisms. Protein disulfide isomerase (PDI) is an oxidoreductase that mediates thiol/disulfide interchange reactions. We provide evidence that PDI is present in human and mouse erythrocyte membranes and that selective blockade with monoclonal antibodies against PDI leads to reduced Gardos channel activity (1.6 +/- 0.03 to 0.56 +/- 0.02 mmol center dot 10(13) cell(-1)center dot min(-1), P<0.001) and density of sickle erythrocytes (D-50: 1.115 +/- 0.001 to 1.104 +/- 0.001 g/ml, P=0.012) with an IC50 of 4 ng/ml. We observed that erythrocyte associated-PDI activity was increased in the presence of ET-1 (3.1 +/- 0.2 to 5.6 +/- 0.4%, P<0.0001) through a mechanism that includes casein kinase II. Consistent with these results, in vivo treatment of BERK sickle transgenic mice with ET-1 receptor antagonists lowered circulating and erythrocyte associated-PDI activity (7.1 +/- 0.3 to 5.2 +/- 0.2%, P<0.0001) while improving hematological parameters and Gardos channel activity. Thus, our results suggest that PDI is a novel target in SCD that regulates erythrocyte volume and oxidative stress and may contribute to cellular adhesion and endothelial activation leading to vasoocclusion as observed in SCD.-Prado, G. N., Romero, J. R., Rivera, A. Endothelin-1 receptor antagonists regulate cell surface-associated protein disulfide isomerase in sickle cell disease.	[Prado, Gregory N.; Rivera, Alicia] Boston Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Prado, Gregory N.; Rivera, Alicia] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Prado, Gregory N.; Romero, Jose R.] Harvard Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Hypertens,Brigham & Women, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Rivera, A (corresponding author), Boston Childrens Hosp, Dept Lab Med, Bader 7,300 Longwood Ave, Boston, MA 02115 USA.	alicia.rivera@childrens.harvard.edu		Romero, Jose Ricardo/0000-0001-8225-0772	U.S. National Institutes of Health [NIH HL090632, HL096518]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096518, R01HL090632] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A preliminary report of these findings was presented in abstract form (63). The authors thank Jessica Alves for her technical assistance; Dr. Gary Bradwin [Manager, Clinical and Epidemiologic Laboratory (CERLab), Boston Children's Hospital] for his kind assistance in setting the ELISA measurements; and Dr. Mary E. Fabry for her invaluable support and contribution with the development of the sickle cell mouse colony. This work was supported by U.S. National Institutes of Health grants NIH HL090632 (to A. R.) and HL096518 (to J.R.R.). Study conception and design was performed by A. R. and J.R.R. Collection and/or assembly of data were performed by G.N.P., J.R.R., and A. R. Data analysis and interpretation were performed by G.N.P., J.R.R., and A. R. Manuscript writing was done by G.N.P., J.R.R., and A. R. Final approval of manuscript was provided by G.N.P., J.R.R, and A. R. The authors declare no conflict of interest.	AKAGI S, 1988, J HISTOCHEM CYTOCHEM, V36, P1069, DOI 10.1177/36.8.3292644; Bailey MA, 2010, J GEN PHYSIOL, V136, P367, DOI 10.1085/jgp.201010430; Bartolucci P, 2012, BLOOD, V120, P3136, DOI 10.1182/blood-2012-04-424184; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Cai S, 1997, J MEMBRANE BIOL, V158, P147, DOI 10.1007/s002329900252; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; CHENG SY, 1986, P NATL ACAD SCI USA, V83, P947, DOI 10.1073/pnas.83.4.947; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Couet J, 1996, BIOCHEMISTRY-US, V35, P14800, DOI 10.1021/bi961359w; DEFRANCESCHI L, 1995, AM J PHYSIOL-CELL PH, V269, pC899, DOI 10.1152/ajpcell.1995.269.4.C899; DEFRANCESCHI L, 1994, J CLIN INVEST, V93, P1670, DOI 10.1172/JCI117149; Donoghue N, 2000, PROTEIN SCI, V9, P2436, DOI 10.1110/ps.9.12.2436; Durpes MC, 2011, J BIOL CHEM, V286, P3057, DOI 10.1074/jbc.M110.173229; Essex DW, 2004, BLOOD, V104, P1383, DOI 10.1182/blood-2004-03-1097; FRELINGER AL, 2013, PLATELETS; FUHRMANN GF, 1985, BIOCHIM BIOPHYS ACTA, V820, P223, DOI 10.1016/0005-2736(85)90116-6; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Graido-Gonzalez E, 1998, BLOOD, V92, P2551, DOI 10.1182/blood.V92.7.2551.2551_2551_2555; HALLIWELL B, 1984, LANCET, V1, P1396; Hatae N, 2007, MOL ENDOCRINOL, V21, P1192, DOI 10.1210/me.2006-0343; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hotchkiss KA, 1998, BBA-PROTEIN STRUCT M, V1388, P478, DOI 10.1016/S0167-4838(98)00211-8; Jasuja R, 2010, BLOOD, V116, P4665, DOI 10.1182/blood-2010-04-278184; Joiner CH, 2004, BLOOD, V104, P2954, DOI 10.1182/blood-2004-01-0112; Kaul DK, 2006, AM J PHYSIOL-HEART C, V291, pH167, DOI 10.1152/ajpheart.01096.2005; KAUL DK, 1983, J CLIN INVEST, V72, P22, DOI 10.1172/JCI110960; Klein H, 2007, J GEN PHYSIOL, V129, P299, DOI 10.1085/jgp.200609726; KRONING H, 1994, SCAND J IMMUNOL, V39, P346, DOI 10.1111/j.1365-3083.1994.tb03384.x; Kutlar A, 2012, AM J HEMATOL, V87, P536, DOI 10.1002/ajh.23147; Laurindo FRM, 2008, ANTIOXID REDOX SIGN, V10, P1101, DOI 10.1089/ars.2007.2011; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; MEGGIO F, 1987, FEBS LETT, V215, P241, DOI 10.1016/0014-5793(87)80154-0; Michael JR, 1997, AM J PHYSIOL-LUNG C, V273, pL768, DOI 10.1152/ajplung.1997.273.4.L768; Muzyamba MC, 2003, J PHYSIOL-LONDON, V547, P903, DOI 10.1113/jphysiol.2002.036467; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Pojoga LH, 2012, AM J HYPERTENS, V25, P243, DOI 10.1038/ajh.2011.197; Prado GN, 2010, BLOOD, V116, P121, DOI 10.1182/blood.V116.21.265.265; RANK BH, 1985, J CLIN INVEST, V75, P1531, DOI 10.1172/JCI111857; Raturi A, 2005, BIOCHEM J, V391, P351, DOI 10.1042/BJ20050770; Raturi A, 2007, FREE RADICAL BIO MED, V43, P62, DOI 10.1016/j.freeradbiomed.2007.03.025; RICEEVANS C, 1986, BIOCHEM J, V237, P265, DOI 10.1042/bj2370265; Rivera A, 2002, BLOOD, V99, P357, DOI 10.1182/blood.V99.1.357; Rivera A, 1999, AM J PHYSIOL-CELL PH, V277, pC746, DOI 10.1152/ajpcell.1999.277.4.C746; Rivera A, 2007, AM J PHYSIOL-CELL PH, V293, pC960, DOI 10.1152/ajpcell.00530.2006; Rivera A, 2013, PHYSIOL GENOMICS, V45, P343, DOI 10.1152/physiolgenomics.00143.2012; Romero JR, 2002, BLOOD, V99, P1103, DOI 10.1182/blood.V99.4.1103; Romero JR, 2004, BLOOD, V103, P2384, DOI 10.1182/blood-2003-01-0237; Rybicki AC, 1998, BLOOD, V92, P2594, DOI 10.1182/blood.V92.7.2594.2594_2594_2596; RYSER HJP, 1999, PLASMA MEMBRANE REDO; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Shartava A, 1999, AM J HEMATOL, V62, P19, DOI 10.1002/(SICI)1096-8652(199909)62:1<19::AID-AJH4>3.0.CO;2-C; Shen J, 2001, J IMMUNOL, V167, P4919, DOI 10.4049/jimmunol.167.9.4919; Sheng K, 1998, BLOOD, V91, P3467, DOI 10.1182/blood.V91.9.3467.3467_3467_3470; Swiatkowska M, 2010, J BIOL CHEM, V285, P29874, DOI 10.1074/jbc.M109.092486; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; TRUDEL M, 1991, EMBO J, V10, P3157, DOI 10.1002/j.1460-2075.1991.tb04877.x; Wagener FADTG, 1997, P SOC EXP BIOL MED, V216, P456; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890	63	17	17	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4619	4629		10.1096/fj.13-228577	http://dx.doi.org/10.1096/fj.13-228577			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23913858	Green Published			2022-12-25	WOS:000329937500027
J	Song, CL; Zhu, SC; Wu, CY; Kang, JH				Song, Chenlin; Zhu, Songcheng; Wu, Chuanyue; Kang, Jiuhong			Histone Deacetylase (HDAC) 10 Suppresses Cervical Cancer Metastasis through Inhibition of Matrix Metalloproteinase (MMP) 2 and 9 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL PROLIFERATION; CARCINOMA-CELLS; OVARIAN-CANCER; IN-VITRO; INVASION; ACTIVATION; MIGRATION; PROTEIN; MATRIX-METALLOPROTEINASE-9	Aberrant expression of histone deacetylases (HDACs) is associated with carcinogenesis. Some HDAC inhibitors are widely considered as promising anticancer therapeutics. A major obstacle for development of HDAC inhibitors as highly safe and effective anticancer therapeutics is that our current knowledge on the contributions of different HDACs in various cancer types remains scant. Here we report that the expression level of HDAC10 was significantly lower in patients exhibiting lymph node metastasis compared with that in patients lacking lymph node metastasis in human cervical squamous cell carcinoma. Forced expression of HDAC10 in cervical cancer cells significantly inhibited cell motility and invasiveness in vitro and metastasis in vivo. Mechanistically, HDAC10 suppresses expression of matrix metalloproteinase (MMP) 2 and 9 genes, which are known to be critical for cancer cell invasion and metastasis. At the molecular level, HDAC10 binds to MMP2 and -9 promoter regions, reduces the histone acetylation level, and inhibits the binding of RNA polymerase II to these regions. Furthermore, an HDAC10 mutant lacking histone deacetylase activity failed to mimic the functions of full-length protein. These results identify a critical role of HDAC10 in suppression of cervical cancer metastasis, underscoring the importance of developing isoform-specific HDAC inhibitors for treatment of certain cancer types such as cervical squamous cell carcinoma.	[Song, Chenlin; Zhu, Songcheng; Kang, Jiuhong] Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hlth Hosp 1, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Tongji University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, 707B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	carywu@pitt.edu; jhkang@tongji.edu.cn			National Institutes of Health [GM65188]; Ministry of Science and Technology [2011CB965100, 2010CB944900, 2011CBA01100, 2011DFA30480, 2010CB945000, 2012CB966603]; National Natural Science Foundation of China [91219305, 31171432, 31101061, 31210103905, 31071306, 31000378, 81170499]; Science and Technology Commission of Shanghai Municipality [11ZR1438500, 11XD1405300]; Ministry of Education [IRT1168, 20110072110039]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM65188(to C. W.). This work was also supported by Ministry of Science and Technology Grants 2011CB965100, 2010CB944900, 2011CBA01100, 2011DFA30480, 2010CB945000, and 2012CB966603; National Natural Science Foundation of China Grants 91219305, 31171432, 31101061, 31210103905, 31071306, 31000378, and 81170499; Science and Technology Commission of Shanghai Municipality Grants 11ZR1438500 and 11XD1405300; and Ministry of Education Grants IRT1168 and 20110072110039.	[Anonymous], 2013, MERCK MAN HOM HLTH H; Armenian Medical Network, 2013, CERV CANC; Armstrong EP, 2010, J MANAGE CARE PHARM, V16, P217, DOI 10.18553/jmcp.2010.16.3.217; Berube M, 2005, MOL VIS, V11, P1101; Boeker KHW, 2002, CLIN CHIM ACTA, V316, P71, DOI 10.1016/S0009-8981(01)00730-6; Boothello R., 2011, MATRIX METALLOPROTEI; Branca M, 2006, ANTICANCER RES, V26, P1543; Chernov AV, 2009, J BIOL CHEM, V284, P12727, DOI 10.1074/jbc.M900273200; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Di Nezza LA, 2002, CANCER, V94, P1466, DOI 10.1002/cncr.10355; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Hellebrekers DMEI, 2007, BBA-REV CANCER, V1775, P76, DOI 10.1016/j.bbcan.2006.07.003; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Im Hogune, 2004, Methods Mol Biol, V284, P129; Kato Y, 2002, ONCOL REP, V9, P565; Kim Y, 2009, BMB REP, V42, P758, DOI 10.5483/BMBRep.2009.42.11.758; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Kristensen LS, 2009, EUR J PHARMACOL, V625, P131, DOI 10.1016/j.ejphar.2009.10.011; Lai IL, 2010, J BIOL CHEM, V285, P7187, DOI 10.1074/jbc.M109.061861; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee JH, 2010, MOL CELLS, V30, P107, DOI 10.1007/s10059-010-0094-z; Lin LF, 2010, CANCER RES, V70, P192, DOI 10.1158/0008-5472.CAN-09-2641; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Michaelis M, 2004, MOL PHARMACOL, V65, P520, DOI 10.1124/mol.65.3.520; Nair SA, 2003, J CANCER RES CLIN, V129, P123, DOI 10.1007/s00432-002-0411-9; Osada H, 2004, INT J CANCER, V112, P26, DOI 10.1002/ijc.20395; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; Roomi MW, 2010, ONCOL REP, V23, P605, DOI 10.3892/or_00000675; Sato T, 2004, GYNECOL ONCOL, V92, P47, DOI 10.1016/j.ygyno.2003.09.012; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Takahra T, 2004, INT J BIOCHEM CELL B, V36, P353, DOI 10.1016/S1357-2725(03)00260-7; Tong JJ, 2002, NUCLEIC ACIDS RES, V30, P1114, DOI 10.1093/nar/30.5.1114; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Vasala K., 2008, ACTA U OUL D, V983; Venkataramani V, 2010, J BIOL CHEM, V285, P10678, DOI 10.1074/jbc.M109.057836; Wang XX, 2013, TUMOR BIOL, V34, P2721, DOI 10.1007/s13277-013-0824-x; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xu P., 2009, MED J W CHINA, V21, P2040; Yang YH, 2013, MOL BIOL REP, V40, P4241, DOI 10.1007/s11033-013-2506-6; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Yu G, 2013, MOL CELL BIOCHEM, V380, P239, DOI 10.1007/s11010-013-1679-6; Zhang L, 2012, MOL CELL BIOCHEM, V361, P39, DOI 10.1007/s11010-011-1085-x; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhou Cai-yun, 2002, Ai Zheng, V21, P735	48	87	99	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28021	28033		10.1074/jbc.M113.498758	http://dx.doi.org/10.1074/jbc.M113.498758			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23897811	hybrid, Green Published			2022-12-25	WOS:000330612800028
J	Mameza, MG; Dvoretskova, E; Bamann, M; Honck, HH; Guler, T; Boeckers, TM; Schoen, M; Verpelli, C; Sala, C; Barsukov, I; Dityatev, A; Kreienkamp, HJ				Mameza, Marie Germaine; Dvoretskova, Elena; Bamann, Margarete; Hoenck, Hans-Hinrich; Gueler, Tuerkan; Boeckers, Tobias M.; Schoen, Michael; Verpelli, Chiara; Sala, Carlo; Barsukov, Igor; Dityatev, Alexander; Kreienkamp, Hans-Juergen			SHANK3 Gene Mutations Associated with Autism Facilitate Ligand Binding to the Shank3 Ankyrin Repeat Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY PROTEINS; ARCHITECTURAL FRAMEWORK; SCAFFOLDING PROTEINS; SYNAPTIC PROTEINS; SPECTRUM DISORDER; FAMILY; SHARPIN; EXPRESSION; BEHAVIORS; COMPLEX	Shank/ProSAP proteins are major scaffold proteins of the postsynaptic density; mutations in the human SHANK3 gene are associated with intellectual disability or autism spectrum disorders. We have analyzed the functional relevance of several SHANK3 missense mutations affecting the N-terminal portion of the protein by expression of wild-type and mutant Shank3 in cultured neurons and by binding assays in heterologous cells. Postsynaptic targeting of recombinant Shank3 was unaltered. In electrophysiological experiments, both wild-type and L68P mutant forms of Shank3 were equally effective in restoring synaptic function after knockdown of endogenous Shank3. We observed that several mutations affected binding to interaction partners of the Shank3 ankyrin repeat region. One of these mutations, L68P, improved binding to both ligands. Leu-68 is located N-terminal to the ankyrin repeats, in a highly conserved region that we identify here as a novel domain termed the Shank/ProSAP N-terminal (SPN) domain. We show that the SPN domain interacts with the ankyrin repeats in an intramolecular manner, thereby restricting access of either Sharpin or alpha-fodrin. The L68P mutation disrupts this blockade, thus exposing the Shank3 ankyrin repeat region to its ligands. Our data identify a new type of regulation of Shank proteins and suggest that mutations in the SHANK3 gene do not necessarily induce a loss of function, but may represent a gain of function with respect to specific interaction partners.	[Mameza, Marie Germaine; Bamann, Margarete; Hoenck, Hans-Hinrich; Gueler, Tuerkan; Kreienkamp, Hans-Juergen] Univ Krankenhaus Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Dvoretskova, Elena; Dityatev, Alexander] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Boeckers, Tobias M.; Schoen, Michael] Univ Ulm, Inst Anat & Cell Biol, D-89069 Ulm, Germany; [Verpelli, Chiara; Sala, Carlo] Univ Milan, Consiglio Nazl Ric, Inst Neurosci, I-20129 Milan, Italy; [Verpelli, Chiara; Sala, Carlo] Univ Milan, Dept Med Biotechnol & Translat Med, I-20129 Milan, Italy; [Sala, Carlo] Neurol Inst Fdn Carlo Besta, Dept Neuromuscular Dis & Neuroimmunol, I-20133 Milan, Italy; [Barsukov, Igor] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Dityatev, Alexander] Deutsch Zentrum Neurodegenerat Erkrankungen, Mol Neuroplast Grp, D-39120 Magdeburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Istituto Italiano di Tecnologia - IIT; Ulm University; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; IRCCS Istituto Neurologico Besta; University of Liverpool; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kreienkamp, HJ (corresponding author), Univ Krankenhaus Hamburg Eppendorf, Inst Humangenet, Martinistr 52, D-20246 Hamburg, Germany.	Kreienkamp@uke.de	Sala, Carlo/A-2493-2009; Dityatev, Alexander/A-4034-2008; Verpelli, Chiara/K-6673-2016; Verpelli, Chiara/AAH-1140-2020	Sala, Carlo/0000-0003-0662-9523; Dityatev, Alexander/0000-0002-0472-0553; Verpelli, Chiara/0000-0003-2949-9725; Verpelli, Chiara/0000-0003-2949-9725; Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	Deutsche Forschungsgemeinschaft [FOR885, IRP2, Kr1312/3-2]; Telethon Fondazione Onlus [GGP11095]; Istituto Italiano di Tecnologia; Seed grant; Ministry of Health in the frame of European Research Area Network NEURON; Programma Nazionale per la Ricerca-Consiglio Nazionale delle Ricerche Aging Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Telethon Fondazione Onlus(Fondazione Telethon); Istituto Italiano di Tecnologia(Istituto Italiano di Tecnologia - IIT); Seed grant; Ministry of Health in the frame of European Research Area Network NEURON; Programma Nazionale per la Ricerca-Consiglio Nazionale delle Ricerche Aging Program	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR885, IRP2, and Kr1312/3-2 (to H.-J. K.), Telethon Fondazione Onlus Grant GGP11095 (to C. S. and A. D.), Istituto Italiano di Tecnologia (to A. D.) and Seed grant (to C. S.), Ministry of Health in the frame of European Research Area Network NEURON (to C. S.), and Programma Nazionale per la Ricerca-Consiglio Nazionale delle Ricerche Aging Program 2012-2014 (to C. S.).	Alie A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-34; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bockers TM, 2001, J BIOL CHEM, V276, P40104, DOI 10.1074/jbc.M102454200; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kreienkamp H-J., 2008, V186, P365, DOI 10.1007/978-3-540-72843-6_15; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sato D, 2012, AM J HUM GENET, V90, P879, DOI 10.1016/j.ajhg.2012.03.017; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Sheng M, 2000, J CELL SCI, V113, P1851; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Verpelli C, 2011, J BIOL CHEM, V286, P34839, DOI 10.1074/jbc.M111.258384; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	39	35	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26697	26708		10.1074/jbc.M112.424747	http://dx.doi.org/10.1074/jbc.M112.424747			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897824	Green Published, hybrid			2022-12-25	WOS:000330594500035
J	Zaccardi, MJ; Yezdimer, EM; Boehr, DD				Zaccardi, Margot J.; Yezdimer, Eric M.; Boehr, David D.			Functional Identification of the General Acid and Base in the Dehydration Step of Indole-3-glycerol Phosphate Synthase Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDOLEGLYCEROL-PHOSPHATE; ESCHERICHIA-COLI; SULFOLOBUS-SOLFATARICUS; MYCOBACTERIUM-TUBERCULOSIS; BIFUNCTIONAL ENZYME; GROUND-STATE; ACTIVE-SITE; MECHANISM; STABILITY; ISOMERASE	The tryptophan biosynthetic enzyme indole-3-glycerol phosphate synthase is a proposed target for new antimicrobials and is a favored starting framework in enzyme engineering studies. Forty years ago, Parry proposed that the enzyme mechanism proceeds through two intermediates in a series of condensation, decarboxylation, and dehydration steps. X-ray crystal structures have suggested that Lys-110 (numbering according to the Sulfolobus solfataricus enzyme) behaves as a general acid both in the condensation and dehydration steps, but did not reveal an efficient pathway for the reprotonation of this critical residue. Our mutagenesis and kinetic experiments suggest an alternative mechanism whereby Lys-110 acts as a general acid in the condensation step, but another invariant residue, Lys-53, acts as the general acid in the dehydration step. These studies also indicate that the conserved residue Glu-51 acts as the general base in the dehydration step. The revised mechanism effectively divides the active site into discrete regions where the catalytic surfaces containing Lys-110 and Lys-53/Glu-51 catalyze the ring closure (i.e. condensation and decarboxylation) and dehydration steps, respectively. These results can be leveraged toward the development of novel inhibitors against this validated antimicrobial target and toward the rational engineering of the enzyme to produce indole derivatives that are highly prized by the pharmaceutical and agricultural industries.	[Zaccardi, Margot J.; Yezdimer, Eric M.; Boehr, David D.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Boehr, DD (corresponding author), Penn State Univ, Dept Chem, 107 Chem Bldg, University Pk, PA 16802 USA.	ddb12@psu.edu			National Science Foundation Career Grant [MCB1053993]; Div Of Molecular and Cellular Bioscience [1053993] Funding Source: National Science Foundation	National Science Foundation Career Grant(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Career Grant MCB1053993 (to D. D. B.).	Barden T.C., 2010, TOP HETEROCYCL CHEM, V26, P31; Czekster CM, 2008, TETRAHEDRON LETT, V49, P5914, DOI 10.1016/j.tetlet.2008.07.149; Czekster CM, 2009, ARCH BIOCHEM BIOPHYS, V486, P19, DOI 10.1016/j.abb.2009.04.001; Darimont B, 1998, PROTEIN SCI, V7, P1221, DOI 10.1002/pro.5560070518; EBERHARD M, 1989, FEBS LETT, V245, P219, DOI 10.1016/0014-5793(89)80225-X; EBERHARD M, 1995, BIOCHEMISTRY-US, V34, P5419, DOI 10.1021/bi00016a013; Hennig M, 2002, J MOL BIOL, V319, P757, DOI 10.1016/S0022-2836(02)00378-9; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Houlihan W. J., 1972, INDOLES; Humphrey GR, 2006, CHEM REV, V106, P2875, DOI 10.1021/cr0505270; Knochel TR, 1996, J MOL BIOL, V262, P502, DOI 10.1006/jmbi.1996.0531; Mazumder-Shivakumar D, 2004, P NATL ACAD SCI USA, V101, P14379, DOI 10.1073/pnas.0406002101; Mazumder-Shivakumar D, 2004, J AM CHEM SOC, V126, P5936, DOI 10.1021/ja049512u; Merz A, 1999, J MOL BIOL, V288, P753, DOI 10.1006/jmbi.1999.2709; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sasaki T, 2012, J BIOSCI BIOENG, V113, P726, DOI 10.1016/j.jbiosc.2012.01.012; Schlee S, 2013, BIOCHEMISTRY-US, V52, P132, DOI 10.1021/bi301342j; Schneider B, 2005, BIOCHEMISTRY-US, V44, P16405, DOI 10.1021/bi051640n; Shen HB, 2010, J MICROBIOL, V48, P337, DOI 10.1007/s12275-010-9315-6; Shen HB, 2009, FEBS J, V276, P144, DOI 10.1111/j.1742-4658.2008.06763.x; Smith M.B., 2007, ADV ORGANIC CHEM REA, V6th ed, DOI 10.1002/9780470084960.ch15; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; WITKOP B, 1951, J AM CHEM SOC, V73, P2188, DOI 10.1021/ja01149a079; WITKOP B, 1951, J AM CHEM SOC, V73, P713, DOI 10.1021/ja01146a066; Zaccardi MJ, 2012, BIOCHEM BIOPH RES CO, V418, P324, DOI 10.1016/j.bbrc.2012.01.020	25	7	7	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26350	26356		10.1074/jbc.M113.487447	http://dx.doi.org/10.1074/jbc.M113.487447			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23900843	Green Published, hybrid			2022-12-25	WOS:000330594500001
J	Alkass, K; Saitoh, H; Buchholz, BA; Bernard, S; Holmlund, G; Senn, DR; Spalding, KL; Druid, H				Alkass, Kanar; Saitoh, Hisako; Buchholz, Bruce A.; Bernard, Samuel; Holmlund, Gunilla; Senn, David R.; Spalding, Kirsty L.; Druid, Henrik			Analysis of Radiocarbon, Stable Isotopes and DNA in Teeth to Facilitate Identification of Unknown Decedents	PLOS ONE			English	Article							ASPARTIC-ACID RACEMIZATION; BOMB C-14 DATA; AGE ESTIMATION; SAMPLE PREPARATION; NUCLEAR TESTS; ION-SOURCE; AMS; HYDROGEN; RATIOS; CARBON	The characterization of unidentified bodies or suspected human remains is a frequent and important task for forensic investigators. However, any identification method requires clues to the person's identity to allow for comparisons with missing persons. If such clues are lacking, information about the year of birth, sex and geographic origin of the victim, is particularly helpful to aid in the identification casework and limit the search for possible matches. We present here results of stable isotope analysis of C-13 and O-18, and bomb-pulse C-14 analyses that can help in the casework. The C-14 analysis of enamel provided information of the year of birth with an average absolute error of 1.8 +/- 1.3 years. We also found that analysis of enamel and root from the same tooth can be used to determine if the C-14 values match the rising or falling part of the bomb-curve. Enamel laydown times can be used to estimate the date of birth of individuals, but here we show that this detour is unnecessary when using a large set of crude C-14 data of tooth enamel as a reference. The levels of C-13 in tooth enamel were higher in North America than in teeth from Europe and Asia, and Mexican teeth showed even higher levels than those from USA. DNA analysis was performed on 28 teeth, and provided individual-specific profiles in most cases and sex determination in all cases. In conclusion, these analyses can dramatically limit the number of possible matches and hence facilitate person identification work.	[Alkass, Kanar; Druid, Henrik] Karolinska Inst, Div Forens Med, Dept Oncol Pathol, Stockholm, Sweden; [Saitoh, Hisako] Chiba Univ, Grad Sch Med, Dept Legal Med, Chiba, Japan; [Buchholz, Bruce A.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA; [Bernard, Samuel] Univ Lyon, CNRS UMR 5208, Inst Camille Jordan, Villeurbanne, France; [Holmlund, Gunilla] Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, Linkoping, Sweden; [Senn, David R.] Univ Texas Hlth Sci Ctr San Antonio, Ctr Educ & Res Forens, San Antonio, TX 78229 USA; [Spalding, Kirsty L.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet; Chiba University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Swedish National Board of Forensic Medicine; University of Texas System; University of Texas Health San Antonio; Karolinska Institutet	Alkass, K (corresponding author), Karolinska Inst, Div Forens Med, Dept Oncol Pathol, Stockholm, Sweden.	kanar.alkass@ki.se	Buchholz, Bruce A/G-1356-2011; spalding, kirsty/I-6046-2017; Spalding, Kirsty/CAF-4248-2022; Bernard, Samuel/A-5623-2009	Buchholz, Bruce A/0000-0002-9531-551X; Spalding, Kirsty/0000-0002-5189-7028; Bernard, Samuel/0000-0002-8442-9968; Druid, Henrik/0000-0002-9198-023X; alkass, kanar/0000-0002-9154-5393	National Center for Research Resources [5P41RR013461]; National Institute of General Medical Sciences [8P41 GM103483-14]; National Institutes of Health; Swedish Strategic Research Council (SSF); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Strategic Research Council (SSF)(Swedish Foundation for Strategic Research); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by grants from the National Center for Research Resources (5P41RR013461), the National Institute of General Medical Sciences (8P41 GM103483-14), the National Institutes of Health and the Swedish Strategic Research Council (SSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkass K, 2011, FORENSIC SCI INT, V209, P34, DOI 10.1016/j.forsciint.2010.12.002; Alkass K, 2011, FORENSIC SCI INT; Alkass K, 2010, MOL CELL PROTEOMICS, V9, P1022, DOI 10.1074/mcp.M900525-MCP200; Bowen GJ, 2007, WATER RESOUR RES, P43; Brown TA, 1997, NUCL INSTRUM METH B, V123, P208, DOI 10.1016/S0168-583X(96)00676-3; Cook GT, 2006, RADIOCARBON, V48, P305, DOI 10.1017/S0033822200038765; DAVIS JC, 1990, NUCL INSTRUM METH B, V52, P269, DOI 10.1016/0168-583X(90)90419-U; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; Fallon SJ, 2007, NUCL INSTRUM METH B, V259, P106, DOI 10.1016/j.nimb.2007.01.149; Guilderson TP, 2003, RADIOCARBON, V45, P75, DOI 10.1017/S0033822200032409; GUSTAFSON G, 1950, J AM DENT ASSOC, V41, P45, DOI 10.14219/jada.archive.1950.0132; HELFMAN PM, 1975, P NATL ACAD SCI USA, V72, P2891, DOI 10.1073/pnas.72.8.2891; Hua Q, 2004, RADIOCARBON, V46, P1273, DOI 10.1017/S0033822200033142; Kelly JF, 2002, OECOLOGIA, V130, P216, DOI 10.1007/s004420100789; Kondo-Nakamura M, 2010, INT J LEGAL MED; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; LIBBY WF, 1964, SCIENCE, V146, P1171; Meinl A, 2007, J FORENSIC SCI, V52, P438, DOI 10.1111/j.1556-4029.2006.00377.x; Mutzel E, 2009, INT J LEGAL MED, V123, P35, DOI 10.1007/s00414-008-0286-7; NAKAHORI Y, 1991, GENOMICS, V9, P264, DOI 10.1016/0888-7543(91)90251-9; Nolla CM, 1960, J DENTAL CHILD, P27; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Ohtani S, 2005, J FORENSIC SCI, V50, P1020; OHTANI S, 2010, J FORENSIC IN PRESS; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Rainio J, 2001, J Clin Forensic Med, V8, P218, DOI 10.1054/jcfm.2001.0519; Reimer PJ, 2004, RADIOCARBON, V46, P1299; Ritz-Timme S, 2000, INT J LEGAL MED, V113, P129, DOI 10.1007/s004140050283; ROZANSKI K, 1992, RADIOCARBON, V34, P506, DOI 10.1017/S0033822200063761; Santos GM, 2004, RADIOCARBON, V46, P165, DOI 10.1017/S0033822200039485; SCHOELLER DA, 1986, ECOL FOOD NUTR, V18, P159, DOI 10.1080/03670244.1986.9990922; SCHOUR I., 1941, JOUR AMER DENTAL ASSOC, V28, P1153; Scott EM, 2003, RADIOCARBON, V45, P493, DOI 10.1017/S0033822200032835; Southon J, 2000, NUCL INSTRUM METH B, V172, P257, DOI 10.1016/S0168-583X(00)00345-1; Spalding KL, 2005, NATURE, V437, P333, DOI 10.1038/437333a; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; SWEET DJ, 1995, J FORENSIC SCI, V40, P310; VOGEL JS, 1987, NUCL INSTRUM METH B, V29, P50, DOI 10.1016/0168-583X(87)90202-3; VRIES HD, 1958, SCIENCE, V128, P250; Winskog C, 2010, FORENSIC SCI MED PAT, V6, P127, DOI 10.1007/s12024-010-9155-z; Zermeno P, 2004, NUCL INSTRUM METH B, V223, P293, DOI 10.1016/j.nimb.2004.04.058	42	27	27	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69597	10.1371/journal.pone.0069597	http://dx.doi.org/10.1371/journal.pone.0069597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922751	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700052
J	Atzori, A; Baker, AE; Chiu, M; Bryce, RA; Bonnet, P				Atzori, Alessio; Baker, Audrey E.; Chiu, Mark; Bryce, Richard A.; Bonnet, Pascal			Effect of Sequence and Stereochemistry Reversal on p53 Peptide Mimicry	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; PROTEIN; SIMULATIONS; MDM2; PEPTIDOMIMETICS; CONFORMATIONS; LIMITATIONS; INHIBITION; P53-MDM2; EXPLICIT	Peptidomimetics effective in modulating protein-protein interactions and resistant to proteolysis have potential in therapeutic applications. An appealing yet underperforming peptidomimetic strategy is to employ D-amino acids and reversed sequences to mimic a lead peptide conformation, either separately or as the combined retro-inverso peptide. In this work, we examine the conformations of inverse, reverse and retro-inverso peptides of p53(15-29) using implicit solvent molecular dynamics simulation and circular dichroism spectroscopy. In order to obtain converged ensembles for the peptides, we find enhanced sampling is required via the replica exchange molecular dynamics method. From these replica exchange simulations, the D-peptide analogues of p53(15-29) result in a predominantly left-handed helical conformation. When the parent sequence is reversed sequence as either the L-peptide and D-peptide, these peptides display a greater helical propensity, feature reflected by NMR and CD studies in TFE/water solvent. The simulations also indicate that, while approximately similar orientations of the side-chains are possible by the peptide analogues, their ability to mimic the parent peptide is severely compromised by backbone orientation (for D-amino acids) and side-chain orientation (for reversed sequences). A retro-inverso peptide is disadvantaged as a mimic in both aspects, and further chemical modification is required to enable this concept to be used fruitfully in peptidomimetic design. The replica exchange molecular simulation approach adopted here, with its ability to provide detailed conformational insights into modified peptides, has potential as a tool to guide structure-based design of new improved peptidomimetics.	[Atzori, Alessio; Bryce, Richard A.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester, Lancs, England; [Baker, Audrey E.; Chiu, Mark] Janssen Res & Dev Inc, Biol Res, Radnor, PA USA; [Bonnet, Pascal] Janssen Res & Dev, Beerse, Belgium	University of Manchester; Johnson & Johnson; Janssen Pharmaceuticals	Bryce, RA (corresponding author), Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester, Lancs, England.	r.a.bryce@manchester.ac.uk; pascal.bonnet@univ-orleans.fr	Bonnet, Pascal/F-7887-2011; Bryce, Richard/F-9955-2015; Bonnet, Pascal/C-7273-2015	Bonnet, Pascal/0000-0001-6485-138X; Bryce, Richard/0000-0002-8145-2345; Bonnet, Pascal/0000-0001-6485-138X	BBSRC; Janssen Research and Development, a division of Janssen Pharmaceutica N.V.; Biotechnology and Biological Sciences Research Council [974207] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Janssen Research and Development, a division of Janssen Pharmaceutica N.V.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC and Janssen Research and Development, a division of Janssen Pharmaceutica N.V. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A J, 1973, Methods Enzymol, V27, P675; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bursulaya BD, 2000, J PHYS CHEM B, V104, P12378, DOI 10.1021/jp0027602; Case D, 2010, AMBER, V11; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; Giannis A., 1997, ADV DRUG RES, V29, P1; GOODMAN M, 1979, ACCOUNTS CHEM RES, V12, P1, DOI 10.1021/ar50133a001; Grauer A, 2009, EUR J ORG CHEM, V2009, P5099, DOI 10.1002/ejoc.200900599; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Guichard G, 1996, TRENDS BIOTECHNOL, V14, P44, DOI 10.1016/0167-7799(96)80919-X; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Li C, 2010, J BIOL CHEM, V285, P19572, DOI 10.1074/jbc.M110.116814; Liu M, 2010, ANGEW CHEM INT EDIT, V49, P3649, DOI 10.1002/anie.201000329; Loregian A, 2002, REV MED VIROL, V12, P239, DOI 10.1002/rmv.356; Molecular Operating Environment (MOE), 2012, MOL OP ENV MOE 2012, V10, P1010; Okur A, 2008, J CHEM THEORY COMPUT, V4, P488, DOI 10.1021/ct7002308; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Rai J, 2007, CHEM BIOL DRUG DES, V70, P552, DOI 10.1111/j.1747-0285.2007.00595.x; Sakurai K, 2004, J AM CHEM SOC, V126, P16288, DOI 10.1021/ja044883w; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184	29	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68723	10.1371/journal.pone.0068723	http://dx.doi.org/10.1371/journal.pone.0068723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922660	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700009
J	Wu, L; Wang, W; Yao, K; Zhou, T; Yin, J; Li, TJ; Yang, L; He, LQ; Yang, XJ; Zhang, HF; Wang, Q; Huang, RL; Yin, YL				Wu, Li; Wang, Wence; Yao, Kang; Zhou, Ting; Yin, Jie; Li, Tiejun; Yang, Lin; He, Liuqin; Yang, Xiaojian; Zhang, Hongfu; Wang, Qi; Huang, Ruilin; Yin, Yulong			Effects of Dietary Arginine and Glutamine on Alleviating the Impairment Induced by Deoxynivalenol Stress and Immune Relevant Cytokines in Growing Pigs	PLOS ONE			English	Article							NATURALLY CONTAMINATED WHEAT; FUSARIUM MYCOTOXINS; SKELETAL-MUSCLE; TRICHOTHECENE MYCOTOXINS; PROTEIN-SYNTHESIS; GENE-EXPRESSION; FEEDING DIETS; GRADED-LEVELS; IN-VIVO; GROWTH	Deoxynivalenol (DON) is a mycotoxin that reduces feed intake and animal performance, especially in swine. Arginine and glutamine play important roles in swine nutrition. The objective of this study was to determine the effects of dietary supplementation with arginine and glutamine on both the impairment induced by DON stress and immune relevant cytokines in growing pigs. A total of forty 60-d-old healthy growing pigs with a mean body weight of 16.2 +/- 61.54 kg were randomly divided into 5 groups, and assigned to 3 amino acid treatments fed 1.0% arginine (Arg), 1.0% glutamine (Gln) and 0.5% Arg+0.5% Gln, respectively, plus a toxin control and a non-toxin control. Pigs in the 3 amino acid treatments were fed the corresponding amino acids, and those in non-toxin control and toxin control were fed commercial diet with 1.64% Alanine as isonitrogenous control for 7 days. The toxin control and amino acid treatments were then challenged by feeding DON-contaminated diet with a final DON concentration of 6 mg/kg of diet for 21 days. No significant differences were observed between toxin control and the amino acid groups with regard to the average daily gain (ADG), although the values for average daily feed intake (ADFI) in the amino acid groups were significantly higher than that in toxin control (P<0.01). The relative liver weight in toxin control was significantly greater than those in non-toxin control, arginine and Arg+Glu groups (P<0.01), but there were no significant differences in other organs. With regard to serum biochemistry, the values of BUN, ALP, ALT and AST in the amino acid groups were lower than those in toxin control. IGF1, GH and SOD in the amino acid groups were significantly higher than those in toxin control (P<0.01). The IL-2 and TNF alpha values in the amino acid groups were similar to those in non-toxin control, and significantly lower than those in toxin control (P<0.01). These results showed the effects of dietary supplementation with arginine and glutamine on alleviating the impairment induced by DON stress and immune relevant cytokines in growing pigs.	[Wu, Li; Yao, Kang; Yin, Jie; Li, Tiejun; He, Liuqin; Huang, Ruilin; Yin, Yulong] Chinese Acad Sci, Res Ctr Hlth Breeding Livestock & Poultry, Hunan Engn & Res Ctr Anim & Poultry Sci, Changsha, Hunan, Peoples R China; [Wu, Li; Yao, Kang; Yin, Jie; Li, Tiejun; He, Liuqin; Huang, Ruilin; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Wang, Wence; Yang, Lin] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Wence; Zhou, Ting; Yang, Xiaojian; Wang, Qi] Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada; [Zhang, Hongfu] Chinese Agr Acad, Beijing Anim & Vet Sci Inst, China Natl Key Lab Anim Nutr, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; South China Agricultural University; Agriculture & Agri Food Canada	Zhou, T (corresponding author), Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada.	Ting.Zhou@agr.gc.ca; yinyulong@isa.ac.cn			National Basic Research Program of China (973 program) [2009CB118806]; Hunan Provincial natural science foundation of China [12JJ2020]; President Fund of South China Agricultural University [4300-k12226]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Hunan Provincial natural science foundation of China(Natural Science Foundation of Hunan Province); President Fund of South China Agricultural University(Chinese Academy of Sciences)	This work was funded by National Basic Research Program of China (973 program, Grant no. 2009CB118806), Hunan Provincial natural science foundation of China (12JJ2020) and President Fund of South China Agricultural University (No.4300-k12226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Awad WA, 2012, J ANIM PHYSIOL AN N, V96, P717, DOI 10.1111/j.1439-0396.2011.01199.x; BERGSJO B, 1993, VET RES COMMUN, V17, P283, DOI 10.1007/BF01839219; Bianco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052051; Bondy GS, 2000, J TOXICOL ENV HEAL B, V3, P109, DOI 10.1080/109374000281113; Chaytor AC, 2011, J ANIM SCI, V89, P124, DOI 10.2527/jas.2010-3005; Cheng YH, 2006, ANIM RES, V55, P579, DOI 10.1051/animres:2006032; Cochard A, 1998, REPROD NUTR DEV, V38, P331, DOI 10.1051/rnd:19980313; Cui ZQ, 2005, GENOMICS, V85, P352, DOI 10.1016/j.ygeno.2004.11.006; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; Dersjant-Li YM, 2003, NUTR RES REV, V16, P223, DOI 10.1079/NRR200368; Doll S, 2003, ARCH ANIM NUTR, V57, P311, DOI 10.1080/00039420310001607680; Frank JW, 2007, J NUTR, V137, P315, DOI 10.1093/jn/137.2.315; Gao KG, 2012, AMINO ACIDS, V42, P2207, DOI 10.1007/s00726-011-0960-9; Giovanardi RO, 2009, J SURG RES, V155, P244, DOI 10.1016/j.jss.2008.07.002; Goyarts T, 2007, FOOD ADDIT CONTAM A, V24, P369, DOI 10.1080/02652030600988038; Goyarts T, 2006, FOOD CHEM TOXICOL, V44, P1953, DOI 10.1016/j.fct.2006.06.017; Grenier B, 2011, MOL NUTR FOOD RES, V55, P761, DOI 10.1002/mnfr.201000402; Guan S, 2011, J FOOD AGRIC ENVIRON, V9, P163; He JW, 2010, TRENDS FOOD SCI TECH, V21, P67, DOI 10.1016/j.tifs.2009.08.002; Iheshiulor O. O. M., 2011, Asian Journal of Animal Sciences, V5, P19; Jacobi S K, 2006, J Anim Sci, V84 Suppl, pE140; Jobgen WJ, 2009, J NUTR, V139, P230, DOI 10.3945/jn.108.096362; Karlovsky P, 2011, APPL MICROBIOL BIOT, V91, P491, DOI 10.1007/s00253-011-3401-5; Kim SW, 2004, J NUTR, V134, P625, DOI 10.1093/jn/134.3.625; Lecleire S, 2008, J NUTR, V138, P2481, DOI 10.3945/jn.108.099127; Li Q, 2012, INNATE IMMUN-LONDON, V18, P804, DOI 10.1177/1753425912441955; Marzocco S, 2009, TOXICOL LETT, V189, P21, DOI 10.1016/j.toxlet.2009.04.024; Merhej J, 2011, APPL MICROBIOL BIOT, V91, P519, DOI 10.1007/s00253-011-3397-x; Mesterhazy A, 2011, TOXINS, V3, P1453, DOI 10.3390/toxins3111453; Mieulet V, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000934; Muriel P, 1998, COMP BIOCHEM PHYS C, V120, P421, DOI 10.1016/S0742-8413(98)10018-X; Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074; Obremski K, 2008, POL J VET SCI, V11, P339; Pestka JJ, 2008, FOOD ADDIT CONTAM A, V25, P1128, DOI 10.1080/02652030802056626; Pinton P, 2012, TOXICOL SCI, V130, P180, DOI 10.1093/toxsci/kfs239; Prelusky Dan B., 1994, Natural Toxins, V2, P97, DOI 10.1002/nt.2620020302; PRELUSKY DB, 1994, J ENVIRON SCI HEAL B, V29, P1203, DOI 10.1080/03601239409372923; Robinson MB, 1998, NEUROCHEM INT, V33, P479, DOI 10.1016/S0197-0186(98)00055-2; Rocha O, 2005, FOOD ADDIT CONTAM A, V22, P369, DOI 10.1080/02652030500058403; ROTTER BA, 1994, FUND APPL TOXICOL, V23, P117, DOI 10.1006/faat.1994.1087; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Smith TK, 1997, J ANIM SCI, V75, P2184; Sobrova Pavlina, 2010, Interdiscip Toxicol, V3, P94, DOI 10.2478/v10102-010-0019-x; Swamy HVLN, 2002, J ANIM SCI, V80, P3257; Tiemann U, 2008, VET J, V176, P188, DOI 10.1016/j.tvjl.2007.02.019; Tiemann U, 2007, FOOD ADDIT CONTAM A, V24, P306, DOI 10.1080/02652030601053626; Tiemann U, 2006, J ANIM SCI, V84, P236, DOI 10.2527/2006.841236x; TRENHOLM HL, 1994, CAN J ANIM SCI, V74, P361, DOI 10.4141/cjas94-049; VANHEUGTEN E, 1994, J ANIM SCI, V72, P658, DOI 10.2527/1994.723658x; Wang WC, 2013, BRIT J NUTR, V110, P823, DOI 10.1017/S0007114512005843; Wu G, 2011, J ANIM SCI, V89, P2017, DOI 10.2527/jas.2010-3614; Wu GY, 2007, LIVEST SCI, V112, P8, DOI 10.1016/j.livsci.2007.07.003; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Yazar S, 2008, INT J MOL SCI, V9, P2062, DOI 10.3390/ijms9112062; Zhang Q, 2011, THROMB RES, V128, P42, DOI 10.1016/j.thromres.2011.02.013; Zhou HR, 1998, TOXICOL APPL PHARM, V151, P347, DOI 10.1006/taap.1998.8469	59	58	62	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69502	10.1371/journal.pone.0069502	http://dx.doi.org/10.1371/journal.pone.0069502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922725	Green Submitted, Green Published, gold			2022-12-25	WOS:000323369700034
J	Hennig, AK; Peng, GH; Chen, SM				Hennig, Anne K.; Peng, Guang-Hua; Chen, Shiming			Transcription Coactivators p300 and CBP Are Necessary for Photoreceptor-Specific Chromatin Organization and Gene Expression	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; LONG-TERM-MEMORY; RUBINSTEIN-TAYBI-SYNDROME; HEPATIC GLUCONEOGENESIS; REGULATE TRANSCRIPTION; RETINAL DEGENERATION; CONE PHOTORECEPTORS; CELL-PROLIFERATION; ROD; MICE	Rod and cone photoreceptor neurons in the mammalian retina possess specialized cellular architecture and functional features for converting light to a neuronal signal. Establishing and maintaining these characteristics requires appropriate expression of a specific set of genes, which is tightly regulated by a network of photoreceptor transcription factors centered on the cone-rod homeobox protein CRX. CRX recruits transcription coactivators p300 and CBP to acetylate promoter-bound histones and activate transcription of target genes. To further elucidate the role of these two coactivators, we conditionally knocked out Ep300 and/or CrebBP in differentiating rods or cones, using opsin-driven Cre recombinase. Knockout of either factor alone exerted minimal effects, but loss of both factors severely disrupted target cell morphology and function: the unique nuclear chromatin organization seen in mouse rods was reversed, accompanied by redistribution of nuclear territories associated with repressive and active histone marks. Transcription of many genes including CRX targets was severely impaired, correlating with reduced histone H3/H4 acetylation (the products of p300/CBP) on target gene promoters. Interestingly, the presence of a single wild-type allele of either coactivator prevented many of these defects, with Ep300 more effective than Cbp. These results suggest that p300 and CBP play essential roles in maintaining photoreceptor-specific structure, function and gene expression.	[Hennig, Anne K.; Peng, Guang-Hua; Chen, Shiming] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Chen, Shiming] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Chen, SM (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	chen@vision.wustl.edu	Huang, Yifei/ABE-7566-2020		National Institutes of Health (NIH) [EY012543, EY02687]; Lew Wasserman Merit Award; Research to Prevent Blindness; National Institutes of Health NIDCD [P30DC04665]; National Institutes of Health [National Cancer Institute Cancer Center Support] [P30 CA91842]; National Center for Research Resources (NCRR) ICTS/CTSA [UL1RR024992]; NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012543, P30EY002687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004665] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lew Wasserman Merit Award; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institutes of Health [National Cancer Institute Cancer Center Support](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR) ICTS/CTSA; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (NIH) [grant numbers EY012543 to SC and EY02687 to WU-DOVS], a Lew Wasserman Merit Award (to SC) and unrestricted funds (to WU-DOVS) from Research to Prevent Blindness. For use of the electron microscope: the Research Center for Auditory and Vestibular Studies is supported by the National Institutes of Health NIDCD Grant P30DC04665 to the Department of Otolaryngology. For genomic analysis: the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine is partially supported by the National Institutes of Health [National Cancer Institute Cancer Center Support grant number P30 CA91842 to the Siteman Cancer Center; National Center for Research Resources (NCRR) ICTS/CTSA grant number UL1RR024992; and the NIH Roadmap for Medical Research]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bassett EA, 2012, TRENDS NEUROSCI, V35, P565, DOI 10.1016/j.tins.2012.05.004; Bedford DC, 2012, AGING-US, V4, P247, DOI 10.18632/aging.100453; Bedford DC, 2011, CELL METAB, V14, P219, DOI 10.1016/j.cmet.2011.06.010; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen JC, 2007, INVEST OPHTH VIS SCI, V48, P2799, DOI 10.1167/iovs.06-0922; Chen SM, 2004, HUM MOL GENET, V13, P53, DOI 10.1093/hmg/ddh005; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cvekl A, 2010, HEREDITY, V105, P135, DOI 10.1038/hdy.2010.16; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Davis DM, 2010, CURR TOP DEV BIOL, V93, P175, DOI [10.1016/B978-0-12-385044-7.00006-0, 10.1016/S0070-2153(10)93006-8]; de Melo J, 2012, P NATL ACAD SCI USA, V109, P4657, DOI 10.1073/pnas.1107488109; Donovan SL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-14; Dowling J. E., 1987, RETINA APPROACHABLE; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; GERDES J, 1984, J IMMUNOL, V133, P1710; Gimenez E, 2001, LAB ANIM-UK, V35, P153, DOI 10.1258/0023677011911525; Gonzalo S, 2005, CELL CYCLE, V4, P752, DOI 10.4161/cc.4.6.1720; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Hao H, 2011, J BIOL CHEM, V286, P34893, DOI 10.1074/jbc.M111.271072; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jaillard C, 2012, HUM MOL GENET, V21, P2298, DOI 10.1093/hmg/dds050; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kalkhoven E, 2003, HUM MOL GENET, V12, P441, DOI 10.1093/hmg/ddg039; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kasper LH, 2002, NATURE, V419, P738, DOI 10.1038/nature01062; Kizilyaprak C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011039; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Lagali Pamela S, 2011, J Ocul Biol Dis Infor, V4, P111, DOI 10.1007/s12177-012-9080-3; Lambard S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013075; Le YZ, 2004, MOL VIS, V10, P1011; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Longworth MS, 2010, CHROMOSOMA, V119, P1, DOI 10.1007/s00412-009-0238-0; Macaluso M, 2006, ANN ONCOL, V17, pVII27, DOI 10.1093/annonc/mdl945; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McManus KJ, 2003, MOL CELL BIOL, V23, P7611, DOI 10.1128/MCB.23.21.7611-7627.2003; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Murata T, 2001, HUM MOL GENET, V10, P1071, DOI 10.1093/hmg/10.10.1071; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oliveira AMM, 2007, LEARN MEMORY, V14, P564, DOI 10.1101/lm.656907; Oliveira AMM, 2011, LEARN MEMORY, V18, P161, DOI 10.1101/lm.1939811; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng GH, 2005, VISUAL NEUROSCI, V22, P575, DOI 10.1017/S0952523805225063; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Peng GH, 2011, P NATL ACAD SCI USA, V108, P17821, DOI 10.1073/pnas.1109209108; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Rodieck R.W., 1998, 1 STEPS SEEING; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; Shechter D, 2009, NATURE PROTOCOLS, V2, P1445; Solovei I, 2013, CELL, V152, P584, DOI 10.1016/j.cell.2013.01.009; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Spella M, 2011, STEM CELLS, V29, P1269, DOI 10.1002/stem.678; Stuck MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032484; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tanaka Y, 2000, MECH DEVELOP, V95, P133, DOI 10.1016/S0925-4773(00)00360-9; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Valor LM, 2011, J NEUROSCI, V31, P1652, DOI 10.1523/JNEUROSCI.4737-10.2011; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van Genderen MM, 2000, BRIT J OPHTHALMOL, V84, P1177, DOI 10.1136/bjo.84.10.1177; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Wood MA, 2006, LEARN MEMORY, V13, P609, DOI 10.1101/lm.213906; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Yanagi Y, 2000, BIOCHEM BIOPH RES CO, V269, P410, DOI 10.1006/bbrc.2000.2304; Yang Y, 2007, J MOL BIOL, V369, P917, DOI 10.1016/j.jmb.2007.04.004; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050; Zimmermann N, 2007, EUR J HUM GENET, V15, P837, DOI 10.1038/sj.ejhg.5201791	95	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69721	10.1371/journal.pone.0069721	http://dx.doi.org/10.1371/journal.pone.0069721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922782	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900073
J	Salvador, VH; Lima, RB; dos Santos, WD; Soares, AR; Bohm, PAF; Marchiosi, R; Ferrarese, MDL; Ferrarese-Filho, O				Salvador, Victor Hugo; Lima, Rogerio Barbosa; dos Santos, Wanderley Dantas; Soares, Anderson Ricardo; Feitoza Boehm, Paulo Alfredo; Marchiosi, Rogerio; Lucio Ferrarese, Maria de Lourdes; Ferrarese-Filho, Osvaldo			Cinnamic Acid Increases Lignin Production and Inhibits Soybean Root Growth	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; FERULIC ACID; IAA-OXIDASE; 4-HYDROXYLASE; LIGNIFICATION; EXPRESSION; L.; ACCUMULATION; ARABIDOPSIS; GERMINATION	Cinnamic acid is a known allelochemical that affects seed germination and plant root growth and therefore influences several metabolic processes. In the present work, we evaluated its effects on growth, indole-3-acetic acid (IAA) oxidase and cinnamate 4-hydroxylase (C4H) activities and lignin monomer composition in soybean (Glycine max) roots. The results revealed that exogenously applied cinnamic acid inhibited root growth and increased IAA oxidase and C4H activities. The allelochemical increased the total lignin content, thus altering the sum and ratios of the p-hydroxyphenyl (H), guaiacyl (G), and syringyl (S) lignin monomers. When applied alone or with cinnamic acid, piperonylic acid (PIP, a quasi-irreversible inhibitor of C4H) reduced C4H activity, lignin and the H, G, S monomer content compared to the cinnamic acid treatment. Taken together, these results indicate that exogenously applied cinnamic acid can be channeled into the phenylpropanoid pathway via the C4H reaction, resulting in an increase in H lignin. In conjunction with enhanced IAA oxidase activity, these metabolic responses lead to the stiffening of the cell wall and are followed by a reduction in soybean root growth.	[Salvador, Victor Hugo; Lima, Rogerio Barbosa; dos Santos, Wanderley Dantas; Soares, Anderson Ricardo; Feitoza Boehm, Paulo Alfredo; Marchiosi, Rogerio; Lucio Ferrarese, Maria de Lourdes; Ferrarese-Filho, Osvaldo] Univ Maringa, Lab Plant Biochem, Maringa, Parana, Brazil		Ferrarese-Filho, O (corresponding author), Univ Maringa, Lab Plant Biochem, Maringa, Parana, Brazil.	osferrarese@gmail.com	Lima, Rogério/N-2693-2013; /L-5229-2019; Santos, Wanderley Dantas dos/AAT-7860-2020; Marchiosi, Rogério/ABG-3227-2020; MARCHIOSI, ROGERIO/A-8101-2019; Santos, Wanderley Dantas dos/A-9019-2013; Ferrarese-Filho, Osvaldo/J-1829-2012; Lucio Ferrarese, Maria de Lourdes/J-6552-2013	Lima, Rogério/0000-0001-9453-3454; Santos, Wanderley Dantas dos/0000-0002-6072-2860; Marchiosi, Rogério/0000-0002-8386-2524; MARCHIOSI, ROGERIO/0000-0002-8386-2524; Ferrarese-Filho, Osvaldo/0000-0002-3477-4544; Lucio Ferrarese, Maria de Lourdes/0000-0001-5312-614X	CNPq (The Brazilian Council for Scientific and Technological Development); Araucaria Foundation	CNPq (The Brazilian Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	Sources of funding that have supported this work: CNPq (The Brazilian Council for Scientific and Technological Development); Araucaria Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenavoli MR, 2010, BIOL PLANTARUM, V54, P149, DOI 10.1007/s10535-010-0024-0; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; BAZIRAMAKENGA R, 1994, J CHEM ECOL, V20, P2821, DOI 10.1007/BF02098391; BellLelong DA, 1997, PLANT PHYSIOL, V113, P729, DOI 10.1104/pp.113.3.729; Blount JW, 2000, PLANT PHYSIOL, V122, P107, DOI 10.1104/pp.122.1.107; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bubna GA, 2011, J PLANT PHYSIOL, V168, P1627, DOI 10.1016/j.jplph.2011.03.005; Chen HC, 2013, PLANT PHYSIOL, V161, P1501, DOI 10.1104/pp.112.210971; Chon SU, 2002, CROP PROT, V21, P1077, DOI 10.1016/S0261-2194(02)00092-3; Devi SR, 1996, BIOL PLANTARUM, V38, P387, DOI 10.1007/BF02896668; Ding J, 2007, J EXP BOT, V58, P3765, DOI 10.1093/jxb/erm227; dos Santos WD, 2008, J CHEM ECOL, V34, P1230, DOI 10.1007/s10886-008-9522-3; dos Santos WD, 2004, J CHEM ECOL, V30, P1203, DOI 10.1023/B:JOEC.0000030272.83794.f0; Einhellig FA, 2004, ALLELOPATHY: CHEMISTRY AND MODE OF ACTION OF ALLELOCHEMICALS, P217; Enkhardt U, 2000, J APPL BOT-ANGEW BOT, V74, P151; Ferrarese MDL, 2002, BIOLOGIA, V57, P541; Hrubcova M, 2000, PLANT PHYSIOL BIOCH, V38, P949, DOI 10.1016/S0981-9428(00)01208-0; Hussain MI, 2012, AUST J BOT, V60, P676, DOI 10.1071/BT12072; Hussain MI, 2011, PLANT PHYSIOL BIOCH, V49, P1290, DOI 10.1016/j.plaphy.2011.08.007; Inderjit, 2003, PLANTA, V217, P529, DOI 10.1007/s00425-003-1054-z; Komatsu S, 2010, AMINO ACIDS, V39, P1435, DOI 10.1007/s00726-010-0608-1; Kovacik J, 2007, PLANT SCI, V172, P393, DOI 10.1016/j.plantsci.2006.10.001; LEE TT, 1980, PHYSIOL PLANTARUM, V50, P107, DOI 10.1111/j.1399-3054.1980.tb04435.x; Lee Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002047; Liu ZH, 1996, BOT BULL ACAD SINICA, V37, P113; Zanardo DIL, 2009, ENVIRON EXP BOT, V66, P25, DOI 10.1016/j.envexpbot.2008.12.014; MACIAS FA, 1995, ALLELOPATHY ORGANISM, P311; Ng PLL, 2003, SEED SCI TECHNOL, V31, P39, DOI 10.15258/sst.2003.31.1.05; QADDOURY A, 2003, BOT B ACAD SIN, V45, P26; Reigosa MJ, 2007, J CHEM ECOL, V33, P1456, DOI 10.1007/s10886-007-9318-x; Schoch GA, 2002, PLANT PHYSIOL, V130, P1022, DOI 10.1104/pp.004309; SIQUEIRA JO, 1991, CRIT REV PLANT SCI, V10, P63, DOI 10.1080/07352689109382307; TALWAR G, 1985, PHYTOCHEMISTRY, V24, P673, DOI 10.1016/S0031-9422(00)84874-8; VANOVERBEEK J, 1951, AM J BOT, V38, P589, DOI 10.2307/2437768; Weir TL, 2004, CURR OPIN PLANT BIOL, V7, P472, DOI 10.1016/j.pbi.2004.05.007; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yamauchi K, 2004, CR BIOL, V327, P791, DOI 10.1016/j.crvi.2004.07.012; Ye SF, 2004, PLANT SOIL, V263, P143, DOI 10.1023/B:PLSO.0000047721.78555.dc; Ye SF, 2006, ENVIRON EXP BOT, V56, P255, DOI 10.1016/j.envexpbot.2005.02.010; Ye ZH, 1996, PLANT SCI, V121, P133, DOI 10.1016/S0168-9452(96)04515-3; Yu JQ, 2009, J CHEM ECOL, V35, P1471, DOI 10.1007/s10886-009-9726-1	41	58	61	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69105	10.1371/journal.pone.0069105	http://dx.doi.org/10.1371/journal.pone.0069105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922685	gold, Green Submitted, Green Published			2022-12-25	WOS:000322838900023
J	Sanz-Cortes, M; Ratta, GA; Figueras, F; Bonet-Carne, E; Padilla, N; Arranz, A; Bargallo, N; Gratacos, E				Sanz-Cortes, Magdalena; Ratta, Giuseppe A.; Figueras, Francesc; Bonet-Carne, Elisenda; Padilla, Nelly; Arranz, Angela; Bargallo, Nuria; Gratacos, Eduard			Automatic Quantitative MRI Texture Analysis in Smallfor- Gestational-Age Fetuses Discriminates Abnormal Neonatal Neurobehavior	PLOS ONE			English	Article							UMBILICAL ARTERY DOPPLER; BEHAVIORAL-ASSESSMENT SCALE; TERM INFANTS; BRAIN; BORN; DIAGNOSIS; NEWBORN; BASES	Background: We tested the hypothesis whether texture analysis (TA) from MR images could identify patterns associated with an abnormal neurobehavior in small for gestational age (SGA) neonates. Methods: Ultrasound and MRI were performed on 91 SGA fetuses at 37 weeks of GA. Frontal lobe, basal ganglia, mesencephalon and cerebellum were delineated from fetal MRIs. SGA neonates underwent NBAS test and were classified as abnormal if >= 1 area was <5th centile and as normal if all areas were >5th centile. Textural features associated with neurodevelopment were selected and machine learning was used to model a predictive algorithm. Results: Of the 91 SGA neonates, 49 were classified as normal and 42 as abnormal. The accuracies to predict an abnormal neurobehavior based on TA were 95.12% for frontal lobe, 95.56% for basal ganglia, 93.18% for mesencephalon and 83.33% for cerebellum. Conclusions: Fetal brain MRI textural patterns were associated with neonatal neurodevelopment. Brain MRI TA could be a useful tool to predict abnormal neurodevelopment in SGA.	[Sanz-Cortes, Magdalena; Ratta, Giuseppe A.; Figueras, Francesc; Bonet-Carne, Elisenda; Padilla, Nelly; Arranz, Angela; Gratacos, Eduard] Univ Barcelona, Hosp Clin, ICGON, Maternal Fetal Med Dept, Barcelona, Spain; [Sanz-Cortes, Magdalena; Ratta, Giuseppe A.; Figueras, Francesc; Bonet-Carne, Elisenda; Padilla, Nelly; Arranz, Angela; Gratacos, Eduard] Inst Invest Biomed August Pi I Sunyer IDIBAPS, Fetal & Perinatal Med Res Grp, Barcelona, Spain; [Sanz-Cortes, Magdalena; Ratta, Giuseppe A.; Figueras, Francesc; Bonet-Carne, Elisenda; Padilla, Nelly; Arranz, Angela; Gratacos, Eduard] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Bargallo, Nuria] Hosp Clin Barcelona, Ctr Diagnost Imatge, Dept Radiol, Barcelona, Spain; [Bargallo, Nuria] Image Platform IDIBAPS, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Sanz-Cortes, M (corresponding author), Univ Barcelona, Hosp Clin, ICGON, Maternal Fetal Med Dept, Barcelona, Spain.	msanz1@clinic.ub.es	Bonet-Carne, Elisenda/ACF-2366-2022; Gratacos, Eduard/AAR-4939-2020; Bargallo, Nuria/G-6854-2016; Padilla, Nelly/T-9998-2019; Rattá, Giuseppe A./AAG-9023-2019; Rattá, Giuseppe A/I-5515-2012	Bonet-Carne, Elisenda/0000-0003-0567-6141; Gratacos, Eduard/0000-0002-7405-7224; Bargallo, Nuria/0000-0001-6284-5402; Rattá, Giuseppe A./0000-0002-5676-9631; Rattá, Giuseppe A/0000-0002-5676-9631; Sanz-Cortes, Magda/0000-0002-0265-9859	Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Thrasher Research Fund (Salt Lake City, USA); Fundacion Dexeus (Barcelona, Spain); Rio Ortega research fellowship, Spain; Instituto de Salud Carlos III Sara Borrell, Spain	Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Thrasher Research Fund (Salt Lake City, USA); Fundacion Dexeus (Barcelona, Spain); Rio Ortega research fellowship, Spain; Instituto de Salud Carlos III Sara Borrell, Spain(Instituto de Salud Carlos III)	This work was supported by grants from The Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK) http://www.cerebra.org.uk/English/Pages/home.aspx, the Thrasher Research Fund (Salt Lake City, USA) http://www.thrasherresearch.org/, the Fundacion Dexeus (Barcelona, Spain) http://www.fundaciondexeus.org. Dr. Sanz Cortes was supported by a Rio Ortega research fellowship, Spain. Dr. Padilla was supported by Instituto de Salud Carlos III Sara Borrell, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als H, 2012, J PERINATOL; [Anonymous], 1997, INT J GYNECOL OBSTET, V59, P269; [Anonymous], [No title captured]; ARDUINI D, 1990, J PERINAT MED, V18, P165, DOI 10.1515/jpme.1990.18.3.165; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Bonilha L, 2003, EPILEPSIA, V44, P1546, DOI 10.1111/j.0013-9580.2003.27103.x; Brazelton T. B., 1995, NEONATAL BEHAV ASSES; Canals J, 2011, ACTA PAEDIATR, V100, P1331, DOI 10.1111/j.1651-2227.2011.02306.x; Cobo T, 2012, FETAL DIAGN THER, V31, P230, DOI 10.1159/000335349; Cruz-Martinez R, 2011, OBSTET GYNECOL, V117, P618, DOI 10.1097/AOG.0b013e31820b0884; DAUBECHIES I, 1988, COMMUN PUR APPL MATH, V41, P909, DOI 10.1002/cpa.3160410705; de Oliveira MS, AJNR AM J NEURORADIO, V32, P60; Depue BE, 2010, PSYCHIAT RES-NEUROIM, V182, P231, DOI 10.1016/j.pscychresns.2010.01.012; Doctor BA, 2001, AM J OBSTET GYNECOL, V185, P652, DOI 10.1067/mob.2001.116749; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Figueras F, 2008, BJOG-INT J OBSTET GY, V115, P590, DOI 10.1111/j.1471-0528.2008.01670.x; Figueras F, 2008, EUR J OBSTET GYN R B, V136, P20, DOI 10.1016/j.ejogrb.2006.12.015; Figueras F, 2008, EUR J OBSTET GYN R B, V136, P34, DOI 10.1016/j.ejogrb.2007.02.016; Figueras F, 2009, PEDIATRICS, V124, pE934, DOI 10.1542/peds.2008-3346; Freeborough PA, 1998, IEEE T MED IMAGING, V17, P475, DOI 10.1109/42.712137; Gagnon Robert, 2003, J Obstet Gynaecol Can, V25, P601; Galaburda AM, 2000, J COGNITIVE NEUROSCI, V12, P74, DOI 10.1162/089892900561995; Godfrey K M, 2001, Public Health Nutr, V4, P611; Herschkowitz N, 1997, NEUROPEDIATRICS, V28, P296, DOI 10.1055/s-2007-973720; Holli K, 2010, ACAD RADIOL, V17, P135, DOI 10.1016/j.acra.2009.08.012; Holli Kirsi K, 2010, BMC Med Imaging, V10, P8, DOI 10.1186/1471-2342-10-8; Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da; Jirak D, 2002, J MAGN RESON IMAGING, V15, P68, DOI 10.1002/jmri.10042; Kernytsky A, 2009, PROTEINS, V75, P75, DOI 10.1002/prot.22211; KJAER L, 1995, ACTA RADIOL, V36, P127; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lundqvist-Persson C, 2001, ACTA PAEDIATR, V90, P345, DOI 10.1080/08035250117666; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Nordahl CW, 2007, J NEUROSCI, V27, P11725, DOI 10.1523/JNEUROSCI.0777-07.2007; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; Olson SL, 2002, J CHILD PSYCHOL PSYC, V43, P435, DOI 10.1111/1469-7610.00035; Padidela Raja Narender Rao, 2003, Indian Pediatr, V40, P1063; Padilla N, 2011, BRAIN RES, V1382, P98, DOI 10.1016/j.brainres.2011.01.032; Pueyo V, 2012, ULTRASOUND OBST GYN, V40, P297, DOI 10.1002/uog.11215; Quellec G, 2010, MED IMAGE ANAL, V14, P227, DOI 10.1016/j.media.2009.11.004; Rees S, 1998, COMP BIOCHEM PHYS A, V119, P653, DOI 10.1016/S1095-6433(98)01001-0; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Sagiv SK, 2008, ENVIRON HEALTH PERSP, V116, P666, DOI 10.1289/ehp.10553; Sanz-Cortes M, 2010, ULTRASOUND OBST GYN, V36, P159, DOI 10.1002/uog.7724; Sanz-Cortes M, 2013, FETAL DIAGN IN PRESS; Story L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.032; Tenorio V, 2011, J ULTRAS MED, V30, P1365, DOI 10.7863/jum.2011.30.10.1365; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E	50	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69595	10.1371/journal.pone.0069595	http://dx.doi.org/10.1371/journal.pone.0069595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922750	Green Submitted, Green Published, gold			2022-12-25	WOS:000322838900058
J	Corrigan, MW; Kerwin-Iosue, CL; Kuczmarski, AS; Amin, KB; Wykoff, DD				Corrigan, Mary W.; Kerwin-Iosue, Christine L.; Kuczmarski, Alexander S.; Amin, Kunj B.; Wykoff, Dennis D.			The Fate of Linear DNA in Saccharomyces cerevisiae and Candida glabrata: The Role of Homologous and Non-Homologous End Joining	PLOS ONE			English	Article							GAP-REPAIR; RECOMBINATION; INTEGRATION; CONSTRUCTION; CENTROMERE; FRAGMENTS; LIGATION; CLONING; LIGASE; SYSTEM	In vivo assembly of plasmids has become an increasingly used process, as high throughput studies in molecular biology seek to examine gene function. In this study, we investigated the plasmid construction technique called gap repair cloning (GRC) in two closely related species of yeast - Saccharomyces cerevisiae and Candida glabrata. GRC utilizes homologous recombination (HR) activity to join a linear vector and a linear piece of DNA that contains base pair homology. We demonstrate that a minimum of 20 bp of homology on each side of the linear DNA is required for GRC to occur with at least 10% efficiency. Between the two species, we determine that S. cerevisiae is slightly more efficient at performing GRC. GRC is less efficient in rad52 deletion mutants, which are defective in HR in both species. In dnl4 deletion mutants, which perform less non-homologous end joining (NHEJ), the frequency of GRC increases in C. glabrata, whereas GRC frequency only minimally increases in S. cerevisiae, suggesting that NHEJ is more prevalent in C. glabrata. Our studies allow for a model of the fate of linear DNA when transformed into yeast cells. This model is not the same for both species. Most significantly, during GRC, C. glabrata performs NHEJ activity at a detectable rate (>5%), while S. cerevisiae does not. Our model suggests that S. cerevisiae is more efficient at HR because NHEJ is less prevalent than in C. glabrata. This work demonstrates the determinants for GRC and that while C. glabrata has a lower efficiency of GRC, this species still provides a viable option for GRC.	[Corrigan, Mary W.; Kerwin-Iosue, Christine L.; Kuczmarski, Alexander S.; Amin, Kunj B.; Wykoff, Dennis D.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA	Villanova University	Wykoff, DD (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.	dennis.wykoff@villanova.edu			National Science Foundation-MCB-RUI grant [1121714]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007059] Funding Source: NIH RePORTER; Direct For Biological Sciences [1121714] Funding Source: National Science Foundation	National Science Foundation-MCB-RUI grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Work was supported by National Science Foundation-MCB-RUI grant #1121714 (http://www.nsf.gov/awardsearch/showAward?AWD_ID = 1121714&HistoricalAwards = false). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Chino A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009652; Ciudad T, 2004, MOL MICROBIOL, V53, P1177, DOI 10.1111/j.1365-2958.2004.04197.x; Eckert-Boulet N, 2012, YEAST, V29, P323, DOI 10.1002/yea.2912; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Guthrie C., 2002, GUIDE YEAST GENETICS; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Holloman WK, 2008, FUNGAL GENET BIOL, V45, pS31, DOI 10.1016/j.fgb.2008.04.006; Kerwin CL, 2009, GENETICS, V182, P471, DOI 10.1534/genetics.109.101063; Kitada K, 1996, GENE, V175, P105, DOI 10.1016/0378-1119(96)00132-1; Kitada K, 1997, CURR GENET, V31, P122, DOI 10.1007/s002940050185; Kojic M, 2008, MOL MICROBIOL, V67, P1156, DOI 10.1111/j.1365-2958.2008.06116.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Matsuo Y, 2010, BIOSCI BIOTECH BIOCH, V74, P685, DOI 10.1271/bbb.90967; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; SCHIESTL RH, 1991, P NATL ACAD SCI USA, V88, P7585, DOI 10.1073/pnas.88.17.7585; SCHIESTL RH, 1993, MOL CELL BIOL, V13, P2697, DOI 10.1128/MCB.13.5.2697; SIKORSKI RS, 1989, GENETICS, V122, P19; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Tseng HM, 2002, J BIOL CHEM, V277, P45630, DOI 10.1074/jbc.M206861200; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wykoff DD, 2001, GENETICS, V159, P1491	24	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69628	10.1371/journal.pone.0069628	http://dx.doi.org/10.1371/journal.pone.0069628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894512	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900085
J	Morgen, CS; Rokholm, B; Brixval, CS; Andersen, CS; Andersen, LG; Rasmussen, M; Andersen, AMN; Due, P; Sorensen, TIA				Morgen, Camilla Schmidt; Rokholm, Benjamin; Brixval, Carina Sjoberg; Andersen, Camilla Schou; Andersen, Lise Geisler; Rasmussen, Mette; Andersen, Anne-Marie Nybo; Due, Pernille; Sorensen, Thorkild I. A.			Trends in Prevalence of Overweight and Obesity in Danish Infants, Children and Adolescents - Are We Still on a Plateau?	PLOS ONE			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; CHILDHOOD OBESITY; BIRTH COHORT; POPULATION; WEIGHT; EPIDEMIC; VALIDITY; FATNESS	Background: After the worldwide steep increase in child and adolescent overweight and obesity during the last decades, there is now evidence of a levelling off in the prevalence in many countries in the Western world. Aim: To examine whether there still is a plateau in the prevalence of overweight and obesity in Danish children and adolescents, or whether the prevalence is decreasing or rising again. Methods: The trends in the prevalence rates were based on three data sets providing comparable repeated estimates: 1) the Danish Health Visitors Child Health Database (DHVCHD) with measurements on infant and childhood height and weight from 2002 to 2011 (n up to 39,984), 2) the Danish National Birth Cohort (DNBC) with maternal reports of measured infant and childhood height and weight from 1998 to 2010 (n up to 56,826) and 3) the Danish part of the Health Behaviour in School-aged Children survey (HBSC) with self-reported information on adolescent height and weight from the years 2002 to 2010 (n = 16,557). Overweight and obesity were categorized according to WHO growth standards. Trends were assessed by repeated point estimates and linear regression analyses providing regression coefficients for changes in per cent per year with 95% confidence intervals (CI). Results: The prevalence rates of overweight and obesity for infants, children and adolescents showed a mixed pattern of decline, stability and increase (ranging from -1.10 through 0.29 per cent per year with CI's from -3.10 through 2.37). Overall, there were no consistent statistically significant trends upwards or downwards, although some significant downward trends in childhood and adolescence were observed. Conclusion: This study, based on data from 1998 through 2011, showed that the prevalence rates of overweight and obesity among Danish infants, children and adolescents were largely still on a plateau with tendencies for a decline among children and adolescents.	[Morgen, Camilla Schmidt; Brixval, Carina Sjoberg; Rasmussen, Mette; Due, Pernille] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Rokholm, Benjamin; Andersen, Camilla Schou; Andersen, Lise Geisler; Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, Capital Region, Denmark; [Andersen, Anne-Marie Nybo] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, DK-1168 Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-1168 Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Morgen, CS (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.	camilla@smorgen.dk	Nybo Andersen, Anne-Marie/AAA-1997-2022; Bjerregaard, Lise Geisler/F-3818-2014	Nybo Andersen, Anne-Marie/0000-0002-4296-8488; Bjerregaard, Lise Geisler/0000-0001-8471-0832; Schmidt Morgen, Camilla/0000-0002-4121-2259; , Carina/0000-0002-2769-1724; Rasmussen, Mette/0000-0002-6276-7341	Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation; Augustinus Foundation; Health Foundation; Lundbeck Foundation [195/04]; Danish Medical Research Council [SSVF 0646]; Health Insurance Foundation [11/216/98, 2003B071, 2004B085]; Danish Cancer Society [93-504]; National Board of Health [407-19-1999]; Danish Ministry of Health [1999-524/04-20]; Nordea Foundation; University of Copenhagen; Health Insurance Foundation	Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation(March of Dimes); Augustinus Foundation; Health Foundation; Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Insurance Foundation; Danish Cancer Society(Danish Cancer Society); National Board of Health; Danish Ministry of Health; Nordea Foundation; University of Copenhagen; Health Insurance Foundation	The DHVCHD study was funded by the Capital Region and the participating municipalities. The Danish National Science Foundation supported establishment of the Danish Epidemiology Science Centre, which initiated and created the Danish National Birth Cohort, and the cohort was also supported by a major grant from this foundation. Additional support for the Danish National Birth Cohort is obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation. The 7-year follow-up was supported by the Lundbeck Foundation (195/04) and the Danish Medical Research Council (SSVF 0646). The Danish HBSC 2002, 2006 and 2010 surveys were funded by The Health Insurance Foundation (no. 11/216/98, 2003B071 and 2004B085), the Danish Cancer Society (no. 93-504), the National Board of Health (no. 407-19-1999), the Danish Ministry of Health (5.kt.j.nr.: 1999-524/04-20) and the Nordea Foundation. Camilla Schmidt Morgen is supported by The University of Copenhagen and The Health Insurance Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AMN, 2002, AM J EPIDEMIOL, V155, P95, DOI 10.1093/aje/155.1.95; Andersen C, 2012, VALIDATION HEIGHT WE; Andersen LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042521; [Anonymous], 2009, COCHRANE DATABASE SY, DOI 10.1002/14651858.CD001872.pub2; [Anonymous], 2004, YOUNG PEOPLES HLTH C; Bua J, 2007, OBESITY, V15, P977, DOI 10.1038/oby.2007.603; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Due P, 2007, OBES REV, V8, P187, DOI 10.1111/j.1467-789X.2006.00291.x; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Elgar FJ, 2005, J ADOLESCENT HEALTH, V37, P371, DOI 10.1016/j.jadohealth.2004.07.014; Freedman DS, 2007, ANN HUM BIOL, V34, P183, DOI 10.1080/03014460601116860; Goodman E, 2000, PEDIATRICS, V106, P52, DOI 10.1542/peds.106.1.52; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Himes JH, 2005, ANN EPIDEMIOL, V15, P272, DOI 10.1016/j.annepidem.2004.08.010; Jacobsen TN, 2010, EUR J EPIDEMIOL, V25, P349, DOI 10.1007/s10654-010-9448-2; Janicke DM, 2007, OBESITY, V15, P1799, DOI 10.1038/oby.2007.214; Matthiessen J, 2008, SCAND J PUBLIC HEALT, V36, P153, DOI 10.1177/1403494807085185; Mei ZG, 2002, AM J CLIN NUTR, V75, P978, DOI 10.1093/ajcn/75.6.978; Moss A, 2012, EUR J PEDIATR, V171, P289, DOI 10.1007/s00431-011-1531-5; Nichols MS, 2011, INT J OBESITY, V35, P916, DOI 10.1038/ijo.2011.64; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Olsen LW, 2006, EPIDEMIOLOGY, V17, P292, DOI 10.1097/01.ede.0000208349.16893.e0; Pearson Seija, 2005, Ugeskr Laeger, V167, P158; Pearson S, 2010, ACTA PAEDIATR, V99, P1675, DOI 10.1111/j.1651-2227.2010.01897.x; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rolland-Cachera MF, 2011, INT J PEDIATR OBES, V6, P325, DOI 10.3109/17477166.2011.607458; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Shiely F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-560; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub2, 10.1002/14651858.CD001871.pub4]; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Viner RM, 2005, BRIT MED J, V330, P1354, DOI 10.1136/bmj.38453.422049.E0	39	61	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69860	10.1371/journal.pone.0069860	http://dx.doi.org/10.1371/journal.pone.0069860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894553	Green Submitted, Green Published, gold			2022-12-25	WOS:000322167900098
J	Byrne, SL; Buckett, PD; Kim, J; Luo, F; Sanford, J; Chen, JX; Enns, C; Wessling-Resnick, M				Byrne, Shaina L.; Buckett, Peter D.; Kim, Jonghan; Luo, Flora; Sanford, Jack; Chen, Juxing; Enns, Caroline; Wessling-Resnick, Marianne			Ferristatin II Promotes Degradation of Transferrin Receptor-1 In Vitro and In Vivo	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS PROTEIN; ANTIMICROBIAL PEPTIDE HEPCIDIN; SMALL-MOLECULE INHIBITORS; BOUND IRON UPTAKE; MEDIATED ENDOCYTOSIS; JUVENILE HEMOCHROMATOSIS; CYTOPLASMIC DOMAIN; CHRONIC DISEASE; HEPATOMA-CELLS; LIPID RAFTS	Previous studies have shown that the small molecule iron transport inhibitor ferristatin (NSC30611) acts by down-regulating transferrin receptor-1 (TfR1) via receptor degradation. In this investigation, we show that another small molecule, ferristatin II (NSC8679), acts in a similar manner to degrade the receptor through a nystatin-sensitive lipid raft pathway. Structural domains of the receptor necessary for interactions with the clathrin pathway do not appear to be necessary for ferristatin II induced degradation of TfR1. While TfR1 constitutively traffics through clathrin-mediated endocytosis, with or without ligand, the presence of Tf blocked ferristatin II induced degradation of TfR1. This effect of Tf was lost in a ligand binding receptor mutant G647A TfR1, suggesting that Tf binding to its receptor interferes with the drug's activity. Rats treated with ferristatin II have lower TfR1 in liver. These effects are associated with reduced intestinal 59 Fe uptake, lower serum iron and transferrin saturation, but no change in liver non-heme iron stores. The observed hypoferremia promoted by degradation of TfR1 by ferristatin II appears to be due to induced hepcidin gene expression.	[Byrne, Shaina L.; Buckett, Peter D.; Kim, Jonghan; Luo, Flora; Sanford, Jack; Wessling-Resnick, Marianne] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Chen, Juxing; Enns, Caroline] Oregon Hlth & Sci Univ, Dept Cell Biol, Portland, OR USA	Harvard University; Harvard T.H. Chan School of Public Health; Oregon Health & Science University	Wessling-Resnick, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	wessling@hsph.harvard.edu			National Institute of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health [R01DK046750, RC1DK086744, R37DK054488]; National Institute of Environmental Health Sciences of the National Institutes of Health [T32ES016645]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054488, R01DK072166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER	National Institute of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research reported in this publication was supported by the National Institute of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health under award numbers R01DK046750 and RC1DK086744 to MW-R and award number R37DK054488 to CAE. SLB was supported by the National Institute of Environmental Health Sciences of the National Institutes of Health under award number T32ES016645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; Auriac A, 2010, HAEMATOL-HEMATOL J, V95, P1269, DOI 10.3324/haematol.2009.019992; Ba Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042703; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; BEARDMORE J, 1987, J CELL SCI, V87, P495; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; BOS RP, 1984, TOXICOLOGY, V31, P271, DOI 10.1016/0300-483X(84)90108-2; Bourseau-Guilmain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025515; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Brown JX, 2004, CHEM BIOL, V11, P407, DOI 10.1016/j.chembiol.2004.02.016; Buckett PD, 2009, AM J PHYSIOL-GASTR L, V296, pG798, DOI 10.1152/ajpgi.90342.2008; Byrne SL, 2013, ANNU REV PHARMACOL, V53, P17, DOI 10.1146/annurev-pharmtox-010611-134648; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Chen JX, 2007, J BIOL CHEM, V282, P36862, DOI 10.1074/jbc.M706720200; CIECHANOVER A, 1983, CELL, V32, P267, DOI 10.1016/0092-8674(83)90517-2; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Dubljevic V, 1999, BIOCHEM J, V341, P11, DOI 10.1042/0264-6021:3410011; Fatih N, 2010, J MOL MED, V88, P477, DOI 10.1007/s00109-009-0588-3; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Ganz T, 2007, J AM SOC NEPHROL, V18, P394, DOI 10.1681/ASN.2006070802; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; GIRONES N, 1989, BIOCHEM J, V264, P35, DOI 10.1042/bj2640035; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Heilig E, 2005, AM J PHYSIOL-LUNG C, V288, pL887, DOI 10.1152/ajplung.00382.2004; Herbison CE, 2009, AM J PHYSIOL-CELL PH, V297, pC1567, DOI 10.1152/ajpcell.00649.2008; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Horonchik L, 2008, CHEM BIOL, V15, P647, DOI 10.1016/j.chembiol.2008.05.011; Kim J, 2011, AM J PHYSIOL-LUNG C, V300, pL659, DOI 10.1152/ajplung.00343.2010; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; Lambe T, 2009, BLOOD, V113, P1805, DOI 10.1182/blood-2007-11-120402; LEDERMAN HM, 1984, BLOOD, V64, P748; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; MCGRAW TE, 1990, CELL REGUL, V1, P369, DOI 10.1091/mbc.1.4.369; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Noulsri E, 2009, AM J HEMATOL, V84, P170, DOI 10.1002/ajh.21350; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Preza GC, 2011, J CLIN INVEST, V121, P4880, DOI 10.1172/JCI57693; PYTOWSKI B, 1995, J BIOL CHEM, V270, P9067, DOI 10.1074/jbc.270.16.9067; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Schmidt PJ, 2010, BLOOD, V116, P5679, DOI 10.1182/blood-2010-04-277954; SELIGMAN PA, 1993, BLOOD, V82, P1608; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Spasic MV, 2008, CELL METAB, V7, P173, DOI 10.1016/j.cmet.2007.11.014; STEIN BS, 1986, J BIOL CHEM, V261, P319; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sun CC, 2012, AM J HEMATOL, V87, P392, DOI 10.1002/ajh.23110; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Theurl I, 2011, BLOOD, V118, P4977, DOI 10.1182/blood-2011-03-345066; VANRENSWOUDE J, 1982, P NATL ACAD SCI-BIOL, V79, P6186; Warren RA, 1997, J BIOL CHEM, V272, P2116; WATTS C, 1985, J CELL BIOL, V100, P633, DOI 10.1083/jcb.100.2.633; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; West AP, 2001, J MOL BIOL, V313, P385, DOI 10.1006/jmbi.2001.5048; Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248; Zuk PA, 2000, J BIOL CHEM, V275, P26754	80	28	29	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70199	10.1371/journal.pone.0070199	http://dx.doi.org/10.1371/journal.pone.0070199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894616	Green Submitted, gold, Green Published			2022-12-25	WOS:000325211000193
J	Chiu, CC; Chen, LJ; Su, PH; Li, HM				Chiu, Chi-Chou; Chen, Lih-Jen; Su, Pai-Hsiang; Li, Hsou-Min			Evolution of Chloroplast J Proteins	PLOS ONE			English	Article							DEHYDROGENASE-LIKE COMPLEX; ESCHERICHIA-COLI DNAJ; HEAT-SHOCK PROTEINS; J-DOMAIN PROTEIN; SP PCC 6803; ARABIDOPSIS-THALIANA; MOLECULAR CHAPERONE; CHLAMYDOMONAS-REINHARDTII; HSP70; IMPORT	Hsp70 chaperones are involved in multiple biological processes and are recruited to specific processes by designated J domain-containing cochaperones, or J proteins. To understand the evolution and functions of chloroplast Hsp70s and J proteins, we identified the Arabidopsis chloroplast J protein constituency using a combination of genomic and proteomic database searches and individual protein import assays. We show that Arabidopsis chloroplasts have at least 19 J proteins, the highest number of confirmed J proteins for any organelle. These 19 J proteins are classified into 11 clades, for which cyanobacteria and glaucophytes only have homologs for one clade, green algae have an additional three clades, and all the other 7 clades are specific to land plants. Each clade also possesses a clade-specific novel motif that is likely used to interact with different client proteins. Gene expression analyses indicate that most land plant-specific J proteins show highly variable expression in different tissues and are down regulated by low temperatures. These results show that duplication of chloroplast Hsp70 in land plants is accompanied by more than doubling of the number of its J protein cochaperones through adding new J proteins with novel motifs, not through duplications within existing families. These new J proteins likely recruit chloroplast Hsp70 to perform tissue specific functions related to biosynthesis rather than to stress resistance.	[Chiu, Chi-Chou; Chen, Lih-Jen; Su, Pai-Hsiang; Li, Hsou-Min] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Chiu, Chi-Chou] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan	Academia Sinica - Taiwan; National Cheng Kung University	Li, HM (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	mbhmli@gate.sinica.edu.tw	Li, Hsou-min/AAZ-8011-2021; Chiu, Chi-Chou/AAH-2620-2020; Chiu, Chi-Chou/J-3610-2019	Li, Hsou-min/0000-0002-0211-7339; 	National Science Council [NSC-101-2321-B-001-003]; Academia Sinica of Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica of Taiwan(Academia Sinica - Taiwan)	This work was supported by grants to HmL from the National Science Council (grant no. NSC-101-2321-B-001-003) and the Academia Sinica of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bonk M, 1996, PLANT PHYSIOL, V111, P931, DOI 10.1104/pp.111.3.931; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CHEN GG, 1994, P NATL ACAD SCI USA, V91, P11497, DOI 10.1073/pnas.91.24.11497; Chen KM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-43; Chiu CC, 2010, PLANT PHYSIOL, V154, P1172, DOI 10.1104/pp.110.161224; Dorn KV, 2010, BIOCHEM J, V427, P205, DOI 10.1042/BJ20091412; Duppre E, 2011, MICROBIOL-SGM, V157, P1269, DOI 10.1099/mic.0.045542-0; Ferro M, 2003, MOL CELL PROTEOMICS, V2, P325, DOI 10.1074/mcp.M300030-MCP200; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Fuhrmann E, 2009, MOL BIOL CELL, V20, P4620, DOI 10.1091/mbc.E09-04-0319; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kroczynska B, 1996, PLANT MOL BIOL, V31, P619, DOI 10.1007/BF00042234; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Liu CM, 2005, MOL BIOL CELL, V16, P1165, DOI 10.1091/mbc.E04-08-0736; Liu CM, 2007, PLANT J, V50, P265, DOI 10.1111/j.1365-313X.2007.03047.x; Loffelhardt W, 1997, CRIT REV PLANT SCI, V16, P393; MADUENO F, 1993, PLANT CELL, V5, P1865, DOI 10.1105/tpc.5.12.1865; MARSHALL JS, 1990, P NATL ACAD SCI USA, V87, P374, DOI 10.1073/pnas.87.1.374; Miernyk JA, 2001, CELL STRESS CHAPERON, V6, P209, DOI 10.1379/1466-1268(2001)006<0209:TJDPOA>2.0.CO;2; Orme W, 2001, PLANT MOL BIOL, V46, P615, DOI 10.1023/A:1010665702621; PERRY SE, 1991, METHOD CELL BIOL, V34, P327; Prasad BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012761; Rajan VBV, 2009, FUNCT INTEGR GENOMIC, V9, P433, DOI 10.1007/s10142-009-0132-0; Ratnayake RMU, 2008, BIOSCI BIOTECH BIOCH, V72, P2926, DOI 10.1271/bbb.80408; Reyes-Prieto A, 2007, MOL BIOL EVOL, V24, P2358, DOI 10.1093/molbev/msm186; Sakurai T, 2005, NUCLEIC ACIDS RES, V33, pD647, DOI 10.1093/nar/gki014; Schlicher T, 1997, PLANT MOL BIOL, V33, P181, DOI 10.1023/A:1005784115363; Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y; Schroda M, 1999, PLANT CELL, V11, P1165, DOI 10.1105/tpc.11.6.1165; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Shi LX, 2010, PLANT CELL, V22, P205, DOI 10.1105/tpc.109.071464; Steiner JM, 2002, TRENDS PLANT SCI, V7, P72, DOI 10.1016/S1360-1385(01)02179-3; Su PH, 2008, PLANT PHYSIOL, V146, P1231, DOI 10.1104/pp.107.114496; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSUGEKI R, 1993, FEBS LETT, V320, P198, DOI 10.1016/0014-5793(93)80585-I; UEGUCHI C, 1994, P NATL ACAD SCI USA, V91, P1054, DOI 10.1073/pnas.91.3.1054; Willmund F, 2008, PLANT PHYSIOL, V148, P2070, DOI 10.1104/pp.108.127944; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; Zhang C, 2006, PLANT PHYSIOL BIOCH, V44, P844, DOI 10.1016/j.plaphy.2006.09.012; ZHOU RG, 1995, PLANT PHYSIOL, V108, P821, DOI 10.1104/pp.108.2.821	49	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70384	10.1371/journal.pone.0070384	http://dx.doi.org/10.1371/journal.pone.0070384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894646	Green Submitted, gold, Green Published			2022-12-25	WOS:000325211000206
J	Uzri, D; Greenberg, HB				Uzri, Dina; Greenberg, Harry B.			Characterization of Rotavirus RNAs That Activate Innate Immune Signaling through the RIG-I-Like Receptors	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; HOST-RANGE RESTRICTION; ANTIVIRAL RESPONSES; 5'-TRIPHOSPHATE RNA; ADAPTER PROTEIN; PLUS-STRAND; CELL-LINES; VIRUS; INTERFERON; RECOGNITION	In mammalian cells, the first line of defense against viral pathogens is the innate immune response, which is characterized by induction of type I interferons (IFN) and other pro-inflammatory cytokines that establish an antiviral milieu both in infected cells and in neighboring uninfected cells. Rotavirus, a double-stranded RNA virus of the Reoviridae family, is the primary etiological agent of severe diarrhea in young children worldwide. Previous studies demonstrated that rotavirus replication induces a MAVS-dependent type I IFN response that involves both RIG-I and MDA5, two cytoplasmic viral RNA sensors. This study reports the isolation and characterization of rotavirus RNAs that activate IFN signaling. Using an in vitro approach with purified rotavirus double-layer particles, nascent single-stranded RNA (ssRNA) transcripts (termed in vitro ssRNA) were found to be potent IFN inducers. In addition, large RNAs isolated from rotavirus-infected cells six hours post-infection (termed in vivo 6 hr large RNAs), also activated IFN signaling, whereas a comparable large RNA fraction isolated from cells infected for only one hour lacked this stimulatory activity. Experiments using knockout murine embryonic fibroblasts showed that RIG-I is required for and MDA5 partly contributes to innate immune signaling by both in vitro ssRNA and in vivo 6 hr large RNAs. Enzymatic studies demonstrated that in vitro ssRNA and in vivo 6 hr large RNA samples contain uncapped RNAs with exposed 5' phosphate groups. RNAs lacking 2'-O-methylated 5' cap structures were also detected in the in vivo 6 hr large RNA sample. Taken together, our data provide strong evidence that the rotavirus VP3 enzyme, which encodes both guanylyltransferase and methyltransferase activities, is not completely efficient at either 5' capping or 2'-O-methylation of the 5' cap structures of viral transcripts, and in this way produces RNA patterns that activate innate immune signaling through the RIG-I-like receptors.	[Uzri, Dina; Greenberg, Harry B.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Uzri, Dina; Greenberg, Harry B.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Uzri, Dina; Greenberg, Harry B.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Greenberg, HB (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	harry.greenberg@stanford.edu		greenberg, harry/0000-0002-2128-9080	National Institutes of Health [R01 AI021362]; VA Merit Review Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, R01AI021362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (R01 AI021362) to HG and a VA Merit Review Grant to HG (http://www1.va.gov/op3/page.cfm?pg = 42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003064; Arnold MM, 2011, J VIROL, V85, P1970, DOI 10.1128/JVI.01801-10; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boyce M, 2007, J VIROL, V81, P2179, DOI 10.1128/JVI.01819-06; BRIDGER JC, 1976, J GEN VIROL, V31, P245, DOI 10.1099/0022-1317-31-2-245; BROOME RL, 1993, J VIROL, V67, P2448, DOI 10.1128/JVI.67.5.2448-2455.1993; Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862; Chen D, 1998, J VIROL, V72, P7387, DOI 10.1128/JVI.72.9.7387-7396.1998; COHEN J, 1977, J GEN VIROL, V36, P395, DOI 10.1099/0022-1317-36-3-395; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Deal EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000931; Estes MK, 2007, FIELDS VIROLOGY, P1917; Feng N, 2008, J VIROL, V82, P7578, DOI 10.1128/JVI.00391-08; Feng N, 2009, J VIROL, V83, P6987, DOI 10.1128/JVI.00585-09; Feng N, 2013, J VIROL IN PRESS; Franco MA, 1996, ARCH VIROL, P141; FURUICHI Y, 1976, J BIOL CHEM, V251, P5043; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; GERNA G, 1990, J CLIN MICROBIOL, V28, P1342, DOI 10.1128/JCM.28.6.1342-1347.1990; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Graff JW, 2007, J GEN VIROL, V88, P613, DOI 10.1099/vir.0.82255-0; Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280; Holloway G, 2013, J GEN VIROL, V94, P1151, DOI 10.1099/vir.0.051276-0; Holloway G, 2009, J VIROL, V83, P4942, DOI 10.1128/JVI.01450-08; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; HOSHINO Y, 1984, J INFECT DIS, V149, P694, DOI 10.1093/infdis/149.5.694; HOSHINO Y, 1995, VIROLOGY, V209, P274, DOI 10.1006/viro.1995.1255; IMAI M, 1983, J VIROL, V47, P125, DOI 10.1128/JVI.47.1.125-136.1983; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Lawton JA, 1999, P NATL ACAD SCI USA, V96, P5428, DOI 10.1073/pnas.96.10.5428; Li W, 2010, NUCLEIC ACIDS RES, V38, P7718, DOI 10.1093/nar/gkq663; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; McNeal MM, 2002, J VIROL, V76, P560, DOI 10.1128/JVI.76.2.560-568.2002; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; NAKAGOMI O, 1990, J CLIN MICROBIOL, V28, P1198, DOI 10.1128/JCM.28.6.1198-1203.1990; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Qin L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-526; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Rojas M, 2010, J VIROL, V84, P10457, DOI 10.1128/JVI.00625-10; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Sen A, 2009, J VIROL, V83, P10322, DOI 10.1128/JVI.01186-09; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; STACYPHIPPS S, 1987, J VIROL, V61, P3479, DOI 10.1128/JVI.61.11.3479-3484.1987; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Tortorici MA, 2006, RNA, V12, P133, DOI 10.1261/rna.2122606; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; YAMAKAWA M, 1981, J BIOL CHEM, V256, P6507; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	78	29	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69825	10.1371/journal.pone.0069825	http://dx.doi.org/10.1371/journal.pone.0069825			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894547	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000160
J	Chen, CM; Wonsey, DR; Lemieux, ME; Kung, AL				Chen, Changmin; Wonsey, Diane R.; Lemieux, Madeleine E.; Kung, Andrew L.			Differential Disruption of EWS-FLI1 Binding by DNA-Binding Agents	PLOS ONE			English	Article							MAGNETIC-RESONANCE INVESTIGATIONS; ACTINOMYCIN-D; EWINGS-SARCOMA; AQUEOUS-SOLUTION; ONCOGENIC TRANSCRIPTION; COMPLEX-FORMATION; GROWTH-FACTOR; GENE; FUSION; TUMOR	Fusion of the EWS gene to FLI1 produces a fusion oncoprotein that drives an aberrant gene expression program responsible for the development of Ewing sarcoma. We used a homogenous proximity assay to screen for compounds that disrupt the binding of EWS-FLI1 to its cognate DNA targets. A number of DNA-binding chemotherapeutic agents were found to non-specifically disrupt protein binding to DNA. In contrast, actinomycin D was found to preferentially disrupt EWS-FLI1 binding by comparison to p53 binding to their respective cognate DNA targets in vitro. In cell-based assays, low concentrations of actinomycin D preferentially blocked EWS-FLI1 binding to chromatin, and disrupted EWS-FLI1-mediated gene expression. Higher concentrations of actinomycin D globally repressed transcription. These results demonstrate that actinomycin D preferentially disrupts EWS-FLI1 binding to DNA at selected concentrations. Although the window between this preferential effect and global suppression is too narrow to exploit in a therapeutic manner, these results suggest that base-preferences may be exploited to find DNA-binding compounds that preferentially disrupt subclasses of transcription factors.	[Chen, Changmin; Wonsey, Diane R.; Lemieux, Madeleine E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Chen, Changmin; Wonsey, Diane R.; Lemieux, Madeleine E.] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA; [Kung, Andrew L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10027 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Columbia University	Kung, AL (corresponding author), Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10027 USA.	akung@columbia.edu	Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; Lemieux, Madeleine/0000-0001-6355-8691	St. Baldrick's Foundation	St. Baldrick's Foundation	Funding provided by St. Baldrick's Foundation (Kung). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY SA, 1994, BIOCHEMISTRY-US, V33, P11493, DOI 10.1021/bi00204a011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BROWN SC, 1984, BIOCHEMISTRY-US, V23, P403, DOI 10.1021/bi00298a003; Chen CM, 2013, EUR J PHARM SCI, V49, P18, DOI 10.1016/j.ejps.2013.02.003; Cotterill SJ, 2000, J CLIN ONCOL, V18, P3108, DOI 10.1200/JCO.2000.18.17.3108; FOX KR, 1984, NUCLEIC ACIDS RES, V12, P9271, DOI 10.1093/nar/12.24.9271; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; GOODISMAN J, 1992, BIOCHEMISTRY-US, V31, P1046, DOI 10.1021/bi00119a013; Grohar PJ, 2011, JNCI-J NATL CANCER I, V103, P962, DOI 10.1093/jnci/djr156; Grohar PJ, 2011, NEOPLASIA, V13, P145, DOI 10.1593/neo.101202; HOLLSTEIN U, 1974, CHEM REV, V74, P625, DOI 10.1021/cr60292a002; Im YH, 2000, CANCER RES, V60, P1536; KAMITORI S, 1992, J MOL BIOL, V225, P445, DOI 10.1016/0022-2836(92)90931-9; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; KRUGH TR, 1973, BIOCHEMISTRY-US, V12, P1775, DOI 10.1021/bi00733a018; KRUGH TR, 1973, BIOCHEMISTRY-US, V12, P4418, DOI 10.1021/bi00746a019; LANE MJ, 1983, P NATL ACAD SCI-BIOL, V80, P3260, DOI 10.1073/pnas.80.11.3260; Leavey PJ, 2008, EXPERT REV ANTICANC, V8, P617, DOI 10.1586/14737140.8.4.617; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Olenyuk BZ, 2004, P NATL ACAD SCI USA, V101, P16768, DOI 10.1073/pnas.0407617101; OUCHIDA M, 1995, ONCOGENE, V11, P1049; PATEL DJ, 1974, BIOCHEMISTRY-US, V13, P2388, DOI 10.1021/bi00708a024; PATEL DJ, 1974, BIOCHEMISTRY-US, V13, P2396, DOI 10.1021/bi00708a025; Patel M, 2012, GENOME RES, V22, P259, DOI 10.1101/gr.125666.111; Raskatov JA, 2012, P NATL ACAD SCI USA, V109, P1023, DOI 10.1073/pnas.1118506109; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; SOBELL HM, 1971, NATURE-NEW BIOL, V231, P200, DOI 10.1038/newbio231200a0; Wang L, 2007, J MOL DIAGN, V9, P498, DOI 10.2353/jmoldx.2007.070053; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106	31	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69714	10.1371/journal.pone.0069714	http://dx.doi.org/10.1371/journal.pone.0069714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894528	gold, Green Published, Green Submitted			2022-12-25	WOS:000322132100077
J	Fang, HB; Nie, LH; Chi, ZF; Liu, J; Guo, D; Lu, XM; Hei, TK; Balajee, AS; Zhao, YL				Fang, Hongbo; Nie, Linghu; Chi, Zhenfen; Liu, Jing; Guo, Dan; Lu, Xuemei; Hei, Tom K.; Balajee, Adayabalam S.; Zhao, Yongliang			RecQL4 Helicase Amplification Is Involved in Human Breast Tumorigenesis	PLOS ONE			English	Article							ROTHMUND-THOMSON-SYNDROME; ANTI-APOPTOSIS GENE; IDENTIFIES CHROMOSOMAL REGIONS; CANCER STATISTICS; SURVIVIN; REPAIR; ROLES; INSTABILITY; PROGNOSIS; CELLS	Breast cancer occur both in hereditary and sporadic forms, and the later one comprises an overwhelming majority of breast cancer cases among women. Numerical and structural alterations involving chromosome 8, with loss of short arm (8p) and gain of long arm (8q), are frequently observed in breast cancer cells and tissues. In this study, we show that most of the human breast tumor cell lines examined display an over representation of 8q24, a chromosomal locus RecQL4 is regionally mapped to, and consequently, a markedly elevated level of RecQL4 expression. An increased RecQL4 mRNA level was also observed in a majority of clinical breast tumor samples (38/43) examined. shRNA-mediated RecQL4 suppression in MDA-MB453 breast cancer cells not only significantly inhibit the in vitro clonogenic survival and in vivo tumorigenicity. Further studies demonstrate that RecQL4 physically interacts with a major survival factor-survivin and its protein level affects survivin expression. Although loss of RecQL4 function due to gene mutations causally linked to occurrence of human RTS with features of premature aging and cancer predisposition, our studies provide the evidence that overexpression of RecQL4 due to gene amplification play a critical role in human breast tumor progression.	[Fang, Hongbo; Nie, Linghu; Chi, Zhenfen; Liu, Jing; Guo, Dan; Lu, Xuemei; Zhao, Yongliang] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing, Peoples R China; [Chi, Zhenfen; Liu, Jing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Hei, Tom K.; Balajee, Adayabalam S.] Columbia Univ, Ctr Radiol Res, Dept Radiat Oncol, Med Ctr, New York, NY 10032 USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Columbia University	Balajee, AS (corresponding author), Columbia Univ, Ctr Radiol Res, Dept Radiat Oncol, Med Ctr, New York, NY 10032 USA.	ab836@columbia.edu; zhaoyongliang@big.ac.cn	Guo, Dan/S-8823-2019	fang, hong bo/0000-0003-1273-9024	National Basic Research Program of China (973 Program) [2013CB911000]; National Natural Science Foundation of China [91131903, 81272929, 30971602]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Work was supported by National Basic Research Program of China (973 Program, No. 2013CB911000) and National Natural Science Foundation of China (91131903, 81272929, 30971602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida C, 1998, LANCET, V351, P882, DOI 10.1016/S0140-6736(05)70294-4; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; [Anonymous], CANCER; [Anonymous], CANCER; [Anonymous], BMC; [Anonymous], LEUK RES; Bhattacharya A, 2011, CLIN CANCER RES, V17, P7024, DOI 10.1158/1078-0432.CCR-11-1944; Chen J, 2003, J BIOL CHEM, V278, P486, DOI 10.1074/jbc.M211119200; Chu WK, 2010, ONCOGENE, V29, P4705, DOI 10.1038/onc.2010.214; DERKALOUSTIAN VM, 1990, AM J MED GENET, V37, P336, DOI 10.1002/ajmg.1320370308; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; El Gammal AT, 2010, CLIN CANCER RES, V16, P56, DOI 10.1158/1078-0432.CCR-09-1423; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fan W, 2008, J BIOL CHEM, V283, P29037, DOI 10.1074/jbc.M801928200; Ghazani AA, 2007, NEOPLASIA, V9, P511, DOI 10.1593/neo.07301; Golas MM, 2010, CANCER GENET CYTOGEN, V197, P95, DOI 10.1016/j.cancergencyto.2009.10.013; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jin WD, 2008, HUM GENET, V123, P643, DOI 10.1007/s00439-008-0518-4; Kanapuru B, 2012, BREAST CANCER RES TR, V134, P853, DOI 10.1007/s10549-012-2115-4; Kawasaki H, 1998, CANCER RES, V58, P5071; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kitao S, 1999, GENOMICS, V61, P268, DOI 10.1006/geno.1999.5959; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Lindor NM, 2000, AM J MED GENET, V90, P223, DOI 10.1002/(SICI)1096-8628(20000131)90:3<223::AID-AJMG7>3.0.CO;2-Z; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Maire G, 2009, NEOPLASIA, V11, P260, DOI 10.1593/neo.81384; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; Monzo M, 1999, J CLIN ONCOL, V17, P2100, DOI 10.1200/JCO.1999.17.7.2100; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Niedzialkowska E, 2012, MOL BIOL CELL, V23, P1457, DOI 10.1091/mbc.E11-11-0904; Rummukainen J, 2001, CANCER GENET CYTOGEN, V126, P1, DOI 10.1016/S0165-4608(00)00387-3; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Schurman SH, 2009, HUM MOL GENET, V18, P3470, DOI 10.1093/hmg/ddp291; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; Soriani S, 2011, LEUK RES, V35; Su YR, 2010, CANCER RES, V70, P9207, DOI 10.1158/0008-5472.CAN-10-1743; Tarkkanen M, 1999, INT J CANCER, V84, P114, DOI 10.1002/(SICI)1097-0215(19990420)84:2<114::AID-IJC4>3.0.CO;2-Q; Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09; Thomassen M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-394; Thomassen M, 2009, GENE CHROMOSOME CANC, V48, P711, DOI 10.1002/gcc.20676; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648; Zhao YL, 2002, ONCOGENE, V21, P7471, DOI 10.1038/sj.onc.1205891; Zhivotovsky B, 2004, NAT REV MOL CELL BIO, V5, P752, DOI 10.1038/nrm1443	54	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69600	10.1371/journal.pone.0069600	http://dx.doi.org/10.1371/journal.pone.0069600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894508	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100072
J	Zhang, JY; Gao, WJ; Yang, X; Kang, JJ; Zhang, YL; Guo, QR; Hu, YX; Xia, GL; Kang, YM				Zhang, Jingyao; Gao, Wenjuan; Yang, Xu; Kang, Jingjing; Zhang, Yongliang; Guo, Qirui; Hu, Yanxin; Xia, Guoliang; Kang, Youmin			Tolerogenic Vaccination Reduced Effector Memory CD4 T Cells and Induced Effector Memory Treg Cells for Type I Diabetes Treatment	PLOS ONE			English	Article							NOD MICE; DNA VACCINATION; IMMUNE-RESPONSE; DENDRITIC CELLS; INSULIN; ANTIGEN; NAIVE; CD4(+)CD25(+); ADJUVANT; GLUCOCORTICOIDS	Background: Vaccination could induce immune tolerance and protected NOD mice from the development of type I diabetes (T1D). We previously demonstrated that insulin peptide (B9-23) combined with dexamethasone (DEX) stimulated the expansion of antigen specific regulatory T (Treg) cells which in turn effectively prevented T1D in NOD mice. Here, we aimed to investigate the therapeutic effect of tolerogenic vaccination for T1D treatment. Methodology/Principal Findings: The diabetic NOD mice (Blood glucose level >= 250 mg/dl) were treated with B9-23 and DEX twice. The tolerance was restored by blocking maturation of dendritic cells (DCs) and inducing Treg cells in treated NOD mice. Remarkably, the reduction of autoreactive effector memory CD4 T (Tm) cells and the induction of functional effector memory Treg (mTreg) cells contributed to the improvement of T1D in treated NOD mice. Conclusions/Significance: Tolerogenic vaccination restored tolerance and ameliorated T1D by suppressing effector CD4 Tm cells and inducing effector mTreg cells. Our findings implicate the potential of tolerogenic vaccination for T1D treatment.	[Zhang, Jingyao; Gao, Wenjuan; Yang, Xu; Zhang, Yongliang; Guo, Qirui; Xia, Guoliang; Kang, Youmin] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Kang, Jingjing] Agr Univ Hebei, Dept Modern Sci & Technol, Baoding, Peoples R China; [Hu, Yanxin] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	China Agricultural University; Hebei Agricultural University; China Agricultural University	Kang, YM (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	kym@cau.edu.cn	Zhang, Yongliang/AAE-7639-2021	Zhang, Yongliang/0000-0002-6790-1044; Kang, Youmin/0000-0003-2597-6117	National Natural Science Foundation of China [31270956]; National Natural Science Foundation [J1103520]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Project: 31270956), the National Natural Science Foundation (Project: J1103520) for Undergraduates and State Experiment Innovation for Undergraduates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleva DG, 2001, J CLIN INVEST, V107, P173, DOI 10.1172/JCI8525; ATKINSON MA, 1990, DIABETES, V39, P933, DOI 10.2337/diabetes.39.8.933; Battaglia M, 2011, SEMIN IMMUNOL, V23, P182, DOI 10.1016/j.smim.2011.07.007; Bluestone JA, 2004, P NATL ACAD SCI USA, V101, P14622, DOI 10.1073/pnas.0405234101; BUDD RC, 1987, J IMMUNOL, V138, P3120; Chen X, 2004, EUR J IMMUNOL, V34, P859, DOI 10.1002/eji.200324506; Dai YD, 2005, CELL MOL IMMUNOL, V2, P169; Danke NA, 2005, J AUTOIMMUN, V25, P303, DOI 10.1016/j.jaut.2005.08.007; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Ferrera F, 2007, ANN NY ACAD SCI, V1110, P99, DOI 10.1196/annals.1423.012; Flynn JC, 2000, IMMUNOPHARM IMMUNOT, V22, P387, DOI 10.3109/08923970009016427; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; GEPTS W, 1981, AM J MED, V70, P105, DOI 10.1016/0002-9343(81)90417-4; Godebu E, 2008, J IMMUNOL, V181, P1798, DOI 10.4049/jimmunol.181.3.1798; Hutchings P, 1998, J AUTOIMMUN, V11, P127, DOI 10.1006/jaut.1997.0184; Kang YM, 2008, J IMMUNOL, V180, P5172, DOI 10.4049/jimmunol.180.8.5172; Kang YM, 2009, J GENE MED, V11, P1064, DOI 10.1002/jgm.1387; Kelemen K, 2004, J IMMUNOL, V172, P3955, DOI 10.4049/jimmunol.172.6.3955; Li CR, 2012, J MOL CELL BIOL, V4, P38, DOI 10.1093/jmcb/mjr040; Li CR, 2011, J AUTOIMMUN, V37, P217, DOI 10.1016/j.jaut.2011.06.002; Lo J, 2006, ANN NY ACAD SCI, V1079, P153, DOI 10.1196/annals.1375.023; Lobell A, 2003, J IMMUNOL, V170, P1806, DOI 10.4049/jimmunol.170.4.1806; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Monfar M, 1996, MOL ENDOCRINOL, V10, P1107, DOI 10.1210/me.10.9.1107; Monti P, 2007, J IMMUNOL, V179, P5785, DOI 10.4049/jimmunol.179.9.5785; Oling V, 2012, CELL IMMUNOL, V273, P133, DOI 10.1016/j.cellimm.2011.12.008; Piemonti L, 1999, J IMMUNOL, V162, P6473; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Tang QZ, 2006, IMMUNOL REV, V212, P217, DOI 10.1111/j.0105-2896.2006.00421.x; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Viglietta V, 2002, J CLIN INVEST, V109, P895, DOI 10.1172/JCI14114; Wang B, 2008, IMMUNOL RES, V41, P175, DOI 10.1007/s12026-008-8020-6; Weber SE, 2006, J IMMUNOL, V176, P4730, DOI 10.4049/jimmunol.176.8.4730; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; YAGI H, 1992, EUR J IMMUNOL, V22, P2387, DOI 10.1002/eji.1830220931; Zhang WJ, 2010, HUM GENE THER, V21, P171, DOI 10.1089/hum.2009.095; Zhao CF, 2010, J EXP MED, V207, P2883, DOI 10.1084/jem.20100598	41	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70056	10.1371/journal.pone.0070056	http://dx.doi.org/10.1371/journal.pone.0070056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894591	gold, Green Published, Green Submitted			2022-12-25	WOS:000322391400080
J	Lazrak, A; Fu, LW; Bali, V; Bartoszewski, R; Rab, A; Havasi, V; Keiles, S; Kappes, J; Kumar, R; Lefkowitz, E; Sorscher, EJ; Matalon, S; Collawn, JF; Bebok, Z				Lazrak, Ahmed; Fu, Lianwu; Bali, Vedrana; Bartoszewski, Rafal; Rab, Andras; Havasi, Viktoria; Keiles, Steve; Kappes, John; Kumar, Ranjit; Lefkowitz, Elliot; Sorscher, Eric J.; Matalon, Sadis; Collawn, James F.; Bebok, Zsuzsanna			The silent codon change I507-ATC -> ATT contributes to the severity of the Delta F508 CFTR channel dysfunction	FASEB JOURNAL			English	Article						ABC protein; channel gating; patch-clamp; single-nucleotide polymorphism; sSNP; cotranslational folding	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; MESSENGER-RNA; QUALITY-CONTROL; SYNONYMOUS MUTATIONS; SECONDARY STRUCTURE; SIDE-CHAIN; EXPRESSION; PROTEIN; STABILITY	The most common disease-causing mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene is the out-of-frame deletion of 3 nucleotides (CTT). This mutation leads to the loss of phenylalanine-508 (F508) and a silent codon change (SCC) for isoleucine-507 (I507-ATCATT). F508 CFTR is misfolded and degraded by endoplasmic reticulum-associated degradation (ERAD). We have demonstrated that the I507-ATCATT SCC alters F508 CFTR mRNA structure and translation dynamics. By comparing the biochemical and functional properties of the I507-ATT and I507-ATC F508 CFTR, we establish that the I507-ATCATT SCC contributes to the cotranslational misfolding, ERAD, and to the functional defects associated with F508 CFTR. We demonstrate that the I507-ATC F508 CFTR is less susceptible to the ER quality-control machinery during translation than the I507-ATT, although 27 degrees C correction is necessary for sufficient cell-surface expression. Whole-cell patch-clamp recordings indicate sustained, thermally stable cAMP-activated Cl- transport through I507-ATC and unstable function of the I507-ATT F508 CFTR. Single-channel recordings reveal improved gating properties of the I507-ATC compared to I507-ATT F508 CFTR (NPo=0.45 +/- 0.037 vs. NPo=0.09 +/- 0.002; P<0.001). Our results signify the role of the I507-ATCATT SCC in the F508 CFTR defects and support the importance of synonymous codon choices in determining the function of gene products.Lazrak, A., Fu, L., Bali, V., Bartoszewski, R., Rab, A., Havasi, V., Keiles, S., Kappes, J., Kumar, R., Lefkowitz, E., Sorscher, E. J., Matalon, S., Collawn, J. F., Bebok, Z. The silent codon change I507-ATCATT contributes to the severity of the F508 CFTR.	[Lazrak, Ahmed; Matalon, Sadis] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35294 USA; [Fu, Lianwu; Bali, Vedrana; Rab, Andras; Collawn, James F.; Bebok, Zsuzsanna] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Kappes, John; Sorscher, Eric J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kappes, John; Kumar, Ranjit; Lefkowitz, Elliot] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Fu, Lianwu; Havasi, Viktoria; Kappes, John; Sorscher, Eric J.; Matalon, Sadis; Collawn, James F.; Bebok, Zsuzsanna] Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Keiles, Steve] Ambry Genet, Aliso Viejo, CA USA; [Bartoszewski, Rafal] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Fahrenheit Universities; Medical University Gdansk	Bebok, Z (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1918 Univ Blvd,MCLM 350A, Birmingham, AL 35294 USA.	bebok@uab.edu	Rab, András/AAR-7804-2021; Havasi, Viktoria/B-1309-2009; Rab, Andras/AAI-9402-2021; Bartoszewski, Rafal A/D-6311-2011	Rab, András/0000-0003-2154-0017; Bartoszewski, Rafal A/0000-0002-2864-6757; Lazrak, Ahmed/0000-0002-4127-1937; Sorscher, Eric J./0000-0001-9341-3354; Fu, Karl/0000-0001-5386-9429; Lefkowitz, Elliot/0000-0002-4748-4925	U.S. National Institutes of Health [HL076587, DK060065, 5U01ES015676, 5R01HL031197, GM095639]; North American Cystic Fibrosis Foundation [Sorsch05xx0, CFF R464, CFF DELUCA03G0]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076587, R01HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095639] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Cystic Fibrosis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible by U.S. National Institutes of Health grants HL076587 (Z.B.), DK060065 (J.F.C.), 5U01ES015676 and 5R01HL031197 (A. L. and S. M.), GM095639 (J.C.K.), University of Alabama at Birmingham Center for Clinical and Translational Science UL1TR000165 (National Center for Advancing Translational Sciences and National Center for Research Resources; R. K. and E. L.), P30 DK07248Z, and North American Cystic Fibrosis Foundation grants Sorsch05xx0, CFF R464 (E.J.S.), and CFF DELUCA03G0 (J.C.K). The authors thank Ms. Nancy Brissie for her outstanding technical support in organizing, maintaining, and preparing the cell clones used in these studies.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Bartoszewski R, 2011, J BIOL CHEM, V286, P41862, DOI 10.1074/jbc.M111.304956; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Cai ZW, 2003, J GEN PHYSIOL, V122, P605, DOI 10.1085/jgp.200308921; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Cui L, 2006, J PHYSIOL-LONDON, V572, P347, DOI 10.1113/jphysiol.2005.099457; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Diatchenko L, 2006, PAIN, V123, P226, DOI 10.1016/j.pain.2006.04.015; Diatchenko L, 2006, AM J MED GENET B, V141B, P449, DOI 10.1002/ajmg.b.30324; Dong Q, 2012, P NATL ACAD SCI USA, V109, P917, DOI 10.1073/pnas.1120065109; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; GRAY MA, 1993, AM J PHYSIOL, V264, pC591, DOI 10.1152/ajpcell.1993.264.3.C591; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Henderson MJ, 2010, J BIOL CHEM, V285, P11314, DOI 10.1074/jbc.M109.044057; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Lazrak A, 2003, AM J PHYSIOL-LUNG C, V285, pL443, DOI 10.1152/ajplung.00412.2002; Lazrak A, 2012, AM J RESP CELL MOL, V46, P342, DOI 10.1165/rcmb.2011-0309OC; Lazrak A, 2011, AM J PHYSIOL-LUNG C, V301, pL557, DOI 10.1152/ajplung.00094.2011; Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Londino JD, 2013, AM J PHYSIOL-LUNG C, V304, pL582, DOI 10.1152/ajplung.00314.2012; Loo TW, 2011, BIOCHEMISTRY-US, V50, P4393, DOI 10.1021/bi2004813; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Mathews D. H., 2007, CURRENT PROTOCOLS NU; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nackley AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005237; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1991, P NATL ACAD SCI USA, V88, P7500, DOI 10.1073/pnas.88.17.7500; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rotin D, 2011, PFLUG ARCH EUR J PHY, V461, P1, DOI 10.1007/s00424-010-0893-2; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Tosoni K, 2013, BIOCHEM J, V449, P295, DOI 10.1042/BJ20121240; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tsao D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024287; Tsao D, 2011, NUCLEIC ACIDS RES, V39, P6201, DOI 10.1093/nar/gkr165; Tseng SC, 2011, PHARMACOGENOMICS, V12, P1147, DOI [10.2217/PGS.11.66, 10.2217/pgs.11.66]; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; Zuker M, 2000, CURR OPIN STRUC BIOL, V10, P303, DOI 10.1016/S0959-440X(00)00088-9; Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116; ZUKER M, 1995, NUCLEIC ACIDS RES, V23, P2791, DOI 10.1093/nar/23.14.2791	78	45	47	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4630	4645		10.1096/fj.13-227330	http://dx.doi.org/10.1096/fj.13-227330			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23907436	Green Published			2022-12-25	WOS:000329937500028
J	Dong, ZZ; Qi, J; Peng, H; Liu, JG; Zhang, JT				Dong, Zizheng; Qi, Jing; Peng, Hui; Liu, Jianguo; Zhang, Jian-Ting			Spectrin Domain of Eukaryotic Initiation Factor 3a Is the Docking Site for Formation of the a:b:i:g Subcomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR EIF3; TRANSLATIONAL CONTROL; CELL-GROWTH; PROTEIN; EXPRESSION; CARCINOMA; CANCER; P170; OVEREXPRESSION; IDENTIFICATION	eIF3a (eukaryotic translation initiation factor 3a), one of the core subunits of the eIF3 complex, has been implicated in regulating translation of different mRNAs and in tumorigenesis. A subcomplex consisting of eIF3a, eIF3b, eIF3g, and eIF3i (eIF3(a:b:i:g)) has also been identified. However, how eIF3a participates in translational regulation and in formation of the eIF3(a: b: i: g) subcomplex remain to be solved. In this study, we used the tandem affinity purification approach in combination with tandem MS/MS and identified the spectrin domain of eIF3a as the docking site for the formation of eIF3(a: b: i: g) subcomplex. Although eIF3b and eIF3i bind concurrently to the spectrin domain of eIF3a within similar to 10-15 amino acids apart, eIF3g binds to eIF3a indirectly via binding to the carboxyl-terminal domain of eIF3b. The binding of eIF3b to the spectrin domain of eIF3a occurs in its RNA recognition motif domain where eIF3j also binds in a mutually exclusive manner. Together, we conclude that the spectrin domain of eIF3a is responsible for the formation of eIF3(a: b: i: g) subcomplex and, because of mutually exclusive nature of bindings of eIF3a and eIF3j to eIF3b, different subcomplexes of eIF3 likely exist and may perform noncanonical functions in translational regulation.	Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, JT (corresponding author), IUSCC, R3-C570,980 W Walnut St, Indianapolis, IN 46202 USA.	jianzhan@iupui.edu	Zhang, Jian-Ting/L-8334-2015	Zhang, Jian-Ting/0000-0002-2803-9914	National Institutes of Heath [R01 CA94961]; Indiana Clinical and Translational Sciences Institute; NATIONAL CANCER INSTITUTE [R01CA094961] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Clinical and Translational Sciences Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the National Institutes of Heath Grant R01 CA94961 (to J.-T. Z.) and by the Indiana Clinical and Translational Sciences Institute.	Bachmann F, 1997, CANCER RES, V57, P988; Chen GP, 2004, INT J CANCER, V112, P393, DOI 10.1002/ijc.20443; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Dong ZZ, 2005, MOL CELL PROTEOMICS, V4, P993, DOI 10.1074/mcp.M500044-MCP200; Dong ZZ, 2004, ONCOGENE, V23, P3790, DOI 10.1038/sj.onc.1207465; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; HEYWOOD SM, 1974, P NATL ACAD SCI USA, V71, P2428, DOI 10.1073/pnas.71.6.2428; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Methot N, 1997, J BIOL CHEM, V272, P1110, DOI 10.1074/jbc.272.2.1110; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Yang YY, 2012, J PROTEOME RES, V11, P1364, DOI 10.1021/pr201003g; Yin JY, 2013, CARCINOGENESIS, V34, P1224, DOI 10.1093/carcin/bgt052; Yin JY, 2011, CLIN CANCER RES, V17, P4600, DOI 10.1158/1078-0432.CCR-10-2591; Yin JY, 2011, BIOSCIENCE REP, V31, P1, DOI 10.1042/BSR20100077; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	27	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27951	27959		10.1074/jbc.M113.483164	http://dx.doi.org/10.1074/jbc.M113.483164			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23921387	Green Published, hybrid			2022-12-25	WOS:000330612800022
J	Lin, YH; Liao, CJ; Huang, YH; Wu, MH; Chi, HC; Wu, SM; Chen, CY; Tseng, YH; Tsai, CY; Chung, IH; Wu, TI; Tsai, MM; Lin, CD; Lin, KH				Lin, Y-H; Liao, C-J; Huang, Y-H; Wu, M-H; Chi, H-C; Wu, S-M; Chen, C-Y; Tseng, Y-H; Tsai, C-Y; Chung, I-H; Wu, T-I; Tsai, M-M; Lin, C. D.; Lin, K-H			Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells	ONCOGENE			English	Article						thyroid hormone; microRNA; p-AKT; matrix metalloproteinases-3; hepatocellular carcinoma	BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; NEGATIVE REGULATION; DOWN-REGULATION; CHROMOSOME 13Q; PROLIFERATION; INVASION; GENES; METALLOPROTEINASES; ACTIVATION	MicroRNAs (miRNAs) are thought to control tumor metastasis through direct interactions with target genes. Thyroid hormone (T-3) and its receptor (TR) are involved in cell growth and cancer progression. However, the issue of whether miRNAs participate in T-3/TR-mediated tumor migration is yet to be established. In the current study, we demonstrated that T-3/TR negatively regulates mature miR-17 transcript expression, both in vitro and in vivo. Luciferase reporter and chromatin immunoprecipitation (ChIP) assays localized the regions responding to TR-mediated repression to positions -2234/-2000 of the miR-17 promoter sequence. Overexpression of miR-17 markedly inhibited cell migration and invasion in vitro and in vivo, mediated via suppression of matrix metalloproteinases (MMP)-3. Moreover, p-AKT expression was increased in miR-17-knockdown cells that led to enhanced cell invasion, which was blocked by LY294002. Notably, low miR-17 expression was evident in highly metastatic cells. The cell migration ability was increased by T3, but partially reduced upon miR-17 overexpression. Notably, TR alpha 1 was frequently upregulated in hepatocellular carcinoma (HCC) samples and associated with low overall survival (P = 0.023). miR-17 expression was significantly negatively associated with TRa1 (P = 0.033) and MMP3 (P = 0.043) in HCC specimens. Data from our study suggest that T-3/TR, miR-17, p-AKT and MMP3 activities are interlinked in the regulation of cancer cell metastasis.	[Lin, Y-H; Liao, C-J; Wu, M-H; Chi, H-C; Wu, S-M; Chen, C-Y; Tseng, Y-H; Tsai, C-Y; Chung, I-H; Wu, T-I; Lin, K-H] Chang Gung Univ, Coll Med, Dept Biochem, Tao Yuan 333, Taiwan; [Huang, Y-H] Chang Gung Mem Hosp, Dept Hepatogastroenterol, Liver Res Ctr, Linkou, Taiwan; [Tsai, M-M] Chang Gung Univ Sci & Technol, Dept Nursing, Tao Yuan, Taiwan; [Lin, C. D.] Pacific Union Coll, Premed Program, Angwin, CA USA	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology	Lin, KH (corresponding author), Chang Gung Univ, Coll Med, Dept Biochem, 259 Wen Hwa 1 Rd, Tao Yuan 333, Taiwan.	khlin@mail.cgu.edu.tw			Chang-Gung University, Taoyuan, Taiwan [CMRPD 34013, NMRP 140511]; National Science Council of the Republic of China [NSC 94-2320-B-182-052, NSC 98-2312-B-182A-001-MY3]	Chang-Gung University, Taoyuan, Taiwan; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang-Gung University, Taoyuan, Taiwan (CMRPD 34013, NMRP 140511) and from the National Science Council of the Republic of China (NSC 94-2320-B-182-052, NSC 98-2312-B-182A-001-MY3).	Barrera-Hernandez G, 1999, ENDOCRINOLOGY, V140, P5267, DOI 10.1210/en.140.11.5267; Bramhall SR, 1996, BRIT J CANCER, V73, P972, DOI 10.1038/bjc.1996.190; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang CC, 2013, ORAL ONCOL S, VS1040-8428, P00070; Chen CY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011270; Chen RN, 2008, ENDOCRINOLOGY, V149, P3817, DOI 10.1210/en.2007-0989; Cheng S Y, 2000, Rev Endocr Metab Disord, V1, P9, DOI 10.1023/A:1010052101214; Chi HC, 2012, CELL DEATH DIFFER, V19, P1802, DOI 10.1038/cdd.2012.58; Davis FB, 2006, CANCER RES, V66, P7270, DOI 10.1158/0008-5472.CAN-05-4365; Hall LC, 2008, J STEROID BIOCHEM, V109, P57, DOI 10.1016/j.jsbmb.2007.12.008; Huang YH, 2010, J CELL PHYSIOL, V222, P347, DOI 10.1002/jcp.21959; Huang Ya-Hui, 2008, Chang Gung Med J, V31, P325; Kress E, 2010, GASTROENTEROLOGY, V138, P1863, DOI 10.1053/j.gastro.2010.01.041; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Liao CH, 2010, ENDOCR-RELAT CANCER, V17, P99, DOI 10.1677/ERC-09-0050; Liao CJ, 2011, CANCER SCI, V102, P2255, DOI 10.1111/j.1349-7006.2011.02102.x; Lin KH, 2000, ENDOCRINOLOGY, V141, P2540, DOI 10.1210/en.141.7.2540; Lin YH, 2013, ONCOGENE, V32, P3904, DOI 10.1038/onc.2013.5; Lin YW, 1999, EUR J CANCER, V35, P1730, DOI 10.1016/S0959-8049(99)00205-1; MULLER D, 1991, INT J CANCER, V48, P550, DOI 10.1002/ijc.2910480412; Nakano K, 2004, BIOCHEM J, V378, P549, DOI 10.1042/BJ20031592; Nomura H, 1996, INT J CANCER, V69, P9, DOI 10.1002/(SICI)1097-0215(19960220)69:1<9::AID-IJC3>3.0.CO;2-8; Okamoto K, 2010, INTERNAL MED, V49, P887, DOI 10.2169/internalmedicine.49.3268; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sze KMF, 2011, HEPATOLOGY, V53, P1558, DOI 10.1002/hep.24232; Thormeyer D, 1999, INT J MOL MED, V4, P351; Tsang YS, 1999, INT J CANCER, V83, P305, DOI 10.1002/(SICI)1097-0215(19991029)83:3<305::AID-IJC3>3.0.CO;2-D; Tsui KH, 2008, PROSTATE, V68, P610, DOI 10.1002/pros.20725; Wu SM, 2011, ONCOGENE, V30, P2057, DOI 10.1038/onc.2010.585; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhang MJ, 2011, MOL CELL BIOCHEM, V357, P387, DOI 10.1007/s11010-011-0909-z	38	39	40	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2013	32	38					4509	4518		10.1038/onc.2013.309	http://dx.doi.org/10.1038/onc.2013.309			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23912452				2022-12-25	WOS:000324831300006
J	Patel, R; Apostolatos, A; Carter, G; Ajmo, J; Gali, M; Cooper, DR; You, M; Bisht, KS; Patel, NA				Patel, Rekha; Apostolatos, Andre; Carter, Gay; Ajmo, Joanne; Gali, Meghanath; Cooper, Denise R.; You, Min; Bisht, Kirpal S.; Patel, Niketa A.			Protein Kinase C delta (PKC delta) Splice Variants Modulate Apoptosis Pathway in 3T3L1 Cells during Adipogenesis IDENTIFICATION OF PKC delta II INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID; CANCER CELLS; PPAR-GAMMA; NT2 CELLS; TNF-ALPHA; RESVERATROL; INSULIN; EXPRESSION; ISOFORM; DIFFERENTIATION	Increased food intake and lack of physical activity results in excess energy stored in adipocytes, and this imbalance contributes to obesity. New adipocytes are required for storage of energy in the white adipose tissue. This process of adipogenesis is widely studied in differentiating 3T3L1 preadipocytes in vitro. We have identified a key signaling kinase, protein kinase C delta (PKC delta), whose alternative splice variant expression is modulated during adipogenesis. We demonstrate that PKC delta II splice variant promotes survival in differentiating 3T3L1 cells through the Bcl2 pathway. Here we demonstrate that resveratrol, a naturally occurring polyphenol, increases apoptosis and inhibits adipogenesis along with disruption of PKC delta alternative splicing during 3T3L1 differentiation. Importantly, we have identified a PKC delta II splice variant inhibitor. This inhibitor may be a valuable tool with therapeutic implications in obesity.	[Carter, Gay; Cooper, Denise R.; Patel, Niketa A.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Patel, Rekha; Apostolatos, Andre; Cooper, Denise R.; Patel, Niketa A.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Ajmo, Joanne; You, Min] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Gali, Meghanath; Bisht, Kirpal S.] Univ S Florida, Dept Chem, Tampa, FL 33612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Patel, NA (corresponding author), James A Haley Vet Hosp, Res Serv VAR 151, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	npatel@health.usf.edu		Patel, Niketa A./0000-0003-4811-8596; Apostolatos, Andre/0000-0002-4527-7084	Department of Veterans Affairs Medical Research grant; Veterans Affairs [I01BX003689] Funding Source: NIH RePORTER	Department of Veterans Affairs Medical Research grant(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Department of Veterans Affairs Medical Research grant (to N. A. P.).	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Ao L, 2008, TOXICOL IN VITRO, V22, P116, DOI 10.1016/j.tiv.2007.08.013; Apostolatos A, 2012, J BIOL CHEM, V287, P9299, DOI 10.1074/jbc.M111.313080; Apostolatos H, 2010, J BIOL CHEM, V285, P25987, DOI 10.1074/jbc.M110.100735; Atten MJ, 2005, INVEST NEW DRUG, V23, P111, DOI 10.1007/s10637-005-5855-8; Brun RP, 1997, J ENDOCRINOL, V155, P217, DOI 10.1677/joe.0.1550217; Carter G., 2013, ISRN OBES, V2013, P161345; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Du KY, 1997, MOL CELL BIOL, V17, P4096, DOI 10.1128/MCB.17.7.4096; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Jiang K, 2008, BIOCHEMISTRY-US, V47, P787, DOI 10.1021/bi7019782; Kawahigashi H, 1998, BBA-GENE STRUCT EXPR, V1397, P305, DOI 10.1016/S0167-4781(98)00021-9; Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001; LIBRI D, 1991, SCIENCE, V252, P1842, DOI 10.1126/science.2063196; Liu SM, 2011, CELL SIGNAL, V23, P1366, DOI 10.1016/j.cellsig.2011.03.019; MADER I, 1997, FASEB J, V24; MAGNELLI L, 1994, BIOCHEM BIOPH RES CO, V204, P84, DOI 10.1006/bbrc.1994.2429; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; McCracken MA, 2003, MOL CANCER THER, V2, P273; Muro AF, 1998, FEBS LETT, V437, P137, DOI 10.1016/S0014-5793(98)01201-0; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; Patel NA, 2006, GENE EXPRESSION, V13, P73, DOI 10.3727/000000006783991890; Peluso JJ, 2001, ENDOCRINOLOGY, V142, P4203, DOI 10.1210/en.142.10.4203; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sakla MS, 2008, HUM GENET, V122, P635, DOI 10.1007/s00439-007-0441-0; Sakurai Y, 2001, BIOL PHARM BULL, V24, P973, DOI 10.1248/bpb.24.973; Shibasaki M, 2002, DIABETOLOGIA, V45, P518, DOI 10.1007/s00125-002-0786-9; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Sorisky A, 2000, INT J OBESITY, V24, pS3, DOI 10.1038/sj.ijo.0801491; Stewart JR, 2004, INVEST NEW DRUG, V22, P107, DOI 10.1023/B:DRUG.0000011787.75522.ec; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Xiao YY, 2010, FEBS J, V277, P687, DOI 10.1111/j.1742-4658.2009.07514.x; Yip WK, 2008, ONCOL REP, V19, P319; Zhang JD, 2009, BIOCHEM BIOPH RES CO, V386, P750, DOI 10.1016/j.bbrc.2009.06.129	41	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26834	26846		10.1074/jbc.M113.482638	http://dx.doi.org/10.1074/jbc.M113.482638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902767	Green Published, hybrid			2022-12-25	WOS:000330594500049
J	Ramabhadran, V; Hatch, AL; Higgs, HN				Ramabhadran, Vinay; Hatch, Anna L.; Higgs, Henry N.			Actin Monomers Activate Inverted Formin 2 by Competing with Its Autoinhibitory Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL FISSION; MOUSE FORMIN; INF2; NUCLEATION; POLYMERIZATION; PROTEIN; MDIA1; MECHANISM; DOMAIN; RHO	INF2 is an unusual formin protein in that it accelerates both actin polymerization and depolymerization, the latter through an actin filament-severing activity. Similar to other formins, INF2 possesses a dimeric formin homology 2 (FH2) domain that binds filament barbed ends and is critical for polymerization and depolymerization activities. In addition, INF2 binds actin monomers through its diaphanous autoregulatory domain (DAD) that resembles a Wiskott-Aldrich syndrome protein homology 2 (WH2) sequence C-terminal to the FH2 that participates in both polymerization and depolymerization. INF2-DAD is also predicted to participate in an autoinhibitory interaction with the N-terminal diaphanous inhibitory domain (DID). In this work, we show that actin monomer binding to the DAD of INF2 competes with the DID/DAD interaction, thereby activating actin polymerization. INF2 is autoinhibited in cells because mutation of a key DID residue results in constitutive INF2 activity. In contrast, purified full-length INF2 is constitutively active in biochemical actin polymerization assays containing only INF2 and actin monomers. Addition of proteins that compete with INF2-DAD for actin binding (profilin or the WH2 from Wiskott-Aldrich syndrome protein) decrease full-length INF2 activity while not significantly decreasing activity of an INF2 construct lacking the DID sequence. Profilin-mediated INF2 inhibition is relieved by an anti-N-terminal antibody for INF2 that blocks the DID/DAD interaction. These results suggest that free actin monomers can serve as INF2 activators by competing with the DID/DAD interaction. We also find that, in contrast to past results, the DID-containing N terminus of INF2 does not directly bind the Rho GTPase Cdc42.	[Ramabhadran, Vinay; Hatch, Anna L.; Higgs, Henry N.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Higgs, HN (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	henry.higgs@dartmouth.edu		Higgs, Henry/0000-0002-2917-9644	National Institutes of Health [R01 GM069818]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM069818 (to H. N. H.). This work was also supported by a National Science Foundation predoctoral fellowship (to A. L. H.).	Andres-Delgado L, 2012, J CELL BIOL, V198, P1025, DOI 10.1083/jcb.201202137; Andres-Delgado L, 2010, BLOOD, V116, P5919, DOI 10.1182/blood-2010-08-300665; Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Higashida C, 2008, J CELL SCI, V121, P3403, DOI 10.1242/jcs.030940; Higashida C, 2013, NAT CELL BIOL, V15, P395, DOI 10.1038/ncb2693; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Husson C, 2010, ANN NY ACAD SCI, V1194, P44, DOI 10.1111/j.1749-6632.2010.05473.x; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Madrid R, 2010, DEV CELL, V18, P814, DOI [10.1016/j.devcel.2010.04.001, 10.1016/j.devce1.2010.04.001]; Maiti S, 2012, CYTOSKELETON, V69, P393, DOI 10.1002/cm.21033; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Nezami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012992; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Otomo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012896; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Ramabhadran V, 2011, MOL BIOL CELL, V22, P4822, DOI 10.1091/mbc.E11-05-0457; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	40	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26847	26855		10.1074/jbc.M113.472415	http://dx.doi.org/10.1074/jbc.M113.472415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23921379	Green Published, hybrid			2022-12-25	WOS:000330594500050
J	Ayoub, E; Hall, A; Scott, AM; Chagnon, MJ; Miquel, G; Halle, M; Noda, M; Bikfalvi, A; Tremblay, ML				Ayoub, Emily; Hall, Anita; Scott, Adam M.; Chagnon, Melanie J.; Miquel, Geraldine; Halle, Maxime; Noda, Masaharu; Bikfalvi, Andreas; Tremblay, Michel L.			Regulation of the Src Kinase-associated Phosphoprotein 55 Homologue by the Protein Tyrosine Phosphatase PTP-PEST in the Control of Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-TRAPPING SYSTEM; SKAP-HOM; SH3 DOMAIN; ADHESION; IDENTIFICATION; MIGRATION; ADAPTER; PHOSPHORYLATION; ACTIVATION; RECEPTOR	PTP-PEST is a cytosolic ubiquitous protein tyrosine phosphatase (PTP) that contains, in addition to its catalytic domain, several protein-protein interaction domains that allow it to interface with several signaling pathways. Among others, PTP-PEST is a key regulator of cellular motility and cytoskeleton dynamics. The complexity of the PTP-PEST interactome underscores the necessity to identify its interacting partners and physiological substrates in order to further understand its role in focal adhesion complex turnover and actin organization. Using a modified yeast substrate trapping two-hybrid system, we identified a cytosolic adaptor protein named Src kinase-associated phosphoprotein 55 homologue (SKAP-Hom) as a novel substrate of PTP-PEST. To confirm PTP-PEST interaction with SKAP-Hom, in vitro pull down assays were performed demonstrating that the PTP catalytic domain and Proline-rich 1 (P1) domain are respectively binding to the SKAP-Hom Y260 and Y297 residues and its SH3 domain. Subsequently, we generated and rescued SKAP-Hom-deficient mouse embryonic fibroblasts (MEFs) with WT SKAP-Hom, SKAP-Hom tyrosine mutants (Y260F, Y260F/Y297F), or SKAP-Hom SH3 domain mutant (W335K). Given the role of PTP-PEST, wound-healing and trans-well migration assays were performed using the generated lines. Indeed, SKAP-Hom-deficient MEFs showed a defect in migration compared with WT-rescued MEFs. Interestingly, the SH3 domain mutant-rescued MEFs showed an enhanced cell migration corresponding potentially with higher tyrosine phosphorylation levels of SKAP-Hom. These findings suggest a novel role of SKAP-Hom and its phosphorylation in the regulation of cellular motility. Moreover, these results open new avenues by which PTP-PEST regulates cellular migration, a hallmark of metastasis.	[Ayoub, Emily; Hall, Anita; Scott, Adam M.; Chagnon, Melanie J.; Halle, Maxime; Tremblay, Michel L.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Ayoub, Emily; Hall, Anita; Scott, Adam M.; Chagnon, Melanie J.; Halle, Maxime; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Miquel, Geraldine; Bikfalvi, Andreas] INSERM, U1029, F-33405 Talence, France; [Miquel, Geraldine; Bikfalvi, Andreas] Univ Bordeaux, F-33405 Talence, France	McGill University; McGill University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Tremblay, ML (corresponding author), McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	michel.tremblay@mcgill.ca	Noda, Masaharu/D-7146-2016	Noda, Masaharu/0000-0002-3796-524X	CRS/Rob Lutterman Pancreatic Cancer Research Grant; Samuel Champlain foundation; McGill Integrated Cancer Research Training Program studentship; Victor K.S. Lui Fellowship; Graduate Excellence Fellowship from McGill Faculty of Medicine; Canderel Studentship; Fonds de la Recherche en Sante du Quebec (FRSQ)	CRS/Rob Lutterman Pancreatic Cancer Research Grant; Samuel Champlain foundation; McGill Integrated Cancer Research Training Program studentship; Victor K.S. Lui Fellowship; Graduate Excellence Fellowship from McGill Faculty of Medicine; Canderel Studentship; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was funded by the CRS/Rob Lutterman Pancreatic Cancer Research Grant and the Samuel Champlain foundation (to M. L. T. and A. B.).; Recipient of the McGill Integrated Cancer Research Training Program studentship, Victor K.S. Lui Fellowship, and Graduate Excellence Fellowship from McGill Faculty of Medicine.; Recipients of the Canderel Studentship.; Recipient of a doctoral training award from Fonds de la Recherche en Sante du Quebec (FRSQ).	Alenghat FJ, 2012, J CELL SCI, V125, P5535, DOI 10.1242/jcs.111260; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bourette RP, 2005, CELL SIGNAL, V17, P941, DOI 10.1016/j.cellsig.2004.11.009; CASTELLANOS RMP, 1985, J BIOL CHEM, V260, P8240; CHAREST A, 1995, GENOMICS, V28, P501, DOI 10.1006/geno.1995.1181; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; CHAREST A, 1995, BIOCHEM J, V308, P425, DOI 10.1042/bj3080425; Charest A, 1997, ONCOGENE, V14, P1643, DOI 10.1038/sj.onc.1201008; Chen PL, 2002, PROTEIN EXPRES PURIF, V24, P481, DOI 10.1006/prep.2001.1599; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Curtis DJ, 2000, EXP HEMATOL, V28, P1250, DOI 10.1016/S0301-472X(00)00537-3; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; GARTON AJ, 1994, EMBO J, V13, P3763, DOI 10.1002/j.1460-2075.1994.tb06687.x; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Gupta RW, 1998, ONCOGENE, V17, P2155, DOI 10.1038/sj.onc.1202158; Halle M, 2007, MOL CELL BIOL, V27, P1172, DOI 10.1128/MCB.02462-05; Harada T, 2009, PANCREATOLOGY, V9, P13, DOI 10.1159/000178871; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Marie-Cardine A, 1998, FEBS LETT, V435, P55, DOI 10.1016/S0014-5793(98)01040-0; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Nishiya N, 1999, J BIOL CHEM, V274, P9847, DOI 10.1074/jbc.274.14.9847; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Playford MP, 2006, J BIOL CHEM, V281, P34104, DOI 10.1074/jbc.M606277200; Sahu SN, 2007, AM J PHYSIOL-CELL PH, V292, pC2288, DOI 10.1152/ajpcell.00503.2006; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Sastry SK, 2002, J CELL SCI, V115, P4305, DOI 10.1242/jcs.00105; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Sirois J, 2006, MECH DEVELOP, V123, P869, DOI 10.1016/j.mod.2006.08.011; Souza CM, 2012, J BIOL CHEM, V287, P43180, DOI 10.1074/jbc.M112.387456; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; St-Pierre J, 2012, CELL METAB, V15, P292, DOI 10.1016/j.cmet.2012.02.004; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Togni M, 2005, MOL CELL BIOL, V25, P8052, DOI 10.1128/MCB.25.18.8052-8063.2005; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Wu Y, 1998, J BIOL CHEM, V273, P30487, DOI 10.1074/jbc.273.46.30487; Yu X, 2011, J BIOL CHEM, V286, P30526, DOI 10.1074/jbc.M111.254722; Zheng YH, 2011, MOL CELL BIOL, V31, P4258, DOI 10.1128/MCB.05547-11	52	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25739	25748		10.1074/jbc.M113.501007	http://dx.doi.org/10.1074/jbc.M113.501007			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897807	hybrid, Green Published			2022-12-25	WOS:000330623300007
J	Agudelo, D; Bourassa, P; Beauregard, M; Berube, G; Tajmir-Riahi, HA				Agudelo, Daniel; Bourassa, Philippe; Beauregard, Marc; Berube, Gervais; Tajmir-Riahi, Heidar-Ali			tRNA Binding to Antitumor Drug Doxorubicin and Its Analogue	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; DNA INTERACTION; ANTHRACYCLINES; COMPLEXES; INTERCALATION; SPECTROSCOPY; AGGREGATION; INHIBITION; DENDRIMERS; IONS	The binding sites of antitumor drug doxorubicin (DOX) and its analogue N-(trifluoroacetyl) doxorubicin (FDOX) with tRNA were located, using FTIR, CD, fluorescence spectroscopic methods and molecular modeling. Different binding sites are involved in drug-tRNA adducts with DOX located in the vicinity of A-29, A-31, A-38, C-25, C-27, C-28, G-30 and U-41, while FDOX bindings involved A-23, A-44, C-25, C-27, G-24, G-42, G-53, G-45 and U-41 with similar free binding energy (-4.44 for DOX and -4.41 kcal/ mol for FDOX adducts). Spectroscopic results showed that both hydrophilic and hydrophobic contacts are involved in drug-tRNA complexation and FDOX forms more stable complexes than DOX with KDOX-tRNA = 4.7 (+/- 0.5) x 10(4) M-1 and KFDOX-tRNA = 6.3 (+/- 0.7) x 10(4) M-1. The number of drug molecules bound per tRNA (n) was 0.6 for DOX and 0.4 for FDOX. No major alterations of tRNA structure were observed and tRNA remained in A-family conformation, while biopolymer aggregation and particle formation occurred at high drug concentrations.	[Agudelo, Daniel; Bourassa, Philippe; Beauregard, Marc; Berube, Gervais; Tajmir-Riahi, Heidar-Ali] Univ Quebec Trois Rivieres, Dept Chem & Phys, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Tajmir-Riahi, HA (corresponding author), Univ Quebec Trois Rivieres, Dept Chem & Phys, Trois Rivieres, PQ GA9 5H7, Canada.	tajmirri@uqtr.ca	Bérubé, Gervais/GQI-4209-2022	Berube, Gervais/0000-0001-8001-0150; Agudelo Pinto, Daniel Steven/0000-0002-8794-4279; Bourassa, Philippe/0000-0003-2662-2118	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work is supported by grant from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACTON EM, 1981, J MED CHEM, V24, P669, DOI 10.1021/jm00138a005; Agudelo D, 2013, INTERCALTION A UNPUB; ALEX S, 1989, INORG CHIM ACTA, V157, P271, DOI 10.1016/S0020-1693(00)80552-6; Andrushchenko V, 2001, BIOPOLYMERS, V61, P243, DOI 10.1002/bip.10159; Arakawa H, 2000, J BIOL CHEM, V275, P10150, DOI 10.1074/jbc.275.14.10150; Arakawa H, 2001, BIOPHYS J, V81, P1580, DOI 10.1016/S0006-3495(01)75812-2; Beng X.D.B., 2008, NANOMED-NANOTECHNOL, V4, P49; BERUBE G, 1991, SYNTHETIC COMMUN, V21, P931, DOI 10.1080/00397919108019778; Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; Bourassa P, 2010, J PHYS CHEM B, V114, P3348, DOI 10.1021/jp9115996; Box VGS, 2007, J MOL GRAPH MODEL, V26, P14, DOI 10.1016/j.jmgm.2006.09.005; Canzoneri JC, 2008, NUCLEIC ACIDS RES, V36, P6825, DOI 10.1093/nar/gkn774; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Charbonneau DM, 2010, J PHYS CHEM B, V114, P1148, DOI 10.1021/jp910077h; Dovbeshko GI, 2002, BIOPOLYMERS, V67, P470, DOI 10.1002/bip.10165; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Froehlich E, 2012, BIOMACROMOLECULES, V13, P282, DOI 10.1021/bm2016515; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Froehlich E, 2011, BIOMACROMOLECULES, V12, P2780, DOI 10.1021/bm200547e; Goto S, 2001, FASEB J, V15, P2702, DOI 10.1096/fj.01-0376com; He WY, 2005, BIOORGAN MED CHEM, V13, P1837, DOI 10.1016/j.bmc.2004.11.038; Iranfar H, 2012, J PHYS CHEM B, V116, P1951, DOI 10.1021/jp210685q; Jiang M, 2004, J MOL STRUCT, V692, P71, DOI 10.1016/j.molstruc.2004.01.003; Kwok JC, 2002, MOL PHARMACOL, V62, P888, DOI 10.1124/mol.62.4.888; Kypr J, 2002, BIOPOLYMERS, V67, P275, DOI 10.1002/bip.10112; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; LAU A, 1995, BIOORGAN MED CHEM, V3, P1305, DOI 10.1016/0968-0896(95)00126-2; Mandeville JS, 2010, BIOCHEM CELL BIOL, V88, P469, DOI [10.1139/O09-158, 10.1139/o09-158]; Mandeville JS, 2010, BIOMACROMOLECULES, V11, P465, DOI 10.1021/bm9011979; MANIGLIA CA, 1981, CHEM-BIOL INTERACT, V33, P319, DOI 10.1016/0009-2797(81)90050-8; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Marty R, 2009, NUCLEIC ACIDS RES, V37, P5197, DOI 10.1093/nar/gkp543; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Ouameur AA, 2010, RNA, V16, P1968, DOI 10.1261/rna.1994310; PEARLMAN LF, 1986, CANCER RES, V46, P341; REICHMANN ME, 1954, J AM CHEM SOC, V76, P3047, DOI 10.1021/ja01640a067; Sarzehi S, 2010, INT J BIOL MACROMOL, V47, P558, DOI 10.1016/j.ijbiomac.2010.08.002; Studzian K, 2001, NEOPLASMA, V48, P412; SUSSMAN JL, 1978, J MOL BIOL, V123, P607, DOI 10.1016/0022-2836(78)90209-7; Tayeh N, 2009, J PHARMACEUT BIOMED, V50, P107, DOI 10.1016/j.jpba.2009.03.015; Turner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056817; Vacchi-Suzzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040395; Vijayalakshmi R, 2000, BIOCHEM BIOPH RES CO, V271, P731, DOI 10.1006/bbrc.2000.2707; Vorlickova M, 1995, BIOPHYS J, V69, P2033, DOI 10.1016/S0006-3495(95)80073-1; WEISS RB, 1992, SEMIN ONCOL, V19, P670; Xu XX, 2005, MOL PHARMACOL, V68, P261, DOI 10.1124/mol.105.013383; Zhang GW, 2008, J MOL STRUCT, V881, P132, DOI 10.1016/j.molstruc.2007.09.002; Zhuang XW, 2000, P NATL ACAD SCI USA, V97, P14241, DOI 10.1073/pnas.97.26.14241	50	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69248	10.1371/journal.pone.0069248	http://dx.doi.org/10.1371/journal.pone.0069248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922696	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700026
J	Wang, Y; Ren, JW; Gao, Y; Ma, JZI; Toh, HC; Chow, P; Chung, AYF; Ooi, LLPJ; Lee, CGL				Wang, Yu; Ren, Jianwei; Gao, Yun; Ma, Joel Z. I.; Toh, Han Chong; Chow, Pierce; Chung, Alexander Y. F.; Ooi, London L. P. J.; Lee, Caroline G. L.			MicroRNA-224 Targets SMAD Family Member 4 to Promote Cell Proliferation and Negatively Influence Patient Survival	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; UP-REGULATION; EXPRESSION; CANCER; PROTEIN; GROWTH; PROGRESSION; MIR-224; GENE	MicroRNA-224 (miR-224) is frequently over-expressed in liver and colorectal cancers. We and others have previously described the role of miR-224 over-expression in cell proliferation in vitro but we have yet to identify the relevant miR-224 direct target. In this study, we further demonstrated that miR-224 up-regulation promotes cell proliferation using both in vitro assays and in vivo tumor growth models. We systematically screened for high confidence miR-224 targets by overlapping in silico predicted targets from multiple algorithms and significantly down-regulated genes in miR-224-expressing cells from whole genome expression microarrays. A total of 72 high confidence miR-224 targets were identified and found to be enriched in various cancer-related processes. SMAD family member 4 (SMAD4) is experimentally validated as the direct cellular target through which miR-224 promotes cell proliferation. The clinical relevance of our experimental observations was supported by a statistically significant inverse correlation between miR-224 and SMAD4 transcript expression in tumor versus paired adjacent non-tumorous tissues from HCC patients (p<0.001, r = -0.45, R-2 = 0.122). Furthermore, miR-224 up-regulation and SMAD4 down-regulation is significantly associated with poorer patient survival (p<0.05). In summary, miR-224/SMAD4 pathway is a clinically relevant pathway to provide new insights in understanding HCC. (191 words).	[Wang, Yu; Ren, Jianwei; Gao, Yun; Toh, Han Chong; Lee, Caroline G. L.] Natl Canc Ctr Singapore, Div Med Sci, Humphrey Oei Inst Canc Res, Singapore, Singapore; [Ma, Joel Z. I.; Lee, Caroline G. L.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Chow, Pierce; Lee, Caroline G. L.] Duke NUS Grad Med Sch, Singapore, Singapore; [Chow, Pierce; Chung, Alexander Y. F.; Ooi, London L. P. J.] Singapore Gen Hosp, Dept Surg, Singapore, Singapore; [Ooi, London L. P. J.] Natl Canc Ctr Singapore, Dept Surg Oncol, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore; Singapore General Hospital; National Cancer Centre Singapore (NCCS)	Lee, CGL (corresponding author), Natl Canc Ctr Singapore, Div Med Sci, Humphrey Oei Inst Canc Res, Singapore, Singapore.	bchleec@nus.edu.sg	Lee, Caroline G/M-8918-2019; Ooi, London Lucien/AGK-1395-2022	Lee, Caroline G/0000-0002-4323-3635; Chow, Pierce/0000-0003-0584-2584; Ma, Joel/0000-0002-0448-6744	National Medical Research Council (NMRC) [NMRC/1131/2007]; BioMedical Research Council (BMRC) of Singapore [BMRC06/1/21/19/449]; Singapore Millennium Foundation (SMF); National Cancer Centre Singapore; DUKENUS Graduate Medical School	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); BioMedical Research Council (BMRC) of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Millennium Foundation (SMF)(Singapore Millennium Foundation); National Cancer Centre Singapore; DUKENUS Graduate Medical School(National University of Singapore)	This work was supported by National Medical Research Council (NMRC), NMRC/1131/2007, the BioMedical Research Council (BMRC), BMRC06/1/21/19/449) of Singapore and the Singapore Millennium Foundation (SMF) as well as block fundings from the National Cancer Centre Singapore and the DUKENUS Graduate Medical School to A/Prof Caroline Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Boguslawska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024541; Vega AB, 2013, ONCOL REP, V30, P320, DOI 10.3892/or.2013.2475; Giannelli G, 2011, BBA-REV CANCER, V1815, P214, DOI 10.1016/j.bbcan.2010.11.004; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang L, 2012, BIOCHEM BIOPH RES CO, V425, P127, DOI 10.1016/j.bbrc.2012.07.025; Li Q, 2010, J GASTROEN HEPATOL, V25, P164, DOI 10.1111/j.1440-1746.2009.05971.x; Li X, 2009, ONCOGENE, V28, P4272, DOI 10.1038/onc.2009.278; Lu S, 2012, CLIN TRANSL ONCOL; Meindl-Beinker NM, 2012, DIGEST DIS, V30, P514, DOI 10.1159/000341704; Miyaki M, 2003, BIOCHEM BIOPH RES CO, V306, P799, DOI 10.1016/S0006-291X(03)01066-0; Ren J, 2011, J CELL SCI; Scisciani C, 2012, J HEPATOL, V56, P855, DOI 10.1016/j.jhep.2011.11.017; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shen SN, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-69; Tang Y, 2005, CANCER RES, V65, P4228, DOI 10.1158/0008-5472.CAN-04-4585; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wang Y, 2012, FASEB J, V26, P3032, DOI 10.1096/fj.11-201855; Wang Y, 2011, EPIGENOMICS-UK, V3, P235, DOI [10.2217/epi.11.5, 10.2217/EPI.11.5]; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Yang G, 2010, INT J BIOL SCI, V6, P1; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432	25	36	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68744	10.1371/journal.pone.0068744	http://dx.doi.org/10.1371/journal.pone.0068744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922662	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700011
J	Xu, HY; Lam, SH; Shen, Y; Gong, ZY				Xu, Hongyan; Lam, Siew Hong; Shen, Yuan; Gong, Zhiyuan			Genome-Wide Identification of Molecular Pathways and Biomarkers in Response to Arsenic Exposure in Zebrafish Liver	PLOS ONE			English	Article							ESTER TRANSFER PROTEIN; INDUCED DNA-DAMAGE; NF-KAPPA-B; OXIDATIVE STRESS; GENE-EXPRESSION; CHROMOSOMAL LOCALIZATION; MONOMETHYLARSONOUS ACID; IRON; FERRITIN; GLUTATHIONE	Inorganic arsenic is a worldwide metalloid pollutant in environment. Although extensive studies on arsenic-induced toxicity have been conducted using in vivo and in vitro models, the exact molecular mechanism of arsenate toxicity remains elusive. Here, the RNA-SAGE (serial analysis of gene expression) sequencing technology was used to analyse hepatic response to arsenic exposure at the transcriptome level. Based on more than 12 million SAGE tags mapped to zebrafish genes, 1,444 differentially expressed genes (750 up-regulated and 694 down-regulated) were identified from a relatively abundant transcripts (> 10 TPM [transcripts per million]) based on minimal two-fold change. By gene ontology analyses, these differentially expressed genes were significantly enriched in several major biological processes including oxidation reduction, translation, iron ion transport, cell redox, homeostasis, etc. Accordingly, the main pathways disturbed include metabolic pathways, proteasome, oxidative phosphorylation, cancer, etc. Ingenity Pathway Analysis further revealed a network with four important upstream factors or hub genes, including Jun, Kras, APoE and Nr2f2. The network indicated apparent molecular events involved in oxidative stress, carcinogenesis, and metabolism. In order to identify potential biomarker genes for arsenic exposure, 27 out of 29 up-regulated transcripts were validated by RT-qPCR analysis in pooled RNA samples. Among these, 14 transcripts were further confirmed for up-regulation by a lower dosage of arsenic in majority of individual zebrafish. Finally, at least four of these genes, frh3 (ferrintin H3), mgst1 (microsomal glutathione S-transferase-like), cmbl (carboxymethylenebutenolidase homolog) and slc40a1 (solute carrier family 40 [iron-regulated transporter], member 1) could be confirmed in individual medaka fish similarly treated by arsenic; thus, these four genes might be robust arsenic biomarkers across species. Thus, our work represents the first comprehensive investigation of molecular mechanism of asenic toxicity and genome-wide search for potential biomarkers for arsenic exposure.	[Xu, Hongyan; Lam, Siew Hong; Shen, Yuan; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Lam, Siew Hong/H-8483-2012; Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme [R-154-000-328-272]	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme(National Research Foundation, Singapore)	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Abernathy CO, 1999, ENVIRON HEALTH PERSP, V107, P593, DOI 10.2307/3434403; Adams PC, 2004, EUR J GASTROEN HEPAT, V16, P857, DOI 10.1097/00042737-200409000-00007; ANDREWS SC, 1992, J INORG BIOCHEM, V47, P161, DOI 10.1016/0162-0134(92)84062-R; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; Aposhian HV, 2000, CHEM RES TOXICOL, V13, P693, DOI 10.1021/tx000114o; Aposhian HV, 2000, TOXICOL APPL PHARM, V165, P74, DOI 10.1006/taap.2000.8922; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Bachmeier BE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-129; Baird SK, 2006, BIOCHEM J, V394, P275, DOI 10.1042/BJ20051143; Barchowsky A, 1999, TOXICOL APPL PHARM, V159, P65, DOI 10.1006/taap.1999.8723; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Beale EG, 2004, TRENDS ENDOCRIN MET, V15, P129, DOI 10.1016/j.tem.2004.02.006; Brittenham GM, 2005, DEV BIOLOGICALS, V120, P77; Cai SM, 2001, BIOCHEM J, V355, P779, DOI 10.1042/bj3550779; Camaschella C, 2011, THESCIENTIFICWORLDJO, V11, P1357, DOI 10.1100/tsw.2011.130; Catchen JM, 2011, METHOD CELL BIOL, V104, P259, DOI 10.1016/B978-0-12-374814-0.00015-X; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Chan AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007955; Chang D, 2012, BIOMED ENVIRON SCI, V25, P156, DOI 10.3967/0895-3988.2012.02.005; Cohen SM, 2007, TOXICOL APPL PHARM, V222, P258, DOI 10.1016/j.taap.2006.10.010; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Darabi M, 2009, HORM METAB RES, V41, P554, DOI 10.1055/s-0029-1192034; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; de Castro MR, 2009, COMP BIOCHEM PHYS C, V150, P337, DOI 10.1016/j.cbpc.2009.05.017; De Domenico I, 2006, EMBO J, V25, P5396, DOI 10.1038/sj.emboj.7601409; De Vizcaya-Ruiz A, 2009, MUTAT RES-GEN TOX EN, V674, P85, DOI 10.1016/j.mrgentox.2008.09.020; Deeg MA, 2001, AM J PHYSIOL-ENDOC M, V281, pE147, DOI 10.1152/ajpendo.2001.281.1.E147; Diaz-Villasenor A, 2007, TOXICOL APPL PHARM, V225, P123, DOI 10.1016/j.taap.2007.08.019; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Doulias PT, 2003, FREE RADICAL BIO MED, V35, P719, DOI 10.1016/S0891-5849(03)00396-4; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; ESWORTHY RS, 1994, GENE, V144, P317, DOI 10.1016/0378-1119(94)90400-6; Fendorf S, 2010, SCIENCE, V328, P1123, DOI 10.1126/science.1172974; Flora SJS, 2005, LIFE SCI, V77, P2324, DOI 10.1016/j.lfs.2005.04.016; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; GANZ T, 2006, HEMATOL-AM SOC HEMAT, V29, P507; Ghosh P, 2008, MUTAT RES-REV MUTAT, V659, P293, DOI 10.1016/j.mrrev.2008.06.003; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Habbersett RC, 2004, CYTOM PART A, V60A, P125, DOI 10.1002/cyto.a.20042; Hasegawa S, 2012, CARCINOGENESIS, V33, P2269, DOI 10.1093/carcin/bgs251; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hei TK, 2004, FREE RADICAL BIO MED, V37, P574, DOI 10.1016/j.freeradbiomed.2004.02.003; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; Huang CF, 2011, KAOHSIUNG J MED SCI, V27, P402, DOI 10.1016/j.kjms.2011.05.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V84, P269; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jiang XP, 2010, ANTICANCER RES, V30, P759; Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649; Kaltreider RC, 1999, MOL CARCINOGEN, V25, P219; Kosa Z, 2012, INT J LAB HEMATOL, V34, P172, DOI 10.1111/j.1751-553X.2011.01377.x; Lam SH, 2006, PHYSIOL GENOMICS, V27, P351, DOI 10.1152/physiolgenomics.00201.2005; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Larade K, 2006, COMP BIOCHEM PHYS B, V143, P85, DOI 10.1016/j.cbpb.2005.10.008; Lee JH, 2009, BIOCHEM BIOPH RES CO, V389, P399, DOI 10.1016/j.bbrc.2009.08.125; Levi S, 2004, INT J BIOCHEM CELL B, V36, P1887, DOI 10.1016/j.biocel.2003.10.020; Liu H, 2010, J EXP ZOOL PART A, V313A, P359, DOI 10.1002/jez.606; Liu J, 2008, TOXICOL SCI, V105, P24, DOI 10.1093/toxsci/kfn120; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Maiti S, 2001, ARCH TOXICOL, V75, P531, DOI 10.1007/s002040100240; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Merkofer M, 2006, CHEM RES TOXICOL, V19, P1263, DOI 10.1021/tx060101w; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Muller F, 2005, ZEBRAFISH, V2, P47, DOI 10.1089/zeb.2005.2.47; Ordas A, 2011, FISH SHELLFISH IMMUN, V31, P716, DOI 10.1016/j.fsi.2010.08.022; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Parr MK, 2012, TOXICOL LETT, V213, P381, DOI 10.1016/j.toxlet.2012.07.020; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; POPESCU NC, 1985, SOMAT CELL MOLEC GEN, V11, P149, DOI 10.1007/BF01534703; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; QIU Y, 1995, GENOMICS, V29, P240, DOI 10.1006/geno.1995.1237; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Rea MA, 2003, CARCINOGENESIS, V24, P747, DOI 10.1093/carcin/bgg010; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Schuliga M, 2002, TOXICOL SCI, V70, P183, DOI 10.1093/toxsci/70.2.183; Shi HL, 2004, MOL CELL BIOCHEM, V255, P67, DOI 10.1023/B:MCBI.0000007262.26044.e8; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Smith AH, 2009, ANNU REV PUBL HEALTH, V30, P107, DOI 10.1146/annurev.publhealth.031308.100143; Stockhammer OW, 2010, MOL IMMUNOL, V48, P179, DOI 10.1016/j.molimm.2010.08.011; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Tenopoulou M, 2005, BIOCHEM J, V387, P703, DOI 10.1042/BJ20041650; Tully DB, 2000, TOXICOL APPL PHARM, V168, P79, DOI 10.1006/taap.2000.9014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zheng WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053562; Zheng WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024019	104	40	43	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68737	10.1371/journal.pone.0068737	http://dx.doi.org/10.1371/journal.pone.0068737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922661	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700010
J	Kabir, A; Kumar, GS				Kabir, Ayesha; Kumar, Gopinatha Suresh			Binding of the Biogenic Polyamines to Deoxyribonucleic Acids of Varying Base Composition: Base Specificity and the Associated Energetics of the Interaction	PLOS ONE			English	Article							PLANT ALKALOID SANGUINARINE; SELF-STRUCTURE INDUCTION; HANDED Z-DNA; TRANSFER-RNA; RAMAN-SPECTROSCOPY; STRUCTURAL-ANALYSIS; OXIDATIVE DAMAGE; SPERMINE; ANALOGS; CONDENSATION	Background: The thermodynamics of the base pair specificity of the binding of the polyamines spermine, spermidine, putrescine, and cadaverine with three genomic DNAs Clostridium perfringens, 27% GC, Escherichia coli, 50% GC and Micrococcus lysodeikticus, 72% GC have been studied using titration calorimetry and the data supplemented with melting studies, ethidium displacement and circular dichroism spectroscopy results. Methodology/Principal Findings: Isothermal titration calorimetry, differential scanning calorimetry, optical melting studies, ethidium displacement, circular dichroism spectroscopy are the various techniques employed to characterize the interaction of four polyamines, spermine, spermidine, putersine and cadaverine with the DNAs. Polyamines bound stronger with AT rich DNA compared to the GC rich DNA and the binding varied depending on the charge on the polyamine as spermine>spermidine>putrescine>cadaverine. Thermodynamics of the interaction revealed that the binding was entropy driven with small enthalpy contribution. The binding was influenced by salt concentration suggesting the contribution from electrostatic forces to the Gibbs energy of binding to be the dominant contributor. Each system studied exhibited enthalpy-entropy compensation. The negative heat capacity changes suggested a role for hydrophobic interactions which may arise due to the non polar interactions between DNA and polyamines. Conclusion/Significance: From a thermodynamic analysis, the AT base specificity of polyamines to DNAs has been elucidated for the first time and supplemented by structural studies.	[Kabir, Ayesha; Kumar, Gopinatha Suresh] CSIR Indian Inst Chem Biol, Div Chem, Biophys Chem Lab, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Kumar, GS (corresponding author), CSIR Indian Inst Chem Biol, Div Chem, Biophys Chem Lab, Kolkata, India.	gskumar@csiriicb.in	Kumar, Gopinatha Suresh/W-1461-2019; Kumar, Dr Suresh/HHZ-2615-2022; KUMAR, P. SURESH/AAT-8951-2020	Kumar, Dr Suresh/0000-0002-2539-6553; KUMAR, P. SURESH/0000-0003-3222-2604	network project GenCODE of the Council of Scientific and Industrial Research (CSIR), Government of India [BSC0123]; CSIR	network project GenCODE of the Council of Scientific and Industrial Research (CSIR), Government of India; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the network project GenCODE (BSC0123) of the Council of Scientific and Industrial Research (CSIR), Government of India and CSIR Senior research fellowship to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra P, 2002, AMINO ACIDS, V22, P155, DOI 10.1007/s007260200004; Bacchi CJ, 2002, ANTIMICROB AGENTS CH, V46, P55, DOI 10.1128/AAC.46.1.55-61.2002; Basu A, 2012, BIOORGAN MED CHEM, V20, P2498, DOI 10.1016/j.bmc.2012.03.006; Buchmueller KL, 2006, BIOCHEMISTRY-US, V45, P13551, DOI 10.1021/bi061245c; Chaires JB, 1997, BIOPOLYMERS, V44, P201, DOI 10.1002/(SICI)1097-0282(1997)44:3<201::AID-BIP2>3.0.CO;2-Z; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; CROTHERS DM, 1971, BIOPOLYMERS, V10, P2147, DOI 10.1002/bip.360101110; Deng H, 2000, NUCLEIC ACIDS RES, V28, P3379, DOI 10.1093/nar/28.17.3379; Frydman B, 2003, CANCER CHEMOTH PHARM, V51, P488, DOI 10.1007/s00280-003-0598-8; FRYDMAN L, 1992, P NATL ACAD SCI USA, V89, P9186, DOI 10.1073/pnas.89.19.9186; GESSNER RV, 1989, J BIOL CHEM, V264, P7921; Giri P, 2008, ARCH BIOCHEM BIOPHYS, V474, P183, DOI 10.1016/j.abb.2008.03.013; Giri P, 2008, J PHOTOCH PHOTOBIO A, V194, P111, DOI 10.1016/j.jphotochem.2007.07.022; Giri P, 2007, BBA-GEN SUBJECTS, V1770, P1419, DOI 10.1016/j.bbagen.2007.05.005; GOSULE LC, 1978, J MOL BIOL, V121, P311, DOI 10.1016/0022-2836(78)90366-2; Guthrie KM, 2007, BIOPHYS CHEM, V126, P117, DOI 10.1016/j.bpc.2006.05.006; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Ha HC, 1998, BIOCHEM BIOPH RES CO, V244, P298, DOI 10.1006/bbrc.1998.8258; HA JH, 1989, J MOL BIOL, V209, P801, DOI 10.1016/0022-2836(89)90608-6; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; Hossain M, 2012, DYES PIGMENTS, V92, P1376, DOI 10.1016/j.dyepig.2011.09.016; Hossain M, 2009, MOL BIOSYST, V5, P1311, DOI 10.1039/b909563b; Hossain M, 2009, J CHEM THERMODYN, V41, P764, DOI 10.1016/j.jct.2008.12.008; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Islam MM, 2009, MOL BIOSYST, V5, P244, DOI 10.1039/b816480k; JAIN S, 1989, BIOCHEMISTRY-US, V28, P2360, DOI 10.1021/bi00432a002; Jen-Jacobson L, 2000, STRUCTURE, V8, P1015, DOI 10.1016/S0969-2126(00)00501-3; Kabir A, 2013, J CHEM THERMODYN, V57, P445, DOI 10.1016/j.jct.2012.09.025; Kumar GS, 2003, BIOORGAN MED CHEM, V11, P4861, DOI 10.1016/j.bmc.2003.09.028; Li YL, 1996, J MED CHEM, V39, P339, DOI 10.1021/jm9500885; LIQUORI AM, 1967, J MOL BIOL, V24, P113, DOI 10.1016/0022-2836(67)90094-0; Marquet R, 1988, J BIOMOL STRUCT DYN, V6, P205; Matulis D, 2000, J MOL BIOL, V296, P1053, DOI 10.1006/jmbi.1999.3470; MCMAHON ME, 1982, BIOCHEMISTRY-US, V21, P5280, DOI 10.1021/bi00264a025; Murphy FV, 2000, STRUCT FOLD DES, V8, pR83, DOI 10.1016/S0969-2126(00)00126-X; N'soukpoe-Kossi CN, 2008, BIOMACROMOLECULES, V9, P2712, DOI 10.1021/bm800412r; N'soukpoe-Kossi CN, 2009, BIOCHEM CELL BIOL, V87, P621, DOI [10.1139/O09-036, 10.1139/o09-036]; Nayvelt I, 2010, BIOMACROMOLECULES, V11, P97, DOI 10.1021/bm900958c; Nguyen B, 2006, BIOPHYS J, V90, P1319, DOI 10.1529/biophysj.105.071381; Ohishi H, 2004, NUCL ACIDS S SERIES, V48, P255; Ohishi H, 2008, BIOCHEM BIOPH RES CO, V366, P275, DOI 10.1016/j.bbrc.2007.10.161; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Ouameur AA, 2010, RNA, V16, P1968, DOI 10.1261/rna.1994310; PEGG AE, 1988, CANCER RES, V48, P759; QUIGLEY GJ, 1978, P NATL ACAD SCI USA, V75, P64, DOI 10.1073/pnas.75.1.64; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Ren JS, 2000, BIOCHEMISTRY-US, V39, P8439, DOI 10.1021/bi000474a; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; Ruiz-Chica AJ, 2001, J MOL STRUCT, V565, P141, DOI 10.1016/S0022-2860(00)00849-8; Ruiz-Chica J, 2003, BBA-GENE STRUCT EXPR, V1628, P11, DOI 10.1016/S0167-4781(03)00098-8; Ruiz-Chica J, 1999, J MOL STRUCT, V481, P455, DOI 10.1016/S0022-2860(98)00819-9; SAKAI TT, 1975, NUCLEIC ACIDS RES, V2, P1005, DOI 10.1093/nar/2.7.1005; Sinha R, 2006, BIOORGAN MED CHEM, V14, P800, DOI 10.1016/j.bmc.2005.09.007; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Thomas T, 2002, ONCOL RES, V13, P123; THOMAS TJ, 1985, BIOPOLYMERS, V24, P2185, DOI 10.1002/bip.360241203; Tippin DB, 1997, J MOL BIOL, V26, P71171; Varnado BL, 2000, BIOORG CHEM, V28, P395, DOI 10.1006/bioo.2000.1195; Wahl MC, 1997, BIOPOLYMERS, V44, P45, DOI 10.1002/(SICI)1097-0282(1997)44:1<45::AID-BIP4>3.0.CO;2-#; Xaplanteri MA, 2005, NUCLEIC ACIDS RES, V33, P2792, DOI 10.1093/nar/gki557	62	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70510	10.1371/journal.pone.0070510	http://dx.doi.org/10.1371/journal.pone.0070510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894663	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900130
J	Pettis, JS; Lichtenberg, EM; Andree, M; Stitzinger, J; Rose, R; Vanengelsdorp, D				Pettis, Jeffery S.; Lichtenberg, Elinor M.; Andree, Michael; Stitzinger, Jennie; Rose, Robyn; vanEngelsdorp, Dennis			Crop Pollination Exposes Honey Bees to Pesticides Which Alters Their Susceptibility to the Gut Pathogen Nosema ceranae	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; APIS-MELLIFERA; GENE-EXPRESSION; HYMENOPTERA; RESIDUES; NECTAR; POLLEN; INSECTICIDES; APIDAE; BLUEBERRY	Recent declines in honey bee populations and increasing demand for insect-pollinated crops raise concerns about pollinator shortages. Pesticide exposure and pathogens may interact to have strong negative effects on managed honey bee colonies. Such findings are of great concern given the large numbers and high levels of pesticides found in honey bee colonies. Thus it is crucial to determine how field-relevant combinations and loads of pesticides affect bee health. We collected pollen from bee hives in seven major crops to determine 1) what types of pesticides bees are exposed to when rented for pollination of various crops and 2) how field-relevant pesticide blends affect bees' susceptibility to the gut parasite Nosema ceranae. Our samples represent pollen collected by foragers for use by the colony, and do not necessarily indicate foragers' roles as pollinators. In blueberry, cranberry, cucumber, pumpkin and watermelon bees collected pollen almost exclusively from weeds and wildflowers during our sampling. Thus more attention must be paid to how honey bees are exposed to pesticides outside of the field in which they are placed. We detected 35 different pesticides in the sampled pollen, and found high fungicide loads. The insecticides esfenvalerate and phosmet were at a concentration higher than their median lethal dose in at least one pollen sample. While fungicides are typically seen as fairly safe for honey bees, we found an increased probability of Nosema infection in bees that consumed pollen with a higher fungicide load. Our results highlight a need for research on sub-lethal effects of fungicides and other chemicals that bees placed in an agricultural setting are exposed to.	[Pettis, Jeffery S.] USDA ARS, Bee Res Lab, Beltsville, MD USA; [Lichtenberg, Elinor M.; Stitzinger, Jennie; vanEngelsdorp, Dennis] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Andree, Michael] Univ Calif, Cooperat Extens Butte Cty, Oroville, CA USA; [Rose, Robyn] USDA APHIS, Riverdale, MD USA	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Vanengelsdorp, D (corresponding author), Univ Maryland, Dept Entomol, Coll Pk, College Pk, MD 20742 USA.	dennis.vanengelsdorp@gmail.com	Lichtenberg, Elinor M./AAG-6251-2020; Lichtenberg, Elinor M./I-4126-2012; vanEngelsdorp, Dennis/E-7934-2010	Lichtenberg, Elinor/0000-0002-2729-4534	National Honey Board; USDA-ARS Areawide Project on Bee Health [412796]	National Honey Board; USDA-ARS Areawide Project on Bee Health	Funding for this study was provided by the National Honey Board (http://www.honey.com/) and the USDA-ARS Areawide Project on Bee Health (http://www.ars.usda.gov/research/projects/projects.htm?accn_no = 412796). Neither the Honey Board nor USDA-ARS Program Staff had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2005, ENV FATE EFFECTS DIV; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; [Anonymous], 2000, CROP POLLINATION BEE; [Anonymous], PET INF PROF; Atkins EL, 1988, RH 7592 TECHNICAL BE; Atkins EL, 1981, EFFECT PESTICIDES AG; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cane JH, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P99; Carleton J, 1999, CARFENTRAZONE ETHYL; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Choudhary A, 2008, ENVIRON MONIT ASSESS, V144, P143, DOI 10.1007/s10661-007-9952-3; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox C., 1994, Journal of Pesticide Reform, V14, P28; Crompton C.W., 1993, POLLEN GRAINS CANADI; Danka RG, 2006, J ECON ENTOMOL, V99, P1565, DOI 10.1603/0022-0493-99.5.1565; de la Cruz Rot M, 2005, B ECOL SOC AM, V86, P41; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Delpuech JM, 1996, ENVIRON TOXICOL CHEM, V15, P2267, DOI [10.1002/etc.5620151221, 10.1897/1551-5028(1996)015&lt;2267:AOIOTC&gt;2.3.CO;2]; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Drummond FA, 2013, COLONY LOSSES STATIO; ECCO-Team, 2012, FULL REP PYR; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; FARRAR CL, 1947, J ECON ENTOMOL, V40, P333, DOI 10.1093/jee/40.3.333; Foley K, 2012, J INVERTEBR PATHOL, V111, P68, DOI 10.1016/j.jip.2012.06.006; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; George PJE, 2004, J APPL ENTOMOL, V128, P600, DOI [10.1111/j.1439-0418.2004.00896.600-604, 10.1111/j.1439-0418.2004.00896.x]; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gough HJ, 1984, PP321 ACUTE CONTACT; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Gregorc A, 2011, PESTIC BIOCHEM PHYS, V99, P200, DOI 10.1016/j.pestbp.2010.12.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; Hodges D, 1964, POLLEN GRAIN DRAWING; HOLM S, 1979, SCAND J STAT, V6, P65; Hooven LA, 2013, EFFECT FUNGICIDES DE; Hoxter KA, 1990, 151 TECHNICAL ASANA; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johansen C.A., 1990, POLLINATOR PROTECTIO; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kirk WDJ., 2006, COLOUR GUIDE POLLEN, V2; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Konietschke F, 2011, NPARCOMP V 1 0 1 R P; Kremen Claire, 2008, P10; Krischik VA, 2007, ENVIRON ENTOMOL, V36, P1238, DOI 10.1603/0046-225X(2007)36[1238:SIITTN]2.0.CO;2; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; *NRC, 2007, STAT POLL N AM; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Sampson BJ, 2004, J ECON ENTOMOL, V97, P735, DOI 10.1603/0022-0493(2004)097[0735:NRBBXV]2.0.CO;2; Smart J., 2004, B ECOL SOC AM, V85, P100, DOI [10.1890/0012-9623(2004)85[100:ANMOPT]2.0.CO;2, DOI 10.1890/0012-9623(2004)85[100:ANMOPT]2.0.CO;2]; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Stubben C, 2012, POPBIO CONSTRUCTION; U.S. Environmental Protection Agency, 1998, PEST FACT SHEET CYPR; U.S. EPA (Environmental Protection Agency), 1998, RER EL DEC RED METH; US Environmental Protection Agency, 1997, RER EL DEC RED PEND; US EPA, 1997, FACT SHEET AZ; US EPA, 1999, RER EL DEC RED CHLOR; US EPA, 2008, RER EL DEC RED CYP; US EPA, 2005, RER EL DEC RED TAU F; US EPA, 1992, RED FACTS HEPT; *US EPA, 2004, INT RER EL DEC IRED; US EPA, 2006, RER EL DEC PENT; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; vanEngelsdorp D., 2013, J APICULT RES, V52, P1, DOI DOI 10.3896/IBRA.1.52.1.08; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Whidden TL, 1996, CAN ENTOMOL, V128, P957, DOI 10.4039/Ent128957-5; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Wilson EE, 2010, MOL ECOL, V19, P4823, DOI 10.1111/j.1365-294X.2010.04849.x; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720	84	290	302	13	360	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70182	10.1371/journal.pone.0070182	http://dx.doi.org/10.1371/journal.pone.0070182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894612	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900111
J	Del Vecchio, S; Marba, N; Acosta, A; Vignolo, C; Traveset, A				Del Vecchio, Silvia; Marba, Nuria; Acosta, Alicia; Vignolo, Clara; Traveset, Anna			Effects of Posidonia Oceanica Beach-Cast on Germination, Growth and Nutrient Uptake of Coastal Dune Plants	PLOS ONE			English	Article							POPULATION-DYNAMICS; SEAGRASS; MARINE; FOOD; L.; LIMITATION; VEGETATION; NITROGEN; MARITIMA; MEADOWS	Seagrass meadows play an important role in marine ecosystems. A part of seagrass production is also exported to adjacent coastal terrestrial systems, possibly influencing their functioning. In this work we experimentally analyzed the effect of Posidonia oceanica beach-cast on plant germination, growth, and nutrient uptake of two plant species (Cakile maritima and Elymus farctus) that grow on upper beaches and fore dunes along the Mediterranean coasts. We compared plants growing in simple sand (control) with those growing in a substrate enriched with P. oceanica wrack (treatment) in laboratory. P. oceanica wrack doubled the N substrate pool and kept the substrate humid. Plants growing in the treated substrate grew faster, were twice as large as those growing in the control substrate, while tissues were enriched in N and P (Cakile by the 1.3 fold in N and 2.5 fold in P; Elymus by 1.5 fold in N and 2 fold in P). Our results suggest a positive effect of seagrass litter for the enhancing of dune species, highlighting its role for the conservation of coastal dune ecosystems.	[Del Vecchio, Silvia; Acosta, Alicia] Univ Roma Tre, Dept Sci, Rome, Italy; [Marba, Nuria; Vignolo, Clara; Traveset, Anna] Inst Mediterraneo Estudios Avanzados CSIC UIB, Mallorca, Balearic Island, Spain	Italfarmaco; Roma Tre University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA)	Del Vecchio, S (corresponding author), Univ Roma Tre, Dept Sci, Rome, Italy.	sdelvecchio@uniroma3.it	Traveset, Anna V/D-7802-2011; Marba, Nuria/H-8136-2015; Alicia T. R, T R Acosta/E-3653-2012; Marbà, Nuria/N-8143-2019	Marba, Nuria/0000-0002-8048-6789; Alicia T. R, T R Acosta/0000-0001-6572-3187; Marbà, Nuria/0000-0002-8048-6789; DEL VECCHIO, Silvia/0000-0001-8458-0433	Spanish Ministry of Economy and Competitiveness [CGL2010-18759BOS, CTM2009-07013]; Roma Tre University	Spanish Ministry of Economy and Competitiveness(Spanish Government); Roma Tre University	This work was funded by the Spanish Ministry of Economy and Competitiveness (projects CGL2010-18759BOS to AT and MEDEICG, ref CTM2009-07013, to NM). The authors thank Florida International University for carrying out the nutrient concentration analysis and the isotope abundance. SV was supported by Roma Tre University fellowship for Research in foreign countries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta A, 2003, PHYTOCOENOLOGIA, V33, P623, DOI 10.1127/0340-269X/2003/0033-0623; Arnaud-Haond S, 2012, PLOS ONE, V7; Atia A, 2009, CR BIOL, V332, P704, DOI 10.1016/j.crvi.2009.03.009; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; BETHOUX JP, 1986, LIMNOL OCEANOGR, V31, P1353, DOI 10.4319/lo.1986.31.6.1353; Buck TL, 2003, J EXP MAR BIOL ECOL, V292, P103, DOI 10.1016/S0022-0981(03)00146-1; Cardona L, 2007, MAR ECOL PROG SER, V335, P123, DOI 10.3354/meps335123; Cardona L, 2008, ACTA OECOL, V34, P97, DOI 10.1016/j.actao.2008.04.003; Carlton JT, 2003, MAR ECOL PROG SER, V256, P271, DOI 10.3354/meps256271; Chapman M. G., 2004, Ecological Management & Restoration, V5, P183, DOI 10.1111/j.1442-8903.2004.00207.x; Colombini I, 2003, OCEANOGR MAR BIOL, V41, P115; Colombini I, 2009, ACTA OECOL, V35, P32, DOI 10.1016/j.actao.2008.07.005; Council EC., 2006, OFFICIAL J EUROPEAN, V206, P7; Coupland GT, 2007, ECOSYSTEMS, V10, P1341, DOI 10.1007/s10021-007-9102-3; Curr R. H. F., 2000, Journal of Coastal Conservation, V6, P15, DOI 10.1007/BF02730463; De Falco G, 2008, J COASTAL RES, V24, P69, DOI 10.2112/06-0800.1; Debez A, 2004, PLANT SOIL, V262, P179, DOI 10.1023/B:PLSO.0000037034.47247.67; Del Vecchio S, 2012, CR BIOL, V335, P26, DOI 10.1016/j.crvi.2011.10.004; Duarte C. M., 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P201, DOI 10.3354/meps067201; Duarte CM, 2010, GLOBAL BIOGEOCHEMICA, V24; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; European Commission DE, 2007, 27 EUR COMM DE EUR; Fenner M., 2000, SEEDS ECOLOGY REGENE; Fenu G, 2012, FOLIA GEOBOT, P1; Feola S, 2011, BIODIVERS CONSERV, V20, P1457, DOI 10.1007/s10531-011-0037-9; Fourqurean JW, 2007, MAR BIOL, V151, P219, DOI 10.1007/s00227-006-0473-3; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; FOURQUREAN JW, 1992, LIMNOL OCEANOGR, V37, P162, DOI 10.4319/lo.1992.37.1.0162; Gotelli N. J., 2007, ECOSIM NULL MODELS S; Gotelli NJ, 1996, NULL MODELS ECOLOGY; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI 10.1017/CBO9780511525551; Ince R, 2007, ESTUAR COAST SHELF S, V74, P77, DOI 10.1016/j.ecss.2007.03.029; KACHI N, 1983, J ECOL, V71, P937, DOI 10.2307/2259603; Keddy PA, 2007, PLANTS AND VEGETATION: ORIGINS, PROCESSES, CONSEQUENCES, P1, DOI 10.1017/CBO9780511812989; Lammerts EJ, 1999, J VEG SCI, V10, P111, DOI 10.2307/3237166; Lehsten V, 2006, ECOGRAPHY, V29, P786, DOI 10.1111/j.0906-7590.2006.04626.x; Lewis TL, 2007, ESTUAR COAST, V30, P451, DOI 10.1007/BF02819391; LINCOLN DE, 1986, OECOLOGIA, V69, P556, DOI 10.1007/BF00410362; Liu HL, 2011, PLANT SOIL, V345, P69, DOI 10.1007/s11104-011-0761-7; Mangla S, 2011, PLANT ECOL, V212, P531, DOI 10.1007/s11258-011-9909-z; Marba N, 2005, ESTUARIES, V28, P53, DOI 10.1007/BF02732753; Marba N, 1996, MAR ECOL PROG SER, V137, P203, DOI 10.3354/meps137203; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Marschner P, 2005, J PLANT NUTR SOIL SC, V168, P343, DOI 10.1002/jpln.200424101; MAUN MA, 1994, VEGETATIO, V111, P59; MCGRAW JB, 1990, ECOLOGY, V71, P1199, DOI 10.2307/1937388; McLachlan A, 2006, ECOLOGY SANDY SHORES, P373, DOI DOI 10.1016/B978-0-12-372569-1.X5000; Montagnoli A, 2010, PLANT BIOSYST, V144, P463, DOI 10.1080/11263501003731979; PAKEMAN RJ, 1991, J ECOL, V79, P155, DOI 10.2307/2260790; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Pinto JR, 2012, CAN J FOREST RES, V42, P333, DOI [10.1139/X11-189, 10.1139/x11-189]; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Qiu S, 2003, MAR FRESHWATER RES, V54, P243, DOI 10.1071/MF02156; Qiu S, 2005, WETLANDS ECOLOGY MAN, V13; Rodriguez-Echeverria S, 2009, BIOL INVASIONS, V11; Scippa GS, 2011, ENVIRON EXP BOT, V72, P320, DOI 10.1016/j.envexpbot.2011.04.005; Shumway SW, 2000, OECOLOGIA, V124, P138, DOI 10.1007/s004420050033; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sun SC, 2006, ACTA OECOL, V30, P212, DOI 10.1016/j.actao.2006.04.001; Sun SC, 2011, J ECOL, V99, P991, DOI 10.1111/j.1365-2745.2011.01830.x; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zwart F., 2001, COASTAL DUNE MANAGEM, P219	66	24	25	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70607	10.1371/journal.pone.0070607	http://dx.doi.org/10.1371/journal.pone.0070607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894678	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000217
J	Kita, Y; Kawakami, K; Takahashi, Y; Murakami, F				Kita, Yoshiaki; Kawakami, Koichi; Takahashi, Yoshiko; Murakami, Fujio			Development of Cerebellar Neurons and Glias Revealed by in Utero Electroporation: Golgi-Like Labeling of Cerebellar Neurons and Glias	PLOS ONE			English	Article							UNIPOLAR BRUSH CELLS; RHOMBIC-LIP; MOUSE CEREBELLUM; GABAERGIC INTERNEURONS; DIVIDING PROGENITORS; CRE RECOMBINASE; RAT CEREBELLUM; WHITE-MATTER; EXPRESSION; CORTEX	Cerebellar cortical functions rely on precisely arranged cytoarchitectures composed of several distinct types of neurons and glias. Studies have indicated that cerebellar excitatory and inhibitory neurons have distinct spatial origins, the upper rhombic lip (uRL) and ventricular zone (VZ), respectively, and that different types of neurons have different birthdates. However, the spatiotemporal relationship between uRL/VZ progenitors and their final phenotype remains poorly understood due to technical limitations. To address this issue, we performed in utero electroporation (IUE) of fluorescent protein plasmids using mouse embryos to label uRL/VZ progenitors at specific developmental stages, and observed labeled cells at maturity. To overcome any potential dilution of the plasmids caused by progenitor division, we also utilized constructs that enable permanent labeling of cells. Cerebellar neurons and glias were labeled in a Golgi-like manner enabling ready identification of labeled cells. Five types of cerebellar neurons, namely Purkinje, Golgi, Lugaro and unipolar brush cells, large-diameter deep nuclei (DN) neurons, and DN astrocytes were labeled by conventional plasmids, whereas plasmids that enable permanent labeling additionally labeled stellate, basket, and granule cells as well as three types of glias. IUE allows us to label uRL/VZ progenitors at different developmental stages. We found that the five types of neurons and DN astrocytes were labeled in an IUE stage-dependent manner, while stellate, basket, granule cells and three types of glias were labeled regardless of the IUE stage. Thus, the results indicate the IUE is an efficient method to track the development of cerebellar cells from uRL/VZ progenitors facing the ventricular lumen. They also indicate that while the generation of the five types of neurons by uRL/VZ progenitors is regulated in a time-dependent manner, the progenitor pool retains multipotency throughout embryonic development.	[Kita, Yoshiaki; Murakami, Fujio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 411, Japan; [Kawakami, Koichi] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Takahashi, Yoshiko] Kyoto Univ, Dept Zool, Grad Sch Sci, Kyoto, Japan	Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Kyoto University	Murakami, F (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	murakami@fbs.osaka-u.ac.jp	Kawakami, Koichi/AAF-1380-2019	Murakami, Fujio/0000-0002-1519-5096; Kita, Yoshiaki/0000-0002-0642-4555	Ministry of Education, Science, Sports and Culture of Japan (MEXT) [KAKENHI22200045002]	Ministry of Education, Science, Sports and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Priority from the Ministry of Education, Science, Sports and Culture of Japan (MEXT KAKENHI22200045002, http://www.mext.go.jp/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ALTMAN J, 1978, J COMP NEUROL, V179, P23, DOI 10.1002/cne.901790104; ALTMAN J, 1996, DEV CEREBELLAR SYSTE; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; BATINI C, 1992, J COMP NEUROL, V315, P74, DOI 10.1002/cne.903150106; Carletti B, 2008, NEUROSCIENTIST, V14, P91, DOI 10.1177/1073858407304629; Chan-Palay V, 1977, CEREBELLAR DENTATE N; Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Chizhikov VV, 2010, P NATL ACAD SCI USA, V107, P10725, DOI 10.1073/pnas.0910786107; DIETRICHS E, 1981, ANAT EMBRYOL, V162, P51, DOI 10.1007/BF00318094; Dino MR, 1999, J NEUROCYTOL, V28, P99, DOI 10.1023/A:1007072105919; Englund C, 2006, J NEUROSCI, V26, P9184, DOI 10.1523/JNEUROSCI.1610-06.2006; Ever L, 2005, CURR OPIN NEUROBIOL, V15, P29, DOI 10.1016/j.conb.2005.01.005; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; Fujiyama T, 2009, DEVELOPMENT, V136, P2049, DOI 10.1242/dev.033480; Grimaldi P, 2009, DEV BIOL, V328, P422, DOI 10.1016/j.ydbio.2009.02.008; Hagan N, 2012, MOL CELL NEUROSCI, V49, P217, DOI 10.1016/j.mcn.2011.11.008; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2004, GENE, V338, P93, DOI 10.1016/j.gene.2004.05.013; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kawauchi D, 2008, DEV BIOL, V322, P345, DOI 10.1016/j.ydbio.2008.08.005; Komuro H, 2003, CELL MOL LIFE SCI, V60, P1084, DOI 10.1007/s00018-003-2248-z; Leto K, 2006, J NEUROSCI, V26, P11682, DOI 10.1523/JNEUROSCI.3656-06.2006; Leto K, 2009, J NEUROSCI, V29, P7079, DOI 10.1523/JNEUROSCI.0957-09.2009; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MATSUSHI.M, 1971, BRAIN RES, V35, P17, DOI 10.1016/0006-8993(71)90592-0; Mecklenburg N, 2011, GLIA, V59, P1946, DOI 10.1002/glia.21236; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; MUGNAINI E, 1994, J COMP NEUROL, V339, P174, DOI 10.1002/cne.903390203; Nishida K, 2010, J BIOL CHEM, V285, P373, DOI 10.1074/jbc.M109.060657; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pascual M, 2007, P NATL ACAD SCI USA, V104, P5193, DOI 10.1073/pnas.0605699104; PIERCE E T, 1975, Brain Research, V95, P503, DOI 10.1016/0006-8993(75)90124-9; Ramon, 1995, HISTOLOGY NERVOUS SY, VII; Rose MF, 2009, P NATL ACAD SCI USA, V106, P22462, DOI 10.1073/pnas.0911579106; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Schilling K, 2008, HISTOCHEM CELL BIOL, V130, P601, DOI 10.1007/s00418-008-0483-y; Sekerkova G, 2004, NEUROSCIENCE, V127, P845, DOI 10.1016/j.neuroscience.2004.05.050; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Shimogori T, 2008, DEV GROWTH DIFFER, V50, P499, DOI [10.1111/j.1440-169x.2008.01045.x, 10.1111/j.1440-169X.2008.01045.x]; Singec I, 2003, J COMP NEUROL, V459, P278, DOI 10.1002/cne.10600; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Sudarov A, 2011, J NEUROSCI, V31, P11055, DOI 10.1523/JNEUROSCI.0479-11.2011; Sunaga S, 1997, MOL REPROD DEV, V46, P109, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;109::AID-MRD1&gt;3.0.CO;2-U; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tanaka DH, 2009, J NEUROSCI, V29, P1300, DOI 10.1523/JNEUROSCI.5446-08.2009; UZMAN LL, 1960, J COMP NEUROL, V114, P137; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Yamanaka H, 2004, NEUROSCI RES, V50, P13, DOI 10.1016/j.neures.2004.06.008; Yoshida A, 2010, GENES CELLS, V15, P501, DOI 10.1111/j.1365-2443.2010.01397.x; Zhang L, 1996, J COMP NEUROL, V370, P536, DOI 10.1002/(SICI)1096-9861(19960708)370:4<536::AID-CNE9>3.0.CO;2-5; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7	60	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70091	10.1371/journal.pone.0070091	http://dx.doi.org/10.1371/journal.pone.0070091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894597	gold, Green Published			2022-12-25	WOS:000325211000184
J	Marmamula, S; Narsaiah, S; Shekhar, K; Khanna, RC; Rao, GN				Marmamula, Srinivas; Narsaiah, Saggam; Shekhar, Konegari; Khanna, Rohit C.; Rao, Gullapalli N.			Visual Impairment in the South Indian State of Andhra Pradesh: Andhra Pradesh - Rapid Assessment of Visual Impairment (AP-RAVI) Project	PLOS ONE			English	Article							NATIONAL BLINDNESS; AVOIDABLE BLINDNESS; VISION 2020; EYE CARE; CATARACT; PREVALENCE; ADULTS; DECADE; SIGHT; CHINA	Purpose: To assess the prevalence and causes of visual impairment in urban and rural population aged >= 40 years in the South India state of Andhra Pradesh. Methods: A population based cross-sectional study was conducted in which 7800 subjects were sampled from two rural and an urban locations. Visual Acuity (VA) was assessed using a tumbling E chart and eye examinations were performed by trained vision technicians. A questionnaire was used to collect personal and demographic information and previous consultation to eye care providers. Blindness and moderate Visual Impairment (VI) was defined as presenting VA<6/60 and <6/18 to 6/60 in the better eye respectively. VI included blindness and moderate VI. Results: Of the 7800 subjects enumerated, 7378 (94.6%) were examined. Among those examined, 46.4% were male and 61.8% of them had no education. The mean age of those examined (51.7 years; standard deviation 10.9 years) was similar to those not examined (52.8 years; standard deviation 9.9 years) (p = 0.048). Age and gender adjusted prevalence of VI was 14.3% (95% CI: 13.5-15.0). Refractive errors were the leading cause of VI accounting for 47.6% of all VI followed by cataract (43.7%). Together, they contributed to over 91.3% of the total VI. With multiple logistic regression, the odds of having VI increased significantly with increasing age. Those respondents who had no education were twice (95% CI: 1.7-2.5) more likely to have VI compared to those who were educated. VI was associated with rural residence (OR: 1.3; 95% CI: 1.1-1.6). The association between VI and gender was not statistically significant. Conclusions: The visual impairment remains a public health challenge in Andhra Pradesh, most of which can be addressed with relatively straight forward interventions like cataract surgery and spectacles. The eye care services need to be streamlined to address this challenge.	[Marmamula, Srinivas; Narsaiah, Saggam; Shekhar, Konegari; Khanna, Rohit C.; Rao, Gullapalli N.] LV Prasad Eye Inst, Int Ctr Adv Rural Eye Care, Allen Foster Community Eye Hlth Res Ctr, Hyderabad, Andhra Pradesh, India; [Marmamula, Srinivas; Rao, Gullapalli N.] LV Prasad Eye Inst, Bausch & Lomb Sch Optometry, Hyderabad, Andhra Pradesh, India; [Marmamula, Srinivas] Johns Hopkins Sch Med, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD USA	L. V. Prasad Eye Institute; Bausch Health; Bausch + Lomb; L. V. Prasad Eye Institute; Johns Hopkins University; Johns Hopkins Medicine	Marmamula, S (corresponding author), LV Prasad Eye Inst, Int Ctr Adv Rural Eye Care, Allen Foster Community Eye Hlth Res Ctr, Hyderabad, Andhra Pradesh, India.	srioptom@lvpei.org			L V Prasad Eye Institute, India	L V Prasad Eye Institute, India	This project is not funded by external agencies. It is undertaken by L V Prasad Eye Institute, India.	Abdull MM, 2009, INVEST OPHTH VIS SCI, V50, P4114, DOI 10.1167/iovs.09-3507; Census, 2011, REG GEN CENS COMM CE; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Dandona R, 2002, BRIT J OPHTHALMOL, V86, P373, DOI 10.1136/bjo.86.4.373; Dandona Rakhi, 2001, Indian Journal of Ophthalmology, V49, P215; Dineen B, 2007, BRIT J OPHTHALMOL, V91, P1005, DOI 10.1136/bjo.2006.108035; Dineen BP, 2003, BRIT J OPHTHALMOL, V87, P820, DOI 10.1136/bjo.87.7.820; Huang SS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1362, DOI 10.1001/archophthalmol.2009.138; Khanna R, 2007, CLIN EXP OPTOM, V90, P406, DOI 10.1111/j.1444-0938.2007.00199.x; Khanna RC, 2012, INDIAN J OPHTHALMOL, V60, P492, DOI 10.4103/0301-4738.100560; Limburg H, 2009, REV PANAM SALUD PUBL, V25, P449, DOI 10.1590/S1020-49892009000500011; Marmamula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055924; Marmamula S, 2012, INDIAN J OPHTHALMOL, V60, P416, DOI 10.4103/0301-4738.100539; Marmamula S, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-26; Mohan M, 1992, SURVEY BLINDNESS IND, P79; Mohan M., 1989, NATL SURVEY BLINDNES; Murthy GVS, 2008, INDIAN J OPHTHALMOL, V56, P489, DOI 10.4103/0301-4738.42774; Murthy GVS, 2012, INDIAN J OPHTHALMOL, V60, P438, DOI 10.4103/0301-4738.100545; Murthy GVS, 2010, OPHTHAL EPIDEMIOL, V17, P185, DOI 10.3109/09286586.2010.483751; Neena J, 2008, PLOS ONE, V3; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Rao GN, 2004, CAN J OPHTHALMOL, V39, P589, DOI 10.1016/S0008-4182(04)80023-1; Rao GN, 2012, INDIAN J OPHTHALMOL, V60, P396, DOI 10.4103/0301-4738.100533; Rao GN, 2011, CURR OPIN OPHTHALMOL, V22, P4, DOI 10.1097/ICU.0b013e3283414fc8; Sapkota YD, 2012, OPHTHAL EPIDEMIOL, V17, P82; Wu M, 2008, OPHTHALMOLOGY, V115, P969, DOI 10.1016/j.ophtha.2007.08.002	26	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70120	10.1371/journal.pone.0070120	http://dx.doi.org/10.1371/journal.pone.0070120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894601	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000186
J	de Blecourt, M; Brumme, R; Xu, JC; Corre, MD; Veldkamp, E				de Blecourt, Marleen; Brumme, Rainer; Xu, Jianchu; Corre, Marife D.; Veldkamp, Edzo			Soil Carbon Stocks Decrease following Conversion of Secondary Forests to Rubber (Hevea brasiliensis) Plantations	PLOS ONE			English	Article							LAND-USE CHANGE; ORGANIC-CARBON; COVER CHANGE; XISHUANGBANNA; CULTIVATION; STORAGE; TURNOVER; NITROGEN	Forest-to-rubber plantation conversion is an important land-use change in the tropical region, for which the impacts on soil carbon stocks have hardly been studied. In montane mainland southeast Asia, monoculture rubber plantations cover 1.5 million ha and the conversion from secondary forests to rubber plantations is predicted to cause a fourfold expansion by 2050. Our study, conducted in southern Yunnan province, China, aimed to quantify the changes in soil carbon stocks following the conversion from secondary forests to rubber plantations. We sampled 11 rubber plantations ranging in age from 5 to 46 years and seven secondary forest plots using a space-for-time substitution approach. We found that forest-to-rubber plantation conversion resulted in losses of soil carbon stocks by an average of 37.4+/-4.7 (SE) Mg C ha(-1) in the entire 1.2-m depth over a time period of 46 years, which was equal to 19.3+/-2.7% of the initial soil carbon stocks in the secondary forests. This decline in soil carbon stocks was much larger than differences between published aboveground carbon stocks of rubber plantations and secondary forests, which range from a loss of 18 Mg C ha(-1) to an increase of 8 Mg C ha(-1). In the topsoil, carbon stocks declined exponentially with years since deforestation and reached a steady state at around 20 years. Although the IPCC tier 1 method assumes that soil carbon changes from forest-to-rubber plantation conversions are zero, our findings show that they need to be included to avoid errors in estimating overall ecosystem carbon fluxes.	[de Blecourt, Marleen; Brumme, Rainer; Corre, Marife D.; Veldkamp, Edzo] Univ Gottingen, Busgen Inst, Soil Sci Trop & Subtrop Ecosyst, D-37073 Gottingen, Germany; [Xu, Jianchu] World Agroforestry Ctr, East Asia Node, Kunming, Peoples R China	University of Gottingen	de Blecourt, M (corresponding author), Univ Gottingen, Busgen Inst, Soil Sci Trop & Subtrop Ecosyst, D-37073 Gottingen, Germany.	mblecou@gwdg.de	Xu, Jianchu/Y-2890-2019; Veldkamp, Edzo/A-6660-2008	Veldkamp, Edzo/0000-0002-8318-8349; Corre, Marife D./0000-0003-0359-2104	German Ministry for Economic Cooperation and Development; Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) [08.7860.3-001.00]	German Ministry for Economic Cooperation and Development; Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	This study is funded by the German Ministry for Economic Cooperation and Development (http://www.bmz.de) and the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)(http://www.giz.de) for the project "Making the Mekong Connected" (No. 08.7860.3-001.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalde H., 2006, 2006 IPCC GUIDELINES; Araujo QR, 2005, AGROFOREST SYST, V63, P193, DOI 10.1007/s10457-004-3198-7; Bruun TB, 2009, HUM ECOL, V37, P375, DOI 10.1007/s10745-009-9257-y; DALAL RC, 1986, AUST J SOIL RES, V24, P281, DOI 10.1071/SR9860281; DAVIDSON EA, 1993, BIOGEOCHEMISTRY, V20, P161, DOI 10.1007/BF00000786; de Koning GHJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002099; DETWILER RP, 1986, BIOGEOCHEMISTRY, V2, P67, DOI 10.1007/BF02186966; Fearnside PM, 1998, FOREST ECOL MANAG, V108, P147, DOI 10.1016/S0378-1127(98)00222-9; Fox J, 2005, ENVIRON MANAGE, V36, P394, DOI 10.1007/s00267-003-0288-7; Fox Jefferson, 2012, Environ Manage, V49, P968, DOI 10.1007/s00267-012-9828-3; Hertge KH., 1986, METHODS SOIL ANAL 1, P377; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Houghton RA, 1999, GLOB CHANGE BIOL, V5, P481, DOI 10.1046/j.1365-2486.1999.00244.x; IUSS Working Group WRB, 2006, WORLD SOIL RESOURCES, V103, P145, DOI DOI 10.1017/S0014479706394902; Jenny H., 1941, FACTORS SOIL FORMATI, DOI 10.1097/00010694-194111000-00009; Konig N, 1996, BERICHTE FORSCHUNGSZ; Lasco RD, 2006, 2006 IPCC GUIDELINES, P51; Li HM, 2008, FOREST ECOL MANAG, V255, P16, DOI 10.1016/j.foreco.2007.06.051; Li Z, 2012, APPL GEOGR, V32, P420, DOI 10.1016/j.apgeog.2011.06.018; Lobe I, 2001, EUR J SOIL SCI, V52, P93, DOI 10.1046/j.1365-2389.2001.t01-1-00362.x; Marin-Spiotta E, 2013, GLOBAL ECOL BIOGEOGR, V22, P105, DOI 10.1111/j.1466-8238.2012.00788.x; Mertz O, 2009, CURR OPIN ENV SUST, V1, P156, DOI 10.1016/j.cosust.2009.10.002; Pinheiro J., 2021, NLME LINEAR NONLINEA; Powers JS, 2011, P NATL ACAD SCI USA, V108, P6318, DOI 10.1073/pnas.1016774108; R Core Team, 2021, R LANG ENV STAT COMP; SALIMON CI, 2009, REV AMBIENT AGUA, V4, P57; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; VELDKAMP E, 1994, SOIL SCI SOC AM J, V58, P175, DOI 10.2136/sssaj1994.03615995005800010025x; Xu J, 2012, ECOLOGICAL IN PRESS; Xu JC, 2005, ENVIRON MANAGE, V36, P404, DOI 10.1007/s00267-003-0289-6; Xu JC, 2006, MT RES DEV, V26, P254, DOI 10.1659/0276-4741(2006)26[254:TPSAET]2.0.CO;2; Yang JC, 2004, J ENVIRON SCI-CHINA, V16, P256; Ziegler AD, 2009, SCIENCE, V324, P1024, DOI 10.1126/science.1173833; Zingore S, 2005, EUR J SOIL SCI, V56, P727, DOI 10.1111/j.1365-2389.2005.00707.x; Zuur Alain F., 2009, P1	36	117	118	7	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69357	10.1371/journal.pone.0069357	http://dx.doi.org/10.1371/journal.pone.0069357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894456	Green Submitted, Green Published, gold			2022-12-25	WOS:000322391400052
J	Estramil, N; Eens, M; Muller, W				Estramil, Natalia; Eens, Marcel; Muller, Wendt			Coadaptation of Offspring Begging and Parental Provisioning - An Evolutionary Ecological Perspective on Avian Family Life	PLOS ONE			English	Article							HATCHING ASYNCHRONY; GENETIC-BASIS; CONFLICT; GROWTH; TESTOSTERONE; HERITABILITY; SOLICITATION; INTENSITY; SELECTION; SUCCESS	Offspring begging and parental provisioning are the two central social behaviours expressed during the period of parental care. Both behaviours influence each other and it is, therefore, hypothesized that they should ultimately become (genetically) correlated, stabilized by fitness costs to parents and/or offspring. By reciprocally exchanging entire clutches in canaries (Serinus canaria), we tested (1) whether there is covariation between these behaviours and (2) whether a mismatch - as introduced by cross-fostering - entails costs. Begging was scored in a standardized begging test and parental provisioning was measured via (a) the actual feeding rate and (b) using the growth rate of the foster nestlings as a proxy. Costs were established in terms of future reproductive investment in subsequent clutches and offspring growth. We found a positive and significant phenotypic covariation between offspring begging and parental feeding when using the growth rate as a proxy and, to a lesser extent, in case of the parental feeding rate. Female parents suffered no future reproductive costs when feeding foster nestlings that were more demanding than their own nestlings. Neither growth measured amongst all offspring nor the reproductive investment measured amongst the female offspring as adults was influenced by their begging behaviour. However, the reproductive investment of female offspring tended to depend on the parental qualities of their foster parents. Thus, offspring may only be able to extract resources within the limit of generosity of their foster parents. This suggests parental control of feeding, which is also supported by the positive covariation between offspring begging and parental feeding.	[Estramil, Natalia; Eens, Marcel; Muller, Wendt] Univ Antwerp, Dept Biol Ethol, B-2020 Antwerp, Belgium	University of Antwerp	Estramil, N (corresponding author), Univ Antwerp, Dept Biol Ethol, B-2020 Antwerp, Belgium.	Natalia.Estramil@ua.ac.be	Eens, Marcel/AAC-8466-2020	Muller, Wendt/0000-0001-7273-4095; Estramil, Natalia/0000-0002-7487-7062	Research Foundation Flanders (FWO) [1503307, 1503307N]; FWO [1.1.512.11.N]; University of Antwerp (BOF NOI UA)	Research Foundation Flanders (FWO)(FWO); FWO(FWO); University of Antwerp (BOF NOI UA)	This work was supported by a postdoctoral grant from the Research Foundation Flanders (FWO) (1503307 and 1503307N to WM), a predoctoral grant from the FWO (1.1.512.11.N to NE); and the University of Antwerp (BOF NOI UA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, SCIENCE, V292, P1710, DOI 10.1126/science.1059910; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Biard C, 2005, OECOLOGIA, V144, P32, DOI 10.1007/s00442-005-0048-x; Boncoraglio G, 2008, BEHAV ECOL SOCIOBIOL, V62, P729, DOI 10.1007/s00265-007-0498-8; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Curley JP, 2004, P ROY SOC B-BIOL SCI, V271, P1303, DOI 10.1098/rspb.2004.2725; Dor R, 2010, J EVOLUTION BIOL, V23, P1605, DOI 10.1111/j.1420-9101.2010.02023.x; Dor R, 2009, EVOLUTION, V63, P738, DOI 10.1111/j.1558-5646.2008.00598.x; Gilby AJ, 2011, ANIM BEHAV, V82, P479, DOI 10.1016/j.anbehav.2011.05.022; Gilby AJ, 2011, ANIM BEHAV, V81, P289, DOI 10.1016/j.anbehav.2010.10.020; Goodship NM, 2006, P ROY SOC B-BIOL SCI, V273, P71, DOI 10.1098/rspb.2005.3289; Grodzinski U, 2007, P R SOC B, V274, P2449, DOI 10.1098/rspb.2007.0658; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hager R, 2003, NATURE, V421, P533, DOI 10.1038/nature01239; HAHN DC, 1981, ANIM BEHAV, V29, P421, DOI 10.1016/S0003-3472(81)80101-7; Helfenstein F, 2008, BEHAV ECOL, V19, P108, DOI 10.1093/beheco/arm103; Hinde CA, 2010, SCIENCE, V327, P1373, DOI 10.1126/science.1186056; Hinde CA, 2009, P ROY SOC B-BIOL SCI, V276, P2787, DOI 10.1098/rspb.2009.0375; HUSSELL DJT, 1972, ECOL MONOGR, V42, P317, DOI 10.2307/1942213; Kelly CD, 2006, Q REV BIOL, V81, P221, DOI 10.1086/506236; Kilner R, 1997, P ROY SOC B-BIOL SCI, V264, P963, DOI 10.1098/rspb.1997.0133; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kilner RM, 2008, ADV STUD BEHAV, V38, P283, DOI 10.1016/S0065-3454(08)00006-5; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Kolliker M, 2005, AM NAT, V166, P506, DOI 10.1086/491687; Kolliker M, 2005, BEHAV GENET, V35, P7, DOI 10.1007/s10519-004-0852-9; Kolliker M, 2001, ANIM BEHAV, V62, P395, DOI 10.1006/anbe.2001.1792; Kolliker M, 2000, P ROY SOC B-BIOL SCI, V267, P2127, DOI 10.1098/rspb.2000.1259; Lack D., 1968, pvii; Lock JE, 2004, AM NAT, V164, P13, DOI 10.1086/421444; Lock JE, 2007, AM NAT, V170, P709, DOI 10.1086/521963; MacColl ADC, 2003, EVOLUTION, V57, P2191; MAGRATH RD, 1989, NATURE, V339, P536, DOI 10.1038/339536a0; Mock DW, 2011, BEHAV ECOL, V22, P909, DOI 10.1093/beheco/arr091; MOCK DW, 1992, TRENDS ECOL EVOL, V7, P409, DOI 10.1016/0169-5347(92)90022-4; MOCK DW, 1990, EVOL ECOL, V4, P249, DOI 10.1007/BF02214333; Moreno-Rueda G, 2011, J EVOLUTION BIOL, V24, P1091, DOI 10.1111/j.1420-9101.2011.02242.x; Muller W, 2010, BEHAV ECOL, V21, P493, DOI 10.1093/beheco/arq010; Noguera JC, 2010, BEHAV ECOL, V21, P479, DOI 10.1093/beheco/arq005; Nussey DH, 2005, J ANIM ECOL, V74, P387, DOI 10.1111/j.1365-2656.2005.00941.x; Parker TH, 2013, BIOL REV, V88, P511, DOI 10.1111/brv.12013; Rauter CM, 2002, EVOLUTION, V56, P96, DOI 10.1111/j.0014-3820.2002.tb00852.x; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; TRIVERS RL, 1974, AM ZOOL, V14, P249; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Wolf JB, 1998, EVOLUTION, V52, P299, DOI [10.1111/j.1558-5646.1998.tb01632.x, 10.2307/2411068]; Zuur Alain F., 2009, P1	48	19	19	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70463	10.1371/journal.pone.0070463	http://dx.doi.org/10.1371/journal.pone.0070463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894662	Green Published, gold, Green Submitted			2022-12-25	WOS:000322391400089
J	Cencetti, F; Bernacchioni, C; Tonelli, F; Roberts, E; Donati, C; Bruni, P				Cencetti, Francesca; Bernacchioni, Caterina; Tonelli, Francesca; Roberts, Edward; Donati, Chiara; Bruni, Paola			TGF beta 1 evokes myoblast apoptotic response via a novel signaling pathway involving S1P(4) transactivation upstream of Rho-kinase-2 activation	FASEB JOURNAL			English	Article						transforming growth factor; sphingosine 1-phosphate; S1P(4); C2C12 myoblasts; skeletal muscle cells	SPHINGOSINE KINASE TYPE-2; TGF-BETA; MYOGENIC DIFFERENTIATION; CELL-PROLIFERATION; MOUSE MODEL; T-CELLS; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; GROWTH; PROTEIN	In view of its multiple detrimental effects, transforming growth factor 1 (TGF1) is recognized as critical negative regulator of skeletal muscle repair. Apoptosis of skeletal muscle precursor cells driven by TGF1 contributes to the negative role exerted by the cytokine in tissue repair, although the underlying molecular mechanisms are still elusive. Herein we report the identification of a new signaling pathway, relying on Rho kinase-2 stimulation, subsequent to SMAD-dependent S1P(4) up-regulation and transactivation via sphingosine kinase (SK)-2, that accounts for TGF1-induced apoptosis in cultured myoblasts. S1P(4)-specific gene silencing reduced by almost 50% activation of caspase-3 and poly-ADP ribosyl transferase cleavage elicited by TGF1. Moreover, the selective S1P(4) antagonist CYM50358 also reduced the TGF1 proapoptotic effects. By employing pharmacological and molecular biological approaches, the involvement of SK2 and ROCK2 in the transmission of the TGF1 apoptotic action was also demonstrated. These results reinforce the notion that the SK/S1P axis plays a fundamental role in TGF1 mode of action in skeletal muscle cells and, by disclosing a novel mechanism by which TGF1 exerts its harmful action, pinpoint new molecular targets that in principle could be beneficial in the treatment of several skeletal muscle disorders or aging-dependent muscle atrophy.Cencetti, F., Bernacchioni, C., Tonelli, F., Roberts, E., Donati, C., Bruni, P. TGF1 evokes myoblast apoptotic response via a novel signaling pathway involving S1P(4) transactivation upstream of Rho-kinase-2 activation.	[Cencetti, Francesca; Bernacchioni, Caterina; Tonelli, Francesca; Donati, Chiara; Bruni, Paola] Univ Florence, Dipartimento Sci Biomed Sperimentali & Clin, I-50134 Florence, Italy; [Cencetti, Francesca; Bernacchioni, Caterina; Tonelli, Francesca; Donati, Chiara; Bruni, Paola] Interuniv Inst Myol, Florence, Italy; [Roberts, Edward] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	University of Florence; Scripps Research Institute	Bruni, P (corresponding author), Univ Florence, Dipartimento Sci Biomed Sperimentali & Clin, Viale GB Morgagni 50, I-50134 Florence, Italy.	paola.bruni@unifi.it	Bruni, Paola/A-1151-2008; cencetti, francesca/J-8372-2018; donati, chiara/AAN-2682-2021	donati, chiara/0000-0003-2224-4199; Bruni, Paola/0000-0002-1151-3413; Cencetti, Francesca/0000-0003-4351-2965; Bernacchioni, Caterina/0000-0002-1023-0067	Italian Ministry of University and Scientific Research; University of Florence; Fondazione Cassa di Risparmio di Pistoia e Pescia	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Florence; Fondazione Cassa di Risparmio di Pistoia e Pescia	This research was supported by grants from Italian Ministry of University and Scientific Research (PRIN2009) to P. B., University of Florence (ex 60%) to C. D., and Fondazione Cassa di Risparmio di Pistoia e Pescia to P. B. The authors are indebted to K. L. Lynch and T. L. MacDonald (University of Virginia, Charlottesville, VA, USA) for the kind gift of VPC96047 and VPC96091.	Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; Bruni P, 2008, CELL MOL LIFE SCI, V65, P3725, DOI 10.1007/s00018-008-8236-6; Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ding G, 2007, J BIOL CHEM, V282, P27493, DOI 10.1074/jbc.M701641200; Donati C, 2004, FASEB J, V18, P449, DOI 10.1096/fj.04-1780fje; Donati C, 2007, STEM CELLS, V25, P1713, DOI 10.1634/stemcells.2006-0725; Donati C, 2009, CELL SIGNAL, V21, P228, DOI 10.1016/j.cellsig.2008.10.007; Gellings Lowe N, 2009, CARDIOVASC RES, V82, P303, DOI 10.1093/cvr/cvp056; Goetzl EJ, 1999, J IMMUNOL, V162, P2049; Golfier S, 2010, FASEB J, V24, P4701, DOI 10.1096/fj.09-141473; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; Guerrero M, 2012, BIOORG MED CHEM LETT, V22, P537, DOI 10.1016/j.bmcl.2011.10.096; Guerrero M, 2011, BIOORG MED CHEM LETT, V21, P3632, DOI 10.1016/j.bmcl.2011.04.097; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Illuzzi G, 2010, J BIOL CHEM, V285, P18594, DOI 10.1074/jbc.M109.072801; Kennedy AJ, 2011, J MED CHEM, V54, P3524, DOI 10.1021/jm2001053; Kharel Y, 2011, BIOCHEM J, V440, P345, DOI 10.1042/BJ20110817; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kono Y, 2007, AM J RESP CELL MOL, V37, P395, DOI 10.1165/rcmb.2007-0065OC; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Li X, 2009, POULTRY SCI, V88, P1725, DOI 10.3382/ps.2008-00534; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; MacDonald EM, 2012, CURR OPIN RHEUMATOL, V24, P628, DOI 10.1097/BOR.0b013e328358df34; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Matsuyuki H, 2006, CELL MOL IMMUNOL, V3, P429; McLennan IS, 2002, INT J DEV BIOL, V46, P559; Meacci E, 2003, BBA-MOL CELL BIOL L, V1633, P133, DOI 10.1016/S1388-1981(03)00106-9; Meacci E, 2008, J CELL PHYSIOL, V214, P210, DOI 10.1002/jcp.21187; Meinen S, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-18; Miller AV, 2008, MOL CELL BIOL, V28, P4142, DOI 10.1128/MCB.01465-07; Miyake M, 2011, J CELL PHYSIOL, V226, P1128, DOI 10.1002/jcp.22434; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Nincheri P, 2010, CELL SIGNAL, V22, P1688, DOI 10.1016/j.cellsig.2010.06.009; Ohotski J, 2012, BRIT J CANCER, V106, P1453, DOI 10.1038/bjc.2012.98; Ohsawa Y, 2012, LAB INVEST, V92, P1100, DOI 10.1038/labinvest.2012.78; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Street CA, 2011, ANTICANCER RES, V31, P3645; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Takuwa Y, 2013, BBA-MOL CELL BIOL L, V1831, P185, DOI 10.1016/j.bbalip.2012.06.008; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Wang WG, 2005, FASEB J, V19, P1731, DOI 10.1096/fj.05-3730fje; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zhou L, 2010, J NEUROPATH EXP NEUR, V69, P771, DOI 10.1097/NEN.0b013e3181e9a34b	57	39	41	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4532	4546		10.1096/fj.13-228528	http://dx.doi.org/10.1096/fj.13-228528			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23913862				2022-12-25	WOS:000329937500020
J	Petti, LM; Talbert-Slagle, K; Hochstrasser, ML; Dimaio, D				Petti, Lisa M.; Talbert-Slagle, Kristina; Hochstrasser, Megan L.; Dimaio, Daniel			A Single Amino Acid Substitution Converts a Transmembrane Protein Activator of the Platelet-derived Growth Factor beta Receptor into an Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPILLOMAVIRUS E5 PROTEIN; SIMIAN SARCOMA-VIRUS; MOUSE C127 CELLS; TRANSFORMING PROTEIN; EGF RECEPTOR; PRODUCTIVE INTERACTION; SIGNAL-TRANSDUCTION; MUTATIONAL ANALYSIS; PDGF RECEPTOR; DOMAIN	Receptors for PDGF play an important role in cell proliferation and migration and have been implicated in certain cancers. The 44-amino acid E5 protein of bovine papillomavirus binds to and activates the PDGF beta receptor (PDGF beta R), resulting in oncogenic transformation of cultured fibroblasts. Previously, we isolated an artificial 36-amino acid transmembrane protein, pTM36-4, which transforms cells because of its ability to activate the PDGF beta R despite limited sequence similarity to E5. Here, we demonstrated complex formation between the PDGF beta R and three pTM36-4 mutants: T21E, T21Q, and T21N. T21Q retained wild type transforming activity and activated the PDGF beta R in a ligand-independent manner as a consequence of binding to the transmembrane domain of the PDGF beta R, but T21E and T21N were severely defective. In fact, T21N substantially inhibited E5-induced PDGF beta R activation and transformation in both mouse and human fibroblasts. T21N did not prevent E5 from binding to the receptor, and genetic evidence suggested that T21N and E5 bind to nonidentical sites in the transmembrane domain of the receptor. T21N also inhibited transformation and PDGF beta R activation induced by v-Sis, a viral homologue of PDGF-BB, as well as PDGF-induced mitogenesis and signaling by preventing phosphorylation of the PDGF beta R at particular tyrosine residues. These results demonstrated that T21N acts as a novel inhibitor of the PDGF beta R and validated a new strategy for designing highly specific short transmembrane protein inhibitors of growth factor receptors and possibly other transmembrane proteins.	[Petti, Lisa M.; Dimaio, Daniel] Yale Univ, Sch Med, Dept Genet, Dept Mol Biophys & Biochem,Dept Therapeut Radiol, New Haven, CT 06510 USA; [Petti, Lisa M.; Dimaio, Daniel] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06510 USA; [Talbert-Slagle, Kristina] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Hochstrasser, Megan L.] Univ Calif Berkeley, Berkeley, CA 94704 USA	Yale University; Yale University; Yale University; University of California System; University of California Berkeley	Dimaio, D (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.	Daniel.dimaio@yale.edu		Hochstrasser, Megan/0000-0002-4404-078X	National Institutes of Health [CA37157]; NATIONAL CANCER INSTITUTE [R37CA037157, R01CA037157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA37157. This work was also supported by a generous gift from Mrs. Laurel Schwartz.	Adduci AJ, 1999, J BIOL CHEM, V274, P10249, DOI 10.1074/jbc.274.15.10249; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; BRAND T, 1993, J BIOL CHEM, V268, P11500; BURKHARDT A, 1987, EMBO J, V6, P2381, DOI 10.1002/j.1460-2075.1987.tb02515.x; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; DRUMMONDBARBOSA D, 1995, MOL CELL BIOL, V15, P2570; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Freeman-Cook LL, 2005, J MOL BIOL, V345, P907, DOI 10.1016/j.jmb.2004.10.072; Freeman-Cook LL, 2004, J MOL BIOL, V338, P907, DOI 10.1016/j.jmb.2004.03.044; GOLDSTEIN DJ, 1992, EMBO J, V11, P4851, DOI 10.1002/j.1460-2075.1992.tb05591.x; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; HORWITZ BH, 1988, MOL CELL BIOL, V8, P4071, DOI 10.1128/MCB.8.10.4071; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; Klein O, 1999, J VIROL, V73, P3264, DOI 10.1128/JVI.73.4.3264-3272.1999; Klein O, 1998, J VIROL, V72, P8921, DOI 10.1128/JVI.72.11.8921-8932.1998; Lai CC, 1998, P NATL ACAD SCI USA, V95, P15241, DOI 10.1073/pnas.95.26.15241; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Lee CT, 2003, CANCER GENE THER, V10, P57, DOI 10.1038/sj.cgt.7700524; Matsushita C, 2013, P NATL ACAD SCI USA, V110, P1646, DOI 10.1073/pnas.1215207110; MEYER AN, 1994, P NATL ACAD SCI USA, V91, P4634, DOI 10.1073/pnas.91.11.4634; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Nappi VM, 2002, J BIOL CHEM, V277, P47149, DOI 10.1074/jbc.M209582200; Nappi VM, 2002, J VIROL, V76, P7976, DOI 10.1128/JVI.76.16.7976-7986.2002; NILSON LA, 1995, J VIROL, V69, P5869, DOI 10.1128/JVI.69.9.5869-5874.1995; NILSON LA, 1993, MOL CELL BIOL, V13, P4137, DOI 10.1128/MCB.13.7.4137; Oates J, 2008, BIOCHEMISTRY-US, V47, P8985, DOI 10.1021/bi8006252; Ostman A, 2007, ADV CANCER RES, V97, P247, DOI 10.1016/S0065-230X(06)97011-0; PETTI L, 1991, EMBO J, V10, P845, DOI 10.1002/j.1460-2075.1991.tb08017.x; PETTI L, 1992, P NATL ACAD SCI USA, V89, P6736, DOI 10.1073/pnas.89.15.6736; Petti LM, 1997, J VIROL, V71, P7318, DOI 10.1128/JVI.71.10.7318-7327.1997; Petti LM, 2000, CELL GROWTH DIFFER, V11, P395; Popa A, 2012, J VIROL, V86, P3014, DOI 10.1128/JVI.05826-11; Ptacek JB, 2007, P NATL ACAD SCI USA, V104, P11945, DOI 10.1073/pnas.0704348104; RIESE DJ, 1995, ONCOGENE, V10, P1431; SCHLEGEL R, 1986, SCIENCE, V233, P464, DOI 10.1126/science.3014660; STAEBLER A, 1995, J VIROL, V69, P6507, DOI 10.1128/JVI.69.10.6507-6517.1995; Surti T, 1998, PROTEINS, V33, P601; Talbert-Slagle K, 2009, J VIROL, V83, P9773, DOI 10.1128/JVI.00946-09; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; Windisch D, 2010, BIOPHYS J, V99, P1764, DOI 10.1016/j.bpj.2010.06.073	48	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27273	27286		10.1074/jbc.M113.470054	http://dx.doi.org/10.1074/jbc.M113.470054			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908351	Green Published, hybrid			2022-12-25	WOS:000330597300024
J	Cabre, EJ; Sanchez-Gorostiaga, A; Carrara, P; Ropero, N; Casanova, M; Palacios, P; Stano, P; Jimenez, M; Rivas, G; Vicente, M				Cabre, Elisa J.; Sanchez-Gorostiaga, Alicia; Carrara, Paolo; Ropero, Noelia; Casanova, Mercedes; Palacios, Pilar; Stano, Pasquale; Jimenez, Mercedes; Rivas, German; Vicente, Miguel			Bacterial Division Proteins FtsZ and ZipA Induce Vesicle Shrinkage and Cell Membrane Invagination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GIANT VESICLES; SEPTAL RING; ACTIN; RECONSTITUTION; LIPOSOMES; PROTOFILAMENTS; MORPHOGENESIS; RECRUITMENT; SEQUENCE	Permeable vesicles containing the proto-ring anchoring ZipA protein shrink when FtsZ, the main cell division protein, polymerizes in the presence of GTP. Shrinkage, resembling the constriction of the cytoplasmic membrane, occurs at ZipA densities higher than those found in the cell and is modulated by the dynamics of the FtsZ polymer. In vivo, an excess of ZipA generates multilayered membrane inclusions within the cytoplasm and causes the loss of the membrane function as a permeability barrier. Overproduction of ZipA at levels that block septation is accompanied by the displacement of FtsZ and two additional division proteins, FtsA and FtsN, from potential septation sites to clusters that colocalize with ZipA near the membrane. The results show that elementary constriction events mediated by defined elements involved in cell division can be evidenced both in bacteria and in vesicles.	[Cabre, Elisa J.; Ropero, Noelia; Jimenez, Mercedes; Rivas, German] CSIC, CIB, E-28040 Madrid, Spain; [Sanchez-Gorostiaga, Alicia; Casanova, Mercedes; Palacios, Pilar; Vicente, Miguel] CSIC, Ctr Nacl Biotecnol, Madrid 28049, Spain; [Carrara, Paolo; Stano, Pasquale] Univ Roma Tre, Dipartimento Biol, I-00146 Rome, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Roma Tre University	Vicente, M (corresponding author), CSIC, Ctr Nacl Biotecnol, C Darwin 3, Madrid 28049, Spain.	mvicente@cnb.csic.es	Sánchez-Gorostiaga, Alicia/K-6049-2014; Stano, Pasquale/ABH-1195-2020; Rivas, German/AFL-7528-2022; Sánchez-Gorostiaga, Alicia/AFV-4900-2022; Stano, Pasquale/AGG-8333-2022; Rivas, German/AAG-7458-2022; Jimenez Sarmiento, Mercedes/K-2691-2014	Sánchez-Gorostiaga, Alicia/0000-0002-2719-5659; Rivas, German/0000-0003-3450-7478; Sánchez-Gorostiaga, Alicia/0000-0002-2719-5659; Stano, Pasquale/0000-0002-2228-2825; Rivas, German/0000-0003-3450-7478; Jimenez Sarmiento, Mercedes/0000-0003-2006-1903; Jimenez-Cabre, Elisa/0000-0002-0493-6477	Human Frontier Science Program [RGP0050/2010]; European Commission [HEALTH-F3-2009-223431]; Spanish Government [BIO2011-28941-C03]	Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by Human Frontier Science Program Grant RGP0050/2010, European Commission Contract HEALTH-F3-2009-223431, and Spanish Government Grant BIO2011-28941-C03 (all to M. V. and G.R.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Carrara P, 2012, CHEMBIOCHEM, V13, P1497, DOI 10.1002/cbic.201200133; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Corbin BD, 2002, EMBO J, V21, P1998, DOI 10.1093/emboj/21.8.1998; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; GARRIDO T, 1993, EMBO J, V12, P3957, DOI 10.1002/j.1460-2075.1993.tb06073.x; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hale CA, 1999, J BACTERIOL, V181, P167, DOI 10.1128/JB.181.1.167-176.1999; Hale CA, 2002, J BACTERIOL, V184, P2552, DOI 10.1128/JB.184.9.2552-2556.2002; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Hernandez-Rocamora VM, 2012, J BIOL CHEM, V287, P30097, DOI 10.1074/jbc.M112.388959; Hotani H, 1999, CURR OPIN COLLOID IN, V4, P358, DOI 10.1016/S1359-0294(99)90021-3; Rico AI, 2010, MOL MICROBIOL, V76, P760, DOI 10.1111/j.1365-2958.2010.07134.x; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; Kenny CH, 2003, ANAL BIOCHEM, V323, P224, DOI 10.1016/j.ab.2003.08.033; Limozin L, 2003, EUR PHYS J E, V10, P319, DOI 10.1140/epje/i2002-10118-9; Liu AP, 2008, NAT PHYS, V4, P789, DOI 10.1038/nphys1071; Lopez-Montero I, 2013, BBA-BIOMEMBRANES, V1828, P687, DOI 10.1016/j.bbamem.2012.11.003; Lopez-Montero I, 2013, FASEB J, V27, P3363, DOI 10.1096/fj.12-224337; Martos A, 2012, TRENDS CELL BIOL, V22, P634, DOI 10.1016/j.tcb.2012.09.003; Martos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039829; Martos A, 2010, BIOCHEMISTRY-US, V49, P10780, DOI 10.1021/bi101495x; Mercier R, 2013, CELL, V152, P997, DOI 10.1016/j.cell.2013.01.043; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Ohashi T, 2002, J BACTERIOL, V184, P4313, DOI 10.1128/JB.184.15.4313-4315.2002; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2011, MOL MICROBIOL, V81, P571, DOI 10.1111/j.1365-2958.2011.07716.x; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Pautot S, 2003, LANGMUIR, V19, P2870, DOI 10.1021/la026100v; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sambrook J., 2002, MOL CLONING LAB MANU; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Sun SX, 2011, MICROBIOL MOL BIOL R, V75, P543, DOI 10.1128/MMBR.00006-11; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Takiguchi K, 2011, LANGMUIR, V27, P11528, DOI 10.1021/la2016287; Takiguchi K, 2009, METHOD ENZYMOL, V464, P31, DOI 10.1016/S0076-6879(09)64003-9; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Vischer N. O. E., 1994, BINARY, V6; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Yanagisawa M, 2011, J AM CHEM SOC, V133, P11774, DOI 10.1021/ja2040859	52	52	53	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26625	26634		10.1074/jbc.M113.491688	http://dx.doi.org/10.1074/jbc.M113.491688			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23921390	Green Published, hybrid			2022-12-25	WOS:000330594500028
J	Wang, Q; Shen, BR; Zheng, PL; Feng, H; Guo, YG; Cao, WY; Chen, L; Liu, X; Zhao, GD; Xu, SZ; Shen, WD; Chen, JG; Teng, JL				Wang, Qiao; Shen, Birong; Zheng, Pengli; Feng, Hui; Guo, Yige; Cao, Wenyuan; Chen, Liang; Liu, Xiao; Zhao, Guodong; Xu, Sizheng; Shen, Weide; Chen, Jianguo; Teng, Junlin			BmCREC Is an Endoplasmic Reticulum (ER) Resident Protein and Required for ER/Golgi Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA SUPERCOILING FACTOR; POSTERIOR SILK GLAND; BOMBYX-MORI; INTRACELLULAR-TRANSPORT; DROSOPHILA-MELANOGASTER; CA2+-BINDING PROTEIN; GOLGI; SECRETION; SEQUENCE; CELLS	Silkworm posterior silkgland is a model for studying intracellular trafficking. Here, using this model, we identify several potential cargo proteins of BmKinesin-1 and focus on one candidate, BmCREC. BmCREC (also known as Bombyx mori DNA supercoiling factor, BmSCF) was previously proposed to supercoil DNA in the nucleus. However, we show here that BmCREC is localized in the ER lumen. Its C-terminal tetrapeptide HDEF is recognized by the KDEL receptor, and subsequently it is retrogradely transported by coat protein I (COPI) vesicles to the ER. Lacking the HDEF tetrapeptide of BmCREC or knocking down COPI subunits results in decreased ER retention and simultaneously increased secretion of BmCREC. Furthermore, we find that BmCREC-knock down markedly disrupts the morphology of the ER and Golgi apparatus and leads to a defect of posterior silkgland tube expansion. Together, our results clarify the ER retention mechanism of BmCREC and reveal that BmCREC is indispensable for maintaining ER/Golgi morphology.	[Wang, Qiao; Shen, Birong; Zheng, Pengli; Feng, Hui; Guo, Yige; Cao, Wenyuan; Chen, Liang; Liu, Xiao; Xu, Sizheng; Chen, Jianguo; Teng, Junlin] Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Wang, Qiao; Shen, Birong; Zheng, Pengli; Feng, Hui; Guo, Yige; Cao, Wenyuan; Chen, Liang; Liu, Xiao; Xu, Sizheng; Chen, Jianguo; Teng, Junlin] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Bioengn, Beijing 100871, Peoples R China; [Chen, Jianguo] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Zhao, Guodong; Shen, Weide] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215006, Peoples R China	Peking University; Peking University; Peking University; Soochow University - China	Chen, JG (corresponding author), Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China.	chenjg@pku.edu.cn; junlinteng@pku.edu.cn	Chen, Liangyi/F-1352-2010; Guo, Yige/B-6670-2016	Chen, Liangyi/0000-0003-1270-7321; Guo, Yige/0000-0001-5573-2020; Shen, Birong/0000-0002-1208-506X; Wang, Qiao/0000-0001-6416-1733; Zheng, Pengli/0000-0002-3797-4023	National Natural Science Foundation of China [31271424]; Major State Basic Research Development Program of China (973 Program) [2010CB833705]; China Agriculture Research System [CARS-22-ZJ0305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); China Agriculture Research System	This work was supported by the National Natural Science Foundation of China Grant 31271424, the Major State Basic Research Development Program of China (973 Program) Grant 2010CB833705, and the China Agriculture Research System Grant CARS-22-ZJ0305.	Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Kakei M, 2005, J INSECT PHYSIOL, V51, P17, DOI 10.1016/j.jinsphys.2004.10.012; Kaletta K, 1998, FEBS LETT, V434, P377, DOI 10.1016/S0014-5793(98)01013-8; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kobayashi M, 1998, MOL CELL BIOL, V18, P6737, DOI 10.1128/MCB.18.11.6737; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; MORIMOTO T, 1968, J CELL BIOL, V38, P604, DOI 10.1083/jcb.38.3.604; OHTA T, 1990, P NATL ACAD SCI USA, V87, P5307, DOI 10.1073/pnas.87.14.5307; OHTA T, 1995, J BIOL CHEM, V270, P15571, DOI 10.1074/jbc.270.26.15571; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ribeiro CMP, 2000, CELL CALCIUM, V27, P175, DOI 10.1054/ceca.2000.0108; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Sahoo SK, 2009, J BIOL CHEM, V284, P31109, DOI 10.1074/jbc.M109.031989; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; SASAKI S, 1981, J CELL SCI, V50, P19; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; von Blume J, 2012, J CELL BIOL, V199, P1057, DOI 10.1083/jcb.201207180; Vorum H, 1999, EXP CELL RES, V248, P473, DOI 10.1006/excr.1999.4431; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035344; Wang Qiao, 2012, Front Biosci (Elite Ed), V4, P998, DOI 10.2741/E435; Wang QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013252; Wang QA, 2010, CELL RES, V20, P713, DOI 10.1038/cr.2010.47; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232	46	2	3	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26649	26657		10.1074/jbc.M113.463018	http://dx.doi.org/10.1074/jbc.M113.463018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23921381	Green Published, hybrid			2022-12-25	WOS:000330594500030
J	Yin, SS; Zhang, JM; Mao, YJ; Hu, Y; Cui, LX; Kang, N; He, W				Yin, Shanshan; Zhang, Jianmin; Mao, Yujia; Hu, Yu; Cui, Lianxian; Kang, Ning; He, Wei			Vav1-phospholipase C-gamma 1 (Vav1-PLC-gamma 1) Pathway Initiated by T Cell Antigen Receptor (TCR gamma delta) Activation Is Required to Overcome Inhibition by Ubiquitin Ligase Cbl-b during gamma delta T Cell Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; RESTING NK CELLS; PHOSPHOLIPASE C-GAMMA-1; GRANULE POLARIZATION; NEGATIVE REGULATION; EFFECTOR FUNCTIONS; INDUCED CALCIUM; C-CBL; VAV1; RECOGNITION	T cell antigen receptor gamma delta (TCR gamma delta) and natural killer group 2, member D (NKG2D) are two crucial receptors for gamma delta T cell cytotoxicity. Compelling evidences suggest that gamma delta T cell cytotoxicity is TCR gamma delta-dependent and can be co-stimulated by NKG2D. However, the molecular mechanism of underlying TCR gamma delta-dependent activation of gamma delta T cells remains unclear. In this study we demonstrated that TCR gamma delta but not NKG2D engagement induced lytic granule polarization and promoted gamma delta T cell cytotoxicity. TCR gamma delta activation alone was sufficient to trigger Vav1-dependent phospholipase C-gamma 1 signaling, resulting in lytic granule polarization and effective killing, whereas NKG2D engagement alone failed to trigger cytotoxicity-related signaling to overcome the inhibitory effect of Cbl-b; therefore, NKG2D engagement alone could not induce effective killing. However, NKG2D ligation augmented the activation of gamma delta T cell cytotoxicity through the Vav1-phospholipase C-gamma 1 pathway. Vav1 overexpression or Cbl-b knockdown not only enhanced TCR gamma delta activation-initiated killing but also enabled NKG2D activation alone to induce gamma delta T cell cytotoxicity. Taken together, our results suggest that the activation of gamma delta T cell cytotoxicity requires a strong activation signal to overcome the inhibitory effect of Cbl-b. Our finding provides new insights into the molecular mechanisms underlying the initiation of gamma delta T cell cytotoxicity and likely implications for optimizing gamma delta T cell-based cancer immunotherapy.	[Kang, Ning; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; Sch Peking Union Med Coll, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Kang, N (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	n.kang@ibms.pumc.edu.cn; hewei@ngd.org.cn			Beijing Natural Science Foundation [5122031]; National Natural Science Foundation of China [30972776]; National High Technology Research and Development Program (863 Program) [2006AA02Z480, 2007AA021109]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China)	This work was supported by Beijing Natural Science Foundation Grant 5122031, National Natural Science Foundation of China Grant 30972776, and National High Technology Research and Development Program (863 Program) Grants 2006AA02Z480 and 2007AA021109.	Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Champagne E, 2011, ARCH IMMUNOL THER EX, V59, P117, DOI 10.1007/s00005-011-0118-1; Chiang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018542; Cruz-Orcutt N, 2009, MOL IMMUNOL, V46, P2274, DOI 10.1016/j.molimm.2009.04.006; Dai YM, 2012, J BIOL CHEM, V287, P16812, DOI 10.1074/jbc.M111.327650; Dalton JE, 2004, J IMMUNOL, V173, P3660, DOI 10.4049/jimmunol.173.6.3660; Das A, 2010, J IMMUNOL, V185, P4698, DOI 10.4049/jimmunol.1001220; Estefania E, 2007, J IMMUNOL, V178, P4402, DOI 10.4049/jimmunol.178.7.4402; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Graham DB, 2006, J IMMUNOL, V177, P2349, DOI 10.4049/jimmunol.177.4.2349; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; Knyazhitsky M, 2012, J BIOL CHEM, V287, P19725, DOI 10.1074/jbc.M111.309799; Kong Y, 2009, BLOOD, V114, P310, DOI 10.1182/blood-2008-12-196287; Kuylenstierna C, 2011, EUR J IMMUNOL, V41, P1913, DOI 10.1002/eji.200940278; Lanca T, 2010, BLOOD, V115, P2407, DOI 10.1182/blood-2009-08-237123; Lewis CM, 2001, CURR OPIN IMMUNOL, V13, P317, DOI 10.1016/S0952-7915(00)00221-1; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li ZX, 2011, INT IMMUNOPHARMACOL, V11, P496, DOI 10.1016/j.intimp.2011.01.001; MamiChouaib F, 1996, HUM IMMUNOL, V51, P13, DOI 10.1016/S0198-8859(96)00164-4; Morita CT, 1999, MICROBES INFECT, V1, P175, DOI 10.1016/S1286-4579(99)80032-X; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Nedellec S, 2010, J IMMUNOL, V185, P55, DOI 10.4049/jimmunol.1000373; Parsons MS, 2010, J LEUKOCYTE BIOL, V88, P905, DOI 10.1189/jlb.1009687; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Peterson ME, 2008, IMMUNITY, V29, P578, DOI 10.1016/j.immuni.2008.07.014; Quann EJ, 2011, NAT IMMUNOL, V12, P647, DOI 10.1038/ni.2033; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Rincon-Orozco B, 2005, J IMMUNOL, V175, P2144, DOI 10.4049/jimmunol.175.4.2144; Rothenfusser S, 2002, CELL IMMUNOL, V215, P32, DOI 10.1016/S0008-8749(02)00001-1; Schmitz ML, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.276pe38; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Sieger N, 2013, ARTHRITIS RHEUM-US, V65, P770, DOI 10.1002/art.37818; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Swat W, 2003, INT IMMUNOL, V15, P215, DOI 10.1093/intimm/dxg021; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325	52	19	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26448	26462		10.1074/jbc.M113.484600	http://dx.doi.org/10.1074/jbc.M113.484600			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897818	Green Published, hybrid			2022-12-25	WOS:000330594500010
J	Mosqueira, M; Baby, SM; Lahiri, S; Khurana, TS				Mosqueira, Matias; Baby, Santhosh M.; Lahiri, Sukhamay; Khurana, Tejvir S.			Ventilatory Chemosensory Drive Is Blunted in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)	PLOS ONE			English	Article							CAROTID-BODY DENERVATION; RESPIRATORY MUSCLE WEAKNESS; PERIPHERAL CHEMORECEPTORS; CHRONIC HYPOXIA; PULMONARY-HYPERTENSION; LUNG-FUNCTION; MICE; RESPONSES; DYSFUNCTION; DIAPHRAGM	Duchenne Muscular Dystrophy (DMD) is caused by mutations in the DMD gene resulting in an absence of dystrophin in neurons and muscle. Respiratory failure is the most common cause of mortality and previous studies have largely concentrated on diaphragmatic muscle necrosis and respiratory failure component. Here, we investigated the integrity of respiratory control mechanisms in the mdx mouse model of DMD. Whole body plethysmograph in parallel with phrenic nerve activity recordings revealed a lower respiratory rate and minute ventilation during normoxia and a blunting of the hypoxic ventilatory reflex in response to mild levels of hypoxia together with a poor performance on a hypoxic stress test in mdx mice. Arterial blood gas analysis revealed low PaO2 and pH and high PaCO2 in mdx mice. To investigate chemosensory respiratory drive, we analyzed the carotid body by molecular and functional means. Dystrophin mRNA and protein was expressed in normal mice carotid bodies however, they are absent in mdx mice. Functional analysis revealed abnormalities in Dejours test and the early component of the hypercapnic ventilatory reflex in mdx mice. Together, these results demonstrate a malfunction in the peripheral chemosensory drive that would be predicted to contribute to the respiratory failure in mdx mice. These data suggest that investigating and monitoring peripheral chemosensory drive function may be useful for improving the management of DMD patients with respiratory failure.	[Mosqueira, Matias; Baby, Santhosh M.; Lahiri, Sukhamay; Khurana, Tejvir S.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Mosqueira, Matias; Baby, Santhosh M.; Khurana, Tejvir S.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Mosqueira, Matias] Heidelberg Univ, Inst Physiol & Pathophysiol, Med Biophys Unit, Heidelberg, Germany	University of Pennsylvania; University of Pennsylvania; Ruprecht Karls University Heidelberg	Khurana, TS (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	tsk@mail.med.upenn.edu	Mosqueira, Matias/C-5899-2019	Mosqueira, Matias/0000-0001-7744-9138	Muscular Dystrophy Association (MDA) [4164]	Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association)	This study was supported in part by a grant (4164) from the Muscular Dystrophy Association (MDA). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2006, TOHOKU J EXP MED, V209, P125, DOI 10.1620/tjem.209.125; Alvarez K, 2002, J CELL BIOCHEM, V85, P703, DOI 10.1002/jcb.10184; Anderson JL, 2002, BRAIN, V125, P4, DOI 10.1093/brain/awf012; ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206; BARBE F, 1994, EUR RESPIR J, V7, P1403, DOI 10.1183/09031936.94.07081403; BAYDUR A, 1990, CHEST, V97, P884, DOI 10.1378/chest.97.4.884; Beck J, 2006, NEUROMUSCULAR DISORD, V16, P161, DOI 10.1016/j.nmd.2006.01.003; BERNARDS JA, 1966, RESP PHYSIOL, V1, P390, DOI 10.1016/0034-5687(66)90006-5; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Blain GM, 2010, J PHYSIOL-LONDON, V588, P2455, DOI 10.1113/jphysiol.2010.187211; Blain GM, 2009, J APPL PHYSIOL, V106, P1564, DOI 10.1152/japplphysiol.91590.2008; BROWN RH, 1988, TRENDS NEUROSCI, V11, P480, DOI 10.1016/0166-2236(88)90006-9; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; BUSCH MA, 1985, J APPL PHYSIOL, V58, P1874, DOI 10.1152/jappl.1985.58.6.1874; CHIOCCHIO SR, 1984, RESP PHYSIOL, V57, P235, DOI 10.1016/0034-5687(84)90096-3; Coles SK, 2002, RESP PHYSIOL NEUROBI, V130, P113, DOI 10.1016/S0034-5687(02)00005-1; Curran AK, 2000, J APPL PHYSIOL, V88, P1840, DOI 10.1152/jappl.2000.88.5.1840; Dachs GU, 2000, EUR J CANCER, V36, P1649, DOI 10.1016/S0959-8049(00)00159-3; Dahan A, 2007, PLOS MED, V4, P1195, DOI 10.1371/journal.pmed.0040239; DARISTOTLE L, 1987, RESP PHYSIOL, V70, P63, DOI 10.1016/S0034-5687(87)80032-4; De Bruin PF, 2001, PEDIATR PULM, V31, P451, DOI 10.1002/ppul.1074; DeBruin PF, 1997, THORAX, V52, P472, DOI 10.1136/thx.52.5.472; DEJOURS P, 1962, PHYSIOL REV, V42, P335, DOI 10.1152/physrev.1962.42.3.335; DEJOURS P, 1963, ANN NY ACAD SCI, V109, P682, DOI 10.1111/j.1749-6632.1963.tb13497.x; Dellorusso C, 2001, J MUSCLE RES CELL M, V22, P467, DOI 10.1023/A:1014587918367; DETROYER A, 1985, J CLIN INVEST, V75, P850, DOI 10.1172/JCI111782; DUANCE VC, 1980, NATURE, V284, P470, DOI 10.1038/284470a0; DUPONTVERSTEEGDEN EE, 1995, MUSCLE NERVE, V18, P1447, DOI 10.1002/mus.880181216; DupontVersteegden EE, 1996, J APPL PHYSIOL, V80, P734, DOI 10.1152/jappl.1996.80.3.734; Dwinell MR, 1999, J APPL PHYSIOL, V87, P817, DOI 10.1152/jappl.1999.87.2.817; Engel A.G., 2004, MYOLOGY; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Essop MF, 2007, J PHYSIOL-LONDON, V584, P715, DOI 10.1113/jphysiol.2007.143511; ESTENNE M, 1993, THORAX, V48, P698, DOI 10.1136/thx.48.7.698; Farkas GA, 2007, MUSCLE NERVE, V36, P708, DOI 10.1002/mus.20858; Fernandez R, 2003, ADV EXP MED BIOL, V536, P489; GAUTIER H, 1979, J APPL PHYSIOL, V46, P1127, DOI 10.1152/jappl.1979.46.6.1127; Gayraud J, 2007, J MUSCLE RES CELL M, V28, P29, DOI 10.1007/s10974-007-9101-1; Gayraud J, 2010, PEDIATR PULM, V45, P552, DOI 10.1002/ppul.21204; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; GOROSPE JRM, 1994, J NEUROL SCI, V122, P44, DOI 10.1016/0022-510X(94)90050-7; Green MF, 1935, AM J PHYSIOL, V112, P488, DOI 10.1152/ajplegacy.1935.112.3.488; Han F, 2002, J APPL PHYSIOL, V92, P1133, DOI 10.1152/japplphysiol.00785.2001; Han F, 2001, J APPL PHYSIOL, V91, P1962, DOI 10.1152/jappl.2001.91.5.1962; HAYASHI F, 1983, PFLUG ARCH EUR J PHY, V396, P121, DOI 10.1007/BF00615516; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoppeler H, 2001, J EXP BIOL, V204, P3133; Huang P, 2011, MUSCLE NERVE, V43, P263, DOI 10.1002/mus.21848; Hukins CA, 2000, AM J RESP CRIT CARE, V161, P166, DOI 10.1164/ajrccm.161.1.9901057; INKLEY SR, 1974, AM J MED, V56, P297, DOI 10.1016/0002-9343(74)90611-1; Izumizaki M, 2004, J APPL PHYSIOL, V97, P1401, DOI 10.1152/japplphysiol.00025.2004; KENNEDY JD, 1995, THORAX, V50, P1173, DOI 10.1136/thx.50.11.1173; Kinali M, 2006, DEV MED CHILD NEUROL, V48, P513, DOI 10.1017/S0012162206001083; Kinali M, 2007, ANN INDIAN ACAD NEUR, V10, pS44; Kline DD, 2002, P NATL ACAD SCI USA, V99, P821, DOI 10.1073/pnas.022634199; Koechlin C, 2005, THORAX, V60, P834, DOI 10.1136/thx.2004.037531; Koistinen PO, 2000, MED SCI SPORT EXER, V32, P800, DOI 10.1097/00005768-200004000-00012; LAHIRI S, 1975, RESP PHYSIOL, V24, P249, DOI 10.1016/0034-5687(75)90017-1; LAHIRI S, 1975, RESP PHYSIOL, V24, P267, DOI 10.1016/0034-5687(75)90018-3; Laws N, 2004, J APPL PHYSIOL, V97, P1970, DOI 10.1152/japplphysiol.01357.2003; Ling LM, 1997, RESP PHYSIOL, V109, P107, DOI 10.1016/S0034-5687(97)00045-5; LLOYD B B, 1958, Q J Exp Physiol Cogn Med Sci, V43, P214; LONG WQ, 1993, J APPL PHYSIOL, V74, P805, DOI 10.1152/jappl.1993.74.2.805; LYNN DJ, 1994, CLIN CHEST MED, V15, P661; Man WDC, 2009, CLIN SCI, V117, P251, DOI 10.1042/CS20080659; Matecki S, 2005, NEUROMUSCULAR DISORD, V15, P427, DOI 10.1016/j.nmd.2005.01.014; Matsumura T, 2000, Rinsho Shinkeigaku, V40, P439; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; MCDOUALL RM, 1990, J NEUROL SCI, V99, P199, DOI 10.1016/0022-510X(90)90156-H; Melacini P, 1996, NEUROMUSCULAR DISORD, V6, P367, DOI 10.1016/0960-8966(96)00357-4; Metzen E, 2004, BIOL CHEM, V385, P223, DOI 10.1515/BC.2004.016; MILLER MJ, 1975, RESP PHYSIOL, V23, P31, DOI 10.1016/0034-5687(75)90069-9; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; Mosqueira M, 2013, MED RES REV, P1; Mosqueira M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037497; Mosqueira M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013450; Mouradian GC, 2012, J PHYSIOL-LONDON, V590, P3335, DOI 10.1113/jphysiol.2012.234658; Onodera M, 1997, JPN J PHYSIOL, V47, P317, DOI 10.2170/jjphysiol.47.317; OU LC, 1980, EXP HEMATOL, V8, P243; PAN LG, 1995, J APPL PHYSIOL, V79, P1120, DOI 10.1152/jappl.1995.79.4.1120; Park JH, 2010, YONSEI MED J, V51, P392, DOI 10.3349/ymj.2010.51.3.392; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; PASTORET C, 1993, NEUROMUSCULAR DISORD, V3, P471, DOI 10.1016/0960-8966(93)90099-6; Personius KE, 2006, NEUROMUSCULAR DISORD, V16, P168, DOI 10.1016/j.nmd.2006.01.002; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Phillips MF, 1999, AM J RESP CRIT CARE, V160, P198, DOI 10.1164/ajrccm.160.1.9805055; Phillips MF, 2001, AM J RESP CRIT CARE, V164, P2191, DOI 10.1164/ajrccm.164.12.2103052; PILLERS DAM, 1993, NAT GENET, V4, P82, DOI 10.1038/ng0593-82; Pistilli EE, 2010, AM J PHYSIOL-REG I, V298, pR96, DOI 10.1152/ajpregu.00138.2009; Powell FL, 1998, RESP PHYSIOL, V112, P123, DOI 10.1016/S0034-5687(98)00026-7; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; RIDEAU Y, 1977, UNION MED CAN, V106, P874; ROBBINS PA, 1988, J PHYSIOL-LONDON, V401, P503, DOI 10.1113/jphysiol.1988.sp017175; Rodman JR, 2001, J APPL PHYSIOL, V91, P328, DOI 10.1152/jappl.2001.91.1.328; Guell MR, 2007, ARCH BRONCONEUMOL, V43, P557, DOI 10.1016/S1579-2129(07)60127-X; Sarton E, 2001, ANESTH ANALG, V93, P1495, DOI 10.1097/00000539-200112000-00031; Smith CA, 2006, J APPL PHYSIOL, V100, P13, DOI 10.1152/japplphysiol.00926.2005; SMITH PEM, 1987, NEW ENGL J MED, V316, P1197, DOI 10.1056/NEJM198705073161906; Soliz J, 2007, AM J PHYSIOL-REG I, V293, pR1702, DOI 10.1152/ajpregu.00350.2007; StCroix CM, 1996, CAN J PHYSIOL PHARM, V74, P640, DOI 10.1139/cjpp-74-6-640; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Takasugi T, 1995, Nihon Kyobu Shikkan Gakkai Zasshi, V33, P17; Tangsrud SE, 2001, RESP MED, V95, P898, DOI 10.1053/rmed.2001.1177; TANKERSLEY CG, 1994, AM J PHYSIOL-REG I, V267, pR1371, DOI 10.1152/ajpregu.1994.267.5.R1371; TATSUMI K, 1991, J APPL PHYSIOL, V70, P748, DOI 10.1152/jappl.1991.70.2.748; Teppema LJ, 2010, PHYSIOL REV, V90, P675, DOI 10.1152/physrev.00012.2009; Timmers HJLM, 2003, J PHYSIOL-LONDON, V553, P3, DOI 10.1113/jphysiol.2003.052415; Willmann R, 2012, NEUROMUSCULAR DISORD, V22, P43, DOI 10.1016/j.nmd.2011.04.012; Yamauchi M, 2007, J APPL PHYSIOL, V103, P1263, DOI 10.1152/japplphysiol.01287.2006; YOTSUKURA M, 1988, JPN CIRC J, V52, P321, DOI 10.1253/jcj.52.321; Zagorska A, 2004, ACTA BIOCHIM POL, V51, P563, DOI 10.18388/abp.2004_3545	113	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69567	10.1371/journal.pone.0069567	http://dx.doi.org/10.1371/journal.pone.0069567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922741	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700044
J	Welin, A; Amirbeagi, F; Christenson, K; Bjorkman, L; Bjornsdottir, H; Forsman, H; Dahlgren, C; Karlsson, A; Bylund, J				Welin, Amanda; Amirbeagi, Firoozeh; Christenson, Karin; Bjorkman, Lena; Bjornsdottir, Halla; Forsman, Huamei; Dahlgren, Claes; Karlsson, Anna; Bylund, Johan			The Human Neutrophil Subsets Defined by the Presence or Absence of OLFM4 Both Transmigrate into Tissue In Vivo and Give Rise to Distinct NETs In Vitro	PLOS ONE			English	Article							WHEAT-GERM-AGGLUTININ; OLFACTOMEDIN 4; EXTRACELLULAR TRAPS; QUANTITATIVE-ANALYSIS; SECRETORY VESICLES; PLASMA-MEMBRANE; INNATE IMMUNITY; GRANULES; HETEROGENEITY; PROTEINASE-3	Neutrophil heterogeneity was described decades ago, but it could not be elucidated at the time whether the existence of different neutrophil subsets had any biological relevance. It has been corroborated in recent years that neutrophil subsets, defined by differential expression of various markers, are indeed present in human blood, calling for renewed attention to this question. The expression of the granule protein olfactomedin 4 (OLFM4) has been suggested to define two such neutrophil subsets. We confirm the simultaneous presence of one OLFM4-positive and one OLFM4-negative neutrophil subpopulation as well as the localization of the protein to specific granules. In vitro, these neutrophil subsets displayed equal tendency to undergo apoptosis and phagocytose bacteria. In addition, the subpopulations were recruited equally to inflammatory sites in vivo, and this was true both in an experimental model of acute inflammation and in naturally occurring pathological joint inflammation. In line with its subcellular localization, only limited OLFM4 release was seen upon in vivo transmigration, and release through conventional degranulation required strong secretagogues. However, extracellular release of OLFM4 could be achieved upon formation of neutrophil extracellular traps (NETs) where it was detected only in a subset of the NETs. Although we were unable to demonstrate any functional differences between the OLFM4-defined subsets, our data show that different neutrophil subsets are present in inflamed tissue in vivo. Furthermore, we demonstrate NETs characterized by different markers for the first time, and our results open up for functions of OLFM4 itself in the extracellular space through exposure in NETs.	[Welin, Amanda; Amirbeagi, Firoozeh; Christenson, Karin; Bjorkman, Lena; Bjornsdottir, Halla; Forsman, Huamei; Dahlgren, Claes; Karlsson, Anna; Bylund, Johan] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Phagocyte Res Grp, Gothenburg, Sweden	University of Gothenburg	Welin, A (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Phagocyte Res Grp, Gothenburg, Sweden.	amanda.welin@rheuma.gu.se		Karlsson, Anna/0000-0001-6796-1154	Swedish Research Council [521-2009-3443]; King Gustav V Memorial Foundation; Lennander's Foundation; Gothenburg Medical Society; Ingabritt and Arne Lundgren's Research Foundation; Gothenburg Rheumatism Association; Swedish state under the LUA/ALF agreement	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustav V Memorial Foundation; Lennander's Foundation; Gothenburg Medical Society; Ingabritt and Arne Lundgren's Research Foundation; Gothenburg Rheumatism Association; Swedish state under the LUA/ALF agreement	This work was supported by the Swedish Research Council (521-2009-3443), the King Gustav V Memorial Foundation, Lennander's Foundation, Gothenburg Medical Society, Ingabritt and Arne Lundgren's Research Foundation, the Gothenburg Rheumatism Association, and the Swedish state under the LUA/ALF agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Beum PV, 2006, J IMMUNOL METHODS, V317, P90, DOI 10.1016/j.jim.2006.09.012; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Bjorkman L, 2010, ARTHRITIS RHEUM-US, V62, P1660, DOI 10.1002/art.27440; Bjorstad A, 2009, ANTIMICROB AGENTS CH, V53, P1027, DOI 10.1128/AAC.01310-08; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P9; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; CHANG KJ, 1975, J BIOL CHEM, V250, P488; Christenson K, 2008, J LEUKOCYTE BIOL, V83, P139, DOI 10.1189/jlb.0507276; Christenson K, 2012, METHODS MOL BIOL, V844, P65, DOI 10.1007/978-1-61779-527-5_5; Christenson K, 2011, J LEUKOCYTE BIOL, V90, P1055, DOI 10.1189/jlb.0111051; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Dwivedi N, 2012, ARTHRITIS RHEUM-US, V64, P982, DOI 10.1002/art.33432; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Faurschou M, 2002, BBA-MOL CELL RES, V1591, P29, DOI 10.1016/S0167-4889(02)00243-4; Follin P, 1999, J IMMUNOL METHODS, V232, P55, DOI 10.1016/S0022-1759(99)00153-2; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; GALLIN JI, 1984, BLOOD, V63, P977; GOLDSCHMEDING R, 1992, BRIT J HAEMATOL, V81, P336, DOI 10.1111/j.1365-2141.1992.tb08237.x; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Jerke U, 2011, J BIOL CHEM, V286, P7070, DOI 10.1074/jbc.M110.171256; Karlsson A, 1999, INFECT IMMUN, V67, P3461, DOI 10.1128/IAI.67.7.3461-3468.1999; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Leffler J, 2012, J IMMUNOL, V188, P3522, DOI 10.4049/jimmunol.1102404; LEW PD, 1986, J CELL BIOL, V102, P2197, DOI 10.1083/jcb.102.6.2197; Liu WL, 2012, J IMMUNOL, V189, P2460, DOI 10.4049/jimmunol.1103179; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Piccard H, 2012, CRIT REV ONCOL HEMAT, V82, P296, DOI 10.1016/j.critrevonc.2011.06.004; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Pillay J, 2010, J LEUKOCYTE BIOL, V88, P211, DOI 10.1189/jlb.1209793; SENGELOV H, 1995, J IMMUNOL, V154, P4157; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Welin A, 2011, J INNATE IMMUN, V3, P508, DOI 10.1159/000325297; Witko-Sarsat V, 1999, J AM SOC NEPHROL, V10, P1224; Wolff J, 2003, BLOOD, V102, P731, DOI 10.1182/blood-2002-09-2831; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yu L, 2011, NEOPLASMA, V58, P9, DOI 10.4149/neo_2011_01_9; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6	45	65	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69575	10.1371/journal.pone.0069575	http://dx.doi.org/10.1371/journal.pone.0069575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922742	Green Submitted, gold, Green Published			2022-12-25	WOS:000323369700045
J	Zhao, ZM; Webb, BT; Jia, PL; Bigdeli, TB; Maher, BS; van den Oord, E; Bergen, SE; Amdur, RL; O'Neill, FA; Walsh, D; Thiselton, DL; Chen, XN; Pato, CN; Riley, BP; Kendler, KS; Fanous, AH				Zhao, Zhongming; Webb, Bradley T.; Jia, Peilin; Bigdeli, T. Bernard; Maher, Brion S.; van den Oord, Edwin; Bergen, Sarah E.; Amdur, Richard L.; O'Neill, Francis A.; Walsh, Dermot; Thiselton, Dawn L.; Chen, Xiangning; Pato, Carlos N.; Riley, Brien P.; Kendler, Kenneth S.; Fanous, Ayman H.		Int Schizophrenia Consortium	Association Study of 167 Candidate Genes for Schizophrenia Selected by a Multi-Domain Evidence-Based Prioritization Algorithm and Neurodevelopmental Hypothesis	PLOS ONE			English	Article							CONVERGENT FUNCTIONAL GENOMICS; COMMON VARIANTS; BETA-CATENIN; NRG1 GENE; LINKAGE; METAANALYSIS; EXPRESSION; IMPUTATION; NETWORK; IRISH	Integrating evidence from multiple domains is useful in prioritizing disease candidate genes for subsequent testing. We ranked all known human genes (n = 3819) under linkage peaks in the Irish Study of High-Density Schizophrenia Families using three different evidence domains: 1) a meta-analysis of microarray gene expression results using the Stanley Brain collection, 2) a schizophrenia protein-protein interaction network, and 3) a systematic literature search. Each gene was assigned a domain-specific p-value and ranked after evaluating the evidence within each domain. For comparison to this ranking process, a large-scale candidate gene hypothesis was also tested by including genes with Gene Ontology terms related to neurodevelopment. Subsequently, genotypes of 3725 SNPs in 167 genes from a custom Illumina iSelect array were used to evaluate the top ranked vs. hypothesis selected genes. Seventy-three genes were both highly ranked and involved in neurodevelopment (category 1) while 42 and 52 genes were exclusive to neurodevelopment (category 2) or highly ranked (category 3), respectively. The most significant associations were observed in genes PRKG1, PRKCE, and CNTN4 but no individual SNPs were significant after correction for multiple testing. Comparison of the approaches showed an excess of significant tests using the hypothesis-driven neurodevelopment category. Random selection of similar sized genes from two independent genome-wide association studies (GWAS) of schizophrenia showed the excess was unlikely by chance. In a further meta-analysis of three GWAS datasets, four candidate SNPs reached nominal significance. Although gene ranking using integrated sources of prior information did not enrich for significant results in the current experiment, gene selection using an a priori hypothesis (neurodevelopment) was superior to random selection. As such, further development of gene ranking strategies using more carefully selected sources of information is warranted.	[Zhao, Zhongming; Jia, Peilin] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Webb, Bradley T.; Bigdeli, T. Bernard; van den Oord, Edwin; Thiselton, Dawn L.; Chen, Xiangning; Riley, Brien P.; Kendler, Kenneth S.; Fanous, Ayman H.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA; [Webb, Bradley T.; van den Oord, Edwin] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Richmond, VA USA; [Maher, Brion S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Bergen, Sarah E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Bergen, Sarah E.] MIT, Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Bergen, Sarah E.] Harvard, Cambridge, MA USA; [Amdur, Richard L.; Fanous, Ayman H.] Washington VA Med Ctr, Washington, DC USA; [O'Neill, Francis A.] Queens Univ, Dept Psychiat, Belfast, Antrim, North Ireland; [Walsh, Dermot] Hlth Res Board, Dublin, Ireland; [Chen, Xiangning; Riley, Brien P.; Kendler, Kenneth S.; Fanous, Ayman H.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Chen, Xiangning; Riley, Brien P.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Fanous, Ayman H.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA; [Pato, Carlos N.; Fanous, Ayman H.] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA	Vanderbilt University; Vanderbilt University; Virginia Commonwealth University; Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Queens University Belfast; Health Research Board - Ireland; Virginia Commonwealth University; Virginia Commonwealth University; Georgetown University; University of Southern California	Fanous, AH (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA.	ayman.fanous@va.gov	Amdur, Richard L/AAE-5345-2019; Bergen, Sarah/I-8313-2012; Fanous, Ayman H/O-1263-2017; Bigdeli, Tim B./AAX-7761-2020; Kendler, Kenneth/AAF-2876-2019; O'Neill, Francis A/C-5582-2008; Webb, Bradley T/B-1459-2009; ferreira de macedo e santos, antonio/M-5737-2013	Bergen, Sarah/0000-0002-5888-0034; Bigdeli, Tim B./0000-0003-2215-5946; O'Neill, Francis A/0000-0002-7531-7657; Webb, Bradley T/0000-0002-0576-5366; ferreira de macedo e santos, antonio/0000-0003-2180-2718	National Institute of Mental Health [N01 MH900001, MH074027]; Eli Lilly and Company; Department of Veterans Affairs Merit Review Program [1I01CX000278]; NARSAD Maltz Investigator Award; NARSAD Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068881, Z01MH900001, R01MH074027, R01MH083094] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eli Lilly and Company(Eli Lilly); Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); NARSAD Maltz Investigator Award; NARSAD Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Two dataset(s) used in the analyses described in this manuscript were obtained from the database of Genotype and Phenotype (dbGaP) found at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number [GAIN: phs000021.v2.p1, nonGAIN: phs00167.v1.p1]. For the GAIN dataset, the genotyping of samples was provided through the Genetic Association Information Network (GAIN). The CATIE trial was funded by a grant from the National Institute of Mental Health (N01 MH900001) along with MH074027 (PI PF Sullivan). Genotyping was funded by Eli Lilly and Company. The CATIE dataset was approved to use in this analysis through the authors' application. This work was supported by Department of Veterans Affairs Merit Review Program (1I01CX000278, to AHF), 2009 NARSAD Maltz Investigator Award (to ZZ) and 2010 NARSAD Young Investigator Award (to PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimohamad H, 2005, BIOL PSYCHIAT, V57, P533, DOI 10.1016/j.biopsych.2004.11.036; Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Batagelj V, 2004, MATH VIS, P77; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Burbach JPH, 2009, TRENDS NEUROSCI, V32, P69, DOI 10.1016/j.tins.2008.11.002; Campbell DB, 2008, SCHIZOPHR RES, V101, P67, DOI 10.1016/j.schres.2008.01.006; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Fernandez T, 2008, AM J HUM GENET, V82, P1385, DOI 10.1016/j.ajhg.2008.04.021; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Green EK, 2010, AM J MED GENET B, V153B, P1347, DOI 10.1002/ajmg.b.31108; Green MJ, 2012, MOL PSYCHIAT; Greenwood TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029630; Guo AY, 2009, MOL PSYCHIATR, V14, P18, DOI 10.1038/mp.2008.88; Guo AY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-10; Holmans PA, 2009, MOL PSYCHIATR, V14, P786, DOI 10.1038/mp.2009.11; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jia PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017162; Kendler KS, 1996, AM J MED GENET, V67, P179, DOI 10.1002/(SICI)1096-8628(19960409)67:2<179::AID-AJMG8>3.0.CO;2-N; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Kwon IK, 2010, ONCOGENE, V29, P3423, DOI 10.1038/onc.2010.91; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Miyamoto Seiya, 2003, Mol Interv, V3, P27, DOI 10.1124/mi.3.1.27; Munafo MR, 2006, MOL PSYCHIATR, V11, P539, DOI 10.1038/sj.mp.4001817; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Park YS, 2006, J NEUROSCI, V26, P8999, DOI 10.1523/JNEUROSCI.2828-06.2006; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Riley B, 2009, SCHIZOPHR RES, V115, P245, DOI 10.1016/j.schres.2009.09.008; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodd ZA, 2007, PHARMACOGENOMICS J, V7, P222, DOI 10.1038/sj.tpj.6500420; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Sun JC, 2011, SCHIZOPHR RES, V125, P201, DOI 10.1016/j.schres.2010.12.002; Sun JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011351; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Thiselton DL, 2008, BIOL PSYCHIAT, V63, P449, DOI 10.1016/j.biopsych.2007.06.005; Webb BT, 2008, PHARMACOGENET GENOM, V18, P751, DOI 10.1097/FPC.0b013e32830162bc	50	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e67776	10.1371/journal.pone.0067776	http://dx.doi.org/10.1371/journal.pone.0067776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922650	gold, Green Submitted, Green Published			2022-12-25	WOS:000323369700002
J	Chiu, SK; Wu, TL; Chuang, YC; Lin, JC; Fung, CP; Lu, PL; Wang, JT; Wang, LS; Siu, LK; Yeh, KM				Chiu, Sheng-Kang; Wu, Tsu-Lan; Chuang, Yin-Ching; Lin, Jung-Chung; Fung, Chang-Phone; Lu, Po-Liang; Wang, Jann-Tay; Wang, Lih-Shinn; Siu, L. Kristopher; Yeh, Kuo-Ming			National Surveillance Study on Carbapenem Non-Susceptible Klebsiella pneumoniae in Taiwan: The Emergence and Rapid Dissemination of KPC-2 Carbapenemase	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; SEQUENCE TYPE 258; RESISTANT KLEBSIELLA; BETA-LACTAMASES; MOLECULAR EPIDEMIOLOGY; K. PNEUMONIAE; UNITED-STATES; ST11; BACTEREMIA; OUTBREAK	Objectives: The global spread and increasing incidence of carbapenem non-susceptible Klebsiella pneumoniae (CnSKP) has made its treatment difficult, increasing the mortality. To establish nationwide data on CnSKP spread and carbapenem-resistance mechanisms, we conducted a national surveillance study in Taiwanese hospitals. Methods: We collected 100 and 247 CnSKP isolates in 2010 and 2012, respectively. The tests performed included antibiotic susceptibility tests; detection of carbapenemase, extended-spectrum beta-lactamases (ESBL), and AmpC beta-lactamases genes; outer membrane porin profiles; and genetic relationship with pulsed-field gel electrophoresis and multilocus sequence type. Results: The resistance rate of CnSKP isolates to cefazolin, cefotaxime, cefoxitin, ceftazidime, and ciprofloxacin was over 90%. Susceptibility rate to tigecycline and colistin in 2010 was 91.0% and 83.0%, respectively; in 2012, it was 91.9% and 87.9%, respectively. In 2010, carbapenemase genes were detected in only 6.0% of isolates (4 bla(IMP-8) and 2 bla(VIM-1)). In 2012, carbapenemase genes were detected in 22.3% of isolates (41 bla(KPC-2), 7 bla(VIM-1), 6 bla(IMP-8), and 1 bla(NDM-1)). More than 95% of isolates exhibited either OmpK35 or OmpK36 porin loss or both. Impermeability due to porin mutation coupled with AmpC b-lactamases or ESBLs were major carbapenem-resistance mechanisms. Among 41 KPC-2-producing K. pneumoniae isolates, all were ST11 with 1 major pulsotype. Conclusions: In 2010 and 2012, the major mechanisms of CnSKP in Taiwan were the concomitance of AmpC with OmpK35/36 loss. KPC-2-KP dissemination with the same ST11 were observed in 2012. The emergence and rapid spread of KPC-2-KP is becoming an endemic problem in Taiwan. The identification of NDM-1 K. pneumoniae case is alarming.	[Chiu, Sheng-Kang; Lin, Jung-Chung; Yeh, Kuo-Ming] Natl Def Med Ctr, Div Infect Dis & Trop Med, Dept Med, Tri Serv Gen Hosp, Taipei, Taiwan; [Chiu, Sheng-Kang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Wu, Tsu-Lan] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan; [Wang, Lih-Shinn] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Fung, Chang-Phone] Natl Yan Ming Univ, Taipei Vet Gen Hosp, Infect Dis Sect, Dept Med, Taipei, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wang, Jann-Tay] Natl Taiwan Univ Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Wang, Lih-Shinn] Buddhist Tzu Chi Gen Hosp, Dept Infect Dis, Hualien, Taiwan; [Siu, L. Kristopher] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Miaoli, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Chang Gung Memorial Hospital; Chi Mei Hospital; Taipei Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; National Health Research Institutes - Taiwan	Yeh, KM (corresponding author), Natl Def Med Ctr, Div Infect Dis & Trop Med, Dept Med, Tri Serv Gen Hosp, Taipei, Taiwan.	kmyeh@ndmctsgh.edu.tw	Lu, Po-Liang/D-4499-2009; Chiu, Sheng-Kang/GQO-8638-2022; Siu, Leung-Kei/C-1368-2010	Lu, Po-Liang/0000-0002-7423-6783; WANG, JANN-TAY/0000-0002-0924-3469	Centers for Disease Control, Taiwan [DOH100-DC-1025, DOH101-DC-1204]	Centers for Disease Control, Taiwan	This study was supported by research grants from the Centers for Disease Control, Taiwan (DOH100-DC-1025 and DOH101-DC-1204). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2004, ANTIMICROB AGENTS CH, V48, P533, DOI 10.1128/AAC.48.2.533-537.2004; Andrade LN, 2011, ANTIMICROB AGENTS CH, V55, P3579, DOI 10.1128/AAC.01783-10; [Anonymous], 2011, ANN REPORT TAIWAN NO; Balm MND, 2012, J CLIN MICROBIOL, V50, P475, DOI 10.1128/JCM.05914-11; Bratu S, 2005, J ANTIMICROB CHEMOTH, V56, P128, DOI 10.1093/jac/dki175; CARLONE GM, 1986, J CLIN MICROBIOL, V24, P330, DOI 10.1128/JCM.24.3.330-332.1986; Centers for Disease Control and Prevention, 2012, GUID CONTR CARB RES; Chung KP, 2011, J ANTIMICROB CHEMOTH, V66, P1182, DOI 10.1093/jac/dkr025; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2010, M100S20U CLIN LAB ST; D'Agata EMC, 2001, INFECT CONT HOSP EP, V22, P550, DOI 10.1086/501950; Damjanova I, 2008, J ANTIMICROB CHEMOTH, V62, P978, DOI 10.1093/jac/dkn287; Department of Health and Human Services Food and Drug Administration, 2009, CLASS 2 SPEC CONTR G; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Eckert C, 2004, ANTIMICROB AGENTS CH, V48, P1249, DOI 10.1128/AAC.48.4.1249-1255.2004; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Giske CG, 2012, ANTIMICROB AGENTS CH, V56, P2735, DOI 10.1128/AAC.06142-11; Hrabak J, 2009, J CLIN MICROBIOL, V47, P3353, DOI 10.1128/JCM.00901-09; Jean SS, 2011, INT J ANTIMICROB AG, V37, P291, DOI 10.1016/j.ijantimicag.2011.01.009; Kallen A, 2012, EURO SURVEILL, V17; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Ko KS, 2010, J MED MICROBIOL, V59, P822, DOI 10.1099/jmm.0.018119-0; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Landman D, 2007, J ANTIMICROB CHEMOTH, V60, P78, DOI 10.1093/jac/dkm129; Landman D, 2012, J ANTIMICROB CHEMOTH, V67, P1427, DOI 10.1093/jac/dks063; Lee CM, 2012, ANTIMICROB AGENTS CH, V56, P5016, DOI 10.1128/AAC.00878-12; Lee MY, 2011, INT J ANTIMICROB AG, V38, P160, DOI 10.1016/j.ijantimicag.2011.03.020; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Mammina C, 2010, J CLIN MICROBIOL, V48, P1506, DOI 10.1128/JCM.00315-10; Neuner EA, 2011, DIAGN MICR INFEC DIS, V69, P357, DOI 10.1016/j.diagmicrobio.2010.10.013; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Pereira PS, 2012, J ANTIMICROB CHEMOTH, DOI 10.193/jac/dks396; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rasheed JK, 1997, ANTIMICROB AGENTS CH, V41, P647, DOI 10.1128/AAC.41.3.647; Siu LK, 2012, LANCET INFECT DIS, V12, P881, DOI 10.1016/S1473-3099(12)70205-0; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Virgincar N, 2011, J HOSP INFECT, V78, P293, DOI 10.1016/j.jhin.2011.03.016; Wendt C, 2010, EUR J CLIN MICROBIOL, V29, P563, DOI 10.1007/s10096-010-0896-0; Woodford N, 2007, INT J ANTIMICROB AG, V29, P456, DOI 10.1016/j.ijantimicag.2006.11.020; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	43	98	106	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69428	10.1371/journal.pone.0069428	http://dx.doi.org/10.1371/journal.pone.0069428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894478	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900069
J	Simpson, JA; Jamsen, KM; Anderson, TJC; Zaloumis, S; Nair, S; Woodrow, C; White, NJ; Nosten, F; Price, RN				Simpson, Julie A.; Jamsen, Kris M.; Anderson, Tim J. C.; Zaloumis, Sophie; Nair, Shalini; Woodrow, Charles; White, Nicholas J.; Nosten, Francois; Price, Ric N.			Nonlinear Mixed-Effects Modelling of In Vitro Drug Susceptibility and Molecular Correlates of Multidrug Resistant Plasmodium falciparum	PLOS ONE			English	Article							ARTESUNATE-MEFLOQUINE; WESTERN BORDER; PFMDR1 GENE; MALARIA; SENSITIVITY; THAILAND; ANTIMALARIALS; DETERMINANTS; NONMEM; ASSAYS	The analysis of in vitro anti-malarial drug susceptibility testing is vulnerable to the effects of different statistical approaches and selection biases. These confounding factors were assessed with respect to pfmdr1 gene mutation and amplification in 490 clinical isolates. Two statistical approaches for estimating the drug concentration associated with 50% effect (EC50) were compared: the commonly used standard two-stage (STS) method, and nonlinear mixed-effects modelling. The in vitro concentration-effect relationships for, chloroquine, mefloquine, lumefantrine and artesunate, were derived from clinical isolates obtained from patients on the western border of Thailand. All isolates were genotyped for polymorphisms in the pfmdr1 gene. The EC50 estimates were similar for the two statistical approaches but 15-28% of isolates in the STS method had a high coefficient of variation (>15%) for individual estimates of EC50 and these isolates had EC50 values that were 32 to 66% higher than isolates derived with more precision. In total 41% (202/490) of isolates had amplification of pfmdr1 and single nucleotide polymorphisms were found in 50 (10%). Pfmdr1 amplification was associated with an increase in EC50 for mefloquine (139% relative increase in EC50 for 2 copies, 188% for 3+ copies), lumefantrine (82% and 75% for 2 and 3+ copies respectively) and artesunate (63% and 127% for 2 and 3+ copies respectively). In contrast pfmdr1 mutation at codons 86 or 1042 were associated with an increase in chloroquine EC50 (44-48%). Sample size calculations showed that to demonstrate an EC50 shift of 50% or more with 80% power if the prevalence was 10% would require 430 isolates and 245 isolates if the prevalence was 20%. In conclusion, although nonlinear mixed-effects modelling did not demonstrate any major advantage for determining estimates of anti-malarial drug susceptibility, the method includes all isolates, thereby, potentially improving confirmation of candidate molecular markers of anti-malarial drug susceptibility.	[Simpson, Julie A.; Jamsen, Kris M.; Zaloumis, Sophie] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Anderson, Tim J. C.; Nair, Shalini] Texas Biomed Res Inst, San Antonio, TX USA; [Woodrow, Charles; White, Nicholas J.; Nosten, Francois; Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Woodrow, Charles; White, Nicholas J.] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Woodrow, Charles; Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, WorldWide Antimalarial Resistance Network WWARN, Ctr Trop Med, Oxford, England; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand; [Price, Ric N.] Charles Darwin Univ, Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT 0909, Australia	University of Melbourne; Texas Biomedical Research Institute; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; Worldwide Antimalarial Resistance Network (WWARN); Mahidol University; Charles Darwin University; Menzies School of Health Research	Simpson, JA (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia.	julieas@unimelb.edu.au	White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019; Zaloumis, Sophie/AAI-4396-2020; Simpson, Julie A/P-7299-2014	White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Zaloumis, Sophie/0000-0002-8253-8896; Price, Richard/0000-0003-2000-2874; Woodrow, Charles/0000-0002-5134-7165; Simpson, Julie/0000-0002-2660-2013	National Health and Medical Research Centre of Australia (NHMRC) [1025319]; NHMRC Centre of Research Excellence [1035261]; Wellcome Trust of Great Britain; National Institutes for Health [RO1 AI48071]; National Center for Research Resources, NIH [C06 RR013556]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048071, R37AI048071] Funding Source: NIH RePORTER	National Health and Medical Research Centre of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Centre of Research Excellence(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust of Great Britain(Wellcome Trust); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the National Health and Medical Research Centre of Australia (NHMRC) Project Grant 1025319. SZ was supported under a NHMRC Centre of Research Excellence grant, ID#1035261, to the Victorian Centre for Biostatistics (ViCBiostat). RNP is a Wellcome Trust Senior Research Fellow in Clinical Science (091625). NJW is a Principal Wellcome Trust Fellow. The research carried out at the Shoklo Malaria Research Unit is part of the Wellcome Trust Mahidol University of Oxford Tropical Medicine Research Programme also supported by the Wellcome Trust of Great Britain. The research carried out at TBRI was supported by National Institutes for Health grant (RO1 AI48071) to Tim JC Anderson, and was conducted in facilities constructed with support from Research Facilities Improvement Program Grant (Number C06 RR013556) from the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2005, ANTIMICROB AGENTS CH, V49, P2180, DOI 10.1128/AAC.49.6.2180-2188.2005; Ashley EA, 2006, ANTIMICROB AGENTS CH, V50, P2281, DOI 10.1128/AAC.00040-06; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Davidian M., 1995, NONLINEAR MODELS REP; Grimberg BT, 2011, J IMMUNOL METHODS, V367, P1, DOI 10.1016/j.jim.2011.01.015; Jullien V, 2010, ANTIMICROB AGENTS CH, V54, P2611, DOI 10.1128/AAC.01496-09; Kosaisavee V, 2006, EXP PARASITOL, V114, P34, DOI 10.1016/j.exppara.2006.02.006; Lindbom L, 2005, COMPUT METH PROG BIO, V79, P241, DOI 10.1016/j.cmpb.2005.04.005; Lindbom L, 2004, COMPUT METH PROG BIO, V75, P85, DOI 10.1016/j.cmpb.2003.11.003; Noedl H, 2003, TRENDS PARASITOL, V19, P175, DOI 10.1016/S1471-4922(03)00028-X; Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003; Pongtavornpinyo W, 2009, EVOL APPL, V2, P52, DOI 10.1111/j.1752-4571.2008.00067.x; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Russell B, 2008, ANTIMICROB AGENTS CH, V52, P1040, DOI 10.1128/AAC.01334-07; Simpson JA, 2006, BRIT J CLIN PHARMACO, V61, P289, DOI 10.1111/j.1365-2125.2005.02567.x; Simpson JA, 2001, T ROY SOC TROP MED H, V95, P347, DOI 10.1016/S0035-9203(01)90178-6; STEIMER JL, 1984, DRUG METAB REV, V15, P265, DOI 10.3109/03602538409015066; Stepniewska K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-4; Zaloumis S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-303	23	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69505	10.1371/journal.pone.0069505	http://dx.doi.org/10.1371/journal.pone.0069505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894496	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900078
J	Zhang, L; Wang, Q; Lin, CD; Ding, CD; Zhou, XL				Zhang, Li; Wang, Qi; Lin, Chongde; Ding, Cody; Zhou, Xinlin			An ERP Study of the Processing of Common and Decimal Fractions: How Different They Are	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MENTAL REPRESENTATION; WHOLE-NUMBER; RATIONAL NUMBERS; DISTANCE; COMPONENT; INFORMATION; ACTIVATION; QUANTITY; ORIGINS	This study explored event-related potential (ERP) correlates of common fractions (1/5) and decimal fractions (0.2). Thirteen subjects performed a numerical magnitude matching task under two conditions. In the common fraction condition, a nonsymbolic fraction was asked to be judged whether its magnitude matched the magnitude of a common fraction; in the decimal fraction condition, a nonsymbolic fraction was asked to be matched with a decimal fraction. Behavioral results showed significant main effects of condition and numerical distance, but no significant interaction of condition and numerical distance. Electrophysiological data showed that when nonsymbolic fractions were compared to common fractions, they displayed larger N1 and P3 amplitudes than when they were compared to decimal fractions. This finding suggested that the visual identification for nonsymbolic fractions was different under the two conditions, which was not due to perceptual differences but to task demands. For symbolic fractions, the condition effect was observed in the N1 and P3 components, revealing stimulus-specific visual identification processing. The effect of numerical distance as an index of numerical magnitude representation was observed in the P2, N3 and P3 components under the two conditions. However, the topography of the distance effect was different under the two conditions, suggesting stimulus specific semantic processing of common fractions and decimal fractions.	[Zhang, Li; Wang, Qi; Ding, Cody] Southwest Univ, Dept Psychol, Chongqing, Peoples R China; [Lin, Chongde] Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China; [Ding, Cody] Univ Missouri, Div Educ Psychol Res & Evaluat, St Louis, MO 63121 USA; [Zhou, Xinlin] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Southwest University - China; Beijing Normal University; University of Missouri System; University of Missouri Saint Louis; Beijing Normal University	Ding, CD (corresponding author), Southwest Univ, Dept Psychol, Chongqing, Peoples R China.	dingc@umsl.edu		Zhang, Li/0000-0003-1045-245X	Fundamental Research Funds for the Central Universities [SWU1209410]; State Key Laboratory of Cognitive Neuroscience and Learning [CNLYB1208]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Laboratory of Cognitive Neuroscience and Learning	This study was supported by the Fundamental Research Funds for the Central Universities (SWU1209410) and Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (CNLYB1208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrea L., 2002, J MATH BEHAV, V20, P503, DOI DOI 10.1016/S0732-3123(02)00087-1; Behr M., 1983, ACQUISITION MATH CON, P91; Bonato M, 2007, J EXP PSYCHOL HUMAN, V33, P1410, DOI 10.1037/0096-1523.33.6.1410; BRIGHT GW, 1988, J RES MATH EDUC, V19, P215, DOI 10.2307/749066; Brousseau G., 2004, J MATH BEHAV, V23, P1, DOI [10.1016/j.jmathb.2003.12.001, DOI 10.1016/J.JMATHB.2003.12.001]; CALLAWAY E, 1982, PSYCHIAT RES, V7, P299, DOI 10.1016/0165-1781(82)90066-X; Cao BH, 2010, BIOL PSYCHOL, V83, P47, DOI 10.1016/j.biopsycho.2009.10.003; Cohen DJ, 2010, J EXP PSYCHOL LEARN, V36, P1389, DOI 10.1037/a0020212; Dehaene S, 1996, J COGNITIVE NEUROSCI, V8, P47, DOI 10.1162/jocn.1996.8.1.47; Dehaene S., 1997, NUMBER SENSE; Faulkenberry TJ, 2011, EXP PSYCHOL, V58, P480, DOI 10.1027/1618-3169/a000116; Fazio LK, 2013, BIENN M SOC RES CHIL; Gabriel F, 2012, MIND BRAIN EDUC, V6, P137, DOI 10.1111/j.1751-228X.2012.01149.x; Ganor-Stern D, 2013, ACTA PSYCHOL, V142, P299, DOI 10.1016/j.actpsy.2013.01.003; Ganor-Stern D, 2012, ACTA PSYCHOL, V139, P350, DOI 10.1016/j.actpsy.2011.11.008; Gruber O, 2001, CEREB CORTEX, V11, P350, DOI 10.1093/cercor/11.4.350; Hecht S., 2007, WHY IS MATH SO HARD, P121; Irwin KC, 2004, MATH ED 3 MILLENNIUM, P312; Ischebeck A, 2009, NEUROIMAGE, V47, P403, DOI 10.1016/j.neuroimage.2009.03.041; Iuculano T, 2011, Q J EXP PSYCHOL, V64, P2088, DOI 10.1080/17470218.2011.604785; Jacob SN, 2009, J NEUROSCI, V29, P4652, DOI 10.1523/JNEUROSCI.0651-09.2009; Jiang T, 2010, NEUROPSYCHOLOGIA, V48, P201, DOI 10.1016/j.neuropsychologia.2009.09.005; Kadosh RC, 2008, CORTEX, V44, P470, DOI 10.1016/j.cortex.2007.08.002; Kallai AY, 2009, J EXP PSYCHOL HUMAN, V35, P1845, DOI 10.1037/a0016892; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Libertus ME, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-1; MACK NK, 1995, J RES MATH EDUC, V26, P422, DOI 10.2307/749431; Meert G, 2009, Q J EXP PSYCHOL, V62, P1598, DOI 10.1080/17470210802511162; Michaelidou N, 2004, P 28 C INT GROUP PSY, V3, P305; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Ni YJ, 2005, EDUC PSYCHOL-US, V40, P27, DOI 10.1207/s15326985ep4001_3; Ni YJ, 2001, CONTEMP EDUC PSYCHOL, V26, P400, DOI 10.1006/ceps.2000.1072; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Plodowski A, 2003, CURR BIOL, V13, P2045, DOI 10.1016/j.cub.2003.11.023; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Prabhakaran V, 2001, NEUROPSYCHOLOGY, V15, P115, DOI 10.1037/0894-4105.15.1.115; Rittle-Johnson B, 2001, J EDUC PSYCHOL, V93, P346, DOI 10.1037/0022-0663.93.2.346; Siegler RS, 2013, TRENDS COGN SCI, V17, P13, DOI 10.1016/j.tics.2012.11.004; Siegler RS, 2011, COGNITIVE PSYCHOL, V62, P273, DOI 10.1016/j.cogpsych.2011.03.001; Smith CL, 2005, COGNITIVE PSYCHOL, V51, P101, DOI 10.1016/j.cogpsych.2005.03.001; Sprute L, 2011, MIND BRAIN EDUC, V5, P42, DOI 10.1111/j.1751-228X.2011.01109.x; Steinle V., 2004, PROCEEDINGS OF THE 2, P541; Szucs D, 2005, COGNITIVE BRAIN RES, V22, P289, DOI 10.1016/j.cogbrainres.2004.04.010; Szucs D, 2004, NEUROSCI LETT, V360, P65, DOI 10.1016/j.neulet.2004.02.038; Szucs D, 2004, COGNITIVE BRAIN RES, V19, P10, DOI 10.1016/j.cogbrainres.2003.11.002; Temple E, 1998, P NATL ACAD SCI USA, V95, P7836, DOI 10.1073/pnas.95.13.7836; Van Opstal F, 2008, PSYCHON B REV, V15, P419, DOI 10.3758/PBR.15.2.419; van Opstal F, 2011, J COGN PSYCHOL, V23, P112, DOI 10.1080/20445911.2011.466796; Varma S, 2013, COGNITIVE PSYCHOL, V66, P283, DOI 10.1016/j.cogpsych.2013.01.002; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Zhang L, 2012, EXP BRAIN RES, V217, P25, DOI 10.1007/s00221-011-2969-4; Zhou XL, 2006, NEUROREPORT, V17, P991, DOI 10.1097/01.wnr.0000221840.12632.9f	52	7	9	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69487	10.1371/journal.pone.0069487	http://dx.doi.org/10.1371/journal.pone.0069487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894491	Green Published, gold			2022-12-25	WOS:000322167900077
J	Harke, MJ; Gobler, CJ				Harke, Matthew J.; Gobler, Christopher J.			Global Transcriptional Responses of the Toxic Cyanobacterium, Microcystis aeruginosa, to Nitrogen Stress, Phosphorus Stress, and Growth on Organic Matter	PLOS ONE			English	Article							FRESH-WATER CYANOBACTERIUM; BLUE-GREEN-ALGAE; LAKE-ERIE; NITRATE ASSIMILATION; AUREOCOCCUS-ANOPHAGEFFERENS; FORMING CYANOBACTERIUM; ENVIRONMENTAL-FACTORS; MARINE ENVIRONMENTS; GENE-EXPRESSION; AMINO-ACIDS	Whole transcriptome shotgun sequencing (RNA-seq) was used to assess the transcriptomic response of the toxic cyanobacterium Microcystis aeruginosa during growth with low levels of dissolved inorganic nitrogen (low N), low levels of dissolved inorganic phosphorus (low P), and in the presence of high levels of high molecular weight dissolved organic matter (HMWDOM). Under low N, one third of the genome was differentially expressed, with significant increases in transcripts observed among genes within the nir operon, urea transport genes (urtBCDE), and amino acid transporters while significant decreases in transcripts were observed in genes related to photosynthesis. There was also a significant decrease in the transcription of the microcystin synthetase gene set under low N and a significant decrease in microcystin content per Microcystis cell demonstrating that N supply influences cellular toxicity. Under low P, 27% of the genome was differentially expressed. The Pho regulon was induced leading to large increases in transcript levels of the alkaline phosphatase phoX, the Pst transport system (pstABC), and the sphX gene, and transcripts of multiple sulfate transporter were also significantly more abundant. While the transcriptional response to growth on HMWDOM was smaller (5-22% of genes differentially expressed), transcripts of multiple genes specifically associated with the transport and degradation of organic compounds were significantly more abundant within HMWDOM treatments and thus may be recruited by Microcystis to utilize these substrates. Collectively, these findings provide a comprehensive understanding of the nutritional physiology of this toxic, bloom-forming cyanobacterium and the role of N in controlling microcystin synthesis.	[Harke, Matthew J.; Gobler, Christopher J.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gobler, CJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	christopher.gobler@stonybrook.edu			NOAA-ECOHAB; National Oceanic and Atmospheric Administration Center for Sponsored Coastal Ocean Research [NA10NOS4780140]	NOAA-ECOHAB(National Oceanic Atmospheric Admin (NOAA) - USA); National Oceanic and Atmospheric Administration Center for Sponsored Coastal Ocean Research(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by the NOAA-ECOHAB program being funded by the National Oceanic and Atmospheric Administration Center for Sponsored Coastal Ocean Research under award # NA10NOS4780140 to Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MM, 1969, ARCH MIKROBIOL, V69, P114, DOI 10.1007/BF00409755; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Aravind L, 2002, PROTEINS, V46, P355, DOI 10.1002/prot.10060; AZAM F, 1994, MICROBIAL ECOL, V28, P167, DOI 10.1007/BF00166806; Benning C, 1998, ANNU REV PLANT PHYS, V49, P53, DOI 10.1146/annurev.arplant.49.1.53; Berg GM, 2003, LIMNOL OCEANOGR, V48, P1825, DOI 10.4319/lo.2003.48.5.1825; Berman T, 2003, AQUAT MICROB ECOL, V31, P279, DOI 10.3354/ame031279; Berman T, 1999, J PLANKTON RES, V21, P1423, DOI 10.1093/plankt/21.8.1423; BERTRAM PE, 1993, J GREAT LAKES RES, V19, P224, DOI 10.1016/S0380-1330(93)71213-7; Brittain SM, 2000, J GREAT LAKES RES, V26, P241, DOI 10.1016/S0380-1330(00)70690-3; Brunberg AK, 1999, FEMS MICROBIOL ECOL, V29, P13, DOI 10.1111/j.1574-6941.1999.tb00594.x; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cho BC, 1996, MAR ECOL PROG SER, V142, P19, DOI 10.3354/meps142019; Codd GA, 1988, BIOCH ALGAE CYANOBAC; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Collier JL, 1999, MICROBIOL-SGM, V145, P447, DOI 10.1099/13500872-145-2-447; Dai RH, 2009, J HAZARD MATER, V161, P730, DOI 10.1016/j.jhazmat.2008.04.015; Davis TW, 2010, AQUAT MICROB ECOL, V61, P149, DOI 10.3354/ame01445; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; DEBUSSCHE L, 1993, J BACTERIOL, V175, P7430, DOI 10.1128/JB.175.22.7430-7440.1993; Dempster EL, 1999, BIOTECHNIQUES, V27, P66, DOI 10.2144/99271bm13; Dirix G, 2004, PEPTIDES, V25, P1425, DOI 10.1016/j.peptides.2003.10.028; Dolman AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038757; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Erdner DL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-88; Fischer WJ, 2001, ENVIRON SCI TECHNOL, V35, P4849, DOI 10.1021/es011182f; Flaherty BL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-332; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Frias JE, 1997, J BACTERIOL, V179, P477, DOI 10.1128/jb.179.2.477-486.1997; GE X, 1990, Canadian Journal of Microbiology, V36, P218, DOI 10.1139/m90-037; Geider RJ, 1998, LIMNOL OCEANOGR, V43, P679, DOI 10.4319/lo.1998.43.4.0679; Gilbert P, 2004, TWO OF ME: THE RATIONAL OUTER ME AND THE EMOTIONAL INNER ME, P73; Gobler CJ, 2007, HARMFUL ALGAE, V6, P119, DOI 10.1016/j.hal.2006.08.003; Gobler CJ, 2003, LIMNOL OCEANOGR, V48, P2314, DOI 10.4319/lo.2003.48.6.2314; GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P289; Harke MJ, 2012, MICROB ECOL, V63, P188, DOI 10.1007/s00248-011-9894-8; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; HERRERO A, 1990, J BIOL CHEM, V265, P3931; Hesse K, 2001, FEMS MICROBIOL ECOL, V37, P39, DOI 10.1111/j.1574-6941.2001.tb00851.x; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Horst GP, 2009, 52 ANN C GREAT LAK R, P95; Hudnell HK, 2008, ADV EXP MED BIOL, V619, P1, DOI 10.1007/978-0-387-75865-7_1; Istvanovics V, 2000, FRESHWATER BIOL, V43, P257, DOI 10.1046/j.1365-2427.2000.00549.x; Jacoby JM, 2000, CAN J FISH AQUAT SCI, V57, P231, DOI 10.1139/cjfas-57-1-231; JONES MN, 1984, WATER RES, V18, P643, DOI 10.1016/0043-1354(84)90215-X; KAMEL MY, 1973, ACTA BIOL MED GER, V30, P457; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kikuchi H, 1996, J BACTERIOL, V178, P5822, DOI 10.1128/jb.178.19.5822-5825.1996; KIRCHMAN DL, 1994, MICROBIAL ECOL, V28, P255, DOI 10.1007/BF00166816; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; KOTAK BG, 1995, J PHYCOL, V31, P248, DOI 10.1111/j.0022-3646.1995.00248.x; Lawrence S.A., 2004, AMINES SYNTHESIS; LIKENS GE, 1971, SCIENCE, V172, P873, DOI 10.1126/science.172.3985.873; Ludwig M, 2011, FRONTIERS MICROBIOLO, V3, P1; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Moisander PH, 2009, HARMFUL ALGAE, V8, P889, DOI 10.1016/j.hal.2009.04.005; Montane MH, 1997, PLANTA, V202, P293, DOI 10.1007/s004250050131; Montane MH, 1999, PLANTA, V208, P519, DOI 10.1007/s004250050589; Moustafa A, 2011, PLOS ONE, V5, P1; Nagata S, 1997, J AOAC INT, V80, P408; Ohashi Y, 2011, J EXP BOT, V62, P1411, DOI 10.1093/jxb/erq427; Okino T., 1974, J FAC SCI SHINSHU U, V8, P135; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; Ouellette AJA, 2006, MICROB ECOL, V51, P154, DOI 10.1007/s00248-004-0146-z; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Paerl H, 2008, ADV EXP MED BIOL, V619, P217, DOI 10.1007/978-0-387-75865-7_10; PAERL HW, 1988, LIMNOL OCEANOGR, V33, P823, DOI 10.4319/lo.1988.33.4_part_2.0823; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pernil R, 2008, MOL MICROBIOL, V67, P1067, DOI 10.1111/j.1365-2958.2008.06107.x; Perovich G, 2008, ADV EXP MED BIOL, V619, P185; Pitt FD, 2010, J BACTERIOL, V192, P3512, DOI 10.1128/JB.00258-10; PRICE NM, 1987, MAR BIOL, V94, P307, DOI 10.1007/BF00392945; Quintero MJ, 2001, GENOME RES, V11, P2034, DOI 10.1101/gr.196301; Rapala J, 1997, APPL ENVIRON MICROB, V63, P2206, DOI 10.1128/AEM.63.6.2206-2212.1997; Reynolds CS, 1981, BIOL SCI, V239, P419; Rinta-Kanto JM, 2005, ENVIRON SCI TECHNOL, V39, P4198, DOI 10.1021/es048249u; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Simis SGH, 2012, PHOTOSYNTH RES, V112, P13, DOI 10.1007/s11120-012-9729-6; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Stolte W, 2002, AQUAT MICROB ECOL, V29, P97, DOI 10.3354/ame029097; Stolte W, 2006, MAR ECOL PROG SER, V327, P71, DOI 10.3354/meps327071; Straub C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016208; Stumpf RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042444; SUZUKI I, 1993, PLANT CELL PHYSIOL, V34, P1311; Thompson AW, 2011, ISME J, V5, P1580, DOI 10.1038/ismej.2011.49; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TURPIN DH, 1991, J PHYCOL, V27, P14, DOI 10.1111/j.0022-3646.1991.00014.x; UTKILEN H, 1995, APPL ENVIRON MICROB, V61, P797, DOI 10.1128/AEM.61.2.797-800.1995; Vahtera E, 2007, AQUAT MICROB ECOL, V46, P225, DOI 10.3354/ame046225; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; Van de Waal DB, 2009, ECOL LETT, V12, P1326, DOI 10.1111/j.1461-0248.2009.01383.x; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; Vezie C, 2002, MICROB ECOL, V43, P443, DOI 10.1007/s00248-001-0041-9; WATANABE MF, 1985, APPL ENVIRON MICROB, V49, P1342, DOI 10.1128/AEM.49.5.1342-1344.1985; WHITTON BA, 1991, MICROB ECOL, V21, P85, DOI 10.1007/BF02539146; Wilhelm SW, 2003, AQUAT MICROB ECOL, V32, P275, DOI 10.3354/ame032275; Wurch LL, 2011, ENVIRON MICROBIOL, V13, P468, DOI 10.1111/j.1462-2920.2010.02351.x; Xu X, 2008, CYANOBACTERIA MOL BI; Yoshida M, 2007, FEMS MICROBIOL LETT, V266, P49, DOI 10.1111/j.1574-6968.2006.00496.x; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	112	110	116	8	210	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69834	10.1371/journal.pone.0069834	http://dx.doi.org/10.1371/journal.pone.0069834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894552	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000164
J	Malaza, A; Mossong, J; Barnighausen, T; Viljoen, J; Newell, ML				Malaza, Abraham; Mossong, Joel; Baernighausen, Till; Viljoen, Johannes; Newell, Marie-Louise			Population-Based CD4 Counts in a Rural Area in South Africa with High HIV Prevalence and High Antiretroviral Treatment Coverage	PLOS ONE			English	Article							DAR-ES-SALAAM; REFERENCE VALUES; LYMPHOCYTE SUBSETS; REFERENCE RANGES; HIV-1-INFECTED ADULTS; COHORT PROFILE; T-LYMPHOCYTES; HEALTHY; THERAPY; INDIVIDUALS	Background: Little is known about the variability of CD4 counts in the general population of sub-Saharan Africa countries affected by the HIV epidemic. We investigated factors associated with CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment (ART) coverage. Methods: CD4 counts, health status, body mass index (BMI), demographic characteristics and HIV status were assessed in 4990 adult resident participants of a demographic surveillance in rural KwaZulu-Natal in South Africa; antiretroviral treatment duration was obtained from a linked clinical database. Multivariable regression analysis, overall and stratified by HIV status, was performed with CD4 count levels as outcome. Results: Median CD4 counts were significantly higher in women than in men overall (714 vs. 630 cells/ml, p<0.0001), both in HIV-uninfected (833 vs. 683 cells/mu l, p<0.0001) and HIV-infected adults (384.5 vs. 333 cells/mu l, p<0.0001). In multivariable regression analysis, women had 19.4% (95% confidence interval (CI) 16.1-22.9) higher CD4 counts than men, controlling for age, HIV status, urban/rural residence, household wealth, education, BMI, self-reported tuberculosis, high blood pressure, other chronic illnesses and sample processing delay. At ART initiation, HIV-infected adults had 21.7% (95% CI 14.6-28.2) lower CD4 counts than treatment-naive individuals; CD4 counts were estimated to increase by 9.2% (95% CI 6.2-12.4) per year of treatment. Conclusions: CD4 counts are primarily determined by sex in HIV-uninfected adults, and by sex, age and duration of antiretroviral treatment in HIV-infected adults. Lower CD4 counts at ART initiation in men could be a consequence of lower CD4 cell counts before HIV acquisition.	[Malaza, Abraham; Mossong, Joel; Baernighausen, Till; Viljoen, Johannes; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, Kwazulu Natal, South Africa; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of London; University College London	Mossong, J (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, Kwazulu Natal, South Africa.	jmossong@africacentre.ac.za	Bärnighausen, Till/Y-2388-2019; Newell, Marie-Louise/AAE-8222-2019; Mossong, Joël/D-4998-2009	Newell, Marie-Louise/0000-0002-1074-7699; Mossong, Joël/0000-0003-0717-9835	Wellcome Trust [050534]; German government through the Centre for International Migration and Development (CIM)	Wellcome Trust(Wellcome TrustEuropean Commission); German government through the Centre for International Migration and Development (CIM)	The Africa Centre is funded by the Wellcome Trust for its core activities, including the household and individual health surveillance (WT #050534). JM received partial financial support from the German government through the Centre for International Migration and Development (CIM). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuye C, 2005, J CLIN IMMUNOL, V25, P127, DOI 10.1007/s10875-005-2818-y; Adoga MP, 2012, SCAND J IMMUNOL, V76, P33, DOI 10.1111/j.1365-3083.2012.02700.x; Aina O, 2005, CLIN DIAGN LAB IMMUN, V12, P525, DOI 10.1128/CDLI.12.4.525-530.2005; Aldrich J, 2000, ARCH INTERN MED, V160, P715, DOI 10.1001/archinte.160.5.715; Auvert B, 2004, JAIDS-J ACQ IMM DEF, V36, P613, DOI 10.1097/00126334-200405010-00010; Barnighausen T, 2012, TROP MED INT HEALTH, V17, pe103, DOI 10.1111/j.1365-3156.2012.02928.x; Bekele Yonas, 2011, Ethiop Med J, V49, P187; Bussmann H, 2004, CLIN DIAGN LAB IMMUN, V11, P930, DOI 10.1128/CDLI.11.5.930-935.2004; Clerici M, 2000, AIDS, V14, P2083, DOI 10.1097/00002030-200009290-00003; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Crampin A C, 2011, Open AIDS J, V5, P74, DOI 10.2174/1874613601105010074; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Julg B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031161; Karcher H, 2006, CYTOM PART B-CLIN CY, V70B, P163, DOI 10.1002/cyto.b.20093; Kassa E, 1999, AIDS, V13, P381, DOI 10.1097/00002030-199902250-00011; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; Kelly P, 2002, ACTA TROP, V83, P151, DOI 10.1016/S0001-706X(02)00095-5; Klose N, 2007, CLIN VACCINE IMMUNOL, V14, P782, DOI 10.1128/CVI.00044-07; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lawrie D, 2009, SAMJ S AFR MED J, V99, P243; Lepri AC, 2001, AIDS, V15, P983, DOI 10.1097/00002030-200105250-00006; Lessells R, JAIDS IN PRESS; Levin A, 1996, INT J STD AIDS, V7, P288, DOI 10.1258/0956462961917825; LEVY JA, 1993, AIDS, V7, P1401, DOI 10.1097/00002030-199311000-00001; Lisse IM, 1996, J ACQ IMMUN DEF SYND, V13, P355, DOI 10.1097/00042560-199612010-00009; Lovvorn AE, 2010, INT J STD AIDS, V21, P342, DOI 10.1258/ijsa.2009.009020; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Maini MK, 1996, GENITOURIN MED, V72, P27; Mair C, 2008, CLIN EXP IMMUNOL, V151, P432, DOI 10.1111/j.1365-2249.2007.03573.x; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Mandala WL, 2010, J ALLERGY CLIN IMMUN, V125, P203, DOI 10.1016/j.jaci.2009.10.010; Messele T, 2001, AIDS RES HUM RETROV, V17, P433, DOI 10.1089/088922201750102526; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Ngowi BJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-1; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; Oladepo DK, 2009, CLIN VACCINE IMMUNOL, V16, P1374, DOI 10.1128/CVI.00378-08; Olgiati A, 2012, TROP MED INT HEALTH, V17, P844, DOI 10.1111/j.1365-3156.2012.03012.x; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; TOLLERUD DJ, 1989, J CLIN IMMUNOL, V9, P214, DOI 10.1007/BF00916817; Tsegaye A, 2003, CLIN IMMUNOL, V109, P338, DOI 10.1016/j.clim.2003.08.008; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; Urassa W, 2004, AIDS, V18, P433, DOI 10.1097/00002030-200402200-00009; Urassa WK, 1996, E AFR MED J, V73, P670; Westerman LE, 2010, AM J CLIN PATHOL, V134, P556, DOI 10.1309/AJCPP7MCHFYLX2FM; Williams BG, 2006, J INFECT DIS, V194, P1450, DOI 10.1086/508206; Yu LM, 1997, INT J EPIDEMIOL, V26, P1367, DOI 10.1093/ije/26.6.1367; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040; Zekeng L, 1997, J ACQ IMMUN DEF SYND, V14, P82, DOI 10.1097/00042560-199701010-00016; Zuch M, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-3	50	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70126	10.1371/journal.pone.0070126	http://dx.doi.org/10.1371/journal.pone.0070126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894603	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000187
J	Pakhomova, ON; Gregory, BW; Semenov, I; Pakhomov, AG				Pakhomova, Olga N.; Gregory, Betsy W.; Semenov, Iurii; Pakhomov, Andrei G.			Two Modes of Cell Death Caused by Exposure to Nanosecond Pulsed Electric Field	PLOS ONE			English	Article							HIGH-INTENSITY; PLASMA-MEMBRANE; APOPTOSIS; PHOSPHATIDYLSERINE; TRANSLOCATION; CARCINOMA; CLEAVAGE; SURVIVAL; THERAPY; DAMAGE	High-amplitude electric pulses of nanosecond duration, also known as nanosecond pulsed electric field (nsPEF), are a novel modality with promising applications for cell stimulation and tissue ablation. However, key mechanisms responsible for the cytotoxicity of nsPEF have not been established. We show that the principal cause of cell death induced by 60- or 300-ns pulses in U937 cells is the loss of the plasma membrane integrity ("nanoelectroporation"), leading to water uptake, cell swelling, and eventual membrane rupture. Most of this early necrotic death occurs within 1-2 hr after nsPEF exposure. The uptake of water is driven by the presence of pore-impermeable solutes inside the cell, and can be counterbalanced by the presence of a pore-impermeable solute such as sucrose in the medium. Sucrose blocks swelling and prevents the early necrotic death; however the long-term cell survival (24 and 48 hr) does not significantly change. Cells protected with sucrose demonstrate higher incidence of the delayed death (6-24 hr post nsPEF). These cells are more often positive for the uptake of an early apoptotic marker dye YO-PRO-1 while remaining impermeable to propidium iodide. Instead of swelling, these cells often develop apoptotic fragmentation of the cytoplasm. Caspase 3/7 activity increases already in 1 hr after nsPEF and poly-ADP ribose polymerase (PARP) cleavage is detected in 2 hr. Staurosporin-treated positive control cells develop these apoptotic signs only in 3 and 4 hr, respectively. We conclude that nsPEF exposure triggers both necrotic and apoptotic pathways. The early necrotic death prevails under standard cell culture conditions, but cells rescued from the necrosis nonetheless die later on by apoptosis. The balance between the two modes of cell death can be controlled by enabling or blocking cell swelling.	[Pakhomova, Olga N.; Gregory, Betsy W.; Semenov, Iurii; Pakhomov, Andrei G.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA	Old Dominion University	Pakhomova, ON (corresponding author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA.	olga@pakhomova.net		Semenov, Iurii/0000-0002-0302-1355; Pakhomov, Andrei/0000-0003-3816-3860	National Cancer Institute [RO1CA125482]; National Institute of General Medical Sciences [RO1GM088303]; NATIONAL CANCER INSTITUTE [R01CA125482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088303] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by RO1CA125482 from the National Cancer Institute and RO1GM088303 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre FM, 2010, BIOELECTROCHEMISTRY, V79, P95, DOI 10.1016/j.bioelechem.2009.12.007; Beebe SJ, 2004, PHYSIOL MEAS, V25, P1077, DOI 10.1088/0967-3334/25/4/023; Beebe SJ, 2003, DNA CELL BIOL, V22, P785, DOI 10.1089/104454903322624993; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Beebe SJ, 2002, IEEE T PLASMA SCI, V30, P286, DOI 10.1109/TPS.2002.1003872; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bowman AM, 2010, J MEMBRANE BIOL, V236, P15, DOI 10.1007/s00232-010-9269-y; Casiano CA, 1998, CELL DEATH DIFFER, V5, P183, DOI 10.1038/sj.cdd.4400336; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Deng JD, 2003, BIOPHYS J, V84, P2709, DOI 10.1016/S0006-3495(03)75076-0; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723; Hall EH, 2005, DNA CELL BIOL, V24, P283, DOI 10.1089/dna.2005.24.283; Ibey BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015642; Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kepp O, 2011, CANCER METAST REV, V30, P61, DOI 10.1007/s10555-011-9273-4; KINOSITA K, 1977, BIOCHIM BIOPHYS ACTA, V471, P227, DOI 10.1016/0005-2736(77)90252-8; KINOSITA K, 1977, NATURE, V268, P438, DOI 10.1038/268438a0; Manns J, 2011, FASEB J, V25, P3250, DOI 10.1096/fj.10-177527; Nesin Olena M, 2011, Biochim Biophys Acta, V1808, P792, DOI 10.1016/j.bbamem.2010.12.012; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Okada Y, 2004, CELL BIOCHEM BIOPHYS, V41, P233, DOI 10.1385/CBB:41:2:233; Pakhomov A.G., 2010, ADV ELECTROPORATION, P178; Pakhomov AG, 2004, IEEE T PLASMA SCI, V32, P1579, DOI 10.1109/TPS.2004.831773; Pakhomov AG, 2010, ADV ELECTROPORATION; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomova ON, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017100; Ren W, 2012, BIOCHEM BIOPH RES CO, V421, P808, DOI 10.1016/j.bbrc.2012.04.094; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468; Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71; Stacey M, 2003, MUTAT RES-GEN TOX EN, V542, P65, DOI 10.1016/j.mrgentox.2003.08.006; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Walker K, 2006, BIOELECTROMAGNETICS, V27, P221, DOI 10.1002/bem.20200; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043213; Winer BJ, 1971, STAT PRINCIPLES EXPT; Yang W, 2011, TECHNOL CANCER RES T, V10, P281, DOI 10.7785/tcrt.2012.500204; Yin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043891; Zhao J, 1998, J BIOL CHEM, V273, P6603, DOI 10.1074/jbc.273.12.6603	44	81	81	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70278	10.1371/journal.pone.0070278	http://dx.doi.org/10.1371/journal.pone.0070278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894630	Green Submitted, Green Published, gold			2022-12-25	WOS:000325211000200
J	Springer, DJ; Saini, D; Byrnes, EJ; Heitman, J; Frothingham, R				Springer, Deborah J.; Saini, Divey; Byrnes, Edmond J.; Heitman, Joseph; Frothingham, Richard			Development of an Aerosol Model of Cryptococcus Reveals Humidity as an Important Factor Affecting the Viability of Cryptococcus during Aerosolization	PLOS ONE			English	Article							FUNGAL PATHOGEN CRYPTOCOCCUS; GATTII SEROTYPE-C; MURINE MODEL; ENVIRONMENTAL SOURCES; ALVEOLAR MACROPHAGES; DENDRITIC CELLS; INFLUENZA-VIRUS; NEOFORMANS; INFECTION; SUSCEPTIBILITY	Cryptococcus is an emerging global health threat that is annually responsible for over 1,000,000 infections and one third of all AIDS patient deaths. There is an ongoing outbreak of cryptococcosis in the western United States and Canada. Cryptococcosis is a disease resulting from the inhalation of the infectious propagules from the environment. The current and most frequently used animal infection models initiate infection via liquid suspension through intranasal instillation or intravenous injection. These models do not replicate the typically dry nature of aerosol exposure and may hinder our ability to decipher the initial events that lead to clearance or the establishment of infection. We have established a standardized aerosol model of murine infection for the human fungal pathogen Cryptococcus. Aerosolized cells were generated utilizing a Collison nebulizer in a whole-body Madison Chamber at different humidity conditions. The aerosols inside the chamber were sampled using a BioSampler to determine viable aerosol concentration and spray factor (ratio of viable aerosol concentration to total inoculum concentration). We have effectively delivered yeast and yeast-spore mixtures to the lungs of mice and observed the establishment of disease. We observed that growth conditions prior to exposure and humidity within the Madison Chamber during exposure can alter Cryptococcus survival and dose retained in mice.	[Springer, Deborah J.; Heitman, Joseph; Frothingham, Richard] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Saini, Divey; Frothingham, Richard] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Byrnes, Edmond J.] NIH, Off Director, Baltimore, MD USA	Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Springer, DJ (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	deborah.springer@duke.edu	Heitman, Joseph/ABC-6006-2021		Dean Voucher Program; Regional Biocontainment Laboratory at Duke [UC6 AI058607]; NIH/NAID [R37 AIO39115-15]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039115, R01AI039115, UC6AI058607] Funding Source: NIH RePORTER	Dean Voucher Program; Regional Biocontainment Laboratory at Duke; NIH/NAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was support by the 2010-11 Dean Voucher Program, UC6 AI058607 (Regional Biocontainment Laboratory at Duke), and NIH/NAID R37 AIO39115-15 to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar SL, 2008, MICROBIOL-SGM, V154, P1939, DOI 10.1099/mic.0.2008/017335-0; Agar SL, 2009, MICROBES INFECT, V11, P205, DOI 10.1016/j.micinf.2008.11.009; Albuquerque PC, 2012, FUTURE MICROBIOL, V7, P319, DOI [10.2217/fmb.11.162, 10.2217/FMB.11.162]; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Aminnejad M, 2012, MYCOPATHOLOGIA, V173, P337, DOI 10.1007/s11046-011-9491-x; Barchiesi F, 2005, J INFECTION, V51, P10, DOI 10.1016/j.jinf.2004.07.013; Baro T, 1999, J CLIN MICROBIOL, V37, P1170; Botes A, 2009, MICROB ECOL, V57, P757, DOI 10.1007/s00248-008-9452-1; Botts MR, 2009, EUKARYOT CELL, V8, P595, DOI 10.1128/EC.00352-08; Bresee J, 2013, NEW ENGL J MED, V368, P589, DOI 10.1056/NEJMp1300375; Capoor MR, 2008, MYCOSES, V51, P258, DOI 10.1111/j.1439-0507.2007.01478.x; Carriconde F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016936; Carroll SF, 2007, COMPARATIVE MED, V57, P9; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Chaturvedi S, 2005, EMERG INFECT DIS, V11, P1686, DOI 10.3201/eid1111.040875; Chen LC, 1999, INFECT IMMUN, V67, P2218, DOI 10.1128/IAI.67.5.2218-2224.1999; Chen SCA, 2012, CLIN INFECT DIS, V55, P789, DOI 10.1093/cid/cis529; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; Cogliati M, 2012, MYCOSES, V55, P262, DOI 10.1111/j.1439-0507.2011.02082.x; Deacon LJ, 2009, ATMOS ENVIRON, V43, P5698, DOI 10.1016/j.atmosenv.2009.07.042; Faith SA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00126; Feldmesser M, 1997, J IMMUNOL, V158, P790; Fu Meiqin, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P169; Ganendren R, 2006, MICROBES INFECT, V8, P1006, DOI 10.1016/j.micinf.2005.10.018; Geunes-Boyer S, 2009, INFECT IMMUN, V77, P2783, DOI 10.1128/IAI.00088-09; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Gross NT, 1997, J MED VET MYCOL, V35, P263; Gross NT, 1998, MYCOPATHOLOGIA, V144, P21, DOI 10.1023/A:1006948825384; Guillot L, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-9; GUYTON AC, 1947, AM J PHYSIOL, V150, P78, DOI 10.1152/ajplegacy.1947.150.1.78; Hagen F, 2012, EMERG INFECT DIS, V18, P1618, DOI 10.3201/eid1810.120068; Hartings Justin M., 2004, Journal of Pharmacological and Toxicological Methods, V49, P39, DOI 10.1016/j.vascn.2003.07.001; Heine HS, 2007, ANTIMICROB AGENTS CH, V51, P1373, DOI 10.1128/AAC.01050-06; HENDERSON DW, 1952, J HYG-CAMBRIDGE, V50, P53, DOI 10.1017/S0022172400019422; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Iatta R, 2012, MYCOPATHOLOGIA, V174, P87, DOI 10.1007/s11046-011-9493-8; Johnston SA, 2013, CELL MICROBIOL, V15, P403, DOI 10.1111/cmi.12067; Kang YQ, 2009, MICROBIOL IMMUNOL, V53, P112, DOI 10.1111/j.1348-0421.2008.00101.x; Kechichian TB, 2007, INFECT IMMUN, V75, P4792, DOI 10.1128/IAI.00587-07; Kidd SE, 2007, APPL ENVIRON MICROB, V73, P1433, DOI 10.1128/AEM.01330-06; Kim SW, 2007, AEROBIOLOGIA, V23, P239, DOI 10.1007/s10453-007-9068-9; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P942, DOI 10.2307/3758813; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; LIM TS, 1980, INFECT IMMUN, V29, P633; Litvintseva AP, 2005, J INFECT DIS, V192, P888, DOI 10.1086/432486; Loperena-Alvarez Y, 2010, MYCOPATHOLOGIA, V170, P279, DOI 10.1007/s11046-010-9296-3; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; Marroni Massimo, 2007, J Infect, V54, pe5, DOI 10.1016/j.jinf.2006.03.018; MARTHI B, 1990, APPL ENVIRON MICROB, V56, P3463, DOI 10.1128/AEM.56.11.3463-3467.1990; McCulloh RJ, 2011, PEDIATR INFECT DIS J, V30, P1111, DOI 10.1097/INF.0b013e31822d14fd; McDevitt JJ, 2012, APPL ENVIRON MICROB, V78, P1666, DOI 10.1128/AEM.06960-11; McFadden DC, 2001, MED MYCOL, V39, P19, DOI 10.1080/714031007; Mednick AJ, 2003, EUR J IMMUNOL, V33, P1744, DOI 10.1002/eji.200323626; Meklin T, 2002, ATMOS ENVIRON, V36, P6031, DOI 10.1016/S1352-2310(02)00769-0; Mershon KL, 2009, INFECT IMMUN, V77, P1061, DOI 10.1128/IAI.01119-08; Nedeljkovic-Davidovic A, 2008, FLUENCE RESPONSE CUR; NEILSON JB, 1977, INFECT IMMUN, V17, P634, DOI 10.1128/IAI.17.3.634-638.1977; Ngamskulrungroj P, 2012, MBIO, V3, DOI 10.1128/mBio.00103-12; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Nuermberger EL, 2004, INFECT IMMUN, V72, P1065, DOI 10.1128/IAI.72.2.1065-1071.2004; Osterholzer JJ, 2009, INFECT IMMUN, V77, P3749, DOI 10.1128/IAI.00454-09; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Ramsay C, 2001, LANCET, V357, P1507, DOI 10.1016/S0140-6736(00)04709-7; RUIZ A, 1981, APPL ENVIRON MICROB, V41, P1225, DOI 10.1128/AEM.41.5.1225-1229.1981; Saini D, 2011, J PHARMACOL TOX MET, V63, P143, DOI 10.1016/j.vascn.2010.09.002; Schoffelen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055579; Sellers B, 2012, AM J MED SCI, V343, P510, DOI 10.1097/MAJ.0b013e3182464bc7; Sheppard DC, 2004, ANTIMICROB AGENTS CH, V48, P1908, DOI 10.1128/AAC.48.5.1908-1911.2004; Sheppard DC, 2006, ANTIMICROB AGENTS CH, V50, P3501, DOI 10.1128/AAC.00787-06; SMITH CD, 1964, J BACTERIOL, V87, P1364, DOI 10.1128/JB.87.6.1364-1368.1964; Springer DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010978; Srinivas U, 2008, INDIAN J PATHOL MICR, V51, P296, DOI 10.4103/0377-4929.41707; STAIB F, 1975, ZBL BAKT-INT J MED M, V232, P355; Stone RC, 2002, AEROSOL SCI TECH, V36, P536, DOI 10.1080/02786820252883775; Sukroongreung S, 1998, MED MYCOL, V36, P419, DOI 10.1080/02681219880000661; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Tay ST, 2010, MYCOSES, V53, P509, DOI 10.1111/j.1439-0507.2009.01750.x; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Voelz K, 2009, INFECT IMMUN, V77, P3450, DOI 10.1128/IAI.00297-09; WEINBERG PB, 1987, AM REV RESPIR DIS, V136, P1242, DOI 10.1164/ajrccm/136.5.1242; Wozniak KL, 2006, INFECT IMMUN, V74, P3817, DOI 10.1128/IAI.00317-06; Wright L, 2002, MICROBES INFECT, V4, P1427, DOI 10.1016/S1286-4579(02)00024-2; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Yang WH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045233, 10.1371/journal.pone.0046789, 10.1371/journal.pone.0053429]	85	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69804	10.1371/journal.pone.0069804	http://dx.doi.org/10.1371/journal.pone.0069804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894542	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000157
J	Pappada, SM; Cameron, BD; Tulman, DB; Bourey, RE; Borst, MJ; Olorunto, W; Bergese, SD; Evans, DC; Stawicki, SPA; Papadimos, TJ				Pappada, Scott M.; Cameron, Brent D.; Tulman, David B.; Bourey, Raymond E.; Borst, Marilyn J.; Olorunto, William; Bergese, Sergio D.; Evans, David C.; Stawicki, Stanislaw P. A.; Papadimos, Thomas J.			Evaluation of a Model for Glycemic Prediction in Critically Ill Surgical Patients	PLOS ONE			English	Article							INTENSIVE INSULIN THERAPY; BLOOD-GLUCOSE; TRAUMA PATIENTS; DIABETES-MELLITUS; CARDIAC-SURGERY; CARE-UNIT; HYPERGLYCEMIA; MORTALITY; MANAGEMENT; ALGORITHM	We evaluated a neural network model for prediction of glucose in critically ill trauma and post-operative cardiothoracic surgical patients. A prospective, feasibility trial evaluating a continuous glucose-monitoring device was performed. After institutional review board approval, clinical data from all consenting surgical intensive care unit patients were converted to an electronic format using novel software. This data was utilized to develop and train a neural network model for real-time prediction of serum glucose concentration implementing a prediction horizon of 75 minutes. Glycemic data from 19 patients were used to "train" the neural network model. Subsequent real-time simulated testing was performed in 5 patients to whom the neural network model was naive. Performance of the model was evaluated by calculating the mean absolute difference percent (MAD%), Clarke Error Grid Analysis, and calculation of the percent of hypoglycemic (<= 70 mg/dL), normoglycemic (>70 and <150 mg/dL), and hyperglycemic (>= 150 mg/dL) values accurately predicted by the model; 9,405 data points were analyzed. The models successfully predicted trends in glucose in the 5 test patients. Clark Error Grid Analysis indicated that 100.0% of predictions were clinically acceptable with 87.3% and 12.7% of predicted values falling within regions A and B of the error grid respectively. Overall model error (MAD%) was 9.0% with respect to actual continuous glucose modeling data. Our model successfully predicted 96.7% and 53.6% of the normo- and hyperglycemic values respectively. No hypoglycemic events occurred in these patients. Use of neural network models for real-time prediction of glucose in the surgical intensive care unit setting offers healthcare providers potentially useful information which could facilitate optimization of glycemic control, patient safety, and improved care. Similar models can be implemented across a wider scale of biomedical variables to offer real-time optimization, training, and adaptation that increase predictive accuracy and performance of therapies.	[Pappada, Scott M.; Cameron, Brent D.] Univ Toledo, Dept Bioengn, Toledo, OH 43606 USA; [Cameron, Brent D.; Bourey, Raymond E.] Univ Toledo, Ctr Diabet & Endocrine Res, Toledo, OH 43606 USA; [Tulman, David B.; Bergese, Sergio D.; Papadimos, Thomas J.] Ohio State Univ, Dept Anesthesiol, Wexner Med Ctr, Columbus, OH 43210 USA; [Bourey, Raymond E.] Univ Toledo, Coll Med, Div Endocrinol, Toledo, OH 43606 USA; [Borst, Marilyn J.; Olorunto, William] Univ Toledo, Dept Surg, Coll Med, Toledo, OH 43606 USA; [Evans, David C.; Stawicki, Stanislaw P. A.] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA	University of Toledo; University of Toledo; Ohio State University; University of Toledo; University of Toledo; Ohio State University	Papadimos, TJ (corresponding author), Ohio State Univ, Dept Anesthesiol, Wexner Med Ctr, Columbus, OH 43210 USA.	Thomas.Papadimos@osumc.edu	Evans, David/D-9015-2012	Bergese, Sergio/0000-0001-5641-5908; Evans, David/0000-0001-7366-3567; Papadimos, Thomas/0000-0002-4024-227X; Stawicki, Stanislaw/0000-0002-8893-6668	University of Toledo College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	University of Toledo College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funding was provided by the University of Toledo College of Medicine. The university had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Clarke William L, 2005, Diabetes Technol Ther, V7, P776, DOI 10.1089/dia.2005.7.776; CLARKE WL, 1987, DIABETES CARE, V10, P622, DOI 10.2337/diacare.10.5.622; Collier B, 2005, JPEN-PARENTER ENTER, V29, P353, DOI 10.1177/0148607105029005353; Dazzi D, 2001, J DIABETES COMPLICAT, V15, P80, DOI 10.1016/S1056-8727(00)00137-9; Doenst T, 2005, J THORAC CARDIOV SUR, V130, P1144, DOI 10.1016/j.jtcvs.2005.05.049; El-Jabali AK, 2005, BIOPROC BIOSYST ENG, V27, P75, DOI 10.1007/s00449-004-0363-3; Filipovsky J, 1996, J HYPERTENS, V14, P229, DOI 10.1097/00004872-199602000-00012; FOODY GM, 1995, INT J REMOTE SENS, V16, P1707, DOI 10.1080/01431169508954507; Furnary AP, 2006, SEMIN THORAC CARDIOV, V18, P339, DOI 10.1053/j.semtcvs.2007.01.004; Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4; Furnary AP, 1999, CIRCULATION, V100, P591; Gogou G, 2001, J Med Syst, V25, P119, DOI 10.1023/A:1005672631019; Goldberg Philip A, 2004, Diabetes Technol Ther, V6, P339, DOI 10.1089/152091504774198034; Holzinger U, 2010, DIABETES CARE, V33, P467, DOI 10.2337/dc09-1352; Jessen ME, 2003, J THORAC CARDIOV SUR, V125, P985, DOI 10.1067/mtc.2003.454; Jones KW, 2008, J DIABETES COMPLICAT, V22, P365, DOI 10.1016/j.jdiacomp.2007.05.006; Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231; Kovatchev BP, 2009, DIABETES TECHNOL THE, V11, P139, DOI 10.1089/dia.2008.0044; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lipshutz AKM, 2009, ANESTHESIOLOGY, V110, P408, DOI 10.1097/ALN.0b013e3181948a80; McShane MJ, 1999, ANAL CHIM ACTA, V388, P251, DOI 10.1016/S0003-2670(99)00080-X; McShane MJ, 1999, APPL SPECTROSC, V53, P1575, DOI 10.1366/0003702991946037; MOLNAR GW, 1974, JAMA-J AM MED ASSOC, V227, P916, DOI 10.1001/jama.227.8.916; Nomura M, 2000, ACTA DIABETOL, V37, P61, DOI 10.1007/s005920070020; Okamura F, 2000, METABOLISM, V49, P1255, DOI 10.1053/meta.2000.9515; Pappada SM, 2011, DIABETES TECHNOL THE, V13, P135, DOI 10.1089/dia.2010.0104; Pappada SM, 2010, PATIENT SAF SURG, V4, DOI 10.1186/1754-9493-4-15; Pappada SM, 2008, J DIABETES SCI TECHN, V2, P793; Pappada SM, 2010, THESIS U TOLEDO OHIO; Perez-Gandia C, 2010, DIABETES TECHNOL THE, V12, P81, DOI 10.1089/dia.2009.0076; Renner G, 2003, COMPUT AIDED DESIGN, V35, P709, DOI 10.1016/S0010-4485(03)00003-4; Riazi A, 2004, DIABETES RES CLIN PR, V66, P237, DOI 10.1016/j.diabres.2004.04.001; Schlotthauer G, 2006, MED ENG PHYS, V28, P240, DOI 10.1016/j.medengphy.2005.04.009; Smith SM, 2007, DIABETES CARE, V30, P2503, DOI 10.2337/dc07-0865; Stawicki S P A, 2011, Int J Crit Illn Inj Sci, V1, P5; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Tresp V, 1999, IEEE T NEURAL NETWOR, V10, P1204, DOI 10.1109/72.788659; Trief PM, 1999, DIABETES CARE, V22, P569, DOI 10.2337/diacare.22.4.569; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716	43	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69475	10.1371/journal.pone.0069475	http://dx.doi.org/10.1371/journal.pone.0069475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894489	gold, Green Published, Green Submitted			2022-12-25	WOS:000322391400060
J	Lum, MA; Balaburski, GM; Murphy, ME; Black, AR; Black, JD				Lum, Michelle A.; Balaburski, Gregor M.; Murphy, Maureen E.; Black, Adrian R.; Black, Jennifer D.			Heat Shock Proteins Regulate Activation-induced Proteasomal Degradation of the Mature Phosphorylated Form of Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TURN MOTIF PHOSPHORYLATION; SMALL-MOLECULE INHIBITOR; INDUCED DOWN-REGULATION; PKC-ALPHA; PERMISSIVE ACTIVATION; MULTIDRUG-RESISTANT; IN-VIVO; HSP70; DEPHOSPHORYLATION; AKT	Although alterations in stimulus-induced degradation of PKC have been implicated in disease, mechanistic understanding of this process remains limited. Evidence supports the existence of both proteasomal and lysosomal mechanisms of PKC processing. An established pathway involves rate-limiting priming site dephosphorylation of the activated enzyme and proteasomal clearance of the dephosphorylated protein. However, here we show that agonists promote down-regulation of endogenous PKC alpha with minimal accumulation of a nonphosphorylated species in multiple cell types. Furthermore, proteasome and lysosome inhibitors predominantly protect fully phosphorylated PKC alpha, pointing to this form as a substrate for degradation. Failure to detect substantive dephosphorylation of activated PKC alpha was not due to rephosphorylation because inhibition of Hsp70/Hsc70, which is required for re-priming, had only a minor effect on agonist-induced accumulation of nonphosphorylated protein. Thus, PKC degradation can occur in the absence of dephosphorylation. Further analysis revealed novel functions for Hsp70/Hsc70 and Hsp90 in the control of agonist-induced PKC alpha processing. These chaperones help to maintain phosphorylation of activated PKC alpha but have opposing effects on degradation of the phosphorylated protein; Hsp90 is protective, whereas Hsp70/Hsc70 activity is required for proteasomal processing of this species. Notably, down-regulation of nonphosphorylated PKC alpha shows little Hsp70/Hsc70 dependence, arguing that phosphorylated and nonphosphorylated species are differentially targeted for proteasomal degradation. Finally, lysosomal processing of activated PKC alpha is not regulated by phosphorylation or Hsps. Collectively, these data demonstrate that phosphorylated PKC alpha is a direct target for agonist-induced proteasomal degradation via an Hsp-regulated mechanism, and highlight the existence of a novel pathway of PKC desensitization in cells.	[Lum, Michelle A.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Lum, Michelle A.; Black, Adrian R.; Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Balaburski, Gregor M.; Murphy, Maureen E.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Nebraska System; University of Nebraska Medical Center; Roswell Park Cancer Institute; The Wistar Institute	Black, JD (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	jennifer.black@unmc.edu		Murphy, Maureen/0000-0001-7644-7296	National Institutes of Health [DK60632, DK54909]; Cancer Center Grants [CA16056, CA036727]; Head and Neck Cancer Keystone at the Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE [P30CA036727, P01CA114046, R01CA139319, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060632, R56DK060632, R01DK054909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Grants; Head and Neck Cancer Keystone at the Fox Chase Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60632 (to J. D. B.) and DK54909 (to J. D. B.), and Cancer Center Grants CA16056 and CA036727. This work was also supported by the Head and Neck Cancer Keystone at the Fox Chase Cancer Center (to G. M. B.).	Abrahamsen H, 2012, J BIOL CHEM, V287, P13262, DOI 10.1074/jbc.M112.349753; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Balaburski G., 2012, AACR ANN M; Balaburski GM, 2013, MOL CANCER RES, V11, P219, DOI 10.1158/1541-7786.MCR-12-0547-T; Basu A, 2010, PROTEIN KINASE C IN CANCER SIGNALING AND THERAPY, P409, DOI 10.1007/978-1-60761-543-9_21; Black A R, 1991, Methods Achiev Exp Pathol, V15, P126; Black JD, 2001, GASTROENTEROLOGY, V120, P1868, DOI 10.1053/gast.2001.25287; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; BORNER C, 1989, J BIOL CHEM, V264, P13902; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Carmena D, 2007, BIOCHEM SOC T, V35, P1043, DOI 10.1042/BST0351043; CAZAUBON S, 1994, BIOCHEM J, V301, P443, DOI 10.1042/bj3010443; CAZAUBON SM, 1993, J BIOL CHEM, V268, P17559; Chan TO, 2012, CELL CYCLE, V11, P475, DOI 10.4161/cc.11.3.19059; Chiosis G, 2003, MOL CANCER THER, V2, P123; CloudHeflin BA, 1996, EUR J BIOCHEM, V239, P796, DOI 10.1111/j.1432-1033.1996.0796u.x; Corbett A, 2012, EXPERT REV NEUROTHER, V12, P535, DOI [10.1586/ern.12.43, 10.1586/ERN.12.43]; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Faghiri Z, 2006, INVEST OPHTH VIS SCI, V47, P397, DOI 10.1167/iovs.05-0290; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Favit A, 1998, P NATL ACAD SCI USA, V95, P5562, DOI 10.1073/pnas.95.10.5562; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; Fiszer-Kierzkowska A, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-27; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2006, J BIOL CHEM, V281, P32461, DOI 10.1074/jbc.M604076200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gould CM, 2011, J BIOL CHEM, V286, P28922, DOI 10.1074/jbc.M111.272526; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Grune T, 2011, FREE RADICAL BIO MED, V51, P1355, DOI 10.1016/j.freeradbiomed.2011.06.015; Guo W, 2011, CELL MOL LIFE SCI, V68, P475, DOI 10.1007/s00018-010-0459-7; Gysin S, 1996, EUR J BIOCHEM, V240, P747, DOI 10.1111/j.1432-1033.1996.0747h.x; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Huang H, 2004, BIOCHEM BIOPH RES CO, V316, P1002, DOI 10.1016/j.bbrc.2004.02.149; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Irie K, 2012, MED RES REV, V32, P518, DOI 10.1002/med.20220; Junoy B, 2002, ENDOCRINOLOGY, V143, P1386, DOI 10.1210/en.143.4.1386; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Lee HW, 1996, AM J PHYSIOL-CELL PH, V271, pC304, DOI 10.1152/ajpcell.1996.271.1.C304; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Lee HW, 1997, MOL PHARMACOL, V51, P439; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liao Y, 2010, AM J TRANSL RES, V2, P19; Ligeti E, 2012, ACTA PHYSIOL, V204, P469, DOI 10.1111/j.1748-1716.2012.02414.x; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Lum MA, 2013, J BIOL CHEM, V288, P13093, DOI 10.1074/jbc.M112.437061; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Mashukova A, 2011, MOL CELL BIOL, V31, P756, DOI 10.1128/MCB.00811-10; Mashukova A, 2009, J CELL SCI, V122, P2491, DOI 10.1242/jcs.046979; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; McKernan LN, 2012, ADV VIROL, V2012, DOI 10.1155/2012/805347; Melnikov S, 2009, CELL SIGNAL, V21, P1607, DOI 10.1016/j.cellsig.2009.06.007; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakamura M, 2006, BIOCHEM BIOPH RES CO, V351, P340, DOI 10.1016/j.bbrc.2006.09.163; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; OLIVIER AR, 1994, J BIOL CHEM, V269, P2758; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PEARS C, 1992, BIOCHEM J, V283, P515, DOI 10.1042/bj2830515; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Prevostel C, 2000, J CELL SCI, V113, P2575; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Srivastava J, 2002, BIOCHEM J, V368, P349, DOI 10.1042/BJ20020737; Srivastava J, 2002, FEBS LETT, V516, P265, DOI 10.1016/S0014-5793(02)02500-0; Su CH, 2011, CELL SIGNAL, V23, P1824, DOI 10.1016/j.cellsig.2011.06.018; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; WARD NE, 1991, CANCER LETT, V58, P189, DOI 10.1016/0304-3835(91)90099-4; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Zemskov EA, 2003, NEUROREPORT, V14, P1435, DOI 10.1097/00001756-200308060-00006; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	91	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27112	27127		10.1074/jbc.M112.437095	http://dx.doi.org/10.1074/jbc.M112.437095			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23900841	Green Published, hybrid			2022-12-25	WOS:000330597300011
J	Zeiger, W; Vetrivel, KS; Buggia-Prevot, V; Nguyen, PD; Wagner, SL; Villereal, ML; Thinakaran, G				Zeiger, William; Vetrivel, Kulandaivelu S.; Buggia-Prevot, Virginie; Nguyen, Phuong D.; Wagner, Steven L.; Villereal, Mitchel L.; Thinakaran, Gopal			Ca2+ Influx through Store-operated Ca2+ Channels Reduces Alzheimer Disease beta-Amyloid Peptide Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-AMINOETHOXYDIPHENYL BORATE 2-APB; PRECURSOR PROTEIN; CALCIUM-RELEASE; PRESENILIN; ENTRY; STIM1; FIBROBLASTS; INCREASE; REVEALS; SENSOR	Alzheimer disease (AD), the leading cause of dementia, is characterized by the accumulation of beta-amyloid peptides (A beta) in senile plaques in the brains of affected patients. Many cellular mechanisms are thought to play important roles in the development and progression of AD. Several lines of evidence point to the dysregulation of Ca2+ homeostasis as underlying aspects of AD pathogenesis. Moreover, direct roles in the regulation of Ca2+ homeostasis have been demonstrated for proteins encoded by familial AD-linked genes such as PSEN1, PSEN2, and APP, as well as A beta peptides. Whereas these studies support the hypothesis that disruption of Ca2+ homeostasis contributes to AD, it is difficult to disentangle the effects of familial AD-linked genes on A beta production from their effects on Ca2+ homeostasis. Here, we developed a system in which cellular Ca2+ homeostasis could be directly manipulated to study the effects on amyloid precursor protein metabolism and A beta production. We overexpressed stromal interaction molecule 1 (STIM1) and Orai1, the components of the store-operated Ca2+ entry pathway, to generate cells with constitutive and store depletion-induced Ca2+ entry. We found striking effects of Ca2+ entry induced by overex-pression of the constitutively active STIM1(D76A) mutant on amyloid precursor protein metabolism. Specifically, constitutive activation of Ca2+ entry by expression of STIM1D76A significantly reduced A beta secretion. Our results suggest that disruptions in Ca2+ homeostasis may influence AD pathogenesis directly through the modulation of A beta production.	[Zeiger, William; Vetrivel, Kulandaivelu S.; Buggia-Prevot, Virginie; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Zeiger, William; Vetrivel, Kulandaivelu S.; Buggia-Prevot, Virginie; Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Zeiger, William; Vetrivel, Kulandaivelu S.; Buggia-Prevot, Virginie; Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Villereal, Mitchel L.] Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA; [Nguyen, Phuong D.; Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of California System; University of California San Diego	Villereal, ML (corresponding author), Univ Chicago, Dept Pharmacol & Physiol Sci, Abbott 102,947 E 58th St, Chicago, IL 60637 USA.	mvillere@bsd.uchicago.edu; gopal@uchicago.edu	Zeiger, William/Z-4395-2019		 [S10OD010649]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS065660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019070, R01AG021495] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010649] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. S. Sisodia (University of Chicago) for the HEK-APP and HEK-APPswe cells. The YFP-STIM1 and YFP-STIM1-D76A expression vectors were a generous gift of T. Meyer (Stanford University). The Orai1<INF>myc</INF> cDNA was a generous gift of M. Prakriya (Northwestern University). Confocal imaging was performed at the Integrated Microscopy Core Facility at the University of Chicago (supported by Grant S10OD010649).	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Baba A, 2003, J NEUROSCI, V23, P7737; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Bouron A, 2005, DEV BRAIN RES, V159, P64, DOI 10.1016/j.devbrainres.2005.07.001; BUXBAUM JD, 1994, P NATL ACAD SCI USA, V91, P4489, DOI 10.1073/pnas.91.10.4489; Chatzistavraki M, 2013, J ALZHEIMERS DIS, V34, P407, DOI 10.3233/JAD-121768; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cho HJ, 2008, AGING CELL, V7, P137, DOI 10.1111/j.1474-9726.2007.00360.x; COLVIN RA, 1991, ANN NY ACAD SCI, V639, P325, DOI 10.1111/j.1749-6632.1991.tb17320.x; Coon AL, 1999, NEUROBIOL AGING, V20, P597, DOI 10.1016/S0197-4580(99)00068-8; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Deyts C, 2012, J NEUROSCI, V32, P1714, DOI 10.1523/JNEUROSCI.5433-11.2012; Gong P, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-87; Gong P, 2010, J BIOL CHEM, V285, P38042, DOI 10.1074/jbc.M110.132613; Green K. N., 2007, V45, P507; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hirashima N, 1996, NEUROBIOL AGING, V17, P549; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kloskowska E, 2008, NEUROSCI LETT, V436, P250, DOI 10.1016/j.neulet.2008.03.034; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Linde CI, 2011, AM J PHYSIOL-CELL PH, V300, pC1502, DOI 10.1152/ajpcell.00379.2010; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Meckler X, 2010, J NEUROSCI, V30, P16160, DOI 10.1523/JNEUROSCI.4436-10.2010; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; PETERSON C, 1986, P NATL ACAD SCI USA, V83, P7999, DOI 10.1073/pnas.83.20.7999; PETERSON C, 1988, NEUROBIOL AGING, V9, P261, DOI 10.1016/S0197-4580(88)80063-0; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; Querfurth HW, 1997, J NEUROCHEM, V69, P1580; Santos SF, 2011, NEUROBIOL AGING, V32, P2308, DOI 10.1016/j.neurobiolaging.2010.01.006; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Selkoe DJ, 2011, BIOL ALZHEIMER DIS; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stieren E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011992; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vetrivel KS, 2011, J BIOL CHEM, V286, P26166, DOI 10.1074/jbc.M111.260471; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Zeiger W, 2011, MOL CELL BIOL, V31, P3710, DOI 10.1128/MCB.05140-11; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	64	34	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26955	26966		10.1074/jbc.M113.473355	http://dx.doi.org/10.1074/jbc.M113.473355			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902769	Green Published, hybrid			2022-12-25	WOS:000330594500060
J	Odintsova, E; van Niel, G; Conjeaud, H; Raposo, G; Iwamoto, R; Mekada, E; Berditchevski, F				Odintsova, Elena; van Niel, Guillaume; Conjeaud, Helene; Raposo, Graca; Iwamoto, Ryo; Mekada, Eisuke; Berditchevski, Fedor			Metastasis Suppressor Tetraspanin CD82/KAI1 Regulates Ubiquitylation of Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CELL-SURFACE DYNAMICS; MEMBRANE-PROTEINS; EGF; INTEGRIN; CBL; ENDOCYTOSIS; TRAFFICKING; BINDING; MORPHOGENESIS	Ligand-induced ubiquitylation of EGF receptor (EGFR) is an important regulatory mechanism that controls endocytic trafficking of the receptor and its signaling potential. Here we report that tetraspanin CD82/KAI1 specifically suppresses ubiquitylation of EGFR after stimulation with heparin-binding EGF or amphiregulin and alters the rate of recruitment of the activated receptor to EEA1-positive endosomes. The suppressive effect of CD82 is dependent on the heparin-binding domain of the ligand. Deletion of the C-terminal cytoplasmic domain of CD82 (CD82 Delta C mutant) inhibits endocytic trafficking of the tetraspanin and compromises its activity toward heparin-binding EGF-activated EGFR. Reduced ubiquitylation of EGFR is accompanied by PKC-dependent increase in serine phosphorylation of c-Cbl in cells expressing elevated levels of CD82. Furthermore, phosphorylation of threonine 654 (PKC phosphorylation site) in the juxtamembrane domain of the receptor is considerably increased in CD82-expressing cells. These results describe previously unsuspected links between tetraspanin proteins and ubiquitylation of their molecular partners (e. g., EGFR). Our data identify CD82 as a new regulator of c-Cbl, which discriminatively controls the activity of this E3 ubiquitin ligase toward heparin-binding ligand-EGFR pairs. Taken together, these observations provide an important new insight into the modulatory role of CD82 in endocytic trafficking of EGF receptor.	[Odintsova, Elena; Berditchevski, Fedor] Univ Birmingham, Sch Canc Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [van Niel, Guillaume; Raposo, Graca] Inst Curie, Ctr Rech, F-75248 Paris, France; [van Niel, Guillaume; Raposo, Graca] CNRS, Unite Mixte Rech 144, F-75248 Paris, France; [Conjeaud, Helene] Univ Paris 07, UMR CNRS 7057, F-75205 Paris, France; [Iwamoto, Ryo; Mekada, Eisuke] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	University of Birmingham; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Osaka University	Odintsova, E (corresponding author), Univ Birmingham, Sch Canc Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.	e.odintsova@bham.ac.uk	van Niel, Guillaume/A-6585-2011; van Niel, Guillaume/HCI-8445-2022	van Niel, Guillaume/0000-0002-8651-9705; Mekada, Eisuke/0000-0001-8858-4781; Raposo, graca/0000-0001-9590-1298	Breast Cancer Campaign Grants [2008MaySP18, 2007PR22, 2003:712]; Grants-in-Aid for Scientific Research [24570212] Funding Source: KAKEN	Breast Cancer Campaign Grants; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Breast Cancer Campaign Grants 2008MaySP18, 2007PR22, and 2003:712 (to E. O. and F. B.).	Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F, 2001, J CELL SCI, V114, P4143; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Cotton CU, 2013, TRAFFIC, V14, P337, DOI 10.1111/tra.12032; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Danglot L, 2010, J CELL SCI, V123, P723, DOI 10.1242/jcs.062497; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fan TC, 2007, TRAFFIC, V8, P1778, DOI 10.1111/j.1600-0854.2007.00650.x; Forsten-Williams K, 2008, ANN BIOMED ENG, V36, P2134, DOI 10.1007/s10439-008-9575-z; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; He B, 2005, J BIOL CHEM, V280, P3346, DOI 10.1074/jbc.M406680200; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; Iwamoto R, 2010, DEVELOPMENT, V137, P2205, DOI 10.1242/dev.048926; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; Kleijmeer Monique J., 1996, Methods (Orlando), V10, P191, DOI 10.1006/meth.1996.0095; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Melander F, 2004, BIOCHEM BIOPH RES CO, V317, P1000, DOI 10.1016/j.bbrc.2004.03.147; Miranti CK, 2009, CELL SIGNAL, V21, P196, DOI 10.1016/j.cellsig.2008.08.023; Odintsova E, 2000, CURR BIOL, V10, P1009, DOI 10.1016/S0960-9822(00)00652-7; Odintsova E, 2006, BIOCHEM J, V400, P315, DOI 10.1042/BJ20060259; Pedraza-Alva G, 2001, J BIOL CHEM, V276, P729, DOI 10.1074/jbc.M008494200; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; SHEARER M, 1992, INT J CANCER, V51, P602, DOI 10.1002/ijc.2910510417; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Takahashi M, 2007, INT J CANCER, V121, P1919, DOI 10.1002/ijc.22887; Takazaki R, 2004, J BIOL CHEM, V279, P47335, DOI 10.1074/jbc.M408556200; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Tsai YC, 2011, FEBS LETT, V585, P3166, DOI 10.1016/j.febslet.2011.08.031; Vyas JM, 2007, J IMMUNOL, V178, P7199, DOI 10.4049/jimmunol.178.11.7199; Xu CF, 2009, FASEB J, V23, P3273, DOI 10.1096/fj.08-123414; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	44	46	47	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26323	26334		10.1074/jbc.M112.439380	http://dx.doi.org/10.1074/jbc.M112.439380			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897813	hybrid, Green Published			2022-12-25	WOS:000330623300061
J	Fukuzawa, T; Ishida, J; Kato, A; Ichinose, T; Ariestanti, DM; Takahashi, T; Ito, K; Abe, J; Suzuki, T; Wakana, S; Fukamizu, A; Nakamura, N; Hirose, S				Fukuzawa, Taku; Ishida, Junji; Kato, Akira; Ichinose, Taro; Ariestanti, Donna Maretta; Takahashi, Tomoya; Ito, Kunitoshi; Abe, Jumpei; Suzuki, Tomohiro; Wakana, Shigeharu; Fukamizu, Akiyoshi; Nakamura, Nobuhiro; Hirose, Shigehisa			Lung Surfactant Levels are Regulated by Ig-Hepta/GPR116 by Monitoring Surfactant Protein D	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PULMONARY SURFACTANT; COUPLED RECEPTOR; SIRP-ALPHA; IG-HEPTA; IN-VIVO; HOMEOSTASIS; MICE; MACROPHAGE; METABOLISM	Lung surfactant is a complex mixture of lipids and proteins, which is secreted from the alveolar type II epithelial cell and coats the surface of alveoli as a thin layer. It plays a crucial role in the prevention of alveolar collapse through its ability to reduce surface tension. Under normal conditions, surfactant homeostasis is maintained by balancing its release and the uptake by the type II cell for recycling and the internalization by alveolar macrophages for degradation. Little is known about how the surfactant pool is monitored and regulated. Here we show, by an analysis of gene-targeted mice exhibiting massive accumulation of surfactant, that Ig-Hepta/GPR116, an orphan receptor, is expressed on the type II cell and sensing the amount of surfactant by monitoring one of its protein components, surfactant protein D, and its deletion results in a pulmonary alveolar proteinosis and emphysema-like pathology. By a coexpression experiment with Sp-D and the extracellular region of Ig-Hepta/GPR116 followed by immunoprecipitation, we identified Sp-D as the ligand of Ig-Hepta/GPR116. Analyses of surfactant metabolism in Ig-Hepta(+/+) and Ig-Hepta(-/-) mice by using radioactive tracers indicated that the Ig-Hepta/GPR116 signaling system exerts attenuating effects on (i) balanced synthesis of surfactant lipids and proteins and (ii) surfactant secretion, and (iii) a stimulating effect on recycling (uptake) in response to elevated levels of Sp-D in alveolar space.	[Fukuzawa, Taku; Kato, Akira; Ichinose, Taro; Ariestanti, Donna Maretta; Takahashi, Tomoya; Ito, Kunitoshi; Abe, Jumpei; Nakamura, Nobuhiro; Hirose, Shigehisa] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan; [Ishida, Junji; Fukamizu, Akiyoshi] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan; [Suzuki, Tomohiro; Wakana, Shigeharu] RIKEN BioResource Ctr, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki, Japan; [Hirose, Shigehisa] Toin Univ Yokohama, Fac Biomed Engn, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology; University of Tsukuba; RIKEN; Toin University of Yokohama	Hirose, S (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan.	shirose@bio.titech.ac.jp	Kato, Akira/E-6328-2010; Nakamura, Nobuhiro/C-4265-2015	Kato, Akira/0000-0002-9083-1443; Nakamura, Nobuhiro/0000-0002-0249-2665	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [21026010, 24117707]; JSPS Research Fellowships for Young Scientists; JSPS [14104002]	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research on Priority Areas (21026010) and Innovative Areas (24117707), COE21 and GCOE Programs from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), JSPS Research Fellowships for Young Scientists, and JSPS Grants-in-Aid for Scientific Research (S, 14104002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2002, J BIOL CHEM, V277, P23391, DOI 10.1074/jbc.M110877200; Abe J, 1999, J BIOL CHEM, V274, P19957, DOI 10.1074/jbc.274.28.19957; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Botas C, 1998, P NATL ACAD SCI USA, V95, P11869, DOI 10.1073/pnas.95.20.11869; Bridges JP, 2013, AM J RESP C IN PRESS; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; CROUCH E, 1994, J BIOL CHEM, V269, P17311; Determann RM, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-6; Dong Q, 1998, AM J PHYSIOL-LUNG C, V274, pL97, DOI 10.1152/ajplung.1998.274.1.L97; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Fournier B, 2012, J BIOL CHEM, V287, P19386, DOI 10.1074/jbc.M111.324533; Fredriksson R, 2002, FEBS LETT, V531, P407, DOI 10.1016/S0014-5793(02)03574-3; Fukuzawa T, 2006, J BIOCHEM, V140, P445, DOI 10.1093/jb/mvj170; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; GOTO Y, 1995, LAB ANIM SCI, V45, P601; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Gurel O, 2001, AM J PHYSIOL-LUNG C, V280, pL1266, DOI 10.1152/ajplung.2001.280.6.L1266; HAWGOOD S, 1990, J CLIN INVEST, V86, P1, DOI 10.1172/JCI114670; Horowitz AD, 1997, AM J PHYSIOL-LUNG C, V273, pL468, DOI 10.1152/ajplung.1997.273.2.L468; Ichinose T, 2009, J PHYSIOL SCI, V59, P269; Ikegami M, 2000, AM J PHYSIOL-LUNG C, V278, pL75, DOI 10.1152/ajplung.2000.278.1.L75; Ikegami M, 2005, AM J PHYSIOL-LUNG C, V288, pL552, DOI 10.1152/ajplung.00142.2004; Ikegami M, 1996, AM J PHYSIOL-LUNG C, V270, pL650, DOI 10.1152/ajplung.1996.270.4.L650; Ikegami M, 2001, AM J PHYSIOL-LUNG C, V281, pL697, DOI 10.1152/ajplung.2001.281.3.L697; Ikegami M, 2000, AM J PHYSIOL-LUNG C, V279, pL468, DOI 10.1152/ajplung.2000.279.3.L468; Ikegami M, 2009, J APPL PHYSIOL, V106, P1545, DOI 10.1152/japplphysiol.91567.2008; JACOBS H, 1983, J BIOL CHEM, V258, P4156; Korfhagen TR, 1998, J BIOL CHEM, V273, P28438, DOI 10.1074/jbc.273.43.28438; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Nie T, 2012, FEBS LETT, V586, P3618, DOI 10.1016/j.febslet.2012.08.006; Promel S, 2012, DEV DYNAM, V241, P1591, DOI 10.1002/dvdy.23841; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Trapnell BC, 2002, ANNU REV PHYSIOL, V64, P775, DOI 10.1146/annurev.physiol.64.090601.113847; Uchida K, 2004, BLOOD, V103, P1089, DOI 10.1182/blood-2003-05-1565; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yang MY, 2013, CELL REP, V3, P1457, DOI 10.1016/j.celrep.2013.04.019; Yona S, 2010, ADV EXP MED BIOL, V706, P1, DOI 10.1007/978-1-4419-7913-1; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	42	51	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69451	10.1371/journal.pone.0069451	http://dx.doi.org/10.1371/journal.pone.0069451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922714	Green Submitted, Green Published, gold			2022-12-25	WOS:000323369700032
J	Kikkas, I; Mallone, R; Tubiana-Rufi, N; Chevenne, D; Carel, JC; Creminon, C; Volland, H; Boitard, C; Morel, N				Kikkas, Ingrid; Mallone, Roberto; Tubiana-Rufi, Nadia; Chevenne, Didier; Carel, Jean Claude; Creminon, Christophe; Volland, Herve; Boitard, Christian; Morel, Nathalie			A Simple and Fast Non-Radioactive Bridging Immunoassay for Insulin Autoantibodies	PLOS ONE			English	Article							ANTIBODY STANDARDIZATION PROGRAM; ASSAYS; ACETYLCHOLINESTERASE	Type 1 diabetes (T1D) is an autoimmune disease which results from the destruction of pancreatic beta cells. Autoantibodies directed against islet antigens are valuable diagnostic tools. Insulin autoantibodies (IAAs) are usually the first to appear and also the most difficult to detect amongst the four major islet autoantibodies. A non-radioactive IAA bridging ELISA was developed to this end. In this assay, one site of the IAAs from serum samples is bound to a hapten-labeled insulin (GC300-insulin), which is subsequently captured on anti-GC300 antibody-coated 96-well plates. The other site of the IAAs is bound to biotinylated insulin, allowing the complex to be detected by an enzyme-streptavidin conjugate. In the present study, 50 serum samples from patients with newly diagnosed T1D and 100 control sera from non-diabetic individuals were analyzed with our new assay and the results were correlated with an IAA radioimmunoassay (RIA). Using IAA bridging ELISA, IAAs were detected in 32 out of 50 T1D children, whereas with IAA RIA, 41 out of 50 children with newly diagnosed T1D were scored as positive. In conclusion, the IAA bridging ELISA could serve as an attractive approach for rapid and automated detection of IAAs in T1D patients for diagnostic purposes.	[Kikkas, Ingrid; Creminon, Christophe; Volland, Herve; Morel, Nathalie] Commisariat Energie Atom Saclay, Serv Pharmacol & Immunoanalyse, iBiTec S, Commisariat Energie Atom, Gif Sur Yvette, France; [Mallone, Roberto; Boitard, Christian] Cochin Inst, DeAR Lab Avenir, Inst Natl Sante & Rech Med, U1016, Paris, France; [Mallone, Roberto; Boitard, Christian] Paris Descartes Univ, Sorbonne Paris Cite, Fac Med, Paris, France; [Mallone, Roberto; Boitard, Christian] AP HP, Serv Diabetol, Paris, France; [Tubiana-Rufi, Nadia; Chevenne, Didier; Carel, Jean Claude] Univ Paris, Hop Robert Debre, F-75252 Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Morel, N (corresponding author), Commisariat Energie Atom Saclay, Serv Pharmacol & Immunoanalyse, iBiTec S, Commisariat Energie Atom, Gif Sur Yvette, France.	nathalie.morel@cea.fr	Morel, Nathalie/O-9012-2016; Carel, Jean-Claude/AAZ-7691-2020; Mallone, Roberto/H-4430-2013	Carel, Jean-Claude/0000-0002-0424-6767; Mallone, Roberto/0000-0002-9846-8861; BOITARD, Christian/0000-0003-3985-9405	Commisariat a l'Energie Atomique	Commisariat a l'Energie Atomique(French Atomic Energy Commission)	Ingrid Kikkas obtained a grant from the PhD programme of the Commisariat a l'Energie Atomique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach Peter, 2005, Curr Diab Rep, V5, P98, DOI 10.1007/s11892-005-0035-y; Attree O, 2007, J IMMUNOL METHODS, V325, P78, DOI 10.1016/j.jim.2007.06.003; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; Bourdage JS, 2005, J PHARMACEUT BIOMED, V39, P685, DOI 10.1016/j.jpba.2005.03.037; Carlsson J, 2008, BIOSENS BIOELECTRON, V24, P876, DOI 10.1016/j.bios.2008.07.018; Clave G, 2010, ORG BIOMOL CHEM, V8, P676, DOI 10.1039/b920193a; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GRASSI J, 1989, J IMMUNOL METHODS, V123, P193, DOI 10.1016/0022-1759(89)90223-8; Khreich N, 2009, TOXICON, V53, P551, DOI 10.1016/j.toxicon.2008.12.021; Liu E, 2007, CLIN IMMUNOL, V125, P120, DOI 10.1016/j.clim.2007.08.005; Lo B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-203; Mire-Sluis AR, 2000, DIABETOLOGIA, V43, P1282, DOI 10.1007/s001250051524; Morel N, 2012, APPL ENVIRON MICROB, V78, P6491, DOI 10.1128/AEM.01282-12; Numata S, 2012, CLIN BIOCH; Schlosser M, 2010, DIABETOLOGIA, V53, P2611, DOI 10.1007/s00125-010-1915-5; Torn C, 2008, DIABETOLOGIA, V51, P846, DOI 10.1007/s00125-008-0967-2; Yu LP, 2012, DIABETES, V61, P179, DOI 10.2337/db11-0670; Yu LP, 2010, J IMMUNOL METHODS, V353, P20, DOI 10.1016/j.jim.2009.12.004	18	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69021	10.1371/journal.pone.0069021	http://dx.doi.org/10.1371/journal.pone.0069021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922678	gold, Green Published, Green Submitted			2022-12-25	WOS:000323369700018
J	Ninkovic, V; Dahlin, I; Vucetic, A; Petrovic-Obradovic, O; Glinwood, R; Webster, B				Ninkovic, Velemir; Dahlin, Iris; Vucetic, Andja; Petrovic-Obradovic, Olivera; Glinwood, Robert; Webster, Ben			Volatile Exchange between Undamaged Plants - a New Mechanism Affecting Insect Orientation in Intercropping	PLOS ONE			English	Article							VEGETATIONAL DIVERSITY; DEFENSE RESPONSES; RESISTANCE; HOST; ENVIRONMENT; ACCEPTANCE; HERBIVORY; PESTS; KEY	Changes in plant volatile emission can be induced by exposure to volatiles from neighbouring insect-attacked plants. However, plants are also exposed to volatiles from unattacked neighbours, and the consequences of this have not been explored. We investigated whether volatile exchange between undamaged plants affects volatile emission and plant-insect interaction. Consistently greater quantities of two terpenoids were found in the headspace of potato previously exposed to volatiles from undamaged onion plants identified by mass spectrometry. Using live plants and synthetic blends mimicking exposed and unexposed potato, we tested the olfactory response of winged aphids, Myzus persicae. The altered potato volatile profile deterred aphids in laboratory experiments. Further, we show that growing potato together with onion in the field reduces the abundance of winged, host-seeking aphids. Our study broadens the ecological significance of the phenomenon; volatiles carry not only information on whether or not neighbouring plants are under attack, but also information on the emitter plants themselves. In this way responding plants could obtain information on whether the neighbouring plant is a competitive threat and can accordingly adjust their growth towards it. We interpret this as a response in the process of adaptation towards neighbouring plants. Furthermore, these physiological changes in the responding plants have significant ecological impact, as behaviour of aphids was affected. Since herbivore host plants are potentially under constant exposure to these volatiles, our study has major implications for the understanding of how mechanisms within plant communities affect insects. This knowledge could be used to improve plant protection and increase scientific understanding of communication between plants and its impact on other organisms.	[Ninkovic, Velemir; Dahlin, Iris; Glinwood, Robert; Webster, Ben] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Vucetic, Andja; Petrovic-Obradovic, Olivera] Univ Belgrade, Fac Agr, Zemun Belgrade, Serbia	Swedish University of Agricultural Sciences; University of Belgrade	Ninkovic, V (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	velemir.ninkovic@slu.se	Ninkovic, Velemir/E-7677-2011	Ninkovic, Velemir/0000-0001-9276-7169; Glinwood, Robert/0000-0001-5082-5076; Dahlin, Iris/0000-0003-0295-6826	Ministry of Education, Science and Technological Development of the Republic of Serbia [III 46008]; Swedish Foundation for Strategic Environmental Research (MISTRA) through the PlantComMistra programme	Ministry of Education, Science and Technological Development of the Republic of Serbia; Swedish Foundation for Strategic Environmental Research (MISTRA) through the PlantComMistra programme(Swedish Foundation for Strategic Research)	The study was financially supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Project No. III 46008- Development of integrated management of harmful organisms in plant production in order to overcome resistance and to improve food quality and safety) and by the Swedish Foundation for Strategic Environmental Research (MISTRA) through the PlantComMistra programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Arimura G, 2002, PLANT J, V29, P87, DOI 10.1046/j.1365-313x.2002.01198.x; Balding DJ, 2004, APPL LONGITUDINAL AN; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Broz AK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-115; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Dahlin I, 2013, J APPL ECOL, V50, P1281, DOI 10.1111/1365-2664.12115; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Degenhardt J, 2000, PLANTA, V210, P815, DOI 10.1007/s004250050684; Dicke M, 2001, BIOCHEM SYST ECOL, V29, P981, DOI 10.1016/S0305-1978(01)00045-X; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Finch S, 2012, ENTOMOL EXP APPL, V142, P87, DOI 10.1111/j.1570-7458.2011.01191.x; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Glinwood R, 2004, ECOL ENTOMOL, V29, P188, DOI 10.1111/j.0307-6946.2004.00582.x; Glinwood R, 2011, PHYTOCHEMISTRY, V72, P1683, DOI 10.1016/j.phytochem.2011.02.010; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Hassanali A, 2008, PHILOS T R SOC B, V363, P611, DOI 10.1098/rstb.2007.2173; Hegde M, 2011, J CHEM ECOL, V37, P741, DOI 10.1007/s10886-011-9980-x; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Himanen SJ, 2010, PLANT SIGNAL BEHAV, V5, P1234, DOI 10.4161/psb.5.10.12919; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Kegge W, 2010, TRENDS PLANT SCI, V15, P126, DOI 10.1016/j.tplants.2009.11.007; Kellner M, 2010, THEOR APPL GENET, V121, P1133, DOI 10.1007/s00122-010-1377-7; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Keuskamp DH, 2010, PLANT SIGNAL BEHAV, V5, P655, DOI 10.4161/psb.5.6.11401; Konar Amitava, 2010, Journal of Entomological Research (New Delhi), V34, P151; Litell R, 2006, SAS MIXED MODELS; Mardon J, 2010, CHEM SENSES, V35, P309, DOI 10.1093/chemse/bjq021; Ninkovic V, 2003, J EXP BOT, V54, P1931, DOI 10.1093/jxb/erg192; Ninkovic V, 2002, ENTOMOL EXP APPL, V102, P177, DOI 10.1023/A:1015851430481; Ninkovic V, 2009, ENTOMOL EXP APPL, V133, P38, DOI 10.1111/j.1570-7458.2009.00900.x; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Pettersson J, 2007, APHIDS AS CROP PESTS, P87, DOI 10.1079/9780851998190.0087; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; POTTS MJ, 1991, ANN APPL BIOL, V119, P207, DOI 10.1111/j.1744-7348.1991.tb04859.x; Poveda K, 2012, J CHEM ECOL, V38, P1341, DOI 10.1007/s10886-012-0203-x; Randlkofer B, 2010, BASIC APPL ECOL, V11, P383, DOI 10.1016/j.baae.2010.03.003; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; RUSSELL EP, 1989, ENVIRON ENTOMOL, V18, P590, DOI 10.1093/ee/18.4.590; SAS Institute Inc, 2008, STAT AN SYST SAS STA; Smith Hugh Adam, 2000, American Entomologist, V46, P154; Soga K, 2005, FUNCT PLANT BIOL, V32, P175, DOI 10.1071/FP04145; Statsoft Inc, 2011, STATISTICA; Taylor L.R., 1984, HDB APHID IDENTIFICA; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Trewavas A, 2005, TRENDS PLANT SCI, V10, P413, DOI 10.1016/j.tplants.2005.07.005; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Webster B, 2012, PHYSIOL ENTOMOL, V37, P10, DOI 10.1111/j.1365-3032.2011.00791.x; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028	54	54	58	4	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69431	10.1371/journal.pone.0069431	http://dx.doi.org/10.1371/journal.pone.0069431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922710	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000323369700029
J	Peng, H; Gao, BL; Kong, LA; Yu, Q; Huang, WK; He, XF; Long, HB; Peng, DL				Peng, Huan; Gao, Bing-li; Kong, Ling-an; Yu, Qing; Huang, Wen-kun; He, Xu-feng; Long, Hai-bo; Peng, De-liang			Exploring the Host Parasitism of the Migratory Plant-Parasitic Nematode Ditylenchus destuctor by Expressed Sequence Tags Analysis	PLOS ONE			English	Article							SOYBEAN CYST-NEMATODE; ROOT-LESION NEMATODE; PINE WOOD NEMATODE; BURSAPHELENCHUS-XYLOPHILUS; DEVELOPMENTAL EXPRESSION; TRANSCRIPTOME ANALYSIS; GLOBODERA-PALLIDA; IDENTIFICATION; GENES; EXPANSIN	The potato rot nematode, Ditylenchus destructor, is a very destructive nematode pest on many agriculturally important crops worldwide, but the molecular characterization of its parasitism of plant has been limited. The effectors involved in nematode parasitism of plant for several sedentary endo-parasitic nematodes such as Heterodera glycines, Globodera rostochiensis and Meloidogyne incognita have been identified and extensively studied over the past two decades. Ditylenchus destructor, as a migratory plant parasitic nematode, has different feeding behavior, life cycle and host response. Comparing the transcriptome and parasitome among different types of plant-parasitic nematodes is the way to understand more fully the parasitic mechanism of plant nematodes. We undertook the approach of sequencing expressed sequence tags (ESTs) derived from a mixed stage cDNA library of D. destructor. This is the first study of D. destructor ESTs. A total of 9800 ESTs were grouped into 5008 clusters including 3606 singletons and 1402 multi-member contigs, representing a catalog of D. destructor genes. Implementing a bioinformatics' workflow, we found 1391 clusters have no match in the available gene database; 31 clusters only have similarities to genes identified from D. africanus, the most closely related species to D. destructor; 1991 clusters were annotated using Gene Ontology (GO); 1550 clusters were assigned enzyme commission (EC) numbers; and 1211 clusters were mapped to 181 KEGG biochemical pathways. 22 ESTs had similarities to reported nematode effectors. Interestedly, most of the effectors identified in this study are involved in host cell wall degradation or modification, such as 1,4-beta-glucanse, 1,3-beta-glucanse, pectate lyase, chitinases and expansin, or host defense suppression such as calreticulin, annexin and venom allergen-like protein. This result implies that the migratory plant-parasitic nematode D. destructor secrets similar effectors to those of sedentary plant nematodes. Finally we further characterized the two D. destructor expansin proteins.	[Peng, Huan; Kong, Ling-an; Huang, Wen-kun; He, Xu-feng; Long, Hai-bo; Peng, De-liang] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Biol Insect Pests & Plant Dis, Beijing 100193, Peoples R China; [Gao, Bing-li] Chinese Acad Sci, Huzhou Modern Agr Biotechnol Innovat Ctr, Shanghai Inst Biol Sci, Beijing 100864, Zhejiang, Peoples R China; [Yu, Qing] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada; [Long, Hai-bo] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Key Lab Pests Comprehens Governance Trop Crops, Danzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Agriculture & Agri Food Canada; Chinese Academy of Tropical Agricultural Sciences	Peng, DL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Biol Insect Pests & Plant Dis, Beijing 100193, Peoples R China.	dlpeng@ippcaas.cn			National Key Basic Research Program of China (973 Program) [2013CB127502]; Special Fund for Agro-scientific Research in the Public Interest [200903040]; National Natural Science Foundation of China [31201493]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work were supported by the National Key Basic Research Program of China (973 Program, 2013CB127502), the Special Fund for Agro-scientific Research in the Public Interest (number 200903040) and National Natural Science Foundation of China (number 31201493). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; [Anonymous], EPPO B, V38, P363; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; de Boer JM, 1998, J NEMATOL, V30, P309; De Boer JM, 2002, MOL PLANT PATHOL, V3, P261, DOI 10.1046/j.1364-3703.2002.00122.x; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Elling AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-58; Furlanetto C, 2005, NEMATOLOGY, V7, P95, DOI 10.1163/1568541054192180; Gao BL, 2004, MOL PLANT PATHOL, V5, P93, DOI 10.1111/J.1364-3703.2004.00209.X; Gao BL, 2002, INT J PARASITOL, V32, P1293, DOI 10.1016/S0020-7519(02)00110-8; Gao BL, 2001, MOL PLANT MICROBE IN, V14, P1247, DOI 10.1094/MPMI.2001.14.10.1247; Gheysen G, 2007, TRENDS BIOTECHNOL, V25, P89, DOI 10.1016/j.tibtech.2007.01.007; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Haegeman A, 2013, MOL PLANT PATHOL, V14, P379, DOI 10.1111/mpp.12014; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Haegeman A, 2010, J MOL EVOL, V70, P441, DOI 10.1007/s00239-010-9343-1; Haegeman A, 2009, MOL BIOCHEM PARASIT, V167, P32, DOI 10.1016/j.molbiopara.2009.04.004; Huang GZ, 2004, MOL PLANT PATHOL, V5, P217, DOI 10.1111/j.1364-3703.2004.00220.x; Huang WK, 2010, RUSS J NEMATOL, V18, P19; Jacob J, 2008, MOL GENET GENOMICS, V280, P1, DOI 10.1007/s00438-008-0340-7; Jaouannet M, 2013, MOL PLANT MICROBE IN, V26, P97, DOI 10.1094/MPMI-05-12-0130-R; Jaubert S, 2004, INT J PARASITOL, V34, P873, DOI 10.1016/j.ijpara.2004.02.008; JONES BL, 1988, PLANT DIS, V72, P453, DOI 10.1094/PD-72-0453F; Kang JS, 2012, INT J PARASITOL, V42, P63, DOI 10.1016/j.ijpara.2011.10.006; Kang MJ, 2010, GENES GENOM, V32, P553, DOI 10.1007/s13258-010-0065-y; Karim N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-525; Kikuchi T, 2005, BIOCHEM J, V389, P117, DOI 10.1042/BJ20042042; Kikuchi T, 2007, MOL BIOCHEM PARASIT, V155, P9, DOI 10.1016/j.molbiopara.2007.05.002; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kikuchi T, 2009, NEMATOLOGY, V11, P355, DOI 10.1163/156854109X446953; Kudla U, 2005, FEBS LETT, V579, P2451, DOI 10.1016/j.febslet.2005.03.047; Lilley CJ, 2012, PARASITOLOGY, V139, P630, DOI 10.1017/S0031182011002071; Long HB, 2012, NEMATOLOGY, V14, P571, DOI 10.1163/156854111X614674; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mc Donald A, 1995, NEMATOLOGY, V7, P647; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; Mitreva M, 2004, MOL BIOCHEM PARASIT, V137, P277, DOI 10.1016/j.molbiopara.2004.05.015; Mitreva Makedonka, 2009, V533, P153, DOI 10.1007/978-1-60327-136-3_8; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Palomares-Rius JE, 2012, MOL PLANT PATHOL, V13, P1120, DOI 10.1111/j.1364-3703.2012.00821.x; Patel N, 2010, J EXP BOT, V61, P235, DOI 10.1093/jxb/erp293; Peng HuAn, 2011, Journal of Agricultural Biotechnology, V19, P924; Peng Huan, 2009, Journal of Agricultural Biotechnology, V17, P1035; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Popeijus H, 2000, NATURE, V406, P36, DOI 10.1038/35017641; Popeijus M, 2000, NEMATOLOGY, V2, P567, DOI 10.1163/156854100509358; Qin L, 2004, NATURE, V427, P30, DOI 10.1038/427030a; Roze E, 2008, MOL PLANT PATHOL, V9, P1, DOI [10.1111/j.1364-3703.2007.00435.x, 10.1111/J.1364-3703.2007.00435.X]; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vanholme B, 2006, PARASITOL RES, V98, P414, DOI 10.1007/s00436-005-0029-3; Wang P, 2006, DEV BIOL, V293, P486, DOI 10.1016/j.ydbio.2005.10.011; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Young Ho Kim, 1995, Korean Journal of Plant Pathology, V11, P39; Yu Q, 2012, PLANT DIS, V96, P297, DOI 10.1094/PDIS-08-11-0697	60	23	28	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69579	10.1371/journal.pone.0069579	http://dx.doi.org/10.1371/journal.pone.0069579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922743	gold, Green Submitted, Green Published			2022-12-25	WOS:000323369700046
J	Servaas, MN; Riese, H; Renken, RJ; Marsman, JBC; Lambregs, J; Ormel, J; Aleman, A				Servaas, Michelle Nadine; Riese, Harriette; Renken, Remco Jan; Marsman, Jan-Bernard Cornelis; Lambregs, Johan; Ormel, Johan; Aleman, Andre			The Effect of Criticism on Functional Brain Connectivity and Associations with Neuroticism	PLOS ONE			English	Article							PREFRONTAL CORTEX; PSYCHOSOCIAL STRESS; FACIAL EXPRESSIONS; EMOTION REGULATION; SOCIAL COGNITION; FRONTAL-CORTEX; 5-FACTOR MODEL; PERSONALITY; SELF; DEPRESSION	Neuroticism is a robust personality trait that constitutes a risk factor for psychopathology, especially anxiety disorders and depression. High neurotic individuals tend to be more self-critical and are overly sensitive to criticism by others. Hence, we used a novel resting-state paradigm to investigate the effect of criticism on functional brain connectivity and associations with neuroticism. Forty-eight participants completed the NEO Personality Inventory Revised (NEO-PI-R) to assess neuroticism. Next, we recorded resting state functional magnetic resonance imaging (rsfMRI) during two sessions. We manipulated the second session before scanning by presenting three standardized critical remarks through headphones, in which the subject was urged to please lie still in the scanner. A seed-based functional connectivity method and subsequent clustering were used to analyse the resting state data. Based on the reviewed literature related to criticism, we selected brain regions associated with self-reflective processing and stress-regulation as regions of interest. The findings showed enhanced functional connectivity between the clustered seed regions and brain areas involved in emotion processing and social cognition during the processing of criticism. Concurrently, functional connectivity was reduced between these clusters and brain structures related to the default mode network and higher-order cognitive control. Furthermore, individuals scoring higher on neuroticism showed altered functional connectivity between the clustered seed regions and brain areas involved in the appraisal, expression and regulation of negative emotions. These results may suggest that the criticized person is attempting to understand the beliefs, perceptions and feelings of the critic in order to facilitate flexible and adaptive social behavior. Furthermore, multiple aspects of emotion processing were found to be affected in individuals scoring higher on neuroticism during the processing of criticism, which may increase their sensitivity to negative social-evaluation.	[Servaas, Michelle Nadine; Renken, Remco Jan; Marsman, Jan-Bernard Cornelis; Lambregs, Johan; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Neuroimaging Ctr, Groningen, Netherlands; [Riese, Harriette; Ormel, Johan] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Riese, Harriette] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Servaas, MN (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Neuroimaging Ctr, Groningen, Netherlands.	m.n.servaas@umcg.nl	Cuscó, Xavier Garcia/S-7576-2019; ormel, johan/AAC-5584-2019; Ormel, Johan/C-6094-2013; Riese, Harriëtte/E-7234-2012	Cuscó, Xavier Garcia/0000-0001-7199-6931; ormel, johan/0000-0002-5463-037X; Riese, Harriëtte/0000-0003-3661-3151; Servaas, Michelle/0000-0002-9222-7397; Renken, Remco Jan/0000-0002-7777-9484	Ministry of Education, Culture and Science of the Netherlands [609022]	Ministry of Education, Culture and Science of the Netherlands	The current study was supported by the Ministry of Education, Culture and Science of the Netherlands (609022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Akel A, 2011, NEUROPSYCHOLOGIA, V49, P2971, DOI 10.1016/j.neuropsychologia.2011.07.012; Alba-Ferrara L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028701; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Atique B, 2011, NEUROIMAGE, V55, P1899, DOI 10.1016/j.neuroimage.2010.12.036; Aziz-Zadeh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008759; Bezdek JC, 1981, PATTERN RECOGNITION, DOI 10.1007/978-1-4757-0450-1; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blair K, 2008, ARCH GEN PSYCHIAT, V65, P1176, DOI 10.1001/archpsyc.65.10.1176; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Bruhl AB, 2011, BRAIN IMAGING BEHAV, V5, P86, DOI 10.1007/s11682-011-9114-7; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Canli T, 2008, ANN NY ACAD SCI, V1129, P153, DOI 10.1196/annals.1417.022; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cauda F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013107; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chan SWY, 2008, NEUROPSYCHOLOGIA, V46, P2896, DOI 10.1016/j.neuropsychologia.2008.05.030; Chan SWY, 2009, BRIT J PSYCHIAT, V194, P139, DOI 10.1192/bjp.bp.107.047993; Clara IP, 2003, PERS INDIV DIFFER, V35, P91, DOI 10.1016/S0191-8869(02)00143-5; Coen SJ, 2011, GASTROENTEROLOGY, V141, P909, DOI 10.1053/j.gastro.2011.06.008; Costa P. T., 1989, NEO PI NEO FFI MAN S; COSTA PT, 1992, J PERS DISORD, V6, P343, DOI 10.1521/pedi.1992.6.4.343; Cremers HR, 2010, NEUROIMAGE, V49, P963, DOI 10.1016/j.neuroimage.2009.08.023; Dedovic K, 2009, NEUROIMAGE, V47, P864, DOI 10.1016/j.neuroimage.2009.05.074; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Ethofer T, 2012, CEREB CORTEX, V22, P191, DOI 10.1093/cercor/bhr113; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Haas BW, 2008, NEUROIMAGE, V42, P385, DOI 10.1016/j.neuroimage.2008.04.027; Harenski CL, 2009, COGN AFFECT BEHAV NE, V9, P1, DOI 10.3758/CABN.9.1.1; Hoekstra H., 1996, NEO PERSOONLIJKHEIDS; Hooley JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044412; Hooley JM, 2009, PSYCHIAT RES-NEUROIM, V171, P106, DOI 10.1016/j.pscychresns.2008.04.001; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Kumari V, 2007, BEHAV NEUROSCI, V121, P643, DOI 10.1037/0735-7044.121.4.643; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Leitman DI, 2010, FRONT HUM NEUROSCI, V26, P4; Liakakis G, 2011, BEHAV BRAIN RES, V225, P341, DOI 10.1016/j.bbr.2011.06.022; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; Northoff G, 2010, PROG NEUROBIOL, V92, P593, DOI 10.1016/j.pneurobio.2010.09.002; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ormel J, 2013, NEUROSCI BIOBEHAV R, V37, P59, DOI 10.1016/j.neubiorev.2012.09.004; Premkumar P, 2013, WORLD J BIOL PSYCHIA, V14, P57, DOI 10.3109/15622975.2011.604101; Pruessner JC, 2008, BIOL PSYCHIAT, V63, P234, DOI 10.1016/j.biopsych.2007.04.041; Pruessner JC, 2010, PSYCHONEUROENDOCRINO, V35, P179, DOI 10.1016/j.psyneuen.2009.02.016; Ray RD, 2012, NEUROSCI BIOBEHAV R, V36, P479, DOI 10.1016/j.neubiorev.2011.08.005; Sabbagh MA, 2004, BRAIN COGNITION, V55, P209, DOI 10.1016/j.bandc.2003.04.002; Spreng RN, 2012, BRAIN RES, V1428, P43, DOI 10.1016/j.brainres.2010.12.024; Spunt RP, 2012, NEUROIMAGE, V59, P3050, DOI 10.1016/j.neuroimage.2011.10.005; Suls J, 2005, J PERS, V73, P1485, DOI 10.1111/j.1467-6494.2005.00356.x; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; WATSON D, 1994, J ABNORM PSYCHOL, V103, P18, DOI 10.1037/0021-843X.103.1.18; Zadeh LA, 1977, FUZZY SET THEIR APPL; Zhu M, 2006, COMPUT STAT DATA AN, V51, P918, DOI 10.1016/j.csda.2005.09.010	63	23	25	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69606	10.1371/journal.pone.0069606	http://dx.doi.org/10.1371/journal.pone.0069606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922755	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900060
J	Yi, XB; Wang, L				Yi, Xiaobo; Wang, Li			Land Suitability Assessment on a Watershed of Loess Plateau Using the Analytic Hierarchy Process	PLOS ONE			English	Article							EROSION CRISSCROSS REGION; GULLY REGION; CHINA; FOREST; RESTORATION; VEGETATION; DESERTIFICATION; FISHERIES; IMPACTS; PROGRAM	In order to reduce soil erosion and desertification, the Sloping Land Conversion Program has been conducted in China for more than 15 years, and large areas of farmland have been converted to forest and grassland. However, this large-scale vegetation-restoration project has faced some key problems (e. g. soil drying) that have limited the successful development of the current ecological-recovery policy. Therefore, it is necessary to know about the land use, vegetation, and soil, and their inter-relationships in order to identify the suitability of vegetation restoration. This study was conducted at the watershed level in the ecologically vulnerable region of the Loess Plateau, to evaluate the land suitability using the analytic hierarchy process (AHP). The results showed that (1) the area unsuitable for crops accounted for 73.3% of the watershed, and the main factors restricting cropland development were soil physical properties and soil nutrients; (2) the area suitable for grassland was about 86.7% of the watershed, with the remaining 13.3% being unsuitable; (3) an area of 3.95 km(2), accounting for 66.7% of the watershed, was unsuitable for forest. Overall, the grassland was found to be the most suitable land-use to support the aims of the Sloping Land Conversion Program in the Liudaogou watershed. Under the constraints of soil water shortage and nutrient deficits, crops and forests were considered to be inappropriate land uses in the study area, especially on sloping land. When selecting species for re-vegetation, non-native grass species with high water requirements should be avoided so as to guarantee the sustainable development of grassland and effective ecological functioning. Our study provides local land managers and farmers with valuable information about the inappropriateness of growing trees in the study area along with some information on species selection for planting in the semi-arid area of the Loess Plateau.	[Yi, Xiaobo; Wang, Li] Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China; [Yi, Xiaobo; Wang, Li] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Wang, L (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China.	wangli5208@nwsuaf.edu.cn	Wang, Li/AAE-6919-2022		National Natural Science Foundation of China [51239009, 41271239]; CAS Action-plan for Western Development [KZCX2-XB3-13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Action-plan for Western Development	This work was financially supported by the National Natural Science Foundation of China (Nos. 51239009 and 41271239) (http://www.nsfc.gov.cn), and the CAS Action-plan for Western Development (KZCX2-XB3-13) (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayalew L, 2005, ENG GEOL, V81, P432, DOI 10.1016/j.enggeo.2005.08.004; Bai WJ, 2005, J ARID LAND RESOURCE, V19, P135; Bennett MT, 2008, ECOL ECON, V65, P699, DOI 10.1016/j.ecolecon.2007.09.017; Bremner J. M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P595; Cay T, 2013, LAND USE POLICY, V30, P541, DOI 10.1016/j.landusepol.2012.04.023; Chakraborty S, 2006, INT J ADV MANUF TECH, V28, P1237, DOI 10.1007/s00170-004-2467-y; Ding CR, 2003, LAND USE POLICY, V20, P109, DOI 10.1016/S0264-8377(02)00073-X; Fahey B, 1997, AGR FOREST METEOROL, V84, P69, DOI 10.1016/S0168-1923(96)02376-3; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Grant CD, 1987, AUSTR J SOIL RES, V27, P169; Hou QC, 1996, B SOIL WATER CONSERV, V16, P36; Hou QC, 1994, MEMOIR NISWC ACAD SI, V18, P136; Huo Z, 2008, PEDOSPHERE, V18, P674, DOI 10.1016/S1002-0160(08)60062-4; Jiang Na, 2007, Journal of Beijing Forestry University, V29, P134; Kurttila M., 2000, Forest Policy and Economics, V1, P41, DOI 10.1016/S1389-9341(99)00004-0; Li M, 2005, APPL RADIAT ISOTOPES, V62, P109, DOI 10.1016/j.apradiso.2004.06.005; Li W, 2008, FOREST ECOL MANAG, V255, P2467, DOI 10.1016/j.foreco.2008.01.006; Li WH, 2004, FOREST ECOL MANAG, V201, P33, DOI 10.1016/j.foreco.2004.06.010; Li YY, 2007, ACTA ECOLOGICA SINIC, V27, P1; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; LUK SH, 1993, CATENA SUPP, V24, P29; Mardle S, 2004, ENVIRON MANAGE, V33, P1, DOI 10.1007/s00267-003-3070-y; McVicar TR, 2007, FOREST ECOL MANAG, V251, P65, DOI 10.1016/j.foreco.2007.06.025; McVicar TR, 2010, FOREST ECOL MANAG, V259, P1277, DOI 10.1016/j.foreco.2009.05.002; Ng CWW, 1998, COMPUT GEOTECH, V22, P1, DOI 10.1016/S0266-352X(97)00036-0; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; Pascoe S, 2013, MAR POLICY, V37, P115, DOI 10.1016/j.marpol.2012.02.016; Pratt PE., 1965, METHOD SOIL ANAL 2, P1022, DOI DOI 10.2134/AGRONMONOGR9.2.C20; REID JB, 1982, J SOIL SCI, V33, P387, DOI 10.1111/j.1365-2389.1982.tb01775.x; Saaty T.L., 1980, ANAL HIERARCHY PROCE, DOI DOI 10.1016/0305-0483(87)90016-8; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; SFA, 2003, SLOP LAND CONV PROGR; Tang KL, 1998, CHINESE SCI BULL, V43, P200; Uchida E, 2005, LAND ECON, V81, P247, DOI 10.3368/le.81.2.247; Wang L, 2012, PLANT BIOSYST, V146, P226, DOI 10.1080/11263504.2012.709198; Wang L, 2006, ENVIRON SCI POLICY, V9, P675, DOI 10.1016/j.envsci.2006.08.003; Wang L, 2012, CLEAN-SOIL AIR WATER, V40, P7, DOI 10.1002/clen.201100367; Wang L, 2011, CATENA, V87, P90, DOI 10.1016/j.catena.2011.05.010; Wang Li, 2009, Journal of Beijing Forestry University, V31, P36; Wang XM, 2010, J ARID ENVIRON, V74, P13, DOI 10.1016/j.jaridenv.2009.08.001; Wang Xiao-li, 2007, Yingyong Shengtai Xuebao, V18, P1281; Wang XH, 2007, LAND USE POLICY, V24, P417, DOI 10.1016/j.landusepol.2006.05.005; Wei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040123; World Bank, 2001, CHIN AIR LAND WAT EN; Yang G, 1993, MEMOIR NW I SOIL WAT, V18, P106; Yang Rong-jin, 2004, Huanjing Kexue, V25, P37; Yang WenZhi, 2004, Acta Pedologica Sinica, V41, P1; Yin RS, 2012, ECOL ECON, V73, P56, DOI 10.1016/j.ecolecon.2011.11.003	48	15	15	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69498	10.1371/journal.pone.0069498	http://dx.doi.org/10.1371/journal.pone.0069498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922723	gold, Green Published, Green Submitted			2022-12-25	WOS:000322838900049
J	Gurr, W; Shaw, M; Herzog, RI; Li, YX; Sherwin, R				Gurr, Werner; Shaw, Margaret; Herzog, Raimund I.; Li, Yanxia; Sherwin, Robert			Vaccination with Single Chain Antigen Receptors for Islet-Derived Peptides Presented on I-A(g7) Delays Diabetes in NOD Mice by Inducing Anergy in Self-Reactive T-Cells	PLOS ONE			English	Article							HUMAN RECOMBINANT ANTIBODIES; MULTIPLE-SCLEROSIS; MONOCLONAL-ANTIBODY; PROTEIN-STRUCTURE; I-TASSER; SPECIFICITY; AUTOANTIGEN; COMPLEX; LIGAND; CLONE	To develop a vaccination approach for prevention of type 1 diabetes (T1D) that selectively attenuates self-reactive T-cells targeting specific autoantigens, we selected phage-displayed single chain antigen receptor libraries for clones binding to a complex of the NOD classII MHC I-A(g7) and epitopes derived from the islet autoantigen RegII. Libraries were generated from B-cell receptor repertoires of classII-mismatched mice immunized with RegII-pulsed NOD antigen presenting cells or from T-cell receptor repertoires in pancreatic lymph nodes of NOD mice. Both approaches yielded clones recognizing a RegII-derived epitope in the context of I-A(g7), which activated autoreactive CD4(+) T-cells. A receptor with different specificity was obtained by converting the BDC2.5 TCR into single chain form. B-but not T-cells from donors vaccinated with the clones transferred protection from diabetes to NOD-SCID recipients if the specificity of the diabetes inducer cell and the single chain receptor were matched. B-cells and antibodies from donors vaccinated with the BDC2.5 single chain receptor induced a state of profound anergy in T-cells of BDC2.5 TCR transgenic NOD recipients while B-cells from donors vaccinated with a single chain receptor specific for I-A(g7) RegII peptide complexes induced only partial non-responsiveness. Vaccination of normal NOD mice with receptors recognizing I-A(g7) RegII peptide complexes or with the BDC2.5 single chain receptor delayed onset of T1D. Thus anti-idiotypic vaccination can be successfully applied to T1D with vaccines either generated from self-reactive T-cell clones or derived from antigen receptor libraries.	[Gurr, Werner; Shaw, Margaret; Herzog, Raimund I.; Li, Yanxia; Sherwin, Robert] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University	Gurr, W (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	werner.gurr@yale.edu			Juvenile Diabetes Research Foundation (JDRF) [4-2007-1059]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK082618] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Juvenile Diabetes Research Foundation (JDRF), grant number 4-2007-1059 "JDRF Center for developing immune therapies in type 1 diabetes" (www.jdrf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2004, AUTOIMMUN REV, V3, P25, DOI 10.1016/S1568-9972(03)00060-0; Arden Bernhard, 1995, Immunogenetics, V42, P501; Aroeira LS, 2006, CLIN IMMUNOL, V119, P252, DOI 10.1016/j.clim.2006.01.003; Babad J, 2010, IMMUNOLOGY, V131, P459, DOI 10.1111/j.1365-2567.2010.03362.x; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Card KF, 2004, CANCER IMMUNOL IMMUN, V53, P345, DOI 10.1007/s00262-003-0450-3; Cohen CJ, 2002, CANCER RES, V62, P5835; Coscia M, 2004, EXPERT OPIN BIOL TH, V4, P959, DOI 10.1517/14712598.4.6.959; Denkberg G, 2003, J IMMUNOL, V171, P2197, DOI 10.4049/jimmunol.171.5.2197; Denkberg G, 2002, P NATL ACAD SCI USA, V99, P9421, DOI 10.1073/pnas.132285699; ELIAS D, 1991, P NATL ACAD SCI USA, V88, P3088, DOI 10.1073/pnas.88.8.3088; Epel M, 2002, CANCER IMMUNOL IMMUN, V51, P565, DOI 10.1007/s00262-002-0312-4; Fujii T, 2009, J AUTOIMMUN, V33, P125, DOI 10.1016/j.jaut.2009.06.001; Gurr W, 2002, DIABETES, V51, P339, DOI 10.2337/diabetes.51.2.339; Gurr W, 2007, DIABETES, V56, P34, DOI 10.2337/db06-0669; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Hellings N, 2004, AUTOIMMUN REV, V3, P267, DOI 10.1016/j.autrev.2003.10.002; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kay B. K, 1996, PHAGE DISPLAY PEPTID; Khandekar SS, 1997, J BIOL CHEM, V272, P32190, DOI 10.1074/jbc.272.51.32190; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Li ZG, 2005, LUPUS, V14, P884, DOI 10.1191/0961203305lu2239oa; MALBY RL, 1994, STRUCTURE, V2, P733, DOI 10.1016/S0969-2126(00)00074-5; McMahan RH, 2003, J BIOL CHEM, V278, P30961, DOI 10.1074/jbc.M300628200; Nikoopour E, 2011, J IMMUNOL, V186, P3831, DOI 10.4049/jimmunol.1003617; NOVOTNY J, 1991, P NATL ACAD SCI USA, V88, P8646, DOI 10.1073/pnas.88.19.8646; Noy R, 2005, EXPERT REV ANTICANC, V5, P523, DOI 10.1586/14737140.5.3.523; Polakova K, 2000, J IMMUNOL, V165, P5703, DOI 10.4049/jimmunol.165.10.5703; Quinn A, 1996, J AUTOIMMUN, V9, P365, DOI 10.1006/jaut.1996.0049; Rognan D, 2000, J COMPUT AID MOL DES, V14, P71, DOI 10.1023/A:1008116522274; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Silverman GJ, 2001, PHAGE DISPLAY LAB MA; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Steenbakkers PGA, 1999, IMMUNOLOGY, V96, P586; Stryhn A, 1996, P NATL ACAD SCI USA, V93, P10338, DOI 10.1073/pnas.93.19.10338; TOMONARI K, 1985, CELL IMMUNOL, V96, P147, DOI 10.1016/0008-8749(85)90347-8; Vandenbark AA, 2001, NEUROCHEM RES, V26, P713, DOI 10.1023/A:1010951706830; Volovitz I, 2010, J AUTOIMMUN, V35, P135, DOI 10.1016/j.jaut.2010.05.003; Weidanz JA, 1998, J IMMUNOL METHODS, V221, P59, DOI 10.1016/S0022-1759(98)00153-7; Yanez R, 2008, J IMMUNOTHER, V31, P310, DOI 10.1097/CJI.0b013e31816a8116; Yoshida K, 2002, INT IMMUNOL, V14, P1439, DOI 10.1093/intimm/dxf106; Zhang Jingwu, 2002, Expert Rev Vaccines, V1, P285, DOI 10.1586/14760584.1.3.285; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	46	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69464	10.1371/journal.pone.0069464	http://dx.doi.org/10.1371/journal.pone.0069464			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894487	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900075
J	Olsvik, PA; Hemre, GI; Waagbo, R				Olsvik, Pal A.; Hemre, Gro-Ingunn; Waagbo, Rune			Exploring Early Micronutrient Deficiencies in Rainbow Trout (Oncorhynchus mykiss) by Next-Generation Sequencing Technology - From Black Box to Functional Genomics	PLOS ONE			English	Article							SALMON SALMO-SALAR; ATLANTIC SALMON; OXIDATIVE STRESS; GENE-EXPRESSION; VITAMIN-E; GROWTH; HEALTH; DIETS	This work studies final nutritional status and transcriptional responses of rainbow trout (Oncorhynchus mykiss Walbaum 1792) (28 g) after a 10 week feeding experiment designed to elucidate the effect of adding a vitamin and mineral premix on growth, health, and nutritional endpoints. Juvenile fish were fed a either a diet supplemented with a vitamin and mineral premix (Diet S) or the same diet without premix supplementation (Diet U). The analyzed micronutrient composition of diets differed accordingly. Pooled livers from 15 fish from each dietary group were used to create suppression subtractive hybridization (SSH) cDNA libraries that were sequenced with 454 FLX GS Titanium Technology. In total 552 812 reads were sequenced from the two cDNA libraries. Ingenuity pathway analysis (IPA) was then used to characterize the hepatic transcriptome of the two dietary groups of rainbow trout. In the present communication we discuss how selected micronutrients may affect the transcriptome at suboptimal status by directly impacting the cellular metabolism, functions, and structures, and by introducing respective compensatory mechanisms. Processes related to lipid metabolism, peptide hydrolysis, oxygen transportation, and growth development were mostly affected. Considering the transcriptomics data relative to changes in nutritional status from the feeding study and the background phenotypic outcome of growth performance and gill histopathology, the outcome of the transcriptional profiling are suggested to be mainly related to suboptimal pantothenic acid and vitamin C nutrition.	[Olsvik, Pal A.; Hemre, Gro-Ingunn; Waagbo, Rune] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway		Olsvik, PA (corresponding author), Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway.	pal.olsvik@nifes.no	Olsvik, Pål A/B-8232-2012; Waagbø, Rune/M-4567-2019	Olsvik, Pål A/0000-0002-5641-9420; Waagbo, Rune/0000-0001-6075-3221	NIFES; EU	NIFES; EU(European Commission)	The biological material for this study was obtained in collaboration with BioMar AS (Trondheim, Norway) by Dr. Arne Guttvik and Dr. Kim Schon Ekmann (BioMar AS, Hirtshals, Denmark). This sideline project activity was financed by NIFES and partly connected to the EU-financed FP7 project ARRAINA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afacan NJ, 2012, MOL ASPECTS MED, V33, P14, DOI 10.1016/j.mam.2011.10.013; Albrektsen S., 1993, Fiskeridirektoratets Skrifter. Serie Ernaring, V6, P21; Albrektsen S, 1995, STUDIES ON VITAMIN B; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banni M, 2011, BIOMETALS, V24, P981, DOI 10.1007/s10534-011-9456-z; Barrows FT, 2008, AQUACULTURE, V283, P148, DOI 10.1016/j.aquaculture.2008.07.014; Bell JG, 2000, J NUTR, V130, P1800, DOI 10.1093/jn/130.7.1800; Berntssen MHG, 1999, AQUAT TOXICOL, V46, P87, DOI 10.1016/S0166-445X(98)00117-9; Bluthgen Nils, 2005, Genome Inform, V16, P106; CEN, 2005, COMITE EUROPEEN DE N; CEN, 2003, COMITE EUROPEEN DE N; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; GABAUDAN J, 2000, ENCY AQUACULTURE, P961; Gatlin III D.M., 2000, ENCY AQUACULTURE, P532; Halver John E., 2002, P61; Hamre K, 2011, AQUACULT NUTR, V17, P98, DOI 10.1111/j.1365-2095.2010.00806.x; HAMRE K, 1994, FISH PHYSIOL BIOCHEM, V12, P421, DOI 10.1007/BF00004306; HARDY RW, 2001, NUTR FISH HLTH, P131; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ikeda S, 1998, J NUTR, V128, P832, DOI 10.1093/jn/128.5.832; Julshamn K, 2001, J AOAC INT, V84, P1976; Julshamn K, 2007, J AOAC INT, V90, P844; Krossoy C, 2009, AQUACULT NUTR, V15, P638, DOI 10.1111/j.1365-2095.2008.00633.x; Kucukbay Z, 2006, AQUACULTURE, V257, P465, DOI 10.1016/j.aquaculture.2006.03.005; Maeland A, 1998, COMP BIOCHEM PHYS A, V121, P249, DOI 10.1016/S1095-6433(98)10125-3; Miller GW, 2012, J NUTR BIOCHEM, V23, P478, DOI 10.1016/j.jnutbio.2011.02.002; Moren M, 2011, LARVAL FISH NUTR, P117, DOI [10.1002/9780470959862.ch4, DOI 10.1002/9780470959862.CH4]; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; NRC, 2011, FISH NUTR, P1; Oliveros JC, 2007, VENNY AN INTERACTIVE; Olsvik PA, 2011, AQUACULT NUTR, V17, pE424, DOI 10.1111/j.1365-2095.2010.00778.x; Olsvik PA, 2011, FOOD CHEM TOXICOL, V49, P3258, DOI 10.1016/j.fct.2011.09.025; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Panserat S, 2010, AQUAC RES, V41, P751, DOI 10.1111/j.1365-2109.2009.02173.x; Sandnes K., 1991, Fiskeridirektoratets Skrifter Serie Ernaering, V4, P3; Spratlin J, 2007, CRIT REV ONCOL HEMAT, V61, P222, DOI 10.1016/j.critrevonc.2006.09.006; Tacchi L, 2011, FISH SHELLFISH IMMUN, V31, P704, DOI 10.1016/j.fsi.2011.02.023; Tacon AGJ, 2011, FAO FISHERIES AND AQ; Trichet VV, 2010, AQUAC RES, V41, P356, DOI 10.1111/j.1365-2109.2009.02374.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waagbo R, 2008, WOODHEAD PUBL FOOD S, P363, DOI 10.1533/9781845694620.2.363; Waagbo R, 1996, AQUACULT NUTR, V2, P65, DOI 10.1111/j.1365-2095.1996.tb00010.x; Waagbo R., 2006, Biology of nutrition in growing animals, P387, DOI 10.1016/S1877-1823(09)70100-6; Waagbo R, 2009, GENOME RES, P637; Zheng D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-548	46	15	16	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69461	10.1371/journal.pone.0069461	http://dx.doi.org/10.1371/journal.pone.0069461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894486	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900074
J	McDermott, SM; Davis, I				McDermott, Suzanne M.; Davis, Ilan			Drosophila Hephaestus/Polypyrimidine Tract Binding Protein Is Required for Dorso-Ventral Patterning and Regulation of Signalling between the Germline and Soma	PLOS ONE			English	Article							MESSENGER-RNA LOCALIZATION; ALPHA-LIKE PROTEIN; POLYPYRIMIDINE-TRACT; DEPENDENT TRANSLATION; BICAUDAL-C; CYTOSKELETAL ORGANIZATION; EPITHELIAL POLARITY; APICAL LOCALIZATION; ANTERIOR-POSTERIOR; ACTIN CYTOSKELETON	In the Drosophila oocyte, gurken (grk) mRNA encodes a secreted TGF-alpha signal that specifies the future embryonic dorsoventral axes by altering the fate of the surrounding epithelial follicle cells. We previously identified a number of RNA binding proteins that associate specifically with the 64 nucleotide grk localization signal, including the Drosophila orthologue of polypyrimidine tract-binding protein (PTB), Hephaestus (Heph). To test whether Heph is required for correct grk mRNA or protein function, we used immunoprecipitation to validate the association of Heph with grk mRNA and characterized the heph mutant phenotype. We found that Heph is a component of grk mRNP complexes but heph germline clones show that Heph is not required for grk mRNA localization. Instead, we identify a novel function for Heph in the germline and show that it is required for proper Grk protein localization. Furthermore, we show that Heph is required in the oocyte for the correct organization of the actin cytoskeleton and dorsal appendage morphogenesis. Our results highlight a requirement for an mRNA binding protein in the localization of Grk protein, which is independent of mRNA localization, and we propose that Heph is required in the germline for efficient Grk signalling to the somatic follicle cells during dorso-ventral patterning.	[McDermott, Suzanne M.; Davis, Ilan] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	McDermott, SM (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	suzanne.mcdermott@seattlebiomed.org; ilan.davis@bioch.ox.ac.uk	McDermott, Suzanne/P-6392-2019	McDermott, Suzanne/0000-0003-2158-1695; Davis, Ilan/0000-0002-5385-3053	Wellcome Trust [081858]; Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Senior Research Fellowship to ID (081858) and a Wellcome Trust PhD studentship to SMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; Babic I, 2009, MOL CELL BIOL, V29, P5564, DOI 10.1128/MCB.00590-09; Berg CA, 2005, TRENDS GENET, V21, P346, DOI 10.1016/j.tig.2005.04.010; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Caceres L, 2009, DEV BIOL, V326, P327, DOI 10.1016/j.ydbio.2008.11.030; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; CASTRILLON DH, 1993, GENETICS, V135, P489; Cheung LS, 2011, CURR OPIN GENET DEV, V21, P719, DOI 10.1016/j.gde.2011.07.009; Chicoine J, 2007, DEV CELL, V13, P691, DOI 10.1016/j.devcel.2007.10.002; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Condeelis J, 2005, BIOL CELL, V97, P97; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; Coutelis JB, 2007, DEVELOPMENT, V134, P1419, DOI 10.1242/dev.02821; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dansereau DA, 2002, DEVELOPMENT, V129, P5553, DOI 10.1242/dev.00153; Davis MB, 2002, MECH DEVELOP, V111, P143, DOI 10.1016/S0925-4773(01)00595-0; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Deng WM, 1997, DEVELOPMENT, V124, P4639; Engels B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033144; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Fred RG, 2006, CURR DIABETES REV, V2, P363, DOI 10.2174/157339906777950570; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; GAVIS ER, 1994, NATURE, V369, P315, DOI 10.1038/369315a0; Geng CY, 2006, MOL CELL BIOL, V26, P9508, DOI 10.1128/MCB.01136-06; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; Herpers B, 2004, MOL BIOL CELL, V15, P5306, DOI 10.1091/mbc.E04-05-0398; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Horne-Badovinac S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040008; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Januschke J, 2007, DEVELOPMENT, V134, P3419, DOI 10.1242/dev.008078; Jaramillo AM, 2008, J CELL SCI, V121, P887, DOI 10.1242/jcs.019091; KELLEY RL, 1993, GENE DEV, V7, P948, DOI 10.1101/gad.7.6.948; Kim DY, 2010, NUCLEIC ACIDS RES, V38, P7068, DOI 10.1093/nar/gkq569; Kim JH, 2004, MOL CELL BIOL, V24, P7878, DOI 10.1128/MCB.24.18.7878-7890.2004; Kim YK, 2000, J MOL BIOL, V304, P119, DOI 10.1006/jmbi.2000.4179; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; King ML, 2005, BIOL CELL, V97, P19; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kugler JM, 2009, DEV BIOL, V328, P160, DOI 10.1016/j.ydbio.2009.01.024; Kugler JM, 2009, FLY, V3, P15, DOI 10.4161/fly.3.1.7751; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lewis RA, 2008, MOL CELL BIOL, V28, P678, DOI 10.1128/MCB.00999-07; Li ZH, 2008, J CELL BIOL, V180, P31, DOI 10.1083/jcb.200707007; Lou H, 1999, MOL CELL BIOL, V19, P78; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; MacDougall N, 2003, DEV CELL, V4, P307, DOI 10.1016/S1534-5807(03)00058-3; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Matlin AJ, 2007, RNA, V13, P1214, DOI 10.1261/rna.219607; McDermott SM, 2012, BIOL OPEN, V1, P488, DOI 10.1242/bio.2012885; Meignin C, 2010, CURR OPIN CELL BIOL, V22, P112, DOI 10.1016/j.ceb.2009.11.011; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Norvell A, 1999, GENE DEV, V13, P864, DOI 10.1101/gad.13.7.864; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Ohno S, 2011, CELL CYCLE, V10, P3706, DOI 10.4161/cc.10.21.17903; Perez I, 1997, RNA, V3, P764; Pizette S, 2009, DEVELOPMENT, V136, P551, DOI 10.1242/dev.031104; RITTENHOUSE KR, 1995, DEVELOPMENT, V121, P3023; Robida M, 2010, P NATL ACAD SCI USA, V107, P12570, DOI 10.1073/pnas.1007935107; Robida MD, 2003, EMBO J, V22, P2924, DOI 10.1093/emboj/cdg301; Robinson DN, 1997, ANNU REV CELL DEV BI, V13, P147, DOI 10.1146/annurev.cellbio.13.1.147; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Saffman EE, 1998, MOL CELL BIOL, V18, P4855, DOI 10.1128/MCB.18.8.4855; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Snee MJ, 2009, DEV BIOL, V328, P434, DOI 10.1016/j.ydbio.2009.02.003; Southby J, 1999, MOL CELL BIOL, V19, P2699; Spellman R, 2005, BIOCHEM SOC T, V33, P457, DOI 10.1042/BST0330457; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; Tian AG, 2013, DEV BIOL, V373, P349, DOI 10.1016/j.ydbio.2012.10.029; Tran DH, 2003, DEVELOPMENT, V130, P6273, DOI 10.1242/dev.00854; Van De Bor V, 2005, DEV CELL, V9, P51, DOI 10.1016/j.devcel.2005.04.012; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Wang Y, 2008, MECH DEVELOP, V125, P142, DOI 10.1016/j.mod.2007.09.008; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Wesley CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021876; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Yakoby N, 2008, DEVELOPMENT, V135, P343, DOI 10.1242/dev.008920; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; Zheng S, 2012, NAT NEUROSCI, V15, P381, DOI 10.1038/nn.3026	95	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69978	10.1371/journal.pone.0069978	http://dx.doi.org/10.1371/journal.pone.0069978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894566	Green Submitted, Green Published, gold			2022-12-25	WOS:000325211000168
J	Hou, YH; Zhou, GS; Xu, ZZ; Liu, T; Zhang, XS				Hou, Yanhui; Zhou, Guangsheng; Xu, Zhenzhu; Liu, Tao; Zhang, Xinshi			Interactive Effects of Warming and Increased Precipitation on Community Structure and Composition in an Annual Forb Dominated Desert Steppe	PLOS ONE			English	Article							ABOVEGROUND BIOMASS PRODUCTION; SIMULATED CLIMATE-CHANGE; PLANT COMMUNITY; ECOSYSTEM CARBON; GRASSLAND ECOSYSTEMS; SPECIES-DIVERSITY; TALLGRASS PRAIRIE; TEMPERATE STEPPE; ARCTIC TUNDRA; RESPONSES	To better understand how warming, increased precipitation and their interactions influence community structure and composition, a field experiment simulating hydrothermal interactions was conducted at an annual forb dominated desert steppe in northern China over 2 years. Increased precipitation increased species richness while warming significantly decreased species richness, and their effects were additive rather than interactive. Although interannual variations in weather conditions may have a major affect on plant community composition on short term experiments, warming and precipitation treatments affected individual species and functional group composition. Warming caused C-4 grasses such as Cleistogenes squarrosa to increase while increased precipitation caused the proportions of non-perennial C-3 plants like Artemisia capillaris to decrease and perennial C-4 plants to increase.	[Hou, Yanhui; Zhou, Guangsheng; Xu, Zhenzhu; Liu, Tao; Zhang, Xinshi] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Hou, Yanhui; Liu, Tao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhou, Guangsheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Meteorological Sciences (CAMS)	Zhou, GS (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	gszhou@ibcas.ac.cn; xuzz@ibcas.ac.cn; xinshiz@yahoo.com	Chen, Yongsheng/D-3256-2011; Xu, Zhenzhu/L-1362-2015	Chen, Yongsheng/0000-0003-1448-8177; Xu, Zhenzhu/0000-0001-5246-8981	Chinese Academy of Sciences [2010CB951303, XDA05050408]; State Key Laboratory of Vegetation and Environmental Change [2011zyts09]	Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Vegetation and Environmental Change	This research was jointly supported by State Key Development Program of Basic Research (2010CB951303), Strategic Priority Research Program - Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences (XDA05050408) and State Key Laboratory of Vegetation and Environmental Change (2011zyts09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, PLANT ECOL, V182, P65, DOI 10.1007/s11258-005-9031-1; [Anonymous], 1996, REV 1996 IPCC GUID N, V2; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Arnone JA, 2011, J ECOL, V99, P678, DOI 10.1111/j.1365-2745.2011.01813.x; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Bates JD, 2006, J ARID ENVIRON, V64, P670, DOI 10.1016/j.jaridenv.2005.06.026; Bates JW, 2005, GLOBAL CHANGE BIOL, V11, P757, DOI [10.1111/j.1365-2486.2005.00953.x, 10.1111/J.1365-2486.2005.00953.X]; Bell JE, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR007908; Bloor JMG, 2010, ECOSYSTEMS, V13, P888, DOI 10.1007/s10021-010-9363-0; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chimner RA, 2010, ECOHYDROLOGY, V3, P284, DOI 10.1002/eco.106; De Valpine P, 2001, ECOLOGY, V82, P637, DOI 10.1890/0012-9658(2001)082[0637:PRTEWI]2.0.CO;2; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Engel EC, 2009, J PLANT ECOL, V2, P1, DOI 10.1093/jpe/rtn026; Fang JY, 2001, SCIENCE, V293, P1723, DOI 10.1126/science.293.5536.1723a; Fay PA, 2002, INT J PLANT SCI, V163, P549, DOI 10.1086/339718; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Gedan KB, 2009, ECOL LETT, V12, P842, DOI 10.1111/j.1461-0248.2009.01337.x; Grime JP, 2008, P NATL ACAD SCI USA, V105, P10028, DOI 10.1073/pnas.0711567105; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; [韩国栋 Han Guodong], 2002, [内蒙古大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Intramongolicae], V33, P83; HARTE J, 1995, SCIENCE, V267, P876, DOI 10.1126/science.267.5199.876; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Hoeppner SS, 2012, GLOBAL CHANGE BIOL, V18, P1754, DOI 10.1111/j.1365-2486.2011.02626.x; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Kang L, 2007, PHILOS T R SOC B, V362, P997, DOI 10.1098/rstb.2007.2029; Kardol P, 2010, GLOBAL CHANGE BIOL, V16, P2676, DOI 10.1111/j.1365-2486.2010.02162.x; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Klanderud K, 2005, J ECOL, V93, P127, DOI 10.1111/j.1365-2745.2004.00944.x; Klanderud K, 2005, ECOLOGY, V86, P2047, DOI 10.1890/04-1563; Klanderud K, 2007, OIKOS, V116, P1279, DOI 10.1111/j.2007.0030-1299.15906.x; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Lin DL, 2010, NEW PHYTOL, V188, P187, DOI 10.1111/j.1469-8137.2010.03347.x; Liston GE, 2002, GLOBAL CHANGE BIOL, V8, P17, DOI 10.1046/j.1354-1013.2001.00416.x; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; Morgan JA, 2007, P NATL ACAD SCI USA, V104, P14724, DOI 10.1073/pnas.0703427104; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Munson SM, 2012, GLOBAL CHANGE BIOL, V18, P1083, DOI 10.1111/j.1365-2486.2011.02598.x; Ni J, 2000, J ARID ENVIRON, V46, P313, DOI 10.1006/jare.2000.0667; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2008, J PLANT ECOL-UK, V1, P103, DOI 10.1093/jpe/rtn003; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Sherry RA, 2008, GLOBAL CHANGE BIOL, V14, P2923, DOI 10.1111/j.1365-2486.2008.01703.x; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sternberg M, 1999, PLANT ECOL, V143, P29, DOI 10.1023/A:1009812024996; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wan SQ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002315; Weltzin JF, 2003, GLOBAL CHANGE BIOL, V9, P141, DOI 10.1046/j.1365-2486.2003.00571.x; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xia JY, 2010, SCI TOTAL ENVIRON, V408, P2807, DOI 10.1016/j.scitotenv.2010.03.016; Xu ZZ, 2004, J ENVIRON SCI, V16, P666; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053; Zhou G, 2002, J VEG SCI, V13, P361, DOI 10.1111/j.1654-1103.2002.tb02060.x	65	27	33	9	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70114	10.1371/journal.pone.0070114	http://dx.doi.org/10.1371/journal.pone.0070114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894600	gold, Green Published, Green Submitted			2022-12-25	WOS:000322391400083
J	Lettner, T; Lang, R; Klausegger, A; Hainzl, S; Bauer, JW; Wally, V				Lettner, Thomas; Lang, Roland; Klausegger, Alfred; Hainzl, Stefan; Bauer, Johann W.; Wally, Verena			MMP-9 and CXCL8/IL-8 Are Potential Therapeutic Targets in Epidermolysis Bullosa Simplex	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; INFLAMMATORY CYTOKINES; FAMILY PROTEINS; CELL-MIGRATION; ACTIVATION; CDC42; KERATIN; INDUCTION; INTERLEUKIN-1; INVOLVEMENT	Epidermolysis bullosa refers to a group of genodermatoses that affects the integrity of epithelial layers, phenotypically resulting in severe skin blistering. Dowling-Meara, the major subtype of epidermolysis bullosa simplex, is inherited in an autosomal dominant manner and can be caused by mutations in either the keratin-5 (K5) or the keratin-14 (K14) gene. Currently, no therapeutic approach is known, and the main objective of this study was to identify novel therapeutic targets. We used microarray analysis, semi-quantitative real-time PCR, western blot and ELISA to identify differentially regulated genes in two K14 mutant cell lines carrying the mutations K14 R125P and K14 R125H, respectively. We found kallikrein-related peptidases and matrix metalloproteinases to be upregulated. We also found elevated expression of chemokines, and we observed deregulation of the Cdc42 pathway as well as aberrant expression of cytokeratins and junction proteins. We further demonstrated, that expression of these genes is dependent on interleukin-1 beta signaling. To evaluate these data in vivo we analysed the blister fluids of epidermolysis bullosa simplex patients vs. healthy controls and identified matrix metalloproteinase-9 and the chemokine CXCL8/IL-8 as potential therapeutic targets.	[Lettner, Thomas; Klausegger, Alfred; Hainzl, Stefan; Bauer, Johann W.; Wally, Verena] Div Expt Dermatol, Salzburg, Austria; [Lettner, Thomas; Klausegger, Alfred; Hainzl, Stefan; Bauer, Johann W.; Wally, Verena] EB House Austria, Salzburg, Austria; [Lang, Roland] Paracelsus Med Univ, Dept Dermatol, Salzburg, Austria	Paracelsus Private Medical University	Lettner, T (corresponding author), Div Expt Dermatol, Salzburg, Austria.	thomas.lettner@gmail.com	Klausegger, Alfred/R-2078-2019; Klausegger, Alfred/G-8001-2018	Klausegger, Alfred/0000-0001-6160-9934; Lettner, Thomas/0000-0002-8130-8394	DEBRA Austria	DEBRA Austria	This work was supported by DEBRA Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Cabral RM, 2012, J CELL SCI, V125, P2853, DOI 10.1242/jcs.084152; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Cirillo N, 2007, J CELL PHYSIOL, V212, P36, DOI 10.1002/jcp.20997; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; Darwich E, 2011, EUR J DERMATOL, V21, P966, DOI 10.1684/ejd.2011.1497; Davis W, 1999, BIOCHEM J, V338, P387, DOI 10.1042/0264-6021:3380387; Fine JD, 2008, LIFE WITH EPIDERMOLY; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Griffin MO, 2010, AM J PHYSIOL-CELL PH, V299, pC539, DOI 10.1152/ajpcell.00047.2010; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ijima Y, 2001, EUR J ORAL SCI, V109, P50, DOI 10.1034/j.1600-0722.2001.00939.x; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Kurisu S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-226; Lai Y, 2011, INT J BIOL SCI, V7, P782, DOI 10.7150/ijbs.7.782; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Liovic M, 2009, EXP CELL RES, V315, P2995, DOI 10.1016/j.yexcr.2009.07.013; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Lu H, 2007, J INVEST DERMATOL, V127, P2781, DOI 10.1038/sj.jid.5700918; Malkinson FD, 1999, ARCH DERMATOL, V135, P997, DOI 10.1001/archderm.135.8.997; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Morley SM, 2003, BRIT J DERMATOL, V149, P46, DOI 10.1046/j.1365-2133.2003.05493.x; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Puls A, 1999, J CELL SCI, V112, P2983; Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407; Russell D, 2010, J INVEST DERMATOL, V130, P671, DOI 10.1038/jid.2009.327; Schmidt E, 2001, CLIN EXP IMMUNOL, V124, P157, DOI 10.1046/j.1365-2249.2001.01503.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tsuruta D, 2011, J DERMATOL, V38, P1177, DOI 10.1111/j.1346-8138.2011.01302.x; Turchi L, 2003, J INVEST DERMATOL, V121, P1291, DOI 10.1111/j.1523-1747.2003.12627.x; Veien NK, 2000, ARCH DERMATOL, V136, P424, DOI 10.1001/archderm.136.3.424-a; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wagner M, 2012, EXP DERMATOL, V21, P111, DOI 10.1111/j.1600-0625.2011.01420.x; Wally V, 2013, J INVEST DERMATOL IN; Wally V, 2010, HUM MOL GENET, V19, P4715, DOI 10.1093/hmg/ddq405; Wan H, 2004, BRIT J DERMATOL, V150, P878, DOI 10.1111/j.1365-2133.2004.05996.x	43	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70123	10.1371/journal.pone.0070123	http://dx.doi.org/10.1371/journal.pone.0070123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894602	gold, Green Published, Green Submitted			2022-12-25	WOS:000322391400084
J	Rishavy, MA; Hallgren, KW; Wilson, LA; Usubalieva, A; Runge, KW; Berkner, KL				Rishavy, Mark A.; Hallgren, Kevin W.; Wilson, Lee A.; Usubalieva, Aisulu; Runge, Kurt W.; Berkner, Kathleen L.			The Vitamin K Oxidoreductase Is a Multimer That Efficiently Reduces Vitamin K Epoxide to Hydroquinone to Allow Vitamin K-dependent Protein Carboxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-IX; BACTERIAL HOMOLOG; ACTIVE-SITE; FACTOR-X; REDUCTASE; MECHANISM; CELLS; INHIBITION; WARFARIN; IDENTIFICATION	The vitamin K oxidoreductase (VKORC1) recycles vitamin K to support the activation of vitamin K-dependent (VKD) proteins, which have diverse functions that include hemostasis and calcification. VKD proteins are activated by Glu carboxylation, which depends upon the oxygenation of vitamin K hydroquinone (KH2). The vitamin K epoxide (KO) product is recycled by two reactions, i.e. KO reduction to vitamin K quinone (K) and then to KH2, and recent studies have called into question whether VKORC1 reduces K to KH2. Analysis in insect cells lacking endogenous carboxylation components showed that r-VKORC1 reduces KO to efficiently drive carboxylation, indicating KH2 production. Direct detection of the vitamin K reaction products is confounded by KH2 oxidation, and we therefore developed a new assay that stabilized KH2 and allowed quantitation. Purified VKORC1 analyzed in this assay showed efficient KO to KH2 reduction. Studies in 293 cells expressing tagged r-VKORC1 revealed that VKORC1 is a multimer, most likely a dimer. A monomer can only perform one reaction, and a dimer is therefore interesting in explaining how VKORC1 accomplishes both reactions. An inactive mutant (VKORC1(C132A/C135A)) was dominant negative in heterodimers with wild type VKORC1, resulting in decreased KO reduction in cells and carboxylation in vitro. The results are significant regarding human VKORC1 mutations, as warfarin-resistant patients have mutant and wild type VKORC1 alleles. A VKORC1 dimer indicates a mixed population of homodimers and heterodimers that may have different functional properties, and VKORC1 reduction may therefore be more complex in these patients than appreciated previously.	[Rishavy, Mark A.; Hallgren, Kevin W.; Wilson, Lee A.; Usubalieva, Aisulu; Berkner, Kathleen L.] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Runge, Kurt W.] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Berkner, KL (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,NB50, Cleveland, OH 44195 USA.	berknek@ccf.org	Runge, Kurt/AAW-9308-2021	Runge, Kurt/0000-0001-8492-0530; Berkner, Kathleen/0000-0001-8054-8081	National Institutes of Health [RO1 81093]; American Heart Association [SDG 0735317N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081093, R01HL055666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019960] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 81093. This work was also supported by Grant SDG 0735317N from the American Heart Association.	Au N, 2008, DRUG METAB REV, V40, P355, DOI 10.1080/03602530801952187 ; Berkner KL, 2008, VITAM HORM, V78, P131, DOI 10.1016/S0083-6729(07)00007-6; Berkner KL, 1997, METHOD ENZYMOL, V282, P313; Berkner KL, 2005, ANNU REV NUTR, V25, P127, DOI 10.1146/annurev.nutr.25.050304.092713; Berkner KL, 1998, P NATL ACAD SCI USA, V95, P466, DOI 10.1073/pnas.95.2.466; Chu PH, 2006, P NATL ACAD SCI USA, V103, P19308, DOI 10.1073/pnas.0609401103; Davidson KW, 1997, METHOD ENZYMOL, V282, P408; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; FASCO MJ, 1983, BIOCHEMISTRY-US, V22, P5655, DOI 10.1021/bi00293a031; FASCO MJ, 1982, BIOCHEM BIOPH RES CO, V104, P187, DOI 10.1016/0006-291X(82)91957-X; Fieser LF, 1941, J BIOL CHEM, V137, P659; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Hallgren KW, 2006, BIOCHEMISTRY-US, V45, P5587, DOI 10.1021/bi051986y; Hallgren KW, 2002, BIOCHEMISTRY-US, V41, P15045, DOI 10.1021/bi026016e; Jin DY, 2007, BIOCHEMISTRY-US, V46, P7279, DOI 10.1021/bi700527j; KNOBLOCH JE, 1987, J BIOL CHEM, V262, P15334; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; Rishavy MA, 2008, BIOCHEMISTRY-US, V47, P9836, DOI 10.1021/bi800296r; Rishavy MA, 2011, J BIOL CHEM, V286, P44821, DOI 10.1074/jbc.M111.249177; Rishavy MA, 2011, J BIOL CHEM, V286, P7267, DOI 10.1074/jbc.M110.172213; Rost S, 2005, THROMB HAEMOSTASIS, V94, P780, DOI 10.1160/TH05-02-0082; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; ROTH DA, 1993, P NATL ACAD SCI USA, V90, P8372, DOI 10.1073/pnas.90.18.8372; Singh AK, 2008, J BIOL CHEM, V283, P15762, DOI 10.1074/jbc.M800982200; Stenina O, 2001, BIOCHEMISTRY-US, V40, P10301, DOI 10.1021/bi0107039; Sugiura I, 1997, P NATL ACAD SCI USA, V94, P9069, DOI 10.1073/pnas.94.17.9069; Sun YM, 2005, BLOOD, V106, P3811, DOI 10.1182/blood-2005-06-2495; Tie JK, 2012, J BIOL CHEM, V287, P33945, DOI 10.1074/jbc.M112.402941; Tie JK, 2012, ANTIOXID REDOX SIGN, V16, P329, DOI 10.1089/ars.2011.4043; Tie JK, 2011, BLOOD, V117, P2967, DOI 10.1182/blood-2010-08-304303; Tie JK, 2005, J BIOL CHEM, V280, P16410, DOI 10.1074/jbc.M500765200; Wajih N, 2005, J BIOL CHEM, V280, P10540, DOI 10.1074/jbc.M413982200; Westhofen P, 2011, J BIOL CHEM, V286, P15085, DOI 10.1074/jbc.M110.210971; WHITLON DS, 1978, BIOCHEMISTRY-US, V17, P1371, DOI 10.1021/bi00601a003	35	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31556	31566		10.1074/jbc.M113.497297	http://dx.doi.org/10.1074/jbc.M113.497297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	23918929	hybrid, Green Published			2022-12-25	WOS:000330596200015
J	Havukainen, H; Munch, D; Baumann, A; Zhong, S; Halskau, O; Krogsgaard, M; Amdam, GV				Havukainen, Heli; Muench, Daniel; Baumann, Anne; Zhong, Shi; Halskau, Oyvind; Krogsgaard, Michelle; Amdam, Gro V.			Vitellogenin Recognizes Cell Damage through Membrane Binding and Shields Living Cells from Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPROTEIN INITIATING DOMAIN; LOW-DENSITY-LIPOPROTEIN; HONEY-BEE WORKERS; APOLIPOPROTEIN-B; APOPTOTIC CELLS; OXIDATIVE STRESS; STRUCTURAL BASIS; PLASMA-MEMBRANE; APIS-MELLIFERA; PROTEIN	Large lipid transfer proteins are involved in lipid transportation and diverse other molecular processes. These serum proteins include vitellogenins, which are egg yolk precursors and pathogen pattern recognition receptors, and apolipoprotein B, which is an anti-inflammatory cholesterol carrier. In the honey bee, vitellogenin acts as an antioxidant, and elevated vitellogenin titer is linked to prolonged life span in this animal. Here, we show that vitellogenin has cell and membrane binding activity and that it binds preferentially to dead and damaged cells. Vitellogenin binds directly to phosphatidylcholine liposomes and with higher affinity to liposomes containing phosphatidylserine, a lipid of the inner leaflet of cell membranes that is exposed in damaged cells. Vitellogenin binding to live cells, furthermore, improves cell oxidative stress tolerance. This study can shed more light on why large lipid transfer proteins have a well conserved alpha-helical domain, because we locate the lipid bilayer-binding ability of vitellogenin largely to this region. We suggest that recognition of cell damage and oxidation shield properties are two mechanisms that allow vitellogenin to extend honey bee life span.	[Havukainen, Heli; Muench, Daniel; Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Havukainen, Heli; Baumann, Anne] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Havukainen, Heli; Zhong, Shi; Krogsgaard, Michelle] NYU, Inst Canc, New York, NY 10016 USA; [Havukainen, Heli] Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland; [Havukainen, Heli; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Halskau, Oyvind] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway	Norwegian University of Life Sciences; University of Bergen; New York University; University of Helsinki; Arizona State University; Arizona State University-Tempe; University of Bergen	Havukainen, H (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, POB 5003, N-1432 As, Norway.	hohavukainen@gmail.com		Salmela, Heli/0000-0002-6917-2922; Halskau, Oyvind/0000-0003-2517-1060	National Institutes of Health, NIA [P01 AG22500]; Research Council of Norway [180504, 185306, 191699]; PEW Charitable Trust; Norwegian Cancer Society [58240001]; National Program for Research in Functional Genomics (FUGE); Norwegian Research Council; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Research Council of Norway(Research Council of Norway); PEW Charitable Trust; Norwegian Cancer Society(Norwegian Cancer Society); National Program for Research in Functional Genomics (FUGE); Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grant P01 AG22500. This work was also supported by Research Council of Norway Grants 180504, 185306, and 191699; the PEW Charitable Trust; and Norwegian Cancer Society Grant 58240001. The PROBE work was partly supported by the National Program for Research in Functional Genomics (FUGE) funded by the Norwegian Research Council.	Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Anderson TA, 1998, STRUCT FOLD DES, V6, P895, DOI 10.1016/S0969-2126(98)00091-4; Avarre JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-3; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; BERGER D, 1990, FEBS LETT, V277, P33, DOI 10.1016/0014-5793(90)80803-Q; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Campanella C, 2011, MOL REPROD DEV, V78, P161, DOI 10.1002/mrd.21282; Cha MK, 2000, BIOCHEMISTRY-US, V39, P6944, DOI 10.1021/bi000034j; Cho NH, 2009, IMMUNOLOGY, V128, pe479, DOI 10.1111/j.1365-2567.2008.03002.x; Cocca BA, 2002, J IMMUNOL, V169, P159, DOI 10.4049/jimmunol.169.1.159; Cocca BA, 2001, P NATL ACAD SCI USA, V98, P13826, DOI 10.1073/pnas.241510698; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Finn RN, 2007, BIOL REPROD, V76, P926, DOI 10.1095/biolreprod.106.059766; FISCHER HD, 1980, J BIOL CHEM, V255, P5069; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gasparovic Ana Cipak, 2013, Methods Mol Biol, V965, P283, DOI 10.1007/978-1-62703-239-1_19; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Havukainen H, 2012, J EXP BIOL, V215, P1837, DOI 10.1242/jeb.065623; Havukainen H, 2011, MOL ECOL, V20, P5111, DOI 10.1111/j.1365-294X.2011.05351.x; Havukainen H, 2011, J EXP BIOL, V214, P582, DOI 10.1242/jeb.048314; Hayward A, 2010, FEBS LETT, V584, P1273, DOI 10.1016/j.febslet.2010.02.056; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Kent CF, 2011, MOL ECOL, V20, P5226, DOI 10.1111/j.1365-294X.2011.05299.x; Kirankumar N, 1997, INSECT BIOCHEM MOLEC, V27, P671, DOI 10.1016/S0965-1748(97)00047-7; Korb LC, 1997, J IMMUNOL, V158, P4525; Ledford AS, 2006, J BIOL CHEM, V281, P8871, DOI 10.1074/jbc.M507657200; Ledford AS, 2009, J LIPID RES, V50, P108, DOI 10.1194/jlr.M800324-JLR200; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Litvack ML, 2010, INNATE IMMUN-LONDON, V16, P191, DOI 10.1177/1753425910369271; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Montaville P, 2002, J BIOL CHEM, V277, P24684, DOI 10.1074/jbc.M109595200; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; PODACK ER, 1991, ANNU REV IMMUNOL, V9, P129, DOI 10.1146/annurev.iy.09.040191.001021; RAAG R, 1988, J MOL BIOL, V200, P553, DOI 10.1016/0022-2836(88)90542-6; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seehuus SC, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5201; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; SIVARAM P, 1994, J BIOL CHEM, V269, P9409; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; Tait JF, 2004, ANAL BIOCHEM, V329, P112, DOI 10.1016/j.ab.2004.02.043; Thapa A, 2008, BIOTECHNIQUES, V44, P787, DOI 10.2144/000112728; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tomkin GH, 2010, EXPERT REV CARDIOVAS, V8, P1015, DOI [10.1586/erc.10.45, 10.1586/ERC.10.45]; Tong Z, 2010, IMMUNOBIOLOGY, V215, P898, DOI 10.1016/j.imbio.2009.10.001; Tseng DY, 2001, COMP BIOCHEM PHYS A, V129, P909, DOI 10.1016/S1095-6433(01)00355-5; Tsimikas S, 2011, CURR PHARM DESIGN, V17, P27, DOI 10.2174/138161211795049831; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Villalba JM, 1997, MOL ASPECTS MED, V18, pS7; Vreugdenhil ACE, 2001, J CLIN INVEST, V107, P225, DOI 10.1172/JCI10832; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Wickman G, 2012, CELL DEATH DIFFER, V19, P735, DOI 10.1038/cdd.2012.25; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	62	72	76	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28369	28381		10.1074/jbc.M113.465021	http://dx.doi.org/10.1074/jbc.M113.465021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23897804	Green Published, hybrid			2022-12-25	WOS:000330612800065
J	Juenemann, K; Schipper-Krom, S; Wiemhoefer, A; Kloss, A; Sanz, AS; Reits, EAJ				Juenemann, Katrin; Schipper-Krom, Sabine; Wiemhoefer, Anne; Kloss, Alexander; Sanz, Alicia Sanz; Reits, Eric A. J.			Expanded Polyglutamine-containing N-terminal Huntingtin Fragments Are Entirely Degraded by Mammalian Proteasomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUROMYCIN-SENSITIVE AMINOPEPTIDASE; NEURONAL INTRANUCLEAR INCLUSIONS; TRIPEPTIDYL-PEPTIDASE-II; MUTANT HUNTINGTIN; AGGREGATE FORMATION; REG-ALPHA; HALF-LIFE; NEUROLOGICAL PHENOTYPE; DEPENDENT PROTEOLYSIS; PROTEIN AGGREGATION	Huntington disease is a neurodegenerative disorder caused by an expanded polyglutamine (polyQ) repeat within the protein huntingtin (Htt). N-terminal fragments of the mutant Htt (mHtt) proteins containing the polyQ repeat are aggregation-prone and form intracellular inclusion bodies. Improving the clearance of mHtt fragments by intracellular degradation pathways is relevant to obviate toxic mHtt species and subsequent neurodegeneration. Because the proteasomal degradation pathway has been the subject of controversy regarding the processing of expanded polyQ repeats, we examined whether the proteasome can efficiently degrade Htt-exon1 with an expanded polyQ stretch both in neuronal cells and in vitro. Upon targeting mHtt-exon1 to the proteasome, rapid and complete clearance of mHtt-exon1 was observed. Proteasomal degradation of mHtt-exon1 was devoid of polyQ peptides as partial cleavage products by incomplete proteolysis, indicating that mammalian proteasomes are capable of efficiently degrading expanded polyQ sequences without an inhibitory effect on the proteasomal activity.	[Juenemann, Katrin; Schipper-Krom, Sabine; Wiemhoefer, Anne; Sanz, Alicia Sanz; Reits, Eric A. J.] Univ Amsterdam, Acad Med Ctr, Dept Cellbiol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Kloss, Alexander] Charite, Inst Biochem CCM, D-10117 Berlin, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Juenemann, K (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cellbiol & Histol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	k.junemann@amc.uva.nl; e.a.reits@amc.uva.nl			Dutch Organization for Scientific Research VIDI Grant NWO-Zon-MW [91796315]; Prinses Beatrix Fonds Grant [W.OR10-25]; Hersenstichting Grant [KS2010(1)-06]	Dutch Organization for Scientific Research VIDI Grant NWO-Zon-MW; Prinses Beatrix Fonds Grant; Hersenstichting Grant	This work was supported by Dutch Organization for Scientific Research VIDI Grant NWO-Zon-MW, 91796315; by Prinses Beatrix Fonds Grant W.OR10-25; and by Hersenstichting Grant KS2010(1)-06.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Bhutani N, 2007, EMBO J, V26, P1385, DOI 10.1038/sj.emboj.7601592; Bromme D, 1996, BIOCHEMISTRY-US, V35, P6706, DOI 10.1021/bi960092y; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Florea BI, 2010, CHEM BIOL, V17, P795, DOI 10.1016/j.chembiol.2010.05.027; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; JOHNSON GD, 1990, ARCH BIOCHEM BIOPHYS, V276, P305, DOI 10.1016/0003-9861(90)90724-D; Johnston SC, 1997, PROTEIN SCI, V6, P2469; Juenemann K, 2011, NEUROTOX RES, V20, P120, DOI 10.1007/s12640-010-9227-6; Kaytor MD, 2004, J NEUROCHEM, V89, P962, DOI 10.1111/j.1471-4159.2004.02376.x; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; LASPADA AR, 1994, ANN NEUROL, V36, P814, DOI 10.1002/ana.410360604; Li J, 2001, EMBO J, V20, P3359, DOI 10.1093/emboj/20.13.3359; Li X, 2010, HUM MOL GENET, V19, P2445, DOI 10.1093/hmg/ddq127; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masson P, 2009, EUKARYOT CELL, V8, P844, DOI 10.1128/EC.00165-08; Menendez-Benito V, 2005, METHOD ENZYMOL, V399, P490, DOI 10.1016/S0076-6879(05)99034-4; Menzies FM, 2010, HUM MOL GENET, V19, P4573, DOI 10.1093/hmg/ddq385; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mo XY, 1999, J IMMUNOL, V163, P5851; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Pratt G, 2008, J BIOL CHEM, V283, P12919, DOI 10.1074/jbc.M709347200; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Raspe M, 2009, J CELL SCI, V122, P3262, DOI 10.1242/jcs.045567; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Rockel B, 2012, BBA-PROTEINS PROTEOM, V1824, P237, DOI 10.1016/j.bbapap.2011.07.002; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ross CA, 1997, BRAIN PATHOL, V7, P1003, DOI 10.1111/j.1750-3639.1997.tb00898.x; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; York IA, 2006, J IMMUNOL, V177, P1434, DOI 10.4049/jimmunol.177.3.1434; Zhang ZG, 1999, BIOCHEMISTRY-US, V38, P5651, DOI 10.1021/bi990056+; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038; Zoeger A, 2006, CLIN CHEM, V52, P2079, DOI 10.1373/clinchem.2006.072496	82	51	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27068	27084		10.1074/jbc.M113.486076	http://dx.doi.org/10.1074/jbc.M113.486076			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908352	Green Published, hybrid			2022-12-25	WOS:000330597300008
J	Le Nours, J; Paton, AW; Byres, E; Troy, S; Herdman, BP; Johnson, MD; Paton, JC; Rossjohn, J; Beddoe, T				Le Nours, Jerome; Paton, Adrienne W.; Byres, Emma; Troy, Sally; Herdman, Brock P.; Johnson, Matthew D.; Paton, James C.; Rossjohn, Jamie; Beddoe, Travis			Structural Basis of Subtilase Cytotoxin SubAB Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-LABILE ENTEROTOXIN; ESCHERICHIA-COLI; HYBRID TOXINS; CHOLERA-TOXIN; CHAPERONE; SUBUNIT; TRAFFICKING; GENERATION	Pathogenic strains of Escherichia coli produce a number of toxins that belong to the AB(5) toxin family, which comprise a catalytic A-subunit that induces cellular dysfunction and a B-pentamer that recognizes host glycans. Although the molecular actions of many of the individual subunits of AB(5) toxins are well understood, how they self-associate and the effect of this association on cytotoxicity are poorly understood. Here we have solved the structure of the holo-SubAB toxin that, in contrast to other AB(5) toxins whose molecular targets are located in the cytosol, cleaves the endoplasmic reticulum chaperone BiP. SubA interacts with SubB in a similar manner to other AB(5) toxins via the A2 helix and a conserved disulfide bond that joins the A1 domain with the A2 helix. The structure revealed that the active site of SubA is not occluded by the B-pentamer, and the B-pentamer does not enhance or inhibit the activity of SubA. Structure-based sequence comparisons with other AB(5) toxin family members, combined with extensive mutagenesis studies on SubB, show how the hydrophobic patch on top of the B-pentamer plays a dominant role in binding the A-subunit. The structure of SubAB and the accompanying functional characterization of various mutants of SubAB provide a framework for understanding the important role of the B-pentamer in the assembly and the intracellular trafficking of this AB(5) toxin.	[Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Australian Res Council ARC Ctr Excellence Struct, Clayton, Vic 3800, Australia; [Le Nours, Jerome; Byres, Emma; Troy, Sally; Johnson, Matthew D.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic, Australia; [Paton, Adrienne W.; Herdman, Brock P.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; University of Adelaide; Cardiff University	Rossjohn, J (corresponding author), Monash Univ, Australian Res Council ARC Ctr Excellence Struct, Clayton, Vic 3800, Australia.	Jamie.Rossjohn@monash.edu; Travis.Beddoe@monash.edu	Rossjohn, Jamie/F-9032-2013; johnson, matthew/L-7626-2017; Beddoe, Travis/F-3415-2014	Rossjohn, Jamie/0000-0002-2020-7522; johnson, matthew/0000-0002-0808-3336; Beddoe, Travis/0000-0003-4550-2277; Le Nours, Jerome/0000-0002-2221-7636	National Health and Medical Research Council of Australia (NHMRC) [565526, 1002792]; Australian Research Council [DP1095420, DP120103178]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by Program Grant 565526 and Project Grant 1002792 from the National Health and Medical Research Council of Australia (NHMRC) and Discovery Grants DP1095420 and DP120103178 from the Australian Research Council.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Bricogne G, 2011, AUTO BUSTER VERSION; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chong DC, 2008, CELL MICROBIOL, V10, P795, DOI 10.1111/j.1462-5822.2007.01085.x; CONNELL TD, 1992, INFECT IMMUN, V60, P1653, DOI 10.1128/IAI.60.4.1653-1661.1992; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W., 2006, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan EK, 2000, CURR OPIN STRUC BIOL, V10, P680, DOI 10.1016/S0959-440X(00)00152-4; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Holst M, 2000, J COMPUT CHEM, V21, P1319, DOI 10.1002/1096-987X(20001130)21:15<1319::AID-JCC1>3.0.CO;2-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Madsen D., 2005, INDONESIA INTEGRATED; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okamoto K, 1998, J BACTERIOL, V180, P1368, DOI 10.1128/JB.180.6.1368-1374.1998; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rodighiero C, 1999, J BIOL CHEM, V274, P3962, DOI 10.1074/jbc.274.7.3962; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAKEDA Y, 1981, INFECT IMMUN, V34, P341, DOI 10.1128/IAI.34.2.341-346.1981; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Tinker JK, 2003, INFECT IMMUN, V71, P4093, DOI 10.1128/IAI.71.7.4093-4101.2003; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; vandenAkker F, 1996, STRUCTURE, V4, P665, DOI 10.1016/S0969-2126(96)00073-1; WEINSTEIN DL, 1989, INFECT IMMUN, V57, P3743, DOI 10.1128/IAI.57.12.3743-3750.1989; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	33	18	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27505	27516		10.1074/jbc.M113.462622	http://dx.doi.org/10.1074/jbc.M113.462622			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921389	hybrid, Green Published			2022-12-25	WOS:000330597300045
J	Tsushima, Y; Nishizawa, H; Tochino, Y; Nakatsuji, H; Sekimoto, R; Nagao, H; Shirakura, T; Kato, K; Imaizumi, K; Takahashi, H; Tamura, M; Maeda, N; Funahashi, T; Shimomura, I				Tsushima, Yu; Nishizawa, Hitoshi; Tochino, Yoshihiro; Nakatsuji, Hideaki; Sekimoto, Ryohei; Nagao, Hirofumi; Shirakura, Takashi; Kato, Kenta; Imaizumi, Keiichiro; Takahashi, Hiroyuki; Tamura, Mizuho; Maeda, Norikazu; Funahashi, Tohru; Shimomura, Iichiro			Uric Acid Secretion from Adipose Tissue and Its Increase in Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISCERAL FAT ACCUMULATION; XANTHINE-OXIDOREDUCTASE; METABOLIC SYNDROME; ENDOTHELIAL-CELLS; ADIPOCYTOKINE DYSREGULATION; INSULIN-RESISTANCE; OXIDATIVE STRESS; IN-VIVO; HYPOXIA; RAT	Obesity is often accompanied by hyperuricemia. However, purine metabolism in various tissues, especially regarding uric acid production, has not been fully elucidated. Here we report, using mouse models, that adipose tissue could produce and secrete uric acid through xanthine oxidoreductase (XOR) and that the production was enhanced in obesity. Plasma uric acid was elevated in obese mice and attenuated by administration of the XOR inhibitor febuxostat. Adipose tissue was one of major organs that had abundant expression and activities of XOR, and adipose tissues in obese mice had higher XOR activities than those in control mice. 3T3-L1 and mouse primary mature adipocytes produced and secreted uric acid into culture medium. The secretion was inhibited by febuxostat in a dose-dependent manner or by gene knockdown of XOR. Surgical ischemia in adipose tissue increased local uric acid production and secretion via XOR, with a subsequent increase in circulating uric acid levels. Uric acid secretion from whole adipose tissue was increased in obese mice, and uric acid secretion from 3T3-L1 adipocytes was increased under hypoxia. Our results suggest that purine catabolism in adipose tissue could be enhanced in obesity.	[Tsushima, Yu; Nishizawa, Hitoshi; Tochino, Yoshihiro; Nakatsuji, Hideaki; Sekimoto, Ryohei; Nagao, Hirofumi; Maeda, Norikazu; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan; [Tsushima, Yu; Shirakura, Takashi; Kato, Kenta; Takahashi, Hiroyuki; Tamura, Mizuho] Teijin Pharma Ltd, Teijin Inst Biomed Res, Hino, Tokyo 1918512, Japan; [Imaizumi, Keiichiro] Teijin Ltd, Kondo Lab, Hino, Tokyo 1918512, Japan; [Funahashi, Tohru] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Suita, Osaka 5650871, Japan	Osaka University; Teijin Pharma Limited; Teijin Limited; Osaka University	Nishizawa, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2-B5 Yamada Oka, Suita, Osaka 5650871, Japan.	hitoshin1127@endmet.med.osaka-u.ac.jp			Kowa Co. Ltd.;  [24591351];  [22590979];  [22126008]	Kowa Co. Ltd.; ; ; 	This work was supported in part by Grants-in-aid for Scientific Research (C) 24591351 (to H. N.) and 22590979 (to N. M.) and by Scientific Research on Innovative Areas Grant 22126008 (to T. F.). Tohru Funahashi is a member of the Department of Metabolism and Atherosclerosis, a sponsored course endowed by Kowa Co. Ltd. In this work, Osaka University's academia-industry collaboration policy positions the collaboration between Osaka University and Teijin Pharma Ltd.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; AOKI T, 1984, ANAL BIOCHEM, V143, P113, DOI 10.1016/0003-2697(84)90564-5; BECKMAN JS, 1989, FREE RADICAL BIO MED, V6, P607, DOI 10.1016/0891-5849(89)90068-3; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Coutinho TD, 2007, AM J HYPERTENS, V20, P83, DOI 10.1016/j.amjhyper.2006.06.015; DELEYN P, 1993, AM J PHYSIOL, V264, pL329, DOI 10.1152/ajplung.1993.264.4.L329; Evrard PA, 1996, PHARMACEUT RES, V13, P12, DOI 10.1023/A:1016056628685; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; FREDERICH RC, 1992, HYPERTENSION, V19, P339, DOI 10.1161/01.HYP.19.4.339; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Goossens GH, 2012, CURR OPIN CLIN NUTR, V15, P539, DOI 10.1097/MCO.0b013e328358fa87; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Hikita M, 2007, INTERNAL MED, V46, P1353, DOI 10.2169/internalmedicine.46.0045; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; IDSTROM JP, 1990, AM J PHYSIOL, V258, pH1668, DOI 10.1152/ajpheart.1990.258.6.H1668; KAMIIKE W, 1982, J BIOCHEM-TOKYO, V91, P1349, DOI 10.1093/oxfordjournals.jbchem.a133822; KATHER H, 1972, BIOCHEM J, V128, P1089, DOI 10.1042/bj1281089; KATHER H, 1990, J CLIN INVEST, V85, P106, DOI 10.1172/JCI114399; Kayyali US, 2001, J BIOL CHEM, V276, P14359, DOI 10.1074/jbc.M010100200; Kelley EE, 2006, FREE RADICAL BIO MED, V40, P952, DOI 10.1016/j.freeradbiomed.2005.11.008; Kim TH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-3; Kishida K, 2000, J BIOL CHEM, V275, P20896, DOI 10.1074/jbc.M001119200; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kurata A, 2006, KIDNEY INT, V70, P1717, DOI 10.1038/sj.ki.5001810; KUROSAKI M, 1995, BIOCHEM J, V306, P225, DOI 10.1042/bj3060225; LAZZARINO G, 1992, FREE RADICAL BIO MED, V13, P489, DOI 10.1016/0891-5849(92)90143-5; Leyva F, 1998, METABOLISM, V47, P657, DOI 10.1016/S0026-0495(98)90026-9; Lin Shi-Dou, 2006, J Chin Med Assoc, V69, P512; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Matsuura F, 1998, METABOLISM, V47, P929, DOI 10.1016/S0026-0495(98)90346-8; Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629, DOI 10.5551/jat.7922; Nakagawa Y, 2011, J ATHEROSCLER THROMB, V18, P240, DOI 10.5551/jat.6593; Nakatani T, 2002, J BIOL CHEM, V277, P9562, DOI 10.1074/jbc.M110132200; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Ohtsubo T, 2009, HYPERTENSION, V54, P868, DOI 10.1161/HYPERTENSIONAHA.109.135152; Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005; Rathmann W, 2007, EUR J EPIDEMIOL, V22, P439, DOI 10.1007/s10654-007-9132-3; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V294, pF710, DOI 10.1152/ajprenal.00454.2007; Sekimoto R, 2012, BIOCHEM BIOPH RES CO, V419, P782, DOI 10.1016/j.bbrc.2012.02.102; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Takano Y, 2005, LIFE SCI, V76, P1835, DOI 10.1016/j.lfs.2004.10.031; Tamba S, 2008, INTERNAL MED, V47, P1175, DOI 10.2169/internalmedicine.47.0603; TERADA LS, 1992, P NATL ACAD SCI USA, V89, P3362, DOI 10.1073/pnas.89.8.3362; Teramoto T, 2008, J ATHEROSCLER THROMB, V15, P1, DOI 10.5551/jat.E580; Tsuda H, 2012, BIOCHEM BIOPH RES CO, V427, P266, DOI 10.1016/j.bbrc.2012.09.032; VANBILSEN M, 1989, AM J PHYSIOL, V257, pH47, DOI 10.1152/ajpheart.1989.257.1.H47; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Wang G, 2008, INT J BIOCHEM CELL B, V40, P461, DOI 10.1016/j.biocel.2007.08.008; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; YAMASHITA S, 1986, INT J OBESITY, V10, P255; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; ZAGER RA, 1991, CIRC RES, V68, P185, DOI 10.1161/01.RES.68.1.185	55	202	214	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27138	27149		10.1074/jbc.M113.485094	http://dx.doi.org/10.1074/jbc.M113.485094			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23913681	hybrid, Green Published			2022-12-25	WOS:000330597300013
J	Grove, JI; Alandiyjany, MN; Delahay, RM				Grove, Jane I.; Alandiyjany, Maher N.; Delahay, Robin M.			Site-specific Relaxase Activity of a VirD2-like Protein Encoded within the tfs4 Genomic Island of Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV SECRETION SYSTEM; DNA TRANSFER; PLASTICITY REGION; DUODENAL-ULCER; CONJUGATIVE ELEMENTS; NICKING REACTION; SXT/R391 FAMILY; TRANSFER ORIT; MOBILIZATION; SEQUENCE	Four different type IV secretion systems are variously represented in the genomes of different Helicobacter pylori strains. Two of these, encoded by tfs3 and tfs4 gene clusters are contained within self-transmissible genomic islands. Although chromosomal excision of tfs4 circular intermediates is reported to be dependent upon the function of a tfs4-encoded XerD tyrosine-like recombinase, other factors required for transfer to a recipient cell have not been demonstrated. Here, we characterize the functional activity of a putative tfs4-encoded VirD2-like relaxase protein. Tfs4 VirD2 was purified as a fusion to maltose-binding protein and demonstrated to bind and nick both super-coiled duplex DNA and oligonucleotides in vitro in a manner dependent upon the presence of Mg2+ but independently of any auxiliary proteins. Unusually, concentration-dependent nicking of duplex DNA appeared to require only transient protein-DNA interaction. Although phylogenetically distinct from established relaxase families, site-specific cleavage of oligonucleotides by Tfs4 VirD2 required the nick region sequence 5'-ATC-CTG-3' common to transfer origins (oriT) recognized by MOBP conjugative relaxases. Cleavage resulted in covalent attachment of MBP-VirD2 to the 5'-cleaved end, consistent with conventional relaxase activity. Identification of an oriT-like sequence upstream of tfs4 virD2 and demonstration of VirD2 protein-protein interaction with a putative VirC1 relaxosome component indicate that transfer initiation of the tfs4 genomic island is analogous to mechanisms underlying mobilization of other integrated mobile elements, such as integrating conjugative elements, requiring site-specific targeting of relaxase activity to a cognate oriT sequence.	[Delahay, Robin M.] Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England; Univ Nottingham, Nottingham Digest Dis Ctr, Natl Inst Hlth Res, Biomed Res Unit, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Delahay, RM (corresponding author), Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England.	rob.delahay@nottingham.ac.uk		Delahay, Rob/0000-0002-7108-565X; Grove, Jane/0000-0002-9950-7201	Nottingham Digestive Diseases Centre National Institute for Health Research Biomedical Research Unit; Medical Research Council [G0901104]; MRC [G0901104] Funding Source: UKRI	Nottingham Digestive Diseases Centre National Institute for Health Research Biomedical Research Unit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was performed in facilities supported by the Nottingham Digestive Diseases Centre National Institute for Health Research Biomedical Research Unit and supported by Medical Research Council Grant G0901104 (to R. M. D.).	Aras RA, 2003, P NATL ACAD SCI USA, V100, P13579, DOI 10.1073/pnas.1735481100; Atmakuri K, 2007, EMBO J, V26, P2540, DOI 10.1038/sj.emboj.7601696; Backert S, 2005, MICROBIOL-SGM, V151, P3493, DOI 10.1099/mic.0.28250-0; Backert S, 1998, MOL MICROBIOL, V30, P673, DOI 10.1046/j.1365-2958.1998.01086.x; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 1995, CANCER RES, V55, P2111; Byrd DR, 1997, MOL MICROBIOL, V25, P1011, DOI 10.1046/j.1365-2958.1997.5241885.x; Ceccarelli D, 2008, J BACTERIOL, V190, P5328, DOI 10.1128/JB.00150-08; Daccord A, 2010, MOL MICROBIOL, V78, P576, DOI 10.1111/j.1365-2958.2010.07364.x; de Jonge R, 2004, FEMS IMMUNOL MED MIC, V41, P161, DOI 10.1016/j.femsim.2004.03.003; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; FURUYA N, 1991, J BACTERIOL, V173, P6612, DOI 10.1128/jb.173.20.6612-6617.1991; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Graham DY, 1998, HELICOBACTER, V3, P145, DOI 10.1046/j.1523-5378.1998.08031.x; Hochhut B, 2000, J BACTERIOL, V182, P2043, DOI 10.1128/JB.182.7.2043-2047.2000; Hofreuter D, 1998, MOL MICROBIOL, V28, P1027, DOI 10.1046/j.1365-2958.1998.00879.x; Hussein NR, 2010, J INFECT DIS, V202, P261, DOI 10.1086/653587; James P, 1996, GENETICS, V144, P1425; Kersulyte D, 2003, J BACTERIOL, V185, P3764, DOI 10.1128/JB.185.13.3764-3772.2003; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; Lee CA, 2007, J BACTERIOL, V189, P7254, DOI 10.1128/JB.00932-07; Llosa M, 2003, P NATL ACAD SCI USA, V100, P10465, DOI 10.1073/pnas.1830264100; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009; Lucas M, 2010, J BIOL CHEM, V285, P8918, DOI 10.1074/jbc.M109.057539; MATSON SW, 1991, J BIOL CHEM, V266, P16232; MATSON SW, 1993, J BACTERIOL, V175, P2599, DOI 10.1128/JB.175.9.2599-2606.1993; Occhialini A, 2000, INFECT IMMUN, V68, P6240, DOI 10.1128/IAI.68.11.6240-6249.2000; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Pansegrau W, 1996, J BIOL CHEM, V271, P13068, DOI 10.1074/jbc.271.22.13068; PANSEGRAU W, 1993, P NATL ACAD SCI USA, V90, P2925, DOI 10.1073/pnas.90.7.2925; PANSEGRAU W, 1990, P NATL ACAD SCI USA, V87, P6555, DOI 10.1073/pnas.87.17.6555; PANSEGRAU W, 1991, NUCLEIC ACIDS RES, V19, P3455, DOI 10.1093/nar/19.12.3455; Parker C, 2005, PLASMID, V53, P113, DOI 10.1016/j.plasmid.2004.12.007; Rocco JM, 2006, J BACTERIOL, V188, P2207, DOI 10.1128/JB.188.6.2207-2213.2006; Rohrer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045623; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos A, 2003, J CLIN MICROBIOL, V41, P1651, DOI 10.1128/JCM.41.4.1651-1655.2003; SCHERZINGER E, 1992, NUCLEIC ACIDS RES, V20, P41, DOI 10.1093/nar/20.1.41; Schroder G, 2002, J BACTERIOL, V184, P2767, DOI 10.1128/JB.184.10.2767-2779.2002; Snipen L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-385; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Street LM, 2003, BBA-PROTEINS PROTEOM, V1646, P86, DOI 10.1016/S1570-9639(02)00553-8; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Kregten M, 2009, MOL PLANT MICROBE IN, V22, P1356, DOI 10.1094/MPMI-22-11-1356; Vedantam G, 2006, MOL MICROBIOL, V59, P288, DOI 10.1111/j.1365-2958.2005.04934.x; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; WATERS VL, 1991, P NATL ACAD SCI USA, V88, P1456, DOI 10.1073/pnas.88.4.1456; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; ZUBAY G, 1972, P NATL ACAD SCI USA, V69, P1100, DOI 10.1073/pnas.69.5.1100	54	16	18	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26385	26396		10.1074/jbc.M113.496430	http://dx.doi.org/10.1074/jbc.M113.496430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23900838	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000330594500004
J	Busser, BW; Gisselbrecht, SS; Shokri, L; Tansey, TR; Gamble, CE; Bulyk, ML; Michelson, AM				Busser, Brian W.; Gisselbrecht, Stephen S.; Shokri, Leila; Tansey, Terese R.; Gamble, Caitlin E.; Bulyk, Martha L.; Michelson, Alan M.			Contribution of Distinct Homeodomain DNA Binding Specificities to Drosophila Embryonic Mesodermal Cell-Specific Gene Expression Programs	PLOS ONE			English	Article							REGULATORY ELEMENTS; HOX SPECIFICITY; IDENTITY GENES; MUSCLE; DIVERSITY; PROTEIN; DIVERSIFICATION; COFACTORS; TINMAN; REPRESSION	Homeodomain (HD) proteins are a large family of evolutionarily conserved transcription factors (TFs) having diverse developmental functions, often acting within the same cell types, yet many members of this family paradoxically recognize similar DNA sequences. Thus, with multiple family members having the potential to recognize the same DNA sequences in cis-regulatory elements, it is difficult to ascertain the role of an individual HD or a subclass of HDs in mediating a particular developmental function. To investigate this problem, we focused our studies on the Drosophila embryonic mesoderm where HD TFs are required to establish not only segmental identities (such as the Hox TFs), but also tissue and cell fate specification and differentiation (such as the NK-2 HDs, Six HDs and identity HDs (I-HDs)). Here we utilized the complete spectrum of DNA binding specificities determined by protein binding microarrays (PBMs) for a diverse collection of HDs to modify the nucleotide sequences of numerous mesodermal enhancers to be recognized by either no or a single subclass of HDs, and subsequently assayed the consequences of these changes on enhancer function in transgenic reporter assays. These studies show that individual mesodermal enhancers receive separate transcriptional input from both I-HD and Hox subclasses of HDs. In addition, we demonstrate that enhancers regulating upstream components of the mesodermal regulatory network are targeted by the Six class of HDs. Finally, we establish the necessity of NK-2 HD binding sequences to activate gene expression in multiple mesodermal tissues, supporting a potential role for the NK-2 HD TF Tinman (Tin) as a pioneer factor that cooperates with other factors to regulate cell-specific gene expression programs. Collectively, these results underscore the critical role played by HDs of multiple subclasses in inducing the unique genetic programs of individual mesodermal cells, and in coordinating the gene regulatory networks directing mesoderm development.	[Busser, Brian W.; Tansey, Terese R.; Gamble, Caitlin E.; Michelson, Alan M.] NHLBI, Lab Dev Syst Biol, NIH, Bethesda, MD 20892 USA; [Gisselbrecht, Stephen S.; Shokri, Leila; Bulyk, Martha L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Gisselbrecht, Stephen S.; Shokri, Leila; Bulyk, Martha L.] Harvard Univ, Sch Med, Boston, MA USA; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol HST, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Michelson, AM (corresponding author), NHLBI, Lab Dev Syst Biol, NIH, Bldg 10, Bethesda, MD 20892 USA.	michelsonam@nhlbi.nih.gov		Gisselbrecht, Stephen/0000-0001-8723-902X	NHLBI Division of Intramural Research; NIH [R01 HG005287]; NIH NRSA [F32 GM090645]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006110] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090645] Funding Source: NIH RePORTER	NHLBI Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the NHLBI Division of Intramural Research (AMM), NIH grant R01 HG005287 (MLB) and NIH NRSA F32 GM090645 (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Bate Michael, 1993, P1013; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; BODMER R, 1993, DEVELOPMENT, V118, P719; Bodmer R, 2010, DEV AGING DROSOPHILA; BOURGOUIN C, 1992, NEURON, V9, P549, DOI 10.1016/0896-6273(92)90192-G; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Busser BW, 2012, P NATL ACAD SCI USA, V109, P20768, DOI 10.1073/pnas.1210415109; Busser BW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002531; Busser BW, 2012, DEVELOPMENT, V139, P1164, DOI 10.1242/dev.077362; Busser BW, 2008, CURR OPIN GENET DEV, V18, P521, DOI 10.1016/j.gde.2008.09.003; Capovilla M, 2001, DEVELOPMENT, V128, P1221; Carrasco-Rando M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002186; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Davidson EH, 2006, REG GEN GEN REG; Enriquez J, 2010, DEVELOPMENT, V137, P457, DOI 10.1242/dev.045286; Galant R, 2002, DEVELOPMENT, V129, P3115; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5; Grienenberger A, 2003, DEVELOPMENT, V130, P5445, DOI 10.1242/dev.00760; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; Hersh BM, 2007, DEV BIOL, V302, P717, DOI 10.1016/j.ydbio.2006.11.011; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; Jagla K, 2001, BIOESSAYS, V23, P125, DOI 10.1002/1521-1878(200102)23:2<125::AID-BIES1019>3.3.CO;2-3; Jagla T, 2002, DEVELOPMENT, V129, P1037; Jakobsen JS, 2007, GENE DEV, V21, P2448, DOI 10.1101/gad.437607; Jin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003195; Junion G, 2007, GENE DEV, V21, P3163, DOI 10.1101/gad.437307; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Mahaffey JW, 2005, CURR OPIN GENET DEV, V15, P422, DOI 10.1016/j.gde.2005.06.009; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; MICHELSON AM, 1994, DEVELOPMENT, V120, P755; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Muller D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014323; Niro C, 2010, DEV BIOL, V338, P168, DOI 10.1016/j.ydbio.2009.11.031; Nose A, 1998, DEVELOPMENT, V125, P215; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Philippakis AA, 2006, PLOS COMPUT BIOL, V2, P439, DOI 10.1371/journal.pcbi.0020053; Richard AF, 2011, DEV BIOL, V359, P303, DOI 10.1016/j.ydbio.2011.08.010; Rieden PMJID, 2004, TRENDS GENET, V20, P76, DOI 10.1016/j.tig.2003.12.001; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Schaub C, 2012, DEVELOPMENT, V139, P1001, DOI 10.1242/dev.073890; Siggers T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.89; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Slattery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014686; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Tixier V, 2010, EXP CELL RES, V316, P3019, DOI 10.1016/j.yexcr.2010.07.013; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhu XM, 2012, DEVELOPMENT, V139, P1457, DOI 10.1242/dev.069005; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	62	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69385	10.1371/journal.pone.0069385	http://dx.doi.org/10.1371/journal.pone.0069385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922708	Green Submitted, gold, Green Published			2022-12-25	WOS:000322838900040
J	Godoy, HE; Khan, ANH; Vethanayagam, RR; Grimm, MJ; Singel, KL; Kolomeyevskaya, N; Sexton, KJ; Parameswaran, A; Abrams, SI; Odunsi, K; Segal, BH				Godoy, Heidi E.; Khan, A. Nazmul H.; Vethanayagam, R. Robert; Grimm, Melissa J.; Singel, Kelly L.; Kolomeyevskaya, Nonna; Sexton, Kevin J.; Parameswaran, Anupama; Abrams, Scott I.; Odunsi, Kunle; Segal, Brahm H.			Myeloid-Derived Suppressor Cells Modulate Immune Responses Independently of NADPH Oxidase in the Ovarian Tumor Microenvironment in Mice	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; HOST-DEFENSE; MOUSE MODEL; T-CELLS; CANCER; ACCUMULATION; INHIBITION; MECHANISM; ANTIGEN; DIFFERENTIATION	The phagocyte NADPH oxidase generates superoxide anion and downstream reactive oxidant intermediates in response to infectious threat, and is a critical mediator of antimicrobial host defense and inflammatory responses. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells that are recruited by cancer cells, accumulate locally and systemically in advanced cancer, and can abrogate anti-tumor immunity. Prior studies have implicated the phagocyte NADPH oxidase as being an important component promoting MDSC accumulation and immunosuppression in cancer. We therefore used engineered NADPH oxidase-deficient (p47(phox-/-)) mice to delineate the role of this enzyme complex in MDSC accumulation and function in a syngeneic mouse model of epithelial ovarian cancer. We found that the presence of NADPH oxidase did not affect tumor progression. The accumulation of MDSCs locally and systemically was similar in tumor-bearing wild-type (WT) and p47(phox-/-) mice. Although MDSCs from tumor-bearing WT mice had functional NADPH oxidase, the suppressive effect of MDSCs on ex vivo stimulated T cell proliferation was NADPH oxidase-independent. In contrast to other tumor-bearing mouse models, our results show that MDSC accumulation and immunosuppression in syngeneic epithelial ovarian cancer is NADPH oxidase-independent. We speculate that factors inherent to the tumor, tumor microenvironment, or both determine the specific requirement for NADPH oxidase in MDSC accumulation and function.	[Godoy, Heidi E.; Kolomeyevskaya, Nonna; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol, Buffalo, NY 14263 USA; [Khan, A. Nazmul H.; Vethanayagam, R. Robert; Grimm, Melissa J.; Sexton, Kevin J.; Parameswaran, Anupama; Segal, Brahm H.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Singel, Kelly L.; Abrams, Scott I.; Odunsi, Kunle; Segal, Brahm H.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Segal, Brahm H.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Med, Buffalo, NY 14260 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Segal, BH (corresponding author), Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.	brahm.segal@roswellpark.org	Singel, Kelly L/N-7792-2014; Khan, ANM Nazmul H/AAR-6749-2020; Segal, Brahm/AAW-2706-2020	Singel, Kelly L/0000-0002-8053-4736; 	University at Buffalo Pilot and Collaborative Translational & Clinical Studies program; Roswell Park Cancer Institute Alliance Award; NIAID [R01AI79253]; Anna-Marie Kellen Clinical Investigator Award of the Cancer Research Institute;  [5T32CA108456];  [5R01CA158318-02];  [R01CA140622]; NATIONAL CANCER INSTITUTE [R01CA140622, R01CA158318, T32CA108456, P30CA016056] Funding Source: NIH RePORTER	University at Buffalo Pilot and Collaborative Translational & Clinical Studies program; Roswell Park Cancer Institute Alliance Award; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Anna-Marie Kellen Clinical Investigator Award of the Cancer Research Institute; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by University at Buffalo Pilot and Collaborative Translational & Clinical Studies program; Roswell Park Cancer Institute Alliance Award; NIAID R01AI79253 (BHS); 5T32CA108456 (HEG and NK); Anna-Marie Kellen Clinical Investigator Award of the Cancer Research Institute; 5R01CA158318-02 (KO) and R01CA140622 (SIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SI, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19334; Ando T, 2008, J IMMUNOL, V181, P8382, DOI 10.4049/jimmunol.181.12.8382; Chang YC, 1998, J CLIN INVEST, V101, P1843, DOI 10.1172/JCI2301; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Eckhorn R, 2004, IEEE T NEURAL NETWOR, V15, P1039, DOI 10.1109/TNN.2004.833130; Efimova O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016013; Eruslanov E, 2010, J LEUKOCYTE BIOL, V88, P839, DOI 10.1189/jlb.1209821; Fortin C, 2012, J IMMUNOL, V189, P1843, DOI 10.4049/jimmunol.1200584; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Hanson EM, 2009, J IMMUNOL, V183, P937; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Kubo H, 1996, J CLIN INVEST, V97, P2680, DOI 10.1172/JCI118718; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kusmartsev S, 2003, J LEUKOCYTE BIOL, V74, P186, DOI 10.1189/jlb.0103010; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lechner MG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-90; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Mantegazza AR, 2008, BLOOD; Meyer C, 2011, P NATL ACAD SCI USA, V108, P17111, DOI 10.1073/pnas.1108121108; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Obermajer N, 2011, CANC RES; Obermajer N, 2011, CANCER RES, V71, P7463, DOI 10.1158/0008-5472.CAN-11-2449; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Pan PY, 2010, CANCER RES, V70, P99, DOI 10.1158/0008-5472.CAN-09-1882; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Scarlett UK, 2012, J EXP MED, V209, P495, DOI 10.1084/jem.20111413; Segal BH, 2000, INFECT IMMUN, V68, P2374, DOI 10.1128/IAI.68.4.2374-2378.2000; Segal BH, 2012, FREE RADIC BIOL MED; Segal BH, 2011, BIOL BLOOD MARROW TR, V17, pS123, DOI 10.1016/j.bbmt.2010.09.008; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; Serafini P, 2008, CANCER RES, V68, P5439, DOI 10.1158/0008-5472.CAN-07-6621; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sinha P, 2012, EUR J IMMUNOL, V42, P2052, DOI 10.1002/eji.201142230; Smith C, 2012, CANCER DISCOV, V2, P722, DOI 10.1158/2159-8290.CD-12-0014; Srivastava MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040677; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	52	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69631	10.1371/journal.pone.0069631	http://dx.doi.org/10.1371/journal.pone.0069631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922763	Green Submitted, Green Published, gold			2022-12-25	WOS:000322838900067
J	Boex-Fontvieille, E; Daventure, M; Jossier, M; Zivy, M; Hodges, M; Tcherkez, G				Boex-Fontvieille, Edouard; Daventure, Marlene; Jossier, Mathieu; Zivy, Michel; Hodges, Michael; Tcherkez, Guillaume			Photosynthetic Control of Arabidopsis Leaf Cytoplasmic Translation Initiation by Protein Phosphorylation	PLOS ONE			English	Article							MESSENGER-RNA; S6 KINASE; PLANT-GROWTH; CAP-BINDING; HEAT-SHOCK; ROOT-TIPS; MAIZE; STRESS; WHEAT; CK2	Photosynthetic CO2 assimilation is the carbon source for plant anabolism, including amino acid production and protein synthesis. The biosynthesis of leaf proteins is known for decades to correlate with photosynthetic activity but the mechanisms controlling this effect are not documented. The cornerstone of the regulation of protein synthesis is believed to be translation initiation, which involves multiple phosphorylation events in Eukaryotes. We took advantage of phosphoproteomic methods applied to Arabidopsis thaliana rosettes harvested under controlled photosynthetic gas-exchange conditions to characterize the phosphorylation pattern of ribosomal proteins (RPs) and eukaryotic initiation factors (eIFs). The analyses detected 14 and 11 new RP and eIF phosphorylation sites, respectively, revealed significant CO2-dependent and/or light/dark phosphorylation patterns and showed concerted changes in 13 eIF phosphorylation sites and 9 ribosomal phosphorylation sites. In addition to the well-recognized role of the ribosomal small subunit protein RPS6, our data indicate the involvement of eIF3, eIF4A, eIF4B, eIF4G and eIF5 phosphorylation in controlling translation initiation when photosynthesis varies. The response of protein biosynthesis to the photosynthetic input thus appears to be the result of a complex regulation network involving both stimulating (e. g. RPS6, eIF4B phosphorylation) and inhibiting (e. g. eIF4G phosphorylation) molecular events.	[Boex-Fontvieille, Edouard; Jossier, Mathieu; Hodges, Michael; Tcherkez, Guillaume] Univ Paris 11, CNRS, Inst Biol Plantes, UMR 8618, F-91405 Orsay, France; [Daventure, Marlene; Zivy, Michel] Ferme Moulon, UMR Genet Vegetale, Plateforme PAPPSO, Gif Sur Yvette, France; [Tcherkez, Guillaume] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut Universitaire de France	Tcherkez, G (corresponding author), Univ Paris 11, CNRS, Inst Biol Plantes, UMR 8618, F-91405 Orsay, France.	guillaume.tcherkez@u-psud.fr	Hodges, Michael/A-8883-2008; Tcherkez, Guillaume/L-1300-2015; Jossier, Mathieu/K-3375-2013	Davanture, Marlene/0000-0001-5324-0583; Zivy, Michel/0000-0002-9814-3792	Institut Federatif de Recherche [87]; Labex Saclay Plant Science; Agence Nationale de la Recherche; project Jeunes Chercheurs [08-330055]	Institut Federatif de Recherche; Labex Saclay Plant Science; Agence Nationale de la Recherche(French National Research Agency (ANR)); project Jeunes Chercheurs	The authors thank the Institut Federatif de Recherche 87 for its financial support for phosphoproteomics. E.B.-F. thanks the Labex Saclay Plant Science for its support through a post-doctoral grant. GT and MH thank the Agence Nationale de la Recherche for supporting running costs of this study, thanks to a project Jeunes Chercheurs, under contract no. 08-330055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo WL, 2011, TRENDS PLANT SCI, V16, P489, DOI 10.1016/j.tplants.2011.05.008; BASSHAM JA, 1964, BIOCHIM BIOPHYS ACTA, V90, P542, DOI 10.1016/0304-4165(64)90233-8; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bonhomme L, 2012, MOL CELL PROTEOMICS, V11, P957, DOI 10.1074/mcp.M111.015867; Browning KS, 2004, BIOCHEM SOC T, V32, P589, DOI 10.1042/BST0320589; BROWNING KS, 1985, PLANT PHYSIOL, V77, P370, DOI 10.1104/pp.77.2.370; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; Browning KS, 1985, COMP FUNCT GENOM, V77, P370; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chang IF, 2005, PLANT PHYSIOL, V137, P848, DOI 10.1104/pp.104.053637; Cheng SJ, 2010, BIOCHEMISTRY-US, V49, P8251, DOI 10.1021/bi1008529; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dennis MD, 2009, J BIOL CHEM, V284, P20602, DOI 10.1074/jbc.M109.006692; Dennis MD, 2009, J BIOL CHEM, V284, P20615, DOI 10.1074/jbc.M109.007658; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; EscobarGutierrez AJ, 1997, PHYSIOL PLANTARUM, V100, P353, DOI 10.1034/j.1399-3054.1997.1000218.x; Gallie DR, 1997, J BIOL CHEM, V272, P1046, DOI 10.1074/jbc.272.2.1046; Immanuel TM, 2012, FUNCT PLANT BIOL, V39, P717, DOI 10.1071/FP12116; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Khan MA, 2004, BIOCHEMISTRY-US, V43, P9092, DOI 10.1021/bi049602b; Kuang ES, 2011, J BIOL CHEM, V286, P41171, DOI 10.1074/jbc.M111.280982; Lageix S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-134; Le H, 2000, J BIOL CHEM, V275, P17452, DOI 10.1074/jbc.M001186200; Lebska M, 2010, J BIOL CHEM, V285, P6217, DOI 10.1074/jbc.M109.018770; Lewandowska-Gnatowska E, 2011, MOL CELL BIOCHEM, V356, P241, DOI 10.1007/s11010-011-0952-9; Lu SX, 2011, PLANT PHYSIOL, V157, P1537, DOI 10.1104/pp.111.179846; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Mayberry LK, 2011, J BIOL CHEM, V286, P42566, DOI 10.1074/jbc.M111.280099; Mehuyas O, 2008, INT REV CEL MOL BIO, V268, P1; Moreno-Romero J, 2008, PLANT J, V55, P118, DOI 10.1111/j.1365-313X.2008.03494.x; Mothes K, 1931, PLANTA, V12, P686; Muench DG, 2012, WIRES RNA, V3, P178, DOI 10.1002/wrna.1104; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Otterhag L, 2006, BIOCHIMIE, V88, P11, DOI 10.1016/j.biochi.2005.07.005; Petracek ME, 1997, PLANT CELL, V9, P2291, DOI 10.1105/tpc.9.12.2291; Pierrat OA, 2007, BIOCHEM SOC T, V35, P1634, DOI 10.1042/BST0351634; Piques M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.68; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P499, DOI 10.1016/j.tplants.2010.05.011; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; SCHARF KD, 1982, CELL, V30, P427, DOI 10.1016/0092-8674(82)90240-9; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Turkina MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029307; Valot B, 2011, PROTEOMICS, V11, P3572, DOI 10.1002/pmic.201100120; WEBSTER C, 1991, J BIOL CHEM, V266, P23341; Williams AJ, 2003, PLANT PHYSIOL, V132, P2086, DOI 10.1104/pp.103.022749	48	47	47	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70692	10.1371/journal.pone.0070692	http://dx.doi.org/10.1371/journal.pone.0070692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894680	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900139
J	Humerick, M; Hanson, J; Rodriguez-Canales, J; Lubelski, D; Rashid, OM; Salinas, YD; Shi, YJ; Ponzio, T; Fields, R; Emmert-Buck, MR; Gainer, H				Humerick, Madison; Hanson, Jeffrey; Rodriguez-Canales, Jaime; Lubelski, Daniel; Rashid, Omar M.; Salinas, Yasmmyn D.; Shi, YiJun; Ponzio, Todd; Fields, Raymond; Emmert-Buck, Michael R.; Gainer, Harold			Analysis of Transcription Factor mRNAs in Identified Oxytocin and Vasopressin Magnocellular Neurons Isolated by Laser Capture Microdissection	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; RAT SUPRAOPTIC NUCLEUS; REAL-TIME PCR; HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM; RIBONUCLEIC-ACIDS; TISSUE SAMPLES; CELL-TYPES; BRAIN; NEUROPEPTIDE; HYBRIDIZATION	The oxytocin (Oxt) and vasopressin (Avp) magnocellular neurons (MCNs) in the hypothalamus are the only neuronal phenotypes that are present in the supraoptic nucleus (SON), and are characterized by their robust and selective expression of either the Oxt or Avp genes. In this paper, we take advantage of the differential expression of these neuropeptide genes to identify and isolate these two individual phenotypes from the rat SON by laser capture microdissection (LCM), and to analyze the differential expression of several of their transcription factor mRNAs by qRT-PCR. We identify these neuronal phenotypes by stereotaxically injecting recombinant Adeno-Associated Viral (rAAV) vectors which contain cell-type specific Oxt or Avp promoters that drive expression of EGFP selectively in either the Oxt or Avp MCNs into the SON. The fluorescent MCNs are then dissected by LCM using a novel Cap Road Map protocol described in this paper, and the purified MCNs are extracted for their RNAs. qRT-PCR of these RNAs show that some transcription factors (RORA and c-jun) are differentially expressed in the Oxt and Avp MCNs.	[Humerick, Madison; Lubelski, Daniel; Rashid, Omar M.; Salinas, Yasmmyn D.; Shi, YiJun; Ponzio, Todd; Fields, Raymond; Gainer, Harold] NINDS, Lab Neurochem, NIH, Bethesda, MD 20892 USA; [Hanson, Jeffrey; Rodriguez-Canales, Jaime; Emmert-Buck, Michael R.] NCI, Laser Microdissect Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gainer, H (corresponding author), NINDS, Lab Neurochem, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	gainerh@ninds.nih.gov	Ponzio, Todd/AAV-2374-2021	Ponzio, Todd/0000-0002-3174-1229; Lubelski, Daniel/0000-0002-9403-9509; Rodriguez-Canales, Jaime/0000-0002-0885-2377	NIH, NINDS	NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the NIH, NINDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; Armstrong WE, 2007, J PHYSIOL-LONDON, V585, P645, DOI 10.1113/jphysiol.2007.145755; Bernard R, 2009, J NEUROSCI METH, V178, P46, DOI 10.1016/j.jneumeth.2008.11.012; Bhattacherjee V, 2008, J VIS EXP; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Chowdhuri SR, 2012, MODERN PATHOL, V25, P548, DOI 10.1038/modpathol.2011.184; Chu K, 1999, J MOL ENDOCRINOL, V23, P337, DOI 10.1677/jme.0.0230337; Eberle FC, 2011, HAEMATOL-HEMATOL J, V96, P558, DOI 10.3324/haematol.2010.033167; Eberle FC, 2010, J MOL DIAGN, V12, P394, DOI 10.2353/jmoldx.2010.090200; El-Serag HB, 2009, SCAND J GASTROENTERO, V44, P787, DOI 10.1080/00365520902898127; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Erickson HS, 2009, NAT PROTOC, V4, P902, DOI 10.1038/nprot.2009.61; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Fields RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032085; Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X; Ginsberg SD, 2012, NEUROBIOL DIS, V45, P99, DOI 10.1016/j.nbd.2011.07.013; Glasgow E, 1999, ENDOCRINOLOGY, V140, P5391, DOI 10.1210/en.140.11.5391; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; Harrell JC, 2008, CLIN EXP METASTAS, V25, P81, DOI 10.1007/s10585-007-9105-7; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Hindmarch C, 2006, P NATL ACAD SCI USA, V103, P1609, DOI 10.1073/pnas.0507450103; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Johann DJ, 2009, J PROTEOME RES, V8, P2310, DOI 10.1021/pr8009403; Keeney PM, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-21; Kerman IA, 2006, J NEUROSCI METH, V153, P71, DOI 10.1016/j.jneumeth.2005.10.010; Klee EW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-13; Kwon B, 2010, J NEUROSCI METH, V186, P155, DOI 10.1016/j.jneumeth.2009.11.011; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Lombardino AJ, 2006, J NEUROSCI METH, V157, P195, DOI 10.1016/j.jneumeth.2006.04.026; Lu LX, 2004, BRAIN RES PROTOC, V13, P18, DOI 10.1016/j.brainresprot.2003.12.003; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marsh ED, 2008, DEV NEUROBIOL, V68, P434, DOI 10.1002/dneu.20602; Mutsuga N, 2004, J NEUROSCI, V24, P7174, DOI 10.1523/JNEUROSCI.2022-04.2004; Paxinos G., 1986, THE RAT BRAIN IN STE; Peter J, 2002, FRONT NEUROENDOCRIN, V23, P342, DOI 10.1016/S0091-3022(02)00005-5; Pietersen CY, 2009, ANN MATH STUD; Ponzio T, 2012, PLOS ONE IN PRESS; RHODES CH, 1981, J COMP NEUROL, V198, P45, DOI 10.1002/cne.901980106; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Segal JP, 2005, J NEUROSCI, V25, P4181, DOI 10.1523/JNEUROSCI.0158-05.2005; Shahar T, 2004, J NEUROSCI, V24, P6553, DOI 10.1523/JNEUROSCI.0886-04.2004; Silvestri A, 2010, LAB INVEST, V90, P787, DOI 10.1038/labinvest.2010.47; Soltesz I, 2006, J COMP NEUROL; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Szerlip NJ, 2007, J NEUROSURG, V107, P560, DOI 10.3171/JNS-07/09/0560; Tangrea MA, 2011, J HISTOCHEM CYTOCHEM, V59, P591, DOI 10.1369/0022155411404704; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Xi D, 1999, ENDOCRINOLOGY, V140, P4677, DOI 10.1210/en.140.10.4677; Yamashita M, 2002, ENDOCRINOLOGY, V143, P4464, DOI 10.1210/en.2002-220516; Ying Z, 1996, MOL BRAIN RES, V39, P109, DOI 10.1016/0169-328X(96)00015-0; Yoshida M, 2006, ENDOCRINOLOGY, V147, P2850, DOI 10.1210/en.2005-1222; Zhu L, 2011, AM J CANCER RES, V1, P574	57	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69407	10.1371/journal.pone.0069407	http://dx.doi.org/10.1371/journal.pone.0069407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894472	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900066
J	Kedikian, X; Faillace, MP; Bernabeu, R				Kedikian, Ximena; Faillace, Maria Paula; Bernabeu, Ramon			Behavioral and Molecular Analysis of Nicotine-Conditioned Place Preference in Zebrafish	PLOS ONE			English	Article							INCENTIVE-SENSITIZATION THEORY; SUBUNIT MESSENGER-RNA; ACETYLCHOLINE-RECEPTORS; DANIO-RERIO; ADDICTION; MODEL; BRAIN; BINDING; SYSTEM; REWARD	Studies using mice and rats have demonstrated that nicotine induces a conditioned place preference (CPP), with more effective results obtained by using biased procedures. Zebrafish have also been used as a model system to identify factors influencing nicotine-associated reward by using an unbiased design. Here, we report that zebrafish exhibited putative nicotine biased CPP to an initially aversive compartment (nicotine-paired group). A counterbalanced nicotine-exposed control group did not show a significant preference shift, providing evidence that the preference shift in the nicotine-paired group was not due to a reduction of aversion for this compartment. Zebrafish preference was corroborated by behavioral analysis of several indicators of drug preference, such as time spent in the drug-paired side, number of entries to the drug-paired side, and distance traveled. These results provided strong evidence that zebrafish may actually develop a preference for nicotine, although the drug was administrated in an aversive place for the fish, which was further supported by molecular studies. Reverse transcription-quantitative real-time PCR analysis depicted a significant increase in the expression of alpha 7 and alpha 6 but not alpha 4 and beta 2 subunits of the nicotinic receptor in nicotine-paired zebrafish brains. In contrast, zebrafish brains from the counterbalanced nicotine group showed no significant changes. Moreover, CREB phosphorylation, an indicator of neural activity, accompanied the acquisition of nicotine-CPP. Our studies offered an incremental value to the drug addiction field, because they further describe behavioral features of CPP to nicotine in zebrafish. The results suggested that zebrafish exposed to nicotine in an unfriendly environment can develop a preference for that initially aversive place, which is likely due to the rewarding effect of nicotine. Therefore, this model can be used to screen exogenous and endogenous molecules involved in nicotine-associated reward in vertebrates.	[Kedikian, Ximena; Faillace, Maria Paula; Bernabeu, Ramon] Univ Buenos Aires, Fac Med, Dept Fisiol, RA-1425 Buenos Aires, DF, Argentina; [Bernabeu, Ramon] Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencias IBCN CONICET, Buenos Aires, DF, Argentina; [Faillace, Maria Paula] Consejo Nacl Invest Cient & Tecn, Inst Quim & Fis Quim Biol IQUIFIB, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bernabeu, R (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, RA-1425 Buenos Aires, DF, Argentina.	rbernabeu@fmed.uba.ar	Faillace, Paula/AGW-7438-2022		FONCyT [PICT0170]; CONICET [PIP0169]; UBACYT [0823]	FONCyT(FONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACYT	This work was supported by grants from the FONCyT PICT0170 2007-2012 (RB); CONICET PIP0169 2009-2012 (MPF); and UBACYT 0823 (MPF, RB) 2011-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Barik Jacques, 2009, Handb Exp Pharmacol, P173, DOI 10.1007/978-3-540-69248-5_7; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Besson M, 2012, PSYCHOPHARMACOLOGY, V220, P1, DOI 10.1007/s00213-011-2422-1; Brennan CH, 2011, REV NEUROSCIENCE, V22, P37, DOI 10.1515/RNS.2011.006; Bretaud S, 2007, NEUROSCIENCE, V146, P1109, DOI 10.1016/j.neuroscience.2006.12.073; Brielmaier JM, 2008, PHARMACOL BIOCHEM BE, V89, P94, DOI 10.1016/j.pbb.2007.11.005; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; CALCAGNETTI DJ, 1994, PROG NEURO-PSYCHOPH, V18, P925, DOI 10.1016/0278-5846(94)90108-2; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Darland T, 2001, P NATL ACAD SCI USA, V98, P11691, DOI 10.1073/pnas.191380698; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Gentry CL, 2002, CNS NEUROL DISORD-DR, V1, P359, DOI 10.2174/1568007023339184; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Guo S, 2004, GENES BRAIN BEHAV, V3, P63, DOI 10.1046/j.1601-183X.2003.00053.x; Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399; Klee EW, 2012, HUM GENET, V131, P977, DOI 10.1007/s00439-011-1128-0; Klee EW, 2011, NICOTINE TOB RES, V13, P301, DOI 10.1093/ntr/ntr010; Koob GF, 2005, NEUROBIOLOGY ADDICTI; Lau B, 2006, GENES BRAIN BEHAV, V5, P497, DOI 10.1111/j.1601-183X.2005.00185.x; Le Foll B, 2005, PSYCHOPHARMACOLOGY, V178, P481, DOI 10.1007/s00213-004-2021-5; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Mathur P, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.201; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Natarajan R, 2011, PHARMACOL BIOCHEM BE, V99, P519, DOI 10.1016/j.pbb.2011.05.004; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Ninkovic J, 2006, METHODS, V39, P262, DOI 10.1016/j.ymeth.2005.12.007; Papke RL, 2012, BIOCHEM PHARMACOL, V84, P352, DOI 10.1016/j.bcp.2012.04.022; Pascual MM, 2009, PSYCHOPHARMACOLOGY, V207, P57, DOI 10.1007/s00213-009-1630-4; Pastor V, 2013, PSYCHOPHARMACOLOGY, V226, P551, DOI 10.1007/s00213-012-2928-1; Pastor V, 2011, J NEUROCHEM, V116, P636, DOI 10.1111/j.1471-4159.2010.07149.x; Pauly JR, 1996, J PHARMACOL EXP THER, V278, P361; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Ryan RE, 2001, NEUROREPORT, V12, P569, DOI 10.1097/00001756-200103050-00027; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; SCHWARTZ RD, 1983, SCIENCE, V220, P214, DOI 10.1126/science.6828889; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Visanji NP, 2006, NEUROPHARMACOLOGY, V50, P36, DOI 10.1016/j.neuropharm.2005.07.013; Walters CL, 2006, PSYCHOPHARMACOLOGY, V184, P339, DOI 10.1007/s00213-005-0295-x; Wang H, 2005, BRAIN RES REV, V48, P420, DOI 10.1016/j.brainresrev.2004.09.003; Webb KJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r81; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; WONNACOTT S, 1990, TRENDS PHARMACOL SCI, V11, P216, DOI 10.1016/0165-6147(90)90242-Z; Xu XJ, 2007, NEUROBIOL LEARN MEM, V87, P72, DOI 10.1016/j.nlm.2006.06.002	55	36	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69453	10.1371/journal.pone.0069453	http://dx.doi.org/10.1371/journal.pone.0069453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894483	Green Published, gold			2022-12-25	WOS:000322167900072
J	Covanova, M; Sauer, M; Rychtar, J; Friml, J; Petrasek, J; Zazimalova, E				Covanova, Milada; Sauer, Michael; Rychtar, Jan; Friml, Jiri; Petrasek, Jan; Zazimalova, Eva			Overexpression of the Auxin Binding PROTEIN1 Modulates PIN-Dependent Auxin Transport in Tobacco Cells	PLOS ONE			English	Article							ZEA-MAYS-L; PM H+-ATPASE; PLASMA-MEMBRANE; COLEOPTILE MEMBRANES; MOLECULAR-CLONING; POLAR TRANSPORT; DIVISION; EFFLUX; PURIFICATION; ENDOCYTOSIS	Background: Auxin binding protein 1 (ABP1) is a putative auxin receptor and its function is indispensable for plant growth and development. ABP1 has been shown to be involved in auxin-dependent regulation of cell division and expansion, in plasma-membrane-related processes such as changes in transmembrane potential, and in the regulation of clathrin-dependent endocytosis. However, the ABP1-regulated downstream pathway remains elusive. Methodology/Principal Findings: Using auxin transport assays and quantitative analysis of cellular morphology we show that ABP1 regulates auxin efflux from tobacco BY-2 cells. The overexpression of ABP1can counterbalance increased auxin efflux and auxin starvation phenotypes caused by the overexpression of PIN auxin efflux carrier. Relevant mechanism involves the ABP1-controlled vesicle trafficking processes, including positive regulation of endocytosis of PIN auxin efflux carriers, as indicated by fluorescence recovery after photobleaching (FRAP) and pharmacological manipulations. Conclusions/Significance: The findings indicate the involvement of ABP1 in control of rate of auxin transport across plasma membrane emphasizing the role of ABP1 in regulation of PIN activity at the plasma membrane, and highlighting the relevance of ABP1 for the formation of developmentally important, PIN-dependent auxin gradients.	[Covanova, Milada; Petrasek, Jan; Zazimalova, Eva] Acad Sci Czech Republ, Inst Expt Bot, Lab Hormonal Regulat Plants, Prague, Czech Republic; [Sauer, Michael] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Sauer, Michael] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Madrid, Spain; [Rychtar, Jan] Univ N Carolina, Dept Math & Stat, Greensboro, NC 27412 USA; [Friml, Jiri] Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria; [Friml, Jiri] Masaryk Univ, Cent European Inst Technol CEITEC, Dept Funct Genom & Prote, Brno, Czech Republic	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Flanders Institute for Biotechnology (VIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of North Carolina; University of North Carolina Greensboro; Institute of Science & Technology - Austria; Masaryk University Brno	Zazimalova, E (corresponding author), Acad Sci Czech Republ, Inst Expt Bot, Lab Hormonal Regulat Plants, Prague, Czech Republic.	zazimalova@ueb.cas.cz	Friml, Jiri/D-9511-2012; Petrasek, Jan/AAW-1081-2021; Petrasek, Jan/C-8240-2009; Eva, Zazimalova/G-7432-2014; Sauer, Michael/F-6519-2014; Covanova, Milada/F-7473-2014	Friml, Jiri/0000-0002-8302-7596; Petrasek, Jan/0000-0002-6719-2735; Petrasek, Jan/0000-0002-6719-2735; Eva, Zazimalova/0000-0002-8325-7092; Sauer, Michael/0000-0002-4014-9825; Rychtar, Jan/0000-0001-6600-2939	Grant Agency of the Czech Republic [P305/11/0797, P501/12/P951]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	The work was supported by the Grant Agency of the Czech Republic, projects P305/11/0797 (to E.Z.) and P501/12/P951 (to M.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN GH, 1985, PLANT PHYSIOL, V79, P568, DOI 10.1104/pp.79.2.568; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; BARRIERBRYGOO H, 1989, P NATL ACAD SCI USA, V86, P891, DOI 10.1073/pnas.86.3.891; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Bronsema FBF, 1998, PROTOPLASMA, V202, P65, DOI 10.1007/BF01280875; Campanoni P, 2003, PLANT PHYSIOL, V133, P1251, DOI 10.1104/pp.103.027953; Chab D, 2008, PLANTA, V228, P929, DOI 10.1007/s00425-008-0792-3; Chen D, 2012, J PLANT PHYSIOL, V169, P127, DOI 10.1016/j.jplph.2011.08.017; Chen D, 2010, J EXP BOT, V61, P1853, DOI 10.1093/jxb/erq056; Chen JG, 2001, PLANT J, V28, P607, DOI 10.1046/j.1365-313x.2001.01152.x; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; COX DN, 1994, PLANT CELL, V6, P1941, DOI 10.1105/tpc.6.12.1941; David KM, 2007, PLANT J, V50, P197, DOI 10.1111/j.1365-313X.2007.03038.x; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Dhonukshe P, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-11; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; DIEKMANN W, 1995, P NATL ACAD SCI USA, V92, P3425, DOI 10.1073/pnas.92.8.3425; Effendi Y, 2011, PLANT J, V65, P282, DOI 10.1111/j.1365-313X.2010.04420.x; FELDWISCH J, 1992, P NATL ACAD SCI USA, V89, P475, DOI 10.1073/pnas.89.2.475; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; HERTEL R, 1972, PLANTA, V107, P325, DOI 10.1007/BF00386394; HESSE T, 1989, EMBO J, V8, P2453, DOI 10.1002/j.1460-2075.1989.tb08380.x; Jelinkova A, 2010, PLANT J, V61, P883, DOI 10.1111/j.1365-313X.2009.04102.x; JONES AM, 1993, PLANT PHYSIOL, V101, P595, DOI 10.1104/pp.101.2.595; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; Kim YS, 2001, J BIOL CHEM, V276, P10730, DOI 10.1074/jbc.M009416200; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; LOBLER M, 1985, J BIOL CHEM, V260, P9848; LOBLER M, 1985, J BIOL CHEM, V260, P9854; Maisch J, 2007, PLANT PHYSIOL, V143, P1695, DOI 10.1104/pp.106.094052; Mravec J, 2008, DEVELOPMENT, V135, P3345, DOI 10.1242/dev.021071; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Napier RM, 2001, J PLANT GROWTH REGUL, V20, P244, DOI 10.1007/s003440010024; Nick P, 2009, PLANT PHYSIOL, V151, P155, DOI 10.1104/pp.109.140111; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Petrasek J, 2006, BIOTECHNOL AGRIC FOR, V58, P107; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Petrasek J, 2003, PLANT PHYSIOL, V131, P254, DOI 10.1104/pp.012740; Petrasek J, 2002, PLANTA, V216, P302, DOI 10.1007/s00425-002-0845-y; RAY PM, 1977, PLANT PHYSIOL, V60, P585, DOI 10.1104/pp.60.4.585; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; RUBERY PH, 1990, SYM SOC EXP BIOL, V44, P119; RUCK A, 1993, PLANT J, V4, P41, DOI 10.1046/j.1365-313X.1993.04010041.x; Sakai A, 2004, BIOTECHNOL AGRIC FOR, V53, P192; SCHWOB E, 1993, PLANT J, V4, P423, DOI 10.1046/j.1365-313X.1993.04030423.x; Shimomura S, 2006, PLANT MOL BIOL, V60, P663, DOI 10.1007/s11103-005-5471-1; Steffens B, 2001, PLANT J, V27, P591, DOI 10.1046/j.1365-313X.2001.01103.x; Takahashi K, 2012, PLANT PHYSIOL, V159, P632, DOI 10.1104/pp.112.196428; Tromas A, 2010, TRENDS PLANT SCI, V15, P436, DOI 10.1016/j.tplants.2010.05.001; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; VENIS MA, 1992, P NATL ACAD SCI USA, V89, P7208, DOI 10.1073/pnas.89.15.7208; Winicur ZM, 1998, PLANT PHYSIOL, V117, P501, DOI 10.1104/pp.117.2.501; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Zazimalova E, 2007, CELL MOL LIFE SCI, V64, P1621, DOI 10.1007/s00018-007-6566-4	57	12	13	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70050	10.1371/journal.pone.0070050	http://dx.doi.org/10.1371/journal.pone.0070050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894588	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000181
J	Totonchy, JE; Osborn, JM; Botto, S; Clepper, L; Moses, AV				Totonchy, Jennifer E.; Osborn, Jessica M.; Botto, Sara; Clepper, Lisa; Moses, Ashlee V.			Aberrant Proliferation in CXCR7+Endothelial Cells via Degradation of the Retinoblastoma Protein	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR7; KAPOSIS-SARCOMA; EXPRESSION; CANCER; CXCL12; VASCULATURE; SELECTIVITY; MECHANISMS; TARGETS; BINDING	Angiogenesis is a critical factor in the growth and dissemination of solid tumors. Indeed, tumor vasculature is abnormal and contributes to the development and spread of malignancies by creating a hostile microenvironment. The alternative SDF-1/CXCL12 receptor, CXCR7, is frequently and specifically expressed in tumor-associated vessels. In this study, we examine the role of endothelium-expressed CXCR7 in tumor vascular dysfunction by specifically examining the contribution of CXCR7 to endothelial cell (EC) proliferation. We demonstrate that CXCR7 expression is sufficient to drive post-confluent growth in EC cultures. Further, we provide a novel mechanism for CXCR7-mediated proliferation via proteasomal degradation of the tumor suppressor protein Rb. These findings identify a heretofore unappreciated role for CXCR7 in vascular dysfunction and confirm this receptor as a plausible target for anti-tumor therapy.	[Totonchy, Jennifer E.; Osborn, Jessica M.; Botto, Sara; Clepper, Lisa; Moses, Ashlee V.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA	Oregon Health & Science University	Moses, AV (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA.	mosesa@ohsu.edu	Totonchy, Jennifer/AAX-6900-2021	Totonchy, Jennifer/0000-0002-8444-8536	National Cancer Institute [5R01CA099906-07]; National Institutes of Health [8P510D011092-53, 5T32AI007472-17]; NATIONAL CANCER INSTITUTE [R01CA099906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007472] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant to Dr. Moses from the National Cancer Institute (grant 5R01CA099906-07) and the National Institutes of Health Core Grant to ONPRC (8P510D011092-53). Dr. Vomaske was supported by fellowship funding from the National Institutes of Health (grant 5T32AI007472-17). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahuja SK, 1996, J BIOL CHEM, V271, P225, DOI 10.1074/jbc.271.1.225; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Costello CM, 2012, EUR RESPIR J, V39, P1415, DOI 10.1183/09031936.00044911; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Furuya M, 2011, GYNECOL ONCOL, V122, P648, DOI 10.1016/j.ygyno.2011.05.034; Gahan JC, 2012, J UROLOGY, V187, P827, DOI 10.1016/j.juro.2011.10.150; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Hume AJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-1; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Luker KE, 2012, ONCOGENE, V31, P4750, DOI 10.1038/onc.2011.633; Lund AW, 2010, J MAMMARY GLAND BIOL, V15, P341, DOI 10.1007/s10911-010-9193-x; Mehrad B, 2007, THROMB HAEMOSTASIS, V97, P755, DOI 10.1160/TH07-01-0040; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Monnier J, 2012, EUR J CANCER, V48, P138, DOI 10.1016/j.ejca.2011.06.044; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Sartina E, 2012, PEDIATR RES, V71, P682, DOI 10.1038/pr.2012.30; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Teicher BA, 2011, BIOCHEM PHARMACOL, V81, P6, DOI 10.1016/j.bcp.2010.09.023; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Vomaske J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000304; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Wurth R, 2011, J NEUROIMMUNOL, V234, P115, DOI 10.1016/j.jneuroim.2011.01.006; Yin X, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-316; Zheng K, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-31	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69828	10.1371/journal.pone.0069828	http://dx.doi.org/10.1371/journal.pone.0069828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894550	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000162
J	Cheng, WY; Zhao, GH; Jia, YQ; Bian, QQ; Du, SZ; Fang, YQ; Qi, MZ; Yu, SK				Cheng, Wen-yu; Zhao, Guang-hui; Jia, Yan-qing; Bian, Qing-qing; Du, Shuai-zhi; Fang, Yan-qing; Qi, Mao-zhen; Yu, San-ke			Characterization of Haemaphysalis flava (Acari: Ixodidae) from Qingling Subspecies of Giant Panda (Ailuropoda melanoleuca qinlingensis) in Qinling Mountains (Central China) by Morphology and Molecular Markers	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; 16S RDNA SEQUENCES; MITOCHONDRIAL 16S; PHYLOGENETIC-RELATIONSHIPS; BAYLISASCARIS-SCHROEDERI; IXODES-SCAPULARIS; GENUS AMBLYOMMA; TICKS ACARI; SPACER; RHIPICEPHALUS	Tick is one of important ectoparasites capable of causing direct damage to their hosts and also acts as vectors of relevant infectious agents. In the present study, the taxa of 10 ticks, collected from Qinling giant pandas (Ailuropoda melanoleuca qinlingensis) in Qinling Mountains of China in April 2010, were determined using morphology and molecular markers (nucleotide ITS2 rDNA and mitochondrial 16S). Microscopic observation demonstrated that the morphological features of these ticks were similar to Haemaphysalis flava. Compared with other Haemaphysalis species, genetic variations between Haemaphysalis collected from A. m. qinlingensis and H. flava were the lowest in ITS2 rDNA and mitochondrial 16S, with sequence differences of 2.06%-2.40% and 1.30%-4.70%, respectively. Phylogenetic relationships showed that all the Haemaphysalis collected from A. m. qinlingensis were grouped with H. flava, further confirmed that the Haemaphysalis sp. is H. flava. This is the first report of ticks in giant panda by combining with morphology and molecular markers. This study also provided evidence that combining morphology and molecular tools provide a valuable and efficient tool for tick identification.	[Cheng, Wen-yu; Zhao, Guang-hui; Jia, Yan-qing; Bian, Qing-qing; Du, Shuai-zhi; Fang, Yan-qing; Qi, Mao-zhen; Yu, San-ke] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi Provinc, Peoples R China	Northwest A&F University - China	Zhao, GH (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi Provinc, Peoples R China.	zgh083@163.com; yusanke15@sohu.com	qi, maozhen/HIA-0257-2022		Funds of Basic Research Key Program [ZD2012010]; Fund for the study of controlling parasitic diseases in goats and sheep in Shenmu county [K332021210]	Funds of Basic Research Key Program; Fund for the study of controlling parasitic diseases in goats and sheep in Shenmu county	This work was supported in part by grants from Funds of Basic Research Key Program (ZD2012010) and the Fund for the study of controlling parasitic diseases in goats and sheep in Shenmu county (K332021210) to S-KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apanaskevich DA, 2011, J PARASITOL, V97, P389, DOI 10.1645/GE-2366.1; Beati L, 2001, J PARASITOL, V87, P32, DOI 10.1645/0022-3395(2001)087[0032:AOTSRA]2.0.CO;2; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Burger TD, 2012, MOL PHYLOGENET EVOL, V64, P45, DOI 10.1016/j.ympev.2012.03.004; Chao LL, 2011, EXP APPL ACAROL, V54, P51, DOI 10.1007/s10493-010-9419-z; Chen K.L, 1992, SHANGHAI J ANIM HUSB, V1, P8; Chen Z, 2012, VET PARASITOL, V189, P344, DOI 10.1016/j.vetpar.2012.04.021; CHILTON NB, 1995, INT J PARASITOL, V25, P647, DOI 10.1016/0020-7519(94)00171-J; Chitimia L, 2009, PARASITOL RES, V105, P1479, DOI 10.1007/s00436-009-1581-z; Chitimia L, 2010, EXP APPL ACAROL, V52, P305, DOI 10.1007/s10493-010-9365-9; Crampton A, 1996, INT J PARASITOL, V26, P511, DOI 10.1016/0020-7519(96)89379-9; Dantas-Torres F, 2012, J PARASITOL, V98, P36, DOI 10.1645/GE-2840.1; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; de Rojas M, 2007, PARASITOL RES, V100, P1041, DOI 10.1007/s00436-006-0356-z; Deng G.F., 1978, EC INSECT FAUNA CHIN, V15, P1; He GZ, 2012, DNA CELL BIOL, V31, P1174, DOI 10.1089/dna.2011.1395; Hlinka O, 2002, HEREDITY, V88, P275, DOI 10.1038/sj.hdy.6800040; Huo T, 2012, PROTEIN CELL, V3, P602, DOI 10.1007/s13238-012-2914-8; Kain DE, 1999, HEREDITY, V83, P378, DOI 10.1038/sj.hdy.6886110; Lai C., 1990, Sichuan Journal of Zoology, V9, P7; Lee Won-Koo, 1997, Korean Journal of Parasitology, V35, P1, DOI 10.3347/kjp.1997.35.1.1; Levin ML, 2012, EXP APPL ACAROL, V58, P51, DOI 10.1007/s10493-012-9561-x; Ma G.Y., 1987, SICHUAN J ZOOL, V6, P34; Mangold AJ, 1998, PARASITOL RES, V84, P478, DOI 10.1007/s004360050433; Marrelli MT, 2007, J MED ENTOMOL, V44, P222, DOI 10.1603/0022-2585(2007)44[222:TAPRBN]2.0.CO;2; MCLAIN DK, 1995, HEREDITY, V75, P303, DOI 10.1038/hdy.1995.139; Murrell A, 2001, INSECT MOL BIOL, V10, P587, DOI 10.1046/j.0962-1075.2001.00298.x; Murrell A, 2001, MOL PHYLOGENET EVOL, V21, P244, DOI 10.1006/mpev.2001.1018; Norris DE, 1996, J MED ENTOMOL, V33, P78, DOI 10.1093/jmedent/33.1.78; OBRIEN SJ, 1994, NATURE, V369, P179, DOI 10.1038/369179a0; OLIVER JH, 1989, ANNU REV ECOL SYST, V20, P397, DOI 10.1146/annurev.es.20.110189.002145; Padgett KA, 2005, J PARASITOL, V91, P1435, DOI 10.1645/GE-3461.1; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peng JJ, 2001, FOLIA ZOOL, V50, P81; Qin Xin-cheng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P608; Qiu MH, 1987, P GIANT PAND DIS TRE, P1; Rumer L, 2011, VECTOR-BORNE ZOONOT, V11, P899, DOI 10.1089/vbz.2009.0191; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Species Survival Commission IUCN, 2008, AIL MEL; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian ZC, 2011, EXP APPL ACAROL, V54, P165, DOI 10.1007/s10493-010-9423-3; Wang CR, 2012, RES VET SCI, V92, P99, DOI 10.1016/j.rvsc.2010.10.024; Wang T, 2008, VACCINE, V26, P6919, DOI 10.1016/j.vaccine.2008.09.079; Wei FW, 2012, MOL ECOL, V21, P5660, DOI 10.1111/mec.12096; WESSON DM, 1993, P NATL ACAD SCI USA, V90, P10221, DOI 10.1073/pnas.90.21.10221; Wickstrom LM, 2005, SYST PARASITOL, V62, P83, DOI 10.1007/s11230-005-5488-5; Wu J, 1985, CHIN J VET MED, V8, P10; Yang G.Y., 2013, PARASITIC DIS WILDLI; Yang Guangyou, 1998, Chinese Journal of Veterinary Science, V18, P206; Zeng CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-315; Zhang H, 2010, GANSU ANIM VET SCI, V212, P40; Zhang JS, 2008, ECOHEALTH, V5, P6, DOI 10.1007/s10393-007-0139-8; Zhang WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041995; Zhang ZH, 2006, GIANT PANDA EXSITU C; Zhao GH, 2012, PARASITOL RES, V111, P1467, DOI 10.1007/s00436-012-2981-z; Zhao GH, 2009, VET PARASITOL, V162, P67, DOI 10.1016/j.vetpar.2009.02.022; Zhu XQ, 2007, MOL CELL PROBE, V21, P97, DOI 10.1016/j.mcp.2006.08.004	58	23	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69793	10.1371/journal.pone.0069793	http://dx.doi.org/10.1371/journal.pone.0069793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894541	gold, Green Submitted, Green Published			2022-12-25	WOS:000322391400071
J	Dutruel, C; Bergmann, F; Rooman, I; Zucknick, M; Weichenhan, D; Geiselhart, L; Kaffenberger, T; Rachakonda, PS; Bauer, A; Giese, N; Hong, C; Xie, H; Costello, JF; Hoheisel, J; Kumar, R; Rehli, M; Schirmacher, P; Werner, J; Plass, C; Popanda, O; Schmezer, P				Dutruel, C.; Bergmann, F.; Rooman, I.; Zucknick, M.; Weichenhan, D.; Geiselhart, L.; Kaffenberger, T.; Rachakonda, P. S.; Bauer, A.; Giese, N.; Hong, C.; Xie, H.; Costello, J. F.; Hoheisel, J.; Kumar, R.; Rehli, M.; Schirmacher, P.; Werner, J.; Plass, C.; Popanda, O.; Schmezer, P.			Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development	ONCOGENE			English	Article						genome-wide screen; CpG island methylation; chronic pancreatitis; pancreatic intraepithelial neoplasia; pancreatic cancer	DNA METHYLATION; CELL TRANSDIFFERENTIATION; INTRAEPITHELIAL NEOPLASIA; ABERRANT METHYLATION; PROTEIN-KINASE; CANCER; BIOLOGY; PROLIFERATION; PROFILE; GENES	Pancreatic ductal adenocarcinoma (PDAC) is usually incurable. Contrary to genetic mechanisms involved in PDAC pathogenesis, epigenetic alterations are ill defined. Here, we determine the contribution of epigenetically silenced genes to the development of PDAC. We analyzed enriched, highly methylated DNAs from PDACs, chronic pancreatitis (CP) and normal tissues using CpG island microarrays and identified WNK2 as a prominent candidate tumor suppressor gene being downregulated early in PDAC development. WNK2 was further investigated in tissue microarrays, methylation analysis of early pancreatic intraepithelial neoplasia (PanIN), mouse models for PDAC and pancreatitis, re-expression studies after demethylation, and cell growth assays using WNK2 overexpression. Demethylation assays confirmed the link between methylation and expression. WNK2 hypermethylation was higher in tumor than in surrounding inflamed tissues and was observed in PanIN lesions as well as in a PDAC mouse model. WNK2 mRNA and protein expressions were lower in PDAC and CP compared with normal tissues both in patients and mouse models. Overexpression of WNK2 led to reduced cell growth, and WNK2 expression in tissues correlated negatively with pERK1/2 expression, a downstream target of WNK2 responsible for cell proliferation. Downregulation of WNK2 by promoter hypermethylation occurs early in PDAC pathogenesis and may support tumor cell growth via the ERK-MAPK pathway.	[Dutruel, C.; Weichenhan, D.; Geiselhart, L.; Kaffenberger, T.; Plass, C.; Popanda, O.; Schmezer, P.] German Canc Res Ctr, Div Epigen & Canc Risk Factors, D-69120 Heidelberg, Germany; [Bergmann, F.; Schirmacher, P.] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Rooman, I.] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Zucknick, M.] German Canc Res Ctr, Div Biostat, D-69120 Heidelberg, Germany; [Rachakonda, P. S.; Xie, H.; Kumar, R.] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Bauer, A.; Hoheisel, J.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Giese, N.; Werner, J.] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Hong, C.; Costello, J. F.] Univ Calif San Francisco, Dept Neurosurg, Helen Diller Family Comprehens Canc Ctr, Brain Tumor Res Ctr, San Francisco, CA USA; [Rehli, M.] Univ Hosp Regensburg, Dept Hematol & Oncol, Regensburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Regensburg	Schmezer, P (corresponding author), German Canc Res Ctr, Div Epigen & Canc Risk Factors, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	p.schmezer@dkfz.de	Kumar, Rajiv/H-6431-2019; Rehli, Michael/E-9093-2011; Popanda, Odilia/P-6917-2019	Kumar, Rajiv/0000-0002-6093-0395; Rehli, Michael/0000-0003-3992-932X; Xie, Huaping/0000-0003-1474-2470; Rooman, Ilse/0000-0001-7264-2246; Bauer, Andrea/0000-0002-7919-0497	Cancer Institute New South Wales, Australia [10FRL203]; German Federal Ministry of Education and Research [PKB-01GS08114]; German Federal Ministry of Education and Research as part of the PaCaNct consortium within the NGFN program; Fulbright commission in Germany; US State Department	Cancer Institute New South Wales, Australia; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research as part of the PaCaNct consortium within the NGFN program; Fulbright commission in Germany; US State Department	We would like to thank Reinhard Gliniorz, Oliver Mucke, Jana Petersen; Peter Waas and Otto Zelezny for their technical support, Dr Marta Faryna and Dr Carolin Konermann for discussions regarding the MCIp/microarray assays, Anna Poetsch and Christopher Schmidt for experimental advices; Dr Rainer Claus and Dr Christopher Oakes for stimulating discussions and Dr Ming-Sound Tsao (Ontario Cancer Institute, Toronto, Canada) for providing us the HPDE6-E6E7 cell line. This work is supported by grants from the Cancer Institute New South Wales, Australia (10FRL203 fellowship), from the German Federal Ministry of Education and Research (PKB-01GS08114) and from the German Federal Ministry of Education and Research as part of the PaCaNct consortium within the NGFN program. We thank the Fulbright commission in Germany and the US State Department for providing external funding (TK).	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fukushima N, 2002, AM J PATHOL, V160, P1573, DOI 10.1016/S0002-9440(10)61104-2; Ghaneh P, 2008, POSTGRAD MED J, V84, P478, DOI 10.1136/gut.2006.103333; Goggins M, 2005, J CLIN ONCOL, V23, P4524, DOI 10.1200/JCO.2005.19.711; Gold DV, 2010, CANCER EPIDEM BIOMAR, V19, P2786, DOI 10.1158/1055-9965.EPI-10-0667; Grapin-Botton A, 2005, INT J BIOCHEM CELL B, V37, P504, DOI 10.1016/j.biocel.2004.07.010; Haas BR, 2011, AM J PHYSIOL-CELL PH, V301, pC1150, DOI 10.1152/ajpcell.00203.2011; Hartwig W, 2011, ANN SURG, V254, P311, DOI 10.1097/SLA.0b013e31821fd334; Heller A, 2010, CANCER IMMUNOL IMMUN, V59, P1389, DOI 10.1007/s00262-010-0870-9; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Jansen M, 2002, CANCER BIOL THER, V1, P293, DOI 10.4161/cbt.84; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Jun P, 2009, NEURO-ONCOLOGY, V11, P414, DOI 10.1215/15228517-2008-096; Kong B, 2011, NAT REV GASTRO HEPAT, V8, P467, DOI 10.1038/nrgastro.2011.114; Kuhmann C, 2011, RADIOTHER ONCOL, V101, P116, DOI 10.1016/j.radonc.2011.05.048; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; Liggett T, 2010, CANCER-AM CANCER SOC, V116, P1674, DOI 10.1002/cncr.24893; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Matsubayashi H, 2006, CANCER RES, V66, P1208, DOI 10.1158/0008-5472.CAN-05-2664; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Moniz S, 2007, ONCOGENE, V26, P6071, DOI 10.1038/sj.onc.1210706; Moniz S, 2008, CELL SIGNAL, V20, P1762, DOI 10.1016/j.cellsig.2008.06.002; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Omura Noriyuki, 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P7; Peng DF, 2006, CARCINOGENESIS, V27, P1160, DOI 10.1093/carcin/bgi361; Pinho AV, 2011, GUT, V60, P958, DOI 10.1136/gut.2010.225920; Sato N, 2003, CANCER RES, V63, P3735; Sato N, 2008, MODERN PATHOL, V21, P238, DOI 10.1038/modpathol.3800991; Schilling E, 2007, GENOMICS, V90, P314, DOI 10.1016/j.ygeno.2007.04.011; Sipos B, 2009, PANCREATOLOGY, V9, P45, DOI 10.1159/000178874; Strobel O, 2007, P NATL ACAD SCI USA, V104, P4419, DOI 10.1073/pnas.0605248104; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Vincent A, 2011, CLIN CANCER RES, V17, P4341, DOI 10.1158/1078-0432.CCR-10-3431; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200	39	24	27	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 26	2014	33	26					3401	3410		10.1038/onc.2013.312	http://dx.doi.org/10.1038/onc.2013.312			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK9WM	23912455				2022-12-25	WOS:000338779300007
J	Terrazas, CA; Alcantara-Hernandez, M; Bonifaz, L; Terrazas, LI; Satoskar, AR				Terrazas, Cesar A.; Alcantara-Hernandez, Marcela; Bonifaz, Laura; Terrazas, Luis I.; Satoskar, Abhay R.			Helminth-excreted/secreted products are recognized by multiple receptors on DCs to block the TLR response and bias Th2 polarization in a cRAF dependent pathway	FASEB JOURNAL			English	Article						CLRs; dendritic cell; mannose receptor; immunomodulation; MGL	ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; C-TYPE LECTINS; DENDRITIC CELLS; TRANSCRIPTION FACTOR; SECRETED PRODUCT; IL-10 PRODUCTION; IMMUNE-RESPONSE; EGG ANTIGENS; MATURATION	Dendritic cells (DCs) recognize pathogens and initiate the T-cell response. The DC-helminth interaction induces an immature phenotype in DCs; as a result, these DCs display impaired responses to TLR stimulation and prime Th2-type responses. However, the DC receptors and intracellular pathways targeted by helminth molecules and their importance in the initiation of the Th2 response are poorly understood. In this report, we found that products excreted/secreted by Taenia crassiceps (TcES) triggered cRAF phosphorylation through MGL, MR, and TLR2. TcES interfered with the LPS-induced NFB p65 and p38 MAPK signaling pathways. In addition, TcES-induced cRAF signaling pathway was critical for down-regulation of the TLR-mediated DC maturation and secretion of IL-12 and TNF-. Finally, we show for the first time that blocking cRAF in DCs abolishes their ability to induce Th2 polarization in vitro after TcES exposure. Our data demonstrate a new mechanism by which helminths target intracellular pathways to block DC maturation and efficiently program Th2 polarization.Terrazas, C. A., Alcantara-Hernandez, M., Bonifaz, L., Terrazas, L. I., Satoskar, A. R. Helminth-excreted/secreted products are recognized by multiple receptors on DCs to block the TLR response and bias Th2 polarization in a cRAF dependent pathway.	[Terrazas, Cesar A.; Terrazas, Luis I.] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Unidad Biomed, Mexico City 04510, DF, Mexico; [Terrazas, Cesar A.; Satoskar, Abhay R.] Ohio State Univ, Dept Microbiol, Med Ctr, Columbus, OH 43210 USA; [Terrazas, Cesar A.; Satoskar, Abhay R.] Ohio State Univ, Dept Pathol, Med Ctr, Columbus, OH 43210 USA; [Alcantara-Hernandez, Marcela; Bonifaz, Laura] Inst Mexicano Seguro Social IMSS, Ctr Med Siglo 21, Unidad Invest Med Inmunoquim, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Instituto Mexicano del Seguro Social	Satoskar, AR (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	literrazas@campus.iztacala.unam.mx; abhay.satoskar@osumc.edu	Terrazas, Luis I/AAV-8858-2020; Satoskar, Abhay/AAB-7748-2019	Alcantara-Hernandez, Marcela/0000-0002-3620-1248; Terrazas, Luis I./0000-0003-1635-9467	Consejo Nacional de Ciencia y Tecnologia (CONACYT; Mexico) [167799]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)-Universidad Nacional Autonoma de Mexico (UNAM) [IN213512]; CONACYT-Mexico, Programa de Doctorado en Ciencias Biomedicas (PDCB) UNAM; Fulbright-Mexico-U.S. Commission for Educational and. Cultural Exchange (COMEXUS); U.S. National Institutes of Health	Consejo Nacional de Ciencia y Tecnologia (CONACYT; Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)-Universidad Nacional Autonoma de Mexico (UNAM); CONACYT-Mexico, Programa de Doctorado en Ciencias Biomedicas (PDCB) UNAM; Fulbright-Mexico-U.S. Commission for Educational and. Cultural Exchange (COMEXUS); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Steve Oghumu for his help with experiments and critical reading of the paper. This work was supported by grant 167799 from Consejo Nacional de Ciencia y Tecnologia (CONACYT; Mexico) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)-Universidad Nacional Autonoma de Mexico (UNAM) IN213512, and is part of the requirements to obtain the Ph.D. degree in the Postgraduate Program in Biomedical Sciences, Facultad de Medicina, UNAM, for C. A. T., who was supported by a fellowship from CONACYT-Mexico, Programa de Doctorado en Ciencias Biomedicas (PDCB) UNAM, and Fulbright-Mexico-U.S. Commission for Educational and. Cultural Exchange (COMEXUS). The research in the A. R. S laboratory is supported by the grants from the U. S. National Institutes of Health. The authors declare no conflicts of interest.	Abdi K, 2012, J IMMUNOL, V188, P5981, DOI 10.4049/jimmunol.1102868; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Amit P, 2011, EXP PARASITOL, V127, P687, DOI 10.1016/j.exppara.2010.11.006; Balic A, 2004, EUR J IMMUNOL, V34, P3047, DOI 10.1002/eji.200425167; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Gomez-Garcia L, 2006, PARASITOL RES, V99, P440, DOI 10.1007/s00436-006-0159-2; Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2010, METHOD ENZYMOL, V480, P151, DOI 10.1016/S0076-6879(10)80008-4; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Guasconi L, 2011, IMMUNOLOGY, V133, P386, DOI 10.1111/j.1365-2567.2011.03449.x; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Kane CM, 2004, J IMMUNOL, V173, P7454, DOI 10.4049/jimmunol.173.12.7454; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Lee JJ, 2005, MOL BIOCHEM PARASIT, V143, P245, DOI 10.1016/j.molbiopara.2005.06.002; LI SF, 1993, P NATL ACAD SCI USA, V90, P9247, DOI 10.1073/pnas.90.20.9247; MacDonald AS, 2008, J EXP MED, V205, P13, DOI 10.1084/jem.20072665; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Napoletano C, 2012, EUR J IMMUNOL, V42, P936, DOI 10.1002/eji.201142086; Okano M, 2001, J IMMUNOL, V167, P442, DOI 10.4049/jimmunol.167.1.442; Okano M, 1999, J IMMUNOL, V163, P6712; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Poncini CV, 2010, MOL IMMUNOL, V47, P1981, DOI 10.1016/j.molimm.2010.04.016; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Qian C, 2006, BLOOD, V108, P2307, DOI 10.1182/blood-2006-03-005595; Reyes JL, 2011, INT J BIOL SCI, V7, P1323, DOI 10.7150/ijbs.7.1323; Reyes JL, 2011, CELL IMMUNOL, V267, P77, DOI 10.1016/j.cellimm.2010.11.006; Reyes JL, 2009, INFECT GENET EVOL, V9, P1115, DOI 10.1016/j.meegid.2009.05.011; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Saunders SP, 2009, INFECT IMMUN, V77, P399, DOI 10.1128/IAI.00762-08; Segura M, 2007, EUR J IMMUNOL, V37, P1887, DOI 10.1002/eji.200636553; Terrazas CA, 2011, INT J BIOL SCI, V7, P1298, DOI 10.7150/ijbs.7.1298; Terrazas CA, 2011, INT J BIOL SCI, V7, P1391, DOI 10.7150/ijbs.7.1391; Terrazas CA, 2010, INT J PARASITOL, V40, P1051, DOI 10.1016/j.ijpara.2010.02.016; Terrazas CA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357106; Terrazas LI, 1998, J PARASITOL, V84, P74, DOI 10.2307/3284533; Terrazas LI, 2008, CURR TOP MED CHEM, V8, P383, DOI 10.2174/156802608783790848; Thomas PG, 2005, J IMMUNOL, V175, P2082, DOI 10.4049/jimmunol.175.4.2082; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; Tundup S, 2012, ANN NY ACAD SCI, V1253, pE1, DOI 10.1111/j.1749-6632.2012.06618.x; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; Van Vliet S. J., 2013, J LEUKOC BIOL, DOI 10.1189/jlb.1012520; van Vliet SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000625; Vanhoutte F, 2007, MICROBES INFECT, V9, P1606, DOI 10.1016/j.micinf.2007.09.013; Villa OF, 1996, PARASITOLOGY, V112, P561, DOI 10.1017/S0031182000066142; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; Zhang SM, 2000, J IMMUNOL, V165, P1374, DOI 10.4049/jimmunol.165.3.1374	51	45	47	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4547	4560		10.1096/fj.13-228932	http://dx.doi.org/10.1096/fj.13-228932			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23907435	Green Published			2022-12-25	WOS:000329937500021
J	Du, ZY; Tong, XM; Ye, X				Du, Zhaoyang; Tong, Xiaomei; Ye, Xin			Cyclin D1 Promotes Cell Cycle Progression through Enhancing NDR1/2 Kinase Activity Independent of Cyclin-dependent Kinase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; CDK INHIBITORS; PROTEIN-KINASE; ACTIVATION; MECHANISM; PHOSPHORYLATION; REPRESSES; APOPTOSIS; RECEPTOR; FAMILY	Cyclin/cyclin-dependent kinases (Cdks) are critical protein kinases in regulating cell cycle progression. Among them, cyclin D1/Cdk4 exerts its function mainly in the G(1) phase. By using the tandem affinity purification tag approach, we identified a set of proteins interacting with Cdk4, including NDR1/2. Interestingly, confirming the interactions between NDR1/2 and cyclin D1/Cdk4, we observed that NDR1/2 interacted with cyclin D1 independent of Cdk4, but NDR1/2 and cyclin D1/Cdk4 did not phosphorylate each other. In addition, we found that NDR1/2 did not affect the kinase activity of cyclin D1/Cdk4 upon phosphorylation of GST-Rb. However, cyclin D1 but not Cdk4 promoted the kinase activity of NDR1/2. We also demonstrated that cyclin D1 K112E, which could not bind Cdk4, enhanced the kinase activity of NDR1/2. To test whether cyclin D1 promotes G(1)/S transition though enhancing NDR1/2 kinase activity, we performed flow cytometry analysis using cyclin D1 and cyclin D1 K112E Tet-On inducible cell lines. The data show that both cyclin D1 and cyclin D1 K112E promoted G(1)/S transition. Importantly, knockdown of NDR1/2 almost completely abolished the function of cyclin D1 K112E in promoting G(1)/S transition. Consistently, we found that the protein level of p21 was reduced in cells overexpressing cyclin D1 K112E but not when NDR1/2 was knocked down. Taken together, these results reveal a novel function of cyclin D1 in promoting cell cycle progression by enhancing NDR kinase activity independent of Cdk4.	[Du, Zhaoyang; Tong, Xiaomei; Ye, Xin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Du, Zhaoyang] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn			National Natural Science Foundation of China [81272272]; Ministry of Science and Technology of China [2012CB519003, 2011CB504705]; Chinese Academy of Sciences Innovation Project [KSCX2-EW-J-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences Innovation Project(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grant 81272272, Ministry of Science and Technology of China Grants 2012CB519003 and 2011CB504705, and Chinese Academy of Sciences Innovation Project KSCX2-EW-J-6.	Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; HARPER JW, 1993, CELL, V75, P805; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hirai H, 1996, MOL CELL BIOL, V16, P6457; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Kohler RS, 2010, MOL CELL BIOL, V30, P4507, DOI 10.1128/MCB.00150-10; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Ratineau C, 2002, J BIOL CHEM, V277, P8847, DOI 10.1074/jbc.M110747200; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stegert MR, 2004, J BIOL CHEM, V279, P23806, DOI 10.1074/jbc.M402472200; Suzuki A, 2006, J BIOL CHEM, V281, P13915, DOI 10.1074/jbc.M511354200; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Zhou YP, 2011, MOL CELL BIOL, V31, P3603, DOI 10.1128/MCB.01389-10; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	24	31	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26678	26687		10.1074/jbc.M113.466433	http://dx.doi.org/10.1074/jbc.M113.466433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897809	Green Published, hybrid			2022-12-25	WOS:000330594500033
J	Heissler, SM; Liu, X; Korn, ED; Sellers, JR				Heissler, Sarah M.; Liu, Xiong; Korn, Edward D.; Sellers, James R.			Kinetic Characterization of the ATPase and Actin-activated ATPase Activities of Acanthamoeba castellanii Myosin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE NONMUSCLE MYOSIN; MOTOR DOMAIN; DICTYOSTELIUM-DISCOIDEUM; II-C; ADENOSINE-TRIPHOSPHATASE; 50/20-KDA JUNCTION; MGATPASE ACTIVITY; IN-VITRO; ISOFORM; PHOSPHORYLATION	Phosphorylation of Ser-639 in loop-2 of the catalytic motor domain of the heavy chain of Acanthamoeba castellanii myosin-2 and the phosphomimetic mutation S639D have been shown previously to down-regulate the actin-activated ATPase activity of both the full-length myosin and single-headed subfragment-1 (Liu, X., Lee, D. Y., Cai, S., Yu, S., Shu, S., Levine, R. L., and Korn, E. D. (2013) Proc. Natl. Acad. Sci. U. S. A. 110, E23-E32). In the present study we determined the kinetic constants for each step in the myosin and actomyosin ATPase cycles of recombinant wild-type S1 and S1-S639D. The kinetic parameter predominantly affected by the S639D mutation is the actin-activated release of inorganic phosphate from the acto myosin.ADP.P-i complex, which is the rate-limiting step in the steady-state actomyosin ATPase cycle. As consequence of this change, the duty ratio of this conventional myosin decreases. We speculate on the effect of Ser-639 phosphorylation on the processive behavior of myosin-2 filaments.	[Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, 50 South Dr,B50-R3519, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov		Korn, Edward/0000-0003-3867-6295	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006117, ZIAHL001786] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Brzeska H., 1996, J BIOL CHEM, V271, P16986; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Geeves M A, 1995, Biophys J, V68, p194S; Geeves M. A, 1995, BIOPHYS J, V68, p199S; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; ITOH K, 1995, J BIOL CHEM, V270, P14533, DOI 10.1074/jbc.270.24.14533; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; Jana SS, 2009, J BIOL CHEM, V284, P11563, DOI 10.1074/jbc.M806574200; Joel PB, 2003, BIOCHEMISTRY-US, V42, P9160, DOI 10.1021/bi034415j; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Kim KY, 2008, BIOCHEM BIOPH RES CO, V369, P124, DOI 10.1016/j.bbrc.2007.11.108; Knetsch MLW, 1999, J BIOL CHEM, V274, P20133, DOI 10.1074/jbc.274.29.20133; Kong HH, 2002, J CELL SCI, V115, P4993, DOI 10.1242/jcs.00159; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; Kuhlman PA, 1998, J MUSCLE RES CELL M, V19, P491, DOI 10.1023/A:1005304408812; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Liu X, 2013, P NATL ACAD SCI USA, V110, pE33, DOI 10.1073/pnas.1219727110; Liu X, 2013, P NATL ACAD SCI USA, V110, pE23, DOI 10.1073/pnas.1219713110; MARSTON SB, 1980, J MOL BIOL, V139, P573, DOI 10.1016/0022-2836(80)90050-9; MARUTA H, 1977, J BIOL CHEM, V252, P6501; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; POLLARD TD, 1978, J BIOL CHEM, V253, P4798; POLLARD TD, 1982, J CELL BIOL, V95, P816, DOI 10.1083/jcb.95.3.816; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; ROTH K, 1991, MAGNET RESON MED, V22, P505, DOI 10.1002/mrm.1910220258; SINARD JH, 1989, J CELL BIOL, V109, P1537, DOI 10.1083/jcb.109.4.1537; SINARD JH, 1989, CELL MOTIL CYTOSKEL, V12, P42, DOI 10.1002/cm.970120106; SPUDICH JA, 1975, J BIOL CHEM, V250, P7485; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; Turbedsky K, 2005, J MOL BIOL, V345, P351, DOI 10.1016/j.jmb.2004.10.049; WAGNER PD, 1981, NATURE, V292, P560, DOI 10.1038/292560a0; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200	46	6	6	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26709	26720		10.1074/jbc.M113.485946	http://dx.doi.org/10.1074/jbc.M113.485946			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897814	Green Published, hybrid			2022-12-25	WOS:000330594500036
J	Shestakova, A; Curtiss, M; Davies, BA; Katzmann, DJ; Babst, M				Shestakova, Anna; Curtiss, Matt; Davies, Brian A.; Katzmann, David J.; Babst, Markus			The Linker Region Plays a Regulatory Role in Assembly and Activity of the Vps4 AAA ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY PATHWAY; ESCRT-III; STRUCTURAL BASIS; MIT DOMAIN; PROTEIN; YEAST; LIP5; AUTOINHIBITION; CYTOKINESIS; TRAFFICKING	The AAA-type ATPase Vps4 functions with components of the ESCRT (endosomal sorting complex required for transport) machinery in membrane fission events that are essential for endosomal maturation, cytokinesis, and the formation of retroviruses. A key step in these events is the assembly of monomeric Vps4 into the active ATPase complex, which is aided in part by binding of Vps4 via its N-terminal MIT (microtubule interacting and trafficking) domain to its substrate ESCRT-III. We found that the 40-amino acid linker region between the MIT and the ATPase domain of Vps4 is not required for proper function but plays a role in regulating Vps4 assembly and ATPase activity. Deletion of the linker is expected to bring the MIT domains into close proximity to the central pore of the Vps4 complex. We propose that this localization of the MIT domain in linker-deleted Vps4 mimics a repositioning of the MIT domain normally caused by binding of Vps4 to ESCRT-III. This structure would allow the Vps4 complex to engage ESCRT-III subunits with both the pore and the MIT domain simultaneously, which might be essential for the ATP-driven disassembly of ESCRT-III.	[Shestakova, Anna; Curtiss, Matt; Babst, Markus] Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT 84112 USA; [Shestakova, Anna; Curtiss, Matt; Babst, Markus] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Davies, Brian A.; Katzmann, David J.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55902 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Mayo Clinic	Babst, M (corresponding author), Univ Utah, Dept Biol, 257 South 1400 E, Salt Lake City, UT 84112 USA.	babst@biology.utah.edu			National Institutes of Health [R01GM074171, R01GM73024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074171, R01GM073024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074171 (to M. B.) and R01GM73024 (to D. J. K.).	Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Babst M, 2011, TRAFFIC, V12, P1298, DOI 10.1111/j.1600-0854.2011.01230.x; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Darsow T, 2000, METHOD ENZYMOL, V327, P95, DOI 10.1016/S0076-6879(00)27270-4; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Hartmann C, 2008, J MOL BIOL, V377, P352, DOI 10.1016/j.jmb.2008.01.010; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Takasu H, 2005, BIOCHEM BIOPH RES CO, V334, P460, DOI 10.1016/j.bbrc.2005.06.110; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009	30	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26810	26819		10.1074/jbc.M113.497032	http://dx.doi.org/10.1074/jbc.M113.497032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23913684	Green Published, hybrid			2022-12-25	WOS:000330594500045
J	Park, YK; Park, B; Lee, S; Choi, K; Moon, Y; Park, H				Park, Young-Kwon; Park, Bongju; Lee, Seongyeol; Choi, Kang; Moon, Yunwon; Park, Hyunsung			Hypoxia-inducible Factor-2 alpha-dependent Hypoxic Induction of Wnt10b Expression in Adipogenic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; BETA-CATENIN; STEM-CELLS; EMBRYONIC-DEVELOPMENT; INHIBIT ADIPOGENESIS; INSULIN-RESISTANCE; BINDING PROTEIN; GENE-EXPRESSION; FACTOR 1-ALPHA; DNA-BINDING	Adipocyte hyperplasia and hypertrophy in obesity can lead to many changes in adipose tissue, such as hypoxia, metabolic dysregulation, and enhanced secretion of cytokines. In this study, hypoxia increased the expression of Wnt10b in both human and mouse adipogenic cells, but not in hypoxia-inducible factor (HIF)-2 alpha-deficient adipogenic cells. Chromatin immunoprecipitation analysis revealed that HIF-2 alpha, but not HIF-1 alpha, bound to the Wnt10b enhancer region as well as upstream of the Wnt1 gene, which is encoded by an antisense strand of the Wnt10b gene. Hypoxia-conditioned medium(H-CM) induced phosphorylation of lipoprotein-receptor-related protein 6 as well as beta-catenin-dependent gene expression in normoxic cells, which suggests that H-CM contains canonical Wnt signals. Furthermore, adipogenesis of both human mesenchymal stem cells and mouse preadipocytes was inhibited by H-CM even under normoxic conditions. These results suggest that O-2 concentration gradients influence the formation of Wnt ligand gradients, which are involved in the regulation of pluripotency, cell proliferation, and cell differentiation.	[Park, Young-Kwon; Park, Bongju; Lee, Seongyeol; Choi, Kang; Moon, Yunwon; Park, Hyunsung] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea	University of Seoul	Park, H (corresponding author), Univ Seoul, Dept Life Sci, Siripdae Gil 13, Seoul 130743, South Korea.	hspark@uos.ac.kr		Park, Young-Kwon/0000-0002-3473-7233	National Research Foundation of Korea (NRF); Korea government [2011-0016318, 2012M3A9B6055343]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government(Korean Government)	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korea government (Grants 2011-0016318 and 2012M3A9B6055343) (to H. P.).	Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Christodoulides C, 2006, J CELL SCI, V119, P2613, DOI 10.1242/jcs.02975; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Fox KE, 2008, J BIOL CHEM, V283, P35096, DOI 10.1074/jbc.M806423200; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gustafson B, 2010, J BIOL CHEM, V285, P14031, DOI 10.1074/jbc.M110.102855; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Park YK, 2010, J BIOL CHEM, V285, P3289, DOI 10.1074/jbc.M109.059212; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Stiehl DP, 2012, ONCOGENE, V31, P2283, DOI 10.1038/onc.2011.417; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	45	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26311	26322		10.1074/jbc.M113.500835	http://dx.doi.org/10.1074/jbc.M113.500835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23900840	Green Published, hybrid			2022-12-25	WOS:000330623300060
J	Zhao, PS; Canals, M; Murphy, JE; Klingler, D; Eriksson, EM; Pelayo, JC; Hardt, M; Bunnett, NW; Poole, DP				Zhao, Peishen; Canals, Meritxell; Murphy, Jane E.; Klingler, Diana; Eriksson, Emily M.; Pelayo, Juan-Carlos; Hardt, Markus; Bunnett, Nigel W.; Poole, Daniel P.			Agonist-biased Trafficking of Somatostatin Receptor 2A in Enteric Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ARRESTIN; CELLS; INTERNALIZATION; ENDOSOMES; MOUSE; ENDOCYTOSIS; OCTREOTIDE; EXPRESSION; ISOFORMS	Somatostatin (SST) 14 and SST 28 activate somatostatin 2A receptors (SSTR2A) on enteric neurons to control gut functions. SST analogs are treatments of neuroendocrine and bleeding disorders, cancer, and diarrhea, with gastrointestinal side effects of constipation, abdominal pain, and nausea. How endogenous agonists and drugs differentially regulate neuronal SSTR2A is unexplored. We evaluated SSTR2A trafficking in murine myenteric neurons and neuroendocrine AtT-20 cells by microscopy and determined whether agonist degradation by endosomal endothelin-converting enzyme 1 (ECE-1) controls SSTR2A trafficking and association with beta-arrestins, key regulators of receptors. SST-14, SST-28, and peptide analogs (octreotide, lanreotide, and vapreotide) stimulated clathrin-and dynamin-mediated internalization of SSTR2A, which colocalized with ECE-1 in endosomes and the Golgi. After incubation with SST-14, SSTR2A recycled to the plasma membrane, which required active ECE-1 and an intact Golgi. SSTR2A activated by SST-28, octreotide, lanreotide, or vapreotide was retained within the Golgi and did not recycle. Although ECE-1 rapidly degraded SST-14, SST-28 was resistant to degradation, and ECE-1 did not degrade SST analogs. SST-14 and SST-28 induced transient interactions between SSTR2A and beta-arrestins that were stabilized by an ECE-1 inhibitor. Octreotide induced sustained SSTR2A/beta-arrestin interactions that were not regulated by ECE-1. Thus, when activated by SST-14, SSTR2A internalizes and recycles via the Golgi, which requires ECE-1 degradation of SST-14 and receptor dissociation from beta-arrestins. After activation by ECE-1-resistant SST-28 and analogs, SSTR2A remains in endosomes because of sustained beta-arrestin interactions. Therapeutic SST analogs are ECE-1-resistant and retain SSTR2A in endosomes, which may explain their long-lasting actions.	[Zhao, Peishen; Canals, Meritxell; Bunnett, Nigel W.; Poole, Daniel P.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Murphy, Jane E.; Pelayo, Juan-Carlos] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Klingler, Diana; Hardt, Markus] Forsyth Inst, Dept Appl Oral Sci, Cambridge, MA 02142 USA; [Eriksson, Emily M.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; Harvard University; Forsyth Institute; University of California System; University of California San Francisco	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	Nigel.Bunnett@Monash.edu; Daniel.Poole@Monash.edu	Poole, Daniel/AET-6645-2022; Zhao, Peishen/AFQ-6840-2022; Hardt, Markus/M-8569-2019	Poole, Daniel/0000-0002-6168-8422; Hardt, Markus/0000-0002-2300-216X; Canals, Meritxell/0000-0002-7942-5006; Eriksson, Emily/0000-0002-7851-973X; Bunnett, Nigel W./0000-0003-3367-0644	NIDCR National Institutes of Health [1R01DE019796]; National Health and Medical Research Council (NHMRC) [63303, 103188]; Monash University; NHMRC [454858]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019796] Funding Source: NIH RePORTER	NIDCR National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by NIDCR National Institutes of Health Grant 1R01DE019796 (to M. H. and N. W. B). This work was also supported by National Health and Medical Research Council (NHMRC) Grants 63303 and 103188 and Monash University (to N. W. B.) and by NHMRC Grant 454858 (to D. P. P.).	Abdu F, 2002, AM J PHYSIOL-GASTR L, V282, pG624, DOI 10.1152/ajpgi.00354.2001; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Csaba Z, 2007, TRAFFIC, V8, P820, DOI 10.1111/j.1600-0854.2007.00580.x; Gilroy John J, 2002, Treat Endocrinol, V1, P149, DOI 10.2165/00024677-200201030-00002; Grider JR, 2003, J PHARMACOL EXP THER, V307, P460, DOI 10.1124/jpet.103.053512; HOFLAND LJ, 1995, ENDOCRINOLOGY, V136, P3698, DOI 10.1210/en.136.9.3698; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kocan M, 2010, FRONT ENDOCRINOL, V1, P12; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Liu QS, 2005, MOL PHARMACOL, V68, P90, DOI 10.1124/mol.105.011767; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Muller L, 2003, J BIOL CHEM, V278, P545, DOI 10.1074/jbc.M208949200; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nunn C, 2004, BRIT J PHARMACOL, V142, P150, DOI 10.1038/sj.bjp.0705735; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oberg KE, 2010, GASTROENTEROLOGY, V139, P742, DOI 10.1053/j.gastro.2010.07.002; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Robinson S, 2008, PROTEOMICS, V8, P435, DOI 10.1002/pmic.200700680; Roosterman D, 2008, ENDOCRINOLOGY, V149, P2200, DOI 10.1210/en.2007-1628; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Sarret P, 2004, J BIOL CHEM, V279, P8029, DOI 10.1074/jbc.M310792200; Sarret P, 1999, J BIOL CHEM, V274, P19294, DOI 10.1074/jbc.274.27.19294; Schmidlin F, 2002, P NATL ACAD SCI USA, V99, P3324, DOI 10.1073/pnas.052161299; Schweizer A, 1997, BIOCHEM J, V328, P871, DOI 10.1042/bj3280871; Sternini C, 1997, J COMP NEUROL, V386, P396; Van Op den Bosch J, 2009, REGUL PEPTIDES, V156, P1; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Yang LH, 1998, J MED CHEM, V41, P2175, DOI 10.1021/jm980194h	32	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25689	25700		10.1074/jbc.M113.496414	http://dx.doi.org/10.1074/jbc.M113.496414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23913690	Green Published, hybrid			2022-12-25	WOS:000330623300003
J	Manic, G; Maurin-Marlin, A; Laurent, F; Vitale, I; Thierry, S; Delelis, O; Dessen, P; Vincendeau, M; Leib-Mosch, C; Hazan, U; Mouscadet, JF; Bury-Mone, S				Manic, Gwenola; Maurin-Marlin, Aurelie; Laurent, Fanny; Vitale, Ilio; Thierry, Sylvain; Delelis, Olivier; Dessen, Philippe; Vincendeau, Michelle; Leib-Moesch, Christine; Hazan, Uriel; Mouscadet, Jean-Francois; Bury-Mone, Stephanie			Impact of the Ku Complex on HIV-1 Expression and Latency	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; DEPENDENT PROTEIN-KINASE; CELLULAR TRANSCRIPTION FACTOR; END-JOINING PATHWAY; DNA-DAMAGE RESPONSE; HUMAN SOMATIC-CELLS; T-CELLS; POSTINTEGRATION LATENCY; RETROVIRAL INFECTION	Ku, a cellular complex required for human cell survival and involved in double strand break DNA repair and multiple other cellular processes, may modulate retroviral multiplication, although the precise mechanism through which it acts is still controversial. Recently, Ku was identified as a possible anti-human immunodeficiency virus type 1 (HIV-1) target in human cells, in two global approaches. Here we investigated the role of Ku on the HIV-1 replication cycle by analyzing the expression level of a panel of non-replicative lentiviral vectors expressing the green fluorescent protein in human colorectal carcinoma HCT 116 cells, stably or transiently depleted of Ku. We found that in this cellular model the depletion of Ku did not affect the efficiency of (pre-)integrative steps but decreased the early HIV-1 expression by acting at the transcriptional level. This negative effect was specific of the HIV-1 promoter, required the obligatory step of viral DNA integration and was reversed by transient depletion of p53. We also provided evidence on a direct binding of Ku to HIV-1 LTR in transduced cells. Ku not only promotes the early transcription from the HIV-1 promoter, but also limits the constitution of viral latency. Moreover, in the presence of a normal level of Ku, HIV-1 expression was gradually lost over time, likely due to the counter-selection of HIV-1-expressing cells. On the contrary, the reactivation of transgene expression from HIV-1 by means of trichostatin A- or tumor necrosis factor alpha-administration was enhanced under condition of Ku haplodepletion, suggesting a phenomenon of provirus latency. These observations plead in favor of the hypothesis that Ku has an impact on HIV-1 expression and latency at early- and mid-time after integration.	[Manic, Gwenola; Maurin-Marlin, Aurelie; Laurent, Fanny; Thierry, Sylvain; Delelis, Olivier; Hazan, Uriel; Mouscadet, Jean-Francois; Bury-Mone, Stephanie] Ecole Normale Super, CNRS UMR8113, Lab Biol & Pharmacol Appl, Cachan, France; [Vitale, Ilio] Regina Elena Inst Canc Res, Rome, Italy; [Vitale, Ilio] Natl Inst Hlth, Rome, Italy; [Dessen, Philippe] Inst Gustave Roussy, Villejuif, France; [Dessen, Philippe] INSERM, U985, Villejuif, France; [Vincendeau, Michelle; Leib-Moesch, Christine] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, Neuherberg, Germany; [Vincendeau, Michelle] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Toxicol & Pharmacol, Res Unit Cellular Signal Integrat, Neuherberg, Germany; [Leib-Moesch, Christine] Heidelberg Univ, Mannheim Med Ctr, Dept Hematol & Oncol, Mannheim, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Istituto Superiore di Sanita (ISS); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg	Bury-Mone, S (corresponding author), Ecole Normale Super, CNRS UMR8113, Lab Biol & Pharmacol Appl, Cachan, France.	stephanie.bury-mone@lbpa.ens-cachan.fr	Vincendeau, Michelle/AAD-4320-2022; Manic, Gwenola/J-8496-2018; Vitale, Ilio/M-3960-2017	Vitale, Ilio/0000-0002-5918-1841; Manic, Gwenola/0000-0003-3759-8029; laurent, frederic/0000-0003-0609-9091; Bury-Mone, Stephanie/0000-0003-2535-2208	Agence Nationale de Recherches (ANR) sur le SIDA; ANR; Association Francaise contre les Myopathies; Italian Association for Cancer Research	Agence Nationale de Recherches (ANR) sur le SIDA(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This study was funded by the Agence Nationale de Recherches (ANR) sur le SIDA and the ANR. GM holds a fellowship from the Association Francaise contre les Myopathies. IV is funded by the Italian Association for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JL, 2005, CELL DEATH DIFFER, V12, P326, DOI 10.1038/sj.cdd.4401565; Ariumi Y, 2005, J VIROL, V79, P2973, DOI 10.1128/JVI.79.5.2973-2978.2005; Baekelandt V, 2000, J VIROL, V74, P11278, DOI 10.1128/JVI.74.23.11278-11285.2000; Bertinato J, 2003, GENE, V302, P53, DOI 10.1016/S0378111902010892; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Choul-li S, 2009, BIOCHEM BIOPH RES CO, V390, P839, DOI 10.1016/j.bbrc.2009.10.059; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Cosnefroy O, 2012, J VIROL, V86, P513, DOI 10.1128/JVI.05425-11; Deshmane SL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-477; Donahue DA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-11; Duverger A, 2009, J VIROL, V83, P3078, DOI 10.1128/JVI.02058-08; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; Errami A, 1996, MOL CELL BIOL, V16, P1519; Fenard D, 2009, NUCLEIC ACIDS RES, V37, P6008, DOI 10.1093/nar/gkp673; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Genovesio A, 2011, J BIOMOL SCREEN, V16, P945, DOI 10.1177/1087057111415521; Ghosh G, 2007, RADIAT RES, V167, P66, DOI 10.1667/RR0692.1; Giffin W, 1999, MOL CELL BIOL, V19, P4065; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Gullo C, 2006, BBA-REV CANCER, V1765, P223, DOI 10.1016/j.bbcan.2006.01.001; Hakre S, 2012, FEMS MICROBIOL REV, V36, P706, DOI 10.1111/j.1574-6976.2012.00335.x; Holcomb VB, 2008, CANCER RES, V68, P9497, DOI 10.1158/0008-5472.CAN-08-2085; ISRAEL N, 1989, J IMMUNOL, V143, P3956; Jeanson L, 2002, VIROLOGY, V300, P100, DOI 10.1006/viro.2002.1515; Jeanson L, 2002, J BIOL CHEM, V277, P4918, DOI 10.1074/jbc.M110830200; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; Kilzer JM, 2003, VIROLOGY, V314, P460, DOI 10.1016/S0042-6822(03)00455-0; Kim H, 2008, AMINO ACIDS, V34, P195, DOI 10.1007/s00726-006-0411-1; Lau A, 2004, EMBO J, V23, P3421, DOI 10.1038/sj.emboj.7600348; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu HB, 2010, BIOCHEM BIOPH RES CO, V397, P245, DOI 10.1016/j.bbrc.2010.05.092; Manic G, 2012, HUM GENE THER METHOD; Masson C, 2007, J VIROL, V81, P7924, DOI 10.1128/JVI.02015-06; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Pearson R, 2008, J VIROL, V82, P12291, DOI 10.1128/JVI.01383-08; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Santos S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-65; Schild-Poulter C, 2003, CANCER RES, V63, P7197; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shi LF, 2007, NUCLEIC ACIDS RES, V35, P2302, DOI 10.1093/nar/gkm117; Shirakawa K, 2013, TRENDS MICROBIOL; SMITH SD, 1984, CANCER RES, V44, P5657; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Studamire B, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-48; Taube R, 2013, VIRUSES-BASEL, V5, P902, DOI 10.3390/v5030902; Thierry S, 2004, J VIROL, V78, P12198, DOI 10.1128/JVI.78.22.12198-12206.2004; Thierry S, 2007, AIDS, V21, P283, DOI 10.1097/QAD.0b013e3280115b50; Tuteja R, 2000, CRIT REV BIOCHEM MOL, V35, P1, DOI 10.1080/10409230091169177; Tyagi S, 2011, J GEN VIROL, V92, P1710, DOI 10.1099/vir.0.029587-0; VanLint C, 1997, J VIROL, V71, P6113, DOI 10.1128/JVI.71.8.6113-6127.1997; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11; WANG LL, 1995, J BIOL CHEM, V270, P25564, DOI 10.1074/jbc.270.43.25564; Wang YB, 2009, P NATL ACAD SCI USA, V106, P12430, DOI 10.1073/pnas.0903362106; Waninger S, 2004, J VIROL, V78, P12829, DOI 10.1128/JVI.78.23.12829-12837.2004; Wei S, 2012, CARCINOGENESIS, V33, P538, DOI 10.1093/carcin/bgr319; Xu P, 2004, J BIOL CHEM, V279, P16057, DOI 10.1074/jbc.M305856200; Yoder K, 2006, P NATL ACAD SCI USA, V103, P4622, DOI 10.1073/pnas.0509828103; Zhao RY, 2011, J NEUROIMMUNE PHARM, V6, P216, DOI 10.1007/s11481-011-9261-z; Zheng YF, 2011, J BIOL CHEM, V286, P17722, DOI 10.1074/jbc.M110.184739	70	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69691	10.1371/journal.pone.0069691	http://dx.doi.org/10.1371/journal.pone.0069691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922776	Green Submitted, Green Published, gold			2022-12-25	WOS:000323369700065
J	Sun, EC; Zhao, J; Sun, L; Xu, QY; Yang, T; Qin, YL; Wang, WS; Wei, P; Sun, J; Wu, DL				Sun, EnCheng; Zhao, Jing; Sun, Liang; Xu, QingYuan; Yang, Tao; Qin, YongLi; Wang, WenShi; Wei, Peng; Sun, Jing; Wu, DongLai			Comprehensive Mapping of Common Immunodominant Epitopes in the Eastern Equine Encephalitis Virus E2 Protein Recognized by Avian Antibody Responses	PLOS ONE			English	Article							WEST-NILE-VIRUS; ENCEPHALOMYELITIS VIRUS; VENEZUELAN; ALPHAVIRUSES; GLYCOPROTEINS; MORTALITY; E1	Eastern equine encephalitis virus (EEEV) is a mosquito-borne virus that can cause both human and equine encephalitis with high case fatality rates. EEEV can also be widespread among birds, including pheasants, ostriches, emu, turkeys, whooping cranes and chickens. The E2 protein of EEEV and other Alphaviruses is an important immunogenic protein that elicits antibodies of diagnostic value. While many therapeutic and diagnostic applications of E2 protein-specific antibodies have been reported, the specific epitopes on E2 protein recognized by the antibody responses of different susceptible hosts, including avian species, remain poorly defined. In the present study, the avian E2-reactive polyclonal antibody (PAb) response was mapped to linear peptide epitopes using PAbs elicited in chickens and ducks following immunization with recombinant EEEV E2 protein and a series of 42 partially overlapping peptides covering the entire EEEV E2 protein. We identified 12 and 13 peptides recognized by the chicken and duck PAb response, respectively. Six of these linear peptides were commonly recognized by PAbs elicited in both avian species. Among them five epitopes recognized by both avian, the epitopes located at amino acids 211-226 and 331-352 were conserved among the EEEV antigenic complex, but not other associated alphaviruses, whereas the epitopes at amino acids 11-26, 30-45 and 151-166 were specific to EEEV subtype I. The five common peptide epitopes were not recognized by avian PAbs against Avian Influenza Virus (AIV) and Duck Plague Virus (DPV). The identification and characterization of EEEV E2 antibody epitopes may be aid the development of diagnostic tools and facilitate the design of epitope-based vaccines for EEEV. These results also offer information with which to study the structure of EEEV E2 protein.	[Sun, EnCheng; Zhao, Jing; Sun, Liang; Xu, QingYuan; Yang, Tao; Qin, YongLi; Wang, WenShi; Wei, Peng; Sun, Jing; Wu, DongLai] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Minist Agr,Key Lab Vet Publ Hlth, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wu, DL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Minist Agr,Key Lab Vet Publ Hlth, Harbin, Peoples R China.	dlwu@hvri.ac.cn			National High-Tech Research and Development Program of China [2011AA10A212]; Heilongjiang Natural Science Foundation of China [ZJN-0602-01]; State Key Laboratory of Veterinary Biotechnology [SKLVBP201018, SKLVBP201210]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Heilongjiang Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province); State Key Laboratory of Veterinary Biotechnology	This study was supported by National High-Tech Research and Development Program of China (No. 2011AA10A212), Heilongjiang Natural Science Foundation of China (No. ZJN-0602-01) and grants from State Key Laboratory of Veterinary Biotechnology (SKLVBP201018 and SKLVBP201210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo NC, 2010, EMERG INFECT DIS, V16, P1373, DOI 10.3201/eid1609.100459; Arrigo NC, 2010, J VIROL, V84, P1014, DOI 10.1128/JVI.01586-09; Beckwith WH, 2002, AM J TROP MED HYG, V66, P422, DOI 10.4269/ajtmh.2002.66.422; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Brault AC, 1999, AM J TROP MED HYG, V61, P579, DOI 10.4269/ajtmh.1999.61.579; Brown TM, 2001, AM J TROP MED HYG, V65, P208, DOI 10.4269/ajtmh.2001.65.208; BROWN TP, 1993, AVIAN DIS, V37, P602, DOI 10.2307/1591696; CORNIOU B, 1972, TROP GEOGR MED, V24, P162; CRANS WJ, 1986, J MED ENTOMOL, V23, P626, DOI 10.1093/jmedent/23.6.626; DEIN FJ, 1986, J AM VET MED ASSOC, V189, P1006; DIETZ WH, 1980, AM J TROP MED HYG, V29, P133, DOI 10.4269/ajtmh.1980.29.133; ELVINGER F, 1994, J AM VET MED ASSOC, V205, P1014; FICKEN MD, 1993, AVIAN DIS, V37, P585, DOI 10.2307/1591693; Garmashova N, 2007, J VIROL, V81, P2472, DOI 10.1128/JVI.02073-06; Hunt AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000739; Itoh M, 2002, J CLIN MICROBIOL, V40, P1733, DOI 10.1128/JCM.40.5.1733-1738.2002; Iversson Lygia Busch, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P355, DOI 10.1590/S0036-46651993000400009; JOHNSON BJB, 1990, VIROLOGY, V177, P676, DOI 10.1016/0042-6822(90)90533-W; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; MORRIS CD, 1980, J MED ENTOMOL, V17, P442, DOI 10.1093/jmedent/17.5.442; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; NELSON DB, 1983, AM J TROP MED HYG, V32, P412, DOI 10.4269/ajtmh.1983.32.412; Pereboev AV, 1996, ARCH VIROL, V141, P2191, DOI 10.1007/BF01718225; Phillpotts RJ, 2006, VIRUS RES, V120, P107, DOI 10.1016/j.virusres.2006.02.003; SABATTINI MS, 1991, MEDICINA-BUENOS AIRE, V51, P3; Schlesinger S, 2001, EXPERT OPIN BIOL TH, V1, P177, DOI 10.1517/14712598.1.2.177; Scott T. W., 1989, Advances in Virus Research, V37, P277, DOI 10.1016/S0065-3527(08)60838-6; SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648; Sun EC, 2012, J GEN VIROL, V93, P50, DOI 10.1099/vir.0.034900-0; Sun EC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-100; TULLY TN, 1992, AVIAN DIS, V36, P808, DOI 10.2307/1591790; WALDER R, 1976, INT J EPIDEMIOL, V5, P375, DOI 10.1093/ije/5.4.375; WEAVER SC, 1993, VIROLOGY, V197, P375, DOI 10.1006/viro.1993.1599; Weaver SC, 2012, ANTIVIR RES, V94, P242, DOI 10.1016/j.antiviral.2012.04.002; WEINACK OM, 1978, AVIAN DIS, V22, P378, DOI 10.2307/1589292; Williams SM, 2000, AVIAN DIS, V44, P1012, DOI 10.2307/1593081; Zhang R, 2011, EMBO J, V30, P3854, DOI 10.1038/emboj.2011.261; Zhao J, 2012, VET IMMUNOL IMMUNOP, V148, P364, DOI 10.1016/j.vetimm.2012.06.021	38	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69349	10.1371/journal.pone.0069349	http://dx.doi.org/10.1371/journal.pone.0069349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922704	Green Submitted, gold, Green Published			2022-12-25	WOS:000322838900036
J	van Schalkwyk, C; Mndzebele, S; Hlophe, T; Calleja, JMG; Korenromp, EL; Stoneburner, R; Pervilhac, C				van Schalkwyk, Cari; Mndzebele, Sibongile; Hlophe, Thabo; Calleja, Jesus Maria Garcia; Korenromp, Eline L.; Stoneburner, Rand; Pervilhac, Cyril			Outcomes and Impact of HIV Prevention, ART and TB Programs in Swaziland - Early Evidence from Public Health Triangulation	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MALAWI	Introduction: Swaziland's severe HIV epidemic inspired an early national response since the late 1980s, and regular reporting of program outcomes since the onset of a national antiretroviral treatment (ART) program in 2004. We assessed effectiveness outcomes and mortality trends in relation to ART, HIV testing and counseling (HTC), tuberculosis (TB) and prevention of mother to child transmission (PMTCT). Methods: Data triangulated include intervention coverage and outcomes according to program registries (2001-2010), hospital admissions and deaths disaggregated by age and sex (2001-2010) and population mortality estimates from the 1997 and 2007 censuses and the 2007 demographic and health survey. Results: By 2010, ART reached 70% of the estimated number of people living with HIV/AIDS with CD4<350/mm(3), with progressively improving patient retention and survival. As of 2010, 88% of health facilities providing antenatal care offered comprehensive PMTCT services. The HTC program recorded a halving in the proportion of adults tested who were HIV-infected; similarly HIV infection rates among HIV-exposed babies halved from 2007 to 2010. Case fatality rates among hospital patients diagnosed with HIV/AIDS started to decrease from 2005-6 in adults and especially in children, contrasting with stable case fatality for other causes including TB. All-cause child in-patient case fatality rates started to decrease from 2005-6. TB case notifications as well as rates of HIV/TB co-infection among notified TB patients continued a steady increase through 2010, while coverage of HIV testing and CPT for co-infected patients increased to above 80%. Conclusion: Against a background of high, but stable HIV prevalence and decreasing HIV incidence, we documented early evidence of a mortality decline associated with the expanded national HIV response since 2004. Attribution of impact to specific interventions (versus natural epidemic dynamics) will require additional data from future household surveys, and improved routine (program, surveillance, and hospital) data at district level.	[van Schalkwyk, Cari] Univ Stellenbosch, Natl Res Fdn Ctr Excellence Epidemiol Modelling &, South African Dept Sci & Technol, Cape Town, South Africa; [Mndzebele, Sibongile; Hlophe, Thabo] Swaziland Minist Hlth, Strateg Informat Dept, Mbabane, Swaziland; [Calleja, Jesus Maria Garcia; Pervilhac, Cyril] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Korenromp, Eline L.] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Stoneburner, Rand] UNAIDS, Geneva, Switzerland	National Research Foundation - South Africa; Stellenbosch University; World Health Organization; Erasmus University Rotterdam; Erasmus MC; UNAIDS	van Schalkwyk, C (corresponding author), Univ Stellenbosch, Natl Res Fdn Ctr Excellence Epidemiol Modelling &, South African Dept Sci & Technol, Cape Town, South Africa.	carivs@sun.ac.za; rlstoneburner@gmail.com; pervilhacc@gmail.com		van Schalkwyk, Cari/0000-0001-5154-1390	Global Fund to fight AIDS, Tuberculosis and Malaria [PO 20024822]	Global Fund to fight AIDS, Tuberculosis and Malaria	The work was supported under direct funding of the Global Fund to fight AIDS, Tuberculosis and Malaria through Contribution Agreement PO 20024822. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GUID MON EV COLL TB; [Anonymous], JOINT UN PROGR HIV A; [Anonymous], 2011, GUID INT TUB CAS FIN; Canadian International Development Agency World Health Organization, 2012, AR WE ACH GOALS GLOB; Chadborn T, 2012, 19 INT AIDS C; Columbia University Mailman School of Public Health, 2012, 1 FIND REL SWAZ HIV; Desmond Christopher, 2004, Afr J AIDS Res, V3, P43, DOI 10.2989/16085900409490317; Floyd S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013499; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; International Health Partnership and World Health Organization, 2011, MON EV REV NAT HLTH; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Johnson LF, 2012, SO AFR J HIV MED, V13; Malawi Ministry of Health the South African DST/NRF Centre of Excellence, 2011, EP MOD AN GLOB UNPUB; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; Organization WH, 2011, GUID MON EV NAT HIV; Rutherford GW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-447; Ruutel K, 2011, HIV EPIDEMIC ESTONIA; Stoneburner R, 2013, USING HLTH SUR UNPUB; Stoneburner R, 2006, 16 INT TOR CAN AIDS; STOP AIDS NOW! The Clinton Health Access Initiative (CHAI), 2010, END NEW HIV INF SWAZ; Swaziland Central Statistical Office, 2006, SWAZ DEM HLTH SURV; Swaziland Central Statistical Office, 2007, SWAZ POP HOUS CENS 2; Swaziland Ministry of Health and Social Services, 2010, SWAZ TUB CONTR ANN R; Swaziland Ministry of Health and Social Services, 2011, PMTCT PROGR ANN REP; Swaziland Ministry of Health and Social Services, 2011, ART PROGR ANN REP; Swaziland Ministry of Health and Social Services, 2010, 12 NAT HIV SER WOM A; Swaziland Ministry of Health and Social Services, 2012, NAT GUID IMPL TUB IN; Swaziland Ministry of Health and Social Services, 2010, SERV AV MAPP; Swaziland Ministry of Health and Social Services World Health Organization United Nations Children's Fund, 2011, EV EFF NAT PREV MOTH; Swaziland Ministry of Health/ Monitoring and Evaluation the South African DST/ NRF Centre of Excellence, 2011, REV EMERGENCIES SWAZ; Swaziland National Emergency Response Council on HIV and AIDS, 2009, NAT MULT FRAM HIV AI; Swaziland National Emergency Response Council on HIV and AIDS Joint. United Nations Programme on HIV/AIDS, 2010, 12 NAT HIV SER WOM A; Swaziland Nutrition Council World Food Programme Action Against Hunger, 2010, NAT GUID INT MAN AC; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2011, MON EV TOOLK 2; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2009, SWZ405G04H GLOB FUND; The Global Fund to Fight AIDS Tuberculosis and Malaria. World Health Organization Joint United Nations Programme on HIV/AIDS, 2009, HIV TRIANG RES GUID; UNAIDS, 2011, ADDR STIGM DISCR HOM; Velephi Okello, 2012, BASELINE CHARACTERIS; Whiteside A, 2007, REV EMERGENCIES SWAZ; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, MEAS IMP NAT PMTCT P; WHO, 2003, PUBL HLTH APPR ANT T; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; World Health Organization, 2003, HIV TEST COUNS GAT T; World Health Organization, 2006, CAS STUD COUNTR ENH, P924; World Health Organization Joint United Nations Programme on HIV/AIDS United Nations Children's Fund, 2010, GLOB FUND FIGHT AIDS; World Health Organization United Nations Children's Fund, 2010, MON EV PREV MOTH TO; World Health Organization United Nations Children's Fund Joint United Nations Programme on HIV/AIDS, 2012, HDB IND KEY HIV INT; [World Health Organization; WHO UNAIDS UNICEF], 2011, EP UPD HLTH SECT PRO; Zachariah R, 2011, INT J TUBERC LUNG D, V15, P933, DOI 10.5588/ijtld.10.0666	50	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69437	10.1371/journal.pone.0069437	http://dx.doi.org/10.1371/journal.pone.0069437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922711	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900041
J	Hu, YX; Gao, L; Shi, K; Chiu, DKY				Hu, Yuxuan; Gao, Lin; Shi, Kai; Chiu, David K. Y.			Detection of Deregulated Modules Using Deregulatory Linked Path	PLOS ONE			English	Article							DYSREGULATED PATHWAYS; SIGNALING NETWORKS; BREAST-CANCER; EXPRESSION; OVEREXPRESSION; HER-2/NEU; SET; PROLIFERATION; ALGORITHMS; MECHANISM	The identification of deregulated modules (such as induced by oncogenes) is a crucial step for exploring the pathogenic process of complex diseases. Most of the existing methods focus on deregulation of genes rather than the links of the path among them. In this study, we emphasize on the detection of deregulated links, and develop a novel and effective regulatory path-based approach in finding deregulated modules. Observing that a regulatory pathway between two genes might involve in multiple rather than a single path, we identify condition-specific core regulatory path (CCRP) to detect the significant deregulation of regulatory links. Using time-series gene expression, we define the regulatory strength within each gene pair based on statistical dependence analysis. The CCRPs in regulatory networks can then be identified using the shortest path algorithm. Finally, we derive the deregulated modules by integrating the differential edges (as deregulated links) of the CCRPs between the case and the control group. To demonstrate the effectiveness of our approach, we apply the method to expression data associated with different states of Human Epidermal Growth Factor Receptor 2 (HER2). The experimental results show that the genes as well as the links in the deregulated modules are significantly enriched in multiple KEGG pathways and GO biological processes, most of which can be validated to suffer from impact of this oncogene based on previous studies. Additionally, we find the regulatory mechanism associated with the crucial gene SNAI1 significantly deregulated resulting from the activation of HER2. Hence, our method provides not only a strategy for detecting the deregulated links in regulatory networks, but also a way to identify concerning deregulated modules, thus contributing to the target selection of edgetic drugs.	[Hu, Yuxuan; Gao, Lin; Shi, Kai] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China; [Shi, Kai] Guilin Univ Technol, Coll Sci, Guilin, Guangxi, Peoples R China; [Chiu, David K. Y.] Univ Guelph, Sch Comp Sci, Guelph, ON N1G 2W1, Canada	Xidian University; Guilin University of Technology; University of Guelph	Gao, L (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China.	lgao@mail.xidian.edu.cn		shi, Kai/0000-0003-0038-625X	NSFC [60933009, 91130006]; Natural Science and Engineering Council of Canada [400297]	NSFC(National Natural Science Foundation of China (NSFC)); Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by NSFC (Grant No. 60933009& 91130006) (URL: http://www.nsfc.gov.cn/Portal0/default166.htm) and partially supported by Natural Science and Engineering Council of Canada (Grant No. 400297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Backes C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1227; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Cabusora L, 2005, BIOINFORMATICS, V21, P2898, DOI 10.1093/bioinformatics/bti440; Carraway KL, 2006, CANCER CELL, V10, P93, DOI 10.1016/j.ccr.2006.07.015; Caruso ML, 1996, ANTICANCER RES, V16, P3813; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hirsch FR, 2004, SEMIN ONCOL, V31, P75, DOI 10.1053/j.seminoncol.2003.12.018; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; JOHNSON DB, 1977, J ACM, V24, P1, DOI 10.1145/321992.321993; Kapitanovic S, 1997, GASTROENTEROLOGY, V112, P1103, DOI 10.1016/S0016-5085(97)70120-3; Keller A, 2009, BIOINFORMATICS, V25, P2787, DOI 10.1093/bioinformatics/btp510; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liu KQ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-126; Luo FM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-26; Martin-Subero JI, 2001, CANCER GENET CYTOGEN, V127, P174, DOI 10.1016/S0165-4608(00)00431-3; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nacu S, 2007, BIOINFORMATICS, V23, P850, DOI 10.1093/bioinformatics/btm019; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Ross JS, 2001, CANCER INVEST, V19, P554, DOI 10.1081/CNV-100103852; Schmitz KJ, 2005, BREAST CANCER RES, V7, pR194, DOI 10.1186/bcr977; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shih YK, 2012, BIOINFORMATICS, V28, pI49, DOI 10.1093/bioinformatics/bts212; Smirnova OV, 2007, WORLD J GASTROENTERO, V13, P6478, DOI 10.3748/wjg.13.6478; Soini Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-73; Stumm G, 1996, INT J CANCER, V69, P17, DOI 10.1002/(SICI)1097-0215(19960220)69:1<17::AID-IJC4>3.3.CO;2-O; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulitsky I, 2008, LECT N BIOINFORMAT, V4955, P347; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Wang JG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr251; Wilson CA, 2005, BREAST CANCER RES, V7, pR1058, DOI 10.1186/bcr1343; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; YAMANAKA Y, 1993, HUM PATHOL, V24, P1127, DOI 10.1016/0046-8177(93)90194-L; Yang HY, 2000, J BIOL CHEM, V275, P24735, DOI 10.1074/jbc.C000147200; Yu HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6; Zhao XM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn145; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	44	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70412	10.1371/journal.pone.0070412	http://dx.doi.org/10.1371/journal.pone.0070412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894653	Green Submitted, Green Published, gold			2022-12-25	WOS:000322167900126
J	Benazzi, S; Nguyen, HN; Kullmer, O; Hublin, JJ				Benazzi, Stefano; Huynh Nhu Nguyen; Kullmer, Ottmar; Hublin, Jean-Jacques			Unravelling the Functional Biomechanics of Dental Features and Tooth Wear	PLOS ONE			English	Article							MOLAR ENAMEL THICKNESS; FINITE-ELEMENT; STRESS-DISTRIBUTION; FRACTURE; FAILURE; TEETH; PATTERNS; MORPHOLOGY; BEHAVIOR; DESIGNS	Most of the morphological features recognized in hominin teeth, particularly the topography of the occlusal surface, are generally interpreted as an evolutionary functional adaptation for mechanical food processing. In this respect, we can also expect that the general architecture of a tooth reflects a response to withstand the high stresses produced during masticatory loadings. Here we use an engineering approach, finite element analysis (FEA), with an advanced loading concept derived from individual occlusal wear information to evaluate whether some dental traits usually found in hominin and extant great ape molars, such as the trigonid crest, the entoconid-hypoconulid crest and the protostylid have important biomechanical implications. For this purpose, FEA was applied to 3D digital models of three Gorilla gorilla lower second molars (M-2) differing in wear stages. Our results show that in unworn and slightly worn M(2)s tensile stresses concentrate in the grooves of the occlusal surface. In such condition, the trigonid and the entoconid-hypoconulid crests act to reinforce the crown locally against stresses produced along the mesiodistal groove. Similarly, the protostylid is shaped like a buttress to suffer the high tensile stresses concentrated in the deep buccal groove. These dental traits are less functional in the worn M-2, because tensile stresses decrease physiologically in the crown with progressing wear due to the enlargement of antagonistic contact areas and changes in loading direction from oblique to nearly parallel direction to the dental axis. This suggests that the wear process might have a crucial influence in the evolution and structural adaptation of molars enabling to endure bite stresses and reduce tooth failure throughout the lifetime of an individual.	[Benazzi, Stefano; Huynh Nhu Nguyen; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Kullmer, Ottmar] Senckenberg Res Inst, Dept Palaeoanthropol & Messel Res, Frankfurt, Germany	Max Planck Society; Senckenberg Gesellschaft fur Naturforschung (SGN)	Benazzi, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	stefano_benazzi@eva.mpg.de	Benazzi, Stefano/AAH-3923-2020	Kullmer, Ottmar/0000-0002-5929-8070; Benazzi, Stefano/0000-0003-4305-6920; Nguyen, Nhu Huynh/0000-0001-5493-3752	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	The Occlusal Fingerprint Analyser software programming is financed by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation). This is publication no. 54 of the DFG Research Unit 771 "Function and performance enhancement in the mammalian dentition - phylogenetic and ontogenetic impact on the masticatory apparatus." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PSL, 2011, J MORPHOL, V272, P50, DOI 10.1002/jmor.10896; Bajaj D, 2009, ACTA BIOMATER, V5, P3045, DOI 10.1016/j.actbio.2009.04.013; Barani A, 2011, ACTA BIOMATER, V7, P2285, DOI 10.1016/j.actbio.2011.01.038; Benazzi S, 2014, CLIN ORAL INVEST, V18, P369, DOI 10.1007/s00784-013-0973-8; Benazzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062263; Benazzi S, 2012, AM J PHYS ANTHROPOL, V147, P128, DOI 10.1002/ajpa.21607; Benazzi S, 2011, J ANAT, V219, P259, DOI 10.1111/j.1469-7580.2011.01396.x; Berthaume M, 2010, ANAT REC, V293, P594, DOI 10.1002/ar.21130; Chai H, 2009, ACTA BIOMATER, V5, P1663, DOI 10.1016/j.actbio.2008.11.007; Chai H, 2009, P NATL ACAD SCI USA, V106, P7289, DOI 10.1073/pnas.0902466106; Chang YH, 2009, MED BIOL ENG COMPUT, V47, P367, DOI 10.1007/s11517-008-0379-y; Cheng YY, 2010, DENT MATER, V26, pE211, DOI 10.1016/j.dental.2010.05.002; Constantino PJ, 2009, AM J PHYS ANTHROPOL, V140, P653, DOI 10.1002/ajpa.21096; Dejak B, 2007, J PROSTHET DENT, V98, P89, DOI 10.1016/S0022-3913(07)60042-0; FIELD C, 2010, J DENT BIOMECH, V1, P1; Fleagle GJ, 1999, PRIMATE ADAPTATION E; Hasegawa A, 2010, INT J BIOMATER, V2010, DOI 10.1155/2010/659802; Hattori Y, 2009, J BIOMECH, V42, P1533, DOI 10.1016/j.jbiomech.2009.03.040; Hlusko LJ, 2004, J HUM EVOL, V46, P579, DOI 10.1016/j.jhevol.2004.03.003; Holmes DC, 1996, J PROSTHET DENT, V75, P140, DOI 10.1016/S0022-3913(96)90090-6; KAY RF, 1985, ANNU REV ANTHROPOL, V14, P315, DOI 10.1146/annurev.an.14.100185.001531; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; KAY RF, 1974, AM J PHYS ANTHROPOL, V40, P227, DOI 10.1002/ajpa.1330400210; KO CC, 1992, J PROSTHET DENT, V68, P421, DOI 10.1016/0022-3913(92)90404-X; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Kullmer O, 2012, ANAT REC, V295, P846, DOI 10.1002/ar.22440; Lawn BR, 2009, ACTA BIOMATER, V5, P2213, DOI 10.1016/j.actbio.2009.02.001; Lee JJW, 2011, BIOL REV, V86, P959, DOI 10.1111/j.1469-185X.2011.00181.x; Lee JJW, 2010, ACTA BIOMATER, V6, P4560, DOI 10.1016/j.actbio.2010.07.023; Li H, 2001, WEAR, V249, P980, DOI 10.1016/S0043-1648(01)00835-3; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Macho GA, 1999, AM J PHYS ANTHROPOL, V109, P211, DOI 10.1002/(SICI)1096-8644(199906)109:2<211::AID-AJPA6>3.3.CO;2-2; Macho GA, 2010, J HUM EVOL, V58, P23, DOI 10.1016/j.jhevol.2009.07.004; Magne P, 2002, INT J PERIODONT REST, V22, P425; Myoung S, 2009, J BIOMECH, V42, P1947, DOI 10.1016/j.jbiomech.2009.05.013; Qasim T, 2007, J BIOMED MATER RES B, V80B, P78, DOI 10.1002/jbm.b.30571; RUBIN C, 1983, J DENT RES, V62, P82, DOI 10.1177/00220345830620021701; Schwartz GT, 2000, AM J PHYS ANTHROPOL, V111, P221, DOI 10.1002/(SICI)1096-8644(200002)111:2<221::AID-AJPA8>3.0.CO;2-G; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Skinner MM, 2009, J HUM EVOL, V56, P76, DOI 10.1016/j.jhevol.2008.08.021; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Sornsuwan T, 2012, ACTA BIOMATER, V8, P4426, DOI 10.1016/j.actbio.2012.08.006; Sornsuwan T, 2011, DENT MATER, V27, P1127, DOI 10.1016/j.dental.2011.08.005; SPEARS IR, 1993, J DENT RES, V72, P1526, DOI 10.1177/00220345930720111101; Ungar P, 2004, J HUM EVOL, V46, P605, DOI 10.1016/j.jhevol.2004.03.004; Ungar PS, 2011, SCIENCE, V334, P190, DOI 10.1126/science.1207701; Ungar PS, 2003, P NATL ACAD SCI USA, V100, P3874, DOI 10.1073/pnas.0637016100; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; Wang M, 2013, J ORAL REHABIL, V40, P69, DOI 10.1111/j.1365-2842.2012.02333.x; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	51	34	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69990	10.1371/journal.pone.0069990	http://dx.doi.org/10.1371/journal.pone.0069990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894570	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000170
J	Hong, YF; Wu, JX; Zhao, JP; Wang, HP; Liu, Y; Chen, TP; Kan, XL; Tao, QS; Shen, XS; Yan, KL; Zhai, ZM				Hong, Yongfeng; Wu, Jianxian; Zhao, Jingpu; Wang, Huiping; Liu, Yi; Chen, Tianping; Kan, Xiuli; Tao, Qianshan; Shen, Xianshan; Yan, Kaili; Zhai, Zhimin			miR-29b and miR-29c Are Involved in Toll-Like Receptor Control of Glucocorticoid-Induced Apoptosis in Human Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NUCLEIC-ACIDS; EXPRESSION; INFECTION; MIR-16; LUPUS	Glucocorticoids (GCs) are frequently used to treat many of the acute disease manifestations associated with inflammatory and autoimmune disorders. However, Toll-like receptor (TLR) pathway-activated plasmacytoid dendritic cells (pDCs) are resistant to GC-induced apoptosis, which leads to the inefficiency of GCs in the treatment of type I interferon-related autoimmune diseases, such as systemic lupus erythematosus (SLE). Therefore, compounds promoting pDC apoptosis may be helpful for improving the efficacy of GCs. In this study, we performed screening to identify microRNAs (miRNAs) involved in TLR-inhibited GC-induced pDC apoptosis and found an array of miRNAs that may regulate pDC apoptosis. Among those demonstrating altered expression, 6 miRNAs were inhibited in TLR-activated pDCs. Bioinformatics analysis and functional studies indicated that miR-29b and miR-29c were 2 key miRNAs involved in TLR-inhibited GC-induced pDC apoptosis. Furthermore, both of these miRNAs promoted pDC apoptosis by directly targeting Mcl-1 and Bcl-2 in human primary pDCs. Our findings provide new targets that could improve the efficacy of GCs for the treatment of SLE.	[Hong, Yongfeng; Wu, Jianxian; Zhao, Jingpu; Liu, Yi; Kan, Xiuli; Shen, Xianshan] Anhui Med Univ, Affiliated Hosp 2, Dept Rehabil, Hefei City, Anhui, Peoples R China; [Wang, Huiping; Chen, Tianping; Tao, Qianshan; Yan, Kaili; Zhai, Zhimin] Anhui Med Univ, Affiliated Hosp 2, Dept Hematol, Hefei City, Anhui, Peoples R China; [Wang, Huiping; Chen, Tianping; Tao, Qianshan; Yan, Kaili; Zhai, Zhimin] Anhui Med Univ, Affiliated Hosp 2, Ctr Blood Res, Hefei City, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Zhai, ZM (corresponding author), Anhui Med Univ, Affiliated Hosp 2, Dept Hematol, Hefei City, Anhui, Peoples R China.	zzzm889@163.com	wang, hui/GRS-4730-2022	Liu, Yi/0000-0003-4641-7904	National Natural Science Foundation of China [81141104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China grant (the impact of cellular senescence and SENEX gene on the peripheral CD4+CD25+ Treg cells enhancement in elderly No. 81141104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chatham WW, 2001, LUPUS, V10, P140, DOI 10.1191/096120301675075008; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Lepelletier Y, 2010, BLOOD, V116, P3389, DOI 10.1182/blood-2010-05-282913; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; MOSER M, 1995, EUR J IMMUNOL, V25, P2818, DOI 10.1002/eji.1830251016; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sampath D, 2012, BLOOD, V119, P1162, DOI 10.1182/blood-2011-05-351510; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380	22	34	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69926	10.1371/journal.pone.0069926	http://dx.doi.org/10.1371/journal.pone.0069926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894561	Green Submitted, gold, Green Published			2022-12-25	WOS:000325211000166
J	Olaya-Abril, A; Jimenez-Munguia, I; Gomez-Gascon, L; Obando, I; Rodriguez-Ortega, MJ				Olaya-Abril, Alfonso; Jimenez-Munguia, Irene; Gomez-Gascon, Lidia; Obando, Ignacio; Rodriguez-Ortega, Manuel J.			Identification of Potential New Protein Vaccine Candidates through Pan-Surfomic Analysis of Pneumococcal Clinical Isolates from Adults	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; STREPTOCOCCUS-PNEUMONIAE; SURFACE PROTEIN; INTRANASAL IMMUNIZATION; COMPARATIVE EFFICACY; PROTEOMIC ANALYSIS; CONJUGATE VACCINE; ECONOMIC BURDEN; CELL-SURFACE; MICE	Purified polysaccharide and conjugate vaccines are widely used for preventing infections in adults and in children against the Gram-positive bacterium Streptococcus pneumoniae, a pathogen responsible for high morbidity and mortality rates, especially in developing countries. However, these polysaccharide-based vaccines have some important limitations, such as being serotype-dependent, being subjected to losing efficacy because of serotype replacement and high manufacturing complexity and cost. It is expected that protein-based vaccines will overcome these issues by conferring a broad coverage independent of serotype and lowering production costs. In this study, we have applied the "shaving" proteomic approach, consisting of the LC/MS/MS analysis of peptides generated by protease treatment of live cells, to a collection of 16 pneumococcal clinical isolates from adults, representing the most prevalent strains circulating in Spain during the last years. The set of unique proteins identified in all the isolates, called "pan-surfome", consisted of 254 proteins, which included most of the protective protein antigens reported so far. In search of new candidates with vaccine potential, we identified 32 that were present in at least 50% of the clinical isolates analyzed. We selected four of them (Spr0012, Spr0328, Spr0561 and SP670_2141), whose protection capacity has not yet been tested, for assaying immunogenicity in human sera. All of them induced the production of IgM antibodies in infected patients, thus indicating that they could enter the pipeline for vaccine studies. The pan-surfomic approach shows its utility in the discovery of new proteins that can elicit protection against infectious microorganisms.	[Olaya-Abril, Alfonso; Jimenez-Munguia, Irene; Rodriguez-Ortega, Manuel J.] Univ Cordoba, Dept Bioquim & Biol Mol, Cordoba, Spain; [Olaya-Abril, Alfonso; Jimenez-Munguia, Irene; Rodriguez-Ortega, Manuel J.] Campus Excelencia Int CeiA3, Cordoba, Spain; [Olaya-Abril, Alfonso; Jimenez-Munguia, Irene; Rodriguez-Ortega, Manuel J.] Hosp Univ Reina Sofia, Cordoba, Spain; [Olaya-Abril, Alfonso; Jimenez-Munguia, Irene; Rodriguez-Ortega, Manuel J.] Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Olaya-Abril, Alfonso; Jimenez-Munguia, Irene; Rodriguez-Ortega, Manuel J.] Inst Salud Carlos III, REIPI, Madrid, Spain; [Gomez-Gascon, Lidia] Univ Cordoba, Dept Sanidad Anim, Cordoba, Spain; [Obando, Ignacio] Hosp Univ Infantil Virgen Rocio, Secc Enfermedades Infecciosas Pediat & Inmunopato, Seville, Spain	Universidad de Cordoba; Hospital Universitario Reina Sofia - Cordoba; Instituto de Salud Carlos III; Universidad de Cordoba	Rodriguez-Ortega, MJ (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Cordoba, Spain.	mjrodriguez@uco.es	IBIS, INMUNODEFICIEN/C-1245-2016; Rodriguez-Ortega, Manuel J/L-8244-2014; GASCÓN, LIDIA GÓMEZ/L-8037-2014; Abril, Alfonso Olaya/L-9176-2014	Rodriguez-Ortega, Manuel J/0000-0002-8744-7045; GASCÓN, LIDIA GÓMEZ/0000-0002-4570-6635; Abril, Alfonso Olaya/0000-0002-8961-1099; Obando, Ignacio/0000-0002-4516-1735	Spanish Ministry of Science and Innovation [SAF2008-00733]; Consejeria de Innovacion, Ciencia y Empresa (Junta de Andalucia) [P09-CTS-4616]; Consejeria de Salud (Junta de Andalucia) [PI-0207-2010]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Innovacion, Ciencia y Empresa (Junta de Andalucia)(Junta de Andalucia); Consejeria de Salud (Junta de Andalucia)(Junta de Andalucia)	This research was funded by Project Grants SAF2008-00733 (Spanish Ministry of Science and Innovation), P09-CTS-4616 from Consejeria de Innovacion, Ciencia y Empresa (Junta de Andalucia) and PI-0207-2010 from Consejeria de Salud (Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683, DOI 10.1128/IAI.62.12.5683-5688.1994; Ampofo K, 2012, PEDIATR INFECT DIS J, V31, P228, DOI 10.1097/INF.0b013e31823dcc72; Ardanuy C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043619; Assaad U, 2012, CLIN INTERV AGING, V7, P453, DOI 10.2147/CIA.S29675; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Blasi F, 2012, CLIN MICROBIOL INFEC, V18, P7, DOI 10.1111/j.1469-0691.2012.03937.x; Cao J, 2008, MICROBES INFECT, V10, P1536, DOI 10.1016/j.micinf.2008.09.007; Cardaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036588; Choi CW, 2010, J MICROBIOL, V48, P872, DOI 10.1007/s12275-010-0220-9; Cron LE, 2011, INFECT IMMUN, V79, P3697, DOI 10.1128/IAI.01383-10; Doro F, 2009, MOL CELL PROTEOMICS, V8, P1728, DOI 10.1074/mcp.M800486-MCP200; Dreisbach A, 2010, PROTEOMICS, V10, P3082, DOI 10.1002/pmic.201000062; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Firacative C, 2009, REV PANAM SALUD PUBL, V25, P337, DOI 10.1590/S1020-49892009000400008; Garibaldi M, 2010, VACCINE, V28, P3609, DOI 10.1016/j.vaccine.2010.01.009; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Gianfaldoni C, 2009, INFECT IMMUN, V77, P2957, DOI 10.1128/IAI.01516-08; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Glover DT, 2008, INFECT IMMUN, V76, P2767, DOI 10.1128/IAI.01126-07; Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10; Gomez-Gascon L, 2012, J PROTEOMICS, V75, P5654, DOI 10.1016/j.jprot.2012.07.025; Grabenstein JD, 2012, CLIN MICROBIOL INFEC, V18, P15, DOI 10.1111/j.1469-0691.2012.03943.x; Grandi G, 2001, TRENDS BIOTECHNOL, V19, P181, DOI 10.1016/S0167-7799(01)01600-6; Grandi Guido, 2006, Methods Biochem Anal, V49, P379; Grau I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042595; Green BA, 2005, INFECT IMMUN, V73, P981, DOI 10.1128/IAI.73.2.981-989.2005; Hagerman A, 2012, CLIN MICROBIOL INFEC, V18, P756, DOI 10.1111/j.1469-0691.2011.03629.x; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hermans PWM, 2006, J BIOL CHEM, V281, P968, DOI 10.1074/jbc.M510014200; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Jomaa M, 2006, VACCINE, V24, P5133, DOI 10.1016/j.vaccine.2006.04.012; Kerr AR, 2004, INFECT IMMUN, V72, P3902, DOI 10.1128/IAI.72.7.3902-3906.2004; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; LOCK RA, 1988, MICROB PATHOGENESIS, V5, P461, DOI 10.1016/0882-4010(88)90007-1; LOCK RA, 1992, MICROB PATHOGENESIS, V12, P137, DOI 10.1016/0882-4010(92)90116-6; Mandanici F, 2010, J PROTEOMICS, V73, P2365, DOI 10.1016/j.jprot.2010.07.009; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Morsczeck C, 2008, CLIN MICROBIOL INFEC, V14, P74, DOI 10.1111/j.1469-0691.2007.01878.x; Musher DM, 2013, INFECT DIS CLIN N AM, V27, P229, DOI 10.1016/j.idc.2012.11.011; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obando I, 2008, EMERG INFECT DIS, V14, P1390, DOI 10.3201/eid1409.071094; Olaya-Abril A, 2012, J PROTEOMICS, V75, P3733, DOI 10.1016/j.jprot.2012.04.037; Overweg K, 2000, INFECT IMMUN, V68, P4180, DOI 10.1128/IAI.68.7.4180-4188.2000; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pittet LF, 2012, CLIN MICROBIOL INFEC, V18, P25, DOI 10.1111/j.1469-0691.2012.03938.x; Porat N, 2008, PEDIATR INFECT DIS J, V27, P709, DOI 10.1097/INF.0b013e31816fca86; Portnoi M, 2006, VACCINE, V24, P1868, DOI 10.1016/j.vaccine.2005.10.053; Rodriguez-Ortega MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-588; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Shah P, 2006, INFECT IMMUN, V74, P5888, DOI 10.1128/IAI.00553-06; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Solis N, 2010, PROTEOMICS, V10, P2037, DOI 10.1002/pmic.200900564; Soualhine H, 2005, MOL MICROBIOL, V58, P1430, DOI 10.1111/j.1365-2958.2005.04914.x; Sun XS, 2011, OMICS, V15, P683, DOI 10.1089/omi.2010.0133; Talkington DF, 1996, MICROB PATHOGENESIS, V21, P17, DOI 10.1006/mpat.1996.0038; Thomas JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018649; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Vanderkooi OG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028547; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Weycker D, 2010, VACCINE, V28, P4955, DOI 10.1016/j.vaccine.2010.05.030; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Wu HY, 1997, J INFECT DIS, V175, P839, DOI 10.1086/513980	71	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70365	10.1371/journal.pone.0070365	http://dx.doi.org/10.1371/journal.pone.0070365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894641	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000205
J	Leucker, TM; Ge, ZD; Procknow, J; Liu, YN; Shi, Y; Bienengraeber, M; Warltier, DC; Kersten, JR				Leucker, Thorsten M.; Ge, Zhi-Dong; Procknow, Jesse; Liu, Yanan; Shi, Yang; Bienengraeber, Martin; Warltier, David C.; Kersten, Judy R.			Impairment of Endothelial-Myocardial Interaction Increases the Susceptibility of Cardiomyocytes to Ischemia/Reperfusion Injury	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DEPENDENT DIABETES-MELLITUS; A(3) ADENOSINE RECEPTOR; IN-VIVO; VASCULAR ENDOTHELIUM; REPERFUSION INJURY; OXIDATIVE STRESS; TETRAHYDROBIOPTERIN; HYPERGLYCEMIA; CELLS	Endothelial-myocardial interactions may be critically important for ischemia/reperfusion injury. Tetrahydrobiopterin (BH4) is a required cofactor for nitric oxide (NO) production by endothelial NO synthase (eNOS). Hyperglycemia (HG) leads to significant increases in oxidative stress, oxidizing BH4 to enzymatically incompetent dihydrobiopterin. How alterations in endothelial BH4 content impact myocardial ischemia/reperfusion injury remains elusive. The aim of this study was to examine the effect of endothelial-myocardial interaction on ischemia/reperfusion injury, with an emphasis on the role of endothelial BH4 content. Langendorff-perfused mouse hearts were treated by triton X-100 to produce endothelial dysfunction and subsequently subjected to 30 min of ischemia followed by 2 h of reperfusion. The recovery of left ventricular systolic and diastolic function during reperfusion was impaired in triton X-100 treated hearts compared with vehicle-treated hearts. Cardiomyocytes (CMs) were co-cultured with endothelial cells (ECs) and subsequently subjected to 2 h of hypoxia followed by 2 h of reoxygenation. Addition of ECs to CMs at a ratio of 1:3 significantly increased NO production and decreased lactate dehydrogenase activity compared with CMs alone. This EC-derived protection was abolished by HG. The addition of 100 mM sepiapterin (a BH4 precursor) or overexpression of GTP cyclohydrolase 1 (the rate-limiting enzyme for BH4 biosynthesis) in ECs by gene trasfer enhanced endothelial BH4 levels, the ratio of eNOS dimer/monomer, eNOS phosphorylation, and NO production and decreased lactate dehydrogenase activity in the presence of HG. These results demonstrate that increased BH4 content in ECs by either pharmacological or genetic approaches reduces myocardial damage during hypoxia/reoxygenation in the presence of HG. Maintaining sufficient endothelial BH4 is crucial for cardioprotection against hypoxia/reoxygenation injury.	[Leucker, Thorsten M.; Ge, Zhi-Dong; Procknow, Jesse; Liu, Yanan; Bienengraeber, Martin; Warltier, David C.; Kersten, Judy R.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Shi, Yang] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA; [Bienengraeber, Martin; Warltier, David C.; Kersten, Judy R.] Med Coll Wisconsin, Deparment Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Ge, ZD (corresponding author), Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA.	zdge@mcw.edu	Leucker, Thorsten/AAW-5971-2020		National Institutes of Health research grants [HL 063705, GM 066730]; United States Public Health Services, Bethesda, Maryland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM089586, P01GM066730] Funding Source: NIH RePORTER	National Institutes of Health research grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Services, Bethesda, Maryland(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by National Institutes of Health research grants HL 063705 (to Dr. Kersten) and GM 066730 (to Drs. Kersten and Warltier) from the United States Public Health Services, Bethesda, Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Amour J, 2010, ANESTHESIOLOGY, V112, P576, DOI 10.1097/ALN.0b013e3181cded1f; Amour J, 2009, ANESTHESIOLOGY, V110, P317, DOI 10.1097/ALN.0b013e3181942cb4; ANVERSA P, 1980, J MOL CELL CARDIOL, V12, P781, DOI 10.1016/0022-2828(80)90080-2; Bauersachs J, 2005, CARDIOVASC RES, V65, P768, DOI 10.1016/j.cardiores.2004.12.011; Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cai S, 2005, DIABETOLOGIA, V48, P1933, DOI 10.1007/s00125-005-1857-5; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cauwels A, 2006, J CLIN INVEST, V116, P2244, DOI 10.1172/JCI25426; Channon KM, 2004, TRENDS CARDIOVAS MED, V14, P323, DOI 10.1016/j.tcm.2004.10.003; Chen CY, 2010, AM J PHYSIOL-HEART C, V299, pH193, DOI 10.1152/ajpheart.00431.2009; Cote GM, 2005, EXP CELL RES, V311, P135, DOI 10.1016/j.yexcr.2005.08.017; Crabtree MJ, 2009, J BIOL CHEM, V284, P28128, DOI 10.1074/jbc.M109.041483; Crabtree MJ, 2009, J BIOL CHEM, V284, P1136, DOI 10.1074/jbc.M805403200; Deedwania P, 2008, CIRCULATION, V117, P1610, DOI 10.1161/CIRCULATIONAHA.107.188629; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Frantz S, 2009, BASIC RES CARDIOL, V104, P773, DOI 10.1007/s00395-009-0041-3; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Ge ZD, 2006, J PHARMACOL EXP THER, V319, P1200, DOI 10.1124/jpet.106.111351; Ge ZD, 2011, CARDIOVASC RES, V91, P340, DOI 10.1093/cvr/cvr079; Ge ZD, 2010, ANESTHESIOLOGY, V112, P73, DOI 10.1097/ALN.0b013e3181c4a607; Gui C, 2012, CARDIOVASC PATHOL, V21, P414, DOI 10.1016/j.carpath.2011.12.006; He GW, 2011, ANN THORAC SURG, V92, P845, DOI 10.1016/j.athoracsur.2011.04.063; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Ishihara M, 2007, AM J CARDIOL, V99, P1674, DOI 10.1016/j.amjcard.2007.01.044; Jamnicki-Abegg M, 2005, ANESTHESIOLOGY, V103, P1006, DOI 10.1097/00000542-200511000-00015; Janssens S, 2004, CIRC RES, V94, P1256, DOI 10.1161/01.RES.0000126497.38281.23; Kennedy RH, 2004, AM J PHYSIOL-HEART C, V287, pH812, DOI 10.1152/ajpheart.01042.2003; Kersten JR, 2001, AM J PHYSIOL-HEART C, V281, pH2097, DOI 10.1152/ajpheart.2001.281.5.H2097; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Kuramochi Y, 2004, J BIOL CHEM, V279, P51141, DOI 10.1074/jbc.M408662200; Lemmens K, 2004, CIRCULATION, V109, P324, DOI 10.1161/01.CIR.0000114521.88547.5E; Lemmens K, 2006, J BIOL CHEM, V281, P19469, DOI 10.1074/jbc.M600399200; Leucker TM, 2011, J MOL CELL CARDIOL, V51, P803, DOI 10.1016/j.yjmcc.2011.06.026; LI K, 1993, CIRC RES, V72, P768, DOI 10.1161/01.RES.72.4.768; Makimattila S, 1996, CIRCULATION, V94, P1276, DOI 10.1161/01.CIR.94.6.1276; Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07; NICHOL CA, 1983, P NATL ACAD SCI-BIOL, V80, P1546, DOI 10.1073/pnas.80.6.1546; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; RAMACIOTTI C, 1993, CIRC RES, V72, P1044, DOI 10.1161/01.RES.72.5.1044; SCHERRER U, 1994, J CLIN INVEST, V94, P2511, DOI 10.1172/JCI117621; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Szelid Z, 2010, BASIC RES CARDIOL, V105, P169, DOI 10.1007/s00395-009-0077-4; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; VANE JR, 1990, NEW ENGL J MED, V323, P27; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Vladic N, 2011, AM J PHYSIOL-HEART C, V301, pH2130, DOI 10.1152/ajpheart.01078.2010; Vo PA, 2005, J BIOL CHEM, V280, P7236, DOI 10.1074/jbc.M411317200; von Bibra Helene, 2011, Curr Heart Fail Rep, V8, P242, DOI 10.1007/s11897-011-0070-8; Wan TC, 2008, J PHARMACOL EXP THER, V324, P234, DOI 10.1124/jpet.107.127480; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695	60	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e70088	10.1371/journal.pone.0070088	http://dx.doi.org/10.1371/journal.pone.0070088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894596	Green Submitted, Green Published, gold			2022-12-25	WOS:000322132100087
J	Li, JF; Lin, Y; Yang, YH; Gan, HL; Liang, Y; Liu, J; Yang, SQ; Zhang, WJ; Cui, N; Zhao, L; Zhai, ZG; Wang, J; Wang, C				Li, Ji-Feng; Lin, Yuan; Yang, Yuan-Hua; Gan, Hui-Li; Liang, Yan; Liu, Jie; Yang, Su-Qiao; Zhang, Wei-Juan; Cui, Na; Zhao, Lan; Zhai, Zhen-Guo; Wang, Jun; Wang, Chen			Fibrinogen A alpha Thr312Ala Polymorphism Specifically Contributes to Chronic Thromboembolic Pulmonary Hypertension by Increasing Fibrin Resistance	PLOS ONE			English	Article							DEEP VENOUS THROMBOSIS; MYOCARDIAL-INFARCTION; GENETIC-VARIATION; GAMMA-CHAINS; RISK; EMBOLISM; BETA	Background: Polymorphisms are associated with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary thromboembolism (PTE), but no polymorphism specific to CTEPH but not PTE has yet been reported. Fibrin resistance is associated with CTEPH, but the mechanism has not been elucidated. Methods: Polymorphisms were analyzed in 101 CTEPH subjects, 102 PTE subjects and 108 healthy controls by Massarray or restriction fragment length polymorphism (RFLP). Plasmin-mediated cleavage of fibrin was characterized in 69 subjects (29 with CTEPH, 21 with PTE and 19 controls). Results: Genotype frequencies and allele frequencies of fibrinogen A alpha Thr312Ala were significantly higher in CTEPH subjects than in controls and PTE subjects, while there was no difference between PTE subjects and controls. The odd ratio (OR 2.037) and 95% confidence interval (95% CI, 1.262-3.289) showed that Thr312Ala polymorphism was a risk factor for CTEPH but not PTE. Fibrin from CTEPH subjects was more resistant to lysis than that from PTE subjects and controls. Fibrin resistance was significantly different between A alpha Thr312Ala (A/G) genotypes within CTEPH subjects, and the fibrin with GG genotype was more resistant than that with AA and AG genotype. Conclusions: Fibrinogen A alpha Thr312Ala (A/G) polymorphism was associated with CTEPH, but not PTE, suggesting that the fibrinogen A alpha Thr312Ala polymorphism may act as a potential biomarker in identifying CTEPH from PTE. GG genotype polymorphism contributes to CTEPH through increasing fibrin resistance, implying that PTE subjects with fibrinogen A alpha GG genotype may need long-term anticoagulation therapy.	[Li, Ji-Feng; Lin, Yuan; Yang, Yuan-Hua; Yang, Su-Qiao; Zhang, Wei-Juan; Cui, Na; Zhai, Zhen-Guo] Capital Med Univ, Dept Resp & Crit Care Med, Beijing Chao Yang Hosp, Beijing, Peoples R China; [Li, Ji-Feng; Lin, Yuan; Yang, Yuan-Hua; Liang, Yan; Yang, Su-Qiao; Zhang, Wei-Juan; Cui, Na; Zhai, Zhen-Guo; Wang, Jun; Wang, Chen] Capital Med Univ, Beijing Inst Resp Med, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing Chao Yang Hosp, Beijing, Peoples R China; [Li, Ji-Feng; Lin, Yuan; Liang, Yan; Liu, Jie; Zhang, Wei-Juan; Wang, Jun] Capital Med Univ, Dept Physiol, Beijing, Peoples R China; [Li, Ji-Feng; Lin, Yuan; Yang, Yuan-Hua; Liang, Yan; Liu, Jie; Yang, Su-Qiao; Zhang, Wei-Juan; Cui, Na; Zhai, Zhen-Guo; Wang, Jun; Wang, Chen] Capital Med Univ, Dept Resp Dis, Beijing, Peoples R China; [Gan, Hui-Li] Capital Med Univ, Dept Cardiac Surg, Beijing An Zhen Hosp, Beijing, Peoples R China; [Zhao, Lan] Univ London Imperial Coll Sci Technol & Med, Ctr Pharmacol & Therapeut, London, England	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Imperial College London	Wang, J (corresponding author), Capital Med Univ, Beijing Inst Resp Med, Beijing Key Lab Resp & Pulm Circulat Disorders, Beijing Chao Yang Hosp, Beijing, Peoples R China.	wang_jun@ccmu.edu.cn; cyh-birm@263.net	Zhai, Zhen/GYA-1598-2022		Fund of China 973 program [2009CB522107]; National Natural Science Foundation of China [81228001, 81070042, 81111130212, 81200041]; Fund of PVRI	Fund of China 973 program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of PVRI	This work was supported by the following funds: Fund of China 973 program (2009CB522107), National Natural Science Foundation of China (81228001, 81070042, 81111130212, 81200041) and Fund of PVRI (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2008, BLOOD, V111, P643, DOI 10.1182/blood-2007-05-091231; Attia John, 2007, J Stroke Cerebrovasc Dis, V16, P173, DOI 10.1016/j.jstrokecerebrovasdis.2007.03.002; Becattini C, 2006, CHEST, V130, P172, DOI 10.1378/chest.130.1.172; Carter AM, 2000, BLOOD, V96, P1177, DOI 10.1182/blood.V96.3.1177.015k25_1177_1179; CULLIS JO, 1993, NUCL MED COMMUN, V14, P4, DOI 10.1097/00006231-199301000-00002; Willige SU, 2007, J THROMB HAEMOST, V5, P1243, DOI 10.1111/j.1538-7836.2007.02566.x; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; Fedullo PF, 2000, EUR RESPIR J, V15, P435, DOI 10.1034/j.1399-3003.2000.15.01.x; Hoeper MM, 2006, CIRCULATION, V113, P2011, DOI 10.1161/CIRCULATIONAHA.105.602565; Humbert M, 2010, EUR RESPIR REV, V19, P59, DOI 10.1183/09059180.00007309; Jacquemin B, 2008, J AM COLL CARDIOL, V52, P941, DOI 10.1016/j.jacc.2008.06.016; Korkmaz A, 2012, CLIN APPL THROMB-HEM, V18, P281, DOI 10.1177/1076029611431956; Kotlin R, 2012, AM J HEMATOL, V87, P555, DOI 10.1002/ajh.23162; Lim BCB, 2003, LANCET, V361, P1424, DOI 10.1016/S0140-6736(03)13135-2; Miniati M, 2010, AM J RESP CRIT CARE, V181, P992, DOI 10.1164/rccm.200907-1135OC; Morris TA, 2007, THROMB RES, V119, P257, DOI 10.1016/j.thromres.2006.02.010; Morris TA, 2006, AM J RESP CRIT CARE, V173, P1270, DOI 10.1164/rccm.200506-916OC; MOSER KM, 1990, CIRCULATION, V81, P1735, DOI 10.1161/01.CIR.81.6.1735; NIELSEN HK, 1994, J INTERN MED, V235, P457, DOI 10.1111/j.1365-2796.1994.tb01103.x; Park R, 2012, THROMB HAEMOSTASIS, V107, P875, DOI 10.1160/TH11-10-0731; Peacock Andrew, 2006, Proc Am Thorac Soc, V3, P608, DOI 10.1513/pats.200605-114LR; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Piazza G, 2011, NEW ENGL J MED, V364, P351, DOI 10.1056/NEJMra0910203; Siegerink B, 2009, J THROMB HAEMOST, V7, P385, DOI 10.1111/j.1538-7836.2008.03266.x; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Standeven KF, 2003, CIRCULATION, V107, P2326, DOI 10.1161/01.CIR.0000066690.89407.CE; Suntharalingam J, 2008, EUR RESPIR J, V31, P736, DOI 10.1183/09031936.00055107; Tetik S, 2011, CLIN APPL THROMB-HEM, V17, P259, DOI 10.1177/1076029610363129; Vlieg AV, 2003, J THROMB HAEMOST, V1, P2677, DOI 10.1111/j.1538-7836.2003.0543b.x; Weisel JW, 2001, ANN NY ACAD SCI, V936, P312; Wolf M, 2000, EUR RESPIR J, V15, P395, DOI 10.1034/j.1399-3003.2000.15b28.x	31	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69635	10.1371/journal.pone.0069635	http://dx.doi.org/10.1371/journal.pone.0069635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894515	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100073
J	Stressler, T; Eisele, T; Schlayer, M; Lutz-Wahl, S; Fischer, L				Stressler, Timo; Eisele, Thomas; Schlayer, Michael; Lutz-Wahl, Sabine; Fischer, Lutz			Characterization of the Recombinant Exopeptidases PepX and PepN from Lactobacillus helveticus ATCC 12046 Important for Food Protein Hydrolysis	PLOS ONE			English	Article							PROLYL-DIPEPTIDYL AMINOPEPTIDASE; SPECIFICITY AMINOPEPTIDASE; GENERAL AMINOPEPTIDASE; SEQUENCE-ANALYSIS; PURIFICATION; EXPRESSION; PEPTIDASES; CLONING; MODEL	The proline-specific X-prolyl dipeptidyl aminopeptidase (PepX; EC 3.4.14.11) and the general aminopeptidase N (PepN; EC 3.4.11.2) from Lactobacillus helveticus ATCC 12046 were produced recombinantly in E. coli BL21(DE3) via bioreactor cultivation. The maximum enzymatic activity obtained for PepX was 800 mu kat(H-Ala-Pro-pNA) L-1, which is approx. 195-fold higher than values published previously. To the best of our knowledge, PepN was expressed in E. coli at high levels for the first time. The PepN activity reached 1,000 mu kat(H-Ala-pNA) L-1. After an automated chromatographic purification, both peptidases were biochemically and kinetically characterized in detail. Substrate inhibition of PepN and product inhibition of both PepX and PepN were discovered for the first time. An apo-enzyme of the Zn2+-dependent PepN was generated, which could be reactivated by several metal ions in the order of Co2+>Zn2+>Mn2+>Ca2+>Mg2+. PepX and PepN exhibited a clear synergistic effect in casein hydrolysis studies. Here, the relative degree of hydrolysis (rDH) was increased by approx. 132%. Due to the remarkable temperature stability at 50 degrees C and the complementary substrate specificities of both peptidases, a future application in food protein hydrolysis might be possible.	[Stressler, Timo; Eisele, Thomas; Schlayer, Michael; Lutz-Wahl, Sabine; Fischer, Lutz] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Biotechnol, Stuttgart, Germany	University Hohenheim	Fischer, L (corresponding author), Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Biotechnol, Stuttgart, Germany.	Lutz.Fischer@uni-hohenheim.de		Eisele, Thomas/0000-0002-5190-8233	German Federal Ministry of Economics and Technology (AIF/FEI Project) [16541 N]	German Federal Ministry of Economics and Technology (AIF/FEI Project)	We express our gratitude to the German Federal Ministry of Economics and Technology (AIF/FEI Project No. 16541 N) for partially financial support of this research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CM, 2000, J FOOD SCI, V65, P1145, DOI 10.1111/j.1365-2621.2000.tb10255.x; BLANC B, 1993, J GEN MICROBIOL, V139, P1441, DOI 10.1099/00221287-139-7-1441; Bouchier PJ, 1999, FEBS LETT, V445, P321, DOI 10.1016/S0014-5793(99)00146-5; Bozic NA, 2005, ELECTROPHORESIS, V26, P2476, DOI 10.1002/elps.200500047; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byun T, 2001, J AGR FOOD CHEM, V49, P2061, DOI 10.1021/jf001091m; CHICH JF, 1992, FEBS LETT, V314, P139, DOI 10.1016/0014-5793(92)80960-O; CHRISTENSEN JE, 1995, GENE, V155, P89, DOI 10.1016/0378-1119(94)00924-H; Clemente A, 2000, TRENDS FOOD SCI TECH, V11, P254, DOI 10.1016/S0924-2244(01)00007-3; Damle MV, 2010, PROCESS BIOCHEM, V45, P1030, DOI 10.1016/j.procbio.2010.03.016; Degraeve P, 2003, INT DAIRY J, V13, P497, DOI 10.1016/S0958-6946(03)00057-8; Eisele T, 2013, EUR FOOD RES TECHNOL, V236, P483, DOI 10.1007/s00217-012-1894-5; Eisele T, 2012, J CHROMATOGR B, V911, P64, DOI 10.1016/j.jchromb.2012.10.031; KHALID NM, 1990, SYST APPL MICROBIOL, V13, P311, DOI 10.1016/S0723-2020(11)80226-2; KHALID NM, 1990, APPL ENVIRON MICROB, V56, P381, DOI 10.1128/AEM.56.2.381-388.1990; Kimura K, 2002, J BIOSCI BIOENG, V93, P589, DOI [10.1263/jbb.93.589, 10.1016/S1389-1723(02)80242-0]; Kunji ERS, 1996, ANTON LEEUW INT J G, V70, P187, DOI 10.1007/BF00395933; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Law J, 1997, INT DAIRY J, V7, P1, DOI 10.1016/0958-6946(95)00073-9; Luoma S, 2001, APPL ENVIRON MICROB, V67, P1232, DOI 10.1128/AEM.67.3.1232-1238.2001; Magboul AAA, 1999, LAIT, V79, P515, DOI 10.1051/lait:1999542; Maldonado J, 1998, EARLY HUM DEV, V53, pS23, DOI 10.1016/S0378-3782(98)00062-0; MIYAKAWA H, 1992, J DAIRY SCI, V75, P27, DOI 10.3168/jds.S0022-0302(92)77734-0; MIYAKAWA H, 1994, MILCHWISSENSCHAFT, V49, P670; Nielsen PM, 2001, J FOOD SCI, V66, P642, DOI 10.1111/j.1365-2621.2001.tb04614.x; NIKKILA P, 1995, J GEN APPL MICROBIOL, V41, P327, DOI 10.2323/jgam.41.327; Pan DD, 2004, FOOD CHEM, V88, P511, DOI 10.1016/j.foodchem.2004.01.082; Sambrook J, 2001, MOL CLONING LAB MANU; Sasaki M, 1996, MICROBIOL-UK, V142, P799, DOI 10.1099/00221287-142-4-799; Soeryapranata E, 2007, INT DAIRY J, V17, P1096, DOI 10.1016/j.idairyj.2007.02.002; Sousa R, 2004, BRAZ J CHEM ENG, V21, P147, DOI 10.1590/S0104-66322004000200003; Stressler T, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-39; Tardioli PW, 2005, ENZYME MICROB TECH, V36, P555, DOI 10.1016/j.enzmictec.2004.12.002; VARMANEN P, 1994, FEMS MICROBIOL LETT, V124, P315, DOI [10.1111/j.1574-6968.1994.tb07302.x, 10.1016/0378-1097(94)00447-1]; Vesanto E, 1995, MICROBIOL-UK, V141, P3067, DOI 10.1099/13500872-141-12-3067; Wang WY, 2005, COMPR REV FOOD SCI F, V4, P63, DOI 10.1111/j.1541-4337.2005.tb00075.x; Yuksel GU, 1996, APPL MICROBIOL BIOT, V44, P766, DOI [10.1007/s002530050630, 10.1007/BF00178616]	37	45	48	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70055	10.1371/journal.pone.0070055	http://dx.doi.org/10.1371/journal.pone.0070055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894590	Green Published, Green Submitted, gold			2022-12-25	WOS:000322391400079
J	Nwugo, CC; Duan, YP; Lin, H				Nwugo, Chika C.; Duan, Yongping; Lin, Hong			Study on Citrus Response to Huanglongbing Highlights a Down-Regulation of Defense-Related Proteins in Lemon Plants Upon 'Ca. Liberibacter asiaticus' Infection	PLOS ONE			English	Article							SWEET ORANGE; GENE-EXPRESSION; SINENSIS; RESISTANCE; DISEASE; STRESS; DIFFERENTIATION; IDENTIFICATION; DEFICIENCY; METABOLISM	Citrus huanglongbing (HLB) is a highly destructive disease of citrus presumably caused by 'Candidatus Liberibacter asiaticus' (Las), a gram-negative, insect-transmitted, phloem-limited alpha-proteobacterium. Although almost all citrus plants are susceptible to HLB, reports have shown reduced susceptibility to Las infection in lemon (Citrus limon) plants. The aim of this study is to identify intra-species specific molecular mechanisms associated with Las-induced responses in lemon plants. To achieve this, comparative 2-DE and mass spectrometry, in addition to Inductively Coupled Plasma Spectroscopy (ICPS) analyses, were applied to investigate differences in protein accumulation and the concentrations of cationic elements in leaves of healthy and Las-infected lemon plants. Results showed a differential accumulation of 27 proteins, including an increase in accumulation of starch synthase but decrease in the production of photosynthesis-related proteins in Las-infected lemon plants compared to healthy plants. Furthermore, there was a 6% increase (P > 0.05) in K concentration in leaves of lemon plants upon Las infection, which support results from previous studies and might represent a common response pattern of citrus plants to Las infection. Interestingly, contrary to reports from prior studies, this study showed a general reduction in the production of defense-related pathogen-response proteins but a 128% increase in Zn concentration in lemon plants in response to Las infection. Taken together, this study sheds light on general and intra-species specific responses associated with the response of citrus plants to Las.	[Nwugo, Chika C.; Lin, Hong] ARS, San Joaquin Valley Agr Sci Ctr, Dept Agr, Parlier, CA USA; [Duan, Yongping] ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA	United States Department of Agriculture (USDA)	Lin, H (corresponding author), ARS, San Joaquin Valley Agr Sci Ctr, Dept Agr, Parlier, CA USA.	hong.lin@ars.usda.gov			US Department of Agriculture, Agricultural Research Service	US Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this project was provided by the US Department of Agriculture, Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Banuelos GS, 2007, COMMUN SOIL SCI PLAN, V38, P1533, DOI 10.1080/00103620701378474; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Bouarab K, 2002, NATURE, V418, P889, DOI 10.1038/nature00950; Bove JM, 2006, J PLANT PATHOL, V88, P7; Cevallos-Cevallos JM, 2011, PHYTOCHEM ANALYSIS, V22, P236, DOI 10.1002/pca.1271; Chen CX, 2008, TREE GENET GENOMES, V4, P1, DOI 10.1007/s11295-007-0083-3; Chevalier F, 2011, J PLANT PHYSIOL, V168, P1885, DOI 10.1016/j.jplph.2011.05.024; Coleman CM, 2005, J CHEM ECOL, V31, P1669, DOI 10.1007/s10886-005-5919-4; DANGL JL, 1992, PLANT CELL, V4, P1359, DOI 10.1105/tpc.4.11.1359; Dannenhoffer JM, 1997, PLANTA, V201, P405, DOI 10.1007/s004250050083; Dordas C, 2009, SUSTAINABLE AGRICULTURE, P443, DOI 10.1007/978-90-481-2666-8_28; Durand TC, 2010, PROTEOMICS, V10, P349, DOI 10.1002/pmic.200900484; Etxeberria E, 2009, PHYSIOL MOL PLANT P, V74, P76, DOI 10.1016/j.pmpp.2009.09.004; Fan J, 2010, PLANT PATHOL, V59, P1037, DOI 10.1111/j.1365-3059.2010.02328.x; Fan J, 2012, MOL PLANT MICROBE IN, V25, P1396, DOI 10.1094/MPMI-06-12-0150-R; Fan J, 2011, PHYSIOL PLANTARUM, V143, P235, DOI 10.1111/j.1399-3054.2011.01502.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Fones H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001093; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Graham R.D., 1991, MICRONUTRIENTS AGR, V4, P329; Grewal HS, 1996, PLANT SOIL, V186, P219, DOI 10.1007/BF02415517; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Huber DM, 2007, LANDBAUFORSCH VOLK, V57, P313; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Kozubowski L, 2011, EUKARYOT CELL, V10, P1396, DOI 10.1128/EC.05087-11; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Liao HL, 2012, J EXP BOT, V63, P3307, DOI 10.1093/jxb/ers070; Lopez-Millan AF, 2009, ENVIRON EXP BOT, V65, P376, DOI 10.1016/j.envexpbot.2008.11.010; Masaoka Y, 2011, JARQ-JPN AGR RES Q, V45, P269, DOI 10.6090/jarq.45.269; Minard LV, 2011, J BIOL CHEM, V286, P7082, DOI 10.1074/jbc.M110.193813; NAKAMURA T, 1995, MOL GEN GENET, V248, P253, DOI 10.1007/BF02191591; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nwugo CC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-59; Nwugo CC, 2011, J PROTEOME RES, V10, P518, DOI 10.1021/pr100716h; Nwugo CC, 2008, J PLANT NUTR SOIL SC, V171, P841, DOI 10.1002/jpln.200800082; Poschenrieder C, 2006, TRENDS PLANT SCI, V11, P288, DOI 10.1016/j.tplants.2006.04.007; Purcino RP, 2007, J EXP BOT, V58, P2733, DOI 10.1093/jxb/erm138; READ SM, 1983, EUR J BIOCHEM, V134, P561, DOI 10.1111/j.1432-1033.1983.tb07603.x; SCHNEIDER H, 1968, PHYTOPATHOLOGY, V58, P1155; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Vahling-Armstrong CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037340; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; YANG JJ, 1994, PLANT SCI, V99, P161, DOI 10.1016/0168-9452(94)90173-2; Zhang MQ, 2012, PHYTOPATHOLOGY, V102, P567, DOI 10.1094/PHYTO-09-11-0265; Zhang MQ, 2010, PHYTOPATHOLOGY, V100, P239, DOI 10.1094/PHYTO-100-3-0239; Zhao HW, 2013, MOL PLANT, V6, P301, DOI 10.1093/mp/sst002	56	49	53	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67442	10.1371/journal.pone.0067442	http://dx.doi.org/10.1371/journal.pone.0067442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23922636	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200135
J	Cheng, CY; Chen, JS; Fang, C; Xia, Y; Shan, Y; Liu, Y; Wen, GL; Song, HH; Fang, WH				Cheng, Changyong; Chen, Jianshun; Fang, Chun; Xia, Ye; Shan, Ying; Liu, Yuan; Wen, Guilan; Song, Houhui; Fang, Weihuan			Listeria monocytogenes aguA1, but Not aguA2, Encodes a Functional Agmatine Deiminase BIOCHEMICAL CHARACTERIZATION OF ITS CATALYTIC PROPERTIES AND ROLES IN ACID TOLERANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AERUGINOSA ARGININE DEIMINASE; STREPTOCOCCUS-MUTANS UA159; SWISS-MODEL WORKSPACE; LISTERIA-MONOCYTOGENES; PSEUDOMONAS-AERUGINOSA; LOW PH; ENTEROCOCCUS-FAECALIS; CRYSTAL-STRUCTURES; GENE-CLUSTER; SYSTEM	Listeria monocytogenes is adaptable to low pH environments and therefore crosses the intestinal barrier to establish systemic infections. L. monocytogenes aguA1 and aguA2 encode putative agmatine deiminases (AgDIs) AguA1 and AguA2. Transcription of aguA1 and aguA2 was significantly induced at pH 5.0. Deletion of aguA1 significantly impaired its survival both in gastric fluid at pH 2.5 and in mouse stomach, whereas aguA2 deletion did not show significant defect of survival in gastric fluid. With agmatine as the sole substrate, AguA1 expressed in Escherichia coli was optimal at 25 C and over a wide range of pH from 3.5 to 10.5. Recombinant AguA2 showed no deiminase activity. Sitedirected mutagenesis revealed that all nine AguA1 mutants completely lost enzymatic activity. AguA2 acquired AgDI activity only when Cys-157 was mutated to glycine. AguA1 mutation at the same site, G157C, also inactivated the enzyme. Thus, we have discovered Gly-157 as a novel residue other than the known catalytic triad (Cys-His-Glu/Asp) in L. monocytogenes that is critical for enzyme activity. Of the two putative AgDIs, we conclude that only AguA1 functionally participates in the AgDI pathway and mediates acid tolerance in L. monocytogenes.	[Cheng, Changyong; Fang, Chun; Xia, Ye; Shan, Ying; Liu, Yuan; Wen, Guilan; Fang, Weihuan] Zhejiang Univ, Inst Prevent Vet Med, Zhejiang Prov Key Lab Prevent Vet Med, Hangzhou 310058, Zhejiang, Peoples R China; [Cheng, Changyong; Fang, Chun; Xia, Ye; Shan, Ying; Liu, Yuan; Wen, Guilan; Fang, Weihuan] Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Jianshun] Zhejiang Fisheries Tech Extens Ctr, Hangzhou 310012, Zhejiang, Peoples R China; [Song, Houhui; Fang, Weihuan] Zhejiang A&F Univ, Coll Anim Sci & Technol, Linan 311300, Zhejiang, Peoples R China	Zhejiang University; Zhejiang A&F University	Fang, WH (corresponding author), Zhejiang Univ, Inst Prevent Vet Med, 388 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	whfang@zju.edu.cn		Cheng, Changyong/0000-0002-7530-5605	National Natural Science Foundation of China [31101829, 31272570]; Natural Science Foundation of Zhejiang Province [Q12C190019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This study was supported by National Natural Science Foundation of China Grants 31101829 and 31272570 and Natural Science Foundation of Zhejiang Province Grant Q12C190019.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Chen JS, 2011, MICROBIOL-SGM, V157, P3150, DOI 10.1099/mic.0.049619-0; Chen JS, 2009, FOODBORNE PATHOG DIS, V6, P365, DOI 10.1089/fpd.2008.0207; Chen JS, 2009, J MICROBIOL BIOTECHN, V19, P238, DOI 10.4014/jmb.0805.304; Cheng CY, 2013, J MED MICROBIOL, V62, P813, DOI 10.1099/jmm.0.055145-0; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Cotter PD, 2001, MOL MICROBIOL, V40, P465, DOI 10.1046/j.1365-2958.2001.02398.x; Cotter PD, 2001, J FOOD PROTECT, V64, P1362, DOI 10.4315/0362-028X-64.9.1362; Cotter PD, 2000, INT J FOOD MICROBIOL, V60, P137, DOI 10.1016/S0168-1605(00)00305-6; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Das K, 2004, STRUCTURE, V12, P657, DOI 10.1016/j.str.2004.02.017; DRIESSEN AJM, 1988, J BACTERIOL, V170, P4522, DOI 10.1128/jb.170.10.4522-4527.1988; Galkin A, 2005, J BIOL CHEM, V280, P34080, DOI 10.1074/jbc.M505471200; Galkin A, 2004, J BIOL CHEM, V279, P14001, DOI 10.1074/jbc.M313410200; Glaser P, 2001, SCIENCE, V294, P849; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Griswold AR, 2006, J BACTERIOL, V188, P834, DOI 10.1128/JB.188.3.834-841.2006; Griswold AR, 2004, J BACTERIOL, V186, P1902, DOI 10.1128/JB.186.6.1902-1904.2004; Janowitz T, 2003, FEBS LETT, V544, P258, DOI 10.1016/S0014-5793(03)00515-5; Jiang LL, 2008, INT J FOOD MICROBIOL, V121, P53, DOI 10.1016/j.ijfoodmicro.2007.10.007; Jones JE, 2010, BIOCHEMISTRY-US, V49, P9413, DOI 10.1021/bi101405y; Jones JE, 2010, BIOORG CHEM, V38, P62, DOI 10.1016/j.bioorg.2009.11.004; Kearney PL, 2005, BIOCHEMISTRY-US, V44, P10570, DOI 10.1021/bi050292m; Knipp M, 2000, ANAL BIOCHEM, V286, P257, DOI 10.1006/abio.2000.4805; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llacer JL, 2007, J BACTERIOL, V189, P1254, DOI 10.1128/JB.01216-06; Lu XF, 2006, BIOCHEMISTRY-US, V45, P1162, DOI 10.1021/bi051591e; Lucas PM, 2007, MICROBIOL-SGM, V153, P2221, DOI 10.1099/mic.0.2007/006320-0; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Nakada Y, 2003, MICROBIOL-SGM, V149, P707, DOI 10.1099/mic.0.26009-0; ODriscoll B, 1996, APPL ENVIRON MICROB, V62, P1693, DOI 10.1128/AEM.62.5.1693-1698.1996; PARK KH, 1991, BIOCHEM BIOPH RES CO, V174, P32, DOI 10.1016/0006-291X(91)90480-U; Ryan S, 2009, ENVIRON MICROBIOL, V11, P432, DOI 10.1111/j.1462-2920.2008.01782.x; Sakakibara Y, 2003, PROTEIN EXPRES PURIF, V30, P88, DOI 10.1016/S1046-5928(03)00071-8; Shirai H, 2001, TRENDS BIOCHEM SCI, V26, P465, DOI 10.1016/S0968-0004(01)01906-5; Shirai H, 2006, PROTEINS, V64, P1010, DOI 10.1002/prot.20863; VANNETTEN P, 1989, INT J FOOD MICROBIOL, V8, P299, DOI 10.1016/0168-1605(89)90001-9; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wei YZ, 2007, PROTEINS, V66, P740, DOI 10.1002/prot.21235; Wiedmann M, 1998, J BACTERIOL, V180, P3650, DOI 10.1128/JB.180.14.3650-3656.1998; Yanagisawa H, 2001, PHYTOCHEMISTRY, V56, P643, DOI 10.1016/S0031-9422(00)00491-X	46	20	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26606	26615		10.1074/jbc.M113.477380	http://dx.doi.org/10.1074/jbc.M113.477380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23918931	Green Published, hybrid			2022-12-25	WOS:000330594500026
J	Essalmani, R; Susan-Resiga, D; Chamberland, A; Asselin, MC; Canuel, M; Constam, D; Creemers, JW; Day, R; Gauthier, D; Prat, A; Seidah, NG				Essalmani, Rachid; Susan-Resiga, Delia; Chamberland, Ann; Asselin, Marie-Claude; Canuel, Maryssa; Constam, Daniel; Creemers, John W.; Day, Robert; Gauthier, Dany; Prat, Annik; Seidah, Nabil G.			Furin Is the Primary in Vivo Convertase of Angiopoietin-like 3 and Endothelial Lipase in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; PROPROTEIN CONVERTASES; LIPID-METABOLISM; HDL CHOLESTEROL; PROTEIN; ANGPTL3; PLASMA; ACTIVATION; BINDING; MICE	The proprotein convertases (PCs) furin, PC5/6, and PACE4 exhibit unique and/or complementary functions. Their knockout (KO) in mice resulted in strong and specific phenotypes demonstrating that, in vivo, these PCs are unique and essential during development. However, they also exhibit redundant functions. Liver angiopoietin-like 3 (ANGPTL3) inhibits lipolysis by binding to lipoprotein lipases. It is found in the plasma as full length and truncated forms. The latter is more active and generated by cleavage at a furin-like site. Endothelial lipase (EL) binds heparin sulfate proteoglycans on cell surfaces and catalyzes the hydrolysis of HDL phospholipids. EL activity is regulated by two endogenous inhibitors, ANGPTL3 and ANGPTL4, and by PCs that inactivate EL through cleavage releasing the N-terminal catalytic and C-terminal lipid-binding domains. Herein, because furin and PC5/6 complete KOs are lethal, we used mice lacking furin or PC5/6 specifically in hepatocytes (hKO) or mice completely lacking PACE4. In primary hepatocytes, ANGPTL3 was processed into a shorter form of ANGPTL3 intracellularly by furin only, and extracellularly mainly by PACE4. In vivo, the absence of furin in hepatocytes reduced by similar to 50% the circulating levels of cleaved ANGPTL3, while the lack of PACE4 had only a minor effect. Analysis of the EL processing in primary hepatocytes and in vivo revealed that it is mostly cleaved by furin. However, the lack of furin or PC5/6 in hepatocytes and complete PACE4 KO did not appreciably modify plasma HDL levels or EL activity. Thus, inhibition of furin in liver would not be expected to modify the plasma lipid profiles.	[Essalmani, Rachid; Susan-Resiga, Delia; Chamberland, Ann; Asselin, Marie-Claude; Canuel, Maryssa; Prat, Annik; Seidah, Nabil G.] Univ Montreal, Inst Rech Clin Montreal, Lab Biochem Neuroendocrinol, Montreal, PQ H2W 1R7, Canada; [Gauthier, Dany] Univ Montreal, Inst Rech Clin Montreal, Lab Neuropeptides Struct & Metab, Montreal, PQ H2W 1R7, Canada; [Constam, Daniel] Ecole Polytech Fed Lausanne, CH-1066 Lausanne, Switzerland; [Creemers, John W.] Katholieke Univ Leuven, Ctr Human Genet, Biochem Neuroendocrinol Lab, B-3000 Louvain, Belgium; [Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; KU Leuven; University of Sherbrooke	Seidah, NG (corresponding author), Inst Rech Clin Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Prat, Annik/S-6757-2018; Seidah, Nabil/I-3596-2013; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Constam, Daniel B./0000-0002-6256-3891	CIHR [44363]; Strauss Foundation; Canada Chair [216684]	CIHR(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair	This research was supported by a CIHR Grant 44363, a Strauss Foundation grant, and a Canada Chair Number 216684.	Basu D, 2013, J LIPID RES, V54, P282, DOI 10.1194/jlr.D031112; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Broedl UC, 2004, TRENDS CARDIOVAS MED, V14, P202, DOI 10.1016/j.tcm.2004.03.003; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Conklin D, 1999, GENOMICS, V62, P477, DOI 10.1006/geno.1999.6041; Constam DB, 2000, GENE DEV, V14, P1146; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fujimoto K, 2006, EXP ANIM TOKYO, V55, P27, DOI 10.1538/expanim.55.27; Fuki IV, 2003, J BIOL CHEM, V278, P34331, DOI 10.1074/jbc.M302181200; Gauster M, 2005, J LIPID RES, V46, P977, DOI 10.1194/jlr.M400500-JLR200; Hara T, 2011, J LIPID RES, V52, P57, DOI 10.1194/jlr.M008417; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Ishida T, 2003, J CLIN INVEST, V111, P347, DOI [10.1172/JCI200316306, 10.1172/JCI16306]; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; Kim WJ, 2012, MOL CELL BIOL, V32, P3382, DOI 10.1128/MCB.06331-11; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Liu J, 2010, J BIOL CHEM, V285, P27561, DOI 10.1074/jbc.M110.144279; Ma K, 2003, P NATL ACAD SCI USA, V100, P2748, DOI 10.1073/pnas.0438039100; Marchesi C, 2011, J MOL MED, V89, P1103, DOI 10.1007/s00109-011-0776-9; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; McCoy MG, 2002, J LIPID RES, V43, P921; Nijstad N, 2009, J BIOL CHEM, V284, P6093, DOI 10.1074/jbc.M807683200; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Qiu G, 2007, CARDIOVASC RES, V76, P528, DOI 10.1016/j.cardiores.2007.08.002; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	46	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26410	26418		10.1074/jbc.M113.501304	http://dx.doi.org/10.1074/jbc.M113.501304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23918928	Green Published, hybrid			2022-12-25	WOS:000330594500006
J	Boczkowska, M; Rebowski, G; Dominguez, R				Boczkowska, Malgorzata; Rebowski, Grzegorz; Dominguez, Roberto			Glia Maturation Factor (GMF) Interacts with Arp2/3 Complex in a Nucleotide State-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-DEPOLYMERIZING FACTOR; ALDRICH-SYNDROME PROTEIN; NUCLEATION-PROMOTING FACTOR; FACTOR HOMOLOGY DOMAIN; ATP HYDROLYSIS; WASP/SCAR PROTEINS; FILAMENT NETWORKS; STRUCTURAL BASIS; FACTOR-GAMMA; BOUND ACTIN	Glia maturation factor (GMF) is a member of the actin-depolymerizing factor (ADF)/cofilin family. ADF/cofilin promotes disassembly of aged actin filaments, where as GMF interacts specifically with Arp2/3 complex at branch junctions and promotes debranching. A distinguishing feature of ADF/cofilin is that it binds tighter to ADP-bound than to ATP-bound monomeric or filamentous actin. The interaction is also regulated by phosphorylation at Ser-3 of mammalian cofilin, which inhibits binding to actin. However, it is unknown whether these two factors play a role in the interaction of GMF with Arp2/3 complex. Here we show using isothermal titration calorimetry that mammalian GMF has very low affinity for ATP-bound Arp2/3 complex but binds ADP-bound Arp2/3 complex with 0.7 mu M affinity. The phosphomimetic mutation S2E in GMF inhibits this interaction. GMF does not bind monomeric ATP- or ADP-actin, confirming its specificity for Arp2/3 complex. We further show that mammalian Arp2/3 complex nucleation activated by the WCA region of the nucleation-promoting factor N-WASP is not affected by GMF, whereas nucleation activated by the WCA region of WAVE2 is slightly inhibited at high GMF concentrations. Together, the results suggest that GMF functions by a mechanism similar to that of other ADF/cofilin family members, displaying a preference for ADP-Arp2/3 complex and undergoing inhibition by phosphorylation of a serine residue near the N terminus. Arp2/3 complex nucleation occurs in the ATP state, and nucleotide hydrolysis promotes debranching, suggesting that the higher affinity of GMF for ADP-Arp2/3 complex plays a physiological role by promoting debranching of aged branch junctions without interfering with Arp2/3 complex nucleation.	[Boczkowska, Malgorzata; Rebowski, Grzegorz; Dominguez, Roberto] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Dominguez, R (corresponding author), Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	droberto@mail.med.upenn.edu			National Institutes of Health [R01 GM073791]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM073791.	Aerbajinai W, 2013, J IMMUNOL, V190, P6093, DOI 10.4049/jimmunol.1203048; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Dominguez R, 2010, CURR OPIN STRUC BIOL, V20, P217, DOI 10.1016/j.sbi.2009.12.012; Gandhi M, 2010, CURR BIOL, V20, P861, DOI 10.1016/j.cub.2010.03.026; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goroncy AK, 2009, PROTEIN SCI, V18, P2384, DOI 10.1002/pro.248; Harris ES, 2006, METHOD ENZYMOL, V406, P190, DOI 10.1016/S0076-6879(06)06015-0; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Ikeda K, 2006, CIRC RES, V99, P424, DOI 10.1161/01.RES.0000237662.23539.0b; Inagaki M, 2004, BBA-GEN SUBJECTS, V1670, P208, DOI 10.1016/j.bbagen.2003.12.006; Ingerman E, 2013, J CELL BIOL, V200, P619, DOI 10.1083/jcb.201211069; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Le Clainche C, 2003, P NATL ACAD SCI USA, V100, P6337, DOI 10.1073/pnas.1130513100; Le Clainche C, 2001, J BIOL CHEM, V276, P46689, DOI 10.1074/jbc.C100476200; Luan Q, 2013, NAT STRUCT MOL BIOL, V20, P1062, DOI 10.1038/nsmb.2628; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACIVER SK, 1994, FEBS LETT, V347, P251, DOI 10.1016/0014-5793(94)00552-4; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakano K, 2010, CYTOSKELETON, V67, P373, DOI 10.1002/cm.20451; Nolen BJ, 2004, P NATL ACAD SCI USA, V101, P15627, DOI 10.1073/pnas.0407149101; Okreglak V, 2007, J CELL BIOL, V178, P1251, DOI 10.1083/jcb.200703092; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Stolmeier D, 2013, NEUROCHEM RES, V38, P1580, DOI 10.1007/s11064-013-1059-3; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Ydenberg CA, 2013, CURR BIOL, V23, P1037, DOI 10.1016/j.cub.2013.04.058; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280	51	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25683	25688		10.1074/jbc.C113.493338	http://dx.doi.org/10.1074/jbc.C113.493338			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897816	Green Published, hybrid			2022-12-25	WOS:000330623300002
J	Zhang, G; He, LS; Wong, YH; Qian, PY				Zhang, Gen; He, Li-Sheng; Wong, Yue Him; Qian, Pei-Yuan			MKK3 Was Involved in Larval Settlement of the Barnacle Amphibalanus amphitrite through Activating the Kinase Activity of p38MAPK	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; PROTEIN-KINASE; SELECTIVE ACTIVATION; NEGATIVE FEEDBACK; P38; PHOSPHORYLATION; METAMORPHOSIS; AUTOPHOSPHORYLATION; IDENTIFICATION; TRANSFORMATION	The p38 mitogen-activated protein kinase (p38MAPK) plays a key role in larval settlement of the barnacle Amphibalanus amphitrite. To study the signaling pathway associated with p38MAPK during larval settlement, we sought to identify the upstream kinase of p38MAPK. Three MKKs (MKK3, MKK4 and MKK7) and three MAPKs (p38MAPK, ERK and JNK) in A. amphitrite were cloned and recombinantly expressed in E. coli. Through kinase assays, we found that MKK3, but not MKK4 or MKK7, phosphorylated p38MAPK. Furthermore, MKK3 activity was specific to p38MAPK, as it did not phosphorylate ERK or JNK. To further investigate the functional relationship between MKK3 and p38MAPK in vivo, we studied the localization of phospho-MKK3 (pMKK3) and MKK3 by immunostaining. Consistent with the patterns of p38MAPK and phospho-p38MAPK (pp38MAPK), pMKK3 and MKK3 mainly localized to the antennules of the cyprids. Western blot analysis revealed that pMKK3 levels, like pp38MAPK levels, were elevated at cyprid stage, compared to nauplii and juvenile stages. Moreover, pMKK3 levels increased after treatment with adult barnacle crude extracts, suggesting that MKK3 might mediate the stimulatory effects of adult barnacle extracts on the p38MAPK pathway.	[Zhang, Gen; He, Li-Sheng; Wong, Yue Him; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Kowloon, Hong Kong, Peoples R China.	boqianpy@ust.hk	Zhang/L-6428-2017	Zhang/0000-0001-8619-3285; Qian, Pei-Yuan/0000-0003-4074-9078	China Ocean Mineral Resources Research and Development Association [DY125-15-T-02]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; Research Grants Council of the Hong Kong Special Administrative Region [GRF661611, GRF662413, AoE/P-04/04-II]	China Ocean Mineral Resources Research and Development Association; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	This work was supported by a grant (DY125-15-T-02) from the China Ocean Mineral Resources Research and Development Association (http://www.comra.org), an award from the King Abdullah University of Science and Technology (SA-C0040/UK-C0016; http://www.kaust.edu.sa) and grants (GRF661611, GRF662413 and AoE/P-04/04-II) from the Research Grants Council (http://www.ugc.edu.hk/eng/rgc/index.htm) of the Hong Kong Special Administrative Region. The funders did not contribute to the experimental design, operation or manuscript writing. Additionally, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banton MC, 2012, J EXP BIOL, V215, P4288, DOI 10.1242/jeb.074799; Bhattacharyya A, 2002, BIOCHEM J, V15, P121; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Clare AS, 2000, BIOFOULING, V15, P57, DOI 10.1080/08927010009386298; Clare AS, 1996, BIOFOULING, V10, P141, DOI 10.1080/08927019609386276; CLARE AS, 1995, J EXP BIOL, V198, P655; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cuenda A, 2000, INT J BIOCHEM CELL B, V32, P581, DOI 10.1016/S1357-2725(00)00003-0; Davidson IC, 2009, BIOFOULING, V25, P645, DOI 10.1080/08927010903046268; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; DOZA YN, 1995, FEBS LETT, V364, P223, DOI 10.1016/0014-5793(95)00346-B; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Guma M, 2012, ARTHRITIS RHEUM-US, V64, P2887, DOI 10.1002/art.34489; Hashimoto H, 2000, EUR J BIOCHEM, V267, P4362, DOI 10.1046/j.1432-1327.2000.01479.x; He LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047195; Holm ER, 2012, INTEGR COMP BIOL, V52, P348, DOI 10.1093/icb/ics042; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Inoue H, 2001, EMBO J, V20, P5421, DOI 10.1093/emboj/20.19.5421; Kato-Yoshinaga Y, 2000, COMP BIOCHEM PHYS A, V125, P511, DOI 10.1016/S1095-6433(00)00179-3; Klein SL, 2002, DEV DYNAM, V225, P384, DOI 10.1002/dvdy.10174; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Lotan TL, 2007, J PATHOL, V212, P386, DOI 10.1002/path.2194; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Matsumura K, 1998, J EXP ZOOL, V281, P12, DOI 10.1002/(SICI)1097-010X(19980501)281:1<12::AID-JEZ3>3.3.CO;2-L; Meier R, 2004, EUR J BIOCHEM, V236, P796; NOTT JA, 1969, PHILOS T ROY SOC B, V256, P115, DOI 10.1098/rstb.1969.0038; Piao CS, 2003, J NEUROSCI RES, V73, P537, DOI 10.1002/jnr.10671; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; SEGER R, 1994, J BIOL CHEM, V269, P25699; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiyagarajan V, 2002, J EXP MAR BIOL ECOL, V280, P79, DOI 10.1016/S0022-0981(02)00415-X; Van Der Houven Van Oordt W., 2000, J CELL BIOL, V149, P307; Wang H, 2010, J EXP ZOOL PART B, V314B, P390, DOI 10.1002/jez.b.21344; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Zhang Y, 2012, J EXP BIOL, V215, P3813, DOI 10.1242/jeb.070235; ZHENG CF, 1993, J BIOL CHEM, V268, P11435	49	16	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69510	10.1371/journal.pone.0069510	http://dx.doi.org/10.1371/journal.pone.0069510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922727	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700036
J	Zhang, Z; Zhou, B				Zhang, Zheng; Zhou, Bin			Accelerated Coronary Angiogenesis by Vegfr1-Knockout Endocardial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; VEGF FAMILY-MEMBERS; CARDIAC MORPHOGENESIS; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; DEVELOPING HEART; MOUSE EMBRYO; NF-ATC; NOTCH; VASCULOGENESIS	During mouse heart development, ventricular endocardial cells give rise to the coronary arteries by angiogenesis. Myocardially-derived vascular endothelial growth factor-a (Vegfa) regulates embryonic coronary angiogenesis through vascular endothelial growth factor-receptor 2 (Vegfr2) expressed in the endocardium. In this study, we investigated the role of endocardially-produced soluble Vegfr1 (sVegfr1) in the coronary angiogenesis. We deleted sVegfr1 in the endocardium of the developing mouse heart and found that this deletion resulted in a precocious formation of coronary plexuses. Using an ex vivo coronary angiogenesis assay, we showed that the Vegfr1-null ventricular endocardial cells underwent excessive angiogenesis and generated extensive endothelial tubular networks. We also revealed by qPCR analysis that expression of genes involved in the Vegf-Notch pathway was augmented in the Vegfr1-null hearts. We further showed that inhibition of Notch signaling blocked the formation of coronary plexuses by the ventricular endocardial cells. These results establish that Vegfr1 produced in the endocardium negatively regulates embryonic coronary angiogenesis, possibly by limiting the Vegf-Notch signaling.	[Zhang, Zheng] Sichuan Univ, West China Med Sch, State Key Lab Biotherapy, Chengdu, USA, Peoples R China; [Zhang, Zheng; Zhou, Bin] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Zhou, Bin] Albert Einstein Coll Med, Dept Pediat, Wilf Family Cardiovasc Res Inst, Bronx, NY 10467 USA; [Zhou, Bin] Albert Einstein Coll Med, Dept Med Cardiol, Wilf Family Cardiovasc Res Inst, Bronx, NY 10467 USA; [Zhou, Bin] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Zhou, Bin] Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China	Sichuan University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Nanjing Medical University; Nanjing Medical University	Zhou, B (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	bin.zhou@einstein.yu.edu			National Institute of Health [HL078881, HL078881S]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078881] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research program was supported by funds from the National Institute of Health (HL078881 and HL078881S) to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chappell JC, 2011, SEMIN CELL DEV BIOL, V22, P1005, DOI 10.1016/j.semcdb.2011.10.006; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Ishii Y, 2009, CELL TISSUE RES, V335, P67, DOI 10.1007/s00441-008-0663-z; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; KOMIYAMA M, 1987, ANAT EMBRYOL, V176, P183, DOI 10.1007/BF00310051; Krueger J, 2011, DEVELOPMENT, V138, P2111, DOI 10.1242/dev.063933; Lavine KJ, 2009, CIRC RES, V104, P159, DOI 10.1161/CIRCRESAHA.108.191239; Luttun A, 2003, CARDIOVASC RES, V58, P378, DOI 10.1016/S0008-6363(03)00258-X; Majesky MW, 2004, CURR TOP DEV BIOL, V62, P225; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; MIKAWA T, 1992, DEV DYNAM, V193, P11, DOI 10.1002/aja.1001930104; Misfeldt AM, 2009, DEV BIOL, V333, P78, DOI 10.1016/j.ydbio.2009.06.033; Nishi JI, 2008, CIRC RES, V103, P261, DOI 10.1161/CIRCRESAHA.108.174128; Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Sugi Y, 1996, DEV BIOL, V175, P66, DOI 10.1006/dbio.1996.0096; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; Tomanek RJ, 2006, CIRC RES, V98, P947, DOI 10.1161/01.RES.0000216974.75994.da; Tomanek RJ, 2002, DEV DYNAM, V225, P233, DOI 10.1002/dvdy.10158; VIRAGH S, 1981, ANAT REC, V201, P157, DOI 10.1002/ar.1092010117; Wada AM, 2003, ARTERIOSCL THROM VAS, V23, P2138, DOI 10.1161/01.ATV.0000098645.38676.CC; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhou B, 2005, DEVELOPMENT, V132, P1137, DOI 10.1242/dev.01640; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	46	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70570	10.1371/journal.pone.0070570	http://dx.doi.org/10.1371/journal.pone.0070570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894673	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900135
J	Wei, LH; Huang, XR; Zhang, Y; Li, YQ; Chen, HY; Heuchel, R; Yan, BP; Yu, CM; Lan, HY				Wei, Li Hua; Huang, Xiao Ru; Zhang, Yang; Li, You Qi; Chen, Hai-yong; Heuchel, Rainer; Yan, Bryan P.; Yu, Cheuk-Man; Lan, Hui Yao			Deficiency of Smad7 Enhances Cardiac Remodeling Induced by Angiotensin II Infusion in a Mouse Model of Hypertension	PLOS ONE			English	Article							PROMOTES RENAL FIBROSIS; TGF-BETA; GENE-EXPRESSION; MESANGIAL CELLS; HEART-DISEASE; INFLAMMATION; MICE; MIR-29; SP1; INHIBITION	Smad7 has been shown to negatively regulate fibrosis and inflammation, but its role in angiotensin II (Ang II)-induced hypertensive cardiac remodeling remains unknown. Therefore, the present study investigated the role of Smad7 in hypertensive cardiopathy induced by angiotensin II infusion. Hypertensive cardiac disease was induced in Smad7 gene knockout (KO) and wild-type (WT) mice by subcutaneous infusion of Ang II (1.46 mg/kg/day) for 28 days. Although equal levels of high blood pressure were developed in both Smad7 KO and WT mice, Smad7 KO mice developed more severe cardiac injury as demonstrated by impairing cardiac function including a significant increase in left ventricular (LV) mass (P<0.01), reduction of LV ejection fraction(P<0.001) and fractional shortening(P<0.001). Real-time PCR, Western blot and immunohistochemistry detected that deletion of Smad7 significantly enhanced Ang II-induced cardiac fibrosis and inflammation, including upregulation of collagen I, alpha-SMA, interleukin-1 beta, TNF-alpha, and infiltration of CD3(+) T cells and F4/80(+) macrophages. Further studies revealed that enhanced activation of the Sp1-TGF beta/Smad3-NF-kappa B pathways and downregulation of miR-29 were mechanisms though which deletion of Smad7 promoted Ang II-mediated cardiac remodeling. In conclusions, Smad7 plays a protective role in AngII-mediated cardiac remodeling via mechanisms involving the Sp1-TGF-beta/Smad3-NF.kappa B-miR-29 regulatory network.	[Wei, Li Hua; Zhang, Yang; Chen, Hai-yong; Yan, Bryan P.; Yu, Cheuk-Man; Lan, Hui Yao] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Huang, Xiao Ru; Li, You Qi; Lan, Hui Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Heuchel, Rainer] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Karolinska Institutet	Lan, HY (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	hylan@cuhk.edu.hk	Yu, Cheuk-man/P-3747-2015; Lan, Hui Yao/C-9734-2015; CHEN, Hai-Yong/K-5853-2019; Heuchel, Rainer/P-7875-2019; Yan, Bryan P/P-5928-2015; Chen, Haiyong/G-6787-2014	Lan, Hui Yao/0000-0003-4283-9755; CHEN, Hai-Yong/0000-0002-4889-2752; Heuchel, Rainer/0000-0002-2782-585X; Chen, Haiyong/0000-0002-4889-2752	Research Grants Council of Hong Kong [RGC GRF468711, CUHK5/CRF/09, CUHK3/CRF/12R, CUHK9/CRF/10]; Chinese University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported by grants from Research Grants Council of Hong Kong (RGC GRF468711, CUHK5/CRF/09 and CUHK3/CRF/12R to H.Y.L.; CUHK9/CRF/10 to C.M.Y); and the Focused Investments Scheme A and B from the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bujak M, 2007, CIRCULATION, V116, P2127, DOI 10.1161/CIRCULATIONAHA.107.704197; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; He XY, 2011, CIRC RES, V108, P164, DOI 10.1161/CIRCRESAHA.110.234369; Hou CC, 2005, AM J PATHOL, V166, P761, DOI 10.1016/S0002-9440(10)62297-3; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Jia LX, 2012, FRONT BIOSCI-LANDMRK, V17, P221, DOI 10.2741/3923; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; LAN HY, 1995, J HISTOCHEM CYTOCHEM, V43, P97, DOI 10.1177/43.1.7822770; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Liu Z, 2012, AM J PHYSIOL-RENAL, V302, pF986, DOI 10.1152/ajprenal.00595.2011; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Motojima M, 2000, BIOCHEM J, V349, P435, DOI 10.1042/0264-6021:3490435; Muller DN, 2000, HYPERTENSION, V35, P193, DOI 10.1161/01.HYP.35.1.193; Ng YY, 2005, KIDNEY INT, V67, pS83, DOI 10.1111/j.1523-1755.2005.09421.x; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Shahbaz AU, 2010, J HYPERTENS, V28, pS25, DOI 10.1097/01.hjh.0000388491.35836.d2; Traylor A, 2007, AM J PHYSIOL-RENAL, V293, pF885, DOI 10.1152/ajprenal.00519.2006; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang BQ, 2002, AM J PHYSIOL-HEART C, V282, pH1685, DOI 10.1152/ajpheart.00266.2001; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Xiao J, 2012, MOL THER, V20, P1251, DOI 10.1038/mt.2012.36; Yang FY, 2010, J PATHOL, V221, P390, DOI 10.1002/path.2721; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Zhao X, 2001, BBA-GENE STRUCT EXPR, V1522, P195, DOI 10.1016/S0167-4781(01)00341-4	36	88	90	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70195	10.1371/journal.pone.0070195	http://dx.doi.org/10.1371/journal.pone.0070195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894614	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000191
J	Gagnon, MM; Bakhtyar, S				Gagnon, Marthe Monique; Bakhtyar, Sajida			Induction of Fish Biomarkers by Synthetic-Based Drilling Muds	PLOS ONE			English	Article							RISK-ASSESSMENT; METABOLITES; TOXICITY	The study investigated the effects of chronic exposure of pink snapper (Pagrus auratus Forster), to synthetic based drilling muds (SBMs). Fish were exposed to three mud systems comprised of three different types of synthetic based fluids (SBFs): an ester (E), an isomerized olefin (IO) and linear alpha olefin (LAO). Condition factor (CF), liver somatic index (LSI), hepatic detoxification (EROD activity), biliary metabolites, DNA damage and stress proteins (HSP-70) were determined. Exposure to E caused biologically significant effects by increasing CF and LSI, and triggered biliary metabolite accumulation. While ester-based SBFs have a rapid biodegradation rate in the environment, they caused the most pronounced effects on fish health. IO induced EROD activity and biliary metabolites and LAO induced EROD activity and stress protein levels. The results demonstrate that while acute toxicity of SBMs is generally low, chronic exposure to weathering cutting piles has the potential to affect fish health. The study illustrates the advantages of the Western Australian government case-by-case approach to drilling fluid management, and highlights the importance of considering the receiving environment in the selection of SBMs.	[Gagnon, Marthe Monique; Bakhtyar, Sajida] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia	Curtin University	Gagnon, MM (corresponding author), Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia.	m.gagnon@curtin.edu.au	GAGNON, Marthe Monique/P-6078-2014	GAGNON, Marthe Monique/0000-0002-3190-5094				[Anonymous], 1986, 3510 US EPA; [Anonymous], 2001, 2452 US EPA; [Anonymous], 2007, 821R02103 US EPA; APHA-AWWA-WEF, 2005, 5220D APHAAWWAWEF; APHA-AWWA-WEF, 2005, 5520F APHAAWWAWEF; Bakhtyar S., 2011, Global Journal of Environmental Research, V5, P21; Bakhtyar S, 2012, GREEN PROCESSES, V9; Bakhtyar S, 2012, ENVIRON MONIT ASSESS, V184, P5311, DOI 10.1007/s10661-011-2342-x; Canadian Association of Petroleum Producers (CAPP), 2001, 20010007 CAPP; Candler JE, 1999, SPE EPA EXPL PROD EN; Cobby GL, 1999, APPEA J, P600; COLLIER TK, 1991, ARCH ENVIRON CON TOX, V20, P462, DOI 10.1007/BF01065834; DMP [Department of Mines and Petroleum Western Australia], 2007, DRILL FLUIDS MAN; Gagnon M., 2012, MONTARA WELL RELEASE; Gagnon Marthe Monique, 1998, Australasian Journal of Ecotoxicology, V4, P29; Gagnon MM, 2002, MAR POLLUT BULL, V44, P230, DOI 10.1016/S0025-326X(01)00245-4; Gagnon MM, 2011, MONTARA WELL RELEASE; Game C, 2006, ECOTOXICOLOGY, V15, P665, DOI 10.1007/s10646-006-0104-2; Getliff J., 1997, OVERVIEW ENV BENEFIT; Government of Australia, 2004, AUSTR COD PRACT CAR; Grant A, 2002, MAR ENVIRON RES, V53, P95, DOI 10.1016/S0141-1136(01)00114-3; Lin ELC, 1996, ECOTOX ENVIRON SAFE, V35, P16, DOI 10.1006/eesa.1996.0077; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Neff JM, 2008, 8 INT SETAC C 3 7 AU; Neff JM, 2000, 2000064 OCS STUD; *NRC, 1983, DRILL DISCH MAR ENV; PATIN S., 1999, ENV IMPACT OFFSHORE; Scholten MCT, 2000, TOXICOL LETT, V112, P283, DOI 10.1016/S0378-4274(99)00238-6; Shugart Lee R., 1996, P205; Stark JD, 2005, INTERG ENV ASSESS MA, V1, P95; Tsvetnenko YB, 2000, ENVIRON TOXICOL, V15, P540; *US EPA, 2001, EPA821R01010; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Webb D, 2002, ENVIRON TOXICOL, V17, P87, DOI 10.1002/tox.10030; Webb D, 2009, ENVIRON TOXICOL, V24, P287, DOI 10.1002/tox.20432	35	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69489	10.1371/journal.pone.0069489	http://dx.doi.org/10.1371/journal.pone.0069489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894492	gold, Green Submitted, Green Published			2022-12-25	WOS:000322132100062
J	Wong, TW; Kita, H; Hanson, CA; Walters, DK; Arendt, BK; Jelinek, DF				Wong, Tina W.; Kita, Hirohito; Hanson, Curtis A.; Walters, Denise K.; Arendt, Bonnie K.; Jelinek, Diane F.			Induction of Malignant Plasma Cell Proliferation by Eosinophils	PLOS ONE			English	Article							MULTIPLE-MYELOMA; BONE-MARROW; LABELING INDEX; STROMAL CELLS; SURVIVAL; NICHE; OSTEOCLAST; RESPONSES; COMPONENT; SUPPORT	The biology of the malignant plasma cells (PCs) in multiple myeloma (MM) is highly influenced by the bone marrow (BM) microenvironment in which they reside. More specifically, BM stromal cells (SCs) are known to interact with MM cells to promote MM cell survival and proliferation. By contrast, it is unclear if innate immune cells within this same space also actively participate in the pathology of MM. Our study shows for the first time that eosinophils (Eos) can contribute to the biology of MM by enhancing the proliferation of some malignant PCs. We first demonstrate that PCs and Eos can be found in close proximity in the BM. In culture, Eos were found to augment MM cell proliferation that is predominantly mediated through a soluble factor(s). Fractionation of cell-free supernatants and neutralization studies demonstrated that this activity is independent of Eos-derived microparticles and a proliferation-inducing ligand (APRIL), respectively. Using a multicellular in vitro system designed to resemble the native MM niche, SCs and Eos were shown to have non-redundant roles in their support of MM cell growth. Whereas SCs induce MM cell proliferation predominantly through the secretion of IL-6, Eos stimulate growth of these malignant cells via an IL-6-independent mechanism. Taken together, our study demonstrates for the first time a role for Eos in the pathology of MM and suggests that therapeutic strategies targeting these cells may be beneficial.	[Wong, Tina W.; Walters, Denise K.; Arendt, Bonnie K.; Jelinek, Diane F.] Mayo Clin, Dept Immunol, Minneapolis, MN USA; [Kita, Hirohito; Jelinek, Diane F.] Mayo Clin, Dept Internal Med, Minneapolis, MN USA; [Hanson, Curtis A.] Mayo Clin, Dept Lab Med & Pathol, Minneapolis, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Jelinek, DF (corresponding author), Mayo Clin, Dept Immunol, Minneapolis, MN USA.	jelinek.diane@mayo.edu			Mayo Foundation; NIH Pre-doctoral Immunology Training Grant [T32 AI07425]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007425] Funding Source: NIH RePORTER	Mayo Foundation; NIH Pre-doctoral Immunology Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Mayo Foundation and NIH Pre-doctoral Immunology Training Grant T32 AI07425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KC, 1989, BLOOD, V73, P1915; Arendt BK, 2008, BLOOD, V112, P1931, DOI 10.1182/blood-2008-03-143040; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Chu VT, 2011, SCAND J IMMUNOL, V73, P508, DOI 10.1111/j.1365-3083.2011.02544.x; Chu VT, 2012, EUR J IMMUNOL, V42, P130, DOI 10.1002/eji.201141953; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Ehrlich LA, 2005, BLOOD, V106, P1407, DOI 10.1182/blood-2005-03-1080; Eshaghian S, 2012, CURR OPIN SUPPORT PA, V6, P330, DOI 10.1097/SPC.0b013e3283565c56; Giuliani N, 2007, LEUKEMIA LYMPHOMA, V48, P2323, DOI 10.1080/10428190701648281; GLANTZ L, 1995, AM J CLIN PATHOL, V103, P583; Gomez MR, 2010, J IMMUNOL, V185, P7180, DOI 10.4049/jimmunol.1002319; GREIPP PR, 1987, MAYO CLIN PROC, V62, P969, DOI 10.1016/S0025-6196(12)65066-6; GREIPP PR, 1993, BLOOD, V81, P3382; He J, 2012, CANCER RES, V72, P6393, DOI 10.1158/0008-5472.CAN-12-2664; JELINEK DF, 1993, CANCER RES, V53, P5320; Kim J, 2012, BRIT J HAEMATOL, V158, P336, DOI 10.1111/j.1365-2141.2012.09154.x; Kukreja A, 2006, J EXP MED, V203, P1859, DOI 10.1084/jem.20052136; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Lee JW, 2004, BLOOD, V103, P2308, DOI 10.1182/blood-2003-06-1992; LOKHORST HM, 1986, BRIT J HAEMATOL, V64, P271, DOI 10.1111/j.1365-2141.1986.tb04119.x; Lotfi R, 2007, J IMMUNOTHER, V30, P16, DOI 10.1097/01.cji.0000211324.53396.f6; Manier S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/157496; Nair JR, 2012, ONCOIMMUNOLOGY, V1, P387, DOI 10.4161/onci.18746; Noll JE, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.38; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Pellegrino A, 2005, BRIT J HAEMATOL, V129, P248, DOI 10.1111/j.1365-2141.2005.05443.x; Roccaro AM, 2011, BLOOD, V118; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Roufosse F, 2012, SEMIN HEMATOL, V49, P138, DOI 10.1053/j.seminhematol.2012.01.003; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steensma DP, 2001, BLOOD, V97, P2522, DOI 10.1182/blood.V97.8.2522; Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001; TAUBE T, 1992, EUR J HAEMATOL, V49, P192; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Westendorf JJ, 1996, LEUKEMIA, V10, P866; Winter O, 2011, IMMUNOL LETT, V141, P145, DOI 10.1016/j.imlet.2011.07.006; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Wong TW, 2013, J IMMUNOL METHODS, V387, P130, DOI 10.1016/j.jim.2012.10.006	40	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e70554	10.1371/journal.pone.0070554	http://dx.doi.org/10.1371/journal.pone.0070554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894671	gold, Green Submitted, Green Published			2022-12-25	WOS:000322132100095
J	Bi, X; Feng, D; Korczeniewska, J; Alper, N; Hu, G; Barnes, BJ				Bi, X.; Feng, D.; Korczeniewska, J.; Alper, N.; Hu, G.; Barnes, B. J.			Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses gamma-irradiation-induced thymic lymphomagenesis	ONCOGENE			English	Article						IRF5; thymic lymphoma; gamma-irradiation; apoptosis; stem cells	INTERFERON REGULATORY FACTOR; PRISTANE-INDUCED LUPUS; TUMOR-SUPPRESSOR; GENE-EXPRESSION; IRF5(-/-) MICE; PUMA; P53; DEATH; INDUCTION; TUMORIGENESIS	Repeated low-dose gamma-irradiation (IR) induces thymic lymphoma in mice because of oncogenic mutations propagating from a primitive hematopoietic stem/progenitor cell (HSC) in the bone marrow. It is well known that IR-induced thymic lymphomagenesis is markedly enhanced by p53 deficiency, yet data also indicate that p53-dependent apoptosis can actively drive tumor formation in this model. The latter was recently expounded on by findings from Puma-deficient mice, indicating that loss of this proapoptotic p53 target gene results in protection from IR-induced lymphomagenesis rather than enhanced susceptibility to. Similar to Puma, the transcription factor interferon regulatory factor 5 (Irf5) has been reported as a p53 target gene and is required for DNA damage-induced apoptosis. To date, no studies have been performed to elucidate the in vivo role of IRF5 in tumorigenesis. Given its essential role in DNA damage-induced apoptosis, we explored the tumor suppressor function of IRF5 in IR-induced thymic lymphomagenesis. Somewhat surprisingly, we found that thymic lymphoma development was significantly suppressed in Irf5(-/-) mice as compared with wild-type littermates. Suppression was due, in part, to reduced thymocyte and HSC apoptosis, resulting in reduced compensatory proliferation, and reduced replication stress-associated DNA damage. The observed effects were independent of p53 or Puma as these proteins were upregulated in Irf5(-/-) mice in response to IR. This study demonstrates an important new role for IRF5 in maintaining HSC homeostasis after IR and supports the non-redundant functions of IRF5, p53 and PUMA in DNA damage-induced lymphomagenesis. We propose that IRF5 may be an attractive target for developing therapeutic agents to ameliorate radiation-induced bone marrow injury.	[Bi, X.; Feng, D.; Korczeniewska, J.; Barnes, B. J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Bi, X.; Feng, D.; Korczeniewska, J.; Alper, N.; Hu, G.; Barnes, B. J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Univ Hosp, Ctr Canc, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Barnes, BJ (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Univ Hosp,Canc Ctr, G1224,205 South Orange Ave, Newark, NJ 07103 USA.	barnesbe@umdnj.edu			New Jersey Medical School-University Hospital Cancer Center; UMDNJ Foundation; New Jersey Commission on Cancer Research (NJCCR)	New Jersey Medical School-University Hospital Cancer Center; UMDNJ Foundation; New Jersey Commission on Cancer Research (NJCCR)	We gratefully acknowledge Dr David Lagunoff for pathology assistance and Dr Lisong Yang for technical assistance. This work was supported in part by funds from the New Jersey Medical School-University Hospital Cancer Center, the UMDNJ Foundation and the New Jersey Commission on Cancer Research (NJCCR).	Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Bi XH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3053; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Feng D, 2012, EUR J IMMUNOL, V42, P1477, DOI 10.1002/eji.201141642; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Fresquet V, 2012, BRIT J HAEMATOL, V158, P712, DOI 10.1111/j.1365-2141.2012.09226.x; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Hu GD, 2009, J BIOL CHEM, V284, P2767, DOI 10.1074/jbc.M804744200; KAPLAN HENRY S., 1964, NAT CANCER INST MONOGR, V14, P207; KAPLAN HS, 1952, J NATL CANCER I, V13, P185; Kelly PN, 2010, CELL DEATH DIFFER, V17, P1655, DOI 10.1038/cdd.2010.43; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kim HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011439; Kominami R, 2006, CANCER SCI, V97, P575, DOI 10.1111/j.1349-7006.2006.00218.x; Labi V, 2010, GENE DEV, V24, P1602, DOI 10.1101/gad.1940210; Liu C, 2011, LEUKEMIA, V25, P1516, DOI 10.1038/leu.2011.113; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Michalak EM, 2010, GENE DEV, V24, P1608, DOI 10.1101/gad.1940110; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Purtha WE, 2012, P NATL ACAD SCI USA, V109, pE898, DOI 10.1073/pnas.1118155109; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Stankovic T, 2004, BLOOD, V103, P291, DOI 10.1182/blood-2003-04-1161; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Watkins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044997; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Xu DS, 2011, J BIOL CHEM, V286, P18261, DOI 10.1074/jbc.M110.210542; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yang LS, 2012, J IMMUNOL, V189, P3741, DOI 10.4049/jimmunol.1201162; Yang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005500; Yu H, 2010, BLOOD, V115, P3472, DOI 10.1182/blood-2009-10-248278	40	11	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 19	2014	33	25					3288	3297		10.1038/onc.2013.295	http://dx.doi.org/10.1038/onc.2013.295			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK5DA	23912454				2022-12-25	WOS:000338443400008
J	Hsieh, ML; James, TD; Knipling, L; Waddell, MB; White, S; Hinton, DM				Hsieh, Meng-Lun; James, Tamara D.; Knipling, Leslie; Waddell, M. Brett; White, Stephen; Hinton, Deborah M.			Architecture of the Bacteriophage T4 Activator MotA/Promoter DNA Interaction during Sigma Appropriation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RNA-POLYMERASE; MOTA TRANSCRIPTION FACTOR; ASIA PROTEIN; MIDDLE PROMOTER; CRYSTAL-STRUCTURE; OPEN COMPLEXES; REGION 4; BINDING; SUBUNIT; DOMAIN	Gene expression can be regulated through factors that direct RNA polymerase to the correct promoter sequence at the correct time. Bacteriophage T4 controls its development in this way using phage proteins that interact with host RNA polymerase. Using a process called sigma appropriation, the T4 co-activator AsiA structurally remodels the sigma(70) subunit of host RNA polymerase, while a T4 activator, MotA, engages the C terminus of sigma(70) and binds to a DNA promoter element, the MotA box. Structures for the N-terminal (NTD) and C-terminal (CTD) domains of MotA are available, but no structure exists for MotA with or without DNA. We report the first molecular map of the MotA/DNA interaction within the sigma-appropriated complex, which we obtained by using the cleaving reagent, iron bromoacetamidobenzyl-EDTA (FeBABE). We conjugated surface-exposed, single cysteines in MotA with FeBABE and performed cleavage reactions in the context of stable transcription complexes. The DNA cleavage sites were analyzed using ICM Molsoft software and three-dimensional physical models of MotA(NTD), MotA(CTD), and the DNA to investigate shape complementarity between the protein and the DNA and to position MotA on the DNA. We found that the unusual "double wing" motif present within MotA(CTD) resides in the major groove of the MotA box. In addition, we have used surface plasmon resonance to show that MotA alone is in a very dynamic equilibrium with the MotA element. Our results demonstrate the utility of fine resolution FeBABE mapping to determine the architecture of protein-DNA complexes that have been recalcitrant to traditional structure analyses.	[Hsieh, Meng-Lun; James, Tamara D.; Knipling, Leslie; Hinton, Deborah M.] NIDDK, Gene Express & Regulat Sect, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [James, Tamara D.] NYU, Struct Biol Program, Sackler Inst, Langone Med Ctr, New York, NY 10016 USA; [Waddell, M. Brett] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [White, Stephen] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); New York University; NYU Langone Medical Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Hinton, DM (corresponding author), NIH, Bldg 8,Rm 2A-13, Bethesda, MD 20892 USA.	dhinton@helix.nih.gov	Hinton, Deborah/AAQ-2596-2021; White, Stephen W/N-8164-2018	Knipling, Leslie/0000-0002-2636-6460; Hsieh, Meng-Lun/0000-0002-6360-005X	National Institutes of Health [GM066934]; Cancer Center Core Grant [CA21765]; NIDDK; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK057802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Core Grant; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066934 (to S. W.), Cancer Center Core Grant CA21765, and by the Intramural Research Program of the NIDDK. This work was also supported by the American Lebanese Syrian Associated Charities (ALSAC; to S. W.)	Bonocora RP, 2008, MOL MICROBIOL, V69, P331, DOI 10.1111/j.1365-2958.2008.06276.x; Bonocora RP, 2011, J BIOL CHEM, V286, P39290, DOI 10.1074/jbc.M111.278762; Boucher PE, 2003, MOL CELL, V11, P163, DOI 10.1016/S1097-2765(03)00007-8; Bown JA, 1999, J BIOL CHEM, V274, P2263, DOI 10.1074/jbc.274.4.2263; Cicero MP, 1998, BIOCHEMISTRY-US, V37, P4977, DOI 10.1021/bi972337s; Colland F, 1999, EMBO J, V18, P4049, DOI 10.1093/emboj/18.14.4049; Colland F, 1998, MOL MICROBIOL, V27, P819, DOI 10.1046/j.1365-2958.1998.00729.x; Creighton T. E., 1984, PROTEINS STRUCTURES, V2nd; Decker K. B., 2013, ANN REV MIC IN PRESS; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; Decker KB, 2011, J MOL BIOL, V409, P692, DOI 10.1016/j.jmb.2011.04.017; Finnin MS, 1997, EMBO J, V16, P1992, DOI 10.1093/emboj/16.8.1992; FINNIN MS, 1993, J MOL BIOL, V232, P301, DOI 10.1006/jmbi.1993.1384; Gerber JS, 1996, J BACTERIOL, V178, P6133, DOI 10.1128/jb.178.21.6133-6139.1996; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Greiner DP, 1997, BIOCONJUGATE CHEM, V8, P44, DOI 10.1021/bc9600731; Hernandez VJ, 1996, J BIOL CHEM, V271, P18775, DOI 10.1074/jbc.271.31.18775; Hinton DM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-289; HINTON DM, 1991, J BIOL CHEM, V266, P18034; Hinton DM, 1996, J MOL BIOL, V256, P235, DOI 10.1006/jmbi.1996.0082; Hook-Barnard IG, 2007, GENE REGUL SYST BIO, V1, P275; Jain D, 2005, MOL CELL, V19, P259, DOI 10.1016/j.molcel.2005.06.006; Jain D, 2004, MOL CELL, V13, P45, DOI 10.1016/S1097-2765(03)00483-0; King JM, 2012, J BACTERIOL, V194, P2573, DOI 10.1128/JB.00107-12; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lambert LJ, 2004, EMBO J, V23, P2952, DOI 10.1038/sj.emboj.7600312; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Le TBK, 2011, NUCLEIC ACIDS RES, V39, P9433, DOI 10.1093/nar/gkr640; Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012; Li N, 2002, MOL MICROBIOL, V43, P1079, DOI 10.1046/j.1365-2958.2002.02809.x; Li N, 2001, BIOCHEMISTRY-US, V40, P4293, DOI 10.1021/bi0028284; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; MARCHAMEGADZIE R, 1995, MOL MICROBIOL, V15, P649, DOI 10.1111/j.1365-2958.1995.tb02374.x; Marr MT, 2004, NUCLEIC ACIDS RES, V32, P1083, DOI 10.1093/nar/gkh261; Marr MT, 2001, P NATL ACAD SCI USA, V98, P8972, DOI 10.1073/pnas.161253298; Mukherjee Srabani, 2003, Biological Procedures Online, V5, P78, DOI 10.1251/bpo49; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Owens JT, 1998, BIOCHEMISTRY-US, V37, P7670, DOI 10.1021/bi980188n; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Pahari S, 1997, FEBS LETT, V411, P60, DOI 10.1016/S0014-5793(97)00668-6; Pai KS, 1996, P NATL ACAD SCI USA, V93, P10647, DOI 10.1073/pnas.93.20.10647; Pal D, 2003, J MOL BIOL, V325, P827, DOI 10.1016/S0022-2836(02)01307-4; Pande S, 2002, J BACTERIOL, V184, P3957, DOI 10.1128/JB.184.14.3957-3964.2002; Pineda M, 2004, J MOL BIOL, V344, P1183, DOI 10.1016/j.jmb.2004.10.003; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; SCHMIDT RP, 1992, J BIOL CHEM, V267, P11399; Severinova E, 1998, J MOL BIOL, V279, P9, DOI 10.1006/jmbi.1998.1742; Sharma M, 1999, J MOL BIOL, V290, P905, DOI 10.1006/jmbi.1999.2928; STEMMER WPC, 1992, BIOTECHNIQUES, V13, P214; STEVENS A, 1973, BIOCHEM BIOPH RES CO, V54, P488, DOI 10.1016/0006-291X(73)91447-2; Stoskiene G, 2007, MOL MICROBIOL, V64, P421, DOI 10.1111/j.1365-2958.2007.05659.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Yuan AH, 2009, P NATL ACAD SCI USA, V106, P6597, DOI 10.1073/pnas.0812832106	56	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27607	27618		10.1074/jbc.M113.475434	http://dx.doi.org/10.1074/jbc.M113.475434			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23902794	hybrid, Green Published			2022-12-25	WOS:000330597300055
J	Lu, J; Vodnala, SK; Gustavsson, AL; Gustafsson, TN; Sjoberg, B; Johansson, HA; Kumar, S; Tjernberg, A; Engman, L; Rottenberg, ME; Holmgren, A				Lu, Jun; Vodnala, Suman K.; Gustavsson, Anna-Lena; Gustafsson, Tomas N.; Sjoberg, Birger; Johansson, Henrik A.; Kumar, Sangit; Tjernberg, Agneta; Engman, Lars; Rottenberg, Martin E.; Holmgren, Arne			Ebsulfur Is a Benzisothiazolone Cytocidal Inhibitor Targeting the Trypanothione Reductase of Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN REDUCTASE; AFRICAN TRYPANOSOMES; DRUG DESIGN; LEISHMANIA-DONOVANI; OXIDATIVE STRESS; BINDING-SITES; ACTIVE-SITE; METABOLISM; MECHANISM; GLUTATHIONE	Trypanosoma brucei is the causing agent of African trypanosomiasis. These parasites possess a unique thiol redox system required for DNA synthesis and defense against oxidative stress. It includes trypanothione and trypanothione reductase (TryR) instead of the thioredoxin and glutaredoxin systems of mammalian hosts. Here, we show that the benzisothiazolone compound ebsulfur (EbS), a sulfur analogue of ebselen, is a potent inhibitor of T. brucei growth with a favorable selectivity index over mammalian cells. EbS inhibited the TryR activity and decreased non-protein thiol levels in cultured parasites. The inhibition of TryR by EbS was irreversible and NADPH-dependent. EbS formed a complex with TryR and caused oxidation and inactivation of the enzyme. EbS was more toxic for T. brucei than for Trypanosoma cruzi, probably due to lower levels of TryR and trypanothione in T. brucei. Furthermore, inhibition of TryR produced high intracellular reactive oxygen species. Hydrogen peroxide, known to be constitutively high in T. brucei, enhanced the EbS inhibition of TryR. The elevation of reactive oxygen species production in parasites caused by EbS induced a programmed cell death. Soluble EbS analogues were synthesized and cured T. brucei brucei infection in mice when used together with nifurtimox. Altogether, EbS and EbS analogues disrupt the trypanothione system, hampering the defense against oxidative stress. Thus, EbS is a promising lead for development of drugs against African trypanosomiasis.	[Lu, Jun; Gustafsson, Tomas N.; Johansson, Henrik A.; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden; [Vodnala, Suman K.; Rottenberg, Martin E.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Gustavsson, Anna-Lena; Sjoberg, Birger] Karolinska Inst, Chem Biol Consortium Sweden, Sci Life Lab, Div Translat Med, SE-17177 Stockholm, Sweden; [Johansson, Henrik A.; Engman, Lars] Uppsala Univ, Dept Chem BMC, SE-75123 Uppsala, Sweden; [Kumar, Sangit] IISER Bhopal, Dept Chem, Bhopal, MP, India; [Tjernberg, Agneta] Swedish Orphan Biovitrum AB, SE-11276 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Uppsala University; Indian Institute of Science Education & Research (IISER) - Bhopal; Swedish Orphan Biovitrum	Rottenberg, ME (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden.	Martin.Rottenberg@ki.se; Arne.Holmgren@ki.se	Lu, Jun/E-9701-2017	Lu, Jun/0000-0002-1699-8835; Gustavsson, Anna-Lena/0000-0003-4332-2336; Rottenberg, Martin/0000-0003-0514-7434; Gustafsson, Tomas/0000-0002-4495-8267; KUMAR, SANGIT/0000-0003-0658-8709	Swedish Cancer Society [961]; Swedish Research Council [13x-3529, 70409201]; Vinnova	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Vinnova(Vinnova)	This work was supported by Swedish Cancer Society Grant 961, Swedish Research Council Grants 13x-3529 and 70409201, Vinnova, The K. A. Wallenberg Foundation, the Ake Wiberg Stiftelse, and the Karolinska Institutet.	ARRICK BA, 1981, J EXP MED, V153, P720, DOI 10.1084/jem.153.3.720; BENSON TJ, 1992, BIOCHEM J, V286, P9, DOI 10.1042/bj2860009; Bhakuni BS, 2012, TETRAHEDRON LETT, V53, P1354, DOI 10.1016/j.tetlet.2012.01.003; Bonse S, 1999, J MED CHEM, V42, P5448, DOI 10.1021/jm990386s; Cerecetto H, 2011, FUTURE MICROBIOL, V6, P847, DOI 10.2217/FMB.11.74; Ceylan S, 2010, J BIOL CHEM, V285, P35224, DOI 10.1074/jbc.M110.165860; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Dahl R, 2011, J MED CHEM, V54, P3661, DOI 10.1021/jm101401a; Dumas C, 1997, EMBO J, V16, P2590, DOI 10.1093/emboj/16.10.2590; Dumas M., 1999, PROGR HUMAN AFRICAN, P215; ENGMAN L, 1989, J ORG CHEM, V54, P2964, DOI 10.1021/jo00273a035; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; FAIRLAMB AH, 1989, P NATL ACAD SCI USA, V86, P2607, DOI 10.1073/pnas.86.8.2607; Gustafsson TN, 2007, ACTA CRYSTALLOGR D, V63, P833, DOI 10.1107/S0907444907026303; Gustafsson TN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413427; He J, 2012, BIOORGAN MED CHEM, V20, P3816, DOI 10.1016/j.bmc.2012.04.033; Holmgren A., 2007, U.S. Patent Appl., Patent No. [2011/2088, 130, 20112088]; HOMBURG CHE, 1995, BLOOD, V85, P532; HUNTER WN, 1992, J MOL BIOL, V227, P322, DOI 10.1016/0022-2836(92)90701-K; Jones DC, 2010, MOL BIOCHEM PARASIT, V169, P12, DOI 10.1016/j.molbiopara.2009.09.002; Kibona SN, 2006, TROP MED INT HEALTH, V11, P144, DOI 10.1111/j.1365-3156.2005.01545.x; KITZ R, 1962, J BIOL CHEM, V237, P3245; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Krauth-Siegel RL, 2012, ANTIOXID REDOX SIGN, V17, P583, DOI 10.1089/ars.2011.4392; KRAUTHSIEGEL RL, 1995, FASEB J, V9, P1138, DOI 10.1096/fasebj.9.12.7672506; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Kristensson K, 2002, CURR TOP MICROBIOL, V265, P227; Lu J, 2013, FASEB J, V27, P1394, DOI 10.1096/fj.12-223305; Masocha W, 2004, J CLIN INVEST, V114, P689, DOI 10.1172/JCI22104; Meiering S, 2005, J MED CHEM, V48, P4793, DOI 10.1021/jm050027z; MLOCHOWSKI J, 1993, LIEBIGS ANN CHEM, P1239; NOZAWA R, 1989, ANTIMICROB AGENTS CH, V33, P1388, DOI 10.1128/AAC.33.8.1388; Olin-Sandoval V, 2010, CURR DRUG TARGETS, V11, P1614, DOI 10.2174/1389450111009011614; Patterson S, 2011, J MED CHEM, V54, P6514, DOI 10.1021/jm200312v; Ranganathan S, 2002, TETRAHEDRON, V58, P2861, DOI 10.1016/S0040-4020(02)00159-X; Richardson JL, 2009, CHEMMEDCHEM, V4, P1333, DOI 10.1002/cmdc.200900097; Saravanamuthu A, 2004, J BIOL CHEM, V279, P29493, DOI 10.1074/jbc.M403187200; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Schmidt Armin, 2002, Current Topics in Medicinal Chemistry, V2, P1239, DOI 10.2174/1568026023393048; Sharlow ER, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000659; Spinks D, 2009, CHEMMEDCHEM, V4, P2060, DOI 10.1002/cmdc.200900262; Tovar J, 1998, P NATL ACAD SCI USA, V95, P5311, DOI 10.1073/pnas.95.9.5311; Tsuda A, 2006, PARASITOL INT, V55, P135, DOI 10.1016/j.parint.2006.01.001; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Welburn SC, 2006, PARASITOLOGY, V132, pS7, DOI 10.1017/S0031182006000825; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wojtowicz H., 2004, Farmaco (Lausanne), V59, P863, DOI 10.1016/j.farmac.2004.07.003; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Zhao R, 2002, J BIOL CHEM, V277, P39456, DOI 10.1074/jbc.M206452200; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399	52	42	45	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27456	27468		10.1074/jbc.M113.495101	http://dx.doi.org/10.1074/jbc.M113.495101			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23900839	hybrid, Green Published			2022-12-25	WOS:000330597300041
J	Justiniano, SE; Elavazhagan, S; Fatehchand, K; Shah, P; Mehta, P; Roda, JM; Mo, XK; Cheney, C; Hertlein, E; Eubank, TD; Marsh, C; Muthusamy, N; Butchar, JP; Byrd, JC; Tridandapani, S				Justiniano, Steven E.; Elavazhagan, Saranya; Fatehchand, Kavin; Shah, Prexy; Mehta, Payal; Roda, Julie M.; Mo, Xiaokui; Cheney, Carolyn; Hertlein, Erin; Eubank, Timothy D.; Marsh, Clay; Muthusamy, Natarajan; Butchar, Jonathan P.; Byrd, John C.; Tridandapani, Susheela			Fc gamma Receptor-induced Soluble Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Production Inhibits Angiogenesis and Enhances Efficacy of Anti-tumor Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; KAPPA-B-ALPHA; HUMAN MONOCYTES; BISPECIFIC ANTIBODY; TUMOR ANGIOGENESIS; MESSENGER-RNA; CELLS; EXPRESSION; CANCER; MICRORNA	Monocytes/macrophages are potent mediators of antitumor antibody therapy, where they engage target cells via Fc gamma receptors (Fc gamma R). Binding of these cells to opsonized tumor targets elicits cytokine production, phagocytosis, and antibody-mediated cellular cytotoxicity. Here we show for the first time that activation of monocyte Fc gamma R results in the secretion of soluble vascular endothelial growth factor receptor-1 (VEGFR-1/sFlt-1), which serves to antagonize VEGF-mediated angiogenesis and tumor growth. Consistent with this, using a murine solid tumor model of antibody therapy, we show that sFlt-1 is involved in restricting tumor growth. Analyzing the mechanism of induction of sFlt-1, we found that the Erk and PI3K pathways were required for transcription, and NF-kappa B was required for translation. Upon closer examination of the role of NF-kappa B, we found that a microRNA, miR181a, negatively regulates Fc gamma R-mediated sFlt-1 production and that NF-kappa B serves to antagonize this microRNA. Taken together, these results demonstrate a novel and biologically important function of monocytes and macrophages during antibody therapy.	[Justiniano, Steven E.; Elavazhagan, Saranya; Shah, Prexy; Roda, Julie M.; Eubank, Timothy D.; Marsh, Clay; Muthusamy, Natarajan; Butchar, Jonathan P.; Byrd, John C.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Fatehchand, Kavin; Tridandapani, Susheela] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Mehta, Payal; Tridandapani, Susheela] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Cheney, Carolyn; Hertlein, Erin; Muthusamy, Natarajan; Butchar, Jonathan P.; Byrd, John C.; Tridandapani, Susheela] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Tridandapani, S (corresponding author), Ohio State Univ, Dept Internal Med, 473 W 12th Ave, Columbus, OH 43210 USA.	tridandapani.2@osu.edu	Butchar, Jonathan/E-2825-2011; Tridandapani, Susheela/E-4209-2011; Roda, Julie/G-8932-2015	Roda, Julie/0000-0001-5631-9908; Eubank, Tim/0000-0002-8225-7824; Justiniano, Steven/0000-0003-1381-9309	National Institutes of Health [R01CA162411, P01 CA095426, K12CA133250, T32 60013191]; American Cancer Society [IRG-67-003-47]; Leukemia and Lymphoma Society [P50-CA140158]; Harry Mangurian Foundation; D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE [P01CA095426, P50CA140158, R01CA162411, K12CA133250, P30CA016058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Harry Mangurian Foundation; D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA162411, P01 CA095426, and K12CA133250 (to J. P. B., X. M., N. M., J. C. B., and S. T.) and Postdoctoral Fellowship T32 60013191 (to S. E. J.). This work was also supported by American Cancer Society Grant IRG-67-003-47 (to J. P. B.) and The Leukemia and Lymphoma Society Grant P50-CA140158, The Harry Mangurian Foundation, and The D. Warren Brown Foundation (to J. P. B. and N. M.).	Akewanlop C, 2001, CANCER RES, V61, P4061; ANDERSON CL, 1990, J EXP MED, V171, P1333, DOI 10.1084/jem.171.4.1333; Ansell SM, 2002, BLOOD, V99, P67, DOI 10.1182/blood.V99.1.67; Banks RE, 1998, MOL HUM REPROD, V4, P377, DOI 10.1093/molehr/4.4.377; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Butchar JP, 2010, CLIN CANCER RES, V16, P2065, DOI 10.1158/1078-0432.CCR-09-2591; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; CASADO JA, 1994, IMMUNOLOGY, V83, P148; Cogswell PC, 2003, J BIOL CHEM, V278, P2963, DOI 10.1074/jbc.M209995200; Cuesta R, 2009, MOL CELL BIOL, V29, P2841, DOI 10.1128/MCB.01971-08; Debernardi S, 2007, LEUKEMIA, V21, P912, DOI 10.1038/sj.leu.2404605; Dudoit S, 2003, BIOTECHNIQUES, P45; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Eubank TD, 2004, IMMUNITY, V21, P831, DOI 10.1016/j.immuni.2004.10.011; Eubank TD, 2011, BLOOD, V117, P323, DOI 10.1182/blood-2010-01-261792; Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405; FANGER MW, 1992, IMMUNOL RES, V11, P203, DOI 10.1007/BF02919127; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh AK, 2009, BLOOD, V113, P5568, DOI 10.1182/blood-2008-10-185686; HOLM S, 1979, SCAND J STAT, V6, P65; Hunt TK, 2008, ADV EXP MED BIOL, V614, P73, DOI 10.1007/978-0-387-74911-2_9; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; KINDT GC, 1993, AM J PHYSIOL, V265, pL178, DOI 10.1152/ajplung.1993.265.2.L178; Kondo K, 1998, GENE, V208, P297, DOI 10.1016/S0378-1119(98)00006-7; Krussel JS, 1999, MOL HUM REPROD, V5, P452, DOI 10.1093/molehr/5.5.452; MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Oflazoglu E, 2009, BRIT J CANCER, V100, P113, DOI 10.1038/sj.bjc.6604812; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Parihar R, 2004, CLIN CANCER RES, V10, P5027, DOI 10.1158/1078-0432.CCR-04-0265; Penichet ML, 1999, LAB ANIM SCI, V49, P179; Rajaram MVS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007919; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Roda JM, 2011, J IMMUNOL, V187, P1970, DOI 10.4049/jimmunol.1100841; Schwind S, 2010, J CLIN ONCOL, V28, P5257, DOI 10.1200/JCO.2010.29.2953; Seoudi AM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002122; SHAW GM, 1978, J CLIN INVEST, V62, P1172, DOI 10.1172/JCI109236; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tailor TD, 2010, MOL CANCER THER, V9, P1798, DOI 10.1158/1535-7163.MCT-09-0856; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Verbeke G, 2000, LINEAR MIXED MODELS, P23; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Watanabe M, 1999, BREAST CANCER RES TR, V53, P199, DOI 10.1023/A:1006145507567	51	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26800	26809		10.1074/jbc.M113.485185	http://dx.doi.org/10.1074/jbc.M113.485185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902770	Green Published, hybrid			2022-12-25	WOS:000330594500044
J	Silla, LMD; Zelmanowicz, A; Mito, I; Michalowski, M; Hellwing, T; Shilling, MA; Friedrisch, JR; Bittar, CM; Albrecht, CAM; Scapinello, E; Conti, C; Albrecht, MAM; Baggio, L; Pezzi, A; Amorin, B; Valim, V; Fogliatto, L; Paz, A; Astigarraga, C; Bittencourt, RI; Fischer, G; Daudt, L				da Rocha Silla, Lucia Mariano; Zelmanowicz, Alice; Mito, Ingrid; Michalowski, Mariana; Hellwing, Tania; Shilling, Marco Antonio; Friedrisch, Joao Ricardo; Bittar, Christina M.; Mentz Albrecht, Cristina Arthmar; Scapinello, Elaine; Conti, Claudia; Mentz Albrecht, Marcia Arthmar; Baggio, Leticia; Pezzi, Annelise; Amorin, Bruna; Valim, Vanessa; Fogliatto, Laura; Paz, Alessandra; Astigarraga, Claudia; Bittencourt, Rosane Isabel; Fischer, Gustavo; Daudt, Liane			High Prevalence of Anemia in Children and Adult Women in an Urban Population in Southern Brazil	PLOS ONE			English	Article							GRANDE-DO-SUL; IRON-DEFICIENCY; DEVELOPING-COUNTRIES; RISK-FACTORS; COWS MILK; DETERMINANTS; PELOTAS; INFANTS; AGE	This population-based study was designed to detect the prevalence of anemia in a healthy population of children (18 months to 7 years) and women (14 to 30 years) tested in 2006-2007 in the state of Rio Grande do Sul, Brazil as part of an effort to tackle this massive problem that still affects so many people in the XXI century. Anemia was defined according to the WHO. Capillary blood was measured and socioeconomic status was determined according to the Brazilian Association of Market Research Agencies. The median prevalence of anemia in 2198 children was 45.4% and in 1999 women 36.4%. Anemia decreased with age during childhood; although significantly more prevalent in lower classes individuals, it was also high in the upper classes. There are indirect evidences that the lack of iron supplementation and/or iron fortified food may play a role in it. Professionals and society wise measures of education have to be implemented in order to address possible biologic factors involved in childhood psychosocial development in southern Brazil.	[da Rocha Silla, Lucia Mariano; Michalowski, Mariana; Friedrisch, Joao Ricardo; Bittar, Christina M.; Fogliatto, Laura; Paz, Alessandra; Astigarraga, Claudia; Bittencourt, Rosane Isabel; Fischer, Gustavo] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [da Rocha Silla, Lucia Mariano] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Mentz Albrecht, Cristina Arthmar; Scapinello, Elaine; Conti, Claudia; Mentz Albrecht, Marcia Arthmar] Hosp Clin Porto Alegre, Assoc Amigos Hematol, Porto Alegre, RS, Brazil; [da Rocha Silla, Lucia Mariano; Baggio, Leticia; Pezzi, Annelise; Amorin, Bruna; Valim, Vanessa] Hosp Clin Porto Alegre, Lab Cell Culture & Mol Anal Hematopoiet, Porto Alegre, RS, Brazil; [Zelmanowicz, Alice; Michalowski, Mariana; Fogliatto, Laura] Fdn Fac Fed Ciencias Med Porto Alegre, Porto Alegre, RS, Brazil; [Hellwing, Tania] Univ Fed Pelotas, Pelotas, RS, Brazil; [Shilling, Marco Antonio] Univ Passo Fundo, Passo Fundo, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Pelotas; Universidade de Passo Fundo	Silla, LMD (corresponding author), Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.	lsilla@hcpa.ufrgs.br	silla, lucia m r/H-6872-2013; Daudt, Liane Esteves/Q-3550-2016; Michalowski, Mariana Bohns/D-5546-2014; Fogliatto, Laura/W-3787-2019; Bittencourt, Rosane/W-3980-2019; Daudt, Liane Esteves/E-9407-2013	Michalowski, Mariana Bohns/0000-0002-9482-0776; Fogliatto, Laura/0000-0002-0610-7971; Daudt, Liane Esteves/0000-0001-9495-6932; Zelmanowicz, Alice/0000-0001-9121-6365	Caixa-RS; Servico Social do Comercio (SESC-RS); Servico Social da Industria do Rio Grande do Sul (SESI-RS); RS	Caixa-RS; Servico Social do Comercio (SESC-RS); Servico Social da Industria do Rio Grande do Sul (SESI-RS); RS	This study was support by a grant from Caixa-RS, Servico Social do Comercio (SESC-RS), Servico Social da Industria do Rio Grande do Sul (SESI-RS) and the State Secretary of Health of RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEP, 2007, ASS BRAS EMPR PESQ; [Anonymous], 2005, PROGRAMA NACL SUPLEM; Assis AMO, 2004, REV SAUDE PUBL, V38, P543, DOI 10.1590/S0034-89102004000400010; Batista Filho Malaquias, 2007, Rev. Bras. Saude Mater. Infant., V7, P487, DOI 10.1590/S1519-38292007000400017; Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bortolini GA, 2010, J PEDIAT-BRAZIL, V86, P488, DOI [10.1590/S0021-75572010000600007, 10.2223/JPED.2039]; Costa JT, 2011, J PEDIAT-BRAZIL, V87, P76, DOI [10.2223/JPED.2049, 10.1590/S0021-75572011000100013]; da Silva LSM, 2001, REV SAUDE PUBL, V35, P66, DOI 10.1590/S0034-89102001000100010; Daudt LE, 2002, NEONATAL SCREENING H, P833, DOI [10.1590/S0102-311X2002000300032, DOI 10.1590/S0102-311X2002000300032]; de Castro TG, 2011, CAD SAUDE PUBLICA, V27, P131, DOI 10.1590/S0102-311X2011000100014; Oliveira CSD, 2011, CAD SAUDE PUBLICA, V27, P1008, DOI 10.1590/S0102-311X2011000500018; Fabian C, 2007, CAD SAUDE PUBLICA, V23, P1199, DOI 10.1590/S0102-311X2007000500021; Assuncao MCF, 2007, REV SAUDE PUBL, V41, P539, DOI 10.1590/S0034-89102006005000031; Assuncao MCF, 2007, REV SAUDE PUBL, V41, P328, DOI 10.1590/S0034-89102007000300002; FROSI VM, 1975, IMIGRACAO ITALIANA N, P38; Galor O, 2001, FOOD THOUGHT BASIC N; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; dos Reis MCG, 2010, REV LAT-AM ENFERM, V18, P792, DOI 10.1590/S0104-11692010000400019; Hadler MCCM, 2004, PREV MED, V39, P713, DOI 10.1016/j.ypmed.2004.02.040; IBGE, 2006, MIS DES POL REND REA; Jordão Regina Esteves, 2009, Rev. paul. pediatr., V27, P90; Leal LP, 2011, REV SAUDE PUBL, V45, P457, DOI 10.1590/S0034-89102011000300003; Levy-Costa RB, 2004, REV SAUDE PUBL, V38, P797; Lisot Cristina Lucia Alberti, 2004, Cad. Saúde Pública, V20, P1595, DOI 10.1590/S0102-311X2004000600017; Lozoff B, 2006, ARCH PEDIAT ADOL MED, V160, P1108, DOI 10.1001/archpedi.160.11.1108; Ministerio da Saude website, 2006, DIM PROC REPR SAUD C; Morris LD, 2007, VOX SANG, V93, P64, DOI 10.1111/j.1423-0410.2007.00919.x; Neri M, 2007, MIS DES POL REND REA; Neuman NA, 2000, REV SAUDE PUBL, V34, P56, DOI 10.1590/S0034-89102000000100011; Oliveira Maria A. A., 2005, J. Pediatr. (Rio J.), V81, P361, DOI [10.2223/JPED.1386, 10.1590/S0021-75572005000600004]; Silla L M, 1999, J Pediatr (Rio J), V75, P145; Sommer Camila K., 2006, Cad. Saúde Pública, V22, P1709, DOI 10.1590/S0102-311X2006000800019; Franca MCT, 2008, REV SAUDE PUBL, V42, P607, DOI 10.1590/S0034-89102008005000028; Dame PKV, 2011, CAD SAUDE PUBLICA, V27, P2154, DOI 10.1590/S0102-311X2011001100009; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Wijndaele K, 2009, J AM DIET ASSOC, V109, P2017, DOI 10.1016/j.jada.2009.09.003; World Health Organization, IR DEF AN ASS PREV C; Zanini RR, 2011, REV SAUDE PUBL, V45, P79, DOI 10.1590/S0034-89102011000100009	39	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68805	10.1371/journal.pone.0068805	http://dx.doi.org/10.1371/journal.pone.0068805			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204MP	23922664	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700013
J	Shiraishi, N; Nomura, T; Tanizaki, H; Nakajima, S; Narumiya, S; Miyachi, Y; Tokura, Y; Kabashima, K				Shiraishi, Noriko; Nomura, Takashi; Tanizaki, Hideaki; Nakajima, Saeko; Narumiya, Shuh; Miyachi, Yoshiki; Tokura, Yoshiki; Kabashima, Kenji			Prostaglandin E-2-EP3 Axis in Fine-Tuning Excessive Skin Inflammation by Restricting Dendritic Cell Functions	PLOS ONE			English	Article							REGULATORY T-CELLS; MURINE CONTACT HYPERSENSITIVITY; CUTANEOUS IMMUNE-RESPONSE; RECEPTOR SUBTYPE EP3; PROSTANOID RECEPTORS; LANGERHANS CELLS; IN-VIVO; MIGRATION; MOUSE; SUPPRESSION	Prostaglandin E-2 (PGE(2)) is produced in the skin and is suggested to play a role in the regulation of cutaneous immune homeostasis and responses. However, the multifaceted functions of PGE(2) continue to elude our understanding, especially because of the multiplicity of PGE(2) receptors-EP1, EP2, EP3, and EP4. While cAMP-elevating EP4 is known to activate the functions of cutaneous dendritic cells (DCs), including Langerhans cells (LCs) and dermal DCs, the role of cAMP-suppressing EP3 in this process remains unknown. Here we demonstrated that an EP3 receptor selective agonist, ONO-AE-248, inhibited chemotaxis and co-stimulatory molecule expressions of DCs in vitro. A suboptimal dose of antigen was sufficient to induce contact hypersensitivity in EP3-deficient mice. Intriguingly, EP3 deficiency did not impair skin inflammation at all when the antigen dose was sufficiently high. EP3 limited the functions of cutaneous DCs only when the antigen dose was low. In contrast to EP4, the observed unappreciated function of EP3 may stabilize the cutaneous DCs to halt the impetuous response to a suboptimal dose of antigen. Taken together, PGE(2)-EP3 signaling is essential for fine-tuning excessive skin inflammation by restricting DC functions.	[Shiraishi, Noriko] Univ Environm & Occupat Hlth, Dept Dermatol, Kitakyushu, Fukuoka, Japan; [Nomura, Takashi; Tanizaki, Hideaki; Nakajima, Saeko; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Tokura, Yoshiki] Hamamatsu Univ, Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4312102, Japan	University of Occupational & Environmental Health - Japan; Kyoto University; Kyoto University; Hamamatsu University School of Medicine	Kabashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.	kaba@kuhp.kyoto-u.ac.jp	Nakajima, Saeko/AAB-1577-2021; Kabashima, Kenji/G-2521-2014	Kabashima, Kenji/0000-0002-0773-0554; Nakajima, Saeko/0000-0003-0831-1447	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli V, 2001, J EXP MED, V193, P1135, DOI 10.1084/jem.193.10.1135; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; Egawa G, 2011, J INVEST DERMATOL, V131, P2178, DOI 10.1038/jid.2011.198; Egawa G, 2011, J INVEST DERMATOL, V131, P977, DOI 10.1038/jid.2010.386; Fedyk ER, 1996, P NATL ACAD SCI USA, V93, P10978, DOI 10.1073/pnas.93.20.10978; GOODWIN JS, 1977, J EXP MED, V146, P1719, DOI 10.1084/jem.146.6.1719; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Honda T, 2011, J DERMATOL SCI, V63, P75, DOI 10.1016/j.jdermsci.2011.06.004; Honda T, 2011, J DERMATOL SCI, V61, P144, DOI 10.1016/j.jdermsci.2010.11.001; Honda T, 2010, CURR DRUG TARGETS, V11, P1605, DOI 10.2174/1389450111009011605; Honda T, 2009, J ALLERGY CLIN IMMUN, V124, P809, DOI 10.1016/j.jaci.2009.04.029; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kabashima K, 2004, J DERMATOL SCI, V34, P177, DOI 10.1016/j.jdermsci.2003.11.008; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; Kocikova A, 1998, J IMMUNOL, V161, P4033; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nagamachi M, 2007, J EXP MED, V204, P2865, DOI 10.1084/jem.20070773; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Nakajima S, 2010, J IMMUNOL, V184, P5595, DOI 10.4049/jimmunol.0903260; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Okano M, 2006, IMMUNOLOGY, V118, P343, DOI 10.1111/j.1365-2567.2006.02376.x; Soontrapa K, 2011, P NATL ACAD SCI USA, V108, P6668, DOI 10.1073/pnas.1018625108; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Ueta M, 2009, J ALLERGY CLIN IMMUN, V123, P466, DOI 10.1016/j.jaci.2008.09.044; Yamamoto Y, 2011, AM J PATHOL, V179, P302, DOI 10.1016/j.ajpath.2011.03.047	34	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69599	10.1371/journal.pone.0069599	http://dx.doi.org/10.1371/journal.pone.0069599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922752	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700053
J	Dong, LP; Rocek, Z; Wang, Y; Jones, MEH				Dong, Liping; Rocek, Zbynek; Wang, Yuan; Jones, Marc E. H.			Anurans from the Lower Cretaceous Jehol Group of Western Liaoning, China	PLOS ONE			English	Article							SKELETAL DEVELOPMENT; FEATHERED DINOSAURS; DISCOGLOSSID FROG; AGE; OSTEOLOGY; AMPHIBIA; BIOTA	Background: To date, the Lower Cretaceous Jehol Group of western Liaoning, China has yielded five monotypic genera of anurans, including Liaobatrachus grabaui, Callobatrachus sanyanensis, Mesophryne beipiaoensis, Dalianbatrachus mengi, and Yizhoubatrachus macilentus. However, the validity and distinctness of these taxa have been questioned. Methodology/Principal Finding: We provide a comprehensive analysis of the Jehol frogs that includes a re-examination of the published taxa as well as an examination of a number of new specimens that have been collected over the past 10 years. The results show that the five previously named taxa can be referred to three species of one genus-Liaobatrachus grabaui, L. beipiaoensis comb. nov. and L. macilentus comb. nov.. The diagnosis of Liaobatrachus is revised, and a new diagnosis is provided for each species of this genus. We also establish Liaobatrachus zhaoi sp. nov., on the basis of a dozen well-preserved specimens from a new locality. This taxon is distinguished by a unique combination of characteristics, including relatively long hind limbs, a rounded rather than triangular acetabulum, and a gradually-tapering cultriform process of the parasphenoid. In addition, an unnamed frog from a higher horizon, which has narrow sacral diapophyses and particularly long legs, is different from Liaobatrachus and represents another form of anuran in the Jehol Biota. Conclusion/Significance: Comparisons with other Mesozoic and extant anurans and the primary phylogenetic analysis both suggest that Liaobatrachus is a member of the anuran crown-group and forms a polytomy with leiopelmatids (Ascaphus and Leiopelma) and the remaining crown-group anurans (Lalagobatrachia).	[Dong, Liping; Wang, Yuan] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China; [Rocek, Zbynek] Acad Sci Czech Republ, Dept Palaeobiol, Inst Geol, Prague, Czech Republic; [Jones, Marc E. H.] UCL, Res Dept Cell & Dev Biol, London, England	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Czech Academy of Sciences; Institute of Geology of the Czech Academy of Sciences; University of London; University College London	Dong, LP (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China.	marie.donglp@gmail.com	Rocek, Zbynek/I-8787-2014; Huw, Emyr/C-1516-2010	Huw, Emyr/0000-0002-0146-9623	National Natural Science Foundation of China [KA211102]; Ministry of Science and Technology of China [KZ129739, KQ207420]; Sino-Czech academic exchange program; Institute of Geology, Academy of Sciences of the Czech Republic, Prague [AV0Z30130516]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Sino-Czech academic exchange program; Institute of Geology, Academy of Sciences of the Czech Republic, Prague	This research was supported by grants from the National Natural Science Foundation of China (KA211102, to YW) and the Ministry of Science and Technology of China (KZ129739 and KQ207420, to YW). It was also supported by the Sino-Czech academic exchange program. ZR was a visiting professor at the Institute of Vertebrate Paleontology and Paleoanthropology (IVPP), Chinese Academy of Sciences, Beijing, while completing this research; he was also partly supported by the Institute of Geology, Academy of Sciences of the Czech Republic, Prague (Institutional Project AV0Z30130516). MEHJ thanks the British Council for travel funds associated with Darwin Now that facilitated a visit to the IVPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baez AM, 2008, J PALEONTOL, V82, P372, DOI 10.1666/06-117.1; Baez Ana Maria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P131; Chang M.-M., 2003, JEHOL BIOTA EMERGENC; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; CLARKE BT, 1987, J NAT HIST, V21, P879, DOI 10.1080/00222938700770531; EVANS SE, 1990, PALAEONTOLOGY, V33, P299; Fabrezi M, 1996, HERPETOLOGICA, V52, P188; Fabrezi M, 2001, ZOOL J LINN SOC-LOND, V131, P227, DOI 10.1006/zjls.2000.0234; Fey B., 1988, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V103, P1; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gao C, 2004, GLOB GEOL, V23, P1; Gao KQ, 2004, CRETACEOUS RES, V25, P761, DOI 10.1016/j.cretres.2004.06.011; Gao KQ, 2001, J VERTEBR PALEONTOL, V21, P460, DOI 10.1671/0272-4634(2001)021[0460:MAFLPC]2.0.CO;2; Gubin YM, 1999, PALEONTOL ZH, V31, P76; He HY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025274; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019790; Hecht M. K., 1970, Am. Mus. Novit., VNo. 2424, P1; Hu YM, 2010, P ROY SOC B-BIOL SCI, V277, P229, DOI 10.1098/rspb.2009.0203; Jenkins FA, 1998, J VERTEBR PALEONTOL, V18, P495, DOI 10.1080/02724634.1998.10011077; Ji Shu'an, 1998, Chinese Geology, V1998, P39; Jones MEH, 2003, ANN CARNEGIE MUS, V72, P65; Lynch J.D., 1971, EVOLUTIONARY RELATIO; Maglia AM, 1998, HERPETOLOGICA, V54, P344; Moore MK, 2003, J HERPETOL, V37, P714, DOI 10.1670/246-01N; NEVO E, 1968, Bulletin of the Museum of Comparative Zoology, V136, P255; Pugener LA, 1997, J MORPHOL, V233, P267, DOI 10.1002/(SICI)1097-4687(199709)233:3<267::AID-JMOR6>3.0.CO;2-0; Pusey HK, 1943, Q J MICROSC SCI, V84, P105; RITLAND RICHARD MARTIN, 1955, J MORPH, V97, P119, DOI 10.1002/jmor.1050970107; Rocek Z, 2008, CRETACEOUS RES, V29, P577, DOI 10.1016/j.cretres.2008.01.005; Rocek Z, 2012, J VERTEBR PALEONTOL, V32, P1285, DOI 10.1080/02724634.2012.700666; Sood M. S., 1938, Current Science Bangalore, V7, P63; Spinar Z.V., 1986, Journal of Vertebrate Paleontology, V6, P113; Stephenson E. M., 1952, Transactions of the Royal Society of New Zealand, V79, P601; STEPHENSON ELSIE M., 1960, TRANS ROY SOC NEW ZEALAND, V88, P473; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Trueb L, 2006, J VERTEBR PALEONTOL, V26, P44, DOI 10.1671/0272-4634(2006)26[44:ROTECC]2.0.CO;2; Trueb L, 1999, HERPETOLOGICA, V55, P139; VAN DIJK D. E., 1955, ANN UNIV STELLENBOSCH SECT A, V31, P1; Wang Y, 1999, CHINESE SCI BULL, V44, P636, DOI 10.1007/BF03182726; Wang Y, 1997, NEW ORLEANS REV, V23, P49; Wang Y, 2006, ORIGINATIONS RAD BIO, P931; Wang Yuan, 2006, Vertebrata Palasiatica, V44, P60; Wang Y, 2007, CRETACEOUS RES, V28, P235, DOI 10.1016/j.cretres.2006.07.003; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Yang W, 2007, CRETACEOUS RES, V28, P177, DOI 10.1016/j.cretres.2006.05.011; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; Zhang GL, 2009, CRETACEOUS RES, V30, P551, DOI 10.1016/j.cretres.2008.10.004; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou ZG, 2006, GEOL J, V41, P377, DOI 10.1002/gj.1045; 陈丕基, 2004, [中国科学. D辑, 地球科学, Science in China], V34, P883	50	36	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69723	10.1371/journal.pone.0069723	http://dx.doi.org/10.1371/journal.pone.0069723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922783	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900074
J	Liang, FM; Xiong, MM				Liang, Faming; Xiong, Momiao			Bayesian Detection of Causal Rare Variants under Posterior Consistency	PLOS ONE			English	Article							STOCHASTIC-APPROXIMATION; VARIABLE-SELECTION; LINEAR-MODELS; MONTE-CARLO; REGRESSION; ASSOCIATION; SEQUENCE; COMMON; GENE	Identification of causal rare variants that are associated with complex traits poses a central challenge on genome-wide association studies. However, most current research focuses only on testing the global association whether the rare variants in a given genomic region are collectively associated with the trait. Although some recent work, e. g., the Bayesian risk index method, have tried to address this problem, it is unclear whether the causal rare variants can be consistently identified by them in the small-n-large-P situation. We develop a new Bayesian method, the so-called Bayesian Rare Variant Detector (BRVD), to tackle this problem. The new method simultaneously addresses two issues: (i) (Global association test) Are there any of the variants associated with the disease, and (ii) (Causal variant detection) Which variants, if any, are driving the association. The BRVD ensures the causal rare variants to be consistently identified in the small-n-large-P situation by imposing some appropriate prior distributions on the model and model specific parameters. The numerical results indicate that the BRVD is more powerful for testing the global association than the existing methods, such as the combined multivariate and collapsing test, weighted sum statistic test, RARECOVER, sequence kernel association test, and Bayesian risk index, and also more powerful for identification of causal rare variants than the Bayesian risk index method. The BRVD has also been successfully applied to the Early-Onset Myocardial Infarction (EOMI) Exome Sequence Data. It identified a few causal rare variants that have been verified in the literature.	[Liang, Faming] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; [Xiong, Momiao] Univ Texas Houston, Sch Publ Hlth, Div Biostat, Houston, TX USA	Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Liang, FM (corresponding author), Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA.	fliang@stat.tamu.edu			National Science Foundation [DMS-1007457, DMS-1106494]; King Abdullah University of Science and Technology (KAUST) [KUS-C1-016-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104411] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	FL's research was partially supported by grants from the National Science Foundation (DMS-1007457 and DMS-1106494) and an award (KUS-C1-016-04) made by King Abdullah University of Science and Technology (KAUST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu C, 2005, SIAM J CONTROL OPTIM, V44, P283, DOI 10.1137/S0363012902417267; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Berger J. O., 2013, STAT DECISION THEORY; BERGER JO, 1987, J AM STAT ASSOC, V82, P112, DOI 10.2307/2289131; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Chen H. F., 2002, STOCHASTIC APPROXIMA; Chen JB, 2007, GENET EPIDEMIOL, V31, P238, DOI 10.1002/gepi.20205; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Eriksson N, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-53; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Inouye M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002907; Jeffreys H., 1961, THEORY PROBABILITY; Jiang WX, 2007, ANN STAT, V35, P1487, DOI 10.1214/009053607000000019; Jiang WX, 2006, NEURAL COMPUT, V18, P2762, DOI 10.1162/neco.2006.18.11.2762; Johnson VE, 2012, J AM STAT ASSOC, V107, P649, DOI 10.1080/01621459.2012.682536; King CR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001202; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liang FM, 2007, J AM STAT ASSOC, V102, P305, DOI 10.1198/016214506000001202; Liang FM, 2013, J AM STAT ASSOC, V108, P589, DOI 10.1080/01621459.2012.761942; Liang FM, 2008, BIOMETRIKA, V95, P961, DOI 10.1093/biomet/asn036; Liang FM, 2009, STAT PROBABIL LETT, V79, P581, DOI 10.1016/j.spl.2008.10.007; Liang F, 2008, J AM STAT ASSOC, V103, P410, DOI 10.1198/016214507000001337; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Neuhaus JM, 1998, J AM STAT ASSOC, V93, P1124, DOI 10.2307/2669855; Pio R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-352; Pirinen M, 2012, NAT GENET, V44, P848, DOI 10.1038/ng.2346; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Quintana MA, 2011, GENET EPIDEMIOL, V35, P638, DOI 10.1002/gepi.20613; Scott JG, 2010, ANN STAT, V38, P2587, DOI 10.1214/10-AOS792; Stingo FC, 2011, ANN APPL STAT, V5, P1978, DOI 10.1214/11-AOAS463; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Wilson MA, 2010, ANN APPL STAT, V4, P1342, DOI 10.1214/09-AOAS322; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xing GA, 2010, GENET EPIDEMIOL, V34, P769, DOI 10.1002/gepi.20526; Yi NJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002382; Yi NJ, 2011, GENET EPIDEMIOL, V35, P57, DOI 10.1002/gepi.20554; Zawistowski M, 2010, AM J HUM GENET, V87, P604, DOI 10.1016/j.ajhg.2010.10.012	42	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69633	10.1371/journal.pone.0069633	http://dx.doi.org/10.1371/journal.pone.0069633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922764	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900068
J	Muzi, H; Bezerra, CGP; Souza, AM; Boldrini, LC; Takiya, CM; Oliveira, FL; Nesi, RT; Valenca, SS; Einicker-Lamas, M; Vieyra, A; Lara, LS; Cunha, VMN				Muzi-Filho, Humberto; Bezerra, Camila G. P.; Souza, Alessandro M.; Boldrini, Leonardo C.; Takiya, Christina M.; Oliveira, Felipe L.; Nesi, Renata T.; Valenca, Samuel S.; Einicker-Lamas, Marcelo; Vieyra, Adalberto; Lara, Lucienne S.; Cunha, Valeria M. N.			Undernutrition Affects Cell Survival, Oxidative Stress, Ca2+ Handling and Signaling Pathways in Vas Deferens, Crippling Reproductive Capacity	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; PROTEIN RESTRICTION; ANGIOTENSIN-II; CA2+-ATPASE; ATPASE; NORADRENALINE; HOMEOSTASIS; INHIBITION; NUMBER; TESTIS	Background: The aim of this work was to investigate the mechanisms by which chronic malnutrition (CM) affects vas deferens function, leading to compromised reproductive capacity. Previous studies have shown that maternal malnutrition affects the reproductive tracts of adult male offspring. However, little is known about the effects of CM, a widespread life-long condition that persists from conception throughout growth to adult life. Methodology/Principal Findings: Young adult male rats, which were chronically malnourished from weaning, presented decreased total and haploid cells in the vas deferens, hypertrophy of the muscle layer in the epididymal portion of the vas deferens and intense atrophy of the muscular coat in its prostatic portion. At a molecular level, the vas deferens tissue of CM rats exhibited a huge rise in lipid peroxidation and protein carbonylation, evidence of an accentuated increase in local reactive oxygen species levels. The kinetics of plasma membrane Ca2+-ATPase activity and its kinase-mediated phosphorylation by PKA and PKC in the vas deferens revealed malnutrition-induced modifications in velocity, Ca2+ affinity and regulation of Ca2+ handling proteins. The severely crippled content of the 12-kDa FK506 binding protein, which controls passive Ca2+ release from the sarco(endo) plasmic reticulum, revealed another target of malnutrition related to intracellular Ca2+ handling, with a potential effect on forward propulsion of sperm cells. As a possible compensatory response, malnutrition led to enhanced sarco(endo) plasmic reticulum Ca2+-ATPase activity, possibly caused by stimulatory PKA-mediated phosphorylation. Conclusions/Significance: The functional correlates of these cellular and molecular hallmarks of chronic malnutrition on the vas deferens were an accentuated reduction in fertility and fecundity.	[Muzi-Filho, Humberto; Bezerra, Camila G. P.; Souza, Alessandro M.; Boldrini, Leonardo C.; Oliveira, Felipe L.; Nesi, Renata T.; Valenca, Samuel S.; Lara, Lucienne S.; Cunha, Valeria M. N.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Muzi-Filho, Humberto; Takiya, Christina M.; Einicker-Lamas, Marcelo; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil; [Muzi-Filho, Humberto; Einicker-Lamas, Marcelo; Vieyra, Adalberto; Lara, Lucienne S.] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Lara, LS (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.	lara@icb.ufrj.br	Oliveira, Felipe L/H-9902-2012; dos Santos Valença, Samuel/C-7772-2009; Morcillo, Lucienne/F-5771-2017; Valenca, Samuel S/J-7986-2013; Takiya, Christina/AAU-5959-2021	dos Santos Valença, Samuel/0000-0002-1868-9905; Morcillo, Lucienne/0000-0002-2204-8799; Valenca, Samuel S/0000-0002-1868-9905; Takiya, Christina/0000-0002-8019-628X; Leite de Oliveira, Felipe/0000-0001-6193-1616; Muzi-Filho, Humberto/0000-0002-9183-1699	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Jose Bonifacio/UFRJ; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Institutos Nacionais de Ciencia e Tecnologia (Brazil); FAPERJ; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Jose Bonifacio/UFRJ; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Institutos Nacionais de Ciencia e Tecnologia (Brazil); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work has been supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Jose Bonifacio/UFRJ, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Institutos Nacionais de Ciencia e Tecnologia (Brazil). Humberto Muzi-Filho and Alessandro M. Souza were recipients of a fellowship from FAPERJ. Camila G. P. Bezerra was recipient of a fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2001, REPRODUCTION, V122, P497, DOI 10.1530/rep.0.1220497; Amobi NIB, 1999, GEN PHARMACOL, V32, P271, DOI 10.1016/S0306-3623(98)00209-2; Assuncao-Miranda I, 2005, REGUL PEPTIDES, V127, P151, DOI 10.1016/j.regpep.2004.11.004; Axelband F, 2012, REGUL PEPTIDES, V177, P27, DOI 10.1016/j.regpep.2012.04.004; Barreira AL, 2009, CELL PHYSIOL BIOCHEM, V24, P585, DOI 10.1159/000257514; BERGENDAHL M, 1995, TRENDS ENDOCRIN MET, V6, P145, DOI 10.1016/1043-2760(95)00081-R; Buege J A, 1978, Methods Enzymol, V52, P302; Cabral LMP, 2007, J BIOL CHEM, V282, P24599, DOI 10.1074/jbc.M701669200; Carafoli E, 1997, BASIC RES CARDIOL, V92, P59, DOI 10.1007/BF00794069; Chavatte-Palmer P, 2008, GYNECOL OBSTET FERTI, V36, P920, DOI 10.1016/j.gyobfe.2008.06.020; Cooper TG, 1996, ANDROLOGIA, V28, P57; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Floyd R, 2007, CELL CALCIUM, V42, P467, DOI 10.1016/j.ceca.2007.05.011; Genovese P, 2010, REPROD DOMEST ANIM, V45, P233, DOI 10.1111/j.1439-0531.2008.01244.x; Gunes A, 2005, FUND CLIN PHARMACOL, V19, P73, DOI 10.1111/j.1472-8206.2004.00312.x; Herken EN, 2009, CELL BIOL TOXICOL, V25, P355, DOI 10.1007/s10565-008-9089-3; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR1768, DOI 10.1152/ajpregu.00442.2006; Iuchi Y, 2004, HISTOCHEM CELL BIOL, V121, P123, DOI 10.1007/s00418-003-0607-3; JOYCE KL, 1993, J ANDROL, V14, P448; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luzardo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021232; Maia J.C.C., 1983, GENES ANTIGENES PARA, P146; Malina RM, 2004, GROWTH MATURATION PH, P509; Menegali BT, 2009, PULM PHARMACOL THER, V22, P567, DOI 10.1016/j.pupt.2009.08.003; Narayanan N, 1997, BASIC RES CARDIOL, V92, P25, DOI 10.1007/BF00794065; Quintas LEM, 2005, EUR J PHARMACOL, V525, P54, DOI 10.1016/j.ejphar.2005.10.006; Scaramello CBV, 2002, J PHARMACOL TOXICOL, V47, P93, DOI 10.1016/S1056-8719(02)00205-8; Scaramello CBV, 2009, J PHARMACOL SCI, V109, P185, DOI 10.1254/jphs.08064FP; SORENSON MM, 1986, J MEMBRANE BIOL, V90, P219, DOI 10.1007/BF01870128; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Strosova MK, 2011, ARCH BIOCHEM BIOPHYS, V511, P40, DOI 10.1016/j.abb.2011.04.011; TEODOSIO NR, 1990, ARCH LATINOAM NUTR, V40, P533; THOMAS AJ, 1983, FERTIL STERIL, V39, P445; Toledo FC, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-94; Valverde RHF, 2005, J BIOL CHEM, V280, P30611, DOI 10.1074/jbc.M501880200; Vieira LD, 2011, ARCH BIOCHEM BIOPHYS, V505, P91, DOI 10.1016/j.abb.2010.09.025; Vieira LD, 2009, CLIN EXP PHARMACOL P, V36, P1157, DOI 10.1111/j.1440-1681.2009.05212.x; VINDELOV LL, 1983, CYTOMETRY, V3, P332, DOI 10.1002/cyto.990030505; Westfall TD, 2001, J PHARMACOL TOX MET, V45, P109, DOI 10.1016/S1056-8719(01)00144-7; Ziolkowski N, 2010, CAN J PHYSIOL PHARM, V88, P220, DOI 10.1139/Y10-013	42	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69682	10.1371/journal.pone.0069682	http://dx.doi.org/10.1371/journal.pone.0069682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922775	gold, Green Submitted, Green Published			2022-12-25	WOS:000322838900070
J	Kapralova, KH; Gudbrandsson, J; Reynisdottir, S; Santos, CB; Baltanas, VC; Maier, VH; Snorrason, SS; Palsson, A				Kapralova, Kalina H.; Gudbrandsson, Johannes; Reynisdottir, Sigrun; Santos, Cristina B.; Baltanas, Vanessa C.; Maier, Valerie H.; Snorrason, Sigurdur S.; Palsson, Arnar			Differentiation at the MHCII alpha and Cath2 Loci in Sympatric Salvelinus alpinus Resource Morphs in Lake Thingvallavatn	PLOS ONE			English	Article							SALMON SALMO-SALAR; POLYMORPHIC ARCTIC CHARR; CLASS-II LOCI; RAINBOW-TROUT; ANTIMICROBIAL PEPTIDES; PARALLEL EVOLUTION; MATE-CHOICE; THREESPINE STICKLEBACKS; DROSOPHILA-MELANOGASTER; ADAPTIVE DIVERGENCE	Northern freshwater fish may be suitable for the genetic dissection of ecological traits because they invaded new habitats after the last ice age (similar to 10.000 years ago). Arctic charr (Salvelinus alpinus) colonizing streams and lakes in Iceland gave rise to multiple populations of small benthic morphotypes, often in sympatry with a pelagic morphotype. Earlier studies have revealed significant, but subtle, genetic differentiation between the three most common morphs in Lake Thingvallavatn. We conducted a population genetic screen on four immunological candidate genes Cathelicidin 2 (Cath2), Hepcidin (Hamp), Liver expressed antimicrobial peptide 2a (Leap-2a), and Major Histocompatibility Complex II alpha (MHCII alpha) and a mitochondrial marker (D-loop) among the three most common Lake Thingvallavatn charr morphs. Significant differences in allele frequencies were found between morphs at the Cath2 and MHCII alpha loci. No such signal was detected in the D-loop nor in the other two immunological genes. In Cath2 the small benthic morph deviated from the other two (F-ST = 0.13), one of the substitutions detected constituting an amino acid replacement polymorphism in the antimicrobial peptide. A more striking difference was found in the MHCII alpha. Two haplotypes were very common in the lake, and their frequency differed greatly between the morphotypes (from 22% to 93.5%, F-ST = 0.67). We then expanded our study by surveying the variation in Cath2 and MHCII alpha in 9 Arctic charr populations from around Iceland. The populations varied greatly in terms of allele frequencies at Cath2, but the variation did not correlate with morphotype. At the MHCII alpha locus, the variation was nearly identical to the variation in the two benthic morphs of Lake Thingvallavatn. The results are consistent with a scenario where parts of the immune systems have diverged substantially among Arctic charr populations in Iceland, after colonizing the island similar to 10.000 years ago.	[Kapralova, Kalina H.; Gudbrandsson, Johannes; Reynisdottir, Sigrun; Santos, Cristina B.; Baltanas, Vanessa C.; Maier, Valerie H.; Snorrason, Sigurdur S.; Palsson, Arnar] Univ Iceland, Inst Life & Environm Sci, Reykjavik, Iceland	University of Iceland	Palsson, A (corresponding author), Univ Iceland, Inst Life & Environm Sci, Reykjavik, Iceland.	apalsson@hi.is	Palsson, Arnar/M-2742-2015	Palsson, Arnar/0000-0002-6525-8112; Gudbrandsson, Johannes/0000-0002-2231-0910; Kapralova, Kalina/0000-0002-5571-0160; Bajo-Santos, Cristina/0000-0002-2694-7572; Maier, Valerie Helene/0000-0003-2193-477X	Icelandic Research foundation [100204011]; University of Iceland	Icelandic Research foundation; University of Iceland	The Palsson laboratory is supported by Icelandic Research foundation and the University of Iceland research fund. Icelandic research foundation (grant of excellence: nr 100204011) to S. S. Sigurdsson, A. Palsson, B. K. Kristjansson, Zophonias O. Jonsson and Ian A. Johnston paid for part of this work. Kalina H. Kapralova and Johannes Gudbrandsson were supported by the University of Iceland doctoral fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Alekseyev SS, 2009, J FISH BIOL, V75, P368, DOI 10.1111/j.1095-8649.2009.02331.x; Allendorf F.W., 1984, P1; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Behnke R.J., 1980, Perspectives in Vertebrate Science, V1, P441; BEHNKE RJ, 1972, J FISH RES BOARD CAN, V29, P639, DOI 10.1139/f72-112; Blais J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000734; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Broekman DC, 2011, PEPTIDES, V32, P2044, DOI 10.1016/j.peptides.2011.09.012; Broekman DC, 2011, DEV COMP IMMUNOL, V35, P296, DOI 10.1016/j.dci.2010.10.002; Brunner PC, 2001, EVOLUTION, V55, P573, DOI 10.1554/0014-3820(2001)055[0573:HPOACS]2.0.CO;2; Chang CI, 2006, ANTIMICROB AGENTS CH, V50, P185, DOI 10.1128/AAC.50.1.185-195.2006; Chang CI, 2005, INFECT IMMUN, V73, P5053, DOI 10.1128/IAI.73.8.5053-5064.2005; Conejeros P, 2008, IMMUNOGENETICS, V60, P325, DOI 10.1007/s00251-008-0290-6; Consuegra S, 2011, HEREDITY, V107, P143, DOI 10.1038/hdy.2010.177; Cuesta A, 2006, MOL IMMUNOL, V43, P1275, DOI 10.1016/j.molimm.2005.07.004; Eiriksson G. M., 1999, Journal of Fish Biology, V55, P175, DOI 10.1111/j.1095-8649.1999.tb01054.x; Eizaguirre C, 2010, J FISH BIOL, V77, P2023, DOI 10.1111/j.1095-8649.2010.02819.x; Eizaguirre C, 2009, MOL ECOL, V18, P3316, DOI 10.1111/j.1365-294X.2009.04243.x; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Elmer KR, 2011, TRENDS ECOL EVOL, V26, P298, DOI 10.1016/j.tree.2011.02.008; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Evans ML, 2010, HEREDITY, V104, P449, DOI 10.1038/hdy.2009.121; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feng CY, 2009, PHYSIOL GENOMICS, V37, P149, DOI 10.1152/physiolgenomics.90373.2008; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fox J, 2011, AN R COMPANION TO AP; FRANDSEN F, 1989, J FISH BIOL, V34, P281, DOI 10.1111/j.1095-8649.1989.tb03309.x; Fraser DJ, 2011, HEREDITY, V106, P404, DOI 10.1038/hdy.2010.167; Gavrilets S., 2004, FITNESS LANDSCAPES A; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; Gislason D, 1999, RAPID AND COUPLED PH; Gordon D, 2003, CURRENT PROTOCOLS IN; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Harstad H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-193; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; HUDSON RR, 1994, GENETICS, V136, P1329; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Johnson L., 1980, CHARRS SALMONID FISH, P15; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Jones FC, 2012, CURR BIOL, V22, P83, DOI 10.1016/j.cub.2011.11.045; Kapralova KH, 2011, HEREDITY, V106, P472, DOI 10.1038/hdy.2010.161; Keller I, 2011, MOL ECOL, V20, P1888, DOI 10.1111/j.1365-294X.2011.05067.x; Kristjansson BK, 2011, BIOL J LINN SOC, V103, P761, DOI 10.1111/j.1095-8312.2011.01670.x; Kristmundsson A, 2009, ICELAND AGR SCI, V22, P5; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Landry L, 2007, J EVOLUTION BIOL, V20, P971, DOI 10.1111/j.1420-9101.2007.01304.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawton-Rauh A, 2003, MOL ECOL, V12, P1301, DOI 10.1046/j.1365-294X.2003.01814.x; Leder EH, 2006, J HERED, V97, P74, DOI 10.1093/jhered/esj004; Lehmann T, THE JOURNAL OF HERED, V94, P133; Lenz TL, 2009, J FISH BIOL, V75, P2122, DOI 10.1111/j.1095-8649.2009.02410.x; Lewontin R. C, 1974, THE GENETIC BASIS OF; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Macqueen DJ, 2011, MOL ECOL, V20, P3167, DOI 10.1111/j.1365-294X.2011.05172.x; Macqueen DJ, 2010, PHYSIOL GENOMICS, V42, P134, DOI 10.1152/physiolgenomics.00045.2010; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Magnadottir B, 2010, MAR BIOTECHNOL, V12, P361, DOI 10.1007/s10126-010-9279-x; MAGNUSSON KP, 1987, ENVIRON BIOL FISH, V20, P67, DOI 10.1007/BF00002026; Maier VH, 2008, MOL IMMUNOL, V45, P3723, DOI 10.1016/j.molimm.2008.06.002; Matthews B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010948; Murphy K., 2007, JANEWAYS IMMUNOBIOLO; Nicholas KB, 1997, GENEDOC ANALYSIS AND; Noakes D.G.L., 1989, BIOL CHARS MASU SALM, P393; Noakes DLG, 2008, ENVIRON BIOL FISH, V83, P7, DOI 10.1007/s10641-008-9379-x; Palsson A, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-44; Palsson A, 2004, GENETICS, V167, P1187, DOI 10.1534/genetics.103.021766; Parsons KJ, 2011, J EVOLUTION BIOL, V24, P1640, DOI 10.1111/j.1420-9101.2011.02301.x; Parsons KJ, EVOLUTION DEVELOPMEN, V12, P246; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Phillips PC, 2005, GENETICA, V123, P15, DOI 10.1007/s10709-004-2704-1; Raff R, 1996, THE SHAPE OF LIFE GE; Reimchen TE, 2006, CAN J ZOOL, V84, P643, DOI 10.1139/Z06-036; Renaut S, 2012, PHILOS T R SOC B, V367, P354, DOI 10.1098/rstb.2011.0197; REYNOLDS J, 1983, GENETICS, V105, P767; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Scocchi M, 2009, COMP BIOCHEM PHYS B, V152, P376, DOI 10.1016/j.cbpb.2009.01.003; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shike H, 2002, EUR J BIOCHEM, V269, P2232, DOI 10.1046/j.1432-1033.2002.02881.x; Sibthorpe D, 2006, COMP BIOCHEM PHYS B, V145, P371, DOI 10.1016/j.cbpb.2006.08.013; Sigursteinsdottir RJ, 2005, ENVIRON BIOL FISH, V74, P239, DOI 10.1007/s10641-005-0499-2; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; SKULASON S, 1989, BIOL J LINN SOC, V38, P281, DOI 10.1111/j.1095-8312.1989.tb01579.x; Skulason S, 1999, EVOLUTION OF BIOLOGICAL DIVERSITY, P70; SLATKIN M, 1995, GENETICS, V139, P457; Smith TJ, 2010, PHARMACOL REV, V62, P199, DOI 10.1124/pr.109.002469; Snorrason Signour S., 2004, P210; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stern DL, 2000, NATURE, V408, P529, DOI 10.1038/35046183; Storz JF, 2004, MOL BIOL EVOL, V21, P1800, DOI 10.1093/molbev/msh192; Tennessen JA, 2005, J EVOLUTION BIOL, V18, P1387, DOI 10.1111/j.1420-9101.2005.00925.x; Thunken T, 2012, P ROY SOC B-BIOL SCI, V279, P2959, DOI 10.1098/rspb.2012.0333; Tonteri A, 2010, MOL ECOL, V19, P1273, DOI 10.1111/j.1365-294X.2010.04573.x; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Volpe JP, 1996, MOL ECOL, V5, P763, DOI 10.1111/j.1365-294X.1996.tb00372.x; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wilson AJ, 2004, MOL ECOL, V13, P1129, DOI 10.1111/j.1365-294X.2004.02149.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang YA, 2004, VET IMMUNOL IMMUNOP, V101, P259, DOI 10.1016/j.vetimm.2004.05.005	110	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69402	10.1371/journal.pone.0069402	http://dx.doi.org/10.1371/journal.pone.0069402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894470	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900065
J	O'Brien, MJ; Philipson, CD; Tay, J; Hector, A				O'Brien, Michael J.; Philipson, Christopher D.; Tay, John; Hector, Andy			The Influence of Variable Rainfall Frequency on Germination and Early Growth of Shade-Tolerant Dipterocarp Seedlings in Borneo	PLOS ONE			English	Article							SEED SIZE; ENVIRONMENTAL-CONDITIONS; NEOTROPICAL PIONEERS; TREE; RESPONSES; FOREST; DROUGHT; GAP; RECRUITMENT; DIVERSITY	Climate change induced alterations to rainfall patterns have the potential to affect the regeneration dynamics of plant species, especially in historically everwet tropical rainforest. Differential species response to infrequent rainfall may influence seed germination and seedling establishment in turn affecting species distributions. We tested the role of watering frequency intervals (from daily to six-day watering) on the germination and the early growth of Dipterocarpaceae seedlings in Borneo. We used seeds that ranged in size from 500 to 20,000 mg in order to test the role of seed mass in mediating the effects of infrequent watering. With frequent rainfall, germination and seedling development traits bore no relationship to seed mass, but all metrics of seedling growth increased with increasing seed mass. Cumulative germination declined by 39.4% on average for all species when plants were watered at six-day intervals, and days to germination increased by 76.5% on average for all species from daily to six-day intervals. Final height and biomass declined on average in the six-day interval by 16% and 30%, respectively, but the percentage decrease in final size was greater for large-seeded species. Rooting depth per leaf area also significantly declined with seed mass indicating large-seeded species allocate relatively more biomass for leaf production. This difference in allocation provided an establishment advantage to large-seeded species when water was non-limiting but inhibited their growth under infrequent rainfall. The observed reduction in the growth of large-seeded species under infrequent rainfall would likely restrict their establishment in drier microsites associated with coarse sandy soils and ridge tops. In total, these species differences in germination and initial seedling growth indicates a possible niche axis that may help explain both current species distributions and future responses to climate change.	[O'Brien, Michael J.; Philipson, Christopher D.; Hector, Andy] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Tay, John] Univ Malaysia Sabah, Sch Int Trop Forestry, Kota Kinabalu, Sabah, Malaysia	University of Zurich; Universiti Malaysia Sabah	O'Brien, MJ (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	mikey.j.obrien@gmail.com	O'Brien, Michael/V-6548-2017; Hector, Andrew/H-4199-2011	O'Brien, Michael/0000-0003-0943-8423; Hector, Andrew/0000-0002-1309-7716; Philipson, Christopher/0000-0001-8987-7260	Swiss National Science Foundation [31003A_125461]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation (Grant #31003A_125461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; BAKER HG, 1972, ECOLOGY, V53, P997, DOI 10.2307/1935413; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; BLAIN D, 1991, J TROP ECOL, V7, P69, DOI 10.1017/S0266467400005101; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; Daws MI, 2008, ANN BOT-LONDON, V102, P945, DOI 10.1093/aob/mcn186; Daws MI, 2007, OECOLOGIA, V154, P445, DOI 10.1007/s00442-007-0848-2; Daws MI, 2002, FUNCT ECOL, V16, P258, DOI 10.1046/j.1365-2435.2002.00615.x; DEKA RN, 1995, EUR J SOIL SCI, V46, P233, DOI 10.1111/j.1365-2389.1995.tb01831.x; Engelbrecht BMJ, 2006, OECOLOGIA, V148, P258, DOI 10.1007/s00442-006-0368-5; Engelbrecht BMJ, 2003, OECOLOGIA, V136, P383, DOI 10.1007/s00442-003-1290-8; FENNER M, 1987, NEW PHYTOL, V106, P35, DOI 10.1111/j.1469-8137.1987.tb04681.x; FOSTER SA, 1986, BOT REV, V52, P260, DOI 10.1007/BF02860997; Gibbons JM, 2003, PLANT ECOL, V164, P1, DOI 10.1023/A:1021210532510; Hector A, 2011, PHILOS T R SOC B, V366, P3303, DOI 10.1098/rstb.2011.0094; Heisler-White JL, 2009, GLOBAL CHANGE BIOL, V15, P2894, DOI 10.1111/j.1365-2486.2009.01961.x; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; Huntington TG, 2006, J HYDROL, V319, P83, DOI 10.1016/j.jhydrol.2005.07.003; Katabuchi M, 2012, J ECOL, V100, P643, DOI [10.1111/J.1365-2745.2011.01937.x, 10.1111/j.1365-2745.2011.01937.x]; LEISHMAN MR, 1994, J ECOL, V82, P249, DOI 10.2307/2261293; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Muller-Landau HC, 2010, P NATL ACAD SCI USA, V107, P4242, DOI 10.1073/pnas.0911637107; Nakagawa M, 2004, SEED SCI RES, V14, P363, DOI 10.1079/SSR2004181; Ng FSP., 1992, MANUAL FOREST FRUITS; O'Brien MJ, 2013, ROLE FUNCTIONAL TRAI; Parent C., 2008, PLANT STRESS, P20, DOI DOI 10.1038/S41598-020-73072-6; Pearson TRH, 2002, ECOLOGY, V83, P2798, DOI 10.1890/0012-9658(2002)083[2798:GEONPI]2.0.CO;2; Philipson CD, 2012, BIOTROPICA, V44, P627, DOI 10.1111/j.1744-7429.2011.00833.x; Pineheiro J, 2000, MIXED EFFECTS MODELS; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Poorter L, 2000, J TROP ECOL, V16, P481, DOI 10.1017/S026646740000153X; Potts MD, 2003, J ECOL, V91, P467, DOI 10.1046/j.1365-2745.2003.00779.x; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Sperry JS, 2002, PLANT CELL ENVIRON, V25, P251, DOI 10.1046/j.0016-8025.2001.00799.x; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; VAZQUEZYANES C, 1993, ANNU REV ECOL SYST, V24, P69, DOI 10.1146/annurev.es.24.110193.000441; Walsh RPD, 1999, PHILOS T R SOC B, V354, P1869, DOI 10.1098/rstb.1999.0528; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114	41	29	29	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70287	10.1371/journal.pone.0070287	http://dx.doi.org/10.1371/journal.pone.0070287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894634	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000322167900116
J	Oit-Wiscombe, I; Virag, L; Soomets, U; Altraja, A				Oit-Wiscombe, Ingrid; Virag, Laszlo; Soomets, Ursel; Altraja, Alan			Increased DNA Damage in Progression Of COPD: A Response By Poly(ADP-Ribose) Polymerase-1	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MURINE MODEL; INFLAMMATION; PARP-1; INHIBITION; EXPRESSION; ACTIVATION; MECHANISM; STRESS; ASTHMA	Chronic oxidative stress (OS), a major mechanism of chronic obstructive pulmonary disease (COPD), may cause significant damage to DNA. Poly(ADP-ribose) polymerase (PARP)-1 is rapidly activated by OS-induced DNA lesions. However, the degree of DNA damage along with the evolution of COPD is unclear. In peripheral blood mononuclear cells of non-smoking individuals, non-obstructive smokers, patients with COPD of all stages and those with COPD exacerbation, we evaluated DNA damage, PARP activity and PARP-1 mRNA expression using Comet Assay IV, biotinylated-NAD incorporation assay and qRT-PCR, respectively and subjected results to ordinal logistic regression modelling. Adjusted for demographics, smoking-related parameters and lung function, novel comet parameters, tail length/cell length ratio and tail migration/cell length ratio, showed the greatest increase along the study groups corresponding to the evolution of COPD [odds ratio (OR) 7.88, 95% CI 4.26-14.57; p<0.001 and OR 3.91, 95% CI 2.69-5.66; p<0.001, respectively]. Analogously, PARP activity increased significantly over the groups (OR = 1.01; 95%; p<0.001). An antioxidant tetrapeptide UPF17 significantly reduced the PARP1 mRNA expression in COPD, compared to that in non-obstructive individuals (p = 0.040). Tail length/cell length and tail migration/cell length ratios provide novel progression-sensitive tools for assessment of DNA damage. However, it remains to be elucidated whether inhibition of an elevated PARP-1 activity has a safe enough potential to break the vicious cycle of the development and progression of COPD.	[Oit-Wiscombe, Ingrid; Altraja, Alan] Univ Tartu, Fac Med, Dept Pulm Med, EE-50090 Tartu, Estonia; [Oit-Wiscombe, Ingrid; Virag, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Chem, Debrecen, Hungary; [Oit-Wiscombe, Ingrid; Soomets, Ursel] Univ Tartu, Ctr Excellence Translat Med, Dept Biochem, Fac Med, EE-50090 Tartu, Estonia	University of Tartu; University of Debrecen; University of Tartu	Oit-Wiscombe, I (corresponding author), Univ Tartu, Fac Med, Dept Pulm Med, Ulikooli 18, EE-50090 Tartu, Estonia.	Ingrid.Oit-Wiscombe@ut.ee	Soomets, Ursel/H-5919-2015	Soomets, Ursel/0000-0002-3681-188X; Virag, Laszlo/0000-0002-7099-6718	Estonian Science Foundation [7856, 9043, 6566]; University of Tartu [PARBK 0906]; Ministry of Education and Science of Estonia [SF0180105s08]; European Union; Hungarian Scientific Research Fund [K73003, K60780, K82009]; Hungarian Social Renewal Operational Programme [4.2.2-08/1-2008-0019, 4.2.1./B-09/1/KONV-2010-0007, 4.2.2.A-111/1/KONV-2012-0025]	Estonian Science Foundation; University of Tartu; Ministry of Education and Science of Estonia(Ministry of Education and Research, Estonia); European Union(European Commission); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Social Renewal Operational Programme	This study was funded with grants No. 7856, 9043 and 6566 from the Estonian Science Foundation, by targeted financing PARBK 0906 from the University of Tartu, by targeted financing from Ministry of Education and Science of Estonia (SF0180105s08) and by the European Union through the European Regional Development. The work was also supported by The Hungarian Scientific Research Fund (K73003, K60780 and K82009) and Hungarian Social Renewal Operational Programme (4.2.2-08/1-2008-0019; 4.2.1./B-09/1/KONV-2010-0007 and 4.2.2.A-111/1/KONV-2012-0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti Alvar G N, 2005, Proc Am Thorac Soc, V2, P367, DOI 10.1513/pats.200504-026SR; Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Bai P, 2012, FEBS LETT, V586, P3771, DOI 10.1016/j.febslet.2012.09.026; Bakondi E, 2002, J HISTOCHEM CYTOCHEM, V50, P91, DOI 10.1177/002215540205000110; Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257; Boots AW, 2003, EUR RESPIR J, V22, p14S, DOI 10.1183/09031936.03.00000403a; Boots AW, 2003, P AM THORAC SOC, V46, p14s; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; Ceylan E, 2006, RESP MED, V100, P1270, DOI 10.1016/j.rmed.2005.10.011; Curtin N.J., 2013, MOL ASPECTS MED; Czapski GA, 2013, NEUROCHEM INT, V62, P664, DOI 10.1016/j.neuint.2013.01.020; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Datta R, 2011, ALLERGY, V66, P853, DOI 10.1111/j.1398-9995.2011.02549.x; Ehrlich K, 2007, FREE RADICAL RES, V41, P779, DOI 10.1080/10715760701348611; Hageman GJ, 2003, FREE RADICAL BIO MED, V35, P140, DOI 10.1016/S0891-5849(03)00237-5; HALLIWELL B, 1987, FASEB J, V1, P358, DOI 10.1096/fasebj.1.5.2824268; Hauser B, 2006, SHOCK, V25, P633, DOI 10.1097/01.shk.0000209561.61951.2e; Hwang JW, 2010, ARCH BIOCHEM BIOPHYS, V500, P203, DOI 10.1016/j.abb.2010.05.013; Ito K, 2012, INT J CHRONIC OBSTR, V7, P641, DOI 10.2147/COPD.S28250; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jijon HB, 2000, AM J PHYSIOL-GASTR L, V279, pG641, DOI 10.1152/ajpgi.2000.279.3.G641; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kovacs K, 2012, FREE RADICAL BIO MED, V53, P1680, DOI 10.1016/j.freeradbiomed.2012.08.579; Mabley JG, 2005, J PHARMACOL EXP THER, V315, P812, DOI 10.1124/jpet.105.090480; Mahlapuu R, 2012, INT J PEPT; Maluf SW, 2007, MUTAT RES-GEN TOX EN, V626, P180, DOI 10.1016/j.mrgentox.2006.10.002; Moulton PV, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/472751; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Rojas E, 1999, J CHROMATOGR B, V722, P225, DOI 10.1016/S0378-4347(98)00313-2; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Virag L, 2005, PHARMACOL RES, V52, P83, DOI 10.1016/j.phrs.2005.02.012; Virag L, 2004, MED SCI MONITOR, V10, pBR77; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Zaremba T, 2011, BIOCHEM J, V436, P671, DOI 10.1042/BJ20101723	36	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70333	10.1371/journal.pone.0070333	http://dx.doi.org/10.1371/journal.pone.0070333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894640	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900119
J	Selcuk, E; Kirimtay, K; Canbaz, D; Cesur, GI; Korulu, S; Karabay, A				Selcuk, Ece; Kirimtay, Koray; Canbaz, Derya; Cesur, Guher Isik; Korulu, Sirin; Karabay, Arzu			Katanin-p80 Gene Promoter Characterization and Regulation via Elk1	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; AAA ATPASE; SPASTIN; SUMO; PROTEIN; IDENTIFICATION; MICROTUBULES; COREPRESSOR; COMPLEX; TARGET	Katanin is an ATPase family member protein that participates in microtubule severing. It has heterodimeric structure consisting of 60 kDa (katanin-p60) and 80 kDa (katanin-p80) subunits encoded by KATNA1 and KATNB1 genes, respectively. Katanin-p60 has the enzymatic activity for microtubule severing, whereas katanin-p80 consists of multiple domains with different functions such as targeting katanin-p60 to the centrosome, augmenting microtubule severing by katanin-p60, and even suppressing microtubule severing. Despite the various important functions of katanin-p80, its transcriptional regulation has not been studied yet. Elk1 transcription factor has been shown to interact with microtubules and regulate the transcription of another microtubule severing protein, spastin. In spite of katanin's importance, and structural and functional similarities to spastin, there is no study on the transcriptional regulation of katanin yet. In this study, we aimed to characterize KATNB1 promoter and analyze the effects of Elk1 on katanin-p80 expression. We identified a 518-bp TATA-less promoter including a critical CpG island and GC boxes as an optimal promoter, and sequential deletion of CpG island and the GC elements gradually decreased the KATNB1 promoter activity. In addition, we showed Elk1 binding on the KATNB1 promoter by EMSA. We found that Elk1 activated KATNB1 promoter, and increased both mRNA and protein levels of katanin-p80 in SH-SY5Y cells. On the other hand, KCl treatment increasing SUMOylation decreased KATNB1 promoter activity. Since microtubule severing is an important cellular mechanism of which malfunctions result in serious diseases such as spastic paraplegia, Alzheimer's disease and cell cycle related disorders, identification of KATNB1 transcriptional regulation is crucial in understanding the coordination of microtubule severing activity by different proteins in the cells.	[Selcuk, Ece; Kirimtay, Koray; Canbaz, Derya; Cesur, Guher Isik; Korulu, Sirin; Karabay, Arzu] Istanbul Tech Univ, Dept Mol Biol & Genet, TR-80626 Istanbul, Turkey	Istanbul Technical University	Karabay, A (corresponding author), Istanbul Tech Univ, Dept Mol Biol & Genet, TR-80626 Istanbul, Turkey.	karabaya@itu.edu.tr	Karabay, Arzu/ABB-3681-2020; Kırımtay, Koray/AHB-4140-2022; Korulu, Sirin/AAP-2168-2020	Karabay, Arzu/0000-0001-5150-5349; Korulu, Sirin/0000-0001-6762-0659	Istanbul Technical University, Scientific Research Projects Department [34776]	Istanbul Technical University, Scientific Research Projects Department(Istanbul Technical University)	This work was supported by Istanbul Technical University, Scientific Research Projects Department (grant number 34776. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FJ, 1999, J CELL BIOL, V145, P305, DOI 10.1083/jcb.145.2.305; [Anonymous], 2011, SOCIETY; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Canbaz D, 2011, J NEUROCHEM, V117, P724, DOI 10.1111/j.1471-4159.2011.07243.x; Cenik C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r29; Daftary GS, 2011, MOL ENDOCRINOL, V25, P1539, DOI 10.1210/me.2011-0001; Demir O, 2009, MOL CELL NEUROSCI, V40, P111, DOI 10.1016/j.mcn.2008.10.004; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gillingwater TH, 2013, NEUROPATH APPL NEURO, V39, P320, DOI 10.1111/nan.12014; Gozes I, 2011, CURR PHARM DESIGN, V17, P3413, DOI 10.2174/138161211798072553; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Henson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036505; Kim KI, 2002, J CELL PHYSIOL, V191, P257, DOI 10.1002/jcp.10100; Lu H, 2009, BIOCHEM BIOPH RES CO, V390, P872, DOI 10.1016/j.bbrc.2009.10.065; Mancuso G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-31; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally KP, 2000, J CELL SCI, V113, P1623; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Morshed M, 2006, CYTOTECHNOLOGY, V52, P159, DOI 10.1007/s10616-006-9017-4; Pastorcic M, 2003, MOL BRAIN RES, V113, P57, DOI 10.1016/S0169-328X(03)00090-1; Ross S, 2002, J BIOL CHEM, V277, P4455, DOI 10.1074/jbc.M110771200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sgambato V, 1998, J NEUROSCI, V18, P214; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Ye B, 2011, J NEUROSCI, V31, P3309, DOI 10.1523/JNEUROSCI.6307-10.2011; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005	35	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69423	10.1371/journal.pone.0069423	http://dx.doi.org/10.1371/journal.pone.0069423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894477	Green Submitted, gold, Green Published			2022-12-25	WOS:000322167900068
J	Estevao, S; van der Heul, HU; Sluijter, M; Hoogenboezem, T; Hartwig, NG; van Rossum, AMC; Vink, C				Estevao, Silvia; van der Heul, Helga U.; Sluijter, Marcel; Hoogenboezem, Theo; Hartwig, Nico G.; van Rossum, Annemarie M. C.; Vink, Cornelis			Functional Analysis of the Superfamily 1 DNA Helicases Encoded by Mycoplasma pneumoniae and Mycoplasma genitalium	PLOS ONE			English	Article							ROLLING-CIRCLE REPLICATION; VIRUS INTEGRASE PROTEIN; REPETITIVE CHROMOSOMAL SEQUENCES; SINGLE-STRANDED-DNA; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; PCRA HELICASE; BIOCHEMICAL-CHARACTERIZATION; HOMOLOGOUS RECOMBINATION; BACILLUS-ANTHRACIS	The DNA recombination and repair machinery of Mycoplasma pneumoniae is composed of a limited set of approximately 11 proteins. Two of these proteins were predicted to be encoded by neighboring open reading frames (ORFs) MPN340 and MPN341. Both ORFs were found to have sequence similarity with genes that encode proteins belonging to the DNA helicase superfamily 1 (SF1). Interestingly, while a homolog of the MPN341 ORF is present in the genome of Mycoplasma genitalium (ORF MG244), MPN340 is an M. pneumoniae-specific ORF that is not found in other mycoplasmas. Moreover, the length of MPN340 (1590 base pairs [bp]) is considerably shorter than that of MPN341 (2148 bp). Examination of the MPN340-encoded amino acid sequence indicated that it may lack a so-called 2B subdomain, which is found in most SF1 DNA helicases. Also, the MPN340-encoded amino acid sequence was found to differ between subtype 1 strain M129 and subtype 2 strain FH at three amino acid positions. Both protein variants, which were termed PcrA(M129)(s) and PcrA(FH)(s), respectively, as well as the MPN341- and MG244-encoded proteins (PcrA(Mpn) and PcrA(Mge), respectively), were purified, and tested for their ability to interact with DNA. While PcrA(Mpn) and PcrA(Mge) were found to bind preferentially to single-stranded DNA, both PcrA(M129)(s) and PcrA(FH)(s) did not demonstrate significant DNA binding. However, all four proteins were found to have divalent cation- and ATP-dependent DNA helicase activity. The proteins displayed highest activity on partially double-stranded DNA substrates carrying 3' single-stranded extensions.	[Estevao, Silvia; van der Heul, Helga U.; Sluijter, Marcel; Hoogenboezem, Theo; Hartwig, Nico G.; van Rossum, Annemarie M. C.; Vink, Cornelis] Erasmus MC Sophia Childrens Hosp, Lab Pediat Pediat Infect Dis & Immun, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Vink, C (corresponding author), Erasmus MC Sophia Childrens Hosp, Lab Pediat Pediat Infect Dis & Immun, Rotterdam, Netherlands.	c.vink@erasmusmc.nl	van Rossum, Annemarie/AAC-7050-2019; Hartwig, Nico/ABI-5467-2020	van Rossum, Annemarie/0000-0002-1259-477X	European Society for Pediatric Infectious Diseases; ZonMW; Erasmus MC	European Society for Pediatric Infectious Diseases; ZonMW(Netherlands Organization for Health Research and Development); Erasmus MC	AMCvR is supported by grants of the European Society for Pediatric Infectious Diseases, ZonMW, and the Erasmus MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO JC, 1988, MOL GEN GENET, V214, P482, DOI 10.1007/BF00330484; Anand SP, 2004, NUCLEIC ACIDS RES, V32, P3190, DOI 10.1093/nar/gkh641; Anand SP, 2004, J BACTERIOL, V186, P2195, DOI 10.1128/JB.186.7.2195-2199.2004; Bird LE, 1998, NUCLEIC ACIDS RES, V26, P2686, DOI 10.1093/nar/26.11.2686; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Bruand C, 2000, MOL MICROBIOL, V35, P204, DOI 10.1046/j.1365-2958.2000.01700.x; Burgos R, 2012, MOL MICROBIOL; Carrasco B, 2001, J BACTERIOL, V183, P5772, DOI 10.1128/JB.183.19.5772-5777.2001; Carvalho FM, 2005, GENE, V360, P111, DOI 10.1016/j.gene.2005.06.012; Chang TL, 2002, J BIOL CHEM, V277, P45880, DOI 10.1074/jbc.M207383200; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278; Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413; Dubaele S, 2007, J BIOCHEM MOL BIOL, V40, P7; Estevao S, 2011, J BACTERIOL, V193, P6425, DOI 10.1128/JB.06003-11; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Ingleston SM, 2002, EUR J BIOCHEM, V269, P1525, DOI 10.1046/j.1432-1033.2002.02805.x; IORDANESCU S, 1993, MOL GEN GENET, V241, P185, DOI 10.1007/BF00280216; Iverson-Cabral SL, 2007, MOL MICROBIOL, V66, P55, DOI 10.1111/j.1365-2958.2007.05898.x; Iverson-Cabral SL, 2006, INFECT IMMUN, V74, P3715, DOI 10.1128/IAI.00239-06; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Kline KA, 2005, J BACTERIOL, V187, P2903, DOI 10.1128/JB.187.8.2903-2907.2005; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Ma L, 2007, MOL MICROBIOL, V66, P220, DOI 10.1111/j.1365-2958.2007.05911.x; Morimatsu K, 2002, P NATL ACAD SCI USA, V99, P11688, DOI 10.1073/pnas.142404499; Naqvi A, 2003, J BACTERIOL, V185, P6633, DOI 10.1128/JB.185.22.6633-6639.2003; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Petit MA, 2002, EMBO J, V21, P3137, DOI 10.1093/emboj/cdf317; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Ruiz-Maso JA, 2006, J BACTERIOL, V188, P7416, DOI 10.1128/JB.01010-06; Shah R, 1997, EMBO J, V16, P1464, DOI 10.1093/emboj/16.6.1464; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Sluijter M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038301; Sluijter M, 2011, J BACTERIOL, V193, P3941, DOI 10.1128/JB.00247-11; Sluijter M, 2010, MOL MICROBIOL, V77, P1261, DOI 10.1111/j.1365-2958.2010.07288.x; Sluijter M, 2009, INFECT IMMUN, V77, P4905, DOI 10.1128/IAI.00747-09; Sluijter M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-167; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Spuesens EBM, 2011, MICROBIOL-SGM, V157, P473, DOI 10.1099/mic.0.045591-0; Spuesens EBM, 2009, MICROBIOL-SGM, V155, P2182, DOI 10.1099/mic.0.028506-0; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; van Cleef KWR, 2004, J GEN VIROL, V85, P2001, DOI 10.1099/vir.0.79864-0; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419; VINK C, 1994, NUCLEIC ACIDS RES, V22, P2176, DOI 10.1093/nar/22.11.2176; VINK C, 1994, J VIROL, V68, P1468, DOI 10.1128/JVI.68.3.1468-1474.1994; VINK C, 1993, TRENDS GENET, V9, P433, DOI 10.1016/0168-9525(93)90107-S; Vink C, 2012, FEMS MICROBIOL REV, V36, P917, DOI 10.1111/j.1574-6976.2011.00321.x	60	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70870	10.1371/journal.pone.0070870	http://dx.doi.org/10.1371/journal.pone.0070870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894687	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000220
J	Saderne, V; Wahl, M				Saderne, Vincent; Wahl, Martin			Differential Responses of Calcifying and Non-Calcifying Epibionts of a Brown Macroalga to Present-Day and Future Upwelling pCO(2)	PLOS ONE			English	Article							CO2-DRIVEN OCEAN ACIDIFICATION; ELECTRA-PILOSA; MEMBRANIPORA-MEMBRANACEA; ENCRUSTING BRYOZOANS; ACIDIFIED SEAWATER; FOOD CONCENTRATION; CARBON-DIOXIDE; COLONY GROWTH; SPIRORBIS L; GIANT-KELP	Seaweeds are key species of the Baltic Sea benthic ecosystems. They are the substratum of numerous fouling epibionts like bryozoans and tubeworms. Several of these epibionts bear calcified structures and could be impacted by the high pCO(2) events of the late summer upwellings in the Baltic nearshores. Those events are expected to increase in strength and duration with global change and ocean acidification. If calcifying epibionts are impacted by transient acidification as driven by upwelling events, their increasing prevalence could cause a shift of the fouling communities toward fleshy species. The aim of the present study was to test the sensitivity of selected seaweed macrofoulers to transient elevation of pCO(2) in their natural microenvironment, i.e. the boundary layer covering the thallus surface of brown seaweeds. Fragments of the macroalga Fucus serratus bearing an epibiotic community composed of the calcifiers Spirorbis spirorbis (Annelida) and Electra pilosa (Bryozoa) and the non-calcifier Alcyonidium hirsutum (Bryozoa) were maintained for 30 days under three pCO(2) conditions: natural 460 +/- 59 mu atm, present-day upwelling 1193 +/- 166 mu atm and future upwelling 3150 +/- 446 mu atm. Only the highest pCO(2) caused a significant reduction of growth rates and settlement of S. spirorbis individuals. Additionally, S. spirorbis settled juveniles exhibited enhanced calcification of 40% during daylight hours compared to dark hours, possibly reflecting a day-night alternation of an acidification-modulating effect by algal photosynthesis as opposed to an acidification-enhancing effect of algal respiration. E. pilosa colonies showed significantly increased growth rates at intermediate pCO(2) (1193 mu atm) but no response to higher pCO(2). No effect of acidification on A. hirsutum colonies growth rates was observed. The results suggest a remarkable resistance of the algal macro-epibionts to levels of acidification occurring at present day upwellings in the Baltic. Only extreme future upwelling conditions impacted the tubeworm S. spirorbis, but not the bryozoans.	[Saderne, Vincent; Wahl, Martin] GEOMAR, Helmholtz Ctr Ocean Res Kiel, Benth Ecol Grp, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Saderne, V (corresponding author), GEOMAR, Helmholtz Ctr Ocean Res Kiel, Benth Ecol Grp, Kiel, Germany.	vsaderne@GEOMAR.de	Wahl, Martin/D-2038-2016; Saderne, Vincent/ABE-5850-2020	Wahl, Martin/0000-0001-8703-3857; saderne, vincent/0000-0003-3968-2718	European community, Marie Curie ITN CALMARO [PITN-GA-2008-215157]	European community, Marie Curie ITN CALMARO	This work was funded by the European community, Marie Curie ITN CALMARO (PITN-GA-2008-215157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOGILY SM, 1985, J EXP MAR BIOL ECOL, V86, P285, DOI 10.1016/0022-0981(85)90109-1; Bayer MM, 1997, INVERTEBR BIOL, V116, P331, DOI 10.2307/3226865; BAYER MM, 1994, J EXP MAR BIOL ECOL, V178, P35, DOI 10.1016/0022-0981(94)90223-2; BEST MA, 1986, MAR BIOL, V93, P371, DOI 10.1007/BF00401104; BISHOP JDD, 1989, BIOL REV, V64, P197, DOI 10.1111/j.1469-185X.1989.tb00675.x; BOADEN PJS, 1975, J EXP MAR BIOL ECOL, V17, P111, DOI 10.1016/0022-0981(75)90026-X; BORNHOLD BD, 1973, J GEOL, V81, P363, DOI 10.1086/627876; Bumguardner BW, 1996, T AM FISH SOC, V125, P143, DOI 10.1577/1548-8659(1996)125&lt;0143:TOOACT&gt;2.3.CO;2; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; DALY JM, 1977, J MAR BIOL ASSOC UK, V57, P219, DOI 10.1017/S0025315400021366; DALY JM, 1978, J MAR BIOL ASSOC UK, V58, P161, DOI 10.1017/S0025315400024474; Desrosiers RR, 1996, CAN J FISH AQUAT SCI, V53, P1382, DOI 10.1139/cjfas-53-6-1382; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Dissard D, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002417; DIXON J, 1981, J PHYCOL, V17, P341, DOI 10.1111/j.1529-8817.1981.tb03120.x; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Dupont S, 2010, J EXP ZOOL PART B, V314B, P382, DOI [10.1002/jezmde.21342, 10.1002/jez.b.21342]; Durrant HMS, 2013, MAR BIOL, V160, P1903, DOI 10.1007/s00227-012-2008-4; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Grawe U, 2011, COAST RES LIBR, V1, P3, DOI 10.1007/978-94-007-0400-8_1; Hageman SJ, 2009, LETHAIA, V42, P438, DOI 10.1111/j.1502-3931.2009.00164.x; HAGERMAN LARS, 1966, OPHELIA, V3, P1; HARVELL D, 1984, ECOLOGY, V65, P716, DOI 10.2307/1938043; Hermansen P, 2001, J EXP MAR BIOL ECOL, V263, P1, DOI 10.1016/S0022-0981(01)00243-X; Hurd CL, 2011, GLOBAL CHANGE BIOL, V17, P3254, DOI 10.1111/j.1365-2486.2011.02473.x; HURD CL, 1994, MAR BIOL, V121, P167, DOI 10.1007/BF00349486; Hurd CL, 2000, J PHYCOL, V36, P453, DOI 10.1046/j.1529-8817.2000.99139.x; HYMAN LH, 1958, BIOL BULL, V114, P106, DOI 10.2307/1538968; Ippolitov A P, 2008, Dokl Biol Sci, V418, P20, DOI 10.1134/S0012496608010079; Javidpour J, 2009, BIOL INVASIONS, V11, P873, DOI 10.1007/s10530-008-9300-8; Kaehler S, 1999, MAR BIOL, V133, P455, DOI 10.1007/s002270050485; KAUTSKY H, 1992, Acta Phytogeographica Suecica, V78, P33; KNIGHTJONES EW, 1951, J MAR BIOL ASSOC UK, V30, P201, DOI 10.1017/S0025315400012716; KNIGHTJONES EW, 1972, MAR BIOL, V12, P289, DOI 10.1007/BF00366328; Krumhansl KA, 2011, MAR ECOL PROG SER, V421, P67, DOI 10.3354/meps08905; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Kurihara H, 2004, MAR ECOL PROG SER, V274, P161, DOI 10.3354/meps274161; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lavigne H., 2010, SEACARB SEAWATER CAR; Lisbjerg D, 2001, MAR ECOL PROG SER, V215, P133, DOI 10.3354/meps215133; Martin S, 2008, BIOL LETTERS, V4, P689, DOI 10.1098/rsbl.2008.0412; Maybury C.A., 1993, Journal of Micropalaeontology, V12, P67; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Mercado JM, 1998, J PHYCOL, V34, P925, DOI 10.1046/j.1529-8817.1998.340925.x; Millero FJ, 2010, MAR FRESHWATER RES, V61, P139, DOI 10.1071/MF09254; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; MUNOZ J, 1991, J MAR BIOL ASSOC UK, V71, P877, DOI 10.1017/S0025315400053522; NESTLER EC, 1994, ECHINODERMS THROUGH TIME, P813; NOTT JA, 1975, J MAR BIOL ASSOC UK, V55, P911, DOI 10.1017/S0025315400017793; OCONNOR RJ, 1980, J EXP MAR BIOL ECOL, V45, P117, DOI 10.1016/0022-0981(80)90055-6; OCONNOR RJ, 1978, J EXP MAR BIOL ECOL, V32, P143, DOI 10.1016/0022-0981(78)90112-0; OKAMURA B, 1988, J EXP MAR BIOL ECOL, V120, P105, DOI 10.1016/0022-0981(88)90083-4; OKAMURA B, 1992, ECOLOGY, V73, P1502, DOI 10.2307/1940693; OSWALD RC, 1984, ESTUAR COAST SHELF S, V19, P697, DOI 10.1016/0272-7714(84)90024-6; PEREZ FF, 1987, MAR CHEM, V21, P315, DOI 10.1016/0304-4203(87)90054-5; Pistevos JCA, 2011, OIKOS, V120, P675, DOI 10.1111/j.1600-0706.2010.19470.x; POTSWALD HE, 1967, BIOL BULL, V132, P91, DOI 10.2307/1539880; Pratt MC, 2008, INTEGR COMP BIOL, V48, P808, DOI 10.1093/icb/icn052; Qian PY, 1999, HYDROBIOLOGIA, V402, P239, DOI 10.1023/A:1003704928668; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Riisgard HU, 1997, MAR ECOL PROG SER, V156, P109, DOI 10.3354/meps156109; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodolfo-Metalpa R, 2010, MAR ECOL-EVOL PERSP, V31, P447, DOI 10.1111/j.1439-0485.2009.00354.x; RUCKER J B, 1969, Journal of Paleontology, V43, P791; Saderne V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062689; Saier B, 2004, BOT MAR, V47, P265, DOI 10.1515/BOT.2004.031; Scheibling RE, 1999, CAN J FISH AQUAT SCI, V56, P2300, DOI 10.1139/cjfas-56-12-2300; Schneider B, 2011, COAST RES LIBR, V1, P33, DOI 10.1007/978-94-007-0400-8_3; Schrum C, 2001, CLIM RES, V18, P31, DOI 10.3354/cr018031; SEED R, 1976, J EXP MAR BIOL ECOL, V24, P1, DOI 10.1016/0022-0981(76)90039-3; SILVA PHD, 1962, J EXP BIOL, V39, P483; Smith AM, 2006, EARTH-SCI REV, V78, P287, DOI 10.1016/j.earscirev.2006.06.001; Smith AM, 2001, PALAEOGEOGR PALAEOCL, V175, P201, DOI 10.1016/S0031-0182(01)00372-8; Soetaert K., 2010, MARELAC TOOLS AQUATI; Spilling K, 2010, J PHYCOL, V46, P1350, DOI 10.1111/j.1529-8817.2010.00894.x; STEBBING AR, 1973, J MAR BIOL ASSOC UK, V53, P247, DOI 10.1017/S0025315400022244; Stevens CL, 1997, HYDROBIOLOGIA, V346, P119, DOI 10.1023/A:1002914015683; TAVENERSMITH R, 1972, PHILOS T R SOC B, V264, P97, DOI 10.1098/rstb.1972.0010; Taylor PD, 2010, SPEC PAP PALAEONTOL, P317; Taylor PD, 2009, PALAIOS, V24, P440, DOI 10.2110/palo.2008.p08-124r; Thomas H, 1999, J MARINE SYST, V22, P53, DOI 10.1016/S0924-7963(99)00030-5; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Tyrrell T, 2008, BIOGEOSCIENCES, V5, P485, DOI 10.5194/bg-5-485-2008; Waeschenbach A, 2012, MOL PHYLOGENET EVOL, V62, P718, DOI 10.1016/j.ympev.2011.11.011; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; WHEELER WN, 1980, MAR BIOL, V56, P103, DOI 10.1007/BF00397128; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	93	27	27	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70455	10.1371/journal.pone.0070455	http://dx.doi.org/10.1371/journal.pone.0070455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894659	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000325211000210
J	Sengul, S; Erturk, S; Khan, AM; Batuman, V				Sengul, Sule; Erturk, Sehsuvar; Khan, Altaf M.; Batuman, Vecihi			Receptor-Associated Protein Blocks Internalization and Cytotoxicity of Myeloma Light Chain in Cultured Human Proximal Tubular Cells	PLOS ONE			English	Article							NF-KAPPA-B; ENDOCYTIC RECEPTORS; EPITHELIAL-CELLS; SPECIALIZED CHAPERONE; MULTIPLE-MYELOMA; KIDNEY-DISEASE; GROWTH-FACTORS; RENAL-DISEASE; IN-VIVO; MEGALIN	Background: Free light chains (LCs) are among the many ligands that bind to cubilin/megalin for endocytosis via the clathrin-dependent endosomal/lysosomal pathway. Receptor associated protein (RAP), is a 39 kDA high-affinity, chaperone-like ligand for megalin that assists in the proper folding and functioning of megalin/cubilin. Although RAP is known to inhibit ligand binding to megalin/cubilin, its effect on LC endocytosis has not been shown directly. Methods and Principal Findings: We investigated whether RAP can block the endocytosis of LC in cultured human proximal tubule cells and whether this can prevent LC cytotoxicity. Immunofluorescence microscopy and flow cytometry showed that fluorescently labeled LC endocytosis was markedly inhibited in HK-2 cells pretreated with human RAP. The effect of RAP was dose-dependent, and was predominantly on endocytosis as it had no effect on the small acid-washable fraction of LC bound to cell membrane. RAP significantly inhibited LC induced cytokine production and phosphorylation of ERK1/2 and p38 MAPK. Prolonged exposure to LC for 48 h resulted in epithelial-to-mesenchymal transformation in HK-2 cells as evidenced by marked reduction in the expression of the epithelial cell marker E-cadherin, and increased the expression of the mesenchymal marker alpha-SMA, which was also prevented by RAP in the endocytosis medium. Conclusions: RAP inhibited LC endocytosis by similar to 88% and ameliorated LC-induced cytokine responses and EMT in human PTCs. The results not only provide additional evidence that LCs endocytosis occurs via the megalin/cubilin endocytic receptor system, but also show that blocking LC endocytosis by RAP can protect proximal tubule cells from LC cytotoxicity.	[Sengul, Sule; Erturk, Sehsuvar] Ankara Univ, Sch Med, Dept Nephrol, TR-06100 Ankara, Turkey; [Khan, Altaf M.; Batuman, Vecihi] Tulane Univ, Sch Med, Div Nephrol, New Orleans, LA 70112 USA; [Batuman, Vecihi] VA Med Ctr, SLVHCS, New Orleans, LA USA	Ankara University; Tulane University	Batuman, V (corresponding author), Tulane Univ, Sch Med, Div Nephrol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	vbatuma@tulane.edu	nergizoglu, gokhan/AAN-5861-2021; Sengul, Sule/AAQ-3466-2021; Erturk, Sehsuvar/B-2743-2011	Erturk, Sehsuvar/0000-0002-7437-318X	Ankara University Research Fund [20030809152]; Veterans Administration, Research Commercialization and Educational Enhancement Program of the Louisiana Board of Regents [013RCEEP-07]; Dialysis Clinic, Inc.; Huberwald Endowed Fund	Ankara University Research Fund(Ankara University); Veterans Administration, Research Commercialization and Educational Enhancement Program of the Louisiana Board of Regents; Dialysis Clinic, Inc.; Huberwald Endowed Fund	Ankara University Research Fund (Drs Erturk and Sengul, Project number: 20030809152), and in part by the Veterans Administration, Research Commercialization and Educational Enhancement Program of the Louisiana Board of Regents (013RCEEP-07, the Dialysis Clinic, Inc., and the Huberwald Endowed Fund (VB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 1998, J AM SOC NEPHROL, V9, P1213; Batuman V, 1997, AM J PHYSIOL-RENAL, V272, pF521, DOI 10.1152/ajprenal.1997.272.4.F521; BATUMAN V, 1990, AM J PHYSIOL, V258, pF1259, DOI 10.1152/ajprenal.1990.258.5.F1259; Batuman V, 1998, AM J PHYSIOL-RENAL, V275, pF246, DOI 10.1152/ajprenal.1998.275.2.F246; Batuman V, 2007, CONTRIB NEPHROL, V153, P87; Batuman V, 2012, ADV CHRONIC KIDNEY D, V19, P282, DOI 10.1053/j.ackd.2012.04.009; Benigni A, 2001, AM J KIDNEY DIS, V37, pS21, DOI 10.1053/ajkd.2001.20734; Benigni A, 1998, J HYPERTENS, V16, pS9; Birn H, 2000, J AM SOC NEPHROL, V11, P191, DOI 10.1681/ASN.V112191; Diwakar R, 2007, AM J PHYSIOL-RENAL, V292, pF1464, DOI 10.1152/ajprenal.00069.2006; Guan S, 1999, J INVEST MED, V47, P496; Hutchison CA, 2008, EXPERT OPIN THER TAR, V12, P667, DOI [10.1517/14728222.12.6.667, 10.1517/14728222.12.6.667 ]; Hutchison CA, 2012, NAT REV NEPHROL, V8, P43, DOI 10.1038/nrneph.2011.168; Khan AM, 2010, NEPHRON EXP NEPHROL, V116, pE32, DOI 10.1159/000317129; Klassen RBS, 2005, J APPL PHYSIOL, V98, P257, DOI 10.1152/japplphysiol.01090.2003; Li M, 2008, AM J PHYSIOL-RENAL, V295, pF82, DOI 10.1152/ajprenal.00091.2008; Li M, 2008, NEPHROL DIAL TRANSPL, V23, P860, DOI 10.1093/ndt/gfm670; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; Nakhoul N, 2011, CONTRIB NEPHROL, V169, P37, DOI 10.1159/000313944; Onodera A, 2012, TOXICOL LETT, V212, P91, DOI 10.1016/j.toxlet.2012.05.012; Pote A, 2000, AM J KIDNEY DIS, V36, P735, DOI 10.1053/ajkd.2000.17620; Prabakaran T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039975; Sarti M, 2000, EXP CELL RES, V260, P199, DOI 10.1006/excr.2000.4993; Sengul S, 2003, AM J PHYSIOL-RENAL, V284, pF1245, DOI 10.1152/ajprenal.00350.2002; Sengul S, 2002, KIDNEY INT, V62, P1977, DOI 10.1046/j.1523-1755.2002.00660.x; Sengul S, 2009, J NEPHROL, V22, P17; Verroust PJ, 2002, KIDNEY INT, V62, P745, DOI 10.1046/j.1523-1755.2002.00501.x; Willnow TE, 1998, BIOL CHEM, V379, P1025; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Wolff NA, 2006, J PHARMACOL EXP THER, V318, P782, DOI 10.1124/jpet.106.102574; Ying WZ, 2011, BLOOD, V117, P1301, DOI 10.1182/blood-2010-08-302505; Zhai XY, 2000, KIDNEY INT, V58, P1523, DOI 10.1046/j.1523-1755.2000.00314.x	32	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70276	10.1371/journal.pone.0070276	http://dx.doi.org/10.1371/journal.pone.0070276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894629	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000199
J	Nordgren, J; Nitiema, LW; Ouermi, D; Simpore, J; Svensson, L				Nordgren, Johan; Nitiema, Leon W.; Ouermi, Djeneba; Simpore, Jacques; Svensson, Lennart			Host Genetic Factors Affect Susceptibility to Norovirus Infections in Burkina Faso	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; NORWALK VIRUS-INFECTION; ACUTE GASTROENTERITIS; MOLECULAR EPIDEMIOLOGY; HOSPITALIZED CHILDREN; HUMAN CALICIVIRUSES; NONSENSE MUTATION; SECRETOR FUT2; MAJOR CAUSE; RESISTANCE	Norovirus (NoV) constitutes the second most common viral pathogen causing pediatric diarrhea after rotavirus. In Africa, diarrhea is a major health problem in children, and yet few studies have been performed regarding NoV. The association of histo-blood group antigens (HBGA) and susceptibility to NoV infection is well established in Caucasian populations with non-secretors being resistant to many common NoV strains. No study regarding HBGA and NoV susceptibility has yet been performed in Africa. We collected 309 stool and 208 saliva samples from diarrheal children in Ouagadougou, Burkina Faso; May 2009 to March 2010. NoV was detected using real-time PCR, and genotyped by sequencing. Saliva samples were ABO, Lewis and secretor phenotyped using in house ELISA assays. NoV was detected in 12% (n = 37) of the samples. The genotype diversity was unusually large; overall the 37 positive samples belonged to 14 genotypes. Only children <2 years of age were NoV positive and the GII.4 NoVs were more frequent in the late dry season (Jan-May). NoV infections were observed less in children with the secretor-negative phenotype or blood group A (OR 0.18; p = 0.012 and OR 0.31; p = 0.054; respectively), with two non-secretors infected with genotypes GII.7 and GII. 4 respectively. Lewis-negative (Le(a-b-)) children, representing 32% of the study population, were susceptible to GII, but were not infected with any NoV GI. GII.4 strains preferentially infected children with blood group B whereas secretor-positive children with blood group O were infected with the largest variety of genotypes. This is the first study identifying host genetic factors associated with susceptibility to NoV in an African population, and suggests that while the non-secretor phenotype provides protection; the Lewis b antigen is not necessary for GII infection.	[Nordgren, Johan; Svensson, Lennart] Linkoping Univ, Div Mol Virol, Dept Clin & Expt Med, Linkoping, Sweden; [Nitiema, Leon W.; Ouermi, Djeneba; Simpore, Jacques] Univ Ouagadougou, Ctr Rech Biomol Pietro Annigoni St Camille CERBA, Ouagadougou, Burkina Faso; [Nitiema, Leon W.] Univ Ouagadougou, CRSBAN, Ouagadougou, Burkina Faso	Linkoping University	Nordgren, J (corresponding author), Linkoping Univ, Div Mol Virol, Dept Clin & Expt Med, Linkoping, Sweden.	johan.nordgren@liu.se	svensson, lennart/K-6163-2019; SIMPORE, Jacques/ABA-4873-2020	SIMPORE, Jacques/0000-0002-0415-9161; Ouermi, Djeneba/0000-0001-9010-2120	Swedish Research Council [10392]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council [grant number 10392]. (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abugalia M, 2011, J MED VIROL, V83, P1849, DOI 10.1002/jmv.22141; Armah GE, 2006, J MED VIROL, V78, P1480, DOI 10.1002/jmv.20722; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Ayukekbong J, 2011, J MED VIROL, V83, P2135, DOI 10.1002/jmv.22243; Bucardo F, 2008, J CLIN MICROBIOL, V46, P2573, DOI 10.1128/JCM.00505-08; Bucardo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025962; Bucardo F, 2010, PEDIATR INFECT DIS J, V29, P934, DOI 10.1097/INF.0b013e3181ed9f2f; Bucardo F, 2009, J MED VIROL, V81, P728, DOI 10.1002/jmv.21426; Carlsson B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005593; Corvelo TCO, 2002, GENET MOL BIOL, V25, P259, DOI 10.1590/S1415-47572002000300001; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Dove W, 2005, J MED VIROL, V77, P522, DOI 10.1002/jmv.20488; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Japhet MO, 2012, J MED VIROL, V84, P1489, DOI 10.1002/jmv.23343; Jin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058605; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Khamrin P, 2007, J MED VIROL, V79, P1921, DOI 10.1002/jmv.21004; Kindberg E, 2007, J CLIN MICROBIOL, V45, P2720, DOI 10.1128/JCM.00162-07; Kindberg E, 2009, FUTURE VIROL, V4, P369, DOI 10.2217/FVL.09.14; Koda Y, 2001, Leg Med (Tokyo), V3, P2, DOI 10.1016/S1344-6223(01)00005-0; Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08; Larsson MM, 2006, J INFECT DIS, V194, P1422, DOI 10.1086/508430; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Mans J, 2010, J CLIN VIROL, V49, P258, DOI 10.1016/j.jcv.2010.08.011; Mattison K, 2010, J MED VIROL, V82, P321, DOI 10.1002/jmv.21682; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Monica B, 2007, J MED VIROL, V79, P544, DOI 10.1002/jmv.20862; Nasir W, 2012, GLYCOBIOLOGY, V22, P1163, DOI 10.1093/glycob/cws084; Nitiema LW, 2011, INT J INFECT DIS, V15, pE646, DOI 10.1016/j.ijid.2011.05.009; Nordgren J, 2008, J CLIN MICROBIOL, V46, P164, DOI 10.1128/JCM.01316-07; Nordgren J, 2012, EMERG INFECT DIS, V18, P589, DOI 10.3201/eid1804.110973; Nordgren J, 2010, EMERG INFECT DIS, V16, P81, DOI 10.3201/eid1601.090633; Parra GI, 2012, VACCINE, V30, P3580, DOI 10.1016/j.vaccine.2012.03.050; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Puustinen L, 2011, SCAND J INFECT DIS, V43, P804, DOI 10.3109/00365548.2011.588610; Rockx BHG, 2005, J INFECT DIS, V191, P749, DOI 10.1086/427779; Rydell GE, 2011, REV MED VIROL, V21, P370, DOI 10.1002/rmv.704; Rydell GE, 2009, GLYCOBIOLOGY, V19, P309, DOI 10.1093/glycob/cwn139; Sanchez-Fauquier A, 2006, EMERG INFECT DIS, V12, P1536, DOI 10.3201/eid1210.060384; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Soejima M, 2009, TRANSFUSION, V49, P959, DOI 10.1111/j.1537-2995.2008.02069.x; Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200; Thorven M, 2005, J VIROL, V79, P15351, DOI 10.1128/JVI.79.24.15351-15355.2005; Tran A, 2010, J CLIN MICROBIOL, V48, P1943, DOI 10.1128/JCM.02181-09; Wang QH, 2005, EMERG INFECT DIS, V11, P1874, DOI 10.3201/eid1112.050485; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	53	89	92	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69557	10.1371/journal.pone.0069557	http://dx.doi.org/10.1371/journal.pone.0069557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894502	Green Published, Green Submitted, gold			2022-12-25	WOS:000322391400062
J	Zhang, XF; Tan, M; Chhabra, M; Dai, YC; Meller, J; Jiang, X				Zhang, Xu-Fu; Tan, Ming; Chhabra, Monica; Dai, Ying-Chun; Meller, Jarek; Jiang, Xi			Inhibition of Histo-blood Group Antigen Binding as a Novel Strategy to Block Norovirus Infections	PLOS ONE			English	Article							CAPSID PROTEIN FORMS; STRUCTURAL BASIS; RECEPTOR-BINDING; HOST INTERACTION; HBGA RECEPTORS; NORWALK VIRUS; P-DOMAIN; GASTROENTERITIS; RECOGNITION; DOCKING	Noroviruses (NoVs) are the most important viral pathogens that cause epidemic acute gastroenteritis. NoVs recognize human histo-blood group antigens (HBGAs) as receptors or attachment factors. The elucidation of crystal structures of the HBGA-binding interfaces of a number of human NoVs representing different HBGA binding patterns opens a new strategy for the development of antiviral compounds against NoVs through rational drug design and computer-aided virtual screening methods. In this study, docking simulations and virtual screening were used to identify hit compounds targeting the A and B antigens binding sites on the surface of the capsid P protein of a GII.4 NoV (VA387). Following validation by re-docking of the A and B ligands, these structural models and AutoDock suite of programs were used to screen a large drug-like compound library (derived from ZINC library) for inhibitors blocking GII.4 binding to HBGAs. After screening >2 million compounds using multistage protocol, 160 hit compounds with best predicted binding affinities and representing a number of distinct chemical classes have been selected for subsequent experimental validation. Twenty of the 160 compounds were found to be able to block the VA387 P dimers binding to the A and/or B HBGAs at an IC50 <40.0 mu M, with top 5 compounds blocking the HBGA binding at an IC50 <10.0 mu M in both oligosaccharide-and saliva-based blocking assays. Interestingly, 4 of the top-5 compounds shared the basic structure of cyclopenta [a] dimethyl phenanthren, indicating a promising structural template for further improvement by rational design.	[Zhang, Xu-Fu; Tan, Ming; Dai, Ying-Chun; Jiang, Xi] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Zhang, Xu-Fu] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Tan, Ming; Jiang, Xi] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Chhabra, Monica] Univ Cincinnati, Dept Comp Sci, Coll Engn, Cincinnati, OH 45221 USA; [Dai, Ying-Chun] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Meller, Jarek] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Southern Medical University - China; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Southern Medical University - China; University System of Ohio; University of Cincinnati	Tan, M (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.	ming.tan@cchmc.org; jason.jiang@cchmc.org	Meller, Jaroslaw/A-1971-2011	Meller, Jaroslaw/0000-0002-1162-8253; Zhang, Xufu/0000-0002-7178-2412	Guangdong Province '211 Project'; National Natural Science Foundation of China [30901992]; National Institutes of Health [R01 AI055649, R01 AI089634, P01 HD13021]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055649, R01AI089634] Funding Source: NIH RePORTER	Guangdong Province '211 Project'; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partially funded by Guangdong Province '211 Project' and the National Natural Science Foundation of China (30901992) to Xu-Fu Zhang, and National Institutes of Health R01 AI055649, R01 AI089634, and P01 HD13021 to Xi Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biesiada Jacek, 2012, Methods Mol Biol, V928, P1, DOI 10.1007/978-1-62703-008-3_1; Biesiada Jacek, 2011, Hum Genomics, V5, P497; Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Cavasotto CN, 2007, CURR TOP MED CHEM, V7, P1006, DOI 10.2174/156802607780906753; Chang DTH, 2005, NUCLEIC ACIDS RES, V33, pW233, DOI 10.1093/nar/gki586; Chen JH, 2007, BIOINFORMATICS, V23, P2348, DOI 10.1093/bioinformatics/btm341; Chen YT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002152; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Feng XZ, 2007, ANTIMICROB AGENTS CH, V51, P324, DOI 10.1128/AAC.00627-06; Feng ZK, 2004, BIOINFORMATICS, V20, P2153, DOI 10.1093/bioinformatics/bth214; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hansman GS, 2011, J VIROL, V85, P6687, DOI 10.1128/JVI.00246-11; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kubota T, 2012, J VIROL, V86, P11138, DOI 10.1128/JVI.00278-12; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000348; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2008, VIROLOGY, V379, P324, DOI 10.1016/j.virol.2008.06.041; Tan M, 2006, J VIROL, V80, P7322, DOI 10.1128/JVI.00233-06; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Tan M, 2011, VIROLOGY, V410, P345, DOI 10.1016/j.virol.2010.11.017; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005058; Taube S, 2012, J VIROL, V86, P5584, DOI 10.1128/JVI.06854-11; Villoutreix BO, 2009, COMB CHEM HIGH T SCR, V12, P1000, DOI 10.2174/138620709789824682; Wolf A, 2010, CURR CLIN PHARMACOL, V5, P37, DOI 10.2174/157488410790410560; Zhang XF, 2012, BIOORGAN MED CHEM, V20, P1616, DOI 10.1016/j.bmc.2011.11.040; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	39	32	36	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69379	10.1371/journal.pone.0069379	http://dx.doi.org/10.1371/journal.pone.0069379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894462	Green Submitted, gold, Green Published			2022-12-25	WOS:000322391400056
J	Wardle, MC; Fitzgerald, DA; Angstadt, M; Sripada, CS; McCabe, K; Phan, KL				Wardle, Margaret C.; Fitzgerald, Daniel A.; Angstadt, Michael; Sripada, Chandra S.; McCabe, Kevin; Luan Phan, K.			The Caudate Signals Bad Reputation during Trust Decisions	PLOS ONE			English	Article							BRAIN RESPONSES; NEURAL BASIS; REWARD; TRUSTWORTHINESS; RECIPROCITY; FACES; GAME; EVOLUTION; STRIATUM; BEHAVIOR	The ability to initiate and sustain trust is critical to health and well-being. Willingness to trust is in part determined by the reputation of the putative trustee, gained via direct interactions or indirectly through word of mouth. Few studies have examined how the reputation of others is instantiated in the brain during trust decisions. Here we use an event-related functional MRI (fMRI) design to examine what neural signals correspond to experimentally manipulated reputations acquired in direct interactions during trust decisions. We hypothesized that the caudate (dorsal striatum) and putamen (ventral striatum) and amygdala would signal differential reputations during decision-making. Twenty-nine healthy adults underwent fMRI scanning while completing an iterated Trust Game as trusters with three fictive trustee partners who had different tendencies to reciprocate (i.e., likelihood of rewarding the truster), which were learned over multiple exchanges with real-time feedback. We show that the caudate (both left and right) signals reputation during trust decisions, such that caudate is more active to partners with two types of "bad" reputations, either indifferent partners (who reciprocate 50% of the time) or unfair partners (who reciprocate 25% of the time), than to those with "good" reputations (who reciprocate 75% of the time). Further, individual differences in caudate activity related to biases in trusting behavior in the most uncertain situation, i.e. when facing an indifferent partner. We also report on other areas that were activated by reputation at p < 0.05 whole brain corrected. Our findings suggest that the caudate is involved in signaling and integrating reputations gained through experience into trust decisions, demonstrating a neural basis for this key social process.	[Wardle, Margaret C.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Fitzgerald, Daniel A.; Luan Phan, K.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Angstadt, Michael; Sripada, Chandra S.; Luan Phan, K.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [McCabe, Kevin] George Mason Univ, Dept Econ, Fairfax, VA 22030 USA; [Luan Phan, K.] Jesse Brown VA Med Ctr, Mental Hlth Serv Line, Chicago, IL USA	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Michigan System; University of Michigan; George Mason University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Phan, KL (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.	klphan@uic.edu	Angstadt, Mike/K-2942-2016; Wardle, Margaret/M-5157-2016	Angstadt, Mike/0000-0003-4870-7649; Wardle, Margaret/0000-0001-6071-6105; McCabe, Kevin/0000-0003-0544-157X	National Institutes Health, National Institute of Mental Health [K23MH076198]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH076198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA020297] Funding Source: NIH RePORTER	National Institutes Health, National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work was supported in part by a grant from the National Institutes Health, National Institute of Mental Health K23MH076198 (to KLP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Boero R., 2009, J SOCIO-ECON, V38, P871, DOI DOI 10.1016/J.SOCEC.2009.05.004; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Cacioppo JT, 2002, PSYCHOSOM MED, V64, P407, DOI 10.1097/00006842-200205000-00005; Coleman J., 1994, FDN SOCIAL THEORY; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Engle-Warnick J, 2004, J ECON BEHAV ORGAN, V55, P553, DOI 10.1016/j.jebo.2003.11.008; Fareri DS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00148; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 2009, PSYCHOANAL DIALOGUES, V19, P519, DOI 10.1080/10481880903231910; Huettel SA, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00171; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Kang Y, 2011, SOC COGN AFFECT NEUR, V6, P507, DOI 10.1093/scan/nsq077; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Knutson B, 2008, BIOL PSYCHIAT, V63, P686, DOI 10.1016/j.biopsych.2007.07.023; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Phan KL, 2010, P NATL ACAD SCI USA, V107, P13099, DOI 10.1073/pnas.1008137107; Rilling JK, 2008, CURR OPIN NEUROBIOL, V18, P159, DOI 10.1016/j.conb.2008.06.003; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Smith DV, 2010, WIRES COGN SCI, V1, P854, DOI 10.1002/wcs.73; Stanley DA, 2012, PHILOS T R SOC B, V367, P744, DOI 10.1098/rstb.2011.0300; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Bos W, 2009, SOC COGN AFFECT NEUR, V4, P294, DOI 10.1093/scan/nsp009; WILLIAMSON OE, 1993, J LAW ECON, V36, P453, DOI 10.1086/467284; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816	35	23	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e68884	10.1371/journal.pone.0068884	http://dx.doi.org/10.1371/journal.pone.0068884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23922638	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800151
J	Timme, S; Ihde, S; Fichter, CD; Waehle, V; Bogatyreva, L; Atanasov, K; Kohler, I; Schopflin, A; Geddert, H; Faller, G; Klimstra, D; Tang, L; Reinheckel, T; Hauschke, D; Busch, H; Boerries, M; Werner, M; Lassmann, S				Timme, S.; Ihde, S.; Fichter, C. D.; Waehle, V.; Bogatyreva, L.; Atanasov, K.; Kohler, I.; Schoepflin, A.; Geddert, H.; Faller, G.; Klimstra, D.; Tang, L.; Reinheckel, T.; Hauschke, D.; Busch, H.; Boerries, M.; Werner, M.; Lassmann, S.			STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas	ONCOGENE			English	Article						STAT3; esophageal cancer; inhibition; cell proliferation; cell migration	GROWTH-FACTOR RECEPTOR; TYROSINE-PHOSPHORYLATED STAT3; ACTIVATED SIGNAL TRANSDUCER; MULTIPOLAR MITOSES; GENE AMPLIFICATION; COLORECTAL-CANCER; TRANSCRIPTION 3; IN-VIVO; PROTEIN; PATHWAY	Signal transducer and activator of transcription 3 (STAT3) is altered in several epithelial cancers and represents a potential therapeutic target. Here, STAT3 expression, activity and cellular functions were examined in two main histotypes of esophageal carcinomas. In situ, immunohistochemistry for STAT3 and STAT3-Tyr705 phosphorylation (P-STAT3) in esophageal squamous cell carcinomas (ESCC, n = 49) and Barrett's adenocarcinomas (BAC, n = 61) revealed similar STAT3 expression in ESCCs and BACs (P = 0.109), but preferentially activated P-STAT3 in ESCCs (P = 0.013). In vitro, strong STAT3 activation was seen by epidermal growth factor (EGF) stimulation in OE21 (ESCC) cells, whereas OE33 (BAC) cells showed constitutive weak STAT3 activation. STAT3 knockdown significantly reduced cell proliferation of OE21 (P = 0.0148) and OE33 (P = 0.0243) cells. Importantly, STAT3 knockdown reduced cell migration of OE33 cells by 2.5-fold in two types of migration assays (P = 0.073, P = 0.015), but not in OE21 cells (P = 0.1079, P = 0.386). Investigation of transcriptome analysis of STAT3 knockdown revealed a reduced STAT3 level associated with significant downregulation of cell cycle genes in both OE21 (P<0.0001) and OE33 (P = 0.01) cells. In contrast, genes promoting cell migration (CTHRC1) were markedly upregulated in OE21 cells, whereas a gene linked to tight-junction stabilization and restricted cell motility (SHROOM2) was downregulated in OE21 but upregulated in OE33 cells. This study shows frequent, but distinct, patterns of STAT3 expression and activation in ESCCs and BACs. STAT3 knockdown reduces cell proliferation in ESCC and BAC cells, inhibits migration of BAC cells and may support cell migration of ESCC cells. Thereby, novel STAT3-regulated genes involved in ESCC and BAC cell proliferation and cell migration were identified. Thus, STAT3 may be further exploited as a potential novel therapeutic target, however, by careful distinction between the two histotypes of esophageal cancers.	[Timme, S.; Ihde, S.; Fichter, C. D.; Waehle, V.; Atanasov, K.; Kohler, I.; Schoepflin, A.; Werner, M.; Lassmann, S.] Univ Freiburg, Univ Med Ctr, Inst Clin Pathol, D-79106 Freiburg, Germany; [Fichter, C. D.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Bogatyreva, L.; Hauschke, D.] Univ Freiburg, Univ Med Ctr, Inst Med Biometry & Med Informat, D-79106 Freiburg, Germany; [Geddert, H.; Faller, G.] St Vincentius Kliniken, Dept Pathol, Karlsruhe, Germany; [Klimstra, D.; Tang, L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Reinheckel, T.; Busch, H.; Boerries, M.] Univ Freiburg, Univ Med Ctr, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany; [Reinheckel, T.; Lassmann, S.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Reinheckel, T.; Werner, M.; Lassmann, S.] Univ Freiburg, Univ Med Ctr, Comprehens Canc Ctr Freiburg, D-79106 Freiburg, Germany; [Busch, H.; Boerries, M.; Werner, M.; Lassmann, S.] German Canc Consortium DKTK, Heidelberg, Germany; [Busch, H.; Boerries, M.; Werner, M.; Lassmann, S.] German Canc Res Ctr, Heidelberg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Memorial Sloan Kettering Cancer Center; University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Lassmann, S (corresponding author), Univ Med Ctr, Inst Clin Pathol, Breisacherstr 115A, D-79106 Freiburg, Germany.	silke.lassmann@uniklinik-freiburg.de	Boerries, Melanie/AAM-2602-2021; Busch, Hauke/R-6452-2016; Reinheckel, Thomas/AAL-9761-2021	Busch, Hauke/0000-0003-4763-4521; Reinheckel, Thomas/0000-0001-9866-9105; Waehle, Verena/0000-0003-0189-8812	Deutsche Forschungsgemeinschaft [SFB850]; Mushett Family Foundation, Chester, NJ, USA; DFG [SFB850]; Mushett Family Foundation, Chester, NJ	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Mushett Family Foundation, Chester, NJ, USA; DFG(German Research Foundation (DFG)); Mushett Family Foundation, Chester, NJ	We thank Martina Gansz for assistance with Cathepsin analyses. We acknowledge the support of the study by the Deutsche Forschungsgemeinschaft (SFB850 project C5 to SL, MW; SFB850 project B7 to TR; Gerok stipend of SFB850 project Z1 to ST). Preliminary work for this study has been supported by the Mushett Family Foundation, Chester, NJ, USA (grant to SL, MW, LT, DK). TR and SL are member and associate members of BIOSS Centre for Biological Signalling Studies, Albert-Ludwigs-University, Freiburg, Germany. This study was supported by DFG SFB850 C5 (MW, SL); DFG SFB850 B7 (TR); DFG SFB850 Z1 (Gerok position to ST); and Mushett Family Foundation, Chester, NJ (DK, LT, MW, SL).	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Andl CD, 2004, AM J PHYSIOL-GASTR L, V287, pG1227, DOI 10.1152/ajpgi.00253.2004; Boehm AL, 2008, MOL PHARMACOL, V73, P1632, DOI 10.1124/mol.107.044636; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Bonner JA, 2011, RADIOTHER ONCOL, V99, P339, DOI 10.1016/j.radonc.2011.05.070; Boonstra JJ, 2010, JNCI-J NATL CANCER I, V102, P271, DOI 10.1093/jnci/djp499; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Dvorak K, 2007, CLIN CANCER RES, V13, P5305, DOI 10.1158/1078-0432.CCR-07-0483; Etournay R, 2007, J CELL SCI, V120, P2838, DOI 10.1242/jcs.002568; Farber MJ, 2011, MOL BIOL CELL, V22, P795, DOI 10.1091/mbc.E10-06-0505; Fichter CD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-13; Gabbert HE, WHO CLASSIFICATION T, V3; Gerlach U, 2006, J PATHOL, V208, P462, DOI 10.1002/path.1914; Gong WD, 2005, CLIN CANCER RES, V11, P1386, DOI 10.1158/1078-0432.CCR-04-0487; Hanawa M, 2006, INT J CANCER, V118, P1173, DOI 10.1002/ijc.21454; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Herz C, 2012, MOL CARCINOGEN, V51, P696, DOI 10.1002/mc.20823; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Jiang RC, 2011, MOL DIAGN THER, V15, P347, DOI 10.2165/11599190-000000000-00000; Jove R, 2000, ONCOGENE, V19, P2466, DOI 10.1038/sj.onc.1203549; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Khoury JD, 2003, CLIN CANCER RES, V9, P3692; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Lassmann S, 2007, J CLIN PATHOL, V60, P173, DOI 10.1136/jcp.2005.035113; Lassmann S, 2009, MODERN PATHOL, V22, P1385, DOI 10.1038/modpathol.2009.111; Lassmann S, 2009, J MOL MED, V87, P211, DOI 10.1007/s00109-008-0419-y; Lee J, 2009, APMIS, V117, P598, DOI 10.1111/j.1600-0463.2009.02512.x; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Morikawa T, 2011, CLIN CANCER RES, V17, P1452, DOI 10.1158/1078-0432.CCR-10-2694; Nagaraj NS, 2011, CLIN CANCER RES, V17, P483, DOI 10.1158/1078-0432.CCR-10-1670; Nasr MR, 2007, AM J CLIN PATHOL, V127, P770, DOI 10.1309/FNY8Y4H6PK1V2MGE; Park EH, 2013, CARCINOGENESIS, V34, P694, DOI 10.1093/carcin/bgs378; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Rauser S, 2007, CLIN CANCER RES, V13, P5115, DOI 10.1158/1078-0432.CCR-07-0465; Reipschlager S, 2012, J BIOL CHEM, V287, P11183, DOI 10.1074/jbc.M111.313395; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Seethala RR, 2008, CLIN CANCER RES, V14, P1303, DOI 10.1158/1078-0432.CCR-07-1543; Sobin L, 2009, TNM CLASSIFICATION M; Souissi I, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-14; Tischoff I, 2007, GUT, V56, P1047, DOI 10.1136/gut.2006.111633; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Werner M, WHO CLASSIFICATION T, V3; Yan S, 2008, CANCER LETT, V271, P85, DOI 10.1016/j.canlet.2008.05.035; Yoon HH, 2012, CLIN CANCER RES, V18, P546, DOI 10.1158/1078-0432.CCR-11-2272; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu WW, 2011, HEPATO-GASTROENTEROL, V58, P426; Zhang HY, 2011, AM J PHYSIOL-GASTR L, V300, pG454, DOI 10.1152/ajpgi.00458.2010; Zhang Y, 2012, GASTROENTEROLOGY, V142, P521, DOI 10.1053/j.gastro.2011.11.023; Zhao W, 2010, J BIOL CHEM, V285, P35855, DOI 10.1074/jbc.M110.154088	52	38	45	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 19	2014	33	25					3256	3266		10.1038/onc.2013.298	http://dx.doi.org/10.1038/onc.2013.298			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK5DA	23912451				2022-12-25	WOS:000338443400005
J	Yu, HX; Segers, F; Sliedregt-Bol, K; Bot, I; Woltman, AM; Boross, P; Verbeek, S; Overkleeft, H; van der Marel, GA; van Kooten, C; van Berkel, TJC; Biessen, EAL				Yu, Haixiang; Segers, Filip; Sliedregt-Bol, Karen; Bot, Ilze; Woltman, Andrea M.; Boross, Peter; Verbeek, Sjef; Overkleeft, Herman; van der Marel, Gijs A.; van Kooten, Cees; van Berkel, Theo J. C.; Biessen, Erik A. L.			Identification of a novel CD40 ligand for targeted imaging of inflammatory plaques by phage display	FASEB JOURNAL			English	Article						CD154; atherosclerosis; autoimmune diseases	SMOOTH-MUSCLE-CELLS; VASCULAR ENDOTHELIAL-CELLS; ACTIVATED T-CELLS; CD40-CD40 LIGAND; FUNCTIONAL CD40; NUCLEAR-FACTOR; GROWTH-FACTOR; K/BXN MOUSE; KAPPA-B; EXPRESSION	The CD40/CD40L dyad is deemed to play a central role in several inflammatory processes, including atherosclerosis. As CD40 is overexpressed in atherosclerotic lesions, it constitutes a promising candidate for targeted imaging approaches. Here we describe the design of a novel, selective peptide ligand for CD40 by phage display. A synthetic peptide corresponding with the phage insert NP31 displayed nanomolar affinity for CD40. Affinity was further enhanced by mutimeric presentation of NP31. An essential 11-mer peptide motif was identified by truncation and alanine scan studies. Enriched phage selectively bound human CD40 and homed to inflammatory joints in a murine model of rheumatoid arthritis. NP31 ablated VEGF and IL-6 transcriptional activation and partially inhibited IL-6 production by CD40L-activated endothelial cells. Notably, NP31 did not only alter the biodistribution profile of a streptavidin scaffold but also markedly increased accumulation of the carrier in atherosclerotic aortic lesions of aged ApoE(-/-) mice in a CD40-dependent manner. This potent and selective peptide ligand has potential for targeted imaging and drug delivery approaches in CD40-dependent inflammatory disorders such as atherosclerosis.Yu, H., Segers, F., Sliedregt-Bol, K., Bot, I., Woltman, A. M.(,) Boross, P., Verbeek, S., Overkleeft, H., van der Marel, G. A., van Kooten, C., van Berkel, T. J. C., Biessen, E. A. L. Identification of a novel CD40 ligand for targeted imaging of inflammatory plaques by phage display.	[Yu, Haixiang; Segers, Filip; Bot, Ilze; van Berkel, Theo J. C.; Biessen, Erik A. L.] Leiden Univ, Div Biopharmaceut, Leiden Amsterdam Ctr Drug Res, Leiden, Netherlands; [Sliedregt-Bol, Karen; Overkleeft, Herman; van der Marel, Gijs A.] Leiden Univ, Dept Bioorgan Chem, Leiden, Netherlands; [Woltman, Andrea M.; van Kooten, Cees] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Boross, Peter; Verbeek, Sjef] Leiden Univ, Med Ctr, Dept Human & Clin Genet, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Biessen, EAL (corresponding author), Univ Hosp Maastricht, Dept Pathol, Debeijelaan 25, NL-6229 HX Maastricht, Netherlands.	erik.biessen@mumc.nl	Boross, Peter/AAD-8928-2022; van Kooten, Cees/E-5694-2018; Van Berkel, Theo/ABD-7677-2021; Woltman, Andrea/GYV-2656-2022	van Kooten, Cees/0000-0002-6257-0899; Woltman, Andrea/0000-0001-9904-6751; Biessen, Erik/0000-0002-6454-8548; Bot, Ilze/0000-0002-1242-1959; Overkleeft, Herman/0000-0001-6976-7005	Netherlands Technology Foundation STW [LFA5952]; Netherlands Heart Foundation [2003T.201]; European Community [LSHM-CT-2003-503254]	Netherlands Technology Foundation STW(Technologiestichting STW); Netherlands Heart Foundation(Netherlands Heart Foundation); European Community(European Commission)	The authors gratefully acknowledge Prof. Dr. Esther Lutgens (Amsterdam Medical Center, Amsterdam, The Netherlands) for critical reading of the manuscript and for helpful suggestions. This study was financially supported by grant LFA5952 from The Netherlands Technology Foundation STW. This study was also supported by the generous grant 2003T.201 (EB) from The Netherlands Heart Foundation. The authors belong to the European Vascular Genomics Network (http://www.evgn.org), a Network of Excellence supported by the European Community's Sixth Framework Program for Research Priority 1 (Life Sciences, Genomics, and Biotechnology for Health; contract LSHM-CT-2003-503254).	ALDERSON MR, 1993, J EXP MED, V178, P669, DOI 10.1084/jem.178.2.669; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Boross P, 2006, SPRINGER SEMIN IMMUN, V28, P339, DOI 10.1007/s00281-006-0049-9; Bruemmer D, 2001, AM J CARDIOL, V87, P21, DOI 10.1016/S0002-9149(00)01266-2; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Clark LB, 1996, ADV IMMUNOL, V63, P43; Ditzel HJ, 2004, TRENDS MOL MED, V10, P40, DOI 10.1016/j.molmed.2003.11.004; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; HOLLENBAUGH D, 1995, J EXP MED, V182, P33, DOI 10.1084/jem.182.1.33; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; KARMANN K, 1995, P NATL ACAD SCI USA, V92, P4342, DOI 10.1073/pnas.92.10.4342; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Krzesz R, 1999, FEBS LETT, V453, P191, DOI 10.1016/S0014-5793(99)00683-3; Kyburz D, 2000, ARTHRITIS RHEUM, V43, P2571, DOI 10.1002/1529-0131(200011)43:11<2571::AID-ANR26>3.0.CO;2-4; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Lutgens E, 2000, P NATL ACAD SCI USA, V97, P7464, DOI 10.1073/pnas.97.13.7464; Lutgens E, 1999, NAT MED, V5, P1313, DOI 10.1038/15271; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Melter M, 2000, BLOOD, V96, P3801, DOI 10.1182/blood.V96.12.3801.h8003801_3801_3808; Molenaar TJM, 2002, BLOOD, V100, P3570, DOI 10.1182/blood-2002-02-0641; Molenaar TJM, 2002, VIROLOGY, V293, P182, DOI 10.1006/viro.2001.1254; Page A, 2012, AM J TRANSPLANT, V12, P115, DOI 10.1111/j.1600-6143.2011.03737.x; PEARSON AM, 1993, J BIOL CHEM, V268, P3546; Pound JD, 1999, INT IMMUNOL, V11, P11, DOI 10.1093/intimm/11.1.11; Richards JL, 2003, EUR J BIOCHEM, V270, P2287, DOI 10.1046/j.1432-1033.2003.03596.x; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Schonbeck U, 2001, CIRC RES, V89, P1092, DOI 10.1161/hh2401.101272; Tai YT, 2002, BLOOD, V99, P1419, DOI 10.1182/blood.V99.4.1419; van Kooten C, 2000, EXP NEPHROL, V8, P203; VanKooten C, 1996, ADV IMMUNOL, V61, P1; vanKooten C, 1997, KIDNEY INT, V51, P711, DOI 10.1038/ki.1997.102; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; YELLIN MJ, 1995, J EXP MED, V182, P1857, DOI 10.1084/jem.182.6.1857; Yu HX, 2006, ARTERIOSCL THROM VAS, V26, P1531, DOI 10.1161/01.ATV.0000225286.30710.af; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566	39	8	8	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4136	4146		10.1096/fj.12-224667	http://dx.doi.org/10.1096/fj.12-224667			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23896727				2022-12-25	WOS:000329747100025
J	Jankowski, V; Tolle, M; Tran, TNA; van der Giet, M; Schuchardt, M; Lehmann, K; Janke, D; Flick, B; Ortiz, AA; Sanchez, NMD; Tepel, M; Zidek, W; Jankowski, J				Jankowski, Vera; Toelle, Markus; Thi Nguyet Anh Tran; van der Giet, Markus; Schuchardt, Mirjam; Lehmann, Kerstin; Janke, Doreen; Flick, Burkhard; Arduan Ortiz, Alberto; Dolores Sanchez, Nino Maria; Tepel, Martin; Zidek, Walter; Jankowski, Joachim			Identification of a Potent Endothelium-Derived Angiogenic Factor	PLOS ONE			English	Article							URIDINE ADENOSINE-TETRAPHOSPHATE; BOVINE ADRENAL-MEDULLA; DIADENOSINE POLYPHOSPHATES; DINUCLEOSIDE POLYPHOSPHATES; GROWTH; CELLS; AP5A; AP4A; INFLAMMATION; ACTIVATION	The secretion of angiogenic factors by vascular endothelial cells is one of the key mechanisms of angiogenesis. Here we report on the isolation of a new potent angiogenic factor, diuridine tetraphosphate (Up(4)U) from the secretome of human endothelial cells. The angiogenic effect of the endothelial secretome was partially reduced after incubation with alkaline phosphatase and abolished in the presence of suramin. In one fraction, purified to homogeneity by reversed phase and affinity chromatography, Up(4)U was identified by MALDI-LIFT-fragment-mass-spectrometry, enzymatic cleavage analysis and retention-time comparison. Beside a strong angiogenic effect on the yolk sac membrane and the developing rat embryo itself, Up(4)U increased the proliferation rate of endothelial cells and, in the presence of PDGF, of vascular smooth muscle cells. Up(4)U stimulated the migration rate of endothelial cells via P2Y2-receptors, increased the ability of endothelial cells to form capillary-like tubes and acts as a potent inducer of sprouting angiogenesis originating from gel-embedded EC spheroids. Endothelial cells released Up(4)U after stimulation with shear stress. Mean total plasma Up(4)U concentrations of healthy subjects (N = 6) were sufficient to induce angiogenic and proliferative effects (1.34+/-0.26 nmol L-1). In conclusion, Up(4)U is a novel strong human endothelium-derived angiogenic factor.	[Jankowski, Vera; Toelle, Markus; Thi Nguyet Anh Tran; van der Giet, Markus; Schuchardt, Mirjam; Zidek, Walter; Jankowski, Joachim] Charite Univ Med Berlin, Med Klin CBF 4, Berlin, Germany; [Lehmann, Kerstin; Janke, Doreen] Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany; [Lehmann, Kerstin; Janke, Doreen] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Flick, Burkhard] Charite Univ Med Berlin, Inst Toxicol CBF, Berlin, Germany; [Arduan Ortiz, Alberto] IIS Fdn Jimenez Diaz UAM, Madrid, Spain; [Arduan Ortiz, Alberto] IRSIN, Madrid, Spain; [Dolores Sanchez, Nino Maria] IdiPAZ, Madrid, Spain; [Tepel, Martin] Univ Southern Denmark, Inst Mol Med, Odense, Denmark	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Fundacion Jimenez Diaz; University of Southern Denmark	Jankowski, J (corresponding author), Charite Univ Med Berlin, Med Klin CBF 4, Berlin, Germany.	Joachim.Jankowski@charite.de	ortiz, alberto/Y-7582-2018; Sanchez-Niño, Maria Dolores/B-7350-2019; Tepel, Martin/GRS-9581-2022; Schuchardt, Mirjam/AAS-3704-2021; Tölle, Markus/GPP-7157-2022	ortiz, alberto/0000-0002-9805-9523; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; Schuchardt, Mirjam/0000-0001-7388-9611; van der Giet, Markus/0000-0003-3590-5451; Tepel, Martin/0000-0002-0086-0997	German Research Foundation (DFG) [Ja-972/11-1]; Sonnenfeld Foundation; Federal Ministry of Education and Research (BMBF) [01GR0807]; European Union [FP7-HEALTH24 2009-2.4.5-2, 241544, HEALTH 2011.2.4.2-2, 278249]; Eutox [FIS PS09/00447]; ISCIII-RETIC [REDinREN/RD12/0021/0001, 0004]; FIS-Sara Borrell; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM); Else-Kroener-foundation;  [Comunidad de Madrid/S2010/BMD-2378]	German Research Foundation (DFG)(German Research Foundation (DFG)); Sonnenfeld Foundation; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Eutox; ISCIII-RETIC(Instituto de Salud Carlos III); FIS-Sara Borrell; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM)(Instituto de Salud Carlos III); Else-Kroener-foundation; 	This study was supported by a grant from the German Research Foundation (DFG, Ja-972/11-1; JJ), the Sonnenfeld Foundation (JJ; VJ) and Federal Ministry of Education and Research (BMBF; 01GR0807 (JJ)). The author (VJ; JJ) was supported by grants FP7-HEALTH24 2009-2.4.5-2 to "SYSKID'' (241544) and "HEALTH 2011.2.4.2-2" to "Mascara'' (278249) from the European Union. Eutox, FIS PS09/00447, ISCIII-RETIC REDinREN/RD12/0021/0001 and 0004. Comunidad de Madrid/S2010/BMD-2378(NMDS; AAO); FIS-Sara Borrell to MDSN, Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) (AAO). VJ received a grant from the Else-Kroener-foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair TH, 2005, AM J PHYSIOL-REG I, V289, pR283, DOI 10.1152/ajpregu.00840.2004; BARNES LD, 1985, ANAL BIOCHEM, V144, P296, DOI 10.1016/0003-2697(85)90120-4; CASTILLO CJF, 1992, J NEUROCHEM, V59, P723, DOI 10.1111/j.1471-4159.1992.tb09428.x; Chang H, 2010, THROMB RES, V125, P159, DOI 10.1016/j.thromres.2009.11.006; DELCASTILLO AR, 1988, J NEUROCHEM, V51, P1696, DOI 10.1111/j.1471-4159.1988.tb01147.x; Delicado EG, 2006, PFLUG ARCH EUR J PHY, V452, P563, DOI 10.1007/s00424-006-0066-5; Ferguson JE, 2005, ARTERIOSCL THROM VAS, V25, P2246, DOI 10.1161/01.ATV.0000183609.55154.44; Flick B, 2006, CURR PHARM DESIGN, V12, P1467, DOI 10.2174/138161206776389822; FLODGAARD H, 1982, BIOCHEM J, V208, P737, DOI 10.1042/bj2080737; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HEIDENREICH S, 1995, J CLIN INVEST, V95, P2862, DOI 10.1172/JCI117992; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Hoyle CHV, 1996, BRIT J PHARMACOL, V118, P1294, DOI 10.1111/j.1476-5381.1996.tb15536.x; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jankowski J, 1999, J BIOL CHEM, V274, P23926, DOI 10.1074/jbc.274.34.23926; Jankowski J, 2003, ARTERIOSCL THROM VAS, V23, P1231, DOI 10.1161/01.ATV.0000075913.00428.FD; Jankowski J, 2003, RAPID COMMUN MASS SP, V17, P1189, DOI 10.1002/rcm.1035; Jankowski J, 2001, ANAL BIOCHEM, V290, P324, DOI 10.1006/abio.2001.5001; Jankowski J, 2001, KIDNEY INT, V59, P1134, DOI 10.1046/j.1523-1755.2001.0590031134.x; Jankowski J, 1998, J CHROMATOGR B, V719, P63, DOI 10.1016/S0378-4347(98)00408-3; Jankowski J, 2001, J BIOL CHEM, V276, P8904, DOI 10.1074/jbc.M009527200; Jankowski V, 2008, J MOL MED-JMM, V86, P333, DOI 10.1007/s00109-008-0306-6; Jankowski V, 2007, KIDNEY INT, V71, P994, DOI 10.1038/sj.ki.5002186; Jankowski V, 2005, NAT MED, V11, P223, DOI 10.1038/nm1188; Jankowski V, 2013, J MOL MED IN PRESS; Jankowski V, 2007, ARTERIOSCL THROM VAS, V27, P1776, DOI 10.1161/ATVBAHA.107.143958; Jankowski V, 2007, ARTERIOSCL THROM VAS, V27, P297, DOI 10.1161/01.ATV.0000253889.09765.5f; Jankowski V, 2009, BRIT J PHARMACOL, V157, P1142, DOI 10.1111/j.1476-5381.2009.00337.x; Kim YW, 2013, J MOL MED, V91, P323, DOI 10.1007/s00109-013-1007-3; KLUG S, 1985, ARCH TOXICOL, V58, P84, DOI 10.1007/BF00348314; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783; Morawietz H, 2000, J PHYSIOL-LONDON, V525, P761, DOI 10.1111/j.1469-7793.2000.00761.x; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Nagase M, 2006, MICROVASC RES, V71, P85, DOI 10.1016/j.mvr.2005.11.006; NG KME, 1987, NUCLEIC ACIDS RES, V15, P3573, DOI 10.1093/nar/15.8.3573; Noonan DM, 2008, CANCER METAST REV, V27, P31, DOI 10.1007/s10555-007-9108-5; Orzechowski HD, 2001, MOL PHARMACOL, V60, P1332, DOI 10.1124/mol.60.6.1332; PINTOR J, 1992, NEUROSCI LETT, V136, P141, DOI 10.1016/0304-3940(92)90034-5; PINTOR J, 1991, LIFE SCI, V48, P2317, DOI 10.1016/0024-3205(91)90268-G; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; SCHLUTER H, 1994, NATURE, V367, P186, DOI 10.1038/367186a0; SDOUGOS HP, 1984, J FLUID MECH, V138, P379, DOI 10.1017/S0022112084000161; Segar CE, 2013, CURR PHARM DESIGN, V19, P3403, DOI 10.2174/1381612811319190007; Valdes TI, 2002, J BIOMED MATER RES, V62, P273, DOI 10.1002/jbm.10152; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Walsh DA, 2007, ADV CLIN CHEM, V44, P187, DOI 10.1016/S0065-2423(07)44006-9; Wiedon A, 2012, BIOCHEM BIOPH RES CO, V417, P1035, DOI 10.1016/j.bbrc.2011.12.088; XU YL, 1994, J INVEST DERMATOL, V102, P833, DOI 10.1111/1523-1747.ep12382086; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053; ZIMMERMANN H, 1993, J PHYSIOLOGY-PARIS, V87, P159, DOI 10.1016/0928-4257(93)90027-Q; Zisa D, 2011, AM J PHYSIOL-HEART C, V301, pH2422, DOI 10.1152/ajpheart.00343.2011	54	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68575	10.1371/journal.pone.0068575	http://dx.doi.org/10.1371/journal.pone.0068575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922657	Green Published, gold			2022-12-25	WOS:000323369700008
J	Baker, DH				Baker, Daniel H.			What Is the Primary Cause of Individual Differences in Contrast Sensitivity?	PLOS ONE			English	Article							HUMAN VISUAL-SYSTEM; STRABISMIC AMBLYOPIA; SPATIAL ATTENTION; NOISE EXCLUSION; PATTERN MASKING; EXTERNAL NOISE; AREA SUMMATION; HUMAN-VISION; DISCRIMINATION; MODEL	One of the primary objectives of early visual processing is the detection of luminance variations, often termed image contrast. Normal observers can differ in this ability by at least a factor of 4, yet this variation is typically overlooked, and has never been convincingly explained. This study uses two techniques to investigate the main source of individual variations in contrast sensitivity. First, a noise masking experiment assessed whether differences were due to the observer's internal noise, or the efficiency with which they extracted information from the stimulus. Second, contrast discrimination functions from 18 previous studies were compared (pairwise, within studies) using a computational model to determine whether differences were due to internal noise or the low level gain properties of contrast transduction. Taken together, the evidence points to differences in contrast gain as being responsible for the majority of individual variation across the normal population. This result is compared with related findings in attention and amblyopia.	Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of York - UK	Baker, DH (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	daniel.baker@york.ac.uk	Baker, Daniel H/A-1674-2009	Baker, Daniel H/0000-0002-0161-443X	EPSRC [EP/H000038/1]; Engineering and Physical Sciences Research Council [EP/H000038/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by EPSRC Grant EP/H000038/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini Y, 2004, J VISION, V4, P993, DOI 10.1167/4.12.2; Adini Y, 2002, NATURE, V415, P790, DOI 10.1038/415790a; Baker DH, 2008, VISION RES, V48, P1625, DOI 10.1016/j.visres.2008.04.017; Baker DH, 2007, VISION RES, V47, P3096, DOI 10.1016/j.visres.2007.08.013; Baker DH, 2012, J VISION, V12, DOI 10.1167/12.10.20; Baker DH, 2009, VISION RES, V49, P451, DOI 10.1016/j.visres.2008.12.002; Benedek G, 2003, NEUROSCI LETT, V345, P161, DOI 10.1016/S0304-3940(03)00520-2; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; BLASDEL GG, 1977, J PHYSIOL-LONDON, V265, P615, DOI 10.1113/jphysiol.1977.sp011734; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1999, VISION RES, V39, P1641, DOI 10.1016/S0042-6989(98)00199-0; BRADLEY A, 1986, VISION RES, V26, P991, DOI 10.1016/0042-6989(86)90155-0; BURTON GJ, 1981, BIOL CYBERN, V40, P27, DOI 10.1007/BF00326678; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chirimuuta M, 2005, VISION RES, V45, P2943, DOI 10.1016/j.visres.2005.06.022; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Dobkins KR, 2000, VISION RES, V40, P613, DOI 10.1016/S0042-6989(99)00211-4; Dorais A, 1997, VISION RES, V37, P1725, DOI 10.1016/S0042-6989(96)00329-X; Dosher BA, 2000, PSYCHOL SCI, V11, P139, DOI 10.1111/1467-9280.00229; ELLIOTT DB, 1992, OPHTHAL PHYSL OPT, V12, P275, DOI 10.1111/j.1475-1313.1992.tb00397.x; Foley JM, 1999, VISION RES, V39, P3855, DOI 10.1016/S0042-6989(99)00104-2; Foley JM, 1997, VISION RES, V37, P2781; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Georgeson MA, 2006, VISION RES, V46, P4294, DOI 10.1016/j.visres.2005.08.024; Goodbourn PT, 2012, PERCEPTION, V41, P226; Goodbourn PT, 2012, P ROY SOC B-BIOL SCI, V279, P4263, DOI 10.1098/rspb.2012.1430; Goris RLT, 2009, J VISION, V9, DOI 10.1167/9.7.15; Gwiazda J, 1997, OPTOMETRY VISION SCI, V74, P785, DOI 10.1097/00006324-199710000-00017; Halpern SD, 1999, J COGNITIVE NEUROSCI, V11, P521, DOI 10.1162/089892999563580; Henning GB, 2007, J VISION, V7, DOI 10.1167/7.1.3; HESS RF, 1977, VISION RES, V17, P1049, DOI 10.1016/0042-6989(77)90009-8; Hess RF, 2008, J VISION, V8, DOI 10.1167/8.1.19; Huang CB, 2007, VISION RES, V47, P22, DOI 10.1016/j.visres.2006.09.015; Huang LQ, 2005, VISION RES, V45, P1201, DOI 10.1016/j.visres.2004.10.024; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Klein SA, 2009, J OPT SOC AM A, V26, pB110, DOI 10.1364/JOSAA.26.00B110; Kontsevich LL, 2002, VISION RES, V42, P1771, DOI 10.1016/S0042-6989(02)00091-3; Kwon MY, 2009, J VISION, V9, DOI 10.1167/9.2.20; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; Levi DM, 2003, J NEUROSCI, V23, P2522; Levi DM, 2008, J VIS, V8, P11; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Lu ZL, 2008, PSYCHOL REV, V115, P44, DOI 10.1037/0033-295X.115.1.44; Maehara G, 2005, OPT REV, V12, P76, DOI 10.1007/s10043-004-0076-5; Maehara G, 2007, PERCEPT PSYCHOPHYS, V69, P1009, DOI 10.3758/BF03193939; Maehara G, 2010, J VISION, V10, DOI 10.1167/10.4.13; Meese TS, 2006, J VISION, V6, P1224, DOI 10.1167/6.11.7; Meese TS, 2007, P R SOC B, V274, P2891, DOI 10.1098/rspb.2007.0957; Meese TS, 2007, J VISION, V7, DOI 10.1167/7.4.7; Meese TS, 2010, J VISION, V10, DOI 10.1167/10.12.9; Meese TS, 2004, J VISION, V4, P930, DOI 10.1167/4.10.8; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Morgan M, 2006, VISION RES, V46, P2412, DOI 10.1016/j.visres.2006.01.019; Morgan MJ, 2011, VISION RES, V51, P2312, DOI 10.1016/j.visres.2011.09.002; Morgan MJ, 2011, VISION RES, V51, P2169, DOI 10.1016/j.visres.2011.07.018; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Pelli DG, 1999, J OPT SOC AM A, V16, P647, DOI 10.1364/JOSAA.16.000647; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Pelli DG, 2004, J VISION, V4, P904, DOI 10.1167/4.10.6; Peterzell DH, 1996, VISION RES, V36, P3077, DOI 10.1016/0042-6989(96)00061-2; Ribeiro MJ, 2010, VISION RES, V50, P1283, DOI 10.1016/j.visres.2010.04.017; ROSS J, 1993, VISION RES, V33, P2051, DOI 10.1016/0042-6989(93)90003-F; Schefrin BE, 1999, VISION RES, V39, P3728, DOI 10.1016/S0042-6989(99)00072-3; Solomon JA, 2007, VISION RES, V47, P3247, DOI 10.1016/j.visres.2007.09.006; Solomon JA, 2009, ATTEN PERCEPT PSYCHO, V71, P435, DOI 10.3758/APP.71.3.435; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Tyler CW, 2000, VISION RES, V40, P3121, DOI 10.1016/S0042-6989(00)00157-7; Van Loon AM, 2013, CURRENT BIOL; Wyart V, 2012, P NATL ACAD SCI USA, V109, P3593, DOI 10.1073/pnas.1120118109; YANG J, 1995, VISION RES, V35, P1965, DOI 10.1016/0042-6989(94)00285-T; Yu C, 2002, J VISION, V2, DOI 10.1167/2.3.4	73	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69536	10.1371/journal.pone.0069536	http://dx.doi.org/10.1371/journal.pone.0069536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922732	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900053
J	Bleckert, A; Parker, ED; Kang, Y; Pancaroglu, R; Soto, F; Lewis, R; Craig, AM; Wong, ROL				Bleckert, Adam; Parker, Edward D.; Kang, YunHee; Pancaroglu, Raika; Soto, Florentina; Lewis, Renate; Craig, Ann Marie; Wong, Rachel O. L.			Spatial Relationships between GABAergic and Glutamatergic Synapses on the Dendrites of Distinct Types of Mouse Retinal Ganglion Cells across Development	PLOS ONE			English	Article							GABA(A) RECEPTOR TRAFFICKING; STARBURST AMACRINE CELLS; INNER PLEXIFORM LAYER; RHESUS-MONKEY RETINA; INHIBITORY SYNAPSES; EXCITATORY SYNAPSES; DYNAMIC MODULATION; NEURONAL DIVERSITY; GLYCINE RECEPTORS; TOTAL NUMBER	Neuronal output requires a concerted balance between excitatory and inhibitory (I/E) input. Like other circuits, inhibitory synaptogenesis in the retina precedes excitatory synaptogenesis. How then do neurons attain their mature balance of I/E ratios despite temporal offset in synaptogenesis? To directly compare the development of glutamatergic and GABAergic synapses onto the same cell, we biolistically transfected retinal ganglion cells (RGCs) with PSD95CFP, a marker of glutamatergic postsynaptic sites, in transgenic Thy1-YFP gamma 2 mice in which GABA(A) receptors are fluorescently tagged. We mapped YFP gamma 2 and PSD95CFP puncta distributions on three RGC types at postnatal day P12, shortly before eye opening, and at P21 when robust light responses in RGCs are present. The mature I-GABA/E ratios varied among ON-Sustained (S) A-type, OFF-S A-type, and bistratified direction selective (DS) RGCs. These ratios were attained at different rates, before eye-opening for ON-S and OFF-S A-type, and after eye-opening for DS RGCs. At both ages examined, the I-GABA/E ratio was uniform across the arbors of the three RGC types. Furthermore, measurements of the distances between neighboring PSD95CFP and YFP gamma 2 puncta on RGC dendrites indicate that their local relationship is established early in development, and cannot be predicted by random organization. These close spatial associations between glutamatergic and GABAergic postsynaptic sites appear to represent local synaptic arrangements revealed by correlative light and EM reconstructions of a single RGC's dendrites. Thus, although RGC types have different I-GABA/E ratios and establish these ratios at separate rates, the local relationship between excitatory and inhibitory inputs appear similarly constrained across the RGC types studied.	[Bleckert, Adam] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Bleckert, Adam; Soto, Florentina; Wong, Rachel O. L.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Parker, Edward D.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Kang, YunHee; Pancaroglu, Raika; Craig, Ann Marie] Brain Res Ctr, Vancouver, BC, Canada; [Lewis, Renate] Washington Univ, Transgen Vector Core, St Louis, MO USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL)	Wong, ROL (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	wongr2@uw.edu	Craig, Ann Marie/M-2054-2014		NIH [EY10699]; Vision Core grant [EY01730]; NIH Developmental Biology Training Grant [T32HD007183]; Neurobiology and Behavior Training Grant [5 T32 GM07108]; CIHR [MOP69096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001730, R01EY010699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vision Core grant; NIH Developmental Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neurobiology and Behavior Training Grant; CIHR(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH EY10699 (ROW), Vision Core grant (EY01730), NIH Developmental Biology Training Grant T32HD007183 and Neurobiology and Behavior Training Grant 5 T32 GM07108 (AB), CIHR MOP69096 (AMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auferkorte ON, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035109; Benson DL, 1996, J NEUROSCI, V16, P6424; Bishop D, 2011, NAT METHODS, V8, P568, DOI [10.1038/NMETH.1622, 10.1038/nmeth.1622]; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; BRANDSTATTER JH, 1995, VISUAL NEUROSCI, V12, P345, DOI 10.1017/S0952523800008026; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; Calkins DJ, 1996, NATURE, V381, P613, DOI 10.1038/381613a0; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chen X., 2011, NATURE; Chen X, 2010, J NEUROPHYSIOL, V103, P2618, DOI 10.1152/jn.01109.2009; COHEN E, 1992, EUR J NEUROSCI, V4, P506, DOI 10.1111/j.1460-9568.1992.tb00901.x; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Diao L, 2004, J NEUROBIOL, V61, P236, DOI 10.1002/neu.20041; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Dong W, 2004, J PHYSIOL-LONDON, V556, P11, DOI 10.1113/jphysiol.2004.060715; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; FREED MA, 1992, P NATL ACAD SCI USA, V89, P236, DOI 10.1073/pnas.89.1.236; FREED MA, 1988, J NEUROSCI, V8, P2303; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; GREFERATH U, 1995, J COMP NEUROL, V353, P553, DOI 10.1002/cne.903530407; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Haverkamp S, 2000, J COMP NEUROL, V424, P1; He QH, 2011, EUR J NEUROSCI, V33, P36, DOI 10.1111/j.1460-9568.2010.07484.x; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Koehler CL, 2011, J NEUROPHYSIOL, V106, P895, DOI 10.1152/jn.01046.2010; Koizumi A, 2011, J COMP NEUROL, V519, P341, DOI 10.1002/cne.22522; KOLB H, 1993, J COMP NEUROL, V329, P85, DOI 10.1002/cne.903290107; Koulen P, 1997, NEUROREPORT, V8, P2845, DOI 10.1097/00001756-199709080-00008; Kubota Y, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.004.2009; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Majumdar S, 2007, VISUAL NEUROSCI, V24, P471, DOI 10.1017/S0952523807070174; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Morgan Josh L, 2012, Cold Spring Harb Protoc, V2012, P114, DOI 10.1101/pdb.prot067066; Morgan JL, 2011, NEURON, V71, P1014, DOI 10.1016/j.neuron.2011.08.025; NISHIMURA Y, 1987, J COMP NEUROL, V262, P290, DOI 10.1002/cne.902620209; NISHIMURA Y, 1985, J COMP NEUROL, V241, P420, DOI 10.1002/cne.902410403; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Owczarzak MT, 1999, ANAT RECORD, V255, P363; Percival KA, 2011, J COMP NEUROL, V519, P2135, DOI 10.1002/cne.22586; Percival KA, 2009, J COMP NEUROL, V517, P655, DOI 10.1002/cne.22183; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; SASSOEPOGNETTO M, 1995, J COMP NEUROL, V357, P1, DOI 10.1002/cne.903570102; SassoePognetto M, 1997, J COMP NEUROL, V381, P158, DOI 10.1002/(SICI)1096-9861(19970505)381:2<158::AID-CNE4>3.0.CO;2-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwartz GW, 2012, NAT NEUROSCI; Sernagor E, 2001, PROG RETIN EYE RES, V20, P139, DOI 10.1016/S1350-9462(00)00024-0; SHOLL DA, 1953, J ANAT, V87, P387; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Soto F, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-31; Spolidoro M, 2009, EXP BRAIN RES, V192, P335, DOI 10.1007/s00221-008-1509-3; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Taylor WR, 2012, VISUAL NEUROSCI, V29, P73, DOI 10.1017/S0952523811000393; Tian N, 2001, NEURON, V32, P439, DOI 10.1016/S0896-6273(01)00470-6; Tretter V, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00023; Unsoeld T, 2008, INT J DEV NEUROSCI, V26, P233, DOI 10.1016/j.ijdevneu.2007.12.001; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; Vannier C, 1997, INT REV CYTOL, V176, P201, DOI 10.1016/S0074-7696(08)61611-3; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Wick MJ, 2000, EUR J NEUROSCI, V12, P2634, DOI 10.1046/j.1460-9568.2000.00160.x; Wu Y, 2010, BIOPHYS J, V98, P493, DOI 10.1016/j.bpj.2009.10.037; Xu Y, 2008, J COMP NEUROL, V507, P1871, DOI 10.1002/cne.21644; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zhao X, 2005, BIOCHEM BIOPH RES CO, V330, P1110, DOI 10.1016/j.bbrc.2005.03.083; Zucker CL, 1998, VISUAL NEUROSCI, V15, P389, DOI 10.1017/S0952523898152173	91	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69612	10.1371/journal.pone.0069612	http://dx.doi.org/10.1371/journal.pone.0069612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922756	Green Published, gold			2022-12-25	WOS:000322838900061
J	Diamond, M; Reape, TJ; Rocha, O; Doyle, SM; Kacprzyk, J; Doohan, FM; McCabe, PF				Diamond, Mark; Reape, Theresa J.; Rocha, Olga; Doyle, Siamsa M.; Kacprzyk, Joanna; Doohan, Fiona M.; McCabe, Paul F.			The Fusarium Mycotoxin Deoxynivalenol Can Inhibit Plant Apoptosis-Like Programmed Cell Death	PLOS ONE			English	Article							RIBOTOXIC STRESS-RESPONSE; ACTIVATED PROTEIN-KINASE; ARABIDOPSIS-THALIANA; CAUSE DISEASE; WHEAT SPIKES; CARROT CELLS; GRAMINEARUM; TRICHOTHECENES; RESISTANCE; GENE	The Fusarium genus of fungi is responsible for commercially devastating crop diseases and the contamination of cereals with harmful mycotoxins. Fusarium mycotoxins aid infection, establishment, and spread of the fungus within the host plant. We investigated the effects of the Fusarium mycotoxin deoxynivalenol (DON) on the viability of Arabidopsis cells. Although it is known to trigger apoptosis in animal cells, DON treatment at low concentrations surprisingly did not kill these cells. On the contrary, we found that DON inhibited apoptosis-like programmed cell death (PCD) in Arabidopsis cells subjected to abiotic stress treatment in a manner independent of mitochondrial cytochrome c release. This suggested that Fusarium may utilise mycotoxins to suppress plant apoptosis-like PCD. To test this, we infected Arabidopsis cells with a wild type and a DON-minus mutant strain of F. graminearum and found that only the DON producing strain could inhibit death induced by heat treatment. These results indicate that mycotoxins may be capable of disarming plant apoptosis-like PCD and thereby suggest a novel way that some fungi can influence plant cell fate.	[Diamond, Mark; Reape, Theresa J.; Rocha, Olga; Doyle, Siamsa M.; Kacprzyk, Joanna; Doohan, Fiona M.; McCabe, Paul F.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	University College Dublin	McCabe, PF (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	paul.mccabe@ucd.ie	Kacprzyk, Janusz/AAX-3998-2020; Kacprzyk, Janusz A./M-9574-2014	Kacprzyk, Janusz/0000-0003-4187-5877; Kacprzyk, Janusz A./0000-0003-4187-5877; Doyle, Siamsa/0000-0003-4889-3496; McCabe, Paul/0000-0002-6146-8307; Doohan, Fiona/0000-0002-1953-6070; Kacprzyk, Joanna/0000-0003-1054-2367	Science Foundation Ireland [10/IN.1/B3028]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This study was supported by the Science Foundation Ireland, principal investigator project 10/IN.1/B3028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu H, 1997, PHYTOPATHOLOGY, V87, P967, DOI 10.1094/PHYTO.1997.87.9.967; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Balk J, 2003, PLANT J, V34, P573, DOI 10.1046/j.1365-313X.2003.01748.x; Burbridge E, 2007, PLANT SCI, V172, P852, DOI 10.1016/j.plantsci.2006.03.023; Bushnell WR, 2010, PHYTOPATHOLOGY, V100, P33, DOI 10.1094/PHYTO-100-1-0033; Chou YM, 1998, J QUAL TECHNOL, V30, P133; CRAWFORD DL, 1993, APPL ENVIRON MICROB, V59, P3899, DOI 10.1128/AEM.59.11.3899-3905.1993; Cuzick A, 2008, NEW PHYTOL, V177, P990, DOI 10.1111/j.1469-8137.2007.02333.x; Desmond OJ, 2008, MOL PLANT PATHOL, V9, P435, DOI 10.1111/J.1364-3703.2008.00475.X; Di R, 2005, MOL PLANT MICROBE IN, V18, P762, DOI 10.1094/MPMI-18-0762; Eudes F, 2001, CAN J PLANT PATHOL, V23, P318, DOI 10.1080/07060660109506948; Fischer SF, 2003, ANN NY ACAD SCI, V1010, P565, DOI 10.1196/annals.1299.105; FRIED HM, 1982, NUCLEIC ACIDS RES, V10, P3133, DOI 10.1093/nar/10.10.3133; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Kacprzyk J, 2011, ADV BOT RES, V60, P169, DOI 10.1016/B978-0-12-385851-1.00004-4; Kazan K, 2012, MOL PLANT PATHOL, V13, P399, DOI 10.1111/j.1364-3703.2011.00762.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li WL, 2001, THEOR APPL GENET, V102, P353, DOI 10.1007/s001220051653; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; MAY MJ, 1993, PLANT PHYSIOL, V103, P621, DOI 10.1104/pp.103.2.621; McCabe PF, 1997, PLANT J, V12, P267, DOI 10.1046/j.1365-313X.1997.12020267.x; McCabe PF, 2000, PLANT MOL BIOL, V44, P359, DOI 10.1023/A:1026500810877; Minervini F, 2004, TOXICOL IN VITRO, V18, P21, DOI 10.1016/S0887-2333(03)00130-9; Mudge AM, 2006, PHYSIOL MOL PLANT P, V69, P73, DOI 10.1016/j.pmpp.2007.01.003; Nasri T, 2006, TOXICOL IN VITRO, V20, P832, DOI 10.1016/j.tiv.2006.01.003; Nganje W. E., 2002, 2002 NAT FUS HEAD BL, P275; Oliver RP, 2004, TRENDS PLANT SCI, V9, P472, DOI 10.1016/j.tplants.2004.08.006; Pestka JJ, 2004, TOXICOL LETT, V153, P61, DOI 10.1016/j.toxlet.2004.04.023; Reape TJ, 2008, NEW PHYTOL, V180, P13, DOI 10.1111/j.1469-8137.2008.02549.x; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; Solomon PS, 2002, PLANTA, V214, P414, DOI 10.1007/s004250100632; Swidzinski JA, 2002, PLANT J, V30, P431, DOI 10.1046/j.1365-313X.2002.01301.x; Urban M, 2002, PLANT J, V32, P961, DOI 10.1046/j.1365-313X.2002.01480.x; Vacca RA, 2004, PLANT PHYSIOL, V134, P1100, DOI 10.1104/pp.103.035956; Visconti A, 2010, CEREAL CHEM, V87, P21, DOI 10.1094/CCHEM-87-1-0021; Wang H, 1996, PLANT CELL, V8, P375, DOI 10.1105/tpc.8.3.375; Yu XH, 2002, CELL DEATH DIFFER, V9, P189, DOI 10.1038/sj.cdd.4400940; Zhao Y, 1999, FEBS LETT, V448, P197, DOI 10.1016/S0014-5793(99)00352-X	44	44	44	2	180	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69542	10.1371/journal.pone.0069542	http://dx.doi.org/10.1371/journal.pone.0069542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922734	gold, Green Submitted, Green Published			2022-12-25	WOS:000322838900054
J	Haggarty, P; Hoad, G; Horgan, GW; Campbell, DM				Haggarty, Paul; Hoad, Gwen; Horgan, Graham W.; Campbell, Doris M.			DNA Methyltransferase Candidate Polymorphisms, Imprinting Methylation, and Birth Outcome	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR; HISTONE DEACETYLASE; NEXT-GENERATION; DNMT3L; WEIGHT; GENES; ASSOCIATION; METAANALYSIS; POPULATION; DISEASE	Background: Birth weight and prematurity are important obstetric outcomes linked to lifelong health. We studied a large birth cohort to look for evidence of epigenetic involvement in birth outcomes. Methods: We investigated the association between birth weight, length, placental weight and duration of gestation and four candidate variants in 1,236 mothers and 1,073 newborns; DNMT1 (rs2162560), DNMT3A (rs734693), DNMT3B (rs2424913) and DNMT3L (rs7354779). We measured methylation of LINE1 and the imprinted genes, PEG3, SNRPN, and IGF2, in cord blood. Results: The minor DNMT3L allele in the baby was associated with higher birth weight (+54 95% CI 10,99 g; p = 0.016), birth length (+0.23 95% CI 0.04,0.42 cm; p = 0.017), placental weight, (+ 18 95% CI 3,33 g; p = 0.017), and reduced risk of being in the lowest birth weight decile (p = 0.018) or requiring neonatal care (p = 0.039). The DNMT3B minor allele in the mother was associated with an increased risk of prematurity (p = 0.001). Placental size was related to PEG3 (p, 0.001) and IGF2 (p, 0.001) methylation. Birth weight was related to LINE1 and IGF2 methylation but only at p = 0.052. The risk of requiring neonatal treatment was related to LINE1 (p = 0.010) and SNRPN (p = 0.001) methylation. PEG3 methylation was influenced by baby DNMT3A genotype (p = 0.012) and LINE1 by baby 3B genotype (p = 0.044). Maternal DNMT3L genotype was related to IGF2 methylation in the cord blood but this effect was only seen in carriers of the minor frequency allele (p = 0.050). Conclusions: The results here suggest that epigenetic processes are linked birth outcome and health in early life. Our emerging understanding of the role of epigenetics in health and biological function across the lifecourse suggests that these early epigenetic events could have longer term implications.	[Haggarty, Paul; Hoad, Gwen] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Horgan, Graham W.] Biomath & Stat Scotland, Aberdeen, Scotland; [Campbell, Doris M.] Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen, Scotland	University of Aberdeen; James Hutton Institute; University of Aberdeen	Haggarty, P (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	p.haggarty@abdn.ac.uk	Horgan, Graham/J-3738-2013		Food Standards Agency [N05040]; Scottish Government(REERAD)	Food Standards Agency; Scottish Government(REERAD)	The birth cohort was funded by Food Standards Agency (grant no: N05040). PH and GH acknowledge the support of the Scottish Government(REERAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapola U, 2002, NUCLEIC ACIDS RES, V30, P3602, DOI 10.1093/nar/gkf474; Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Arnaud P, 2006, HUM MOL GENET, V15, P589, DOI 10.1093/hmg/ddi475; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Bao Q, 2011, INT J COLORECTAL DIS, V26, P1107, DOI 10.1007/s00384-011-1199-3; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Borghese B, 2012, AM J PATHOL, V180, P1781, DOI 10.1016/j.ajpath.2012.01.009; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; CAMPBELL D, 1993, BRIT J OBSTET GYNAEC, V100, P436, DOI 10.1111/j.1471-0528.1993.tb15268.x; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; Coppede F, 2013, HUM REPROD, V28, P545, DOI 10.1093/humrep/des376; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Czerwinski SA, 2007, AM J HUM BIOL, V19, P684, DOI 10.1002/ajhb.20663; de VS, 2011, CANCER CAUSE CONTROL, V22, P1, DOI 10.1007/s10552-010-9659-6; Deplus R, 2002, NUCLEIC ACIDS RES, V30, P3831, DOI 10.1093/nar/gkf509; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; El-Maarri O, 2009, HUM MOL GENET, V18, P1755, DOI 10.1093/hmg/ddp088; Elovainio M, 2011, AM J EPIDEMIOL; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Haggarty P, 2006, LANCET, V367, P1513, DOI 10.1016/S0140-6736(06)68651-0; Haggarty P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011329; Hata K, 2002, DEVELOPMENT, V129, P1983; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Huang JX, 2012, REPROD BIOMED ONLINE, V24, P66, DOI 10.1016/j.rbmo.2011.09.004; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kaneda M, 2010, GENES CELLS, V15, P169, DOI 10.1111/j.1365-2443.2009.01374.x; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; LIU Z, 2008, CANC LETT; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matte TD, 2001, BRIT MED J, V323, P310, DOI 10.1136/bmj.323.7308.310; Michels KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025254; Reik W, 2003, J PHYSIOL-LONDON, V547, P35, DOI 10.1113/jphysiol.2002.033274; Reik W, 2001, NOVART FDN SYMP, V237, P19, DOI 10.1002/0470846666.ch3; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Scientific Advisory Committee on Nutrition, 2007, INFL MAT FET CHILD N; Sebert S, 2011, AM J CLIN NUTR, V94, p1953S, DOI 10.3945/ajcn.110.001040; Silva ID, 2008, PLOS MED, V5, P1372, DOI 10.1371/journal.pmed.0050193; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; Trasler JM, 2006, REPROD FERT DEVELOP, V18, P63, DOI 10.1071/RD05118; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Walter J, 2006, CYTOGENET GENOME RES, V113, P109, DOI 10.1159/000090821; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; White Helen E, 2006, Clin Chem, V52, P1005, DOI 10.1373/clinchem.2005.065086; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1	55	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e68896	10.1371/journal.pone.0068896	http://dx.doi.org/10.1371/journal.pone.0068896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922667	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900011
J	DiStasio, MM; Francis, JT				DiStasio, Marcello M.; Francis, Joseph T.			Use of Frontal Lobe Hemodynamics as Reinforcement Signals to an Adaptive Controller	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; SPATIAL WORKING-MEMORY; NEURONAL-ACTIVITY; DOPAMINERGIC INNERVATION; OXYGENATION CHANGES; BRAIN ACTIVATION; MACAQUE MONKEY; NEURAL SYSTEMS; RHESUS-MONKEY; REWARD VALUE	Decision-making ability in the frontal lobe (among other brain structures) relies on the assignment of value to states of the animal and its environment. Then higher valued states can be pursued and lower (or negative) valued states avoided. The same principle forms the basis for computational reinforcement learning controllers, which have been fruitfully applied both as models of value estimation in the brain, and as artificial controllers in their own right. This work shows how state desirability signals decoded from frontal lobe hemodynamics, as measured with near-infrared spectroscopy (NIRS), can be applied as reinforcers to an adaptable artificial learning agent in order to guide its acquisition of skills. A set of experiments carried out on an alert macaque demonstrate that both oxy- and deoxyhemoglobin concentrations in the frontal lobe show differences in response to both primarily and secondarily desirable (versus undesirable) stimuli. This difference allows a NIRS signal classifier to serve successfully as a reinforcer for an adaptive controller performing a virtual tool-retrieval task. The agent's adaptability allows its performance to exceed the limits of the NIRS classifier decoding accuracy. We also show that decoding state desirabilities is more accurate when using relative concentrations of both oxyhemoglobin and deoxyhemoglobin, rather than either species alone.	[DiStasio, Marcello M.; Francis, Joseph T.] Suny Downstate Med Ctr, Biomed Engn Program, Brooklyn, NY 11203 USA; [DiStasio, Marcello M.; Francis, Joseph T.] NYU Polytech, Brooklyn, NY USA; [Francis, Joseph T.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Francis, Joseph T.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	DiStasio, MM (corresponding author), Suny Downstate Med Ctr, Biomed Engn Program, Brooklyn, NY 11203 USA.	marcello.distasio@downstate.edu		Francis, Joseph/0000-0002-2874-0452	DARPA REPAIR project [N66001-10-C-2008]	DARPA REPAIR project	This work was supported by DARPA REPAIR project N66001-10-C-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RA, 1985, J COMP NEUROL, V232, P443, DOI 10.1002/cne.902320403; Asaad WF, 2011, J NEUROSCI, V31, P17772, DOI 10.1523/JNEUROSCI.3793-11.2011; Averbeck BB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000050; Bae J, 2011, NEUR ENG NER 5 INT I; BERGER B, 1991, TRENDS NEUROSCI, V14, P21, DOI 10.1016/0166-2236(91)90179-X; Bluestone AY, 2001, OPT EXPRESS, V9, P272, DOI 10.1364/OE.9.000272; Boas DA, 2003, PHYS MED BIOL, V48, P2405, DOI 10.1088/0031-9155/48/15/311; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Chhatbar PY, 2010, J NEUROSCI METH, V188, P187, DOI 10.1016/j.jneumeth.2010.02.006; Choi JK, 2006, NEUROIMAGE, V30, P700, DOI 10.1016/j.neuroimage.2005.10.029; Courtney SM, 1998, PHILOS T R SOC B, V353, P1819, DOI 10.1098/rstb.1998.0334; Coyle S, 2004, PHYSIOL MEAS, V25, P815, DOI 10.1088/0967-3334/25/4/003; Crites R., 1996, ADV NEURAL INFORM PR, V8; CUI WJ, 1991, P SOC PHOTO-OPT INS, V1431, P180, DOI 10.1117/12.44189; DiGiovanna J, 2007, 2007 3RD INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, VOLS 1 AND 2, P530, DOI 10.1109/CNE.2007.369726; DiStasio M, 2006, ISC NA MIC WORKSH OP; EDVINSSON L, 1985, BRIT J PHARMACOL, V85, P403, DOI 10.1111/j.1476-5381.1985.tb08875.x; Farber M, 2011, THESIS SUNY DOWNSTAT; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GAFFAN D, 1990, J NEUROSCI, V10, P3479; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Hasegawa R, 1998, J NEUROPHYSIOL, V79, P322, DOI 10.1152/jn.1998.79.1.322; Hastie T., 2009, UNSUPERVISED LEARNIN; Histed MH, 2009, NEURON, V63, P244, DOI 10.1016/j.neuron.2009.06.019; Holper L, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-34; ILINSKY IA, 1985, J COMP NEUROL, V236, P315, DOI 10.1002/cne.902360304; Izzetoglu M, 2005, IEEE T BIO-MED ENG, V52, P934, DOI 10.1109/TBME.2005.845243; Izzetoglu M, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-16; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Kanoh S, 2009, IEEE ENG MED BIOL MA, V31; KAREL L, 1946, P SOC EXP BIOL MED, V61, P291; KAWAMURA K, 1984, Neuroscience Research, V1, P89, DOI 10.1016/S0168-0102(84)80007-3; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; Lee J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001760; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Leon-Carrion J, 2007, NEUROSCI LETT, V416, P55, DOI 10.1016/j.neulet.2007.01.058; Li JA, 2011, P NATL ACAD SCI USA, V108, P55, DOI 10.1073/pnas.1014938108; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luu S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016003; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 1996, J NEUROSCI, V16, P5154; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; PANDYA DN, 1971, BRAIN RES, V31, P35, DOI 10.1016/0006-8993(71)90632-9; Papademetris X., 2006, ISC NA MIC WORKSH OP; Pauling L, 1936, P NATL ACAD SCI USA, V22, P210, DOI 10.1073/pnas.22.4.210; ROBERTSON A, 1989, BEHAV NEUROSCI, V103, P770, DOI 10.1037/0735-7044.103.4.770; ROBERTSON A, 1989, NEUROSCI BIOBEHAV R, V13, P163, DOI 10.1016/S0149-7634(89)80026-0; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rummery G. A., 1994, TECHNICAL REPORT; Sallet J, 2011, NEURAL BASIS OF MOTIVATIONAL AND COGNITIVE CONTROL, P5; Sanchez JC, 2011, I IEEE EMBS C NEUR E, P525, DOI 10.1109/NER.2011.5910601; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Singh S, 2000, MACH LEARN, V38, P287, DOI 10.1023/A:1007678930559; Steinbrink J, 2006, MAGN RESON IMAGING, V24, P495, DOI 10.1016/j.mri.2005.12.034; Stone P, 2005, ADAPT BEHAV, V13, P165, DOI 10.1177/105971230501300301; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tarigoppula A, 2012, NEUR ENG NER 6 INT I; Taylor M, 2007, P 22 C ART INT AAAI; Tobler PN, 2008, J NEUROSCI, V28, P11703, DOI 10.1523/JNEUROSCI.2870-08.2008; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Valette J, 2006, J MAGN RESON IMAGING, V23, P408, DOI 10.1002/jmri.20511; Virtanen J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3606576; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2; Zhang W, 1995, ADV NEURAL INFORM PR, V8	81	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69541	10.1371/journal.pone.0069541	http://dx.doi.org/10.1371/journal.pone.0069541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894500	gold, Green Published, Green Submitted			2022-12-25	WOS:000322132100067
J	Pedersen, AF; Hansen, RP; Vedsted, P				Pedersen, Anette F.; Hansen, Rikke P.; Vedsted, Peter			Patient Delay in Colorectal Cancer Patients: Associations with Rectal Bleeding and Thoughts about Cancer	PLOS ONE			English	Article							DIAGNOSIS; PREVALENCE; SYMPTOMS; CONSULTATION; AWARENESS	Rectal bleeding is considered to be an alarm symptom of colorectal cancer. However, the symptom is seldom reported to the general practitioner and it is often assumed that patients assign the rectal bleeding to benign conditions. The aims of this questionnaire study were to examine whether rectal bleeding was associated with longer patient delays in colorectal cancer patients and whether rectal bleeding was associated with cancer worries. All incident colorectal cancer patients during a 1-year period in the County of Aarhus, Denmark, received a questionnaire. 136 colorectal cancer patients returned the questionnaire (response rate: 42%). Patient delay was assessed as the interval from first symptom to help-seeking and was reported by the patient. Patients with rectal bleeding (N = 81) reported longer patient intervals than patients without rectal bleeding when adjusting for confounders including other symptoms such as pain and changes in bowel habits (HR = 0.43; p = 0.004). Thoughts about cancer were not associated with the patient interval (HR = 1.05; p = 0.887), but more patients with rectal bleeding reported to have been wondering if their symptom(s) could be due to cancer than patients without rectal bleeding (chi(2) = 15.29; p<0.001). Conclusively, rectal bleeding was associated with long patient delays in colorectal cancer patients although more patients with rectal bleeding reported to have been wondering if their symptom(s) could be due to cancer than patients without rectal bleeding. This suggests that assignment of symptoms to benign conditions is not the only explanation of long patient delays in this patient group and that barriers for timely help-seeking should be examined.	[Pedersen, Anette F.; Hansen, Rikke P.; Vedsted, Peter] Aarhus Univ, Res Unit Gen Practice, Res Ctr Canc Diag Primary Care CaP, Aarhus C, Denmark	Aarhus University	Pedersen, AF (corresponding author), Aarhus Univ, Res Unit Gen Practice, Res Ctr Canc Diag Primary Care CaP, Aarhus C, Denmark.	afp@alm.au.dk	Pedersen, Anette F/T-7737-2017; Vedsted, Peter/C-2583-2008	Vedsted, Peter/0000-0003-2113-5599; Pedersen, Anette Fischer/0000-0003-0253-3671	Danish Cancer Society; Novo Nordisk Foundation	Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The Danish Cancer Society and the Novo Nordisk Foundation have supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RS, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-189; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; CROSLAND A, 1995, BRIT MED J, V311, P486, DOI 10.1136/bmj.311.7003.486; de Nooijer J, 2001, PATIENT EDUC COUNS, V42, P145, DOI 10.1016/S0738-3991(00)00104-X; DENT OF, 1990, DIS COLON RECTUM, V33, P851, DOI 10.1007/BF02051921; Gonzalez-Hermoso F, 2004, WORLD J SURG, V28, P716, DOI 10.1007/s00268-004-7232-8; Hamilton W, 2004, FAM PRACT, V21, P99, DOI 10.1093/fampra/cmh121; Hamilton W, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-17; Hansen H J, 1997, Ugeskr Laeger, V159, P1941; Harris G J, 1998, Ann R Coll Surg Engl, V80, P246; Hashim SM, 2010, ASIAN PAC J CANCER P, V11, P1335; KEMPPAINEN M, 1993, AGE AGEING, V22, P260, DOI 10.1093/ageing/22.4.260; Korsgaard M, 2006, COLORECTAL DIS, V8, P688, DOI 10.1111/j.1463-1318.2006.01014.x; Langenbach MR, 2003, WORLD J SURG, V27, P304, DOI 10.1007/s00268-002-6678-9; Lund-Nielsen B, 2011, CANCER NURS, V34, P277, DOI 10.1097/NCC.0b013e3182025020; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Mitchell E, 2008, BRIT J CANCER, V98, P60, DOI 10.1038/sj.bjc.6604096; Mor V, 1990, J Community Health, V15, P253, DOI 10.1007/BF01350291; Riss S, 2012, INT J COLORECTAL DIS, V27, P215, DOI 10.1007/s00384-011-1316-3; Ristvedt SL, 2005, DIS COLON RECTUM, V48, P1736, DOI 10.1007/s10350-005-0069-x; Ristvedt SL, 2008, PSYCHOL HEALTH, V23, P935, DOI 10.1080/08870440701657494; Robb K, 2009, BRIT J CANCER, V101, pS18, DOI 10.1038/sj.bjc.6605386; Robb KA, 2006, PREV MED, V43, P187, DOI 10.1016/j.ypmed.2006.04.015; Svendsen RP, 2010, SCAND J PRIM HEALTH, V28, P132, DOI 10.3109/02813432.2010.505412; Torring ML, 2012, J CLIN EPIDEMIOL, V65, P669, DOI 10.1016/j.jclinepi.2011.12.006; Tromp DM, 2004, EUR J CANCER, V40, P1509, DOI 10.1016/j.ejca.2004.03.009; UNESCO, 2011, GEN C PAR UNESCO 36; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68	28	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69700	10.1371/journal.pone.0069700	http://dx.doi.org/10.1371/journal.pone.0069700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894527	Green Published, gold, Green Submitted			2022-12-25	WOS:000322132100076
J	Meir, YJJ; Lin, A; Huang, MF; Lin, JR; Weirauch, MT; Chou, HC; Lin, SJA; Wu, SCY				Meir, Yaa-Jyuhn James; Lin, Angelique; Huang, Meng-Fan; Lin, Jiao-Rung; Weirauch, Matthew T.; Chou, Hsiang-Chen; Lin, Siang-Jin Ashley; Wu, Sareina Chiung-Yuan			A versatile, highly efficient, and potentially safer piggyBac transposon system for mammalian genome manipulations	FASEB JOURNAL			English	Article						gene therapy; functional genomics; remobilization; induced pluripotent stem cell	CANCER GENE DISCOVERY; SLEEPING-BEAUTY; LENTIVIRAL VECTORS; MUTAGENESIS; TRANSFORMATION; SCREEN; LINES; TOL2; MOS1; TOOL	The piggyBac transposon is one of the most attractive nonviral tools for mammalian genome manipulations. Given that piggybac mobilizes in a cut-and-paste fashion, integrant remobilization could potentially damage the host genome. Here, we report a novel piggyBac transposon system with a series of recombinant transposases. We found that the transposition activity of wild-type (PBase) and hyperactive (hyPBase) piggyBac transposases can be significantly increased by peptide fusions in a cell-type dependent fashion, with the greatest change typically seen in mouse embryonic stem (ES) cells. The two most potent recombinant transposases, TPLGMH and ThyPLGMH, give a 9- and 7-fold increase, respectively, in the number of integrants in HEK293 compared with Myc-tagged PBase (MycPBase), and both display 4-fold increase in generating induced pluripotential stem cells. Interestingly, ThyPLGMH but not TPLGMH shows improved chromosomal excision activity (2.5-fold). This unique feature of TPLGMH provides the first evidence that integration activity of a transposase can be drastically improved without increasing its remobilization activity. Transposition catalyzed by ThyPLGMH is more random and occurs further from CpG islands than that catalyzed by MycPBase or TPLGMH. Our transposon system diversifies the mammalian genetic toolbox and provides a spectrum of piggyBac transposases that is better suited to different experimental purposes.Meir, Y.-J. J., Lin, A., Huang, M.-F., Lin, J.-R., Weirauch, M. T., Chou, H.-C., Lin, S.-J., Wu, S. C. A versatile, highly efficient, and potentially safer piggyBac transposon system for mammalian genome manipulations.	[Meir, Yaa-Jyuhn James; Chou, Hsiang-Chen; Lin, Siang-Jin Ashley] Chang Gung Univ, Dept Biomed Sci, Coll Med, Tao Yuan 333, Taiwan; [Lin, Angelique; Huang, Meng-Fan; Lin, Jiao-Rung; Wu, Sareina Chiung-Yuan] Chang Gung Univ, Inst Mol Med, Coll Med, Tao Yuan 333, Taiwan; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA	Chang Gung University; Chang Gung University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Wu, SCY (corresponding author), Chang Gung Univ, Inst Mol Med, Coll Med, Tao Yuan 333, Taiwan.	jmeir@mail.cgu.edu.tw; sareinaw@mail.cgu.edu.tw	Weirauch, Matthew/M-5459-2019	Wu, Sareina, Chiung-Yuan/0000-0002-6346-4406; Huang, Meng-Fan/0000-0001-5113-1746	National Science Council of Taiwan [NSC99-2320-B-182-010-MY3]; Chang Gung Memorial Hospital [CMRPD3A0011-3]; Molecular Medicine Research Center [EMRPD1B0171]; Healthy Aging Research Center of Chang Gung University [EMRPD1C0261]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Molecular Medicine Research Center; Healthy Aging Research Center of Chang Gung University	The authors thank Evan Snyder (Sanford Burnham Medical Research Institute, La Jolla, CA, USA) for providing C17.2. ATP1, pHAhyPBase, and the ES reporter cell line HPRT<SUP>PB-in2</SUP> were a kind gift of Allan Bradley (Wellcome Trust Sanger Institute, Hinxton, UK). This work is supported by the National Science Council of Taiwan (NSC99-2320-B-182-010-MY3), Chang Gung Memorial Hospital (CMRPD3A0011-3), and the Molecular Medicine Research Center (EMRPD1B0171) and Healthy Aging Research Center of Chang Gung University (EMRPD1C0261).	Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Belay E, 2011, CURR GENE THER, V11, P406; Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2010, METHOD ENZYMOL, V477, P53, DOI 10.1016/S0076-6879(10)77004-X; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Gonzalez-Estevez C, 2003, P NATL ACAD SCI USA, V100, P14046, DOI 10.1073/pnas.2335980100; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Handler AM, 2002, INSECT BIOCHEM MOLEC, V32, P1211, DOI 10.1016/S0965-1748(02)00084-X; Hayes F, 2003, ANNU REV GENET, V37, P3, DOI 10.1146/annurev.genet.37.110801.142807; Hofherr SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017076, 10.1371/journal.pone.0023376]; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kettlun C, 2011, MOL THER, V19, P1636, DOI 10.1038/mt.2011.129; Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011; Madonna R, 2012, MOL BIOTECHNOL, V52, P193, DOI 10.1007/s12033-012-9504-0; Maragathavally KJ, 2006, FASEB J, V20, P1880, DOI 10.1096/fj.05-5485fje; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Meir YJJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-28; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; Nagy K, 2011, STEM CELL REV REP, V7, P693, DOI 10.1007/s12015-011-9239-5; OSBORNE BI, 1995, CURR OPIN CELL BIOL, V7, P406, DOI 10.1016/0955-0674(95)80097-2; Owens JB, 2012, NUCLEIC ACIDS RES, V40, P6978, DOI 10.1093/nar/gks309; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Plasterk RHA, 1996, CURR TOP MICROBIOL, V204, P125; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Sambrook J, 2001, MOL CLONING LAB MANU; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024	40	13	17	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4429	4443		10.1096/fj.12-223586	http://dx.doi.org/10.1096/fj.12-223586			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23896728	Bronze			2022-12-25	WOS:000329937500011
J	Galdieri, L; Chang, J; Mehrotra, S; Vancura, A				Galdieri, Luciano; Chang, Jennifer; Mehrotra, Swati; Vancura, Ales			Yeast Phospholipase C Is Required for Normal Acetyl-CoA Homeostasis and Global Histone Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; CHROMATIN-REMODELING COMPLEXES; RIBOSOMAL-PROTEIN GENES; SACCHAROMYCES-CEREVISIAE; INOSITOL PYROPHOSPHATES; GENOME-WIDE; HEXOSE TRANSPORTERS; GLUCOSE SENSORS; TELOMERE LENGTH; CODING REGIONS	Phospholipase C (Plc1p) is required for the initial step of inositol polyphosphate (InsP) synthesis, and yeast cells with deletion of the PLC1 gene are completely devoid of any InsPs and display aberrations in transcriptional regulation. Here we show that Plc1p is required for a normal level of histone acetylation; plc1 Delta cells that do not synthesize any InsPs display decreased acetylation of bulk histones and global hypoacetylation of chromatin histones. In accordance with the role of Plc1p in supporting histone acetylation, plc1 Delta mutation is synthetically lethal with mutations in several subunits of SAGA and NuA4 histone acetyltransferase (HAT) complexes. Conversely, the growth rate, sensitivity to multiple stresses, and the transcriptional defects of plc1 Delta cells are partially suppressed by deletion of histone deacetylase HDA1. The histone hypoacetylation in plc1 Delta cells is due to the defect in degradation of repressor Mth1p, and consequently lower expression of HXT genes and reduced conversion of glucose to acetyl-CoA, a substrate for HATs. The histone acetylation and transcriptional defects can be partially suppressed and the overall fitness improved in plc1 Delta cells by increasing the cellular concentration of acetyl-CoA. Together, our data indicate that Plc1p and InsPs are required for normal acetyl-CoA homeostasis, which, in turn, regulates global histone acetylation.	[Galdieri, Luciano; Chang, Jennifer; Mehrotra, Swati; Vancura, Ales] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA	Saint John's University	Vancura, A (corresponding author), 8000 Utopia Pkwy, Queens, NY 11439 USA.	vancuraa@stjohns.edu	Galdieri, Luciano/GYD-4538-2022	Vancura, Ales/0000-0002-5895-1218	National Institutes of Health [GM087674]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM106324, R15GM087674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087674 (to A. V.).	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Cooper KF, 1999, MOL CELL BIOL, V19, P3338; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; DeLillo N, 2003, MOL GENET GENOMICS, V269, P261, DOI 10.1007/s00438-003-0832-4; Demczuk A, 2008, EUKARYOT CELL, V7, P967, DOI 10.1128/EC.00438-07; Desai P, 2009, MOL GENET GENOMICS, V281, P511, DOI 10.1007/s00438-009-0427-9; Erkina TY, 2006, MOL CELL BIOL, V26, P7587, DOI 10.1128/MCB.00666-06; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Friis RMN, 2009, BIOCHEM CELL BIOL, V87, P107, DOI 10.1139/O08-097; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Galdieri L, 2012, METHODS MOL BIOL, V809, P255, DOI 10.1007/978-1-61779-376-9_17; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Guha N, 2007, MOL BIOL CELL, V18, P2419, DOI 10.1091/mbc.E06-10-0946; Heyland J, 2009, MICROBIOL-SGM, V155, P3827, DOI 10.1099/mic.0.030213-0; Hogan C, 2007, MUTAT RES-FUND MOL M, V618, P41, DOI 10.1016/j.mrfmmm.2006.07.010; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JH, 2006, EUKARYOT CELL, V5, P167, DOI 10.1128/EC.5.1.167-173.2006; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KRAAKMAN LS, 1993, MOL GEN GENET, V239, P196, DOI 10.1007/BF00281618; Krebs JE, 2007, MOL BIOSYST, V3, P590, DOI 10.1039/b703923a; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kristjuhan A, 2003, P NATL ACAD SCI USA, V100, P7551, DOI 10.1073/pnas.1332299100; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lafuente MJ, 2000, MOL MICROBIOL, V35, P161, DOI 10.1046/j.1365-2958.2000.01688.x; Lakshmanan J, 2003, CURR GENET, V44, P19, DOI 10.1007/s00294-003-0423-2; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lin HY, 2000, MOL CELL BIOL, V20, P3597, DOI 10.1128/MCB.20.10.3597-3607.2000; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lindstrom KC, 2006, MOL CELL BIOL, V26, P6117, DOI 10.1128/MCB.00642-06; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Ozcan S, 1996, MOL CELL BIOL, V16, P6419; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Rathmell JC, 2009, SCIENCE, V324, P1021, DOI 10.1126/science.1174665; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Roberts SM, 1997, GENETICS, V147, P451; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Sandmeier JJ, 2002, EMBO J, V21, P4959, DOI 10.1093/emboj/cdf498; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Sassone-Corsi P, 2013, SCIENCE, V339, P148, DOI 10.1126/science.1233423; Schmidt MC, 1999, MOL CELL BIOL, V19, P4561; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Smedsgaard J, 2005, J EXP BOT, V56, P273, DOI 10.1093/jxb/eri068; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Tsui MM, 2010, ADV ENZYME REGUL, V50, P324, DOI 10.1016/j.advenzreg.2009.12.002; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York JD, 2008, NAT CHEM BIOL, V4, P16, DOI 10.1038/nchembio0108-16; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Yoshida A, 2012, J BIOL CHEM, V287, P701, DOI 10.1074/jbc.M111.322222; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000; Yu YX, 2003, MOL CELL BIOL, V23, P1910, DOI 10.1128/MCB.23.6.1910-1921.2003; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	106	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27986	27998		10.1074/jbc.M113.492348	http://dx.doi.org/10.1074/jbc.M113.492348			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23913687	Green Published, hybrid			2022-12-25	WOS:000330612800025
J	van Vliet, SJ; Vuist, IM; Lenos, K; Tefsen, B; Kalay, H; Garcia-Vallejo, JJ; van Kooyk, Y				van Vliet, Sandra J.; Vuist, Ilona M.; Lenos, Kristiaan; Tefsen, Boris; Kalay, Hakan; Garcia-Vallejo, Juan J.; van Kooyk, Yvette			Human T Cell Activation Results in Extracellular Signal-regulated Kinase (ERK)-Calcineurin-dependent Exposure of Tn Antigen on the Cell Surface and Binding of the Macrophage Galactose-type Lectin (MGL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLYCOSYLATION; TRANSCRIPTIONAL REGULATION; GNT-V; PROTEIN; GENE; CD45; EXPRESSION; RECOGNITION; CHAPERONE; GLYCANS	The C-type lectin macrophage galactose-type lectin (MGL) exerts an immunosuppressive role reflected by its interaction with terminal GalNAc moieties, such as the Tn antigen, on CD45 of effector T cells, thereby down-regulating T cell receptor signaling, cytokine responses, and induction of T cell death. Here, we provide evidence for the pathways that control the specific expression of GalNAc moieties on human CD4(+) T cells. GalNAc epitopes were readily detectable on the cell surface after T cell activation and required de novo protein synthesis. Expression of GalNAc-containing MGL ligands was completely dependent on PKC and did not involve NF-kappa B. Instead, activation of the downstream ERK MAPK pathway led to decreased mRNA levels and activity of the core 1 beta 3GalT enzyme and its chaperone Cosmc, favoring the expression of Tn antigen. In conclusion, expression of GalNAc moieties mirrors the T cell activation status, and thus only highly stimulated T cells are prone to the suppressive action of MGL.	[van Vliet, Sandra J.; Vuist, Ilona M.; Lenos, Kristiaan; Tefsen, Boris; Kalay, Hakan; Garcia-Vallejo, Juan J.; van Kooyk, Yvette] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Vliet, SJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, POB 7057, NL-1081 BT Amsterdam, Netherlands.	s.vanvliet@vumc.nl	Garcia-Vallejo, Juan/H-4162-2012; Vallejo, Juan Garcia/AAA-3765-2020; Tefsen, Boris/J-1503-2012; Van Vliet, Sandra/AAO-9534-2020	Garcia-Vallejo, Juan/0000-0001-6238-7069; Tefsen, Boris/0000-0001-6668-217X; van Vliet, Sandra/0000-0003-1811-2687; Van Kooyk, Yvette/0000-0001-5997-3665	Dutch Organization for Health and Disease (NWO) VENI [863.10.017]; VU Medical Center Institute for Cancer and Immunology [CCA2011-5-03]; Dutch Technology Foundation (STW) [10622]; Mizutani Foundation for Glycoscience Research [090032]	Dutch Organization for Health and Disease (NWO) VENI; VU Medical Center Institute for Cancer and Immunology; Dutch Technology Foundation (STW)(Technologiestichting STW); Mizutani Foundation for Glycoscience Research	This work was supported by Dutch Organization for Health and Disease (NWO) VENI Grant 863.10.017, VU Medical Center Institute for Cancer and Immunology Grant CCA2011-5-03, Dutch Technology Foundation (STW) Grant 10622, and Mizutani Foundation for Glycoscience Research Grant 090032.	Amado M, 2004, J BIOL CHEM, V279, P36689, DOI 10.1074/jbc.M405629200; Antonopoulos A, 2012, J BIOL CHEM, V287, P11240, DOI 10.1074/jbc.M111.320820; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Borgert A, 2012, ACS CHEM BIOL, V7, P1031, DOI 10.1021/cb300076s; Chen HL, 2009, J BIOL CHEM, V284, P32454, DOI 10.1074/jbc.M109.023630; Cheng J, 2011, IMMUNOL RES, V50, P113, DOI 10.1007/s12026-011-8216-z; Chia J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.59; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; GALILI U, 1988, J BIOL CHEM, V263, P17755; Garcia GG, 2005, EUR J IMMUNOL, V35, P622, DOI 10.1002/eji.200425538; Garcia-Vallejo JJ, 2005, J BIOL CHEM, V280, P12676, DOI 10.1074/jbc.M410093200; Garcia-Vallejo JJ, 2004, ANAL BIOCHEM, V329, P293, DOI 10.1016/j.ab.2004.02.037; Garcia-Vallejo Juan J., 2006, V347, P187; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Gringhuis SI, 2005, MOL CELL BIOL, V25, P6454, DOI 10.1128/MCB.25.15.6454-6463.2005; Guo HB, 2010, P NATL ACAD SCI USA, V107, P21116, DOI 10.1073/pnas.1013405107; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hernandez JD, 2007, INT IMMUNOL, V19, P847, DOI 10.1093/intimm/dxm053; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; Ju TZ, 2011, GLYCOBIOLOGY, V21, P352, DOI 10.1093/glycob/cwq168; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kang R, 1996, J BIOL CHEM, V271, P26706, DOI 10.1074/jbc.271.43.26706; Ko JH, 1999, J BIOL CHEM, V274, P22941, DOI 10.1074/jbc.274.33.22941; LANZAVECCHIA A, 1988, J EXP MED, V167, P345, DOI 10.1084/jem.167.2.345; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Marcos Nuno T, 2011, Front Biosci (Elite Ed), V3, P1443; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Nakahara S, 2006, FASEB J, V20, P2451, DOI 10.1096/fj.05-5066com; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Taniguchi A, 2008, CURR DRUG TARGETS, V9, P310, DOI 10.2174/138945008783954998; Tefsen B, 2012, BIOL CHEM, V393, P767, DOI 10.1515/hsz-2012-0134; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wu AM, 2009, GLYCOCONJUGATE J, V26, P899, DOI 10.1007/s10719-008-9119-7; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024	49	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27519	27532		10.1074/jbc.M113.471045	http://dx.doi.org/10.1074/jbc.M113.471045			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23918927	hybrid, Green Published			2022-12-25	WOS:000330597300048
J	Ahsan, A; Ray, D; Ramanand, SG; Hegde, A; Whitehead, C; Rehemtulla, A; Morishima, Y; Pratt, WB; Osawa, Y; Lawrence, TS; Nyati, MK				Ahsan, Aarif; Ray, Dipankar; Ramanand, Susmita G.; Hegde, Ashok; Whitehead, Christopher; Rehemtulla, Alnawaz; Morishima, Yoshihiro; Pratt, William B.; Osawa, Yoichi; Lawrence, Theodore S.; Nyati, Mukesh K.			Destabilization of the Epidermal Growth Factor Receptor (EGFR) by a Peptide That Inhibits EGFR Binding to Heat Shock Protein 90 and Receptor Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE DOMAIN; CHAPERONE MACHINERY; TYROSINE KINASES; NECK-CANCER; IN-VITRO; HSP90; DEGRADATION; GELDANAMYCIN; ACTIVATION; CELLS	An eight-amino acid segment is known to be responsible for the marked difference in the rates of degradation of the EGF receptor (ErbB1) and ErbB2 upon treatment of cells with the Hsp90 inhibitor geldanamycin. We have scrambled the first six amino acids of this segment of the EGF receptor (EGFR), which lies in close association with the ATP binding cleft and the dimerization face. Scrambling these six amino acids markedly reduces EGFR stability, EGF-stimulated receptor dimerization, and autophosphorylation activity. Two peptides were synthesized as follows: one containing the wildtype sequence of the eight-amino acid segment, which we call Disruptin; and one with the scrambled sequence. Disruptin inhibits Hsp90 binding to the EGFR and causes slow degradation of the EGFR in two EGFR-dependent cancer cell lines, whereas the scrambled peptide is inactive. This effect is specific for EGFR versus other Hsp90 client proteins. In the presence of EGF, Disruptin, but not the scrambled peptide, inhibits EGFR dimerization and causes rapid degradation of the EGFR. In contrast to the Hsp90 inhibitor geldanamycin, Disruptin inhibits cancer cell growth by a nonapoptotic mechanism. Disruptin provides proof of concept for the development of a new class of anti-tumor drugs that specifically cause EGFR degradation.	[Ahsan, Aarif; Ray, Dipankar; Ramanand, Susmita G.; Hegde, Ashok; Rehemtulla, Alnawaz; Lawrence, Theodore S.; Nyati, Mukesh K.] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Whitehead, Christopher] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48109 USA; [Morishima, Yoshihiro; Pratt, William B.; Osawa, Yoichi] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nyati, MK (corresponding author), Univ Michigan, Sch Med, Dept Radiat Oncol, Med Sci Bldg 1, Ann Arbor, MI 48109 USA.	nyati@umich.edu			National Institutes of Health [R01CA131290, R01CA160981, GM077430, P50CA097248]; Cancer Center Support Grant [P30CA46592]; Michigan Institute for Clinical and Health Research; James Stuart and Barbara Padnos Funds for Cancer Research; Alfred Taubman Scholarship; NATIONAL CANCER INSTITUTE [P30CA046592, P50CA097248, R01CA131290, R01CA160981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; Michigan Institute for Clinical and Health Research; James Stuart and Barbara Padnos Funds for Cancer Research; Alfred Taubman Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA131290 (to M. K. N.), R01CA160981 (to D. R.), GM077430 (to Y. O.), P50CA097248 (project IV to M. K. N.), P50CA097248 (Career Development award to A. A.), and Cancer Center Support Grant P30CA46592. This work was also supported by the Michigan Institute for Clinical and Health Research (to M. K. N.), the James Stuart and Barbara Padnos Funds for Cancer Research (to M. K. N.), and an Alfred Taubman Scholarship (to T. S. L.). This project is a component of the University of Michigan Medical School's Fast Forward Strategic Research Initiative.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Ahsan A, 2012, NEOPLASIA, V14, P670, DOI 10.1593/neo.12986; Ahsan A, 2010, CANCER RES, V70, P2862, DOI 10.1158/0008-5472.CAN-09-4294; Ahsan A, 2009, CANCER RES, V69, P5108, DOI 10.1158/0008-5472.CAN-09-0466; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Bisht KS, 2003, CANCER RES, V63, P8984; Burtness B, 2005, EXPERT OPIN BIOL TH, V5, P1085, DOI 10.1517/14712598.5.8.1085; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hostein I, 2001, CANCER RES, V61, P4003; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kaul S, 2002, J BIOL CHEM, V277, P36223, DOI 10.1074/jbc.M206748200; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; LaBelle JL, 2012, J CLIN INVEST, V122, P2018, DOI 10.1172/JCI46231; LAWRENCE TS, 1988, CANCER RES, V48, P725; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Morishima Y, 2011, BIOCHEMISTRY-US, V50, P7146, DOI 10.1021/bi200751t; Nimmanapalli R, 2001, CANCER RES, V61, P1799; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rerole AL, 2011, CANCER RES, V71, P484, DOI 10.1158/0008-5472.CAN-10-1443; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Shen SS, 2009, J CELL BIOL, V185, P629, DOI 10.1083/jcb.200810183; Shrivastava A, 2009, CURR PHARM DESIGN, V15, P675, DOI 10.2174/138161209787315620; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Tikhomirov O, 2003, CANCER RES, V63, P39; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	40	26	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26879	26886		10.1074/jbc.M113.492280	http://dx.doi.org/10.1074/jbc.M113.492280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897823	Green Published, hybrid			2022-12-25	WOS:000330594500053
J	Al-Greene, NT; Means, AL; Lu, PC; Jiang, AX; Schmidt, CR; Chakravarthy, B; Merchant, NB; Washington, MK; Zhang, B; Shyr, Y; Deane, NG; Beauchamp, RD				Al-Greene, Nicole T.; Means, Anna L.; Lu, Pengcheng; Jiang, Aixiang; Schmidt, Carl R.; Chakravarthy, Bapsi; Merchant, Nipun B.; Washington, M. Kay; Zhang, Bing; Shyr, Yu; Deane, Natasha G.; Beauchamp, R. Daniel			Four Jointed Box 1 Promotes Angiogenesis and Is Associated with Poor Patient Survival in Colorectal Carcinoma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MITOCHONDRIAL COMPLEX-III; SQUAMOUS-CELL CARCINOMA; ENDOTHELIAL-CELLS; GENE-EXPRESSION; COLON-CANCER; ADULT BRAIN; IN-VIVO; GROWTH; OXYGEN	Angiogenesis, the recruitment and re-configuration of pre-existing vasculature, is essential for tumor growth and metastasis. Increased tumor vascularization often correlates with poor patient outcomes in a broad spectrum of carcinomas. We identified four jointed box 1 (FJX1) as a candidate regulator of tumor angiogenesis in colorectal cancer. FJX1 mRNA and protein are upregulated in human colorectal tumor epithelium as compared with normal epithelium and colorectal adenomas, and high expression of FJX1 is associated with poor patient prognosis. FJX1 mRNA expression in colorectal cancer tissues is significantly correlated with changes in known angiogenesis genes. Augmented expression of FJX1 in colon cancer cells promotes growth of xenografts in athymic mice and is associated with increased tumor cell proliferation and vascularization. Furthermore, FJX1 null mice develop significantly fewer colonic polyps than wild-type littermates after combined dextran sodium sulfate (DSS) and azoxymethane (AOM) treatment. In vitro, conditioned media from FJX1 expressing cells promoted endothelial cell capillary tube formation in a HIF1-alpha dependent manner. Taken together our results support the conclusion that FJX1 is a novel regulator of tumor progression, due in part, to its effect on tumor vascularization.	[Al-Greene, Nicole T.; Means, Anna L.; Beauchamp, R. Daniel] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Lu, Pengcheng; Jiang, Aixiang; Shyr, Yu] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Means, Anna L.; Schmidt, Carl R.; Merchant, Nipun B.; Deane, Natasha G.; Beauchamp, R. Daniel] Vanderbilt Univ, Dept Surg, Nashville, TN 37240 USA; [Chakravarthy, Bapsi] Vanderbilt Univ, Dept Radiat Oncol, Nashville, TN 37240 USA; [Merchant, Nipun B.; Deane, Natasha G.; Beauchamp, R. Daniel] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37240 USA; [Deane, Natasha G.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37240 USA; [Beauchamp, R. Daniel] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37240 USA; [Zhang, Bing] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37240 USA; [Washington, M. Kay] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Washington, M. Kay] Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Beauchamp, RD (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	daniel.beauchamp@vanderbilt.edu		Beauchamp, Robert Daniel/0000-0002-8446-4114; Jiang, Aixiang/0000-0002-6153-7595	GI Cancer SPORE [CA095103]; Vanderbilt-Ingram Cancer Center [CA0684845]; Clinical and Translational Science Award [NCRR/NIH UL1RR024975]; Digestive Disease Research Center [P30DK058404]; Cooperative Human Tissue Network [UO1CA094664, U01CA094664];  [DK052334];  [CA069457];  [GM088822]; NATIONAL CANCER INSTITUTE [F32CA094664, P30CA068485, P50CA095103, R01CA069457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052334, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088822] Funding Source: NIH RePORTER	GI Cancer SPORE; Vanderbilt-Ingram Cancer Center; Clinical and Translational Science Award; Digestive Disease Research Center; Cooperative Human Tissue Network; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants: DK052334, CA069457, The GI Cancer SPORE (CA095103), GM088822, the Vanderbilt-Ingram Cancer Center (CA0684845), the Clinical and Translational Science Award (NCRR/NIH UL1RR024975), the Digestive Disease Research Center (P30DK058404), the Cooperative Human Tissue Network (UO1CA094664) and (U01CA094664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2009, CELL TISSUE RES, V335, P271, DOI 10.1007/s00441-008-0672-y; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Ashery-Padan R, 1999, MECH DEVELOP, V80, P213, DOI 10.1016/S0925-4773(98)00218-4; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Blaine SA, 2010, DEVELOPMENT, V137, P2289, DOI 10.1242/dev.048421; Buchanan FG, 2007, CANCER RES, V67, P9380, DOI 10.1158/0008-5472.CAN-07-0710; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fujita T, 1998, CANCER RES, V58, P4823; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Johnson JC, 2006, CLIN GASTROENTEROL H, V4, P1358, DOI 10.1016/j.cgh.2006.07.015; Kober L, 2006, EUR J HEART FAIL, V8, P591, DOI 10.1016/j.ejheart.2005.11.007; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Lai VK, 2012, J MOL MED, V90, P719, DOI 10.1007/s00109-011-0852-1; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Melani M, 2010, ANNU REV CELL DEV BI, V26, P639, DOI 10.1146/annurev.cellbio.093008.093324; MORIKAWA K, 1988, CANCER RES, V48, P6863; Nam KT, 2007, GASTROENTEROLOGY, V132, P1804, DOI 10.1053/j.gastro.2007.03.040; Nasarre P, 2010, CELL ADHES MIGR, V4, P130, DOI 10.4161/cam.4.1.10882; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Osada-Oka M, 2008, J CELL BIOCHEM, V104, P1918, DOI 10.1002/jcb.21759; Probst B, 2007, DEV BIOL, V312, P461, DOI 10.1016/j.ydbio.2007.09.054; Rock R, 2005, DEV DYNAM, V234, P602, DOI 10.1002/dvdy.20553; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Seppinen L, 2011, MATRIX BIOL, V30, P83, DOI 10.1016/j.matbio.2010.11.001; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Simon MP, 2008, J CELL PHYSIOL, V217, P809, DOI 10.1002/jcp.21558; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Spinella F, 2009, CANCER RES, V69, P2669, DOI 10.1158/0008-5472.CAN-08-1879; Strutt H, 2004, DEVELOPMENT, V131, P881, DOI 10.1242/dev.00996; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Wan J, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-77; Wolf N, 2010, ENDOCRINOLOGY, V151, P2835, DOI 10.1210/en.2009-1195; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	58	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69660	10.1371/journal.pone.0069660	http://dx.doi.org/10.1371/journal.pone.0069660			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922772	Green Submitted, gold, Green Published			2022-12-25	WOS:000323369700062
J	Kirst, ME; Li, EC; Wang, CX; Dong, HJ; Liu, C; Fried, MW; Nelson, DR; Wang, GP				Kirst, Mariana E.; Li, Eric C.; Wang, Cindy X.; Dong, Hui-Jia; Liu, Chen; Fried, Michael W.; Nelson, David R.; Wang, Gary P.			Deep Sequencing Analysis of HCV NS3 Resistance-Associated Variants and Mutation Linkage in Liver Transplant Recipients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; TREATMENT-NAIVE; DECREASED SENSITIVITY; PROTEASE; GENOTYPE; TELAPREVIR; BOCEPREVIR; INHIBITORS	Viral variants with decreased susceptibility to HCV protease inhibitors (PIs) occur naturally and preexist at low levels within HCV populations. In patients failing PI monotherapy, single and double mutants conferring intermediate to high-level resistance to PIs have been selected in vivo. The abundance, temporal dynamics and linkage of naturally occurring resistance-associated variants (RAVs), however, have not been characterized in detail. Here, using high-density pyrosequencing, we analyzed HCV NS3 gene segments from 20 subjects with chronic HCV infection, including 12 subjects before and after liver transplantation. Bioinformatics analysis revealed that Q80 substitution was a dominant variant in 40% of the subjects, whereas other RAVs circulate at low levels within quasispecies populations. Low frequency mutation linkage was detectable by Illumina paired-end sequencing in as low as 0.5% of the mock populations constructed from in vitro RNA transcripts but were uncommon in vivo. We show that naturally occurring RAVs are common and can persist long term following liver transplant at low levels not readily detectable by conventional sequencing. Our results indicate that mutation linkage at low levels could be identified using the Illumina paired-end approach. The methods described here should facilitate the analysis of low frequency HCV drug resistance, mutation linkage and evolution, which may inform future therapeutic strategies in patients undergoing direct acting antiviral therapies.	[Kirst, Mariana E.; Li, Eric C.; Wang, Cindy X.; Wang, Gary P.] Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA; [Dong, Hui-Jia; Liu, Chen] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA; [Fried, Michael W.] Univ North Carolina Chapel Hill, Dept Med, Div Gastroenterol, Chapel Hill, NC USA; [Nelson, David R.] Univ Florida, Coll Med, Dept Med, Div Gastroenterol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; State University System of Florida; University of Florida	Wang, GP (corresponding author), Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA.	gary.wang@medicine.ufl.edu			National Institute of Health [K08 AI077713]; University of Florida Department of Medicine; Merck Sharp Dohme Corp.; NIH/NCATS Clinical and Translational Science Award [UL1 TR000064]; National Institute of Health - NCI [K24 CA139570]; NIDDK [K24 DK066144]; NATIONAL CANCER INSTITUTE [K24CA139570] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI077713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK066144] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Department of Medicine; Merck Sharp Dohme Corp.(Merck & Company); NIH/NCATS Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Health - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health [K08 AI077713]; the University of Florida Department of Medicine; and in part by a research grant from the Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp. DRN is supported in part by the NIH/NCATS Clinical and Translational Science Award to the University of Florida [UL1 TR000064] and by National Institute of Health - NCI [K24 CA139570]. MWF funded in part by NIDDK [K24 DK066144]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babrzadeh F, 2013, J ANTIMICROB CHEMOTH, V68, P414, DOI 10.1093/jac/dks409; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bae A, 2010, ANTIMICROB AGENTS CH, V54, P5288, DOI 10.1128/AAC.00777-10; Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; Cubero M, 2008, VIROLOGY, V370, P237, DOI 10.1016/j.virol.2007.10.006; Drummond AJ., 2011, GENEIOUS PRO 5 4; Feliu A, 2004, LIVER TRANSPLANT, V10, P1131, DOI 10.1002/lt.20206; Gaudieri S, 2009, HEPATOLOGY, V49, P1069, DOI 10.1002/hep.22773; Gray RR, 2012, J VIROL, V86, P8432, DOI 10.1128/JVI.00749-12; Guedj J, 2010, J VIRAL HEPATITIS, V17, P825, DOI 10.1111/j.1365-2893.2010.01348.x; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Hughes MG, 2009, LIVER TRANSPLANT, V15, P1395, DOI 10.1002/lt.21866; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jensen DM, 2011, NEW ENGL J MED, V364, P1272, DOI 10.1056/NEJMe1100829; Kim AY, 2009, J INFECT DIS, V199, P737, DOI 10.1086/596657; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sandres-Saune K, 2003, J VIROL METHODS, V109, P187, DOI 10.1016/S0166-0934(03)00070-3; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Tong X, 2008, ANTIVIR RES, V77, P177, DOI 10.1016/j.antiviral.2007.11.010; Vermehren J, 2012, J VIRAL HEPATITIS, V19, P120, DOI 10.1111/j.1365-2893.2011.01449.x; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wang GP, 2010, J VIROL, V84, P6218, DOI 10.1128/JVI.02271-09; Welker MW, 2009, HEPATOLOGY, V49, P665, DOI 10.1002/hep.22706; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	40	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69698	10.1371/journal.pone.0069698	http://dx.doi.org/10.1371/journal.pone.0069698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922778	Green Submitted, gold, Green Published			2022-12-25	WOS:000323369700067
J	Leao, PN; Costa, M; Ramos, V; Pereira, AR; Fernandes, VC; Domingues, VF; Gerwick, WH; Vasconcelos, VM; Martins, R				Leao, Pedro N.; Costa, Margarida; Ramos, Vitor; Pereira, Alban R.; Fernandes, Virginia C.; Domingues, Valentina F.; Gerwick, William H.; Vasconcelos, Vitor M.; Martins, Rosario			Antitumor Activity of Hierridin B, a Cyanobacterial Secondary Metabolite Found in both Filamentous and Unicellular Marine Strains	PLOS ONE			English	Article							BIOSYNTHESIS; PRIMIN; SYNTHETASE; MICONIDIN; QUINONES; PHENOLS; GENES	Cyanobacteria are widely recognized as a valuable source of bioactive metabolites. The majority of such compounds have been isolated from so-called complex cyanobacteria, such as filamentous or colonial forms, which usually display a larger number of biosynthetic gene clusters in their genomes, when compared to free-living unicellular forms. Nevertheless, picocyanobacteria are also known to have potential to produce bioactive natural products. Here, we report the isolation of hierridin B from the marine picocyanobacterium Cyanobium sp. LEGE 06113. This compound had previously been isolated from the filamentous epiphytic cyanobacterium Phormidium ectocarpi SAG 60.90, and had been shown to possess antiplasmodial activity. A phylogenetic analysis of the 16S rRNA gene from both strains confirmed that these cyanobacteria derive from different evolutionary lineages. We further investigated the biological activity of hierridin B, and tested its cytotoxicity towards a panel of human cancer cell lines; it showed selective cytotoxicity towards HT-29 colon adenocarcinoma cells.	[Leao, Pedro N.; Costa, Margarida; Ramos, Vitor; Vasconcelos, Vitor M.; Martins, Rosario] Univ Porto, CIIMAR CIMAR Interdisciplinary Ctr Marine & Envir, P-4100 Porto, Portugal; [Leao, Pedro N.; Pereira, Alban R.; Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Fernandes, Virginia C.; Domingues, Valentina F.] Inst Politecn Porto, Inst Super Engn, REQUIMTE, Porto, Portugal; [Gerwick, William H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Vasconcelos, Vitor M.] Univ Porto, Fac Sci, Dept Biol, P-4100 Porto, Portugal; [Martins, Rosario] Polytech Inst Porto, Super Sch Hlth Technol Porto, Ctr Hlth & Environm Res CISA, Vila Nova De Gaia, Portugal; [Martins, Rosario] Univ Porto, Inst Mol & Cell Biol IBMC, P-4100 Porto, Portugal	Universidade do Porto; University of California System; University of California San Diego; Scripps Institution of Oceanography; Polytechnic Institute of Porto; Universidade do Porto; University of California System; University of California San Diego; Universidade do Porto; Polytechnic Institute of Porto; Universidade do Porto	Leao, PN (corresponding author), Univ Porto, CIIMAR CIMAR Interdisciplinary Ctr Marine & Envir, Rua Campo Alegre 823, P-4100 Porto, Portugal.	pleao@ciimar.up.pt	Ramos, Vitor M.C./A-4540-2011; Domingues, Valentina Fernandes/ABB-8500-2020; Fernandes, Virgínia/G-4985-2010; Domingues, Valentina Fernandes/D-4778-2013; Vasconcelos, Vitor/A-8933-2008; Leão, Pedro N./E-1630-2011	Ramos, Vitor M.C./0000-0002-5824-3633; Domingues, Valentina Fernandes/0000-0003-3472-849X; Fernandes, Virgínia/0000-0003-3979-7523; Domingues, Valentina Fernandes/0000-0003-3472-849X; Vasconcelos, Vitor/0000-0003-3585-2417; Leão, Pedro N./0000-0001-5064-9164; Martins, Rosario/0000-0002-9882-4651; Costa, Margarida/0000-0001-9147-8621	FCT - Foundation for Science and Technology [SFRH/BPD/70233/2010, BTI/PTDC/MAR/102638/2008/2010-025, SFRH/BD/80153/2011]; European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; FCT [PEst-C/MAR/LA0015/2011, PTDC/MAR/102258/2008, PTDC/MAR/102638/2008]; National Institutes of Health [CA100851]; NATIONAL CANCER INSTITUTE [R01CA100851] Funding Source: NIH RePORTER	FCT - Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	PNL, MC and VR acknowledge funding from FCT - Foundation for Science and Technology (SFRH/BPD/70233/2010, BTI/PTDC/MAR/102638/2008/2010-025 and SFRH/BD/80153/2011, respectively). This research was partially supported by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme and national funds through FCT, under the projects PEst-C/MAR/LA0015/2011, PTDC/MAR/102258/2008 and PTDC/MAR/102638/2008. WHG acknowledges funding from the National Institutes of Health CA100851. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; BERNAYS E, 1984, EXPERIENTIA, V40, P1010, DOI 10.1007/BF01946484; BLANK CE, 2012, Patent No. 20120244603; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, P473, DOI DOI 10.1007/978-0-387-21609-6_27; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Donia MS, 2011, P NATL ACAD SCI USA, V108, pE1423, DOI 10.1073/pnas.1111712108; FUKUYAMA Y, 1991, CHEM PHARM BULL, V39, P1877, DOI 10.1248/cpb.39.1877; Gu LC, 2009, NATURE, V459, P731, DOI 10.1038/nature07870; Gunatilaka AAL, 2001, J NAT PROD, V64, P2, DOI 10.1021/np000219r; HORPER W, 1995, NAT PROD LETT, V6, P163, DOI 10.1080/10575639508043153; Horper W, 1996, PHYTOCHEMISTRY, V41, P451, DOI 10.1016/0031-9422(95)00590-0; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones AC, 2010, NAT PROD REP, V27, P1048, DOI 10.1039/c000535e; Komarek J, 1998, CYANOPROKARYOTA; Kotai J., 1972, INSTRUCTIONS PREPARA, V11; Leao PN, 2012, NAT PROD REP, V29, P372, DOI 10.1039/c2np00075j; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; MARNER FJ, 1992, HELV CHIM ACTA, V75, P1557, DOI 10.1002/hlca.19920750509; Martins R, 2007, TOXICON, V50, P791, DOI 10.1016/j.toxicon.2007.06.020; MENDES LBB, 2011, Patent No. 7955505; Mikalsen B, 2003, J BACTERIOL, V185, P2774, DOI 10.1128/JB.185.9.2774-2785.2003; Moffitt MC, 2001, FEMS MICROBIOL LETT, V196, P207, DOI 10.1111/j.1574-6968.2001.tb10566.x; Nakamura H, 2012, J AM CHEM SOC, V134, P18518, DOI 10.1021/ja308318p; Neilan BA, 1997, INT J SYST BACTERIOL, V47, P693, DOI 10.1099/00207713-47-3-693; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Nunnery JK, 2010, CURR OPIN BIOTECH, V21, P787, DOI 10.1016/j.copbio.2010.09.019; Papendorf O, 1998, PHYTOCHEMISTRY, V49, P2383, DOI 10.1016/S0031-9422(98)00440-3; Pinevich A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00173; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SepulvedaBoza S, 1996, PLANTA MED, V62, P98, DOI 10.1055/s-2006-957827; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tasdemir D, 2006, CHEM BIODIVERS, V3, P1230, DOI 10.1002/cbdv.200690124; Tidgewell K, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 2: NATURAL PRODUCTS STRUCTURAL DIVERSITY-II: SECONDARY METABOLITES: SOURCES, STRUCTURES AND CHEMICAL BIOLOGY, P141; Tidgewell K, 2010, CHEMBIOCHEM, V11, P1458, DOI 10.1002/cbic.201000070; Wilmotte A., 2001, BERGEYS MANUAL SYSTE, P487; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	41	38	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69562	10.1371/journal.pone.0069562	http://dx.doi.org/10.1371/journal.pone.0069562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922738	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700042
J	Lin, CL; Theodorides, ML; McDaniel, AH; Tordoff, MG; Zhang, QM; Li, X; Bosak, N; Bachmanov, AA; Reed, DR				Lin, Cailu; Theodorides, Maria L.; McDaniel, Amanda H.; Tordoff, Michael G.; Zhang, Qinmin; Li, Xia; Bosak, Natalia; Bachmanov, Alexander A.; Reed, Danielle R.			QTL Analysis of Dietary Obesity in C57BL/6byj X 129P3/J F-2 Mice: Diet- and Sex-Dependent Effects	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BODY-WEIGHT; HIGH-FAT; INSULIN-RESISTANCE; INDUCED ADIPOSITY; CANDIDATE GENES; MOUSE; STRAIN; GROWTH; MODEL	Obesity is a heritable trait caused by complex interactions between genes and environment, including diet. Gene-by-diet interactions are difficult to study in humans because the human diet is hard to control. Here, we used mice to study dietary obesity genes, by four methods. First, we bred 213 F-2 mice from strains that are susceptible [C57BL/6ByJ (B6)] or resistant [129P3/J (129)] to dietary obesity. Percent body fat was assessed after mice ate low-energy diet and again after the same mice ate high-energy diet for 8 weeks. Linkage analyses identified QTLs associated with dietary obesity. Three methods were used to filter candidate genes within the QTL regions: (a) association mapping was conducted using >40 strains; (b) differential gene expression and (c) comparison of genomic DNA sequence, using two strains closely related to the progenitor strains from Experiment 1. The QTL effects depended on whether the mice were male or female or which diet they were recently fed. After feeding a low-energy diet, percent body fat was linked to chr 7 (LOD = 3.42). After feeding a high-energy diet, percent body fat was linked to chr 9 (Obq5; LOD = 3.88), chr 12 (Obq34; LOD = 3.88), and chr 17 (LOD = 4.56). The Chr 7 and 12 QTLs were sex dependent and all QTL were diet-dependent. The combination of filtering methods highlighted seven candidate genes within the QTL locus boundaries: Crx, Dmpk, Ahr, Mrpl28, Glo1, Tubb5, and Mut. However, these filtering methods have limitations so gene identification will require alternative strategies, such as the construction of congenics with very small donor regions.	[Lin, Cailu; Theodorides, Maria L.; McDaniel, Amanda H.; Tordoff, Michael G.; Zhang, Qinmin; Li, Xia; Bosak, Natalia; Bachmanov, Alexander A.; Reed, Danielle R.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Reed, DR (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	reed@monell.org	Lin, Cailu/E-5316-2011; Bachmanov, Alexander A./AAH-8857-2020	Lin, Cailu/0000-0001-8909-7758; Bachmanov, Alexander A./0000-0002-2861-3322; Reed, Danielle/0000-0002-4374-6107; Tordoff, Michael/0000-0003-1977-9520	National Institutes of Health [DK094759, DK058797, AA011028, DC000882]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094759, R01DK058797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000882, P30DC011735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	These studies were funded by the National Institutes of Health, DK094759, DK058797, AA011028, and DC000882. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Cheverud JM, 2004, DIABETES, V53, P3328, DOI 10.2337/diabetes.53.12.3328; Choi JW, 2012, J PROTEOMICS, V75, P1386, DOI 10.1016/j.jprot.2011.11.012; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Davis RC, 2005, DIABETES, V54, P1191, DOI 10.2337/diabetes.54.4.1191; Ehrich TH, 2005, DIABETES, V54, P1863, DOI 10.2337/diabetes.54.6.1863; Farber CR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2146-7-102; FENTON PF, 1953, J NUTR, V49, P319, DOI 10.1093/jn/49.2.319; Ishimori N, 2004, J LIPID RES, V45, P1624, DOI 10.1194/jlr.M400098-JLR200; Jerez-Timaure NC, 2005, PHYSIOL GENOMICS, V21, P411, DOI 10.1152/physiolgenomics.00256.2004; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kerley-Hamilton JS, 2012, ENVIRON HEALTH PERSP, V120, P1252, DOI 10.1289/ehp.1205003; Kumar KG, 2007, AM J PHYSIOL-REG I, V292, pR207, DOI 10.1152/ajpregu.00491.2006; Kumar KG, 2008, J NUTRIGENET NUTRIGE, V1, P155, DOI 10.1159/000113657; Lawson HA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002256; Lee BH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001219; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; Liu PY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000651; Llagostera E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001134; Llagostera E, 2009, FEBS LETT, V583, P2121, DOI 10.1016/j.febslet.2009.05.043; Masinde GL, 2002, CALCIFIED TISSUE INT, V71, P421, DOI 10.1007/s00223-001-1113-z; McDaniel AH, 2006, MAMM GENOME, V17, P1078, DOI 10.1007/s00335-006-0055-1; Millward CA, 2009, MAMM GENOME, V20, P71, DOI 10.1007/s00335-008-9165-2; Nellaker C, 2012, GENOME BIOL, V13, P45; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Payseur BA, 2007, GENETICS, V175, P1999, DOI 10.1534/genetics.106.067868; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Reddy GB, 2009, INVEST OPHTH VIS SCI, V50, P3456, DOI 10.1167/iovs.08-2498; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; Reed DR, 2006, MAMM GENOME, V17, P1065, DOI 10.1007/s00335-006-0054-2; Reed DR, 2004, J NEUROSCI, V24, P938, DOI 10.1523/JNEUROSCI.1374-03.2004; Reed DR, 2003, MAMM GENOME, V14, P302, DOI 10.1007/s00335-002-2170-y; SCHEMMEL R, 1970, J NUTR, V100, P1041; Scherneck S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000541; Schmitt AO, 2007, OMICS, V11, P341, DOI 10.1089/omi.2007.0015; SIMS EAH, 1968, AM J CLIN NUTR, V21, P1455, DOI 10.1093/ajcn/21.12.1455; Solberg LC, 2004, MAMM GENOME, V15, P648, DOI 10.1007/s00335-004-2326-z; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Srivastava AK, 2006, J LIPID RES, V47, P123, DOI 10.1194/jlr.M500295-JLR200; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; Stylianou IM, 2006, MAMM GENOME, V17, P22, DOI 10.1007/s00335-005-0091-2; Su Z, 2008, INT J OBESITY, V32, P1180, DOI 10.1038/ijo.2008.56; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Taylor BA, 1999, MAMM GENOME, V10, P963, DOI 10.1007/s003359901141; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vitarius JA, 2006, P NATL ACAD SCI USA, V103, P19860, DOI 10.1073/pnas.0609232103; Wang JR, 2012, GENETICS, V190, P449, DOI 10.1534/genetics.111.132381; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; WEST DB, 1995, AM J PHYSIOL-REG I, V268, pR658, DOI 10.1152/ajpregu.1995.268.3.R658; Witmer PD, 2003, GENOME RES, V13, P485, DOI 10.1101/gr.717903; Yalcin B, 2012, MAMM GENOME, V23, P490, DOI 10.1007/s00335-012-9402-6; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	69	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68776	10.1371/journal.pone.0068776	http://dx.doi.org/10.1371/journal.pone.0068776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922663	Green Submitted, Green Published, gold			2022-12-25	WOS:000323369700012
J	Chang, YC; Chiu, YF; Liu, PH; Hee, SW; Chang, TJ; Jiang, YD; Lee, WJ; Lee, PC; Kao, HY; Hwang, JJ; Chuang, LM				Chang, Yi-Cheng; Chiu, Yen-Feng; Liu, Pi-Hua; Hee, Siow Wei; Chang, Tien-Jyun; Jiang, Yi-Der; Lee, Wei-Jei; Lee, Po-Chu; Kao, Hui-Yi; Hwang, Juey-Jen; Chuang, Lee-Ming			Genetic Variation in the NOC Gene Is Associated with Body Mass Index in Chinese Subjects	PLOS ONE			English	Article							METABOLIC SYNDROME; CIRCADIAN-RHYTHMS; GLUCOSE SENSOR; CLOCK GENE; NOCTURNIN; OBESITY; SUSCEPTIBILITY; POLYMORPHISMS; ADIPOGENESIS; RESISTANCE	Circadian clock genes are critical regulators of energy homeostasis and metabolism. However, whether variation in the circadian genes is associated with metabolic phenotypes in humans remains to be explored. In this study, we systemically genotyped 20 tag single nucleotide polymorphisms (SNPs) in 8 candidate genes involved in circadian clock, including CLOCK, BMAL1(ARNTL), PER1, PER2, CRY1, CRY2, CSNK1E,, and NOC(CCRN4L) in 1,510 non-diabetic Chinese subjects in Taipei and Yunlin populations in Taiwan. Their associations with metabolic phenotypes were analyzed. We found that genetic variation in the NOC gene, rs9684900 was associated with body mass index (BMI) (P = 0.0016, Bonferroni corrected P = 0.032). Another variant, rs135764 in the CSNK1E gene was associated with fasting glucose (P = 0.0023, Bonferroni corrected P = 0.046). These associations were consistent in both Taipei and Yunlin populations. Significant epistatic and joint effects between SNPs on BMI and related phenotypes were observed. Furthermore, NOC mRNA levels in human abdominal adipose tissue were significantly increased in obese subjects compared to non-obese controls. Conclusion: Genetic variation in the NOC gene is associated with BMI in Chinese subjects.	[Chang, Yi-Cheng; Hee, Siow Wei; Chang, Tien-Jyun; Jiang, Yi-Der; Hwang, Juey-Jen; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chang, Yi-Cheng] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chang, Yi-Cheng] Natl Taiwan Univ, Degree Program Translat Med, Taipei 10764, Taiwan; [Chiu, Yen-Feng; Kao, Hui-Yi] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan; [Liu, Pi-Hua] Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Tao Yuan, Taiwan; [Lee, Wei-Jei] Ming Sheng Gen Hosp, Dept Surg, Tao Yuan, Taiwan; [Lee, Po-Chu] Natl Taiwan Univ Hosp, Dept Gen Surg, Taipei 100, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Taiwan University; National Health Research Institutes - Taiwan; Chang Gung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chuang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	leeming@ntu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019; Chang, Yi-cheng/O-1334-2018; Chiu, Yen-Feng/E-3847-2010	Chang, Yi-cheng/0000-0002-8077-5011; CHANG, TIEN-JYUN/0000-0001-9437-5847; CHUANG, LEE-MING/0000-0003-0978-2662; Hwang, Juey-Jen/0000-0001-6437-0455; LEE, PO-CHU/0000-0001-5053-1895; Liu, Pi-Hua/0000-0002-7165-6248	National Science Council of Taiwan [NSC 97-2314-B-002-047-MY3]; National Taiwan University College of Medicine, Taipei, Taiwan [99C101-601]; National Health Research Institutes in Taiwan [PH-102-PP-04]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University College of Medicine, Taipei, Taiwan; National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	This work was supported in part by a grant (NSC 97-2314-B-002-047-MY3) from the National Science Council of Taiwan and a grant (99C101-601) from the National Taiwan University College of Medicine, Taipei, Taiwan. This study is also partially supported by the grant PH-102-PP-04 from the National Health Research Institutes in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2009, COLD SPRING HARB PRO, V2009; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Chang YC, 2007, DIABETES, V56, P2631, DOI 10.2337/db07-0421; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Garaulet M, 2010, INT J OBESITY, V34, P516, DOI 10.1038/ijo.2009.255; Garaulet M, 2010, J AM DIET ASSOC, V110, P917, DOI 10.1016/j.jada.2010.03.017; Garaulet M, 2009, AM J CLIN NUTR, V90, P1466, DOI 10.3945/ajcn.2009.27536; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hee SW, 2012, OBESITY, V20, P1558, DOI 10.1038/oby.2012.37; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Kawai M, 2010, P NATL ACAD SCI USA, V107, P10508, DOI 10.1073/pnas.1000788107; Lin JW, 2009, DIABETES CARE, V32, P2294, DOI 10.2337/dc09-0694; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Pasula S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-17; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Stubblefield JJ, 2012, TRENDS ENDOCRIN MET, V23, P326, DOI 10.1016/j.tem.2012.03.007; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104	25	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69622	10.1371/journal.pone.0069622	http://dx.doi.org/10.1371/journal.pone.0069622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922759	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900063
J	Lamas, DJM; Carabajal, E; Prestifilippo, JP; Rossi, L; Elverdin, JC; Merani, S; Bergoc, RM; Rivera, ES; Medina, VA				Martinel Lamas, Diego J.; Carabajal, Eliana; Prestifilippo, Juan P.; Rossi, Luis; Elverdin, Juan C.; Merani, Susana; Bergoc, Rosa M.; Rivera, Elena S.; Medina, Vanina A.			Protection of Radiation-Induced Damage to the Hematopoietic System, Small Intestine and Salivary Glands in Rats by JNJ7777120 Compound, a Histamine H-4 Ligand	PLOS ONE			English	Article							BONE-MARROW; SUBMANDIBULAR-GLAND; IONIZING-RADIATION; MICRONUCLEUS TEST; IN-VIVO; RECEPTOR; BLOOD; PHARMACOLOGY; MECHANISMS; SECRETION	Based on previous data on the histamine radioprotective effect on highly radiosensitive tissues, in the present work we aimed at investigating the radioprotective potential of the H4R ligand, JNJ7777120, on ionizing radiation-induced injury and genotoxic damage in small intestine, salivary glands and hematopoietic tissue. For that purpose, rats were divided into 4 groups. JNJ7777120 and JNJ7777120-irradiated groups received a daily subcutaneous JNJ7777120 injection (10 mg/kg) starting 24 h before irradiation. Irradiated groups received a single dose of 5 Gy on whole-body using Cesium-137 source and were sacrificed 3 or 30 days after irradiation. Tissues were removed, fixed, stained with hematoxylin and eosin or PAS staining and histological characteristics were evaluated. Proliferative and apoptotic markers were studied by immunohistochemistry, while micronucleus assay was performed to evaluate DNA damage. Submandibular gland (SMG) function was evaluated by methacholine-induced salivation. Results indicate that JNJ7777120 treatment diminished mucosal atrophy and preserved villi and the number of crypts after radiation exposure (240 +/- 8 vs. 165 +/- 10, P<0.01). This effect was associated to a reduced apoptosis and DNA damage in intestinal crypts. JNJ7777120 reduced radiation-induced aplasia, preserving medullar components and reducing formation of micronucleus and also it accelerated bone marrow repopulation. Furthermore, it reduced micronucleus frequency in peripheral blood (27 +/- 8 vs. 149 +/- 22, in 1,000 erythrocytes, P<0.01). JNJ7777120 completely reversed radiation-induced reduced salivation, conserving glandular mass with normal histological appearance and reducing apoptosis and atrophy of SMG. JNJ7777120 exhibits radioprotective effects against radiation-induced cytotoxic and genotoxic damages in small intestine, SMG and hematopoietic tissues and, thus, could be of clinical value for patients undergoing radiotherapy.	[Martinel Lamas, Diego J.; Carabajal, Eliana; Bergoc, Rosa M.; Rivera, Elena S.; Medina, Vanina A.] Univ Buenos Aires, Sch Pharm & Biochem, Lab Radioisotopes, Buenos Aires, DF, Argentina; [Carabajal, Eliana] Patagon Natl Ctr CONICET, Chubut, Argentina; [Prestifilippo, Juan P.; Elverdin, Juan C.] Univ Buenos Aires, Sch Dent, Dept Physiol, Buenos Aires, DF, Argentina; [Rossi, Luis; Merani, Susana] Univ Buenos Aires, Sch Med, Ctr Res Reprod, Buenos Aires, DF, Argentina; [Merani, Susana; Medina, Vanina A.] Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Medina, VA (corresponding author), Univ Buenos Aires, Sch Pharm & Biochem, Lab Radioisotopes, Buenos Aires, DF, Argentina.	vmedina@ffyb.uba.ar		Rossi, Luis F./0000-0003-4711-8500; Medina, Vanina/0000-0002-7767-0729	University of Buenos Aires [20020110200253, 20020100100270]; CONICET [PIP 11220110101121]; EU-FP7 COST Action [BM0806]	University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); EU-FP7 COST Action	This work has been supported by grants from the University of Buenos Aires, 20020110200253, 20020100100270, CONICET (PIP 11220110101121), and from the EU-FP7 COST Action BM0806 (Recent advances in histamine receptor H4R research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpolat M, 2009, ARCH TOXICOL, V83, P609, DOI 10.1007/s00204-008-0352-4; Beck PL, 2004, GASTROENTEROLOGY, V126, P796, DOI 10.1053/j.gastro.2003.12.004; Borda E, 2002, MEDIAT INFLAMM, V11, P337, DOI 10.1080/0962935021000051520; Carabajal E, 2012, EUR J HISTOCHEM, V56, P302, DOI 10.4081/ejh.2012.e48; Castro I, 2013, AUTOIMMUN REV, V12, P567, DOI 10.1016/j.autrev.2012.10.018; CHAUBEY RC, 1993, INT J RADIAT BIOL, V63, P239, DOI 10.1080/09553009314550311; De la Cal C, 2012, OPEN DENT J, V6, P8, DOI 10.2174/1874210601206010008; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fliedner TM, 2002, CANCER BIOTHER RADIO, V17, P405, DOI 10.1089/108497802760363204; Gresz V, 2004, AM J PHYSIOL-GASTR L, V287, pG151, DOI 10.1152/ajpgi.00480.2003; Hall EJ, 2006, RADIOBIOLOGY RADIOBI, p[129, 303]; Koukourakis MI, 2012, BRIT J RADIOL, V85, P313, DOI 10.1259/bjr/16386034; Lee HJ, 2006, AM J PATHOL, V169, P1601, DOI 10.2353/ajpath.2006.060327; Leurs R, 2009, BRIT J PHARMACOL, V157, P14, DOI 10.1111/j.1476-5381.2009.00250.x; Li ZM, 2006, RADIAT RES, V165, P678, DOI 10.1667/RR3569.1; Massari NA, 2011, MELANOMA RES, V21, P395, DOI 10.1097/CMR.0b013e328347ee53; Medina V, 2006, CANCER BIOL THER, V5, P1462, DOI 10.4161/cbt.5.11.3273; Medina VA, 2007, INT J RADIAT BIOL, V83, P653, DOI 10.1080/09553000701570238; Medina Vanina A, 2011, Front Biosci (Elite Ed), V3, P1042; Medina VA, 2011, INT J RADIAT BIOL, V87, P284, DOI 10.3109/09553002.2010.533247; Medina VA, 2010, BRIT J PHARMACOL, V161, P755, DOI 10.1111/j.1476-5381.2010.00961.x; Medina VA, 2010, INT J RADIAT BIOL, V86, P283, DOI 10.3109/09553000903564067; Pinto MMPD, 2010, RADIAT ENVIRON BIOPH, V49, P567, DOI 10.1007/s00411-010-0311-3; Rosethorne EM, 2011, MOL PHARMACOL, V79, P749, DOI 10.1124/mol.110.068395; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; Seifert R, 2011, MOL PHARMACOL, V79, P631, DOI 10.1124/mol.111.071266; Stegaev V, 2012, ARTHRITIS RHEUM-US, V64, P2663, DOI 10.1002/art.34484; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Vanhauwaert A, 2001, MUTAGENESIS, V16, P39, DOI 10.1093/mutage/16.1.39; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1	30	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69106	10.1371/journal.pone.0069106	http://dx.doi.org/10.1371/journal.pone.0069106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922686	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900024
J	Watts, P; Phillips, G; Petticrew, M; Hayes, R; Bottomley, C; Yu, G; Schmidt, E; Tobi, P; Moore, D; Frostick, C; Lock, K; Renton, A				Watts, Paul; Phillips, Gemma; Petticrew, Mark; Hayes, Richard; Bottomley, Christian; Yu, Ge; Schmidt, Elena; Tobi, Patrick; Moore, Derek; Frostick, Caroline; Lock, Karen; Renton, Adrian			Physical Activity in Deprived Communities in London: Examining Individual and Neighbourhood-Level Factors	PLOS ONE			English	Article							ENVIRONMENTAL DETERMINANTS; ACTIVITY QUESTIONNAIRE; ADULTS PARTICIPATION; LOGISTIC-REGRESSION; HEALTH; RELIABILITY; BOUNDARIES; EUROQOL; WALKING; AUDIT	Introduction: The objectives of this study were to examine relationships between neighbourhood-level and individual-level characteristics and physical activity in deprived London neighbourhoods. Methods: In 40 of the most deprived neighbourhoods in London (ranked in top 11% in London by Index of Multiple Deprivation) a cross-sectional survey (n = 4107 adults aged >= 16 years), neighbourhood audit tool, GIS measures and routine data measured neighbourhood and individual-level characteristics. The binary outcome was meeting the minimum recommended (CMO, UK) 5x30 mins moderate physical activity per week. Multilevel modelling was used to examine associations between physical activity and individual and neighbourhood-level characteristics. Results: Respondents living more than 300 m away from accessible greenspace had lower odds of achieving recommended physical activity levels than those who lived within 300 m; from 301-600 m (OR = 0.7; 95% CI 0.5-0.9) and from 601-900 m (OR = 0.6; 95% CI 0.4-0.8). There was substantial residual between-neighbourhood variance in physical activity (median odds ratio = 1.7). Other objectively measured neighbourhood-level characteristics were not associated with physical activity levels. Conclusions: Distance to nearest greenspace is associated with meeting recommended physical activity levels in deprived London neighbourhoods. Despite residual variance in physical activity levels between neighbourhoods, we found little evidence for the influence of other measured neighbourhood-level characteristics.	[Watts, Paul; Tobi, Patrick; Renton, Adrian] Univ E London, Inst Hlth & Human Dev, London E15 4LZ, England; [Phillips, Gemma; Lock, Karen] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Petticrew, Mark] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Hayes, Richard; Bottomley, Christian] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, Trop Epidemiol Grp, London WC1, England; [Yu, Ge] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Schmidt, Elena] Sightsavers, Haywards Heath, W Sussex, England; [Moore, Derek; Frostick, Caroline] Univ E London, Inst Res Child Dev, London E15 4LZ, England	University of East London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Leeds; University of East London	Watts, P (corresponding author), Univ E London, Inst Hlth & Human Dev, London E15 4LZ, England.	p.n.watts@uel.ac.uk	Watts, Paul/N-6930-2016; Yu, Ge/J-6246-2019; Petticrew, Mark/AAY-6274-2021	Yu, Ge/0000-0002-0891-2501; Bottomley, Christian/0000-0002-5241-8412; Hayes, Richard/0000-0002-1729-9892; Watts, Paul/0000-0003-1754-4031; Moore, Derek/0000-0003-3496-0846	Wellcome Trust [083679/Z/07/Z]; Big Lottery; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish; National Institute for Health Research [PDF/01/2008/031] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Big Lottery; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The Well London programme is funded by the Wellcome Trust, grant number 083679/Z/07/Z and the Big Lottery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman A.E., 2007, ENV CORRELATES PHYS; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Boarnet MG, 2006, AM J PREV MED, V30, P153, DOI 10.1016/j.amepre.2005.09.018; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Campbell E, 2009, J URBAN AFF, V31, P461, DOI 10.1111/j.1467-9906.2009.00450.x; Cerin E, 2009, PUBLIC HEALTH NUTR, V12, P1182, DOI 10.1017/S1368980008003649; Chief Medical Officers, 2011, START ACT STAY ACT R; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Clapp JM, 2006, J URBAN ECON, V59, P259, DOI 10.1016/j.jue.2005.10.003; Clifton KJ, 2007, LANDSCAPE URBAN PLAN, V80, P95, DOI 10.1016/j.landurbplan.2006.06.008; Cochrane T, 2010, SMALL AREA INDIVIDUA; Coombes E, 2010, SOC SCI MED, V70, P816, DOI 10.1016/j.socscimed.2009.11.020; Coulson JC, 2011, HEALTH PLACE, V17, P300, DOI 10.1016/j.healthplace.2010.11.003; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Department of Health, 2009, HLTH SURV ENGL 2008; Ding D, 2011, HLTH PLACE; Government Department for Culture and Leisure, 2008, ENGLISH INDICES DEPR; Green H., 2003, SOCIAL CAPITAL HARMO; Harper R, 2003, MEASURING SOCIAL CAP; Hillsdon M., 2004, EFFECTIVENESS PUBLIC; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Lachowycz K, 2011, OBESITY REV; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Neighbourhood Renewal Unit, 2004, ENGL IND DEPR 2004 S; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Pikora T, 2003, SOC SCI MED, V56, P1693, DOI 10.1016/S0277-9536(02)00163-6; Pikora TJ, 2002, AM J PREV MED, V23, P187, DOI 10.1016/S0749-3797(02)00498-1; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Royston P, 2009, STATA J, V9, P13; Royston P, 2005, STATA J, V5, P10; Royston P, 2009, STATA J, V9, P33; Royston P, 2005, STATA J, V5, P14; Royston P, 2004, STATA J, V4, P15; Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103; Smith GR, 2009, SOCIOECOLOGICAL MAPP; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Spence JC, 2003, PSYCHOL SPORT EXERC, V4, P7, DOI 10.1016/S1469-0292(02)00014-6; Sport England, 2012, SPORT ENGL; Taylor BT, 2011, AM J PREV MED, V40, P105, DOI 10.1016/j.amepre.2010.10.024; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; VANAGT HME, 1994, SOC SCI MED, V39, P1537, DOI 10.1016/0277-9536(94)90005-1; Wall M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-207; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Weiss L, 2007, AM J PREV MED, V32, pS154, DOI 10.1016/j.amepre.2007.02.034; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yu G, 2011, HLTH PLACE	52	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69472	10.1371/journal.pone.0069472	http://dx.doi.org/10.1371/journal.pone.0069472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922717	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000322838900044
J	Valind, A; Jin, YS; Gisselsson, D				Valind, Anders; Jin, Yuesheng; Gisselsson, David			Elevated Tolerance to Aneuploidy in Cancer Cells: Estimating the Fitness Effects of Chromosome Number Alterations by In Silico Modelling of Somatic Genome Evolution	PLOS ONE			English	Article							TELOMERE DYSFUNCTION; SITU HYBRIDIZATION; HUMAN BRAIN; DNA-DAMAGE; INSTABILITY; SEGREGATION; ABERRATIONS; MECHANISM; TUMORS; LINES	An unbalanced chromosome number (aneuploidy) is present in most malignant tumours and has been attributed to mitotic mis-segregation of chromosomes. However, recent studies have shown a relatively high rate of chromosomal mis-segregation also in non-neoplastic human cells, while the frequency of aneuploid cells remains low throughout life in most normal tissues. This implies that newly formed aneuploid cells are subject to negative selection in healthy tissues and that attenuation of this selection could contribute to aneuploidy in cancer. To test this, we modelled cellular growth as discrete time branching processes, during which chromosome gains and losses were generated and their host cells subjected to selection pressures of various magnitudes. We then assessed experimentally the frequency of chromosomal mis-segregation as well as the prevalence of aneuploid cells in human non-neoplastic cells and in cancer cells. Integrating these data into our models allowed estimation of the fitness reduction resulting from a single chromosome copy number change to an average of approximate to 30% in normal cells. In comparison, cancer cells showed an average fitness reduction of only 6% (p = 0.0008), indicative of aneuploidy tolerance. Simulations based on the combined presence of chromosomal mis-segregation and aneuploidy tolerance reproduced distributions of chromosome aberrations in >400 cancer cases with higher fidelity than models based on chromosomal mis-segregation alone. Reverse engineering of aneuploid cancer cell development in silico predicted that aneuploidy intolerance is a stronger limiting factor for clonal expansion of aneuploid cells than chromosomal mis-segregation rate. In conclusion, our findings indicate that not only an elevated chromosomal mis-segregation rate, but also a generalised tolerance to novel chromosomal imbalances contribute to the genomic landscape of human tumours.	[Gisselsson, David] Lund Univ, Dept Clin Genet, Lund, Sweden; Skane Reg & Univ Labs, Lund, Sweden	Lund University	Gisselsson, D (corresponding author), Lund Univ, Dept Clin Genet, Lund, Sweden.	david.gisselsson_nord@med.lu.se		Gisselsson, David/0000-0002-0301-426X; Valind, Anders/0000-0002-1654-6978	Swedish Childhood Cancer Foundation; Swedish Cancer Society; Swedish Research Council; Gunnar Nilsson Cancer Foundation; BioCare Strategic Research Programme	Swedish Childhood Cancer Foundation(European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson Cancer Foundation; BioCare Strategic Research Programme	Funding: Swedish Childhood Cancer Foundation, Swedish Cancer Society, Swedish Research Council, Gunnar Nilsson Cancer Foundation, and the BioCare Strategic Research Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami J, 2003, INT J CANCER, V107, P365, DOI 10.1002/ijc.11429; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Aviv H, 2001, ATHEROSCLEROSIS, V159, P281, DOI 10.1016/S0021-9150(01)00506-8; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Cimini D, 1999, MUTAGENESIS, V14, P563, DOI 10.1093/mutage/14.6.563; DREWINKO B, 1976, CANCER RES, V36, P467; Duncan AW, 2012, J CLIN INVEST, V122, P3307, DOI 10.1172/JCI64026; Duncan AW, 2012, GASTROENTEROLOGY, V142, P25, DOI 10.1053/j.gastro.2011.10.029; Frigyesi A, 2003, CANCER RES, V63, P7094; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Gisselsson David, 2001, Methods in Cell Science, V23, P23, DOI 10.1023/A:1013129212367; Gisselsson D, 2010, P NATL ACAD SCI USA, V107, P20489, DOI 10.1073/pnas.1006829107; GUTTENBACH M, 1995, AM J HUM GENET, V57, P1143; Hoglund M, 2005, GENE CHROMOSOME CANC, V42, P327, DOI 10.1002/gcc.20143; Hoglund M, 2002, CANCER RES, V62, P5939; Hoglund M, 2002, CANCER RES, V62, P2675; Iourov IY, 2009, NEUROBIOL DIS, V34, P212, DOI 10.1016/j.nbd.2009.01.003; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Li M, 2005, FERTIL STERIL, V84, P1395, DOI 10.1016/j.fertnstert.2005.04.068; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Masramon L, 2000, CANCER GENET CYTOGEN, V121, P17, DOI 10.1016/S0165-4608(00)00219-3; Melcher R, 2002, CYTOGENET GENOME RES, V98, P22, DOI 10.1159/000068544; MUKHERJEE AB, 1995, MECH AGEING DEV, V80, P11, DOI 10.1016/0047-6374(94)01544-V; Mukherjee AB, 1997, EXP CELL RES, V235, P161, DOI 10.1006/excr.1997.3673; Munne S, 2005, FERTIL STERIL, V84, P1328, DOI 10.1016/j.fertnstert.2005.06.025; NEURATH P, 1970, NATURE, V225, P281, DOI 10.1038/225281a0; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Peterson SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023018; PETERSSON H, 1985, HEREDITAS, V102, P33, DOI 10.1111/j.1601-5223.1985.tb00462.x; Sheltzer JM, 2011, TRENDS GENET, V27, P446, DOI 10.1016/j.tig.2011.07.003; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Stewenius Y, 2007, CLIN CANCER RES, V13, P6593, DOI 10.1158/1078-0432.CCR-07-1081; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Tomlinson I, 1999, NAT MED, V5, P11, DOI 10.1038/4687; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Tsushimi T, 2001, CANCER GENET CYTOGEN, V126, P34, DOI 10.1016/S0165-4608(00)00391-5; Upender MB, 2004, CANCER RES, V64, P6941, DOI 10.1158/0008-5472.CAN-04-0474; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Westra JW, 2010, J COMP NEUROL, V518, P3981, DOI 10.1002/cne.22436; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Yuen RKC, 2011, PLACENTA, V32, pS136, DOI 10.1016/j.placenta.2011.01.003; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558; Zhu J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002719	50	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70445	10.1371/journal.pone.0070445	http://dx.doi.org/10.1371/journal.pone.0070445			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894657	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900128
J	Serres, E; Debarbieux, F; Stanchi, F; Maggiorella, L; Grall, D; Turchi, L; Burel-Vandenbos, F; Figarella-Branger, D; Virolle, T; Rougon, G; Van Obberghen-Schilling, E				Serres, E.; Debarbieux, F.; Stanchi, F.; Maggiorella, L.; Grall, D.; Turchi, L.; Burel-Vandenbos, F.; Figarella-Branger, D.; Virolle, T.; Rougon, G.; Van Obberghen-Schilling, E.			Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice	ONCOGENE			English	Article						extracellular matrix; adhesion; glioma; migration; angiogenesis	EXTRACELLULAR-MATRIX COMPONENTS; STEM-LIKE CELLS; VASCULOGENIC MIMICRY; ENDOTHELIAL-CELLS; GENE-EXPRESSION; MALIGNANT GLIOMAS; ASTROCYTOMA; VIVO; ALPHA-5-BETA-1; SPHEROIDS	Glioblastoma multiforme (GBM) are highly invasive and angiogenic malignancies with a median survival time from diagnosis of <15 months. Previous work has revealed robust overexpression of fibronectin (FN) mRNA in GBM, although immunohistochemical staining of FN in these tumors is typically associated with the angiogenic vasculature. Here we sought to examine the expression of tumor cell FN and address its possible involvement in the invasive phenotype of GBM. We found that FN was expressed and assembled into fibrillar arrays in human tumors and in established GBM lines. Cultured cells spontaneously formed dense cellular networks and spheroid-like domes. Depletion of FN by targeted-short hairpin RNA expression disrupted matrix assembly and multicellular network organization by exerting profound effects on cell adhesion and motility. Although FN depletion enhanced persistent directional migration of single cells, it compromised collective invasion of spheroids through a laminin-rich matrix and sensitized cells to ionizing radiation. In orthotopic grafts, FN depletion significantly reduced tumor growth and angiogenesis. Together our results show that FN produced by the tumor cells has a role in GBM pathophysiology and they provide insights into the implications that targeting FN interactions may have for combating this dreaded disease.	[Serres, E.; Maggiorella, L.; Grall, D.; Turchi, L.; Burel-Vandenbos, F.; Virolle, T.; Van Obberghen-Schilling, E.] Univ Nice Sophia Antipolis, F-06108 Nice 2, France; [Serres, E.; Grall, D.; Turchi, L.; Burel-Vandenbos, F.; Virolle, T.; Van Obberghen-Schilling, E.] Fac Med Nice, INSERM, Inst Biol Valrose, CNRS,UMR7277,U1091, F-06034 Nice, France; [Debarbieux, F.; Stanchi, F.; Rougon, G.] Aix Marseille Univ, IBDML, CNRS, UMR7288, Marseille, France; [Burel-Vandenbos, F.] CHU Nice, Hop Pasteur, Serv Anatomopathol, F-06202 Nice, France; [Figarella-Branger, D.] Aix Marseille Univ, INSERM, UMR911, Marseille, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Van Obberghen-Schilling, E (corresponding author), Univ Nice Sophia Antipolis, CNRS, IBV, UMR7277,INSERM,U1091,UNS, Parc Valrose, F-06108 Nice 2, France.	vanobber@unice.fr	Van Obberghen-Schilling, Ellen/Q-4372-2019; Virolle, Thierry/E-5838-2016; Van Obberghen-Schilling, Ellen/O-1581-2016	Van Obberghen-Schilling, Ellen/0000-0003-2961-0059; Van Obberghen-Schilling, Ellen/0000-0003-2961-0059; Stanchi, Fabio/0000-0003-3393-2472; Turchi, Laurent/0000-0003-2020-5831; ROUGON, Genevieve/0000-0003-1316-8200	French National Institute of Cancer (INCa) [RS018]; French Association of Cancer Research (ARC) [4965, 5095]; National Agency for Research (JCC PathoVisu3dyn); Fondation de Recherche sur le Cerveau; Canceropole PACA; l'Agence Nationale pour la Recherche (ANR, Jeunes Chercheurs, 'GLIOMIRSTEM')	French National Institute of Cancer (INCa)(Institut National du Cancer (INCA) France); French Association of Cancer Research (ARC); National Agency for Research (JCC PathoVisu3dyn)(French National Research Agency (ANR)); Fondation de Recherche sur le Cerveau; Canceropole PACA(Region Grand-Est); l'Agence Nationale pour la Recherche (ANR, Jeunes Chercheurs, 'GLIOMIRSTEM')(French National Research Agency (ANR))	We thank Jean-Francois Michiels and Philippe Paquis (Pathology and Neurosurgery Departments of the Nice CHU) for their collaboration. We also thank Botond Cseh, Nathalie Baeza-Kallee, Clement Ricard, Sandeep Gopal and Juliette Thariat for valuable discussions, cell lines, help with intracranial xenograft experiments and statistical analyses. Patrick Stern and Richard Hynes are kindly acknowledged for providing the lentiviral vector, Aurelie Rossin for assistance with cytometry, Sebastien Schaub (PRISM Platform, CNRS-UMR6543) and the PICSIL Platform (CNRS-6216) for expert help with image analyses. Serge Marcie and Jean-Louis Fischel (Centre A. Lacassagnc) are gratefully acknowledged for helping with irradiation experiments, and Arnaud Borderie, Sandrine Destree, Coralie Hagnere et Berengere Szczepaniak for immunohistochemistry. Financial support for this work was provided by the French National Institute of Cancer (INCa, RS018), the French Association of Cancer Research (ARC 4965 to EVO-S and 5095 to GB), the National Agency for Research (JCC PathoVisu3dyn to FD), la Fondation de Recherche sur le Cerveau to FD, Canceropole PACA and l'Agence Nationale pour la Recherche (ANR Jeunes Chercheurs, 'GLIOMIRSTEM' to TV).	Argyriou AA, 2009, CRIT REV ONCOL HEMAT, V69, P199, DOI 10.1016/j.critrevonc.2008.05.005; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; BERNSTEIN JJ, 1995, NEUROSURGERY, V36, P124, DOI 10.1227/00006123-199501000-00016; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Burden-Gulley SM, CANC RES, V71, P5932; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Castellani P, 2002, AM J PATHOL, V161, P1695, DOI 10.1016/S0002-9440(10)64446-X; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Colin C, 2006, ONCOGENE, V25, P2818, DOI 10.1038/sj.onc.1209305; Cseh B, 2010, J CELL SCI, V123, P3989, DOI 10.1242/jcs.073346; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Farber K, 2008, MOL CELL NEUROSCI, V39, P579, DOI 10.1016/j.mcn.2008.08.005; Friedlander DR, 1996, CANCER RES, V56, P1939; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Lal A, 1999, CANCER RES, V59, P5403; Maglott A, 2006, CANCER RES, V66, P6002, DOI 10.1158/0008-5472.CAN-05-4105; Mahesparan R, 2003, ACTA NEUROPATHOL, V105, P49, DOI 10.1007/s00401-002-0610-0; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Martinkova E, 2010, INT J CANCER, V127, P1240, DOI 10.1002/ijc.25187; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Ohnishi T, 1997, CLIN EXP METASTAS, V15, P538, DOI 10.1023/A:1018422926361; Ohnishi T, 1998, CLIN EXP METASTAS, V16, P729, DOI 10.1023/A:1006532812408; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Ricard C, 2013, PLOS ONE IN PRESS; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Salmenpera P, 2008, EXP CELL RES, V314, P3444, DOI 10.1016/j.yexcr.2008.09.004; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Spencer VA, 2010, J MAMMARY GLAND BIOL, V15, P65, DOI 10.1007/s10911-010-9163-3; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Tabatabai G, 2010, TARGET ONCOL, V5, P175, DOI 10.1007/s11523-010-0156-3; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; VENSTROM KA, 1993, FASEB J, V7, P996, DOI 10.1096/fasebj.7.11.8370483; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vouret-Craviari V, 2004, J CELL SCI, V117, P4559, DOI 10.1242/jcs.01331; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Yue WY, 2005, J HISTOCHEM CYTOCHEM, V53, P997, DOI 10.1369/jhc.4A6521.2005; Zamecnik J, 2005, ACTA NEUROPATHOL, V110, P435, DOI 10.1007/s00401-005-1078-5	44	93	93	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 26	2014	33	26					3451	3462		10.1038/onc.2013.305	http://dx.doi.org/10.1038/onc.2013.305			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK9WM	23912459				2022-12-25	WOS:000338779300012
J	Stura, EA; Visse, R; Cuniasse, P; Dive, V; Nagase, H				Stura, Enrico A.; Visse, Robert; Cuniasse, Philippe; Dive, Vincent; Nagase, Hideaki			Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain	FASEB JOURNAL			English	Article						matrix metalloproteinases; collagen; substrate binding; X-ray crystallography; extracellular matrix	C-TERMINAL DOMAIN; X-RAY-STRUCTURE; MATRIX METALLOPROTEINASES; BINDING; ACTIVATION; MECHANISM; SIZE; SEDIMENTATION; FLEXIBILITY; SPECIFICITY	Matrix metalloproteinase (MMP)-13 is one of the mammalian collagenases that play key roles in tissue remodelling and repair and in progression of diseases such as cancer, arthritis, atherosclerosis, and aneurysm. For collagenase to cleave triple helical collagens, the triple helical structure has to be locally unwound before hydrolysis, but this process is not well understood. We report crystal structures of catalytically inactive full-length human MMP-13(E223A) in complex with peptides of 14-26 aa derived from the cleaved prodomain during activation. Peptides are bound to the active site of the enzyme by forming an extended -strand with Glu(40) or Tyr(46) inserted into the S-1 specificity pocket. The structure of the N-terminal part of the peptides is variable and interacts with different parts of the catalytic domain. Those areas are designated substrate-dependent exosites, in that they accommodate different peptide structures, whereas the precise positioning of the substrate backbone is maintained in the active site. These modes of peptide-MMP-13 interactions have led us to propose how triple helical collagen strands fit into the active site cleft of the collagenase.Stura, E. A., Visse, R., Cuniasse, P., Dive, V., Nagase, H. Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.	[Stura, Enrico A.; Cuniasse, Philippe; Dive, Vincent] Commissariat Energie Atom & Energies Alternat CEA, Serv Ingn Mol Prot, Gif Sur Yvette, France; [Visse, Robert; Nagase, Hideaki] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7FY, England	CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Nagase, H (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Roosevelt Dr, Oxford OX3 7FY, England.	vincent.dive@cea.fr; hideaki.nagase@kennedy.ox.ac.uk	STURA, Enrico/A-2793-2010	STURA, Enrico/0000-0001-6718-2118	Wellcome Trust [075473]; Arthritis Research UK; U.S. National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Disease (NIH/NIAMS) [AR40994]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); U.S. National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Disease (NIH/NIAMS); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Noriko Itoh for construction of the MMP-13(E223A) expression vector; Alan Lyons and Toyoko Nakamura for help in expressing and purifying the protein; Laura Vera for efforts with cryoprotection to improve data quality; the European Synchrotron Radiation Facility (ESRF; Grenoble, France) and Soleil for beam time; and Drs. Andrew McCarthy on line ID14-4, Max Nanao on line ID23-2; and Andrew Thomson on Proxima 1 for assistance with the synchrotron experiments. This work was supported by the Wellcome Trust (grant 075473), Arthritis Research UK, and the U.S. National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Disease (NIH/NIAMS; grant AR40994; R. V. and H.N.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Deng SJ, 2000, J BIOL CHEM, V275, P31422, DOI 10.1074/jbc.M004538200; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fulcher YG, 2011, BIOCHEMISTRY-US, V50, P9488, DOI 10.1021/bi2009807; Gall AL, 2001, J MOL BIOL, V307, P577, DOI 10.1006/jmbi.2001.4493; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; GRAMS F, 1995, EUR J BIOCHEM, V228, P830, DOI 10.1111/j.1432-1033.1995.tb20329.x; Hashimoto H, 2011, J BIOL CHEM, V286, P33236, DOI 10.1074/jbc.M111.264176; Hiller O, 2000, J BIOL CHEM, V275, P33008, DOI 10.1074/jbc.M001836200; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Lu K. G., 2013, J MOL BIOL; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; Nagase H, 1997, BIOL CHEM, V378, P151; Nagase H, 2011, BIOL EXTRACELL MATR, P95, DOI 10.1007/978-3-642-16861-1_5; Nerenberg PS, 2008, J MOL BIOL, V382, P246, DOI 10.1016/j.jmb.2008.07.009; Newman J, 2004, ACTA CRYSTALLOGR D, V60, P610, DOI 10.1107/S0907444903029640; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pendas AM, 2000, CLIN CHIM ACTA, V291, P137, DOI 10.1016/S0009-8981(99)00225-9; REINEMER P, 1994, FEBS LETT, V338, P227, DOI 10.1016/0014-5793(94)80370-6; Robichaud TK, 2011, J BIOL CHEM, V286, P37535, DOI 10.1074/jbc.M111.273391; Salsas-Escat R, 2010, BIOCHEMISTRY-US, V49, P4147, DOI 10.1021/bi9021473; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; STURA EA, 1999, PRACT APPROACH SER, V210, P177; Takaishi H, 2008, CURR PHARM BIOTECHNO, V9, P47, DOI 10.2174/138920108783497659; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vera L., 2013, CRYST GROWTH DES, DOI 10.1021/cg301531f; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Woessner JF, 1998, BIOL EXTRAC, P1; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 	62	26	28	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4395	4405		10.1096/fj.13-233601	http://dx.doi.org/10.1096/fj.13-233601			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23913860	Green Published			2022-12-25	WOS:000329937500008
J	Croft, W; Hill, C; McCann, E; Bond, M; Esparza-Franco, M; Bennett, J; Rand, D; Davey, J; Ladds, G				Croft, Wayne; Hill, Claire; McCann, Eilish; Bond, Michael; Esparza-Franco, Manuel; Bennett, Jeannette; Rand, David; Davey, John; Ladds, Graham			A Physiologically Required G Protein-coupled Receptor (GPCR)-Regulator of G Protein Signaling (RGS) Interaction That Compartmentalizes RGS Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PLASMA-MEMBRANE; DEP-DOMAIN; P-FACTOR; PHEROMONE; REGULATORS; EXPRESSION; PALMITOYLATION; IDENTIFICATION; TRANSLOCATION	G protein-coupled receptors (GPCRs) can interact with regulator of G protein signaling (RGS) proteins. However, the effects of such interactions on signal transduction and their physiological relevance have been largely undetermined. Ligand-bound GPCRs initiate by promoting exchange of GDP for GTP on the G alpha subunit of heterotrimeric G proteins. Signaling is terminated by hydrolysis of GTP to GDP through intrinsic GTPase activity of the G alpha subunit, a reaction catalyzed by RGS proteins. Using yeast as a tool to study GPCR signaling in isolation, we define an interaction between the cognate GPCR (Mam2) and RGS (Rgs1), mapping the interaction domains. This reaction tethers Rgs1 at the plasma membrane and is essential for physiological signaling response. In vivo quantitative data inform the development of a kinetic model of the GTPase cycle, which extends previous attempts by including GPCR-RGS interactions. In vivo and in silico data confirm that GPCR-RGS interactions can impose an additional layer of regulation through mediating RGS subcellular localization to compartmentalize RGS activity within a cell, thus highlighting their importance as potential targets to modulate GPCR signaling pathways.	[Croft, Wayne; McCann, Eilish; Bond, Michael; Bennett, Jeannette; Davey, John; Ladds, Graham] Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England; [Hill, Claire] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Esparza-Franco, Manuel; Rand, David] Univ Warwick, Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick; University of Warwick	Ladds, G (corresponding author), Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England.	Graham.Ladds@warwick.ac.uk	Rand, David A/J-9085-2012	Rand, David A/0000-0002-2217-3274; Ladds, Graham/0000-0001-7320-9612	Warwick Postgraduate Research Scholarship; University Hospitals of Coventry and Warwickshire National Health Service Trust; Biotechnology and Biological Sciences Research Council [BB/G01227X/1]; Birmingham Science City Research Alliance; BBSRC [BB/G01227X/1] Funding Source: UKRI	Warwick Postgraduate Research Scholarship; University Hospitals of Coventry and Warwickshire National Health Service Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Birmingham Science City Research Alliance; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Warwick Postgraduate Research Scholarship (to M. B.), the University Hospitals of Coventry and Warwickshire National Health Service Trust (to G. L.), Biotechnology and Biological Sciences Research Council Grant BB/G01227X/1 (to W.C., J.B., and G.L.), and the Birmingham Science City Research Alliance (to G.L.).	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; Chen SH, 2006, DEV CELL, V11, P436, DOI 10.1016/j.devcel.2006.09.011; DAVEY J, 1995, METH MOL G, V6, P247, DOI DOI 10.1016/S1067-2389(06)80016-6; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; Didmon M, 2002, CURR GENET, V41, P241, DOI 10.1007/s00294-002-0301-3; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Druey KM, 1998, J BIOL CHEM, V273, P18405, DOI 10.1074/jbc.273.29.18405; Dulin NO, 1999, MOL CELL BIOL, V19, P714; Elliott CM, 2012, J R SOC INTERFACE, V9, P3027, DOI 10.1098/rsif.2012.0276; Faurobert E, 1997, P NATL ACAD SCI USA, V94, P2945, DOI 10.1073/pnas.94.7.2945; Garzon J, 2004, NEUROPSYCHOPHARMACOL, V29, P1091, DOI 10.1038/sj.npp.1300408; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hepler JR, 2003, MOL PHARMACOL, V64, P547, DOI 10.1124/mol.64.3.547; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Hill C, 2008, CELL SIGNAL, V20, P323, DOI 10.1016/j.cellsig.2007.10.016; Hoffman CS, 2005, EUKARYOT CELL, V4, P495, DOI 10.1128/EC.4.3.495-503.2005; IMAI Y, 1991, MOL CELL BIOL, V11, P3088, DOI 10.1128/MCB.11.6.3088; IMAI Y, 1992, MOL CELL BIOL, V12, P1827, DOI 10.1128/MCB.12.4.1827; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Kofahl B, 2004, YEAST, V21, P831, DOI 10.1002/yea.1122; Ladds G, 2000, MOL MICROBIOL, V37, P606, DOI 10.1046/j.1365-2958.2000.02028.x; Ladds G, 2005, MOL MICROBIOL, V55, P482, DOI 10.1111/j.1365-2958.2004.04394.x; Ladds G, 1996, MOL MICROBIOL, V20, P35, DOI 10.1111/j.1365-2958.1996.tb02486.x; Ladds G, 2000, MOL MICROBIOL, V36, P377, DOI 10.1046/j.1365-2958.2000.01855.x; Ladds G, 2004, CURR OPIN DRUG DISC, V7, P683; Ladds G, 2003, MOL MICROBIOL, V47, P781, DOI 10.1046/j.1365-2958.2003.03336.x; Ladds G, 2007, CELL SIGNAL, V19, P103, DOI 10.1016/j.cellsig.2006.05.027; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Milligan G, 1998, TRENDS ENDOCRIN MET, V9, P13, DOI 10.1016/S1043-2760(98)00004-6; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; ONARAN HO, 1993, MOL PHARMACOL, V43, P245; Pereira PS, 2001, GENES CELLS, V6, P789, DOI 10.1046/j.1365-2443.2001.00465.x; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Sayar K, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-23; Sethakorn N, 2010, CELL SIGNAL, V22, P1274, DOI 10.1016/j.cellsig.2010.03.016; Sjogren B, 2010, MOL PHARMACOL, V78, P550, DOI 10.1124/mol.110.065219; Smith B, 2009, CELL SIGNAL, V21, P1151, DOI 10.1016/j.cellsig.2009.03.004; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Turner EM, 2012, ACS MED CHEM LETT, V3, P146, DOI 10.1021/ml200263y; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Xue-Franzen YT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-303; Yildirim N, 2004, METHOD ENZYMOL, V389, P383; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	63	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27327	27342		10.1074/jbc.M113.497826	http://dx.doi.org/10.1074/jbc.M113.497826			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23900842	Green Published, hybrid			2022-12-25	WOS:000330597300029
J	Kang, J; Kim, E; Kim, W; Seong, KM; Youn, H; Kim, JW; Kim, J; Youn, B				Kang, JiHoon; Kim, EunGi; Kim, Wanyeon; Seong, Ki Moon; Youn, HyeSook; Kim, Jung Woo; Kim, Joon; Youn, BuHyun			Rhamnetin and Cirsiliol Induce Radiosensitization and Inhibition of Epithelial-Mesenchymal Transition (EMT) by miR-34a-mediated Suppression of Notch-1 Expression in Non-small Cell Lung Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE INHIBITOR; GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; IONIZING-RADIATION; PANCREATIC-CANCER; DOWN-REGULATION; SIGNALING PATHWAY; GENE-EXPRESSION; POOR-PROGNOSIS; NECK-CANCER	Radioresistance is a major cause of decreasing the efficiency of radiotherapy for non-small cell lung cancer (NSCLC). To understand the radioresistance mechanisms in NSCLC, we focused on the radiation-induced Notch-1 signaling pathway involved in critical cell fate decisions by modulating cell proliferation. In this study, we investigated the use of Notch-1-regulating flavonoid compounds as novel therapeutic drugs to regulate radiosensitivity in NSCLC cells, NCI-H1299 and NCI-H460, with different levels of radioresistance. Rhamnetin and cirsiliol were selected as candidate Notch-1-regulating radiosensitizers based on the results of assay screening for activity and pharmacological properties. Treatment with rhamnetin or cirsiliol reduced the proliferation of NSCLC cells through the suppression of radiation-induced Notch-1 expression. Indeed, rhamnetin and cirsiliol increased the expression of tumor-suppressive microRNA, miR-34a, in a p53-dependent manner, leading to inhibition of Notch-1 expression. Consequently, reduced Notch-1 expression promoted apoptosis through significant down-regulation of the nuclear factor-kappa B pathway, resulting in a radiosensitizing effect on NSCLC cells. Irradiation-induced epithelial-mesenchymal transition was also notably attenuated in the presence of rhamnetin and cirsiliol. Moreover, an in vivo xenograft mouse model confirmed the radiosensitizing and epithelial-mesenchymal transition inhibition effects of rhamnetin and cirsiliol we observed in vitro. In these mice, tumor volume was significantly reduced by combinational treatment with irradiation and rhamnetin or cirsiliol compared with irradiation alone. Taken together, our findings provided evidence that rhamnetin and cirsiliol can act as promising radiosensitizers that enhance the radiotherapeutic efficacy by inhibiting radiation-induced Notch-1 signaling associated with radioresistance possibly via miR-34a-mediated pathways.	[Kang, JiHoon; Kim, EunGi; Kim, Wanyeon; Youn, BuHyun] Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea; [Seong, Ki Moon] Korea Hydro & Nucl Power Co Ltd, Div Radiat Effect Res, Radiat Hlth Res Inst, Seoul 132703, South Korea; [Youn, HyeSook] Sejong Univ, Dept Biosci & Biotechnol, Inst Biosci, Seoul 143747, South Korea; [Kim, Jung Woo] Pai Chai Univ, Dept Life Sci & Biotechnol, Taejon 302735, South Korea; [Kim, Joon] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kim, Joon] Korea Univ, BioInst, Seoul 136701, South Korea	Pusan National University; Korea Hydro & Nuclear Power; Sejong University; Pai Chai University; Korea University; Korea University	Youn, B (corresponding author), Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea.	bhyoun72@pusan.ac.kr	Seong, Ki Moon/Y-6083-2019; Kim, EunGi/AAZ-6121-2021		Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2012-0003201]; National R&D Program for Cancer Control; Ministry for Health and Welfare, Republic of Korea [1320100]; Radiation Technology R&D Program through the National Research Foundation of Korea; Ministry of Science, ITC & Future Planning [2013M2A2A7042502]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National R&D Program for Cancer Control(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Radiation Technology R&D Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ITC & Future Planning	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012-0003201), a grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1320100), and the Radiation Technology R&D Program through the National Research Foundation of Korea funded by the Ministry of Science, ITC & Future Planning (2013M2A2A7042502).	Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bauer RA, 2010, CURR OPIN CHEM BIOL, V14, P308, DOI 10.1016/j.cbpa.2010.02.001; Baumann M, 2004, LUNG CANCER, V45, pS187, DOI 10.1016/j.lungcan.2004.07.975; Bianco C, 2002, CLIN CANCER RES, V8, P3250; Buchler P, 2005, ANN SURG, V242, P791, DOI 10.1097/01.sla.0000189115.94847.f1; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen SM, 2011, CANCER LETT, V306, P76, DOI 10.1016/j.canlet.2011.02.034; Chinnaiyan P, 2005, CANCER RES, V65, P3328, DOI 10.1158/0008-5472.CAN-04-3547; Das AK, 2006, CANCER RES, V66, P9601, DOI 10.1158/0008-5472.CAN-06-2627; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greenberger LM, 2008, MOL CANCER THER, V7, P3598, DOI 10.1158/1535-7163.MCT-08-0510; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hillman GG, 2011, RADIOTHER ONCOL, V101, P329, DOI 10.1016/j.radonc.2011.10.020; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jang MS, 2004, J CELL PHYSIOL, V199, P418, DOI 10.1002/jcp.10467; Ji XM, 2012, INT J CANCER, V131, P2668, DOI 10.1002/ijc.27549; Jundt F, 2002, BLOOD, V99, P3398, DOI 10.1182/blood.V99.9.3398; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kashat M, 2012, AM J TRANSL RES, V4, P432; Kawamoto A, 2012, ONCOL REP, V27, P51, DOI 10.3892/or.2011.1485; Keum JS, 1999, BRIT J CANCER, V81, P127, DOI 10.1038/sj.bjc.6690661; Kim W, 2013, PHARMACOL RES, V70, P90, DOI 10.1016/j.phrs.2013.01.005; Kim W, 2011, RADIAT RES, V176, P539, DOI 10.1667/RR2609.1; Kim W, 2010, J RADIAT RES, V51, P285, DOI 10.1269/jrr.09141; Kim WJ, 2012, MOL CELL, V45, P587, DOI 10.1016/j.molcel.2011.12.025; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Koh PK, 2012, CANCER TREAT REV, V38, P626, DOI 10.1016/j.ctrv.2011.11.003; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Li Y, 2010, BIOL-TARGETS THER, V4, P163; Lin JT, 2010, ANN SURG ONCOL, V17, P2976, DOI 10.1245/s10434-010-1118-9; Lin J, 2010, ARCH MED RES, V41, P519, DOI 10.1016/j.arcmed.2010.10.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuno Y, 2012, INT J BIOCHEM CELL B, V44, P776, DOI 10.1016/j.biocel.2012.01.021; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Nishimura Y, 2007, INT J RADIAT ONCOL, V69, P786, DOI 10.1016/j.ijrobp.2007.04.008; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Okuhashi Y, 2011, ANTICANCER RES, V31, P893; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Pan H, 2012, INT J MOL MED, V30, P337, DOI 10.3892/ijmm.2012.990; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Park CC, 2003, P NATL ACAD SCI USA, V100, P10728, DOI 10.1073/pnas.1832185100; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Saad S, 2010, INT J BIOCHEM CELL B, V42, P1115, DOI 10.1016/j.biocel.2010.03.016; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sapra P, 2008, CLIN CANCER RES, V14, P1888, DOI 10.1158/1078-0432.CCR-07-4456; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Seelinger G, 2008, MOLECULES, V13, P2628, DOI 10.3390/molecules13102628; Shohet JM, 2011, CANCER RES, V71, P3841, DOI 10.1158/0008-5472.CAN-10-4391; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Terzuoli E, 2010, CANCER RES, V70, P6837, DOI 10.1158/0008-5472.CAN-10-1075; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Toschi L, 2010, TARGET ONCOL, V5, P5, DOI 10.1007/s11523-010-0132-y; Wang AM, 2009, J CELL BIOCHEM, V106, P682, DOI 10.1002/jcb.22065; Wang M, 2011, CANCER RES, V71, P6261, DOI 10.1158/0008-5472.CAN-11-0213; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059319; Yang HJ, 2011, BIOCHEM PHARMACOL, V82, P524, DOI 10.1016/j.bcp.2011.05.027; Yu SD, 2011, ONCOL REP, V26, P1323, DOI 10.3892/or.2011.1402; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zenz T, 2009, BLOOD, V113, P3801, DOI 10.1182/blood-2008-08-172254; Zhang SL, 2013, J CELL MOL MED, V17, P854, DOI 10.1111/jcmm.12068; Zhao LQ, 2012, CARCINOGENESIS, V33, P2220, DOI 10.1093/carcin/bgs235; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y; Zhu Z, 2009, HEPATOLOGY, V49, P504, DOI 10.1002/hep.22675	83	137	145	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27343	27357		10.1074/jbc.M113.490482	http://dx.doi.org/10.1074/jbc.M113.490482			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23902763	hybrid, Green Published			2022-12-25	WOS:000330597300030
J	Young, HE; Donohue, MP; Smirnova, TI; Smirnov, AI; Zhou, P				Young, Hayley E.; Donohue, Matthew P.; Smirnova, Tatyana I.; Smirnov, Alex I.; Zhou, Pei			The UDP-diacylglucosamine Pyrophosphohydrolase LpxH in Lipid A Biosynthesis Utilizes Mn2+ Cluster for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; Q-BAND EPR; ESCHERICHIA-COLI; PROTEIN PHOSPHATASE; MAGNETIC-PROPERTIES; STRUCTURAL BASIS; SPIN PARAMETERS; ACTIVE-SITES; X-BAND; BINDING	In Escherichia coli and the majority of beta- and gamma-proteobacteria, the fourth step of lipid A biosynthesis, i.e. cleavage of the pyrophosphate group of UDP-2,3-diacyl-GlcN, is carried out by LpxH. LpxH has been previously suggested to contain signature motifs found in the calcineurin-like phosphoesterase (CLP) family of metalloenzymes; however, it cleaves a pyrophosphate bond instead of a phosphoester bond, and its substrate contains nucleoside diphosphate moieties more common to the Nudix family rather than to the CLP family. Furthermore, the extent of biochemical data fails to demonstrate a significant level of metal activation in enzymatic assays, which is inconsistent with the behavior of a metalloenzyme. Here, we report cloning, purification, and detailed enzymatic characterization of Haemophilus influenzae LpxH (HiLpxH). HiLpxH shows over 600-fold stimulation of hydrolase activity in the presence of Mn2+. EPR studies reveal the presence of a Mn2+ cluster in LpxH. Finally, point mutants of residues in the conserved metal-binding motifs of the CLP family greatly inhibit HiLpxH activity, highlighting their importance in enzyme function. Contrary to previous analyses of LpxH, we find HiLpxH does not obey surface dilution kinetics. Overall, our work unambiguously establishes LpxH as a calcineurin-like phosphoesterase containing a Mn2+ cluster coordinated by conserved residues. These results set the scene for further structural investigation of the enzyme and for design of novel antibiotics targeting lipid A biosynthesis.	[Young, Hayley E.; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Donohue, Matthew P.; Smirnova, Tatyana I.; Smirnov, Alex I.] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA	Duke University; University of North Carolina; North Carolina State University	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Smirnov, Alex I/Q-9818-2016; Donohue, Matthew/I-3967-2016; Zhou, Pei/O-6704-2019	Smirnov, Alex I/0000-0002-0037-2555; Donohue, Matthew/0000-0003-4117-0930; Zhou, Pei/0000-0002-7823-3416; Smirnova, Tatyana/0000-0001-7867-7116	National Institutes of Health [DE-FG02-02ER15354]; National Science Foundation [MCB-0451510]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the late Dr. Christian R. H. Raetz for his meaningful contributions to the foundations of this work as well as supportive guidance. Additionally, we thank Dr. Louis Metzger and the members of the Raetz laboratory for helpful discussions. The EPR experiments at North Carolina State University were supported by National Institutes of Health Grant DE-FG02-02ER15354 (to A. I. S.) and National Science Foundation Grant MCB-0451510 (to T. I. S.).	Ago H, 2006, J BIOL CHEM, V281, P16157, DOI 10.1074/jbc.M601089200; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Babinski KJ, 2002, J BIOL CHEM, V277, P25937, DOI 10.1074/jbc.M204067200; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Battistuzzi G, 1997, BIOCHEM J, V323, P593, DOI 10.1042/bj3230593; Blanchard S, 2003, CHEM-EUR J, V9, P4260, DOI 10.1002/chem.200304759; Blanchard S, 2003, INORG CHEM, V42, P4568, DOI 10.1021/ic0301066; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHAKRABORTY P, 1994, POLYHEDRON, V13, P683, DOI 10.1016/S0277-5387(00)84746-4; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; Dismukes GC, 1996, CHEM REV, V96, P2909, DOI 10.1021/cr950053c; Epel B, 2005, J BIOL INORG CHEM, V10, P636, DOI 10.1007/s00775-005-0015-3; Gelasco A, 1997, INORG CHEM, V36, P1829, DOI 10.1021/ic970140i; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Golombek AP, 2003, J MAGN RESON, V165, P33, DOI 10.1016/j.jmr.2003.07.001; Hayden JA, 2010, J BIOL INORG CHEM, V15, P729, DOI 10.1007/s00775-010-0640-3; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Howard T, 2000, INORG CHEM, V39, P3379, DOI 10.1021/ic0000247; KESSISSOGLOU DP, 1987, INORG CHEM, V26, P2487, DOI 10.1021/ic00262a030; KOONIN EV, 1994, PROTEIN SCI, V3, P356; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; MABAD B, 1986, INORG CHEM, V25, P1420, DOI 10.1021/ic00229a025; MATHUR P, 1983, J AM CHEM SOC, V105, P7093, DOI 10.1021/ja00362a012; MATHUR P, 1987, J AM CHEM SOC, V109, P5227, DOI 10.1021/ja00251a030; Metzger LE, 2010, BIOCHEMISTRY-US, V49, P6715, DOI 10.1021/bi1008744; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; Opiyo SO, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-362; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; RADIKA K, 1988, J BIOL CHEM, V263, P14859; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rusnak F, 1999, BIOCHEMISTRY-US, V38, P6943, DOI 10.1021/bi982606u; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Schenk G, 1999, ACTA CRYSTALLOGR D, V55, P2051, DOI 10.1107/S0907444999012597; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; SMIRNOV AI, 1995, J MAGN RESON SER A, V113, P65, DOI 10.1006/jmra.1995.1057; Su JY, 2011, J BIOL CHEM, V286, P13481, DOI 10.1074/jbc.M109.036467; Tzima TD, 2013, POLYHEDRON, V52, P706, DOI 10.1016/j.poly.2012.07.084; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; Wehenkel A, 2007, J MOL BIOL, V374, P890, DOI 10.1016/j.jmb.2007.09.076; White DJ, 2001, BIOCHEMISTRY-US, V40, P8918, DOI 10.1021/bi010637a; ZHUO SQ, 1994, J BIOL CHEM, V269, P26234	47	13	14	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					26987	27001		10.1074/jbc.M113.497636	http://dx.doi.org/10.1074/jbc.M113.497636			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23897835	Green Published, hybrid			2022-12-25	WOS:000330597300002
J	Anderson, DM; Feix, JB; Monroe, AL; Peterson, FC; Volkman, BF; Haas, AL; Frank, DW				Anderson, David M.; Feix, Jimmy B.; Monroe, Andrew L.; Peterson, Francis C.; Volkman, Brian F.; Haas, Arthur L.; Frank, Dara W.			Identification of the Major Ubiquitin-binding Domain of the Pseudomonas aeruginosa ExoU A(2) Phospholipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL TYPE-III; EXOENZYME-S; CYTOTOXIN EXOU; PROTEIN; TOXIN; ACTIVATION; EFFECTOR; LOCALIZATION; EXPLOITATION; PREDICTION	Numerous Gram-negative bacterial pathogens use type III secretion systems to deliver effector molecules into the cytoplasm of a host cell. Many of these effectors have evolved to manipulate the host ubiquitin system to alter host cell physiology or the location, stability, or function of the effector itself. ExoU is a potent A(2) phospholipase used by Pseudomonas aeruginosa to destroy membranes of infected cells. The enzyme is held in an inactive state inside of the bacterium due to the absence of a required eukaryotic activator, which was recently identified as ubiquitin. This study sought to identify the region of ExoU required to mediate this interaction and determine the properties of ubiquitin important for binding, ExoU activation, or both. Biochemical and biophysical approaches were used to map the ubiquitin-binding domain to a C-terminal four-helix bundle of ExoU. The hydrophobic patch of ubiquitin is required for full binding affinity and activation. Binding and activation were uncoupled by introducing an L8R substitution in ubiquitin. Purified L8R demonstrated a parental binding phenotype to ExoU but did not activate the phospholipase in vitro. Utilizing these new biochemical data and intermolecular distance measurements by double electron-electron resonance, we propose a model for an ExoU-monoubiquitin complex.	[Anderson, David M.; Monroe, Andrew L.; Frank, Dara W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Anderson, David M.; Monroe, Andrew L.; Frank, Dara W.] Med Coll Wisconsin, Ctr Infect Dis Res, Milwaukee, WI 53226 USA; [Feix, Jimmy B.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Peterson, Francis C.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Frank, DW (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	frankd@mcw.edu	Volkman, Brian F./ABE-7306-2020; Volkman, Brian F./ABE-7312-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179	National Institutes of Health [P41 EB001980]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049577, R01AI104922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The National Biomedical EPR Center, Department of Biophysics, is supported by National Institutes of Health Grant P41 EB001980.	Anderson DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002823; Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Arena ET, 2011, INFECT IMMUN, V79, P4392, DOI 10.1128/IAI.05478-11; Benson MA, 2011, BIOPHYS J, V100, P1335, DOI 10.1016/j.bpj.2011.01.056; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; El-Solh AA, 2012, CRIT CARE MED, V40, P1157, DOI 10.1097/CCM.0b013e3182377906; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Gendrin C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002637; Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369; Halavaty AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049388; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicks SW, 2010, CURR OPIN MICROBIOL, V13, P41, DOI 10.1016/j.mib.2009.11.008; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; IGLEWSKI BH, 1978, P NATL ACAD SCI USA, V75, P3211, DOI 10.1073/pnas.75.7.3211; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kubori T, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00145; Liu SY, 1997, J BACTERIOL, V179, P1609, DOI 10.1128/jb.179.5.1609-1613.1997; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Phillips RM, 2003, J BIOL CHEM, V278, P41326, DOI 10.1074/jbc.M302472200; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Sanada T, 2012, NATURE, V483, P623, DOI 10.1038/nature10894; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2006, BIOCHEMISTRY-US, V45, P10368, DOI 10.1021/bi060788j; Schmalzer KM, 2010, J BACTERIOL, V192, P1801, DOI 10.1128/JB.00904-09; Steele-Mortimer O, 2011, TRAFFIC, V12, P162, DOI 10.1111/j.1600-0854.2010.01137.x; Stirling FR, 2006, CELL MICROBIOL, V8, P1294, DOI 10.1111/j.1462-5822.2006.00710.x; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; Tan KS, 2010, J IMMUNOL, V184, P5160, DOI 10.4049/jimmunol.0902663; Tyson GH, 2013, INFECT IMMUN, V81, P2873, DOI 10.1128/IAI.00414-13; Veesenmeyer JL, 2010, INFECT IMMUN, V78, P3346, DOI 10.1128/IAI.00223-10; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899	43	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26741	26752		10.1074/jbc.M113.478529	http://dx.doi.org/10.1074/jbc.M113.478529			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23908356	hybrid, Green Published			2022-12-25	WOS:000330594500039
J	Bai, QF; Zhang, Y; Ban, YH; Liu, HX; Yao, XJ				Bai, Qifeng; Zhang, Yang; Ban, Yihe; Liu, Huanxiang; Yao, Xiaojun			Computational Study on the Different Ligands Induced Conformation Change of beta 2 Adrenergic Receptor-Gs Protein Complex	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BETA(2) ADRENERGIC-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; COUPLED RECEPTORS; CRYSTAL-STRUCTURE; ENERGY LANDSCAPE; ACCESS CHANNELS; ACTIVE-SITE; ADRENOCEPTOR; ACTIVATION	beta(2) adrenergic receptor (beta(2)AR) regulated many key physiological processes by activation of a heterotrimeric GTP binding protein (Gs protein). This process could be modulated by different types of ligands. But the details about this modulation process were still not depicted. Here, we performed molecular dynamics (MD) simulations on the structures of beta(2)AR-Gs protein in complex with different types of ligands. The simulation results demonstrated that the agonist BI-167107 could form hydrogen bonds with Ser203(5.42), Ser207(5.46) and Asn293(6.55) more than the inverse agonist ICI 118,551. The different binding modes of ligands further affected the conformation of beta(2)AR. The energy landscape profiled the energy contour map of the stable and dissociated conformation of G alpha s and G alpha gamma when different types of ligands bound to beta(2)AR. It also showed the minimum energy pathway about the conformational change of G alpha s and G beta gamma along the reaction coordinates. By using interactive essential dynamics analysis, we found that G alpha s and G beta gamma domain of Gs protein had the tendency to separate when the inverse agonist ICI 118,551 bound to beta(2)AR. The alpha 5-helix had a relatively quick movement with respect to transmembrane segments of beta(2)AR when the inverse agonist ICI 118,551 bound to beta(2)AR. Besides, the analysis of the centroid distance of G alpha s and G beta gamma showed that the G alpha s was separated from G beta gamma during the MD simulations. Our results not only could provide details about the different types of ligands that induced conformational change of beta(2)AR and Gs protein, but also supplied more information for different efficacies of drug design of beta(2)AR.	[Bai, Qifeng; Ban, Yihe; Yao, Xiaojun] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China; [Zhang, Yang] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China; [Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University	Yao, XJ (corresponding author), Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China.	xjyao@lzu.edu.cn	Bai, Qifeng/A-2950-2019	Bai, Qifeng/0000-0001-7296-6187; Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21175063]; Fundamental Research Funds for the Central Universities [lzujbky-2011-19]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 21175063), the Fundamental Research Funds for the Central Universities (Grant Nos. lzujbky-2011-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019856; Bhattacharya S, 2008, BIOPHYS J, V94, P2027, DOI 10.1529/biophysj.107.117648; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Caro LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018226; Case D. A., 2012, AMBER; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Cui YL, 2013, CHEM-EUR J, V19, P548, DOI 10.1002/chem.201202627; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Du Y, 2012, J AM CHEM SOC, V134, P6720, DOI 10.1021/ja211941d; Edelsbrunner H, 2003, P NATL ACAD SCI USA, V100, P2203, DOI 10.1073/pnas.0537830100; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; Fanelli F, 2005, CHEM REV, V105, P3297, DOI 10.1021/cr000095n; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feng ZW, 2012, J CHEM INF MODEL, V52, P1005, DOI 10.1021/ci200594d; Frisch G.W., 2016, GAUSSIAN 16 REVISION; Furse KE, 2003, J MED CHEM, V46, P4450, DOI 10.1021/jm0301437; Goetz A, 2011, J MOL BIOL, V414, P611, DOI 10.1016/j.jmb.2011.10.015; Goral V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019282; Gouldson PR, 1997, J MED CHEM, V40, P3871, DOI 10.1021/jm960647n; Gouldson PR, 2000, NEUROPSYCHOPHARMACOL, V23, pS60, DOI 10.1016/S0893-133X(00)00153-6; Greene D, 2012, J BIOL CHEM, V287, P23690, DOI 10.1074/jbc.M112.366955; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivetac A, 2010, CHEM BIOL DRUG DES, V76, P201, DOI 10.1111/j.1747-0285.2010.01012.x; Johnson M, 2006, J ALLERGY CLIN IMMUN, V117, P18, DOI 10.1016/j.jaci.2005.11.012; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Ma XJ, 2012, J BIOL CHEM, V287, P18925, DOI 10.1074/jbc.M112.352260; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McGraw Dennis W, 2005, Proc Am Thorac Soc, V2, P292, DOI 10.1513/pats.200504-027SR; MILLIGAN G, 1994, BIOCHEM PHARMACOL, V48, P1059; Mongan J, 2004, J COMPUT AID MOL DES, V18, P433, DOI 10.1007/s10822-004-4121-z; Papaleo E, 2009, J MOL GRAPH MODEL, V27, P889, DOI 10.1016/j.jmgm.2009.01.006; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Provasi D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002193; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; Sadiq SK, 2013, CURR MED CHEM, V20, P22; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scarselli M, 2012, J BIOL CHEM, V287, P16768, DOI 10.1074/jbc.M111.329912; Simpson LM, 2010, CURR OPIN PHARMACOL, V10, P30, DOI 10.1016/j.coph.2009.11.001; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vaidehi N, 2010, DRUG DISCOV TODAY, V15, P951, DOI 10.1016/j.drudis.2010.08.018; Vanni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001053; Vanni S, 2009, BIOCHEMISTRY-US, V48, P4789, DOI 10.1021/bi900299f; Vilar S, 2011, J MOL GRAPH MODEL, V29, P614, DOI 10.1016/j.jmgm.2010.11.005; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zhou RH, 2001, P NATL ACAD SCI USA, V98, P14931, DOI 10.1073/pnas.201543998	54	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68138	10.1371/journal.pone.0068138	http://dx.doi.org/10.1371/journal.pone.0068138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922653	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700005
J	Agrawal, T; Sharvani, V; Nair, D; Medigeshi, GR				Agrawal, Tanvi; Sharvani, Vats; Nair, Deepa; Medigeshi, Guruprasad R.			Japanese Encephalitis Virus Disrupts Cell-Cell Junctions and Affects the Epithelial Permeability Barrier Functions	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TIGHT JUNCTION; CORE PROTEIN; RIG-I; NUCLEAR-LOCALIZATION; CLINICAL-FEATURES; ENDOTHELIAL-CELLS; INFECTION; EXPRESSION; CLAUDIN	Japanese encephalitis virus (JEV) is a neurotropic flavivirus, which causes viral encephalitis leading to death in about 20-30% of severely-infected people. Although JEV is known to be a neurotropic virus its replication in non-neuronal cells in peripheral tissues is likely to play a key role in viral dissemination and pathogenesis. We have investigated the effect of JEV infection on cellular junctions in a number of non-neuronal cells. We show that JEV affects the permeability barrier functions in polarized epithelial cells at later stages of infection. The levels of some of the tight and adherens junction proteins were reduced in epithelial and endothelial cells and also in hepatocytes. Despite the induction of antiviral response, barrier disruption was not mediated by secreted factors from the infected cells. Localization of tight junction protein claudin-1 was severely perturbed in JEV-infected cells and claudin-1 partially colocalized with JEV in intracellular compartments and targeted for lysosomal degradation. Expression of JEV-capsid alone significantly affected the permeability barrier functions in these cells. Our results suggest that JEV infection modulates cellular junctions in non-neuronal cells and compromises the permeability barrier of epithelial and endothelial cells which may play a role in viral dissemination in peripheral tissues.	[Agrawal, Tanvi; Sharvani, Vats; Nair, Deepa; Medigeshi, Guruprasad R.] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Medigeshi, GR (corresponding author), Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon, India.	gmedigeshi@thsti.res.in	Medigeshi, Guruprasad/V-1566-2019	Medigeshi, Guruprasad/0000-0001-5333-9743	Department of Biotechnology [BT/PR5132/MED/15/85/2012]; vaccine research innovation award of the institute	Department of Biotechnology; vaccine research innovation award of the institute	This study was supported by the institutional grant and by the extra-mural funds from the Department of Biotechnology to GRM (BT/PR5132/MED/15/85/2012). TA is supported by vaccine research innovation award of the institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, COLD SPRING HARBOR P, V1; Araki Y, 2005, FREE RADICAL BIO MED, V39, P769, DOI 10.1016/j.freeradbiomed.2005.04.026; Armah HB, 2007, BRAIN PATHOL; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bhowmick S, 2007, NEUROSCI LETT, V414, P45, DOI 10.1016/j.neulet.2006.11.070; Bhuvanakantham R, 2010, MICROBES INFECT, V12, P615, DOI 10.1016/j.micinf.2010.04.005; Borah J, 2011, J CLIN VIROL, V52, P45, DOI 10.1016/j.jcv.2011.06.001; Bosco-Lauth A, 2011, AM J TROP MED HYG, V84, P727, DOI 10.4269/ajtmh.2011.11-0012; Bozym RA, 2011, MOL BIOL CELL, V22, P3010, DOI 10.1091/mbc.E11-02-0094; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655; Comstock AT, 2011, J VIROL, V85, P6795, DOI 10.1128/JVI.02074-10; Cuzzocrea S, 2000, MOL MED, V6, P766, DOI 10.1007/BF03402192; Das S, 2008, J NEUROIMMUNOL, V195, P60, DOI 10.1016/j.jneuroim.2008.01.009; Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Haridas V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002005; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; HUANG CH, 1963, ACTA VIROL, V7, P322; Huang JL, 2004, J MED VIROL, V74, P589, DOI 10.1002/jmv.20218; Kajino-Sakamoto R, 2010, J IMMUNOL, V185, P4729, DOI 10.4049/jimmunol.0903587; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507; Krautkramer E, 2011, J VIROL, V85, P9811, DOI 10.1128/JVI.00568-11; Kumar R, 2006, CLIN INFECT DIS, V43, P123, DOI 10.1086/505121; Lai CY, 2012, J NEUROCHEM, V123, P250, DOI 10.1111/j.1471-4159.2012.07889.x; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Liu P, 2009, J INFECT DIS, V200, P191, DOI 10.1086/599795; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; LOPEZVANCELL R, 1984, J MEMBRANE BIOL, V81, P171, DOI 10.1007/BF01868711; Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814; MAKINO Y, 1989, J GEN VIROL, V70, P1417, DOI 10.1099/0022-1317-70-6-1417; Man S, 2008, CLIN DEV IMMUNOL, V2008; MATHUR A, 1981, INFECT IMMUN, V34, P26, DOI 10.1128/IAI.34.1.26-29.1981; MATHUR A, 1989, J GEN VIROL, V70, P461, DOI 10.1099/0022-1317-70-2-461; Medigeshi GR, 2011, FUTURE VIROL, V6, P1075, DOI 10.2217/FVL.11.85; Medigeshi GR, 2009, J VIROL, V83, P6125, DOI 10.1128/JVI.02617-08; MILTON SG, 1990, J CELL PHYSIOL, V144, P498, DOI 10.1002/jcp.1041440318; Mishra MK, 2009, NEUROCHEM INT, V55, P717, DOI 10.1016/j.neuint.2009.07.006; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761; Nazmi A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000892; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Siirin MT, 2007, AM J TROP MED HYG, V76, P299, DOI 10.4269/ajtmh.2007.76.299; Sobo K, 2011, J VIROL, V85, P12376, DOI 10.1128/JVI.00016-11; SVENSSON L, 1991, J VIROL, V65, P4190, DOI 10.1128/JVI.65.8.4190-4197.1991; Swarup V, 2007, NEUROSCI LETT, V420, P144, DOI 10.1016/j.neulet.2007.04.071; TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Tchao Ruy, 2002, CLAO Journal, V28, P151; Urbanowski MD, 2008, CELL SIGNAL, V20, P1227, DOI 10.1016/j.cellsig.2007.12.018; Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036; Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; Xu RF, 2012, BRAIN RES, V1436, P13, DOI 10.1016/j.brainres.2011.11.052; Xu ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037886	64	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69465	10.1371/journal.pone.0069465	http://dx.doi.org/10.1371/journal.pone.0069465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894488	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900076
J	Johnson, CA; Raubenheimer, D; Rothman, JM; Clarke, D; Swedell, L				Johnson, Caley A.; Raubenheimer, David; Rothman, Jessica M.; Clarke, David; Swedell, Larissa			30 Days in the Life: Daily Nutrient Balancing in a Wild Chacma Baboon	PLOS ONE			English	Article							PAPIO-URSINUS; CAPE PENINSULA; GEOMETRIC ANALYSIS; FOOD RESOURCES; GORILLA DIETS; ECOLOGY; POPULATION; STRATEGIES; NUTRITION; NITROGEN	For most animals, the ability to regulate intake of specific nutrients is vital to fitness. Recent studies have demonstrated nutrient regulation in nonhuman primates over periods of one observation day, though studies of humans indicate that such regulation extends to longer time frames. Little is known about longer-term regulation in nonhuman primates, however, due to the challenges of multiple-day focal follows. Here we present the first detailed study of nutrient intake across multiple days in a wild nonhuman primate. We conducted 30 consecutive all day follows on one female chacma baboon (Papio hamadryas ursinus) in the Cape Peninsula of South Africa. We documented dietary composition, compared the nutritional contribution of natural and human-derived foods to the diet, and quantified nutrient intake using the geometric framework of nutrition. Our focus on a single subject over consecutive days allowed us to examine daily dietary regulation within an individual over time. While the amounts varied daily, our subject maintained a strikingly consistent balance of protein to non-protein (fat and carbohydrate) energy across the month. Human-derived foods, while contributing a minority of the diet, were higher in fat and lower in fiber than naturally-derived foods. Our results demonstrate nutrient regulation on a daily basis in our subject, and demonstrate that she was able to maintain a diet with a constant proportional protein content despite wide variation in the composition of component foods. From a methodological perspective, the results of this study suggest that nutrient intake is best estimated over at least an entire day, with longer-term regulatory patterns (e. g., during development and reproduction) possibly requiring even longer sampling. From a management and conservation perspective, it is notable that nearly half the subject's daily energy intake derived from exotic foods, including those currently being eradicated from the study area for replacement by indigenous vegetation.	[Johnson, Caley A.; Rothman, Jessica M.; Swedell, Larissa] CUNY, Grad Ctr, Doctoral Program Anthropol, New York, NY USA; [Johnson, Caley A.; Rothman, Jessica M.; Swedell, Larissa] New York Consortium Evolutionary Primatol, New York, NY USA; [Swedell, Larissa] CUNY, Queens Coll, Dept Anthropol, Queens, NY USA; [Swedell, Larissa] Univ Cape Town, Dept Archaeol, ZA-7925 Cape Town, South Africa; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Rothman, Jessica M.] CUNY Hunter Coll, Dept Anthropol, New York, NY 10021 USA; [Clarke, David] CUNY, Queens Coll, Dept Biol, Queens, NY USA	City University of New York (CUNY) System; City University of New York (CUNY) System; University of Cape Town; University of Sydney; University of Sydney; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Swedell, L (corresponding author), CUNY, Grad Ctr, Doctoral Program Anthropol, New York, NY USA.	LSwedell@qc.edu	Swedell, Larissa/E-8587-2013	Swedell, Larissa/0000-0001-6909-2669; Raubenheimer, David/0000-0001-9050-1447	National Science Foundation (NSF) URM Grant [0731613]; NSF GRFP [1037525]; New York Consortium in Evolutionary Primatology; NSF DGE [0333415]; Gravida: The National Research Centre for Growth and Development, New Zealand	National Science Foundation (NSF) URM Grant; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); New York Consortium in Evolutionary Primatology; NSF DGE(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); Gravida: The National Research Centre for Growth and Development, New Zealand	Funding for this study was provided by National Science Foundation (NSF) URM Grant #0731613 to Queens College, NSF GRFP #1037525 to C. Johnson, and The New York Consortium in Evolutionary Primatology (funded by NSF DGE #0333415). DR and JMR were partially funded by Gravida: The National Research Centre for Growth and Development, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SA, 1998, FORAGING SURVIVAL YE; Altmann SA, 1970, BABOON ECOLOGY AFRIC; Association of Official Analytical Chemists, 1990, OFFICIAL METHODS ANA; Barrett L, 1997, S AFR J SCI, V93, P436; Barton RA, 1996, BEHAV ECOL SOCIOBIOL, V38, P321, DOI 10.1007/s002650050248; Beamish EK, 2010, THESIS U CAPE TOWN S; BIELERT C, 1983, PHYSIOL BEHAV, V30, P103, DOI 10.1016/0031-9384(83)90045-8; BULGER J, 1987, INT J PRIMATOL, V8, P635, DOI 10.1007/BF02735781; BYRNE RW, 1993, BEHAV ECOL SOCIOBIOL, V33, P233, DOI 10.1007/BF02027120; Chambers PG, 1995, ANIM BEHAV, V50, P1513, DOI 10.1016/0003-3472(95)80007-7; Codron D, 2006, AM J PHYS ANTHROPOL, V129, P204, DOI 10.1002/ajpa.20253; Conklin-Brittain Nancy Lou, 2006, P445; Cowling RM, 1996, BIODIVERS CONSERV, V5, P527, DOI 10.1007/BF00137608; de Castro J, 2000, NEURAL CONTROL MACRO, P43; Doran DM, 1998, EVOL ANTHROPOL, V6, P120; Emaga TH, 2007, FOOD CHEM, V103, P590, DOI 10.1016/j.foodchem.2006.09.006; Felton AM, 2009, INT J PRIMATOL, V30, P675, DOI 10.1007/s10764-009-9367-9; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Goering HK, 1970, FORAGE FIBER ANAL, P1; Gosby AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025929; HAMILTON WJ, 1978, AM NAT, V112, P911, DOI 10.1086/283331; Hoffman TS, 2012, AM J PRIMATOL, V74, P853, DOI 10.1002/ajp.22040; Hoffman TS, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-1; Hoffman TS, 2011, INT J PRIMATOL, V32, P308, DOI 10.1007/s10764-010-9467-6; Janson Charles H., 1999, P237, DOI 10.1017/CBO9780511542381.015; Jensen K, 2011, ANIM BEHAV, V81, P993, DOI 10.1016/j.anbehav.2011.01.035; Kansky R, 2000, BABOON MANAGEMENT ST; Kaplan BS, 2011, INT J PRIMATOL, V32, P1397, DOI 10.1007/s10764-011-9541-8; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; Martindale B, 2007, THESIS U WITWATERSRA; Martinez-Cordero C, 2012, APPETITE, V59, P312, DOI 10.1016/j.appet.2012.05.013; MILTON K, 1981, AM NAT, V117, P496, DOI 10.1086/283730; National Research Council, 2003, NUTR REQ NONH PRIM; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; RAUBENHEIMER D, 1993, ANIM BEHAV, V45, P953, DOI 10.1006/anbe.1993.1114; Raubenheimer D, 2011, ECOL MONOGR, V81, P407, DOI 10.1890/10-1707.1; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Rothman JM, 2008, AM J PRIMATOL, V70, P690, DOI 10.1002/ajp.20540; Rothman JM, 2008, OECOLOGIA, V155, P111, DOI 10.1007/s00442-007-0901-1; Rothman JM, 2012, INT J PRIMATOL, V33, P542, DOI 10.1007/s10764-011-9568-x; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; SIMPSON SJ, 1995, J INSECT PHYSIOL, V41, P545, DOI 10.1016/0022-1910(95)00006-G; Simpson SJ, 2003, APPETITE, V41, P123, DOI 10.1016/S0195-6663(03)00049-7; SIMPSON SJ, 1993, PHILOS T R SOC B, V342, P381, DOI 10.1098/rstb.1993.0166; Simpson SJ, 2012, NATURE NUTR UNIFYING; STACEY PB, 1986, BEHAV ECOL SOCIOBIOL, V18, P175, DOI 10.1007/BF00290821; Stephens D.W., 1986, pi; U.S. Department of Agriculture, 2011, AGR RES SERV USDA NA; van Doorn A, 2009, INTERFACE SOCIOECOLO; van Doorn AC, 2010, AM J PRIMATOL, V72, P104, DOI 10.1002/ajp.20759; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; White T. C. R., 1993, INADEQUATE ENV NITRO; WHITEN A, 1991, PHILOS T ROY SOC B, V334, P187, DOI 10.1098/rstb.1991.0108; WHITEN A, 1987, INT J PRIMATOL, V8, P367, DOI 10.1007/BF02737389	57	64	65	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70383	10.1371/journal.pone.0070383	http://dx.doi.org/10.1371/journal.pone.0070383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894645	Green Published, gold			2022-12-25	WOS:000322167900122
J	Montarolo, F; Parolisi, R; Hoxha, E; Boda, E; Tempia, F				Montarolo, Francesca; Parolisi, Roberta; Hoxha, Eriola; Boda, Enrica; Tempia, Filippo			Early Enriched Environment Exposure Protects Spatial Memory and Accelerates Amyloid Plaque Formation in APP(Swe)/PS1(L166P) Mice	PLOS ONE			English	Article							INTRANEURONAL A-BETA; ALZHEIMERS-DISEASE; MOUSE MODEL; COGNITIVE DEFICITS; PHYSICAL-ACTIVITY; IMPROVES COGNITION; TRANSGENIC MICE; DEPOSITION; ONSET; RATS	Enriched environment exposure improves several aspects of cognitive performance in Alzheimer's disease patients and in animal models and, although the role of amyloid plaques is questionable, several studies also assessed their response to enriched environment, with contrasting results. Here we report that rearing APP(Swe)/PS1(L166P) mice in an enriched environment since birth rescued the spatial memory impairment otherwise present at 6 months of age. At the same time, the exposure to the enriched environment caused a transient acceleration of plaque formation, while there was no effect on intracellular staining with the 6E10 antibody, which recognizes beta-amyloid, full length amyloid precursor protein and its C-terminal fragments. The anticipation of plaque formation required exposure during early development, suggesting an action within critical periods for circuits formation. On the other hand, chronic neuronal activity suppression by tetrodotoxin decreased the number of plaques without affecting intracellular amyloid. These results indicate that enriched environment exposure since early life has a protective effect on cognitive deterioration although transiently accelerates amyloid deposition. In addition, the effects of the enriched environment might be due to increased neuronal activity, because plaques were reduced by suppression of electrical signaling by tetrodotoxin.	[Montarolo, Francesca; Parolisi, Roberta; Hoxha, Eriola; Boda, Enrica; Tempia, Filippo] Univ Turin, Inst Cavalieri Ottolenghi NICO, Turin, Italy; [Tempia, Filippo] Univ Turin, Dept Neurosci, Turin, Italy; [Tempia, Filippo] Univ Turin, Natl Inst Neurosci Italy INN, Turin, Italy	University of Turin; University of Turin; University of Turin	Tempia, F (corresponding author), Univ Turin, Inst Cavalieri Ottolenghi NICO, Turin, Italy.	filippo.tempia@unito.it	Montarolo, F/K-3331-2018; Hoxha, Eriola/N-1752-2017; Boda, Enrica/AFM-7909-2022	Montarolo, F/0000-0002-3633-8746; Hoxha, Eriola/0000-0002-4452-889X; Tempia, Filippo/0000-0003-2778-0943; Parolisi, Roberta/0000-0002-1948-7766; BODA, Enrica/0000-0002-1006-2577	Ministero dell'Istruzione, Universita e Ricerca scientifica (PRIN); Fondazione Cassa di Risparmio di Torino (Progetto Alfieri bando)	Ministero dell'Istruzione, Universita e Ricerca scientifica (PRIN); Fondazione Cassa di Risparmio di Torino (Progetto Alfieri bando)	The experiments were supported by grants from: Ministero dell'Istruzione, Universita e Ricerca scientifica (PRIN-2007) and Fondazione Cassa di Risparmio di Torino (Progetto Alfieri bando 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Ambree O, 2006, AM J PATHOL, V169, P544, DOI 10.2353/ajpath.2006.051107; Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; Bennett JC, 2006, NEUROBIOL LEARN MEM, V85, P139, DOI 10.1016/j.nlm.2005.09.003; Berardi N, 2007, J ALZHEIMERS DIS, V11, P359; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; BONAIUTO S, 1995, NEUROEPIDEMIOLOGY, V14, P101, DOI 10.1159/000109785; Braak H, 1998, J NEURAL TRANSM-SUPP, P97; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Colcombe SJ, 2004, J MOL NEUROSCI, V24, P9, DOI 10.1385/JMN:24:1:009; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Cotel MC, 2012, NEUROBIOL AGING, V33, P96, DOI 10.1016/j.neurobiolaging.2010.02.012; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; Frisoni GB, 2007, BRAIN, V130, P720, DOI 10.1093/brain/awl377; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Hardy J, 2001, BIOCHEM SOC SYMP, V67, P51; Herring A, 2011, NEUROBIOL DIS, V42, P530, DOI 10.1016/j.nbd.2011.03.007; HOLLOWAY RALPH L., 1966, BRAIN RES, V2, P393, DOI 10.1016/0006-8993(66)90009-6; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Katzman R, 1988, Ann Neurol, V24, P384; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Koenig J, 2008, HIPPOCAMPUS, V18, P99, DOI 10.1002/hipo.20368; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Melnikova T, 2013, J NEUROSCI, V33, P3765, DOI 10.1523/JNEUROSCI.4251-12.2013; Mirochnic S, 2009, HIPPOCAMPUS, V19, P1008, DOI 10.1002/hipo.20560; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; ROSENZWEIG MR, 1964, J COMP PHYSIOL PSYCH, V57, P438, DOI 10.1037/h0046387; Selkoe DJ, 2000, JAMA-J AM MED ASSOC, V283, P1615, DOI 10.1001/jama.283.12.1615; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Tampellini D, 2010, J NEUROSCI, V30, P14299, DOI 10.1523/JNEUROSCI.3383-10.2010; Tampellini D, 2009, J NEUROSCI, V29, P9704, DOI 10.1523/JNEUROSCI.2292-09.2009; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Um HS, 2008, INT J MOL MED, V22, P529, DOI 10.3892/ijmm_00000052; WEST RW, 1972, BEHAV BIOL, V7, P279, DOI 10.1016/S0091-6773(72)80207-4; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Wolfe KJ, 2011, SEMIN CELL DEV BIOL, V22, P476, DOI 10.1016/j.semcdb.2011.03.011	46	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69381	10.1371/journal.pone.0069381	http://dx.doi.org/10.1371/journal.pone.0069381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894463	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900060
J	Swift, W; Wong, A; Li, KM; Arnold, JC; McGregor, IS				Swift, Wendy; Wong, Alex; Li, Kong M.; Arnold, Jonathon C.; McGregor, Iain S.			Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile	PLOS ONE			English	Article							THC; DELTA(9)-TETRAHYDROCANNABINOL; PSYCHOSIS; SATIVA; SCHIZOPHRENIA; ACID; RATS; DELTA(9)-THC; SYMPTOMS; BEHAVIOR	Recent analysis of the cannabinoid content of cannabis plants suggests a shift towards use of high potency plant material with high levels of Delta(9)-tetrahydrocannabinol (THC) and low levels of other phytocannabinoids, particularly cannabidiol (CBD). Use of this type of cannabis is thought by some to predispose to greater adverse outcomes on mental health and fewer therapeutic benefits. Australia has one of the highest per capita rates of cannabis use in the world yet there has been no previous systematic analysis of the cannabis being used. In the present study we examined the cannabinoid content of 206 cannabis samples that had been confiscated by police from recreational users holding 15 g of cannabis or less, under the New South Wales "Cannabis Cautioning" scheme. A further 26 "Known Provenance" samples were analysed that had been seized by police from larger indoor or outdoor cultivation sites rather than from street level users. An HPLC method was used to determine the content of 9 cannabinoids: THC, CBD, cannabigerol (CBG), and their plant-based carboxylic acid precursors THC-A, CBD-A and CBG-A, as well as cannabichromene (CBC), cannabinol (CBN) and tetrahydrocannabivarin (THC-V). The "Cannabis Cautioning" samples showed high mean THC content (THC+THC-A = 14.88%) and low mean CBD content (CBD+CBD-A = 0.14%). A modest level of CBG was detected (CBG+CBG-A = 1.18%) and very low levels of CBC, CBN and THC-V (<0.1%). "Known Provenance" samples showed no significant differences in THC content between those seized from indoor versus outdoor cultivation sites. The present analysis echoes trends reported in other countries towards the use of high potency cannabis with very low CBD content. The implications for public health outcomes and harm reduction strategies are discussed.	[Swift, Wendy] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Wong, Alex; Li, Kong M.; Arnold, Jonathon C.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Arnold, Jonathon C.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [McGregor, Iain S.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney	Swift, W (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia.	w.swift@unsw.edu.au	Arnold, Jonathon C/ACF-5231-2022; Wong, Alexander/GZM-2929-2022; Li, Kong M./R-4655-2019	Wong, Alexander/0000-0002-5295-2797; Arnold, Jonathon/0000-0002-0159-9997; mcgregor, iain/0000-0002-9307-7159; Li, Kong/0000-0003-2709-0344	Australian Government Department of Health and Ageing through the National Cannabis Prevention and Information Centre	Australian Government Department of Health and Ageing through the National Cannabis Prevention and Information Centre(Australian GovernmentDepartment of Health & Ageing)	This research was funded by the Australian Government Department of Health and Ageing through the National Cannabis Prevention and Information Centre (http://ncpic.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JC, 2012, CURR PHARM DESIGN, V18, P5113, DOI 10.2174/138161212802884726; Australian Crime Commission, 2012, ILL DRUG DAT REP 201; Bhattacharyya S, 2012, ARCH GEN PSYCHIAT, V69, P27, DOI 10.1001/archgenpsychiatry.2011.161; Bruci Z, 2012, FORENSIC SCI INT, V222, P40, DOI 10.1016/j.forsciint.2012.04.032; Burgdorf JR, 2011, DRUG ALCOHOL DEPEN, V117, P59, DOI 10.1016/j.drugalcdep.2010.11.031; CARTWRIGHT L G, 1972, Australian Journal of Pharmaceutical Sciences, V1, P49; Cascini Fidelia, 2012, Curr Drug Abuse Rev, V5, P32; Cascio MG, 2010, BRIT J PHARMACOL, V159, P129, DOI 10.1111/j.1476-5381.2009.00515.x; De Backer B, 2012, J FORENSIC SCI, V57, P918, DOI 10.1111/j.1556-4029.2012.02068.x; De Backer B, 2009, J CHROMATOGR B, V877, P4115, DOI 10.1016/j.jchromb.2009.11.004; Degenhardt L, 2003, DRUG ALCOHOL DEPEN, V71, P37, DOI 10.1016/S0376-8716(03)00064-4; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Di Forti M, 2009, BRIT J PSYCHIAT, V195, P488, DOI 10.1192/bjp.bp.109.064220; Dussy FE, 2005, FORENSIC SCI INT, V149, P3, DOI 10.1016/j.forsciint.2004.05.015; Englund A, 2013, J PSYCHOPHARMACOL, V27, P19, DOI 10.1177/0269881112460109; European monitoring center for Drugs and Drug Addiction Insights, 2012, CANN PROD MARK EUR; Food and Drug Administration, 2001, GUID IND BIOAN METH; Hardwick S, 2008, HOME OFFICE CANNABIS; Hickman M, 2007, ADDICTION, V102, P597, DOI 10.1111/j.1360-0443.2006.01710.x; Izzo AA, 2012, BRIT J PHARMACOL, V166, P1444, DOI 10.1111/j.1476-5381.2012.01879.x; King LA, 2005, ADDICTION, V100, P884, DOI 10.1111/j.1360-0443.2005.001137.x; Klein C, 2011, PSYCHOPHARMACOLOGY, V218, P443, DOI 10.1007/s00213-011-2342-0; Knight G, 2010, FORENSIC SCI INT, V202, P36, DOI 10.1016/j.forsciint.2010.04.022; Korf DJ, 2007, INT J DRUG POLICY, V18, P168, DOI 10.1016/j.drugpo.2006.08.002; Maione S, 2011, BRIT J PHARMACOL, V162, P584, DOI 10.1111/j.1476-5381.2010.01063.x; McLaren J, 2008, ADDICTION, V103, P1100, DOI 10.1111/j.1360-0443.2008.02230.x; Mehmedic Z, 2010, J FORENSIC SCI, V55, P1209, DOI 10.1111/j.1556-4029.2010.01441.x; Moldzio R, 2012, PHYTOMEDICINE, V19, P819, DOI 10.1016/j.phymed.2012.04.002; Morgan CJA, 2008, BRIT J PSYCHIAT, V192, P306, DOI 10.1192/bjp.bp.107.046649; Morgan CJA, 2010, BRIT J PSYCHIAT, V197, P285, DOI 10.1192/bjp.bp.110.077503; Morgan CJA, 2010, NEUROPSYCHOPHARMACOL, V35, P1879, DOI 10.1038/npp.2010.58; Pertwee RG, 2007, BRIT J PHARMACOL, V150, P586, DOI 10.1038/sj.bjp.0707124; Pijlman FTA, 2005, ADDICT BIOL, V10, P171, DOI 10.1080/13556210500123217; Potter DJ, 2008, J FORENSIC SCI, V53, P90, DOI 10.1111/j.1556-4029.2007.00603.x; Rock EM, 2013, BRIT J PHARMACOL, V169, P685, DOI 10.1111/bph.12162; Romano B., 2013, BR J PHARM; Roxburgh A, 2010, ADDICTION, V105, P1071, DOI 10.1111/j.1360-0443.2010.02903.x; Russo EB, 2011, BRIT J PHARMACOL, V163, P1344, DOI 10.1111/j.1476-5381.2011.01238.x; Schubart CD, 2011, SCHIZOPHR RES, V130, P216, DOI 10.1016/j.schres.2011.04.017; Sevigny EL, 2013, DRUG TEST ANAL, V5, P62, DOI 10.1002/dta.1430; Stafford J., 2012, AUSTR DRUG TRENDS 20; Swift W, 2013, EMERGING TARGETS DRU; Swift Wendy, 2005, Harm Reduct J, V2, P18, DOI 10.1186/1477-7517-2-18; Takeda S, 2012, TOXICOL LETT, V214, P314, DOI 10.1016/j.toxlet.2012.08.029; Taura F, 2007, CHEM BIODIVERS, V4, P1649, DOI 10.1002/cbdv.200790145; Teesson M, 2012, AUST NZ J PSYCHIAT, V46, P1182, DOI 10.1177/0004867412460591; Tsumura Y, 2012, FORENSIC SCI INT, V221, P77, DOI 10.1016/j.forsciint.2012.04.005; TURNER CE, 1980, J NAT PROD, V43, P169, DOI 10.1021/np50008a001; United Nations Office on Drugs and Crime, 2012, WORLD DRUG REP 2012	49	118	120	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70052	10.1371/journal.pone.0070052	http://dx.doi.org/10.1371/journal.pone.0070052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894589	gold, Green Published			2022-12-25	WOS:000322167900106
J	Xia, ZL; Wei, YY; Sun, KL; Wu, JY; Wang, YX; Wu, K				Xia, Zongliang; Wei, Yangyang; Sun, Kaile; Wu, Jianyu; Wang, Yongxia; Wu, Ke			The Maize AAA-Type Protein SKD1 Confers Enhanced Salt and Drought Stress Tolerance in Transgenic Tobacco by Interacting with Lyst-Interacting Protein 5	PLOS ONE			English	Article							ATPASE SKD1; MOUSE SKD1; ARABIDOPSIS; EXPRESSION; GENE; TRAFFICKING; NETWORK; CLONING; MUTANT; VPS4P	ATPase associated with various cellular activities (AAA) proteins are important regulators involved in diverse cellular functions. To date, the molecular mechanisms of AAA proteins involved in response to salt and drought stresses in plants are largely unknown. In this study, a putative SKD1 (suppressor of K+ transport growth defect 1) ortholog from Zea mays (ZmSKD1), which encodes a putative AAA protein, was isolated. The transcript levels of ZmSKD1 were higher in aerial tissues and were markedly up-regulated by salt or drought stress. Over-expression of ZmSKD1 in tobacco plants enhanced their tolerances not only to salt but to drought. Moreover, reactive oxygen species accumulations in ZmSKD1 transgenic lines were relative less than those in wild-type plants during salt or PEG-induced water stress. The interaction between ZmSKD1 and NtLIP5 (Lyst-Interacting Protein 5 homolog from Nicotiana tabacum) was confirmed by both yeast two-hybrid and immuno-precipitation assays; moreover, the alpha-helix-rich domain in the C-terminus of ZmSKD1 was identified to be required for its interaction with NtLIP5 using truncation mutations. Collectively, these data demonstrate that ZmSKD1could be involved in salt and drought stress responses and its over-expression enhances salt or drought stress tolerance possibly through interacting with LIP5 in tobacco. This study may facilitate our understandings of the biological roles of SKD1-mediated ESCRT pathway under stress conditions in higher plants and accelerate genetic improvement of crop plants tolerant to environmental stresses.	[Xia, Zongliang; Wei, Yangyang; Sun, Kaile; Wu, Jianyu; Wu, Ke] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Xia, Zongliang; Wei, Yangyang; Sun, Kaile; Wu, Jianyu; Wang, Yongxia] Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Xia, ZL (corresponding author), Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China.	xiazl08@163.com; wujianyu40@126.com		Wu, Jianyu/0000-0002-9090-2512	National Natural Science Foundation of China [30971548]; subject of national "973 project" [2009CB118402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); subject of national "973 project"	This work was financially supported by the National Natural Science Foundation of China (30971548) and the subject of national "973 project" (2009CB118402) partially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Gong ZZ, 2001, PLANT PHYSIOL, V126, P363, DOI 10.1104/pp.126.1.363; Haas TJ, 2007, PLANT CELL, V19, P1295, DOI 10.1105/tpc.106.049346; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Ho LW, 2010, FUNCT PLANT BIOL, V37, P962, DOI 10.1071/FP10049; Jia XY, 2008, J EXP BOT, V59, P739, DOI 10.1093/jxb/erm369; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jou Y, 2006, PLANT PHYSIOL, V141, P135, DOI 10.1104/pp.106.076786; Jou Y, 2004, PLANT MOL BIOL, V54, P881, DOI 10.1007/s11103-004-0335-7; Katsiarimpa A, 2011, PLANT CELL, V23, P3026, DOI 10.1105/tpc.111.087254; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logg K, 2008, BBA-MOL CELL RES, V1783, P974, DOI 10.1016/j.bbamcr.2008.02.022; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; PERIER F, 1994, FEBS LETT, V351, P286, DOI 10.1016/0014-5793(94)00879-5; Richardson LGL, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00020; Ruotolo R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r67; Scheuring S, 1999, GENE, V234, P149, DOI 10.1016/S0378-1119(99)00163-8; Shahriari M, 2010, PLANT J, V64, P71, DOI 10.1111/j.1365-313X.2010.04310.x; Spitzer C, 2009, PLANT CELL, V21, P749, DOI 10.1105/tpc.108.064865; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; Xia ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037383; Xia ZL, 2012, ARCH VIROL, V157, P1233, DOI 10.1007/s00705-012-1288-9; Xia ZL, 2012, GENE, V495, P146, DOI 10.1016/j.gene.2011.12.028; Xia ZL, 2012, MOL BIOL REP, V39, P2429, DOI 10.1007/s11033-011-0993-x; Yen HE, 2000, PHYSIOL PLANTARUM, V110, P402, DOI 10.1034/j.1399-3054.2000.1100315.x; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	31	23	23	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69787	10.1371/journal.pone.0069787	http://dx.doi.org/10.1371/journal.pone.0069787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894539	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900094
J	Xu, W; Cui, QH; Li, F; Liu, AZ				Xu, Wei; Cui, Qinghua; Li, Fei; Liu, Aizhong			Transcriptome-Wide Identification and Characterization of MicroRNAs from Castor Bean (Ricinus communis L.)	PLOS ONE			English	Article							PLANT MICRORNAS; JATROPHA-CURCAS; EXPRESSION; TARGETS; MIRNAS; BIOGENESIS; PREDICTION; DIVERSITY; GENOMICS; MIRBASE	Background: MicroRNAs (miRNAs) are endogenously encoded small RNAs that post-transcriptionally regulate gene expression and play essential roles in numerous developmental and physiological processes. Currently, little information on the transcriptome and tissue-specific expression of miRNAs is available in the model non-edible oilseed crop castor bean (Ricinus communis L.), one of the most important non-edible oilseed crops cultivated worldwide. Recent advances in sequencing technologies have allowed the identification of conserved and novel miRNAs in many plant species. Here, we used high-throughput sequencing technologies to identify and characterize the miRNAs in castor bean. Results: Five small RNA libraries were constructed for deep sequencing from root tips, leaves, developing seeds (at the initial stage, seed1; and at the fast oil accumulation stage, seed2) and endosperms in castor bean. High-throughput sequencing generated a large number of sequence reads of small RNAs in this study. In total, 86 conserved miRNAs were identified, including 63 known and 23 newly identified. Sixteen miRNA isoform variants in length were found from the conserved miRNAs of castor bean. MiRNAs displayed diverse organ-specific expression levels among five libraries. Combined with criteria for miRNA annotation and a RT-PCR approach, 72 novel miRNAs and their potential precursors were annotated and 20 miRNAs newly identified were validated. In addition, new target candidates for miRNAs newly identified in this study were proposed. Conclusions: The current study presents the first high-throughput small RNA sequencing study performed in castor bean to identify its miRNA population. It characterizes and increases the number of miRNAs and their isoforms identified in castor bean. The miRNA expression analysis provides a foundation for understanding castor bean miRNA organ-specific expression patterns. The present study offers an expanded picture of miRNAs for castor bean and other members in the family Euphorbiaceae.	[Xu, Wei; Liu, Aizhong] Chinese Acad Sci, Kunming Inst Bot, Kunming, Peoples R China; [Cui, Qinghua] Yunnan Univ, Coll Life Sci, Kunming, Peoples R China; [Li, Fei; Liu, Aizhong] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Plant Resource Sci, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Yunnan University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Liu, AZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Kunming, Peoples R China.	liuaizhong@mail.kib.ac.cn		Xu, Wei/0000-0003-0581-7872	Chinese Academy of Sciences [30871548]; National Natural Science Foundation of China [30871548]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the "hundreds of Talents" program of the Chinese Academy of Sciences to AL and the National Natural Science Foundation of China (30871548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpan U., 2006, LEONARDO J SCI, V8, P43, DOI [10.1074/jbc.M204802200, DOI 10.1074/JBC.M204802200]; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Atsmon D., 1989, OILCROPS WORLD THEIR, P438; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Ebhardt H Alexander, 2010, Silence, V1, P12, DOI 10.1186/1758-907X-1-12; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Fahlgren N, 2009, RNA, V15, P992, DOI 10.1261/rna.1473809; Fiedler SD, 2010, METHODS MOL BIOL, V630, P49, DOI 10.1007/978-1-60761-629-0_4; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gebelin V, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-18; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gressel J, 2008, PLANT SCI, V174, P246, DOI 10.1016/j.plantsci.2007.11.009; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lelandais-Briere C, 2010, CURR GENOMICS, V11, P14, DOI 10.2174/138920210790217918; Lertpanyasampatha M, 2012, PLANTA, V236, P437, DOI 10.1007/s00425-012-1622-1; Li HY, 2011, PLANTA, V233, P611, DOI 10.1007/s00425-010-1327-2; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Motameny S, 2010, GENES-BASEL, V1, P70, DOI 10.3390/genes1010070; Ogunniyi DS, 2006, BIORESOURCE TECHNOL, V97, P1086, DOI 10.1016/j.biortech.2005.03.028; Patanun O, 2013, MOL BIOTECHNOL, V53, P257, DOI 10.1007/s12033-012-9521-z; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Scholza V, 2008, BIOMASS BIOENERG, V32, P95, DOI 10.1016/j.biombioe.2007.08.004; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Sujatha M, 2008, BIOTECHNOL ADV, V26, P424, DOI 10.1016/j.biotechadv.2008.05.004; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Wan LC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-132; Wang CM, 2012, INT J BIOL SCI, V8, P418, DOI 10.7150/ijbs.3676; Wang FD, 2012, MOL GENET GENOMICS, V287, P555, DOI 10.1007/s00438-012-0699-3; Wu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044385; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Yang TW, 2007, PLANT SCI, V172, P423, DOI 10.1016/j.plantsci.2006.10.009; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang L, 2009, BMC GENOMICS, V5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	23	27	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69995	10.1371/journal.pone.0069995	http://dx.doi.org/10.1371/journal.pone.0069995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894571	Green Published, gold			2022-12-25	WOS:000322167900103
J	Zhang, MQ; Guo, HQ; Xie, X; Zhang, TT; Ouyang, ZT; Zhao, B				Zhang, Mo-Qian; Guo, Hai-Qiang; Xie, Xiao; Zhang, Ting-Ting; Ouyang, Zu-Tao; Zhao, Bin			Identification of Land-Cover Characteristics Using MODIS Time Series Data: An Application in the Yangtze River Estuary	PLOS ONE			English	Article							VEGETATION DYNAMICS; NDVI; PHENOLOGY; INDEX	Land-cover characteristics have been considered in many ecological studies. Methods to identify these characteristics by using remotely sensed time series data have previously been proposed. However, these methods often have a mathematical basis, and more effort is required to better illustrate the ecological meanings of land-cover characteristics. In this study, a method for identifying these characteristics was proposed from the ecological perspective of sustained vegetation growth trend. Improvement was also made in parameter extraction, inspired by a method used for determining the hyperspectral red edge position. Five land-cover types were chosen to represent various ecosystem growth patterns and MODIS time series data were adopted for analysis. The results show that the extracted parameters can reflect ecosystem growth patterns and portray ecosystem traits such as vegetation growth strategy and ecosystem growth situations.	[Zhang, Mo-Qian; Guo, Hai-Qiang; Xie, Xiao; Zhang, Ting-Ting; Ouyang, Zu-Tao; Zhao, Bin] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Coastal Ecosyst Res Stn Yangtze River, Shanghai 200433, Peoples R China	Fudan University	Zhao, B (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Coastal Ecosyst Res Stn Yangtze River, Shanghai 200433, Peoples R China.	zhaobin@fudan.edu.cn	Zhao, Bin/E-5349-2010; Zhao, Bin/I-3651-2013	Zhao, Bin/0000-0002-3530-2469	National Basic Research Program of China [2013CB430404]; Natural Science Foundation of China [31170450]; National Key Technology RD Program [2010BAK69B15]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program)	This research was financially supported by the National Basic Research Program of China (No. 2013CB430404), the Natural Science Foundation of China (grant No 31170450), and the National Key Technology R&D Program (No. 2010BAK69B15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck PSA, 2006, REMOTE SENS ENVIRON, V100, P321, DOI 10.1016/j.rse.2005.10.021; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; Cho MA, 2006, REMOTE SENS ENVIRON, V101, P181, DOI 10.1016/j.rse.2005.12.011; Duchemin B, 1999, REMOTE SENS ENVIRON, V67, P68, DOI 10.1016/S0034-4257(98)00067-4; Eklundh L., 2009, TIMESAT 3 0 SOFTWARE; Geerken RA, 2009, ISPRS J PHOTOGRAMM, V64, P422, DOI 10.1016/j.isprsjprs.2009.03.001; Hird JN, 2009, REMOTE SENS ENVIRON, V113, P248, DOI 10.1016/j.rse.2008.09.003; Jiang ZY, 2008, REMOTE SENS ENVIRON, V112, P3833, DOI 10.1016/j.rse.2008.06.006; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Jonsson P, 2002, IEEE T GEOSCI REMOTE, V40, P1824, DOI 10.1109/TGRS.2002.802519; Luo YQ, 2011, TRENDS ECOL EVOL, V26, P96, DOI 10.1016/j.tree.2010.11.003; Lupo F, 2007, INT J REMOTE SENS, V28, P2469, DOI 10.1080/01431160600921943; Martinez B, 2009, REMOTE SENS ENVIRON, V113, P1823, DOI 10.1016/j.rse.2009.04.016; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; REED BC, 1994, J VEG SCI, V5, P703, DOI 10.2307/3235884; Reed BC, 2003, TASK VEG SC, V39, P365; Rotenberg E, 2011, GLOBAL CHANGE BIOL, V17, P1536, DOI 10.1111/j.1365-2486.2010.02320.x; Senay GB, 2002, INT J REMOTE SENS, V23, P299, DOI 10.1080/01431160010014855; Turner BL, 2007, P NATL ACAD SCI USA, V104, P20666, DOI 10.1073/pnas.0704119104; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Zhang XY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031447; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9	22	8	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70079	10.1371/journal.pone.0070079	http://dx.doi.org/10.1371/journal.pone.0070079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894594	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900107
J	Durand, B; Lecollinet, S; Beck, C; Martinez-Lopez, B; Balenghien, T; Chevalier, V				Durand, Benoit; Lecollinet, Sylvie; Beck, Cecile; Martinez-Lopez, Beatriz; Balenghien, Thomas; Chevalier, Veronique			Identification of Hotspots in the European Union for the Introduction of Four Zoonotic Arboviroses by Live Animal Trade	PLOS ONE			English	Article							WEST-NILE-VIRUS; INTERNATIONAL-TRADE; ENCEPHALITIS-VIRUS; EMERGING PATHOGENS; RISK-FACTORS; USUTU-VIRUS; HOST-RANGE; EMERGENCE; BLUETONGUE; OUTBREAK	Live animal trade is considered a major mode of introduction of viruses from enzootic foci into disease-free areas. Due to societal and behavioural changes, some wild animal species may nowadays be considered as pet species. The species diversity of animals involved in international trade is thus increasing. This could benefit pathogens that have a broad host range such as arboviruses. The objective of this study was to analyze the risk posed by live animal imports for the introduction, in the European Union (EU), of four arboviruses that affect human and horses: Eastern and Western equine encephalomyelitis, Venezuelan equine encephalitis and Japanese encephalitis. Importation data for a five-years period (2005-2009, extracted from the EU TRACES database), environmental data (used as a proxy for the presence of vectors) and horses and human population density data (impacting the occurrence of clinical cases) were combined to derive spatially explicit risk indicators for virus introduction and for the potential consequences of such introductions. Results showed the existence of hotspots where the introduction risk was the highest in Belgium, in the Netherlands and in the north of Italy. This risk was higher for Eastern equine encephalomyelitis (EEE) than for the three other diseases. It was mainly attributed to exotic pet species such as rodents, reptiles or cage birds, imported in small-sized containments from a wide variety of geographic origins. The increasing species and origin diversity of these animals may have in the future a strong impact on the risk of introduction of arboviruses in the EU.	[Durand, Benoit; Lecollinet, Sylvie; Beck, Cecile] Anses, Lab Sante Anim, Maisons Alfort, France; [Lecollinet, Sylvie; Beck, Cecile] European Union Reference Lab Equine Dis, Lab Sante Anim, Maisons Alfort, France; [Martinez-Lopez, Beatriz] Univ Complutense, Dept Anim Hlth, Sch Vet, VISAVET Grp, E-28040 Madrid, Spain; [Balenghien, Thomas] Cirad, UMR Controle Malad, Montpellier, France; [Chevalier, Veronique] Cirad, AGIRs Unit, Montpellier, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Complutense University of Madrid; CIRAD; CIRAD	Durand, B (corresponding author), Anses, Lab Sante Anim, Maisons Alfort, France.	benoit.durand@anses.fr	Lecollinet, Sylvie/AAV-5276-2021; Durand, Benoit/GSE-2511-2022; Lopez, Beatriz Martinez/AAE-6692-2021; studies, IT VISAVET Account for bibliometric/C-3115-2014; Lecollinet, Sylvie/M-1728-2019	studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Durand, Benoit/0000-0003-0669-1394; Lecollinet, Sylvie/0000-0001-8535-2133	European Commission through Network of Excellence for Epizootic Disease Diagnosis and Control (EPIZONE) [FP6-2004-Food-3-A]	European Commission through Network of Excellence for Epizootic Disease Diagnosis and Control (EPIZONE)	This work was funded by the European Commission through the FP6-2004-Food-3-A Network of Excellence for Epizootic Disease Diagnosis and Control (EPIZONE, http://www.epizone-eu.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TB, 2012, 2012 38TH EUROPEAN CONFERENCE AND EXHIBITION ON OPTICAL COMMUNICATIONS (ECOC); Arrigo NC, 2010, EMERG INFECT DIS, V16, P1373, DOI 10.3201/eid1609.100459; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; BARZON L, 2012, EUROSURVEILLANCE, V17, P74456; Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058; Chaskopoulou A., 2011, EURO SURVEILL, V16; de La Rocque S, 2011, REV SCI TECH OIE, V30, P119; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Durand B, 2010, VET RES, V41, DOI 10.1051/vetres/2010004; ENGLER M, 2007, OPPORTUNITY THREAT R, P52; European Environment Agency, 2007, CLC 2006 TECHN GUID; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Gallego FJ, 2010, POPUL ENVIRON, V31, P460, DOI 10.1007/s11111-010-0108-y; Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Graham SP, 2012, AM J TROP MED HYG, V86, P540, DOI 10.4269/ajtmh.2012.11-0283; GUSHULAK BD, 2010, INFECT DIS MOVEMENT, P52; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; HUMBLET MF, 2012, EMERG INFECT DIS, V18, DOI DOI 10.3201/EID1804.111151.PUBMED:22469519; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; LILJENSTOLPE C, 2009, HORSES EUROPE, P27; McMichael AJ, 2004, PHILOS T ROY SOC B, V359, P1049, DOI 10.1098/rstb.2004.1480; Miller Mark J., 2010, P41; Mintiens K, 2008, PREV VET MED, V87, P131, DOI 10.1016/j.prevetmed.2008.06.011; Murgue B, 2001, EMERG INFECT DIS, V7, P692; PAGES N, 2009, SCI REPORT UNPUB; Pfeffer M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-35; REITER P, 2010, INFECT DIS MOVEMENT, P150; Reperant LA, 2010, VECTOR-BORNE ZOONOT, V10, P105, DOI 10.1089/vbz.2008.0208; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; RUSSELL RC, 1987, B WORLD HEALTH ORGAN, V65, P659; Saegerman C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009405; Scholte E. J., 2012, European Mosquito Bulletin, P1; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Suk JE, 2011, AM J PUBLIC HEALTH, V101, P2068, DOI 10.2105/AJPH.2011.300181; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Toussaint JF, 2007, EMERG INFECT DIS, V13, P614, DOI 10.3201/eid1304.061136; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Weissenbock H, 2013, EMERG INFECT DIS, V19, P274, DOI 10.3201/eid1902.121191; White G, 2011, AM J TROP MED HYG, V85, P421, DOI 10.4269/ajtmh.2011.11-0006; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023; ZELLER H, 2012, EUROSURVEILLANCE, V17, P13941; Zhang ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015314	53	23	23	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70000	10.1371/journal.pone.0070000	http://dx.doi.org/10.1371/journal.pone.0070000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894573	Green Accepted, Green Published, gold			2022-12-25	WOS:000325211000172
J	Mavhu, W; Berwick, J; Chirawu, P; Makamba, M; Copas, A; Dirawo, J; Willis, N; Araya, R; Abas, MA; Corbett, EL; Mungofa, S; Laver, SM; Cowan, FM				Mavhu, Webster; Berwick, Jessica; Chirawu, Petronella; Makamba, Memory; Copas, Andrew; Dirawo, Jeffrey; Willis, Nicola; Araya, Ricardo; Abas, Melanie A.; Corbett, Elizabeth L.; Mungofa, Stanley; Laver, Susan M.; Cowan, Frances M.			Enhancing Psychosocial Support for HIV Positive Adolescents in Harare, Zimbabwe	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; UNIVERSAL PREVENTION TRIAL; DZIVE SHIRI PROJECT; DRUG-RESISTANCE; UNITED-KINGDOM; MENTAL-HEALTH; ADHERENCE; CHILDREN	Background: There is a recognized gap in the evidence base relating to the nature and components of interventions to address the psycho-social needs of HIV positive young people. We used mixed methods research to strengthen a community support group intervention for HIV positive young people based in Harare, Zimbabwe. Methods: A quantitative questionnaire was administered to HIV positive Africaid support group attendees. Afterwards, qualitative data were collected from young people aged 15-18 through tape-recorded in-depth interviews (n = 10), 3 focus group discussions (FGDs) and 16 life history narratives. Data were also collected from caregivers, health care workers, and community members through FGDs (n = 6 groups) and in-depth interviews (n = 12). Quantitative data were processed and analysed using STATA 10. Qualitative data were analysed using thematic analysis. Results: 229/310 young people completed the quantitative questionnaire (74% participation). Median age was 14 (range 618 years); 59% were female. Self-reported adherence to antiretrovirals was sub-optimal. Psychological well being was poor (median score on Shona Symptom Questionnaire 9/14); 63% were at risk of depression. Qualitative findings suggested that challenges faced by positive children include verbal abuse, stigma, and discrimination. While data showed that support group attendance is helpful, young people stressed that life outside the confines of the group was more challenging. Caregivers felt ill-equipped to support the children in their care. These data, combined with a previously validated conceptual framework for family-centred interventions, were used to guide the development of the existing programme of adolescent support groups into a more comprehensive evidence-based psychosocial support programme encompassing caregiver and household members. Conclusions: This study allowed us to describe the lived experiences of HIV positive young people and their caregivers in Zimbabwe. The findings contributed to the enhancement of Africaid's existing programme of support to better promote psychological well being and ART adherence.	[Mavhu, Webster; Chirawu, Petronella; Makamba, Memory; Dirawo, Jeffrey; Cowan, Frances M.] Univ Zimbabwe, Coll Hlth Sci, Dept Community Med, Zimbabwe AIDS Prevent Project, Harare, Zimbabwe; [Mavhu, Webster; Dirawo, Jeffrey; Cowan, Frances M.] Ctr Sexual Hlth & HIV AIDS Res Zimbabwe CeSHHAR Z, Harare, Zimbabwe; [Mavhu, Webster; Copas, Andrew; Cowan, Frances M.] UCL, Res Dept Infect & Populat Hlth, Ctr Sexual Hlth & HIV Res, London, England; [Berwick, Jessica] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Willis, Nicola] Africaid, Harare, Zimbabwe; [Araya, Ricardo] Sch Social & Community Med, Bristol, Avon, England; [Abas, Melanie A.] Kings Coll London, Inst Psychiat, London, England; [Corbett, Elizabeth L.] London Sch Hyg & Trop Med, London WC1, England; [Mungofa, Stanley] Harare City Hlth Dept, Harare, Zimbabwe; [Laver, Susan M.] UNICEF, CCORE, Harare, Zimbabwe	University of Zimbabwe; University of London; University College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Bristol; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Mavhu, W (corresponding author), Univ Zimbabwe, Coll Hlth Sci, Dept Community Med, Zimbabwe AIDS Prevent Project, Harare, Zimbabwe.	wmavhu@gmail.com	Araya, Ricardo/S-3144-2019	Araya, Ricardo/0000-0002-0420-5148; Corbett, Elizabeth/0000-0002-3552-3181; Cowan, Frances/0000-0003-3087-4422; abas, melanie/0000-0003-1716-5584; Mavhu, Webster/0000-0003-1881-4398; Copas, Andrew/0000-0001-8968-5963	UNICEF Zimbabwe	UNICEF Zimbabwe	The study was funded by UNICEF Zimbabwe under a project cooperation agreement - there was no grant number. Dr. Sue Laver of UNICEF Zimbabwe assisted with data interpretation and commented on drafts of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attride-Stirling J, 2001, QUALITATIVE RES, V1; Bandason T, 2013, AIDS CARE, V25, P1520, DOI 10.1080/09540121.2013.780120; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2004, ADHERENCE ANTIRETROV, P20; Barrett PM, 2006, J CLIN CHILD ADOLESC, V35, P403, DOI 10.1207/s15374424jccp3503_5; Barrett PM, 2001, BEHAV CHANGE, V18, P78, DOI 10.1375/bech.18.2.78; Barth RE, 2011, PEDIATR INFECT DIS J, V30, P52, DOI 10.1097/INF.0b013e3181ed2af3; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Bygrave H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052856; Campos LN, 2010, AIDS BEHAV, V14, P289, DOI 10.1007/s10461-008-9435-8; Cavarelli M, 2011, J INTERN MED, V270, P561, DOI 10.1111/j.1365-2796.2011.02458.x; Cowan FM, 2008, TROP MED INT HEALTH, V13, P1235, DOI 10.1111/j.1365-3156.2008.02137.x; Cowan FM, 2010, AIDS, V24, P2533, DOI 10.1097/QAD.0b013e32833e77c9; Creswell J. W, 2015, CONCISE INTRO MIXED; Doerholt K, 2006, PEDIATR INFECT DIS J, V25, P420, DOI 10.1097/01.inf.0000214994.44346.d3; Edstrom J, 2009, IDS BULL-I DEV STUD, V40, P41, DOI 10.1111/j.1759-5436.2009.00007.x; Ferrand RA, 2007, CLIN INFECT DIS, V44, P874, DOI 10.1086/511878; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Freire P., 2005, PEDAGOGY OPPRESSED; Global Network of People Living with HIV UNAIDS, 2011, POS HLTH DIGN PREV P; Gray GE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000227; Green G, 2004, HIV MED, V5, P1, DOI 10.1111/j.1468-1293.2004.00211.x; Grossman CI, 2010, AIDS BEHAV, V14, P263, DOI 10.1007/s10461-008-9496-8; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Jaccard J., 1999, SOCIAL PSYCHOL CULTU, P95, DOI [DOI 10.4135/9781452220550.N7, 10. 4135/ 9781452220550. n7]; Jaccard James, 2002, New Dir Child Adolesc Dev, P9; Jones A., 2004, DOING RES CHILDREN Y, P113; Langhaug LF, 2010, J COMMUN HEALTH, V35, P355, DOI 10.1007/s10900-010-9261-6; Lowry-Webster HM, 2003, BEHAV CHANGE, V20, P25, DOI 10.1375/bech.20.1.25.24843; Mavhu W, 2011, AIDS CARE, V23, P52, DOI 10.1080/09540121.2010.490257; Ministry of Health and Child Welfare, 2009, NAT PSYCH SUPP TRAIN; Ministry of Health and Child Welfare, 2012, GLOB AIDS RES ZIMB C; MOHCC, 2010, ZIMB NAT HIV EST 200; Moussa Z, 2009, RIVERS LIFE PLA, P183; Mullen J, 2002, J MED VIROL, V68, P299, DOI 10.1002/jmv.10203; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; National AIDS Council Ministry of Health and Child Welfare Zimbabwe National Family Planning Council, 2002, ZIMB YOUNG AD SURV Y; O'Cathain A, 2009, J MIX METHOD RES, V3, P3, DOI 10.1177/1558689808326272; Organization WH, 2004, PREVENTION MENTAL DI; Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, 2011, GUID US ANT AG PED H; Parsons R., 2012, ONE DAY THIS WILL AL; Patel V, 1997, ACTA PSYCHIAT SCAND, V95, P469, DOI 10.1111/j.1600-0447.1997.tb10134.x; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Reisner Sari L, 2009, Top HIV Med, V17, P14; Remien RH, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000298104.02356.b3; Resino S, 2006, CLIN INFECT DIS, V43, P243, DOI 10.1086/505213; Rueda S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001442.pub2; Safren SA, 2009, HEALTH PSYCHOL, V28, P1, DOI 10.1037/a0012715; San-Andres FJ, 2003, CLIN INFECT DIS, V36, P1177, DOI 10.1086/374358; Save the Children Fund, 2000, INV YOUNG RES EN YOU; Save the Children Fund, 2000, YOUNG PEOPL RES; Shenton A.K., 2004, ED INF, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Sikkema KJ, 2010, AIDS BEHAV, V14, P252, DOI 10.1007/s10461-009-9650-y; Skovdal M, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18468; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; Tashakkori A., 1998, MIXED METHODOLOGY CO; UNAIDS, 2011, WORLD REF DAY 2019 H; UNAIDS, 2012, REP GLOB AIDS EP; *UNAIDS, 2009, AIDS EP UPD; Van Dyke RB, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e61; van Rossum AMC, 2002, LANCET INFECT DIS, V2, P93, DOI 10.1016/S1473-3099(02)00183-4; Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325; Williams PL, 2006, PEDIATRICS, V118, pE1745, DOI 10.1542/peds.2006-0493; Zimbabwe Central Statistical Office, 2007, ZIMB DEM HLTH SURV Z	65	89	89	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70254	10.1371/journal.pone.0070254	http://dx.doi.org/10.1371/journal.pone.0070254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228SX	23894625	Green Published, Green Accepted, gold			2022-12-25	WOS:000325211000197
J	Qi, Y; Xiong, XL; Wang, XL; Duan, CS; Jia, YJ; Jiao, J; Gong, WP; Wen, BH				Qi, Yong; Xiong, Xiaolu; Wang, Xile; Duan, Changsong; Jia, Yinjun; Jiao, Jun; Gong, Wenping; Wen, Bohai			Proteome Analysis and Serological Characterization of Surface-Exposed Proteins of Rickettsia heilongjiangensis	PLOS ONE			English	Article							SPOTTED-FEVER; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; COXIELLA-BURNETII; GENOME SEQUENCE; GUINEA-PIGS; IDENTIFICATION; INVASION; ADHERENCE; ACTIN	Background: Rickettsia heilongjiangensis, the agent of Far-Eastern spotted fever (FESF), is an obligate intracellular bacterium. The surface-exposed proteins (SEPs) of rickettsiae are involved in rickettsial adherence to and invasion of host cells, intracellular bacterial growth, and/or interaction with immune cells. They are also potential molecular candidates for the development of diagnostic reagents and vaccines against rickettsiosis. Methods: R. heilongjiangensis SEPs were identified by biotin-streptavidin affinity purification and 2D electrophoreses coupled with ESI-MS/MS. Recombinant SEPs were probed with various sera to analyze their serological characteristics using a protein microarray and an enzyme-linked immune sorbent assay (ELISA). Results: Twenty-five SEPs were identified, most of which were predicted to reside on the surface of R. heilongjiangensis cells. Bioinformatics analysis suggests that these proteins could be involved in bacterial pathogenesis. Eleven of the 25 SEPs were recognized as major seroreactive antigens by sera from R. heilongjiangensis-infected mice and FESF patients. Among the major seroreactive SEPs, microarray assays and/or ELISAs revealed that GroEL, OmpA-2, OmpB-3, PrsA, RplY, RpsB, SurA and YbgF had modest sensitivity and specificity for recognizing R. heilongjiangensis infection and/or spotted fever. Conclusions: Many of the SEPs identified herein have potentially important roles in R. heilongjiangensis pathogenicity. Some of them have potential as serodiagnostic antigens or as subunit vaccine antigens against the disease.	[Qi, Yong; Xiong, Xiaolu; Wang, Xile; Duan, Changsong; Jia, Yinjun; Jiao, Jun; Gong, Wenping; Wen, Bohai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Wen, BH (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	wenbohai@yahoo.com	Qi, Yong/AAK-8798-2021; Jiao, Jun/ABE-7519-2021; Gong, Wenping/B-8183-2018	Qi, Yong/0000-0001-6186-9023; Gong, Wenping/0000-0002-0333-890X	National Basic Research Program of China [2010CB530200/2010CB530205]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (grant number 2010CB530200/2010CB530205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman NC, 2008, J BACTERIOL, V190, P6234, DOI 10.1128/JB.00794-08; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Ando S, 2010, EMERG INFECT DIS, V16, P1306, DOI 10.3201/eid1608.100049; Balraj P, 2009, ANN NY ACAD SCI, V1166, P94, DOI 10.1111/j.1749-6632.2009.04517.x; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Boonjakuakul JK, 2007, INFECT IMMUN, V75, P2548, DOI 10.1128/IAI.01974-06; Cardwell MM, 2009, INFECT IMMUN, V77, P5272, DOI 10.1128/IAI.00201-09; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chan YGY, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00139; Croquet-Valdes PA, 2001, VACCINE, V20, P979; Deringer JR, 2011, MICROBIOL-SGM, V157, P526, DOI 10.1099/mic.0.043513-0; Diaz-Montero CM, 2001, AM J TROP MED HYG, V65, P371, DOI 10.4269/ajtmh.2001.65.371; Duan CS, 2011, J BACTERIOL, V193, P5564, DOI 10.1128/JB.05852-11; Duan CS, 2011, AM J TROP MED HYG, V85, P504, DOI 10.4269/ajtmh.2011.10-0660; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; Farn J, 2004, INFECT IMMUN, V72, P7357, DOI 10.1128/IAI.72.12.7357-7359.2004; Fournier PE, 2003, J CLIN MICROBIOL, V41, P5456, DOI 10.1128/JCM.41.12.5456-5465.2003; Gatlin CL, 2006, PROTEOMICS, V6, P1530, DOI 10.1002/pmic.200500253; Ge Y, 2007, J BACTERIOL, V189, P7819, DOI 10.1128/JB.00866-07; Ge Y, 2007, INFECT IMMUN, V75, P3833, DOI 10.1128/IAI.00188-07; Gerken H, 2009, MOL MICROBIOL, V72, P1408, DOI 10.1111/j.1365-2958.2009.06728.x; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Heinzen RA, 2003, ANN NY ACAD SCI, V990, P535, DOI 10.1111/j.1749-6632.2003.tb07424.x; Imai K, 2008, BIOINFORMATION, V2, P417, DOI 10.6026/97320630002417; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Jiang XM, 2006, MOL MICROBIOL, V5, P695; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Konig J, 2007, FEBS J, V274, P5643, DOI 10.1111/j.1742-4658.2007.06087.x; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Li QF, 2005, ANN NY ACAD SCI, V1063, P130, DOI 10.1196/annals.1355.021; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; Lou D, 1985, CHIN J MICROBIOL IMM, V5, P250; McBride JW, 2002, INFECT IMMUN, V70, P2700, DOI 10.1128/IAI.70.5.2700-2703.2002; Mediannikov O, 2009, CLIN MICROBIOL INFEC, V15, P288, DOI 10.1111/j.1469-0691.2008.02239.x; Mediannikov OY, 2004, EMERG INFECT DIS, V10, P810, DOI 10.3201/eid1005.030437; Mendum TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005940; Meng YanFen, 2011, Chinese Journal of Zoonoses, V27, P470; Ogawa M, 2007, PROTEOMICS, V7, P1232, DOI 10.1002/pmic.200600721; Park H, 2011, J BIOL CHEM, V286, P35096, DOI 10.1074/jbc.M111.263855; Pornwiroon W, 2009, INFECT IMMUN, V77, P5262, DOI 10.1128/IAI.00911-09; Ramachandran N, 2008, NAT METHODS, V5, P535, DOI 10.1038/NMETH.1210; Renesto P, 2005, FEMS MICROBIOL LETT, V245, P231, DOI 10.1016/j.femsle.2005.03.004; Renesto P, 2006, RES MICROBIOL, V157, P605, DOI 10.1016/j.resmic.2006.02.002; Riley SP, 2010, INFECT IMMUN, V78, P1895, DOI 10.1128/IAI.01165-09; Santhanagopalan V, 2006, GENE, V369, P119, DOI 10.1016/j.gene.2005.10.030; Sears KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002856; Shpynov SN, 2006, AM J TROP MED HYG, V74, P440, DOI 10.4269/ajtmh.2006.74.440; Spence JM, 2000, INFECT IMMUN, V68, P5002, DOI 10.1128/IAI.68.9.5002-5010.2000; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; SUMNER JW, 1995, VACCINE, V13, P29, DOI 10.1016/0264-410X(95)80007-Z; Uchiyama T, 2003, ANN NY ACAD SCI, V990, P585, DOI 10.1111/j.1749-6632.2003.tb07431.x; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Vellaiswamy M, 2011, MICROB PATHOGENESIS, V50, P233, DOI 10.1016/j.micpath.2011.01.009; VISHWANATH S, 1990, INFECT IMMUN, V58, P646, DOI 10.1128/IAI.58.3.646-653.1990; Vitikainen M, 2004, J BIOL CHEM, V279, P19302, DOI 10.1074/jbc.M400861200; Williams RC, 2003, J BIOL CHEM, V278, P18056, DOI 10.1074/jbc.M301244200; Wilson DS, 2002, CURR OPIN CHEM BIOL, V6, P81, DOI 10.1016/S1367-5931(01)00281-2; Wu Yi-min, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P1173; Xiong XL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-35; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	66	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70440	10.1371/journal.pone.0070440	http://dx.doi.org/10.1371/journal.pone.0070440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894656	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000208
J	Robert, S; Khalf, M; Goulet, MC; D'Aoust, MA; Sainsbury, F; Michaud, D				Robert, Stephanie; Khalf, Moustafa; Goulet, Marie-Claire; D'Aoust, Marc-Andre; Sainsbury, Frank; Michaud, Dominique			Protection of Recombinant Mammalian Antibodies from Development-Dependent Proteolysis in Leaves of Nicotiana benthamiana	PLOS ONE			English	Article							FECAL-OCCULT-BLOOD; SERVICES TASK-FORCE; HEALTH BELIEF MODEL; COLORECTAL-CANCER; BARRIERS; SIGMOIDOSCOPY; PERCEPTIONS; COLONOSCOPY; KNOWLEDGE; CHINESE	The expression of clinically useful proteins in plants has been bolstered by the development of high-yielding systems for transient protein expression using agroinfiltration. There is a need now to know more about how host plant development and metabolism influence the quantity and quality of recombinant proteins. Endogenous proteolysis is a key determinant of the stability and yield of recombinant proteins in plants. Here we characterised cysteine (C1A) and aspartate (A1) protease profiles in leaves of the widely used expression host Nicotiana benthamiana, in relation with the production of a murine IgG, C5-1, targeted to the cell secretory pathway. Agroinfiltration significantly altered the distribution of C1A and A1 proteases along the leaf age gradient, with a correlation between leaf age and the level of proteolysis in whole-cell and apoplast protein extracts. The co-expression of tomato cystatin S/CYS8, an inhibitor of C1A proteases, alongside C5-1 increased antibody yield by nearly 40% after the usual 6-days incubation period, up to similar to 3 mg per plant. No positive effect of S/CYS8 was observed in oldest leaves, in line with an increased level of C1A protease activity and a very low expression rate of the inhibitor. By contrast, C5-1 yield was greater by an additional 40% following 8- to 10-days incubations in younger leaves, where high S/CYS8 expression was maintained. These findings confirm that the co-expression of recombinant protease inhibitors is a promising strategy for increasing recombinant protein yields in plants, but that further opportunity exists to improve this approach by addressing the influence of leaf age and proteases of other classes.	[Robert, Stephanie; Khalf, Moustafa; Goulet, Marie-Claire; Sainsbury, Frank; Michaud, Dominique] Univ Laval, Dept Phytol, Ctr Rech Hort, Quebec City, PQ G1K 7P4, Canada; [D'Aoust, Marc-Andre] Medicago Inc, Quebec City, PQ, Canada	Laval University	Sainsbury, F (corresponding author), Univ Laval, Dept Phytol, Ctr Rech Hort, Quebec City, PQ G1K 7P4, Canada.	frank.sainsbury.1@ulaval.ca; dominique.michaud@fsaa.ulaval.ca	Sainsbury, Frank/I-2311-2013	Sainsbury, Frank/0000-0001-8152-3820; Goulet, Marie-Claire/0000-0001-7538-5783	Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a Strategic project grant from the Natural Science and Engineering Research Council of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Comm Canc Prevention, 2000, EUR J CANCER, V36, P1473; Berkowitz Z, 2008, J AM GERIATR SOC, V56, P307, DOI 10.1111/j.1532-5415.2007.01547.x; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Champion V L, 1984, ANS Adv Nurs Sci, V6, P73; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goulard H., 2007, EVALUATION EPIDEMIOL; Guessous I, 2010, PREV MED, V50, P3, DOI 10.1016/j.ypmed.2009.12.005; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Katz MH, 2006, MULTIVARIABLE ANALYSIS: A PRACTICAL GUIDE FOR CLINICIANS, 2ND EDITION, P68; Klabunde CN, 2006, AM J PREV MED, V30, P313, DOI 10.1016/j.amepre.2005.11.006; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lewis SF, 1996, J GEN INTERN MED, V11, P542, DOI 10.1007/BF02599602; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; McCaffery K, 2001, SOC SCI MED, V53, P679, DOI 10.1016/S0277-9536(00)00375-0; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Rawl SM, 2000, CANCER PRACT, V8, P32, DOI 10.1046/j.1523-5394.2000.81006.x; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Saito H, 2006, J MED SCREEN, V13, pS6; Stacy R, 2008, J CANCER EDUC, V23, P238, DOI 10.1080/08858190802189030; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Sung JJY, 2008, AM J GASTROENTEROL, V103, P974, DOI 10.1111/j.1572-0241.2007.01649.x; Weller D, 2007, BRIT J CANCER, V97, P1601, DOI 10.1038/sj.bjc.6604089; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wong CKH, 2012, J EVAL CLIN PRACT, V18, P1203, DOI 10.1111/j.1365-2753.2011.01776.x; Wong MCS, 2010, ALIMENT PHARM THER, V32, P74, DOI 10.1111/j.1365-2036.2010.04312.x; Wong MCS, 2012, CANCER CAUSE CONTROL, V23, P1541, DOI 10.1007/s10552-012-0031-x	31	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70203	10.1371/journal.pone.0070203	http://dx.doi.org/10.1371/journal.pone.0070203			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894618	gold, Green Published, Green Submitted			2022-12-25	WOS:000325211000195
J	Ribacke, U; Moll, K; Albrecht, L; Ismail, HA; Normark, J; Flaberg, E; Szekely, L; Hultenby, K; Persson, KEM; Egwang, TG; Wahlgren, M				Ribacke, Ulf; Moll, Kirsten; Albrecht, Letusa; Ismail, Hodan Ahmed; Normark, Johan; Flaberg, Emilie; Szekely, Laszlo; Hultenby, Kjell; Persson, Kristina E. M.; Egwang, Thomas G.; Wahlgren, Mats			Improved In Vitro Culture of Plasmodium falciparum Permits Establishment of Clinical Isolates with Preserved Multiplication, Invasion and Rosetting Phenotypes	PLOS ONE			English	Article							SURFACE-ANTIGEN EXPRESSION; VIRULENCE PROTEIN PFEMP1; HUMAN CEREBRAL MALARIA; INFECTED ERYTHROCYTES; ALPHA-THALASSEMIA; SERUM; ASSOCIATION; CYTOADHERENCE; MECHANISM; ADHESIVE	To be able to robustly propagate P. falciparum at optimal conditions in vitro is of fundamental importance for genotypic and phenotypic studies of both established and fresh clinical isolates. Cryo-preserved P. falciparum isolates from Ugandan children with severe or uncomplicated malaria were investigated for parasite phenotypes under different in vitro growth conditions or studied directly from the peripheral blood. The parasite cultures showed a minimal loss of parasite-mass and preserved percentage of multiple infected pRBCs to that in peripheral blood, maintained adhesive phenotypes and good outgrowth and multiplication rates when grown in suspension and supplemented with gas. In contrast, abnormal and greatly fluctuating levels of multiple infections were observed during static growth conditions and outgrowth and multiplication rates were inferior. Serum, as compared to Albumax, was found necessary for optimal presentation of PfEMP1 at the pRBC surface and/or for binding of serum proteins (immunoglobulins). Optimal in vitro growth conditions of P. falciparum therefore include orbital shaking (50 rev/min), human serum (10%) and a fixed gas composition (5% O-2, 5% CO2, 90% N-2). We subsequently established 100% of 76 frozen patient isolates and found rosetting with schizont pRBCs in every isolate (>26% schizont rosetting rate). Rosetting during schizogony was often followed by invasion of the bound RBC as seen by regular and time-lapse microscopy as well as transmission electron microscopy. The peripheral parasitemia, the level of rosetting and the rate of multiplication correlated positively to one another for individual isolates. Rosetting was also more frequent with trophozoite and schizont pRBCs of children with severe versus uncomplicated malaria (p,also more frequent with trophozoite and schizont pRBCs of children with severe versus uncomplicated malaria (p<0.002; p<0.004). The associations suggest that rosetting enhances the ability of the parasite to multiply within the human host.	[Ribacke, Ulf; Moll, Kirsten; Albrecht, Letusa; Ismail, Hodan Ahmed; Normark, Johan; Flaberg, Emilie; Szekely, Laszlo; Persson, Kristina E. M.; Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Egwang, Thomas G.] Med Biotech Labs, Kampala, Uganda	Karolinska Institutet; Karolinska Institutet	Moll, K (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	kirsten.moll@ki.se; mats.wahlgren@ki.se	Albrecht, Letusa/I-1837-2012; Szekely, Laszlo/B-1268-2009	Albrecht, Letusa/0000-0001-6406-2057; Szekely, Laszlo/0000-0001-6144-6573; Persson, Kristina E M/0000-0003-2661-3115	European Union (EvimalaR); Swedish Research Council; Karolinska Institutet; Swedish International Development Cooperation Agency (Sida/SAREC)	European Union (EvimalaR); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Swedish International Development Cooperation Agency (Sida/SAREC)	The work was supported by grants from the European Union (EvimalaR), the Swedish Research Council, Karolinska Institutet, and the Swedish International Development Cooperation Agency (Sida/SAREC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RJ, MOL BIOCH PARASITOL, V169, P63; ALYAMAN F, 1995, T ROY SOC TROP MED H, V89, P55, DOI 10.1016/0035-9203(95)90658-4; Angeletti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050758; [Anonymous], 2008, METHODS MALARIA RES; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; BUTCHER GA, 1981, ANN TROP MED PARASIT, V75, P7, DOI 10.1080/00034983.1981.11687402; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Clough B, 1998, EXP PARASITOL, V89, P129, DOI 10.1006/expr.1998.4275; Cooke BM, 2004, TRENDS PARASITOL, V20, P581, DOI 10.1016/j.pt.2004.09.008; Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775; DAVID PH, 1988, AM J TROP MED HYG, V38, P289, DOI 10.4269/ajtmh.1988.38.289; Deans AM, 2006, AM J TROP MED HYG, V74, P554, DOI 10.4269/ajtmh.2006.74.554; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Frankland S, 2007, EUKARYOT CELL, V6, P1584, DOI 10.1128/EC.00063-07; Frankland S, 2006, EUKARYOT CELL, V5, P849, DOI 10.1128/EC.5.5.849-860.2006; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Gysin J, 1999, INFECT IMMUN, V67, P6596; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Horata N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-184; KAUL DK, 1991, BLOOD, V78, P812; Le Scanf C, 2008, MICROBES INFECT, V10, P447, DOI 10.1016/j.micinf.2007.12.012; Luginbuhl A, 2007, INFECT IMMUN, V75, P1771, DOI 10.1128/IAI.01514-06; LUZZI GA, 1991, IMMUNOL LETT, V30, P233, DOI 10.1016/0165-2478(91)90031-5; LUZZI GA, 1991, J EXP MED, V173, P785, DOI 10.1084/jem.173.4.785; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Mok BW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001982; MOLYNEUX ME, 1989, Q J MED, V71, P441; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 2002, AM J TROP MED HYG, V66, P692, DOI 10.4269/ajtmh.2002.66.692; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Scholander C, 1996, NAT MED, V2, P204, DOI 10.1038/nm0296-204; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Somner EA, 2000, BLOOD, V95, P674, DOI 10.1182/blood.V95.2.674; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Treutiger CJ, 1998, AM J TROP MED HYG, V59, P202, DOI 10.4269/ajtmh.1998.59.202; Treutiger CJ, 1999, EXP PARASITOL, V93, P215, DOI 10.1006/expr.1999.4454; UDEINYA IJ, 1983, EXP PARASITOL, V56, P207, DOI 10.1016/0014-4894(83)90064-4; WAHLGREN M, 1989, PARASITOL TODAY, V5, P183, DOI 10.1016/0169-4758(89)90141-5; WHO O, 2009, T R SOC TROP MED HYG, V94, P1; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190	53	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69781	10.1371/journal.pone.0069781	http://dx.doi.org/10.1371/journal.pone.0069781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894537	Green Submitted, gold, Green Published			2022-12-25	WOS:000322132100081
J	Bystrom, P; Ask, P; Andersson, J; Persson, L				Bystrom, Par; Ask, Per; Andersson, Jens; Persson, Lennart			Preference for Cannibalism and Ontogenetic Constraints in Competitive Ability of Piscivorous Top Predators	PLOS ONE			English	Article							PERCH PERCA-FLUVIATILIS; TROUT SALMO-TRUTTA; SIZE-STRUCTURED POPULATIONS; CHAR SALVELINUS-ALPINUS; ROACH RUTILUS-RUTILUS; ARCTIC CHAR; INTRAGUILD PREDATION; FORAGING CAPACITIES; NICHE SHIFTS; PREY	Occurrence of cannibalism and inferior competitive ability of predators compared to their prey have been suggested to promote coexistence in size-structured intraguild predation (IGP) systems. The intrinsic size-structure of fish provides the necessary prerequisites to test whether the above mechanisms are general features of species interactions in fish communities where IGP is common. We first experimentally tested whether Arctic char (Salvelinus alpinus) were more efficient as a cannibal than as an interspecific predator on the prey fish ninespine stickleback (Pungitius pungitius) and whether ninespine stickleback were a more efficient competitor on the shared zooplankton prey than its predator, Arctic char. Secondly, we performed a literature survey to evaluate if piscivores in general are more efficient as cannibals than as interspecific predators and whether piscivores are inferior competitors on shared resources compared to their prey fish species. Both controlled pool experiments and outdoor pond experiments showed that char imposed a higher mortality on YOY char than on ninespine sticklebacks, suggesting that piscivorous char is a more efficient cannibal than interspecific predator. Estimates of size dependent attack rates on zooplankton further showed a consistently higher attack rate of ninespine sticklebacks compared to similar sized char on zooplankton, suggesting that ninespine stickleback is a more efficient competitor than char on zooplankton resources. The literature survey showed that piscivorous top consumers generally selected conspecifics over interspecific prey, and that prey species are competitively superior compared to juvenile piscivorous species in the zooplankton niche. We suggest that the observed selectivity for cannibal prey over interspecific prey and the competitive advantage of prey species over juvenile piscivores are common features in fish communities and that the observed selectivity for cannibalism over interspecific prey has the potential to mediate coexistence in size structured intraguild predation systems.	[Bystrom, Par; Ask, Per; Andersson, Jens; Persson, Lennart] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Umea University	Bystrom, P (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	par.bystrom@emg.umu.se	Persson, Lennart/B-2885-2012		Swedish Reseach Council FORMAS; Swedish Research Council Vr	Swedish Reseach Council FORMAS(Swedish Research Council Formas); Swedish Research Council Vr(Swedish Research Council)	Financial support was provided by the Swedish Reseach Council FORMAS, to Par Bystrom and the Swedish Research Council Vr to Lennart Persson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen PA, 2003, HYDROBIOLOGIA, V497, P109, DOI 10.1023/A:1025465705717; AMUNDSEN PA, 1994, J FISH BIOL, V45, P181, DOI 10.1006/jfbi.1994.1222; Bizina EV, 2000, ZH OBSHCH BIOL, V61, P601; Bystrom P, 2006, J ANIM ECOL, V75, P434, DOI 10.1111/j.1365-2656.2006.01064.x; Bystrom P, 1998, ECOLOGY, V79, P2153, DOI 10.1890/0012-9658(1998)079[2153:CPAPJB]2.0.CO;2; Bystrom P, 2005, OIKOS, V110, P523, DOI 10.1111/j.0030-1299.2005.13543.x; Bystrom P, 2004, OIKOS, V104, P109, DOI 10.1111/j.0030-1299.2004.12759.x; Bystrom P, 2007, FRESHWATER BIOL, V52, P1271, DOI 10.1111/j.1365-2427.2007.01763.x; CHRISTENSEN B, 1993, BEHAV ECOL SOCIOBIOL, V32, P1; Claessen D, 2004, P ROY SOC B-BIOL SCI, V271, P333, DOI 10.1098/rspb.2003.2555; Claessen D, 2000, AM NAT, V155, P219, DOI 10.1086/303315; Diehl S, 2000, AM NAT, V155, P200, DOI 10.1086/303319; Dorner H, 2007, ECOL FRESHW FISH, V16, P307, DOI 10.1111/j.1600-0633.2006.00223.x; Dorner H, 2003, HYDROBIOLOGIA, V506, P427, DOI 10.1023/B:HYDR.0000008608.22869.99; EKLOV P, 1989, OIKOS, V56, P149, DOI 10.2307/3565330; Finstad AG, 2001, ECOL FRESHW FISH, V10, P220, DOI 10.1034/j.1600-0633.2001.100404.x; Grey J, 2002, FRESHWATER BIOL, V47, P1235, DOI 10.1046/j.1365-2427.2002.00838.x; Hammar J, 2000, OIKOS, V88, P33, DOI 10.1034/j.1600-0706.2000.880105.x; HANSSON S, 1990, J PLANKTON RES, V12, P1099, DOI 10.1093/plankt/12.5.1099; Hin V, 2011, AM NAT, V178, P701, DOI 10.1086/662676; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; Ivlev V. S, 1961, EXPT ECOLOGY FEEDING, P302; Jansen PA, 2002, CAN J FISH AQUAT SCI, V59, P6, DOI 10.1139/F01-184; Juanes F, 2003, CAN J FISH AQUAT SCI, V60, P594, DOI 10.1139/F03-051; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; KOHLMEIER C, 1995, B MATH BIOL, V57, P401, DOI 10.1007/BF02460632; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LIVINGSTON PA, 1993, MAR ECOL PROG SER, V102, P205, DOI 10.3354/meps102205; MACPHERSON E, 1994, MAR BIOL, V119, P145, DOI 10.1007/BF00350116; Mahe K, 2007, ICES J MAR SCI, V64, P1210, DOI 10.1093/icesjms/fsm100; Mylius SD, 2001, AM NAT, V158, P259, DOI 10.1086/321321; Ohlberger J, 2012, AM NAT, V180, P791, DOI 10.1086/668080; OLSON MH, 1995, ECOLOGY, V76, P1758, DOI 10.2307/1940708; Persson A, 2002, ECOLOGY, V83, P3014; Persson A, 2002, OIKOS, V97, P271, DOI 10.1034/j.1600-0706.2002.970213.x; Persson L, 2000, ECOLOGY, V81, P1058; PERSSON L, 1990, ECOLOGY, V71, P44, DOI 10.2307/1940246; PERSSON L, 1987, OECOLOGIA, V73, P170, DOI 10.1007/BF00377504; Persson L., 1988, P203; PERSSON L, 1995, ECOLOGY, V76, P70, DOI 10.2307/1940632; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Rudolf VHW, 2008, ECOLOGY, V89, P1650, DOI 10.1890/07-0709.1; Rudolf VHW, 2007, ECOLOGY, V88, P2697, DOI 10.1890/06-1266.1; SAVINO JF, 1989, ANIM BEHAV, V37, P311, DOI 10.1016/0003-3472(89)90120-6; Smith C., 1991, Reviews in Fish Biology and Fisheries, V1, P41, DOI 10.1007/BF00042661; Werner E.E., 1988, P60; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WERNER EE, 1977, AM NAT, V111, P553, DOI 10.1086/283184; Weyl OLF, 1999, ENVIRON BIOL FISH, V54, P53, DOI 10.1023/A:1007452320609; Wilbur H.M., 1988, P157; WITTE F, 1992, ENVIRON BIOL FISH, V34, P1, DOI 10.1007/BF00004782	53	17	18	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70404	10.1371/journal.pone.0070404	http://dx.doi.org/10.1371/journal.pone.0070404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894650	Green Published, Green Submitted, gold			2022-12-25	WOS:000322391400088
J	Mosbech, MB; Kruse, R; Harvald, EB; Olsen, ASB; Gallego, SF; Hannibal-Bach, HK; Ejsing, CS; Faergeman, NJ				Mosbech, Mai-Britt; Kruse, Rikke; Harvald, Eva Bang; Olsen, Anne Sofie Braun; Gallego, Sandra Fernandez; Hannibal-Bach, Hans Kristian; Ejsing, Christer S.; Faergeman, Nils J.			Functional Loss of Two Ceramide Synthases Elicits Autophagy-Dependent Lifespan Extension in C. elegans	PLOS ONE			English	Article							RESTRICTION-INDUCED LONGEVITY; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; GENETICS; LAG1; INHIBITOR; PATHWAYS; HOMOLOGS; SURVIVAL; LIPIDOME	Ceramide and its metabolites constitute a diverse group of lipids, which play important roles as structural entities of biological membranes as well as regulators of cellular growth, differentiation, and development. The C. elegans genome comprises three ceramide synthase genes; hyl-1, hyl-2, and lagr-1. HYL-1 function is required for synthesis of ceramides and sphingolipids containing very long acyl-chains (>= C24), while HYL-2 is required for synthesis of ceramides and sphingolipids containing shorter acyl-chains (<= C22). Here we show that functional loss of HYL-2 decreases lifespan, while loss of HYL-1 or LAGR-1 does not affect lifespan. We show that loss of HYL-1 and LAGR-1 functions extend lifespan in an autophagy-dependent manner, as knock down of the autophagy-associated gene ATG-12 abolishes hyl-1; lagr-1 longevity. The transcription factors PHA-4/FOXA, DAF-16/FOXO, and SKN-1 are also required for the observed lifespan extension, as well as the increased number of autophagosomes in hyl-1; lagr-1 animals. Both autophagic events and the transcription factors PHA-4/FOXA, DAF-16, and SKN-1 have previously been associated with dietary restriction-induced longevity. Accordingly, we find that hyl-1; lagr-1 animals display reduced feeding, increased resistance to heat, and reduced reproduction. Collectively, our data suggest that specific sphingolipids produced by different ceramide synthases have opposing roles in determination of C. elegans lifespan. We propose that loss of HYL-1 and LAGR-1 result in dietary restriction-induced autophagy and consequently prolonged longevity.	[Mosbech, Mai-Britt; Kruse, Rikke; Harvald, Eva Bang; Olsen, Anne Sofie Braun; Gallego, Sandra Fernandez; Hannibal-Bach, Hans Kristian; Ejsing, Christer S.; Faergeman, Nils J.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Southern Denmark	Faergeman, NJ (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark.	nils.f@bmb.sdu.dk	Ejsing, Christer S/R-5922-2016	Faergeman, Nils/0000-0002-9281-5287; Harvald, Eva/0000-0002-3536-3886; F. Gallego, Sandra/0000-0001-7960-9860; Ejsing, Christer S./0000-0003-4963-0276	Danish Research Council for Independent Research [23363, 09-072484]; Novo-Nordisk Foundation [13514]; Lundbeckfonden [95-310-13591]	Danish Research Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo-Nordisk Foundation(Novo Nordisk Foundation); Lundbeckfonden(Lundbeckfonden)	The present work was supported by funds from The Danish Research Council for Independent Research (grant numbers 23363 (NJF), 09-072484 (CSE)), The Novo-Nordisk Foundation (grant number 13514 (NJF)), and Lundbeckfonden (95-310-13591 (CSE)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Beljanski V, 2010, J PHARMACOL EXP THER, V333, P454, DOI 10.1124/jpet.109.163337; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BRENNER S, 1974, GENETICS, V77, P71; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Guillas I, 2003, J BIOL CHEM, V278, P37083, DOI 10.1074/jbc.M307554200; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hars ES, 2007, AUTOPHAGY, V3, P93, DOI 10.4161/auto.3636; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lapierre LR, 2012, TRENDS ENDOCRIN MET, V23, P637, DOI 10.1016/j.tem.2012.07.007; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lavieu G, 2007, AUTOPHAGY, V3, P45, DOI 10.4161/auto.3416; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Marza E, 2009, J CELL SCI, V122, P822, DOI 10.1242/jcs.042754; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Munoz MJ, 2003, MECH AGEING DEV, V124, P43, DOI 10.1016/S0047-6374(02)00168-9; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Tedesco P, 2008, AGE, V30, P43, DOI 10.1007/s11357-008-9046-3	40	43	48	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70087	10.1371/journal.pone.0070087	http://dx.doi.org/10.1371/journal.pone.0070087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894595	Green Submitted, gold, Green Published			2022-12-25	WOS:000322391400081
J	Thotala, D; Craft, JM; Ferraro, DJ; Kotipatruni, RP; Bhave, SR; Jaboin, JJ; Hallahan, DE				Thotala, Dinesh; Craft, Jeffrey M.; Ferraro, Daniel J.; Kotipatruni, Rama P.; Bhave, Sandeep R.; Jaboin, Jerry J.; Hallahan, Dennis E.			Cytosolic PhospholipaseA2 Inhibition with PLA-695 Radiosensitizes Tumors in Lung Cancer Animal Models	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; ENDOTHELIAL-CELLS; ANGIOGENESIS; A(2); RADIOTHERAPY; THERAPY; ACTIVATION; A(2)-ALPHA; INDUCTION; MECHANISM	Lung cancer remains the leading cause of cancer deaths in the United States and the rest of the world. The advent of molecularly directed therapies holds promise for improvement in therapeutic efficacy. Cytosolic phospholipase A2 (cPLA(2)) is associated with tumor progression and radioresistance in mouse tumor models. Utilizing the cPLA(2) specific inhibitor PLA-695, we determined if cPLA2 inhibition radiosensitizes non small cell lung cancer (NSCLC) cells and tumors. Treatment with PLA-695 attenuated radiation induced increases of phospho-ERK and phospho-Akt in endothelial cells. NSCLC cells (LLC and A549) co-cultured with endothelial cells (bEND3 and HUVEC) and pre-treated with PLA-695 showed radiosensitization. PLA-695 in combination with irradiation (IR) significantly reduced migration and proliferation in endothelial cells (HUVEC & bEND3) and induced cell death and attenuated invasion by tumor cells (LLC & A549). In a heterotopic tumor model, the combination of PLA-695 and radiation delayed growth in both LLC and A549 tumors. LLC and A549 tumors treated with a combination of PLA-695 and radiation displayed reduced tumor vasculature. In a dorsal skin fold model of LLC tumors, inhibition of cPLA(2) in combination with radiation led to enhanced destruction of tumor blood vessels. The anti-angiogenic effects of PLA-695 and its enhancement of the efficacy of radiotherapy in mouse models of NSCLC suggest that clinical trials for its capacity to improve radiotherapy outcomes are warranted.	[Thotala, Dinesh; Craft, Jeffrey M.; Ferraro, Daniel J.; Kotipatruni, Rama P.; Jaboin, Jerry J.; Hallahan, Dennis E.] Washington Univ, Dept Radiat Oncol, St Louis, MO 63130 USA; [Thotala, Dinesh; Jaboin, Jerry J.; Hallahan, Dennis E.] Washington Univ, Siteman Canc Ctr, St Louis, MO USA; [Hallahan, Dennis E.] Washington Univ, Hope Ctr, St Louis, MO USA; [Hallahan, Dennis E.] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO USA; [Bhave, Sandeep R.] Washington Univ, Sch Med, St Louis, MO USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hallahan, DE (corresponding author), Washington Univ, Dept Radiat Oncol, St Louis, MO 63130 USA.	dhallahan@radonc.wustl.edu	K, R/F-5701-2011	K, R/0000-0001-9853-2686	NIH [R01-CA12575706, R01-CA14022002]; Department of Radiation Oncology; Washington University in Saint Louis; Pfizer Inc.	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Radiation Oncology; Washington University in Saint Louis; Pfizer Inc.(Pfizer)	NIH grants R01-CA12575706 and R01-CA14022002, Startup funds for Thotala from Department of Radiation Oncology, Siteman Cancer Research Fund from Washington University in Saint Louis and Grant from Pfizer Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambesi A, 2009, MOL CANCER RES, V7, P255, DOI 10.1158/1541-7786.MCR-08-0195; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Chakraborti S, 2003, CELL SIGNAL, V15, P637, DOI 10.1016/S0898-6568(02)00144-4; Clamon G, 1999, J CLIN ONCOL, V17, P4, DOI 10.1200/JCO.1999.17.1.4; Das A, 2001, J INFECT DIS, V184, P732, DOI 10.1086/322986; Elshaikh M, 2006, ANNU REV MED, V57, P19, DOI 10.1146/annurev.med.57.121304.131431; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Folkman J, 2001, J NATL CANCER I, V93, P734, DOI 10.1093/jnci/93.10.734; Fujita Y, 2006, ENDOCRINOLOGY, V147, P1377, DOI 10.1210/en.2005-0644; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Grewal S, 2005, FEBS J, V272, P1278, DOI 10.1111/j.1742-4658.2005.04565.x; Heasley LE, 1997, J BIOL CHEM, V272, P14501, DOI 10.1074/jbc.272.23.14501; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Herbert SP, 2007, J BIOL CHEM, V282, P34468, DOI 10.1074/jbc.M701541200; Herbert SP, 2009, J BIOL CHEM, V284, P5784, DOI 10.1074/jbc.M807282200; Kleibeuker EA, 2012, DRUG RESIST UPDATE, V15, P173, DOI 10.1016/j.drup.2012.04.002; Koh PK, 2012, CANCER TREAT REV, V38, P626, DOI 10.1016/j.ctrv.2011.11.003; Lee JH, 1999, RADIOLOGY, V213, P845, DOI 10.1148/radiology.213.3.r99dc23845; LEUNIG M, 1992, CANCER RES, V52, P6553; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Linkous A, 2010, CELL MICROBIOL, V12, P1369, DOI 10.1111/j.1462-5822.2010.01505.x; Linkous A, 2009, CLIN CANCER RES, V15, P1635, DOI 10.1158/1078-0432.CCR-08-1905; Linkous AG, 2010, JNCI-J NATL CANCER I, V102, P1398, DOI 10.1093/jnci/djq290; Nakanishi M, 2006, BBA-MOL CELL BIOL L, V1761, P1335, DOI 10.1016/j.bbalip.2006.09.005; Ringborg U, 2003, ACTA ONCOL, V42, P357, DOI 10.1080/02841860310010826; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Valerie K, 2007, MOL CANCER THER, V6, P789, DOI 10.1158/1535-7163.MCT-06-0596; Wagner H, 2000, CHEST, V117, p110S, DOI 10.1378/chest.117.4_suppl_1.110S; Yazlovitskaya EM, 2008, CELL DEATH DIFFER, V15, P1641, DOI 10.1038/cdd.2008.93; Zhang HL, 2009, CANCER RES, V69, P5441, DOI 10.1158/0008-5472.CAN-09-0302; Zhao M, 2001, FEBS LETT, V509, P399, DOI 10.1016/S0014-5793(01)03184-2	33	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69688	10.1371/journal.pone.0069688	http://dx.doi.org/10.1371/journal.pone.0069688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894523	gold, Green Published, Green Submitted			2022-12-25	WOS:000322391400065
J	Khan, S; Fung, KW; Rodriguez, E; Patel, R; Gor, J; Mulloy, B; Perkins, SJ				Khan, Sanaullah; Fung, Ka Wai; Rodriguez, Elizabeth; Patel, Rima; Gor, Jayesh; Mulloy, Barbara; Perkins, Stephen J.			The Solution Structure of Heparan Sulfate Differs from That of Heparin IMPLICATIONS FOR FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; NEUTRON-SCATTERING; SEDIMENTATION-VELOCITY; SOLUTION CONFORMATION; PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; AQUEOUS-SOLUTION; PROTEOGLYCANS; BINDING; DOMAINS	The highly sulfated polysaccharides heparin and heparan sulfate (HS) play key roles in the regulation of physiological and pathophysiological processes. Despite its importance, no molecular structures of free HS have been reported up to now. By combining analytical ultracentrifugation, small angle x-ray scattering, and constrained scattering modeling recently used for heparin, we have analyzed the solution structures for eight purified HS fragments dp6-dp24 corresponding to the predominantly unsulfated GlcA-GlcNAc domains of heparan sulfate. Unlike heparin, the sedimentation coefficient s(20,w) of HS dp6-dp24 showed a small rotor speed dependence, where similar s(20,w) values of 0.82-1.26 S (absorbance optics) and 1.05-1.34 S (interference optics) were determined. The corresponding x-ray scattering measurements of HS dp6-dp24 gave radii of gyration R-G values from 1.03 to 2.82 nm, cross-sectional radii of gyration R-XS values from 0.31 to 0.65 nm, and maximum lengths L from 3.0 to 10.0 nm. These data showed that HS has a longer and more bent structure than heparin. Constrained scattering modeling starting from 5,000 to 12,000 conformationally randomized HS structures gave best fit dp6-dp24 molecular structures that were longer and more bent than their equivalents in heparin. Alternative fits were obtained for HS dp18 and dp24, indicating their higher bending and flexibility. We conclude that HS displays bent conformations that are significantly distinct from that for heparin. The difference is attributed to the different predominant monosaccharide sequence and reduced sulfation of HS, indicating that HS may interact differently with proteins compared with heparin.	[Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Mulloy, Barbara] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosciences Lab, London W12 0NN, England	University of London; University College London; Imperial College London	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk	KHAN, SANAULLAH/A-8386-2015	KHAN, SANAULLAH/0000-0003-2480-6239	Higher Education Commission of Pakistan; Biotechnology and Biological Sciences Research Council; Henry Smith Charity; Mercer Fund of the Fight for Sight Charity; BBSRC [BB/E013104/1] Funding Source: UKRI; EPSRC [EP/K039121/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K039121/1] Funding Source: researchfish; Medical Research Council [1076433] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA006973, T32CA009071] Funding Source: NIH RePORTER	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Henry Smith Charity; Mercer Fund of the Fight for Sight Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Higher Education Commission of Pakistan, the Biotechnology and Biological Sciences Research Council, the Henry Smith Charity, and the Mercer Fund of the Fight for Sight Charity.	Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CASU B, 1983, ARZNEIMITTELFORSCH, V33-1, P135; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Conrad H. E., 1998, HEPARIN BINDING PROT; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Dam J, 2004, METHOD ENZYMOL, V384, P185; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; FUJIWARA S, 1984, EUR J BIOCHEM, V143, P145, DOI 10.1111/j.1432-1033.1984.tb08353.x; Furtado PB, 2008, J MOL BIOL, V375, P102, DOI 10.1016/j.jmb.2007.09.085; Gallagher J T, 2012, Handb Exp Pharmacol, P347, DOI 10.1007/978-3-642-23056-1_15; GALLAGHER JT, 1992, ADV EXP MED BIOL, V313, P49; Gilbert HE, 2006, J MOL BIOL, V362, P1132, DOI 10.1016/j.jmb.2006.08.012; Glatter O., 1982, SMALL ANGLE X RAY SC; Hricovini M, 1997, CARBOHYD RES, V300, P69, DOI 10.1016/S0008-6215(97)00036-0; Khan S, 2012, BIOCHEM J, V444, P417, DOI 10.1042/BJ20120183; Khan S, 2011, J BIOL CHEM, V286, P24842, DOI 10.1074/jbc.M111.226027; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE DL, 1989, HEPARIN CHEM BIOL PR; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; Lutteke T, 2009, ACTA CRYSTALLOGR D, V65, P156, DOI 10.1107/S0907444909001905; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Lyon M, 1998, MATRIX BIOL, V17, P485, DOI 10.1016/S0945-053X(98)90096-8; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Mobli M, 2008, GLYCOCONJUGATE J, V25, P401, DOI 10.1007/s10719-007-9081-9; MULLOY B, 1994, CARBOHYD RES, V255, P1, DOI 10.1016/S0008-6215(00)90968-6; Mulloy B, 1997, THROMB HAEMOSTASIS, V77, P668; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; Pavlov G, 2003, EUR BIOPHYS J BIOPHY, V32, P437, DOI 10.1007/s00249-003-0316-9; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Perkins SJ, 1998, INT J BIOL MACROMOL, V22, P1, DOI 10.1016/S0141-8130(97)00088-3; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; PERKINS SJ, 1983, J MOL BIOL, V168, P847, DOI 10.1016/S0022-2836(83)80078-3; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877; Powell AK, 2010, NAT PROTOC, V5, P821, DOI 10.1038/nprot.2010.17; RICE KG, 1985, ANAL BIOCHEM, V150, P325, DOI 10.1016/0003-2697(85)90518-4; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Sasisekharan R, 1997, Angiogenesis, V1, P45, DOI 10.1023/A:1018318914258; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shaya D, 2010, J BIOL CHEM, V285, P20051, DOI 10.1074/jbc.M110.101071; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; STEVENS ES, 1989, J AM CHEM SOC, V111, P4149, DOI 10.1021/ja00194a001; Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508; Stringer SE, 2002, BLOOD, V100, P1543, DOI 10.1182/blood.V100.5.1543.h81702001543_1543_1550; Vives RR, 2001, BIOCHEM J, V354, P141, DOI 10.1042/0264-6021:3540141	59	29	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27737	27751		10.1074/jbc.M113.492223	http://dx.doi.org/10.1074/jbc.M113.492223			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23921391	hybrid, Green Published			2022-12-25	WOS:000330612800004
J	Herrera, I; Cisneros, J; Maldonado, M; Ramirez, R; Ortiz-Quintero, B; Anso, E; Chandel, NS; Selman, M; Pardo, A				Herrera, Iliana; Cisneros, Jose; Maldonado, Mariel; Ramirez, Remedios; Ortiz-Quintero, Blanca; Anso, Elena; Chandel, Navdeep S.; Selman, Moises; Pardo, Annie			Matrix Metalloproteinase (MMP)-1 Induces Lung Alveolar Epithelial Cell Migration and Proliferation, Protects from Apoptosis, and Represses Mitochondrial Oxygen Consumption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; I COLLAGEN; EXPRESSION; PATHOGENESIS; METABOLISM; EMPHYSEMA; THERAPY; RELEASE	Idiopathic pulmonary fibrosis is a devastating lung disorder of unknown etiology. Although its pathogenesis is unclear, considerable evidence supports an important role of aberrantly activated alveolar epithelial cells (AECs), which produce a large variety of mediators, including several matrix metalloproteases (MMPs), which participate in fibroblast activation and lung remodeling. MMP-1 has been shown to be highly expressed in AECs from idiopathic pulmonary fibrosis lungs although its role is unknown. In this study, we explored the role of MMP-1 in several AECs functions. Mouse lung epithelial cells (MLE12) transfected with human Mmp-1 showed significantly increased cell growth and proliferation at 36 and 48 h of culture (p < 0.01). Also, MMP-1 promoted MLE12 cell migration through collagen I, accelerated wound closing, and protected cells from staurosporine- and bleomycin-induced apoptosis compared with mock cells (p < 0.01). MLE12 cells expressing human MMP-1 showed a significant repression of oxygen consumption ratio compared with the cells with the empty vector. As under hypoxic conditions hypoxia-inducible factor-1 alpha (HIF-1 alpha) mediates a transition from oxidative to glycolytic metabolism, we analyzed activation of HIF-1 alpha. Higher activation of this factor was detected in MMP-1-transfected cells under normoxia and hypoxia. Likewise, a significant decrease of both total and mitochondrial reactive oxygen species was observed in MMP-1-transfected cells. Paralleling these findings, attenuation of MMP-1 expression by shRNA in A549 (human) AECs markedly reduced proliferation and migration (p < 0.01) and increased the oxygen consumption ratio. These findings indicate that epithelial expression of MMP-1 inhibits mitochondrial function, increases HIF-1 alpha expression, decreases reactive oxygen species production, and contributes to a proliferative, migratory, and anti-apoptotic AEC phenotype.	[Herrera, Iliana; Maldonado, Mariel; Ramirez, Remedios; Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico; [Cisneros, Jose; Ortiz-Quintero, Blanca; Selman, Moises] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City 14080, DF, Mexico; [Anso, Elena; Chandel, Navdeep S.] Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	Universidad Nacional Autonoma de Mexico; Northwestern University	Pardo, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Ciudad Univ, Mexico City 04510, DF, Mexico.	apardos@unam.mx		Maldonado, Mariel/0000-0002-4227-2704; Cisneros, Jose/0000-0002-4592-4464; ortiz, blanca/0000-0001-6298-0073; HERRERA, ILIANA/0000-0002-4086-7456	Consejo Nacional de Ciencia y Tecnologia, Mexico [177641]; UNAM	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported by Consejo Nacional de Ciencia y Tecnologia, Mexico Grant 177641.; This paper constitutes a partial fulfillment of the Graduate Program in Bio-medical Sciences of the Universidad Nacional Autonoma de Mexico (UNAM). Supported by the Consejo Nacional de Ciencia y Tecnologia, Mexico and UNAM.	Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Conant K, 2002, J NEUROCHEM, V82, P885, DOI 10.1046/j.1471-4159.2002.01038.x; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; Hamanaka RB, 2012, J EXP MED, V209, P211, DOI 10.1084/jem.20120162; Hamanaka RB, 2011, SCIENCE, V334, P1219, DOI 10.1126/science.1215637; Hatfield KJ, 2010, CURR MED CHEM, V17, P4448; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Limb GA, 2005, AM J PATHOL, V166, P1555, DOI 10.1016/S0002-9440(10)62371-1; Martins VL, 2013, CELL TISSUE RES, V351, P255, DOI 10.1007/s00441-012-1410-z; Mateos J, 2012, J PROTEOMICS, V75, P2869, DOI 10.1016/j.jprot.2011.12.042; McColgan P, 2009, INT J CANCER, V125, P1473, DOI 10.1002/ijc.24441; Mercer BA, 2004, J BIOL CHEM, V279, P17690, DOI 10.1074/jbc.M313842200; Nakayama K, 2013, J BIOL CHEM, V288, P22584, DOI 10.1074/jbc.M112.421636; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pardo A, 2008, INT J BIOCHEM CELL B, V40, P1141, DOI 10.1016/j.biocel.2007.11.020; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Rajah Roopa, 1995, Progress in Growth Factor Research, V6, P273, DOI 10.1016/0955-2235(95)00012-7; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Tzouvelekis A, 2007, AM J RESP CRIT CARE, V176, P1108, DOI 10.1164/rccm.200705-683OC; WALAKOVITS LA, 1992, ARTHRITIS RHEUM, V35, P35, DOI 10.1002/art.1780350106; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	32	76	79	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25964	25975		10.1074/jbc.M113.459784	http://dx.doi.org/10.1074/jbc.M113.459784			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23902766	Green Published, hybrid			2022-12-25	WOS:000330623300027
J	Bowers, AS; Reid, HL; Greenidge, A; Landis, C; Reid, M				Bowers, Andre S.; Reid, Harvey L.; Greenidge, Andre; Landis, Clive; Reid, Marvin			Blood Viscosity and the Expression of Inflammatory and Adhesion Markers in Homozygous Sickle Cell Disease Subjects with Chronic Leg Ulcers	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; OXYGEN DELIVERY INDEX; PULMONARY-HYPERTENSION; LACTATE-DEHYDROGENASE; FACTOR-ALPHA; SS DISEASE; TNF-ALPHA; ULCERATION; INTERLEUKIN-1; AMPUTATION	Objective: To determine differences in TNF-alpha, IL-1 beta, IL-10, sICAM-1 concentrations, leg hypoxia and whole blood viscosity (WBV) at shear rates of 46 sec(-1) and 230 sec(-1) in persons with homozygous S sickle cell disease (SCD) with and without chronic leg ulceration and in AA genotype controls. Design: & Methods: fifty-five age-matched participants were recruited into the study: 31 SS subjects without leg ulcers (SSn), 24 SS subjects with leg ulcers (SSu) and 18 AA controls. Haematological indices were measured using an AC. Tron Coulter Counter. Quantification of inflammatory, anti-inflammatory and adhesion molecules was performed by ELISA. Measurement of whole blood viscosity was done using a Wells Brookfield cone-plate viscometer. Quantification of microvascular tissue oxygenation was done by Visible Lightguide spectrophotometry. Results: TNF-alpha and whole blood viscosity at 46 sec(-1) and 230 sec(-1) (1.75, 2.02 vs. 0.83, 1.26, p<0.05) were significantly greater in sickle cell disease subjects than in controls. There were no differences in plasma concentration of sICAM-1, IL-1 beta and IL-10 between SCD subjects and controls. IL-1 beta (median, IQR: 0.96, 1.7 vs. 0, 0.87; p<0.01) and sICAM-1 (226.5, 156.48 vs. 107.63, 121.5, p<0.005) were significantly greater in SSu group compared with SSn. However there were no differences in TNF-alpha (2, 3.98 vs. 0, 2.66) and IL-10 (13.34, 5.95 vs. 11.92, 2.99) concentrations between SSu and SSn. WBV in the SSu group at 46 sec(-1) and at 230 Sec 1 were 1.9 (95%CI; 1.2, 3.1) and 2.3 (1.2, 4.4) times greater than in the SSn group. There were no differences in the degree of tissue hypoxia as determined by lightguide spectrophotometry. Conclusion: Inflammatory, adhesion markers and WBV may be associated with leg ulceration in sickle cell disease by way of inflammation-mediated vasoocclusion/vasoconstriction. Impaired skin oxygenation does not appear to be associated with chronic ulcers in these subjects with sickle cell disease.	[Bowers, Andre S.; Reid, Harvey L.] Univ W Indies, Dept Basic Med Sci, Physiol Sect, Kingston 7, Jamaica; [Greenidge, Andre; Landis, Clive] Univ W Indies, Chron Dis Res Ctr, Edmund Cohen Lab Vasc Res, St Michael, Barbados; [Reid, Marvin] Univ W Indies, Res Inst Trop Med, Sickle Cell Unit, Kingston 7, Jamaica	University West Indies Mona Jamaica; University West Indies Mona Jamaica; University of the West Indies Open Campus; University West Indies Mona Jamaica	Bowers, AS (corresponding author), Univ W Indies, Dept Basic Med Sci, Physiol Sect, Kingston 7, Jamaica.	andre.bowers@uwimona.edu.jm	Reid, Marvin/J-2884-2014	Reid, Marvin/0000-0003-4005-9384	Office of Graduate Studies and Research, University of the West Indies, Mona	Office of Graduate Studies and Research, University of the West Indies, Mona	Funding was provided by the Office of Graduate Studies and Research, University of the West Indies, Mona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouaesha F, 2001, DIABETES CARE, V24, P1270, DOI 10.2337/diacare.24.7.1270; Alexy T, 2006, TRANSFUSION, V46, P912, DOI 10.1111/j.1537-2995.2006.00823.x; ALLEYNE SI, 1977, SOUTHERN MED J, V70, P213, DOI 10.1097/00007611-197702000-00033; Ashley-Koch AE, 2008, BLOOD, V111, P5721, DOI 10.1182/blood-2007-02-074849; Asleh R, 2005, VASC HEALTH RISK MAN, V1, P19, DOI 10.2147/vhrm.1.1.19.58930; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; BAUER KA, 1989, BLOOD, V74, P165; Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Bijl M, 2003, NETH J MED, V61, P273; Bogar L, 2006, CLIN HEMORHEOL MICRO, V35, P99; Bogar L, 2005, EUR J CLIN INVEST, V35, P687, DOI 10.1111/j.1365-2362.2005.01562.x; Bowers AS, 2009, BRIT J BIOMED SCI, V66, P148, DOI 10.1080/09674845.2009.11730262; Bowers AS, 2008, CLIN HEMORHEOL MICRO, V40, P303, DOI 10.3233/CH-2008-1142; CROIZAT H, 1994, BRIT J HAEMATOL, V87, P592, DOI 10.1111/j.1365-2141.1994.tb08318.x; Cumming V, 2008, BRIT J HAEMATOL, V142, P119, DOI 10.1111/j.1365-2141.2008.07115.x; de Montalembert M, 2007, HAEMATOLOGICA, V92, P1709, DOI 10.3324/haematol.11253; Fitzhugh CD, 2010, AM J HEMATOL, V85, P36, DOI 10.1002/ajh.21569; FRANCIS RB, 1992, J NATL MED ASSOC, V84, P611; GNIADECKA M, 1994, ACTA DERM-VENEREOL, V74, P191; Harrison DK, 2005, ADV EXP MED BIOL, V566, P325; Harrison DK, 1995, PROSTHET ORTHOT INT, V19, P139; Harrison DK, 1996, ADV EXP MED BIOL, V388, P45; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; HERZYK DJ, 1992, J IMMUNOL, V149, P3052; JONECKIS CC, 1993, BLOOD, V82, P3548; Kameneva MV, 1999, CLIN HEMORHEOL MICRO, V21, P357; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; KOSHY M, 1989, BLOOD, V74, P1403; Kuvibidila S, 1997, J NATL MED ASSOC, V89, P609; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; MALAVE I, 1993, ACTA HAEMATOL-BASEL, V90, P172; Mohan J, 1998, CLIN SCI, V94, P111, DOI 10.1042/cs0940111; Mohan JS, 1997, CLIN SCI, V92, P153, DOI 10.1042/cs0920153; Mohan JS, 2000, CLIN SCI, V98, P667, DOI 10.1042/CS20000004; Morel C, 2001, J FR OPHTALMOL, V24, P987; MOVAT HZ, 1987, J LAB CLIN MED, V110, P668; Musa BOP, 2010, CLIN VACCINE IMMUNOL, V17, P602, DOI 10.1128/CVI.00145-09; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; POBER JS, 1986, J IMMUNOL, V136, P1680; POWARS D, 1990, SEMIN HEMATOL, V27, P360; Quimby KR, 2010, RHEUMATOLOGY, V49, P2454, DOI 10.1093/rheumatology/keq227; Rajbhandari SM, 1999, DIABETES CARE, V22, P1292, DOI 10.2337/diacare.22.8.1292; RATLIFF DA, 1984, BRIT J SURG, V71, P219, DOI 10.1002/bjs.1800710320; Ribeiro SP, 1996, AM J RESP CRIT CARE, V154, P1843, DOI 10.1164/ajrccm.154.6.8970379; SERJEANT GR, 1974, ARCH INTERN MED, V133, P690, DOI 10.1001/archinte.133.4.690; SERJEANT RG, 2001, SICKLE CELL DIS, V56; Shin YT, 2000, BLOOD, V95, P3232; Singh DB, 2008, ADV EXP MED BIOL, V614, P227, DOI 10.1007/978-0-387-74911-2_26; Smith Philip Coleridge, 2006, Int J Low Extrem Wounds, V5, P160, DOI 10.1177/1534734606292429; Sohn MW, 2011, DIABETES-METAB RES, V27, P402, DOI 10.1002/dmrr.1193; SWERLICK RA, 1993, J INVEST DERMATOL, V100, pS111, DOI 10.1111/1523-1747.ep12356595; THOMAS AN, 1982, BRIT MED J, V285, P633, DOI 10.1136/bmj.285.6342.633; THOMSON APJ, 1988, CLIN LAB HAEMATOL, V10, P397; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; Tsushima N, 1996, DIABETES, V45, pS101, DOI 10.2337/diab.45.3.S101; Upchurch G R Jr, 1997, Cardiovasc Surg, V5, P32, DOI 10.1016/S0967-2109(96)00070-1; Volpe F, 1997, FEBS LETT, V419, P41, DOI 10.1016/S0014-5793(97)01426-9	58	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e68929	10.1371/journal.pone.0068929	http://dx.doi.org/10.1371/journal.pone.0068929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922670	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900014
J	Domenech, R; Hernandez-Cifre, JG; Bacarizo, J; Diez-Pena, AI; Martinez-Rodriguez, S; Cavasotto, CN; de la Torre, JG; Camara-Artigas, A; Velazquez-Campoy, A; Neira, JL				Domenech, Rosa; Hernandez-Cifre, Jose G.; Bacarizo, Julio; Diez-Pena, Ana I.; Martinez-Rodriguez, Sergio; Cavasotto, Claudio N.; Garcia de la Torre, Jose; Camara-Artigas, Ana; Velazquez-Campoy, Adrian; Neira, Jose L.			The Histidine-Phosphocarrier Protein of the Phosphoenolpyruvate: Sugar Phosphotransferase System of Bacillus sphaericus Self-Associates	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR PHOSPHOENOLPYRUVATE; N-ACETYLGLUCOSAMINE METABOLISM; CARBON CATABOLITE REPRESSION; ENZYME-I; CONFORMATIONAL STABILITY; CIRCULAR-DICHROISM; TERMINAL DOMAIN; CARBOHYDRATE-METABOLISM; AGGREGATION-PRONE; MOLTEN GLOBULE	The phosphotransferase system (PTS) is involved in the use of carbon sources in bacteria. Bacillus sphaericus, a bacterium with the ability to produce insecticidal proteins, is unable to use hexoses and pentoses as the sole carbon source, but it has ptsHI genes encoding the two general proteins of the PTS: enzyme I (EI) and the histidine phosphocarrier (HPr). In this work, we describe the biophysical and structural properties of HPr from B. sphaericus, HPrbs, and its affinity towards EI of other species to find out whether there is inter-species binding. Conversely to what happens to other members of the HPr family, HPrbs forms several self-associated species. The conformational stability of the protein is low, and it unfolds irreversibly during heating. The protein binds to the N-terminal domain of EI from Streptomyces coelicolor, EINsc, with a higher affinity than that of the natural partner of EINsc, HPrsc. Modelling of the complex between EINsc and HPrbs suggests that binding occurs similarly to that observed in other HPr species. We discuss the functional implications of the oligomeric states of HPrbs for the glycolytic activity of B. sphaericus, as well as a strategy to inhibit binding between HPrsc and EINsc.	[Domenech, Rosa; Martinez-Rodriguez, Sergio; Neira, Jose L.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain; [Hernandez-Cifre, Jose G.; Diez-Pena, Ana I.; Garcia de la Torre, Jose] Univ Murcia, Dept Quim Fis, Murcia, Spain; [Bacarizo, Julio; Martinez-Rodriguez, Sergio; Camara-Artigas, Ana] Univ Almeria, Dept Quim & Fis, Campus Excelencia Int Agroalimentario, Almeria, Spain; [Cavasotto, Claudio N.] Inst Invest Biomed Buenos Aires IBioBA CONICET, Partner Inst Max Planck Soc, Buenos Aires, DF, Argentina; [Velazquez-Campoy, Adrian; Neira, Jose L.] Univ Zaragoza, Unidad Asociada IQFR CSIC BIFI, Inst Biocomp & Fis Sistemas Complejos, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Fdn ARAID, Diputac Gen Aragon, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain	Universidad Miguel Hernandez de Elche; University of Murcia; Universidad de Almeria; Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza	Neira, JL (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain.	jlneira@umh.es	Velazquez-Campoy, Adrian/E-7946-2012; Neira, Jose/ABF-4210-2021; Cifre, José G. H./K-3807-2017; Cavasotto, Claudio/GQY-7627-2022; MARTINEZ-RODRIGUEZ, SERGIO/H-3448-2015; Camara-Artigas, Ana/M-2252-2019; de la Torre, Jose Garcia/A-7923-2015	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Cifre, José G. H./0000-0003-1764-5748; MARTINEZ-RODRIGUEZ, SERGIO/0000-0001-6675-1550; Camara-Artigas, Ana/0000-0003-2197-726X; de la Torre, Jose Garcia/0000-0001-9116-8957; Cavasotto, Claudio/0000-0002-1372-0379; Neira, Jose Luis/0000-0002-4933-0428	Spanish Ministerio de Ciencia e Innovacion (MCINN) [CTQ2011-24393, CSD2008-00005, BIO2009-13261-C02-01/02, P09-CVI-5063, BFU2010-19451]; Fondo Social Europeo (ESF); Diputacion General de Aragon [PI044/09]; BIFI; Junta de Andalucia [BIO-328]; Agencia Nacional de Promocion Cientifica y Tecnologica Argentina (ANPCyT) [PICT-2011-2778]; Spanish Ministerio de Ciencia e Innovacion [BFU2008-02302-BMC]	Spanish Ministerio de Ciencia e Innovacion (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo Social Europeo (ESF)(European Social Fund (ESF)); Diputacion General de Aragon(Gobierno de Aragon); BIFI; Junta de Andalucia(Junta de Andalucia); Agencia Nacional de Promocion Cientifica y Tecnologica Argentina (ANPCyT)(ANPCyT); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (MCINN) (CTQ2011-24393, and CSD2008-00005 to JLN; BIO2009-13261-C02-01/02 and P09-CVI-5063, with Fondo Social Europeo (ESF) to ACA; and BFU2010-19451 to AVC), Diputacion General de Aragon (PI044/09 to AVC), intramural BIFI 2011 projects (to AVC and JLN), Junta de Andalucia (BIO-328 to ACA), and by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica Argentina (ANPCyT; PICT-2011-2778) (to CNC). SMR was supported by the CSD2008-00005. The stays of RD in the laboratory of AVC were supported by the Spanish Ministerio de Ciencia e Innovacion (BFU2008-02302-BMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1992, J MOL BIOL, V225, P519, DOI 10.1016/0022-2836(92)90936-E; ACKERS GK, 1967, J BIOL CHEM, V242, P3026; ALEXANDER B, 1990, J GEN MICROBIOL, V136, P367, DOI 10.1099/00221287-136-2-367; Alice AF, 2003, MICROBIOL-SGM, V149, P1687, DOI 10.1099/mic.0.26231-0; Alice AF, 2002, APPL ENVIRON MICROB, V68, P6410, DOI 10.1128/aem.68.12.6410-6415.2002; ANGLISTER J, 1993, J BIOMOL NMR, V3, P121; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Casares S, 2004, BIOPHYS J, V86, P2403, DOI 10.1016/S0006-3495(04)74297-6; Cavasotto CN, 2011, CURR TOP MED CHEM, V11, P1528; Cavasotto CN, 2009, DRUG DISCOV TODAY, V14, P676, DOI 10.1016/j.drudis.2009.04.006; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Czypionka A, 2007, BIOCHEMISTRY-US, V46, P12764, DOI 10.1021/bi701343q; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Diaz P, 2009, CHEMMEDCHEM, V4, P1615, DOI 10.1002/cmdc.200900226; Domenech R, 2012, BIOCHEMISTRY-US, V51, P7393, DOI 10.1021/bi3010494; Domenech R, 2012, ARCH BIOCHEM BIOPHYS, V526, P44, DOI 10.1016/j.abb.2012.07.004; Doyle CM, 2013, ARCH BIOCHEM BIOPHYS, V531, P44, DOI 10.1016/j.abb.2012.12.005; Favier A, 2002, J MOL BIOL, V317, P131, DOI 10.1006/jmbi.2002.5397; Fernandez-Ballester G, 2003, EUR J BIOCHEM, V270, P2254, DOI 10.1046/j.1432-1033.2003.03594.x; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hernandez JA, 2005, BIOPHYS J, V89, P4188, DOI 10.1529/biophysj.105.065805; HINZ HJ, 1971, BIOCHEMISTRY-US, V10, P1347; Hurtado-Gomez E, 2005, BIOPHYS CHEM, V115, P229, DOI 10.1016/j.bpc.2004.12.032; Hurtado-Goomez E, 2008, BIOPHYS J, V95, P1336, DOI 10.1529/biophysj.107.126664; Hurtado-Gomez EA, 2006, BIOPHYS J, V90, P4592, DOI 10.1529/biophysj.105.076935; Huyghues-Despointes B M, 2001, Methods Mol Biol, V168, P69; ICM, 2012, VERS 3 7 2; Juy M, 2003, J MOL BIOL, V332, P767, DOI 10.1016/S0022-2836(03)00918-5; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lengeler JW, 2009, CONTRIB MICROBIOL, V16, P65, DOI 10.1159/000219373; Monti MC, 2009, CHEM-EUR J, V15, P1155, DOI 10.1002/chem.200801512; Neira JL, 2004, EUR J BIOCHEM, V271, P2165, DOI 10.1111/j.1432-1033.2004.4142.x; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Nothaft H, 2003, J BACTERIOL, V185, P7019, DOI 10.1128/JB.185.23.7019-7023.2003; Nothaft H, 2003, J BACTERIOL, V185, P929, DOI 10.1128/JB.185.3.929-937.2003; Parche S, 1999, EUR J BIOCHEM, V265, P308, DOI 10.1046/j.1432-1327.1999.00727.x; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Phatak SS, 2010, J CHEM INF MODEL, V50, P2119, DOI 10.1021/ci100285f; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Priest FG, 2000, ENTOMOPATHOGENIC BAC, P1; Privalov Peter L., 1992, P83; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Razvi A, 2006, BIOCHEMISTRY-US, V45, P4084, DOI 10.1021/bi060038+; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; RUSSELL BL, 1989, APPL ENVIRON MICROB, V55, P294, DOI 10.1128/AEM.55.2.294-297.1989; Scholtz JM, 2009, METHOD ENZYMOL, V466, P549, DOI 10.1016/S0076-6879(09)66023-7; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; Sridharan S, 2005, J MOL BIOL, V346, P919, DOI 10.1016/j.jmb.2004.12.008; TANG LH, 1977, BIOPHYS CHEM, V7, P121, DOI 10.1016/0301-4622(77)80005-7; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Titgemeyer F, 2002, ANTON LEEUW INT J G, V82, P59, DOI 10.1023/A:1020628909429; WEIGEL N, 1982, J BIOL CHEM, V257, P4477; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Wuthrich K, 1986, NMR PROTEINS NUCL AC	63	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69307	10.1371/journal.pone.0069307	http://dx.doi.org/10.1371/journal.pone.0069307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922699	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900031
J	Fumia, HF; Martins, ML				Fumia, Herman F.; Martins, Marcelo L.			Boolean Network Model for Cancer Pathways: Predicting Carcinogenesis and Targeted Therapy Outcomes	PLOS ONE			English	Article							CELL-CYCLE; BREAST; TUMOR; APOPTOSIS; HALLMARKS; SEQUENCE; GENES	A Boolean dynamical system integrating the main signaling pathways involved in cancer is constructed based on the currently known protein-protein interaction network. This system exhibits stationary protein activation patterns - attractors - dependent on the cell's microenvironment. These dynamical attractors were determined through simulations and their stabilities against mutations were tested. In a higher hierarchical level, it was possible to group the network attractors into distinct cell phenotypes and determine driver mutations that promote phenotypic transitions. We find that driver nodes are not necessarily central in the network topology, but at least they are direct regulators of central components towards which converge or through which crosstalk distinct cancer signaling pathways. The predicted drivers are in agreement with those pointed out by diverse census of cancer genes recently performed for several human cancers. Furthermore, our results demonstrate that cell phenotypes can evolve towards full malignancy through distinct sequences of accumulated mutations. In particular, the network model supports routes of carcinogenesis known for some tumor types. Finally, the Boolean network model is employed to evaluate the outcome of molecularly targeted cancer therapies. The major find is that monotherapies were additive in their effects and that the association of targeted drugs is necessary for cancer eradication.	[Fumia, Herman F.] Univ Fed Vicosa, Dept Fis, Vicosa, MG, Brazil; [Martins, Marcelo L.] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil	Universidade Federal de Vicosa	Martins, ML (corresponding author), Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil.	mmartins@ufv.br		Fialho Fumia, Herman/0000-0002-6392-1398	Brazilian supporting agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Brazilian supporting agency Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior; Brazilian supporting agency Faculdade de Medicina da Universidade Federal de Minas Gerais; Brazilian supporting agency Facepe	Brazilian supporting agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian supporting agency Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior; Brazilian supporting agency Faculdade de Medicina da Universidade Federal de Minas Gerais; Brazilian supporting agency Facepe	The authors thank the Brazilian supporting agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior, Faculdade de Medicina da Universidade Federal de Minas Gerais and Facepe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; [Anonymous], KEGG PATHW DAT; [Anonymous], 2010, ROBBINS COTRAN PATHO; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bunz F., 2008, PRINCIPLES CANC GENE; Calzone L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.7; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CLARK WH, 1991, BRIT J CANCER, V64, P631, DOI 10.1038/bjc.1991.375; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Ferreira SC, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021907; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kauffman S.A., 1993, ORIGINS ORDER; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mai ZX, 2009, J THEOR BIOL, V259, P760, DOI 10.1016/j.jtbi.2009.04.024; Martins ML, 2010, CURR OPIN COLLOID IN, V15, P18, DOI 10.1016/j.cocis.2009.04.004; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Murray CJL, 1997, LANCET, V349, P1448; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Paiva LR, 2009, CANCER RES, V69, P1205, DOI 10.1158/0008-5472.CAN-08-2173; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Silva HS, 2003, PHYSICA A, V322, P555, DOI 10.1016/S0378-4371(02)01807-1; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; The Cancer Genome Atlas Research Network, 2008, NATURE, V489, P519; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weinberg RA, 2007, BIOL CANC; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309	47	89	90	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69008	10.1371/journal.pone.0069008	http://dx.doi.org/10.1371/journal.pone.0069008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922675	gold, Green Submitted, Green Published			2022-12-25	WOS:000322838900016
J	Groenenboom, M; Gomez-Roldan, V; Stigter, H; Astola, L; van Daelen, R; Beekwilder, J; Bovy, A; Hall, R; Molenaar, J				Groenenboom, Marian; Gomez-Roldan, Victoria; Stigter, Hans; Astola, Laura; van Daelen, Raymond; Beekwilder, Jules; Bovy, Arnaud; Hall, Robert; Molenaar, Jaap			The Flavonoid Pathway in Tomato Seedlings: Transcript Abundance and the Modeling of Metabolite Dynamics	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS SEEDLINGS; SYSTEMS BIOLOGY; FRUIT; BIOSYNTHESIS; ACCUMULATION; EVOLUTION; ENZYMES; PLANTS	Flavonoids are secondary metabolites present in all terrestrial plants. The flavonoid pathway has been extensively studied, and many of the involved genes and metabolites have been described in the literature. Despite this extensive knowledge, the functioning of the pathway in vivo is still poorly understood. Here, we study the flavonoid pathway using both experiments and mathematical models. We measured flavonoid metabolite dynamics in two tissues, hypocotyls and cotyledons, during tomato seedling development. Interestingly, the same backbone of interactions leads to very different accumulation patterns in the different tissues. Initially, we developed a mathematical model with constant enzyme concentrations that described the metabolic networks separately in both tissues. This model was unable to fit the measured flavonoid dynamics in the hypocotyls, even if we allowed unrealistic parameter values. This suggested us to investigate the effect of transcript abundance on flavonoid accumulation. We found that the expression of candidate flavonoid genes varies considerably with time. Variation in transcript abundance results in enzymatic variation, which could have a large effect on metabolite accumulation. Candidate transcript abundance was included in the mathematical model as representative for enzyme concentration. We fitted the resulting model to the flavonoid dynamics in the cotyledons, and tested it by applying it to the data from hypocotyls. When transcript abundance is included, we are indeed able to explain flavonoid dynamics in both tissues. Importantly, this is possible under the biologically relevant restriction that the enzymatic properties estimated by the model are conserved between the tissues.	[Groenenboom, Marian; Stigter, Hans; Astola, Laura; Molenaar, Jaap] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Gomez-Roldan, Victoria; Beekwilder, Jules; Bovy, Arnaud; Hall, Robert] Plant Res Int, Wageningen, Netherlands; [Groenenboom, Marian; Gomez-Roldan, Victoria; Astola, Laura; Hall, Robert; Molenaar, Jaap] Netherlands Consortium Syst Biol NCSB, Amsterdam, Netherlands; [van Daelen, Raymond] Keygene NV, Wageningen, Netherlands; [Bovy, Arnaud; Hall, Robert] Ctr BioSyst Genom CBSG, Wageningen, Netherlands	Wageningen University & Research; Keygene N.V.; Centre for BioSystems Genomics	Stigter, H (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	hans.stigter@wur.nl	HALL, ROBERT D/B-8707-2015; Beekwilder, Jules/A-6802-2011; Gomez, Maria M/H-5391-2018	HALL, ROBERT D/0000-0002-5786-768X; Beekwilder, Jules/0000-0003-3238-4427; Gomez, Maria M/0000-0002-8428-1588; Stigter, Johannes Daniel/0000-0001-5210-5929; Bovy, Arnaud/0000-0003-2643-7377	Netherlands Genomics Initiative	Netherlands Genomics Initiative	This work results from a collaboration between plant biologists and mathematicians, initiated by the Netherlands Consortium for Systems Biology (NCSB) and Centre for Biosystems Genomics (CBSG). Both the NCSB and CBSG are Centres of Excellence under the auspices of the Netherlands Genomics Initiative. The authors are grateful to Adele van Houwelingen for help with transcript abundance analysis.	Apri M, 2012, J THEOR BIOL, V304, P16, DOI 10.1016/j.jtbi.2012.03.019; Astola L, TREE GRAPHS IDENTIFI; Bieza K, 2001, PLANT PHYSIOL, V126, P1105, DOI 10.1104/pp.126.3.1105; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bovy A, 2002, PLANT CELL, V14, P2509, DOI 10.1105/tpc.004218; Bovy A.G., 2010, RECENT ADV POLYPHENO, V2; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Castellarin SD, 2007, PLANTA, V227, P101, DOI 10.1007/s00425-007-0598-8; Clark ST, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-343; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Crosby KC, 2011, FEBS LETT, V585, P2193, DOI 10.1016/j.febslet.2011.05.066; Gomez-Roldan M, TOMATO SEEDLINGS VAL; Groenenboom MAC, FUNCTION PREDI UNPUB; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hodgson JM, 2010, MOL ASPECTS MED, V31, P495, DOI 10.1016/j.mam.2010.09.004; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; KOES RE, 1994, BIOESSAYS, V16, P123, DOI 10.1002/bies.950160209; KUBASEK WL, 1992, PLANT CELL, V4, P1229, DOI 10.1105/tpc.4.10.1229; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; Nakabayashi R, 2010, NEW BIOTECHNOL, V27, P829, DOI 10.1016/j.nbt.2010.03.004; Olsen KM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-21; Pelletier MK, 1999, PLANT MOL BIOL, V40, P45, DOI 10.1023/A:1026414301100; Prasad S, 2010, PLANTA MED, V76, P1044, DOI 10.1055/s-0030-1250111; Preuss A, 2009, FEBS LETT, V583, P1981, DOI 10.1016/j.febslet.2009.05.006; Rodriguez A, 2011, NET BIOL, V1, P34; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Trabelsi N., 2011, Journal of Biophysical Chemistry, V2, P332, DOI 10.4236/jbpc.2011.23038; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; Zifkin M, 2012, PLANT PHYSIOL, V158, P200, DOI 10.1104/pp.111.180950	33	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e68960	10.1371/journal.pone.0068960	http://dx.doi.org/10.1371/journal.pone.0068960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922672	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900015
J	Hilborn, ED; Soares, RM; Servaites, JC; Delgado, AG; Magalhaes, VF; Carmichael, WW; Azevedo, SMFO				Hilborn, Elizabeth D.; Soares, Raquel M.; Servaites, Jerome C.; Delgado, Alvima G.; Magalhaes, Valeria F.; Carmichael, Wayne W.; Azevedo, Sandra M. F. O.			Sublethal Microcystin Exposure and Biochemical Outcomes among Hemodialysis Patients	PLOS ONE			English	Article							BLUE-GREEN-ALGA; LIVER-DAMAGE; CYANOBACTERIA; SERUM; CYANOTOXINS; AERUGINOSA; BRAZIL; WATER; LR; INTOXICATION	Cyanobacteria are commonly-occurring contaminants of surface waters worldwide. Microcystins, potent hepatotoxins, are among the best characterized cyanotoxins. During November, 2001, a group of 44 hemodialysis patients were exposed to microcystins via contaminated dialysate. Serum microcystin concentrations were quantified with enzyme-linked immunosorbent assay which measures free serum microcystin LR equivalents (ME). We describe serum ME concentrations and biochemical outcomes among a subset of patients during 8 weeks following exposure. Thirteen patients were included; 6 were males, patients' median age was 45 years (range 16-80), one was seropositive for hepatitis B surface antigen. The median serum ME concentration was 0.33 ng/mL (range:,0.16-0.96). One hundred thirty nine blood samples were collected following exposure. Patients' biochemical outcomes varied, but overall indicated a mixed liver injury. Linear regression evaluated each patient's weekly mean biochemical outcome with their maximum serum ME concentration; a measure of the extrinsic pathway of clotting function, prothrombin time, was negatively and significantly associated with serum ME concentrations. This group of exposed patients' biochemical outcomes display evidence of a mixed liver injury temporally associated with microcystin exposure. Interpretation of biochemical outcomes are complicated by the study population's underlying chronic disease status. It is clear that dialysis patients are a distinct 'at risk' group for cyanotoxin exposures due to direct intravenous exposure to dialysate prepared from surface drinking water supplies. Careful monitoring and treatment of water supplies used to prepare dialysate is required to prevent future cyanotoxin exposure events.	[Hilborn, Elizabeth D.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA; [Soares, Raquel M.; Delgado, Alvima G.; Magalhaes, Valeria F.; Azevedo, Sandra M. F. O.] Univ Fed Rio de Janeiro, Lab Ecophysiol & Toxicol Cyanobacteria, Carlos Chagas Filho Biophys Inst, Rio De Janeiro, Brazil; [Servaites, Jerome C.; Carmichael, Wayne W.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA	United States Environmental Protection Agency; Universidade Federal do Rio de Janeiro; University System of Ohio; Wright State University Dayton	Hilborn, ED (corresponding author), US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.	hilborn.e@epa.gov	de oliveira e azevedo, sandra maria feliciano/G-8362-2015; Soares, Raquel/C-9863-2014; Magalhães, Valéria/Y-4335-2019	de oliveira e azevedo, sandra maria feliciano/0000-0002-3046-0652; Hilborn, Elizabeth/0000-0002-3035-3101; Soares, Raquel/0000-0003-3880-6248	Brazilian Council for Scientific and Technological Development (CNPq); Carlos Chagas Filho Rio de Janeiro State Research Supporting Foundation (FAPERJ); Foundation for the Coordination of Higher Education and Graduate Training (CAPES); United States Environmental Protection Agency (USEPA) [2D-5849-NAEX]; USEPA [EP-D-07-109]	Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Rio de Janeiro State Research Supporting Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Foundation for the Coordination of Higher Education and Graduate Training (CAPES); United States Environmental Protection Agency (USEPA)(United States Environmental Protection Agency); USEPA(United States Environmental Protection Agency)	Funded by The Brazilian Council for Scientific and Technological Development (CNPq); The Carlos Chagas Filho Rio de Janeiro State Research Supporting Foundation (FAPERJ); and The Foundation for the Coordination of Higher Education and Graduate Training (CAPES); United States Environmental Protection Agency (USEPA) Contract grant number: 2D-5849-NAEX; USEPA Contract number: EP-D-07-109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley VR, 2000, J TOXICOL ENV HEAL A, V61, P281, DOI 10.1080/00984100050136599; BENICHOU C, 1990, J HEPATOL, V11, P272; Bommer J, 2001, NEPHROL DIAL TRANSPL, V16, P1992, DOI 10.1093/ndt/16.10.1992; Burns J, 2008, ADV EXP MED BIOL, V619, P127, DOI 10.1007/978-0-387-75865-7_5; Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781; Chen J, 2009, TOXICOL SCI, V108, P81, DOI 10.1093/toxsci/kfp009; CHU FS, 1990, J ASSOC OFF ANA CHEM, V73, P451; Corran P, 1999, WHO TECH REP SER, V889, P1; Ding WX, 1998, ENVIRON RES, V78, P12, DOI 10.1006/enrs.1998.3843; Fabrizi F, 2003, INT J ARTIF ORGANS, V26, P1048, DOI 10.1177/039139880302601202; FALCONER IR, 1983, MED J AUSTRALIA, V1, P511, DOI 10.5694/j.1326-5377.1983.tb136192.x; FALCONER IR, 1986, AUST J BIOL SCI, V39, P17; Favaloro EJ, 2011, PATHOLOGY, V43, P682, DOI 10.1097/PAT.0b013e32834bf5f4; Fiorillo C, 1998, CLIN CHEM LAB MED, V36, P149, DOI 10.1515/CCLM.1998.028; Foxall TL, 1981, EFFECTS HEPATIC TOXI; Galli F, 2001, KIDNEY INT, V59, pS148, DOI 10.1046/j.1523-1755.2001.07846.x; Giannuzzi L, 2011, MAR DRUGS, V9, P2164, DOI 10.3390/md9112164; GUH JY, 1995, NEPHRON, V69, P459, DOI 10.1159/000188520; Hilborn ED, 2007, ENVIRON TOXICOL, V22, P459, DOI 10.1002/tox.20281; Himmelfarb J, 2010, NEW ENGL J MED, V363, P1833, DOI 10.1056/NEJMra0902710; HOOSER SB, 1989, VET PATHOL, V26, P246, DOI 10.1177/030098588902600309; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Knight JA, 2005, J INFUS MURS, V28, P108, DOI 10.1097/00129804-200503000-00004; Kullak-Ublick GA, 2000, J HEPATOL, V32, P3, DOI 10.1016/S0168-8278(00)80411-0; Li Y, 2011, ENVIRON HEALTH PERSP, V119, P1483, DOI 10.1289/ehp.1002412; Molino D, 2004, SEMIN NEPHROL, V24, P495, DOI 10.1016/j.semnephrol.2004.06.004; ONO K, 1995, CLIN NEPHROL, V43, P405; Pouria S, 1998, LANCET, V352, P21, DOI 10.1016/S0140-6736(97)12285-1; ROBINSON NA, 1991, J PHARMACOL EXP THER, V256, P176; Runnegar MT, 1982, S AFR MED J; Sacher RA, 2000, WIDMANNS CLIN INTERP; Soares RM, 2006, ENVIRON TOXICOL, V21, P95, DOI 10.1002/tox.20160; Wada H, 2008, SEMIN THROMB HEMOST, V34, P772, DOI 10.1055/s-0029-1145259; WHO Expert Committee on Biological Standardization, 1999, WHO TECH REP SER, V889, pi; WOLF PL, 1972, CLIN CHEM, V18, P567; Yen HK, 2011, TOXICON, V58, P209, DOI 10.1016/j.toxicon.2011.06.003; Zamyadi A, 2012, WATER RES, V46, P1511, DOI 10.1016/j.watres.2011.11.012	37	24	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69518	10.1371/journal.pone.0069518	http://dx.doi.org/10.1371/journal.pone.0069518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894497	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900079
J	Lapenna, A; B-Lynch, C; Kapeni, C; Aspinall, R				Lapenna, Antonio; B-Lynch, Christopher; Kapeni, Chrysa; Aspinall, Richard			A Simple Model System Enabling Human CD34(+) Cells to Undertake Differentiation Towards T Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DELTA-LIKE 4; LINEAGE COMMITMENT; HUMAN SKIN; IN-VITRO; BONE-MARROW; CORD BLOOD; B-CELL; THYMUS; AGE	Background: Channelling the development of haematopoietic progenitor cells into T lymphocytes is dependent upon a series of extrinsic prompts whose temporal and spatial sequence is critical for a productive outcome. Simple models of human progenitor cells development depend in the main on the use of xenogeneic systems which may provide some limitations to development. Methods and Findings: Here we provide evidence that a simple model system which utilises both human keratinocyte and fibroblast cell lines arrayed on a synthetic tantalum coated matrix provides a permissive environment for the development of human CD34(+) haematopoietic cells into mature CD4(+) or CD8(+) T lymphocytes in the presence of Interleukin 7 (IL-7), Interleukin 15 (IL-15) and the Fms-like tyrosine kinase 3 ligand (Flt-3L). This system was used to compare the ability of CD34(+) cells to produce mature thymocytes and showed that whilst these cells derived from cord blood were able to productively differentiate into thymocytes the system was not permissive for the development of CD34(+) cells from adult peripheral blood. Conclusions/Significance: Our study provides direct evidence for the capacity of human cord blood CD34(+) cells to differentiate along the T lineage in a simple human model system. Productive commitment of the CD34(+) cells to generate T cells was found to be dependent on a three-dimensional matrix which induced the up-regulation of the Notch delta-like ligand 4 (Dll-4) by epithelial cells.	[Lapenna, Antonio; B-Lynch, Christopher; Kapeni, Chrysa; Aspinall, Richard] Cranfield Univ, Cranfield Hlth, Regenerat Med Grp, Cranfield MK43 0AL, Beds, England; [Lapenna, Antonio] Hebrew Univ Jerusalem, Fac Med, Dept Immunol & Canc Res, Jerusalem, Israel	Cranfield University; Hebrew University of Jerusalem	Lapenna, A (corresponding author), Cranfield Univ, Cranfield Hlth, Regenerat Med Grp, Cranfield MK43 0AL, Beds, England.	antoniolapenna@hotmail.com	Aspinall, Richard/E-4924-2013	Aspinall, Richard/0000-0002-1648-1887; Kapeni, Chrysa/0000-0003-0408-2106	Myrtle Peach Trust UK [1048297]; Cranfield University	Myrtle Peach Trust UK; Cranfield University	This research was funded in part by Myrtle Peach Trust UK (Registered Charity No. 1048297): http://www.mkheritage.co.uk/shhs/mpeach.htm and from Cranfield University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 2008, J IMMUNOL, V181, P7435, DOI 10.4049/jimmunol.181.11.7435; Awong G, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-22; Beaudette-Zlatanova BC, 2011, EXP HEMATOL, V39, P570, DOI 10.1016/j.exphem.2011.01.014; Beerman I, 2010, CURR OPIN IMMUNOL, V22, P500, DOI 10.1016/j.coi.2010.06.007; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Billiard F, 2011, EUR J IMMUNOL, V41, P2207, DOI 10.1002/eji.201041343; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cederig R, 2012, NAT IMMUNOL, V13, P309, DOI [10.1038/ni.2265, DOI 10.1038/NI.2265.PUBMED:22430774]; Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005; Clark RA, 2005, J CLIN INVEST, V115, P3239, DOI 10.1172/JCI24731; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de la Hera A, 1989, Int Immunol, V1, P471, DOI 10.1093/intimm/1.5.471; de Pooter R, 2007, CURR OPIN IMMUNOL, V19, P163, DOI 10.1016/j.coi.2007.02.011; De Smedt M, 2011, HAEMATOL-HEMATOL J, V96, P646, DOI 10.3324/haematol.2010.036343; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; GALY A, 1993, J EXP MED, V178, P391, DOI 10.1084/jem.178.2.391; Hao QL, 2008, BLOOD, V111, P1318, DOI 10.1182/blood-2007-08-106294; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; KINGSTON R, 1985, NATURE, V317, P811, DOI 10.1038/317811a0; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; LAW LW, 1966, NATURE, V210, P1118, DOI 10.1038/2101118a0; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Meek B, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-17; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Mitchell WA, 2010, CLIN EXP IMMUNOL, V161, P497, DOI 10.1111/j.1365-2249.2010.04209.x; Mohtashami M, 2006, J IMMUNOL, V176, P730, DOI 10.4049/jimmunol.176.2.730; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Radtke F, 2004, CURR OPIN IMMUNOL, V16, P174, DOI 10.1016/j.coi.2004.01.002; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; SCHMITT C, 1995, LEUKEMIA LYMPHOMA, V17, P43, DOI 10.3109/10428199509051702; Spits H, 1998, IMMUNOL REV, V165, P75, DOI 10.1111/j.1600-065X.1998.tb01231.x; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Verschuren MCM, 1997, J IMMUNOL, V158, P1208; Wang JW, 2011, CURR OPIN IMMUNOL, V23, P532, DOI 10.1016/j.coi.2011.05.004; Zediak VP, 2007, BLOOD, V110, P1161, DOI 10.1182/blood-2007-01-071605	41	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69572	10.1371/journal.pone.0069572	http://dx.doi.org/10.1371/journal.pone.0069572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894504	gold, Green Submitted, Green Published			2022-12-25	WOS:000325211000136
J	Wassinger, A; Zhang, L; Tracy, E; Munson, RS; Kathariou, S; Wang, HH				Wassinger, Andrew; Zhang, Lu; Tracy, Erin; Munson, Robert S., Jr.; Kathariou, Sophia; Wang, Hua H.			Role of a GntR-Family Response Regulator LbrA in Listeria monocytogenes Biofilm Formation	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; GENE-EXPRESSION; VIRULENCE; SYSTEM; TRANSMISSION; BACTERIOCIN; COMPETENCE; MOTILITY	The formation of Listeria monocytogenes biofilms contributes to persistent contamination in food processing facilities. A microarray comparison of L. monocytogenes between the transcriptome of the strong biofilm forming strain (Bfm(s)) Scott A and the weak biofilm forming (Bfm(w)) strain F2365 was conducted to identify genes potentially involved in biofilm formation. Among 951 genes with significant difference in expression between the two strains, a GntR-family response regulator encoding gene (LMOf2365_0414), designated lbrA, was found to be highly expressed in Scott A relative to F2365. A Scott A lbrA-deletion mutant, designated AW3, formed biofilm to a much lesser extent as compared to the parent strain by a rapid attachment assay and scanning electron microscopy. Complementation with lbrA from Scott A restored the Bfm(s) phenotype in the AW3 derivative. A second microarray assessment using the lbrA deletion mutant AW3 and the wild type Scott A revealed a total of 304 genes with expression significantly different between the two strains, indicating the potential regulatory role of LbrA in L. monocytogenes. A cloned copy of Scott A lbrA was unable to confer enhanced biofilm forming potential in F2365, suggesting that additional factors contributed to weak biofilm formation by F2365.	[Wassinger, Andrew; Zhang, Lu; Wang, Hua H.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA; [Tracy, Erin; Munson, Robert S., Jr.] Ohio State Univ, Res Inst, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Tracy, Erin; Munson, Robert S., Jr.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Kathariou, Sophia] N Carolina State Univ, Dept Food Sci, Raleigh, NC 27695 USA; [Munson, Robert S., Jr.; Wang, Hua H.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of North Carolina; North Carolina State University; University System of Ohio; Ohio State University	Wang, HH (corresponding author), Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA.	wang.707@osu.edu	Munson, Jr, Robert/E-3710-2011	Munson, Jr, Robert/0000-0002-3204-3019	The United States Department of Agriculture (USDA)-National Resources Inventory [2006-35201-17377]; Center for Innovative Food Technology; USDA NNF program	The United States Department of Agriculture (USDA)-National Resources Inventory; Center for Innovative Food Technology; USDA NNF program	The United States Department of Agriculture (USDA)-National Resources Inventory grant number 2006-35201-17377, Center for Innovative Food Technology (http://ciftinnovation.org/), USDA NNF program (http://www.nifa.usda.gov/funding/rfas/national_needs.html) provided funding to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Aravind L, 2003, FEMS MICROBIOL LETT, V222, P17, DOI 10.1016/S0378-1097(03)00242-8; Ballering KS, 2009, J BACTERIOL, V191, P2806, DOI 10.1128/JB.01688-08; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Desmond C, 2004, APPL ENVIRON MICROB, V70, P5929, DOI 10.1128/AEM.70.10.5929-5936.2004; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hanna SE, 2006, J FOOD PROTECT, V69, P2754, DOI 10.4315/0362-028X-69.11.2754; Jordan SJ, 2008, APPL ENVIRON MICROB, V74, P5451, DOI 10.1128/AEM.02419-07; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Kim JH, 2007, PLASMID, V58, P275, DOI 10.1016/j.plasmid.2007.05.004; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; Lemon KP, 2010, J BACTERIOL, V192, P3969, DOI 10.1128/JB.00179-10; Li YH, 2002, J BACTERIOL, V184, P2699, DOI 10.1128/JB.184.10.2699-2708.2002; LINNAN MJ, 1988, NEW ENGL J MED, V319, P823, DOI 10.1056/NEJM198809293191303; Luo HL, 2005, APPL ENVIRON MICROB, V71, P2970, DOI 10.1128/AEM.71.6.2970-2978.2005; Manuzon M, 2006, BIOFILMS FOOD ENV, P105; Marsh EJ, 2003, FEMS MICROBIOL LETT, V228, P203, DOI 10.1016/S0378-1097(03)00752-3; McLoon AL, 2011, J BACTERIOL, V193, P679, DOI 10.1128/JB.01186-10; Mirouze N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002048; Moretro T., 2004, Biofilms, V1, P107, DOI 10.1017/S1479050504001322; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Petersen FC, 2006, MOL MICROBIOL, V61, P1322, DOI 10.1111/j.1365-2958.2006.05312.x; Prepiak P, 2011, MOL MICROBIOL, V80, P1014, DOI 10.1111/j.1365-2958.2011.07627.x; Promadej N, 1999, J BACTERIOL, V181, P418, DOI 10.1128/JB.181.2.418-425.1999; Renier S, 2011, ENVIRON MICROBIOL, V13, P835, DOI 10.1111/j.1462-2920.2010.02378.x; Renye JA, 2010, J APPL MICROBIOL, V108, P2142, DOI 10.1111/j.1365-2672.2009.04615.x; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sheehan B, 1994, Curr Top Microbiol Immunol, V192, P187; Todhanakasem T, 2008, J BACTERIOL, V190, P6030, DOI 10.1128/JB.00155-08; Travier L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003131; van der Veen S, 2010, MICROBIOL-SGM, V156, P3782, DOI 10.1099/mic.0.043000-0; Wong ACL, 1998, J DAIRY SCI, V81, P2765, DOI 10.3168/jds.S0022-0302(98)75834-5; Yonezawa H, 2005, ANTIMICROB AGENTS CH, V49, P541, DOI 10.1128/AAC.49.2.541-548.2005; YOUSEF AE, 1988, APPL ENVIRON MICROB, V54, P2643, DOI 10.1128/AEM.54.11.2643-2649.1988; Zhou QC, 2011, CURR MICROBIOL, V63, P186, DOI 10.1007/s00284-011-9964-7; Zhu XN, 2011, FOODBORNE PATHOG DIS, V8, P495, DOI 10.1089/fpd.2010.0697; Zhu XN, 2008, APPL ENVIRON MICROB, V74, P7675, DOI 10.1128/AEM.01229-08	44	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70448	10.1371/journal.pone.0070448	http://dx.doi.org/10.1371/journal.pone.0070448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894658	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000209
J	Asnani, MR; Lynch, O; Reid, ME				Asnani, Monika R.; Lynch, O'Neil; Reid, Marvin E.			Determining Glomerular Filtration Rate in Homozygous Sickle Cell Disease: Utility of Serum Creatinine Based Estimating Equations	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RENAL-FUNCTION; ANEMIA; ALBUMINURIA; PREVALENCE	Background: Various estimating equations have been developed to estimate glomerular filtration rate (GFR) for use in clinical practice. However, the unique renal physiological and pathological processes that occur in sickle cell disease (SCD) may invalidate these estimates in this patient population. This study aims to compare GFR estimated using common existing GFR predictive equations to actual measured GFR in persons with homozygous SCD. If the existing equations perform poorly, we propose to develop a new estimating equation for use in persons with SCD. Methods: 98 patients with the homozygous SS disease (55 females: 43 males; mean age 34 +/- 2.3 years) had serum measurements of creatinine, as well as had GFR measured using Tc-99m-DTPA nuclear renal scan. GFR was estimated using the Modification of Diet in Renal Disease (MDRD), Cockcroft-Gault (CG), and the serum creatinine based CKD-EPI equations. The Bland-Altman limit of agreement method was used to determine agreement between measured and estimated GFR values. A SCD-specific estimating equation for GFR (JSCCS-GFR equation) was generated by means of multiple regression via backward elimination. Results: The mean measured GFR +/- SD was 94.9 +/- 27.4 mls/min/1.73 m(2) BSA, with a range of 6.4-159.0 mls/min/1.73 m(2). The MDRD and CG equations both overestimated GFR, with the agreement worsening with higher GFR values. The serum creatinine based CKD-EPI equation performed relatively well, but with a systematic bias of about 45 mls/min. The new equation developed resulted in a better fit to our sickle cell disease data than the MDRD equation. Conclusion: Current estimating equations, other than the CKD-EPI equation, do not perform very accurately in persons with homozygous SS disease. A fairly accurate estimating equation, suitable for persons with GFR >60 mls/min/1.73 m(2) has been developed from our dataset and validated within a simulated dataset.	[Asnani, Monika R.; Lynch, O'Neil; Reid, Marvin E.] Univ W Indies, Res Inst Trop Med, Sickle Cell Unit, Kingston 7, Jamaica	University West Indies Mona Jamaica	Asnani, MR (corresponding author), Univ W Indies, Res Inst Trop Med, Sickle Cell Unit, Mona Campus, Kingston 7, Jamaica.	monika.parshadasnani@uwimona.edu.jm	Reid, Marvin/J-2884-2014	Reid, Marvin/0000-0003-4005-9384	Caribbean Health Research Council	Caribbean Health Research Council	The work was supported by a grant from the Caribbean Health Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu A, 2011, ANN AFR MED, V10, P34, DOI 10.4103/1596-3519.76578; Alvarez O., 2012, PEDIAT BLOOD CANC; APARICIO SAJ, 1990, J CLIN PATHOL, V43, P370, DOI 10.1136/jcp.43.5.370; Aygun B, 2011, PEDIATR NEPHROL, V26, P1285, DOI 10.1007/s00467-011-1857-2; Bolarinwa RA, 2012, SAUDI J KIDNEY DIS T, V23, P171; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fontsere N, 2006, NEPHROL DIAL TRANSPL, V21, P2152, DOI 10.1093/ndt/gfl221; Guasch A, 2006, J AM SOC NEPHROL, V17, P2228, DOI 10.1681/ASN.2002010084; Gurkan S, 2010, PEDIATR NEPHROL, V25, P2123, DOI 10.1007/s00467-010-1560-8; Haymann JP, 2010, CLIN J AM SOC NEPHRO, V5, P756, DOI 10.2215/CJN.08511109; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Revuelta KL, 2011, NEFROLOGIA, V31, P591, DOI 10.3265/Nefrologia.pre2011.Feb.10737; Marouf R, 2006, J CLIN PATHOL, V59, P345, DOI 10.1136/jcp.2005.026799; Poge U, 2006, NEPHROL DIAL TRANSPL, V21, P660, DOI 10.1093/ndt/gfi305; Poggio ED, 2005, AM J KIDNEY DIS, V46, P242, DOI 10.1053/j.ajkd.2005.04.023; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Serjeant GR, 2007, NEW ENGL J MED, V356, P642, DOI 10.1056/NEJMc066547; SIEKMANN L, 1985, J CLIN CHEM CLIN BIO, V23, P137; Silva GB, 2012, BRAZ J MED BIOL RES, V45, P652, DOI 10.1590/S0100-879X2012007500079; Stevens LA, 2005, MED CLIN N AM, V89, P457, DOI 10.1016/j.mcna.2004.11.009; Thompson J, 2007, ARCH INTERN MED, V167, P701, DOI 10.1001/archinte.167.7.701; Vassalotti JA, 2007, AM J KIDNEY DIS, V50, P169, DOI 10.1053/j.ajkd.2007.06.013; Verhave JC, 2005, AM J KIDNEY DIS, V46, P233, DOI 10.1053/j.ajkd.2005.05.011; Ware RE, 2010, J PEDIATR-US, V156, P66, DOI 10.1016/j.jpeds.2009.06.060; Yee MM, 2011, CLIN J AM SOC NEPHRO, V6, P2628, DOI 10.2215/CJN.01600211	28	35	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69922	10.1371/journal.pone.0069922	http://dx.doi.org/10.1371/journal.pone.0069922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894560	Green Submitted, gold, Green Published			2022-12-25	WOS:000322391400074
J	Wall, EC; Cartwright, K; Scarborough, M; Ajdukiewicz, KM; Goodson, P; Mwambene, J; Zijlstra, EE; Gordon, SB; French, N; Faragher, B; Heyderman, RS; Lalloo, DG				Wall, Emma C.; Cartwright, Katharine; Scarborough, Matthew; Ajdukiewicz, Katherine M.; Goodson, Patrick; Mwambene, James; Zijlstra, Eduard E.; Gordon, Stephen B.; French, Neil; Faragher, Brian; Heyderman, Robert S.; Lalloo, David G.			High Mortality amongst Adolescents and Adults with Bacterial Meningitis in Sub-Saharan Africa: An Analysis of 715 Cases from Malawi	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PNEUMOCOCCAL CONJUGATE VACCINE; MENINGOCOCCAL DISEASE; HEALTH-CARE; HIGH HIV; CHILDREN; ERA; PREVALENCE; PENICILLIN; INFECTION	Mortality from bacterial meningitis in African adults is significantly higher than those in better resourced settings and adjunctive therapeutic interventions such as dexamethasone and glycerol have been shown to be ineffective. We conducted a study analysing data from clinical trials of bacterial meningitis in Blantyre, Malawi to investigate the clinical parameters associated with this high mortality. Methods: We searched for all clinical trials undertaken in Blantyre investigating bacterial meningitis from 1990 to the current time and combined the data from all included trial datasets into one database. We used logistic regression to relate individual clinical parameters to mortality. Adults with community acquired bacterial meningitis were included if the CSF culture isolate was consistent with meningitis or if the CSF white cell count was >100 cells/mm(3) (>50% neutrophils) in HIV negative participants and >5 cells/mm(3) in HIV positive participants. Outcome was measured by mortality at discharge from hospital (after 10 days of antibiotic therapy) and community follow up (day 40). Results: Seven hundred and fifteen episodes of bacterial meningitis were evaluated. The mortality rate was 45% at day 10 and 54% at day 40. The most common pathogens were S. pneumoniae (84% of positive CSF isolates) and N. meningitidis (4%). 607/694 (87%) participants tested were HIV antibody positive. Treatment delays within the hospital system were marked. The median presenting GCS was 12/15, 17% had GCS<8 and 44.9% had a seizure during the illness. Coma, seizures, tachycardia and anaemia were all significantly associated with mortality on multivariate analysis. HIV status and pneumococcal culture positivity in the CSF were not associated with mortality. Adults with community acquired bacterial meningitis in Malawi present with a severe clinical phenotype. Predictors of high mortality are different to those seen in Western settings. Optimising in-hospital care and minimising treatment delays presents an opportunity to improve outcomes considerably.	[Wall, Emma C.; Gordon, Stephen B.; Faragher, Brian; Heyderman, Robert S.; Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England; [Wall, Emma C.; French, Neil; Heyderman, Robert S.] Malawi Liverpool Wellcome Trust, Dept Clin Res, Blantyre, Malawi; [Cartwright, Katharine] Univ Hosp Leicestershire NHS Trust, Dept Microbiol, Leicester, Leics, England; [Scarborough, Matthew] John Radcliffe Hosp, Dept Infect Dis, Oxford OX3 9DU, England; [Ajdukiewicz, Katherine M.] North Manchester Gen Hosp, Dept Infect Dis, Manchester, Lancs, England; [Cartwright, Katharine; Ajdukiewicz, Katherine M.; Goodson, Patrick; Mwambene, James; Heyderman, Robert S.] Queen Elizabeth Cent Hosp, Coll Med, Dept Med, Blantyre, Malawi; [Zijlstra, Eduard E.] Rotterdam Ctr Trop Med, Dept Infect Dis, Rotterdam, Netherlands; [French, Neil] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University Hospitals of Leicester NHS Trust; University of Oxford; University of Malawi; University of Liverpool	Wall, EC (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England.	emma.wall@doctors.org.uk	French, Neil/A-2994-2012	Lalloo, David/0000-0001-7680-2200; Heyderman, Robert/0000-0003-4573-449X; Gordon, Stephen/0000-0001-6576-1116; Scarborough, Matthew/0000-0002-0455-0785; Wall, Emma/0000-0003-2732-4497; French, Neil/0000-0003-4814-8293	Wellcome Trust; MLW core programme grant; Meningitis Research Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); MLW core programme grant; Meningitis Research Foundation(Meningitis Research Foundation (MRF))	Wellcome Trust Clinical PhD fellowship to EW and MLW core programme grant (RSH), The SAM study, the Glycerol for Adult Meningitis and the cohort study were funded by the Meningitis Research Foundation. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Ajdukiewicz KM, 2011, LANCET INFECT DIS; Auburtin M, 2006, CRIT CARE MED, V34, P2758, DOI 10.1097/01.CCM.0000239434.26669.65; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Brouwer MC, 2007, QJM-INT J MED, V100, P37, DOI 10.1093/qjmed/hcl131; Brouwer MC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub5; Burgos J, 2012, JAIDS-J ACQ IMM DEF, V59, P31, DOI 10.1097/QAI.0b013e31823d0f5f; Cohen C, 2010, AIDS, V24, P1351, DOI 10.1097/QAD.0b013e32833a2520; Cohen DB, 2010, TROP MED INT HEALTH, V15, P910, DOI 10.1111/j.1365-3156.2010.02565.x; Cornick JE, 2011, EMERG INFECT DIS, V17, P1107, DOI [10.3201/eid1706.101404, 10.3201/eid/1706.101404]; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Domingo P, 2009, JAIDS-J ACQ IMM DEF, V51, P582, DOI 10.1097/QAI.0b013e3181adcb01; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Gans J. de, 2002, New England Journal of Medicine, V347, P1549, DOI 10.1056/NEJMoa021334; Georges H, 2009, EUR J CLIN MICROBIOL, V28, P1317, DOI 10.1007/s10096-009-0782-9; Gjini AB, 2006, QJM-INT J MED, V99, P761, DOI 10.1093/qjmed/hcl111; Glennie SJ, 2013, CLIN INFECT DIS, V56, P291, DOI 10.1093/cid/cis842; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Grau I, 2005, ARCH INTERN MED, V165, P1533, DOI 10.1001/archinte.165.13.1533; Hakim JG, 2000, AIDS, V14, P1401, DOI 10.1097/00002030-200007070-00013; Harnden A, 2006, BRIT MED J, V332, P1295, DOI 10.1136/bmj.38789.723611.55; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Koster-Rasmussen R, 2008, J INFECTION, V57, P449, DOI 10.1016/j.jinf.2008.09.033; Lewis DK, 2005, T ROY SOC TROP MED H, V99, P561, DOI 10.1016/j.trstmh.2005.01.002; Manga N M, 2008, Med Trop (Mars), V68, P625; McCormick DW, 2012, PEDIAT INFECT DIS J; Molyneux E, 2005, J NEUROVIROL, V11, P6, DOI 10.1080/13550280500511337; Mugisha JO, 2008, TROP MED INT HEALTH, V13, P788, DOI 10.1111/j.1365-3156.2008.02069.x; Nadel S, 1998, J ACCID EMERG MED, V15, P298; Nyasulu P, 2011, PEDIATR INFECT DIS J, V30, P1075, DOI 10.1097/INF.0b013e31822cca05; PROKESCH RC, 1983, SOUTH MED J, V76, P322, DOI 10.1097/00007611-198303000-00014; SanJoaquin MA, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001400; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Schut ES, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-57; Schutte CM, 2000, INFECTION, V28, P3, DOI 10.1007/PL00012241; Swartz MN, 2004, NEW ENGL J MED, V351, P1826, DOI 10.1056/NEJMp048246; Thigpen MC, 2011, NEW ENGL J MED, V364, P2016, DOI 10.1056/NEJMoa1005384; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845	41	33	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69783	10.1371/journal.pone.0069783	http://dx.doi.org/10.1371/journal.pone.0069783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894538	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000322391400070
J	Zhu, Y; Yao, Z; Wu, Z; Mei, Y; Wu, M				Zhu, Y.; Yao, Z.; Wu, Z.; Mei, Y.; Wu, M.			Role of tumor necrosis factor alpha-induced protein 1 in paclitaxel resistance	ONCOGENE			English	Article						TNFAIP1; tubulin; paclitaxel resistance	HELA-CELLS; POLYMERIZED TUBULIN; NATURAL-PRODUCTS; MITOTIC ARREST; BETA-TUBULIN; TAXOL; CANCER; MICROTUBULES; EXPRESSION; DEATH	Paclitaxel has been extensively used as an antitumor drug to treat a broad range of epithelial cancers, including breast and cervical cancers. However, the efficacy of this drug is greatly limited by the development of acquired resistance. Identification of the underlying resistance mechanisms may inform the development of new therapies that elicit long-term response of tumors to paclitaxel treatment. Here we report that increased expression of TNFAIP1 (tumor necrosis factor alpha-induced protein 1) confers acquired resistance to paclitaxel. TNFAIP1 is shown to compete with paclitaxel for binding to beta-tubulin, thereby preventing paclitaxel-induced tubulin polymerization, cell cycle arrest and ultimate cell death. We also show that expression of TNFAIP1 is regulated by the transcriptional factor Sp1. In a xenograft mouse model, increased expression of TNFAIP1 decreases, whereas knockdown of TNFAIP1 increases tumor response to paclitaxel. Therefore, these results reveal tnfaip1 as a novel paclitaxel-resistance associated gene and suggest that TNFAIP1 may represent a valuable therapeutic target for the treatment of cancer.	[Zhu, Y.; Yao, Z.; Mei, Y.; Wu, M.] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Zhu, Y.; Yao, Z.; Mei, Y.; Wu, M.] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Wu, Z.] Anhui Med Univ, Dept Pathol, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University	Mei, Y (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, 96 Huangshan Rd, Hefei 230027, Anhui, Peoples R China.	meiyide@ustc.edu.cn; wumian@ustc.edu.cn	Mei, Yide/M-4468-2013; Wu, Mian/H-2494-2018; Yao, Zhan/AAK-6756-2020	Wu, Mian/0000-0002-2714-0500; YAO, ZHAN/0000-0001-5391-5691	National Natural Science Foundation of China [31030046, 31171316]; Ministry of Science and Technology of China [2010CB912804, 2011CB966302]; Chinese Academy of Sciences [XDA01020104]; Fundamental Research Funds for Central Universities [WK2060190018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from National Natural Science Foundation of China 31030046 (to MW) and 31171316 (to YM); the Ministry of Science and Technology of China (2010CB912804 and 2011CB966302); Chinese Academy of Sciences (XDA01020104) and the Fundamental Research Funds for Central Universities (WK2060190018).	Bai ZG, 2010, MOL MED REP, V3, P1071, DOI 10.3892/mmr.2010.371; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; BRADLEY G, 1994, CANCER METAST REV, V13, P223, DOI 10.1007/BF00689638; Burkhart C.A., 2001, BIOCHIM BIOPHYS ACTA, V1471, P1; CAMBRAYDEAKIN MA, 1987, J CELL BIOL, V104, P1569, DOI 10.1083/jcb.104.6.1569; CERNY T, 1994, BRIT J CANCER, V70, P384, DOI 10.1038/bjc.1994.311; Cheung CHA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012564; DEBRABANDER M, 1981, P NATL ACAD SCI-BIOL, V78, P5608; Dong Y, 2010, CANCER RES, V70, P2624, DOI 10.1158/0008-5472.CAN-09-3415; Duan ZF, 2006, CANCER CHEMOTH PHARM, V57, P25, DOI 10.1007/s00280-005-0026-3; Einzig A I, 1991, Cancer Treat Res, V58, P89; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; HENNEQUIN C, 1995, BRIT J CANCER, V71, P1194, DOI 10.1038/bjc.1995.232; Horwitz Susan Band, 1993, Journal of the National Cancer Institute Monographs, V0, P55; Ilson DH, 2007, ANN ONCOL, V18, P898, DOI 10.1093/annonc/mdm004; Jordan MA, 1996, CANCER RES, V56, P816; Kamath K, 2005, J BIOL CHEM, V280, P12902, DOI 10.1074/jbc.M414477200; Kim DM, 2009, INT J CANCER, V125, P2520, DOI 10.1002/ijc.24617; Lih CJ, 2006, GENE DEV, V20, P2082, DOI 10.1101/gad.1441306; Lin MC, 2005, WORLD J GASTROENTERO, V11, P7564, DOI 10.3748/wjg.v11.i48.7564; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Liu MJ, 2010, MOL BIOL REP, V37, P1699, DOI 10.1007/s11033-009-9588-1; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Ojima I, 1999, P NATL ACAD SCI USA, V96, P4256, DOI 10.1073/pnas.96.8.4256; PARNESS J, 1981, J CELL BIOL, V91, P479, DOI 10.1083/jcb.91.2.479; Rowinsky EK, 1997, ANNU REV MED, V48, P353; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; SEIDMAN AD, 1995, CLIN CANCER RES, V1, P247; Seve P, 2010, LUNG CANCER, V67, P136, DOI 10.1016/j.lungcan.2009.09.007; SLICHENMYER WJ, 1990, J CLIN PHARMACOL, V30, P770, DOI 10.1002/j.1552-4604.1990.tb01873.x; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; Suzuki M, 2003, JPN J CLIN ONCOL, V33, P297, DOI 10.1093/jjco/hyg054; Torres K, 1998, CANCER RES, V58, P3620; Wang JX, 2012, STEM CELLS, V30, P1405, DOI 10.1002/stem.1121; Wang YQ, 2006, BIOCHEMISTRY-US, V45, P185, DOI 10.1021/bi051207d; Wang YQ, 2005, BBA-MOL CELL RES, V1744, P245, DOI 10.1016/j.bbamcr.2004.12.003; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; WOLF FW, 1992, J BIOL CHEM, V267, P1317; Yao Z, 2007, EMBO J, V26, P1068, DOI 10.1038/sj.emboj.7601571; Yin SH, 2010, MOL CANCER THER, V9, P327, DOI 10.1158/1535-7163.MCT-09-0674; Zhou JL, 2005, J EXP ZOOL PART A, V303A, P227, DOI 10.1002/jez.a.150	42	18	20	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 19	2014	33	25					3246	3255		10.1038/onc.2013.299	http://dx.doi.org/10.1038/onc.2013.299			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK5DA	23912453				2022-12-25	WOS:000338443400004
J	Garner, JM; Fan, MY; Yang, CH; Du, ZY; Sims, M; Davidoff, AM; Pfeffer, LM				Garner, Jo Meagan; Fan, Meiyun; Yang, Chuan He; Du, Ziyun; Sims, Michelle; Davidoff, Andrew M.; Pfeffer, Lawrence M.			Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor kappa B Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; GENE-EXPRESSION; BREAST-CANCER; IN-VITRO; GROWTH; PROTEINS; RECEPTOR; SURVIVAL; LINES	Malignant gliomas are locally aggressive, highly vascular tumors that have a dismal prognosis, and present therapies provide little improvement in the disease course and outcome. Many types of malignancies, including glioblastoma, originate from a population of cancer stem cells (CSCs) that are able to initiate and maintain tumors. Although CSCs only represent a small fraction of cells within a tumor, their high tumor-initiating capacity and therapeutic resistance drives tumorigenesis. Therefore, it is imperative to identify pathways associated with CSCs to devise strategies to selectively target them. In this study, we describe a novel relationship between glioblastoma CSCs and the Notch pathway, which involves the constitutive activation of STAT3 and NF-kappa B signaling. Glioma CSCs were isolated and maintained in vitro using an adherent culture system, and the biological properties were compared with the traditional cultures of CSCs grown as multicellular spheres under nonadherent culture conditions. Interestingly, both adherent and spheroid glioma CSCs show constitutive activation of the STAT3/NF-kappa B signaling pathway and up-regulation of STAT3- and NF-kappa B-dependent genes. Gene expression profiling also identified components of the Notch pathway as being deregulated in glioma CSCs, and the deregulated expression of these genes was sensitive to treatment with STAT3 and NF-kappa B inhibitors. This finding is particularly important because Notch signaling appears to play a key role in CSCs in a variety of cancers and controls cell fate determination, survival, proliferation, and the maintenance of stem cells. The constitutive activation of STAT3 and NF-kappa B signaling pathways that leads to the regulation of Notch pathway genes in glioma CSCs identifies novel therapeutic targets for the treatment of glioma.	[Garner, Jo Meagan; Fan, Meiyun; Yang, Chuan He; Du, Ziyun; Sims, Michelle; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Garner, Jo Meagan; Fan, Meiyun; Yang, Chuan He; Du, Ziyun; Sims, Michelle; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Ctr Canc Res, Memphis, TN 38163 USA; [Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Pfeffer, LM (corresponding author), Canc Res Bldg,19 South Manassas St Room 154, Memphis, TN 38163 USA.	lpfeffer@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA133322]; Department of Defense [W81XWH-11-1-0533]; Cancer Center Support Grant from the National Cancer Institute and the Assisi Foundation of Memphis [21766]; UTHSC Muirhead Chair Endowment; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA133322, R01CA140346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Cancer Center Support Grant from the National Cancer Institute and the Assisi Foundation of Memphis; UTHSC Muirhead Chair Endowment; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA133322 (to L. M. P. and A. M. D.). This work was also supported by Department of Defense Grant W81XWH-11-1-0533 (to L. M. P.), by Cancer Center Support Grant 21766 from the National Cancer Institute and the Assisi Foundation of Memphis (to A. M. D.), by the UTHSC Muirhead Chair Endowment (to L. M. P.), and by the American Lebanese Syrian Associated Charities (to A. M. D.).	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Ang HL, 2007, BIOESSAYS, V29, P1039, DOI 10.1002/bies.20647; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; Du ZY, 2009, J BIOL CHEM, V284, P27808, DOI 10.1074/jbc.M109.028324; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Gill JS, 2002, BIOMATERIALS, V23, P2773, DOI 10.1016/S0142-9612(02)00013-3; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hitoshi S, 2011, NAT NEUROSCI, V14, P957, DOI 10.1038/nn.2875; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lino MM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-72; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ma YH, 2008, J NEURO-ONCOL, V86, P31, DOI 10.1007/s11060-007-9439-7; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Mlarotta LLC, 2009, CURR OPIN GENET DEV, V19, P44, DOI 10.1016/j.gde.2008.12.003; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Wu A, 2008, STEM CELLS DEV, V17, P173, DOI 10.1089/scd.2007.0133; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	39	131	143	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26167	26176		10.1074/jbc.M113.477950	http://dx.doi.org/10.1074/jbc.M113.477950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23902772	Green Published, hybrid			2022-12-25	WOS:000330623300045
J	Jiang, SN; Park, DW; Stigler, WS; Creighton, J; Ravi, S; Darley-Usmar, V; Zmijewski, JW				Jiang, Shaoning; Park, Dae Won; Stigler, William S.; Creighton, Judy; Ravi, Saranya; Darley-Usmar, Victor; Zmijewski, Jaroslaw W.			Mitochondria and AMP-activated Protein Kinase-dependent Mechanism of Efferocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; PERSISTENT CELL-MIGRATION; FIND-ME SIGNALS; APOPTOTIC CELLS; ENDOTHELIAL-CELLS; GAMMA-SUBUNITS; ENERGY SENSOR; T-CELLS; CLEARANCE; LYSOPHOSPHATIDYLCHOLINE	Defective clearance of apoptotic cells is frequently associated with perpetuation of inflammatory conditions. Our results show a rapid activation of AMP-activated kinase (AMPK) in macrophages upon exposure to apoptotic cells or lysophosphatidylcholine, a specific phospholipid that is produced and released from dying cells. AMPK activation resulted from inhibition of mitochondrial oxygen consumption and ATP production and further depended on Ca2+ mobilization and mitochondrial reactive oxygen species generation. Once activated, AMPK increased microtubule synthesis and chemokinesis and provided adaptation to energy demand during tracking and engulfment. Uptake of apoptotic cells was increased in lungs of mice that received lysophosphatidylcholine. Furthermore, inhibition of AMPK diminished clearance of apoptotic thymocytes in vitro and in dexamethasone-treated mice. Taken together, we conclude that the mitochondrial AMPK axis is a sensor and enhancer of tracking and removal of apoptotic cell, processes crucial to resolution of inflammatory conditions and a return to tissue homeostasis.	[Jiang, Shaoning; Park, Dae Won; Stigler, William S.; Zmijewski, Jaroslaw W.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Creighton, Judy] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35294 USA; [Ravi, Saranya; Darley-Usmar, Victor] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Darley-Usmar, Victor; Zmijewski, Jaroslaw W.] Univ Alabama Birmingham, Ctr Free Radical Biol, Birmingham, AL 35294 USA; [Park, Dae Won] Korea Univ, Ansan Hosp, Div Infect Dis, Ansan 425707, South Korea	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Korea University; Korea University Medicine (KU Medicine)	Zmijewski, JW (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, 901 19th St South,BMRII-304, Birmingham, AL 35294 USA.	zmijewsk@uab.edu	Kim, Il/L-6481-2019; Ha, C/GZL-9046-2022	Park, Dae Won/0000-0002-7653-686X; Darley-Usmar, Victor/0000-0001-8921-7086	National Institutes of Health [GM87748, HL107585, P30 AR 48311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102296, R01HL107585, R03HL110803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM87748 and HL107585 (to J. W. Z.) and P30 AR 48311 (to the Flow Cytometry Core, Arthritis and Musculoskeletal Center, University of Alabama at Birmingham).	Bae HB, 2013, J IMMUNOL, V190, P2273, DOI 10.4049/jimmunol.1200625; Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Banerjee S, 2011, J IMMUNOL, V187, P4686, DOI 10.4049/jimmunol.1101500; Baron SJ, 2005, CIRC RES, V96, P337, DOI 10.1161/01.RES.0000155723.53868.d2; Bergheim I, 2006, J PHARMACOL EXP THER, V316, P1053, DOI 10.1124/jpet.105.092122; Chan O, 2012, J BIOL CHEM, V287, P29406, DOI 10.1074/jbc.M112.348946; Chang WG, 2012, CARDIOVASC DRUG THER, V26, P467, DOI 10.1007/s10557-012-6422-0; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Duffin R, 2010, IMMUNOL REV, V236, P28, DOI 10.1111/j.1600-065X.2010.00922.x; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Friggeri A, 2011, J IMMUNOL, V186, P6191, DOI 10.4049/jimmunol.1004134; Gaskin FS, 2011, AM J PHYSIOL-HEART C, V300, pH1352, DOI 10.1152/ajpheart.00944.2010; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Hoogendijk AJ, 2013, J BIOL CHEM, V288, P7047, DOI 10.1074/jbc.M112.413138; Huang QQ, 2008, J BIOL CHEM, V283, P25887, DOI 10.1074/jbc.M801163200; Iseli TJ, 2008, J BIOL CHEM, V283, P4799, DOI 10.1074/jbc.M708298200; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Khandani A, 2007, J LEUKOCYTE BIOL, V82, P417, DOI 10.1189/jlb.0706469; Kim EK, 2011, J BIOL CHEM, V286, P24036, DOI 10.1074/jbc.M110.209908; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; Laiosa MD, 2003, J IMMUNOL, V171, P4582, DOI 10.4049/jimmunol.171.9.4582; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Meares GP, 2013, J IMMUNOL, V190, P372, DOI 10.4049/jimmunol.1202390; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Peter C, 2012, AUTOIMMUNITY, V45, P568, DOI 10.3109/08916934.2012.719947; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sulahian TH, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-59; Tadie JM, 2013, AM J PHYSIOL-LUNG C, V304, pL342, DOI 10.1152/ajplung.00151.2012; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Watanabe N, 2006, AM J PATHOL, V168, P1737, DOI 10.2353/ajpath.2006.050648; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031056; Yan JJ, 2004, NAT MED, V10, P161, DOI 10.1038/nm989; Yuan YP, 1996, J BIOL CHEM, V271, P27090, DOI 10.1074/jbc.271.43.27090; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; Zmijewski JW, 2009, J BIOL CHEM, V284, P22213, DOI 10.1074/jbc.M109.028902; Zmijewski JW, 2005, AM J PHYSIOL-HEART C, V289, pH852, DOI 10.1152/ajpheart.00015.2005	60	45	46	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26013	26026		10.1074/jbc.M113.489468	http://dx.doi.org/10.1074/jbc.M113.489468			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23897815	Green Published, hybrid			2022-12-25	WOS:000330623300032
J	Marriner, N; Flaux, C; Morhange, C; Stanley, JD				Marriner, Nick; Flaux, Clement; Morhange, Christophe; Stanley, Jean-Daniel			Tracking Nile Delta Vulnerability to Holocene Change	PLOS ONE			English	Article							SEA-LEVEL CHANGES; MISSISSIPPI DELTA; CLIMATE-CHANGE; SEDIMENT; FLUCTUATIONS; SETTLEMENTS; RESPONSES; AFRICA; SAHARA; IMPACT	Understanding deltaic resilience in the face of Holocene climate change and human impacts is an important challenge for the earth sciences in characterizing the full range of present and future wetland responses to global warming. Here, we report an 8000-year mass balance record from the Nile Delta to reconstruct when and how this sedimentary basin has responded to past hydrological shifts. In a global Holocene context, the long-term decrease in Nile Delta accretion rates is consistent with insolation-driven changes in the 'monsoon pacemaker', attested throughout the mid-latitude tropics. Following the early to mid-Holocene growth of the Nile's deltaic plain, sediment losses and pronounced erosion are first recorded after similar to 4000 years ago, the corollaries of falling sediment supply and an intensification of anthropogenic impacts from the Pharaonic period onwards. Against the backcloth of the Saharan 'depeopling', reduced river flow underpinned by a weakening of monsoonal precipitation appears to have been particularly conducive to the expansion of human activities on the delta by exposing productive floodplain lands for occupation and irrigation agriculture. The reconstruction suggests that the Nile Delta has a particularly long history of vulnerability to extreme events (e. g. floods and storms) and sea-level rise, although the present sediment-starved system does not have a direct Holocene analogue. This study highlights the importance of the world's deltas as sensitive archives to investigate Holocene geosystem responses to climate change, risks and hazards, and societal interaction.	[Marriner, Nick] Univ Franche Comte, CNRS, Lab Chronoenvironm, F-25030 Besancon, France; [Marriner, Nick] CNRS, Ctr Rech & Enseignement Geosci Environm, Aix En Provence, France; [Flaux, Clement; Morhange, Christophe] Univ Aix Marseille, Ctr Rech & Enseignement Geosci Environm, Aix En Provence, France; [Stanley, Jean-Daniel] Smithsonian Inst, Natl Museum Nat Hist, Geoarchaeol Program, Washington, DC 20560 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Smithsonian Institution; Smithsonian National Museum of Natural History	Marriner, N (corresponding author), Univ Franche Comte, CNRS, Lab Chronoenvironm, F-25030 Besancon, France.	marriner@cerege.fr	Marriner, Nick/AAA-3004-2019	Marriner, Nick/0000-0002-7916-6059	Agence Nationale de la Recherche [Paleomed: 09-BLAN-0323-01, Geomar: ANR-12-SENV-0008-03]; Artemis Institut National des Sciences de l'Univers	Agence Nationale de la Recherche(French National Research Agency (ANR)); Artemis Institut National des Sciences de l'Univers	This research was funded by the Agence Nationale de la Recherche (Paleomed: 09-BLAN-0323-01 and Geomar: ANR-12-SENV-0008-03) and Artemis Institut National des Sciences de l'Univers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony E., 2008, ELSEVIER SCI; Becker RH, 2009, HOLOCENE, V19, P949, DOI 10.1177/0959683609336558; Bernhardt CE, 2012, GEOLOGY, V40, P615, DOI 10.1130/G33012.1; Bianchi TS, 2009, P NATL ACAD SCI USA, V106, P8085, DOI 10.1073/pnas.0812878106; Blanchet CL, 2013, EARTH PLANET SC LETT, V364, P98, DOI 10.1016/j.epsl.2013.01.009; Blum MD, 2007, LARGE RIVERS GEOMORP, P627, DOI 10.1002/9780470723722.ch30; Blum MD, 2012, ANNU REV EARTH PL SC, V40, P655, DOI 10.1146/annurev-earth-042711-105248; Blum MD, 2009, NAT GEOSCI, V2, P488, DOI 10.1038/ngeo553; Bohannon J, 2010, SCIENCE, V327, P1444, DOI 10.1126/science.327.5972.1444; Bronk Ramsey C, 2000, OXCAL PROGRAM V 3 5; Brooks N, 2006, QUATERN INT, V151, P29, DOI 10.1016/j.quaint.2006.01.013; Brueckner H, 2005, MEDITERRANEE, V104, P95, DOI DOI 10.4000/MEDITERRANEE.2342; Butzer K.W., 1976, EARLY HYDRAULIC CIVI; Chen ZY, 2008, QUATERNARY RES, V70, P301, DOI 10.1016/j.yqres.2008.03.011; Chen ZY, 2005, HOLOCENE, V15, P915, DOI 10.1191/0959683605hl862rr; COUTELLIER V, 1987, MAR GEOL, V77, P257, DOI 10.1016/0025-3227(87)90116-2; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Ericson JP, 2006, GLOBAL PLANET CHANGE, V50, P63, DOI 10.1016/j.gloplacha.2005.07.004; Flaux C, 2012, THESIS AIX MARSEILLE; Flaux C, 2012, J ARCHAEOL SCI, V39, P3493, DOI 10.1016/j.jas.2012.06.010; Flaux C, 2011, GEOMORPHOLOGIE, P261; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Garcin Y, 2012, EARTH PLANET SC LETT, V331, P322, DOI 10.1016/j.epsl.2012.03.016; Gasse F, 2004, ADV GLOB CHANGE RES, V21, P313; Giosan L, 2012, P NATL ACAD SCI USA, V109, pE1688, DOI 10.1073/pnas.1112743109; Kennett D.J., 2006, J ISLAND COASTAL ARC, V1, P67, DOI DOI 10.1080/15564890600586283; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Krom MD, 2002, GEOLOGY, V30, P71, DOI 10.1130/0091-7613(2002)030<0071:NRSFOT>2.0.CO;2; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Macklin MG, 2012, PHILOS T R SOC A, V370, P2143, DOI 10.1098/rsta.2011.0608; Macklin MG, 2013, GEOLOGY, V41, P695, DOI 10.1130/G34037.1; Magny M, 2013, CLIM PAST, V9, P2043, DOI 10.5194/cp-9-2043-2013; Marriner N, 2012, GEOLOGY, V40, P1083, DOI 10.1130/G33209.1; Marriner N, 2012, QUATERNARY SCI REV, V45, P73, DOI 10.1016/j.quascirev.2012.04.022; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Menot G, 2006, SCIENCE, V313, P1623, DOI 10.1126/science.1130511; Nicholls RJ, 2004, GLOBAL ENVIRON CHANG, V14, P69, DOI 10.1016/j.gloenvcha.2003.10.007; Permanent Service for Mean Sea Level, 2013, AL TID GAUG DAT; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Revel M, 2010, QUATERNARY SCI REV, V29, P1342, DOI 10.1016/j.quascirev.2010.02.006; Said R., 1993, RIVER NILE GEOLOGY H; Shahin M.M., 1985, HYDROLOGY NILE BASIN; SHAW I, 2000, OXFORD HIST ANCIENT; Sivan D, 2004, EARTH PLANET SC LETT, V222, P315, DOI 10.1016/j.epsl.2004.02.007; Sivan D, 2001, PALAEOGEOGR PALAEOCL, V167, P101, DOI 10.1016/S0031-0182(00)00234-0; SNEH A, 1986, QUATERNARY RES, V26, P194, DOI 10.1016/0033-5894(86)90104-3; Stanley D, 1997, GSA TODAY, V7, P1; STANLEY DJ, 1993, SCIENCE, V260, P628, DOI 10.1126/science.260.5108.628; Stanley J-D, 1996, SMITHSONIAN CONTRIBU; Stanley JD, 2008, J COASTAL RES, V24, P451, DOI 10.2112/07A-0021.1; Stanley JD, 2009, J COASTAL RES, V25, P158, DOI 10.2112/08A-0013.1; Syvitski JPM, 2007, GLOBAL PLANET CHANGE, V57, P261, DOI 10.1016/j.gloplacha.2006.12.001; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Syvitski JPM, 2008, SUSTAIN SCI, V3, P23, DOI 10.1007/s11625-008-0043-3; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; TORNQVIST TE, 1994, GEOLOGY, V22, P711, DOI 10.1130/0091-7613(1994)022<0711:MALHAH>2.3.CO;2; Tristant Y., 2011, PYRAMIDS ORIGINS EGY, V33, P45; Williams MAJ, 2009, GLOBAL PLANET CHANGE, V69, P1, DOI 10.1016/j.gloplacha.2009.07.005; Wilson P, 2009, W NILE DELTA REGIONA; WONG P. P, 2007, CLIMATE CHANGE, P315, DOI DOI 10.1017/CB09781107415379; Woodward JC, 2007, LARGE RIVERS GEOMORP, P261, DOI DOI 10.1002/9780470723722.CH13; Wunderlich J, 1989, MARBURGER GEOGRAPHIS; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	64	31	31	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69195	10.1371/journal.pone.0069195	http://dx.doi.org/10.1371/journal.pone.0069195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922692	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700022
J	Raizada, RDS; Lee, YS				Raizada, Rajeev D. S.; Lee, Yune-Sang			Smoothness without Smoothing: Why Gaussian Naive Bayes Is Not Naive for Multi-Subject Searchlight Studies	PLOS ONE			English	Article							DISTRIBUTED PATTERNS; HUMAN BRAIN; FMRI; CLASSIFIERS; RECOGNITION; SPEECH; CORTEX; TASK	Spatial smoothness is helpful when averaging fMRI signals across multiple subjects, as it allows different subjects' corresponding brain areas to be pooled together even if they are slightly misaligned. However, smoothing is usually not applied when performing multivoxel pattern-based analyses (MVPA), as it runs the risk of blurring away the information that fine-grained spatial patterns contain. It would therefore be desirable, if possible, to carry out pattern-based analyses which take unsmoothed data as their input but which produce smooth images as output. We show here that the Gaussian Naive Bayes (GNB) classifier does precisely this, when it is used in "searchlight" pattern-based analyses. We explain why this occurs, and illustrate the effect in real fMRI data. Moreover, we show that analyses using GNBs produce results at the multi-subject level which are statistically robust, neurally plausible, and which replicate across two independent data sets. By contrast, SVM classifiers applied to the same data do not generate a replication, even if the SVM-derived searchlight maps have smoothing applied to them. An additional advantage of GNB classifiers for searchlight analyses is that they are orders of magnitude faster to compute than more complex alternatives such as SVMs. Collectively, these results suggest that Gaussian Naive Bayes classifiers may be a highly non-naive choice for multi-subject pattern-based fMRI studies.	[Raizada, Rajeev D. S.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Lee, Yune-Sang] Dartmouth Coll, Hanover, NH 03755 USA; [Lee, Yune-Sang] Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	Cornell University; Dartmouth College; University of Pennsylvania; Pennsylvania Medicine	Lee, YS (corresponding author), Dartmouth Coll, Hanover, NH 03755 USA.	yslee@sas.upenn.edu		Lee, Yune Sang/0000-0001-8401-6007; Raizada, Rajeev/0000-0002-2784-1964	Dartmouth Brain Imaging Center (DBIC); Neukom Institute	Dartmouth Brain Imaging Center (DBIC); Neukom Institute	The authors thank Dartmouth Brain Imaging Center (DBIC) and Neukom Institute for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickel PJ, 2004, BERNOULLI, V10, P989, DOI 10.3150/bj/1106314847; Bode S, 2009, NEUROIMAGE, V45, P606, DOI 10.1016/j.neuroimage.2008.11.031; Chen Y, 2011, NEUROIMAGE, V56, P582, DOI 10.1016/j.neuroimage.2010.07.035; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Demsar J, 2006, J MACH LEARN RES, V7, P1; Domingos P, 1997, MACH LEARN, V29, P103, DOI 10.1023/A:1007413511361; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Hand DJ, 2001, INT STAT REV, V69, P385, DOI 10.1111/j.1751-5823.2001.tb00465.x; HASTIE T, 2009, SPRINGER SERIES STAT; Johnson JD, 2009, NEURON, V63, P697, DOI 10.1016/j.neuron.2009.08.011; Kahnt T, 2011, NEUROIMAGE, V56, P709, DOI 10.1016/j.neuroimage.2010.05.058; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Ku SP, 2008, MAGN RESON IMAGING, V26, P1007, DOI 10.1016/j.mri.2008.02.016; Lee YS, 2012, J NEUROSCI, V32, P3942, DOI 10.1523/JNEUROSCI.3814-11.2012; Li YM, 2013, NEUROIMAGE, V72, P91, DOI 10.1016/j.neuroimage.2013.01.034; Mangasaian OL, 2001, J MACH LEARN RES, V1, P161, DOI 10.1162/15324430152748218; Mikl M, 2008, MAGN RESON IMAGING, V26, P490, DOI 10.1016/j.mri.2007.08.006; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Myers EB, 2007, NEUROPSYCHOLOGIA, V45, P1463, DOI 10.1016/j.neuropsychologia.2006.11.005; Myers EB, 2009, PSYCHOL SCI, V20, P895, DOI 10.1111/j.1467-9280.2009.02380.x; Ng Y, 2002, ADV NEURAL INFORM PR, V14, P841; Op de Beeck HP, 2010, NEUROIMAGE, V49, P1943, DOI 10.1016/j.neuroimage.2009.02.047; Pereira F, 2011, NEUROIMAGE, V56, P476, DOI 10.1016/j.neuroimage.2010.05.026; Raizada RDS, 2007, NEURON, V56, P726, DOI 10.1016/j.neuron.2007.11.001; RAUDYS SJ, 1991, IEEE T PATTERN ANAL, V13, P252, DOI 10.1109/34.75512; Schmah T, 2010, NEURAL COMPUT, V22, P2729, DOI 10.1162/NECO_a_00024; Shinkareva SV, 2011, NEUROIMAGE, V54, P2418, DOI 10.1016/j.neuroimage.2010.10.042; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Walther DB, 2009, J NEUROSCI, V29, P10573, DOI 10.1523/JNEUROSCI.0559-09.2009; Zhang H, 2004, P 17 INT FLAIRS C, V17; Zhang L, 2005, PROC CVPR IEEE, P1211	33	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69566	10.1371/journal.pone.0069566	http://dx.doi.org/10.1371/journal.pone.0069566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922740	Green Submitted, Green Published, gold			2022-12-25	WOS:000322838900056
J	Subramaniam, KS; Tham, T; Mohamed, Z; Woo, YL; Adenan, NAM; Chung, I				Subramaniam, Kavita S.; Tham, Seng Tian; Mohamed, Zahurin; Woo, Yin Ling; Adenan, Noor Azmi Mat; Chung, Ivy			Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STROMAL CELLS; TUMOR-STROMA; METALLOPROTEINASE EXPRESSION; LUNG-CANCER; MIGRATION; RECEPTOR; PATHWAY; TARGET; INTERLEUKIN-8	Endometrial cancer is the most commonly diagnosed gynecologic malignancy worldwide; yet the tumor microenvironment, especially the fibroblast cells surrounding the cancer cells, is poorly understood. We established four primary cultures of fibroblasts from human endometrial cancer tissues (cancer-associated fibroblasts, CAFs) using antibody-conjugated magnetic bead isolation. These relatively homogenous fibroblast cultures expressed fibroblast markers (CD90, vimentin and alpha-smooth muscle actin) and hormonal (estrogen and progesterone) receptors. Conditioned media collected from CAFs induced a dose-dependent proliferation of both primary cultures and cell lines of endometrial cancer in vitro (175%) when compared to non-treated cells, in contrast to those from normal endometrial fibroblast cell line (51%) (P<0.0001). These effects were not observed in fibroblast culture derived from benign endometrial hyperplasia tissues, indicating the specificity of CAFs in affecting endometrial cancer cell proliferation. To determine the mechanism underlying the differential fibroblast effects, we compared the activation of PI3K/Akt and MAPK/Erk pathways in endometrial cancer cells following treatment with normal fibroblasts-and CAFs-conditioned media. Western blot analysis showed that the expression of both phosphorylated forms of Akt and Erk were significantly down-regulated in normal fibroblasts-treated cells, but were up-regulated/maintained in CAFs-treated cells. Treatment with specific inhibitors LY294002 and U0126 reversed the CAFs-mediated cell proliferation (P<0.0001), suggesting for a role of these pathways in modulating endometrial cancer cell proliferation. Rapamycin, which targets a downstream molecule in PI3K pathway (mTOR), also suppressed CAFs-induced cell proliferation by inducing apoptosis. Cytokine profiling analysis revealed that CAFs secrete higher levels of macrophage chemoattractant protein (MCP)-1, interleukin (IL)-6, IL-8, RANTES and vascular endothelial growth factor (VEGF) than normal fibroblasts. Our data suggests that in contrast to normal fibroblasts, CAFs may exhibit a pro-tumorigenic effect in the progression of endometrial cancer, and PI3K/Akt and MAPK/Erk signaling may represent critical regulators in how endometrial cancer cells respond to their microenvironment.	[Subramaniam, Kavita S.; Mohamed, Zahurin; Chung, Ivy] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Tham, Seng Tian; Woo, Yin Ling] Univ Malaya, Fac Med, Dept Obstet & Gynecol, Kuala Lumpur 50603, Malaysia; [Mohamed, Zahurin] Univ Malaya, Fac Med, Dept Pharmacol, Pharmacogen Lab, Kuala Lumpur 50603, Malaysia; [Subramaniam, Kavita S.; Tham, Seng Tian; Woo, Yin Ling; Chung, Ivy] Univ Malaya, Fac Med, Canc Res Inst, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Chung, I (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	ivychung@ummc.edu.my	Woo, Yin Ling/B-5198-2010; Woo, Yin Ling/GPX-0086-2022; Mat Adenan, Noor Azmi/R-5144-2016; MAT ADENAN, NOOR AZMI/B-9264-2010; Mohamed, Zahurin/C-1112-2010; Chung, Ivy/C-3804-2012	Woo, Yin Ling/0000-0003-1742-1066; Woo, Yin Ling/0000-0003-1742-1066; Mat Adenan, Noor Azmi/0000-0002-0428-0316; Mohamed, Zahurin/0000-0002-4396-0517; S SUBRAMANIAM, Kavita/0000-0002-3809-9013	University Malaya [RG336/11HTM, UM HIR/MOHE/MED-12, HIR-MOHE E-00025-20001]	University Malaya(Universiti Malaya)	This work is funded by University Malaya Research Grants RG336/11HTM (Chung), UM HIR/MOHE/MED-12 (Chung) and HIR-MOHE E-00025-20001 (Mohamed). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell K, 2005, CELL CYCLE, V4, P897, DOI 10.4161/cc.4.7.1837; Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Arentz Georgia, 2011, Clin Proteomics, V8, P16, DOI 10.1186/1559-0275-8-16; Arnold JT, 2002, CANCER RES, V62, P79; Arnold JT, 2001, HUM REPROD, V16, P836, DOI 10.1093/humrep/16.5.836; Bae-Jump VL, 2009, CANCER-AM CANCER SOC, V115, P3887, DOI 10.1002/cncr.24431; Bakkum-Gamez JN, 2008, MAYO CLIN PROC, V83, P97, DOI 10.4065/83.1.97; Ban S, 2009, WORLD J GASTROENTERO, V15, P4976, DOI 10.3748/wjg.15.4976; Becker C, 2005, CELL CYCLE, V4, P217; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; BOURNAZOU EB, 2013, TARGETING TUMOR MICR; Brachtel EF, 2005, AM J SURG PATHOL, V29, P1322, DOI 10.1097/01.pas.0000171001.87599.e2; Burger JA, 2011, EXPERT REV ANTICANC, V11, P621, DOI [10.1586/era.11.11, 10.1586/ERA.11.11]; Burke JM, 1999, INVEST OPHTH VIS SCI, V40, P2963; Chung I, 2007, J BIOL CHEM, V282, P8704, DOI 10.1074/jbc.M608894200; CHUNG LWK, 1992, J CELL BIOCHEM, P99; Classen-Linke I, 2000, STEROIDS, V65, P763, DOI 10.1016/S0039-128X(00)00180-X; COOKE PS, 1986, P NATL ACAD SCI USA, V83, P2109, DOI 10.1073/pnas.83.7.2109; Coso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039558; Cunha G R, 1992, Epithelial Cell Biol, V1, P18; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; CUNHA GR, 1985, CELL DIFFER DEV, V17, P137, DOI 10.1016/0045-6039(85)90481-6; Dagouassat M, 2010, INT J CANCER, V126, P1095, DOI 10.1002/ijc.24800; Donjacour A A, 1991, Cancer Treat Res, V53, P335; DUDLEY AC, 2012, COLD SPRING HARB PER, P2; Franco OE, 2012, ADV PHARMACOL, V65, P267, DOI 10.1016/B978-0-12-397927-8.00009-9; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Gadducci A, 2008, GYNECOL ENDOCRINOL, V24, P239, DOI 10.1080/09513590801953556; Gangadhara S, 2012, FUTURE ONCOL, V8, P1427, DOI [10.2217/FON.12.134, 10.2217/fon.12.134]; Gelmini S, 2009, CLIN EXP METASTAS, V26, P261, DOI 10.1007/s10585-009-9240-4; Gentilini D, 2007, MOL HUM REPROD, V13, P317, DOI 10.1093/molehr/gam001; HAMMOND MG, 1993, AM J OBSTET GYNECOL, V168, P1131, DOI 10.1016/0002-9378(93)90356-N; Huang CY, 2009, BIOCHEM PHARMACOL, V77, P794, DOI 10.1016/j.bcp.2008.11.014; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johansson AC, 2012, MOL CANCER RES, V10, P1158, DOI 10.1158/1541-7786.MCR-12-0030; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kamat AA, 2007, CLIN CANCER RES, V13, P7487, DOI 10.1158/1078-0432.CCR-07-1017; Kinoshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060914; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kruger W, 1999, CYTOTHERAPY, V1, P135, DOI 10.1080/0032472031000141251; Kruger W, 2000, TRANSFUSION, V40, P1489, DOI 10.1046/j.1537-2995.2000.40121489.x; Lai Y, 2012, EUR REV MED PHARMACO, V16, P630; LEE YS, 2010, BRIT J CANCER, V106, P1833; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Luo Y, 2006, CHINESE MED J-PEKING, V119, P713, DOI 10.1097/00029330-200605010-00002; Luppi F, 2007, LUNG CANCER, V56, P25, DOI 10.1016/j.lungcan.2006.11.014; MATRISIAN LM, 1994, CONTRIB NEPHROL, V107, P94; Modugno F, 2005, CANCER EPIDEM BIOMAR, V14, P2840, DOI 10.1158/1055-9965.EPI-05-0493; Mutter GL, 2007, INT J GYNECOL PATHOL, V26, P103, DOI 10.1097/PGP.0b013e31802e4696; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; OSTEEN KG, 1994, P NATL ACAD SCI USA, V91, P10129, DOI 10.1073/pnas.91.21.10129; Pinto MP, 2010, CANCER RES, V70, P2655, DOI 10.1158/0008-5472.CAN-09-4373; Plataniotis G., 2010, ANN ONCOLOGY S5, V21, pv41, DOI DOI 10.1093/ANN0NC/MDQ245.PUBMED:20555100; RAZ Y, 2013, EXP CELL RES; Samalecos A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-76; Schlemmer SR, 2000, MOL CARCINOGEN, V28, P70, DOI 10.1002/1098-2744(200006)28:2<70::AID-MC2>3.0.CO;2-9; Shafer A, 2010, INT J CANCER, V126, P1144, DOI 10.1002/ijc.24837; Shi M, 2011, GYNECOL ONCOL, V123, P387, DOI 10.1016/j.ygyno.2011.07.004; Slomovitz BM, 2010, CANCER-AM CANCER SOC, V116, P5415, DOI 10.1002/cncr.25515; *SOC AC, 2012, CANC FACTS FIG 2012; Squillace RM, 2011, MOL CANCER THER, V10, P1959, DOI 10.1158/1535-7163.MCT-11-0273; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Szeto CC, 2005, NEPHROL DIAL TRANSPL, V20, P105, DOI 10.1093/ndt/gfh574; Tanaka R, 2003, GYNECOL ONCOL, V90, P297, DOI 10.1016/S0090-8258(03)00335-4; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; TRAWEEK ST, 1993, AM J PATHOL, V142, P1111; Trimble CL, 2006, CANCER-AM CANCER SOC, V106, P812, DOI 10.1002/cncr.21650; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Tu YP, 2000, CANCER RES, V60, P6763; Vong Sylvia, 2011, Genes Cancer, V2, P1139, DOI 10.1177/1947601911423940; Wagatsuma S, 1998, CANCER, V82, P520, DOI 10.1002/(SICI)1097-0142(19980201)82:3<520::AID-CNCR14>3.0.CO;2-3; Wang S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010700; Yamaji H, 2004, CANCER IMMUNOL IMMUN, V53, P786, DOI 10.1007/s00262-004-0533-9; Yokoyama Y, 2003, CLIN CANCER RES, V9, P1361; Yoshimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058791; Yuan A, 2005, FRONT BIOSCI-LANDMRK, V10, P853, DOI 10.2741/1579; Zagouri F, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/749579; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	83	69	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e68923	10.1371/journal.pone.0068923	http://dx.doi.org/10.1371/journal.pone.0068923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922669	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900013
J	Williams, DW; Calderon, TM; Lopez, L; Carvallo-Torres, L; Gaskill, PJ; Eugenin, EA; Morgello, S; Berman, JW				Williams, Dionna W.; Calderon, Tina M.; Lopez, Lillie; Carvallo-Torres, Loreto; Gaskill, Peter J.; Eugenin, Eliseo A.; Morgello, Susan; Berman, Joan W.			Mechanisms of HIV Entry into the CNS: Increased Sensitivity of HIV Infected CD14(+)CD16(+) Monocytes to CCL2 and Key Roles of CCR2, JAM-A, and ALCAM in Diapedesis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CELL-ADHESION MOLECULE; CEREBROSPINAL-FLUID; TRANSENDOTHELIAL MIGRATION; CHEMOATTRACTANT PROTEIN-1; LEUKOCYTE TRAFFICKING; POTENTIAL MECHANISM; VIRUS; EXPRESSION; INVASION	As HIV infected individuals live longer, the prevalence of HIV associated neurocognitive disorders is increasing, despite successful antiretroviral therapy. CD14(+)CD16(+) monocytes are critical to the neuropathogenesis of HIV as they promote viral seeding of the brain and establish neuroinflammation. The mechanisms by which HIV infected and uninfected monocytes cross the blood brain barrier and enter the central nervous system are not fully understood. We determined that HIV infection of CD14(+)CD16(+) monocytes resulted in their highly increased transmigration across the blood brain barrier in response to CCL2 as compared to uninfected cells, which did not occur in the absence of the chemokine. This exuberant transmigration of HIV infected monocytes was due, at least in part, to increased CCR2 and significantly heightened sensitivity to CCL2. The entry of HIV infected and uninfected CD14(+)CD16(+) monocytes into the brain was facilitated by significantly increased surface JAM-A, ALCAM, CD99, and PECAM-1, as compared to CD14(+) cells that are CD16 negative. Upon HIV infection, there was an additional increase in surface JAM-A and ALCAM on CD14(+)CD16(+) monocytes isolated from some individuals. Antibodies to ALCAM and JAM-A inhibited the transmigration of both HIV infected and uninfected CD14(+)CD16(+) monocytes across the BBB, demonstrating their importance in facilitating monocyte transmigration and entry into the brain parenchyma. Targeting CCR2, JAM-A, and ALCAM present on CD14(+)CD16(+) monocytes that preferentially infiltrate the CNS represents a therapeutic strategy to reduce viral seeding of the brain as well as the ongoing neuroinflammation that occurs during HIV pathogenesis.	[Williams, Dionna W.; Calderon, Tina M.; Lopez, Lillie; Carvallo-Torres, Loreto; Gaskill, Peter J.; Berman, Joan W.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Eugenin, Eliseo A.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Eugenin, Eliseo A.] Univ Med & Dent New Jersey, Dept Immunol & Mol Genet, Newark, NJ 07103 USA; [Morgello, Susan] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Morgello, Susan] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Morgello, Susan] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Berman, Joan W.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine	Berman, JW (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	joan.berman@einstein.yu.edu	Gaskill, Peter Jesse/O-5096-2019; Williams, Dionna/L-1579-2018; Williams, Dionna/K-1840-2019; Carvallo, Loreto/C-2237-2019	Gaskill, Peter Jesse/0000-0003-0095-5424; Williams, Dionna/0000-0001-5029-2628; Carvallo, Loreto/0000-0001-9943-1342	NIH [MH075679, MH090958, MH080663, MH096625, MH083501]; NIAID [T32AI070117]; UNCF/Merck Graduate Science Dissertation Fellowship; Center for AIDS Research at the Albert Einstein College of Medicine; Montefiore Medical Center [AI-051519];  [DA025567];  [DA029476]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070117, P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080663, U01MH083501, U24MH100931, R01MH075679, R01MH090958, R01MH096625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025567, K01DA029476] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UNCF/Merck Graduate Science Dissertation Fellowship; Center for AIDS Research at the Albert Einstein College of Medicine; Montefiore Medical Center; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This was supported by NIH grants MH075679 (JWB), MH090958 (JWB, LC), MH080663 (SM. Pilot funds, Mount Sinai Institute for NeuroAIDS Disparities DWW), MH096625 (EAE), MH083501 (SM); DA025567 (JWB, TMC), DA029476 (PJG); NIAID T32AI070117 (DWW); UNCF/Merck Graduate Science Dissertation Fellowship (DWW); and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center (AI-051519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Ances BM, 2007, SEMIN NEUROL, V27, P86, DOI 10.1055/s-2006-956759; Bazzoni G, 2011, ANTIOXID REDOX SIGN, V15, P1221, DOI 10.1089/ars.2010.3867; Buckner CM, 2011, CELL IMMUNOL, V267, P109, DOI 10.1016/j.cellimm.2010.12.004; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chen YP, 2009, NEW ENGL J MED, V361, P1067, DOI 10.1056/NEJMoa0904267; Cinque P, 1998, AIDS, V12, P1327, DOI 10.1097/00002030-199811000-00014; CLARKSON SB, 1988, J EXP MED, V167, P408, DOI 10.1084/jem.167.2.408; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; de Almeida SN, 2005, J NEUROIMMUNOL, V169, P144, DOI 10.1016/j.jneuroim.2005.07.012; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Eugenin EA, 2006, J LEUKOCYTE BIOL, V79, P444, DOI 10.1189/jlb.0405215; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Eugenin EA, 2003, METHODS, V29, P351, DOI 10.1016/S1046-2023(02)00359-6; Eugenin EA, 2007, J NEUROSCI, V27, P12844, DOI 10.1523/JNEUROSCI.4154-07.2007; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Han JY, 2009, JAIDS-J ACQ IMM DEF, V52, P553, DOI 10.1097/QAI.0b013e3181c1d4fe; Harezlak J, 2011, AIDS, V25, P625, DOI 10.1097/QAD.0b013e3283427da7; HURWITZ AA, 1993, BRAIN RES, V625, P238, DOI 10.1016/0006-8993(93)91064-Y; Imbert AM, 2006, BLOOD, V108, P2578, DOI 10.1182/blood-2005-12-010827; Kamat A, 2012, JAIDS-J ACQ IMM DEF, V60, P234, DOI 10.1097/QAI.0b013e318256f3bc; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Kusao I, 2012, J NEUROPSYCH CLIN N, V24, P71, DOI 10.1176/appi.neuropsych.11050109; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Mankowski JL, 2004, J NEUROIMMUNOL, V157, P66, DOI 10.1016/j.jneuroim.2004.08.031; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Nolting T, 2012, J NEUROVIROL, V18, P157, DOI 10.1007/s13365-012-0091-4; Nourshargh S, 2006, J LEUKOCYTE BIOL, V80, P714, DOI 10.1189/jlb.1105645; Ofori-Acquah SF, 2008, TRANSL RES, V151, P122, DOI 10.1016/j.trsl.2007.09.006; Penton-Rol G, 1998, J IMMUNOL, V160, P3869; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Salentin R, 2003, J LEUKOCYTE BIOL, V74, P252, DOI 10.1189/jlb.1102565; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Soulas C, 2011, AM J PATHOL, V178, P2121, DOI 10.1016/j.ajpath.2011.01.023; SPUDICH S, 2012, HIV 1 RELATED CENTRA, V2; STOCKINGER H, 1990, J IMMUNOL, V145, P3889; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Volpe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037208; Weber C, 1999, ATHEROSCLEROSIS, V145, P115, DOI 10.1016/S0021-9150(99)00021-0; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Weiss JM, 1998, J NEUROIMMUNOL, V91, P190, DOI 10.1016/S0165-5728(98)00183-0; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Williams DW, 2012, J LEUKOCYTE BIOL, V91, P401, DOI 10.1189/jlb.0811394; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2; Yao HH, 2011, J NEUROSCI, V31, P5942, DOI 10.1523/JNEUROSCI.5618-10.2011; Yuan L, 2013, J NEUROVIROL, V19, P144, DOI 10.1007/s13365-013-0150-5; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	53	98	101	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69270	10.1371/journal.pone.0069270	http://dx.doi.org/10.1371/journal.pone.0069270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922698	gold, Green Published, Green Submitted			2022-12-25	WOS:000322838900030
J	Aldhamen, YA; Seregin, SS; Rastall, DPW; Aylsworth, CF; Pepelyayeva, Y; Busuito, CJ; Godbehere-Roosa, S; Kim, S; Amalfitano, A				Aldhamen, Yasser A.; Seregin, Sergey S.; Rastall, David P. W.; Aylsworth, Charles F.; Pepelyayeva, Yuliya; Busuito, Christopher J.; Godbehere-Roosa, Sarah; Kim, Sungjin; Amalfitano, Andrea			Endoplasmic Reticulum Aminopeptidase-1 Functions Regulate Key Aspects of the Innate Immune Response	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; COMPLEX CLASS-I; GENOME-WIDE ASSOCIATION; ANKYLOSING-SPONDYLITIS; NKT CELLS; DEVELOPMENTAL PATHWAYS; GENETIC ASSOCIATION; SUSCEPTIBILITY LOCI; PRESENTED PEPTIDES; ERAP1	Endoplasmic reticulum aminopeptidase-1 (ERAP1) is a multifunctional, ubiquitously expressed enzyme whose peptide-trimming role during antigen processing for presentation by MHC I molecules is well established, however, a role for ERAP1 in modulating global innate immune responses has not been described to date. Here we demonstrate that, relative to wild type mice, mice lacking ERAP1 exhibit exaggerated innate immune responses early during pathogen recognition, as characterized by increased activation of splenic and hepatic NK and NKT cells and enhanced production of pro-inflammatory cytokines such as IL12 and MCP1. Our data also revealed that ERAP1 is playing a critical role in NK cell development and function. We observed higher frequencies of terminally matured NK cells, as well as higher frequencies of licensed NK cells (expressing the Ly49C and Ly49I receptors) in ERAP1-KO mice, results that positively correlated with an enhanced NK activation and IFNc production by ERAP1-KO mice challenged with pro-inflammatory stimuli. Furthermore, during pathogen recognition, ERAP1 regulates IL12 production by CD11c(+) DCs specifically, with increases in IL12 production positively correlated with an increased phagocytic activity of splenic DCs and macrophages. Collectively, our results demonstrate a previously unrecognized, more central role for the ERAP1 protein in modulating several aspects of both the development of the innate immune system, and its responses during the initial stages of pathogen recognition. Such a role may explain why ERAP1 has been implicated by GWAS in the pathogenesis of autoimmune diseases that may be precipitated by aberrant responses to pathogen encounters.	[Aldhamen, Yasser A.; Seregin, Sergey S.; Rastall, David P. W.; Aylsworth, Charles F.; Pepelyayeva, Yuliya; Busuito, Christopher J.; Godbehere-Roosa, Sarah; Kim, Sungjin; Amalfitano, Andrea] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University	Amalfitano, A (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	amalfit1@msu.edu		Pepelyayeva, Yuliya/0000-0001-8205-3613; Aldhamen, Yasser/0000-0002-9560-8013	National Institutes of Health [5R01AR056981-02]; MSU Foundation; Osteopathic Heritage Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSU Foundation; Osteopathic Heritage Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	A.A. was supported by the National Institutes of Health grant 5R01AR056981-02, the MSU Foundation as well as the Osteopathic Heritage Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhamen YA, 2012, J IMMUNOL, V189, P1349, DOI 10.4049/jimmunol.1200736; Appledorn DM, 2008, GENE THER, V15, P885, DOI 10.1038/gt.2008.18; Appledorn DM, 2010, PLOS ONE, V5, pA130, DOI 10.1371/journal.pone.0009579; Aylsworth CF, 2013, HUM IMMUNOL; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Blanchard N, 2010, J IMMUNOL, V184, P3033, DOI 10.4049/jimmunol.0903712; Carnaud C, 1999, J IMMUNOL, V163, P4647; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Cifaldi L, 2012, INT J MOL SCI, V13, P8338, DOI 10.3390/ijms13078338; Cifaldi L, 2011, CANCER RES, V71, P1597, DOI 10.1158/0008-5472.CAN-10-3326; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Evnouchidou I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003658; Fierabracci A, 2012, AUTOIMMUN REV, V12, P281, DOI 10.1016/j.autrev.2012.04.007; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; French AR, 2004, ARTHRITIS RES THER, V6, P8, DOI 10.1186/ar1034; Fruci D, 2006, J IMMUNOL, V176, P4869, DOI 10.4049/jimmunol.176.8.4869; Fruci D, 2012, ONCOIMMUNOLOGY, V1, P81, DOI 10.4161/onci.1.1.17828; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Garcia- Medel N, 2012, MOL CELL PROTEOMICS; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Guerini FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029931; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; Harvey D, 2009, HUM MOL GENET, V18, P4204, DOI 10.1093/hmg/ddp371; Hodges BL, 2001, J VIROL, V75, P5913, DOI 10.1128/JVI.75.13.5913-5920.2001; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Ichikawa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035880; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; Jiang Li-na, 2011, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V27, P1191; Kadi A, 2013, ANN RHEUM DIS, V72, P608, DOI 10.1136/annrheumdis-2012-201783; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kim S, 2011, NAT IMMUNOL, V12, P984, DOI 10.1038/ni.2097; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Marcoe JP, 2012, NAT IMMUNOL, V13, P843, DOI 10.1038/ni.2388; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Newman KC, 2007, NAT REV IMMUNOL, V7, P279, DOI 10.1038/nri2057; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Ng Philip, 2002, Methods Mol Med, V69, P389; Orange JS, 1996, J IMMUNOL, V156, P1138; Orr MT, 2011, CURR TOP MICROBIOL, V350, P67, DOI 10.1007/82_2010_85; Procko E, 2009, CURR OPIN IMMUNOL, V21, P84, DOI 10.1016/j.coi.2009.02.003; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Rosenberg B, 2005, INT J CANCER, V114, P756, DOI 10.1002/ijc.20801; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schleinitz N, 2010, IMMUNOLOGY, V131, P451, DOI 10.1111/j.1365-2567.2010.03360.x; Seregin SS, 2009, GENE THER, V16, P1245, DOI 10.1038/gt.2009.77; Seregin SS, 2010, VIRUSES-BASEL, V2, P2013, DOI 10.3390/v2092013; Seregin SS, 2010, BLOOD, V116, P1669, DOI 10.1182/blood-2010-03-276949; Seregin SS, 2009, MOL THER, V17, P685, DOI 10.1038/mt.2008.297; Seregin SS, 2013, AUTOIMMUNIT IN PRESS; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Yamamoto N, 2002, HUM MUTAT, V19, P251, DOI 10.1002/humu.10047; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	68	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69539	10.1371/journal.pone.0069539	http://dx.doi.org/10.1371/journal.pone.0069539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894499	gold, Green Submitted, Green Published			2022-12-25	WOS:000322167900080
J	Lu, SJ; Gao, WJ; Wei, ZG; Wu, WW; Liao, M; Ding, YQ; Zhang, ZJ; Li, LJ				Lu, Shaojia; Gao, Weijia; Wei, Zhaoguo; Wu, Weiwei; Liao, Mei; Ding, Yuqiang; Zhang, Zhijun; Li, Lingjiang			Reduced Cingulate Gyrus Volume Associated with Enhanced Cortisol Awakening Response in Young Healthy Adults Reporting Childhood Trauma	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; HIPPOCAMPAL VOLUME; SALIVARY CORTISOL; STRESS; DEPRESSION; ABUSE; DISORDER; HORMONE; WOMEN; PSYCHOPATHOLOGY	Background: Preclinical studies have demonstrated the relationship between stress-induced increased cortisol levels and atrophy of specific brain regions, however, this association has been less revealed in clinical samples. The aim of the present study was to investigate the changes and associations of the hypothalamic-pituitary-adrenal (HPA) axis activity and gray matter volumes in young healthy adults with self-reported childhood trauma exposures. Methods: Twenty four healthy adults with childhood trauma and 24 age-and gender-matched individuals without childhood trauma were recruited. Each participant collected salivary samples in the morning at four time points: immediately upon awakening, 30, 45, and 60 min after awakening for the assessment of cortisol awakening response (CAR). The 3D T1-weighted magnetic resonance imaging data were obtained on a Philips 3.0 Tesla scanner. Voxel-based morphometry analyses were conducted to compare the gray matter volume between two groups. Correlations of gray matter volume changes with severity of childhood trauma and CAR data were further analyzed. Results: Adults with self-reported childhood trauma showed an enhanced CAR and decreased gray matter volume in the right middle cingulate gyrus. Moreover, a significant association was observed between salivary cortisol secretions after awaking and the right middle cingulate gyrus volume reduction in subjects with childhood trauma. Conclusions: The present research outcomes suggest that childhood trauma is associated with hyperactivity of the HPA axis and decreased gray matter volume in the right middle cingulate gyrus, which may represent the vulnerability for developing psychosis after childhood trauma experiences. In addition, this study demonstrates that gray matter loss in the cingulate gyrus is related to increased cortisol levels.	[Lu, Shaojia; Gao, Weijia; Wei, Zhaoguo; Wu, Weiwei; Liao, Mei; Ding, Yuqiang; Li, Lingjiang] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China; [Wei, Zhaoguo] Shenzhen Kangning Hosp, Dept Psychiat, Shenzhen, Guangdong, Peoples R China; [Ding, Yuqiang] Tongji Univ, Sch Med, East Hosp, Minist Educ,Key Lab Arrhythmias, Shanghai 200092, Peoples R China; [Zhang, Zhijun] SE Univ, ZhongDa Hosp, Dept Neuropsychiat, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhijun] SE Univ, ZhongDa Hosp, Inst Neuropsychiat Res, Nanjing, Jiangsu, Peoples R China; [Li, Lingjiang] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China	Central South University; Tongji University; Southeast University - China; Southeast University - China; Chinese University of Hong Kong	Li, LJ (corresponding author), Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China.	llj2920@163.com		Lu, Shaojia/0000-0001-6121-7754; Ding, Yu-Qiang/0000-0003-1202-4635	Major Project of Chinese National Programs for Fundamental Research and Development (973 program) [2009CB918303]; National Natural Science Foundation of China [30830046, 81171286, 91232714]; Innovation Project of Hunan Graduate Education [CX2012B100]; National Hi-Tech Research and Development Program of China (863 program) [2008AA02Z413]	Major Project of Chinese National Programs for Fundamental Research and Development (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Hunan Graduate Education; National Hi-Tech Research and Development Program of China (863 program)(National High Technology Research and Development Program of China)	The authors sincerely thank the support of funds from the Major Project of Chinese National Programs for Fundamental Research and Development (973 program, 2009CB918303 to LJL), the National Natural Science Foundation of China (30830046, 81171286 & 91232714 to LJL), the Innovation Project of Hunan Graduate Education (CX2012B100 to SJL), and National Hi-Tech Research and Development Program of China (863 program, 2008AA02Z413 to ZJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; [Anonymous], 2002, BIOL PSYCHIAT; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Aubry JM, 2010, J PSYCHIATR RES, V44, P1199, DOI 10.1016/j.jpsychires.2010.04.015; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bhagwagar Z, 2003, AM J PSYCHIAT, V160, P1890, DOI 10.1176/appi.ajp.160.10.1890; Bitter T, 2010, BRAIN RES, V1347, P42, DOI 10.1016/j.brainres.2010.06.003; Bouma EMC, 2009, PSYCHONEUROENDOCRINO, V34, P884, DOI 10.1016/j.psyneuen.2009.01.003; Buss C, 2007, J NEUROSCI, V27, P2592, DOI 10.1523/JNEUROSCI.3252-06.2007; Caetano SC, 2006, BIOL PSYCHIAT, V59, P702, DOI 10.1016/j.biopsych.2005.10.011; Carpenter LL, 2007, BIOL PSYCHIAT, V62, P1080, DOI 10.1016/j.biopsych.2007.05.002; Cerqueira JJ, 2005, J PSYCHIATR RES, V39, P451, DOI 10.1016/j.jpsychires.2005.01.003; CINTRA A, 1994, ANN NY ACAD SCI, V746, P42; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; DIORIO D, 1993, J NEUROSCI, V13, P3839; Edmiston EE, 2011, ARCH PEDIAT ADOL MED, V165, P1069, DOI 10.1001/archpediatrics.2011.565; Engert V, 2011, PSYCHOPHARMACOLOGY, V214, P261, DOI 10.1007/s00213-010-1918-4; Gordijn MS, 2012, PSYCHONEUROENDOCRINO, V37, P1448, DOI 10.1016/j.psyneuen.2012.01.014; Gunnar MR, 2001, DEV PSYCHOPATHOL, V13, P611, DOI 10.1017/S095457940100311X; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Heim C, 2008, BIOL PSYCHIAT, V63, P398, DOI 10.1016/j.biopsych.2007.07.002; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Lu SJ, 2013, COMPR PSYCHIAT, V54, P953, DOI 10.1016/j.comppsych.2013.03.026; MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878; Mangold D, 2011, J PSYCHIATR RES, V45, P902, DOI 10.1016/j.jpsychires.2011.01.001; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Meinlschmidt G, 2005, PSYCHONEUROENDOCRINO, V30, P568, DOI 10.1016/j.psyneuen.2005.01.006; Pollak SD, 2010, CHILD DEV, V81, P224, DOI 10.1111/j.1467-8624.2009.01391.x; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Rinne T, 2002, BIOL PSYCHIAT, V52, P1102, DOI 10.1016/S0006-3223(02)01395-1; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schafer Ingo, 2011, Dialogues Clin Neurosci, V13, P360; Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; Treadway MT, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004887, 10.1371/journal.pone.0006598]; Tyrka AR, 2008, BIOL PSYCHIAT, V63, P1147, DOI 10.1016/j.biopsych.2008.01.011; Vasic N, 2008, J AFFECT DISORDERS, V109, P107, DOI 10.1016/j.jad.2007.11.011; Wang F, 2008, BRIT J PSYCHIAT, V193, P126, DOI 10.1192/bjp.bp.107.048793; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042824; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	45	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69350	10.1371/journal.pone.0069350	http://dx.doi.org/10.1371/journal.pone.0069350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894454	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900058
J	Papanastasiou, SA; Nakas, CT; Carey, JR; Papadopoulos, NT				Papanastasiou, Stella A.; Nakas, Christos T.; Carey, James R.; Papadopoulos, Nikos T.			Condition-Dependent Effects of Mating on Longevity and Fecundity of Female Medflies: The Interplay between Nutrition and Age of Mating	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLY; MALE DROSOPHILA-MELANOGASTER; CERATITIS-CAPITATA DIPTERA; LIFE-HISTORY RESPONSE; MATE CHOICE; CALLOSOBRUCHUS-MACULATUS; EGG-PRODUCTION; DIETARY RESTRICTION; SEXUAL PERFORMANCE; COPULA DURATION	Background: In various species mating exerts direct and indirect effects on female demographic traits ranging from life span shortening to behavioural shifts. A wealth of data regarding effects of nutrition on longevity and reproduction output also exists. Nonetheless, little is known regarding the interaction between the age of mating and nutrition on female fitness. Methodology: We studied, the effects of protein deprivation and age of mating on female fitness traits, using a wild population of the Mediterranean fruit fly (medfly). We tested the hypotheses that (a) protein availability increases female lifespan and fecundity, (b) female longevity and egg production are independent of mating and the age of mating, and (c) female mating behaviour is independent of their age and nutritional status. Thus, we recorded the mating success and the copulation characteristics, as well as the egg production and survival of females mated at young or at old age and fed a full or a protein-deprived diet. Results: Mating boosts egg production and reduces longevity of protein-fed females. On the contrary, mating increases the longevity of protein-deprived females. Mortality responses (negative or positive) to mating are expressed after a long lag phase. Old females are more receptive and less selective than young females regardless of the food regime. Conclusions: Our findings suggest that condition (nutritional status and age) defines the positive or negative output of mating in female medflies. These results contribute towards understanding the effects of mating, aging, resource allocation and their interactions on survival and female reproduction.	[Papanastasiou, Stella A.; Nakas, Christos T.; Papadopoulos, Nikos T.] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Volos, Magnisia, Greece; [Carey, James R.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of Thessaly; University of California System; University of California Davis	Papadopoulos, NT (corresponding author), Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Volos, Magnisia, Greece.	nikopap@uth.gr	Papadopoulos, Nikos T./B-9156-2011; Nakas, Christos T/F-3052-2011; Papadopoulos, Nikos/AAJ-1721-2020; Papanastasiou, Stella/GRO-7360-2022	Papadopoulos, Nikos T./0000-0003-2480-8189; Nakas, Christos T/0000-0003-4155-722X; Papadopoulos, Nikos/0000-0003-2480-8189; Papanastasiou, Stella/0000-0003-3975-7089	National Institute on Ageing [P01-AG022500-01, P01-AG08761-10]; NATIONAL INSTITUTE ON AGING [P01AG008761, P01AG022500] Funding Source: NIH RePORTER	National Institute on Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by the National Institute on Ageing, grants P01-AG022500-01 and P01-AG08761-10 awarded to James R. Carey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aluja M, 2009, J INSECT PHYSIOL, V55, P1091, DOI 10.1016/j.jinsphys.2009.07.012; Aluja M, 2001, J INSECT BEHAV, V14, P759, DOI 10.1023/A:1013037400676; Anjos-Duarte CS, 2011, J INSECT BEHAV, V24, P11, DOI 10.1007/s10905-010-9232-x; Blay S, 1999, ANN ENTOMOL SOC AM, V92, P278, DOI 10.1093/aesa/92.2.278; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; Boonstra R, 2001, ECOLOGY, V82, P1930, DOI 10.2307/2680058; Burger JMS, 2007, AGING CELL, V6, P63, DOI 10.1111/j.1474-9726.2006.00261.x; CANGUSSU JA, 1995, J INSECT PHYSIOL, V41, P223, DOI 10.1016/0022-1910(94)00099-3; Cangussu Jomara Alves, 1997, Revista Brasileira de Biologia, V57, P611; Carey JR, 2012, ECOL ENTOMOL, V37, P359, DOI 10.1111/j.1365-2311.2012.01372.x; CAREY JR, 1995, GERONTOLOGIST, V35, P588, DOI 10.1093/geront/35.5.588; Carey JR, 2002, AGING CELL, V1, P140, DOI 10.1046/j.1474-9728.2002.00019.x; Carey JR, 2002, FUNCT ECOL, V16, P313, DOI 10.1046/j.1365-2435.2002.00633.x; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; Carey JR, 1998, J GERONTOL A-BIOL, V53, pB245, DOI 10.1093/gerona/53A.4.B245; CAREY JR, 1986, ENTOMOL EXP APPL, V42, P159, DOI 10.1007/BF00343543; CAREY JR, 2005, LONGEVITY FRAILTY, P1, DOI DOI 10.1007/3-540-27388-3_1; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; Chapman T, 1998, P ROY SOC B-BIOL SCI, V265, P1879, DOI 10.1098/rspb.1998.0516; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Cordts R, 1996, ANIM BEHAV, V52, P269, DOI 10.1006/anbe.1996.0172; DELISLE J, 1995, J INSECT BEHAV, V8, P781, DOI 10.1007/BF02009506; Diamantidis AD, 2008, ENTOMOL EXP APPL, V128, P389, DOI 10.1111/j.1570-7458.2008.00730.x; Diamantidis AD, 2009, BIOL J LINN SOC, V97, P106, DOI 10.1111/j.1095-8312.2009.01178.x; Field SA, 1999, ETHOL ECOL EVOL, V11, P61, DOI 10.1080/08927014.1999.9522842; FOX CW, 1993, OECOLOGIA, V96, P139, DOI 10.1007/BF00318042; Fricke C, 2010, J EVOLUTION BIOL, V23, P157, DOI 10.1111/j.1420-9101.2009.01882.x; Gray DA, 1999, J INSECT BEHAV, V12, P691, DOI 10.1023/A:1020983821436; Hebets EA, 2008, ANIM BEHAV, V76, P355, DOI 10.1016/j.anbehav.2007.12.021; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; Jones TM, 2007, BEHAV ECOL, V18, P251, DOI 10.1093/beheco/arl077; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; Koref-Santibanez S, 2001, BEHAV GENET, V31, P287, DOI 10.1023/A:1012279325621; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Liedo P, 2002, FLA ENTOMOL, V85, P94, DOI 10.1653/0015-4040(2002)085[0094:EOAOTM]2.0.CO;2; Manrakhan A, 2006, B ENTOMOL RES, V96, P259, DOI 10.1079/BER2006421; Martin OY, 2004, J EVOLUTION BIOL, V17, P357, DOI 10.1046/j.1420-9101.2003.00668.x; Milonas PG, 2010, ANIM BEHAV, V79, P509, DOI 10.1016/j.anbehav.2009.12.005; Miyatake T, 1997, HEREDITY, V78, P93, DOI 10.1038/hdy.1997.11; Moore PJ, 2001, P NATL ACAD SCI USA, V98, P9171, DOI 10.1073/pnas.161154598; Moskalik B, 2011, ANIM BEHAV, V81, P715, DOI 10.1016/j.anbehav.2010.12.016; Muller HG, 2009, P ROY SOC B-BIOL SCI, V276, P4409, DOI 10.1098/rspb.2009.1461; Muller HG, 1997, BIOMETRIKA, V84, P881, DOI 10.1093/biomet/84.4.881; Ohgushi T, 1996, OECOLOGIA, V106, P345, DOI 10.1007/BF00334562; Papadopoulos NT, 1998, ENTOMOL EXP APPL, V89, P175, DOI 10.1023/A:1003580814122; Papadopoulos NT, 2002, ANN ENTOMOL SOC AM, V95, P564, DOI 10.1603/0013-8746(2002)095[0564:DPOTMF]2.0.CO;2; Papanastasiou SA, 2011, J INSECT PHYSIOL, V57, P1368, DOI 10.1016/j.jinsphys.2011.07.004; PARTRIDGE L, 1987, J INSECT PHYSIOL, V33, P745, DOI 10.1016/0022-1910(87)90060-6; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; Perez-Staples D, 2007, PHYSIOL ENTOMOL, V32, P225, DOI 10.1111/j.1365-3032.2007.00568.x; Prowse N, 1997, J INSECT PHYSIOL, V43, P501, DOI 10.1016/S0022-1910(97)00014-0; Sarakatsanou A, 2011, J APPL ENTOMOL, V135, P554, DOI 10.1111/j.1439-0418.2011.01610.x; Shelly TE, 2000, ANN ENTOMOL SOC AM, V93, P559, DOI 10.1603/0013-8746(2000)093[0559:FOFOFF]2.0.CO;2; Shelly TE, 2002, FLA ENTOMOL, V85, P572, DOI 10.1653/0015-4040(2002)085[0572:IOMDOM]2.0.CO;2; Shelly T, 2012, ANN ENTOMOL SOC AM, V105, P368, DOI 10.1603/AN11125; TATAR M, 1995, ECOLOGY, V76, P2066, DOI 10.2307/1941681; TATAR M, 1993, EVOLUTION, V47, P1302, DOI [10.1111/j.1558-5646.1993.tb02156.x, 10.2307/2410149]; Taylor PW, 1999, ANIM BEHAV, V58, P247, DOI 10.1006/anbe.1999.1137; Taylor PW, 2000, PHYSIOL ENTOMOL, V25, P94, DOI 10.1046/j.1365-3032.2000.00169.x; TURNER ME, 1983, EVOLUTION, V37, P714, DOI 10.1111/j.1558-5646.1983.tb05593.x; WHITTIER TS, 1993, J KANSAS ENTOMOL SOC, V66, P200; WHITTIER TS, 1991, ANN ENTOMOL SOC AM, V84, P608, DOI 10.1093/aesa/84.6.608; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051	65	32	31	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70181	10.1371/journal.pone.0070181	http://dx.doi.org/10.1371/journal.pone.0070181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894611	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900110
J	Sutin, AR; Terracciano, A				Sutin, Angelina R.; Terracciano, Antonio			Perceived Weight Discrimination and Obesity	PLOS ONE			English	Article							BODY-WEIGHT; OPIOID SYSTEM; FOOD-INTAKE; STIGMA; ADOLESCENTS; STRESS; BIAS; VICTIMIZATION; AMERICANS	Weight discrimination is prevalent in American society. Although associated consistently with psychological and economic outcomes, less is known about whether weight discrimination is associated with longitudinal changes in obesity. The objectives of this research are (1) to test whether weight discrimination is associated with risk of becoming obese (Body Mass Index >= 30; BMI) by follow-up among those not obese at baseline, and (2) to test whether weight discrimination is associated with risk of remaining obese at follow-up among those already obese at baseline. Participants were drawn from the Health and Retirement Study, a nationally representative longitudinal survey of community-dwelling US residents. A total of 6,157 participants (58.6% female) completed the discrimination measure and had weight and height available from the 2006 and 2010 assessments. Participants who experienced weight discrimination were approximately 2.5 times more likely to become obese by follow-up (OR = 2.54, 95% CI = 1.58-4.08) and participants who were obese at baseline were three times more likely to remain obese at follow up (OR = 3.20, 95% CI = 2.06-4.97) than those who had not experienced such discrimination. These effects held when controlling for demographic factors (age, sex, ethnicity, education) and when baseline BMI was included as a covariate. These effects were also specific to weight discrimination; other forms of discrimination (e.g., sex, race) were unrelated to risk of obesity at follow-up. The present research demonstrates that, in addition to poorer mental health outcomes, weight discrimination has implications for obesity. Rather than motivating individuals to lose weight, weight discrimination increases risk for obesity.	[Sutin, Angelina R.; Terracciano, Antonio] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Sutin, AR (corresponding author), Florida State Univ, Coll Med, Tallahassee, FL 32306 USA.	angelina.sutin@med.fsu.edu	Terracciano, Antonio/H-7403-2019	Terracciano, Antonio/0000-0001-5799-8885				Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Andreyeva T, 2008, OBESITY, V16, P1129, DOI 10.1038/oby.2008.35; Annis Natasha Milkewicz, 2004, Body Image, V1, P155, DOI 10.1016/j.bodyim.2003.12.001; [Anonymous], 2012, HLTH RET STUD 2006 2; Ashmore Jamile A, 2008, Eat Behav, V9, P203, DOI 10.1016/j.eatbeh.2007.09.006; Ayotte BJ, 2012, AM HEART J, V163, P677, DOI 10.1016/j.ahj.2012.01.006; Baum CL, 2004, HEALTH ECON, V13, P885, DOI 10.1002/hec.881; Borrell C, 2010, J WOMENS HEALTH, V19, P741, DOI 10.1089/jwh.2009.1594; Boyes AD, 2009, J SEX MARITAL THER, V35, P282, DOI 10.1080/00926230902851280; Carels RA, 2010, EAT BEHAV, V11, P180, DOI 10.1016/j.eatbeh.2010.03.002; Carr D, 2005, J HEALTH SOC BEHAV, V46, P244, DOI 10.1177/002214650504600303; Dickerson SS, 2004, J PERS, V72, P1191, DOI 10.1111/j.1467-6494.2004.00295.x; Drolet G, 2001, PROG NEURO-PSYCHOPH, V25, P729, DOI 10.1016/S0278-5846(01)00161-0; Durso LE, 2012, INT J EAT DISORDER, V45, P423, DOI 10.1002/eat.20933; Epel E, 2001, PSYCHONEUROENDOCRINO, V26, P37, DOI 10.1016/S0306-4530(00)00035-4; Finkelstein LM, 2007, HUM RESOUR MANAGE-US, V46, P203, DOI 10.1002/hrm.20157; Guyll M, 2001, HEALTH PSYCHOL, V20, P315, DOI 10.1037/0278-6133.20.5.315; Han E, 2011, ECON HUM BIOL, V9, P381, DOI 10.1016/j.ehb.2011.07.002; Hebl MR, 2001, INT J OBESITY, V25, P1246, DOI 10.1038/sj.ijo.0801681; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; Krukowski RA, 2009, INT J PEDIATR OBES, V4, P274, DOI 10.3109/17477160902846203; Lewis TT, 2010, BRAIN BEHAV IMMUN, V24, P438, DOI 10.1016/j.bbi.2009.11.011; Major B, 2013, SOC PSYCHOL IN PRESS; Muennig P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-128; Neumark-Sztainer D, 2002, INT J OBESITY, V26, P123, DOI 10.1038/sj.ijo.0801853; Nogueiras R, 2012, OBESITY FACTS, V5, P196, DOI 10.1159/000338163; Puhl RM, 2007, OBESITY, V15, P19, DOI 10.1038/oby.2007.521; Puhl RM, 2012, J YOUTH ADOLESCENCE, V41, P27, DOI 10.1007/s10964-011-9713-z; Puhl RM, 2011, J SCHOOL HEALTH, V81, P696, DOI 10.1111/j.1746-1561.2011.00646.x; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Purnell JQ, 2012, AM J PUBLIC HEALTH, V102, P844, DOI 10.2105/AJPH.2012.300694; Roehling MV, 2007, J VOCAT BEHAV, V71, P300, DOI 10.1016/j.jvb.2007.04.008; Schafer MH, 2011, SOC PSYCHOL QUART, V74, P76, DOI 10.1177/0190272511398197; Schmalz DL, 2010, OBESITY FACTS, V3, P15, DOI 10.1159/000273210; Sims M, 2012, AM J PUBLIC HEALTH, V102, pS258, DOI 10.2105/AJPH.2011.300523; Sutin AR, 2013, OBESITY IN PRESS; Tataranni PA, 1996, AM J PHYSIOL-ENDOC M, V271, pE317, DOI 10.1152/ajpendo.1996.271.2.E317; Vartanian LR, 2008, J HEALTH PSYCHOL, V13, P131, DOI 10.1177/1359105307084318; Vartanian LR, 2011, OBESITY, V19, P757, DOI 10.1038/oby.2010.234; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305	41	209	210	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70048	10.1371/journal.pone.0070048	http://dx.doi.org/10.1371/journal.pone.0070048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894586	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900105
J	Kim, S; Swaminathan, S; Inlow, M; Risacher, SL; Nho, K; Shen, L; Foroud, TM; Petersen, RC; Aisen, PS; Soares, H; Toledo, JB; Shaw, LM; Trojanowski, JQ; Weiner, MW; McDonald, BC; Farlow, MR; Ghetti, B; Saykin, AJ				Kim, Sungeun; Swaminathan, Shanker; Inlow, Mark; Risacher, Shannon L.; Nho, Kwangsik; Shen, Li; Foroud, Tatiana M.; Petersen, Ronald C.; Aisen, Paul S.; Soares, Holly; Toledo, Jon B.; Shaw, Leslie M.; Trojanowski, John Q.; Weiner, Michael W.; McDonald, Brenna C.; Farlow, Martin R.; Ghetti, Bernardino; Saykin, Andrew J.		ADNI	Influence of Genetic Variation on Plasma Protein Levels in Older Adults Using a Multi-Analyte Panel	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; NEUROIMAGING INITIATIVE ADNI; THYROXINE-BINDING GLOBULIN; MILD COGNITIVE IMPAIRMENT; WHOLE-GENOME ASSOCIATION; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; FACTOR-H; FUNCTIONAL ANNOTATION; ANGIOTENSINOGEN GENE	Proteins, widely studied as potential biomarkers, play important roles in numerous physiological functions and diseases. Genetic variation may modulate corresponding protein levels and point to the role of these variants in disease pathophysiology. Effects of individual single nucleotide polymorphisms (SNPs) within a gene were analyzed for corresponding plasma protein levels using genome-wide association study (GWAS) genotype data and proteomic panel data with 132 quality-controlled analytes from 521 Caucasian participants in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Linear regression analysis detected 112 significant (Bonferroni threshold p = 2.44x10(-5)) associations between 27 analytes and 112 SNPs. 107 out of these 112 associations were tested in the Indiana Memory and Aging Study (IMAS) cohort for replication and 50 associations were replicated at uncorrected p<0.05 in the same direction of effect as those in the ADNI. We identified multiple novel associations including the association of rs7517126 with plasma complement factor H-related protein 1 (CFHR1) level at p<1.46x10(-60), accounting for 40 percent of total variation of the protein level. We serendipitously found the association of rs6677604 with the same protein at p<9.29x10(-112). Although these two SNPs were not in the strong linkage disequilibrium, 61 percent of total variation of CFHR1 was accounted for by rs6677604 without additional variation by rs7517126 when both SNPs were tested together. 78 other SNP-protein associations in the ADNI sample exceeded genome-wide significance (5x10(-8)). Our results confirmed previously identified gene-protein associations for interleukin-6 receptor, chemokine CC-4, angiotensin-converting enzyme, and angiotensinogen, although the direction of effect was reversed in some cases. This study is among the first analyses of gene-protein product relationships integrating multiplex-panel proteomics and targeted genes extracted from a GWAS array. With intensive searches taking place for proteomic biomarkers for many diseases, the role of genetic variation takes on new importance and should be considered in interpretation of proteomic results.	[Kim, Sungeun; Swaminathan, Shanker; Inlow, Mark; Risacher, Shannon L.; Nho, Kwangsik; Shen, Li; Foroud, Tatiana M.; McDonald, Brenna C.; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Ctr Neuroimaging, Indianapolis, IN 46202 USA; [Kim, Sungeun; Shen, Li; Foroud, Tatiana M.; Saykin, Andrew J.] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Swaminathan, Shanker; Foroud, Tatiana M.; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Inlow, Mark] Rose Hulman Inst Technol, Dept Math, Terre Haute, IN 47803 USA; [Foroud, Tatiana M.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Aisen, Paul S.] Univ Calif San Diego, Dept Neurol, San Diego, CA 92103 USA; [Soares, Holly] Bristol Myers Squibb Co, Wallingford, CT 06492 USA; [Toledo, Jon B.; Shaw, Leslie M.; Trojanowski, John Q.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Weiner, Michael W.] Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Farlow, Martin R.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Rose Hulman Institute Technology; Mayo Clinic; University of California System; University of California San Diego; Bristol-Myers Squibb; University of Pennsylvania; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Saykin, AJ (corresponding author), Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Ctr Neuroimaging, Indianapolis, IN 46202 USA.	asaykin@iupui.edu	Risacher, Shannon/AAI-2141-2019; Shen, Li/AAB-6870-2021; Saykin, Andrew/A-1318-2007	Toledo, Jon/0000-0003-4366-9268; Risacher, Shannon/0000-0002-3304-7943; Saykin, Andrew/0000-0002-1376-8532; Shen, Li/0000-0002-5443-0503	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NIA [R01AG19771, P30AG010133, U01AG032984, U24AG021886]; National Institutes of Health [R01 AG19771]; National Institute on Aging [P30AG10133-18S1]; National Institute on Aging via Indiana Alzheimer Disease Center [P30AG010133]; National Library of Medicine [R01 LM011360, K99 LM011384]; National Science Foundation [IIS-1117335]; National Institutes of Health Clinical and Translational Sciences Institute Pre-doctoral Training Fellowship [TL1 RR025759]; Direct For Computer & Info Scie & Enginr [1117335] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG024904, K01AG030514, P30AG010133, U24AG021886, P30AG010129, R01AG019771, U19AG010483, U01AG032984] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K99LM011384, R01LM011360, R00LM011384] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging via Indiana Alzheimer Disease Center; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health Clinical and Translational Sciences Institute Pre-doctoral Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514, the Dana Foundation, NIA R01AG19771, P30AG010133, U01AG032984, and the Foundation for the NIH for data analysis. Samples from the NCRAD, which receives government support under a cooperative agreement (U24AG021886) awarded by the NIA were used in the ADNI. This study was also supported by an investigator-initiated research grant from the National Institutes of Health (R01 AG19771) to A.J.S., National Institute on Aging (P30AG10133-18S1 Core Supplement to Drs. B. Ghetti and AJS), National Institute on Aging via Indiana Alzheimer Disease Center pilot grant (P30AG010133) to S. K, National Library of Medicine (R01 LM011360) and National Science Foundation (IIS-1117335) to L. S., National Institutes of Health Clinical and Translational Sciences Institute Pre-doctoral Training Fellowship (Training Grant TL1 RR025759) to S. L. R, National Library of Medicine (K99 LM011384) to K.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia TS, 2009, DNA CELL BIOL, V28, P141, DOI 10.1089/dna.2008.0810; Balam-Ortiz E, 2012, HYPERTENSION, V59, P847, DOI 10.1161/HYPERTENSIONAHA.111.176453; Balam-Ortiz E, 2011, AM J MED SCI, V342, P205, DOI 10.1097/MAJ.0b013e3182121020; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BARTALENA L, 1990, ENDOCR REV, V11, P47, DOI 10.1210/edrv-11-1-47; Boot RG, 2004, BLOOD, V103, P33, DOI 10.1182/blood-2003-05-1612; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; Chen-Plotkin AS, 2011, ANN NEUROL, V69, P655, DOI 10.1002/ana.22271; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cruikshank WW, 2000, J LEUKOCYTE BIOL, V67, P757, DOI 10.1002/jlb.67.6.757; DESAI K, 1989, J LIPID RES, V30, P831; Domingues-Montanari S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.01.019; Edwards TL, 2009, AM J MED GENET B, V150B, P721, DOI 10.1002/ajmg.b.30899; Fisher E, 2009, CIRC-CARDIOVASC GENE, V2, P607, DOI 10.1161/CIRCGENETICS.109.870410; Friedman David B., 2008, V428, P93; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garge N, 2010, MOL CELL PROTEOMICS, V9, P1383, DOI 10.1074/mcp.M900378-MCP200; Geroldi D, 2005, NEUROSCI LETT, V386, P176, DOI 10.1016/j.neulet.2005.06.014; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Gupta VB, 2011, NEUROLOGY, V76, P1091, DOI 10.1212/WNL.0b013e318211c352; Han J, 2012, HYPERTENS RES; Hu WT, 2012, NEUROLOGY, V79, P897, DOI 10.1212/WNL.0b013e318266fa70; Hu WT, 2010, ACTA NEUROPATHOL, V120, P385, DOI 10.1007/s00401-010-0723-9; Huang CW, 2009, J CLIN NEUROSCI, V16, P1283, DOI 10.1016/j.jocn.2008.12.026; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357; JANSSEN OE, 1992, TRENDS ENDOCRIN MET, V3, P49, DOI 10.1016/1043-2760(92)90043-Z; Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341; Kodera M, 2005, ARTHRITIS RHEUM-US, V52, P2889, DOI 10.1002/art.21257; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Laske C, 2009, EUR ARCH PSY CLIN N, V259, P80, DOI 10.1007/s00406-008-0838-3; Leban N, 2012, INT J IMMUNOGENET, V39, P110, DOI 10.1111/j.1744-313X.2011.01071.x; Lei Jian-kang, 2010, Zhonghua Yi Xue Za Zhi, V90, P2894; Leveziel N, 2010, M S-MED SCI, V26, P509; Lourdusamy A, 2012, HUM MOL GENET; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Martinez-Barricarte R, 2012, INVEST OPHTH VIS SCI, V53, P1087, DOI 10.1167/iovs.11-8709; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Mooijaart SP, 2006, PLOS MED, V3, P874, DOI 10.1371/journal.pmed.0030176; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Ning M, 2010, ALZ DIS ASSOC DIS; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risacher SL, 2012, NEUROBIOLOGY AGING; Rotimi C, 1997, CIRCULATION, V95, P2348, DOI 10.1161/01.CIR.95.10.2348; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Schroder A, 2013, PHARMACOGENOMICS J, V13, P12, DOI 10.1038/tpj.2011.44; Servais A, 2012, KIDNEY INT; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Soares HD, 2012, ARCH NEUROL-CHICAGO, V69, P1310, DOI 10.1001/archneurol.2012.1070; Souza-Talarico JN, 2010, J ALZHEIMERS DIS, V19, P839, DOI 10.3233/JAD-2010-1282; Struyf S, 2003, AM J PATHOL, V163, P2065, DOI 10.1016/S0002-9440(10)63564-X; Taddei K, 1997, NEUROSCI LETT, V223, P29, DOI 10.1016/S0304-3940(97)13394-8; TAKEDA K, 1989, J CLIN INVEST, V83, P1344, DOI 10.1172/JCI114021; Thambisetty M, 2008, J NEUROL, V255, P1712, DOI 10.1007/s00415-008-0006-8; Toledo JB, 2011, ACTA NEUROPATHOL; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; van Vliet P, 2007, ANN NY ACAD SCI, V1100, P140, DOI 10.1196/annals.1395.012; Watkins WS, 2010, AM J HYPERTENS, V23, P917, DOI 10.1038/ajh.2010.83; Yang MH, 2012, J PROTEOMICS, V75, P3617, DOI 10.1016/j.jprot.2012.04.017; Youn BS, 1998, BIOCHEM BIOPH RES CO, V247, P217, DOI 10.1006/bbrc.1998.8762; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079	72	41	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70269	10.1371/journal.pone.0070269	http://dx.doi.org/10.1371/journal.pone.0070269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894628	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000198
J	Peira, N; Pourtois, G; Fredrikson, M				Peira, Nathalie; Pourtois, Gilles; Fredrikson, Mats			Learned Cardiac Control with Heart Rate Biofeedback Transfers to Emotional Reactions	PLOS ONE			English	Article							FEAR; PSYCHOPHYSIOLOGY; ANXIETY; SCALE	Emotions involve subjective feelings, action tendencies and physiological reactions. Earlier findings suggest that biofeedback might provide a way to regulate the physiological components of emotions. The present study investigates if learned heart rate regulation with biofeedback transfers to emotional situations without biofeedback. First, participants learned to decrease heart rate using biofeedback. Then, inter-individual differences in the acquired skill predicted how well they could decrease heart rate reactivity when later exposed to negative arousing pictures without biofeedback. These findings suggest that (i) short lasting biofeedback training improves heart rate regulation and (ii) the learned ability transfers to emotion challenging situations without biofeedback. Thus, heart rate biofeedback training may enable regulation of bodily aspects of emotion also when feedback is not available.	[Peira, Nathalie; Fredrikson, Mats] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Peira, Nathalie; Pourtois, Gilles] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Uppsala University; Ghent University	Peira, N (corresponding author), Uppsala Univ, Dept Psychol, Uppsala, Sweden.	nathalie.peira@gmail.com		Pourtois, Gilles/0000-0002-5109-2801	European Research Council [200758]; Belgian Science Policy, Interuniversity Attraction Poles program [P7/11]	European Research Council(European Research Council (ERC)European Commission); Belgian Science Policy, Interuniversity Attraction Poles program(Belgian Federal Science Policy Office)	The project was founded by the Swedish Research Council. Gilles Pourtois was supported by a grant from the European Research Council (Starting Grant #200758) and by the Belgian Science Policy, Interuniversity Attraction Poles program (P7/11) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bont JIC, 2004, PSICOTHEMA, V16, P661; Critchley HD, 2002, NEUROIMAGE, V16, P909, DOI 10.1006/nimg.2002.1147; Cuthbert BN, 2003, PSYCHOPHYSIOLOGY, V40, P407, DOI 10.1111/1469-8986.00043; FREDRIKSON M, 1981, PSYCHOPHYSIOLOGY, V18, P456, DOI 10.1111/j.1469-8986.1981.tb02480.x; Gross J.J., 2007, HDB EMOTION REGULATI, P3; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang P.J., 2008, A8 U FLOR; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Mauss I. B., 2004, ADV THEORY ASSESSMEN, P62; Meganck R, 2008, ASSESSMENT, V15, P36, DOI 10.1177/1073191107306140; Peira N, 2013, CONTROLLING EM UNPUB; Rieffe C, 2007, PERS INDIV DIFFER, V43, P95, DOI 10.1016/j.paid.2006.11.015; Roberts NA, 2008, INT J PSYCHOPHYSIOL, V70, P82, DOI 10.1016/j.ijpsycho.2008.06.003; ROGER D, 1989, PERS INDIV DIFFER, V10, P845, DOI 10.1016/0191-8869(89)90020-2; Rozin P., 2000, HDB EMOTIONS, P637; SHARPLEY CF, 1994, J BEHAV MED, V17, P309, DOI 10.1007/BF01857955; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Telch MJ, 2000, BEHAV RES THER, V38, P373, DOI 10.1016/S0005-7967(99)00038-8; Whitmer A. J., 2012, PSYCHOL B; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905	21	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70004	10.1371/journal.pone.0070004	http://dx.doi.org/10.1371/journal.pone.0070004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228SX	23894574	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000173
J	Chang, JS; Tsai, CR; Chen, LT				Chang, Jeffrey S.; Tsai, Chia-Rung; Chen, Li-Tzong			Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control Study	PLOS ONE			English	Article							BILIARY-TRACT CANCER; HEPATITIS-B-VIRUS; PRIMARY SCLEROSING CHOLANGITIS; INTRAHEPATIC CHOLANGIOCARCINOMA; C-VIRUS; EXTRAHEPATIC CHOLANGIOCARCINOMA; HEPATOCELLULAR-CARCINOMA; UNITED-STATES; INFECTION; GALLSTONES	Background: Cholangiocarcinoma, including intra- and extrahepatic cholangiocarcinoma, is a rare but highly lethal cancer. Despite effort in finding the risk factors of cholangiocarcinoma, the causes of most cholangiocarcinoma remain unknown. This study utilized a population-based case-control design using data from the National Health Insurance Research Database (NHIRD) of Taiwan to assess the medical conditions associated with cholangiocarcinoma. Methods: 5,157 incident cases of cholangiocarcinoma diagnosed during 2004 to 2008 and 20,628 controls matched to the cases on sex, age, and time of diagnosis (reference date for the controls) were identified from the NHIRD. Medical risk factors were ascertained from the NHIRD for each individual. Conditional logistic regression was performed to evaluate the association between cholangiocarcinoma and each medical risk factor. Results: The results showed that factors associated with an increased risk of cholangiocarcinoma included cholangitis, cholelithiasis, cholecystitis, cirrhosis of liver, alcoholic liver disease, chronic non-alcoholic liver disease, hepatitis B, hepatitis C, diabetes, chronic pancreatitis, inflammatory bowel disease, and peptic ulcer. In addition, sex and age differences were observed. Conclusions: This study confirms the association between cholangiocarcinoma and several less established risk factors, including diabetes, inflammatory bowel disease, hepatitis B, hepatitis C, and peptic ulcer (proxy for the presence of Helicobacter Pylori). Future studies should focus on finding additional environmental and genetic causes of cholangiocarcinoma.	[Chang, Jeffrey S.; Tsai, Chia-Rung; Chen, Li-Tzong] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chen, Li-Tzong] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Chen, Li-Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Li-Tzong] Natl Cheng Kung Univ, Inst Mol Med, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University	Chang, JS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	jeffreychang@nhri.org.tw; leochen@nhri.org.tw	Chen, Li-Tzong/D-2071-2010; Chang, Jeffrey Shu-Ming/B-1092-2010; Chang, Jeffrey Shu-Ming/AAR-4161-2020	Chang, Jeffrey Shu-Ming/0000-0002-3236-6205	Establishment of Cancer Research System Excellence Program; Department of Health, Taiwan, R.O.C. [DOH101-TD-C-111-004]	Establishment of Cancer Research System Excellence Program; Department of Health, Taiwan, R.O.C.	This study was supported by the Establishment of Cancer Research System Excellence Program funded by the Department of Health, Taiwan, R.O.C.; Grant number: DOH101-TD-C-111-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti G, 2008, CANCER EPIDEM BIOMAR, V17, P525, DOI 10.1158/1055-9965.EPI-07-2704; Boberg KM, 2002, SCAND J GASTROENTERO, V37, P1205, DOI 10.1080/003655202760373434; Bulajic M, 2002, CANCER-AM CANCER SOC, V95, P1946, DOI 10.1002/cncr.10893; Cai WK, 2011, WORLD J GASTROENTERO, V17, P249, DOI 10.3748/wjg.v17.i2.249; Chaiteerakij R, 2013, HEPATOLOGY, V57, P648, DOI 10.1002/hep.26092; DeSantis A, 1997, HEPATOLOGY, V25, P787, DOI 10.1002/hep.510250401; Donato F, 2001, CANCER CAUSE CONTROL, V12, P959, DOI 10.1023/A:1013747228572; El-Serag HB, 2009, HEPATOLOGY, V49, P116, DOI 10.1002/hep.22606; Fwu CW, 2011, HEPATOLOGY, V53, P1217, DOI 10.1002/hep.24150; Gatto M, 2010, DIGEST LIVER DIS, V42, P253, DOI 10.1016/j.dld.2009.12.008; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Grainge MJ, 2009, BRIT J CANCER, V100, P178, DOI 10.1038/sj.bjc.6604765; Hsing AW, 2008, BRIT J CANCER, V99, P811, DOI 10.1038/sj.bjc.6604616; Hsing AW, 2007, BRIT J CANCER, V97, P1577, DOI 10.1038/sj.bjc.6604047; Hsing AW, 2008, INT J CANCER, V122, P1849, DOI 10.1002/ijc.23251; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Lee CH, 2009, BRIT J CANCER, V100, P1765, DOI 10.1038/sj.bjc.6605063; Lee TY, 2008, AM J GASTROENTEROL, V103, P1716, DOI 10.1111/j.1572-0241.2008.01796.x; Li M, 2012, J GASTROEN HEPATOL, V27, P1561, DOI 10.1111/j.1440-1746.2012.07207.x; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Morris-Stiff G, 2008, DIGEST SURG, V25, P126, DOI 10.1159/000128169; Nava S, 2005, DIFFERENTIATION, V73, P249, DOI 10.1111/j.1432-0436.2005.00019.x; Novacek G, 2006, WIEN MED WOCHENSCHR, V156, P527, DOI 10.1007/s10354-006-0346-x; Palmer WC, 2012, J HEPATOL, V57, P69, DOI 10.1016/j.jhep.2012.02.022; Pandey M, 2009, SURG ONCOL, V18, P51, DOI 10.1016/j.suronc.2008.07.002; Parente F, 2007, HEPATOLOGY, V45, P1267, DOI 10.1002/hep.21537; Park SK, 2010, CARCINOGENESIS, V31, P842, DOI 10.1093/carcin/bgq038; Parsi MA, 2013, WORLD J GASTROENTERO, V19, P457, DOI 10.3748/wjg.v19.i4.457; Peng NF, 2011, ANN SURG ONCOL, V18, P1258, DOI 10.1245/s10434-010-1458-5; Ponsioen CY, 2002, GUT, V51, P562, DOI 10.1136/gut.51.4.562; Saich R, 2008, WORLD J GASTROENTERO, V14, P331, DOI 10.3748/wjg.14.331; Shaib YH, 2007, AM J GASTROENTEROL, V102, P1016, DOI 10.1111/j.1572-0241.2007.01104.x; Shaib YH, 2005, GASTROENTEROLOGY, V128, P620, DOI 10.1053/j.gastro.2004.12.048; Shebl FM, 2010, BRIT J CANCER, V103, P115, DOI 10.1038/sj.bjc.6605706; Shin HR, 1996, INT J EPIDEMIOL, V25, P933, DOI 10.1093/ije/25.5.933; SU CH, 1992, DIGEST DIS SCI, V37, P764, DOI 10.1007/BF01296436; Szklo M, 2000, EPIDEMIOLOGY BASICAS; Tanaka M, 2010, J VIRAL HEPATITIS, V17, P742, DOI 10.1111/j.1365-2893.2009.01243.x; Tao LY, 2010, LIVER INT, V30, P215, DOI 10.1111/j.1478-3231.2009.02149.x; Tseng TS, 2008, INT J BEHAV MED, V15, P14, DOI [10.1080/10705500701783819, 10.1007/BF03003069]; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Vijungco JD, 2003, WORLD J SURG, V27, P1258, DOI 10.1007/s00268-003-7246-7; Welzel TM, 2007, INT J CANCER, V120, P638, DOI 10.1002/ijc.22283; Welzel TM, 2007, CLIN GASTROENTEROL H, V5, P1221, DOI 10.1016/j.cgh.2007.05.020; Wu Q, 2012, ASIAN PAC J CANCER P, V13, P1963, DOI 10.7314/APJCP.2012.13.5.1963; Yamamoto S, 2004, CANCER SCI, V95, P592, DOI 10.1111/j.1349-7006.2004.tb02492.x; Yu MW, 2001, J NATL CANCER I, V93, P1644, DOI 10.1093/jnci/93.21.1644; Zhou HB, 2010, EUR J CANCER, V46, P1056, DOI 10.1016/j.ejca.2010.02.005; Zhou YM, 2008, WORLD J GASTROENTERO, V14, P632, DOI 10.3748/wjg.14.632	49	52	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69981	10.1371/journal.pone.0069981	http://dx.doi.org/10.1371/journal.pone.0069981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894567	gold, Green Submitted, Green Published			2022-12-25	WOS:000322132100085
J	Cui, J; Shi, SZ; Sun, XF; Cai, GY; Cui, SY; Hong, Q; Chen, XM; Bai, XY				Cui, Jing; Shi, Suozhu; Sun, Xuefeng; Cai, Guangyan; Cui, Shaoyuan; Hong, Quan; Chen, Xiangmei; Bai, Xue-Yuan			Mitochondrial Autophagy Involving Renal Injury and Aging Is Modulated by Caloric Intake in Aged Rat Kidneys	PLOS ONE			English	Article							MAMMALIAN AUTOPHAGY; IN-VIVO; RESTRICTION; PARKIN; MITOPHAGY; EXPRESSION; DISEASE; CELLS; MUSCLE; DIET	Background: A high-calorie (HC) diet induces renal injury and promotes aging, and calorie restriction (CR) may ameliorate these responses. However, the effects of long-term HC and CR on renal damage and aging have been not fully determined. Autophagy plays a crucial role in removing protein aggregates and damaged organelles to maintain intracellular homeostasis and function. The role of autophagy in HC-induced renal damage is unknown. Methods: We evaluated the expression of LC3/Atg8 as a marker of the autophagosome; p62/SQSTM1; polyubiquitin aggregates as markers of autophagy flux; Ambra1, PINK1, Parkin and Bnip3 as markers of mitophagy; 8-hydroxydeoxyguanosine (8-OHdG) as a marker of DNA oxidative damage; and p16 as a marker of organ aging by western blot and immunohistochemical staining in the kidneys of 24-month-old Fischer 344 rats. We also observed mitochondrial structure and autolysosomes by transmission electron microscopy. Results: Expression of the autophagosome formation marker LC3/Atg8 and markers of mitochondrial autophagy (mitophagy) were markedly decreased in the kidneys of the HC group, and markedly increased in CR kidneys. p62/SQSTM1 and polyubiquitin aggregates increased in HC kidneys, and decreased in CR kidneys. Transmission electron microscopy demonstrated that HC kidneys showed severe abnormal mitochondrial morphology with fewer autolysosomes, while CR kidneys exhibited normal mitochondrial morphology with numerous autolysosomes. The level of 8-hydroxydeoxyguanosine was increased in HC kidneys and decreased in CR kidneys. Markers of aging, such as p16 and senescence-associated-galactosidase, were increased significantly in the HC group and decreased significantly in the CR group. Conclusion: The study firstly suggests that HC diet inhibits renal autophagy and aggravates renal oxidative damage and aging, while CR enhances renal autophagy and ameliorates oxidative damage and aging in the kidneys.	[Cui, Jing; Shi, Suozhu; Sun, Xuefeng; Cai, Guangyan; Cui, Shaoyuan; Hong, Quan; Chen, Xiangmei; Bai, Xue-Yuan] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Dept Nephrol, Beijing, Peoples R China; [Cui, Jing; Shi, Suozhu; Sun, Xuefeng; Cai, Guangyan; Cui, Shaoyuan; Hong, Quan; Chen, Xiangmei; Bai, Xue-Yuan] Coll Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Chen, XM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Dept Nephrol, Beijing, Peoples R China.; Chen, XM (corresponding author), Coll Med, Beijing, Peoples R China.	xmchen301@126.com; xueyuan_bai@yahoo.com.cn			National Basic Research Program of China [2011CBA01003]; National Key Scientific Program of China [2011CB964904]	National Basic Research Program of China(National Basic Research Program of China); National Key Scientific Program of China	This work was supported by a grant (No. 2011CBA01003) from the National Basic Research Program of China to X.Y.B. and a grant (No. 2011CB964904) from the National Key Scientific Program of China to X.Y.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1986, AM J MED, V80, P435, DOI 10.1016/0002-9343(86)90718-7; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Cheng CH, 2008, TRANSPL P, V40, P2373, DOI 10.1016/j.transproceed.2008.06.013; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding GH, 2001, EXP MOL PATHOL, V70, P43, DOI 10.1006/exmp.2000.2346; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Floege J, 1997, KIDNEY INT, V51, P230, DOI 10.1038/ki.1997.28; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Fujitani Y, 2009, AUTOPHAGY, V5, P280, DOI 10.4161/auto.5.2.7656; Hard GC, 2004, TOXICOL PATHOL, V32, P171, DOI 10.1080/01926230490422574; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Jin SK, 2008, AUTOPHAGY, V4, P563, DOI 10.4161/auto.5830; Kadowaki M, 2009, METHOD ENZYMOL, V452, P199, DOI 10.1016/S0076-6879(08)03613-6; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lee JH, 2004, EXP GERONTOL, V39, P1361, DOI 10.1016/j.exger.2004.06.015; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lucas EA, 2011, BRIT J NUTR, V106, P1495, DOI 10.1017/S0007114511002066; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com; McKiernan S, 2004, FASEB J, V18, P580, DOI 10.1096/fj.03-0667fje; McKiernan SH, 2007, AM J PHYSIOL-RENAL, V292, pF1751, DOI 10.1152/ajprenal.00307.2006; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nicoletti VG, 2005, NEUROCHEM RES, V30, P737, DOI 10.1007/s11064-005-6867-7; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Rao GN, 2002, TOXICOL PATHOL, V30, P651, DOI 10.1080/01926230290166733; Rascon B, 2012, AGING-US, V4, P499, DOI 10.18632/aging.100474; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697; Spallarossa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015583; Stern JS, 2001, J NUTR, V131, p913S, DOI 10.1093/jn/131.3.913S; Suzuki C, 2008, BIOCHEM BIOPH RES CO, V368, P100, DOI 10.1016/j.bbrc.2008.01.059; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Van Humbeeck C, 2011, AUTOPHAGY, V7, P1555, DOI 10.4161/auto.7.12.17893; Ventruti A, 2007, CURR NEUROL NEUROSCI, V7, P443, DOI 10.1007/s11910-007-0068-5; Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	58	46	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69720	10.1371/journal.pone.0069720	http://dx.doi.org/10.1371/journal.pone.0069720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894530	gold, Green Submitted, Green Published			2022-12-25	WOS:000322132100078
J	Nagy, T; Frank, D; Katai, E; Yahiro, RKK; Poor, VS; Montsko, G; Zrinyi, Z; Kovacs, GL; Miseta, A				Nagy, Tamas; Frank, Dorottya; Katai, Emese; Yahiro, Rikki K. K.; Poor, Viktor S.; Montsko, Gergely; Zrinyi, Zita; Kovacs, Gabor L.; Miseta, Attila			Lithium Induces ER Stress and N-Glycan Modification in Galactose-Grown Jurkat Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SACCHAROMYCES-CEREVISIAE; ALZHEIMERS-DISEASE; BIPOLAR DISORDER; INTRACELLULAR CALCIUM; GLUCOSE STARVATION; SERUM TRANSFERRIN; MAMMALIAN-CELLS; INCREASES; PROTEINS	We previously reported that lithium had a significant impact on Ca2+ regulation and induced unfolded protein response (UPR) in yeast cells grown on galactose due to inhibition of phosphoglucomutase (PGM), however the exact mechanism has not been established yet. In this study, we analysed lithium's effect in galactose-fed cells to clarify whether these ER-related changes are the result of a relative hypoglycemic state. Furthermore, we investigated whether the alterations in galactose metabolism impact protein post-translational modifications. Thus, Jurkat cells were incubated in glucose or galactose containing media with or without lithium treatment. We found that galactose-fed and lithium treated cells showed better survivability than fasting cells. We also found higher UDP-Hexose and glycogen levels in these cells compared to fasting cells. On the other hand, the UPR (X-box binding protein 1 mRNA levels) of galactose-fed and lithium treated cells was even greater than in fasting cells. We also found increased amount of proteins that contained N-linked N-acetyl-glucosamine, similar to what was reported in fasting cells by a recent study. Our results demonstrate that lithium treatment of galactose-fed cells can induce stress responses similar to hypoglycemia, however cell survival is still secured by alternative pathways. We propose that clarifying this process might be an important addition toward the better understanding of the molecular mechanisms that regulate ER-associated stress response.	[Nagy, Tamas; Frank, Dorottya; Katai, Emese; Yahiro, Rikki K. K.; Montsko, Gergely; Zrinyi, Zita; Kovacs, Gabor L.; Miseta, Attila] Univ Pecs, Dept Lab Med, Pecs, Hungary; [Frank, Dorottya] Univ Pecs, Dept Dent Oral & Maxillofacial Surg, Pecs, Hungary; [Poor, Viktor S.] Univ Pecs, Dept Forens Med, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs	Miseta, A (corresponding author), Univ Pecs, Dept Lab Med, Pecs, Hungary.	attila.miseta@aok.pte.hu	Nagy, Tamas/W-9340-2019; Poór, Viktor Soma/A-2512-2011	Nagy, Tamas/0000-0001-5437-1411; Poór, Viktor Soma/0000-0002-0269-0645; Miseta, Attila/0000-0002-7984-3347	Hungarian Fund OTKA [73591, 78480]; Research Fund of the University of Pecs, Faculty of Medicine [AOK-KA 2013/19]	Hungarian Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Research Fund of the University of Pecs, Faculty of Medicine	This work was supported by Hungarian Fund OTKA (73591 and 78480) and by the Research Fund of the University of Pecs, Faculty of Medicine (AOK-KA 2013/19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA PB, 1995, EUR J PEDIATR, V154, pS87, DOI 10.1007/BF02143811; Aiello DP, 2004, J BIOL CHEM, V279, P38495, DOI 10.1074/jbc.M400833200; Akasaka-Manya K, 2010, GLYCOBIOLOGY, V20, P99, DOI 10.1093/glycob/cwp152; BAUMANN H, 1983, J BIOL CHEM, V258, P3942; BERRY GT, 1995, LANCET, V346, P1073, DOI 10.1016/S0140-6736(95)91745-4; Bhat PJ, 2003, MED HYPOTHESES, V60, P123, DOI 10.1016/S0306-9877(02)00347-X; BLAKELY RD, 1994, J EXP BIOL, V196, P263; Bro C, 2003, J BIOL CHEM, V278, P32141, DOI 10.1074/jbc.M304478200; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Cai B, 1998, J CELL PHYSIOL, V177, P282, DOI 10.1002/(SICI)1097-4652(199811)177:2<282::AID-JCP10>3.0.CO;2-C; Cannon DM, 2007, BIOL PSYCHIAT, V62, P870, DOI 10.1016/j.biopsych.2007.03.016; Charlwood J, 1998, GLYCOBIOLOGY, V8, P351, DOI 10.1093/glycob/8.4.351; Chen XZ, 2008, J NEUROCHEM, V106, P1563, DOI 10.1111/j.1471-4159.2008.05501.x; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Coss KP, 2011, MOL GENET METAB, P1; Csutora P, 2005, AM J PHYSIOL-CELL PH, V289, pC58, DOI 10.1152/ajpcell.00464.2004; De Sarno P, 2008, J IMMUNOL, V181, P338, DOI 10.4049/jimmunol.181.1.338; GERSHMAN H, 1981, J BIOL CHEM, V256, P7774; Gould TD, 2004, MOL PSYCHIATR, V9, P734, DOI 10.1038/sj.mp.4001518; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HAYHOE FGJ, 1984, HISTOCHEM J, V16, P1051, DOI 10.1007/BF01002894; Hiroi T, 2005, PHARMACOGENOMICS J, V5, P102, DOI 10.1038/sj.tpj.6500296; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Kiernan J.A., 1999, HISTOLOGICAL HISTOCH, V3rd ed; Lazarus JH, 2009, BEST PRACT RES CL EN, V23, P723, DOI 10.1016/j.beem.2009.06.002; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee D, 2007, J MOL BIOL, V372, P331, DOI 10.1016/j.jmb.2007.06.071; Liu KJ, 2011, J CELL PHYSIOL, V226, P424, DOI 10.1002/jcp.22348; Lorenzi M, 2007, EXP DIABETES RES, DOI 10.1155/2007/61038; Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Masuda CA, 2001, J BIOL CHEM, V276, P37794; Miseta A, 2003, EUKARYOT CELL, V2, P534, DOI 10.1128/EC.2.3.534-541.2003; Nagy T, 2006, AM J PHYSIOL-CELL PH, V290, pC57, DOI 10.1152/ajpcell.00263.2005; Nagy T, 2010, EUR BIOPHYS J BIOPHY, V39, P1207, DOI 10.1007/s00249-009-0573-3; Nunes PV, 2007, BRIT J PSYCHIAT, V190, P359, DOI 10.1192/bjp.bp.106.029868; Pasquali L, 2010, BEHAV PHARMACOL, V21, P473, DOI 10.1097/FBP.0b013e32833da5da; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Sato Y, 2001, FEBS LETT, V496, P152, DOI 10.1016/S0014-5793(01)02421-8; Schou M, 2001, J AFFECT DISORDERS, V67, P21, DOI 10.1016/S0165-0327(01)00380-9; Schulz JM, 2005, J BIOL CHEM, V280, P13493, DOI 10.1074/jbc.M414045200; Shao L, 2006, LIFE SCI, V78, P1317, DOI 10.1016/j.lfs.2005.07.007; Slepak TI, 2007, MOL GENET METAB, V92, P78, DOI 10.1016/j.ymgme.2007.06.005; Sturiale L, 2005, GLYCOBIOLOGY, V15, P1268, DOI 10.1093/glycob/cwj021; Thomsen K, 2006, NEPHROL DIAL TRANSPL, V21, P869, DOI 10.1093/ndt/gfk029; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Wang C, 2002, J CEREBR BLOOD F MET, V22, P206, DOI 10.1097/00004647-200202000-00008; Weinberg JM, 1997, J CLIN INVEST, V100, P713, DOI 10.1172/JCI119584	50	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e70410	10.1371/journal.pone.0070410	http://dx.doi.org/10.1371/journal.pone.0070410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894652	Green Submitted, Green Published, gold			2022-12-25	WOS:000322132100093
J	Rosini, F; Federighi, P; Pretegiani, E; Piu, P; Leigh, RJ; Serra, A; Federico, A; Rufa, A				Rosini, Francesca; Federighi, Pamela; Pretegiani, Elena; Piu, Pietro; Leigh, R. John; Serra, Alessandro; Federico, Antonio; Rufa, Alessandra			Ocular-Motor Profile and Effects of Memantine in a Familial Form of Adult Cerebellar Ataxia with Slow Saccades and Square Wave Saccadic Intrusions	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; MICROSACCADES	Fixation instability due to saccadic intrusions is a feature of autosomal recessive spinocerebellar ataxias, and includes square wave intrusions (SWI) and macrosaccadic oscillations (MSO). A recent report suggested that the non-competitive antagonist of NMDA receptors, memantine, could decrease MSO and improve fixation in patients with spinocerebellar ataxia with saccadic intrusions (SCASI). We similarly tested two sisters, respectively of 58 and 60 years, with an unrecognized form of recessive, adult-onset cerebellar ataxia, peripheral neuropathy and slow saccades, who showed prominent SWI and also complained with difficulty in reading. We tested horizontal visually guided saccades (10 degrees-18 degrees) and three minutes of steady fixation in each patient and in thirty healthy controls. Both patients showed a significant reduction of peak and mean velocity compared with control subjects. Large SWI interrupting steady fixation were prominent during steady fixation and especially following visually guided saccades. Eye movements were recorded before and during the treatment with memantine, 20 mg/daily for 6 months. The treatment with memantine reduced both the magnitude and frequency of SWI (the former significantly), but did not modified neurological conditions or saccade parameters. Thus, our report suggests that memantine may have some general suppressive effect on saccadic intrusions, including both SWI and MSO, thereby restoring the capacity of reading and visual attention in these and in other recessive forms of ataxia, including Friedreich's, in which saccadic intrusions are prominent.	[Rosini, Francesca; Federighi, Pamela; Pretegiani, Elena; Piu, Pietro; Rufa, Alessandra] Univ Siena, Eye Tracking & Visual Applicat Lab, EVA Lab, I-53100 Siena, Italy; [Leigh, R. John; Serra, Alessandro] Case Western Reserve Univ, Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Federico, Antonio] Univ Siena, I-53100 Siena, Italy	University of Siena; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Siena	Rufa, A (corresponding author), Univ Siena, Eye Tracking & Visual Applicat Lab, EVA Lab, Via Laterina 8, I-53100 Siena, Italy.	rufa@unisi.it	Federighi, Pamela/ABD-1184-2020; Serra, Alessandro/X-4965-2019; Rufa, Alessandra/E-8298-2011	Federighi, Pamela/0000-0002-0756-7400; Rufa, Alessandra/0000-0002-2254-2869; Piu, Pietro/0000-0002-7504-1822; federico, antonio/0000-0002-5246-1621	European Commission Framework Programme for Research and Technological Development (EC FP7) International Fellowships Research Executive Agency (REA) Marie Curie Actions PEOPLE CERVISO [269263]; National Institutes of Health [R01EY06717]; NATIONAL EYE INSTITUTE [R01EY006717] Funding Source: NIH RePORTER	European Commission Framework Programme for Research and Technological Development (EC FP7) International Fellowships Research Executive Agency (REA) Marie Curie Actions PEOPLE CERVISO; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by European Commission Framework Programme for Research and Technological Development (EC FP7) International Fellowships Research Executive Agency (REA) Marie Curie Actions PEOPLE CERVISO no 269263 and National Institutes of Health grant R01EY06717. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi R, 2004, VISION RES, V44, P2675, DOI 10.1016/j.visres.2004.05.009; AverbuchHeller L, 1996, NEURO-OPHTHALMOLOGY, V16, P99, DOI 10.3109/01658109609009668; Becker W, 1991, EYE MOVEMENTS VISION, V8, P95; Chen Athena L, 2010, Front Neurol, V1, P147, DOI 10.3389/fneur.2010.00147; Fahey MC, 2008, BRAIN, V131, P1035, DOI 10.1093/brain/awm323; Federighi P, 2011, BRAIN, V134, P879, DOI 10.1093/brain/awr009; FELDON SE, 1977, NEUROLOGY, V27, P278, DOI 10.1212/WNL.27.3.278; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; Kanazawa M, 2009, MOVEMENT DISORD, V24, P1312, DOI 10.1002/mds.22583; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Otero-Millan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058535; Otero-Millan J, 2011, ANN NY ACAD SCI, V1233, P107, DOI 10.1111/j.1749-6632.2011.06177.x; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; SELHORST JB, 1976, BRAIN, V99, P509, DOI 10.1093/brain/99.3.509; Serra A, 2008, NEUROLOGY, V70, P810, DOI 10.1212/01.wnl.0000286952.01476.eb; Siegal S., 1988, NONPARAMETRIC TESTS; Swartz BE, 2003, ANN NEUROL, V54, P824, DOI 10.1002/ana.10758; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6	19	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69522	10.1371/journal.pone.0069522	http://dx.doi.org/10.1371/journal.pone.0069522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894498	Green Published, gold, Green Submitted			2022-12-25	WOS:000322132100066
J	Kembabazi, A; Bajunirwe, F; Hunt, PW; Martin, JN; Muzoora, C; Haberer, JE; Bangsberg, DR; Siedner, MJ				Kembabazi, Annet; Bajunirwe, Francis; Hunt, Peter W.; Martin, Jeffrey N.; Muzoora, Conrad; Haberer, Jessica E.; Bangsberg, David R.; Siedner, Mark J.			Disinhibition in Risky Sexual Behavior in Men, but Not Women, during Four Years of Antiretroviral Therapy in Rural, Southwestern Uganda	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SOUTH-AFRICA; PROSPECTIVE COHORT; HOMOSEXUAL-MEN; PREVENTION; TRANSMISSION; SEROCONVERSION; INTERVENTIONS; METAANALYSIS; ESTIMATOR	Background: In resource-rich areas, risky sexual behavior (RSB) largely diminishes after initiation of anti-retroviral therapy, with notable exceptions among some populations who perceive a protected benefit from anti-retroviral therapy (ART). Yet, there is limited data about long-term trends in risky sexual behavior among HIV-infected people in sub-Saharan Africa after initiation of anti-retroviral therapy. Methods: We administered questionnaires every three months to collect sexual behavior data among patients taking ART in southwestern Uganda over four years of follow-up time. We defined RSB as having unprotected sex with an HIV-negative or unknown status partner, or unprotected sex with a casual partner. We fit logistic regression models to estimate changes in RSB by time on ART, with and without adjustment for calendar year and CD4 count. Results: 506 participants were enrolled between 2005 and 2011 and contributed a median of 13 visits and 3.5 years of observation time. The majority were female (70%) and median age was 34 years (interquartile range 29-39). There was a decrease in the proportion of men reporting RSB from the pre-ART visit to the first post-ART visit (16.2 to 4.3%, p < 0.01) but not women (14.1 to 13.3%, p = 0.80). With each year of ART, women reported decreasing RSB (OR 0.85 per year, 95% CI 0.74-0.98, p = 0.03). In contrast, men had increasing odds of reporting RSB with each year of ART to near pre-treatment rates (OR 1.41, 95% CI 1.14-1.74, p = 0.001), which was partially confounded by changes in calendar time and CD4 count (AOR = 1.24, 95% CI 0.92-1.67, p = 0.16). Conclusions: Men in southwestern Uganda reported increasing RSB over four years on ART, to levels approaching pretreatment rates. Strategies to promote long-term safe sex practices targeted to HIV-infected men on ART might have a significant impact on preventing HIV transmission in this setting.	[Kembabazi, Annet; Muzoora, Conrad] Mbarara Univ Sci & Technol, Dept Med, Mbarara, Uganda; [Bajunirwe, Francis] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Hunt, Peter W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Haberer, Jessica E.; Bangsberg, David R.; Siedner, Mark J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Haberer, Jessica E.; Bangsberg, David R.; Siedner, Mark J.] Harvard Univ, Sch Med, Boston, MA USA; [Bangsberg, David R.] Ragon Inst Massachusetts Gen Hosp MIT & Harvard, Cambridge, MA USA; [Bangsberg, David R.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Mbarara University of Science & Technology; Mbarara University of Science & Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Kembabazi, A (corresponding author), Mbarara Univ Sci & Technol, Dept Med, Mbarara, Uganda.	akembabazi2005@yahoo.com	Hunt, Peter W./P-2976-2017; Muzoora, Conrad/AAV-7023-2021; Haberer, Jessica/AAH-7976-2019	Hunt, Peter W./0000-0002-4571-4870; Muzoora, Conrad/0000-0002-7866-5198; Haberer, Jessica/0000-0001-5845-3190	U.S. National Institutes of Health (NIH) [R01 MH54907, P30 AI27763]; NIH [K23 MH087228, K24 MH87227, T32 AI007433]; Harvard Institute for Global Health; Mark and Lisa Schwartz Family Foundation; Sullivan Family Foundation; Bacca Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH099916, K24MH087227, K23MH087228, R01MH054907] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Institute for Global Health; Mark and Lisa Schwartz Family Foundation; Sullivan Family Foundation; Bacca Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Uganda AIDS Rural Treatment Outcomes Study is funded by U.S. National Institutes of Health (NIH) R01 MH54907 and P30 AI27763. The authors also acknowledge the following additional sources of salary support: NIH K23 MH087228 (Haberer); NIH K24 MH87227 (Bangsberg); the Harvard Institute for Global Health and NIH T32 AI007433 (Siedner). Additional study funding was provided by the Mark and Lisa Schwartz Family Foundation, the Sullivan Family Foundation, and the Bacca Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, UNAIDS REPROT GLOBAL; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bateganya M, 2005, AIDS PATIENT CARE ST, V19, P760, DOI 10.1089/apc.2005.19.760; Bechange S, 2010, AIDS BEHAV, V14, P816, DOI 10.1007/s10461-008-9481-2; Berhan A, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-14; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Cohen MS, 2012, AIDS, V26, P1585, DOI 10.1097/QAD.0b013e3283543e83; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; Cornman DH, 2008, JAIDS-J ACQ IMM DEF, V48, P553, DOI 10.1097/QAI.0b013e31817bebd7; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; De Walque D, 2012, ECON DEV CULT CHANGE, V61, P97, DOI 10.1086/666951; Dukers NHTM, 2001, AIDS, V15, P369, DOI 10.1097/00002030-200102160-00010; Freedman DA, 2006, AM STAT, V60, P299, DOI 10.1198/000313006X152207; Heijman T, 2012, AIDS, V26, P489, DOI 10.1097/QAD.0b013e32834f9d7c; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Huber PJ, 1967, BEHAV MAXIMUM LIKELI, P221; Kaida A, 2008, AIDS CARE, V20, P21, DOI 10.1080/09540120701426540; Kalichman SC, 1997, HEALTH PSYCHOL, V16, P369, DOI 10.1037/0278-6133.16.4.369; Kalichman SC, 2001, AM J PREV MED, V21, P84, DOI 10.1016/S0749-3797(01)00324-5; Luchters S, 2008, AIDS PATIENT CARE ST, V22, P587, DOI 10.1089/apc.2007.0247; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Moatti JP, 2003, AIDS, V17, pS69, DOI 10.1097/00002030-200317003-00010; Ostrow DE, 2002, AIDS, V16, P775, DOI 10.1097/00002030-200203290-00013; Peltzer K, 2010, SEX HEALTH, V7, P135, DOI 10.1071/SH09109; Rogers HW, 1993, STATA TECHNICAL B, V13, P19; Sarna A, 2008, INT J STD AIDS, V19, P85, DOI 10.1258/ijsa.2007.007097; Scheer S, 2001, LANCET, V357, P432, DOI 10.1016/S0140-6736(00)04007-1; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Shafer LA, 2011, AIDS, V25, P671, DOI 10.1097/QAD.0b013e328341fb18; Stolte IG, 2004, AIDS, V18, P303, DOI 10.1097/00002030-200401230-00021; Tun W, 2004, CLIN INFECT DIS, V38, P1167, DOI 10.1086/383033; Van de Ven P, 2002, INT J STD AIDS, V13, P181, DOI 10.1258/0956462021924884; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wolf K, 2003, JAIDS-J ACQ IMM DEF, V33, P494, DOI 10.1097/00126334-200308010-00010	36	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69634	10.1371/journal.pone.0069634	http://dx.doi.org/10.1371/journal.pone.0069634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191CY	23894514	Green Published, gold, Green Submitted			2022-12-25	WOS:000322391400063
J	Wayakanon, K; Thornhill, MH; Douglas, CWI; Lewis, AL; Warren, NJ; Pinnock, A; Armes, SP; Battaglia, G; Murdoch, C				Wayakanon, Kornchanok; Thornhill, Martin H.; Douglas, C. W. Ian; Lewis, Andrew L.; Warren, Nicholas J.; Pinnock, Abigail; Armes, Steven P.; Battaglia, Giuseppe; Murdoch, Craig			Polymersome-mediated intracellular delivery of antibiotics to treat Porphyromonas gingivalis-infected oral epithelial cells	FASEB JOURNAL			English	Article						periodontal disease; antimicrobial chemotherapy; nanotechnology	ZWITTERIONIC DIBLOCK COPOLYMER; IN-VITRO; PERIODONTAL-DISEASES; INVASION; VESICLES; PH; BACTERIA; BINDING; DRUG; ENCAPSULATION	The gram-negative anaerobe Porphyromonas gingivalis colonizes the gingival crevice and is etiologically associated with periodontal disease that can lead to alveolar bone damage and resorption, promoting tooth loss. Although susceptible to antibiotics, P. gingivalis can evade antibiotic killing by residing within gingival keratinocytes. This provides a reservoir of organisms that may recolonize the gingival crevice once antibiotic therapy is complete. Polymersomes are nanosized amphiphilic block copolymer vesicles that can encapsulate drugs. Cells internalize polymersomes by endocytosis into early endosomes, where they are disassembled by the low pH, causing intracellular release of their drug load. In this study, polymersomes were used as vehicles to deliver antibiotics in an attempt to kill intracellular P. gingivalis within monolayers of keratinocytes and organotypic oral mucosal models. Polymersome-encapsulated metronidazole or doxycycline, free metronidazole, or doxycycline, or polymersomes alone as controls, were used, and the number of surviving intracellular P. gingivalis was quantified after host cell lysis. Polymersome-encapsulated metronidazole or doxycycline significantly (P<0.05) reduced the number of intracellular P. gingivalis in both monolayer and organotypic cultures compared to free antibiotic or polymersome alone controls. Polymersomes are effective delivery vehicles for antibiotics that do not normally gain entry to host cells. This approach could be used to treat recurrent periodontitis or other diseases caused by intracellular-dwelling organisms.Wayakanon, K., Thornhill, M. H., Douglas, C. W. I., Lewis, A. L., Warren, N. J., Pinnock, A., Armes, S. P., Battaglia, G., Murdoch, C. Polymersome-mediated intracellular delivery of antibiotics to treat Porphyromonas gingivalis-infected oral epithelial cells.	[Wayakanon, Kornchanok; Thornhill, Martin H.; Pinnock, Abigail; Battaglia, Giuseppe; Murdoch, Craig] Univ Sheffield, Sch Clin Dent, Acad Unit Oral & Maxillofacial Med & Surg, Sheffield S10 2TA, S Yorkshire, England; [Douglas, C. W. Ian] Univ Sheffield, Sch Clin Dent, Acad Unit Oral & Maxillofacial Pathol, Sheffield S10 2TA, S Yorkshire, England; [Warren, Nicholas J.; Armes, Steven P.] Univ Sheffield, Dept Chem, Sheffield S10 2TA, S Yorkshire, England; [Battaglia, Giuseppe] UCL, Dept Chem, London, England; [Lewis, Andrew L.] Biocompatibles UK Ltd, Farnham, Surrey, England	University of Sheffield; University of Sheffield; University of Sheffield; University of London; University College London; Biocompatibles International PLC	Murdoch, C (corresponding author), Univ Sheffield, Sch Clin Dent, Unit Oral & Maxillofacial Med & Surg, Sheffield S10 2TA, S Yorkshire, England.	g.battaglia@ucl.ac.uk; c.murdoch@sheffield.ac.uk	Warren, Nicholas/AAE-9388-2021; Battaglia, Giuseppe/I-2142-2013; Warren, Nicholas J/I-1588-2013	Warren, Nicholas/0000-0002-8298-1417; Battaglia, Giuseppe/0000-0003-3349-6770; Warren, Nicholas J/0000-0002-8298-1417; Thornhill, Martin/0000-0003-0681-4083; Armes, Steven/0000-0002-8289-6351; Murdoch, Craig/0000-0001-9724-122X; Lewis, Andrew/0000-0001-5779-5631	Oral and Dental Research Trust, UK; Biocompatibles UK Ltd.; Government of Thailand	Oral and Dental Research Trust, UK; Biocompatibles UK Ltd.; Government of Thailand	This work was supported by funding from the Oral and Dental Research Trust, UK (K. W., C. M.) and Biocompatibles UK Ltd. (G. B., A. L. L.). K. W. was the recipient of a Ph.D. scholarship from the Government of Thailand.	Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012; Ahmed F, 2006, MOL PHARMACEUT, V3, P340, DOI 10.1021/mp050103u; Andrian E, 2004, INFECT IMMUN, V72, P4689, DOI 10.1128/IAI.72.8.4689-4698.2004; Belton CM, 1999, CELL MICROBIOL, V1, P215, DOI 10.1046/j.1462-5822.1999.00022.x; Blanazs A, 2011, J AM CHEM SOC, V133, P16581, DOI 10.1021/ja206301a; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Canton I, 2013, FASEB J, V27, P98, DOI 10.1096/fj.12-212183; Canton I, 2012, CHEM SOC REV, V41, P2718, DOI 10.1039/c2cs15309b; Chen T, 2004, MICROB PATHOGENESIS, V36, P205, DOI 10.1016/j.micpath.2003.12.001; Christian DA, 2009, EUR J PHARM BIOPHARM, V71, P463, DOI 10.1016/j.ejpb.2008.09.025; Colley HE, 2011, BRIT J CANCER, V105, P1582, DOI 10.1038/bjc.2011.403; Dickinson BC, 2011, MOL ORAL MICROBIOL, V26, P210, DOI 10.1111/j.2041-1014.2011.00609.x; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Dorn BR, 2000, FEMS MICROBIOL LETT, V187, P139, DOI 10.1016/S0378-1097(00)00191-9; Du JZ, 2005, J AM CHEM SOC, V127, P17982, DOI 10.1021/ja056514l; GEISOW MJ, 1984, EXP CELL RES, V150, P36, DOI 10.1016/0014-4827(84)90699-2; Giacomelli C, 2006, BIOMACROMOLECULES, V7, P817, DOI 10.1021/bm0508921; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hearnden V, 2009, PHARM RES-DORDR, V26, P1718, DOI 10.1007/s11095-009-9882-6; Hirsch R, 2012, J PERIODONTAL RES, V47, P137, DOI 10.1111/j.1600-0765.2011.01418.x; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; ISOGAI E, 1992, ARCH ORAL BIOL, V37, P667, DOI 10.1016/0003-9969(92)90130-Z; JENSEN RL, 1974, J PERIODONTOL, V45, P786, DOI 10.1902/jop.1974.45.11.786; Kim Younghoon, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4350; Kim YH, 2009, J CONTROL RELEASE, V134, P132, DOI 10.1016/j.jconrel.2008.10.020; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; LAMONT RJ, 1992, ORAL MICROBIOL IMMUN, V7, P364, DOI 10.1111/j.1399-302X.1992.tb00637.x; Lomas H, 2008, FARADAY DISCUSS, V139, P143, DOI 10.1039/b717431d; Lomas H, 2010, MACROMOL BIOSCI, V10, P513, DOI 10.1002/mabi.201000083; LoPresti C, 2011, ACS NANO, V5, P1775, DOI 10.1021/nn102455z; Madianos PN, 1996, INFECT IMMUN, V64, P660, DOI 10.1128/IAI.64.2.660-664.1996; Massignani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010459; Massignani M, 2009, SMALL, V5, P2424, DOI 10.1002/smll.200900578; Mombelli A, 2004, INT DENT J, V54, P3, DOI 10.1111/j.1875-595X.2004.tb00246.x; Mombelli A, 2012, FRONT ORAL BIOL, V15, P133, DOI 10.1159/000329676; Murdoch C, 2010, NANOMEDICINE-UK, V5, P1025, DOI 10.2217/NNM.10.97; Nakagawa I, 2005, MICROBES INFECT, V7, P157, DOI 10.1016/j.micinf.2004.10.007; Nakhjiri SF, 2001, FEMS MICROBIOL LETT, V200, P145, DOI 10.1111/j.1574-6968.2001.tb10706.x; Njoroge T, 1997, INFECT IMMUN, V65, P1980, DOI 10.1128/IAI.65.5.1980-1984.1997; Poulet PP, 1999, J CLIN PERIODONTOL, V26, P261, DOI 10.1034/j.1600-051X.1999.260411.x; Shen L, 2008, LANGMUIR, V24, P10019, DOI 10.1021/la801190z; Suwannakul S, 2010, MICROBIOL-SGM, V156, P3052, DOI 10.1099/mic.0.038075-0; Tsuda K, 2008, CELL STRUCT FUNCT, V33, P123, DOI 10.1247/csf.08012; Umeda JE, 2006, ORAL MICROBIOL IMMUN, V21, P415, DOI 10.1111/j.1399-302X.2006.00312.x; VanWinkelhoff AJ, 1996, PERIODONTOL 2000, V10, P45; Wang LG, 2012, ANGEW CHEM INT EDIT, V51, P11122, DOI 10.1002/anie.201204169; Weinmann Stephen B, 2011, J Int Acad Periodontol, V13, P31; Yadev NR, 2011, MICROB PATHOGENESIS, V50, P278, DOI 10.1016/j.micpath.2010.11.009; Yilmaz O, 2003, MICROBIOL-SGM, V149, P2417, DOI 10.1099/mic.0.26483-0; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x; Yuan LH, 2007, FEMS IMMUNOL MED MIC, V51, P388, DOI 10.1111/j.1574-695X.2007.00326.x	51	50	51	4	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4455	4465		10.1096/fj.12-225219	http://dx.doi.org/10.1096/fj.12-225219			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23921377				2022-12-25	WOS:000329937500013
J	Mishra, S; Mohan, S; Godavarthi, S; Sen, R				Mishra, Saurabh; Mohan, Shalini; Godavarthi, Sapna; Sen, Ranjan			The Interaction Surface of a Bacterial Transcription Elongation Factor Required for Complex Formation with an Antiterminator during Transcription Antitermination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI NUSA; LAMBDA N PROTEIN; RNA-EXIT CHANNEL; PHAGE-LAMBDA; BACTERIOPHAGE-LAMBDA; ALPHA-SUBUNIT; NUT RNA; POLYMERASE; TERMINATION; BINDING	The bacterial transcription elongation factor, NusA, functions as an antiterminator when it is bound to the lambdoid phage derived antiterminator protein, N. The mode of N-NusA interaction is unknown, knowledge of which is essential to understand the anti-termination process. It was reported earlier that in the absence of the transcription elongation complex (EC), N interacts with the C-terminal AR1 domain of NusA. However, the functional significance of this interaction is obscure. Here we identified mutations in NusA N terminus (NTD) specifically defective for N-mediated antitermination. These are located at a convex surface of the NusA-NTD, situated opposite its concave RNA polymerase(RNAP) binding surface. These NusA mutants disrupt the N-nut site interactions on the nascent RNA emerging out of a stalled EC. In the N/NusA-modified EC, a Cys-53 (S53C) from the convex surface of the NusA-NTD forms a specific disulfide(S-S) bridge with a Cys-39 (S39C) of the NusA binding region of the N protein. We conclude that when bound to the EC, the N interaction surface of NusA shifts from the AR1 domain to its NTD domain. This occurred due to a massive away-movement of the adjacent AR2 domain of NusA upon binding to the EC. We propose that the close proximity of this altered N-interaction site of NusA to its RNAP binding surface, enables N to influence the NusA-RNAP interaction during transcription antitermination that in turn facilitates the conversion of NusA into an antiterminator.	[Mishra, Saurabh; Mohan, Shalini; Godavarthi, Sapna; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Sen, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Tuljaguda Complex,4-1-714 Mozamjahi Rd, Hyderabad 500001, Andhra Pradesh, India.	rsen@cdfd.org.in	Sen, Ranjan/AAP-7075-2021		Department of Science and Technology, Government of India; Centre for DNA Fingerprinting and Diagnostics	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Centre for DNA Fingerprinting and Diagnostics	This work was supported by the Department of Science and Technology, Government of India and Centre for DNA Fingerprinting and Diagnostics intramural funding.	Banerjee S, 2006, J MICROBIOL, V44, P11; Berdygulova Z, 2012, NUCLEIC ACIDS RES, V40, P4052, DOI 10.1093/nar/gkr1285; Beuth B, 2005, EMBO J, V24, P3576, DOI 10.1038/sj.emboj.7600829; Bonin I, 2004, P NATL ACAD SCI USA, V101, P13762, DOI 10.1073/pnas.0405883101; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; CHATTOPADHYAY S, 1995, P NATL ACAD SCI USA, V92, P4061, DOI 10.1073/pnas.92.9.4061; Cheeran A, 2005, J MOL BIOL, V352, P28, DOI 10.1016/j.jmb.2005.06.052; Cheeran A, 2007, J BIOL CHEM, V282, P30997, DOI 10.1074/jbc.M704864200; FARNHAM PJ, 1982, CELL, V29, P945, DOI 10.1016/0092-8674(82)90457-3; FRIEDMAN DI, 1974, VIROLOGY, V58, P141, DOI 10.1016/0042-6822(74)90149-4; Gusarov I, 2001, CELL, V107, P437, DOI 10.1016/S0092-8674(01)00582-7; Ha KS, 2010, J MOL BIOL, V401, P708, DOI 10.1016/j.jmb.2010.06.036; LAU LF, 1983, J BIOL CHEM, V258, P9391; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; Mah TF, 1999, MOL MICROBIOL, V34, P523, DOI 10.1046/j.1365-2958.1999.01618.x; Mah TF, 2000, GENE DEV, V14, P2664, DOI 10.1101/gad.822900; Mogridge J, 1998, MOL CELL, V1, P265, DOI 10.1016/S1097-2765(00)80027-1; Muteeb G, 2012, NUCLEIC ACIDS RES, V40, P11213, DOI 10.1093/nar/gks872; Muteeb G, 2010, METHODS MOL BIOL, V634, P411, DOI 10.1007/978-1-60761-652-8_29; Neely MN, 1998, MOL MICROBIOL, V28, P1255, DOI 10.1046/j.1365-2958.1998.00890.x; Neely MN, 2000, MOL MICROBIOL, V38, P1074, DOI 10.1046/j.1365-2958.2000.02217.x; NODWELL JR, 1993, CELL, V72, P261, DOI 10.1016/0092-8674(93)90665-D; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Prasch S, 2006, BIOCHEMISTRY-US, V45, P4542, DOI 10.1021/bi0523411; Santangelo TJ, 2011, NAT REV MICROBIOL, V9, P319, DOI 10.1038/nrmicro2560; SCHMIDT MC, 1987, J MOL BIOL, V195, P809, DOI 10.1016/0022-2836(87)90486-4; Schweimer K, 2011, STRUCTURE, V19, P945, DOI 10.1016/j.str.2011.03.024; Sen R, 2002, MOL MICROBIOL, V46, P215, DOI 10.1046/j.1365-2958.2002.03154.x; Sen R., 2008, NUS FACTORS ESCHERIC; Shankar S, 2007, MOL CELL, V27, P914, DOI 10.1016/j.molcel.2007.07.025; SIGMUND CD, 1988, BIOCHEMISTRY-US, V27, P5622, DOI 10.1021/bi00415a034; VanGilst MR, 1997, J MOL BIOL, V274, P160, DOI 10.1006/jmbi.1997.1389; Weisberg RA, 1999, J BACTERIOL, V181, P359, DOI 10.1128/JB.181.2.359-367.1999; Yang X, 2009, EMBO REP, V10, P997, DOI 10.1038/embor.2009.155; ZHENG CH, 1994, P NATL ACAD SCI USA, V91, P7543, DOI 10.1073/pnas.91.16.7543; Zhou Y, 2002, J MOL BIOL, V318, P1175, DOI 10.1016/S0022-2836(02)00238-3; Zhou Y, 2001, J MOL BIOL, V310, P33, DOI 10.1006/jmbi.2001.4722	38	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28089	28103		10.1074/jbc.M113.472209	http://dx.doi.org/10.1074/jbc.M113.472209			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23913688	Green Published, hybrid			2022-12-25	WOS:000330612800034
J	Kemp, LE; Rusch, M; Adibekian, A; Bullen, HE; Graindorge, A; Freymond, C; Rottmann, M; Braun-Breton, C; Baumeister, S; Porfetye, AT; Vetter, IR; Hedberg, C; Soldati-Favre, D				Kemp, Louise E.; Rusch, Marion; Adibekian, Alexander; Bullen, Hayley E.; Graindorge, Arnault; Freymond, Celine; Rottmann, Matthias; Braun-Breton, Catherine; Baumeister, Stefan; Porfetye, Arthur T.; Vetter, Ingrid R.; Hedberg, Christian; Soldati-Favre, Dominique			Characterization of a Serine Hydrolase Targeted by Acyl-protein Thioesterase Inhibitors in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; SARCOCYSTIS-MURIS APICOMPLEXA; SMALL-MOLECULE INHIBITION; DENSE-GRANULE ANTIGEN; HOST-CELL INVASION; MAXIMUM-LIKELIHOOD; H-RAS; MALARIA PARASITES; PLASMODIUM; DEPALMITOYLATION	In eukaryotic organisms, cysteine palmitoylation is an important reversible modification that impacts protein targeting, folding, stability, and interactions with partners. Evidence suggests that protein palmitoylation contributes to key biological processes in Apicomplexa with the recent palmitome of the malaria parasite Plasmodium falciparum reporting over 400 substrates that are modified with palmitate by a broad range of protein S-acyl transferases. Dynamic palmitoylation cycles require the action of an acyl-protein thioesterase (APT) that cleaves palmitate from substrates and conveys reversibility to this posttranslational modification. In this work, we identified candidates for APT activity in Toxoplasma gondii. Treatment of parasites with low micromolar concentrations of beta-lactone- or triazole urea-based inhibitors that target human APT1 showed varied detrimental effects at multiple steps of the parasite lytic cycle. The use of an activity-based probe in combination with these inhibitors revealed the existence of several serine hydrolases that are targeted by APT1 inhibitors. The active serine hydrolase, TgASH1, identified as the homologue closest to human APT1 and APT2, was characterized further. Biochemical analysis of TgASH1 indicated that this enzyme cleaves substrates with a specificity similar to APTs, and homology modeling points toward an APT-like enzyme. TgASH1 is dispensable for parasite survival, which indicates that the severe effects observed with the beta-lactone inhibitors are caused by the inhibition of non-TgASH1 targets. Other ASH candidates for APT activity were functionally characterized, and one of them was found to be resistant to gene disruption due to the potential essential nature of the protein.	[Kemp, Louise E.; Bullen, Hayley E.; Graindorge, Arnault; Soldati-Favre, Dominique] Univ Geneva, Dept Microbiol & Mol Med, CMU, CH-1211 Geneva 4, Switzerland; [Rusch, Marion; Hedberg, Christian] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44227 Dortmund, Germany; [Baumeister, Stefan; Porfetye, Arthur T.; Vetter, Ingrid R.] Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, D-44227 Dortmund, Germany; [Adibekian, Alexander] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Freymond, Celine; Rottmann, Matthias] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Freymond, Celine; Rottmann, Matthias] Univ Basel, CH-4003 Basel, Switzerland; [Braun-Breton, Catherine] Univ Montpellier 2, CNRS, UMR 5235, Montpellier, France	University of Geneva; Max Planck Society; Max Planck Society; University of Geneva; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Soldati-Favre, D (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, CMU, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	dominique.soldati-favre@unige.ch		Rottmann, Matthias/0000-0002-2207-7899; Soldati-Favre, Dominique/0000-0003-4156-2109; Bullen, Hayley/0000-0003-4923-3019; Graindorge, Arnault/0000-0002-6076-3646	FP7 [215281]; Swiss National Foundation [FN3100A0-116722]; Swiss National Centre for Competence in Research: Chemical Biology; Fonds der Chemischen Industrie	FP7; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss National Centre for Competence in Research: Chemical Biology; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	Supported by FP7-funded Marie Curie Initial Training Network Project 215281-InterMal Training and Swiss National Foundation Grant FN3100A0-116722.; Supported by the Swiss National Centre for Competence in Research: Chemical Biology and the Fonds der Chemischen Industrie.	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Cabrera A, 2012, TRAFFIC, V13, P1335, DOI 10.1111/j.1600-0854.2012.01394.x; CAMP LA, 1993, J BIOL CHEM, V268, P22566; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dekker FJ, 2011, BIOORGAN MED CHEM, V19, P1376, DOI 10.1016/j.bmc.2010.11.025; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Ding M, 2000, J CELL SCI, V113, P2409; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Frenal K, 2013, TRAFFIC, V14, P895, DOI 10.1111/tra.12081; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Freyer B, 1999, PARASITOL RES, V85, P923, DOI 10.1007/s004360050659; Freyer B, 1998, PARASITOL RES, V84, P583, DOI 10.1007/s004360050453; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta P, 2003, P NATL ACAD SCI USA, V100, P12325, DOI 10.1073/pnas.2033229100; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Hedberg C, 2011, ANGEW CHEM INT EDIT, V50, P9832, DOI 10.1002/anie.201102965; HUBER W, 1993, ACTA TROP, V55, P257, DOI 10.1016/0001-706X(93)90083-N; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jones ML, 2012, TRENDS PARASITOL, V28, P496, DOI 10.1016/j.pt.2012.08.009; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Mercker M, 2009, CURR GENET, V55, P151, DOI 10.1007/s00294-009-0232-3; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Resh M. D., 2006, SCI STKE, V2006, pre14; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Soyombo AA, 1997, J BIOL CHEM, V272, P27456, DOI 10.1074/jbc.272.43.27456; Sugimoto H, 1996, J BIOL CHEM, V271, P7705, DOI 10.1074/jbc.271.13.7705; Tardy C, 2009, BBA-MOL CELL RES, V1793, P1250, DOI 10.1016/j.bbamcr.2009.03.007; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329	66	18	18	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27002	27018		10.1074/jbc.M113.460709	http://dx.doi.org/10.1074/jbc.M113.460709			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23913689	hybrid, Green Published			2022-12-25	WOS:000330597300003
J	Cruz-Gallardo, I; Aroca, A; Persson, C; Karlsson, BG; Diaz-Moreno, I				Cruz-Gallardo, Isabel; Aroca, Angeles; Persson, Cecilia; Karlsson, B. Goran; Diaz-Moreno, Irene			RNA Binding of T-cell Intracellular Antigen-1 (TIA-1) C-terminal RNA Recognition Motif Is Modified by pH Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN STRESS GRANULES; MESSENGER-RNAS; PROTEIN COMPLEX; DOMAIN; NMR; PHOSPHORYLATION; IDENTIFICATION; HEMAGGLUTININ; RECRUITMENT; REGULATOR	T-cell intracellular antigen-1 (TIA-1) is a DNA/RNA-binding protein that regulates critical events in cell physiology by the regulation of pre-mRNA splicing and mRNA translation. TIA-1 is composed of three RNA recognition motifs (RRMs) and a glutamine-rich domain and binds to uridine-rich RNA sequences through its C-terminal RRM2 and RRM3 domains. Here, we show that RNA binding mediated by either isolated RRM3 or the RRM23 construct is controlled by slight environmental pH changes due to the protonation/deprotonation of TIA-1 RRM3 histidine residues. The auxiliary role of the C-terminal RRM3 domain in TIA-1 RNA recognition is poorly understood, and this work provides insight into its binding mechanisms.	[Cruz-Gallardo, Isabel; Aroca, Angeles; Diaz-Moreno, Irene] Univ Seville, Consejo Super Invest Cient CSIC, Inst Bioquim Vegetal & Fotosintesis IBVF, Ctr Invest Cient Isla Cartuja CicCartuja, Seville 41092, Spain; [Persson, Cecilia; Karlsson, B. Goran] Univ Gothenburg, Swedish NMR Ctr, SE-40530 Gothenburg, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-JA-USE - Centro de Investigaciones Cientificas Isla de La Cartuja (CICIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); University of Gothenburg	Diaz-Moreno, I (corresponding author), Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis IBVF, CicCartuja, Avda Amer Vespucio 49, Seville 41092, Spain.	idiazmoreno@us.es	Díaz-Moreno, Irene/E-7181-2010; Aguilar, Angeles Aroca/G-1162-2014; Cruz-Gallardo, Isabel/J-7042-2014; Karlsson, Göran/E-8686-2011	Díaz-Moreno, Irene/0000-0002-5318-7644; Aguilar, Angeles Aroca/0000-0003-4915-170X; Cruz-Gallardo, Isabel/0000-0002-5936-2749; Karlsson, Goran/0000-0002-1821-4715	Andalusian Government [P07-CVI-02896, P11-CVI-7216, BIO198]; European Community [261863]; Federation of the Societies of Biochemistry and Molecular Biology (FEBS)	Andalusian Government; European Community(European Commission); Federation of the Societies of Biochemistry and Molecular Biology (FEBS)	This work was supported in part by Andalusian Government Grants P07-CVI-02896, P11-CVI-7216, and BIO198. Access to the Bio-NMR research infrastructure is co-funded under the 7th Framework Programme of European Community (FP7/2007-2013) Grant agreement 261863.; Supported by a short-term fellowship from the Federation of the Societies of Biochemistry and Molecular Biology (FEBS).	Anderson P, 2002, J CELL SCI, V115, P3227; Aroca A, 2011, FEBS LETT, V585, P2958, DOI 10.1016/j.febslet.2011.07.037; AVNI D, 1994, MOL CELL BIOL, V14, P3822, DOI 10.1128/MCB.14.6.3822; Bauer WJ, 2012, J MOL BIOL, V415, P727, DOI 10.1016/j.jmb.2011.11.040; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Diaz-Moreno I, 2010, NUCLEIC ACIDS RES, V38, P5193, DOI 10.1093/nar/gkq216; DOMS RW, 1985, J BIOL CHEM, V260, P2973; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Goddard T. D., 2006, SPARKY 3; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kruse C, 1996, BIOCHEM J, V320, P247, DOI 10.1042/bj3200247; Kruse C, 2000, BIOCHEM J, V346, P107, DOI 10.1042/0264-6021:3460107; Kumar AO, 2008, BIOCHEM BIOPH RES CO, V367, P813, DOI 10.1016/j.bbrc.2008.01.027; Kuwasako K, 2008, BIOCHEMISTRY-US, V47, P6437, DOI 10.1021/bi7024723; Lorieau JL, 2012, P NATL ACAD SCI USA, V109, P19994, DOI 10.1073/pnas.1213801109; Mikles DC, 2013, FEBS J, V280, P3669, DOI 10.1111/febs.12360; Netter C, 2009, RNA, V15, P1305, DOI 10.1261/rna.1359909; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Santiveri CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024481; Scheiba RM, 2012, EUR BIOPHYS J BIOPHY, V41, P597, DOI 10.1007/s00249-012-0827-3; Seksek O, 1996, J CELL SCI, V109, P257; Suswam EA, 2005, NUCLEIC ACIDS RES, V33, P4507, DOI 10.1093/nar/gki763; Vollbrandt T, 2004, INT J BIOCHEM CELL B, V36, P1306, DOI 10.1016/j.biocel.2003.11.006; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669	39	15	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					25986	25994		10.1074/jbc.M113.489070	http://dx.doi.org/10.1074/jbc.M113.489070			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23902765	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000330623300029
J	Blaustein, M; Perez-Munizaga, D; Sanchez, MA; Urrutia, C; Grande, A; Risso, G; Srebrow, A; Alfaro, J; Colman-Lerner, A				Blaustein, Matias; Perez-Munizaga, Daniela; Alejandro Sanchez, Manuel; Urrutia, Carolina; Grande, Alicia; Risso, Guillermo; Srebrow, Anabella; Alfaro, Jennifer; Colman-Lerner, Alejandro			Modulation of the Akt Pathway Reveals a Novel Link with PERK/eIF2 alpha, which Is Relevant during Hypoxia	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HUMAN-MELANOMA CELLS; KINASE-B; UP-REGULATION; PHOSPHORYLATION; ACTIVATION; INHIBITION; PERK; CANCER	The unfolded protein response (UPR) and the Akt signaling pathway share several regulatory functions and have the capacity to determine cell outcome under specific conditions. However, both pathways have largely been studied independently. Here, we asked whether the Akt pathway regulates the UPR. To this end, we used a series of chemical compounds that modulate PI3K/Akt pathway and monitored the activity of the three UPR branches: PERK, IRE1 and ATF6. The antiproliferative and antiviral drug Akt-IV strongly and persistently activated all three branches of the UPR. We present evidence that activation of PERK/eIF2 alpha requires Akt and that PERK is a direct Akt target. Chemical activation of this novel Akt/PERK pathway by Akt-IV leads to cell death, which was largely dependent on the presence of PERK and IRE1. Finally, we show that hypoxia-induced activation of eIF2 alpha requires Akt, providing a physiologically relevant condition for the interaction between Akt and the PERK branch of the UPR. These data suggest the UPR and the Akt pathway signal to one another as a means of controlling cell fate.	[Blaustein, Matias; Alejandro Sanchez, Manuel; Grande, Alicia; Risso, Guillermo; Srebrow, Anabella; Colman-Lerner, Alejandro] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fis Biol Mol & Neurociencias, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Blaustein, Matias; Alejandro Sanchez, Manuel; Grande, Alicia; Risso, Guillermo; Srebrow, Anabella; Colman-Lerner, Alejandro] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis Biol Mol & Celular, Buenos Aires, DF, Argentina; [Perez-Munizaga, Daniela; Urrutia, Carolina; Alfaro, Jennifer] Fdn Ciencia & Vida, Santiago, Chile; [Perez-Munizaga, Daniela] Univ Andres Bello, Fac Ciencias Biol, Santiago, Chile	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Universidad Andres Bello	Colman-Lerner, A (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fis Biol Mol & Neurociencias, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	colman-lerner@fbmc.fcen.uba.ar	Blaustein, Matías/ABF-7951-2020; Colman-Lerner, Alejandro/ABC-3808-2020	Blaustein, Matías/0000-0001-6309-6888; Colman-Lerner, Alejandro/0000-0002-2557-8883	CONICET; FONDECYT [1080449]; Conicyt [Programa-PFB-16]; Argentine Agency of Research and Technology (ANPCYT) [PICT2007-847, PICT2010-2248]; National Institute of General Medical Sciences, National Institutes of Health [1R01GM097479-01, 0000713502]; University of Buenos Aires [UBACYT 20020100300003]; ANPCYT [PICT2011-0065]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097479] Funding Source: NIH RePORTER	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Argentine Agency of Research and Technology (ANPCYT)(ANPCyT); National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Buenos Aires(University of Buenos Aires); ANPCYT(ANPCyT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank CONICET (http://www.conicet.gov.ar/) for providing fellowships to MB, AG and GR and CIN to MAS. This work was supported by grants FONDECYT 1080449 and Conicyt Programa-PFB-16 to SB; grants PICT2007-847 (http://www.conicyt.cl/), and PICT2010-2248 from the Argentine Agency of Research and Technology (ANPCYT, http://www.agencia.mincyt.gob.ar/), and grant 1R01GM097479-01, subaward 0000713502 from the National Institute of General Medical Sciences, National Institutes of Health (http://www.nih.gov/) to ACL; and grants UBACYT 20020100300003 from the University of Buenos Aires (http://www.uba.ar/) and PICT2011-0065 from ANPCYT to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Berndt N, 2010, CELL DEATH DIFFER, V17, P1795, DOI 10.1038/cdd.2010.63; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Blaustein M, 2009, J CELL BIOCHEM, V107, P826, DOI 10.1002/jcb.22181; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Buchkovich NJ, 2008, J VIROL, V82, P31, DOI 10.1128/JVI.01881-07; Conus NM, 2002, J BIOL CHEM, V277, P38021, DOI 10.1074/jbc.M203387200; Deldicque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020993; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dunn EF, 2009, J VIROL, V83, P11665, DOI 10.1128/JVI.01092-09; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Gaitonde S, 2009, PIGM CELL MELANOMA R, V22, P187, DOI 10.1111/j.1755-148X.2009.00544.x; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Hu MC, 2007, BIOCHEM BIOPH RES CO, V359, P778, DOI 10.1016/j.bbrc.2007.05.183; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ishigaki S, 2010, CELL DEATH DIFFER, V17, P774, DOI 10.1038/cdd.2009.175; Jiang CC, 2009, NEOPLASIA, V11, P436, DOI 10.1593/neo.09208; Jo H, 2011, P NATL ACAD SCI USA, V108, P6486, DOI 10.1073/pnas.1019062108; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Karyala P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014408; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kim SY, 2012, BIOCHEM BIOPH RES CO, V419, P466, DOI 10.1016/j.bbrc.2012.02.015; Koomoa DLT, 2008, CANCER RES, V68, P9825, DOI 10.1158/0008-5472.CAN-08-1865; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; LEMASTERS JJ, 1987, NATURE, V325, P78, DOI 10.1038/325078a0; Liao Y, 2010, AM J TRANSL RES, V2, P19; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Liu XS, 2006, J BIOL CHEM, V281, P31380, DOI 10.1074/jbc.M606603200; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Mahajan K, 2012, J BIOL CHEM; Mahajan K, 2012, J CELL PHYSL; Mahajan K, 2012, AM J PATHOL, V180, P1386, DOI 10.1016/j.ajpath.2011.12.028; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Mak BC, 2008, J BIOL CHEM, V283, P23462, DOI 10.1074/jbc.M803194200; Mao WK, 2006, AM J PHYSIOL-CELL PH, V290, pC1373, DOI 10.1152/ajpcell.00369.2005; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Matheny RW, 2009, EXP BIOL MED, V234, P1264, DOI 10.3181/0904-MR-138; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Mounir Z, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001630; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Okuzumi T, 2010, MOL BIOSYST, V6, P1389, DOI 10.1039/c003917a; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Pyrko P, 2007, MOL CANCER THER, V6, P1262, DOI 10.1158/1535-7163.MCT-06-0629; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shaw J, 2006, CIRC RES, V98, P7, DOI 10.1161/01.RES.0000200397.22663.b6; So A, 2009, CANCER METAST REV, V28, P219, DOI 10.1007/s10555-008-9180-5; Sun Q, 2011, J MED CHEM, V54, P1126, DOI 10.1021/jm100912b; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Trujillo-Alonso V, 2011, J VIROL, V85, P12594, DOI 10.1128/JVI.05620-11; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wei JQ, 2011, J BIOL CHEM, V286, P13995, DOI 10.1074/jbc.M110.211334; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yacoub A, 2006, MOL PHARMACOL, V70, P589, DOI 10.1124/mol.106.025007; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063	86	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69668	10.1371/journal.pone.0069668	http://dx.doi.org/10.1371/journal.pone.0069668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922774	gold, Green Published, Green Submitted			2022-12-25	WOS:000323369700064
J	Zhong, RQ; McCarthy, RL; Haghighat, M; Ye, ZH				Zhong, Ruiqin; McCarthy, Ryan L.; Haghighat, Marziyeh; Ye, Zheng-Hua			The Poplar MYB Master Switches Bind to the SMRE Site and Activate the Secondary Wall Biosynthetic Program during Wood Formation	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; POPULUS-TRICHOCARPA; LIGNIN BIOSYNTHESIS; GLOBAL ANALYSIS; DIRECT TARGET; ARABIDOPSIS; NAC; DOMAIN; GENES; IDENTIFICATION	Wood is mainly composed of secondary walls, which constitute the most abundant stored carbon produced by vascular plants. Understanding the molecular mechanisms controlling secondary wall deposition during wood formation is not only an important issue in plant biology but also critical for providing molecular tools to custom-design wood composition suited for diverse end uses. Past molecular and genetic studies have revealed a transcriptional network encompassing a group of wood-associated NAC and MYB transcription factors that are involved in the regulation of the secondary wall biosynthetic program during wood formation in poplar trees. Here, we report the functional characterization of poplar orthologs of MYB46 and MYB83 that are known to be master switches of secondary wall biosynthesis in Arabidopsis. In addition to the two previously-described PtrMYB3 and PtrMYB20, two other MYBs, PtrMYB2 and PtrMYB21, were shown to be MYB46/MYB83 orthologs by complementation and overexpression studies in Arabidopsis. The functional roles of these PtrMYBs in regulating secondary wall biosynthesis were further demonstrated in transgenic poplar plants showing an ectopic deposition of secondary walls in PtrMYB overexpressors and a reduction of secondary wall thickening in their dominant repressors. Furthermore, PtrMYB2/3/20/21 together with two other tree MYBs, the Eucalyptus EgMYB2 and the pine PtMYB4, were shown to differentially bind to and activate the eight variants of the 7-bp SMRE consensus sequence, composed of ACC(A/T)A(A/C)(T/C). Together, our results indicate that the tree MYBs, PtrMYB2/3/20/21, EgMYB2 and PtMYB4, are master transcriptional switches that activate the SMRE sites in the promoters of target genes and thereby regulate secondary wall biosynthesis during wood formation.	[Zhong, Ruiqin; McCarthy, Ryan L.; Haghighat, Marziyeh; Ye, Zheng-Hua] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Ye, ZH (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	zhye@plantbio.uga.edu			US Department of Agriculture National Institute of Food and Agriculture [AFRI Plant Biology program] [2010-65116-20468]; National Science Foundation [ISO-1051900]	US Department of Agriculture National Institute of Food and Agriculture [AFRI Plant Biology program]; National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the US Department of Agriculture National Institute of Food and Agriculture [AFRI Plant Biology program (#2010-65116-20468)] and the National Science Foundation (ISO-1051900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; Bomal C, 2008, J EXP BOT, V59, P3925, DOI 10.1093/jxb/ern234; Burk DH, 2006, J INTEGR PLANT BIOL, V48, P85, DOI 10.1111/j.1744-7909.2006.00202.x; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Du JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017458; Du J, 2009, PLANT J, V60, P1000, DOI 10.1111/j.1365-313X.2009.04017.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Gampala SSL, 2001, J BIOL CHEM, V276, P9855, DOI 10.1074/jbc.M009168200; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Handakumbura PP, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00074; Hiratsu K, 2004, BIOCHEM BIOPH RES CO, V321, P172, DOI 10.1016/j.bbrc.2004.06.115; HUGHES J, 1975, STAIN TECHNOL, V50, P319, DOI 10.3109/10520297509117082; Kim WC, 2012, PLANT MOL BIOL, V78, P489, DOI 10.1007/s11103-012-9880-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Legay S, 2007, PLANT SCI, V173, P542, DOI 10.1016/j.plantsci.2007.08.007; LEPLE JC, 1992, PLANT CELL REP, V11, P137, DOI 10.1007/BF00232166; McCarthy RL, 2010, PLANT CELL PHYSIOL, V51, P1084, DOI 10.1093/pcp/pcq064; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patzlaff A, 2003, PLANT J, V36, P743, DOI 10.1046/j.1365-313X.2003.01916.x; Pavy N, 2008, NEW PHYTOL, V180, P766, DOI 10.1111/j.1469-8137.2008.02615.x; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Prassinos C, 2005, PLANT CELL PHYSIOL, V46, P1213, DOI 10.1093/pcp/pci130; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Rigault P, 2011, PLANT PHYSIOL, V157, P14, DOI 10.1104/pp.111.179663; Robischon M, 2011, PLANT PHYSIOL, V155, P1214, DOI 10.1104/pp.110.167007; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Sonbol FM, 2009, PLANT MOL BIOL, V70, P283, DOI 10.1007/s11103-009-9473-2; Valdivia ER, 2013, J EXP BOT, V64, P1333, DOI 10.1093/jxb/ers394; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Zhao QA, 2010, PLANT J, V63, P100, DOI 10.1111/j.1365-313X.2010.04223.x; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007; Zhong RQ, 2010, PLANT SIGNAL BEHAV, V5, P469, DOI 10.4161/psb.5.4.11400; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhong RQ, 2010, PLANT PHYSIOL, V152, P1044, DOI 10.1104/pp.109.148270; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	50	88	97	7	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69219	10.1371/journal.pone.0069219	http://dx.doi.org/10.1371/journal.pone.0069219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922694	gold, Green Submitted, Green Published			2022-12-25	WOS:000323369700024
J	Zuliani, T; Saiagh, S; Knol, AC; Esbelin, J; Dreno, B				Zuliani, Thomas; Saiagh, Soraya; Knol, Anne-Chantal; Esbelin, Julie; Dreno, Brigitte			Fetal Fibroblasts and Keratinocytes with Immunosuppressive Properties for Allogeneic Cell-Based Wound Therapy	PLOS ONE			English	Article							T-CELL; INDOLEAMINE 2,3-DIOXYGENASE; GROWTH-FACTOR; TRYPTOPHAN CATABOLISM; SKIN SUBSTITUTES; SCAR FORMATION; TISSUE-REPAIR; PROLIFERATION; EXPRESSION; INHIBITION	Fetal skin heals rapidly without scar formation early in gestation, conferring to fetal skin cells a high and unique potential for tissue regeneration and scar management. In this study, we investigated the possibility of using fetal fibroblasts and keratinocytes to stimulate wound repair and regeneration for further allogeneic cell-based therapy development. From a single fetal skin sample, two clinical batches of keratinocytes and fibroblasts were manufactured and characterized. Tolerogenic properties of the fetal cells were investigated by allogeneic PBMC proliferation tests. In addition, the potential advantage of fibroblasts/keratinocytes co-application for wound healing stimulation has been examined in co-culture experiments with in vitro scratch assays and a multiplex cytokines array system. Based on keratin 14 and prolyl-4-hydroxylase expression analyses, purity of both clinical batches was found to be above 98% and neither melanocytes nor Langerhans cells could be detected. Both cell types demonstrated strong immunosuppressive properties as shown by the dramatic decrease in allogeneic PBMC proliferation when co-cultured with fibroblasts and/or keratinocytes. We further showed that the indoleamine 2,3 dioxygenase (IDO) activity is required for the immunoregulatory activity of fetal skin cells. Co-cultures experiments have also revealed that fibroblasts-keratinocytes interactions strongly enhanced fetal cells secretion of HGF, GM-CSF, IL-8 and to a lesser extent VEGF-A. Accordingly, in the in vitro scratch assays the fetal fibroblasts and keratinocytes co-culture accelerated the scratch closure compared to fibroblast or keratinocyte mono-cultures. In conclusion, our data suggest that the combination of fetal keratinocytes and fibroblasts could be of particular interest for the development of a new allogeneic skin substitute with immunomodulatory activity, acting as a reservoir for wound healing growth factors.	[Zuliani, Thomas; Saiagh, Soraya; Dreno, Brigitte] Hotel Dieu Univ Hosp, CIC Biotherapy INSERM 0503, Cell & Gene Therapy Unit, Nantes, France; [Knol, Anne-Chantal; Dreno, Brigitte] Hotel Dieu Univ Hosp, Lab Immunodermatol, INSERM CNRS6299 U892, CRCNA, Nantes, France; [Esbelin, Julie] HME Hosp, Dept Gynecol & Obstet, Nantes, France; [Dreno, Brigitte] Hotel Dieu Univ Hosp, CIC Biotherapy INSERM 0503, Unit Dermatocancerol, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Dreno, B (corresponding author), Hotel Dieu Univ Hosp, CIC Biotherapy INSERM 0503, Cell & Gene Therapy Unit, Nantes, France.	brigitte.dreno@wanadoo.fr	KNOL, Anne Chantal C/K-7974-2015	KNOL, Anne Chantal C/0000-0003-4011-5008	Association Francaise contre les Myopathies (AFM); Societe francaise de dermatologie; Fondation Coloplast	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Societe francaise de dermatologie; Fondation Coloplast	This work was supported by the "Association Francaise contre les Myopathies (AFM)", the "Societe francaise de dermatologie" and the "Fondation Coloplast". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Beidler SK, 2009, J VASC SURG, V49, P1013, DOI 10.1016/j.jvs.2008.11.049; Breuhahn A, 2000, CELL GROWTH DIFFER, V11, P111; Chavez-Munoz C, 2012, J INVEST DERMATOL, V132, P1501, DOI 10.1038/jid.2011.467; Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715; Delehedde M, 2002, J BIOL CHEM, V277, P12456, DOI 10.1074/jbc.M111345200; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293; FOGLIA RP, 1986, ANN SURG, V204, P402, DOI 10.1097/00000658-198610000-00008; Forouzandeh F, 2010, WOUND REPAIR REGEN, V18, P614, DOI 10.1111/j.1524-475X.2010.00635.x; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Funeshima-Fuji N, 2008, TRANSPL IMMUNOL, V18, P302, DOI 10.1016/j.trim.2007.10.009; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hainz U, 2007, TRANSPL INT, V20, P118, DOI 10.1111/j.1432-2277.2006.00370.x; He CS, 2004, AM J TRANSPLANT, V4, P698, DOI 10.1111/j.1600-6143.2004.00416.x; Hohlfeld J, 2005, LANCET, V366, P840, DOI 10.1016/S0140-6736(05)67107-3; Johnen C, 2012, BURNS; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781; LONGAKER MT, 1994, ANN SURG, V219, P65, DOI 10.1097/00000658-199401000-00011; LORENZ HP, 1992, DEVELOPMENT, V114, P253; MaasSzabowski N, 1996, J INVEST DERMATOL, V107, P849, DOI 10.1111/1523-1747.ep12331158; MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664; Mansbridge JN, 2009, CURR OPIN BIOTECH, V20, P563, DOI 10.1016/j.copbio.2009.08.008; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; MICHEL G, 1992, FEBS LETT, V305, P241, DOI 10.1016/0014-5793(92)80677-9; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; POSTLETHWAITE AE, 1988, J CELL BIOL, V106, P311, DOI 10.1083/jcb.106.2.311; Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318; Ramelet AA, 2009, EXP GERONTOL, V44, P208, DOI 10.1016/j.exger.2008.11.004; ROWLATT U, 1979, VIRCHOWS ARCH A, V381, P353, DOI 10.1007/BF00432477; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; Shakespeare PG, 2005, CLIN DERMATOL, V23, P413, DOI 10.1016/j.clindermatol.2004.07.015; Shen HT, 2012, WOUND REPAIR REGEN, V20, P580, DOI 10.1111/j.1524-475X.2012.00812.x; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; Spiekstra SW, 2007, WOUND REPAIR REGEN, V15, P708, DOI 10.1111/j.1524-475X.2007.00280.x; Still J, 2003, BURNS, V29, P837, DOI 10.1016/S0305-4179(03)00164-5; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Szpaderska AM, 2003, J INVEST DERMATOL, V120, P1130, DOI 10.1046/j.1523-1747.2003.12253.x; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; TUSCHIL A, 1992, J INVEST DERMATOL, V99, P294, DOI 10.1111/1523-1747.ep12616634; WAELTI ER, 1992, J INVEST DERMATOL, V98, P805, DOI 10.1111/1523-1747.ep12499961; Wang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040951; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Yang GP, 2003, WOUND REPAIR REGEN, V11, P411, DOI 10.1046/j.1524-475X.2003.11604.x	51	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70408	10.1371/journal.pone.0070408	http://dx.doi.org/10.1371/journal.pone.0070408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894651	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900125
J	Kouguchi, H; Matsumoto, J; Nakao, R; Yamano, K; Oku, Y; Yagi, K				Kouguchi, Hirokazu; Matsumoto, Jun; Nakao, Ryo; Yamano, Kimiaki; Oku, Yuzaburo; Yagi, Kinpei			Characterization of a Surface Glycoprotein from Echinococcus multilocularis and Its Mucosal Vaccine Potential in Dogs	PLOS ONE			English	Article							NIPPOSTRONGYLUS-BRASILIENSIS; INTESTINAL HELMINTHS; HYDATID-DISEASE; GRANULOSUS; ANTIGENS; IMMUNIZATION; RESPONSES; MUCIN; FOXES	Alveolar echinococcosis is a refractory disease caused by the metacestode stage of Echinococcus multilocularis. The life cycle of this parasite is maintained primarily between foxes and many species of rodents; thus, dogs are thought to be a minor definitive host except in some endemic areas. However, dogs are highly susceptible to E. multilocularis infection. Because of the close contact between dogs and humans, infection of dogs with this parasite can be an important risk to human health. Therefore, new measures and tools to control and prevent parasite transmission required. Using 2-dimensional electrophoresis followed by western blot (2D-WB) analysis, a large glycoprotein component of protoscoleces was identified based on reactivity to intestinal IgA in dogs experimentally infected with E. multilocularis. This component, designated SRf1, was purified by gel filtration using a Superose 6 column. Glycosylation analysis and immunostaining revealed that SRf1 could be distinguished from Em2, a major mucin-type antigen of E. multilocularis. Dogs (n = 6) were immunized intranasally with 500 mg of SRf1 with cholera toxin subunit B by using a spray syringe, and a booster was given orally using an enteric capsule containing 15 mg of the same antigen. As a result, dogs immunized with this antigen showed an 87.6% reduction in worm numbers compared to control dogs (n = 5) who received only PBS administration. A weak serum antibody response was observed in SRf1-immunized dogs, but there was no correlation between antibody response and worm number. We demonstrated for the first time that mucosal immunization using SRf1, a glycoprotein component newly isolated from E. multilocularis protoscoleces, induced a protection response to E. multilocularis infection in dogs. Thus, our data indicated that mucosal immunization using surface antigens will be an important tool to facilitate the development of practical vaccines for definitive hosts.	[Kouguchi, Hirokazu; Yamano, Kimiaki; Yagi, Kinpei] Hokkaido Inst Publ Hlth, Dept Infect Dis, Sapporo, Hokkaido 0600819, Japan; [Matsumoto, Jun] Nihon Univ, Lab Med Zool, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Nakao, Ryo] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Oku, Yuzaburo] Tottori Univ, Fac Agr, Sch Vet Med, Dept Parasitol, Tottori 680, Japan	Nihon University; Hokkaido University; Tottori University	Yagi, K (corresponding author), Hokkaido Inst Publ Hlth, Dept Infect Dis, Kita 19 Jo Nishi 12 Chome, Sapporo, Hokkaido 0600819, Japan.	kinpei@iph.pref.hokkaido.jp		Matsumoto, Jun/0000-0003-0690-7474	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [23790404, 24790407, 23580433]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Young Scientists (B) #23790404, #24790407 and Grant-in-Aid for Scientific Research (C) #23580433 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budke CM, 2005, INT J PARASITOL, V35, P163, DOI 10.1016/j.ijpara.2004.10.026; Budke CM, 2005, VET PARASITOL, V127, P43, DOI 10.1016/j.vetpar.2004.08.024; Carol H, 1998, VET IMMUNOL IMMUNOP, V65, P29, DOI 10.1016/S0165-2427(98)00171-8; FORSTNER JF, 1981, AM J PHYSIOL, V240, pG10, DOI 10.1152/ajpgi.1981.240.1.G10; Fu YC, 1999, MOL BIOCHEM PARASIT, V102, P43, DOI 10.1016/S0166-6851(99)00084-5; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; GEMMELL MA, 1986, PARASITOLOGY, V92, P599, DOI 10.1017/S0031182000065483; GEMMELL MA, 1962, IMMUNOLOGY, V5, P496; GOTTSTEIN B, 1990, PARASITE IMMUNOL, V12, P163, DOI 10.1111/j.1365-3024.1990.tb00945.x; Heath D, 2006, PARASITOL INT, V55, pS247, DOI 10.1016/j.parint.2005.11.052; Hegglin D, 2003, EMERG INFECT DIS, V9, P1266; HERD RP, 1975, INT J PARASITOL, V5, P395, DOI 10.1016/0020-7519(75)90004-1; Hulsmeier AJ, 2002, J BIOL CHEM, V277, P5742, DOI 10.1074/jbc.M107161200; ISHIKAWA N, 1994, IMMUNOLOGY, V81, P480; Ito A, 2003, PARASITOLOGY, V127, pS159, DOI 10.1017/S0031182003003718; Kato A, 2012, J MED CHEM, V55, P10347, DOI 10.1021/jm301304e; Kato N, 2005, PARASITOL RES, V95, P339, DOI 10.1007/s00436-005-1303-0; Kouguchi H, 2005, PROTEIN J, V24, P57, DOI 10.1007/s10930-004-0606-9; Kouguchi H, 2011, EXP PARASITOL, V128, P50, DOI 10.1016/j.exppara.2011.02.002; Kouguchi H, 2010, EXP PARASITOL, V124, P238, DOI 10.1016/j.exppara.2009.09.016; Kurata K, 2004, VET IMMUNOL IMMUNOP, V102, P441, DOI 10.1016/j.vetimm.2004.08.004; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; LENCER WI, 1990, AM J PHYSIOL, V258, pG96, DOI 10.1152/ajpgi.1990.258.1.G96; Lycke N, 2007, VACCINE ADJUVANTS DE, P53; Montagne L, 2000, J DAIRY SCI, V83, P507, DOI 10.3168/jds.S0022-0302(00)74910-1; Movsesijan M., 1970, Veterinarski Glasnik, V24, P189; NAWA Y, 1983, J PARASITOL, V69, P1168, DOI 10.2307/3280890; Petavy AF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000125; PIERCE NF, 1980, INFECT IMMUN, V27, P632, DOI 10.1128/IAI.27.2.632-637.1980; PIERCE NF, 1982, INFECT IMMUN, V37, P687, DOI 10.1128/IAI.37.2.687-694.1982; Romig T, 2007, HELMINTHOLOGIA, V44, P137, DOI 10.2478/s11687-007-0021-9; Tackmann K, 2001, EPIDEMIOL INFECT, V127, P577, DOI 10.1017/S0950268801006112; Tanabe H, 2007, BIOSCI BIOTECH BIOCH, V71, P575, DOI 10.1271/bbb.60448; Tanaka Rika, 1998, Japanese Journal of Veterinary Research, V46, P138; Torgerson PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000722; Torgerson PR, 2009, TRENDS PARASITOL, V25, P57, DOI 10.1016/j.pt.2008.10.003; Torgerson PR, 2003, RES VET SCI, V74, P191, DOI 10.1016/S0034-5288(03)00006-7; Tuji N, 2003, INFECT IMMUN, V71, P5314; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Zhang WB, 2003, MOL BIOCHEM PARASIT, V126, P25, DOI 10.1016/S0166-6851(02)00241-4; Zhang WB, 2008, TRENDS PARASITOL, V24, P419, DOI 10.1016/j.pt.2008.05.008; Zhang WB, 2006, J INFECT DIS, V194, P966, DOI 10.1086/506622	42	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69821	10.1371/journal.pone.0069821	http://dx.doi.org/10.1371/journal.pone.0069821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894545	Green Submitted, Green Published, gold			2022-12-25	WOS:000325211000158
J	Huy, NT; Shima, Y; Maeda, A; Men, TT; Hirayama, K; Hirase, A; Miyazawa, A; Kamei, K				Nguyen Tien Huy; Shima, Yusuke; Maeda, Atsushi; Tran Thanh Men; Hirayama, Kenji; Hirase, Ai; Miyazawa, Atsuo; Kamei, Kaeko			Phospholipid Membrane-Mediated Hemozoin Formation: The Effects of Physical Properties and Evidence of Membrane Surrounding Hemozoin	PLOS ONE			English	Article							BETA-HEMATIN FORMATION; PARASITE PLASMODIUM-FALCIPARUM; RED-BLOOD-CELLS; HEME CRYSTALLIZATION; ANTIMALARIAL-DRUGS; SCHISTOSOMA-MANSONI; COLORIMETRIC METHOD; DIGESTIVE VACUOLE; MALARIA PARASITES; LIPID-COMPOSITION	Phospholipid membranes are thought to be one of the main inducers of hemozoin formation in Plasmodia and other blood-feeding parasites. The "membrane surrounding hemozoin" has been observed in infected cells but has not been observed in in vitro experiments. This study focused on observing the association of phospholipid membranes and synthetic beta-hematin, which is chemically identical to hemozoin, and on a further exploration into the mechanism of phospholipid membrane-induced beta-hematin formation. Our results showed that beta-hematin formation was induced by phospholipids in the fluid phase but not in the gel phase. The ability of phospholipids to induce beta-hematin formation was inversely correlated with gel-to-liquid phase transition temperatures, suggesting an essential insertion of heme into the hydrocarbon chains of the phospholipid membrane to form beta-hematin. For this study, a cryogenic transmission electron microscope was used to achieve the first direct observation of the formation of a monolayer of phospholipid membrane surrounding beta-hematin.	[Nguyen Tien Huy; Shima, Yusuke; Maeda, Atsushi; Kamei, Kaeko] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto, Japan; [Nguyen Tien Huy] Nagasaki Univ, Dept Clin Prod Dev, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Nguyen Tien Huy; Hirayama, Kenji] Nagasaki Univ, Program Nurturing Global Leaders Trop & Emerging, Nagasaki 852, Japan; [Tran Thanh Men; Kamei, Kaeko] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto, Japan; [Hirayama, Kenji] Nagasaki Univ, Dept Immunogenet, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Hirase, Ai; Miyazawa, Atsuo] RIKEN SPring8 Ctr, Harima Inst, Biomultisome Res Team, Sayo, Japan	Kyoto Institute of Technology; Nagasaki University; Nagasaki University; Kyoto Institute of Technology; Nagasaki University; RIKEN	Kamei, K (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto, Japan.	kame@kit.ac.jp	Tran, Thanh Men/AAH-4085-2021; Hirayama, Kenji/AAN-7065-2021; Huy, Nguyen Tien/B-2573-2010	Tran, Thanh Men/0000-0001-9885-7827; Huy, Nguyen Tien/0000-0002-9543-9440; Hirayama, Kenji/0000-0001-9467-1777				Adams PA, 1996, J INORG BIOCHEM, V63, P69, DOI 10.1016/0162-0134(95)00212-X; ATAMNA H, 1995, J BIOL CHEM, V270, P24876, DOI 10.1074/jbc.270.42.24876; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Blauer G, 2002, ARCH BIOCHEM BIOPHYS, V398, P7, DOI 10.1006/abbi.2001.2638; Bohle DS, 1997, J BIOL CHEM, V272, P713, DOI 10.1074/jbc.272.2.713; CANNON JB, 1984, BIOCHEMISTRY-US, V23, P3715, DOI 10.1021/bi00311a022; Cevc G., 1993, PHOSPHOLIPIDS HDB, P939; Cibulskis RE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001142; Combrinck JM, 2013, ACS CHEM BIOL, V8, P133, DOI 10.1021/cb300454t; Soares JBR, 2007, FEBS LETT, V581, P1742, DOI 10.1016/j.febslet.2007.03.054; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; ECKMAN JR, 1977, J LAB CLIN MED, V90, P767; EGAN TJ, 1994, FEBS LETT, V352, P54, DOI 10.1016/0014-5793(94)00921-X; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Egan TJ, 2000, J MED CHEM, V43, P283, DOI 10.1021/jm990437l; Egan TJ, 1999, J INORG BIOCHEM, V73, P101, DOI 10.1016/S0162-0134(98)10095-8; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Hempelmann E, 2003, TRENDS PARASITOL, V19, P23, DOI 10.1016/S1471-4922(02)00011-9; Hoang AN, 2010, BIOCHEMISTRY-US, V49, P10107, DOI 10.1021/bi101397u; Hoang AN, 2010, DALTON T, V39, P1235, DOI 10.1039/b914359a; Huy N, 2002, J BIOCHEM, V131, P437, DOI 10.1093/oxfordjournals.jbchem.a003119; Huy NT, 2007, ACTA TROP, V101, P130, DOI 10.1016/j.actatropica.2007.01.001; Huy NT, 2007, ANTIMICROB AGENTS CH, V51, P350, DOI 10.1128/AAC.00985-06; Huy NT, 2006, ANAL BIOCHEM, V354, P305, DOI 10.1016/j.ab.2005.08.005; Huy NT, 2003, J BIOCHEM, V133, P693, DOI 10.1093/jb/mvg089; Huy NT, 2002, J BIOL CHEM, V277, P4152, DOI 10.1074/jbc.M107285200; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Kapishnikov S, 2012, P NATL ACAD SCI USA, V109, P11188, DOI 10.1073/pnas.1118120109; Kapishnikov S, 2012, P NATL ACAD SCI USA, V109, P11184, DOI 10.1073/pnas.1118134109; LIGHT WR, 1990, J BIOL CHEM, V265, P15632; Muller O, 2009, LANCET, V374, P1419, DOI 10.1016/S0140-6736(09)61857-2; Nishino Y, 2007, J ELECTRON MICROSC, V56, P93, DOI 10.1093/jmicro/dfm008; Noland GS, 2003, MOL BIOCHEM PARASIT, V130, P91, DOI 10.1016/S0166-6851(03)00163-4; Oliveira MF, 2005, FEBS LETT, V579, P6010, DOI 10.1016/j.febslet.2005.09.035; Orjih AU, 2001, EXP BIOL MED, V226, P746, DOI 10.1177/153537020222600806; Orjih AU, 2012, EXP BIOL MED, V237, P884, DOI 10.1258/ebm.2012.012013; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; PISCIOTTA JM, 2006, BIOCH J; Pisciotta JM, 2007, BIOCHEM J, V402, P197, DOI 10.1042/BJ20060986; Rebelo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061606; Ridley RG, 1997, ANN TROP MED PARASIT, V91, P559, DOI 10.1080/00034989760932; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; Saha RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051774; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Stiebler R, 2011, J BIOENERG BIOMEMBR, V43, P93, DOI 10.1007/s10863-011-9335-x; Stiebler R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012694; Sullivan DJ, 2002, INT J PARASITOL, V32, P1645, DOI 10.1016/S0020-7519(02)00193-5; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; Thomas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041006; TIPPING E, 1979, BIOCHEM J, V180, P327, DOI 10.1042/bj1800327; Men TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-272; Trang DTX, 2006, ANAL BIOCHEM, V349, P292, DOI 10.1016/j.ab.2005.11.022; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; Tripathi AK, 2001, LIFE SCI, V69, P2725, DOI 10.1016/S0024-3205(01)01349-2; Uyen DT, 2008, BIOL PHARM BULL, V31, P1483, DOI 10.1248/bpb.31.1483; Wood BR, 2003, FEBS LETT, V554, P247, DOI 10.1016/S0014-5793(03)00975-X; Xuan Trang DT, 2005, ANAL BIOCH	58	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70025	10.1371/journal.pone.0070025	http://dx.doi.org/10.1371/journal.pone.0070025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894579	Green Submitted, Green Published, gold			2022-12-25	WOS:000325211000176
J	Hirsova, P; Ibrahim, SH; Bronk, SF; Yagita, H; Gores, GJ				Hirsova, Petra; Ibrahim, Samar H.; Bronk, Steven F.; Yagita, Hideo; Gores, Gregory J.			Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							HEDGEHOG PATHWAY ACTIVATION; IMMUNE-SYSTEM; HEPATOCYTE APOPTOSIS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; FIBROSIS; DISEASE; DEATH; FIBROGENESIS; EXPRESSION	Hedgehog signaling pathway activation has been implicated in the pathogenesis of NASH. Despite this concept, hedgehog pathway inhibitors have not been explored. Thus, we examined the effect of vismodegib, a hedgehog signaling pathway inhibitor, in a diet-induced model of NASH. C57BL/6 mice were placed on 3-month chow or FFC (high saturated fats, fructose, and cholesterol) diet. One week prior to sacrifice, mice were treated with vismodegib or vehicle. Mice fed the FFC diet developed significant steatosis, which was unchanged by vismodegib therapy. In contrast, vismodegib significantly attenuated FFC-induced liver injury as manifested by reduced serum ALT and hepatic TUNEL-positive cells. In line with the decreased apoptosis, vismodegib prevented FFC-induced strong upregulation of death receptor DR5 and its ligand TRAIL. In addition, FFC-fed mice, but not chow-fed animals, underwent significant liver injury and apoptosis following treatment with a DR5 agonist; however, this injury was prevented by pre-treatment with vismodegib. Consistent with a reduction in liver injury, vismodegib normalized FFC-induced markers of inflammation including mRNA for TNF-alpha, IL-1 beta, IL-6, monocyte chemotactic protein-1 and a variety of macrophage markers. Furthermore, vismodegib in FFC-fed mice abrogated indices of hepatic fibrogenesis. In conclusion, inhibition of hedgehog signaling with vismodegib appears to reduce TRAIL-mediated liver injury in a nutrient excess model of NASH, thereby attenuating hepatic inflammation and fibrosis. We speculate that hedgehog signaling inhibition may be salutary in human NASH.	[Hirsova, Petra; Ibrahim, Samar H.; Bronk, Steven F.; Gores, Gregory J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Hirsova, Petra] Charles Univ Prague, Fac Med Hradec Kralove, Dept Pharmacol, Hradec Kralove, Czech Republic; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	Mayo Clinic; Charles University Prague; University Hospital Hradec Kralove; Juntendo University	Gores, GJ (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	gores.gregory@mayo.edu	Hirsova, Petra/B-8943-2018	Hirsova, Petra/0000-0003-0494-0924; Ibrahim, Samar H./0000-0001-8470-8337	National Institutes of Health grant [R01 DK41876]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041876, P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01 DK41876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri N, 2011, EXPERT REV GASTROENT, V5, P201, DOI [10.1586/EGH.11.6, 10.1586/egh.11.6]; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bohinc BN, 2012, CLIN LIVER DIS, V16, P549, DOI 10.1016/j.cld.2012.05.002; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Cazanave SC, 2011, J BIOL CHEM, V286, P39336, DOI 10.1074/jbc.M111.280420; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Garcia-Monzon C, 2011, J HEPATOL, V54, P142, DOI 10.1016/j.jhep.2010.06.021; Guy CD, 2012, HEPATOLOGY, V55, P1711, DOI 10.1002/hep.25559; Kurita S, 2010, ONCOGENE, V29, P4848, DOI 10.1038/onc.2010.235; Lin CW, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003423; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Michelotti GA, 2013, J CLIN INVE IN PRESS; Milic S, 2012, DIGEST DIS, V30, P158, DOI 10.1159/000336669; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Omenetti A, 2009, HEPATOLOGY, V50, P518, DOI 10.1002/hep.23019; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Philips GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023943; Pratap A, 2012, J DRUG TARGET, V20, P770, DOI 10.3109/1061186X.2012.719900; Rangwala F, 2011, J PATHOL, V224, P401, DOI 10.1002/path.2888; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Roy S, 2012, DIFFERENTIATION, V83, pS43, DOI 10.1016/j.diff.2011.11.010; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Swiderska-Syn M, 2013, HEPATOLOGY, V57, P1814, DOI 10.1002/hep.26230; Sydor S, 2013, LAB INVEST, V93, P20, DOI 10.1038/labinvest.2012.142; Syn WK, 2012, GUT, V61, P1323, DOI 10.1136/gutjnl-2011-301857; Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998; Takeda K, 2004, J EXP MED, V199, P437, DOI 10.1084/jem.20031457; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655	37	66	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e70599	10.1371/journal.pone.0070599	http://dx.doi.org/10.1371/journal.pone.0070599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894677	Green Submitted, gold, Green Published			2022-12-25	WOS:000322132100096
J	Kawada-Matsuo, M; Yoshida, Y; Zendo, T; Nagao, J; Oogai, Y; Nakamura, Y; Sonomoto, K; Nakamura, N; Komatsuzawa, H				Kawada-Matsuo, Miki; Yoshida, Yuuma; Zendo, Takeshi; Nagao, Junichi; Oogai, Yuichi; Nakamura, Yasunori; Sonomoto, Kenji; Nakamura, Norifumi; Komatsuzawa, Hitoshi			Three Distinct Two-Component Systems Are Involved in Resistance to the Class I Bacteriocins, Nukacin ISK-1 and Nisin A, in Staphyloccus aureus	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; CELL-WALL BIOSYNTHESIS; VRAFG ABC TRANSPORTER; LIPID II; ANTIMICROBIAL PEPTIDES; BACITRACIN-RESISTANCE; STRESS-RESPONSE; WARNERI ISK-1; SUSCEPTIBILITY; PATHWAY	Staphylococcus aureus uses two-component systems (TCSs) to adapt to stressful environmental conditions. To colonize a host, S. aureus must resist bacteriocins produced by commensal bacteria. In a comprehensive analysis using individual TCS inactivation mutants, the inactivation of two TCSs, graRS and braRS, significantly increased the susceptibility to the class I bacteriocins, nukacin ISK-1 and nisin A, and inactivation of vraSR slightly increased the susceptibility to nukacin ISK-1. In addition, two ABC transporters (BraAB and VraDE) regulated by BraRS and one transporter (VraFG) regulated by GraRS were associated with resistance to nukacin ISK-1 and nisin A. We investigated the role of these three TCSs of S. aureus in co-culture with S. warneri, which produces nukacin ISK-1, and Lactococcus lactis, which produces nisin A. When co-cultured with S. warneri or L. lactis, the braRS mutant showed a significant decrease in its population compared with the wild-type, whereas the graRS and vraSR mutants showed slight decreases. Expression of vraDE was elevated significantly in S. aureus co-cultured with nisin A/nukacin ISK-1-producing strains. These results suggest that three distinct TCSs are involved in the resistance to nisin A and nukacin ISK-1. Additionally, braRS and its related transporters played a central role in S. aureus survival in co-culture with the strains producing nisin A and nukacin ISK-1.	[Kawada-Matsuo, Miki; Yoshida, Yuuma; Oogai, Yuichi; Komatsuzawa, Hitoshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Microbiol, Kagoshima 890, Japan; [Yoshida, Yuuma; Nakamura, Yasunori; Nakamura, Norifumi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Surg, Kagoshima 890, Japan; [Zendo, Takeshi; Sonomoto, Kenji] Kyushu Univ, Fac Agr, Grad Sch,Dept Biosci & Biotechnol, Lab Microbial Technol,Div Appl Mol Microbiol & Bi, Fukuoka 812, Japan; [Nagao, Junichi] Fukuoka Dent Coll, Dept Funct Biosci, Sect Infect Biol, Fukuoka, Japan	Kagoshima University; Kagoshima University; Kyushu University; Fukuoka Dental College (FDC)	Komatsuzawa, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Microbiol, Kagoshima 890, Japan.	hkomatsu@dent.kagoshima-u.ac.jp	Komatsuzawa, Hitoshi/AAC-7731-2019	Nagao, Jun-ichi/0000-0003-1489-4140; Zendo, Takeshi/0000-0001-5147-7026	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaduzzaman SM, 2009, ANTIMICROB AGENTS CH, V53, P3595, DOI 10.1128/AAC.01623-08; Asaduzzaman SM, 2009, J BIOSCI BIOENG, V107, P475, DOI 10.1016/j.jbiosc.2009.01.003; Aso Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1403, DOI 10.1271/bbb.69.1403; Aso YJ, 2005, PLASMID, V53, P164, DOI 10.1016/j.plasmid.2004.08.003; BAREFOOT SF, 1983, APPL ENVIRON MICROB, V45, P1808, DOI 10.1128/AEM.45.6.1808-1815.1983; Belcheva A, 2008, J BIOL CHEM, V283, P12354, DOI 10.1074/jbc.M710010200; Blake KL, 2011, ANTIMICROB AGENTS CH, V55, P2362, DOI 10.1128/AAC.01077-10; Chandrapati S, 2002, MOL MICROBIOL, V46, P467, DOI 10.1046/j.1365-2958.2002.03163.x; Cook HA, 2007, AM J INFECT CONTROL, V35, P231, DOI 10.1016/j.ajic.2006.05.291; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; de Kruijff B, 2008, PROSTAG LEUKOTR ESS, V79, P117, DOI 10.1016/j.plefa.2008.09.020; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Eguchi Y, 2008, ADV EXP MED BIOL, V631, P1, DOI 10.1007/978-0-387-78885-2_1; Falord M, 2012, ANTIMICROB AGENTS CH, V56, P1047, DOI 10.1128/AAC.05054-11; Falord M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021323; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Fujita K, 2007, APPL ENVIRON MICROB, V73, P2871, DOI 10.1128/AEM.02286-06; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hiron A, 2011, MOL MICROBIOL, V81, P602, DOI 10.1111/j.1365-2958.2011.07735.x; Hyde AJ, 2006, P NATL ACAD SCI USA, V103, P19896, DOI 10.1073/pnas.0608373104; Islam MR, 2012, J AM CHEM SOC, V134, P3687, DOI 10.1021/ja300007h; Jung G, 1991, NISIN NOVEL LANTIBIO; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Kolar SL, 2011, MICROBIOL-SGM, V157, P2206, DOI 10.1099/mic.0.049692-0; Komatsuzawa H, 2004, MOL MICROBIOL, V53, P1221, DOI 10.1111/j.1365-2958.2004.04200.x; KOMATSUZAWA H, 1994, J ANTIMICROB CHEMOTH, V34, P885, DOI 10.1093/jac/34.6.885; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; LIN WS, 1994, J BACTERIOL, V176, P7005, DOI 10.1128/JB.176.22.7005-7016.1994; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luong TT, 2006, MICROBIOL-SGM, V152, P3123, DOI 10.1099/mic.0.29177-0; Manders SM, 1998, J AM ACAD DERMATOL, V39, P383, DOI 10.1016/S0190-9622(98)70314-7; Manson JM, 2004, ANTIMICROB AGENTS CH, V48, P3743, DOI 10.1128/AAC.48.10.3743-3748.2004; Matsuo M, 2011, MICROBIOL-SGM, V157, P1786, DOI 10.1099/mic.0.044727-0; Matsuo M, 2010, J ANTIMICROB CHEMOTH, V65, P1536, DOI 10.1093/jac/dkq141; McCallum N, 2011, ANTIMICROB AGENTS CH, V55, P1391, DOI 10.1128/AAC.01213-10; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Nagase N, 2002, J VET MED SCI, V64, P245, DOI 10.1292/jvms.64.245; Nissen-Meyer J, 2009, CURR PHARM BIOTECHNO, V10, P19, DOI 10.2174/138920109787048661; NissenMeyer J, 1997, ARCH MICROBIOL, V167, P67, DOI 10.1007/s002030050418; Ohki R, 2003, MOL MICROBIOL, V49, P1135, DOI 10.1046/j.1365-2958.2003.03653.x; Ouyang J, 2010, ANTIMICROB AGENTS CH, V54, P3895, DOI 10.1128/AAC.01802-09; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; PODLESEK Z, 1995, MOL MICROBIOL, V16, P969, DOI 10.1111/j.1365-2958.1995.tb02322.x; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Yoshida Y, 2011, FEMS MICROBIOL LETT, V320, P33, DOI 10.1111/j.1574-6968.2011.02291.x	51	37	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69455	10.1371/journal.pone.0069455	http://dx.doi.org/10.1371/journal.pone.0069455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894484	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100061
J	Saverioni, D; Notari, S; Capellari, S; Poggiolini, I; Giese, A; Kretzschmar, HA; Parchi, P				Saverioni, Daniela; Notari, Silvio; Capellari, Sabina; Poggiolini, Ilaria; Giese, Armin; Kretzschmar, Hans A.; Parchi, Piero			Analyses of Protease Resistance and Aggregation State of Abnormal Prion Protein across the Spectrum of Human Prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; STRAIN VARIATION; TRUNCATED FORMS; SCRAPIE; VARIANT; PRPSC; CLASSIFICATION; INSIGHTS; GLYCOSAMINOGLYCANS; CONFORMATION	Prion diseases are characterized by tissue accumulation of a misfolded, beta-sheet-enriched isoform (scrapie prion protein (PrPSc)) of the cellular prion protein (PrPC). At variance with PrPC, PrPSc shows a partial resistance to protease digestion and forms highly aggregated and detergent-insoluble polymers, two properties that have been consistently used to distinguish the two proteins. In recent years, however, the idea that PrPSc itself comprises heterogeneous species has grown. Most importantly, a putative proteinase K (PK)-sensitive form of PrPSc (sPrP(Sc)) is being increasingly investigated for its possible role in prion infectivity, neurotoxicity, and strain variability. The study of sPrP(Sc), however, remains technically challenging because of the need of separating it from PrPC without using proteases. In this study, we have systematically analyzed both PK resistance and the aggregation state of purified PrPSc across the whole spectrum of the currently characterized human prion strains. The results show that PrPSc isolates manifest significant strain-specific differences in their PK digestion profile that are only partially explained by differences in the size of aggregates, suggesting that other factors, likely acting on PrPSc aggregate stability, determine its resistance to proteolysis. Fully protease-sensitive low molecular weight aggregates were detected in all isolates but in a limited proportion of the overall PrPSc (i.e. <10%), arguing against a significant role of slowly sedimenting PK-sensitive PrPSc in the biogenesis of prion strains. Finally, we highlight the limitations of current operational definitions of sPrP(Sc) and of the quantitative analytical measurements that are not based on the isolation of a fully PK-sensitive PrPSc form.	[Capellari, Sabina; Parchi, Piero] Ist Sci Neurol Bologna, IRCCS, I-40139 Bologna, Italy; [Saverioni, Daniela; Capellari, Sabina; Poggiolini, Ilaria; Parchi, Piero] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, I-40123 Bologna, Italy; [Giese, Armin; Kretzschmar, Hans A.] Univ Munich, Inst Neuropathol, D-81377 Munich, Germany; [Notari, Silvio] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA	IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Munich; Case Western Reserve University	Parchi, P (corresponding author), Ist Sci Neurol Bologna, IRCCS, Via Altura 3, I-40139 Bologna, Italy.	piero.parchi@unibo.it	capellari, sabina/F-5545-2012; Giese, Armin/F-3271-2010; Parchi, Piero/L-9833-2015	capellari, sabina/0000-0003-1631-1439; Giese, Armin/0000-0002-8238-4102; Parchi, Piero/0000-0002-9444-9524	Italian Ministry of Health [RF-2009-1474624]; University of Bologna [RFO 2008-2010]; Gino Galletti Foundation	Italian Ministry of Health(Ministry of Health, Italy); University of Bologna; Gino Galletti Foundation	This work was supported by Italian Ministry of Health Grant RF-2009-1474624, University of Bologna Grants RFO 2008-2010, and the Gino Galletti Foundation.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Cancellotti E, 2013, EMBO J, V32, P756, DOI 10.1038/emboj.2013.6; Cancellotti E, 2010, J VIROL, V84, P3464, DOI 10.1128/JVI.02374-09; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chen SG, 1997, NAT MED, V3, P1009, DOI 10.1038/nm0997-1009; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Choi YG, 2004, J BIOL CHEM, V279, P30402, DOI 10.1074/jbc.M400854200; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Falsig J, 2008, HFSP J, V2, P332, DOI 10.2976/1.2990786; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Ghetti B, 2003, CLIN LAB MED, V23, P65, DOI 10.1016/S0272-2712(02)00064-1; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Immel F, 2007, J BIOL CHEM, V282, P7912, DOI 10.1074/jbc.M608652200; Ironside JW, 2010, HAEMOPHILIA, V16, P175, DOI 10.1111/j.1365-2516.2010.02317.x; Jansen C, 2011, J NEUROPATH EXP NEUR, V70, P698, DOI 10.1097/NEN.0b013e3182270c54; Khalili-Shirazi A, 2005, J GEN VIROL, V86, P2635, DOI 10.1099/vir.0.80375-0; Kim C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002835; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Kobayashi A, 2005, J GEN VIROL, V86, P237, DOI 10.1099/vir.0.80389-0; Masel J, 1999, P ROY SOC B-BIOL SCI, V266, P1927, DOI 10.1098/rspb.1999.0868; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; Moda F, 2012, BRAIN PATHOL, V22, P662, DOI 10.1111/j.1750-3639.2012.00572.x; Monaco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032382; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Notari S, 2004, J BIOL CHEM, V279, P16797, DOI 10.1074/jbc.M313220200; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Papy-Garcia D, 2011, CURR PROTEIN PEPT SC, V12, P258, DOI 10.2174/138920311795860188; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; Parchi P, 2010, BRAIN, V133, P3030, DOI 10.1093/brain/awq234; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Pham N, 2008, BIOCHEM BIOPH RES CO, V368, P875, DOI 10.1016/j.bbrc.2008.01.172; Polymenidou M, 2011, BRAIN PATHOL, V21, P209, DOI 10.1111/j.1750-3639.2010.00439.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Thackray AM, 2007, J VIROL, V81, P12119, DOI 10.1128/JVI.01434-07; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vicente Miranda H, 2010, J PATHOL, V221, P13, DOI 10.1002/path.2682; Weber P, 2008, BIOCHEM BIOPH RES CO, V369, P924, DOI 10.1016/j.bbrc.2008.02.115; Weber P, 2006, P NATL ACAD SCI USA, V103, P15818, DOI 10.1073/pnas.0605608103; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhou Xiao-bo, 2004, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V18, P118; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200; Zsila F, 2006, BIOCHEM BIOPH RES CO, V346, P1267, DOI 10.1016/j.bbrc.2006.06.033	63	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27972	27985		10.1074/jbc.M113.477547	http://dx.doi.org/10.1074/jbc.M113.477547			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23897825	hybrid, Green Published			2022-12-25	WOS:000330612800024
J	Gann, PH; Deaton, R; Amatya, A; Mohnani, M; Rueter, EE; Yang, YR; Ananthanarayanan, V				Gann, Peter H.; Deaton, Ryan; Amatya, Anup; Mohnani, Mahesh; Rueter, Erika Enk; Yang, Yirong; Ananthanarayanan, Viju			Development of a Nuclear Morphometric Signature for Prostate Cancer Risk in Negative Biopsies	PLOS ONE			English	Article							IMAGE-ANALYSIS; INTRAEPITHELIAL NEOPLASIA; CHROMATIN TEXTURE; EPITHELIAL-CELLS; FOLLOW-UP; PREDICTS; METASTASIS; RECURRENCE; KARYOMETRY; NUCLEOLAR	Background: Our objective was to develop and validate a multi-feature nuclear score based on image analysis of direct DNA staining, and to test its association with field effects and subsequent detection of prostate cancer (PCa) in benign biopsies. Methods: Tissue sections from 39 prostatectomies were Feulgen-stained and digitally scanned (4006), providing maps of DNA content per pixel. PCa and benign epithelial nuclei were randomly selected for measurement of 52 basic morphometric features. Logistic regression models discriminating benign from PCa nuclei, and benign from malignant nuclear populations, were built and cross-validated by AUC analysis. Nuclear populations were randomly collected <1 mm or >5 mm from cancer foci, and from cancer-free prostates, HGPIN, and PCa Gleason grade 3-5. Nuclei also were collected from negative biopsy subjects who had a subsequent diagnosis of PCa and age-matched cancer-free controls (20 pairs). Results: A multi-feature nuclear score discriminated cancer from benign cell populations with AUCs of 0.91 and 0.79, respectively, in training and validation sets of patients. In prostatectomy samples, both nuclear-and population-level models revealed cancer-like features in benign nuclei adjacent to PCa, compared to nuclei that were more distant or from PCa-free glands. In negative biopsies, a validated model with 5 variance features yielded significantly higher scores in cases than controls (P = 0.026). Conclusions: A multifeature nuclear morphometric score, obtained by automated digital analysis, was validated for discrimination of benign from cancer nuclei. This score demonstrated field effects in benign epithelial nuclei at varying distance from PCa lesions, and was associated with subsequent PCa detection in negative biopsies. Impact: This nuclear score shows promise as a risk predictor among men with negative biopsies and as an intermediate biomarker in Phase II chemoprevention trials. The results also suggest that subvisual disturbances in nuclear structure precede the development of pre-neoplastic lesions.	[Gann, Peter H.; Deaton, Ryan; Mohnani, Mahesh; Rueter, Erika Enk] Univ Illinois, Dept Pathol, Chicago, IL 60607 USA; [Amatya, Anup] New Mexico State Univ, Dept Publ Hlth Sci, Las Cruces, NM 88003 USA; [Yang, Yirong] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA; [Ananthanarayanan, Viju] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; New Mexico State University; University of New Mexico; University of Chicago	Gann, PH (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60607 USA.	pgann@uic.edu			National Institutes of Health/National Cancer Institute [RO1 CA155301, RO1 CA90759]; NATIONAL CANCER INSTITUTE [R01CA155301, R01CA090759] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Institutes of Health/National Cancer Institute RO1 CA155301 and RO1 CA90759. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 2007, CANCER EPIDEM BIOMAR, V16, P2704, DOI 10.1158/1055-9965.EPI-07-0595; Bacus JW, 1999, CANCER EPIDEM BIOMAR, V8, P1087; Bartels PH, 2008, CANCER EPIDEM BIOMAR, V17, P1689, DOI 10.1158/1055-9965.EPI-08-0313; Bartels PH, 1998, ANAL QUANT CYTOL, V20, P397; Boone CW, 2001, UROLOGY, V57, P129, DOI 10.1016/S0090-4295(00)00956-0; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Debes JD, 2005, CANCER RES, V65, P708; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DIAMOND DA, 1982, PROSTATE, V3, P321, DOI 10.1002/pros.2990030402; Doudkine A., 1995, Pathologica (Genoa), V87, P286; Ellinger J, 2010, PROSTATE, V70, P61, DOI 10.1002/pros.21038; Fischer AH, 2004, J CELL BIOCHEM, V91, P170, DOI 10.1002/jcb.10735; Frank DH, 2009, BREAST CANCER RES TR, V115, P661, DOI 10.1007/s10549-008-0274-0; Ikeda N, 1998, LUNG CANCER-J IASLC, V19, P161, DOI 10.1016/S0169-5002(97)00095-0; Isharwal S, 2008, PROSTATE, V68, P1097, DOI 10.1002/pros.20772; Isharwal S, 2010, BJU INT, V105, P329, DOI 10.1111/j.1464-410X.2009.08791.x; Jia ZY, 2011, CANCER RES, V71, P2476, DOI 10.1158/0008-5472.CAN-10-2585; Koh CM, 2011, AM J PATHOL, V178, P1824, DOI 10.1016/j.ajpath.2010.12.040; Mairinger T, 1999, PROSTATE, V41, P12; Metze K, 2010, EPIGENOMICS-UK, V2, P601, DOI 10.2217/EPI.10.50; Mohamed MA, 2007, BJU INT, V99, P908, DOI 10.1111/j.1464-410X.2006.06704.x; Montironi R, 1999, EUR UROL, V35, P468, DOI 10.1159/000019881; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; PARTIN AW, 1992, CANCER, V70, P161, DOI 10.1002/1097-0142(19920701)70:1<161::AID-CNCR2820700126>3.0.CO;2-5; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; Veltri RW, 2008, CANCER EPIDEM BIOMAR, V17, P102, DOI 10.1158/1055-9965.EPI-07-0175; Veltri RW, 2012, ASIAN J ANDROL, V14, P375, DOI 10.1038/aja.2011.148; Veltri RW, 2010, PROSTATE, V70, P1333, DOI 10.1002/pros.21168; Veltri RW, 2004, CLIN CANCER RES, V10, P3465, DOI 10.1158/1078-0432.CCR-03-0635; Wolfe P, 2004, CANCER EPIDEM BIOMAR, V13, P976	31	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69457	10.1371/journal.pone.0069457	http://dx.doi.org/10.1371/journal.pone.0069457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922715	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900042
J	Bian, YX; Zhao, SX; Zhu, SM; Zeng, JF; Li, TT; Fu, YS; Wang, YZ; Zheng, X; Zhang, L; Wang, WJ; Yang, BC; Zhou, YP; Allain, JP; Li, CY				Bian, Yixin; Zhao, Shuoxian; Zhu, Shaomei; Zeng, Jinfeng; Li, Tingting; Fu, Yongshui; Wang, Yuanzhan; Zheng, Xin; Zhang, Ling; Wang, Wenjing; Yang, Baocheng; Zhou, Yuanping; Allain, Jean-Pierre; Li, Chengyao			Significance of Monoclonal Antibodies against the Conserved Epitopes within Non-Structural Protein 3 Helicase of Hepatitis C Virus	PLOS ONE			English	Article							RNA HELICASE; NS3 PROTEIN; CLONE; REPLICATION; INFECTION; ENZYMES; MOTIFS; TARGET; DOMAIN; ROLES	Nonstructural protein 3 (NS3) of hepatitis C virus (HCV), codes for protease and helicase carrying NTPase enzymatic activities, plays a crucial role in viral replication and an ideal target for diagnosis, antiviral therapy and vaccine development. In this study, monoclonal antibodies (mAbs) to NS3 helicase were characterized by epitope mapping and biological function test. A total of 29 monoclonal antibodies were produced to the truncated NS3 helicase of HCV-1b (T1b-rNS3, aa1192-1459). Six mAbs recognized 8/29 16mer peptides, which contributed to identify 5 linear and 1 discontinuous putative epitope sequences. Seven mAbs reacted with HCV-2a JFH-1 infected Huh-7.5.1 cells by immunofluorescent staining, of which 2E12 and 3E5 strongly bound to the exposed linear epitope (1231)PTGSGKSTK(1239) (EP05) or core motif (1373)IPFYGKAI(1380) (EP21), respectively. Five other mAbs recognized semi-conformational or conformational epitopes of HCV helicase. MAb 2E12 binds to epitope EP05 at the ATP binding site of motif I in domain 1, while mAb 3E5 reacts with epitope EP21 close to helicase nucleotide binding region of domain 2. Epitope EP05 is totally conserved and EP21 highly conserved across HCV genotypes. These two epitope peptides reacted strongly with 59-79% chronic and weakly with 30-58% resolved HCV infected blood donors, suggesting that these epitopes were dominant in HCV infection. MAb 2E12 inhibited 50% of unwinding activity of NS3 helicase in vitro. Novel monoclonal antibodies recognize highly conserved epitopes at crucial functional sites within NS3 helicase, which may become important antibodies for diagnosis and antiviral therapy in chronic HCV infection.	[Bian, Yixin; Zhao, Shuoxian; Zhu, Shaomei; Li, Tingting; Zhang, Ling; Wang, Wenjing; Allain, Jean-Pierre; Li, Chengyao] Southern Med Univ, Dept Transfus Med, Guangzhou, Guangdong, Peoples R China; [Zeng, Jinfeng; Zheng, Xin; Yang, Baocheng] Shenzhen Blood Ctr, Shenzhen, Peoples R China; [Fu, Yongshui] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Yuanzhan; Zhou, Yuanping] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Allain, Jean-Pierre] Univ Cambridge, Dept Hematol, Cambridge, England	Southern Medical University - China; Guangzhou Blood Center; Southern Medical University - China; University of Cambridge	Li, CY (corresponding author), Southern Med Univ, Dept Transfus Med, Guangzhou, Guangdong, Peoples R China.	chengyaoli@hotmail.com			National Basic Research Program of China (973 Program) [2012CBA01305, 2010CB530204, 13 2009CB522507]; National Natural Science Foundation of China [81071348, 30972765]; S&T Grand Special Program of China [2009ZX10004-305]; Guangdong Provincial Science and Technology Foundation [2010B060500010]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); S&T Grand Special Program of China; Guangdong Provincial Science and Technology Foundation	This work was supported by the grants 2012CBA01305, 2010CB530204 and 13 2009CB522507 from National Basic Research Program of China (973 Program), the grants 81071348 and 30972765 from National Natural Science Foundation of China, the grant 2009ZX10004-305 from S&T Grand Special Program of China, and the grant 2010B060500010 from Guangdong Provincial Science and Technology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukh J, 1999, VIROLOGY, V262, P470, DOI 10.1006/viro.1999.9941; Cao YL, 2009, NEPHROL DIAL TRANSPL, V24, P2745, DOI 10.1093/ndt/gfp167; Chandra PK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-118; Chang SC, 2000, J VIROL, V74, P9732, DOI 10.1128/JVI.74.20.9732-9737.2000; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; Chen M, 1998, HEPATOLOGY, V28, P219, DOI 10.1002/hep.510280128; Dillingham MS, 2001, P NATL ACAD SCI USA, V98, P8381, DOI 10.1073/pnas.131009598; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Giugliano S, 2009, HEPATOLOGY, V50, P707, DOI 10.1002/hep.23096; HIRAMATSU N, 1992, HEPATOLOGY, V16, P306, DOI 10.1002/hep.1840160205; Jolivet-Reynaud C, 2004, J MED VIROL, V72, P385, DOI 10.1002/jmv.20002; KHUDYAKOV YE, 1995, VIROLOGY, V206, P666, DOI 10.1016/S0042-6822(95)80086-7; Kim WR, 2002, MICROBES INFECT, V4, P1219, DOI 10.1016/S1286-4579(02)01649-0; Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200; Li CY, 2001, J VIROL, V75, P12412, DOI 10.1128/JVI.75.24.12412-12420.2001; Li TT, 2011, BIOCHEM BIOPH RES CO, V415, P503, DOI 10.1016/j.bbrc.2011.10.102; MONDELL MU, 1994, J VIROL, V68, P4829, DOI 10.1128/JVI.68.8.4829-4836.1994; Prabhu R, 2004, AM J PATHOL, V165, P1163, DOI 10.1016/S0002-9440(10)63377-9; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Rice Charles M, 2011, Top Antivir Med, V19, P117; Sullivan DE, 2002, J HEPATOL, V37, P660, DOI 10.1016/S0168-8278(02)00270-2; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Tani H, 2010, BIOCHEM BIOPH RES CO, V393, P131, DOI 10.1016/j.bbrc.2010.01.100; VANDERPOEL CL, 1991, LANCET, V337, P317, DOI 10.1016/0140-6736(91)90942-I; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wilkinson J, 2009, J VIROL, V83, P1312, DOI 10.1128/JVI.01890-08; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042455; Zhang ZX, 2000, CLIN DIAGN LAB IMMUN, V7, P58, DOI 10.1128/CDLI.7.1.58-63.2000	28	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70214	10.1371/journal.pone.0070214	http://dx.doi.org/10.1371/journal.pone.0070214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894620	Green Submitted, Green Published, gold			2022-12-25	WOS:000322167900112
J	Jury, LA; Sitzlar, B; Kundrapu, S; Cadnum, JL; Summers, KM; Muganda, CP; Deshpande, A; Sethi, AK; Donskey, CJ				Jury, Lucy A.; Sitzlar, Brett; Kundrapu, Sirisha; Cadnum, Jennifer L.; Summers, Kim M.; Muganda, Christine P.; Deshpande, Abhishek; Sethi, Ajay K.; Donskey, Curtis J.			Outpatient Healthcare Settings and Transmission of Clostridium difficile	PLOS ONE			English	Article							FACILITY RESIDENTS; INFECTION; CONTAMINATION; EPIDEMIOLOGY; ACQUISITION; VANCOMYCIN; STRAINS; USA	Background: Recent reports suggest that community-associated Clostridium difficile infection (CDI) (i.e., no healthcare facility admission within 90 days) may be increasing in frequency. We hypothesized that outpatient clinics could be an important source for acquisition of community-associated CDI. Methods: We performed a 6-month prospective study of CDI patients to determine frequency of and risk factors for skin and environmental shedding during outpatient visits and to derive a prediction rule for positive cultures. We performed a point-prevalence culture survey to assess the frequency of C. difficile contamination in outpatient settings and evaluated the frequency of prior outpatient visits in patients with community-associated CDI. Results: Of 67 CDI patients studied, 54 (81%) had 1 or more outpatient visits within 12 weeks after diagnosis. Of 44 patients cultured during outpatient visits, 14 (32%) had skin contamination and 12 (27%) contaminated environmental surfaces. Decreased mobility, fecal incontinence, and treatment with non-CDI antibiotics were associated with positive cultures, whereas vancomycin taper therapy was protective. In patients not on CDI therapy, a prediction rule including incontinence or decreased mobility was 90% sensitive and 79% specific for detection of spore shedding. Of 84 clinic and emergency department rooms cultured, 12 (14%) had 1 or more contaminated environmental sites. For 33 community-associated CDI cases, 31 (94%) had an outpatient visit during the 12 weeks prior to onset of diarrhea. Conclusions: Patients with recent CDI present a significant risk for transmission of spores during outpatient visits. The outpatient setting may be an underappreciated source of community-associated CDI cases.	[Jury, Lucy A.; Sitzlar, Brett; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA; [Kundrapu, Sirisha; Cadnum, Jennifer L.; Deshpande, Abhishek; Donskey, Curtis J.] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA; [Summers, Kim M.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Muganda, Christine P.; Sethi, Ajay K.] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA	Geriatric Research Education & Clinical Center; Case Western Reserve University; University of Wisconsin System; University of Wisconsin Madison	Donskey, CJ (corresponding author), Cleveland Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA.	curtisd123@yahoo.com	Deshpande, Abhishek/A-7695-2012	Deshpande, Abhishek/0000-0001-5522-2995	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This research work was supported by a Merit Review Grant from the Department of Veterans Affairs to CJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nassir WN, 2008, CLIN INFECT DIS, V47, P56, DOI 10.1086/588293; Boyce JM, 2007, INFECT CONT HOSP EP, V28, P1142, DOI 10.1086/520737; Campbell RJ, 2009, INFECT CONT HOSP EP, V30, P526, DOI 10.1086/597507; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Dumford DM, 2009, AM J INFECT CONTROL, V37, P15, DOI 10.1016/j.ajic.2008.07.009; Dumyati G, 2012, EMERG INFECT DIS, V18, P392, DOI 10.3201/eid1803.102023; Guerrero DM, 2012, AM J INFECT CONTROL, V40, P556, DOI 10.1016/j.ajic.2011.08.002; Jinno S, 2012, INFECT CONT HOSP EP, V33, P638, DOI 10.1086/665712; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Kutty PK, 2010, EMERG INFECT DIS, V16, P197, DOI 10.3201/eid1602.090953; Mayer RA, 2003, AM J INFECT CONTROL, V31, P221, DOI 10.1067/mic.2003.45; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Naggie S, 2010, INFECTION, V38, P297, DOI 10.1007/s15010-010-0025-0; Naggie S, 2011, AM J MED, V124, P276, DOI 10.1016/j.amjmed.2010.10.013; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Tescher AN, 2012, J WOUND OSTOMY CONT, V39, P282, DOI 10.1097/WON.0b013e3182435715; Wilcox MH, 2008, J ANTIMICROB CHEMOTH, V62, P388, DOI 10.1093/jac/dkn163	19	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70175	10.1371/journal.pone.0070175	http://dx.doi.org/10.1371/journal.pone.0070175			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894609	Green Submitted, Green Published, gold			2022-12-25	WOS:000322167900109
J	Segarra, C; Bougard, D; Moudjou, M; Laude, H; Beringue, V; Coste, J				Segarra, Christiane; Bougard, Daisy; Moudjou, Mohammed; Laude, Hubert; Beringue, Vincent; Coste, Joliette			Plasminogen-Based Capture Combined with Amplification Technology for the Detection of PrPTSE in the Pre-Clinical Phase of Infection	PLOS ONE			English	Article							MISFOLDING CYCLIC AMPLIFICATION; CREUTZFELDT-JAKOB-DISEASE; IN-VITRO AMPLIFICATION; RESISTANT PRION PROTEIN; SPONGIFORM ENCEPHALOPATHY; PRESYMPTOMATIC DETECTION; VARIANT CJD; BLOOD; SCRAPIE; SHEEP	Background: Variant Creutzfeldt-Jakob disease (vCJD) is a neurodegenerative infectious disorder, characterized by a prominent accumulation of pathological isoforms of the prion protein (PrPTSE) in the brain and lymphoid tissues. Since the publication in the United Kingdom of four apparent vCJD cases following transfusion of red blood cells and one apparent case following treatment with factor VIII, the presence of vCJD infectivity in the blood seems highly probable. For effective blood testing of vCJD individuals in the preclinical or clinical phase of infection, it is considered necessary that assays detect PrPTSE concentrations in the femtomolar range. Methodology/Principal Findings: We have developed a three-step assay that firstly captures PrPTSE from infected blood using a plasminogen-coated magnetic-nanobead method prior to its serial amplification via protein misfolding cyclic amplification (PMCA) and specific PrPTSE detection by western blot. We achieved a PrPTSE capture yield of 95% from scrapie-infected material. We demonstrated the possibility of detecting PrPTSE in white blood cells, in buffy coat and in plasma isolated from the blood of scrapie-infected sheep collected at the pre-clinical stage of the disease. The test also allowed the detection of PrPTSE in human plasma spiked with a 10 28 dilution of vCJD-infected brain homogenate corresponding to the level of sensitivity (femtogram) required for the detection of the PrPTSE in asymptomatic carriers. The 100% specificity of the test was revealed using a blinded panel comprising 96 human plasma samples. Conclusion/Significance: We have developed a sensitive and specific amplification assay allowing the detection of PrPTSE in the plasma and buffy coat fractions of blood collected at the pre-clinical phase of the disease. This assay represents a good candidate as a confirmatory assay for the presence of PrPTSE in blood of patients displaying positivity in large scale screening tests.	[Segarra, Christiane; Bougard, Daisy; Coste, Joliette] EFS PyMed Etab Francais Sang Pyrenees Mediterrane, R&D TransDiag, Securite Transfus & Innovat Diagnost, Montpellier, France; [Moudjou, Mohammed; Laude, Hubert; Beringue, Vincent] INRA, UR892, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Coste, J (corresponding author), EFS PyMed Etab Francais Sang Pyrenees Mediterrane, R&D TransDiag, Securite Transfus & Innovat Diagnost, Montpellier, France.	joliette.coste@efs.sante.fr		BOUGARD, Daisy/0000-0002-8779-9251	Etablissement Francais du Sang	Etablissement Francais du Sang	Etablissement Francais du Sang. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002782; Beringue V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001419; Bons N, 2002, TRANSFUSION, V42, P513, DOI 10.1046/j.1537-2995.2002.00098.x; Brown P, 2001, J LAB CLIN MED, V137, P5, DOI 10.1067/mlc.2001.111951; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2004, TECHNIQUES PRION RES, P198, DOI [10.1007/978-3-0348-7949-1_14, DOI 10.1007/978-3-0348-7949-1_14]; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; Collinge J, 2012, SCIENCE, V335, P411, DOI 10.1126/science.1218167; Cooper JK, 2012, VOX SANG, V102, P100, DOI 10.1111/j.1423-0410.2011.01525.x; Cuccioloni M, 2005, PROTEINS, V58, P728, DOI 10.1002/prot.20346; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Ellis V, 2002, BIOCHEMISTRY-US, V41, P6891, DOI 10.1021/bi025676g; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Fujihara A, 2009, FEBS J, V276, P2841, DOI 10.1111/j.1742-4658.2009.07007.x; Garske T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015626; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; HPA, 2012, HEALTH PROTECTION RE; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; Jones M, 2009, TRANSFUSION, V49, P376, DOI 10.1111/j.1537-2995.2008.01954.x; Kornblatt JA, 2003, BIOCHEM BIOPH RES CO, V305, P518, DOI 10.1016/S0006-291X(03)00804-0; Lacroux C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042019; Lacroux C, 2012, J VIROL, V86, P2056, DOI 10.1128/JVI.06532-11; Langevin C, 2011, NEUROBIOL DIS, V41, P219, DOI 10.1016/j.nbd.2010.09.010; Laude H, 2002, CR BIOL, V325, P49, DOI 10.1016/S1631-0691(02)01393-8; Maissen M, 2001, LANCET, V357, P2026, DOI 10.1016/S0140-6736(00)05110-2; Mays CE, 2010, FASEB J, V24, P5102, DOI 10.1096/fj.10-163600; McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169; Minton AP, 1998, METHOD ENZYMOL, V295, P127; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Negredo C, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-43; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; Notari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008765; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Segarra C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005796; Soto C, 2004, NAT REV MICROBIOL, V2, P809, DOI 10.1038/nrmicro1003; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Tattum MH, 2010, TRANSFUSION, V50, P996, DOI 10.1111/j.1537-2995.2010.02595.x; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859	49	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69632	10.1371/journal.pone.0069632	http://dx.doi.org/10.1371/journal.pone.0069632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894513	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900086
J	Zhang, YN; Jin, JY; Jin, R; Xia, YH; Zhou, JJ; Deng, JY; Dong, SL				Zhang, Ya-Nan; Jin, Jun-Yan; Jin, Rong; Xia, Yi-Han; Zhou, Jing-Jiang; Deng, Jian-Yu; Dong, Shuang-Lin			Differential Expression Patterns in Chemosensory and Non-Chemosensory Tissues of Putative Chemosensory Genes Identified by Transcriptome Analysis of Insect Pest the Purple Stem Borer Sesamia inferens (Walker)	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; MOTH HELIOTHIS-VIRESCENS; SOUTHERN HOUSE MOSQUITO; SEX-PHEROMONE RECEPTOR; TIME RT-PCR; BOMBYX-MORI; MOLECULAR CHARACTERIZATION; APIS-MELLIFERA; HONEY-BEE; DROSOPHILA-MELANOGASTER	Background: A large number of insect chemosensory genes from different gene subfamilies have been identified and annotated, but their functional diversity and complexity are largely unknown. A systemic examination of expression patterns in chemosensory organs could provide important information. Methodology/Principal Findings: We identified 92 putative chemosensory genes by analysing the transcriptome of the antennae and female sex pheromone gland of the purple stem borer Sesamia inferens, among them 87 are novel in this species, including 24 transcripts encoding for odorant binding proteins (OBPs), 24 for chemosensory proteins (CSPs), 2 for sensory neuron membrane proteins (SNMPs), 39 for odorant receptors (ORs) and 3 for ionotropic receptors (IRs). The transcriptome analyses were validated and quantified with a detailed global expression profiling by Reverse Transcription-PCR for all 92 transcripts and by Quantitative Real Time RT-PCR for selected 16 ones. Among the chemosensory gene subfamilies, CSP transcripts are most widely and evenly expressed in different tissues and stages, OBP transcripts showed a clear antenna bias and most of OR transcripts are only detected in adult antennae. Our results also revealed that some OR transcripts, such as the transcripts of SNMP2 and 2 IRs were expressed in non-chemosensory tissues, and some CSP transcripts were antenna-biased expression. Furthermore, no chemosensory transcript is specific to female sex pheromone gland and very few are found in the heads. Conclusion: Our study revealed that there are a large number of chemosensory genes expressed in S. inferens, and some of them displayed unusual expression profile in non-chemosensory tissues. The identification of a large set of putative chemosensory genes of each subfamily from a single insect species, together with their different expression profiles provide further information in understanding the functions of these chemosensory genes in S. inferens as well as other insects.	[Zhang, Ya-Nan; Jin, Jun-Yan; Jin, Rong; Xia, Yi-Han; Dong, Shuang-Lin] Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Educ Minist, Nanjing, Jiangsu, Peoples R China; [Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England; [Deng, Jian-Yu] Zhejiang Agr & Forestry Univ, Dept Plant Protect, Linan, Zhejiang, Peoples R China	Nanjing Agricultural University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Zhejiang A&F University	Deng, JY (corresponding author), Zhejiang Agr & Forestry Univ, Dept Plant Protect, Linan, Zhejiang, Peoples R China.	jydeng70@yahoo.com.cn; sldong@njau.edu.cn	Xia, Yihan/F-3025-2016	Xia, Yihan/0000-0002-4213-9524	Special Fund for Agro-scientific Research in the Public Interest [201203036]; National Natural Science Foundation [31071978]; Zhejiang Provincial Natural Foundation, China [Y3100384]; BBSRC [BBS/E/C/00005194] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194] Funding Source: researchfish	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Foundation, China; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Special Fund for Agro-scientific Research in the Public Interest (201203036), and grants from the National Natural Science Foundation (31071978) and the Zhejiang Provincial Natural Foundation (Y3100384) of China.	Abraham D, 2005, INSECT BIOCHEM MOLEC, V35, P1100, DOI 10.1016/j.ibmb.2005.05.002; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BGI, 2010, GENOME RESEARCH; Calvello M, 2005, INSECT BIOCHEM MOLEC, V35, P297, DOI 10.1016/j.ibmb.2005.01.002; Chai HN, 2012, INT J MOL SCI, V13, P10236, DOI 10.3390/ijms130810236; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Gao YL, 2010, J INVERTEBR PATHOL, V105, P11, DOI 10.1016/j.jip.2010.05.002; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gong L, 2012, BULL ENTOMOL RES, P1; Gong ZJ, 2009, INSECT MOL BIOL, V18, P405, DOI 10.1111/j.1365-2583.2009.00886.x; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Liu SJ, 2012, ARCH INSECT BIOCHEM, V80, P123, DOI 10.1002/arch.21036; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Pelletier J, 2011, J INSECT PHYSIOL, V57, P915, DOI 10.1016/j.jinsphys.2011.04.003; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Picimbon JF, 2000, ARCH INSECT BIOCHEM, V44, P120, DOI 10.1002/1520-6327(200007)44:3&lt;120::AID-ARCH3&gt;3.0.CO;2-H; Picimbon JF, 2002, INSECT BIOCHEM MOLEC, V32, P839, DOI 10.1016/S0965-1748(01)00172-2; Poivet E, 2012, NAT COMMUN, P1; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Tamura K, 2011, MEGA5 MOLECULAR EVOL; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Tunstall NE, 2012, ADV EXP MED BIOL, V739, P59, DOI 10.1007/978-1-4614-1704-0_4; Vogt RG, 2003, BIOCHEMICAL DIVERSIT; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; [王晓梅 Wang Xiaomei], 2011, [华北农学报, Acta Agriculturae Boreali-Sinica], V26, P94; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Xiu WM, 2008, J CHEM ECOL, V34, P487, DOI 10.1007/s10886-008-9452-0; [徐丽娜 Xu LiNa], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P244; Xu PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041653; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang HY, 2012, CHINA RICE, V18, P29; Zhang YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047611; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JingJiang, 2010, Outlooks on Pest Management, V21, P31, DOI 10.1564/21feb08	73	163	173	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69715	10.1371/journal.pone.0069715	http://dx.doi.org/10.1371/journal.pone.0069715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894529	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900092
J	Zhao, GX; Jin, ZM; Allewell, NM; Tuchman, M; Shi, DS				Zhao, Gengxiang; Jin, Zhongmin; Allewell, Norma M.; Tuchman, Mendel; Shi, Dashuang			Crystal Structure of the N-Acetyltransferase Domain of Human N-Acetyl-L-Glutamate Synthase in Complex with N-Acetyl-L-Glutamate Provides Insights into Its Catalytic and Regulatory Mechanisms	PLOS ONE			English	Article							ACETYLGLUTAMATE SYNTHASE; ARGININE-BIOSYNTHESIS; EXPRESSION; CLONING	N-acetylglutamate synthase (NAGS) catalyzes the conversion of AcCoA and L-glutamate to CoA and N-acetyl-L-glutamate (NAG), an obligate cofactor for carbamyl phosphate synthetase I (CPSI) in the urea cycle. NAGS deficiency results in elevated levels of plasma ammonia which is neurotoxic. We report herein the first crystal structure of human NAGS, that of the catalytic N-acetyltransferase (hNAT) domain with N-acetyl-L-glutamate bound at 2.1 angstrom resolution. Functional studies indicate that the hNAT domain retains catalytic activity in the absence of the amino acid kinase (AAK) domain. Instead, the major functions of the AAK domain appear to be providing a binding site for the allosteric activator, L-arginine, and an N-terminal proline-rich motif that is likely to function in signal transduction to CPS1. Crystalline hNAT forms a dimer similar to the NAT-NAT dimers that form in crystals of bifunctional N-acetylglutamate synthase/kinase (NAGS/K) from Maricaulis maris and also exists as a dimer in solution. The structure of the NAG binding site, in combination with mutagenesis studies, provide insights into the catalytic mechanism. We also show that native NAGS from human and mouse exists in tetrameric form, similar to those of bifunctional NAGS/K.	[Zhao, Gengxiang; Tuchman, Mendel; Shi, Dashuang] George Washington Univ, Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20052 USA; [Zhao, Gengxiang; Tuchman, Mendel; Shi, Dashuang] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA; [Jin, Zhongmin] Argonne Natl Lab, Adv Photon Source, Southeast Reg Collaborat Access Team, Argonne, IL 60439 USA; [Allewell, Norma M.] Univ Maryland, Coll Comp Math & Nat Sci, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Allewell, Norma M.] Univ Maryland, Coll Comp Math & Nat Sci, Dept Chem & Biochem, College Pk, MD 20742 USA	Children's National Health System; George Washington University; George Washington University; United States Department of Energy (DOE); Argonne National Laboratory; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Shi, DS (corresponding author), George Washington Univ, Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20052 USA.	dshi@cnmcresearch.org		Shi, Dashuang/0000-0002-5491-1104	Public Health Service grants from the National Institute of Diabetes, Digestive and Kidney Diseases [DK-DK064913]; U.S. Department of Energy, Office of Science and Office of Basic Energy Sciences [W-31-109-Eng-38]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064913] Funding Source: NIH RePORTER	Public Health Service grants from the National Institute of Diabetes, Digestive and Kidney Diseases; U.S. Department of Energy, Office of Science and Office of Basic Energy Sciences(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service grants DK-DK064913 (MT) from the National Institute of Diabetes, Digestive and Kidney Diseases. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science and Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; Caldovic L, 2006, MOL GENET METAB, V87, P226, DOI 10.1016/j.ymgme.2005.10.003; Caldovic L, 2002, BIOCHEM BIOPH RES CO, V299, P581, DOI 10.1016/S0006-291X(02)02696-7; Caldovic L, 2002, BIOCHEM J, V364, P825, DOI 10.1042/BJ20020161; Caldovic L, 2007, HUM MUTAT, V28, P754, DOI 10.1002/humu.20518; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Haskins Nantaporn, 2008, BMC Biochemistry, V9, P24, DOI 10.1186/1471-2091-9-24; He HZ, 2003, J MOL BIOL, V325, P1019, DOI 10.1016/S0022-2836(02)01284-6; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Kaieda S, 2010, BIOCHEMISTRY-US, V49, P5143, DOI 10.1021/bi100563z; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Mew NA, 2009, MOL GENET METAB, V98, P325, DOI 10.1016/j.ymgme.2009.07.010; Min L, 2009, J BIOL CHEM, V284, P4873, DOI 10.1074/jbc.M805348200; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Qu Qiuhao, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-4; Ramon-Maiques S, 2006, J MOL BIOL, V356, P695, DOI 10.1016/j.jmb.2005.11.079; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schlundt A, 2009, MOL CELL PROTEOMICS, V8, P2474, DOI 10.1074/mcp.M800337-MCP200; Shi D, 2008, J BIOL CHEM, V283, P7176, DOI 10.1074/jbc.M707678200; Shi DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028825; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	30	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70369	10.1371/journal.pone.0070369	http://dx.doi.org/10.1371/journal.pone.0070369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894642	gold, Green Submitted, Green Published			2022-12-25	WOS:000322167900120
J	Al-Khalaf, HH; Aboussekhra, A				Al-Khalaf, Huda H.; Aboussekhra, Abdelilah			p16(INK4A) Positively Regulates p21(WAF1) Expression by suppressing AUF1-dependent mRNA decay	PLOS ONE			English	Article							D-DEPENDENT KINASES; TUMOR-SUPPRESSOR; CDK INHIBITORS; P21; BINDING; SUSCEPTIBILITY; LOCALIZATION; FIBROBLASTS; MECHANISMS; SENESCENCE	Background: p16(INK4a) and p21(WAF1) are two independent cyclin-dependent kinase inhibitors encoded by the CDKN2A and CDKN1A genes, respectively. p16(INK4a) and p21(WAF1) are similarly involved in various anti-cancer processes, including the regulation of the critical G1 to S phase transition of the cell cycle, senescence and apoptosis. Therefore, we sought to elucidate the molecular mechanisms underlying the link between these two important tumor suppressor proteins. Methodology/Principal Findings: We have shown here that the p16(INK4a) protein positively controls the expression of p21(WAF1) in both human and mouse cells. p16(INK4a) stabilizes the CDKN1A mRNA through negative regulation of the mRNA decay-promoting AUF1 protein. Immunoprecipitation of AUF1-associated RNAs followed by quantitative RTPCR indicated that endogenous AUF1 binds to the CDKN1A mRNA in a p16(INK4a)-dependent manner. Furthermore, while AUF1 down-regulation increased the expression level of the CDKN1A mRNA, the concurrent knockdown of AUF1 and CDKN2A, using specific silencing RNAs, restored the normal expression of the gene. Moreover, we used EGFP reporter fused to the CDKN2A AU-rich element (ARE) to demonstrate that p16(INK4a) regulation of the CDKN1A mRNA is AUF1- and ARE-dependent. Furthermore, ectopic expression of p16(INK4a) in p16(INK4a)-deficient breast epithelial MCF-10A cells significantly increased the level of p21(WAF1), with no effect on cell proliferation. In addition, we have shown direct correlation between p16(INK4a) and p21(WAF1) levels in various cancer cell lines. Conclusion/Significance: These findings show that p16(INK4a) stabilizes the CDKN1A mRNA in an AUF1-dependent manner, and further confirm the presence of a direct link between the 2 important cancer-related pathways, pRB/p16(INK4a) and p14(ARF)/p53/p21(WAF1).	[Al-Khalaf, Huda H.; Aboussekhra, Abdelilah] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia; [Al-Khalaf, Huda H.] King Abdulaziz City Sci & Technol, Joint Ctr Genom Res, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Abdulaziz City for Science & Technology	Aboussekhra, A (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia.	aboussekhra@kfshrc.edu.sa	Alkhalaf, Huda/Z-5701-2019					Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; Al-Ansari MM, 2013, ONCOGENE, V32, P2356, DOI 10.1038/onc.2012.270; Al-Haj L, 2012, NUCLEIC ACIDS RES, V40, P7739, DOI 10.1093/nar/gks545; Al-Khalaf HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021111; Al-Mohanna MA, 2004, ONCOGENE, V23, P201, DOI 10.1038/sj.onc.1206927; Al-Mohanna MA, 2007, NUCLEIC ACIDS RES, V35, P223, DOI 10.1093/nar/gkl1075; Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Anderson WF, 2007, CANCER CAUSE CONTROL, V18, P1187, DOI 10.1007/s10552-007-9057-x; Bardeesy N, 2001, SEMIN CANCER BIOL, V11, P201, DOI 10.1006/scbi.2000.0371; Bodner SM, 1999, GENE, V229, P223, DOI 10.1016/S0378-1119(98)00591-5; Bond JA, 1999, MOL CELL BIOL, V19, P3103; CANNONALBRIGHT LA, 1994, GENOMICS, V23, P265, DOI 10.1006/geno.1994.1491; CHENG JQ, 1994, CANCER RES, V54, P5547; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; De la Cueva E, 2006, ONCOGENE, V25, P4128, DOI 10.1038/sj.onc.1209432; Dotto, 2000, BIOCHIM BIOPHYS ACTA, V1471, pM43; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Fukushima K, 2001, HEPATOL RES, V20, P52, DOI 10.1016/S1386-6346(00)00122-4; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 1998, ONCOGENE, V17, P3463, DOI 10.1038/sj.onc.1202240; Gartel AL, 2006, MOL CANCER THER, V5, P1385, DOI 10.1158/1535-7163.MCT-06-0163; Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hawsawi NM, 2008, CANCER RES, V68, P2717, DOI 10.1158/0008-5472.CAN-08-0192; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Li JN, 2011, BIOCHEMISTRY-US, V50, P5566, DOI 10.1021/bi200642e; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Mitra J, 1999, MOL CELL BIOL, V19, P3916; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Parry D, 1999, MOL CELL BIOL, V19, P1775; Pei XH, 2005, ONCOGENE, V24, P2787, DOI 10.1038/sj.onc.1208611; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang WG, 2005, EMBO REP, V6, P158, DOI 10.1038/sj.embor.7400346; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590	43	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70133	10.1371/journal.pone.0070133	http://dx.doi.org/10.1371/journal.pone.0070133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894605	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000188
J	Bayer, I; Groth, P; Schneckener, S				Bayer, Immanuel; Groth, Philip; Schneckener, Sebastian			Prediction Errors in Learning Drug Response from Gene Expression Data - Influence of Labeling, Sample Size, and Machine Learning Algorithm	PLOS ONE			English	Article							MICROARRAY; SELECTION; REGULARIZATION; CLASSIFICATION; UPDATE	Model-based prediction is dependent on many choices ranging from the sample collection and prediction endpoint to the choice of algorithm and its parameters. Here we studied the effects of such choices, exemplified by predicting sensitivity (as IC50) of cancer cell lines towards a variety of compounds. For this, we used three independent sample collections and applied several machine learning algorithms for predicting a variety of endpoints for drug response. We compared all possible models for combinations of sample collections, algorithm, drug, and labeling to an identically generated null model. The predictability of treatment effects varies among compounds, i.e. response could be predicted for some but not for all. The choice of sample collection plays a major role towards lowering the prediction error, as does sample size. However, we found that no algorithm was able to consistently outperform the other and there was no significant difference between regression and two-or three class predictors in this experimental setting. These results indicate that response-modeling projects should direct efforts mainly towards sample collection and data quality, rather than method adjustment.	[Bayer, Immanuel] Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci AICES, Aachen, Germany; [Groth, Philip] Bayer Pharma AG, Therapeut Res Grp, Berlin, Germany; [Schneckener, Sebastian] Bayer Technol Serv GmbH, Syst Biol, Leverkusen, Germany	RWTH Aachen University; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG	Schneckener, S (corresponding author), Bayer Technol Serv GmbH, Syst Biol, Leverkusen, Germany.	sebastian.schneckener@bayer.com			BMBF (Federal Ministry of Education and Research); MedSys projects PREDICT [0315428F]; OncoPred [0315416B]	BMBF (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); MedSys projects PREDICT; OncoPred	Some of the authors have received (partial) funding from the BMBF (Federal Ministry of Education and Research), MedSys projects PREDICT (0315428F) and OncoPred (0315416B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop CM, 2007, COMMITTEES PATTERN R, P655; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Good PI, 2000, TBD PERMUTATION TEST; Guyon I, 1993, ADV NEURAL INFORM PR, V5, P147; Hanczar B, 2010, CURR BIOINFORM, V5, P29, DOI 10.2174/157489310790596376; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Hastie T, 2011, ELEMENTS STAT LEARNI, P649; Hastie T, 2011, RANDOM FORESTS ELEME, P587; Holbeck SL, 2004, EUR J CANCER, V40, P785, DOI 10.1016/j.ejca.2003.11.022; Hornik M, 2012, R PACKAGE VERSION 1; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Kaufman L., 1990, FINDING GROUPS DATA, P68, DOI [10.1002/9780470316801.ch2, DOI 10.1002/9780470316801.CH2]; Meyer D, 2011, E1071 MISC FUNCTIONS; Miller CJ, 2007, SIMPLEAFFY VERY SIMP; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Provost F., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P445; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schneckener S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-73; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Therneau T.M., 2011, RPART RECURSIVE PART; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Zhu J, 2004, BIOSTATISTICS, V5, P427, DOI 10.1093/biostatistics/kxg046; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	33	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70294	10.1371/journal.pone.0070294	http://dx.doi.org/10.1371/journal.pone.0070294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894636	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000203
J	Chen, XY; Gao, HW; Yao, XH; Chen, ZH; Fang, HD; Ye, SF				Chen, Xiaoyan; Gao, Huiwang; Yao, Xiaohong; Chen, Zhenhua; Fang, Hongda; Ye, Shufeng			Ecosystem Health Assessment in the Pearl River Estuary of China by Considering Ecosystem Coordination	PLOS ONE			English	Article							CHANGJIANG YANGTZE; OXYGEN DEPLETION; BAY; BIODIVERSITY; RESTORATION; IMPACTS	Marine ecosystem is a complex nonlinear system. However, ecosystem health assessment conventionally builds on a linear superposition of changes in ecosystem components and probably fails to evaluate nonlinear interactions among various components. To better reflect the intrinsic interactions and their impacts on ecosystem health, an ecosystem coordination index, defined as the matching level of ecosystem structure/services, is proposed and incorporated into the ecosystem health index for a systematic diagnosis in the Pearl River Estuary, China. The analysis results show that the ecosystem health index over the last three decades decreased from 0.91 to 0.50, indicating deteriorating from healthy to unhealthy status. The health index is 3-16% lower than that calculated using the common method without considering ecosystem coordination. Ecosystem health degradation in the Pearl River Estuary manifested as significant decreases in structure/services and somewhat mismatching among them. Overall, the introduction of coordination in ecosystem health assessment could improve the understanding of the mechanism of marine ecosystem change and facilitate effective restoration of ecosystem health.	[Chen, Xiaoyan; Gao, Huiwang; Yao, Xiaohong] OceanUniv China, Key Lab Marine Environm & Ecol, Minist Educ China, Qingdao, Peoples R China; [Chen, Zhenhua] Ocean Univ China, Coll Phys & Environm Oceanog, Qingdao, Peoples R China; [Fang, Hongda] State Ocean Adm, South China Sea Branch, South China Sea Environm Monitoring Ctr, Guangzhou, Guangdong, Peoples R China; [Ye, Shufeng] State Ocean Adm, East China Sea Branch, East China Sea Environm Monitoring Ctr, Guangzhou, Guangdong, Peoples R China	Ministry of Education, China; Ocean University of China; State Oceanic Administration; State Oceanic Administration	Gao, HW (corresponding author), OceanUniv China, Key Lab Marine Environm & Ecol, Minist Educ China, Qingdao, Peoples R China.	hwgao@ouc.edu.cn			Marine Public Welfare Research Project of China [201205001, 200905010-6, 201105010]	Marine Public Welfare Research Project of China	Marine Public Welfare Research Project of China (201205001, 200905010-6, 201105010) http://www.soa.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, REP PEARL RIV EST EC; [Anonymous], 2009, SEA LEV B CHIN; [Anonymous], 2009, MAR ENV QUAL B GUANG; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chen SS, 2005, OCEAN COAST MANAGE, V48, P65, DOI 10.1016/j.ocecoaman.2004.11.004; Chen T, 2010, MAMMALIA, V74, P117, DOI 10.1515/MAMM.2010.024; Chen W, 2004, J XIAMEN U NATURAL S, V43, P230; Chen XY, 2010, ENVIRON SCI TECHNOL, V44, P7589, DOI 10.1021/es1008592; [陈裕隆 CHEN Yulong], 2008, [海洋环境科学, Marine Environmental Science], V27, P580; Dai MH, 2006, MAR CHEM, V102, P159, DOI 10.1016/j.marchem.2005.09.020; Depledge MH, 2005, FRONT ECOL ENVIRON, V3, P251; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; Gan Ju-li, 2010, Marine Environmental Science, V29, P36; [甘居利 GAN Juli], 2008, [海洋环境科学, Marine Environmental Science], V27, P149; Gao Y, 2010, INT GEOSCI REMOTE SE, P429, DOI 10.1109/IGARSS.2010.5651648; Harrison PJ, 2008, CONT SHELF RES, V28, P1405, DOI 10.1016/j.csr.2007.02.011; Huang Jian-sheng, 2007, China Environmental Science, V27, P461; Huang Liangmin, 1997, Marine Environmental Science, V16, P1; Huang XP, 2003, MAR POLLUT BULL, V47, P30, DOI 10.1016/S0025-326X(02)00474-5; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; [贾培宏 JIA Peihong], 2007, [海洋通报, Marine Science Bulletin], V26, P66; Jiang Jie, 2009, Journal of Environment and Health, V26, P814; Jiang Wan-xiang, 2010, Journal of Ecology and Rural Environment, V26, P132; Jo T, 1999, ECOLOGICAL IMPACT AS; Kang Y, 2005, ACTA SCI CIRCUMSTANT, V25, P45; Knap A, 2002, ENVIRON HEALTH PERSP, V110, P839, DOI 10.1289/ehp.02110839; Li DJ, 2002, SCI CHINA SER D, V45, P1137, DOI 10.1360/02yd9110; [黎夏 Li Xia], 2006, [地理学报, Acta Geographica Sinica], V61, P26; [Liu Xiaonan 刘晓南], 2004, Journal of Geographical Sciences, V14, P219; [马媛 MA Yuan], 2009, [海洋学报, Acta Oceanologica Sinica], V31, P69; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; Midgley GF, 2012, SCIENCE, V335, P174, DOI 10.1126/science.1217245; Millennium Ecosystem Assessment Program, 2005, EC HUM WELL BEING OU; Peng XZ, 2005, MAR POLLUT BULL, V50, P856, DOI 10.1016/j.marpolbul.2005.02.031; Peng Y., 2009, ACTA ECOL SIN, V29, P357, DOI DOI 10.1016/j.chnaes.2009.09.017; PRECWDNNR, 2010, HEAV POLL AR S CHIN; Rabouille C, 2008, CONT SHELF RES, V28, P1527, DOI 10.1016/j.csr.2008.01.020; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Reid WV, 2009, SCIENCE, V325, P245, DOI 10.1126/science.1178591; [施祺 SHI Qi], 2007, [海洋环境科学, Marine Environmental Science], V26, P553; Shi Xiao-jun, 2008, Marine Geology & Quaternary Geology, V28, P127; Solimini AG, 2009, TRAC-TREND ANAL CHEM, V28, P143, DOI 10.1016/j.trac.2008.10.015; Stokstad E, 2009, SCIENCE, V324, P1138, DOI 10.1126/science.324_1138; Tang C, 2006, J OCEANOGR TAIWAN ST, V25, P101; Tang Q., 2007, DPS DATA PROCESSING; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Wang C, 2007, PROD RES; Wang SF, 2008, HYDROBIOLOGIA, V596, P79, DOI 10.1007/s10750-007-9059-4; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wursig B, 2002, MAR ENVIRON RES, V54, P129, DOI 10.1016/S0141-1136(02)00099-5; Yin KD, 2004, CONT SHELF RES, V24, P1935, DOI 10.1016/j.csr.2004.06.017; You D., 2009, GUANGDONG METEOROL, V31, P4; Zhang H, 2010, J MARINE SYST, V79, P65, DOI 10.1016/j.jmarsys.2009.07.002; [张敬怀 ZHANG Jing-huai], 2009, [海洋通报, Marine Science Bulletin], V28, P26; Zhang L, 2009, ESTUAR COAST SHELF S, V85, P190, DOI 10.1016/j.ecss.2009.07.035; Zhou HY, 2004, CONT SHELF RES, V24, P1857, DOI 10.1016/j.csr.2004.06.012	59	22	24	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70547	10.1371/journal.pone.0070547	http://dx.doi.org/10.1371/journal.pone.0070547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894670	Green Submitted, gold, Green Published			2022-12-25	WOS:000325211000215
J	Galbally, J; Martinez-Diaz, M; Fierrez, J				Galbally, Javier; Martinez-Diaz, Marcos; Fierrez, Julian			Aging in Biometrics: An Experimental Analysis on On-Line Signature	PLOS ONE			English	Article							SCORE NORMALIZATION; AGE; VERIFICATION; PERFORMANCE; FACE; UPDATE	The first consistent and reproducible evaluation of the effect of aging on dynamic signature is reported. Experiments are carried out on a database generated from two previous datasets which were acquired, under very similar conditions, in 6 sessions distributed in a 15-month time span. Three different systems, representing the current most popular approaches in signature recognition, are used in the experiments, proving the degradation suffered by this trait with the passing of time. Several template update strategies are also studied as possible measures to reduce the impact of aging on the system's performance. Different results regarding the way in which signatures tend to change with time, and their most and least stable features, are also given.	[Galbally, Javier; Martinez-Diaz, Marcos; Fierrez, Julian] Univ Autonoma Madrid, Biometr Recognit Grp ATVS, Madrid, Spain	Autonomous University of Madrid	Galbally, J (corresponding author), Univ Autonoma Madrid, Biometr Recognit Grp ATVS, Madrid, Spain.	javier.galbally@uam.es	Fierrez, Julian/A-1884-2008; Martinez-Diaz, Marcos/O-7134-2019; Martinez-Diaz, Marcos/L-2547-2013	Fierrez, Julian/0000-0002-6343-5656; Martinez-Diaz, Marcos/0000-0001-5518-1126; Martinez-Diaz, Marcos/0000-0001-5518-1126; GALBALLY, JAVIER/0000-0002-2009-0256	CAM [S2009/TIC-1485]; Spanish MECD [TEC2009-11186, TEC2012-34881]; Catedra UAM-Telefonica; Spanish Direccion General de laGuardia Civil	CAM; Spanish MECD(Spanish Government); Catedra UAM-Telefonica; Spanish Direccion General de laGuardia Civil	This work has been partially supported by projects Contexts (S2009/TIC-1485) from CAM, by Bio-Challenge (TEC2009-11186) and Bio-Shield (TEC2012-34881) from Spanish MECD, by Catedra UAM-Telefonica, and by the Spanish Direccion General de laGuardia Civil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert AM, 2007, FORENSIC SCI INT, V172, P1, DOI 10.1016/j.forsciint.2007.03.015; Alonso-Fernandez F, 2009, P INT S IM SIGN PROC, P16; [Anonymous], 2005, 197947 ISOIEC; [Anonymous], P INT C SPOK LANG PR; [Anonymous], 2005, 3952005 ANSIINCITS; [Anonymous], 2005, 1979411 ISOIEC; Cappelli R, 2006, IEEE T PATTERN ANAL, V28, P3, DOI 10.1109/TPAMI.2006.20; Carls JW, 2009, THESIS US AIR FORCE; Coleman Sydney R, 2006, Aesthet Surg J, V26, pS4, DOI 10.1016/j.asj.2005.09.012; DIXON RA, 1993, PSYCHOL AGING, V8, P360, DOI 10.1037/0882-7974.8.3.360; Dobry G, 2011, IEEE T AUDIO SPEECH, V19, P1975, DOI 10.1109/TASL.2011.2104955; Erbilek M, 2012, IET BIOMETRICS, V1, P136, DOI 10.1049/iet-bmt.2012.0011; Faundez-Zanuy M, 2012, INT CARN CONF SECU, P105, DOI 10.1109/CCST.2012.6393544; Fierrez J, 2010, PATTERN ANAL APPL, V13, P235, DOI 10.1007/s10044-009-0151-4; Fierrez J, 2007, PATTERN RECOGN LETT, V28, P2325, DOI 10.1016/j.patrec.2007.07.012; Fierrez J, 2007, PATTERN RECOGN, V40, P1389, DOI 10.1016/j.patcog.2006.10.014; Fierrez-Aguilar J, 2005, LECT NOTES COMPUT SC, V3546, P523; Fierrez-Aguilar J, 2005, IEEE T SYST MAN CY C, V35, P418, DOI 10.1109/TSMCC.2005.848181; Galbally Javier, 2009, 2009 10th International Conference on Document Analysis and Recognition (ICDAR), P1295, DOI 10.1109/ICDAR.2009.38; Galbally J, 2008, INT CONF ACOUST SPEE, P1697, DOI 10.1109/ICASSP.2008.4517955; Geng X, 2007, IEEE T PATTERN ANAL, V29, P2234, DOI 10.1109/TPAMI.2007.70733; Guest R, 2006, PATTERN RECOGN LETT, V27, P1098, DOI 10.1016/j.patrec.2005.12.008; Haibin Ling, 2007, 2007 11th IEEE International Conference on Computer Vision, P1; Hasan Muhammad Z, 2012, P OPT FIB COMM LOS A, P1; Houmani N, 2012, PATTERN RECOGN, V45, P993, DOI 10.1016/j.patcog.2011.08.008; Houmani N, 2009, 2009 IEEE 3RD INTERNATIONAL CONFERENCE ON BIOMETRICS: THEORY, APPLICATIONS AND SYSTEMS, P159; Jain A, 2005, PATTERN RECOGN, V38, P2270, DOI 10.1016/j.patcog.2005.01.012; Jain A.K., 2008, HDB BIOMETRICS; Jain AK, 2002, PATTERN RECOGN, V35, P2963, DOI 10.1016/S0031-3203(01)00240-0; Jain AK, 2006, IEEE T INF FOREN SEC, V1, P125, DOI 10.1109/TIFS.2006.873653; James L., 2005, BIOMETRIC SYSTEMS TE; Ketcham CJ, 2003, P IGS 2003, P42; Kholmatov A, 2005, PATTERN RECOGN LETT, V26, P2400, DOI 10.1016/j.patrec.2005.04.017; Kwon YH, 1999, COMPUT VIS IMAGE UND, V74, P1, DOI 10.1006/cviu.1997.0549; Lanitis A, 2004, IEEE T SYST MAN CY B, V34, P621, DOI 10.1109/TSMCB.2003.817091; Lanitis A, 2002, IEEE T PATTERN ANAL, V24, P442, DOI 10.1109/34.993553; Lanitis A., 2008, IEEE INT C AUT FAC G, P1, DOI DOI 10.1109/AFGR.2008.4813349; Lanitis A, 2010, INT J BIOMETRICS, V2, P34, DOI 10.1504/IJBM.2010.030415; Lumini A, 2006, PATTERN RECOGN, V39, P495, DOI 10.1016/j.patcog.2005.11.004; Martinez-Diaz M., 2009, ENCY BIOMETRICS, P1185; Martinez-Diaz M., 2009, ENCY BIOMETRICS, P1192; Modi SK, 2007, 2007 IEEE WORKSHOP ON AUTOMATIC IDENTIFICATION ADVANCED TECHNOLOGIES, PROCEEDINGS, P19, DOI 10.1109/AUTOID.2007.380586; Modi SK, 2006, 6 INT C REC ADV SOFT, P10; MORGAN M, 1994, BRAIN COGNITION, V25, P194, DOI 10.1006/brcg.1994.1030; Mueller PB, 1997, SEMINARS SPEECH LANG, V18; O'Reilly C., 2012, 2012 11th International Conference on Information Sciences, Signal Processing and their Applications (ISSPA), P787, DOI 10.1109/ISSPA.2012.6310660; Ortega-Garcia J, 2010, IEEE T PATTERN ANAL, V32, P1097, DOI 10.1109/TPAMI.2009.76; Park U, 2010, IEEE T PATTERN ANAL, V32, P947, DOI 10.1109/TPAMI.2010.14; Poh N, 2006, P WORKSH MULT US AUT, P1; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Ramanathan N, 2006, IEEE T IMAGE PROCESS, V15, P3349, DOI 10.1109/TIP.2006.881993; Rattani A, 2009, LECT NOTES COMPUT SC, V5558, P847, DOI 10.1007/978-3-642-01793-3_86; Rattani A, 2008, 2008 BIOMETRICS SYMPOSIUM (BSYM), P23, DOI 10.1109/BSYM.2008.4655518; Rawls AW, 2009, LECT NOTES COMPUT SC, V5707, P17, DOI 10.1007/978-3-642-04391-8_3; Roli F, 2007, LECT NOTES COMPUT SC, V4642, P1194; Scheidat T, 2012, LECT NOTES COMPUT SC, V7394, P107; Scheidat T, 2011, PROC SPIE, V7881, DOI 10.1117/12.872417; Suo J. L., 2007, IEEE C COMP VIS PATT, P1, DOI DOI 10.1109/CVPR.2007.383055; Uludag U, 2004, PATTERN RECOGN, V37, P1533, DOI 10.1016/j.patcog.2003.11.012; van Drempt N, 2011, AUST OCCUP THER J, V58, P321, DOI 10.1111/j.1440-1630.2011.00960.x; Veres GV, 2005, PROCEEDINGS OF THE 2005 INTELLIGENT SENSORS, SENSOR NETWORKS & INFORMATION PROCESSING CONFERENCE, P325; Walton J, 1997, FORENSIC SCI INT, V88, P197, DOI 10.1016/S0379-0738(97)00105-9; Yeung DY, 2004, LECT NOTES COMPUT SC, V3072, P16	64	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69897	10.1371/journal.pone.0069897	http://dx.doi.org/10.1371/journal.pone.0069897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894557	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000165
J	Wu, H; Hou, C; Huang, LQ; Yan, FS; Wang, CZ				Wu, Han; Hou, Chao; Huang, Ling-Qiao; Yan, Fu-Shun; Wang, Chen-Zhu			Peripheral Coding of Sex Pheromone Blends with Reverse Ratios in Two Helicoverpa Species	PLOS ONE			English	Article							TOBACCO BUDWORM MOTH; OLFACTORY RECEPTOR NEURONS; ASSULTA GUENEE LEPIDOPTERA; CORN-EARWORM MOTH; ANTENNAL LOBE; HELIOTHIS-VIRESCENS; CHEMICAL COMMUNICATION; ODOR MIXTURES; MACROGLOMERULAR COMPLEX; NUCLEAR GENE	The relative proportions of components in a pheromone blend play a major role in sexual recognition in moths. Two sympatric species, Helicoverpa armigera and Helicoverpa assulta, use (Z)-11-hexadecenal (Z11-16: Ald) and (Z)-9-hexadecenal (Z9-16: Ald) as essential sex pheromone components but in very different ratios, 97: 3 and 7: 93 respectively. Using wind tunnel tests, single sensillum recording and in vivo calcium imaging, we comparatively studied behavioral responses and physiological activities at the level of antennal sensilla and antennal lobe (AL) in males of the two species to blends of the two pheromone components in different ratios (100: 0, 97: 3, 50: 50, 7: 93, 0: 100). Z11-16: Ald and Z9-16: Ald were recognized by two populations of olfactory sensory neurons (OSNs) in different trichoid sensilla on antennae of both species. The ratios of OSNs responding to Z11-16: Ald and Z9-16: Ald OSNs were 100:28.9 and 21.9:100 in H. armigera and H. assulta, respectively. The Z11-16: Ald OSNs in H. armigera exhibited higher sensitivity and efficacy than those in H. assulta, while the Z9-16: Ald OSNs in H. armigera had the same sensitivity but lower efficacy than those in H. assulta. At the dosage of 10 mg, Z11-16: Ald and Z9-16: Ald evoked calcium activity in 8.5% and 3.0% of the AL surface in H. armigera, while 5.4% and 8.6% of AL in H. assulta, respectively. The calcium activities in the AL reflected the peripheral input signals of the binary pheromone mixtures and correlated with the behavioral output. These results demonstrate that the binary pheromone blends were precisely coded by the firing frequency of individual OSNs tuned to Z11-16: Ald or Z9-16: Ald, as well as their population sizes. Such information was then accurately reported to ALs of H. armigera and H. assulta, eventually producing different behaviors.	[Wu, Han; Hou, Chao; Huang, Ling-Qiao; Yan, Fu-Shun; Wang, Chen-Zhu] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Wang, CZ (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	czwang@ioz.ac.cn			National Natural Science Foundation of China [31130050]; National Basic Research Program of China [2012CB114105]; Chinese Academy of Sciences innovation program [KSCX2-EW-N-005]; National Science Fund for Distinguished Young Scholars [30925026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences innovation program(Chinese Academy of Sciences); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Natural Science Foundation of China (Grant No. 31130050), National Basic Research Program of China (Grant No. 2012CB114105), the Chinese Academy of Sciences innovation program (Grant No. KSCX2-EW-N-005), and National Science Fund for Distinguished Young Scholars (Grant No. 30925026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMAAS TJ, 1990, J CHEM ECOL, V16, P1331, DOI 10.1007/BF01021030; ALMAAS TJ, 1991, J CHEM ECOL, V17, P953, DOI 10.1007/BF01395602; ALMAAS TJ, 1991, J COMP PHYSIOL A, V169, P249; ARN H, 1992, LIST SEX PHEROMONES; Baker TC, 2012, CHEM SENSES, V37, P299, DOI 10.1093/chemse/bjr122; Baker TC, 2004, J COMP PHYSIOL A, V190, P155, DOI 10.1007/s00359-003-0483-2; Baker TC, 2008, J CHEM ECOL, V34, P971, DOI 10.1007/s10886-008-9468-5; Belmabrouk H, 2011, P NATL ACAD SCI USA, V108, P19790, DOI 10.1073/pnas.1112367108; Berg BG, 2005, J COMP NEUROL, V486, P209, DOI 10.1002/cne.20544; Berg BG, 2002, J COMP NEUROL, V446, P123, DOI 10.1002/cne.10180; Berg BG, 1998, J COMP PHYSIOL A, V183, P669, DOI 10.1007/s003590050290; BERG BG, 1995, J COMP PHYSIOL A, V177, P683, DOI 10.1007/BF00187627; BERG BG, 1995, J COMP PHYSIOL A, V177, P527, DOI 10.1007/BF00207182; Carlsson MA, 2007, CHEM SENSES, V32, P433, DOI 10.1093/chemse/bjm009; CHO SW, 1995, MOL BIOL EVOL, V12, P650; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; CHRISTENSEN TA, 1991, J COMP PHYSIOL A, V169, P259; CORK A, 1992, J CHEM ECOL, V18, P403, DOI 10.1007/BF00994240; Cosse AA, 1998, J COMP PHYSIOL A, V182, P585, DOI 10.1007/s003590050205; COSSE AA, 1995, EXPERIENTIA, V51, P809, DOI 10.1007/BF01922435; Deisig N, 2006, EUR J NEUROSCI, V24, P1161, DOI 10.1111/j.1460-9568.2006.04959.x; Deisig N, 2010, J NEUROPHYSIOL, V103, P2185, DOI 10.1152/jn.00342.2009; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Fang QQ, 1997, SYST BIOL, V46, P269, DOI 10.2307/2413623; Galizia C. Giovanni, 2005, P349; Galizia CG, 1998, EUR J NEUROSCI, V10, P2964, DOI 10.1111/j.1460-9568.1998.00303.x; Galizia CG, 2000, J COMP PHYSIOL A, V186, P1049, DOI 10.1007/s003590000156; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; HANSSON BS, 1994, TISSUE CELL, V26, P503, DOI 10.1016/0040-8166(94)90003-5; HANSSON BS, 1991, J COMP NEUROL, V312, P264, DOI 10.1002/cne.903120209; Hansson BS, 2003, J COMP PHYSIOL A, V189, P301, DOI 10.1007/s00359-003-0403-5; HANSSON BS, 1987, NATURWISSENSCHAFTEN, V74, P497, DOI 10.1007/BF00447935; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kaissling KE, 2009, J COMP PHYSIOL A, V195, P895, DOI 10.1007/s00359-009-0461-4; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; KAISSLING KE, 1989, ARCH INSECT BIOCHEM, V10, P273, DOI 10.1002/arch.940100403; Kaissling KE, 1974, BIOCH SENSORY FUNCTI, P243; Kandel E. R., 2001, PRINCIPLES NEURAL SC; Karpati Z, 2008, J EXP BIOL, V211, P3351, DOI 10.1242/jeb.025049; Karpati Z, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-286; KEHAT M, 1980, ENTOMOL EXP APPL, V27, P188, DOI 10.1007/BF00573893; KLUN JA, 1980, J CHEM ECOL, V6, P165, DOI 10.1007/BF00987535; Kuebler LS, 2012, J NEUROSCI, V32, P5772, DOI 10.1523/JNEUROSCI.6225-11.2012; Lee SG, 2006, CHEM SENSES, V31, P821, DOI 10.1093/chemse/bjl025; Lee SG, 2006, J COMP PHYSIOL A, V192, P351, DOI 10.1007/s00359-005-0071-8; Lei H, 2008, J CHEM ECOL, V34, P915, DOI 10.1007/s10886-008-9487-2; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Ming QL, 2007, J INSECT PHYSIOL, V53, P170, DOI 10.1016/j.jinsphys.2006.11.007; MITTER C, 1993, ANNU REV ENTOMOL, V38, P207, DOI 10.1146/annurev.en.38.010193.001231; Mustaparta H, 1997, INSECT PHEROMONE RESEARCH, P144; Party V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052897; POPE MM, 1984, J INSECT PHYSIOL, V30, P943, DOI 10.1016/0022-1910(84)90072-6; ROELOFS W, 1987, P NATL ACAD SCI USA, V84, P7585, DOI 10.1073/pnas.84.21.7585; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Schneider D, 1970, NEUROSCIENCES 2ND ST, P511; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Skiri HT, 2005, J COMP NEUROL, V491, P367, DOI 10.1002/cne.20692; SUGIE H, 1991, APPL ENTOMOL ZOOL, V26, P151, DOI 10.1303/aez.26.151; Szyszka P, 2005, J NEUROPHYSIOL, V94, P3303, DOI 10.1152/jn.00397.2005; TEAL PEA, 1984, CAN ENTOMOL, V116, P777, DOI 10.4039/Ent116777-5; Vickers NJ, 2003, CHEM SENSES, V28, P325, DOI 10.1093/chemse/28.4.325; VICKERS NJ, 1991, J COMP PHYSIOL A, V169, P275; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang CZ, 2007, CHINESE SCI BULL, V52, P284, DOI 10.1007/s11434-007-0029-z; Wang HL, 2005, INSECT BIOCHEM MOLEC, V35, P575, DOI 10.1016/j.ibmb.2005.01.018; Wu Kunjun, 1997, Entomologia Sinica, V4, P277; Zavada A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016308; Zhao XC, 2006, J COMP PHYSIOL A, V192, P1037, DOI 10.1007/s00359-006-0141-6; Zhao XC, 2010, CHEM SENSES, V35, P511, DOI 10.1093/chemse/bjq043	71	57	64	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70078	10.1371/journal.pone.0070078	http://dx.doi.org/10.1371/journal.pone.0070078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894593	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000183
J	Chen, SC; Yin, YP; Chen, XS; Wang, HC; Yu, YH; Wei, WH; Han, Y; Jiang, N; Wang, BX				Chen, Shaochun; Yin, Yueping; Chen, Xiangsheng; Wang, Hongchun; Yu, Yanhua; Wei, Wanhui; Han, Yan; Jiang, Ning; Wang, Baoxi			Seropositivity and Risk Factors for Herpes Simplex Virus Type 2 Infection among Female Sex Workers in Guangxi, China	PLOS ONE			English	Article							YUNNAN PROVINCE; HIV-1; ACQUISITION; CONDOMS	Objectives: To determine seropositivity of herpes simplex virus type 2 (HSV-2) infection and associated risk factors among female sex workers (FSWs) in Guangxi, China. Methods: A convenience sample of FSWs was recruited from different types of sex work venues in two cities (Wuzhou and Hezhou) in Guangxi. Blood specimens were collected for ELISA-based detection of HSV-2 antibodies to examine the seropositivity of HSV-2 infection. Socio-demographic and behavioral data were collected through a structured questionnaire interview. Association of HSV-2 seropositivity with socio-demographic and behavioral characteristics and HIV status was analyzed. Results: The overall prevalence of HSV-2 seropositivity among 2453 FSWs was 54.9% (95% confidence interval [CI], 52.956.9%). The HSV-2 seropositivity was independently associated with older age, low education level, non-Han minority, migration status, working in lower-tier venues and positive HIV status. Conclusions: The study indicates a high prevalence of HSV-2 infection among FSWs, particularly in those working in low-tier venues in study areas, suggesting the needs to further emphasize the inclusion of HSV-2 in surveillance and intervention programs in this population.	[Yin, Yueping] Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China; Chinese Acad Med Sci, Nanjing, Jiangsu, Peoples R China; Peking Union Med Coll, Inst Dermatol, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College	Yin, YP (corresponding author), Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China.	yinyp@ncstdlc.org		Chen, Shaochun/0000-0002-6447-928X	Mega Project of the National Science Research of China for the 11th Five-Year Plan [2008ZX10001-005]	Mega Project of the National Science Research of China for the 11th Five-Year Plan	This study is supported by grants from the Mega Project of the National Science Research of China for the 11th Five-Year Plan (2008ZX10001-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XS, 2005, AIDS PATIENT CARE ST, V19, P853, DOI 10.1089/apc.2005.19.853; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; COWAN FM, 1994, BRIT MED J, V309, P1325, DOI 10.1136/bmj.309.6965.1325; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Martin ET, 2009, ARCH INTERN MED, V169, P1233, DOI 10.1001/archinternmed.2009.177; Ngo TD, 2008, INT J STD AIDS, V19, P694, DOI 10.1258/ijsa.2008.008072; Renzi C, 2003, J INFECT DIS, V187, P19, DOI 10.1086/345867; Wald A, 2005, ANN INTERN MED, V143, P707, DOI 10.7326/0003-4819-143-10-200511150-00007; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wang BX, 2012, J INFECT DIS, V206, P907, DOI 10.1093/infdis/jis466; Wang HB, 2008, INT J STD AIDS, V19, P635, DOI 10.1258/ijsa.2008.008013; Wang L, 2010, CHINESE MED J-PEKING, V123, P3495, DOI 10.3760/cma.j.issn.0366-6999.2010.23.022; Wang Q, 2009, CHIN J AIDS STDS, V15, P398; Wei Shan-Bo, 2004, Sex Health, V1, P141, DOI 10.1071/SH03011; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b; Yang XS, 2006, AIDS EDUC PREV, V18, P333, DOI 10.1521/aeap.2006.18.4.333; Yang Y, 2011, AIDS CARE, V23, P37, DOI 10.1080/09540121.2011.555740; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006; Zhu TF, 2005, CELL RES, V15, P852, DOI 10.1038/sj.cr.7290358	20	1	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69697	10.1371/journal.pone.0069697	http://dx.doi.org/10.1371/journal.pone.0069697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894526	Green Submitted, Green Published, gold			2022-12-25	WOS:000322132100075
J	Tingling, JD; Bake, S; Holgate, R; Rawlings, J; Nagsuk, PP; Chandrasekharan, J; Schneider, SL; Miranda, RC				Tingling, Joseph D.; Bake, Shameena; Holgate, Rhonda; Rawlings, Jeremy; Nagsuk, Phillips P.; Chandrasekharan, Jayashree; Schneider, Sarah L.; Miranda, Rajesh C.			CD24 Expression Identifies Teratogen-Sensitive Fetal Neural Stem Cell Subpopulations: Evidence from Developmental Ethanol Exposure and Orthotopic Cell Transfer Models	PLOS ONE			English	Article							ALCOHOL SPECTRUM DISORDERS; ADULT SUBVENTRICULAR ZONE; RAT CEREBRAL-CORTEX; EX-VIVO MODEL; PROGENITOR CELLS; PRENATAL EXPOSURE; NERVOUS-SYSTEM; DENTATE GYRUS; IN-VITRO; DIFFERENTIATION	Background: Ethanol is a potent teratogen. Its adverse neural effects are partly mediated by disrupting fetal neurogenesis. The teratogenic process is poorly understood, and vulnerable neurogenic stages have not been identified. Identifying these is a prerequisite for therapeutic interventions to mitigate effects of teratogen exposures. Methods: We used flow cytometry and qRT-PCR to screen fetal mouse-derived neurosphere cultures for ethanol-sensitive neural stem cell (NSC) subpopulations, to study NSC renewal and differentiation. The identity of vulnerable NSC populations was validated in vivo, using a maternal ethanol exposure model. Finally, the effect of ethanol exposure on the ability of vulnerable NSC subpopulations to integrate into the fetal neurogenic environment was assessed following ultrasound guided, adoptive transfer. Results: Ethanol decreased NSC mRNAs for c-kit, Musashi-1and GFAP. The CD24(+) NSC population, specifically the CD24(+) CD15(+) double-positive subpopulation, was selectively decreased by ethanol. Maternal ethanol exposure also resulted in decreased fetal forebrain CD24 expression. Ethanol pre-exposed CD24(+) cells exhibited increased proliferation, and deficits in cell-autonomous and cue-directed neuronal differentiation, and following orthotopic transplantation into naive fetuses, were unable to integrate into neurogenic niches. CD24(depleted) cells retained neurosphere regeneration capacity, but following ethanol exposure, generated increased numbers of CD24(+) cells relative to controls. Conclusions: Neuronal lineage committed CD24(+) cells exhibit specific vulnerability, and ethanol exposure persistently impairs this population's cell-autonomous differentiation capacity. CD24(+) cells may additionally serve as quorum sensors within neurogenic niches; their loss, leading to compensatory NSC activation, perhaps depleting renewal capacity. These data collectively advance a mechanistic hypothesis for teratogenesis leading to microencephaly.	[Tingling, Joseph D.; Bake, Shameena; Holgate, Rhonda; Rawlings, Jeremy; Nagsuk, Phillips P.; Chandrasekharan, Jayashree; Schneider, Sarah L.; Miranda, Rajesh C.] Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Bryan, TX USA; [Tingling, Joseph D.; Bake, Shameena; Holgate, Rhonda; Rawlings, Jeremy; Nagsuk, Phillips P.; Chandrasekharan, Jayashree; Schneider, Sarah L.; Miranda, Rajesh C.] Texas A&M Hlth Sci Ctr, Womens Hlth Neurosci Program, Bryan, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Miranda, RC (corresponding author), Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Bryan, TX USA.	miranda@medicine.tamhsc.edu		Nagsuk, Phillips/0000-0002-7786-3344; Miranda, Rajesh/0000-0002-8359-892X	National Institute of Alcohol Abuse and Alcoholism [R01AA013440]; Texas A&M Health Science Center; Woman's Health in Neuroscience Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013440] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Texas A&M Health Science Center; Woman's Health in Neuroscience Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a grant from the National Institute of Alcohol Abuse and Alcoholism (R01AA013440) and by a pilot grant from the Texas A&M Health Science Center, Woman's Health in Neuroscience Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI J, 1991, J STUD ALCOHOL, V52, P448, DOI 10.15288/jsa.1991.52.448; Agur Z, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-20; Archer TC, 2011, DEV BIOL, V350, P429, DOI 10.1016/j.ydbio.2010.12.013; Archibald SL, 2001, DEV MED CHILD NEUROL, V43, P148, DOI 10.1017/S0012162201000299; Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101; Bake S, 2012, ALCOHOL CLIN EXP RES, V36, P748, DOI 10.1111/j.1530-0277.2011.01676.x; Balaraman S, 2012, ALCOHOL CLIN EXP RES, V36, P1669, DOI 10.1111/j.1530-0277.2012.01793.x; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; BARNES DE, 1981, DEV BRAIN RES, V1, P333, DOI 10.1016/0165-3806(81)90071-7; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Blumcke I, 1999, MICROSC RES TECHNIQ, V46, P53; Bonthius DJ, 2002, DEV BRAIN RES, V138, P45, DOI 10.1016/S0165-3806(02)00458-3; BROWN J, 1991, INT IMMUNOL, V3, P175, DOI 10.1093/intimm/3.2.175; Camarillo C, 2008, GENE EXPRESSION, V14, P159; Camarillo C, 2007, ALCOHOL CLIN EXP RES, V31, P324, DOI 10.1111/j.1530-0277.2006.00308.x; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chen SZ, 2012, J NEUROCHEM, V123, P602, DOI 10.1111/j.1471-4159.2012.07954.x; CLARREN SK, 1978, J PEDIATR-US, V92, P64, DOI 10.1016/S0022-3476(78)80072-9; Corsini NS, 2010, CELL STEM CELL, V6, P403, DOI 10.1016/j.stem.2010.04.003; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Erlandsson A, 2004, EXP CELL RES, V301, P201, DOI 10.1016/j.yexcr.2004.08.009; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Godin EA, 2010, ALCOHOL CLIN EXP RES, V34, P98, DOI 10.1111/j.1530-0277.2009.01071.x; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; JONES KL, 1973, LANCET, V1, P1267; KOTKOSKIE LA, 1989, EXP NEUROL, V106, P283, DOI 10.1016/0014-4886(89)90161-1; Lemoine P, 1968, OUEST MED, V21, P476; Littner Y, 2013, ALCOHOL CLIN EXP RES, V37, P383, DOI 10.1111/j.1530-0277.2012.01944.x; Liu J, 2012, STEM CELL REV REP, V8, P1129, DOI 10.1007/s12015-012-9411-6; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Maier SE, 1999, NEUROTOXICOL TERATOL, V21, P285, DOI 10.1016/S0892-0362(98)00056-7; Mattson SN, 2011, NEUROPSYCHOL REV, V21, P81, DOI 10.1007/s11065-011-9167-9; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; MILLER MW, 1989, J COMP NEUROL, V287, P326, DOI 10.1002/cne.902870305; MILLER MW, 1993, ALCOHOL CLIN EXP RES, V17, P304, DOI 10.1111/j.1530-0277.1993.tb00768.x; Miranda Rajesh C., 2012, Frontiers in Genetics, V3, P77, DOI 10.3389/fgene.2012.00077; Mooney SM, 2004, CEREB CORTEX, V14, P1071, DOI 10.1093/cercor/bhh066; NEDELEC J, 1992, EUR J BIOCHEM, V203, P433, DOI 10.1111/j.1432-1033.1992.tb16567.x; Nieoullon V, 2005, MOL CELL NEUROSCI, V28, P462, DOI 10.1016/j.mcn.2004.10.007; Nieoullon V, 2007, CELL TISSUE RES, V329, P457, DOI 10.1007/s00441-007-0395-5; O'Leary-Moore SK, 2010, BIRTH DEFECTS RES A, V88, P953, DOI 10.1002/bdra.20719; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; PAPANDRIKOPOULOU A, 1989, NATURE, V340, P650, DOI 10.1038/340650a0; Parish CR, 2009, CURR PROTOC IMMUNOL; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Prock TL, 2007, ALCOHOL CLIN EXP RES, V31, P694, DOI 10.1111/j.1530-0277.2007.00354.x; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Riikonen RS, 2005, BIOL PSYCHIAT, V57, P1565, DOI 10.1016/j.biopsych.2005.01.029; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Roitbak T, 2011, EXP NEUROL, V229, P522, DOI 10.1016/j.expneurol.2011.03.007; Runz S, 2008, BIOCHEM BIOPH RES CO, V365, P35, DOI 10.1016/j.bbrc.2007.10.139; SAMHSA, 2009, NSDUH REP SUBST US W NSDUH REP SUBST US W; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Santillano DR, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-59; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; SAVAGE DD, 1991, ALCOHOL, V8, P193, DOI 10.1016/0741-8329(91)90806-8; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Shewan D, 1996, J NEUROSCI, V16, P2624; Sudheendran N, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.020506; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tal TL, 2012, FASEB J, V26, P1452, DOI 10.1096/fj.11-194464; Talos F, 2010, CELL DEATH DIFFER, V17, P1816, DOI 10.1038/cdd.2010.131; Vangipuram SD, 2008, ALCOHOL CLIN EXP RES, V32, P339, DOI 10.1111/j.1530-0277.2007.00568.x; Vangipuram SD, 2012, ALCOHOL CLIN EXP RES, V36, P788, DOI 10.1111/j.1530-0277.2011.01682.x; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Vogel W, 2003, HAEMATOLOGICA, V88, P126; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhou F. C., 2011, ALCOHOL CLIN EXP RES, V35, P1	74	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69560	10.1371/journal.pone.0069560	http://dx.doi.org/10.1371/journal.pone.0069560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894503	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100069
J	Gordon, CA; Hartono, SR; Chedin, F				Gordon, Catherine A.; Hartono, Stella R.; Chedin, Frederic			Inactive DNMT3B Splice Variants Modulate De Novo DNA Methylation	PLOS ONE			English	Article							METHYLTRANSFERASE 3B; CHROMOSOME CONDENSATION; EXPRESSION; PROTEIN; BINDING; 3A; HYPOMETHYLATION; OVEREXPRESSION; MAINTENANCE; MUTATIONS	Inactive DNA methyltransferase (DNMT) 3B splice isoforms are associated with changes in DNA methylation, yet the mechanisms by which they act remain largely unknown. Using biochemical and cell culture assays, we show here that the inactive DNMT3B3 and DNMT3B4 isoforms bind to and regulate the activity of catalytically competent DNMT3A or DNMT3B molecules. DNMT3B3 modestly stimulated the de novo methylation activity of DNMT3A and also counteracted the stimulatory effects of DNMT3L, therefore leading to subtle and contrasting effects on activity. DNMT3B4, by contrast, significantly inhibited de novo DNA methylation by active DNMT3 molecules, most likely due to its ability to reduce the DNA binding affinity of co-complexes, thereby sequestering them away from their substrate. Immunocytochemistry experiments revealed that in addition to their effects on the intrinsic catalytic function of active DNMT3 enzymes, DNMT3B3 and DNMT34 drive distinct types of chromatin compaction and patterns of histone 3 lysine 9 tri-methylation (H3K9me3) deposition. Our findings suggest that regulation of active DNMT3 members through the formation of co-complexes with inactive DNMT3 variants is a general mechanism by which DNMT3 variants function. This may account for some of the changes in DNA methylation patterns observed during development and disease.	[Gordon, Catherine A.; Hartono, Stella R.; Chedin, Frederic] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Chedin, F (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	flchedin@ucdavis.edu		Chedin, Frederic/0000-0002-1306-5335	March of Dimes Foundation [5-FY07-502]; Concern Foundation; Floyd and Mary Schwall Fellowship; George Lee Fellowship; UCD & Humanities Graduate Research Awards	March of Dimes Foundation(March of Dimes); Concern Foundation; Floyd and Mary Schwall Fellowship; George Lee Fellowship; UCD & Humanities Graduate Research Awards	This work was supported by grants from the March of Dimes Foundation (5-FY07-502) and the Concern Foundation awarded to FC; and the Floyd and Mary Schwall Fellowship, George Lee Fellowship, and UCD & Humanities Graduate Research Awards awarded to CAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chedin F, 2011, PROG MOL BIOL TRANSL, V101, P255, DOI 10.1016/B978-0-12-387685-0.00007-X; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Chen ZX, 2005, BIOCHEM CELL BIOL, V83, P438, DOI 10.1139/O05-138; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Esteller M, 2002, SCIENCE, V297, P1807; Geiman TM, 2004, NUCLEIC ACIDS RES, V32, P2716, DOI 10.1093/nar/gkh589; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gopalakrishnan S, 2009, MOL CANCER RES, V7, P1622, DOI 10.1158/1541-7786.MCR-09-0018; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Huntriss J, 2004, MOL REPROD DEV, V67, P323, DOI 10.1002/mrd.20030; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Komashko VM, 2010, EPIGENETICS-US, V5; Merkiene E, 2005, NUCLEIC ACIDS RES, V33, P307, DOI 10.1093/nar/gki175; Moarefi AH, 2011, J MOL BIOL, V409, P758, DOI 10.1016/j.jmb.2011.04.050; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Ostler K, 2007, ONCOGENE, V26, P5553, DOI 10.1038/sj.onc.1210351; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; Saito Y, 2002, P NATL ACAD SCI USA, V99, P10060, DOI 10.1073/pnas.152121799; Shah MY, 2010, CANCER RES, V70, P5840, DOI 10.1158/0008-5472.CAN-10-0847; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Soejima K, 2003, ONCOGENE, V22, P4723, DOI 10.1038/sj.onc.1206510; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Svedruzic ZM, 2004, BIOCHEMISTRY-US, V43, P11460, DOI 10.1021/bi0496743; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; Van Emburgh BO, 2011, NUCLEIC ACIDS RES, V39, P4984, DOI 10.1093/nar/gkr116; Wang J, 2006, CANCER RES, V66, P8361, DOI 10.1158/0008-5472.CAN-06-2031; Weidtkamp-Peters S, 2006, HISTOCHEM CELL BIOL, V125, P91, DOI 10.1007/s00418-005-0063-3; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Weissmann F, 2003, MOL CELL BIOL, V23, P2577, DOI 10.1128/MCB.23.7.2577-2586.2003; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8	43	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69486	10.1371/journal.pone.0069486	http://dx.doi.org/10.1371/journal.pone.0069486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894490	Green Published, gold, Green Submitted			2022-12-25	WOS:000322391400061
J	Auer, M; Gruber, C; Bellei, M; Pirker, KF; Zamocky, M; Kroiss, D; Teufer, SA; Hofbauer, S; Soudi, M; Battistuzzi, G; Furtmuller, PG; Obinger, C				Auer, Markus; Gruber, Clemens; Bellei, Marzia; Pirker, Katharina F.; Zamocky, Marcel; Kroiss, Daniela; Teufer, Stefan A.; Hofbauer, Stefan; Soudi, Monika; Battistuzzi, Gianantonio; Furtmueller, Paul G.; Obinger, Christian			A Stable Bacterial Peroxidase with Novel Halogenating Activity and an Autocatalytically Linked Heme Prosthetic Group	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE LACTOPEROXIDASE; HUMAN MYELOPEROXIDASE; REDOX THERMODYNAMICS; CRYSTAL-STRUCTURE; EVOLUTION; OXIDATION; COUPLE; HALIDE; MECHANISMS; KINETICS	Reconstructing the phylogenetic relationships of the main evolutionary lines of the mammalian peroxidases lactoperoxidase and myeloperoxidase revealed the presence of novel bacterial heme peroxidase subfamilies. Here, for the first time, an ancestral bacterial heme peroxidase is shown to possess a very high bromide oxidation activity (besides conventional peroxidase activity). The recombinant protein allowed monitoring of the autocatalytic peroxide-driven formation of covalent heme to protein bonds. Thereby, the high spin ferric rhombic heme spectrum became similar to lactoperoxidase, the standard reduction potential of the Fe(III)/Fe(II) couple shifted to more positive values (-145 +/- 10 mV at pH 7), and the conformational and thermal stability of the protein increased significantly. We discuss structure-function relationships of this new peroxidase in relation to its mammalian counterparts and ask for its putative physiological role.	[Auer, Markus; Gruber, Clemens; Pirker, Katharina F.; Zamocky, Marcel; Kroiss, Daniela; Teufer, Stefan A.; Hofbauer, Stefan; Soudi, Monika; Furtmueller, Paul G.; Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Dept Chem, Div Biochem, A-1190 Vienna, Austria; [Bellei, Marzia] Univ Modena & Reggio Emilia, Dept Life Sci, I-41100 Modena, Italy; [Battistuzzi, Gianantonio] Univ Modena & Reggio Emilia, Dept Chem & Geol, I-41100 Modena, Italy; [Zamocky, Marcel] Slovak Acad Sci, Inst Mol Biol, Bratislava 84551, Slovakia	University of Natural Resources & Life Sciences, Vienna; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Slovak Academy of Sciences	Obinger, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria.	christian.obinger@boku.ac.at	Furtmüller, Paul G./Y-5819-2018; Hofbauer, Stefan/I-3889-2014; Battistuzzi, Gianantonio/L-7183-2015; Obinger, Christian/AAV-3173-2021; Zamocky, Marcel/AAC-2882-2019	Furtmüller, Paul G./0000-0002-1199-2469; Hofbauer, Stefan/0000-0003-3375-7715; Battistuzzi, Gianantonio/0000-0003-4716-5745; Zamocky, Marcel/0000-0002-2443-2823; Grunwald-Gruber, Clemens/0000-0002-6097-8348; Obinger, Christian/0000-0002-7133-3430	Austrian Science Funds FWF [P20664, P25538]; Doctoral Program BioToP-Biomolecular Technology of Proteins FWF Project [W1224]	Austrian Science Funds FWF(Austrian Science Fund (FWF)); Doctoral Program BioToP-Biomolecular Technology of Proteins FWF Project	This work was supported by Austrian Science Funds FWF Projects P20664 and P25538 and Doctoral Program BioToP-Biomolecular Technology of Proteins FWF Project W1224.	Arnhold J, 2001, EUR J BIOCHEM, V268, P5142, DOI 10.1046/j.0014-2956.2001.02449.x; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Banerjee S, 2011, BIOTECHNOL J, V6, P231, DOI 10.1002/biot.201000375; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; Battistuzzi G, 2002, J AM CHEM SOC, V124, P26, DOI 10.1021/ja017188m; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V494, P72, DOI 10.1016/j.abb.2009.11.021; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; de Montellano PRO, 2008, DRUG METAB REV, V40, P405, DOI [10.1080/03602530802186439, 10.1080/03602530802186439 ]; DePillis GD, 1997, J BIOL CHEM, V272, P8857; Dick GJ, 2008, APPL ENVIRON MICROB, V74, P2646, DOI 10.1128/AEM.01656-07; Doerge DR, 1997, ANAL BIOCHEM, V250, P10, DOI 10.1006/abio.1997.2191; Fayadat L, 1999, J BIOL CHEM, V274, P10533, DOI 10.1074/jbc.274.15.10533; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2005, J INORG BIOCHEM, V99, P1220, DOI 10.1016/j.jinorgbio.2005.02.021; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Huang LS, 2006, ARCH BIOCHEM BIOPHYS, V446, P77, DOI 10.1016/j.abb.2005.11.011; KETTLE AJ, 1988, BIOCHIM BIOPHYS ACTA, V957, P185, DOI 10.1016/0167-4838(88)90271-3; OHLSSON PI, 1983, ACTA CHEM SCAND B, V37, P917, DOI 10.3891/acta.chem.scand.37b-0917; Passardi F, 2007, PHYTOCHEMISTRY, V68, P1605, DOI 10.1016/j.phytochem.2007.04.005; Santamaria-Hernando S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040698; Singh AK, 2009, BIOPHYS J, V96, P646, DOI 10.1016/j.bpj.2008.09.019; Soderhall K, 1999, DEV COMP IMMUNOL, V23, P263; Soudi M, 2012, CHEM BIODIVERS, V9, P1776, DOI 10.1002/cbdv.201100438; Stampler J, 2011, ARCH BIOCHEM BIOPHYS, V516, P21, DOI 10.1016/j.abb.2011.09.007; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zamocky M, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P7, DOI 10.1007/978-3-642-12627-7_2; Zamocky M, 2010, ARCH BIOCHEM BIOPHYS, V500, P45, DOI 10.1016/j.abb.2010.03.024; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g	41	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27181	27199		10.1074/jbc.M113.477067	http://dx.doi.org/10.1074/jbc.M113.477067			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23918925	Green Published, hybrid			2022-12-25	WOS:000330597300017
J	Apostolidis, SA; Rauen, T; Hedrich, CM; Tsokos, GC; Crispin, JC				Apostolidis, Sokratis A.; Rauen, Thomas; Hedrich, Christian M.; Tsokos, George C.; Crispin, Jose C.			Protein Phosphatase 2A Enables Expression of Interleukin 17 (IL-17) through Chromatin Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ARYL-HYDROCARBON RECEPTOR; T-CELL APOPTOSIS; ROR-GAMMA-T; REGULATORY NETWORK; T(H)17 DEVELOPMENT; GENE LOCUS; PP2A; DIFFERENTIATION; TRANSCRIPTION	Protein phosphatase 2A (PP2A) is a heterotrimeric serine/threonine phosphatase involved in essential cellular functions. T cells from patients with systemic lupus erythematosus (SLE) express high levels of the catalytic subunit of PP2A (PP2Ac). A mouse overexpressing PP2Ac in T cells develops glomerulonephritis in an IL-17-dependent manner. Here, using microarray analyses, we demonstrate that increased expression of PP2Ac grants T cells the capacity to produce an array of proinflammatory effector molecules. Because IL-17 is important in the expression of glomerulonephritis, we studied the mechanism through which PP2Ac dysregulation facilitates its production. We report that PP2Ac is involved in the regulation of the Il17 locus by enhancing histone 3 acetylation through a mechanism that involves activation of interferon regulatory factor 4. Increased histone 3 acetylation of the Il17 locus is shared between T cells of PP2Ac transgenic mice and patients with SLE. We propose that, by promoting the inflammatory capacity of T cells, PP2Ac dysregulation contributes to the pathogenesis of SLE.	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Tsokos, GC (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, 330 Brookline Ave,CLS 928, Boston, MA 02215 USA.	gtsokos@bidmc.harvard.edu; jcrispin@bidmc.harvard.edu	Crispín, José/I-4919-2019; Hedrich, Christian/AAW-3958-2020; Hedrich, Christian/AAD-6855-2019; Rauen, Thomas/GLR-8682-2022; tsokos, george C/O-3360-2013	Crispín, José/0000-0002-7590-3621; tsokos, george C/0000-0001-9589-2360; Hedrich, Christian/0000-0002-1295-6179	National Institutes of Health [RO1 AI068787]; Alliance for Lupus Research grant; Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research grant; Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI068787 (to G. C. T.). This work was also supported by an Alliance for Lupus Research grant (to J. C. C.).; Recipient of an Arthritis Foundation postdoctoral fellowship award.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Ballestar E, 2006, J IMMUNOL, V176, P7143, DOI 10.4049/jimmunol.176.12.7143; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Biswas PS, 2012, J EXP MED, V209, P581, DOI 10.1084/jem.20111195; Biswas PS, 2010, J CLIN INVEST, V120, P3280, DOI 10.1172/JCI42856; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chung HY, 1999, CELL SIGNAL, V11, P575, DOI 10.1016/S0898-6568(99)00033-9; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Crispin JC, 2012, J IMMUNOL, V188, P3567, DOI 10.4049/jimmunol.1200143; Crispin JC, 2011, P NATL ACAD SCI USA, V108, P12443, DOI 10.1073/pnas.1103915108; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Isgro J, 2013, ARTHRITIS RHEUM-US, V65, P1592, DOI 10.1002/art.37934; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurimchak A, 2012, GENE, V499, P1, DOI 10.1016/j.gene.2012.02.015; Landrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021521; Lech M, 2011, J AM SOC NEPHROL, V22, P1443, DOI 10.1681/ASN.2010121260; Lee TY, 2010, J BIOL CHEM, V285, P21567, DOI 10.1074/jbc.M109.094953; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Pisitkun P, 2012, IMMUNITY, V37, P1104, DOI 10.1016/j.immuni.2012.08.014; R Core Team, 2021, R LANG ENV STAT COMP; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Stirzaker RA, 2012, LUPUS, V21, P656, DOI 10.1177/0961203312436862; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wang Y, 2010, CLIN EXP IMMUNOL, V159, P1, DOI 10.1111/j.1365-2249.2009.04031.x; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	66	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26775	26784		10.1074/jbc.M113.483743	http://dx.doi.org/10.1074/jbc.M113.483743			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23918926	Green Published, hybrid			2022-12-25	WOS:000330594500042
J	Hahne, S; van Houdt, R; Koedijk, F; van Ballegooijen, M; Cremer, J; Bruisten, S; Coutinho, R; Boot, H				Hahne, Susan; van Houdt, Robin; Koedijk, Femke; van Ballegooijen, Marijn; Cremer, Jeroen; Bruisten, Sylvia; Coutinho, Roel; Boot, Hein			Selective Hepatitis B Virus Vaccination Has Reduced Hepatitis B Virus Transmission in The Netherlands	PLOS ONE			English	Article							GENETIC DIVERSITY; CHRONIC INFECTION; INDUCED IMMUNITY; RISK GROUPS; DRUG-USERS; COALESCENT; GENOTYPES; REGION; SEX; MEN	Background & Aims: In the Netherlands, a selective hepatitis B virus (HBV) vaccination programme started in 2002 for men having sex with men, drug users, commercial sex workers and heterosexuals with frequent partner changes. We assessed the programme's effectiveness to guide policy on HBV prevention. Methods: We analysed reports of acute HBV infection in the Netherlands between 2004 and 2010 requesting serum from patients for HBV-genome S- and C-region sequencing. We used coalescence analyses to assess genetic diversity of nonimported genotype-A cases over time. Results: 1687 patients with acute HBV infection were reported between 2004 and 2010. The incidence of reported acute HBV infection decreased from 1.8 to 1.2 per 100,000 inhabitants, mostly due to a reduction in the number of cases in men who have sex with men. Men were overrepresented among cases with an unknown route of transmission, especially among genotype A2 cases mainly associated with transmission through male homosexual contact. The genetic diversity of nonimported genotype-A strains obtained from men who have sex with men decreased from 2006 onwards, suggesting HBV incidence in this group decreased. Conclusions: The selective HBV-vaccination programme for behavioural high-risk groups very likely reduced the incidence of HBV infection in the Netherlands mainly by preventing HBV infections in men who have sex with men. A considerable proportion of cases in men who did not report risk behaviour was probably acquired through homosexual contact. Our findings support continuation of the programme, and adopting similar approaches in other countries where HBV transmission is focused in high-risk adults.	[Hahne, Susan; Koedijk, Femke; van Ballegooijen, Marijn; Cremer, Jeroen; Coutinho, Roel; Boot, Hein] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van Houdt, Robin; Bruisten, Sylvia] Amsterdam Publ Hlth Serv, Amsterdam, Netherlands; [Bruisten, Sylvia] Amsterdam Med Ctr, Amsterdam, Netherlands; [Coutinho, Roel] Univ Utrecht, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University	Hahne, S (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	susan.hahne@rivm.nl			Netherlands Organization for Health Research and Development (ZonMW) [125010004]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This work was supported by The Netherlands Organization for Health Research and Development (ZonMW) [grant number 125010004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D, 2012, LANCET, V380, P439, DOI 10.1016/S0140-6736(12)60920-9; Andersson MI, 2012, EPIDEMIOL INFECT, V140, P47, DOI 10.1017/S0950268811000148; [Anonymous], 2010, HEP B C EU NEIGHB PR; Blystad H, 2005, EURO SURVEILL, V10; Boot HJ, 2008, J MED VIROL, V80, P233, DOI 10.1002/jmv.21080; Cowan SA, 2005, EURO SURVEILL, V10; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Edmunds WJ, 1996, T ROY SOC TROP MED H, V90, P436, DOI 10.1016/S0035-9203(96)90539-8; Fu YX, 2006, THEOR POPUL BIOL, V69, P385, DOI 10.1016/j.tpb.2005.11.005; Hahne SJM, 2012, EPIDEMIOL INFECT, V140, P1469, DOI 10.1017/S095026881100224X; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hallett RL, 2004, CLIN INFECT DIS, V39, P945, DOI 10.1086/423962; Hayashi K, 2008, J GASTROENTEROL, V43, P558, DOI 10.1007/s00535-008-2197-2; Health Council of the Netherlands, 2009, 200803E HLTH COUNC N; Houweling H, 2010, VACCINE, V28, P7723, DOI 10.1016/j.vaccine.2010.09.068; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Kahn J, 2002, CLIN INFECT DIS, V35, P1382, DOI 10.1086/343044; Koedijk F D H, 2007, Ned Tijdschr Geneeskd, V151, P2389; Mast E, 2006, MORB MORTAL WKLY REP; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; Max Planck Institut, 2012, INF GEN GENO2PHENO; Mayerat C, 1999, J VIRAL HEPATITIS, V6, P299, DOI 10.1046/j.1365-2893.1999.00174.x; Mereckiene J, 2010, VACCINE, V28, P4470, DOI 10.1016/j.vaccine.2010.04.037; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Reiter PL, 2011, SEX TRANSM DIS, V38, P235, DOI 10.1097/OLQ.0b013e3181f422bb; Roy KM, 2008, SCOT MED J, V53, P13; Schorer, 2010, SCHOR MON; Statistics Netherlands, 2012, MIGR NETH COUNTR BIR; Tamada Y, 2012, GUT, V61, P765, DOI 10.1136/gutjnl-2011-300832; Teshale EH, 2011, CLIN INFECT DIS, V53, P751, DOI 10.1093/cid/cir495; van Ballegooijen WM, 2009, AM J EPIDEMIOL, V170, P1455, DOI 10.1093/aje/kwp375; van de Laar MJW, 2005, HIV SEXUALLY TRANSMI; van Houdt R, 2007, J MED VIROL, V79, P895, DOI 10.1002/jmv.20820; van Houdt R, 2009, VACCINE, V27, P3530, DOI 10.1016/j.vaccine.2009.03.072; van Houdt R, 2009, J MED VIROL, V81, P1163, DOI 10.1002/jmv.21504; van Steenbergen JE, 2002, J HEPATOL, V37, P507, DOI 10.1016/S0168-8278(02)00213-1; Volz EM, 2012, GENETICS, V190, P187, DOI 10.1534/genetics.111.134627; Vriend HJ, 2011, 2102610092011 RIVM; WHO, 2008, HEP B FACT SHEET; World Health Organisation, 2009, WEEKLY EPIDEMIOL REC, V40, P405; Xridou M, 2009, EPIDEMIOL INFECT, V137, P504, DOI 10.1017/S0950268808000976	43	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e67866	10.1371/journal.pone.0067866	http://dx.doi.org/10.1371/journal.pone.0067866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922651	Green Submitted, gold, Green Published			2022-12-25	WOS:000323369700003
J	Wang, H; Guo, Y; Zhao, X; Li, HY; Fan, GW; Mao, HP; Miao, L; Gao, XM				Wang, Hong; Guo, Ying; Zhao, Xin; Li, Huiying; Fan, Guanwei; Mao, Haoping; Miao, Lin; Gao, Xiumei			An Estrogen Receptor Dependent Mechanism of Oroxylin A in the Repression of Inflammatory Response	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; CYCLOOXYGENASE-2 EXPRESSION; INDUCED APOPTOSIS; RAW264.7 CELLS; TNF-ALPHA; FLAVONOIDS; BETA; IDENTIFICATION; MACROPHAGES	Oroxylin A, a natural flavonoid, is one of the main bioactive compounds that underlie the anti-inflammatory effect of the medicinal herb Scutellaria baicalensis Georgi widely used in southeastern Asia; however, the molecular mechanisms for the therapeutic benefits remain largely unclear. In this study, we found that Oroxylin A induces estrogen-responsive gene expression and promoter activity. In macrophages, Oroxylin A treatment significantly attenuates lipopolysaccharide (LPS)-induced but not basal inflammatory response, including nitric oxide (NO) production and the expression of inflammatory mediators (i.e., iNOS and COX-2) and cytokines (i.e., TNF-alpha, IL-1 beta, and IL-6), in an estrogen receptor (ER)-dependent manner. Oroxylin A treatment also dramatically decreases LPS-induced secretion of pro-inflammatory cytokines. Furthermore, the downregulation of all these inflammatory parameters by Oroxylin A was abolished when cells were pretreated with specific ER antagonist. Thus, Oroxylin A is a novel phytoestrogen and exhibits anti-inflammatory effects that are mediated by ER activity.	[Wang, Hong; Guo, Ying; Zhao, Xin; Fan, Guanwei; Miao, Lin] Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Wang, Hong; Guo, Ying; Zhao, Xin; Fan, Guanwei; Miao, Lin] Tianjin Univ Tradit Chinese Med, Minist Educ, Key Lab Pharmacol Tradit Chinese Med Formulae, Tianjin, Peoples R China; [Wang, Hong; Li, Huiying; Gao, Xiumei] Tianjin Key Lab Tradit Chinese Med Pharmacol, Tianjin, Peoples R China; [Mao, Haoping; Gao, Xiumei] Tianjin Univ Tradit Chinese Med, Inst Tradit Chinese Med, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Gao, XM (corresponding author), Tianjin Key Lab Tradit Chinese Med Pharmacol, Tianjin, Peoples R China.	gaoxiumei@tjutcm.edu.cn	guanwei, fan/M-8193-2019; FAN, GUANWEI/GWV-6480-2022		National Natural Science Foundation of China [81173592, 81125024]; Tianjin Applied Basic Research and Frontier Technological Program [11JCZDJC21100]; Program for Changjiang Scholars and Innovative Research Team in University, PCSIRT [IRT0973IRT1276]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Applied Basic Research and Frontier Technological Program; Program for Changjiang Scholars and Innovative Research Team in University, PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (81173592, 81125024), Tianjin Applied Basic Research and Frontier Technological Program (11JCZDJC21100), and the Program for Changjiang Scholars and Innovative Research Team in University, PCSIRT (IRT0973IRT1276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu KS, 2005, BIOORG MED CHEM LETT, V15, P3953, DOI 10.1016/j.bcml.2005.05.045; Barrios-Rodiles M, 1999, J IMMUNOL, V163, P963; CUTOLO M, 1995, CLIN EXP RHEUMATOL, V13, P217; Cuzzocrea S, 2000, ENDOCRINOLOGY, V141, P1455, DOI 10.1210/en.141.4.1455; Cuzzocrea S, 2001, MOL MED, V7, P478, DOI 10.1007/BF03401853; Duval DL, 1996, MOL PHARMACOL, V50, P277; Faulds MH, 2001, MOL ENDOCRINOL, V15, P1929, DOI 10.1210/me.15.11.1929; Grip Olof, 2003, Current Drug Targets - Inflammation and Allergy, V2, P155, DOI 10.2174/1568010033484179; Han HS, 2002, J NEUROSCI, V22, P3921, DOI 10.1523/JNEUROSCI.22-10-03921.2002; Hayashi T, 1998, J CARDIOVASC PHARM, V31, P292, DOI 10.1097/00005344-199802000-00016; Hu, 1996, NATL REGULATORY AUTH; Hu Y, 2006, BIOCHEM BIOPH RES CO, V351, P521, DOI 10.1016/j.bbrc.2006.10.064; Kim AR, 2005, ARCH PHARM RES, V28, P297, DOI 10.1007/BF02977796; Kim HK, 1999, BIOCHEM PHARMACOL, V58, P759, DOI 10.1016/S0006-2952(99)00160-4; Kim SS, 2003, LIFE SCI, V73, P337, DOI 10.1016/S0024-3205(03)00288-1; Krakauer Teresa, 2004, Current Drug Targets - Inflammation and Allergy, V3, P317; Kuiper GGJM, 1997, FEBS LETT, V410, P87, DOI 10.1016/S0014-5793(97)00413-4; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lee S, 2010, NEUROCHEM RES, V35, P1725, DOI 10.1007/s11064-010-0235-y; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Mu R, 2009, MOL CARCINOGEN, V48, P1159, DOI 10.1002/mc.20570; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; Saito S, 1999, J HEART LUNG TRANSPL, V18, P937, DOI 10.1016/S1053-2498(99)00060-1; Vegeto E, 1999, FASEB J, V13, P793, DOI 10.1096/fasebj.13.8.793; Wanda GJMK, 2006, PHYTOMEDICINE, V13, P139, DOI 10.1016/j.phymed.2005.06.003; Wang H, 2011, FOOD CHEM, V129, P408, DOI 10.1016/j.foodchem.2011.04.092; Wang J, 2002, J AGR FOOD CHEM, V50, P850, DOI 10.1021/jf010976a; Wilkinson AP, 2002, J CHROMATOGR B, V777, P93, DOI 10.1016/S1570-0232(02)00095-8; Willoughby DA, 2000, LANCET, V355, P646, DOI 10.1016/S0140-6736(99)12031-2; XIE QW, 1994, J BIOL CHEM, V269, P4705; Xin D, 2010, PHYTOMEDICINE, V17, P126, DOI 10.1016/j.phymed.2009.05.015; Zancan V, 1999, ENDOCRINOLOGY, V140, P2004, DOI 10.1210/en.140.5.2004; Zhang G, 2007, J BONE MINER RES, V22, P1072, DOI 10.1359/JBMR.070405	33	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69555	10.1371/journal.pone.0069555	http://dx.doi.org/10.1371/journal.pone.0069555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922737	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700041
J	Joye, Y; Pals, R; Steg, L; Evans, B				Joye, Yannick; Pals, Roos; Steg, Linda; Evans, Ben Lewis			New Methods for Assessing the Fascinating Nature of Nature Experiences	PLOS ONE			English	Article							SELECTIVE ATTENTION; STRESS RECOVERY; ENVIRONMENTS; BENEFITS; RESTORATION; PREFERENCE; ATTITUDES; RESPONSES; EXPOSURE; BIASES	In recent years, numerous environmental psychology studies have demonstrated that contact with nature as opposed to urban settings can improve an individual's mood, can lead to increased levels of vitality, and can offer an opportunity to recover from stress. According to Attention Restoration Theory (ART) the restorative potential of natural environments is situated in the fact that nature can replenish depleted attentional resources. This replenishment takes place, in part, because nature is deemed to be a source of fascination, with fascination being described as having an "attentional'', an "affective'' and an "effort'' dimension. However, the claim that fascination with nature involves these three dimensions is to a large extent based on intuition or derived from introspection-based measurement methods, such as self-reports. In three studies, we aimed to more objectively assess whether these three dimensions indeed applied to experiences related to natural environments, before any (attentional) depletion has taken place. The instruments that were used were: (a) the affect misattribution procedure (Study 1), (b) the dot probe paradigm (Study 2) and (c) a cognitively effortful task (Study 3). These instrument were respectively aimed at verifying the affective, attentional and effort dimension of fascination. Overall, the results provide objective evidence for the claims made within the ART framework, that natural as opposed to urban settings are affectively positive (cfr., affective dimension) and that people have an attentional bias to natural (rather than urban) environments (cfr., attentional dimension). The results regarding the effort dimension are less straightforward, and suggest that this dimension only becomes important in sufficiently difficult cognitive tasks.	[Joye, Yannick] Univ Louvain, Fac Business & Econ, Res Ctr Mkt & Consumer Sci, Res Fdn Flanders FWO, Louvain, Belgium; [Pals, Roos] Hanze Univ Appl Sci, Sch Social Studies, Groningen, Netherlands; [Steg, Linda; Evans, Ben Lewis] Univ Groningen, Dept Psychol, Fac Behav & Social Sci, NL-9712 TS Groningen, Netherlands	University of Groningen	Joye, Y (corresponding author), Univ Louvain, Fac Business & Econ, Res Ctr Mkt & Consumer Sci, Res Fdn Flanders FWO, Louvain, Belgium.	yannick.joye@kuleuven.be	Steg, Linda/H-6878-2014	Steg, Linda/0000-0002-8375-9607; Joye, Yannick/0000-0002-7306-799X	Science Foundation Flanders	Science Foundation Flanders	The research reported in the article was supported by a postdoctoral research grant from the Science Foundation Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Berto R, 2008, J ENVIRON PSYCHOL, V28, P185, DOI 10.1016/j.jenvp.2007.11.004; Berto R, 2010, J ENVIRON PSYCHOL, V30, P494, DOI 10.1016/j.jenvp.2009.12.002; Cackowski JM, 2003, ENVIRON BEHAV, V35, P736, DOI 10.1177/0013916503256267; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; Ehrman RN, 2002, DRUG ALCOHOL DEPEN, V67, P185, DOI 10.1016/S0376-8716(02)00065-0; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Grier S, 2005, ANNU REV PUBL HEALTH, V26, P319, DOI 10.1146/annurev.publhealth.26.021304.144610; Hagerhall CM, 2004, J ENVIRON PSYCHOL, V24, P247, DOI 10.1016/j.jenvp.2003.12.004; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; Hartig T, 1996, SCAND J PSYCHOL, V37, P378, DOI 10.1111/j.1467-9450.1996.tb00670.x; Hartig T., 1997, 5 UPPS U; Hartig T., 2008, BRINGING BUILDINGS L, P133; Haviland-Jones J., 2005, EVOL PSYCHOL-US, V3, P104, DOI [DOI 10.1177/147470490500300109,147470490500300109, 10.1177/147470490500300109, DOI 10.1177/147470490500300109]; Herzog TR, 1997, J ENVIRON PSYCHOL, V17, P165, DOI 10.1006/jevp.1997.0051; Hietanen JK, 2007, PSYCHOL RES-PSYCH FO, V71, P539, DOI 10.1007/s00426-006-0064-4; Kaplan R, 1989, EXPERIENCE NATURE PS; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; KAPLAN S, 1993, ENVIRON BEHAV, V25, P725, DOI 10.1177/0013916593256004; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Karmanov D, 2008, LANDSCAPE URBAN PLAN, V86, P115, DOI 10.1016/j.landurbplan.2008.01.004; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, DOI 10.1080/13504620220145401, 10.1080/13504620220145401]; Korpela KM, 2002, ENVIRON BEHAV, V34, P634, DOI 10.1177/0013916502034005004; Kweon BS, 2008, ENVIRON BEHAV, V40, P355, DOI 10.1177/0013916506298797; Larsen L, 1998, ENVIRON BEHAV, V30, P261, DOI 10.1177/001391659803000301; Laumann K, 2003, J ENVIRON PSYCHOL, V23, P125, DOI 10.1016/S0272-4944(02)00110-X; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Masicampo EJ, 2008, PSYCHOL SCI, V19, P255, DOI 10.1111/j.1467-9280.2008.02077.x; Mathieu P, 2009, HYPERTENSION, V53, P577, DOI 10.1161/HYPERTENSIONAHA.108.110320; Mogg K, 1998, BEHAV RES THER, V36, P227, DOI 10.1016/S0005-7967(97)00062-4; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Nisbet EK, 2011, PSYCHOL SCI, V22, P1101, DOI 10.1177/0956797611418527; NORRIS R, 1992, J PSYCHOSOM RES, V36, P55, DOI 10.1016/0022-3999(92)90114-H; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ouellette P, 2005, J ENVIRON PSYCHOL, V25, P175, DOI 10.1016/j.jenvp.2005.06.001; Pals R, 2009, J ENVIRON PSYCHOL, V29, P441, DOI 10.1016/j.jenvp.2009.08.005; Parsons R, 1998, J ENVIRON PSYCHOL, V18, P113, DOI 10.1006/jevp.1998.0086; Payne BK, 2010, PERS SOC PSYCHOL B, V36, P1397, DOI 10.1177/0146167210383440; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Pratt J, 2010, PSYCHOL SCI, V21, P1724, DOI 10.1177/0956797610387440; Reber R, 2004, CONSCIOUS COGN, V13, P47, DOI 10.1016/S1053-8100(03)00049-7; Redies C, 2008, SPATIAL VISION, V21, P97, DOI 10.1163/156856808782713780; Rousselet GA, 2005, VIS COGN, V12, P852, DOI 10.1080/13506280444000553; Rozin P, 2004, APPETITE, V43, P147, DOI 10.1016/j.appet.2004.03.005; Ryan RM, 2010, J ENVIRON PSYCHOL, V30, P159, DOI 10.1016/j.jenvp.2009.10.009; Salemink E, 2007, BEHAV RES THER, V45, P607, DOI 10.1016/j.brat.2006.04.004; Ulrich R. S., 1983, BEHAV NATURAL ENV, P85, DOI [10.1007/978-1-4613-3539-9_4, DOI 10.1007/978-1-4613-3539-9_4]; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; van den Berg AE, 2007, J SOC ISSUES, V63, P79, DOI 10.1111/j.1540-4560.2007.00497.x; Yang JJ, 2012, EMOTION, V12, P540, DOI 10.1037/a0026848	53	28	28	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e65332	10.1371/journal.pone.0065332	http://dx.doi.org/10.1371/journal.pone.0065332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922645	gold, Green Published, Green Submitted			2022-12-25	WOS:000322838900002
J	Ordonez, L; Bernard, I; Chabod, M; Augusto, JF; Lauwers-Cances, V; Cristini, C; Cuturi, MC; Subra, JF; Saoudi, A				Ordonez, Laurence; Bernard, Isabelle; Chabod, Marianne; Augusto, Jean-Francois; Lauwers-Cances, Valerie; Cristini, Christelle; Cuturi, Maria-Cristina; Subra, Jean-Francois; Saoudi, Abdelhadi			A Higher Risk of Acute Rejection of Human Kidney Allografts Can Be Predicted from the Level of CD45RC Expressed by the Recipients' CD8 T Cells	PLOS ONE			English	Article							RENAL-TRANSPLANT TOLERANCE; VERSUS-HOST-DISEASE; MONOCLONAL-ANTIBODY; IFN-GAMMA; IN-VIVO; MEMORY; SUBSETS; IDENTIFICATION; LYMPHOCYTES; PREVENTION	Although transplantation is the common treatment for end-stage renal failure, allograft rejection and marked morbidity from the use of immunosuppressive drugs remain important limitations. A major challenge in the field is to identify easy, reliable and noninvasive biomarkers allowing the prediction of deleterious alloreactive immune responses and the tailoring of immunosuppressive therapy in individuals according to the rejection risk. In this study, we first established that the expression of the RC isoform of the CD45 molecule (CD45RC) on CD4 and CD8 T cells from healthy individuals identifies functionally distinct alloreactive T cell subsets that behave differently in terms of proliferation and cytokine secretion. We then investigated whether the frequency of the recipients CD45RC T cell subsets before transplantation would predict acute graft rejection in a cohort of 89 patients who had undergone their first kidney transplantation. We showed that patients exhibiting more than 54.7% of CD8 CD45RC(high) T cells before transplantation had a 6 fold increased risk of acute kidney graft rejection. In contrast, the proportions of CD4 CD45RC T cells were not predictive. Thus, a higher risk of acute rejection of human kidney allografts can be predicted from the level of CD45RC expressed by the recipients' CD8 T cells.	[Ordonez, Laurence; Bernard, Isabelle; Chabod, Marianne; Saoudi, Abdelhadi] Fac Med Toulouse, INSERM, U1043, F-31073 Toulouse, France; [Ordonez, Laurence; Bernard, Isabelle; Chabod, Marianne; Saoudi, Abdelhadi] CNRS, U5282, Toulouse, France; [Ordonez, Laurence; Bernard, Isabelle; Chabod, Marianne; Saoudi, Abdelhadi] Univ Toulouse, Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Augusto, Jean-Francois; Subra, Jean-Francois] CHU Angers, Serv Nephrol Dialyse Transplantat, INSERM, U892, Angers, France; [Augusto, Jean-Francois; Subra, Jean-Francois] Univ Angers, Angers, France; [Lauwers-Cances, Valerie; Cristini, Christelle] CHU Toulouse, Epidemiol Unit, Toulouse, France; [Cuturi, Maria-Cristina] INSERM, Ctr Res Transplantat & Immunol, U1046, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Saoudi, A (corresponding author), Fac Med Toulouse, INSERM, U1043, U317, F-31073 Toulouse, France.	abdelhadi.saoudi@inserm.fr	SAOUDI, Abdelhadi/K-6719-2014; Jean-François, Augusto/L-2887-2015; SUBRA, Jean-François/L-3986-2015	SAOUDI, Abdelhadi/0000-0001-7015-8178; Jean-François, Augusto/0000-0003-1498-2132; Chabod, Marianne/0000-0003-4579-6279; Bernard, Isabelle/0000-0002-5847-1281	Institut National de la Sante et de la Recherche Medicale; Association Francaise Contre les Myopathies; Association de la Recherche Contre le Cancer; Region Midi-Pyrenees; Centre National de la Recherche Scientifique; INSERM; Ministere de l'Education Nationale, de la Recherche et de la Technologie and Fondation pour la Recherche Medicale	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Association de la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale, de la Recherche et de la Technologie and Fondation pour la Recherche Medicale	This work was supported by Institut National de la Sante et de la Recherche Medicale, Association Francaise Contre les Myopathies, Association de la Recherche Contre le Cancer, Region Midi-Pyrenees. AS is supported by Centre National de la Recherche Scientifique, IB by INSERM, LO by grants from Ministere de l'Education Nationale, de la Recherche et de la Technologie and Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Anderson BE, 2003, J CLIN INVEST, V112, P101, DOI 10.1172/JCI200317601; BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; Benghiat Fleur Samantha, 2009, Transplant Rev (Orlando), V23, P11, DOI 10.1016/j.trre.2008.08.007; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chen BJ, 2007, BLOOD, V109, P3115, DOI 10.1182/blood-2006-04-016410; Cornell LD, 2008, ANNU REV PATHOL-MECH, V3, P189, DOI 10.1146/annurev.pathmechdis.3.121806.151508; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Davies JD, 1999, J IMMUNOL, V163, P5353; Ford ML, 2009, TRANSPLANTATION, V87, pS69, DOI 10.1097/TP.0b013e3181a2a701; Foster AE, 2004, BLOOD, V104, P2403, DOI 10.1182/blood-2003-12-4431; Fournie GJ, 2001, IMMUNOL REV, V184, P145, DOI 10.1034/j.1600-065x.2001.1840114.x; FOWELL D, 1991, IMMUNOL REV, V123, P37, DOI 10.1111/j.1600-065X.1991.tb00605.x; Guillonneau C, 2007, J CLIN INVEST, V117, P1096, DOI 10.1172/JCI28801; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; KRENSKY AM, 1990, NEW ENGL J MED, V322, P510, DOI 10.1056/NEJM199002223220805; Lazarovits AI, 1996, NATURE, V380, P717, DOI 10.1038/380717a0; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Liu ZM, 2013, IMMUNOL REV, V252, P183, DOI 10.1111/imr.12038; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ordonez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005287; Pedros C, 2013, GENES IMMUN IN PRESS; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; POWRIE F, 1990, J EXP MED, V172, P1701, DOI 10.1084/jem.172.6.1701; ROSENBERG AS, 1990, J IMMUNOL, V144, P4648; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saoudi A, 1996, IMMUNOL REV, V149, P195, DOI 10.1111/j.1600-065X.1996.tb00905.x; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; SPICKETT GP, 1983, J EXP MED, V158, P795, DOI 10.1084/jem.158.3.795; STREULI M, 1987, J EXP MED, V166, P1548, DOI 10.1084/jem.166.5.1548; Subra JF, 2001, J IMMUNOL, V166, P2944, DOI 10.4049/jimmunol.166.5.2944; Tchilian EZ, 2006, TRENDS IMMUNOL, V27, P146, DOI 10.1016/j.it.2006.01.001; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; Valujskikh A, 2003, IMMUNOL REV, V196, P65, DOI 10.1046/j.1600-065X.2003.00087.x; van den Boogaardt DEM, 2006, TRANSPLANTATION, V82, P844, DOI 10.1097/01.tp.0000229448.64363.18; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Xystrakis E, 2004, BLOOD, V104, P3294, DOI 10.1182/blood-2004-03-1214; Xystrakis E, 2004, J IMMUNOL, V173, P3140, DOI 10.4049/jimmunol.173.5.3140; Xystrakis E, 2004, EUR J IMMUNOL, V34, P408, DOI 10.1002/eji.200324528; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Zheng H, 2008, BLOOD, V111, P2476, DOI 10.1182/blood-2007-08-109678; Zhong RZ, 1998, J MOL MED-JMM, V76, P572, DOI 10.1007/s001090050252	53	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69791	10.1371/journal.pone.0069791	http://dx.doi.org/10.1371/journal.pone.0069791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894540	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900095
J	Escobar, S; Servili, A; Espigares, F; Gueguen, MM; Brocal, I; Felip, A; Gomez, A; Carrillo, M; Zanuy, S; Kah, O				Escobar, Sebastian; Servili, Arianna; Espigares, Felipe; Gueguen, Marie-Madeleine; Brocal, Isabel; Felip, Alicia; Gomez, Ana; Carrillo, Manuel; Zanuy, Silvia; Kah, Olivier			Expression of Kisspeptins and Kiss Receptors Suggests a Large Range of Functions for Kisspeptin Systems in the Brain of the European Sea Bass	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; GOLDFISH CARASSIUS-AURATUS; NITRIC-OXIDE SYNTHASE; DICENTRARCHUS-LABRAX; GROWTH-HORMONE; NEUROENDOCRINE CONTROL; TYROSINE-HYDROXYLASE; ARCUATE NUCLEUS; PREOPTIC REGION; PITUITARY-CELLS	This study, conducted in the brain of a perciform fish, the European sea bass, aimed at raising antibodies against the precursor of the kisspeptins in order to map the kiss systems and to correlate the expression of kisspeptins, kiss1 and kiss2, with that of kisspeptin receptors (kiss-R1 and kiss-R2). Specific antibodies could be raised against the preprokiss2, but not the preoprokiss1. The data indicate that kiss2 neurons are mainly located in the hypothalamus and project widely to the subpallium and pallium, the preoptic region, the thalamus, the pretectal area, the optic tectum, the torus semicircularis, the mediobasal medial and caudal hypothalamus, and the neurohypophysis. These results were compared to the expression of kiss-R1 and kiss-R2 messengers, indicating a very good correlation between the wide distribution of Kiss2-positive fibers and that of kiss-R2 expressing cells. The expression of kiss-R1 messengers was more limited to the habenula, the ventral telencephalon and the proximal pars distalis of the pituitary. Attempts to characterize the phenotype of the numerous cells expressing kiss-R2 showed that neurons expressing tyrosine hydroxylase, neuropeptide Y and neuronal nitric oxide synthase are targets for kisspeptins, while GnRH1 neurons did not appear to express kiss-R1 or kiss-R2 messengers. In addition, a striking result was that all somatostatin-positive neurons expressed-kissR2. These data show that kisspeptins are likely to regulate a wide range of neuronal systems in the brain of teleosts.	[Escobar, Sebastian; Espigares, Felipe; Brocal, Isabel; Felip, Alicia; Gomez, Ana; Carrillo, Manuel; Zanuy, Silvia] CSIC, Inst Acuicultura Torre Sal, Ribera De Cabanes, Castellon, Spain; [Servili, Arianna; Gueguen, Marie-Madeleine; Kah, Olivier] Univ Rennes 1, INSERM, U1085, Res Inst Hlth Environm & Occupat, Rennes, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Zanuy, S (corresponding author), CSIC, Inst Acuicultura Torre Sal, Torre de la Sal S-N, Ribera De Cabanes, Castellon, Spain.	zanuy@iats.csic.es; olivier.kah@univ-rennes1.fr	GUEGUEN, marie madeleine/K-1731-2015; Zanuy, Silvia/K-4259-2014; Espigares, Felipe/AFO-8544-2022; ALICIA, FELIP/H-5200-2016; Aguirre, Sebastián Escobar/AAC-1454-2021; kah, olivier/K-7624-2012; Gómez, Ana/K-6998-2014	Espigares, Felipe/0000-0002-6122-9031; ALICIA, FELIP/0000-0003-4708-9754; Aguirre, Sebastián Escobar/0000-0001-8826-2096; Gómez, Ana/0000-0003-4714-8064; Zanuy, Silvia/0000-0002-8231-8260; Servili, Arianna/0000-0002-6813-7500	EU project LIFECYCLE [FP7-222719-1]; EU INTEREG TC2N; Generalitat Valenciana (REPROBASS) [PROMETEO/2010/003]; JAE-Predoc CSIC; LIFECYCLE project	EU project LIFECYCLE; EU INTEREG TC2N; Generalitat Valenciana (REPROBASS)(Center for Forestry Research & Experimentation (CIEF)); JAE-Predoc CSIC; LIFECYCLE project	This work was supported by the EU project LIFECYCLE (FP7-222719-1) to O.K. and S.Z., the EU INTEREG TC2N to O.K. and the Generalitat Valenciana (REPROBASS; PROMETEO/2010/003). S. E., F. E. were sponsored by a JAE-Predoc CSIC and I. B. received a JAE-Doc postdoctoral fellow (Spain). A. S. was supported by the LIFECYCLE project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asturiano JF, 2000, J FISH BIOL, V56, P1155, DOI 10.1111/j.1095-8649.2000.tb02131.x; Begtashi I, 2004, AQUACULTURE, V241, P539, DOI 10.1016/j.aquaculture.2004.07.011; Bellefontaine N, 2011, NEUROENDOCRINOLOGY, V93, P74, DOI 10.1159/000324147; Biran J, 2008, BIOL REPROD, V79, P776, DOI 10.1095/biolreprod.107.066266; BURGUS R, 1973, P NATL ACAD SCI USA, V70, P684, DOI 10.1073/pnas.70.3.684; Canosa LF, 2005, AM J PHYSIOL-REG I, V289, pR125, DOI 10.1152/ajpregu.00759.2004; Canosa LF, 2002, NEUROENDOCRINOLOGY, V76, P8, DOI 10.1159/000063679; Canosa LF, 2007, GEN COMP ENDOCR, V151, P1, DOI 10.1016/j.ygcen.2006.12.010; Carrillo M, 2009, ANN NY ACAD SCI, V1163, P49, DOI 10.1111/j.1749-6632.2008.03645.x; Cerda-Reverter JM, 1999, AM J PHYSIOL-REG I, V277, pR1627, DOI 10.1152/ajpregu.1999.277.6.R1627; Cerda-Reverter JM, 2000, J CHEM NEUROANAT, V19, P197, DOI 10.1016/S0891-0618(00)00063-6; Cerda-Reverter JM, 2001, J MORPHOL, V247, P217, DOI 10.1002/1097-4687(200103)247:3<217::AID-JMOR1013>3.0.CO;2-U; Cerda-Reverter JM, 2001, J MORPHOL, V247, P229, DOI 10.1002/1097-4687(200103)247:3<229::AID-JMOR1014>3.0.CO;2-K; Chang JP, 2012, GEN COMP ENDOCR, V179, P38, DOI 10.1016/j.ygcen.2012.07.028; CIOFI P, 1987, NEUROENDOCRINOLOGY, V45, P425, DOI 10.1159/000124769; Clasadonte J, 2008, ENDOCRINOLOGY, V149, P587, DOI 10.1210/en.2007-1260; DUBOIS MP, 1975, P NATL ACAD SCI USA, V72, P1340, DOI 10.1073/pnas.72.4.1340; Escobar S, 2013, J COMP NEUROL, V521, P933, DOI 10.1002/cne.23211; Felip A, 2009, MOL CELL ENDOCRINOL, V312, P61, DOI 10.1016/j.mce.2008.11.017; Filby AL, 2008, BIOL REPROD, V78, P278, DOI 10.1095/biolreprod.107.063420; FRYER JN, 1979, GEN COMP ENDOCR, V39, P244, DOI 10.1016/0016-6480(79)90229-6; Gaikwad A, 2009, J CHEM NEUROANAT, V37, P170, DOI 10.1016/j.jchemneu.2008.12.006; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gonzalez-Martinez D, 2001, J COMP NEUROL, V429, P144, DOI 10.1002/1096-9861(20000101)429:1&lt;144::AID-CNE11&gt;3.0.CO;2-B; Gonzalez-Martinez D, 2002, J COMP NEUROL, V446, P95, DOI 10.1002/cne.10190; Hanchate NK, 2012, J NEUROSCI, V32, P932, DOI 10.1523/JNEUROSCI.4765-11.2012; Herbison AE, 1996, J NEUROENDOCRINOL, V8, P73, DOI 10.1111/j.1365-2826.1996.tb00688.x; Herbison AE, 2010, ENDOCRINOLOGY, V151, P312, DOI 10.1210/en.2009-0552; Holmqvist B, 2000, NEUROSCI LETT, V292, P119, DOI 10.1016/S0304-3940(00)01460-9; KAH O, 1987, NEUROENDOCRINOLOGY, V45, P451, DOI 10.1159/000124774; KAH O, 1982, CR ACAD SCI III-VIE, V294, P519; KAH O, 1984, NEUROSCI LETT, V48, P293, DOI 10.1016/0304-3940(84)90053-3; Kah O., 2010, HORMONES REPROD VERT, V1, P15; Kanda S, 2012, J NEUROENDOCRINOL, V24, P897, DOI 10.1111/j.1365-2826.2012.02296.x; Kanda S, 2008, ENDOCRINOLOGY, V149, P2467, DOI 10.1210/en.2007-1503; Kanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062776; Kitahashi T, 2009, ENDOCRINOLOGY, V150, P821, DOI 10.1210/en.2008-0940; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Linard B, 1996, NEUROENDOCRINOLOGY, V63, P156, DOI 10.1159/000126952; MARCHANT TA, 1987, REGUL PEPTIDES, V17, P41, DOI 10.1016/0167-0115(87)90031-0; Matsuda K, 2012, NEUROPEPTIDES, V46, P275, DOI 10.1016/j.npep.2012.09.006; Meints AN, 2012, J NEUROENDOCRINOL, V24, P1166, DOI 10.1111/j.1365-2826.2012.02323.x; Migaud H, 2012, GEN COMP ENDOCR, V179, P384, DOI 10.1016/j.ygcen.2012.07.033; Cerda-Reverter JM, 2008, ACTA HISTOCHEM, V110, P433, DOI 10.1016/j.acthis.2008.01.001; Moles G, 2011, BIOL REPROD, V85, P848, DOI 10.1095/biolreprod.111.091868; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Parhar IS, 2004, ENDOCRINOLOGY, V145, P3613, DOI 10.1210/en.2004-0395; Pasquier J, 2011, GEN COMP ENDOCR, V173, P216, DOI 10.1016/j.ygcen.2011.05.019; Pasquier Jeremy, 2012, Front Endocrinol (Lausanne), V3, P173, DOI 10.3389/fendo.2012.00173; Pasquier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048931; PENG C, 1993, ENDOCRINOLOGY, V132, P1820, DOI 10.1210/en.132.4.1820; Pielecka-Fortuna J, 2008, ENDOCRINOLOGY, V149, P1979, DOI 10.1210/en.2007-1365; PONTET A, 1989, CELL TISSUE RES, V255, P529; Roa J, 2007, GEN COMP ENDOCR, V153, P132, DOI 10.1016/j.ygcen.2007.01.026; SAS E, 1990, J COMP NEUROL, V292, P127, DOI 10.1002/cne.902920109; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; Sheridan MA, 2010, GEN COMP ENDOCR, V167, P360, DOI 10.1016/j.ygcen.2009.09.002; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Tena-Sempere M, 2010, ANN ENDOCRINOL-PARIS, V71, P201, DOI 10.1016/j.ando.2010.02.018; Tena-Sempere M, 2012, GEN COMP ENDOCR, V175, P234, DOI 10.1016/j.ygcen.2011.11.015; THIBAULT J, 1981, BIOCHEM BIOPH RES CO, V99, P960, DOI 10.1016/0006-291X(81)91256-0; van Aerle R, 2008, PEPTIDES, V29, P57, DOI 10.1016/j.peptides.2007.10.018; Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001; Yang B, 2010, GEN COMP ENDOCR, V165, P60, DOI 10.1016/j.ygcen.2009.06.001; YU KL, 1991, GEN COMP ENDOCR, V81, P256, DOI 10.1016/0016-6480(91)90010-4; YU KL, 1990, NEUROENDOCRINOLOGY, V52, P276, DOI 10.1159/000125598; Zhang XB, 2012, NEUROENDOCRINOLOGY, V96, P68, DOI 10.1159/000335985; Zmora N, 2002, J ENDOCRINOL, V172, P105, DOI 10.1677/joe.0.1720105; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	69	74	77	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70177	10.1371/journal.pone.0070177	http://dx.doi.org/10.1371/journal.pone.0070177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894610	Green Submitted, gold, Green Published			2022-12-25	WOS:000325211000190
J	Wu, LJ; Wang, SX; Chen, X; Wang, XT; Wu, LC; Zu, XF; Chen, YH				Wu, Liuji; Wang, Shunxi; Chen, Xiao; Wang, Xintao; Wu, Liancheng; Zu, Xiaofeng; Chen, Yanhui			Proteomic and Phytohormone Analysis of the Response of Maize (Zea mays L.) Seedlings to Sugarcane Mosaic Virus	PLOS ONE			English	Article							SALICYLIC-ACID; STRESS TOLERANCE; SCMV RESISTANCE; CROSS-TALK; PROTEINS; ARABIDOPSIS; DEFENSE; PLANTS; GENES; IDENTIFICATION	Background: Sugarcane mosaic virus (SCMV) is an important virus pathogen in crop production, causing serious losses in grain and forage yields in susceptible cultivars. Control strategies have been developed, but only marginal successes have been achieved. For the efficient control of this virus, a better understanding of its interactions and associated resistance mechanisms at the molecular level is required. Methodology/Principal Findings: The responses of resistant and susceptible genotypes of maize to SCMV and the molecular basis of the resistance were studied using a proteomic approach based on two-dimensional polyacrylamide gel electrophoresis (2-DE) and matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS/MS) analysis. Ninety-six protein spots showed statistically significant differences in intensity after SCMV inoculation. The classification of differentially expressed proteins showed that SCMV-responsive proteins were mainly involved in energy and metabolism, stress and defense responses, and photosynthesis. Most of the proteins identified were located in chloroplasts, chloroplast membranes, and the cytoplasm. Analysis of changes in phytohormone levels after virus inoculation suggested that salicylic acid, abscisic acid, jasmonic acid, and azelaic acid may played important roles in the maize response to SCMV infection. Conclusions/Significance: Among these identified proteins, 19 have not been identified previously as virus-responsive proteins, and seven were new and did not have assigned functions. These proteins may be candidate proteins for future investigation, and they may present new biological functions and play important roles in plant-virus interactions. The behavioural patterns of the identified proteins suggest the existence of defense mechanisms operating during the early stages of infection that differed in two genotypes. In addition, there are overlapping and specific phytohormone responses to SCMV infection between resistant and susceptible maize genotypes. This study may provide important insights into the molecular events during plant responses to virus infection.	[Wu, Liuji; Wang, Shunxi; Wang, Xintao; Wu, Liancheng; Zu, Xiaofeng; Chen, Yanhui] Henan Agr Univ, Zhengzhou, Peoples R China; [Wu, Liuji; Wang, Shunxi; Wang, Xintao; Wu, Liancheng; Zu, Xiaofeng; Chen, Yanhui] Synerget Innovat Ctr Henan Grain Crops, Zhengzhou, Peoples R China; [Wu, Liuji; Wu, Liancheng; Chen, Yanhui] Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China; [Chen, Xiao] Henan Prov Seed Control Stn, Zhengzhou, Peoples R China	Henan Agricultural University	Chen, YH (corresponding author), Henan Agr Univ, Zhengzhou, Peoples R China.	chy9890@163.com			National Natural Science Foundation of China [31101158]; Specialized Research Fund for the Doctor Program of Higher Education [20114105120002]; China Postdoctoral Science Foundation [20100470993]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctor Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (number 31101158), the Specialized Research Fund for the Doctor Program of Higher Education (20114105120002) and China Postdoctoral Science Foundation (20100470993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson M, 2006, POPUL ENVIRON, V28, P113, DOI 10.1007/s11111-007-0035-8; BEVAN M, 1998, NATURE, V391, P485; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Block A, 2005, PLANT PHYSIOL, V138, P1481, DOI 10.1104/pp.105.059246; Bohmer M, 2011, PLANT J, V67, P105, DOI 10.1111/j.1365-313X.2011.04579.x; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Chan ZL, 2008, PROTEOMICS, V8, P4791, DOI 10.1002/pmic.200701155; Chastain CJ, 2003, PLANT PHYSIOL BIOCH, V41, P523, DOI 10.1016/S0981-9428(03)00065-2; Cheng FY, 2009, J PROTEOME RES, V8, P82, DOI 10.1021/pr800649s; Cho K, 2007, J PROTEOME RES, V6, P3581, DOI 10.1021/pr070358v; Cruz SS, 1999, TRENDS MICROBIOL, V7, P237, DOI 10.1016/S0966-842X(99)01508-5; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Di Carli M, 2010, J PROTEOME RES, V9, P5684, DOI 10.1021/pr100487x; Dolja V V, 1995, Virology, V206, P1007, DOI 10.1006/viro.1995.1023; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Escalante-Perez M, 2011, P NATL ACAD SCI USA, V108, P15492, DOI 10.1073/pnas.1112535108; FELLER U, 1994, CRIT REV PLANT SCI, V13, P241, DOI 10.1080/713608059; Ferry N, 2011, PROTEOMICS, V11, P1985, DOI 10.1002/pmic.200900801; Gan DF, 2010, PLANT CELL REP, V29, P1261, DOI 10.1007/s00299-010-0911-z; Guo HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022255; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; Hong Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006098; Igarashi D, 2003, PLANT J, V33, P975, DOI 10.1046/j.1365-313X.2003.01688.x; Igarashi D, 2006, PLANT PHYSIOL, V142, P901, DOI 10.1104/pp.106.085514; Jarsch IK, 2011, MOL PLANT MICROBE IN, V24, P7, DOI 10.1094/MPMI-07-10-0166; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kim MJ, 2005, PLANT MOL BIOL, V59, P981, DOI 10.1007/s11103-005-2619-y; Kim ST, 2008, PROTEOMICS, V8, P3577, DOI 10.1002/pmic.200800183; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Kuntze L, 1997, PLANT BREEDING, V116, P499, DOI 10.1111/j.1439-0523.1997.tb01038.x; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Li H, 2006, ONCOGENE, V25, P713, DOI 10.1038/sj.onc.1209111; Li KP, 2011, GENE, V485, P106, DOI 10.1016/j.gene.2011.06.016; Li XM, 2011, J EXP BOT, V62, P4763, DOI 10.1093/jxb/err084; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Mininno M, 2012, J BIOL CHEM, V287, P21034, DOI 10.1074/jbc.M112.359976; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Parker JE, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.270pe31; Pechanova O, 2010, PROTEOMICS, V10, P3051, DOI 10.1002/pmic.200900833; Pineda M, 2010, PHOTOSYNTH RES, V103, P31, DOI 10.1007/s11120-009-9499-y; Rasmussen AL, 2011, J VIROL, V85, P11646, DOI 10.1128/JVI.05605-11; Safarnejad MR, 2011, BIOTECHNOL ADV, V29, P961, DOI 10.1016/j.biotechadv.2011.08.011; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shen Y, 2008, BMB REP, V41, P645, DOI 10.5483/BMBRep.2008.41.9.645; Shi C, 2005, MOL BREEDING, V16, P173, DOI 10.1007/s11032-005-8357-7; Shi C, 2006, PLANT SCI, V170, P159, DOI 10.1016/j.plantsci.2005.08.016; Shi C, 2005, MOL GENET GENOMICS, V273, P450, DOI 10.1007/s00438-004-1103-8; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; Uzarowska A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-15; VANLOON LC, 1987, ADV VIRUS RES, V33, P205, DOI 10.1016/S0065-3527(08)60319-X; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Wu LJ, 2013, PLANT MOL BIOL REP, V31, P507, DOI 10.1007/s11105-012-0522-7; Wu LJ, 2012, CROP PROT, V42, P74, DOI 10.1016/j.cropro.2012.07.005; Wu LJ, 2011, PLANT MOL BIOL REP, V29, P1006, DOI 10.1007/s11105-011-0296-3; Xia XC, 1999, PHYTOPATHOLOGY, V89, P660, DOI 10.1094/PHYTO.1999.89.8.660; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Zagrobelny M, 2004, PHYTOCHEMISTRY, V65, P293, DOI 10.1016/j.phytochem.2003.10.016; Zoeller M, 2012, PLANT PHYSIOL, V160, P365, DOI 10.1104/pp.112.202846	63	23	25	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70295	10.1371/journal.pone.0070295	http://dx.doi.org/10.1371/journal.pone.0070295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894637	Green Submitted, Green Published, gold			2022-12-25	WOS:000325211000204
J	Yang, Y; Wu, YL; Zhang, ST; Song, WH				Yang, Yi; Wu, Yili; Zhang, Shuting; Song, Weihong			High Glucose Promotes A beta Production by Inhibiting APP Degradation	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INSULIN-DEGRADING ENZYME; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; MESSENGER-RNA; DIABETIC-PATIENTS; COGNITIVE FUNCTION; MOLECULAR-CLONING; GAMMA-SECRETASE; RETINOIC ACID	Abnormal deposition of neuriticplaques is the uniqueneuropathological hallmark of Alzheimer's disease (AD). Amyloid beta protein (A beta), the major component of plaques, is generated from sequential cleavage of amyloidb precursor protein (APP) by beta-secretase and gamma-secretase complex. Patients with diabetes mellitus (DM), characterized by chronic hyperglycemia, have increased risk of AD development. However, the role of high blood glucose in APP processing and A beta generation remains elusive. In this study, we investigated the effect of high glucose on APP metabolism and A beta generation in cultured human cells. We found that high glucose treatment significantly increased APP protein level in both neuronal-like and non-neuronal cells, and promoted A beta generation. Furthermore, we found that high glucose-induced increase of APP level was not due to enhancement of APP gene transcription but resulted from inhibition of APP protein degradation. Taken together, our data indicated that hyperglycemia could promote AD pathogenesis by inhibiting APP degradation and enhancing A beta production. More importantly, the elevation of APP level and A beta generation by high glucose was caused by reduction of APP turnover rate. Thus, our study provides a molecular mechanism of increased risk of developing AD in patients with DM and suggests thatglycemic control might be potentially beneficial for reducing the incidence of AD in diabetic patients and delaying the AD progression.	[Yang, Yi; Zhang, Shuting; Song, Weihong] Univ British Columbia, Dept Psychiat, Townsend Family Labs, Brain Res Ctr,Grad Program Neurosci, Vancouver, BC, Canada; [Wu, Yili; Song, Weihong] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Wu, Yili; Song, Weihong] Chongqing Med Univ, Childrens Hosp, Chongqing City Key Lab Translat Med Res Cognit De, Chongqing, Peoples R China	University of British Columbia; Chongqing Medical University; Chongqing Medical University	Song, WH (corresponding author), Univ British Columbia, Dept Psychiat, Townsend Family Labs, Brain Res Ctr,Grad Program Neurosci, Vancouver, BC, Canada.	weihong@mail.ubc.ca	Song, Weihong/O-7623-2017	Song, Weihong/0000-0001-9928-889X; wu, yili/0000-0002-2369-6974	Canadian Institutes of Health Research (CIHR) [MOP-97825]; Chinese Scholarship Council	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Chinese Scholarship Council(China Scholarship Council)	The authors declare no conflict of interest. This work was supported by the Canadian Institutes of Health Research (CIHR) Operating grant MOP-97825. W. Song is the holder of the Tier 1 Canada Research Chair in Alzheimer's Disease. Y. Yang and S. Zhang are supported by the Chinese Scholarship Council award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1991, NEUROSCI LETT, V125, P169, DOI 10.1016/0304-3940(91)90019-P; Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Ando K, 1999, J NEUROSCI, V19, P4421; Authier F, 1996, CLIN INVEST MED, V19, P149; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Brouwers N, 2006, BRAIN, V129, P2984, DOI 10.1093/brain/awl212; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; Carantoni M, 2000, DEMENT GERIATR COGN, V11, P176, DOI 10.1159/000017232; Cheon MS, 2008, AMINO ACIDS, V35, P339, DOI 10.1007/s00726-007-0618-9; COLE GM, 1992, ANN NY ACAD SCI, V674, P103; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Deng Y, 2013, EUR J NEUROSCI; DEWJI NN, 1995, MOL BRAIN RES, V33, P245, DOI 10.1016/0169-328X(95)00131-B; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Georgopoulou N, 2001, BIOCHEM SOC SYMP, V67, P23; Ghosh AK, 2008, NEUROTHERAPEUTICS, V5, P399, DOI 10.1016/j.nurt.2008.05.007; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Goldgaber DES, 1991, BRAIN RES REV, V16, P89; GRILLI M, 1995, J BIOL CHEM, V270, P26774, DOI 10.1074/jbc.270.45.26774; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hare JF, 2006, ARCH BIOCHEM BIOPHYS, V451, P79, DOI 10.1016/j.abb.2006.05.002; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; JAGUSCH W, 1992, DIABETES NUTR METAB, V5, P265; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jolivalt CG, 2010, EXP NEUROL, V223, P422, DOI 10.1016/j.expneurol.2009.11.005; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; KNOPS J, 1992, J BIOL CHEM, V267, P16022; KONIG G, 1990, FEBS LETT, V269, P305, DOI 10.1016/0014-5793(90)81181-M; Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li Y, 2006, FASEB J, V20, P285, DOI 10.1096/fj.05-4986com; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; McFarlane I, 1999, NEUROSCIENCE, V90, P15, DOI 10.1016/S0306-4522(98)00361-3; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; NOMURA S, 1994, THROMB HAEMOSTASIS, V72, P519; Nunan J, 2003, J NEUROSCI RES, V74, P378, DOI 10.1002/jnr.10646; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Oda A, 2010, J NEUROSCI RES, V88, P1137, DOI 10.1002/jnr.22271; OYAMA F, 1994, J NEUROCHEM, V62, P1062; Peres GB, 2013, BBA-MOL BASIS DIS, V1832, P85, DOI 10.1016/j.bbadis.2012.09.011; PERLMUTER LC, 1984, AM J MED, V77, P1043, DOI 10.1016/0002-9343(84)90186-4; Pivovarova O, 2009, DIABETOLOGIA, V52, P1656, DOI 10.1007/s00125-009-1350-7; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Queisser MA, 2010, DIABETES, V59, P670, DOI 10.2337/db08-1565; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quiroz-Baez R, 2009, NEUROCHEM INT, V55, P662, DOI 10.1016/j.neuint.2009.06.012; Razay G, 2007, ARCH NEUROL-CHICAGO, V64, P93, DOI 10.1001/archneur.64.1.93; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Salon ML, 2003, EXP NEUROL, V180, P131, DOI 10.1016/S0014-4886(02)00060-2; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; SHIGEMATSU K, 1992, BRAIN RES, V592, P353, DOI 10.1016/0006-8993(92)91697-D; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; Song WH, 1998, GENE, V217, P165, DOI 10.1016/S0378-1119(98)00340-0; Song WH, 1998, GENE, V217, P151, DOI 10.1016/S0378-1119(98)00337-0; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Theuns J, 2000, HUM MOL GENET, V9, P2383, DOI 10.1093/hmg/9.16.2383; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; TOMIMOTO H, 1995, BRAIN RES, V672, P187, DOI 10.1016/0006-8993(94)01160-J; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wimo A, 2010, WORLD ALZHEIMER REPO; Wu YL, 2013, FASEB J, V27, P208, DOI 10.1096/fj.12-213124; Yang YX, 1998, MOL BRAIN RES, V60, P40, DOI 10.1016/S0169-328X(98)00164-8; Yazaki M, 1996, NEUROSCI LETT, V221, P57, DOI 10.1016/S0304-3940(96)13285-7; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; ZIMMERMANN K, 1988, EMBO J, V7, P367, DOI 10.1002/j.1460-2075.1988.tb02822.x	90	48	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69824	10.1371/journal.pone.0069824	http://dx.doi.org/10.1371/journal.pone.0069824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894546	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000159
J	Fang, JY; Chung, JD; Chiang, YC; Chang, CT; Chen, CY; Hwang, SY				Fang, Jing-Yu; Chung, Jeng-Der; Chiang, Yu-Chung; Chang, Chung-Te; Chen, Chia-Ying; Hwang, Shih-Ying			Divergent Selection and Local Adaptation in Disjunct Populations of an Endangered Conifer, Keteleeria davidiana var. formosana (Pinaceae)	PLOS ONE			English	Article							DETECT CANDIDATE LOCI; LINKAGE DISEQUILIBRIUM; GENOME-SCAN; ADAPTIVE DIVERGENCE; GENETIC DIVERSITY; NUCLEOTIDE DIVERSITY; POLYMORPHISM; SOFTWARE; DOMINANT; MARKERS	The present study investigated the genetic diversity, population structure, F-ST outliers, and extent and pattern of linkage disequilibrium in five populations of Keteleeria davidiana var. formosana, which is listed as a critically endangered species by the Council of Agriculture, Taiwan. Twelve amplified fragment length polymorphism primer pairs generated a total of 465 markers, of which 83.74% on average were polymorphic across populations, with a mean Nei's genetic diversity of 0.233 and a low level of genetic differentiation (approximately 6%) based on the total dataset. Linkage disequilibrium and HICKORY analyses suggested recent population bottlenecks and inbreeding in K. davidiana var. formosana. Both STRUCTURE and BAPS observed extensive admixture of individual genotypes among populations based on the total dataset in various clustering scenarios, which probably resulted from incomplete lineage sorting of ancestral variation rather than a high rate of recent gene flow. Our results based on outlier analysis revealed generally high levels of genetic differentiation and suggest that divergent selection arising from environmental variation has been driven by differences in temperature, precipitation, and humidity. Identification of ecologically associated outliers among environmentally disparate populations further support divergent selection and potential local adaptation.	[Fang, Jing-Yu; Chang, Chung-Te; Chen, Chia-Ying; Hwang, Shih-Ying] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chung, Jeng-Der] Taiwan Forestry Res Inst, Div Silviculture, Taipei, Taiwan; [Chiang, Yu-Chung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	National Taiwan Normal University; National Sun Yat Sen University	Hwang, SY (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	hsy9347@ntnu.edu.tw	Chiang, Yu-Chung/E-9143-2011; Chang, Chung Te/M-9443-2013	Chang, Chung Te/0000-0003-0064-1935	National Science Council of Taiwan [NSC101-2313-B-003-001-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan (Grant No. NSC101-2313-B-003-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Black WC, 2001, ANNU REV ENTOMOL, V46, P441, DOI 10.1146/annurev.ento.46.1.441; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Bothwell H, 2013, CONSERV GENET, V14, P467, DOI 10.1007/s10592-012-0411-5; Bradshaw AD, 1984, PERSPECTIVES PLANT P, P213; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; BROWN AHD, 1980, GENETICS, V96, P523; Brown GR, 2004, P NATL ACAD SCI USA, V101, P15255, DOI 10.1073/pnas.0404231101; Carrera-Hernandez JJ, 2007, J HYDROL, V336, P231, DOI 10.1016/j.jhydrol.2006.12.021; Chou FuShan, 2009, Taiwan Journal of Forest Science, V24, P257; Chung JD, 2004, MOL PHYLOGENET EVOL, V33, P791, DOI 10.1016/j.ympev.2004.08.011; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Despres L, 2002, MOL ECOL, V11, P2337, DOI 10.1046/j.1365-294X.2002.01618.x; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Elias Marianne, 2012, International Journal of Ecology, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FARJON A, 1989, Notes from the Royal Botanic Garden Edinburgh, V46, P81; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Goldberg EE, 2007, AM NAT, V170, P297, DOI 10.1086/518946; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Haubold B, 1998, GENETICS, V150, P1341; Hedrick P.W., 2000, GENETICS POPULATIONS; Hedrick PW, 2006, ANNU REV ECOL EVOL S, V37, P67, DOI 10.1146/annurev.ecolsys.37.091305.110132; Herrera CM, 2009, MOL ECOL, V18, P2602, DOI 10.1111/j.1365-294X.2009.04229.x; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hohenlohe PA, 2012, PHILOS T R SOC B, V367, P395, DOI 10.1098/rstb.2011.0245; Holsinger K. E., 2003, HICKORY PACKAGE ANAL; Holsinger KE, 2004, MOL ECOL, V13, P887, DOI 10.1111/j.1365-294X.2004.02052.x; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Hung SC, 2004, TAIWAN FOR J, V13, P50; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Jensen JD, 2007, TRENDS GENET, V23, P568, DOI 10.1016/j.tig.2007.08.009; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Joost S, 2008, MOL ECOL RESOUR, V8, P957, DOI 10.1111/j.1755-0998.2008.02162.x; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Kanehira R, 1936, FORMOSAN TRESS INDIG, P51; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Li H., 1994, FLORA TAIWAN, P568; Liew P.M., 2001, W PACIFIC EARTH SCI, V1, P405; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Manel S, 2012, MOL ECOL, V21, P3729, DOI 10.1111/j.1365-294X.2012.05656.x; Manel S, 2010, MOL ECOL, V19, P3760, DOI 10.1111/j.1365-294X.2010.04717.x; MARUYAMA T, 1985, GENETICS, V111, P675; Meyer CL, 2009, MOL ECOL, V18, P2050, DOI 10.1111/j.1365-294X.2009.04159.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Nunes VL, 2011, MOL ECOL, V20, P193, DOI 10.1111/j.1365-294X.2010.04936.x; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; OHTA T, 1969, GENETICS, V63, P229; Parchman TL, 2011, AM J BOT, V98, P669, DOI 10.3732/ajb.1000378; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petit RJ, 2005, MOL ECOL, V14, P885, DOI 10.1111/j.1365-294X.2005.02446.x; Poncet BN, 2010, MOL ECOL, V19, P2896, DOI 10.1111/j.1365-294X.2010.04696.x; Pritchard JK, 2000, GENETICS, V155, P945; Przeworski M, 2002, GENETICS, V160, P1179; Pyhajarvi T, 2011, TREE GENET GENOMES, V7, P385, DOI 10.1007/s11295-010-0340-8; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; SAS Institute Inc, 2007, JMP VERS 7; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Su H. J., 1984, Quarterly Journal of Chinese Forestry, V17, P57; Tang SQ, 2008, GENETICA, V133, P21, DOI 10.1007/s10709-007-9178-x; Terrab A, 2008, AM J BOT, V95, P1262, DOI 10.3732/ajb.0800010; Tsukada M., 1967, PALAEOGEOGR PALAEOCL, V3, P49, DOI DOI 10.1016/0031-0182(67)90005-3; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wall JD, 2002, GENETICS, V162, P203; Wang YN, 1987, THESIS NATL TAIWAN U; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035; Yang Jeng-Chuann, 2006, Taiwan Journal of Forest Science, V21, P179; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	102	14	14	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e70162	10.1371/journal.pone.0070162	http://dx.doi.org/10.1371/journal.pone.0070162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894608	gold, Green Published, Green Submitted			2022-12-25	WOS:000322132100089
J	Harlow, ML; Szule, JA; Xu, J; Jung, JH; Marshall, RM; McMahan, UJ				Harlow, Mark L.; Szule, Joseph A.; Xu, Jing; Jung, Jae Hoon; Marshall, Robert M.; McMahan, Uel J.			Alignment of Synaptic Vesicle Macromolecules with the Macromolecules in Active Zone Material that Direct Vesicle Docking	PLOS ONE			English	Article							FROG NEUROMUSCULAR-JUNCTION; INTEGRAL MEMBRANE-PROTEIN; MOTOR-NERVE TERMINALS; TRANSMITTER RELEASE; FREEZE-FRACTURE; ELECTRON TOMOGRAPHY; NEUROTRANSMITTER RELEASE; STRUCTURAL-CHANGES; SYNAPSIN-I; ARCHITECTURE	Synaptic vesicles dock at active zones on the presynaptic plasma membrane of a neuron's axon terminals as a precondition for fusing with the membrane and releasing their neurotransmitter to mediate synaptic impulse transmission. Typically, docked vesicles are next to aggregates of plasma membrane-bound macromolecules called active zone material (AZM). Electron tomography on tissue sections from fixed and stained axon terminals of active and resting frog neuromuscular junctions has led to the conclusion that undocked vesicles are directed to and held at the docking sites by the successive formation of stable connections between vesicle membrane proteins and proteins in different classes of AZM macromolecules. Using the same nanometer scale 3D imaging technology on appropriately stained frog neuromuscular junctions, we found that similar to 10% of a vesicle's luminal volume is occupied by a radial assembly of elongate macromolecules attached by narrow projections, nubs, to the vesicle membrane at similar to 25 sites. The assembly's chiral, bilateral shape is nearly the same vesicle to vesicle, and nubs, at their sites of connection to the vesicle membrane, are linked to macromolecules that span the membrane. For docked vesicles, the orientation of the assembly's shape relative to the AZM and the presynaptic membrane is the same vesicle to vesicle, whereas for undocked vesicles it is not. The connection sites of most nubs on the membrane of docked vesicles are paired with the connection sites of the different classes of AZM macromolecules that regulate docking, and the membrane spanning macromolecules linked to these nubs are also attached to the AZM macromolecules. We conclude that the luminal assembly of macromolecules anchors in a particular arrangement vesicle membrane macromolecules, which contain the proteins that connect the vesicles to AZM macromolecules during docking. Undocked vesicles must move in a way that aligns this arrangement with the AZM macromolecules for docking to proceed.	[Harlow, Mark L.; Szule, Joseph A.; Xu, Jing; Jung, Jae Hoon; Marshall, Robert M.; McMahan, Uel J.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Xu, Jing] Stanford Univ, Dept Appl Phys, Sch Humanities Sci, Stanford, CA 94305 USA; [Jung, Jae Hoon] Stanford Univ, Dept Phys, Sch Humanities Sci, Stanford, CA 94305 USA; [Harlow, Mark L.; Szule, Joseph A.; Jung, Jae Hoon; Marshall, Robert M.; McMahan, Uel J.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Stanford University; Stanford University; Stanford University; Texas A&M University System; Texas A&M University College Station	McMahan, UJ (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	grantser@tamu.edu			National Institute of Neurological Disorders and Stroke [NS014506, NS007158]; National Institute of Mental Health (Human Brain Project/Neuroinformatics) [MH068065]; National Science and Engineering Research Council of Canada; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014506] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health (Human Brain Project/Neuroinformatics); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by the National Institute of Neurological Disorders and Stroke (NS014506 and NS007158), The National Institute of Mental Health (Human Brain Project/Neuroinformatics, MH068065), and a postdoctoral fellowship from the National Science and Engineering Research Council of Canada (to JAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, NATURE, V395, P347; Arfken GB., 1999, MATH METHODS PHYS; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BESHARSE JC, 1980, J CELL BIOL, V87, P451, DOI 10.1083/jcb.87.2.451; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, NEURON, V9, P805, DOI 10.1016/0896-6273(92)90235-6; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; BUCKLEY KM, 1983, J NEUROCYTOL, V12, P67, DOI 10.1007/BF01148088; CARLSON SS, 1978, BIOCHEMISTRY-US, V17, P1188, DOI 10.1021/bi00600a009; Castorph S, 2010, BIOPHYS J, V98, P1200, DOI 10.1016/j.bpj.2009.12.4278; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; COUTEAUX R, 1974, CR ACAD SCI D NAT, V278, P291; COUTEAUX R, 1970, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences Serie D Sciences Naturelles, V271, P2346; DICKINSONNELSON A, 1983, J NEUROSCI, V3, P42; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; Frank J, 2006, ELECT TOMOGRAPHY MET, Vxiv; GARCIASEGURA LM, 1986, NEUROSCIENCE, V19, P63, DOI 10.1016/0306-4522(86)90006-0; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; HEUSER JE, 1974, J NEUROCYTOL, V3, P109, DOI 10.1007/BF01111936; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Heuser JE, 1977, HDB PHYSL, VI, P261; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Katz B, 1969, RELEASE NEURAL TRANS, Vix; LANDIS DMD, 1974, J COMP NEUROL, V155, P67, DOI 10.1002/cne.901550106; LANDIS DMD, 1974, J COMP NEUROL, V155, P93, DOI 10.1002/cne.901550107; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; McDonald K, 2002, METHOD ENZYMOL, V351, P96; MCGUINNESS TL, 1989, J NEUROSCI, V9, P4138; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; Nagwaney S, 2009, J COMP NEUROL, V513, P457, DOI 10.1002/cne.21975; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PERIN MS, 1991, J BIOL CHEM, V266, P615; Peters A, 1991, FINE STRUCTURE NERVO, Vxviii; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; Reigada D, 2003, P NATL ACAD SCI USA, V100, P3485, DOI 10.1073/pnas.0336914100; Ress D, 1999, J ELECTRON MICROSC, V48, P277, DOI 10.1093/oxfordjournals.jmicro.a023679; Ress DB, 2004, STRUCTURE, V12, P1763, DOI 10.1016/j.str.2004.07.022; Rizzoli SO, 2007, TRAFFIC, V8, P1137, DOI 10.1111/j.1600-0854.2007.00614.x; Robinson A.H., 1974, INT YB CARTOGR, V14, P145; Rochon D, 2001, J NEUROSCI, V21, P3819, DOI 10.1523/JNEUROSCI.21-11-03819.2001; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Siksou L, 2009, EUR J NEUROSCI, V30, P49, DOI 10.1111/j.1460-9568.2009.06811.x; SILINSKY EM, 1975, J PHYSIOL-LONDON, V247, P145, DOI 10.1113/jphysiol.1975.sp010925; SMITH DO, 1991, J PHYSIOL-LONDON, V432, P343, DOI 10.1113/jphysiol.1991.sp018388; Sosinsky GE, 2008, J STRUCT BIOL, V161, P359, DOI 10.1016/j.jsb.2007.09.002; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Szule JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033333; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; THEODOSIS DT, 1978, J CELL BIOL, V78, P542, DOI 10.1083/jcb.78.2.542; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zampighi GA, 2008, J NEUROSCI, V28, P4151, DOI 10.1523/JNEUROSCI.4639-07.2008; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004	70	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69410	10.1371/journal.pone.0069410	http://dx.doi.org/10.1371/journal.pone.0069410			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894473	Green Published, gold, Green Submitted			2022-12-25	WOS:000322132100057
J	Navarro-Quezada, A; Schumann, N; Quint, M				Navarro-Quezada, Aura; Schumann, Nadine; Quint, Marcel			Plant F-Box Protein Evolution Is Determined by Lineage-Specific Timing of Major Gene Family Expansion Waves	PLOS ONE			English	Article							GENOME EVOLUTION; ARABIDOPSIS; IMPROVEMENT; ALIGNMENTS; SELECTION; RESOURCE; BLOCKS	F-box proteins (FBPs) represent one of the largest and fastest evolving gene/protein families in the plant kingdom. The FBP superfamily can be divided in several subfamilies characterized by different C-terminal protein-protein interaction domains that recruit targets for proteasomal degradation. Hence, a clear picture of their phylogeny and molecular evolution is of special interest for the general understanding of evolutionary histories of multi-domain and/or large protein families in plants. In an effort to further understand the molecular evolution of F-box family proteins, we asked whether the largest subfamily in Arabidopsis thaliana, which carries a C-terminal F-box associated domain (FBA proteins) shares evolutionary patterns and signatures of selection with other FBPs. To address this question, we applied phylogenetic and molecular evolution analyses in combination with the evaluation of transcriptional profiles. Based on the 2219 FBA proteins we de novo identified in 34 completely sequenced plant genomes, we compared their evolutionary patterns to a previously analyzed large subfamily carrying C-terminal kelch repeats. We found that these two large FBP subfamilies generally tend to evolve by massive waves of duplication, followed by sequence conservation of the F-box domain and sequence diversification of the target recruiting domain. We conclude that the earlier in evolutionary time a major wave of expansion occurred, the more pronounced these selection signatures are. As a consequence, when performing cross species comparisons among FBP subfamilies, significant differences will be observed in the selective signatures of protein-protein interaction domains. Depending on the species, the investigated subfamilies comprise up to 45% of the complete superfamily, indicating that other subfamilies possibly follow similar modes of evolution.	[Navarro-Quezada, Aura] Leibniz Inst Plant Biochem, Dept Stress & Dev Biol, Halle, Saale, Germany; [Schumann, Nadine; Quint, Marcel] Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Halle, Saale, Germany; [Navarro-Quezada, Aura] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie; Max Planck Society	Quint, M (corresponding author), Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Halle, Saale, Germany.	mquint@ipb-halle.de	quint, marcel/J-8483-2012; Quezada, Aura Navarro/L-2557-2019	Quezada, Aura Navarro/0000-0001-8301-5088; Quint, Marcel/0000-0003-2935-4083	Deutsche Forschungsgemeinschaft [SFB 648 - TPB8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft within the SFB 648 - TPB8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheng YT, 2011, P NATL ACAD SCI USA, V108, P14694, DOI 10.1073/pnas.1105685108; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Comeron JM, 1995, J MOL EVOL, V41, P1152, DOI 10.1007/BF00173196; Dong L, 2006, PLANT MOL BIOL, V60, P599, DOI 10.1007/s11103-005-5257-5; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gou MY, 2009, PLANT J, V60, P757, DOI 10.1111/j.1365-313X.2009.03995.x; Graham MA, 2004, PLANT PHYSIOL, V135, P1179, DOI 10.1104/pp.104.037531; Hua ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016219; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim HS, 2002, PLANT CELL, V14, P1469, DOI 10.1105/tpc.001867; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Peng J, 2012, SCI CHINA LIFE SCI, V55, P497, DOI 10.1007/s11427-012-4332-9; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmidt HA, 2002, MAXIMUM LIKELIHOOD A; Schumann N, 2011, PLANT PHYSIOL, V155, P835, DOI 10.1104/pp.110.166579; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stone SL, 2007, CURR OPIN PLANT BIOL, V10, P624, DOI 10.1016/j.pbi.2007.07.010; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wang L, 2004, PLANT MOL BIOL, V56, P929, DOI 10.1007/s11103-004-6236-y; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Yang ZF, 2008, GENOMICS, V92, P246, DOI 10.1016/j.ygeno.2008.06.001; Yang ZF., 2000, MARINE FORECASTS, V17, P41; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Zwickl D., 2006, GARLI GENETIC ALGORI	44	22	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e68672	10.1371/journal.pone.0068672	http://dx.doi.org/10.1371/journal.pone.0068672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23904908	gold, Green Published, Green Submitted			2022-12-25	WOS:000322391400019
J	Campolo, M; Esposito, E; Ahmad, A; Di Paola, R; Wallace, JL; Cuzzocrea, S				Campolo, Michela; Esposito, Emanuela; Ahmad, Akbar; Di Paola, Rosanna; Wallace, John L.; Cuzzocrea, Salvatore			A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury	FASEB JOURNAL			English	Article						inflammation; apoptosis; central nervous system; motor recovery; nonsteroidal anti-inflammatory drug	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; NITRIC-OXIDE; INFLAMMATORY RESPONSE; SIGNALING MOLECULE; OXIDATIVE STRESS; MOUSE MODEL; RAT; EXPRESSION; APOPTOSIS	Spinal cord trauma causes loss of motor function that is in part due to the ensuing inflammatory response. Hydrogen sulfide (H2S) is a potent, endogenous anti-inflammatory and neuroprotective substance that has been explored for use in the design of novel nonsteroidal anti-inflammatory drugs. In the current study, we evaluated the potential beneficial effects of ATB-346 [2-(6-methoxynapthalen- 2-yl)-propionic acid 4-thiocarbamoyl-phenyl ester], an H2S-releasing derivative of naproxen, in a murine model of spinal cord injury (SCI). SCI was induced in mice by spinal cord compression, produced through the application of vascular clips to the dura via a T5 to T8 laminectomy. ATB-346, naproxen (both at 30 mol/kg), or vehicle was orally administered to the mice 1 and 6 h after SCI and once daily thereafter for 10 d. Motor function [Basso Mouse Scale (BMS) of locomotion] improved gradually in the mice treated with naproxen. However, those treated with ATB-346 exhibited a significantly more rapid and sustained recovery of motor function, achieving greater than double the increase in locomotion score of the naproxen group by the 10th day of treatment. ATB-346 also significantly reduced the severity of inflammation (proinflammatory cytokines, apoptosis of neural tissue, and nitrosative stress) that characterized the secondary effects of SCI. Again, the effects of ATB-346 were superior to those of naproxen for several parameters. These results showed marked beneficial effects of an H2S-releasing derivative of naproxen in an animal model of SCI, significantly enhancing recovery of motor function, possibly by reducing the secondary inflammation and tissue injury that characterizes this model. The combination of inhibition of cyclooxygenase and delivery of H2S may offer a promising alternative to existing therapies for traumatic injury.Campolo, M., Esposito, E., Ahmad, A., Di Paola, R., Wallace, J. L., Cuzzocrea, A. Hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury.	[Campolo, Michela; Esposito, Emanuela; Ahmad, Akbar; Di Paola, Rosanna; Cuzzocrea, Salvatore] Univ Messina, Dept Biol & Environm Sci, Messina, Italy; [Wallace, John L.] Univ Calgary, Inflammat Res Network, Calgary, AB T2N 4N1, Canada; [Cuzzocrea, Salvatore] Univ Manchester, Manchester Royal Infirm, Sch Med, Manchester Biomed Res Ctr, Manchester M13 9WL, Lancs, England	University of Messina; University of Calgary; University of Manchester	Wallace, JL (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada.	altapharm@hotmail.com	Campolo, Michela/K-6432-2016; di paola, rosanna/U-4356-2019; Wallace, John/AAL-3763-2021	di paola, rosanna/0000-0001-6725-8581; Esposito, Emanuela/0000-0002-2663-6387; Ahmad, Akbar/0000-0003-1841-9670; Cuzzocrea, Salvatore/0000-0001-6131-3690; Campolo, Michela/0000-0002-5124-3876	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Carmelo La Spada for excellent technical assistance during this study, Caterina Cutrona for secretarial assistance, and Valentina Malvagni for editorial assistance with the manuscript. This work was supported by a grant from the Canadian Institutes of Health Research (to J.L.W.). J.L.W. is a founder and shareholder of Antibe Therapeutics, Inc.	Abe K, 1996, J NEUROSCI, V16, P1066; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Bao F, 2003, NEUROSCIENCE, V116, P59, DOI 10.1016/S0306-4522(02)00571-7; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bethea JR, 1998, J NEUROSCI, V18, P3251; Blackler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035196; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BOUGHTONSMITH NK, 1988, AGENTS ACTIONS, V25, P115, DOI 10.1007/BF01969102; BRACKEN MB, 1990, MED J AUSTRALIA, V153, P368, DOI 10.5694/j.1326-5377.1990.tb136976.x; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Chu QJ, 2013, J SURG RES, V183, P330, DOI 10.1016/j.jss.2012.12.003; Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Finnerup NB, 2001, SPINAL CORD, V39, P256, DOI 10.1038/sj.sc.3101161; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Geng B, 2004, BIOCHEM BIOPH RES CO, V313, P362, DOI 10.1016/j.bbrc.2003.11.130; Genovese T, 2006, J NEUROSURG-SPINE, V4, P145, DOI 10.3171/spi.2006.4.2.145; Genovese T, 2008, SHOCK, V30, P142, DOI 10.1097/SHK.0b013e31815dd381; Gomes-Leal W, 2005, BRAIN RES, V1066, P57, DOI 10.1016/j.brainres.2005.10.069; Gong QH, 2010, PHARMACOL BIOCHEM BE, V96, P52, DOI 10.1016/j.pbb.2010.04.006; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kimura H, 2005, ANTIOXID REDOX SIGN, V7, P778, DOI 10.1089/ars.2005.7.778; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; La Rosa G, 2004, J NEUROSURG-SPINE, V1, P311, DOI 10.3171/spi.2004.1.3.0311; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Lin H, 2006, ANN NEUROL, V60, P399, DOI 10.1002/ana.20965; Liu KL, 2006, J AGR FOOD CHEM, V54, P3472, DOI 10.1021/jf060043k; Malaspina A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-500; Matsuyama Y, 1998, J SPINAL DISORD, V11, P248; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Resnick DK, 2004, NEUROREPORT, V15, P837, DOI 10.1097/00001756-200404090-00020; Schmitt Caroline, 2006, Spine J, V6, P113, DOI 10.1016/j.spinee.2005.05.379; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Wallace J. L., 2008, United States Patent Application, Patent No. [WO/2008/009127, 2008009127]; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2010, BRIT J PHARMACOL, V159, P1236, DOI 10.1111/j.1476-5381.2009.00611.x; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yip PK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-6; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	61	34	37	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2013	27	11					4489	4499		10.1096/fj.13-234716	http://dx.doi.org/10.1096/fj.13-234716			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292YB	23901068				2022-12-25	WOS:000329937500016
J	Bloemink, MJ; Deacon, JC; Resnicow, DI; Leinwand, LA; Geeves, MA				Bloemink, Marieke J.; Deacon, John C.; Resnicow, Daniel I.; Leinwand, Leslie A.; Geeves, Michael A.			The Superfast Human Extraocular Myosin Is Kinetically Distinct from the Fast Skeletal IIa, IIb, and IId Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; DROSOPHILA MUSCLE MYOSIN; HEAVY-CHAIN GENE; ATPASE ACTIVITY; ACTOMYOSIN SUBFRAGMENT-1; TEMPERATURE-DEPENDENCE; ADENOSINE-DIPHOSPHATE; FUNCTIONAL DIVERSITY; SHORTENING VELOCITY; RECOVERY STROKE	Humans express five distinct myosin isoforms in the sarcomeres of adult striated muscle (fast IIa, IId, the slow/cardiac isoform I/beta, the cardiac specific isoform alpha, and the specialized extraocular muscle isoform). An additional isoform, IIb, is present in the genome but is not normally expressed in healthy human muscles. Muscle fibers expressing each isoform have distinct characteristics including shortening velocity. Defining the properties of the isoforms in detail has been limited by the availability of pure samples of the individual proteins. Here we study purified recombinant human myosin motor domains expressed in mouse C2C12 muscle cells. The results of kinetic analysis show that among the closely related adult skeletal isoforms, the affinity of ADP for actin.myosin (K-AD) is the characteristic that most readily distinguishes the isoforms. The three fast muscle myosins have K-AD values of 118, 80, and 55 mu M for IId, IIa, and IIb, respectively, which follows the speed in motility assays from fastest to slowest. Extraocular muscle is unusually fast with a far weaker K-AD = 352 mu M. Sequence comparisons and homology modeling of the structures identify a few key areas of sequence that may define the differences between the isoforms, including a region of the upper 50-kDa domain important in signaling between the nucleotide pocket and the actin-binding site.	[Bloemink, Marieke J.; Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Deacon, John C.; Resnicow, Daniel I.; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Kent; University of Colorado System; University of Colorado Boulder	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leslie.leinwand@colorado.edu; m.a.geeves@kent.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; LEINWAND, LESLIE/0000-0003-1470-4810; Bloemink, Marieke Johanna/0000-0001-9441-2783	National Institutes of Health [T32 GM65013, GM29090]; Wellcome Trust Program [085309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103, F32GM065013, R01GM029090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Program(Wellcome Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM65013 (to J. C. D. and D. I. R.) and GM29090 (to L. A. L.). This work was also supported by Wellcome Trust Program Grant 085309 (to M. A. G.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Bernstein SI, 1997, J MOL BIOL, V271, P1, DOI 10.1006/jmbi.1997.1160; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; Brueckner JK, 1996, J MUSCLE RES CELL M, V17, P297; Budde BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001362; Canepari M, 2010, ACTA PHYSIOL, V199, P465, DOI 10.1111/j.1748-1716.2010.02118.x; Coviello DA, 1997, AM J HUM GENET, V61, pA329; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; Harrison BC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-5; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kjellgren D, 2003, INVEST OPHTH VIS SCI, V44, P1419, DOI 10.1167/iovs.02-0638; Koppole S, 2007, STRUCTURE, V15, P825, DOI 10.1016/j.str.2007.06.008; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; Kurzawa-Goertz SE, 1998, BIOCHEMISTRY-US, V37, P7517, DOI 10.1021/bi972844+; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; LUCAS CA, 1995, J MUSCLE RES CELL M, V16, P368, DOI 10.1007/BF00114502; Malnasi-Csizmadia A, 2007, J BIOL CHEM, V282, P17658, DOI 10.1074/jbc.M701447200; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Miller BM, 2007, J MOL BIOL, V368, P1051, DOI 10.1016/j.jmb.2007.02.042; Miller BM, 2003, J BIOL CHEM, V278, P50293, DOI 10.1074/jbc.M308318200; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; SARTORE S, 1987, J MUSCLE RES CELL M, V8, P161, DOI 10.1007/BF01753992; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SLEEP JA, 1980, BIOCHEMISTRY-US, V19, P1276, DOI 10.1021/bi00548a002; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Stienen GJM, 1996, J PHYSIOL-LONDON, V493, P299, DOI 10.1113/jphysiol.1996.sp021384; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Weiss A, 1999, J MOL BIOL, V290, P61, DOI 10.1006/jmbi.1999.2865; Yu B, 2005, J CLIN PATHOL, V58, P479, DOI 10.1136/jcp.2004.021642	41	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27469	27479		10.1074/jbc.M113.488130	http://dx.doi.org/10.1074/jbc.M113.488130			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908353	hybrid, Green Published			2022-12-25	WOS:000330597300042
J	Palmer, CS; Elgass, KD; Parton, RG; Osellame, LD; Stojanovski, D; Ryan, MT				Palmer, Catherine S.; Elgass, Kirstin D.; Parton, Robert G.; Osellame, Laura D.; Stojanovski, Diana; Ryan, Michael T.			Adaptor Proteins MiD49 and MiD51 Can Act Independently of Mff and Fis1 in Drp1 Recruitment and Are Specific for Mitochondrial Fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-LIKE PROTEIN-1; PEROXISOMAL FISSION; MAMMALIAN-CELLS; OUTER-MEMBRANE; ANCHORED PROTEINS; FUSION; AUTOPHAGY; DIVISION; DLP1; COMPLEXES	Drp1 (dynamin-related protein 1) is recruited to both mitochondrial and peroxisomal membranes to execute fission. Fis1 and Mff are Drp1 receptor/effector proteins of mitochondria and peroxisomes. Recently, MiD49 and MiD51 were also shown to recruit Drp1 to the mitochondrial surface; however, different reports have ascribed opposing roles in fission and fusion. Here, we show that MiD49 or MiD51 overexpression blocked fission by acting in a dominant-negative manner by sequestering Drp1 specifically at mitochondria, causing unopposed fusion events at mitochondria along with elongation of peroxisomes. Mitochondrial elongation caused by MiD49/51 overexpression required the action of fusion mediators mitofusins 1 and 2. Furthermore, at low level overexpression when MiD49 and MiD51 form discrete foci at mitochondria, mitochondrial fission events still occurred. Unlike Fis1 and Mff, MiD49 and MiD51 were not targeted to the peroxisomal surface, suggesting that they specifically act to facilitate Drp1-directed fission at mitochondria. Moreover, when MiD49 or MiD51 was targeted to the surface of peroxisomes or lysosomes, Drp1 was specifically recruited to these organelles. Moreover, the Drp1 recruitment activity of MiD49/51 appeared stronger than that of Mff or Fis1. We conclude that MiD49 and MiD51 can act independently of Mff and Fis1 in Drp1 recruitment and suggest that they provide specificity to the division of mitochondria.	[Palmer, Catherine S.; Elgass, Kirstin D.; Osellame, Laura D.; Stojanovski, Diana; Ryan, Michael T.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Palmer, Catherine S.; Elgass, Kirstin D.; Stojanovski, Diana; Ryan, Michael T.] La Trobe Univ, ARC Ctr Excellence Coherent Xray Sci, Melbourne, Vic 3086, Australia; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld 4072, Australia	La Trobe University; La Trobe University; University of Queensland; University of Queensland	Ryan, MT (corresponding author), La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia.	m.ryan@latrobe.edu.au	; Parton, Robert/C-5673-2009	PALMER, CATHERINE/0000-0002-5124-2400; Stojanovski, Diana/0000-0002-0199-3222; Parton, Robert/0000-0002-7494-5248	National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); National Health and Medical Research Council of Australia [569542, 511005]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC).; Supported by Fellowship 569542 and Grant 511005 from the National Health and Medical Research Council of Australia.	Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch A, 2004, J CELL SCI, V117, P3995, DOI 10.1242/jcs.01268; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koch J, 2012, J CELL SCI, V125, P3813, DOI 10.1242/jcs.102178; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kriechbaumer V, 2009, TRAFFIC, V10, P1753, DOI 10.1111/j.1600-0854.2009.00991.x; Lan L, 2000, BIOCHEM J, V349, P611, DOI 10.1042/0264-6021:3490611; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Okamoto K, 2012, BBA-GEN SUBJECTS, V1820, P595, DOI 10.1016/j.bbagen.2011.08.001; Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211; Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Rambold AS, 2011, CELL CYCLE, V10, P4032, DOI 10.4161/cc.10.23.18384; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; Scott I, 2006, J EXP BOT, V57, P1275, DOI 10.1093/jxb/erj096; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang XC, 2008, MOL PLANT, V1, P1036, DOI 10.1093/mp/ssn056; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zhao J, 2013, CELL MOL LIFE SCI, V70, P951, DOI 10.1007/s00018-012-1066-6; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	61	176	189	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27584	27593		10.1074/jbc.M113.479873	http://dx.doi.org/10.1074/jbc.M113.479873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921378	Green Published, hybrid			2022-12-25	WOS:000330597300053
J	Boudes, M; Uvin, P; Pinto, S; Freichel, M; Birnbaumer, L; Voets, T; De Ridder, D; Vennekens, R				Boudes, Mathieu; Uvin, Pieter; Pinto, Silvia; Freichel, Marc; Birnbaumer, Lutz; Voets, Thomas; De Ridder, Dirk; Vennekens, Rudi			Crucial Role of TRPC1 and TRPC4 in Cystitis-Induced Neuronal Sprouting and Bladder Overactivity	PLOS ONE			English	Article							ROOT GANGLION NEURONS; INTERSTITIAL CYSTITIS; RAT BLADDER; URINARY-BLADDER; NERVE INJURY; RECEPTOR; EXPRESSION; CHANNEL; MIGRATION; INFLAMMATION	Purpose: During cystitis, increased innervation of the bladder by sensory nerves may contribute to bladder overactivity and pain. The mechanisms whereby cystitis leads to hyperinnervation of the bladder are, however, poorly understood. Since TRP channels have been implicated in the guidance of growth cones and survival of neurons, we investigated their involvement in the increases in bladder innervation and bladder activity in rodent models of cystitis. Materials and Methods: To induce bladder hyperactivity, we chronically injected cyclophosphamide in rats and mice. All experiments were performed a week later. We used quantitative transcriptional analysis and immunohistochemistry to determine TRP channel expression on retrolabelled bladder sensory neurons. To assess bladder function and referred hyperalgesia, urodynamic analysis, detrusor strip contractility and Von Frey filament experiments were done in wild type and knock-out mice. Results: Repeated cyclophosphamide injections induce a specific increase in the expression of TRPC1 and TRPC4 in bladder-innervating sensory neurons and the sprouting of sensory fibers in the bladder mucosa. Interestingly, cyclophosphamide-treated Trpc1/c4(-/-) mice no longer exhibited increased bladder innervations, and, concomitantly, the development of bladder overactivity was diminished in these mice. We did not observe a difference neither in bladder contraction features of double knock-out animals nor in cyclophosphamide-induced referred pain behavior. Conclusions: Collectively, our data suggest that TRPC1 and TRPC4 are involved in the sprouting of sensory neurons following bladder cystitis, which leads to overactive bladder disease.	[Boudes, Mathieu; Uvin, Pieter; De Ridder, Dirk] Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Expt Urol, Louvain, Belgium; [Boudes, Mathieu; Uvin, Pieter; Pinto, Silvia; Voets, Thomas; Vennekens, Rudi] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Ion Channel Res, Louvain, Belgium; [Boudes, Mathieu; Uvin, Pieter; Pinto, Silvia; Voets, Thomas; De Ridder, Dirk; Vennekens, Rudi] TRP Res Platform Leuven, Louvain, Belgium; [Freichel, Marc] Univ Saarland, Homburg, Germany; [Freichel, Marc] Heidelberg Univ, Inst Pharmakol, Heidelberg, Germany; [Birnbaumer, Lutz] Natl Inst Environm Hlth Sci, Lab Neurobiol Signal Transduct, NIH, Res Triangle Pk, NC USA	KU Leuven; KU Leuven; Saarland University; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Boudes, M (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Expt Urol, Louvain, Belgium.	mathieu.boudes@med.kuleuven.be; rudi.vennekens@med.kuleuven.be	Vennekens, Rudi/AAQ-1664-2020; Voets, Thomas/E-2466-2012; Voets, Thomas/AAD-4389-2019; Uvin, Pieter/A-9221-2016; De Ridder, Dirk JMK/G-2481-2010	Vennekens, Rudi/0000-0002-2564-5150; Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Uvin, Pieter/0000-0003-1264-2417; De Ridder, Dirk JMK/0000-0001-6914-0077	Research Foundation Flanders (FWO) [G0565.07, G0686.09]; Research Council of the KU Leuven [GOA 2009/07, EF/ 95/010]; TRPLe; Astellas; National Institutes of Health [ZO1-ES-101684]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101643, ZIAES101684, Z01ES101684] Funding Source: NIH RePORTER	Research Foundation Flanders (FWO)(FWO); Research Council of the KU Leuven(KU Leuven); TRPLe; Astellas(Astellas Pharmaceuticals); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by Research Foundation Flanders (FWO) Grants G0565.07 and G0686.09 and Research Council of the KU Leuven Grants GOA 2009/07, EF/ 95/010 and TRPLe, an unrestricted educational grant by Astellas, and in part by the Intramural Research Program of the National Institutes of Health (project ZO1-ES-101684 to LB). MB is Marie Curie Fellow and PU is a PhD student of the FWO. DDR is a senior clinical researcher of the FWO Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2010, BJU INT, V106, P1114, DOI 10.1111/j.1464-410X.2010.09650.x; Avelino A, 2002, NEUROSCIENCE, V109, P787, DOI 10.1016/S0306-4522(01)00496-1; Boudes M, 2011, NEUROUROL URODYNAM, V30, P1659, DOI 10.1002/nau.21180; Boudes M, 2009, J NEUROSCI, V29, P10063, DOI 10.1523/JNEUROSCI.1312-09.2009; Brumovsky PR, 2009, AM J PHYSIOL-GASTR L, V297, pG1250, DOI 10.1152/ajpgi.00329.2009; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHRISTMAS TJ, 1990, VIRCHOWS ARCH A, V416, P447, DOI 10.1007/BF01605152; Cui Kai, 2007, P55; Dang K, 2008, J NEUROPHYSIOL, V99, P49, DOI 10.1152/jn.00211.2007; de Groat William C, 2009, Handb Exp Pharmacol, P91, DOI 10.1007/978-3-540-79090-7_4; Dickson A, 2006, NEUROSCIENCE, V141, P1631, DOI 10.1016/j.neuroscience.2006.06.006; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Du S, 2007, UROLOGY, V70, P826, DOI 10.1016/j.urology.2007.06.1110; Elg S, 2007, J COMP NEUROL, V503, P35, DOI 10.1002/cne.21351; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Gnanamanickam GJE, 2011, J COMP NEUROL, V519, P621, DOI 10.1002/cne.22515; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; HAND JR, 1949, J UROLOGY, V61, P291, DOI 10.1016/S0022-5347(17)69067-0; Hayashi T, 2009, NEUROSCI RES, V65, P245, DOI 10.1016/j.neures.2009.07.005; Hu TW, 2003, UROLOGY, V61, P1123, DOI 10.1016/S0090-4295(03)00009-8; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Irwin DE, 2010, EUR UROL, V58, P532, DOI 10.1016/j.eururo.2010.06.007; Irwin DE, 2009, BJU INT, V103, P202, DOI 10.1111/j.1464-410X.2008.08036.x; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; LUNDEBERG T, 1993, BRIT J UROL, V71, P427, DOI 10.1111/j.1464-410X.1993.tb15986.x; Merrill L, 2012, J MOL NEUROSCI, V48, P744, DOI 10.1007/s12031-012-9867-5; Okragly AJ, 1999, J UROLOGY, V161, P438, DOI 10.1016/S0022-5347(01)61915-3; Schnegelsberg B, 2010, AM J PHYSIOL-REG I, V298, pR534, DOI 10.1152/ajpregu.00367.2009; Shibata Y, 2011, NEUROREPORT, V22, P61, DOI 10.1097/WNR.0b013e3283424c9c; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Smith CP, 2005, NEUROCHEM INT, V47, P291, DOI 10.1016/j.neuint.2005.04.021; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sun BY, 2010, AUTON NEUROSCI-BASIC, V153, P26, DOI 10.1016/j.autneu.2009.07.003; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Uvin P, 2012, JOVE-J VIS EXP, DOI 10.3791/3869; Vera PL, 2008, EXP BIOL MED, V233, P620, DOI 10.3181/0709-RM-240; Vera PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003898; Vizzard MA, 2001, J CHEM NEUROANAT, V21, P125, DOI 10.1016/S0891-0618(00)00115-0; Vizzard MA, 1996, AID CNE5 3 0 CO 2 Y; Wu D, 2008, J BIOL CHEM, V283, P416, DOI 10.1074/jbc.M703177200; Yildirim E, 2012, AM J PHYSIOL-LUNG C, V303, pL539, DOI 10.1152/ajplung.00389.2011; Yu WQ, 2011, AM J PHYSIOL-RENAL, V300, pF49, DOI 10.1152/ajprenal.00349.2010	47	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69550	10.1371/journal.pone.0069550	http://dx.doi.org/10.1371/journal.pone.0069550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922735	Green Submitted, Green Published, gold			2022-12-25	WOS:000323369700040
J	Seeliger, J; Werkmuller, A; Winter, R				Seeliger, Janine; Werkmueller, Alexander; Winter, Roland			Macromolecular Crowding as a Suppressor of Human IAPP Fibril Formation and Cytotoxicity	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; PROTEIN AGGREGATION; AMYLOID FORMATION; LIPID-MEMBRANES; A-BETA; DIFFUSION; KINETICS; CELLS; AMYLOIDOGENESIS; ASSOCIATION	The biological cell is known to exhibit a highly crowded milieu, which significantly influences protein aggregation and association processes. As several cell degenerative diseases are related to the self-association and fibrillation of amyloidogenic peptides, understanding of the impact of macromolecular crowding on these processes is of high biomedical importance. It is further of particular relevance as most in vitro studies on amyloid aggregation have been performed in diluted solution which does not reflect the complexity of their cellular surrounding. The study presented here focuses on the self-association of the type-2 diabetes mellitus related human islet amyloid polypeptide (hIAPP) in various crowded environments including network-forming macromolecular crowding reagents and protein crowders. It was possible to identify two competing processes: a crowder concentration and type dependent stabilization of globular off-pathway species and a - consequently - retarded or even inhibited hIAPP fibrillation reaction. The cause of these crowding effects was revealed to be mainly excluded volume in the polymeric crowders, whereas non-specific interactions seem to be most dominant in protein crowded environments. Specific hIAPP cytotoxicity assays on pancreatic beta-cells reveal non-toxicity for the stabilized globular species, in contrast to the high cytotoxicity imposed by the normal fibrillation pathway. From these findings it can be concluded that cellular crowding is able to effectively stabilize the monomeric conformation of hIAPP, hence enabling the conduction of its normal physiological function and prevent this highly amyloidogenic peptide from cytotoxic aggregation and fibrillation.	[Seeliger, Janine; Werkmueller, Alexander; Winter, Roland] Tech Univ Dortmund, Fac Chem, Dortmund, Germany	Dortmund University of Technology	Winter, R (corresponding author), Tech Univ Dortmund, Fac Chem, Dortmund, Germany.	roland.winter@tu-dortmund.de		Winter, Roland/0000-0002-3512-6928	Deutsche Forschungsgemeinschaft (DFG) [EXC 1069]; DFG [FOR 1583]; Max Planck Society (International Max Planck Research School of Chemical Biology, Dortmund)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Max Planck Society (International Max Planck Research School of Chemical Biology, Dortmund)	The authors thank the Cluster of Excellence RESOLV (EXC 1069) funded by the Deutsche Forschungsgemeinschaft (DFG), the DFG-FOR 1583, and the Max Planck Society (International Max Planck Research School of Chemical Biology, Dortmund) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MN, 2011, BIOPHYS CHEM, V156, P43, DOI 10.1016/j.bpc.2010.12.007; Bhak G, 2009, BMB REP, V42, P541, DOI 10.5483/BMBRep.2009.42.9.541; Brovchenko I, 2009, LANGMUIR, V25, P8111, DOI 10.1021/la9006058; Cino EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049876; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Cort JR, 2009, PROTEIN ENG DES SEL, V22, P497, DOI 10.1093/protein/gzp029; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DUBIN SB, 1971, J CHEM PHYS, V54, P5158, DOI 10.1063/1.1674810; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008; Finn TE, 2012, J BIOL CHEM, V287, P21530, DOI 10.1074/jbc.M112.372961; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hirata Y, 2003, CARBOHYD POLYM, V53, P331, DOI 10.1016/S0144-8617(03)00107-3; Jha S, 2009, J MOL BIOL, V389, P907, DOI 10.1016/j.jmb.2009.04.077; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; Khemtemourian L, 2008, EXP DIABETES RES, DOI 10.1155/2008/421287; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Le Coeur C, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031910; Lee CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400580; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036288; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Minton AP, 2007, J PHARM SCI-US, V96, P3466, DOI 10.1002/jps.20964; Minton AP, 2013, BIOPOLYMERS, V99, P239, DOI 10.1002/bip.22163; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mishra R, 2009, CHEMBIOCHEM, V10, P1769, DOI 10.1002/cbic.200900237; Moon YU, 2000, J SOLUTION CHEM, V29, P699, DOI 10.1023/A:1005112927213; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; MURAMATSU N, 1988, P NATL ACAD SCI USA, V85, P2984, DOI 10.1073/pnas.85.9.2984; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Perham M, 2007, FEBS LETT, V581, P5065, DOI 10.1016/j.febslet.2007.09.049; Periasamy N, 1998, BIOPHYS J, V75, P557, DOI 10.1016/S0006-3495(98)77545-9; Phillip Y, 2012, BIOPHYS J, V103, P1011, DOI 10.1016/j.bpj.2012.08.009; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Rivas G, 2001, P NATL ACAD SCI USA, V98, P3150, DOI 10.1073/pnas.051634398; Rosen J, 2011, J PHYS CHEM B, V115, P2683, DOI 10.1021/jp200625k; Seeliger J, 2012, J MOL BIOL, V421, P348, DOI 10.1016/j.jmb.2012.01.048; Seeliger J, 2012, ANGEW CHEM INT EDIT, V51, P679, DOI 10.1002/anie.201105877; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sellin D, 2010, BIOPHYS CHEM, V150, P73, DOI 10.1016/j.bpc.2010.01.006; Singh G, 2008, BIOPHYS J, V95, P3208, DOI [10.1529/biophysj.108.136226, 10.1529/biophysj.108.13622]; Sukenik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015608; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; van den Berg B, 2000, EMBO J, V19, P3870, DOI 10.1093/emboj/19.15.3870; Weise K, 2011, LIPIDS CELLULAR MEMB, P93; Weise K, 2010, CHEMBIOCHEM, V11, P1280, DOI 10.1002/cbic.201000039; Wenner JR, 1999, BIOPHYS J, V77, P3234, DOI 10.1016/S0006-3495(99)77154-7; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Zhang DL, 2012, ACTA BIOCH BIOPH SIN, V44, P703, DOI 10.1093/abbs/gms052; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	56	54	54	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69652	10.1371/journal.pone.0069652	http://dx.doi.org/10.1371/journal.pone.0069652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922768	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700059
J	Kim, YN; Kim, S; Kim, IY; Shin, JH; Cho, S; Yi, SS; Kim, WK; Kim, KS; Lee, S; Seong, JK				Kim, Yo Na; Kim, Sangok; Kim, Il-Yong; Shin, Jae Hoon; Cho, Sooyoung; Yi, Sun Shin; Kim, Wan Kyu; Kim, Kyung-Sub; Lee, Sanghyuk; Seong, Je Kyung			Transcriptomic Analysis of Insulin-Sensitive Tissues from Anti-Diabetic Drug Treated ZDF Rats, a T2DM Animal Model	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION PROFILE; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; DIABETES-MELLITUS; ADIPOSE-TISSUE; ROSIGLITAZONE; METFORMIN; GLUCOSE; RESISTANCE	Gene expression changes have been associated with type 2 diabetes mellitus (T2DM); however, the alterations are not fully understood. We investigated the effects of anti-diabetic drugs on gene expression in Zucker diabetic fatty (ZDF) rats using oligonucleotide microarray technology to identify gene expression changes occurring in T2DM. Global gene expression in the pancreas, adipose tissue, skeletal muscle, and liver was profiled from Zucker lean control (ZLC) and anti-diabetic drug treated ZDF rats compared with those in ZDF rats. We showed that anti-diabetic drugs regulate the expression of a large number of genes. We provided a more integrated view of the diabetic changes by examining the gene expression networks. The resulting sub-networks allowed us to identify several biological processes that were significantly enriched by the antidiabetic drug treatment, including oxidative phosphorylation (OXPHOS), systemic lupus erythematous, and the chemokine signaling pathway. Among them, we found that white adipose tissue from ZDF rats showed decreased expression of a set of OXPHOS genes that were normalized by rosiglitazone treatment accompanied by rescued blood glucose levels. In conclusion, we suggest that alterations in OXPHOS gene expression in white adipose tissue may play a role in the pathogenesis and drug mediated recovery of T2DM through a comprehensive gene expression network study after multidrug treatment of ZDF rats.	[Kim, Yo Na; Kim, Il-Yong; Shin, Jae Hoon; Cho, Sooyoung; Seong, Je Kyung] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Lab Dev Biol & Genom,Program Vet Sci BK21, Seoul, South Korea; [Cho, Sooyoung; Seong, Je Kyung] Seoul Natl Univ, Program Canc Biol, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Cho, Sooyoung; Seong, Je Kyung] Seoul Natl Univ, BIO MAX Inst, Seoul, South Korea; [Yi, Sun Shin] Soonchunhyang Univ, Coll Med Sci, Dept Biomed Lab Sci, Asan, Chungnam, South Korea; [Kim, Sangok; Kim, Wan Kyu; Lee, Sanghyuk] Ewha Womans Univ, Ewha Res Ctr Syst Biol, Div Mol & Life Sci, Seoul, South Korea; [Kim, Kyung-Sub] Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Inst Genet Sci,Dept Biochem & Mol Biol,Brain Kore, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Soonchunhyang University; Ewha Womans University; Yonsei University; Yonsei University Health System	Seong, JK (corresponding author), Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Lab Dev Biol & Genom,Program Vet Sci BK21, Seoul, South Korea.	snumouse@snu.ac.kr		kim, wankyu/0000-0003-3181-0594; Seong, Je Kyung/0000-0003-1177-6958	Korea Food and Drug Administration [1470001450]; National Research Foundation (NRF); Korean government (MEST) [2012055344, 2012M3A9D1054622]; Research Institute for Veterinary Science, Seoul National University; Brain Korea 21 Program for Veterinary Science	Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); National Research Foundation (NRF); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Research Institute for Veterinary Science, Seoul National University; Brain Korea 21 Program for Veterinary Science(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the grant from the Korea Food and Drug Administration (1470001450) to SJK and KKS; a grant by National Research Foundation (NRF), which is funded by the Korean government (MEST)(2012055344 and 2012M3A9D1054622) to SJK. This study was also partially supported by the Research Institute for Veterinary Science, Seoul National University. SJK, KYN, SJH, and KIY were supported by the Brain Korea 21 Program for Veterinary Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CJ, 2005, DIABETES OBES METAB, V7, P675, DOI 10.1111/j.1463-1326.2005.00497.x; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Cortes S, 2008, LUPUS, V17, P977, DOI 10.1177/0961203308091539; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edvardsson U, 1999, J LIPID RES, V40, P1177; El-Batran SA, 2006, PHARMACOL RES, V53, P69, DOI 10.1016/j.phrs.2005.08.008; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gerhold DL, 2002, ENDOCRINOLOGY, V143, P2106, DOI 10.1210/en.143.6.2106; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Irons BK, 2006, PHARMACOTHERAPY, V26, P168, DOI 10.1592/phco.26.2.168; Kerr MK, 2003, J COMPUT BIOL, V10, P891, DOI 10.1089/106652703322756131; Koshiba K, 2006, J MED INVESTIG, V53, P87, DOI 10.2152/jmi.53.87; Krall RL, 2007, LANCET, V369, P1995, DOI 10.1016/S0140-6736(07)60824-1; Kramer D, 2001, METABOLISM, V50, P1294, DOI 10.1053/meta.2001.27202; KRAMER W, 1995, DIABETES RES CLIN PR, V28, pS67, DOI 10.1016/0168-8227(95)01076-P; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lessard SJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE251, DOI 10.1152/ajpendo.00096.2005; Loffler M, 2006, J PHARMACOL EXP THER, V316, P797, DOI 10.1124/jpet.105.093831; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muller G, 1996, HORM METAB RES, V28, P469, DOI 10.1055/s-2007-979839; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pardo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026989; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Reifel-Miller A, 2005, MOL ENDOCRINOL, V19, P1593, DOI 10.1210/me.2005-0015; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanchez JC, 2003, PROTEOMICS, V3, P1500, DOI 10.1002/pmic.200300484; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Setter SM, 2003, CLIN THER, V25, P2991, DOI 10.1016/S0149-2918(03)90089-0; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Tiikkainen M, 2004, DIABETES, V53, P2169, DOI 10.2337/diabetes.53.8.2169; Tsuda T, 2006, BIOCHEM PHARMACOL, V71, P1184, DOI 10.1016/j.bcp.2005.12.042; Wei D, 2007, J BIOL INORG CHEM, V12, P1265, DOI 10.1007/s00775-007-0294-y; Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x	44	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69624	10.1371/journal.pone.0069624	http://dx.doi.org/10.1371/journal.pone.0069624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922760	gold, Green Published, Green Submitted			2022-12-25	WOS:000322838900064
J	Krishnan, NS; Zehnder, D; Daga, S; Lowe, D; Lam, FT; Kashi, H; Imray, C; Imray, C; Hamer, R; Briggs, D; Raymond, N; Higgins, RM				Krishnan, Nithya S.; Zehnder, Daniel; Daga, Sunil; Lowe, Dave; Lam, F. T.; Kashi, Habib; Tan, Lam Chin; Imray, Christopher; Hamer, Rizwan; Briggs, David; Raymond, Neil; Higgins, Robert M.			Behaviour of Non-Donor Specific Antibodies during Rapid Re-Synthesis of Donor Specific HLA Antibodies after Antibody Incompatible Renal Transplantation	PLOS ONE			English	Article							KIDNEY-TRANSPLANTATION; HUMORAL IMMUNITY; RECIPIENTS; REJECTION; CELLS; IMMUNIZATION; VACCINATION; ACTIVATION; INFECTION; ANTIGENS	Background: HLA directed antibodies play an important role in acute and chronic allograft rejection. During viral infection of a patient with HLA antibodies, the HLA antibody levels may rise even though there is no new immunization with antigen. However it is not known whether the converse occurs, and whether changes on non-donor specific antibodies are associated with any outcomes following HLA antibody incompatible renal transplantation. Methods: 55 patients, 31 women and 24 men, who underwent HLAi renal transplant in our center from September 2005 to September 2010 were included in the studies. We analysed the data using two different approaches, based on; i) DSA levels and ii) rejection episode post transplant. HLA antibody levels were measured during the early post transplant period and corresponding CMV, VZV and Anti-HBs IgG antibody levels and blood group IgG, IgM and IgA antibodies were quantified. Results: Despite a significant DSA antibody rise no significant non-donor specific HLA antibody, viral or blood group antibody rise was found. In rejection episode analyses, multiple logistic regression modelling showed that change in the DSA was significantly associated with rejection (p = 0.002), even when adjusted for other antibody levels. No other antibody levels were predictive of rejection. Increase in DSA from pre treatment to a post transplant peak of 1000 was equivalent to an increased chance of rejection with an odds ratio of 1.47 (1.08, 2.00). Conclusion: In spite of increases or decreases in the DSA levels, there were no changes in the viral or the blood group antibodies in these patients. Thus the DSA rise is specific in contrast to the viral, blood group or third party antibodies post transplantation. Increases in the DSA post transplant in comparison to pre-treatment are strongly associated with occurrence of rejection.	[Krishnan, Nithya S.; Zehnder, Daniel; Daga, Sunil; Lam, F. T.; Kashi, Habib; Tan, Lam Chin; Imray, Christopher; Hamer, Rizwan; Higgins, Robert M.] Univ Hosp Coventry, Dept Nephrol, Coventry, W Midlands, England; [Krishnan, Nithya S.; Zehnder, Daniel; Daga, Sunil; Lam, F. T.; Kashi, Habib; Tan, Lam Chin; Imray, Christopher; Hamer, Rizwan; Higgins, Robert M.] Warwickshire Natl Hlth Serv, Coventry, W Midlands, England; [Lowe, Dave; Briggs, David] Natl Hlth Serv Blood & Transplant, Dept Histocompatibil & Immunogenet, Birmingham, W Midlands, England; [Zehnder, Daniel; Daga, Sunil] Univ Warwick, Warwick Med Sch, Clin Sci Res Lab, Coventry CV4 7AL, W Midlands, England; [Raymond, Neil] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; NHS Blood & Transplant (NHSBT); University of Warwick; University of Warwick	Krishnan, NS (corresponding author), Univ Hosp Coventry, Dept Nephrol, Coventry, W Midlands, England.	nithya.krishnan@uhcw.nhs.uk		DAGA, Sunil/0000-0002-4592-8561; Christopher, Imray/0000-0001-9889-6308; Briggs, David/0000-0002-6796-7086; imray, chris/0000-0001-8451-4102	Department of Health [DRF-2010-03-88] Funding Source: Medline; National Institute for Health Research [DRF-2010-03-88] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Adams AB, 2003, IMMUNOL REV, V196, P147, DOI 10.1046/j.1600-065X.2003.00082.x; Aiello FB, 2004, MODERN PATHOL, V17, P189, DOI 10.1038/modpathol.3800033; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Avery RK, 2008, AM J TRANSPLANT, V8, P9, DOI 10.1111/j.1600-6143.2007.02051.x; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Briggs D, 2009, CONTRIB NEPHROL, V162, P107, DOI 10.1159/000170843; Burgess C, 2009, EVALUATION REPORT EV; Candon S, 2009, AM J TRANSPLANT, V9, P2346, DOI 10.1111/j.1600-6143.2009.02787.x; Collins AB, 1999, J AM SOC NEPHROL, V10, P2208; Di Genova G, 2006, BLOOD, V107, P2806, DOI 10.1182/blood-2005-08-3255; Forman JL, 2004, J AM SOC NEPHROL, V15, P3249, DOI 10.1097/01.ASN.0000145896.16153.43; Haas M, 2006, AM J TRANSPLANT, V6, P1829, DOI 10.1111/j.1600-6143.2006.01356.x; Higgins R, 2009, TRANSPLANTATION, V87, P882, DOI 10.1097/TP.0b013e31819a6788; Katerinis I, 2011, AM J TRANSPLANT, V11, P1727, DOI 10.1111/j.1600-6143.2011.03604.x; Krishnan NS, 2008, TRANSPLANTATION, V86, P474, DOI 10.1097/TP.0b013e31817c4c4c; Locke JE, 2009, AM J TRANSPLANT, V9, P2136, DOI 10.1111/j.1600-6143.2009.02764.x; Monteiro F, 2012, TRANSPL P, V44, P2411, DOI 10.1016/j.transproceed.2012.07.005; Morris PJ, 2004, TRANSPLANTATION, V78, P179, DOI 10.1097/01.TP.0000136579.49054.35; Rentenaar RJ, 2002, KIDNEY INT, V62, P319, DOI 10.1046/j.1523-1755.2002.00425.x; Roddy M, 2005, TRANSPLANTATION, V80, P297, DOI 10.1097/01.tp.0000168148.56669.61; Shimmura H, 2005, TRANSPLANTATION, V80, P985, DOI 10.1097/01.tp.0000173647.43616.78; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Tanabe K, 2003, ABO INCOMPATIBLE REN, P175; TUDER RM, 1994, J HEART LUNG TRANSPL, V13, P129; Tyden G, 2005, AM J TRANSPLANT, V5, P145, DOI 10.1111/j.1600-6143.2004.00653.x; Vilchez RA, 2002, AM J TRANSPLANT, V2, P287, DOI 10.1034/j.1600-6143.2002.20315.x; Zachary AA, 2003, TRANSPLANTATION, V76, P1519, DOI 10.1097/01.TP.0000090868.88895.E0	27	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e68663	10.1371/journal.pone.0068663	http://dx.doi.org/10.1371/journal.pone.0068663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922659	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900009
J	Ma, W; Kong, Q; Arondel, V; Kilaru, A; Bates, PD; Thrower, NA; Benning, C; Ohlrogge, JB				Ma, Wei; Kong, Que; Arondel, Vincent; Kilaru, Aruna; Bates, Philip D.; Thrower, Nicholas A.; Benning, Christoph; Ohlrogge, John B.			WRINKLED1, A Ubiquitous Regulator in Oil Accumulating Tissues from Arabidopsis Embryos to Oil Palm Mesocarp	PLOS ONE			English	Article							BIOSYNTHESIS; GENES; EXPRESSION; MATURATION; PROTEINS; FAMILY; DOMAIN; SEEDS; RNAS	WRINKLED1 (AtWRI1) is a key transcription factor in the regulation of plant oil synthesis in seed and non-seed tissues. The structural features of WRI1 important for its function are not well understood. Comparison of WRI1 orthologs across many diverse plant species revealed a conserved 9 bp exon encoding the amino acids "VYL". Site-directed mutagenesis of amino acids within the 'VYL' exon of AtWRI1 failed to restore the full oil content of wri1-1 seeds, providing direct evidence for an essential role of this small exon in AtWRI1 function. Arabidopsis WRI1 is predicted to have three alternative splice forms. To understand expression of these splice forms we performed RNASeq of Arabidopsis developing seeds and queried other EST and RNASeq databases from several tissues and plant species. In all cases, only one splice form was detected and VYL was observed in transcripts of all WRI1 orthologs investigated. We also characterized a phylogenetically distant WRI1 ortholog (EgWRI1) as an example of a non-seed isoform that is highly expressed in the mesocarp tissue of oil palm. The C-terminal region of EgWRI1 is over 90 amino acids shorter than AtWRI1 and has surprisingly low sequence conservation. Nevertheless, the EgWRI1 protein can restore multiple phenotypes of the Arabidopsis wri1-1 loss-of-function mutant, including reduced seed oil, the "wrinkled" seed coat, reduced seed germination, and impaired seedling establishment. Taken together, this study provides an example of combining phylogenetic analysis with mutagenesis, deep-sequencing technology and computational analysis to examine key elements of the structure and function of the WRI1 plant transcription factor.	[Ma, Wei; Kilaru, Aruna; Ohlrogge, John B.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Ma, Wei; Kong, Que; Kilaru, Aruna; Thrower, Nicholas A.; Benning, Christoph; Ohlrogge, John B.] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Kong, Que; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Arondel, Vincent] Univ Bordeaux Segalen, Lab Biogenese Membranaire, Bordeaux, France; [Bates, Philip D.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Michigan State University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Washington State University	Ma, W (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	mawei@msu.edu	Bates, Philip D/I-7550-2013; Benning, Christoph/Y-2528-2019; Bates, Philip David/O-9980-2019	Bates, Philip D/0000-0002-1291-3363; Benning, Christoph/0000-0001-8585-3667; Bates, Philip David/0000-0002-1291-3363; Ma, Wei/0000-0002-1301-5119; Thrower, Nicholas/0000-0002-7357-6639; Kong, Que/0000-0001-9181-0137	Department of Energy-Great Lakes Bioenergy Research Center Cooperative Agreement [DE-FC02-07ER6449]	Department of Energy-Great Lakes Bioenergy Research Center Cooperative Agreement	This work was supported by Department of Energy-Great Lakes Bioenergy Research Center Cooperative Agreement DE-FC02-07ER6449 (J.B.O. and C.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; Baud S, 2009, PLANT J, V60, P933, DOI 10.1111/j.1365-313X.2009.04011.x; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Cernac A, 2006, PLANT PHYSIOL, V141, P745, DOI 10.1104/pp.106.079574; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Kriechbaumer V, 2012, PLANT J, V70, P292, DOI 10.1111/j.1365-313X.2011.04866.x; Krizek BA, 2003, NUCLEIC ACIDS RES, V31, P1859, DOI 10.1093/nar/gkg292; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Liu J, 2010, PLANT PHYSIOL BIOCH, V48, P9, DOI 10.1016/j.plaphy.2009.09.007; Maeo K, 2009, PLANT J, V60, P476, DOI 10.1111/j.1365-313X.2009.03967.x; Masaki T, 2005, PLANT CELL PHYSIOL, V46, P547, DOI 10.1093/pcp/pci072; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; Pouvreau B, 2011, PLANT PHYSIOL, V156, P674, DOI 10.1104/pp.111.173641; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Riechmann JL, 1998, BIOL CHEM, V379, P633; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; Seo PJ, 2012, PLANT CELL, V24, P2427, DOI 10.1105/tpc.112.098723; Seo PJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1303; Shen B, 2010, PLANT PHYSIOL, V153, P980, DOI 10.1104/pp.110.157537; Suzuki Y, 2004, BIOTECHNIQUES, V37, P542, DOI 10.2144/04374BM03; To A, 2012, PLANT CELL, V24, P5007, DOI 10.1105/tpc.112.106120; Tranbarger TJ, 2011, PLANT PHYSIOL, V156, P564, DOI 10.1104/pp.111.175141; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Volfovsky N, 2003, GENOME RES, V13, P1216, DOI 10.1101/gr.677503	33	91	96	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e68887	10.1371/journal.pone.0068887	http://dx.doi.org/10.1371/journal.pone.0068887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922666	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900010
J	Quraan, MA; McCormick, C; Cohn, M; Valiante, TA; McAndrews, P				Quraan, Maher A.; McCormick, Cornelia; Cohn, Melanie; Valiante, Taufik A.; McAndrews, Pat			Altered Resting State Brain Dynamics in Temporal Lobe Epilepsy Can Be Observed in Spectral Power, Functional Connectivity and Graph Theory Metrics	PLOS ONE			English	Article							SPONTANEOUS MEG ACTIVITY; SMALL-WORLD NETWORKS; THEORETICAL ANALYSIS; PARKINSONS-DISEASE; CORTICAL NETWORKS; LOW-FREQUENCY; DEFAULT MODE; EEG; SYNCHRONIZATION; HIPPOCAMPAL	Despite a wealth of EEG epilepsy data that accumulated for over half a century, our ability to understand brain dynamics associated with epilepsy remains limited. Using EEG data from 15 controls and 9 left temporal lobe epilepsy (LTLE) patients, in this study we characterize how the dynamics of the healthy brain differ from the "dynamically balanced'' state of the brain of epilepsy patients treated with anti-epileptic drugs in the context of resting state. We show that such differences can be observed in band power, synchronization and network measures, as well as deviations from the small world network (SWN) architecture of the healthy brain. The theta (4-7 Hz) and high alpha (10-13 Hz) bands showed the biggest deviations from healthy controls across various measures. In particular, patients demonstrated significantly higher power and synchronization than controls in the h band, but lower synchronization and power in the high alpha band. Furthermore, differences between controls and patients in graph theory metrics revealed deviations from a SWN architecture. In the h band epilepsy patients showed deviations toward an orderly network, while in the high alpha band they deviated toward a random network. These findings show that, despite the focal nature of LTLE, the epileptic brain differs in its global network characteristics from the healthy brain. To our knowledge, this is the only study to encompass power, connectivity and graph theory metrics to investigate the reorganization of resting state functional networks in LTLE patients.	[Quraan, Maher A.; McCormick, Cornelia; Cohn, Melanie; McAndrews, Pat] Univ Hlth Network, Krembil Neurosci Ctr, Toronto, ON, Canada; [Quraan, Maher A.; McCormick, Cornelia; Cohn, Melanie; McAndrews, Pat] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [McCormick, Cornelia; McAndrews, Pat] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Cohn, Melanie; McAndrews, Pat] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Valiante, Taufik A.] Univ Toronto, Dept Neurosurg, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Quraan, MA (corresponding author), Univ Hlth Network, Krembil Neurosci Ctr, Toronto, ON, Canada.	mquraan@gmail.com	McAndrews, Mary Pat/ABD-9479-2021; Quraan, Maher A/J-9697-2019; McAndrews, MP/GWV-3841-2022; Valiante, Taufik A/C-3285-2015	McAndrews, Mary Pat/0000-0002-2287-5145; Valiante, Taufik A/0000-0002-3443-3790; Cohn, Melanie/0000-0003-2921-7505; McCormick, Cornelia/0000-0003-1259-4558	Canadian Institutes of Health Research (CIHR); McDonnell Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McDonnell Foundation	The authors would like to thank the Canadian Institutes of Health Research (CIHR) and McDonnell Foundation for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Ahmadlou M, 2010, J NEURAL TRANSM, V117, P1099, DOI 10.1007/s00702-010-0450-3; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Bernhardt BC, 2012, NEUROLOGY, V78, P129, DOI 10.1212/WNL.0b013e31823efd0d; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bosboom JLW, 2009, J NEURAL TRANSM, V116, P193, DOI 10.1007/s00702-008-0132-6; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campi C, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/982185; Cea-del Rio CA, 2010, J NEUROSCI, V30, P6011, DOI 10.1523/JNEUROSCI.5040-09.2010; Chauviere L, 2012, ANN NEUROL, V71, P805, DOI 10.1002/ana.23549; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; Chen ACN, 2008, NEUROIMAGE, V41, P561, DOI 10.1016/j.neuroimage.2007.12.064; Contreras D, 1997, NEUROSCIENCE, V76, P11; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Coombes S, 2012, EUR J NEUROSCI, V36, P2118, DOI 10.1111/j.1460-9568.2012.08185.x; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Deco G, 2011, NEUROSCIENTIST, V17, P107, DOI 10.1177/1073858409354384; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Douw L, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00174; Douw L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010839; Geday J, 2009, BRAIN COGNITION, V69, P344, DOI 10.1016/j.bandc.2008.08.009; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Guye M, 2006, BRAIN, V129, P1917, DOI 10.1093/brain/awl151; Hinrikus H, 2009, MED BIOL ENG COMPUT, V47, P1291, DOI 10.1007/s11517-009-0554-9; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; Jin SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028682; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Kramer MA, 2012, NEUROSCIENTIST, V18, P360, DOI 10.1177/1073858411422754; Kramer MA, 2010, J NEUROSCI, V30, P10076, DOI 10.1523/JNEUROSCI.6309-09.2010; Lawrence JJ, 2006, J NEUROSCI, V26, P12325, DOI 10.1523/JNEUROSCI.3521-06.2006; Lee CR, 2009, J NEURAL TRANSM-SUPP, P71, DOI 10.1007/978-3-211-92660-4_6; Lehnertz K, 2009, J NEUROSCI METH, V183, P42, DOI 10.1016/j.jneumeth.2009.05.015; Li Y, 2008, IEEE T NEUR SYS REH, V16, P62, DOI 10.1109/TNSRE.2007.911084; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Long CJ, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P5164; Long CJ, 2011, ANN APPL STAT, V5, P1207, DOI 10.1214/11-AOAS483; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Meyer MC, 2012, BRAIN TOPOGR; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Mills T, 2012, BRAIN TOPOGR, V25, P248, DOI 10.1007/s10548-012-0217-2; Mormann F, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021912; Munro E, 2012, J NEUROPHYSIOL, V107, P2833, DOI 10.1152/jn.00709.2011; Munro E, 2010, J COMPUT NEUROSCI, V28, P539, DOI 10.1007/s10827-010-0235-6; Murta T, 2012, NEUROIMAGE, V62, P1634, DOI 10.1016/j.neuroimage.2012.05.053; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Nymotin SA, 2011, TRAINING OSCILLATORY; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Pouliot P, 2012, J NEUROSCI METH, V204, P326, DOI 10.1016/j.jneumeth.2011.11.016; Poza J, 2007, P ANN INT IEEE EMBS, P6180; Poza J, 2007, MED ENG PHYS, V29, P1073, DOI 10.1016/j.medengphy.2006.11.006; Poza J, 2008, IEEE ENG MED BIO, P5712, DOI 10.1109/IEMBS.2008.4650511; Quraan MA, 2011, MAGNETOENCEPHELOGRAP; Quraan MA, 2011, HUM BRAIN MAPP, V32, P812, DOI 10.1002/hbm.21068; Quraan MA, 2010, NEUROIMAGE, V49, P2387, DOI 10.1016/j.neuroimage.2009.10.012; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salinsky MC, 2002, EPILEPSIA, V43, P482, DOI 10.1046/j.1528-1157.2002.22501.x; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Singer BH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.021910; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Steriade M, 1998, Adv Neurol, V77, P105; Stoffers D, 2008, EXP NEUROL, V213, P191, DOI 10.1016/j.expneurol.2008.05.021; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tahaei MS, 2012, IEEE T NEUR SYS REH, V20, P636, DOI 10.1109/TNSRE.2012.2202127; TUUNAINEN A, 1995, EPILEPSIA, V36, P817, DOI 10.1111/j.1528-1157.1995.tb01620.x; Ullah G, 2009, J COMPUT NEUROSCI, V26, P171, DOI 10.1007/s10827-008-0130-6; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wendling F, 2008, COMPUTATIONAL NEUROSCIENCE IN EPILEPSY, P356, DOI 10.1016/B978-012373649-9.50026-0; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Wipf DP, 2010, NEUROIMAGE, V49, P641, DOI 10.1016/j.neuroimage.2009.06.083; Xie Teng, 2011, Front Psychiatry, V2, P77, DOI 10.3389/fpsyt.2011.00077; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zhang ZJ, 2011, EPILEPSY RES, V97, P290, DOI 10.1016/j.eplepsyres.2011.09.025; Zhang ZJ, 2012, J NEUROSCI, V32, P2499, DOI 10.1523/JNEUROSCI.4247-11.2012; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	91	62	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e68609	10.1371/journal.pone.0068609	http://dx.doi.org/10.1371/journal.pone.0068609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922658	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900008
J	Sanchez-Martin, P; Raththagala, M; Bridges, TM; Husodo, S; Gentry, MS; Sanz, P; Roma-Mateo, C				Sanchez-Martin, Pablo; Raththagala, Madushi; Bridges, Travis M.; Husodo, Satrio; Gentry, Matthew S.; Sanz, Pascual; Roma-Mateo, Carlos			Dimerization of the Glucan Phosphatase Laforin Requires the Participation of Cysteine 329	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; DUAL-SPECIFICITY PHOSPHATASE; GLYCOGEN-SYNTHESIS; BINDING DOMAIN; PROTEIN-KINASE; DISEASE; MALIN; CARBOHYDRATE; MUTATIONS; METABOLISM	Laforin, encoded by a gene that is mutated in Lafora Disease (LD, OMIM 254780), is a modular protein composed of a carbohydrate-binding module and a dual-specificity phosphatase domain. Laforin is the founding member of the glucan-phosphatase family and regulates the levels of phosphate present in glycogen. Multiple reports have described the capability of laforin to form dimers, although the function of these dimers and their relationship with LD remains unclear. Recent evidence suggests that laforin dimerization depends on redox conditions, suggesting that disulfide bonds are involved in laforin dimerization. Using site-directed mutagenesis we constructed laforin mutants in which individual cysteine residues were replaced by serine and then tested the ability of each protein to dimerize using recombinant protein as well as a mammalian cell culture assay. Laforin-Cys329Ser was the only Cys/Ser mutant unable to form dimers in both assays. We also generated a laforin truncation lacking the last three amino acids, laforin-Cys329X, and this truncation also failed to dimerize. Interestingly, laforin-Cys329Ser and laforin-Cys329X were able to bind glucans, and maintained wild type phosphatase activity against both exogenous and biologically relevant substrates. Furthermore, laforin-Cys329Ser was fully capable of participating in the ubiquitination process driven by a laforin-malin complex. These results suggest that dimerization is not required for laforin phosphatase activity, glucan binding, or for the formation of a functional laforin-malin complex. Cumulatively, these results suggest that cysteine 329 is specifically involved in the dimerization process of laforin. Therefore, the C329S mutant constitutes a valuable tool to analyze the physiological implications of laforin's oligomerization.	[Sanchez-Martin, Pablo; Sanz, Pascual; Roma-Mateo, Carlos] CSIC, Inst Biomed Valencia, Valencia, Spain; [Sanchez-Martin, Pablo; Sanz, Pascual; Roma-Mateo, Carlos] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia, Spain; [Raththagala, Madushi; Bridges, Travis M.; Husodo, Satrio; Gentry, Matthew S.] Univ Kentucky, Struct Biol Ctr, Dept Mol & Cellular Biochem, Lexington, KY USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Kentucky	Roma-Mateo, C (corresponding author), CSIC, Inst Biomed Valencia, Valencia, Spain.	croma@ibv.csic.es	Raththagala, Madushi/AAU-5254-2020; Sanz, Pascual/K-2751-2014; Raththagala, Madushi U/A-5086-2015; Romá-Mateo, Carlos/B-6640-2016	Raththagala, Madushi/0000-0001-6227-6203; Sanz, Pascual/0000-0002-2399-4103; Raththagala, Madushi U/0000-0002-4513-629X; Romá-Mateo, Carlos/0000-0002-7981-7157; Sanchez-Martin, Pablo/0000-0002-2734-2014	Spanish Ministry of Education and Science [SAF2011-27442]; la Fundacio La Marato de TV3 [100130]; Generalitat Valenciana [Prometeo 2009/051]; National Institutes of Health [P20RR020171, R01NS070899]; University of Kentucky College of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070899] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); la Fundacio La Marato de TV3; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kentucky College of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the Spanish Ministry of Education and Science (SAF2011-27442), a grant from la Fundacio La Marato de TV3 (ref. 100130) and a grant from Generalitat Valenciana (Prometeo 2009/051) to PS as well as National Institutes of Health Grants P20RR020171 and R01NS070899 and University of Kentucky College of Medicine startup funds to MSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; Alonso A, 2004, TOP CURR GENET, V5, P333; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Chan EM, 2003, J MED GENET, V40, P671, DOI 10.1136/jmg.40.9.671; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; Criado O, 2012, HUM MOL GENET, V21, P1521, DOI 10.1093/hmg/ddr590; Dukhande VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024040; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-138; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gentry MS, 2012, FEBS J; Gentry MS, 2009, TRENDS BIOCH SCI; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Kaiser P, 2005, METHOD ENZYMOL, V399, P243, DOI 10.1016/S0076-6879(05)99016-2; Koksal AC, 2011, J BIOL CHEM, V286, P14373, DOI 10.1074/jbc.M111.226357; Kooi CWV, 2010, P NATL ACAD SCI USA, V107, P15379, DOI 10.1073/pnas.1009386107; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Liu Y, 2009, HUM MOL GENET, V18, P2622, DOI 10.1093/hmg/ddp196; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Mittal S, 2007, HUM MOL GENET, V16, P753, DOI 10.1093/hmg/ddm006; Monaghan TS, 2010, CNS DRUGS, V24, P549, DOI 10.2165/11319250-000000000-00000; Nitschke F, 2013, CELL METAB, V17, P756, DOI 10.1016/j.cmet.2013.04.006; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pulido R, 2008, FEBS J, V275, P848, DOI 10.1111/j.1742-4658.2008.06250.x; Puri R, 2010, AUTOPHAGY, V6, P1229, DOI 10.4161/auto.6.8.13307; Rao SNR, 2010, HUM MOL GENET, V19, P4726, DOI 10.1093/hmg/ddq407; Rao SNR, 2010, J BIOL CHEM, V285, P1404, DOI 10.1074/jbc.M109.006312; Roach PJ, 2011, FEBS LETT, V585, P3216, DOI 10.1016/j.febslet.2011.09.009; Roma-Mateo C, 2012, IUBMB LIFE, V64, P801, DOI 10.1002/iub.1072; Roma-Mateo C, 2011, BIOCHEM J, V439, P265, DOI 10.1042/BJ20110150; Rubio-Villena C, 2013, INT J BIOCH CELL BIO; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; SCHNABEL R, 1968, Pathologia Europaea, V3, P218; Sengupta S, 2011, J CELL SCI, V124, P2277, DOI 10.1242/jcs.082800; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Sherwood AR, 2013, ANAL BIOCHEM, V435, P54, DOI 10.1016/j.ab.2012.10.044; Sorimachi K, 1997, STRUCTURE, V5, P647, DOI 10.1016/S0969-2126(97)00220-7; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2006, BIOCHEM BIOPH RES CO, V350, P588, DOI 10.1016/j.bbrc.2006.09.091; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200	56	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69523	10.1371/journal.pone.0069523	http://dx.doi.org/10.1371/journal.pone.0069523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922729	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900051
J	Chen, H; Ma, LKA; Guo, W; Yang, Y; Guo, T; Feng, C				Chen, He; Ma, Lekuan; Guo, Wei; Yang, Ying; Guo, Tong; Feng, Cheng			Linking Water Quality and Quantity in Environmental Flow Assessment in Deteriorated Ecosystems: A Food Web View	PLOS ONE			English	Article							RIVERS; METHODOLOGIES; BIODIVERSITY; CHALLENGE; CRITERIA; AQUATOX; REGIME; MODEL; NEEDS; FISH	Most rivers worldwide are highly regulated by anthropogenic activities through flow regulation and water pollution. Environmental flow regulation is used to reduce the effects of anthropogenic activities on aquatic ecosystems. Formulating flow alteration-ecological response relationships is a key factor in environmental flow assessment. Traditional environmental flow models are characterized by natural relationships between flow regimes and ecosystem factors. However, food webs are often altered from natural states, which disturb environmental flow assessment in such ecosystems. In ecosystems deteriorated by heavy anthropogenic activities, the effects of environmental flow regulation on species are difficult to assess with current modeling approaches. Environmental flow management compels the development of tools that link flow regimes and food webs in an ecosystem. Food web approaches are more suitable for the task because they are more adaptive for disordered multiple species in a food web deteriorated by anthropogenic activities. This paper presents a global method of environmental flow assessment in deteriorated aquatic ecosystems. Linkages between flow regimes and food web dynamics are modeled by incorporating multiple species into an ecosystem to explore ecosystem-based environmental flow management. The approach allows scientists and water resources managers to analyze environmental flows in deteriorated ecosystems in an ecosystem-based way.	[Chen, He; Ma, Lekuan; Yang, Ying; Guo, Tong; Feng, Cheng] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China; [Ma, Lekuan] Chinese Acad Environm Planning, Beijing, Peoples R China; [Guo, Wei] North China Elect Power Univ, Res Ctr Ecol Engn & Nonlinear Sci, Beijing, Peoples R China; [Guo, Tong] Free Univ Berlin, Inst Biol, Berlin, Germany; [Guo, Tong] Free Univ Berlin, DCPS, Inst Biol, Berlin, Germany	Beijing Normal University; North China Electric Power University; Free University of Berlin; Free University of Berlin	Chen, H (corresponding author), Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China.	chenhe@bnu.edu.cn			National Natural Science Foundation of China [51179007, 51009006]; National Science and Technology Support Program [2011BAC09B07]; National Basic Research Program of China [2010CB951104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (51179007, 51009006), National Science and Technology Support Program (2011BAC09B07), and National Basic Research Program of China (2010CB951104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2006, FRONT ECOL ENVIRON, V4, P309, DOI 10.1890/1540-9295(2006)4[309:IFNISA]2.0.CO;2; Arthington AH, 2003, RIVER RES APPL, V19, P641, DOI 10.1002/rra.728; Arthington AH, 2006, ECOL APPL, V16, P1311, DOI 10.1890/1051-0761(2006)016[1311:TCOPEF]2.0.CO;2; Arthington AH, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02340.x; Brett MT, 1997, SCIENCE, V275, P384, DOI 10.1126/science.275.5298.384; Carleton JN, 2009, ENVIRON MANAGE, V44, P485, DOI 10.1007/s00267-009-9344-2; Chen H, 2012, PROCEDIA ENVIRON SCI, V13, P1444, DOI 10.1016/j.proenv.2012.01.136; Chen H, 2011, ECOL MODEL, V222, P253, DOI 10.1016/j.ecolmodel.2009.12.020; Chen WM, 2005, SURVEY METHODS FOR L; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Durham BW, 2009, T AM FISH SOC, V138, P666, DOI 10.1577/T07-234.1; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Guo T, 2012, PROCEDIA ENVIRON SCI, V13, P363, DOI 10.1016/j.proenv.2012.01.034; Huckstorf V, 2008, RIVER RES APPL, V24, P519, DOI 10.1002/rra.1131; Jorgensen SE, 2007, ENERGY, V32, P673, DOI 10.1016/j.energy.2006.06.011; Jorgensen SE, 2010, ECOL COMPLEX, V7, P311, DOI 10.1016/j.ecocom.2009.12.003; Lopes LFG, 2004, ECOL MODEL, V173, P197, DOI 10.1016/j.ecolmodel.2003.07.009; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Merritt DM, 2010, FRESHWATER BIOL, V55, P206, DOI 10.1111/j.1365-2427.2009.02206.x; Middelboe AL, 1997, FRESHWATER BIOL, V37, P553, DOI 10.1046/j.1365-2427.1997.00183.x; Ministry of environmental protection, 2002, ENVIRONMENTAL QUALIT; Nilsson C, 2008, ECOL SOC, V13; ODUM E P, 1971, P574; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Opperman JJ, 2010, J AM WATER RESOUR AS, V46, P211, DOI 10.1111/j.1752-1688.2010.00426.x; Palmer C., 2007, WATERSA, V31, P161, DOI DOI 10.4314/wsa.v31i2.5198; Park RA, 2008, ECOL MODEL, V213, P1, DOI 10.1016/j.ecolmodel.2008.01.015; Petts GE, 2009, J AM WATER RESOUR AS, V45, P1071, DOI 10.1111/j.1752-1688.2009.00360.x; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 2010, FRESHWATER BIOL, V55, P194, DOI 10.1111/j.1365-2427.2009.02272.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Powell SJ, 2008, ECOL MODEL, V211, P350, DOI 10.1016/j.ecolmodel.2007.09.013; Power ME, 1996, ENVIRON MANAGE, V20, P887, DOI 10.1007/BF01205969; Rashleigh B, 2003, J FRESHWATER ECOL, V18, P515, DOI 10.1080/02705060.2003.9663992; Reid MA, 2012, RIVER RES APPL, V28, P827, DOI 10.1002/rra.1491; Richter BD, 2012, RIVER RES APPL, V28, P1312, DOI 10.1002/rra.1511; Richter BD, 2006, RIVER RES APPL, V22, P297, DOI 10.1002/rra.892; Sabo JL, 2010, SCIENCE, V330, P965, DOI 10.1126/science.1196005; Scherman PA, 2003, RIVER RES APPL, V19, P483, DOI 10.1002/rra.751; Shafroth PB, 2010, FRESHWATER BIOL, V55, P68, DOI 10.1111/j.1365-2427.2009.02271.x; Slocombe DS, 1998, ENVIRON MANAGE, V22, P483, DOI 10.1007/s002679900121; Tharme RE, 2003, RIVER RES APPL, V19, P397, DOI 10.1002/rra.736; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; [No title captured]	44	17	17	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70537	10.1371/journal.pone.0070537	http://dx.doi.org/10.1371/journal.pone.0070537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894669	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900133
J	Dominguez, SR; Travanty, EA; Qian, ZH; Mason, RJ				Dominguez, Samuel R.; Travanty, Emily A.; Qian, Zhaohui; Mason, Robert J.			Human Coronavirus HKU1 Infection of Primary Human Type II Alveolar Epithelial Cells: Cytopathic Effects and Innate Immune Response	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; SPIKE-PROTEIN; MURINE CORONAVIRUS; CULTURED-CELLS; COMMON COLD; FUSION; VIRUSES; CLEAVAGE; CHILDREN; LUNG	Because they are the natural target for respiratory pathogens, primary human respiratory epithelial cells provide the ideal in vitro system for isolation and study of human respiratory viruses, which display a high degree of cell, tissue, and host specificity. Human coronavirus HKU1, first discovered in 2005, has a worldwide prevalence and is associated with both upper and lower respiratory tract disease in both children and adults. Research on HCoV-HKU1 has been difficult because of its inability to be cultured on continuous cell lines and only recently it was isolated from clinical specimens using primary human, ciliated airway epithelial cells. Here we demonstrate that HCoV-HKU1 can infect and be serially propagated in primary human alveolar type II cells at the air-liquid interface. We were not able to infect alveolar type I-like cells or alveolar macrophages. Type II alveolar cells infected with HCoV-HKU1 demonstrated formation of large syncytium. At 72 hours post inoculation, HCoV-HKU1 infection of type II cells induced increased levels of mRNAs encoding IL29,CXCL10, CCL5, and IL-6 with no significant increases in the levels of IFN beta. These studies demonstrate that type II cells are a target cell for HCoV-HKU1 infection in the lower respiratory tract, that type II alveolar cells are immune-competent in response to infection exhibiting a type III interferon and proinflammatory chemokine response, and that cell to cell spread may be a major factor for spread of infection. Furthermore, these studies demonstrate that human alveolar cells can be used to isolate and study novel human respiratory viruses that cause lower respiratory tract disease.	[Dominguez, Samuel R.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Dominguez, Samuel R.; Qian, Zhaohui] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA; [Travanty, Emily A.; Mason, Robert J.] Natl Jewish Hlth, Dept Med, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Dominguez, SR (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA.	samuel.dominguez@ucdenver.edu	Qian, Zhaohui/AFR-9488-2022	Qian, Zhaohui/0000-0003-4116-4450	NIH [K08 AI-073525, U01AI082982]; Exxon Mobil Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI073525, U01AI082982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Exxon Mobil Foundation(Exxon Mobil Corporation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study received financial support through NIH grant #K08 AI-073525 to SRD and NIH grant # U01AI082982 and funding from the Exxon Mobil Foundation to RJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chow KC, 2004, AM J CLIN PATHOL, V121, P574, DOI 10.1309/C0EDU0RAQBTXBHCE; de Haan CAM, 2004, J VIROL, V78, P6048, DOI 10.1128/JVI.78.11.6048-6054.2004; Dijkman R, 2013, J VIROL; Dominguez SR, 2009, J MED VIROL, V81, P1597, DOI 10.1002/jmv.21541; Dominguez SR, 2012, J GEN VIROL; Esper F, 2006, EMERG INFECT DIS, V12, P775, DOI 10.3201/eid1205.051316; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Follis KE, 2006, VIROLOGY, V350, P358, DOI 10.1016/j.virol.2006.02.003; FRANA MF, 1985, J VIROL, V56, P912, DOI 10.1128/JVI.56.3.912-920.1985; Funk CJ, 2012, J GEN VIROL, V93, P494, DOI 10.1099/vir.0.038414-0; Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Knipe D, 2001, FIELDS VIROLOGY, P1187; Kuypers J, 2007, PEDIATRICS, V119, pE70, DOI 10.1542/peds.2006-1406; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; MASON RJ, 1982, P NATL ACAD SCI-BIOL, V79, P6033, DOI 10.1073/pnas.79.19.6033; Mesel-Lemoine M, 2012, J VIROL, V86, P7577, DOI 10.1128/JVI.00269-12; Miura TA, 2006, ADV EXP MED BIOL, V581, P351; Miura TA, 2009, J LEUKOCYTE BIOL, V86, P1145, DOI 10.1189/jlb.0209078; MIZZEN L, 1983, VIROLOGY, V128, P407, DOI 10.1016/0042-6822(83)90266-0; Mossel EC, 2008, VIROLOGY, V372, P127, DOI 10.1016/j.virol.2007.09.045; Nakagaki K, 2005, J VIROL, V79, P6102, DOI 10.1128/JVI.79.10.6102-6110.2005; Pyrc K, 2010, J VIROL, V84, P11255, DOI 10.1128/JVI.00947-10; Qian Z, 2013, AM J RESP CRITICAL C; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sattentau QJ, 2011, CURR OPIN VIROL, V1, P396, DOI 10.1016/j.coviro.2011.09.004; Shieh WJ, 2005, HUM PATHOL, V36, P303, DOI 10.1016/j.humpath.2004.11.006; Simmons G, 2011, VIROLOGY, V413, P265, DOI 10.1016/j.virol.2011.02.020; Sloots TP, 2006, J CLIN VIROL, V35, P99, DOI 10.1016/j.jcv.2005.09.008; Vabret A, 2006, CLIN INFECT DIS, V42, P634, DOI 10.1086/500136; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Wang JR, 2011, AM J RESP CELL MOL, V45, P582, DOI 10.1165/rcmb.2010-0108OC; Wang JR, 2009, J IMMUNOL, V182, P1296, DOI 10.4049/jimmunol.182.3.1296; Weinheimer VK, 2012, J INFECT DIS, V206, P1685, DOI 10.1093/infdis/jis455; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Woo PCY, 2005, J INFECT DIS, V192, P1898, DOI 10.1086/497151; Yamada Y, 2009, J VIROL, V83, P8744, DOI 10.1128/JVI.00613-09; Yamada Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006130; Ye JX, 2007, AM J PATHOL, V170, P538, DOI 10.2353/ajpath.2007.060469	42	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70129	10.1371/journal.pone.0070129	http://dx.doi.org/10.1371/journal.pone.0070129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894604	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900108
J	Eberhardt, AT; Costa, SA; Marini, MR; Racca, A; Baldi, CJ; Robles, MR; Moreno, PG; Beldomenico, PM				Eberhardt, Ayelen T.; Costa, Sebastian A.; Marini, M. Rocio; Racca, Andrea; Baldi, Cecilia J.; Robles, M. Rosario; Moreno, Pablo G.; Beldomenico, Pablo M.			Parasitism and Physiological Trade-Offs in Stressed Capybaras	PLOS ONE			English	Article							HYDROCHOERUS-HYDROCHAERIS; INNATE IMMUNITY; GERM-FREE; WILD; POPULATIONS; IMMUNOLOGY; HEALTH; FIELD; HELMINTHS; NEMATODA	Parasites play a key role in regulating wildlife population dynamics, but their impact on the host appears to be context-dependent. Evidence indicates that a synergistic interaction between stress, host condition and parasites is implicated in this phenomenon, but more studies are needed to better understand this context-dependency. With the goal to assess the net effect of two types of chronic stress on various host-parasite interactions, we conducted an experiment in capybaras to evaluate the impact of food restriction and physical restraint on the infection intensity of specific gastrointestinal nematodes and coccidia, and how these stressors affected the growth, body condition, and some immuno-physiological parameters. Our hypothesis was that both forms of stress would result in an alteration in the host-parasite interactions, with deteriorated condition and reduced immunological investment leading to high parasite burdens and vice versa. Stressed capybaras had significantly higher coccidia infection intensities; but among individuals that were smaller, those stressed consistently showed lower helminth burdens than controls. Both stress treatments had a marked negative impact on growth and body condition, but concomitantly they had a significant positive effect on some components of the immune system. Our results suggest, on the one hand, that during prolonged periods of stress capybaras preventatively invest in some components of their immunity, such as innate humoural defenses and cells that combat helminths, which could be considered a stress-dependent prophylaxis. On the other hand, stress was found to cause greater infection intensities of protozoans but lower burdens of nematodes, indicating that the relationship between stress, physiological trade-offs and infection depends on the type of parasite in question. Moreover, both findings might be related in a causal way, as one of the immunological parameters enhanced in stressed capybaras is associated with the immune response to control helminths.	[Eberhardt, Ayelen T.; Costa, Sebastian A.; Racca, Andrea; Baldi, Cecilia J.; Moreno, Pablo G.; Beldomenico, Pablo M.] Univ Nacl Litoral, Consejo Invest Cient & Tecn UNL CONICET, Lab Ecol Enfermedades, Inst Ciencias Vet Litoral, Esperanza, Santa Fe, Argentina; [Marini, M. Rocio] Univ Nacl Litoral, Fac Ciencias Vet, Catedra Patol Basica, Esperanza, Santa Fe, Argentina; [Robles, M. Rosario] Ctr Estudios Parasitol & Vectores CONICET, La Plata, Buenos Aires, Argentina	National University of the Littoral; National University of the Littoral; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Eberhardt, AT (corresponding author), Univ Nacl Litoral, Consejo Invest Cient & Tecn UNL CONICET, Lab Ecol Enfermedades, Inst Ciencias Vet Litoral, Esperanza, Santa Fe, Argentina.	aeberhardt@fcv.unl.edu.ar		BELDOMENICO, Pablo/0000-0001-5039-8975	Secretaria de Estado de Ciencia, Tecnologia e Innovacion de la Provincia de Santa Fe [SECTEI-21-08-12]; Universidad Nacional del Litoral [CAI+D 002-009]; Argentine Agency for the Promotion of Science and Technology [PICT2010-2202]	Secretaria de Estado de Ciencia, Tecnologia e Innovacion de la Provincia de Santa Fe; Universidad Nacional del Litoral; Argentine Agency for the Promotion of Science and Technology	This work was funded by Secretaria de Estado de Ciencia, Tecnologia e Innovacion de la Provincia de Santa Fe, SECTEI-21-08-12, Universidad Nacional del Litoral, CAI+D 002-009 and Argentine Agency for the Promotion of Science and Technology, PICT2010-2202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque GR, 2008, PESQUI VET BRASIL, V28, P323, DOI 10.1590/S0100-736X2008000700001; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Anderson RC, 1974, CHI KEYS NEMATODE PA; Baayen RH, 2011, LANGUAGER DATA SETS; BARUS V, 1975, Folia Parasitologica (Ceske Budejovice), V22, P207; Beldomenico PM, 2008, J ANIM ECOL, V77, P984, DOI 10.1111/j.1365-2656.2008.01413.x; Beldomenico PM, 2010, TRENDS ECOL EVOL, V25, P21, DOI 10.1016/j.tree.2009.06.015; Boero JJ, 1967, REV FACULTAD CIENCIA, V9, P161; Bolkovic M. L., 2006, MANEJO FAUNA SILVEST, P105; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; BUNDY DAP, 1987, PARASITOLOGY, V95, P623, DOI 10.1017/S0031182000058042; Burthe S, 2006, J ANIM ECOL, V75, P1416, DOI 10.1111/j.1365-2656.2006.01166.x; Busato A, 1998, J VET MED B, V45, P519, DOI 10.1111/j.1439-0450.1998.tb00823.x; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; CHITTY D, 1952, PHILOS T ROY SOC B, V236, P505, DOI 10.1098/rstb.1952.0009; COX DD, 1962, J AM VET MED ASSOC, V141, P706; Daugschies A, 2005, J VET MED B, V52, P417, DOI 10.1111/j.1439-0450.2005.00894.x; Robles MD, 2011, J PARASITOL, V97, P319, DOI 10.1645/GE-2434.1; Diaz-Ungria C, 1976, EXC PARASITOL MEM E; Douglas B, 2013, LME4 LINEAR MIXED EF; Chaves LF, 2010, J MED ENTOMOL, V47, P291, DOI 10.1603/ME09250; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Frank SA, 2008, J EVOLUTION BIOL, V21, P396, DOI 10.1111/j.1420-9101.2007.01480.x; Freitas Texeira JF, 1936, MEMORIAS I OSWALDO C, V3, P123; French SS, 2007, FUNCT ECOL, V21, P1115, DOI 10.1111/j.1365-2435.2007.01311.x; French SS, 2009, INTEGR COMP BIOL, V49, P246, DOI 10.1093/icb/icp032; FURUSE M, 1984, BRIT J NUTR, V51, P255, DOI 10.1079/BJN19840030; Gibbons L. M., 2009, Keys to the nematode parasites of vertebrates: supplementary volume, pv, DOI 10.1079/9781845935719.0000; Grenfell BT, 1995, PARASITOLOGY, V111, pS135, DOI 10.1017/S0031182000075867; Gulland F. M. D., 1995, P20, DOI 10.1017/CBO9780511629396.002; Hangalapura BN, 2005, POULTRY SCI, V84, P1520, DOI 10.1093/ps/84.10.1520; Herrera E, 1984, ENCY MAMMALS, P696; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Jubb K.V.F., 2007, PATHOLOGY DOMESTIC A, V5th; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Latimer KS, 2003, DUNCAN PRASSES VET L; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Madella Daniela Alves, 2006, Cienc. Rural, V36, P1321, DOI 10.1590/S0103-84782006000400046; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Martin LB, 2009, GEN COMP ENDOCR, V163, P70, DOI 10.1016/j.ygcen.2009.03.008; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; Merino S, 2006, J ANIM ECOL, V75, P1147, DOI 10.1111/j.1365-2656.2006.01135.x; MORAVEC F, 1982, FOLIA PARASIT, V29, P119; Nogueira MF, 2007, DOENCAS CAPIVARA; Ojasti J, 2011, ESTUDIO BIOL CHIGUIR; OJASTI J, 1985, ACTA ZOOL FENN, V173, P81; Oli MK, 1999, THEOR POPUL BIOL, V56, P293, DOI 10.1006/tpbi.1999.1427; OULD P, 1980, CAN J ZOOL, V58, P228, DOI 10.1139/z80-026; Paterson S, 2003, TRENDS PARASITOL, V19, P370, DOI 10.1016/S1471-4922(03)00149-1; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; PEREIRA P, 1986, EUR J IMMUNOL, V16, P685, DOI 10.1002/eji.1830160616; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Ribeiro S. M. B., 2003, Arquivos do Instituto Biologico (Sao Paulo), V70, P155; Ribeiro S. M. B., 2003, Arquivos do Instituto Biologico (Sao Paulo), V70, P145; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Salas V, 2004, MEM I OSWALDO CRUZ, V99, P563, DOI 10.1590/S0074-02762004000600004; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Scott ME, 1988, CONSERV BIOL, V2; Sinkoc AL, 2009, BRAZ ARCH BIOL TECHN, V52, P327, DOI 10.1590/S1516-89132009000200009; SNYDER DL, 1987, LAB ANIM SCI, V37, P320; Tompkins DM, 1999, PARASITOL TODAY, V15, P311, DOI 10.1016/S0169-4758(99)01484-2; Townsend AK, 2010, P ROY SOC B-BIOL SCI, V277, P2875, DOI 10.1098/rspb.2010.0480; TRAVASSOS L., 1916, BRAS MED, V30, P313; Travassos L, 1937, MONOGR I O CRUZ; UENO H, 1988, MANUAL DIAGNOSTICO H; Vicente JJ, 1997, REV BRAS ZOOL, V14, P1, DOI DOI 10.1590/S0101-81751997000500001.VIEIRA; Vinkler M, 2012, ANIM BEHAV, V83, P17, DOI 10.1016/j.anbehav.2011.10.001; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Weindruch R., 1988, RETARDATION AGING DI; Wilson K., 2002, P6; Wilson K, 1998, ECOL ENTOMOL, V23, P100, DOI 10.1046/j.1365-2311.1998.00107.x; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	73	34	38	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70382	10.1371/journal.pone.0070382	http://dx.doi.org/10.1371/journal.pone.0070382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894644	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900121
J	Koers-Wunrau, C; Wehmeyer, C; Hillmann, A; Pap, T; Dankbar, B				Koers-Wunrau, Christina; Wehmeyer, Corinna; Hillmann, Anja; Pap, Thomas; Dankbar, Berno			Cell Surface-Bound TIMP3 Induces Apoptosis in Mesenchymal Cal78 Cells through Ligand-Independent Activation of Death Receptor Signaling and Blockade of Survival Pathways	PLOS ONE			English	Article							MEDIATED GENE DELIVERY; TISSUE INHIBITOR; TUMOR-GROWTH; IN-VITRO; METALLOPROTEINASES (TIMP)-3; CASPASE-8 EXPRESSION; EXTRACELLULAR-MATRIX; EPITHELIAL-CELLS; MELANOMA-CELLS; INVASION	Background: The matrix metalloproteinases (MMPs) and their endogenous regulators, the tissue inhibitor of metalloproteinases (TIMPs 1-4) are responsible for the physiological remodeling of the extracellular matrix (ECM). Among all TIMPs, TIMP3 appears to play a unique role since TIMP3 is a secreted protein and, unlike the other TIMP family members, is tightly bound to the ECM. Moreover TIMP3 has been shown to be able to induce apoptotic cell death. As little is known about the underlying mechanisms, we set out to investigate the pro-apoptotic effect of TIMP3 in human mesenchymal cells. Methodology/Principal Findings: Lentiviral overexpression of TIMP3 in mesenchymal cells led to a strong dose-dependent induction of ligand-independent apoptosis as reflected by a five-fold increase in caspase 3 and 7 activity compared to control (pLenti6/V5-GW/lacZ) or uninfected cells, whereas exogenous TIMP3 failed to induce apoptosis. Concordantly, increased cleavage of death substrate PARP and the caspases 3 and 7 was observed in TIMP3 overexpressing cultures. Notably, activation of caspase-8 but not caspase-9 was observed in TIMP3-overexpressing cells, indicating a death receptor-dependent mechanism. Moreover, overexpression of TIMP3 led to a further induction of apoptosis after stimulation with TNF-alpha, FasL and TRAIL. Most interestingly, TIMP3-overexpression was associated with a decrease in phosphorylation of cRaf, extracellular signal-regulated protein kinase (Erk1/2), ribosomal S6 kinase (RSK1) and Akt and serum deprivation of TIMP3-overexpressing cells resulted in a distinct enhancement of apoptosis, pointing to an impaired signaling of serum-derived survival factors. Finally, heparinase treatment of heparan sulfate proteoglycans led to the release of TIMP3 from the surface of overexpressing cells and to a significant decrease in apoptosis indicating that the binding of TIMP3 is necessary for apoptosis induction. Conclusion: The results demonstrate that exclusively cell surface-bound endogenous TIMP3 induces apoptosis in mesenchymal Cal78 cells through ligand-independent activation of death receptor signaling and blockade of survival signaling pathways.	[Koers-Wunrau, Christina; Wehmeyer, Corinna; Hillmann, Anja; Pap, Thomas; Dankbar, Berno] Univ Hosp Muenster, Inst Expt Musculoskeletal Med, Munster, Germany	University of Munster	Dankbar, B (corresponding author), Univ Hosp Muenster, Inst Expt Musculoskeletal Med, Munster, Germany.	bernodankbar@web.de			DFG [DA 1143/2-1]	DFG(German Research Foundation (DFG))	This study was supported by a grant from the DFG (DA 1143/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Ahonen M, 2002, MOL THER, V5, P705, DOI 10.1006/mthe.2002.0606; Ahonen M, 1998, CANCER RES, V58, P2310; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; AnandApte B, 1996, BIOCHEM CELL BIOL, V74, P853, DOI 10.1139/o96-090; Anania MC, 2011, ONCOGENE, V30, P3011, DOI 10.1038/onc.2011.18; Bachman KE, 1999, CANCER RES, V59, P798; Baker AH, 1999, BRIT J CANCER, V79, P1347, DOI 10.1038/sj.bjc.6690217; Baker AH, 1998, J CLIN INVEST, V101, P1478, DOI 10.1172/JCI1584; Bernot D, 2010, J BIOL CHEM, V285, P6508, DOI 10.1074/jbc.M109.078444; Bian JH, 1996, CARCINOGENESIS, V17, P1805, DOI 10.1093/carcin/17.9.1805; Bond M, 2002, J BIOL CHEM, V277, P13787, DOI 10.1074/jbc.M111507200; Bond M, 2000, J BIOL CHEM, V275, P41358, DOI 10.1074/jbc.M007929200; Borland G, 1999, J BIOL CHEM, V274, P2810, DOI 10.1074/jbc.274.5.2810; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Carey DJ, 1997, BIOCHEM J, V327, P1; Cruz-Munoz W, 2006, ONCOGENE, V25, P6489, DOI 10.1038/sj.onc.1209663; Cruz-Munoz W, 2006, ONCOGENE, V25, P650, DOI 10.1038/sj.onc.1209104; Deng XY, 2006, EUR J CANCER, V42, P3267, DOI 10.1016/j.ejca.2006.07.003; Dulaimi E, 2004, CLIN CANCER RES, V10, P3972, DOI 10.1158/1078-0432.CCR-04-0175; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Finan KM, 2006, LUNG CANCER-J IASLC, V53, P273, DOI 10.1016/j.lungcan.2006.06.006; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; Hammoud L, 2009, AM J PHYSIOL-CELL PH, V296, pC735, DOI 10.1152/ajpcell.00246.2008; Hargreaves PG, 1998, BRIT J HAEMATOL, V101, P694, DOI 10.1046/j.1365-2141.1998.00754.x; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Hopkins-Donaldson S, 2000, CANCER RES, V60, P4315; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; MAEDA S, 1995, ANN RHEUM DIS, V54, P970, DOI 10.1136/ard.54.12.970; Majid MA, 2002, BRIT J OPHTHALMOL, V86, P97, DOI 10.1136/bjo.86.1.97; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Spurbeck WW, 2002, BLOOD, V100, P3361, DOI 10.1182/blood.V100.9.3361; Wang WM, 2006, BIOCHEM J, V398, P515, DOI 10.1042/BJ20060630; Wetzel M, 2008, CELL DEATH DIFFER, V15, P143, DOI 10.1038/sj.cdd.4402246; Wild A, 2003, J CLIN ENDOCR METAB, V88, P1367, DOI 10.1210/jc.2002-021027; Wunrau C, 2009, ARTHRITIS RHEUM-US, V60, P2606, DOI 10.1002/art.24782; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200	43	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70709	10.1371/journal.pone.0070709	http://dx.doi.org/10.1371/journal.pone.0070709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894681	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900140
J	Lee, YG; Kim, BK; Lim, YH; Kim, MK; Choi, BY; Shin, JH				Lee, Yonggu; Kim, Bae Keun; Lim, Young-Hyo; Kim, Mi Kyung; Choi, Bo Youl; Shin, Jinho			The Relationship between Adiponectin and Left Ventricular Mass Index Varies with the Risk of Left Ventricular Hypertrophy	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; PLASMA ADIPONECTIN; INSULIN-RESISTANCE; ASSOCIATION; ADIPOKINE; MORTALITY; LEVEL	Background: Adiponectin directly protects against cardiac remodeling. Despite this beneficial effect, most epidemiological studies have reported a negative relationship between adiponectin level and left ventricular mass index (LVMI). However, a positive relationship has also been reported in subjects at high risk of left ventricular hypertrophy (LVH). Based on these conflicting results, we hypothesized that the relationship between serum adiponectin level and LVMI varies with the risk of LVH. Methods: A community-based, cross-sectional study was performed on 1414 subjects. LVMI was measured by echocardiography. Log-transformed adiponectin levels (Log-ADPN) were used for the analysis. Results: Serum adiponectin level had a biphasic distribution (an increase after a decrease) with increasing LVMI. Although Log-ADPN did not correlate with LVMI, Log-ADPN was modestly associated with LVMI in the multivariate analysis (beta = 0.079, p = 0.001). The relationship between adiponectin level and LVMI was bidirectional according to the risk of LVH. In normotensive subjects younger than 50 years, Log-ADPN negatively correlated with LVMI (r = -0.204, p = 0.005); however, Log-ADPN positively correlated with LVMI in >= 50-year-old obese subjects with high arterial stiffness (r = 0.189, p = 0.030). The correlation coefficient between Log-ADPN and LVMI gradually changed from negative to positive with increasing risk factors for LVH. The risk of LVH significantly interacted with the relationship between Log-ADPN and LVMI. In the multivariate analysis, Log-ADPN was associated with LVMI in the subjects at risk of LVH; however, Log-ADPN was either not associated or negatively associated with LVMI in subjects at low risk of LVH. Conclusion: Adiponectin level and LVMI are negatively associated in subjects at low risk of LVH and are positively associated in subjects at high risk of LVH. Therefore, the relationship between adiponectin and LVMI varies with the risk of LVH.	[Lee, Yonggu; Kim, Bae Keun; Lim, Young-Hyo; Shin, Jinho] Hanyang Univ Hosp, Dept Cardiol, Seoul, South Korea; [Kim, Mi Kyung; Choi, Bo Youl] Hanyang Univ, Coll Med, Seoul 133791, South Korea; [Lee, Yonggu] Myungji St Marys Hosp, Cardiol Clin, Seoul, South Korea	Hanyang University; Hanyang University Hospital; Hanyang University	Shin, JH (corresponding author), Hanyang Univ Hosp, Dept Cardiol, Seoul, South Korea.	jhs2003@hanyang.ac.kr	Lee, Yonggu/Q-3832-2018	Lee, Yonggu/0000-0002-3757-3692; Shin, Jinho/0000-0001-6706-6504	Hanyang University, Preventive Medicine	Hanyang University, Preventive Medicine	Funded by Hanyang University, Preventive Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2011, CLIN TRANSPLANT, V25, P561, DOI 10.1111/j.1399-0012.2010.01330.x; Amin RH, 2010, AM J PHYSIOL-HEART C, V299, pH690, DOI 10.1152/ajpheart.01032.2009; Bidulescu A, 2011, CIRC-HEART FAIL, V4, P747, DOI 10.1161/CIRCHEARTFAILURE.110.959742; Ebinc FA, 2009, J NEPHROL, V22, P216; Ebinc H, 2008, ENDOCR J, V55, P523, DOI 10.1507/endocrj.K07E-098; Frankel DS, 2009, J AM COLL CARDIOL, V53, P754, DOI 10.1016/j.jacc.2008.07.073; Fu MQ, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-106; Hong SJ, 2004, BLOOD PRESSURE, V13, P236, DOI 10.1080/08037050410021397; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Komaba H, 2007, NEPHRON CLIN PRACT, V107, pC103, DOI 10.1159/000108651; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Liao YL, 2010, BIOCHEM BIOPH RES CO, V393, P519, DOI 10.1016/j.bbrc.2010.02.039; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lu JY, 2008, J BIOMED SCI, V15, P565, DOI 10.1007/s11373-008-9261-z; Luchner A, 2000, J HYPERTENS, V18, P1121, DOI 10.1097/00004872-200018080-00018; Mitsuhashi H, 2007, HYPERTENSION, V49, P1448, DOI 10.1161/HYPERTENSIONAHA.106.079509; Mondal AK, 2012, METAB SYNDR RELAT D, V10, P297, DOI 10.1089/met.2012.0002; Paakko T, 2010, ANN MED, V42, P131, DOI 10.3109/07853890903449827; Park M, 2012, HEART FAIL REV; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shinmura K, 2010, HEART FAIL REV, V15, P457, DOI 10.1007/s10741-010-9159-5; Siervo M, 2010, J INTERN MED, V268, P338, DOI 10.1111/j.1365-2796.2010.02255.x; Skurk C, 2008, EUR HEART J, V29, P1168, DOI 10.1093/eurheartj/ehn136; Sung SH, 2011, HEART, V97, P648, DOI 10.1136/hrt.2010.211110; Tamura T, 2007, CIRC J, V71, P623, DOI 10.1253/circj.71.623; Tekes S, 2007, J HUM HYPERTENS, V21, P546, DOI 10.1038/sj.jhh.1002194; Thorndike RL, 1947, RES PROBLEMS TECHNIQ, Vviii; Tsukamoto O, 2009, J AM COLL CARDIOL, V53, P2070, DOI 10.1016/j.jacc.2009.02.038; Wang C, 2010, J CELL PHYSIOL, V222, P149, DOI 10.1002/jcp.21931; Weisell RC, 2002, ASIA PAC J CLIN NUTR, V11, pS681, DOI 10.1046/j.1440-6047.11.s8.5.x; Wiecek A, 2007, NEPHROL DIAL TRANSPL, V22, P981, DOI 10.1093/ndt/gfl814; Yang YJ, 2010, BRIT J NUTR, V104, P1202, DOI 10.1017/S0007114510001893; Zhang H, 2012, AM J MED SCI	34	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70246	10.1371/journal.pone.0070246	http://dx.doi.org/10.1371/journal.pone.0070246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894624	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900113
J	Wright, B; Hopkinson, A; Leyland, M; Connon, CJ				Wright, Bernice; Hopkinson, Andrew; Leyland, Martin; Connon, Che J.			The Secretome of Alginate-Encapsulated Limbal Epithelial Stem Cells Modulates Corneal Epithelial Cell Proliferation	PLOS ONE			English	Article							ADIPOSE-TISSUE; SPARC; TRANSPLANTATION; ANGIOGENESIS; INHIBITION; ALLOGRAFT	Limbal epithelial stem cells may ameliorate limbal stem cell deficiency through secretion of therapeutic proteins, delivered to the cornea in a controlled manner using hydrogels. In the present study the secretome of alginate-encapsulated limbal epithelial stem cells is investigated. Conditioned medium was generated from limbal epithelial stem cells encapsulated in 1.2% (w/v) calcium alginate gels. Conditioned medium proteins separated by 1-D gel electrophoresis were visualized by silver staining. Proteins of interest including secreted protein acidic and rich in cysteine, profilin-1, and galectin-1 were identified by immunoblotting. The effect of conditioned medium (from alginate-encapsulated limbal epithelial stem cells) on corneal epithelial cell proliferation was quantified and shown to significantly inhibit (P <= 0.05) their growth. As secreted protein acidic and rich in cysteine was previously reported to attenuate proliferation of epithelial cells, this protein may be responsible, at least in part, for inhibition of corneal epithelial cell proliferation. We conclude that limbal epithelial stem cells encapsulated in alginate gels may regulate corneal epithelialisation through secretion of inhibitory proteins.	[Wright, Bernice; Connon, Che J.] Univ Reading, Sch Pharm, Reading, Berks, England; [Hopkinson, Andrew] Univ Nottingham, Div Ophthalmol & Visual Sci, Nottingham NG7 2RD, England; [Leyland, Martin] Royal Berkshire Hosp, Reading RG1 5AN, Berks, England	University of Reading; University of Nottingham; Royal Berkshire Hospital	Connon, CJ (corresponding author), Univ Reading, Sch Pharm, Reading, Berks, England.	c.j.connon@reading.ac.uk	Connon, Che/B-3128-2012	Connon, Che/0000-0001-8264-6531	Medical Research Council [G/0900877]; MRC [G0900877] Funding Source: UKRI; Medical Research Council [G0900877] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the Medical Research Council Grant Ref: G/0900877; URL: http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Bassuk JA, 1999, EXP EYE RES, V68, P321, DOI 10.1006/exer.1998.0608; Chen B, 2013, TISSUE ENG C; Chen B, 2012, SOFT MATTER, V8, P8379, DOI 10.1039/c2sm26175h; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Daya SM, 2005, OPHTHALMOLOGY, V112, P470, DOI 10.1016/j.ophtha.2004.09.023; Estrada R, 2009, J CELL PHYSIOL, V219, P563, DOI 10.1002/jcp.21701; Farina A, 2011, PROTEOMICS, V11, P3972, DOI 10.1002/pmic.201100063; Francki A, 2003, J CELL BIOCHEM, V88, P802, DOI 10.1002/jcb.10424; Jester JV, 1996, CORNEA, V15, P505; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Koizumi N, 2001, ARCH OPHTHALMOL-CHIC, V119, P298; Li HX, 2010, AM J PHYSIOL-HEART C, V299, pH1772, DOI 10.1152/ajpheart.00557.2010; Li RH, 1996, BIOTECHNOL BIOENG, V50, P365, DOI 10.1002/(SICI)1097-0290(19960520)50:4<365::AID-BIT3>3.0.CO;2-J; Mishima H, 1998, INVEST OPHTH VIS SCI, V39, P2547; Motamed K, 2002, J CELL BIOCHEM, V84, P759, DOI 10.1002/jcb.10095; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Rabinovich GA, 2005, BRIT J CANCER, V92, P1188, DOI 10.1038/sj.bjc.6602493; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Ribeiro CA, 2011, J TISSUE ENG REGEN M, V5, P668, DOI 10.1002/term.365; Ribeiro CA, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt109; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Shanley LJ, 2004, INVEST OPHTH VIS SCI, V45, P1088, DOI 10.1167/iovs.03-1064; TSAI RJF, 1994, CORNEA, V13, P389, DOI 10.1097/00003226-199409000-00003; Tseng SCG, 2010, CURR MOL MED, V10, P841; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873; Wright B, 2012, REGEN MED, V7, P295, DOI [10.2217/RME.12.7, 10.2217/rme.12.7]; Yang MH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/901329; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024	31	12	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70860	10.1371/journal.pone.0070860	http://dx.doi.org/10.1371/journal.pone.0070860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894686	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000322167900143
J	Du, WY; Josephrajan, A; Adhikary, S; Bowles, T; Bielinsky, AK; Eichman, BF				Du, Wenyue; Josephrajan, Ajeetha; Adhikary, Suraj; Bowles, Timothy; Bielinsky, Anja-Katrin; Eichman, Brandt F.			Mcm10 Self-Association Is Mediated by an N-Terminal Coiled-Coil Domain	PLOS ONE			English	Article							DNA-POLYMERASE-ALPHA; SIZE-DISTRIBUTION ANALYSIS; MALTOSE-BINDING PROTEIN; GCN4 LEUCINE-ZIPPER; MCM2-7 HELICASE; BUDDING YEAST; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; CHROMATIN ASSOCIATION	Minichromosome maintenance protein 10 (Mcm10) is an essential eukaryotic DNA-binding replication factor thought to serve as a scaffold to coordinate enzymatic activities within the replisome. Mcm10 appears to function as an oligomer rather than in its monomeric form (or rather than as a monomer). However, various orthologs have been found to contain 1, 2, 3, 4, or 6 subunits and thus, this issue has remained controversial. Here, we show that self-association of Xenopus laevis Mcm10 is mediated by a conserved coiled-coil (CC) motif within the N-terminal domain (NTD). Crystallographic analysis of the CC at 2.4 angstrom resolution revealed a three-helix bundle, consistent with the formation of both dimeric and trimeric Mcm10 CCs in solution. Mutation of the side chains at the subunit interface disrupted in vitro dimerization of both the CC and the NTD as monitored by analytical ultracentrifugation. In addition, the same mutations also impeded self-interaction of the full-length protein in vivo, as measured by yeast-two hybrid assays. We conclude that Mcm10 likely forms dimers or trimers to promote its diverse functions during DNA replication.	[Du, Wenyue; Adhikary, Suraj; Bowles, Timothy; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Josephrajan, Ajeetha; Bielinsky, Anja-Katrin] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA	Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities	Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	brandt.eichman@vanderbilt.edu		Adhikary, Suraj/0000-0003-1073-0966; Bielinsky, Anja/0000-0003-1783-619X; Josephrajan, Ajeetha/0000-0001-7727-5174; Eichman, Brandt/0000-0002-0965-2297; Bowles, Timothy/0000-0002-4840-3787	National Institutes of Health [R01 GM080570, R01 GM074917]; Leukemia & Lymphoma Scholar Award [1023-09]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080570, R01GM074917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Scholar Award(Leukemia and Lymphoma Society); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grants R01 GM080570 to BFE and R01 GM074917 to AKB and a Leukemia & Lymphoma Scholar Award (1023-09) to AKB. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of LS-CAT/Sector 21 beamline was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The funders supplied money used for personnel, equipment and supply costs, and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Apger J, 2010, GENETICS, V185, P1151, DOI 10.1534/genetics.110.117234; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Center RJ, 1998, PROTEIN SCI, V7, P1612, DOI 10.1002/pro.5560070715; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Ciani B, 2010, P NATL ACAD SCI USA, V107, P19850, DOI 10.1073/pnas.1008502107; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; Du W, 2012, SUBCELL BIOCH, V62, P197; Dutta K, 2001, PROTEIN SCI, V10, P2531, DOI 10.1110/ps.ps.28801; Dutta K, 2003, PROTEIN SCI, V12, P257, DOI 10.1110/ps.0223903; Eisenberg S, 2009, J BIOL CHEM, V284, P25412, DOI 10.1074/jbc.M109.033175; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fatoba ST, 2013, NUCLEIC ACIDS RES, V41, P4065, DOI 10.1093/nar/gkt131; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fien K, 2006, J BIOL CHEM, V281, P22248, DOI 10.1074/jbc.M512997200; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Gibbons DL, 2000, J VIROL, V74, P7772, DOI 10.1128/JVI.74.17.7772-7780.2000; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hart EA, 2002, CURR GENET, V41, P342, DOI 10.1007/s00294-002-0316-9; Haworth J, 2010, MOL BIOL CELL, V21, P3205, DOI 10.1091/mbc.E09-06-0452; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Homesley L, 2000, GENE DEV, V14, P913; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laue TN, 1992, ANAL ULTRACENTRIFUGA, V224, P90; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lee C, 2010, MOL CELL BIOL, V30, P423, DOI 10.1128/MCB.01240-09; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; LOWEY S, 1965, J BIOL CHEM, V240, P2421; MacNeill S., 2012, EUKARYOTIC REPLISOME; Marvin JS, 1997, P NATL ACAD SCI USA, V94, P4366, DOI 10.1073/pnas.94.9.4366; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Mueller GA, 2010, J ALLERGY CLIN IMMUN, V125, P909, DOI 10.1016/j.jaci.2009.12.016; Noelken M, 1964, BIOCH MUSCLE CONTRAC, P374; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Spinola-Amilibia M, 2013, J MOL BIOL, V425, P2147, DOI 10.1016/j.jmb.2013.03.005; Spinola-Amilibia M, 2011, J MOL BIOL, V411, P1114, DOI 10.1016/j.jmb.2011.07.006; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Thepaut M, 2004, J MOL BIOL, V342, P275, DOI 10.1016/j.jmb.2004.06.065; Thu YM, 2013, TRENDS BIOCHEM SCI, V38, P184, DOI 10.1016/j.tibs.2012.12.003; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Warren EM, 2009, J BIOL CHEM, V284, P24662, DOI 10.1074/jbc.M109.020438; Watase G, 2012, CURR BIOL, V22, P343, DOI 10.1016/j.cub.2012.01.023; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	79	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70518	10.1371/journal.pone.0070518	http://dx.doi.org/10.1371/journal.pone.0070518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894664	Green Published, Green Submitted, gold			2022-12-25	WOS:000325211000212
J	Marucci, A; di Mauro, L; Menzaghi, C; Prudente, S; Mangiacotti, D; Fini, G; Lotti, G; Trischitta, V; Di Paola, R				Marucci, Antonella; di Mauro, Lazzaro; Menzaghi, Claudia; Prudente, Sabrina; Mangiacotti, Davide; Fini, Grazia; Lotti, Giuseppe; Trischitta, Vincenzo; Di Paola, Rosa			GALNT2 Expression Is Reduced in Patients with Type 2 Diabetes: Possible Role of Hyperglycemia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ADIPOSE-TISSUE; O-GLCNAC; INSULIN; OBESITY; DISEASE; RISK; LOCI	Impaired insulin action plays a major role in the pathogenesis of type 2 diabetes, a chronic metabolic disorder which imposes a tremendous burden to morbidity and mortality worldwide. Unraveling the molecular mechanisms underlying insulin resistance would improve setting up preventive and treatment strategies of type 2 diabetes. Down-regulation of GALNT2, an UDPN-acetyl-alpha-D-galactosamine polypeptideN-acetylgalactosaminyltransferase-2 (ppGalNAc-T2), causes impaired insulin signaling and action in cultured human liver cells. In addition, GALNT2 mRNA levels are down-regulated in liver of spontaneously insulin resistant, diabetic Goto-Kakizaki rats. To investigate the role of GALNT2 in human hyperglycemia, we measured GALNT2 mRNA expression levels in peripheral whole blood cells of 84 non-obese and 46 obese non-diabetic individuals as well as of 98 obese patients with type 2 diabetes. We also measured GALNT2 mRNA expression in human U937 cells cultured under different glucose concentrations. In vivo studies indicated that GALNT2 mRNA levels were significantly reduced from non obese control to obese non diabetic and to obese diabetic individuals (p<0.001). In vitro studies showed that GALNT2 mRNA levels was reduced in U937 cells exposed to high glucose concentrations (i.e. 25 mmol/l glucose) as compared to cells exposed to low glucose concentration (i.e. 5.5 mmol/l glucose +19.5 mmol/l mannitol). In conclusion, our data indicate that GALNT2 is down-regulated in patients with type 2 diabetes and suggest that this association is, at least partly, secondary to hyperglycemia. Further studies are needed to understand whether GALNT2 down-regulation plays a pathogenic role in maintaining and/or aggravating the metabolic abnormalities of diabetic milieu.	[Marucci, Antonella; Menzaghi, Claudia; Mangiacotti, Davide; Fini, Grazia; Trischitta, Vincenzo; Di Paola, Rosa] IRCCS Casa Sollievo Sofferenza, Res Unit, San Giovanni Rotondo, Italy; [di Mauro, Lazzaro; Lotti, Giuseppe] Blood Bank IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; [Prudente, Sabrina] CSS Mendel, Rome, Italy; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome	Trischitta, V (corresponding author), IRCCS Casa Sollievo Sofferenza, Res Unit, San Giovanni Rotondo, Italy.	v.trischitta@operapadrepio.it; r.dipaola@operapadrepio.it	Di Paola, Rosa/G-7813-2011; fini, grazia/AAM-3320-2020; mangiacotti, davide/AAM-8142-2020; Trischitta, Vincenzo/K-1487-2016; marucci, antonella/B-8722-2017; Prudente, Sabrina/H-2886-2016; Menzaghi, Claudia/J-7210-2016	Di Paola, Rosa/0000-0001-5837-9111; Trischitta, Vincenzo/0000-0003-1174-127X; marucci, antonella/0000-0001-8131-8317; Prudente, Sabrina/0000-0001-9220-8981; Menzaghi, Claudia/0000-0002-7438-8955	Italian Ministry of Health [RC2011 RC2012 RC2013]; Fondazione Roma "Sostegno alla ricerca scientifica biomedica"	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma "Sostegno alla ricerca scientifica biomedica"(Fondazione Roma)	This research was supported by Italian Ministry of Health Grants: RC2011 RC2012 RC2013 (R.D.P.), RC2011 (C.M.), RC2011 (S.P.), RC2011 (V.T.); and Fondazione Roma "Sostegno alla ricerca scientifica biomedica 2008'' (V.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon RR, 2009, J ENDOCRINOL, V200, P331, DOI [10.1677/JOE-80-0404, 10.1677/JOE-08-0404]; American Diabetes Association, 2003, Diabetes Care, V26 Suppl 1, pS21; Camargo A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-253; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Gonzalez Y, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-19; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Marucci A, 2013, BBA-MOL CELL RES, V1833, P1388, DOI 10.1016/j.bbamcr.2013.02.032; Park S, 2005, INT J VEHICLE DES, V37, P1, DOI 10.1504/IJVD.2005.006092; Rosenberg S, 2010, ANN INTERN MED, V153, P425, DOI 10.7326/0003-4819-153-7-201010050-00005; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WINGROVE JA, 2008, CIRC CARDIOVASC GENE; Yakeu G, 2010, ATHEROSCLEROSIS, V212, P668, DOI 10.1016/j.atherosclerosis.2010.07.002; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668	24	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e70159	10.1371/journal.pone.0070159	http://dx.doi.org/10.1371/journal.pone.0070159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894607	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100088
J	Chen, YY; Zhu, Y; Wan, QH; Lou, JK; Li, WJ; Ge, YF; Fang, SG				Chen, Yi-Yan; Zhu, Ying; Wan, Qiu-Hong; Lou, Ji-Kang; Li, Wen-Jing; Ge, Yun-Fa; Fang, Sheng-Guo			Patterns of Adaptive and Neutral Diversity Identify the Xiaoxiangling Mountains as a Refuge for the Giant Panda	PLOS ONE			English	Article							BEARS URSUS-ARCTOS; AMINO-ACID SITES; COMPLEX CLASS-I; AILUROPODA-MELANOLEUCA; GENETIC DIVERSITY; NATURAL-SELECTION; MHC; POPULATION; SEQUENCE; SUBSTITUTION	Genetic variation plays a significant role in maintaining the evolutionary potential of a species. Comparing the patterns of adaptive and neutral diversity in extant populations is useful for understanding the local adaptations of a species. In this study, we determined the fine-scale genetic structure of 6 extant populations of the giant panda (Ailuropoda melanoleuca) using mtDNA and DNA fingerprints, and then overlaid adaptive variations in 6 functional Aime-MHC class II genes (DRA, DRB3, DQA1, DQA2, DQB1, and DQB2) on this framework. We found that: (1) analysis of the mtDNA and DNA fingerprint-based networks of the 6 populations identified the independent evolutionary histories of the 2 panda subspecies; (2) the basal (ancestral) branches of the fingerprint-based Sichuan-derived network all originated from the smallest Xiaoxiangling (XXL) population, suggesting the status of a glacial refuge in XXL; (3) the MHC variations among the tested populations showed that the XXL population exhibited extraordinary high levels of MHC diversity in allelic richness, which is consistent with the diversity characteristics of a glacial refuge; (4) the phylogenetic tree showed that the basal clades of giant panda DQB sequences were all occupied by XXL-specific sequences, providing evidence for the ancestor-resembling traits of XXL. Finally, we found that the giant panda had many more DQ alleles than DR alleles (33:13), contrary to other mammals, and that the XXL refuge showed special characteristics in the DQB loci, with 7 DQB members of 9 XXL-unique alleles. Thus, this study identified XXL as a glacial refuge, specifically harboring the most number of primitive DQB alleles.	[Chen, Yi-Yan; Zhu, Ying; Wan, Qiu-Hong; Lou, Ji-Kang; Li, Wen-Jing; Ge, Yun-Fa; Fang, Sheng-Guo] Zhejiang Univ, Coll Life Sci, State Conservat Ctr Gene Resources Endangered Wil, Key Lab Conservat Biol Endangered Wildlife,Minist, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Fang, SG (corresponding author), Zhejiang Univ, Coll Life Sci, State Conservat Ctr Gene Resources Endangered Wil, Key Lab Conservat Biol Endangered Wildlife,Minist, Hangzhou 310003, Zhejiang, Peoples R China.	sgfanglab@zju.edu.cn		Zhu, Ying/0000-0002-3234-0523	National Basic Research Program of the People's Republic of China (973 Program) [2007CB411600]; State Forestry Administration of the People's Republic of China [WH0627]; Fundamental Research Funds for the Central Universities of the People's Republic of China	National Basic Research Program of the People's Republic of China (973 Program)(National Basic Research Program of China); State Forestry Administration of the People's Republic of China; Fundamental Research Funds for the Central Universities of the People's Republic of China	This work was supported by a grant from the National Basic Research Program of the People's Republic of China (973 Program; No. 2007CB411600), a special grant (No. WH0627) for the giant panda from the State Forestry Administration of the People's Republic of China, and by the Fundamental Research Funds for the Central Universities of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Blais J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000734; Bondinas GP, 2007, IMMUNOGENETICS, V59, P539, DOI 10.1007/s00251-007-0224-8; Chen YY, 2010, J EXP ZOOL PART B, V314B, P208, DOI 10.1002/jez.b.21327; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Cronin JK, 2007, P NATL ACAD SCI USA, V104, P2773, DOI 10.1073/pnas.0611226104; Doxiadis GGM, 2001, IMMUNOL REV, V183, P76, DOI 10.1034/j.1600-065x.2001.1830106.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fang SG, 2003, J APPL ANIM RES, V24, P137, DOI 10.1080/09712119.2003.9706448; Fang SG, 2002, J APPL ANIM RES, V21, P65, DOI 10.1080/09712119.2002.9706358; Fang SG, 2002, MOL ECOL NOTES, V2, P352, DOI 10.1046/j.1471-8286.2002.00245.x; Fang Shengguo, 1997, Acta Theriologica Sinica, V17, P248; Goda N, 2010, TISSUE ANTIGENS, V76, P404, DOI 10.1111/j.1399-0039.2010.01528.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He W, 2008, CONSERV GENET, V9, P1541, DOI 10.1007/s10592-007-9493-x; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; Hedrick PW, 2000, HEREDITY, V85, P617, DOI 10.1046/j.1365-2540.2000.00805.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hu JC, 2001, RES GIANT PANDA; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kennedy LJ, 2002, IMMUNOGENETICS, V54, P348, DOI 10.1007/s00251-002-0465-5; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; Kuduk K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-197; Lu Z, 2001, CONSERV BIOL, V15, P1596, DOI 10.1046/j.1523-1739.2001.00086.x; Nielsen R, 1998, GENETICS, V148, P929; Nigenda-Morales S, 2008, J HERED, V99, P14, DOI 10.1093/jhered/esm087; Pan W., 1988, GIANT PANDAS NATURAL; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 5; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Sambrook J, 2001, MOL CLONING LAB MANU; Shen FJ, 2009, MOL ECOL, V18, P1061, DOI 10.1111/j.1365-294X.2009.04086.x; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; State Forestry Administration, 2021, 4 NAT SURV REP GIANT; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1995, GENETICS, V140, P767; Wan QH, 2005, CHINESE SCI BULL, V50, P1879, DOI 10.1360/982005-834; Wan QH, 2005, J MAMMAL, V86, P397, DOI 10.1644/BRB-226.1; Wan QH, 2003, ELECTROPHORESIS, V24, P1353, DOI 10.1002/elps.200390174; Wan QH, 2006, MOL ECOL, V15, P2441, DOI 10.1111/j.1365-294X.2006.02966.x; Wan QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014518; Wan QH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004147; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yasukochi Y, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-230; Zeng C. J., 2005, CYTOGENET GENOME RES, V109, p534H, DOI [10. 1159/000084222, DOI 10.1159/000084222]; Zeng CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-315; Zhan XJ, 2007, MOL ECOL, V16, P3792, DOI 10.1111/j.1365-294X.2007.03450.x; Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang RZ, 1998, ZOOGEOGRAPHY CHINA; Zhang YP, 1997, SCI CHINA SER C, V40, P210, DOI 10.1007/BF02882050; Zhao SC, 2013, NAT GENET, V45, P67, DOI 10.1038/ng.2494; Zhu LF, 2010, CONSERV BIOL, V24, P1299, DOI 10.1111/j.1523-1739.2010.01499.x	69	11	12	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70229	10.1371/journal.pone.0070229	http://dx.doi.org/10.1371/journal.pone.0070229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894623	Green Submitted, Green Published, gold			2022-12-25	WOS:000322391400086
J	de Muinck, EJ; Stenseth, NC; Sachse, D; vander Roost, J; Ronningen, KS; Rudi, K; Trosvik, P				de Muinck, Eric J.; Stenseth, Nils Chr; Sachse, Daniel; vander Roost, Jan; Ronningen, Kjersti S.; Rudi, Knut; Trosvik, Pal			Context-Dependent Competition in a Model Gut Bacterial Community	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MEDIATED INDIRECT INTERACTIONS; ESCHERICHIA-COLI; ECOLOGICAL COMMUNITIES; MOUSE INTESTINE; GENOME SEQUENCE; POPULATIONS; MICROBIOTA; EVOLUTION; GROWTH	Understanding the ecological processes that generate complex community structures may provide insight into the establishment and maintenance of a normal microbial community in the human gastrointestinal tract, yet very little is known about how biotic interactions influence community dynamics in this system. Here, we use natural strains of Escherichia coli and a simplified model microbiota to demonstrate that the colonization process on the strain level can be context dependent, in the sense that the outcome of intra-specific competition may be determined by the composition of the background community. These results are consistent with previous models for competition between organisms where one competitor has adapted to low resource environments whereas the other is optimized for rapid reproduction when resources are abundant. The genomic profiles of E. coli strains representing these differing ecological strategies provide clues for deciphering the genetic underpinnings of niche adaptation within a single species. Our findings extend the role of ecological theory in understanding microbial systems and the conceptual toolbox for describing microbial community dynamics. There are few, if any, concrete examples of context-dependent competition on a single trophic level. However, this phenomenon can have potentially dramatic effects on which bacteria will successfully establish and persist in the gastrointestinal system, and the principle should be equally applicable to other microbial ecosystems.	[de Muinck, Eric J.; Stenseth, Nils Chr; vander Roost, Jan; Trosvik, Pal] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [de Muinck, Eric J.] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [de Muinck, Eric J.] NOFIMA Norwegian Inst Food Fisheries & Aquacultur, As, Norway; [Sachse, Daniel] Univ Oslo, Inst Clin Med, Oslo, Norway; [Sachse, Daniel] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Ronningen, Kjersti S.] Oslo Univ Hosp, Dept Paediat Res, Oslo, Norway; [Rudi, Knut] Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway	University of Oslo; Norwegian Institute of Public Health (NIPH); Nofima; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Life Sciences	Trosvik, P (corresponding author), Univ Oslo, Dept Biosci, CEES, Oslo, Norway.	pal.trosvik@ibv.uio.no	Rudi, Knut/AAZ-9858-2020; Stenseth, Nils Chr./G-5212-2016	Stenseth, Nils Chr./0000-0002-1591-5399; Sachse, Daniel/0000-0002-3121-1236; de Muinck, Eric/0000-0001-5606-3172	Norwegian Foundation for Health and Rehabilitation; Research Council of Norway Grant [179569/V40]	Norwegian Foundation for Health and Rehabilitation; Research Council of Norway Grant	This work was supported by The Norwegian Foundation for Health and Rehabilitation and Research Council of Norway Grant 179569/V40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; Abrams PA, 2004, ECOLOGY, V85, P372, DOI 10.1890/02-0684; Adlerberth I, 2008, NESTLE NUTR WORKS SE, V62, P13, DOI 10.1159/000146245; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; BEGON M, ECOLOGY INDIVIDUALS; Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; BUTTON DK, 1991, APPL ENVIRON MICROB, V57, P2033, DOI 10.1128/AEM.57.7.2033-2038.1991; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; DE FELICE M, 1979, Microbiological Reviews, V43, P42; de Muinck EJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-81; de Muinck EJ, 2011, ENV MICROBIOL REP, V3, P352, DOI 10.1111/j.1758-2229.2010.00231.x; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Fonknechten N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-555; Foster KR, 2012, CURR BIOL, V22, P1845, DOI 10.1016/j.cub.2012.08.005; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; FREDRICKSON AG, 1981, SCIENCE, V213, P972, DOI 10.1126/science.7268409; Friswell M, 2010, GUT LIVER, V4, P295, DOI 10.5009/gnl.2010.4.3.295; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; GOTTSCHAL JC, 1993, ANTON LEEUW INT J G, V63, P299, DOI 10.1007/BF00871225; Grover J. P., 1997, RESOURCE COMPETITION; Harcombe WR, 2005, APPL ENVIRON MICROB, V71, P5254, DOI 10.1128/AEM.71.9.5254-5259.2005; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; JOHNSON LR, 2000, GASTROINTESTINAL PHY; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kiesecker JM, 1999, ECOLOGY, V80, P2442, DOI 10.1890/0012-9658(1999)080[2442:PRCBLA]2.0.CO;2; Koch A L, 1971, Adv Microb Physiol, V6, P147, DOI 10.1016/S0065-2911(08)60069-7; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Leveque C, 2003, DYNAMICS COMMUNITIES, P216; LEVIN BR, 1972, SCIENCE, V175, P1272, DOI 10.1126/science.175.4027.1272; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Monod J., 1942, ACTUALITES SCI IND; Peacor SD, 1997, ECOLOGY, V78, P1146, DOI 10.1890/0012-9658(1997)078[1146:TMIIIA]2.0.CO;2; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Relyea RA, 2000, ECOLOGY, V81, P2278, DOI 10.1890/0012-9658(2000)081[2278:TMIEIL]2.0.CO;2; Rhodes JM, 2007, GUT, V56, P610, DOI 10.1136/gut.2006.111872; Rudi K, 2012, LETT APPL MICROBIOL, V54, P447, DOI 10.1111/j.1472-765X.2012.03229.x; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Sepehri S, 2009, INFLAMM BOWEL DIS, V15, P1737, DOI 10.1002/ibd.20966; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; Storro O, 2011, CLIN EXP ALLERGY, V41, P1545, DOI 10.1111/j.1365-2222.2011.03817.x; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; Trosvik P, 2007, APPL ENVIRON MICROB, V73, P4975, DOI 10.1128/AEM.00128-07; Trosvik P, 2010, ENVIRON MICROBIOL, V12, P2677, DOI 10.1111/j.1462-2920.2010.02236.x; Trosvik P, 2010, ISME J, V4, P151, DOI 10.1038/ismej.2009.96; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; Vejborg RM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-316; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Vieira-Silva S, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000808, DOI 10.1371/J0URNAL.PGEN.1000808.PUBMED:20090831]; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WISSINGER S, 1993, ECOLOGY, V74, P207, DOI 10.2307/1939515	64	16	16	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67210	10.1371/journal.pone.0067210	http://dx.doi.org/10.1371/journal.pone.0067210			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23922635	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300107
J	Chacon-Martinez, CA; Kiessling, N; Winterhoff, M; Faix, J; Muller-Reichert, T; Jessberger, R				Chacon-Martinez, Carlos Andres; Kiessling, Nadine; Winterhoff, Moritz; Faix, Jan; Mueller-Reichert, Thomas; Jessberger, Rolf			The Switch-associated Protein 70 (SWAP-70) Bundles Actin Filaments and Contributes to the Regulation of F-actin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Biology; Cofilin; Cytoskeleton; Mast Cell; F-actin Bundling; SWAP-70	ARP2/3 COMPLEX; CELL-ADHESION; COFILIN ACTIVITY; CROSS-LINKING; ADF/COFILIN; TURNOVER; MOTILITY; POLYMERIZATION; MECHANISM; RICH	Coordinated assembly and disassembly of actin into filaments and higher order structures such as stress fibers and lamellipodia are fundamental for cell migration and adhesion. However, the precise spatiotemporal regulation of F-actin structures is not completely understood. SWAP-70, a phosphatidylinositol 3,4,5-trisphosphate-interacting, F-actin-binding protein, participates in actin rearrangements through yet unknown mechanisms. Here, we show that SWAP-70 is an F-actin-bundling protein that oligomerizes through a Gln/Glu-rich stretch within a coiled-coil region. SWAP-70 bundles filaments in parallel and anti-parallel fashion through its C-terminal F-actin binding domain and delays dilution-induced F-actin depolymerization. We further demonstrate that SWAP-70 co-localizes and directly interacts with cofilin, an F-actin severing and depolymerization factor, and contributes to the regulation of cofilin activity in vivo. In line with these activities, upon stem cell factor stimulation, murine bone marrow-derived mast cells lacking SWAP-70 display aberrant regulation of F-actin and actin free barbed ends dynamics. Moreover, proper stem cell factor-dependent cofilin activation via dephosphorylation and subcellular redistribution into a detergent-resistant cytoskeletal compartment also require SWAP-70. Together, these findings reveal an important role of SWAP-70 in the dynamic spatiotemporal regulation of F-actin networks.	[Chacon-Martinez, Carlos Andres; Kiessling, Nadine; Jessberger, Rolf] Tech Univ Dresden, Inst Physiol Chem, D-01307 Dresden, Germany; [Mueller-Reichert, Thomas] Tech Univ Dresden, Expt Ctr, Fac Med Carl Gustav Carus, D-01307 Dresden, Germany; [Winterhoff, Moritz; Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-3062 Hannover, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Hannover Medical School	Jessberger, R (corresponding author), Tech Univ Dresden, Inst Physiol Chem, Fiedlerstr 42, D-01307 Dresden, Germany.	rolf.jessberger@tu-dresden.de	Chacón-Martínez, Carlos Andrés/L-1782-2019	Winterhoff, Moritz/0000-0002-9029-9266	Deutsche Forschungsgemeinschaft [SPP1394, SPP1464]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SPP1394 (to R. J.) and SPP1464 (to J. F.).	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Borggrefe T, 1999, EUR J IMMUNOL, V29, P1812, DOI 10.1002/(SICI)1521-4141(199906)29:06<1812::AID-IMMU1812>3.0.CO;2-J; Borggrefe T, 2001, EUR J IMMUNOL, V31, P2467, DOI 10.1002/1521-4141(200108)31:8<2467::AID-IMMU2467>3.0.CO;2-P; Breitsprecher D, 2011, J CELL SCI, V124, P3305, DOI 10.1242/jcs.086934; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Chopin M, 2011, EUR J IMMUNOL, V41, P3063, DOI 10.1002/eji.201141742; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hamill KJ, 2013, FASEB J, V27, P546, DOI 10.1096/fj.12-217406; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2006, METHOD ENZYMOL, V406, P190, DOI 10.1016/S0076-6879(06)06015-0; Hey F, 2012, J BIOL CHEM, V287, P31073, DOI 10.1074/jbc.M112.346767; Hilpela P, 2003, MOL BIOL CELL, V14, P3242, DOI 10.1091/mbc.e03-01-0043; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; LINDBERG U, 1988, BIOCHIM BIOPHYS ACTA, V967, P391, DOI 10.1016/0304-4165(88)90102-X; Lorenz M, 2004, CELL MOTIL CYTOSKEL, V57, P207, DOI 10.1002/cm.10171; Marshall TW, 2009, J CELL SCI, V122, P3061, DOI 10.1242/jcs.051482; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Mullins RD, 2000, METHOD ENZYMOL, V325, P214; Ocana-Morgner C, 2011, J IMMUNOL, V186, P5345, DOI 10.4049/jimmunol.1003461; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; Pearce G, 2011, BLOOD, V117, P1574, DOI 10.1182/blood-2010-07-295659; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Reymann AC, 2012, SCIENCE, V336, P1310, DOI 10.1126/science.1221708; Ripich T, 2011, HAEMATOL-HEMATOL J, V96, P1743, DOI 10.3324/haematol.2011.050468; Schmoller KM, 2011, J STRUCT BIOL, V173, P350, DOI 10.1016/j.jsb.2010.09.003; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Sivalenka RR, 2004, MOL CELL BIOL, V24, P10277, DOI 10.1128/MCB.24.23.10277-10288.2004; Skau CT, 2011, J BIOL CHEM, V286, P26964, DOI 10.1074/jbc.M111.239004; Stevenson RP, 2012, J CELL SCI, V125, P1073, DOI 10.1242/jcs.093799; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Wakamatsu I, 2006, MOL CELL BIOCHEM, V293, P137, DOI 10.1007/s11010-006-9236-1; WATTS RG, 1992, CELL MOTIL CYTOSKEL, V21, P25, DOI 10.1002/cm.970210104; Yamakita Y, 2011, J IMMUNOL, V186, P2850, DOI 10.4049/jimmunol.1001667	64	20	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28687	28703		10.1074/jbc.M113.461277	http://dx.doi.org/10.1074/jbc.M113.461277			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23921380	Green Published, hybrid			2022-12-25	WOS:000330298800023
J	Onono, F; Subramanian, T; Sunkara, M; Subramanian, KL; Spielmann, HP; Morris, AJ				Onono, Fredrick; Subramanian, Thangaiah; Sunkara, Manjula; Subramanian, Karunai Leela; Spielmann, H. Peter; Morris, Andrew J.			Efficient Use of Exogenous Isoprenols for Protein Isoprenylation by MDA-MB-231 Cells Is Regulated Independently of the Mevalonate Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA REDUCTASE; FARNESOL; INHIBITORS; GERANYLGERANIOL; ACCUMULATION; LOVASTATIN; ANALOGS; LIVER	Mammalian cells can use exogenous isoprenols to generate isoprenoid diphosphate substrates for protein isoprenylation, but the mechanism, efficiency, and biological importance of this process are not known. We developed mass spectrometry-based methods using chemical probes and newly synthesized stable isotope-labeled tracers to quantitate incorporation of exogenously provided farnesol, geranylgeraniol, and unnatural analogs of these isoprenols containing an aniline group into isoprenoid diphosphates and protein isoprenylcysteines by cultured human cancer cell lines. We found that at exogenous isoprenol concentrations > 10 mu M, this process can generate as much as 50% of the cellular isoprenoid diphosphate pool used for protein isoprenylation. Mutational activation of p53 in MDA-MB-231 breast cancer cells up-regulates the mevalonate pathway to promote tumor invasiveness. p53 silencing or pharmacological inhibition of HMG-CoA reductase in these cells decreases protein isoprenylation from endogenously synthesized isoprenoids but enhances the use of exogenous isoprenols for this purpose, indicating that this latter process is regulated independently of the mevalonate pathway. Our observations suggest unique opportunities for design of cancer cell-directed therapies and may provide insights into mechanisms underlying pleiotropic therapeutic benefits and unwanted side effects of mevalonate pathway inhibition.	[Onono, Fredrick; Subramanian, Thangaiah; Spielmann, H. Peter] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Markey Canc Ctr,Kentucky Ctr Struct Biol, Lexington, KY 40536 USA; [Onono, Fredrick; Subramanian, Thangaiah; Spielmann, H. Peter] Univ Kentucky, Coll Med, Dept Chem, Lexington, KY 40536 USA; [Sunkara, Manjula; Subramanian, Karunai Leela; Morris, Andrew J.] Univ Kentucky, Coll Med, Div Cardiovasc Med, Lexington, KY 40536 USA; [Morris, Andrew J.] Lexington Vet Affairs Med Ctr, Lexington, KY 40502 USA	University of Kentucky; University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Spielmann, HP (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	hps@uky.edu; a.j.morris@uky.edu	sunkara, Manjula/H-7944-2016	sunkara, Manjula/0000-0001-6151-1929	National Institutes of Health [GM50388, GM66152]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050388, P20GM103527, R01GM066152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM50388 (to A. J. M.) and GM66152 (to H. P. S.). This work was conducted in part with resources provided by the Lexington Veterans Affairs Medical Center.	Beigneux A, 2002, J BIOL CHEM, V277, P38358, DOI 10.1074/jbc.M205183200; Buettner C, 2008, PHARMACOGENOMICS, V9, P1133, DOI 10.2217/14622416.9.8.1133; Chang SY, 2012, J LIPID RES, V53, P1176, DOI 10.1194/jlr.M026161; Crick DC, 1998, J NEUROCHEM, V70, P2397; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; FLIESLER SJ, 1995, BIOCHEM BIOPH RES CO, V210, P695, DOI 10.1006/bbrc.1995.1715; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Holstein SA, 2009, LIPIDS, V44, P1055, DOI 10.1007/s11745-009-3355-x; Keller RK, 1996, ARCH BIOCHEM BIOPHYS, V328, P324, DOI 10.1006/abbi.1996.0180; Miriyala S, 2010, J BIOL CHEM, V285, P13918, DOI 10.1074/jbc.M109.083931; Nielsen Sune F, 2013, Ugeskr Laeger, V175, P76; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Onono FO, 2010, MOL CELL PROTEOMICS, V9, P742, DOI 10.1074/mcp.M900597-MCP200; Ownby SE, 2002, LIPIDS, V37, P185, DOI 10.1007/s11745-002-0879-1; Subramanian T, 2013, J LABELLED COMPD RAD, V56, P370, DOI 10.1002/jlcr.3049; Subramanian T, 2012, SYNLETT, P2539, DOI 10.1055/s-0031-1290461; Subramanian T, 2012, BIOCHEMISTRY-US, V51, P8307, DOI 10.1021/bi3011362; Thai L, 1999, P NATL ACAD SCI USA, V96, P13080, DOI 10.1073/pnas.96.23.13080; Thurnher M, 2012, CLIN CANCER RES, V18, P3524, DOI 10.1158/1078-0432.CCR-12-0489; Tong HX, 2005, ANAL BIOCHEM, V336, P51, DOI 10.1016/j.ab.2004.09.024; Troutman JM, 2005, BIOCONJUGATE CHEM, V16, P1209, DOI 10.1021/bc050068+; Yang SH, 2011, HUM MOL GENET, V20, P436, DOI 10.1093/hmg/ddq490; Zeichner S, 2012, J CANCER RES THER, V8, P176, DOI 10.4103/0973-1482.98967; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	25	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27444	27455		10.1074/jbc.M113.482307	http://dx.doi.org/10.1074/jbc.M113.482307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23908355	hybrid, Green Published			2022-12-25	WOS:000330597300040
J	Sorokowska, A; Sorokowski, P; Hummel, T; Huanca, T				Sorokowska, Agnieszka; Sorokowski, Piotr; Hummel, Thomas; Huanca, Tomas			Olfaction and Environment: Tsimane' of Bolivian Rainforest Have Lower Threshold of Odor Detection Than Industrialized German People	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; IDENTIFICATION; QUALITY; SMELL; TASTE; DISCRIMINATION; SENSITIVITY; POPULATION; INFECTIONS; DISORDERS	Olfactory sensitivity varies between individuals. However, data regarding cross-cultural and inter-group differences are scarce. We compared the thresholds of odor detection of the traditional society of Tsimane' (native Amazonians of the Bolivian rainforest; n = 151) and people living in Dresden (Germany; n = 286) using "Sniffin' Sticks" threshold subtest. Tsimane' detected n-butanol at significantly lower concentrations than the German subjects. The distribution of thresholds of the Tsimane' was very specific, with 25% of Tsimane' obtaining better results in the olfactory test than any member of the German group. These data suggest that differences in olfactory sensitivity seem to be especially salient between industrialized and non-industrialized populations inhabiting different environmental conditions. We hypothesize that the possible sources of such differences are: (i) the impact of pollution which impairs the olfactory abilities of people from industrialized countries; (ii) better training of olfaction because of the higher importance of smell in traditional populations; (iii) environmental pressures shaping olfactory abilities in these populations.	[Sorokowska, Agnieszka; Sorokowski, Piotr] Univ Wroclaw, Inst Psychol, PL-50138 Wroclaw, Poland; [Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, D-01062 Dresden, Germany; [Huanca, Tomas] Ctr Boliviano Invest & Desarrollo Socio Integral, Beni, Bolivia	University of Wroclaw; Technische Universitat Dresden	Sorokowska, A (corresponding author), Univ Wroclaw, Inst Psychol, PL-50138 Wroclaw, Poland.	sorokowska@gmail.com		Sorokowska, Agnieszka/0000-0003-3999-8851; Sorokowski, Piotr/0000-0001-9225-9965	Polish Ministry of Science and Higher Education for science [IP 2011 051571]; Foundation for Polish Science START	Polish Ministry of Science and Higher Education for science; Foundation for Polish Science START(Austrian Science Fund (FWF)Foundation for Polish Science)	The research was supported by funds of Polish Ministry of Science and Higher Education for science (research grant #IP 2011 051571 to P. S.; years 2012-2014). During the project A. S. was supported by scholarship from Foundation for Polish Science START (http://www.fnp.org.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; AMOORE JE, 1967, NATURE, V214, P1095, DOI 10.1038/2141095a0; Ayabe-Kanamura S, 1998, CHEM SENSES, V23, P31, DOI 10.1093/chemse/23.1.31; Baldasano JM, 2003, SCI TOTAL ENVIRON, V307, P141, DOI 10.1016/S0048-9697(02)00537-5; Byron E., 2003, MARKET INTEGRATION H; CAIN WS, 1980, JAPCA J AIR WASTE MA, V30, P1295, DOI 10.1080/00022470.1980.10465185; Capaldi ED, 2007, APPETITE, V49, P712, DOI 10.1016/j.appet.2007.08.001; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Doty R., 2003, HDB OLFACTION GUSTAT, P479; Doty R L, 1979, Am J Otolaryngol, V1, P57, DOI 10.1016/S0196-0709(79)80010-1; DOTY RL, 1985, NEUROPSYCHOLOGIA, V23, P667, DOI 10.1016/0028-3932(85)90067-3; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gollin Lisa X., 2004, Journal of Ethnobiology, V24, P173; GROSSISSEROFF R, 1992, NEUROSCI LETT, V141, P115, DOI 10.1016/0304-3940(92)90347-A; Guarneros M, 2009, CHEM SENSES, V34, P819, DOI 10.1093/chemse/bjp071; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; HENKIN RI, 1975, ANN OTO RHINOL LARYN, V84, P672, DOI 10.1177/000348947508400519; Hudson R, 1999, J COMP PHYSIOL A, V185, P297, DOI 10.1007/s003590050390; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Jernigan KA, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-12; Keller A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-122; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Murphy C., 2003, HDB OLFACTION GUSTAT, V3rd ed, P461; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Schiffman SS, 1997, JAMA-J AM MED ASSOC, V278, P1357, DOI 10.1001/jama.278.16.1357; Seiden AM, 2004, OTOLARYNG CLIN N AM, V37, P1159, DOI 10.1016/j.otc.2004.06.007; Shepard GH, 2004, AM ANTHROPOL, V106, P252; Sorokowska A, 2012, EUR J PERSONALITY, V26, P496, DOI 10.1002/per.848; Stevens DA, 1996, PHYSIOL BEHAV, V60, P211, DOI 10.1016/0031-9384(96)00019-4; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Vadez V, 2004, HUM ECOL, V32, P635, DOI 10.1007/s10745-004-6100-3; Van den Bergh O, 1999, OCCUP ENVIRON MED, V56, P295, DOI 10.1136/oem.56.5.295; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Welge-Lussen A, 2006, ADV OTO-RHINO-LARYNG, V63, P125, DOI 10.1159/000093758	39	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69203	10.1371/journal.pone.0069203	http://dx.doi.org/10.1371/journal.pone.0069203			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204MP	23922693	gold, Green Submitted, Green Published			2022-12-25	WOS:000323369700023
J	Eguchi, T; Kumagai, C; Fujihara, T; Takemasa, T; Ozawa, T; Numata, O				Eguchi, Tomoaki; Kumagai, Chiaki; Fujihara, Takashi; Takemasa, Thoru; Ozawa, Tetsuo; Numata, Osamu			Black Tea High-Molecular-Weight Polyphenol Stimulates Exercise Training-Induced Improvement of Endurance Capacity in Mouse via the Link between AMPK and GLUT4	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; TRANSLOCATION; ADAPTATION; CELLS	Aerobic exercise can promote "fast-to-slow transition" in skeletal muscles, i.e. an increase in oxidative fibers, mitochondria, and myoglobin and improvement in glucose and lipid metabolism. Here, we found that mice administered Mitochondria Activation Factor (MAF) combined with exercise training could run longer distances and for a longer time compared with the exercise only group; MAF is a high-molecular-weight polyphenol purified from black tea. Furthermore, MAF intake combined with exercise training increased phosphorylation of AMPK and mRNA level of glucose transporter 4 (GLUT4). Thus, our data demonstrate for the first time that MAF activates exercise training-induced intracellular signaling pathways that involve AMPK, and improves endurance capacity.	[Eguchi, Tomoaki; Fujihara, Takashi; Numata, Osamu] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kumagai, Chiaki; Takemasa, Thoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Ozawa, Tetsuo] Shizuoka Org Creat Ind, Shizuoka, Shizuoka, Japan	University of Tsukuba; University of Tsukuba	Numata, O (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	numata.osamu.gb@u.tsukuba.ac.jp			Shizuoka Prefecture; Shizuoka City program for Collaboration of Regional Entities for the Advancement of Technological Excellence, Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [24657128] Funding Source: KAKEN	Shizuoka Prefecture; Shizuoka City program for Collaboration of Regional Entities for the Advancement of Technological Excellence, Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by the Shizuoka Prefecture and Shizuoka City program for Collaboration of Regional Entities for the Advancement of Technological Excellence, Japan Science and Technology Agency (JST). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Daugaard JR, 2001, ACTA PHYSIOL SCAND, V171, P267, DOI 10.1046/j.1365-201x.2001.00829.x; Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S; Fujihara T, 2007, BIOSCI BIOTECH BIOCH, V71, P711, DOI 10.1271/bbb.60562; GOODYEAR LJ, 1991, AM J PHYSIOL, V261, pE795, DOI 10.1152/ajpendo.1991.261.6.E795; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hutchinson DS, 2006, DIABETES, V55, P682, DOI 10.2337/diabetes.55.03.06.db05-0901; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jensen TE, 2009, ACTA PHYSIOL, V196, P155, DOI 10.1111/j.1748-1716.2009.01979.x; Jessen N, 2005, J APPL PHYSIOL, V99, P330, DOI 10.1152/japplphysiol.00175.2005; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lauritzen HPMM, 2010, DIABETES, V59, P2134, DOI 10.2337/db10-0233; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; LUND S, 1995, P NATL ACAD SCI USA, V92, P5817, DOI 10.1073/pnas.92.13.5817; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; MacLean PS, 2002, BIOCHEM BIOPH RES CO, V292, P409, DOI 10.1006/bbrc.2002.6654; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miyazaki M, 2005, ABV EXERC SPORTS PHY, V11, P15; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Winder WW, 2006, MED SCI SPORT EXER, V38, P1945, DOI 10.1249/01.mss.0000233798.62153.50; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	32	19	21	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69480	10.1371/journal.pone.0069480	http://dx.doi.org/10.1371/journal.pone.0069480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922719	gold, Green Published, Green Submitted			2022-12-25	WOS:000322838900046
J	Friedman-Levi, Y; Mizrahi, M; Frid, K; Binyamin, O; Gabizon, R				Friedman-Levi, Yael; Mizrahi, Michal; Frid, Kati; Binyamin, Orli; Gabizon, Ruth			PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease	PLOS ONE			English	Article							TRANSGENIC MICE; MOUSE MODEL; WILD-TYPE; MUTATION; NEURODEGENERATION; CLASSIFICATION; DEFICITS; ISOFORM	While the conversion of PrPC into PrPSc in the transmissible form of prion disease requires a preexisting PrPSc seed, in genetic prion disease accumulation of disease related PrP could be associated with biochemical and metabolic modifications resulting from the designated PrP mutation. To investigate this possibility, we looked into the time related changes of PrP proteins in the brains of TgMHu2ME199K/wt mice, a line modeling for heterozygous genetic prion disease linked to the E200K PrP mutation. We found that while oligomeric entities of mutant E199KPrP exist at all ages, aggregates of wt PrP in the same brains presented only in advanced disease, indicating a late onset conversion process. We also show that most PK resistant PrP in TgMHu2ME199K mice is soluble and truncated (PrPST), a pathogenic form never before associated with prion disease. We next looked into brain samples from E200K patients and found that both PK resistant PrPs, PrPST as in TgMHu2ME199K mice, and "classical" PrPSc as in infectious prion diseases, coincide in the patient's post mortem brains. We hypothesize that aberrant metabolism of mutant PrPs may result in the formation of previously unknown forms of the prion protein and that these may be central for the fatal outcome of the genetic prion condition.	[Friedman-Levi, Yael; Mizrahi, Michal; Frid, Kati; Binyamin, Orli; Gabizon, Ruth] Hadassah Univ Hosp, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Gabizon, R (corresponding author), Hadassah Univ Hosp, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, IL-91120 Jerusalem, Israel.	gabizonr@hadassah.org.il			ISF foundation	ISF foundation	The work was done by a grant from the ISF foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante EA, 2009, J GEN VIROL, V90, P546, DOI 10.1099/vir.0.007930-0; Ashe KH, 2013, PRION, V7, P55, DOI 10.4161/pri.23061; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Cali I, 2006, BRAIN, V129, P2266, DOI 10.1093/brain/awl224; Canello T, 2012, NEUROBIOL DIS, V45, P1010, DOI 10.1016/j.nbd.2011.12.020; Canello T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000977; Chen SG, 1997, NAT MED, V3, P1009, DOI 10.1038/nm0997-1009; Cohen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054433; Dossena S, 2008, NEURON, V60, P598, DOI 10.1016/j.neuron.2008.09.008; Friedman-Levi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002350; Gabizon R, 1996, NAT MED, V2, P59, DOI 10.1038/nm0196-59; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Harris DA, 2000, ARCH VIROL, P103; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; HSIAO K, 1990, NEUROLOGY, V40, P1820, DOI 10.1212/WNL.40.12.1820; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Jackson WS, 2009, NEURON, V63, P438, DOI 10.1016/j.neuron.2009.07.026; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; KORCZYN AD, 1991, ANN NY ACAD SCI, V640, P171; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Lee HS, 1999, AM J HUM GENET, V64, P1063, DOI 10.1086/302340; Lehmann S, 1996, P NATL ACAD SCI USA, V93, P5610, DOI 10.1073/pnas.93.11.5610; Lesne SE, 2013, BRAIN; Ma QL, 2013, J BIOL CHEM, V288, P4056, DOI 10.1074/jbc.M112.393751; Meiner Z, 2011, J NEUROL, V258, P255, DOI 10.1007/s00415-010-5738-6; Meli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019093; MOHRI S, 1992, VET REC, V131, P537; Monaco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032382; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Rosenmann H, 2001, J NEUROCHEM, V76, P1654, DOI 10.1046/j.1471-4159.2001.00195.x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Simon ES, 2000, ANN NEUROL, V47, P257, DOI 10.1002/1531-8249(200002)47:2<257::AID-ANA20>3.0.CO;2-U; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Varges D, 2013, J NEUROL; Xiao XZ, 2013, AGING-US, V5, P155, DOI 10.18632/aging.100543	41	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69583	10.1371/journal.pone.0069583	http://dx.doi.org/10.1371/journal.pone.0069583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922744	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900057
J	Osselaere, A; Santos, R; Hautekiet, V; De Backer, P; Chiers, K; Ducatelle, R; Croubels, S				Osselaere, Ann; Santos, Regiane; Hautekiet, Veerle; De Backer, Patrick; Chiers, Koen; Ducatelle, Richard; Croubels, Siska			Deoxynivalenol Impairs Hepatic and Intestinal Gene Expression of Selected Oxidative Stress, Tight Junction and Inflammation Proteins in Broiler Chickens, but Addition of an Adsorbing Agent Shifts the Effects to the Distal Parts of the Small Intestine	PLOS ONE			English	Article							T-2 TOXIN; MYCOTOXIN DEOXYNIVALENOL; LIPID-PEROXIDATION; DNA-DAMAGE; FEED; PERFORMANCE; ABSORPTION; EPITHELIUM; HYPOXIA; CELLS	Broiler chickens are rather resistant to deoxynivalenol and thus, clinical signs are rarely seen. However, effects of subclinical concentrations of deoxynivalenol on both the intestine and the liver are less frequently studied at the molecular level. During our study, we investigated the effects of three weeks of feeding deoxynivalenol on the gut wall morphology, intestinal barrier function and inflammation in broiler chickens. In addition, oxidative stress was evaluated in both the liver and intestine. Besides, the effect of a clay-based mycotoxin adsorbing agent on these different aspects was also studied. Our results show that feeding deoxynivalenol affects the gut wall morphology both in duodenum and jejenum of broiler chickens. A qRT-PCR analysis revealed that deoxynivalenol acts in a very specific way on the intestinal barrier, since only an up-regulation in mRNA expression of claudin 5 in jejunum was observed, while no effects were seen on claudin 1, zona occludens 1 and 2. Addition of an adsorbing agent resulted in an up-regulation of all the investigated genes coding for the intestinal barrier in the ileum. Up-regulation of Toll-like receptor 4 and two markers of oxidative stress (heme-oxigenase or HMOX and xanthine oxidoreductase or XOR) were mainly seen in the jejunum and to a lesser extent in the ileum in response to deoxynivalenol, while in combination with an adsorbing agent main effect was seen in the ileum. These results suggest that an adsorbing agent may lead to higher concentrations of deoxynivalenol in the more distal parts of the small intestine. In the liver, XOR was up-regulated due to DON exposure. HMOX and HIF-1 alpha (hypoxia-inducible factor 1 alpha) were down-regulated due to feeding DON but also due to feeding the adsorbing agent alone or in combination with DON.	[Osselaere, Ann; De Backer, Patrick; Croubels, Siska] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium; [Santos, Regiane] Univ Utrecht, Fac Vet Med, Div Toxicol Vet Pharmacol Pharmacotherapy & Toxi, Utrecht, Netherlands; [Hautekiet, Veerle] Sanluc Int NV, Gijzenzele, Belgium; [Chiers, Koen; Ducatelle, Richard] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium	Ghent University; Utrecht University; Ghent University	Osselaere, A (corresponding author), Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium.	ann.osselaere@ugent.be	Santos, Regiane Rodrigues/B-5160-2010; Haesebrouck, Freddy/M-3857-2014	Santos, Regiane Rodrigues/0000-0001-7030-6097; Haesebrouck, Freddy/0000-0002-1709-933X; Croubels, Siska/0000-0001-6357-3517	Ghent University [01J08309]	Ghent University(Ghent University)	This work was supported by the BOF-project 01J08309 from Ghent University. There were no additional external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, REV MYCOTOXIN DETOXI; [Anonymous], 2006, OFFICIAL J EUROPEAN; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Atroshi F, 1997, MOL ASPECTS MED, V18, pS255; Awad WA, 2007, POULTRY SCI, V86, P15, DOI 10.1093/ps/86.1.15; Awad WA, 2006, POULTRY SCI, V85, P974, DOI 10.1093/ps/85.6.974; Awad WA, 2012, POULTRY SCI, V91, P550, DOI 10.3382/ps.2011-01742; Awad W. A., 2008, International Journal of Poultry Science, V7, P827; Awad WA, 2004, POULTRY SCI, V83, P1964, DOI 10.1093/ps/83.12.1964; Awad WA, 2011, INT J MOL SCI, V12, P7996, DOI 10.3390/ijms12117996; Bensassi F, 2009, TOXICOLOGY, V264, P104, DOI 10.1016/j.tox.2009.07.020; Binder EM, 2007, ANIM FEED SCI TECH, V137, P265, DOI 10.1016/j.anifeedsci.2007.06.005; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Carro MD, 2009, POULTRY SCI, V88, P2406, DOI 10.3382/ps.2009-00278; CAST, 2003, MYCOTOXINS RISKS PLA; DeSesso JM, 2001, FOOD CHEM TOXICOL, V39, P209, DOI 10.1016/S0278-6915(00)00136-8; El Golli-Bennour E, 2011, TOXICOLOGY, V287, P1, DOI 10.1016/j.tox.2011.06.002; Eriksen GS, 2004, ANIM FEED SCI TECH, V114, P205, DOI 10.1016/j.anifeedsci.2003.08.008; Frankic T, 2006, FOOD CHEM TOXICOL, V44, P1838, DOI 10.1016/j.fct.2006.06.002; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Giusti S, 2012, J NEUROSCI RES, V90, P468, DOI 10.1002/jnr.22766; Goossens J, 2012, TOXINS, V4, P281, DOI 10.3390/toxins4040281; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Kasuga F, 1998, MYCOPATHOLOGIA, V142, P161, DOI 10.1023/A:1006923808748; Kouadio JH, 2005, TOXICOLOGY, V213, P56, DOI 10.1016/j.tox.2005.05.010; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Leal M, 1999, TOXICOL LETT, V109, P1, DOI 10.1016/S0378-4274(99)00062-4; Lee K, 2007, PHARMACOL THERAPEUT, V113, P229, DOI 10.1016/j.pharmthera.2006.08.001; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; Maresca M, 2008, TOXICOL APPL PHARM, V228, P84, DOI 10.1016/j.taap.2007.11.013; Minervini F, 2005, TOXICOLOGY, V210, P81, DOI 10.1016/j.tox.2005.01.007; Monbaliu S, 2010, J AGR FOOD CHEM, V58, P66, DOI 10.1021/jf903859z; Osselaere A, 2012, POULTRY SCI, V91, P2046, DOI 10.3382/ps.2012-02245; Oswald IP, 2006, VET RES, V37, P359, DOI 10.1051/vetres:2006006; Ozden O, 2010, ANAT REC, V293, P1175, DOI 10.1002/ar.21163; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Reynolds JM, 2012, P NATL ACAD SCI USA, V109, P13064, DOI 10.1073/pnas.1120585109; RIZZO AF, 1994, J VET MED A, V41, P81, DOI 10.1111/j.1439-0442.1994.tb00070.x; Sergent T, 2006, TOXICOL LETT, V164, P167, DOI 10.1016/j.toxlet.2005.12.006; Shan Y, 2004, BBA-GENE STRUCT EXPR, V1679, P87, DOI 10.1016/j.bbaexp.2004.05.003; Sparkenbaugh EM, 2011, J PHARMACOL EXP THER, V338, P492, DOI 10.1124/jpet.111.180521; Streit E, 2012, TOXINS, V4, P788, DOI 10.3390/toxins4100788; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; UENO Y, 1984, FUND APPL TOXICOL, V4, pS124, DOI 10.1016/0272-0590(84)90144-1; Van de Walle J, 2010, TOXICOL APPL PHARM, V245, P291, DOI 10.1016/j.taap.2010.03.012; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; VANDENMUNCKHOF RJM, 1995, HISTOCHEM J, V27, P897; Vila B, 2002, FOOD CHEM TOXICOL, V40, P479, DOI 10.1016/S0278-6915(01)00122-3; Wenger RH, 2000, J EXP BIOL, V203, P1253; Yang H, 2008, TOXICOLOGY, V243, P145, DOI 10.1016/j.tox.2007.10.002; Yunus AW, 2012, POULTRY SCI, V91, P852, DOI 10.3382/ps.2011-01903	55	113	124	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69014	10.1371/journal.pone.0069014	http://dx.doi.org/10.1371/journal.pone.0069014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922676	gold, Green Published, Green Submitted			2022-12-25	WOS:000322838900017
J	Provencal, N; Suderman, MJ; Vitaro, F; Szyf, M; Tremblay, RE				Provencal, Nadine; Suderman, Matthew J.; Vitaro, Frank; Szyf, Moshe; Tremblay, Richard E.			Childhood Chronic Physical Aggression Associates with Adult Cytokine Levels in Plasma	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MAJOR DEPRESSION; STRESS; INTERLEUKIN-6; TRAJECTORIES; IMMUNE; BOYS; PREDICTORS; BEHAVIOR; ABNORMALITIES	Background: An increasing number of animal and human studies are indicating that inflammation is associated with behavioral disorders including aggression. This study investigates the association between chronic physical aggression during childhood and plasma cytokine levels in early adulthood. Methodology/Principal Findings: Two longitudinal studies were used to select males on a chronic physical aggression trajectory from childhood to adolescence (n = 7) and a control group from the same background (n = 25). Physical aggression was assessed yearly by teachers from childhood to adolescence and plasma levels of 10 inflammatory cytokines were assessed at age 26 and 28 years. Compared to the control group, males on a chronic physical aggression trajectory from childhood to adolescence had consistently lower plasma levels of five cytokines: lower pro-inflammatory interleukins IL-1 alpha (T(28.7) = 3.48, P=0.002) and IL-6 (T(26.9) = 3.76, P=0.001), lower anti-inflammatory interleukin IL-4 (T(27.1) = 4.91, P=0.00004) and IL-10 (T(29.8) = 2.84, P=0.008) and lower chemokine IL-8 (T(26) = 3.69, P=0.001). The plasma levels of four cytokines accurately predicted aggressive and control group membership for all subjects. Conclusions/Significance: Physical aggression of boys during childhood is a strong predictor of reduced plasma levels of cytokines in early adulthood. The causal and physiological relations underlying this association should be further investigated since animal data suggest that some cytokines such as IL-6 and IL-1 beta play a causal role in aggression.	[Provencal, Nadine; Suderman, Matthew J.; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Provencal, Nadine; Vitaro, Frank; Tremblay, Richard E.] Univ Montreal, Res Unit Childrens Psychosocial Maladjustment, Montreal, PQ, Canada; [Provencal, Nadine; Vitaro, Frank; Tremblay, Richard E.] Univ Montreal, Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Provencal, Nadine; Suderman, Matthew J.; Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol & Pediat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland; [Suderman, Matthew J.] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Vitaro, Frank] Univ Montreal, Sch Psychoeduc, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; University College Dublin; McGill University; Universite de Montreal	Szyf, M (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	moshe.szyf@mcgill.ca; richard.tremblay@ucd.ie	Tremblay, Richard E./O-1360-2014	Provencal, Nadine/0000-0002-2079-8393; Suderman, Matthew/0000-0002-2715-9930	Genes, Environment and Health Training Program from Canadian Institutes of Health Research (CIHR); Canadian Institutes of Health Research; Social Sciences Humanities Research Council of Canada; Quebec Health Research Fund (FRSQ); Quebec Social Science and Culture Fund (FQRSC); Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research	Genes, Environment and Health Training Program from Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Quebec Health Research Fund (FRSQ)(Fonds de la Recherche en Sante du Quebec); Quebec Social Science and Culture Fund (FQRSC); Sackler Program in Psychobiology and Epigenetics at McGill University; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	This work was supported by a fellowship from the Genes, Environment and Health Training Program from Canadian Institutes of Health Research (CIHR) to NP, grants from the Canadian Institutes of Health Research, the Social Sciences Humanities Research Council of Canada, the Quebec Health Research Fund (FRSQ) and the Quebec Social Science and Culture Fund (FQRSC) to RET, grants from the Canadian Institutes of Health Research, the Sackler Program in Psychobiology and Epigenetics at McGill University and from the Canadian Institute for Advanced Research to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; Alleva E, 1998, EUR J NEUROSCI, V10, P3664, DOI 10.1046/j.1460-9568.1998.00377.x; Barker ED, 2008, ARCH GEN PSYCHIAT, V65, P1185, DOI 10.1001/archpsyc.65.10.1185; Barker ED, 2007, ARCH GEN PSYCHIAT, V64, P592, DOI 10.1001/archpsyc.64.5.592; Barkhudaryan N, 1999, NEUROCHEM RES, V24, P1169, DOI 10.1023/A:1020720722209; Bauer ME, 2010, NEUROIMMUNOMODULAT, V17, P192, DOI 10.1159/000258721; Brebner K, 2000, NEUROPSYCHOPHARMACOL, V22, P566, DOI 10.1016/S0893-133X(99)00166-9; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Campbell SB, 2006, J CHILD PSYCHOL PSYC, V47, P791, DOI 10.1111/j.1469-7610.2006.01636.x; Campbell SB, 2010, DEV PSYCHOPATHOL, V22, P133, DOI 10.1017/S0954579409990319; Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014; Carpenter LL, 2010, NEUROPSYCHOPHARMACOL, V35, P2617, DOI 10.1038/npp.2010.159; Chen E, 2006, J ALLERGY CLIN IMMUN, V117, P1014, DOI 10.1016/j.jaci.2006.01.036; Chida Y, 2007, AM J RESP CRIT CARE, V175, P316, DOI 10.1164/rccm.200607-898OC; Cirulli F, 1998, BRAIN RES, V791, P308, DOI 10.1016/S0006-8993(98)00137-1; Cote SM, 2007, ARCH GEN PSYCHIAT, V64, P1305, DOI 10.1001/archpsyc.64.11.1305; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; Dimitrov S, 2004, BRAIN BEHAV IMMUN, V18, P341, DOI 10.1016/j.bbi.2003.08.004; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Elenkov IJ, 2008, NEUROCHEM INT, V52, P40, DOI 10.1016/j.neuint.2007.06.037; Ferris Craig, 2005, Novartis Foundation Symposium, V268, P190; Granger DA, 2001, DEV PSYCHOPATHOL, V13, P599, DOI 10.1017/S0954579401003108; Groer MW, 2007, PSYCHONEUROENDOCRINO, V32, P133, DOI 10.1016/j.psyneuen.2006.11.007; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; HOLLIDAY MR, 1994, IMMUNOLOGY, V82, P70; Huang Ruo-Pan, 2004, Methods Mol Biol, V264, P215; Janelidze S, 2011, BRAIN BEHAV IMMUN, V25, P335, DOI 10.1016/j.bbi.2010.10.010; Kawamura A, 2001, JPN CIRC J, V65, P858, DOI 10.1253/jcj.65.858; Kokko K, 2000, DEV PSYCHOL, V36, P463, DOI 10.1037/0012-1649.36.4.463; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Marsland AL, 2008, BRAIN BEHAV IMMUN, V22, P753, DOI 10.1016/j.bbi.2007.11.008; Misener VL, 2008, NEUROPSYCHOBIOLOGY, V58, P71, DOI 10.1159/000159775; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin DS, 2001, ARCH GEN PSYCHIAT, V58, P389, DOI 10.1001/archpsyc.58.4.389; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; O'Brien SM, 2004, HUM PSYCHOPHARM CLIN, V19, P397, DOI 10.1002/hup.609; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; PETITTO JM, 1994, BRAIN BEHAV IMMUN, V8, P111, DOI 10.1006/brbi.1994.1011; Petrovsky N, 1998, Int Rev Immunol, V16, P635, DOI 10.3109/08830189809043012; Pingault JB, 2011, AM J PSYCHIAT; R Development Core Team, 2007, R LANG ENV STAT COMP; Romano E, 2001, J CHILD PSYCHOL PSYC, V42, P451, DOI 10.1111/1469-7610.00739; Seguin JR, 2004, J ABNORM PSYCHOL, V113, P603, DOI 10.1037/0021-843X.113.4.603; SEGUIN JR, 1995, J ABNORM PSYCHOL, V104, P614, DOI 10.1037/0021-843X.104.4.614; Shibasaki T, 1998, BRAIN RES, V808, P84, DOI 10.1016/S0006-8993(98)00843-9; Siegel A, 2007, CURR NEUROPHARMACOL, V5, P135, DOI 10.2174/157015907780866929; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; Socha LA, 2006, INTENS CARE MED, V32, P244, DOI 10.1007/s00134-005-0020-6; SOTHERN RB, 1995, J ALLERGY CLIN IMMUN, V95, P1029, DOI 10.1016/S0091-6749(95)70104-4; Suarez EC, 2002, BRAIN BEHAV IMMUN, V16, P675, DOI 10.1016/S0889-1591(02)00019-3; TREMBLAY RE, 1991, J ABNORM CHILD PSYCH, V19, P285, DOI 10.1007/BF00911232; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; Tremblay RE, 2010, J CHILD PSYCHOL PSYC, V51, P341, DOI 10.1111/j.1469-7610.2010.02211.x; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; van Bokhoven I, 2005, J NEURAL TRANSM, V112, P1083, DOI 10.1007/s00702-004-0253-5; Vgontzas AN, 2002, METABOLISM, V51, P887, DOI 10.1053/meta.2002.33357; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; Zalcman SS, 2006, BRAIN BEHAV IMMUN, V20, P507, DOI 10.1016/j.bbi.2006.05.002; Zhao LX, 2004, J NEUROSCI, V24, P2226, DOI 10.1523/JNEUROSCI.4922-03.2004; Zwillinger D., 2000, CRC STANDARD PROBABI, DOI 10.1201/b16923	62	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69481	10.1371/journal.pone.0069481	http://dx.doi.org/10.1371/journal.pone.0069481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922720	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900047
J	Gilles, A; Van Hal, G; De Ridder, D; Wouters, K; Van de Heyning, P				Gilles, Annick; Van Hal, Guido; De Ridder, Dirk; Wouters, Kristien; Van de Heyning, Paul			Epidemiology of Noise-Induced Tinnitus and the Attitudes and Beliefs towards Noise and Hearing Protection in Adolescents	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; LOUD MUSIC; UNIVERSITY-STUDENTS; LISTENING DEVICES; THRESHOLD SHIFTS; AMPLIFIED MUSIC; YOUNG-ADULTS; MP3 PLAYERS; CHILDREN 6	Background and objectives: Previous research showed an increase of noise-induced symptoms in adolescents. Permanent tinnitus as a consequence of loud music exposure is usually considered as noise-induced damage. The objective was to perform an epidemiological study in order to obtain prevalence data of permanent noise-induced tinnitus as well as temporary tinnitus following noise exposure in a young population. In addition the attitudes and beliefs towards noise and hearing protection were evaluated in order to explain the use/non-use of hearing protection in a young population. Methods: A questionnaire was completed by 3892 high school students (mean age: 16.64 years old, SD: 1.29 years). The prevalence of temporary and permanent tinnitus was assessed. In addition the 'Youth Attitudes to Noise Scale' and the 'Beliefs About Hearing Protection and Hearing Loss' were used in order to assess the attitudes and beliefs towards noise and hearing protection respectively. Results: The prevalence of temporary noise-induced tinnitus and permanent tinnitus in high school students was respectively 74.9% and 18.3%. An increasing prevalence of temporary tinnitus with age was present. Most students had a 'neutral attitude' towards loud music and the use of hearing protection was minimal (4.7%). The limited use of hearing protection is explained by a logistic regression analysis showing the relations between certain parameters and the use of hearing protection. Conclusions: Despite the very high prevalence of tinnitus in such a young population, the rate of hearing protection use and the knowledge about the risks of loud music is extremely low. Future preventive campaigns should focus more on tinnitus as a warning signal for noise-induced damage and emphasize that also temporary symptoms can result in permanent noise-induced damage.	[Gilles, Annick; Van de Heyning, Paul] Univ Antwerp Hosp, Univ Dept Otorhinolaryngol & Head & Neck Surg, Edegem, Belgium; [Gilles, Annick; Van de Heyning, Paul] Univ Antwerp, Fac Med, Antwerp, Belgium; [Van Hal, Guido] Univ Antwerp, Dept Epidemiol & Social Med, Antwerp, Belgium; [Gilles, Annick; Van de Heyning, Paul] Univ Antwerp Hosp, Tinnitus Res Initiat Ctr TRI, Edegem, Belgium; [De Ridder, Dirk] Univ Otago, Dunedin Sch Med, Dept Surg Sci, Christchurch, New Zealand; [Wouters, Kristien] Univ Antwerp Hosp, Dept Med Management, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Otago; University of Antwerp	Gilles, A (corresponding author), Univ Antwerp Hosp, Univ Dept Otorhinolaryngol & Head & Neck Surg, Edegem, Belgium.	annick.gilles@uza.be	Heyning, Paul H Vande/I-8278-2017; Wouters, Kristien/ADM-4146-2022; Van Hal, Guido F/B-5948-2017	Heyning, Paul H Vande/0000-0002-8424-3717; Van Hal, Guido F/0000-0002-4611-4076; Gilles, Annick/0000-0003-3669-6428	Stavros Niarchos Foundation; TOP-BOF mandate of the University Antwerp	Stavros Niarchos Foundation; TOP-BOF mandate of the University Antwerp	The research on noise-induced tinnitus in young adults was financially supported by the Stavros Niarchos Foundation and a TOP-BOF mandate of the University Antwerp. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 1980, UNDERSTANDING ATITTU; Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995; Bohlin MC, 2011, NOISE HEALTH, V13, P310, DOI 10.4103/1463-1741.82964; Chung JH, 2005, PEDIATRICS, V115, P861, DOI 10.1542/peds.2004-0173; Crandell C, 2004, J NATL MED ASSOC, V96, P176; Dalton DS, 2001, AUDIOLOGY, V40, P1; Daniel E, 2007, J SCHOOL HEALTH, V77, P225, DOI 10.1111/j.1746-1561.2007.00197.x; Davis A. C., 1998, Noise Health, V1, P40; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Fligor BJ, 2009, NOISE HEALTH, V11, P129, DOI 10.4103/1463-1741.53356; Zocoli AMF, 2009, INT J AUDIOL, V48, P692, DOI 10.1080/14992020902971331; Gilles A, 2012, OTOL NEUROTOL, V33, P899, DOI 10.1097/MAO.0b013e31825d640a; Henderson E, 2011, PEDIATRICS, V127, pE39, DOI 10.1542/peds.2010-0926; ISING H, 1994, HNO, V42, P465; Jokitulppo JS, 1997, SCAND AUDIOL, V26, P257, DOI 10.3109/01050399709048017; Keppler H, 2010, THESIS U GHENT; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Maassen M., 2001, Noise Health, V4, P1; McNeill K, 2010, J ACOUST SOC AM, V128, P646, DOI 10.1121/1.3458853; Mercier Vlasta, 2002, Noise Health, V4, P47; MeyerBisch C, 1996, AUDIOLOGY, V35, P121; National Institute for Occupational Safety and Health, 1998, DHHS NIOSH PUBL, V98-126; Niskar AS, 1998, JAMA-J AM MED ASSOC, V279, P1071, DOI 10.1001/jama.279.14.1071; Niskar AS, 2001, PEDIATRICS, V108, P40, DOI 10.1542/peds.108.1.40; Portnuff CDF, 2011, J AM ACAD AUDIOL, V22, P663, DOI 10.3766/jaaa.22.10.5; Potier M, 2009, EAR HEARING, V30, P291, DOI 10.1097/AUD.0b013e31819769fc; Quintanilla-Dieck MD, 2009, J PEDIATR-US, V155, P550, DOI 10.1016/j.jpeds.2009.04.053; Sadhra S, 2002, ANN OCCUP HYG, V46, P455, DOI 10.1093/annhyg/mef051; Serra MR, 2005, INT J AUDIOL, V44, P65, DOI 10.1080/14992020400030010; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Smith PA, 2000, NOISE HEALTH, V2, P41; Svensson EB, 2004, INT J AUDIOL, V43, P585, DOI 10.1080/14992020400050075; Vogel I, 2008, J PEDIATR-US, V152, P400, DOI 10.1016/j.jpeds.2007.07.009; Vogel I, 2007, AM J PREV MED, V33, P124, DOI 10.1016/j.amepre.2007.03.016; Vogel I, 2009, PEDIATRICS, V123, pE953, DOI 10.1542/peds.2008-3179; Weichbold V, 2003, INT J AUDIOL, V42, P489, DOI 10.3109/14992020309081519; Weichbold V, 2007, INT J AUDIOL, V46, P128, DOI 10.1080/14992020601126849; Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003; Widen SE, 2006, INT J AUDIOL, V45, P273, DOI 10.1080/14992020500485676; Widen SE, 2009, INT J AUDIOL, V48, P537, DOI 10.1080/14992020902894541; Widen S E Olsen, 2004, Noise Health, V7, P29; Widen SE, 2013, INT J AUDIOL, V52, P57, DOI 10.3109/14992027.2012.728724	43	66	68	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70297	10.1371/journal.pone.0070297	http://dx.doi.org/10.1371/journal.pone.0070297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894638	gold, Green Published			2022-12-25	WOS:000322167900117
J	Porter, JL; Tobias, NJ; Pidot, SJ; Falgner, S; Tuck, KL; Vettiger, A; Hong, H; Leadlay, PF; Stinear, TP				Porter, Jessica L.; Tobias, Nicholas J.; Pidot, Sacha J.; Falgner, Steffen; Tuck, Kellie L.; Vettiger, Andrea; Hong, Hui; Leadlay, Peter F.; Stinear, Timothy P.			The Cell Wall-Associated Mycolactone Polyketide Synthases Are Necessary but Not Sufficient for Mycolactone Biosynthesis	PLOS ONE			English	Article							MYCOBACTERIUM-ULCERANS; BURULI ULCER; TOXIN MYCOLACTONE; CLINICAL ISOLATE; CARRIER PROTEIN; MACROLIDE TOXIN; VIRULENCE; EXPRESSION; RECOMBINATION; HETEROGENEITY	Mycolactones are polyketide-derived lipid virulence factors made by the slow-growing human pathogen, Mycobacterium ulcerans. Three unusually large and homologous plasmid-borne genes (mlsA1: 51 kb, mlsB: 42 kb and mlsA2: 7 kb) encode the mycolactone type I polyketide synthases (PKS). The extreme size and low sequence diversity of these genes has posed significant barriers for exploration of the genetic and biochemical basis of mycolactone synthesis. Here, we have developed a truncated, more tractable 3-module version of the 18-module mycolactone PKS and we show that this engineered PKS functions as expected in the natural host M. ulcerans to produce an additional polyketide; a triketide lactone (TKL). Cell fractionation experiments indicated that this 3-module PKS and the putative accessory enzymes encoded by mup045 and mup038 associated with the mycobacterial cell wall, a finding supported by confocal microscopy. We then assessed the capacity of the faster growing, Mycobacterium marinum to harbor and express the 3-module Mls PKS and accessory enzymes encoded by mup045 and mup038. RT-PCR, immunoblotting, and cell fractionation experiments confirmed that the truncated Mls PKS multienzymes were expressed and also partitioned with the cell wall material in M. marinum. However, this heterologous host failed to produce TKL. The systematic deconstruction of the mycolactone PKS presented here suggests that the Mls multienzymes are necessary but not sufficient for mycolactone synthesis and that synthesis is likely to occur (at least in part) within the mycobacterial cell wall. This research is also the first proof-of-principle demonstration of the potential of this enzyme complex to produce tailored small molecules through genetically engineered rearrangements of the Mls modules.	[Porter, Jessica L.; Tobias, Nicholas J.; Pidot, Sacha J.; Falgner, Steffen; Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Hong, Hui; Leadlay, Peter F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Tuck, Kellie L.] Monash Univ, Sch Chem, Clayton, Vic, Australia; [Tobias, Nicholas J.; Stinear, Timothy P.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Vettiger, Andrea] Swiss Trop & Publ Hlth Inst, Mol Immunol Unit, Basel, Switzerland; [Vettiger, Andrea] Univ Basel, Basel, Switzerland	University of Melbourne; University of Cambridge; Monash University; Monash University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Stinear, TP (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	tstinear@unimelb.edu.au	Tuck, Kellie/AAV-2596-2020; Pidot, Sacha/Y-3421-2018	Tuck, Kellie/0000-0002-9104-3158; Pidot, Sacha/0000-0003-1202-6614; Vettiger, Andrea/0000-0002-1245-0987; Leadlay, Peter/0000-0002-3247-509X; Stinear, Timothy/0000-0003-0150-123X; Tobias, Nicholas/0000-0003-2725-3043	Australian Research Council [DP110101577]	Australian Research Council(Australian Research Council)	The research was supported by the Australian Research Council (DP110101577). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulkroun S, 2010, J IMMUNOL, V184, P1436, DOI 10.4049/jimmunol.0902854; Coutanceau E, 2005, CELL MICROBIOL, V7, P1187, DOI 10.1111/j.1462-5822.2005.00546.x; Coutanceau E, 2007, J EXP MED, V204, P1395, DOI 10.1084/jem.20070234; Doig KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-258; Fidanze S, 2001, J AM CHEM SOC, V123, P10117, DOI 10.1021/ja011824z; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Guenin-Mace L, 2013, J CLIN INVEST, V123, P1501, DOI 10.1172/JCI66576; Guo X, 2012, BIOCHEMISTRY-US, V51, P879, DOI 10.1021/bi201768v; Hong H, 2003, CHEM COMMUN, P2822, DOI 10.1039/b308163j; Hong H, 2005, CHEM COMMUN, P4306, DOI 10.1039/b506835e; Hong H, 2005, CHEMBIOCHEM, V6, P643, DOI 10.1002/cbic.200400339; Hong H, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000325; Hong H, 2008, NAT PROD REP, V25, P447, DOI 10.1039/b803101k; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Judd TC, 2004, ORG LETT, V6, P4901, DOI 10.1021/ol0479996; Kim HJ, 2008, J AM CHEM SOC, V130, P1842, DOI 10.1021/ja7111838; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Mve-Obiang A, 2005, INFECT IMMUN, V73, P3307, DOI 10.1128/IAI.73.6.3307-3312.2005; Mve-Obiang A, 2003, INFECT IMMUN, V71, P774, DOI 10.1128/IAI.71.2.774-783.2003; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; Phillips R, 2009, J INFECT DIS, V200, P1675, DOI 10.1086/646615; Pidot SJ, 2010, MOL MICROBIOL, V78, P1216, DOI 10.1111/j.1365-2958.2010.07401.x; Pidot SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-462; Pidot SJ, 2010, PLOS NEGL TROP DIS, V4; Porter JL, 2009, MICROBIOL-SGM, V155, P1923, DOI 10.1099/mic.0.027029-0; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Ramakrishnan L, 1997, J BACTERIOL, V179, P5862, DOI 10.1128/jb.179.18.5862-5868.1997; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Simmonds RE, 2009, J IMMUNOL, V182, P2194, DOI 10.4049/jimmunol.0802294; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Stinear TP, 2005, MICROBIOL-SGM, V151, P683, DOI 10.1099/mic.0.27674-0; Stinear TP, 2005, J BACTERIOL, V187, P1668, DOI 10.1128/JB.187.5.1668-1676.2005; Stragier P, 2008, FEMS MICROBIOL LETT, V286, P93, DOI 10.1111/j.1574-6968.2008.01264.x; Tafelmeyer P, 2008, PROTEOMICS, V8, P3124, DOI 10.1002/pmic.200701018; Tobias NJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000553; Weissman KJ, 2009, METHOD ENZYMOL, V459, P3, DOI 10.1016/S0076-6879(09)04601-1; Xu XP, 2008, FEMS MICROBIOL LETT, V287, P15, DOI 10.1111/j.1574-6968.2008.01289.x	38	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70520	10.1371/journal.pone.0070520	http://dx.doi.org/10.1371/journal.pone.0070520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894666	gold, Green Published, Green Submitted			2022-12-25	WOS:000325211000214
J	Ariza, ME; Rivailler, P; Glaser, R; Chen, M; Williams, MV				Ariza, Maria Eugenia; Rivailler, Pierre; Glaser, Ronald; Chen, Min; Williams, Marshall V.			Epstein-Barr Virus Encoded dUTPase Containing Exosomes Modulate Innate and Adaptive Immune Responses in Human Dendritic Cells and Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							EPITHELIAL-CELLS; VIRAL-INFECTION; HUMAN MONOCYTES; EBV; EXPRESSION; RECOGNITION; LYMPHOMA; PYROPHOSPHATASE; MACROPHAGES; ACTIVATION	We have recently demonstrated that Epstein-Barr virus (EBV)-encoded deoxyuridine triphosphate nucleotidohydrolase (dUTPase) modulates innate immunity in human primary monocyte-derived macrophages through toll-like receptor (TLR) 2 leading to NF-kappa B activation and the production of pro-inflammatory cytokines. Our previous depletion studies indicated that dendritic cells (DCs) may also be a target of the EBV-encoded dUTPase. However, the role of EBV-encoded dUTPase in DC activation/function and its potential contribution to the inflammatory cellular milieu characteristic of EBV-associated diseases remains poorly understood. In the present study, we demonstrate that EBV-encoded dUTPase significantly altered the expression of genes involved in oncogenesis, inflammation and viral defense mechanisms in human primary DCs by microarray analysis. Proteome array studies revealed that EBV-encoded dUTPase modulates DC immune responses by inducing the secretion of pro-inflammatory T(H)1/T(H)17 cytokines. More importantly, we demonstrate that EBV-encoded dUTPase is secreted in exosomes from chemically induced Raji cells at sufficient levels to induce NF-kappa B activation and cytokine secretion in primary DCs and peripheral blood mononuclear cells (PBMCs). Interestingly, the production of pro-inflammatory cytokines in DCs and PBMCs was TLR2-dependent. Together these findings suggest that the EBV-encoded dUTPase may act as an intercellular signaling molecule capable of modulating the cellular microenvironment and thus, it may be important in the pathophysiology of EBV related diseases.	[Ariza, Maria Eugenia; Glaser, Ronald; Williams, Marshall V.] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Ariza, Maria Eugenia; Glaser, Ronald; Chen, Min; Williams, Marshall V.] Ohio State Univ, Coll Med, Inst Behav Med Res, Columbus, OH 43210 USA; [Rivailler, Pierre] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Glaser, Ronald; Williams, Marshall V.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Ariza, ME (corresponding author), Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	maria.ariza@osumc.edu			National Psoriasis Foundation; National Institutes of Health [R01 A1084898]; Ohio State University Comprehensive Cancer Center [CA10658]; NCI; Gilbert and Kathryn Mitchell Endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084898] Funding Source: NIH RePORTER	National Psoriasis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Comprehensive Cancer Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gilbert and Kathryn Mitchell Endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Psoriasis Foundation (to M.E.A.), the National Institutes of Health R01 A1084898 (to R.G.) and The Ohio State University Comprehensive Cancer Center CA10658 (NCI and the Gilbert and Kathryn Mitchell Endowment (to R.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Tabaa Y, 2011, J CLIN VIROL, V52, P33, DOI 10.1016/j.jcv.2011.05.023; Al Tabaa Y, 2009, BLOOD, V113, P604, DOI 10.1182/blood-2008-02-136903; Almohmeed YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061110; Anand Paras K, 2010, Commun Integr Biol, V3, P405, DOI 10.4161/cib.3.5.12474; Anand PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010136; Angelini DF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003220; Argraves GL, 2005, BMC BIOINFORMATICS, P6; Ariza ME, 2011, J INVEST DERMATOL, V131, P2419, DOI 10.1038/jid.2011.217; Ayehunie S, 2003, MATTEK CORPORATION T, V322; Balandraud N, 2004, AUTOIMMUN REV, V3, P362, DOI 10.1016/j.autrev.2004.02.002; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Baumforth KRN, 2008, AM J PATHOL, V173, P195, DOI 10.2353/ajpath.2008.070845; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Braz-Silva PH, 2011, INT J CANCER, V128, P2501, DOI 10.1002/ijc.25597; Bu HF, 2010, J CELL PHYSIOL, V222, P658, DOI 10.1002/jcp.21985; Buschow SI, 2010, IMMUNOL CELL BIOL, V88, P851, DOI 10.1038/icb.2010.64; Chung SH, 2007, J VIROL, V81, P4787, DOI 10.1128/JVI.02855-06; Costenbader KH, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1893; Draborg AH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/370516; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Fiola S, 2010, J IMMUNOL, V185, P3620, DOI 10.4049/jimmunol.0903736; Fleischmann J, 2002, J MED VIROL, V68, P568, DOI 10.1002/jmv.10234; Gaudreault E, 2007, J VIROL, V81, P8016, DOI 10.1128/JVI.00403-07; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Glaser R, 2006, VIROLOGY, V346, P205, DOI 10.1016/j.virol.2005.10.034; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Isobe Y, 2004, CANCER RES, V64, P2167, DOI 10.1158/0008-5472.CAN-03-1562; Jefferies C, 2011, NAT REV IMMUNOL, V11, P617, DOI 10.1038/nri3043; Jenson HB, 1998, CLIN DIAGN LAB IMMUN, V5, P91, DOI 10.1128/CDLI.5.1.91-97.1998; Kanegane H, 1998, BLOOD, V91, P2085, DOI 10.1182/blood.V91.6.2085.2085_2085_2091; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Keryer-Bibens C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-283; Kimura H, 2005, J INFECT DIS, V191, P531, DOI 10.1086/427239; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Larochelle B, 1998, BLOOD, V92, P291, DOI 10.1182/blood.V92.1.291.413k34_291_299; Larsen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002328; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Lerner AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047891; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li LQ, 2002, BLOOD, V99, P3725, DOI 10.1182/blood.V99.10.3725; Lim WH, 2007, BLOOD, V109, P1043, DOI 10.1182/blood-2005-12-024802; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McLellan AD, 2009, CRIT REV IMMUNOL, V29, P203, DOI 10.1615/CritRevImmunol.v29.i3.20; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Nicholls JM, 1998, LAB INVEST, V78, P1031; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pender MP, 2009, AUTOIMMUN REV, V8, P563, DOI 10.1016/j.autrev.2009.01.017; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Punj V, 2009, BLOOD, V113, P5660, DOI 10.1182/blood-2008-10-186403; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Ressing ME, 2008, SEMIN CANCER BIOL, V18, P397, DOI 10.1016/j.semcancer.2008.10.008; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Savard M, 2000, J VIROL, V74, P2612, DOI 10.1128/JVI.74.6.2612-2619.2000; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shannon-Lowe C, 2009, J VIROL, V83, P7749, DOI 10.1128/JVI.00108-09; Singh PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018564; Summers KL, 2001, AM J PATHOL, V159, P285, DOI 10.1016/S0002-9440(10)61694-X; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Vallhov H, 2011, J IMMUNOL, V186, P73, DOI 10.4049/jimmunol.1001145; van Gent M, 2011, J IMMUNOL, V186, P1694, DOI 10.4049/jimmunol.0903120; Waldman WJ, 2008, BRAIN BEHAV IMMUN, V22, P215, DOI 10.1016/j.bbi.2007.07.007; Walling DM, 2007, J VIROL, V81, P7249, DOI 10.1128/JVI.02754-06; Wang JJ, 2012, BRAZ J INFECT DIS, V16, P19, DOI 10.1590/S1413-86702012000100004; Weiss RS, 1997, J VIROL, V71, P1857, DOI 10.1128/JVI.71.3.1857-1870.1997; WILLIAMS MV, 1985, VIROLOGY, V142, P326, DOI 10.1016/0042-6822(85)90341-1; Wu MP, 2006, PROTEOMICS, V6, P3001, DOI 10.1002/pmic.200500767; WU Z, 2003, DEP BIOSTATISTICS WO; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006; Zhang HG, 2011, CLIN CANCER RES, V17, P959, DOI 10.1158/1078-0432.CCR-10-1489; Zhang Y, 2006, BRIT J CANCER, V94, P599, DOI 10.1038/sj.bjc.6602968	80	54	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69827	10.1371/journal.pone.0069827	http://dx.doi.org/10.1371/journal.pone.0069827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894549	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100082
J	Hao, EK; Lang, FF; Chen, Y; Zhang, HL; Cong, X; Shen, XQ; Su, GH				Hao, Enkui; Lang, Fangfang; Chen, Yong; Zhang, Huilin; Cong, Xiao; Shen, Xiaoqian; Su, Guohai			Resveratrol Alleviates Endotoxin-Induced Myocardial Toxicity via the Nrf2 Transcription Factor	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; CARDIAC-SPECIFIC OVEREXPRESSION; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TNF-ALPHA; PROTECTS CARDIOMYOCYTES; REPERFUSION INJURY; SIGNALING PATHWAY; INDUCED APOPTOSIS; HEART-FAILURE	Background/Aims: Septic cardiomyopathy is a severe condition that remains a challenge for clinical management. This study investigated whether the natural polyphenolic compound resveratrol could be used as a prophylactic treatment to alleviate sepsis-related myocardial injury; the underlying molecular mechanisms were deciphered by both in vitro and in vivo experiments. Methods: A mouse model of endotoxin-induced cardiomyopathy was developed by intraperitoneal injection of LPS, and resveratrol was administered prophylatically to the animals. Serum LDH and CK activities were measured to detect myocardial injury, and echocardiography was performed to monitor cardiac structure and function. Various cytokines/chemokines and the Nrf2 antioxidant defense system were examined in the heart tissue. The effects of resveratrol on LPS-induced Nrf2 activation, ROS generation, and apoptotic cell death were further investigated in cultured primary human cardiomyocytes. An Nrf2 specific siRNA was used to define its role in resveratrol-mediated cardiomyocyte protective effect. Results: Resveratrol pretreatment significantly attenuated LPS-induced myocardial injury in mice, which was associated with suppressed proinflammatory cytokine production and enhanced Nrf2 activation in the heart. In cultured primary human cardiomyocytes, resveratrol activated Nrf2, inhibited LPS-induced ROS generation, and effectively protected the cells from LPS-induced apoptotic cell death. Knockdown of Nrf2 abrogated resveratrol-mediated protection of the cells from LPS-induced cell death. Conclusion: Resveratrol effectively alleviates endotoxin-induced cardiac toxicity through mechanisms that involve the Nrf2 antioxidant defense pathway. Our data suggest that resveratrol might be developed as a useful prophylactic management for septic cardiomyopathy.	[Hao, Enkui; Cong, Xiao; Shen, Xiaoqian; Su, Guohai] Shandong Univ, Jinan Cent Hosp, Dept Cardiol, Jinan 250100, Peoples R China; [Lang, Fangfang] Shandong Univ, Jinan Cent Hosp, Dept Obstet & Gynecol, Jinan 250100, Peoples R China; [Chen, Yong] Peoples Hosp Rizhao, Dept Pharm, Rizhao, Peoples R China; [Zhang, Huilin] Shandong Univ, Jinan Cent Hosp, Cent Lab, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Su, GH (corresponding author), Shandong Univ, Jinan Cent Hosp, Dept Cardiol, Jinan 250100, Peoples R China.	luckhaonk@gmail.com			promotive research fund for young and middle-aged scientists of Shandong Province [07-21]	promotive research fund for young and middle-aged scientists of Shandong Province	This study was supported by the promotive research fund for young and middle-aged scientists of Shandong Province (Grant No. 07-21, EH, GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Aukrust P, 2004, AUTOIMMUN REV, V3, P221, DOI 10.1016/S1568-9972(03)00103-4; Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Chagnon F, 2005, CIRC RES, V96, P1095, DOI 10.1161/01.RES.0000168327.22888.4d; Chatterjee Kanu, 2002, Am J Cardiovasc Drugs, V2, P1, DOI 10.2165/00129784-200202010-00001; Chen CJ, 2009, BIOCHEM BIOPH RES CO, V378, P389, DOI 10.1016/j.bbrc.2008.11.110; Chen Jian, 2004, Chin J Traumatol, V7, P113; Chua D, 2007, ANN PHARMACOTHER, V41, P647, DOI 10.1345/aph.1H550; Comstock KL, 1998, J MOL CELL CARDIOL, V30, P2761, DOI 10.1006/jmcc.1998.0851; Du J, 2012, PATHOL RES PRACT, V208, P82, DOI 10.1016/j.prp.2011.11.008; Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; Gu J, 2012, CARDIOVASC TOXICOL, V12, P341, DOI 10.1007/s12012-012-9178-7; Hall G, 2005, AM J PHYSIOL-HEART C, V289, pH2103, DOI 10.1152/ajpheart.00393.2005; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2003, SCAND J INFECT DIS, V35, P585, DOI 10.1080/00365540310015692; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hu YY, 2009, IMMUNOPHARM IMMUNOT, V31, P550, DOI 10.3109/08923970902814129; Isoyama Shogen, 2002, Heart Fail Rev, V7, P63; Jardin F, 1998, INTENS CARE MED, V24, P990, DOI 10.1007/PL00012691; Jiang SJ, 2012, MICROCIRCULATION; Kamoun WS, 2006, HEPATOLOGY, V43, P182, DOI 10.1002/hep.20940; KAWANO H, 1994, JPN HEART J, V35, P745; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kimura Y, 2001, J NUTR, V131, P1844, DOI 10.1093/jn/131.6.1844; Klouche K, 2002, J NEPHROL, V15, P150; Kroon PA, 2010, CURR MED CHEM, V17, P2442; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lanzilli G, 2012, INFLAMMATION, V35, P240, DOI 10.1007/s10753-011-9310-z; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Magyar K, 2012, CLIN HEMORHEOL MICRO, V50, P179, DOI 10.3233/CH-2011-1424; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; Mann Giovanni E., 2007, Shengli Xuebao, V59, P117; Matsuno K, 2012, FREE RADICAL BIO MED, V53, P1718, DOI 10.1016/j.freeradbiomed.2012.08.590; McCarty MF, 2010, MED HYPOTHESES, V75, P141, DOI 10.1016/j.mehy.2009.12.025; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; Panaro MA, 2010, CURR PHARM DESIGN, V16, P766, DOI 10.2174/138161210790883624; Panaro M, 2011, CARDIOVASC TOXICOL, V11, P347, DOI 10.1007/s12012-011-9127-x; Panaro MA, 2010, CURR PHARM DESIGN, V16, P754, DOI 10.2174/138161210790883516; PARKER MM, 1990, CHEST, V97, P126, DOI 10.1378/chest.97.1.126; Reinhart K, 2012, CLIN MICROBIOL REV, V25, P609, DOI 10.1128/CMR.00016-12; Rezk BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030276; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Samuel SM, 2008, J AGR FOOD CHEM, V56, P9692, DOI 10.1021/jf802050h; Sundaresan NR, 2011, J MOL CELL CARDIOL, V51, P614, DOI 10.1016/j.yjmcc.2011.01.008; Tantini B, 2002, FEBS LETT, V512, P75, DOI 10.1016/S0014-5793(02)02222-6; Tracey K J, 1988, Prog Clin Biol Res, V272, P77; Turan B, 2012, J BIOENERG BIOMEMBR, V44, P281, DOI 10.1007/s10863-012-9429-0; Turdi S, 2012, FREE RADICAL BIO MED, V53, P1327, DOI 10.1016/j.freeradbiomed.2012.07.084; Ungvari Z, 2011, EXERC SPORT SCI REV, V39, P128, DOI 10.1097/JES.0b013e3182141f80; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Venardos KM, 2007, CURR MED CHEM, V14, P1539, DOI 10.2174/092986707780831078; WAISBREN BA, 1951, ARCH INTERN MED, V88, P467, DOI 10.1001/archinte.1951.03810100051005; Wen ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018278; Xuan WL, 2012, CRIT CARE MED, V40, P3026, DOI 10.1097/CCM.0b013e31825fd7da; Xue BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045990; Zghonda N, 2011, BIOSCI BIOTECH BIOCH, V75, P1259, DOI 10.1271/bbb.110022; Zhang C, 2012, INT J MOL MED, V29, P557, DOI 10.3892/ijmm.2012.885; Zhao P, 2009, SHOCK, V32, P100, DOI 10.1097/SHK.0b013e31818ec609; Zhu HQ, 2011, CARDIOVASC RES, V92, P75, DOI 10.1093/cvr/cvr145; Zhu HQ, 2010, J BIOL CHEM, V285, P9429, DOI 10.1074/jbc.M109.071274	61	83	91	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69452	10.1371/journal.pone.0069452	http://dx.doi.org/10.1371/journal.pone.0069452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894482	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100060
J	Morais, JKS; Bader, O; Weig, M; Oliveira, JTA; Arantes, MR; Gomes, VM; Da Cunha, M; Oliveira, HD; Sousa, DOB; Lourencao, AL; Vasconcelos, IM				Morais, Janne K. S.; Bader, Oliver; Weig, Michael; Oliveira, Jose Tadeu A.; Arantes, Mariana R.; Gomes, Valdirene M.; Da Cunha, Maura; Oliveira, Hermogenes D.; Sousa, Daniele O. B.; Lourencao, Andre L.; Vasconcelos, Ilka M.			Soybean Toxin (SBTX) Impairs Fungal Growth by Interfering with Molecular Transport, Carbohydrate/Amino Acid Metabolism and Drug/Stress Responses	PLOS ONE			English	Article							CANDIDA-ALBICANS; GENE-EXPRESSION; PROTEIN; MORPHOGENESIS; PATHWAY; PLANT	Soybean toxin (SBTX) is an antifungal protein from soybeans with broad inhibitory activity against the growth and filamentation of many fungi, including human and plant pathogenic species such as Candida albicans, Candida parapsilosis, Aspergillus niger, Penicillium herquei, Cercospora sojina and Cercospora kikuchii. Understanding the mechanism by which SBTX acts on fungi and yeasts may contribute to the design of novel antifungal drugs and/or the development of transgenic plants resistant to pathogens. To this end, the polymorphic yeast C. albicans was chosen as a model organism and changes in the gene expression profile of strain SC5314 upon exposure to SBTX were examined. Genes that were differentially regulated in the presence of SBTX were involved in glucose transport and starvation-associated stress responses as well as in the control of both the induction and repression of C. albicans hyphal formation. Transmission electron microscopy showed that C. albicans cells exposed to SBTX displayed severe signs of starvation and were heavily granulated. Our data were indicative of C. albicans cell starvation despite sufficient nutrient availability in the medium; therefore, it can be speculated that SBTX blocks nutrient uptake systems. Because neither the starvation signal nor the alkaline response pathway lead to the induction of hyphae, we hypothesise that conflicting signals are transmitted to the complex regulatory network controlling morphogenesis, eventually preventing the filamentation signal from reaching a significant threshold.	[Morais, Janne K. S.; Oliveira, Jose Tadeu A.; Arantes, Mariana R.; Oliveira, Hermogenes D.; Sousa, Daniele O. B.; Vasconcelos, Ilka M.] Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil; [Morais, Janne K. S.; Bader, Oliver; Weig, Michael] Univ Med Ctr Groningen, Inst Med Microbiol, Gottingen, Niedersachsen, Germany; [Morais, Janne K. S.; Bader, Oliver; Weig, Michael] Univ Med Ctr Groningen, German Natl Reference Ctr Syst Mycoses, Gottingen, Niedersachsen, Germany; [Gomes, Valdirene M.; Da Cunha, Maura] State Univ North Fluminense, Biosci & Biotecnol Ctr, Rio De Janeiro, Brazil; [Lourencao, Andre L.] Agron Inst Campinas, Campinas, SP, Brazil	Universidade Federal do Ceara; University of Gottingen; University of Gottingen; Instituto Agronomico de Campinas (IAC)	Vasconcelos, IM (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil.	imvasco@ufc.br	Bader, Oliver/C-7650-2015; Da Cunha, Maura/L-1412-2014; da Silva Oliveira, José Tarcísio/AAA-3115-2019; Lourenção, André L./E-5880-2012; De Oliveira, Hermógenes David/M-1372-2018; Gomes, Valdirene/G-1805-2015	Bader, Oliver/0000-0002-1534-440X; da Silva Oliveira, José Tarcísio/0000-0003-3375-9227; De Oliveira, Hermógenes David/0000-0003-4633-5597; Gomes, Valdirene/0000-0003-4145-428X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP); German Agency for International Cooperation (GIZ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); German Agency for International Cooperation (GIZ)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) and the German Agency for International Cooperation (GIZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; Benson ES, 2002, EUKARYOT CELL, V1, P787, DOI 10.1128/EC.1.5.787-798.2002; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; Cannon RD, 1999, CRIT REV ORAL BIOL M, V10, P359, DOI 10.1177/10454411990100030701; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Crump JA, 2000, EUR J CLIN MICROBIOL, V19, P1, DOI 10.1007/s100960050001; Cruz LP, 2010, PROTEIN PEPTIDE LETT, V17, P311, DOI 10.2174/092986610790780305; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; Eschrich D, 2002, FEMS YEAST RES, V2, P315, DOI 10.1016/S1567-1356(02)00087-9; Ferreira RB, 2007, MOL PLANT PATHOL, V8, P677, DOI [10.1111/j.1364-3703.2007.00419.x, 10.1111/J.1364-3703.2007.00419.X]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gomes VM, 1998, BBA-GEN SUBJECTS, V1379, P207, DOI 10.1016/S0304-4165(97)00100-1; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Morais JKS, 2010, J AGR FOOD CHEM, V58, P10356, DOI 10.1021/jf101688k; Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x; Postier B, 2008, J MICROBIOL METH, V74, P26, DOI 10.1016/j.mimet.2007.07.004; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ribeiro SFF, 2012, ANTON LEEUW INT J G, V101, P657, DOI 10.1007/s10482-011-9683-x; Shareck J, 2011, EUKARYOT CELL, V10, P1004, DOI 10.1128/EC.05030-11; Simonetti E, 2012, LETT APPL MICROBIOL, V55, P170, DOI 10.1111/j.1472-765X.2012.03266.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Upchurch RG, 2010, PHYSIOL MOL PLANT P, V75, P64, DOI 10.1016/j.pmpp.2010.08.007; Varma A, 2000, FEMS MICROBIOL LETT, V182, P15, DOI 10.1111/j.1574-6968.2000.tb08866.x; Vasconcelos IM, 2008, TOXICON, V51, P952, DOI 10.1016/j.toxicon.2007.10.005; Wang H, 2011, FEMS YEAST RES, V11, P430, DOI 10.1111/j.1567-1364.2011.00730.x; Wang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035339; Wei Guo-Xian, 2007, Ann Clin Microbiol Antimicrob, V6, P14, DOI 10.1186/1476-0711-6-14	33	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e70425	10.1371/journal.pone.0070425	http://dx.doi.org/10.1371/journal.pone.0070425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894655	gold, Green Published, Green Submitted			2022-12-25	WOS:000322132100094
J	Sendow, I; Ratnawati, A; Taylor, T; Adjid, RMA; Saepulloh, M; Barr, J; Wong, F; Daniels, P; Field, H				Sendow, Indrawati; Ratnawati, Atik; Taylor, Trevor; Adjid, R. M. Abdul; Saepulloh, Muharam; Barr, Jennifer; Wong, Frank; Daniels, Peter; Field, Hume			Nipah Virus in the Fruit Bat Pteropus vampyrus in Sumatera, Indonesia	PLOS ONE			English	Article							RT-PCR; INFECTION; HENIPAVIRUS; ANTIBODIES; LYLEI	Nipah virus causes periodic livestock and human disease with high case fatality rate, and consequent major economic, social and psychological impacts. Fruit bats of the genus Pteropus are the natural reservoir. In this study, we used real time PCR to screen the saliva and urine of P. vampyrus from North Sumatera for Nipah virus genome. A conventional reverse transcriptase (RT-PCR) assay was used on provisionally positive samples to corroborate findings. This is the first report of Nipah virus detection in P. vampyrus in Sumatera, Indonesia.	[Sendow, Indrawati; Ratnawati, Atik; Adjid, R. M. Abdul; Saepulloh, Muharam] Indonesian Res Ctr Vet Sci, Bogor, Indonesia; [Taylor, Trevor; Barr, Jennifer; Wong, Frank; Daniels, Peter] Australian Anim Hlth Lab, Geelong, Vic, Australia; [Field, Hume] Queensland Ctr Emerging Infect Dis, Dept Agr Fisheries & Forestry, Coopers Plains, Qld, Australia; [Field, Hume] EcoHlth Alliance, New York, NY USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland Department of Agriculture & Fisheries; EcoHealth Alliance	Field, H (corresponding author), Queensland Ctr Emerging Infect Dis, Dept Agr Fisheries & Forestry, Coopers Plains, Qld, Australia.	hume.field@ecohealthalliance.org	Wong, Frank/H-1950-2013	Wong, Frank/0000-0003-2471-9549; Barr, Jennifer/0000-0001-5266-9142	Dept, of Veterinary Services, Indonesia; Queensland Centre for Emerging Infectious Diseases, Dept. of Agriculture, Fisheries & Forestry, Queensland, Australia; CSIRO Australian Animal health Laboratory	Dept, of Veterinary Services, Indonesia; Queensland Centre for Emerging Infectious Diseases, Dept. of Agriculture, Fisheries & Forestry, Queensland, Australia; CSIRO Australian Animal health Laboratory	IS, AR, AA, and MS are core-funded by the Dept, of Veterinary Services, Indonesia. HF is core-funded by the Queensland Centre for Emerging Infectious Diseases, Dept. of Agriculture, Fisheries & Forestry, Queensland, Australia. PD, TT and JB are core- funded by CSIRO Australian Animal health Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; Epstein JH, 2009, J APPL ECOL, V46, P991, DOI 10.1111/j.1365-2664.2009.01699.x; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Guillaume V, 2004, J VIROL METHODS, V120, P229, DOI 10.1016/j.jviromet.2004.05.018; Hasebe F, 2012, EMERG INFECT DIS, V18, P536, DOI 10.3201/eid1803.111121; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Li Y, 2008, EMERG INFECT DIS, V14, P1974, DOI 10.3201/eid1412.080359; Lo MK, 2008, J CLIN VIROL, V43, P396, DOI 10.1016/j.jcv.2008.08.007; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Olson JG, 2002, EMERG INFECT DIS, V8, P987, DOI 10.3201/eid0809.010515; Rahman SA, 2013, EMERG INFECT DIS, V19, P51, DOI 10.3201/eid1901.120221; Rahman SA, 2010, EMERG INFECT DIS, V16, P1990, DOI 10.3201/eid1612.091790; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Sendow I, 2006, EMERG INFECT DIS, V12, P711, DOI 10.3201/eid1204.051181; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wacharapluesadee S, 2007, J VIROL METHODS, V141, P97, DOI 10.1016/j.jviromet.2006.11.023; Wacharapluesadee S, 2006, CLIN INFECT DIS, V43, P269, DOI 10.1086/505311; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; Wild TF, 2009, PATHOL BIOL, V57, P188, DOI 10.1016/j.patbio.2008.04.006; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; Yadav PD, 2012, AM J TROP MED HYG	30	19	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69544	10.1371/journal.pone.0069544	http://dx.doi.org/10.1371/journal.pone.0069544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894501	Green Submitted, Green Published, gold			2022-12-25	WOS:000322132100068
J	Domingues, JFD; van der Mei, HC; Busscher, HJ; van Kooten, TG				Domingues, Joana F. da Silva; van der Mei, Henny C.; Busscher, Henk J.; van Kooten, Theo G.			Phagocytosis of Bacteria Adhering to a Biomaterial Surface in a Surface Thermodynamic Perspective	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS RP62A; HOST-DEFENSE; HUMAN NEUTROPHILS; HUMAN MACROPHAGES; BIOFILM FORMATION; OXIDATIVE-BURST; AUREUS; CELLS; INFLAMMATION; INFECTIONS	Bacterial biofilms can increase the pathogenicity of infection and constitute a major problem in modern health-care, especially on biomaterial implants and devices. Biofilms are difficult to eradicate by the host immune system, even with antibiotics, and have been the number one cause of biomaterial implant and device failure for decades. Therefore, it is important to understand how immune cells interact with adhering pathogens. This study firstly aims to develop a simple method to quantify phagocytosis of six different strains of staphylococci adhering on a surface with phase-contrast-microscopy. Phagocytosis of adhering staphylococci to a glass surface by phagocytes was quantified in a parallel plate flow chamber, and expressed as a phagocytosis rate, accounting for the number of adhering staphylococci initially present and for the duration of phagocytosis. Murine macrophages were more effective in clearing staphylococci from a surface than human phagocytes, which require differentiation from their monocyte or promyelocytic state during an experiment. Direct visualization of internalization of a GFP-modified S. aureus strain inside phagocytes confirmed the validity of the method proposed. As a second aim, the differences in phagocytosis rates observed were investigated on a surface thermodynamic basis using measured contact angles of liquids on macroscopic lawns of staphylococci and phagocytes, confirming that phagocytosis of adhering pathogens can be regarded as a surface phenomenon. In addition, surface thermodynamics revealed that phagocytosis of adhering pathogens is determined by an interplay of physical attraction between pathogens and phagocytes and the influence of chemo-attractants. For future studies, these results will help to place in vitro experiments and murine infection models in better perspective with respect to human ones.	[van Kooten, Theo G.] Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands; Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen	van Kooten, TG (corresponding author), Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.	t.g.van.kooten@umcg.nl	Busscher, Henk/AAU-2113-2020	Busscher, Henk/0000-0002-3644-5533				Anderson JM., 2004, BIOMATER SCI-UK, P296; Bien J, 2011, J PATHOG, V2011, DOI 10.4061/2011/601905; Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369; Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2; Chamberlain LM, 2009, J BIOMED MATER RES A, V88A, P858, DOI 10.1002/jbm.a.31930; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; GALLAGHER R, 1979, BLOOD, V54, P713; Guenther F, 2009, INT J ARTIF ORGANS, V32, P565, DOI 10.1177/039139880903200905; Gunther F, 2009, MOL IMMUNOL, V46, P1805, DOI 10.1016/j.molimm.2009.01.020; Heilmann C., 2010, BACTERIAL SIGNALING, P7; Heinzelmann M, 1997, CLIN DIAGN LAB IMMUN, V4, P705, DOI 10.1128/CDLI.4.6.705-710.1997; Herald MC, 2010, B MATH BIOL, V72, P765, DOI 10.1007/s11538-009-9468-9; Hess KL, 1997, CYTOMETRY, V27, P145; Malik AF, 2011, P NATL ACAD SCI USA, V108, P20095, DOI 10.1073/pnas.1105152108; Mantovani A, 2009, BLOOD, V114, P3135, DOI 10.1182/blood-2009-07-231795; Maye I, 1998, CELL BIOL TOXICOL, V14, P411, DOI 10.1023/A:1007547612154; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Miller M, 2011, J PROTEOME RES, V10, P4018, DOI 10.1021/pr200224x; Peltroche-Llacsahuanga H, 2000, FEMS MICROBIOL LETT, V191, P151, DOI 10.1111/j.1574-6968.2000.tb09332.x; Robin S, 2011, RSC NANOSCI NANOTECH, P122, DOI 10.1039/9781849733366-00122; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; ROT A, 1987, P NATL ACAD SCI USA, V84, P7967, DOI 10.1073/pnas.84.22.7967; Schommer NN, 2011, INFECT IMMUN, V79, P2267, DOI 10.1128/IAI.01142-10; Skovbjerg S, 2010, J INTERF CYTOK RES, V30, P23, DOI 10.1089/jir.2009.0033; Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005; TABATA Y, 1989, J COLLOID INTERF SCI, V127, P132, DOI 10.1016/0021-9797(89)90013-1; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; VANOSS CJ, 1978, ANNU REV MICROBIOL, V32, P19, DOI 10.1146/annurev.mi.32.100178.000315; VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01; Xing S, 2002, J BIOMED MATER RES, V61, P619, DOI 10.1002/jbm.10078	36	9	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70046	10.1371/journal.pone.0070046	http://dx.doi.org/10.1371/journal.pone.0070046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894585	gold, Green Published, Green Submitted			2022-12-25	WOS:000322391400078
J	Seassau, M; Bucci, MP				Seassau, Magali; Bucci, Maria-Pia			Reading and Visual Search: A Developmental Study in Normal Children	PLOS ONE			English	Article							BINOCULAR COORDINATION; EYE-MOVEMENTS; FIXATION; SACCADES; SPAN	Studies dealing with developmental aspects of binocular eye movement behaviour during reading are scarce. In this study we have explored binocular strategies during reading and during visual search tasks in a large population of normal young readers. Binocular eye movements were recorded using an infrared video-oculography system in sixty-nine children (aged 6 to 15) and in a group of 10 adults (aged 24 to 39). The main findings are (i) in both tasks the number of progressive saccades (to the right) and regressive saccades (to the left) decreases with age; (ii) the amplitude of progressive saccades increases with age in the reading task only; (iii) in both tasks, the duration of fixations as well as the total duration of the task decreases with age; (iv) in both tasks, the amplitude of disconjugacy recorded during and after the saccades decreases with age; (v) children are significantly more accurate in reading than in visual search after 10 years of age. Data reported here confirms and expands previous studies on children's reading. The new finding is that younger children show poorer coordination than adults, both while reading and while performing a visual search task. Both reading skills and binocular saccades coordination improve with age and children reach a similar level to adults after the age of 10. This finding is most likely related to the fact that learning mechanisms responsible for saccade yoking develop during childhood until adolescence.	[Seassau, Magali] Eye BRAIN, Ivry, France; [Bucci, Maria-Pia] Hop Robert Debre, Inserm Paris 7, UMR 676, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Seassau, M (corresponding author), Eye BRAIN, Ivry, France.	magali.seassau@eye-brain.com						BASSOU L, 1992, CR ACAD SCI III-VIE, V315, P159; Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Bucci MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033458; Bucci MP, 2006, VISION RES, V46, P457, DOI 10.1016/j.visres.2005.05.004; Bucci MP, 2002, INVEST OPHTH VIS SCI, V43, P1040; Buswell G. T., 1922, FUNDAMENTAL READING; Collewijn H, 1997, VISION RES, V37, P1049, DOI 10.1016/S0042-6989(96)00245-3; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P157, DOI 10.1113/jphysiol.1988.sp017284; CORNELISSEN P, 1993, DEV MED CHILD NEUROL, V35, P777; FIORAVANTI F, 1995, VISION RES, V35, P3217, DOI 10.1016/0042-6989(95)00152-5; Gaertner C, 2013, VISION RES; Heller D, 1999, CURRENT OCULOMOTOR R; Hering E., 1977, THEORY BINOCULAR VIS; Jainta S, 2012, INVEST OPHTH VIS SCI, V53, P5762, DOI 10.1167/iovs.12-9707; Kennedy A, 1998, Q J EXP PSYCHOL-A, V51, P135, DOI 10.1080/713755746; Kirkby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027105; Kirkby JA, 2010, VISION RES, V50, P171, DOI 10.1016/j.visres.2009.11.008; Levy-Schoen A, 1979, PROCESSING VISIBLE L; LEWIS RF, 1995, VISION RES, V35, P3255, DOI 10.1016/0042-6989(95)00026-B; Lions C, 2013, INVEST OPHTH VIS SCI, V54, P620, DOI 10.1167/iovs.12-10526; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; McConkie G.W., 1991, VISION VISUAL DYSLEX; Nystrom M, 2010, BEHAV RES METHODS, V42, P188, DOI 10.3758/BRM.42.1.188; Olulade OA, 2013, BRAIN LANG, V125, P134, DOI 10.1016/j.bandl.2012.04.003; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1986, J EXP CHILD PSYCHOL, V41, P211, DOI 10.1016/0022-0965(86)90037-8; Simos PG, 2001, DEV NEUROPSYCHOL, V19, P191, DOI 10.1207/S15326942DN1902_4; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065	29	33	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70261	10.1371/journal.pone.0070261	http://dx.doi.org/10.1371/journal.pone.0070261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191CY	23894627	gold, Green Submitted, Green Published			2022-12-25	WOS:000322391400087
J	Nakagawa, T; Ge, Q; Pawlosky, R; Wynn, RM; Veech, RL; Uyeda, K				Nakagawa, Tsutomu; Ge, Qiang; Pawlosky, Robert; Wynn, R. Max; Veech, Richard L.; Uyeda, Kosaku			Metabolite Regulation of Nucleo-cytosolic Trafficking of Carbohydrate Response Element-binding Protein (ChREBP) ROLE OF KETONE BODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; SUBCELLULAR-LOCALIZATION; XYLULOSE 5-PHOSPHATE; RAT-LIVER; GLUCOSE; KINASE; GENE; PHOSPHORYLATION; LIPOGENESIS; DEFICIENCY	The carbohydrate response element-binding protein (ChREBP) is a glucose-responsive transcription factor that plays a critical role in converting excess carbohydrate to storage fat in liver. In response to changing glucose levels, ChREBP activity is regulated by nucleo-cytoplasmic shuttling of ChREBP via interactions with 14-3-3 proteins and importins. The nuclear/cytosol trafficking is regulated partly by phosphorylation/dephosphorylation of serine 196 mediated by cAMP-dependent protein kinase and protein phosphatase. Weshow here that protein-free extracts of starved and high fat-fed livers contain metabolites that activate interaction of ChREBP center dot 14-3-3 and inhibit the ChREBP/importin alpha interaction, resulting in cytosolic localization. These metabolites were identified as beta-hydroxybutyrate and acetoacetate. Nuclear localization of GFP-ChREBP is rapidly inhibited in hepatocytes incubated in beta-hydroxybutyrate or fatty acids, and the observed inhibition is closely correlated with the production of ketone bodies. These observations show that ketone bodies play an important role in the regulation of ChREBP activity by restricting ChREBP localization to the cytoplasm, thus inhibiting fat synthesis during periods of ketosis.	Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Uyeda, Kosaku] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA; [Pawlosky, Robert; Veech, Richard L.] NIAAA, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Uyeda, K (corresponding author), Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA.	Kosaku.Uyeda@utsouthwestern.edu		Wynn, Richard/0000-0002-1879-2136	National Institutes of Health [DK06394804]; Veterans Affairs Merit Review; Welch Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Welch Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant DK06394804. This work was also supported by Veterans Affairs Merit Review and a Welch Grant.	Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Cairo S, 2001, HUM MOL GENET, V10, P617, DOI 10.1093/hmg/10.6.617; Dentin R, 2012, J HEPATOL, V56, P199, DOI 10.1016/j.jhep.2011.07.019; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Ge Q, 2012, J BIOL CHEM, V287, P41914, DOI 10.1074/jbc.M112.418855; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Koehler-Stec EM, 1998, AM J PHYSIOL-ENDOC M, V275, pE516, DOI 10.1152/ajpendo.1998.275.3.E516; LAWSON JWR, 1987, J BIOL CHEM, V262, P3165; Lawson JWR, 1976, GLUCONEOGENESIS ITS; Li MV, 2010, BIOCHEM BIOPH RES CO, V395, P395, DOI 10.1016/j.bbrc.2010.04.028; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; NEWTON RP, 1984, BIOCHEM J, V221, P665, DOI 10.1042/bj2210665; Orii KE, 2008, TOHOKU J EXP MED, V215, P227, DOI 10.1620/tjem.215.227; Sakiyama H, 2010, BIOCHEM BIOPH RES CO, V402, P784, DOI 10.1016/j.bbrc.2010.10.113; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298	25	34	38	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28358	28367		10.1074/jbc.M113.498550	http://dx.doi.org/10.1074/jbc.M113.498550			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23918932	Green Published, hybrid			2022-12-25	WOS:000330612800064
J	Liu, GJ; Fang, Y; Wu, JH				Liu, Guangjian; Fang, Ying; Wu, Jianhua			A Mechanism for Localized Dynamics-driven Affinity Regulation of the Binding of von Willebrand Factor to Platelet Glycoprotein Ib alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR A1 DOMAIN; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; DISEASE MUTATIONS; SHEAR-STRESS; SNAKE-VENOM; GPIB-ALPHA; PROTEIN; COMPLEX; ACTIVATION	Binding of the A1 domain of von Willebrand factor (vWF) to glycoprotein Ib alpha (GPIb alpha) results in platelet adhesion, activation, and aggregation that initiates primary hemostasis. Both the elevated shear stress and the mutations associated with type 2B von Willebrand disease enhance the interaction between A1 and GPIb alpha. Through molecular dynamics simulations for wildtype vWF-A1 and its eight gain of function mutants (R543Q, I546V, Delta SS, etc.), we found that the gain of function mutations destabilize the N-terminal arm, increase a clock pendulum-like movement of the alpha 2-helix, and turn a closed A1 conformation into a partially open one favoring binding to GPIb alpha. The residue Arg(578) at the alpha 2-helix behaves as a pivot in the destabilization of the N-terminal arm and a consequent dynamic change of the alpha 2-helix. These results suggest a localized dynamics-driven affinity regulation mechanism for vWF-GPIb alpha interaction. Allosteric drugs controlling this intrinsic protein dynamics may be effective in blocking the GPIb-vWF interaction.	[Liu, Guangjian; Fang, Ying; Wu, Jianhua] S China Univ Technol, Sch Biosci & Bioengn, Inst Biomech, Guangzhou 510006, Guangdong, Peoples R China	South China University of Technology	Fang, Y (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China.	yfang@scut.edu.cn; wujianhua@scut.edu.cn			National Natural Science Foundation of China [10972081, 11072080, 31170887]; Guangdong Natural Science Foundation [S2011010005451]; Specialized Research Fund for the Doctoral Program of Higher Education [20110172110030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China Grants 10972081 (to Y. F.) and 11072080 and 31170887 (to J. W.) and by Guangdong Natural Science Foundation Grant S2011010005451 (to J. W.) and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20110172110030 (to J. W.).	Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; Auton M, 2012, J BIOL CHEM, V287, P14579, DOI 10.1074/jbc.M112.348573; Auton M, 2010, BIOPHYS J, V99, P1192, DOI 10.1016/j.bpj.2010.06.002; Auton M, 2010, J BIOL CHEM, V285, P22829, DOI 10.1074/jbc.M110.103358; Auton M, 2009, BIOPHYS J, V97, P618, DOI 10.1016/j.bpj.2009.05.009; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bruice TC, 2006, CHEM REV, V106, P3119, DOI 10.1021/cr050283j; Casana P, 1998, AM J HEMATOL, V59, P57, DOI 10.1002/(SICI)1096-8652(199809)59:1<57::AID-AJH11>3.0.CO;2-Z; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Chaplin M, 2006, NAT REV MOL CELL BIO, V7, P861, DOI 10.1038/nrm2021; Cooney KA, 1996, BLOOD, V87, P2322, DOI 10.1182/blood.V87.6.2322.bloodjournal8762322; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Fu XY, 2011, BLOOD, V118, P5283, DOI 10.1182/blood-2011-01-331074; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hilbert L, 1998, BRIT J HAEMATOL, V103, P877, DOI 10.1046/j.1365-2141.1998.01040.x; Huang RH, 2009, STRUCTURE, V17, P1476, DOI 10.1016/j.str.2009.09.011; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Interlandi G, 2010, PROTEINS, V78, P2506, DOI 10.1002/prot.22759; Ishikawa H, 2008, P NATL ACAD SCI USA, V105, P8619, DOI 10.1073/pnas.0803764105; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; Li QH, 2012, EXP CELL RES, V318, P1649, DOI 10.1016/j.yexcr.2012.05.018; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; MATSUSHITA T, 1995, J BIOL CHEM, V270, P13406, DOI 10.1074/jbc.270.22.13406; Miura S, 2000, J BIOL CHEM, V275, P7539, DOI 10.1074/jbc.275.11.7539; Miyata S, 1996, J BIOL CHEM, V271, P9046, DOI 10.1074/jbc.271.15.9046; Miyata S, 1999, J BIOL CHEM, V274, P6586, DOI 10.1074/jbc.274.10.6586; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; RANDI AM, 1992, J BIOL CHEM, V267, P21187; Romijn R. A., 2002, THESIS U UTRECHT; Ruggeri ZM, 2007, THROMB HAEMOSTASIS, V98, P55, DOI 10.1160/TH07-04-0279; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Springer TA, 2011, J THROMB HAEMOST, V9, P130, DOI 10.1111/j.1538-7836.2011.04320.x; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; Wallnoefer HG, 2010, J AM CHEM SOC, V132, P10330, DOI 10.1021/ja909908y; Wang Y., 2012, BIOL MED PHYS BIOMED, P3, DOI [10.1007/978-1-4614-2146-7_1, DOI 10.1007/978-1-4614-2146-7_1]; Wayman AM, 2010, BIOPHYS J, V99, P1166, DOI 10.1016/j.bpj.2010.05.040; Whitley MJ, 2009, CURR PROTEIN PEPT SC, V10, P116, DOI 10.2174/138920309787847563; Whitten ST, 2005, P NATL ACAD SCI USA, V102, P4282, DOI 10.1073/pnas.0407499102; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zhang H, 2009, PROTEINS, V76, P617, DOI 10.1002/prot.22375; Zhou Z, 2012, CURR VASC PHARMACOL, V10, P762, DOI 10.2174/157016112803520837	62	16	23	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26658	26667		10.1074/jbc.M113.453803	http://dx.doi.org/10.1074/jbc.M113.453803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902764	Green Published, hybrid			2022-12-25	WOS:000330594500031
J	Boudousq, V; Bobyk, L; Busson, M; Garambois, V; Jarlier, M; Charalambatou, P; Pelegrin, A; Paillas, S; Chouin, N; Quenet, F; Maquaire, P; Torgue, J; Navarro-Teulon, I; Pouget, JP				Boudousq, Vincent; Bobyk, Laure; Busson, Muriel; Garambois, Veronique; Jarlier, Marta; Charalambatou, Paraskevi; Pelegrin, Andre; Paillas, Salome; Chouin, Nicolas; Quenet, Francois; Maquaire, Patrick; Torgue, Julien; Navarro-Teulon, Isabelle; Pouget, Jean-Pierre			Comparison between Internalizing Anti-HER2 mAbs and Non-Internalizing Anti-CEA mAbs in Alpha-Radioimmunotherapy of Small Volume Peritoneal Carcinomatosis Using Pb-212	PLOS ONE			English	Article							HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; EPITHELIAL OVARIAN-CANCER; MONOCLONAL-ANTIBODY; THERAPEUTIC-EFFICACY; NUDE-MICE; CYTOREDUCTIVE SURGERY; PROSTATE-CANCER; BREAST-CANCER; PARTICLE RADIOIMMUNOTHERAPY; CARCINOEMBRYONIC ANTIGEN	Background and Purpose: We assessed the contribution of antibody internalization in the efficacy and toxicity of intraperitoneal alpha-radioimmunotherapy (RIT) of small volume carcinomatosis using Pb-212-labeled monoclonal antibodies (mAbs) that target HER2 (internalizing) or CEA (non-internalizing) receptors. Materials and Methods: Athymic nude mice bearing 2-3 mm intraperitoneal tumor xenografts were intraperitoneally injected with similar activities (370, 740 and 1480 kBq; 37 MBq/mg) of Pb-212-labeled 35A7 (anti-CEA), trastuzumab (anti-HER2) or PX (non-specific) mAbs, or with equivalent amounts of unlabeled mAbs, or with NaCl. Tumor volume was monitored by bioluminescence and survival was reported. Hematologic toxicity and body weight were assessed. Biodistribution of Pb-212-labeled mAbs and absorbed dose-effect relationships using MIRD formalism were established. Results: Transient hematological toxicity, as revealed by white blood cells and platelets numbering, was reported in mice treated with the highest activities of Pb-212-labeled mAbs. The median survival (MS) was significantly higher in mice injected with 1.48 MBq of Pb-212-35A7 (non-internalizing mAbs) (MS = 94 days) than in animals treated with the same activity of Pb-212-PX mAbs or with NaCl (MS = 18 days). MS was even not reached after 130 days when follow-up was discontinued in mice treated with 1.48 MBq of Pb-212-trastuzumab. The later efficacy was unexpected since final absorbed dose resulting from injection of 1.48 MBq, was higher for Pb-212-35A7 (35.5 Gy) than for Pb-212-trastuzumab (27.6 Gy). These results also highlight the lack of absorbed dose-effect relationship when mean absorbed dose was calculated using MIRD formalism and the requirement to perform small-scale dosimetry. Conclusions: These data indicate that it might be an advantage of using internalizing anti-HER2 compared with non-internalizing anti-CEA Pb-212-labeled mAbs in the therapy of small volume xenograft tumors. They support clinical investigations of Pb-212-mAbs RIT as an adjuvant treatment after cytoreductive surgery in patients with peritoneal carcinomatosis.	[Boudousq, Vincent; Bobyk, Laure; Busson, Muriel; Garambois, Veronique; Charalambatou, Paraskevi; Pelegrin, Andre; Paillas, Salome; Navarro-Teulon, Isabelle; Pouget, Jean-Pierre] Univ Montpellier, Inst Natl Sante & Rech Med U896, Inst Rech Cancerol Montpellier, F-34059 Montpellier, France; [Boudousq, Vincent] Ctr Hosp Univ Nimes, Nucl Med Serv, Nimes, France; [Boudousq, Vincent; Bobyk, Laure; Busson, Muriel; Garambois, Veronique; Jarlier, Marta; Charalambatou, Paraskevi; Pelegrin, Andre; Paillas, Salome; Quenet, Francois; Navarro-Teulon, Isabelle; Pouget, Jean-Pierre] Inst Reg Canc Montpellier, Montpellier, France; [Chouin, Nicolas] Oniris, Nantes, France; [Maquaire, Patrick] AREVA NC, Beaumont Hague, France; [Torgue, Julien] AREVA Med LLC, Bethesda, MD USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Nimes; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Areva; Areva	Pouget, JP (corresponding author), Univ Montpellier, Inst Natl Sante & Rech Med U896, Inst Rech Cancerol Montpellier, F-34059 Montpellier, France.	jean-pierre.pouget@inserm.fr	Pèlegrin, André/J-3167-2016; Chouin, Nicolas/M-7914-2016	Chouin, Nicolas/0000-0003-1489-4351; Pelegrin, Andre/0000-0001-9254-2648; POUGET, Jean-Pierre/0000-0001-8551-2029; Torgue, Julien/0000-0002-5898-1521	Institut National du Cancer [R09080FF/RPT09005FFA]; Action No1.1 of Plan Cancer [ASC 13038FSA]; AREVA Med LLC	Institut National du Cancer(Institut National du Cancer (INCA) France); Action No1.1 of Plan Cancer; AREVA Med LLC	This work was supported by the Institut National du Cancer, grant R09080FF/RPT09005FFA, by Action No1.1 of Plan Cancer 2009-2013 (ASC 13038FSA) and by AREVA Med LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Julien Torgue and Patrick Maquaire have affiliation to the commercial funders of this research (AREVA Med LLC). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aarts F, 2007, ANN SURG ONCOL, V14, P3274, DOI 10.1245/s10434-007-9509-2; Allen BJ, 2011, IMMUNOTHERAPY-UK, V3, P1041, DOI [10.2217/IMT.11.97, 10.2217/imt.11.97]; Almqvist Y, 2007, CANCER BIOTHER RADIO, V22, P480, DOI 10.1089/cbr.2007.349A; Andersson H, 2009, J NUCL MED, V50, P1153, DOI 10.2967/jnumed.109.062604; Baselga J, 1998, CANCER RES, V58, P2825; Bell JC, 2012, ANN SURG ONCOL; Boswell CA, 2007, NUCL MED BIOL, V34, P757, DOI 10.1016/j.nucmedbio.2007.04.001; Boudousq V, 2010, J NUCL MED, V51, P1748, DOI 10.2967/jnumed.110.080226; Ceelen WP, 2010, NAT REV CLIN ONCOL, V7, P108, DOI 10.1038/nrclinonc.2009.217; Chappell LL, 2000, NUCL MED BIOL, V27, P93, DOI 10.1016/S0969-8051(99)00086-4; Chouin N, 2009, RADIAT RES, V171, P657, DOI 10.1667/RR1371.1; Dadachova E, 1999, NUCL MED BIOL, V26, P977, DOI 10.1016/S0969-8051(99)00054-2; Dahle J, 2011, CURR RADIOPHARM, V4, P321, DOI 10.2174/1874471011104040321; Eckerman KF, 2008, MIRD RADIONUCLIDE DA; Elgqvist J, 2005, J NUCL MED, V46, P1907; Elgqvist J, 2006, NUCL MED BIOL, V33, P1065, DOI 10.1016/j.nucmedbio.2006.07.009; Elias D, 2012, ANN SURG ONCOL, V19, P5, DOI 10.1245/s10434-011-1897-7; Glehen O, 2004, LANCET ONCOL, V5, P219, DOI 10.1016/S1470-2045(04)01425-1; Glockzin G, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-5; Gustafsson AME, 2012, NUCL MED BIOL, V39, P15, DOI 10.1016/j.nucmedbio.2011.07.003; HAMMARSTROM S, 1989, CANCER RES, V49, P4852; Horak E, 1997, J NUCL MED, V38, P1944; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Jurcic JG, 2002, BLOOD, V100, P1233, DOI 10.1182/blood.V100.4.1233.h81602001233_1233_1239; KOHLER G, 1976, EUR J IMMUNOL, V6, P292, DOI 10.1002/eji.1830060411; Koppe MJ, 2005, BRIT J SURG, V92, P264, DOI 10.1002/bjs.4936; Li Y, 2009, CLIN CANCER RES, V15, P865, DOI 10.1158/1078-0432.CCR-08-1203; Lingappa M, 2010, CANCER RES, V70, P6815, DOI 10.1158/0008-5472.CAN-09-4548; McDevitt MR, 2000, CANCER RES, V60, P6095; Milenic DE, 2005, CANCER BIOTHER RADIO, V20, P557, DOI 10.1089/cbr.2005.20.557; Milenic DE, 2008, CLIN CANCER RES, V14, P5108, DOI 10.1158/1078-0432.CCR-08-0256; Milenic DE, 2007, CLIN CANCER RES, V13, P1926, DOI 10.1158/1078-0432.CCR-06-2300; Nikula TK, 1999, J NUCL MED, V40, P166; Oei AL, 2007, INT J CANCER, V120, P2710, DOI 10.1002/ijc.22663; Palm S, 2007, INT J RADIAT ONCOL, V69, P572, DOI 10.1016/j.ijrobp.2007.06.023; Pfost B, 2009, J NUCL MED, V50, DOI 10.2967/jnumed.109.065961; Pomel C, 2010, EJSO-EUR J SURG ONC, V36, P589, DOI 10.1016/j.ejso.2010.04.005; Pouget JP, 2008, RADIAT RES, V170, P192, DOI 10.1667/RR1359.1; Pouget JP, 2011, NAT REV CLIN ONCOL, V8, P720, DOI 10.1038/nrclinonc.2011.160; Robert B, 1996, CANCER RES, V56, P4758; Rosenblat TL, 2010, CLIN CANCER RES, V16, P5303, DOI 10.1158/1078-0432.CCR-10-0382; Ruble G, 1996, INT J RADIAT ONCOL, V34, P609, DOI 10.1016/0360-3016(95)02119-1; RUEGG CL, 1990, CANCER RES, V50, P4221; Santoro L, 2009, J NUCL MED, V50, P2033, DOI 10.2967/jnumed.109.066993; Sgouros G, 2010, J NUCL MED, V51, P311, DOI 10.2967/jnumed.108.058651; Sharkey RM, 2011, IMMUNOTHERAPY-UK, V3, P349, DOI 10.2217/IMT.10.114; Song EY, 2008, CANCER BIOL THER, V7, P76, DOI 10.4161/cbt.7.1.5132; Song H, 2008, CANCER RES, V68, P3873, DOI 10.1158/0008-5472.CAN-07-6308; Sugarbaker PH, 2011, AM J SURG, V201, P157, DOI 10.1016/j.amjsurg.2010.04.010; Sugarbaker PH, 2009, EXPERT OPIN PHARMACO, V10, P1965, DOI 10.1517/14656560903044974; Tan ZQ, 2012, INT J ONCOL, V40, P1881, DOI 10.3892/ijo.2012.1357; Verheijen RH, 2006, J CLIN ONCOL, V24, P571, DOI 10.1200/JCO.2005.02.5973; Wild D, 2011, CANCER RES, V71, P1009, DOI 10.1158/0008-5472.CAN-10-1186; Yong K, 2011, DALTON T, V40, P6068, DOI 10.1039/c0dt01387k; Zalutsky MR, 2008, J NUCL MED, V49, P30, DOI 10.2967/jnumed.107.046938; Zhang Z, 2006, BLOOD, V108, P1007, DOI 10.1182/blood-2005-11-4757	56	43	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69613	10.1371/journal.pone.0069613	http://dx.doi.org/10.1371/journal.pone.0069613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922757	Green Published, gold			2022-12-25	WOS:000323369700055
J	Reina, A; Subramaniam, AB; Laromaine, A; Samuel, ADT; Whitesides, GM				Reina, Alfonso; Subramaniam, Anand Bala; Laromaine, Anna; Samuel, Aravinthan D. T.; Whitesides, George M.			Shifts in the Distribution of Mass Densities Is a Signature of Caloric Restriction in Caenorhabditis elegans	PLOS ONE			English	Article							GERMLINE STEM-CELLS; LIFE-SPAN; C. ELEGANS; FAT-METABOLISM; LONGEVITY; STARVATION; GENETICS; STORAGE; RESISTANCE; GLYCOGEN	Although the starvation response of the model multicellular organism Caenorhabditis elegans is a subject of much research, there is no convenient phenotypic readout of caloric restriction that can be applicable to large numbers of worms. This paper describes the distribution of mass densities of populations of C. elegans, from larval stages up to day one of adulthood, using isopycnic centrifugation, and finds that density is a convenient, if complex, phenotypic readout in C. elegans. The density of worms in synchronized populations of wildtype N2 C. elegans grown under standard solid-phase culture conditions was normally distributed, with distributions peaked sharply at a mean of 1.091 g/cm(3) for L1, L2 and L3 larvae, 1.087 g/cm(3) for L4 larvae, 1.081 g/cm(3) for newly molted adults, and 1.074 g/cm(3) at 24 hours of adulthood. The density of adult worms under starvation stress fell well outside this range, falling to a mean value of 1.054 g/cm(3) after eight hours of starvation. This decrease in density correlated with the consumption of stored glycogen in the food-deprived worms. The density of the worms increased when deprived of food for longer durations, corresponding to a shift in the response of the worms: worms sacrifice their bodies by retaining larvae, which consume the adults from within. Density-based screens with the drug Ivermectin on worms cultured on single plates resulted in a clear bimodal (double-peaked) distribution of densities corresponding to drug exposed and non-exposed worms. Thus, measurements of changes in density could be used to conduct screens on the effects of drugs on several populations of worms cultured on single plates.	[Reina, Alfonso; Subramaniam, Anand Bala; Laromaine, Anna; Whitesides, George M.] Harvard Univ, Dept Chem & Chem Biol, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Samuel, Aravinthan D. T.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Samuel, Aravinthan D. T.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu	Laromaine, Anna/D-1964-2009; Laromaine, Anna/M-5294-2019	Laromaine, Anna/0000-0002-4764-0780; Laromaine, Anna/0000-0002-4764-0780; Subramaniam, Anand/0000-0002-1998-9299	Vertex Pharmaceuticals Incorporated; Bill and Melinda Gates Foundations [51308]	Vertex Pharmaceuticals Incorporated(Vertex Pharmaceuticals); Bill and Melinda Gates Foundations	This work was funded by a grant from Vertex Pharmaceuticals Incorporated and the Bill and Melinda Gates Foundations, award # 51308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Azevedo RBR, 2002, GENETICS, V162, P755; BRENNER S, 1974, GENETICS, V77, P71; Bridgman WB, 1942, J AM CHEM SOC, V64, P2349, DOI 10.1021/ja01262a037; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; Castro PV, 2012, PLOS ONE, P7; Chen JJ, 2004, J NEMATOL, V36, P107; COOPER AF, 1970, J NEMATOL, V2, P305; COX GN, 1981, DEV BIOL, V86, P456, DOI 10.1016/0012-1606(81)90204-9; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066; Greenstein D., 2005, CONTROL OOCYTE MEIOT; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Hulme SE, 2011, ANGEW CHEM INT EDIT, V50, P4774, DOI 10.1002/anie.201005461; Hulme SE, 2010, LAB CHIP, V10, P589, DOI 10.1039/b919265d; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; Lee I, 2012, PLOS ONE, P7; Lemieux GA, 2011, NAT CHEM BIOL, V7, P206, DOI [10.1038/nchembio.534, 10.1038/NCHEMBIO.534]; Lucanic M, 2011, NATURE, V473, P226, DOI 10.1038/nature10007; Miersch C, 2012, PLOS ONE, P7; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Reis T, 2010, PLOS GENET, P6; Riddle D.L., 1997, GENETIC ENV REGULATI; Seidel HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028074; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stiernagle T, 2006, MAINTENANCE C ELEGAN; Sutphin GL, 2008, EXP GERONTOL, V43, P130, DOI 10.1016/j.exger.2007.10.019; Tan KT, 2011, CELL METAB, V14, P390, DOI 10.1016/j.cmet.2011.06.019; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Zarse K, 2008, PLOS ONE, P3	44	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69651	10.1371/journal.pone.0069651	http://dx.doi.org/10.1371/journal.pone.0069651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922767	gold, Green Published, Green Submitted			2022-12-25	WOS:000323369700058
J	Steensma, MR; Tyler, WK; Shaber, AG; Goldring, SR; Ross, FP; Williams, BO; Healey, JH; Purdue, PE				Steensma, Matthew R.; Tyler, Wakenda K.; Shaber, Allison G.; Goldring, Steven R.; Ross, F. Patrick; Williams, Bart O.; Healey, John H.; Purdue, P. Edward			Targeting the Giant Cell Tumor Stromal Cell: Functional Characterization and a Novel Therapeutic Strategy	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; NF-KAPPA-B; RECEPTOR ACTIVATOR; OSTEOCLAST DIFFERENTIATION; BLOOD MONOCYTES; DEFICIENT MICE; EXPRESSION; LIGAND; RANKL; OSTEOPROTEGERIN	Giant cell tumor of bone (GCTB) is a benign, locally destructive neoplasm, with tumors comprised of mesenchymal fibroblast-like stromal cells; monocytic, mononuclear cells of myeloid lineage; and the characteristic osteoclast-like, multinucleated giant cells. Hampering the study of the complex interaction of its constituent cell types is the propensity of longstanding, repeatedly passaged cell cultures to undergo phenotypic alteration and loss of osteoclast-inducing capacities. In this study, we employed a novel, single-step technique to purify freshly harvested stromal cells using a CD14-negative selection column. Using 9 freshly harvested GCTB specimens and the purified stromal cell component, we performed analyses for markers of osteoblast lineage and analyzed the capacity of the stromal cells to undergo osteoblastic differentiation and induce osteoclastogenesis in co-cultures with monocytic cells. Successful purification of the CD14-negative stromal cells was confirmed via flow cytometric analysis and immunocytochemistry. Osteogenic media upregulated the expression of osteocalcin, suggesting an osteoblastic lineage of the GCTB stromal cells. The effects of the Wnt pathway agonist, SB415286, and recombinant human bone morphogenetic protein (BMP)-2 on osteoblastogenesis varied among samples. Notably, osteogenic media and SB415286 reversed the receptor activator of NF-kappa B ligand (RANKL)/osteoprotegerin (OPG) expression ratio resulting in diminished osteoclastogenic capacity. Recombinant human BMP2 had the opposite effect, resulting in enhanced and sustained support of osteoclastogenesis. Targeting the giant cell tumor stromal cell may be an effective adjunct to existing anti-resorptive strategies.	[Steensma, Matthew R.] Michigan State Univ, Coll Human Med, Spectrum Hlth Med Grp, Dept Surg, Grand Rapids, MI USA; [Steensma, Matthew R.; Williams, Bart O.] Van Andel Res Inst, Ctr Skeletal Dis & Tumor Metastasis, Grand Rapids, MI USA; [Tyler, Wakenda K.] Univ Rochester, Sch Med & Dent, Dept Orthopaed, Rochester, NY USA; [Shaber, Allison G.; Goldring, Steven R.; Ross, F. Patrick; Purdue, P. Edward] Hosp Special Surg, Div Res, New York, NY 10021 USA; [Healey, John H.] Mem Sloan Kettering Canc Ctr, Dept Surg, Orthopaed Serv, New York, NY 10021 USA	Michigan State University; Michigan State University College of Human Medicine; Spectrum Health Medical Group; Van Andel Institute; University of Rochester; Memorial Sloan Kettering Cancer Center	Steensma, MR (corresponding author), Michigan State Univ, Coll Human Med, Spectrum Hlth Med Grp, Dept Surg, Grand Rapids, MI USA.	matt.steensma@vai.org	Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301; Healey, John/0000-0002-0802-1186	Boehringer Ingelheim; Bone Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000095] Funding Source: NIH RePORTER	Boehringer Ingelheim(Boehringer Ingelheim); Bone Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We have the following interests. The institution of some of the authors SRG, EP and FPR at the Hospital for Special Surgery, New York has received grants from Boehringer Ingelheim. SRG serves on the board of and owns stock in Telik Inc and is a paid consultant to Bone Therapeutics. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Atkins GJ, 2006, J BONE MINER RES, V21, P1339, DOI 10.1359/JBMR.060604; Baud'Huin M, 2010, J PATHOL, V221, P77, DOI 10.1002/path.2684; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1; Boyce BF, 2005, CELL METAB, V2, P344, DOI 10.1016/j.cmet.2005.11.011; Branstetter DG, 2012, CLIN CANCER RES, V18, P4415, DOI 10.1158/1078-0432.CCR-12-0578; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cowan RW, 2013, BONE, V52, P238, DOI 10.1016/j.bone.2012.10.002; Cowan RW, 2012, J ORTHOP RES, V30, P877, DOI 10.1002/jor.22020; Forsyth RG, 2009, J BONE MINER RES, V24, P70, DOI 10.1359/JBMR.080905; Fujita K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-71; Ghert M, 2007, CLIN ORTHOP RELAT R, P8, DOI 10.1097/BLO.0b013e31804856a1; GOLDRING SR, 1987, J CLIN INVEST, V79, P483, DOI 10.1172/JCI112838; GOLDRING SR, 1986, CLIN ORTHOP RELAT R, P59; Guo W, 1999, CLIN ORTHOP RELAT R, P175; Gupta R, 2008, ANN DIAGN PATHOL, V12, P239, DOI 10.1016/j.anndiagpath.2007.09.002; HASEGAWA T, 1993, J PATHOL, V170, P305, DOI 10.1002/path.1711700314; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Huang L, 2004, BONE, V34, P393, DOI 10.1016/j.bone.2003.10.013; Huang L, 2000, AM J PATHOL, V156, P761, DOI 10.1016/S0002-9440(10)64942-5; HUVOS AG, 1991, BONE TUMORS DIAGNOSI, P445; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656; James DE, 2010, J IMMUNOL, V185, P1265, DOI 10.4049/jimmunol.0902808; JOYNER CJ, 1992, BONE MINER, V16, P37, DOI 10.1016/0169-6009(92)90820-4; Kadowaki A, 2004, BONE, V34, P993, DOI 10.1016/j.bone.2004.01.018; Kang L, 2010, J HAND SURG-AM, V35A, P1850, DOI 10.1016/j.jhsa.2010.07.010; Kudo N, 2009, ANTICANCER RES, V29, P2219; Lau YS, 2005, HUM PATHOL, V36, P945, DOI 10.1016/j.humpath.2005.07.005; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Maeda K, 2013, J MOL MED, V91, P15, DOI 10.1007/s00109-012-0974-0; MARCOVE RC, 1994, CANCER, V74, P1253, DOI 10.1002/1097-0142(19940815)74:4<1253::AID-CNCR2820740412>3.0.CO;2-9; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Miyamoto N, 2000, J ORTHOP RES, V18, P647, DOI 10.1002/jor.1100180418; Morgan T, 2005, AM J PATHOL, V167, P117, DOI 10.1016/S0002-9440(10)62959-8; Murata A, 2005, J ORTHOP SCI, V10, P581, DOI 10.1007/s00776-005-0946-0; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nishimura M, 2005, J ORTHOP RES, V23, P979, DOI 10.1016/j.orthres.2005.01.004; OREFFO ROC, 1993, CLIN ORTHOP RELAT R, P229; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; ROBINSON D, 1994, J CELL BIOCHEM, V55, P300, DOI 10.1002/jcb.240550305; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rodriguez JES, 2009, J BONE MINER RES, V24, P1917, DOI [10.1359/jbmr.090507, 10.1359/JBMR.090507]; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; Salerno M, 2008, CLIN ORTHOP RELAT R, V466, P2081, DOI 10.1007/s11999-008-0327-z; SCHWARTZ HS, 1993, CANCER GENET CYTOGEN, V71, P132, DOI 10.1016/0165-4608(93)90018-H; SCHWARTZ HS, 1991, CANCER GENET CYTOGEN, V56, P263, DOI 10.1016/0165-4608(91)90179-X; SCHWARTZ HS, 1995, CANCER, V75, P1094, DOI 10.1002/1097-0142(19950301)75:5<1094::AID-CNCR2820750507>3.0.CO;2-B; Schwartz HS, 2002, J ORTHOPAED RES, V20, P387, DOI 10.1016/S0736-0266(01)00117-6; SCHWARTZ HS, 1989, CLIN ORTHOP RELAT R, P250; Seeherman HJ, 2010, J BONE JOINT SURG AM, V92A, P411, DOI 10.2106/JBJS.H.01732; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Tachi K, 2010, CELL TISSUE RES, V342, P213, DOI 10.1007/s00441-010-1052-y; Takahashi N, 2011, FRONT BIOSCI-LANDMRK, V16, P21, DOI 10.2741/3673; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Thomas D, 2010, LANCET ONCOL, V11, P275, DOI 10.1016/S1470-2045(10)70010-3; Toth JM, 2009, SPINE, V34, P539, DOI 10.1097/BRS.0b013e3181952695; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Wulling M, 2003, HUM PATHOL, V34, P983, DOI 10.1053/S0046-8177(03)00413-1	61	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69101	10.1371/journal.pone.0069101	http://dx.doi.org/10.1371/journal.pone.0069101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922683	gold, Green Published, Green Submitted			2022-12-25	WOS:000322838900021
J	Mahlknecht, P; Kiechl, S; Bloem, BR; Willeit, J; Scherfler, C; Gasperi, A; Rungger, G; Poewe, W; Seppi, K				Mahlknecht, Philipp; Kiechl, Stefan; Bloem, Bastiaan R.; Willeit, Johann; Scherfler, Christoph; Gasperi, Arno; Rungger, Gregorio; Poewe, Werner; Seppi, Klaus			Prevalence and Burden of Gait Disorders in Elderly Men and Women Aged 60-97 Years: A Population-Based Study	PLOS ONE			English	Article							OLDER-ADULTS; PEOPLE; FALLS; RISK; ASSOCIATION; MOBILITY; WALKING	Background: Although gait disorders are common in the elderly, the prevalence and overall burden of these disorders in the general community is not well defined. Methods: In a cross-sectional investigation of the population-based Bruneck Study cohort, 488 community-residing elderly aged 60-97 years underwent a thorough neurological assessment including a standardized gait evaluation. Gait disorders were classified according to an accepted scheme and their associations to falls, neuropsychological measures, and quality of life were explored. Results: Overall, 32.2% (95% confidence interval [CI] 28.2%-36.4%) of participants presented with impaired gait. Prevalence increased with age (p < 0.001), but 38.3% (95% CI 30.1%-47.3%) of the subjects aged 80 years or older still had a normally preserved gait. A total of 24.0% (95% CI 20.4%-28.0%) manifested neurological gait disorders, 17.4% (14.3%-21.0%) non-neurological gait problems, and 9.2% (6.9%-12.1%) a combination of both. While there was no association of neurological gait disorders with gender, non-neurological gait disorders were more frequent in women (p = 0.012). Within the group of neurological gait disorders 69.2% (95% CI 60.3%-76.9%) had a single distinct entity and 30.8% (23.1%-39.7%) had multiple neurological causes for gait impairment. Gait disorders had a significant negative impact on quantitative gait measures, but only neurological gait disorders were associated with recurrent falls (odds ratio 3.3; 95% CI 1.4-7.5; p = 0.005 for single and 7.1; 2.7-18.7; p < 0.001 for multiple neurological gait disorders). Finally, we detected a significant association of gait disorders, in particular neurological gait disorders, with depressed mood, cognitive dysfunction, and compromised quality of life. Conclusions: Gait disorders are common in the general elderly population and are associated with reduced mobility. Neurological gait disorders in particular are associated with recurrent falls, lower cognitive function, depressed mood, and diminished quality of life.	[Mahlknecht, Philipp; Kiechl, Stefan; Willeit, Johann; Scherfler, Christoph; Poewe, Werner; Seppi, Klaus] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Gasperi, Arno; Rungger, Gregorio] Hosp Bruneck, Dept Neurol, Brunico, Italy	Medical University of Innsbruck; Radboud University Nijmegen	Seppi, K (corresponding author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria.	Klaus.Seppi@uki.at	Mahlknecht, Philipp/AAI-6137-2020; Bloem, Bastiaan/H-8013-2014	Mahlknecht, Philipp/0000-0003-0671-0516; Bloem, Bastiaan/0000-0002-6371-3337; Seppi, Klaus/0000-0001-6503-1455; Scherfler, Christoph/0000-0002-4885-5265	medical University of Innsbruck [IFTZ 2007152]; Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen; Gesundheitsbezirk Bruneck; mayor of Bruneck; "Assessorat fuer Gesundheit'', Province of Bolzano, Italy	medical University of Innsbruck; Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen; Gesundheitsbezirk Bruneck; mayor of Bruneck; "Assessorat fuer Gesundheit'', Province of Bolzano, Italy	Philipp Mahlknecht holds a grant from the medical University of Innsbruck (IFTZ 2007152). The Bruneck Study 2010 was supported by the "Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen'', the Gesundheitsbezirk Bruneck, the mayor of Bruneck, and the "Assessorat fuer Gesundheit'', Province of Bolzano, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Alexander NB, 2005, CLEV CLIN J MED, V72, P586, DOI 10.3949/ccjm.72.7.586; Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Bloem B R, 1992, J Geriatr Psychiatry Neurol, V5, P78; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; Camicioli R, 2007, J NEURAL TRANSM, V114, P1355, DOI 10.1007/s00702-007-0778-5; Das SK, 2008, BEST PRACT RES CL RH, V22, P657, DOI 10.1016/j.berh.2008.07.002; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; HAUSER SL, 1983, NEW ENGL J MED, V308, P173, DOI 10.1056/NEJM198301273080401; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Jankovic J, 2001, ADV NEUROL, V87, P119; Jokinen H, 2009, CEREBROVASC DIS, V27, P336, DOI 10.1159/000202010; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Mold JW, 2004, J AM BOARD FAM PRACT, V17, P309, DOI 10.3122/jabfm.17.5.309; NUTT JG, 1993, NEUROLOGY, V43, P268, DOI 10.1212/WNL.43.2.268; ODENHEIMER G, 1994, ARCH NEUROL-CHICAGO, V51, P573, DOI 10.1001/archneur.1994.00540180051013; Oh-Park M, 2011, J AM GERIATR SOC, V59, P1225, DOI 10.1111/j.1532-5415.2011.03475.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Scherder E, 2007, NEUROSCI BIOBEHAV R, V31, P485, DOI 10.1016/j.neubiorev.2006.11.007; Schwaiger J, 2009, CEPHALALGIA, V29, P179, DOI 10.1111/j.1468-2982.2008.01705.x; Snijders AH, 2007, LANCET NEUROL, V6, P63, DOI 10.1016/S1474-4422(06)70678-0; Sudarsky L, 2001, ADV NEUROL, V87, P111; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Verghese J, 2006, J AM GERIATR SOC, V54, P255, DOI 10.1111/j.1532-5415.2005.00580.x; Verghese J, 2002, NEW ENGL J MED, V347, P1761, DOI 10.1056/NEJMoa020441; Verghese J, 2010, J NEUROL, V257, P392, DOI 10.1007/s00415-009-5332-y; Wenning GK, 2005, LANCET NEUROL, V4, P815, DOI 10.1016/S1474-4422(05)70226-X	30	114	117	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69627	10.1371/journal.pone.0069627	http://dx.doi.org/10.1371/journal.pone.0069627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	188BY	23894511	gold, Green Published, Green Submitted			2022-12-25	WOS:000322167900084
J	Matthes, R; Bender, C; Schluter, R; Koban, I; Bussiahn, R; Reuter, S; Lademann, J; Weltmann, KD; Kramer, A				Matthes, Rutger; Bender, Claudia; Schlueter, Rabea; Koban, Ina; Bussiahn, Rene; Reuter, Stephan; Lademann, Juergen; Weltmann, Klaus-Dieter; Kramer, Axel			Antimicrobial Efficacy of Two Surface Barrier Discharges with Air Plasma against In Vitro Biofilms	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; TISSUE-TOLERABLE PLASMA; PSEUDOMONAS-AERUGINOSA; ANTISEPTIC EFFICACY; JET; CHLORHEXIDINE; INFECTIONS; BACTERIA; ADHESION; CELLS	The treatment of infected wounds is one possible therapeutic aspect of plasma medicine. Chronic wounds are often associated with microbial biofilms which limit the efficacy of antiseptics. The present study investigates two different surface barrier discharges with air plasma to compare their efficacy against microbial biofilms with chlorhexidine digluconate solution (CHX) as representative of an important antibiofilm antiseptic. Pseudomonas aeruginosa SG81 and Staphylococcus epidermidis RP62A were cultivated on polycarbonate discs. The biofilms were treated for 30, 60, 150, 300 or 600 s with plasma or for 600 s with 0.1% CHX, respectively. After treatment, biofilms were dispensed by ultrasound and the antimicrobial effects were determined as difference in the number of the colony forming units by microbial culture. A high antimicrobial efficacy on biofilms of both plasma sources in comparison to CHX treatment was shown. The efficacy differs between the used strains and plasma sources. For illustration, the biofilms were examined under a scanning electron microscope before and after treatment. Additionally, cytotoxicity was determined by the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay with L929 mouse fibroblast cell line. The cell toxicity of the used plasma limits its applicability on human tissue to maximally 150 s. The emitted UV irradiance was measured to estimate whether UV could limit the application on human tissue at the given parameters. It was found that the UV emission is negligibly low. In conclusion, the results support the assumption that air plasma could be an option for therapy of chronic wounds.	[Matthes, Rutger; Bender, Claudia; Kramer, Axel] Univ Med Greifswald, Inst Hyg & Environm Med, Greifswald, Germany; [Schlueter, Rabea] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany; [Koban, Ina] Univ Med Greifswald, Sch Dent, Unit Periodontol, Greifswald, Germany; [Bussiahn, Rene; Reuter, Stephan; Weltmann, Klaus-Dieter] Leibniz Inst Plasma Sci & Technol INP Greifswald, Greifswald, Germany; [Reuter, Stephan] Ctr Innovat Competence ZIK Plasmatis, Greifswald, Germany; [Lademann, Juergen] Charite, Dept Dermatol Venerol & Allergol, Ctr Expt & Appl Cutaneous Physiol CCP, D-13353 Berlin, Germany	Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; Leibniz Institut fur Plasmaforschung und Technologie; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Matthes, R (corresponding author), Univ Med Greifswald, Inst Hyg & Environm Med, Greifswald, Germany.	rutger.matthes@uni-greifswald.de	Reuter, Stephan/D-2890-2014	Reuter, Stephan/0000-0002-4858-1081; Jurgen, Lademann/0000-0003-1828-7460	German Ministry of Education and Research (BMBF) [13N9779, 13N11181, 03Z2DN12]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the German Ministry of Education and Research (BMBF, grant No. 13N9779, 13N11181 and 03Z2DN12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawareek MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044289; [Anonymous], 1988, J TISSUE CULT METHOD; [Anonymous], 2007, 1040D DIN EN; [Anonymous], 2007, CEN TC 206 BIOCOMPAT; Becker K, 1996, MICROB ECOL, V32, P23; Bender C, 2012, ANTIMICROBIAL EFFICA; Bender C, 2012, NATO SCI PEACE SEC A; Bender C, 2011, TOXICOL IN VITRO, V25, P530, DOI 10.1016/j.tiv.2010.11.012; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Campbell KE, 2003, WOUNDS, V15, P40; Cotter JJ, 2011, J HOSP INFECT, V78, P204, DOI 10.1016/j.jhin.2011.03.019; Daeschlein G, 2010, PLASMA PROCESS POLYM, V7, P224, DOI 10.1002/ppap.200900059; Deredjian A, 2011, RES MICROBIOL, V162, P689, DOI 10.1016/j.resmic.2011.06.007; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Emmert S, 2013, CLIN PLASMA MED, V1, P24, DOI 10.1016/j.cpme.2012.11.002; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Gomez-Suarez C, 2002, MICROBIOL-SGM, V148, P1161, DOI 10.1099/00221287-148-4-1161; Hahnel M, 2011, PLASMA PROCESS POLYM, V8, P70, DOI 10.1002/ppap.201000084; Hammann A, 2010, SKIN PHARMACOL PHYS, V23, P328, DOI 10.1159/000314724; Hawkey PM, 2008, J ANTIMICROB CHEMOTH, V62, pI1, DOI 10.1093/jac/dkn241; Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P28, DOI 10.1159/000318265; *ICNIRP, 2004, HEALTH PHYS, V87, P117; Isbary G, 2012, BRIT J DERMATOL, V167, P404, DOI 10.1111/j.1365-2133.2012.10923.x; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kamgang JO, 2007, J APPL MICROBIOL, V103, P621, DOI 10.1111/j.1365-2672.2007.03286.x; Koban I, 2011, J CLIN PERIODONTOL, V38, P956, DOI 10.1111/j.1600-051X.2011.01740.x; Koban I, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073039; Kramer A, 2009, GMS KRANKENHAUSHYG I, V4; Kramer A, 2008, GMS HYG INFECT CONTR, V3; Lademann J, 2012, SKIN PHARMACOL PHYS, V25, P100, DOI 10.1159/000335558; Lademann J, 2013, SKIN RES TECHNOL, V19, pe552; Lademann J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3247156; Lademann O, 2011, SKIN PHARMACOL PHYS, V24, P284, DOI 10.1159/000329913; Lange H, 2009, IEEE T PLASMA SCI, V37, P859, DOI 10.1109/TPS.2009.2019982; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Laroussi M, 2002, APPL PHYS LETT, V81, P772, DOI 10.1063/1.1494863; Linton CJ, 1999, J APPL MICROBIOL, V86, P194, DOI 10.1046/j.1365-2672.1999.00650.x; Matthes R, 2010, GMS HYG INFECT CONTR, V5, DOI 10.3205/dgkh000145; Matthes R, 2013, PLASMA PROCESS POLYM, V10, P161, DOI 10.1002/ppap.201100133; Matthes R, 2012, GMS HYG INFECT CONTR, V7, DOI 10.3205/dgkh000186; Metelmann HR, 2012, AM J COSMET SURG, V29, P52, DOI DOI 10.5992/AJCS-D-11-00042.1; Moshrefi Abdy, 2002, J West Soc Periodontol Periodontal Abstr, V50, P5; Muangman P, 2011, INT J MOL SCI, V12, P5031, DOI 10.3390/ijms12085031; Mueller G, 2008, J ANTIMICROB CHEMOTH, V61, P1281, DOI 10.1093/jac/dkn125; Neues Rezeptur- Formularium NRFS, 2010, CHLORHEXIDIN ZAHNARZ; Nosenko T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115013; Oehmigen K, 2010, PLASMA PROCESS POLYM, V7, P250, DOI 10.1002/ppap.200900077; Park GY, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/043001; Pompl R, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115023; Powell DG, 1998, MED APPL POLYCARBONA; Randler C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-282; Reuter S, 2012, IEEE T PLASMA SCI, V40, P2986, DOI 10.1109/TPS.2012.2207130; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Tielen P, 2010, MICROBIOL-SGM, V156, P2239, DOI 10.1099/mic.0.037036-0; Uckay I, 2009, ANN MED, V41, P109, DOI 10.1080/07853890802337045; Vinh Donald C, 2005, J Long Term Eff Med Implants, V15, P467, DOI 10.1615/JLongTermEffMedImplants.v15.i5.20; Wagner HE, 2003, VACUUM, V71, P417, DOI 10.1016/S0042-207X(02)00765-0; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Weltmann KD, 2010, PURE APPL CHEM, V82, P1223, DOI 10.1351/PAC-CON-09-10-35; Weltmann KD, 2012, IEEE T PLASMA SCI, V40, P2963, DOI 10.1109/TPS.2012.2204279; Widerstrom M, 2011, APMIS, V119, P505, DOI 10.1111/j.1600-0463.2011.02757.x; Zhang Q, 2012, J APPL PHYS, V111	66	61	65	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70462	10.1371/journal.pone.0070462	http://dx.doi.org/10.1371/journal.pone.0070462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894661	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900129
J	Rustgi, S; Shafqat, MN; Kumar, N; Baenziger, PS; Ali, ML; Dweikat, I; Campbell, BT; Gill, KS				Rustgi, Sachin; Shafqat, Mustafa N.; Kumar, Neeraj; Baenziger, P. Stephen; Ali, M. Liakat; Dweikat, Ismail; Campbell, B. Todd; Gill, Kulvinder Singh			Genetic Dissection of Yield and Its Component Traits Using High-Density Composite Map of Wheat Chromosome 3A: Bridging Gaps between QTLs and Underlying Genes	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; BREAD WHEAT; AGRONOMIC TRAITS; GRAIN-YIELD; EAR EMERGENCE; LINKAGE MAP; MARKERS; LOCI; RICE; SUBSTITUTIONS	Earlier we identified wheat (Triticum aestivum L.) chromosome 3A as a major determinant of grain yield and its component traits. In the present study, a high-density genetic linkage map of 81 chromosome 3A-specific markers was developed to increase the precision of previously identified yield component QTLs, and to map QTLs for biomass-related traits. Many of the previously identified QTLs for yield and its component traits were confirmed and were localized to narrower intervals. Four novel QTLs one each for shoot biomass (Xcfa2262-Xbcd366), total biomass (wPt2740-Xcfa2076), kernels/spike (KPS) (Xwmc664-Xbarc67), and Pseudocercosporella induced lodging (PsIL) were also detected. The major QTLs identified for grain yield (GY), KPS, grain volume weight (GVWT) and spikes per square meter (SPSM) respectively explained 23.2%, 24.2%, 20.5% and 20.2% of the phenotypic variation. Comparison of the genetic map with the integrated physical map allowed estimation of recombination frequency in the regions of interest and suggested that QTLs for grain yield detected in the marker intervals Xcdo549-Xbarc310 and Xpsp3047-Xbarc356 reside in the high-recombination regions, thus should be amenable to map-based cloning. On the other hand, QTLs for KPS and SPSM flanked by markers Xwmc664 and Xwmc489 mapped in the low-recombination region thus are not suitable for map-based cloning. Comparisons with the rice (Oryza sativa L.) genomic DNA sequence identified 11 candidate genes (CGs) for yield and yield related QTLs of which chromosomal location of two (CKX2 and GID2-like) was confirmed using wheat aneuploids. This study provides necessary information to perform high-resolution mapping for map-based cloning and for CG-based cloning of yield QTLs.	[Rustgi, Sachin; Shafqat, Mustafa N.; Kumar, Neeraj; Gill, Kulvinder Singh] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Shafqat, Mustafa N.] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Baenziger, P. Stephen; Ali, M. Liakat; Dweikat, Ismail] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Campbell, B. Todd] ARS, Coastal Plains Soil Water & Plant Res Ctr, Florence, SC USA	Washington State University; COMSATS University Islamabad (CUI); University of Nebraska System; University of Nebraska Lincoln	Gill, KS (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	ksgill@wsu.edu	Rustgi, Sachin/AAF-5590-2020; Baenziger, Peter S/C-6490-2014	Baenziger, Peter S/0000-0002-9109-6954; Rustgi, Sachin/0000-0002-6881-9501; kumar, neeraj/0000-0001-9344-3481	United States Department of Agriculture, Agricultural Research Service [5248-22000-012-00D]; Vogel Endowment funds	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Vogel Endowment funds	This project was supported in part by the United States Department of Agriculture, Agricultural Research Service (5248-22000-012-00D) and The Vogel Endowment funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Ali ML, 2011, CROP SCI, V51, P553, DOI 10.2135/cropsci2010.06.0359; Baenziger PS, 2011, CZECH J GENET PLANT, V47, pS77, DOI 10.17221/3259-CJGPB; BERKE TG, 1992, CROP SCI, V32, P628, DOI 10.2135/cropsci1992.0011183X003200030011x; BERKE TG, 1992, CROP SCI, V32, P621, DOI 10.2135/cropsci1992.0011183X003200030010x; Campbell BT, 2004, CROP SCI, V44, P620, DOI 10.2135/cropsci2004.6200; Campbell BT, 2003, CROP SCI, V43, P1493, DOI 10.2135/cropsci2003.1493; Dhungana P, 2007, CROP SCI, V47, P477, DOI 10.2135/cropsci2006.06.0425; Dilbirligi M, 2006, GENOMICS, V88, P74, DOI 10.1016/j.ygeno.2006.02.001; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Gepts, 2004, PLANT BREEDING REV, V24, P1; GILL KS, 1991, GENOME, V34, P362, DOI 10.1139/g91-058; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hackett CA, 2002, PLANT MOL BIOL, V48, P585, DOI 10.1023/A:1014896712447; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HALLORAN GM, 1975, THEOR APPL GENET, V46, P79, DOI 10.1007/BF00281646; Hayden MJ, 2006, THEOR APPL GENET, V113, P1271, DOI 10.1007/s00122-006-0381-4; HOOGENDOORN J, 1985, EUPHYTICA, V34, P545, DOI 10.1007/BF00022954; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Kuraparthy V, 2008, FUNCT INTEGR GENOMIC, V8, P33, DOI 10.1007/s10142-007-0057-4; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Mameaux S, 2012, PLANT BIOTECHNOL J, V10, P67, DOI 10.1111/j.1467-7652.2011.00645.x; Mao SL, 2010, EUPHYTICA, V174, P343, DOI 10.1007/s10681-010-0128-9; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; Mengistu N, 2012, CROP SCI, V52, P1622, DOI 10.2135/cropsci2011.12.0677; Miura H, 1999, PLANT BREEDING, V118, P85, DOI 10.1046/j.1439-0523.1999.118001085.x; Munkvold JD, 2004, GENETICS, V168, P639, DOI 10.1534/genetics.104.034819; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Roder MS, 1998, GENETICS, V149, P2007; Sandhu D, 2001, GENETICS, V157, P1735; Saville RJ, 2012, J EXP BOT, V63, P1271, DOI 10.1093/jxb/err350; Sehgal SK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-64; Shah MM, 1999, CROP SCI, V39, P1728, DOI 10.2135/cropsci1999.3961728x; Shah MM, 1999, CROP SCI, V39, P1016, DOI 10.2135/cropsci1999.0011183X003900040009x; Shah MM, 2000, EUPHYTICA, V114, P135, DOI 10.1023/A:1003993930447; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Stephenson P, 1998, THEOR APPL GENET, V97, P946, DOI 10.1007/s001220050975; Thomson MJ, 2006, GENETICS, V172, P2501, DOI 10.1534/genetics.105.050500; Torada A, 2006, THEOR APPL GENET, V112, P1042, DOI 10.1007/s00122-006-0206-5; Wang JS, 2011, EUPHYTICA, V177, P277, DOI 10.1007/s10681-010-0267-z; Wang S, 2005, WINDOWS QTL CARTOGRA; Wu XS, 2010, J EXP BOT, V61, P2923, DOI 10.1093/jxb/erq117; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; YEN Y, 1992, GENOME, V35, P827, DOI 10.1139/g92-125; ZEMETRA RS, 1986, CROP SCI, V26, P531, DOI 10.2135/cropsci1986.0011183X002600030020x	52	33	34	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70526	10.1371/journal.pone.0070526	http://dx.doi.org/10.1371/journal.pone.0070526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894667	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900131
J	Harvey, R; Schuster, E; Jennings, BH				Harvey, Robert; Schuster, Eugene; Jennings, Barbara H.			Pleiohomeotic Interacts with the Core Transcription Elongation Factor Spt5 to Regulate Gene Expression in Drosophila	PLOS ONE			English	Article							RNA-POLYMERASE-II; POLYCOMB RESPONSE ELEMENT; DNA-BINDING; CHROMATIN LANDSCAPES; GENOME-WIDE; GAGA FACTOR; PROTEIN; COMPLEX; MELANOGASTER; REPRESSION	The early elongation checkpoint regulated by Positive Transcription Elongation Factor b (P-TEFb) is a critical control point for the expression of many genes. Spt5 interacts directly with RNA polymerase II and has an essential role in establishing this checkpoint, and also for further transcript elongation. Here we demonstrate that Drosophila Spt5 interacts both physically and genetically with the Polycomb Group (PcG) protein Pleiohomeotic (Pho), and the majority of Pho binding sites overlap with Spt5 binding sites across the genome in S2 cells. Our results indicate that Pho can interact with Spt5 to regulate transcription elongation in a gene specific manner.	[Harvey, Robert; Jennings, Barbara H.] UCL, UCL Canc Inst, Transcript Regulat Grp, London, England; [Schuster, Eugene] UCL, Dept Genet Evolut & Environm, London, England	University of London; University College London; University of London; University College London	Jennings, BH (corresponding author), UCL, UCL Canc Inst, Transcript Regulat Grp, London, England.	barbara.jennings@ucl.ac.uk		Harvey, Robert/0000-0002-0023-1146; Jennings, Barbara/0000-0003-1696-5256; Schuster, Eugene/0000-0001-5076-2810	MRC Career Development Award [G0800310, G0800339]; Medical Research Council [G0800310, G0800339] Funding Source: researchfish; MRC [G0800310, G0800339] Funding Source: UKRI	MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a MRC Career Development Award to Barbara Jennings (G0800310) and a MRC Career Development Award to Eugene Schuster (G0800339). http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Bantignies F, 2000, MOL CELL BIOL, V20, P9317, DOI 10.1128/MCB.20.24.9317-9330.2000; Beisel C, 2007, P NATL ACAD SCI USA, V104, P16615, DOI 10.1073/pnas.0701538104; Bhatia S, 2010, GENES CELLS, V15, P725, DOI 10.1111/j.1365-2443.2010.01416.x; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Busturia A, 2001, DEVELOPMENT, V128, P2163; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; Chou TB, 1996, GENETICS, V144, P1673; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; Fujioka M, 2008, DEVELOPMENT, V135, P4131, DOI 10.1242/dev.024554; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Ghosh SKB, 2011, MOL CELL BIOL, V31, P4232, DOI 10.1128/MCB.05930-11; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2012, BBA-GENE REGUL MECH, V1819, P700, DOI 10.1016/j.bbagrm.2012.02.015; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; GIRTON JR, 1994, DEV BIOL, V161, P393, DOI 10.1006/dbio.1994.1040; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Hartzog GA, 2013, BBA-GENE REGUL MECH, V1829, P105, DOI 10.1016/j.bbagrm.2012.08.007; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Jennings BH, 2008, EMBO REP, V9, P76, DOI 10.1038/sj.embor.7401122; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jennings BH, 2013, BIOESSAYS, V35, P553, DOI 10.1002/bies.201200179; Jennings BH, 2004, CURR BIOL, V14, P1680, DOI 10.1016/j.cub.2004.08.066; Jennings BH, 1999, MOL CELL BIOL, V19, P4600; Kassis JA, 2013, ADV GENET, V81, P83, DOI 10.1016/B978-0-12-407677-8.00003-8; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Mahmoudi T, 2003, NUCLEIC ACIDS RES, V31, P4147, DOI 10.1093/nar/gkg479; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mohd-Sarip A, 2002, MOL CELL BIOL, V22, P7473, DOI 10.1128/MCB.22.21.7473-7483.2002; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; PATTATUCCI AM, 1991, GENETICS, V129, P443; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Wang XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011498; Werner F, 2012, J MOL BIOL, V417, P13, DOI 10.1016/j.jmb.2012.01.031; Wilkinson L, 2012, IEEE T VIS COMPUT GR, V18, P321, DOI 10.1109/TVCG.2011.56; XU T, 1993, DEVELOPMENT, V117, P1223; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	62	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e70184	10.1371/journal.pone.0070184	http://dx.doi.org/10.1371/journal.pone.0070184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894613	gold, Green Published, Green Submitted			2022-12-25	WOS:000322132100090
J	Chatziefstratiou, EK; Bohrer, G; Bova, AS; Subramanian, R; Frasson, RPM; Scherzer, A; Butler, BW; Dickinson, MB				Chatziefstratiou, Efthalia K.; Bohrer, Gil; Bova, Anthony S.; Subramanian, Ravishankar; Frasson, Renato P. M.; Scherzer, Amy; Butler, Bret W.; Dickinson, Matthew B.			FireStem2D-A Two-Dimensional Heat Transfer Model for Simulating Tree Stem Injury in Fires	PLOS ONE			English	Article							CAMBIUM NECROSIS; MORTALITY; TEMPERATURES; PREDICTION; BARK	FireStem2D, a software tool for predicting tree stem heating and injury in forest fires, is a physically-based, two-dimensional model of stem thermodynamics that results from heating at the bark surface. It builds on an earlier one-dimensional model (FireStem) and provides improved capabilities for predicting fire-induced mortality and injury before a fire occurs by resolving stem moisture loss, temperatures through the stem, degree of bark charring, and necrotic depth around the stem. We present the results of numerical parameterization and model evaluation experiments for FireStem2D that simulate laboratory stem-heating experiments of 52 tree sections from 25 trees. We also conducted a set of virtual sensitivity analysis experiments to test the effects of unevenness of heating around the stem and with aboveground height using data from two studies: a low-intensity surface fire and a more intense crown fire. The model allows for improved understanding and prediction of the effects of wildland fire on injury and mortality of trees of different species and sizes.	[Chatziefstratiou, Efthalia K.; Bohrer, Gil; Bova, Anthony S.; Subramanian, Ravishankar; Frasson, Renato P. M.] Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; [Bova, Anthony S.; Scherzer, Amy; Dickinson, Matthew B.] US Forest Serv, No Res Stn, Delaware, OH USA; [Butler, Bret W.] US Forest Serv, Rocky Mt Res Stn, Missoula Fire Sci Lab, Missoula, MT USA	University System of Ohio; Ohio State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Chatziefstratiou, EK (corresponding author), Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA.	chatziefstratiou.1@osu.edu	Bohrer, Gil/A-9731-2008; de Moraes Frasson, Renato Prata/F-5816-2010	Bohrer, Gil/0000-0002-9209-9540; de Moraes Frasson, Renato Prata/0000-0003-4299-1730; Dickinson, Matthew/0000-0003-3635-1219	NASA-NESSF-Earth Sciences Fellowship [NNX09AO26]; US Forest Service, Delaware Research Station [09-CR-11242302-033]	NASA-NESSF-Earth Sciences Fellowship; US Forest Service, Delaware Research Station	The study was funded by NASA-NESSF-Earth Sciences Fellowship #NNX09AO26 to Anthony Bova and Gil Bohrer, and by the National Fire Plan through agreement #09-CR-11242302-033 from the US Forest Service, Delaware Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman T.L., 2011, INTRO HEAT TRANSFER, Vsix; Bova AS, 2005, CAN J FOREST RES, V35, P814, DOI 10.1139/X05-004; Bovard BD, 2005, TREE PHYSIOL, V25, P31, DOI 10.1093/treephys/25.1.31; Burgan RE, 1984, BEHAVE FIRE BEHAVIOR; Butler BW, 2010, FIRE ECOL, V6, P55, DOI 10.4996/fireecology.0601055; Butler BW, 2004, CAN J FOREST RES, V34, P1577, DOI [10.1139/x04-060, 10.1139/X04-060]; Cassagne N, 2011, ECOL MODEL, V222, P1502, DOI 10.1016/j.ecolmodel.2011.02.004; Costa J. J., 1991, International Journal of Wildland Fire, V1, P87, DOI 10.1071/WF9910087; CRANK J, 1947, P CAMB PHILOS SOC, V43, P50, DOI 10.1007/BF02127704; Dickinson M.B., 2001, FOREST FIRES, P477, DOI [10.1016/b978-012386660-8/50016-7, DOI 10.1016/B978-012386660-8/50016-7]; Dickinson MB, 2004, AUST J BOT, V52, P757, DOI 10.1071/BT03111; Dickinson MB, 2004, CAN J FOREST RES, V34, P546, DOI 10.1139/X03-223; Dickinson MB, 2002, PROCEEDINGS FOREST F; Ducrey M, 1996, CAN J FOREST RES, V26, P1366, DOI 10.1139/x26-152; Flint HR., 1925, IDAHO FORESTER, V7, P41; GILL AM, 1968, AUST J BOT, V16, P491, DOI 10.1071/BT9680491; Glass SV, 2010, WOOD HDB WOOD ENG MA; Gutsell SL, 1996, CAN J FOREST RES, V26, P166, DOI 10.1139/x26-020; Hale J. D., 1955, Pulp and Paper in Canada, V56, P113; HARMON ME, 1984, ECOLOGY, V65, P796, DOI 10.2307/1938052; Hyde K, 2013, INT J WILDLAND FIRE, V22, P37, DOI 10.1071/WF11143; JACOBY PW, 1992, J RANGE MANAGE, V45, P216, DOI 10.2307/4002787; Jones JK, 2004, CAN J FOREST RES, V34, P20, DOI [10.1139/x03-187, 10.1139/X03-187]; Jones JL, 2006, INT J WILDLAND FIRE, V15, P3, DOI 10.1071/WF05017; Jones JL, 2003, THESIS B YOUNG U; Kavanagh KL, 2010, FIRE ECOL, V6, P80, DOI 10.4996/fireecology.0601080; Laasasenaho J, 2005, FOREST ECOL MANAG, V206, P35, DOI 10.1016/j.foreco.2004.10.058; Martin R. E., 1963, Forest Products Journal, V13, P419; Martin RE, 1963, 2 TALL TIMB FIR EC C, V2, P151; McCarthy EF, 1935, J FOREST, V33, P155; Mell W, 2007, INT J WILDLAND FIRE, V16, P1, DOI 10.1071/WF06002; Michaletz ST, 2012, NEW PHYTOL, V194, P254, DOI 10.1111/j.1469-8137.2011.04021.x; Milliken D. E., 1955, Pulp and Paper in Canada, V56, P106; Morvan D, 2001, COMBUST FLAME, V127, P1981, DOI 10.1016/S0010-2180(01)00302-9; Patankar S. V., 1980, NUMERICAL HEAT TRANS, P214; PETERSON DL, 1986, ENVIRON MANAGE, V10, P797, DOI 10.1007/BF01867732; Potter BE, 2002, CAN J FOREST RES, V32, P548, DOI 10.1139/X01-226; RAGLAND KW, 1991, BIORESOURCE TECHNOL, V37, P161, DOI 10.1016/0960-8524(91)90205-X; Rego F, 1990, 3 INT S FIR EC FIR E, P257; Reinhardt ED, 1989, ESTIMATING TREE MORT; Ryan K. C., 1991, International Journal of Wildland Fire, V1, P107, DOI 10.1071/WF9910107; Shirley HL, 1936, J AGRIC RES, V53, P0239; SIAU JF, 1983, WOOD SCI TECHNOL, V17, P75, DOI 10.1007/BF00351834; Spalt KW., 1962, BARK CHARACTERISTICS; Starker TJ., 1934, J FOREST, V32, P462; VINES RG, 1968, AUST J BOT, V16, P499, DOI 10.1071/BT9680499; Wade D.D., 1989, TECH PUBL; William S., 1999, WOOD HDB WOOD ENG MA, P463	48	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70110	10.1371/journal.pone.0070110	http://dx.doi.org/10.1371/journal.pone.0070110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894599	gold, Green Published, Green Submitted			2022-12-25	WOS:000322391400082
J	Intarapat, S; Stern, CD				Intarapat, Sittipon; Stern, Claudio D.			Sexually Dimorphic and Sex-Independent Left-Right Asymmetries in Chicken Embryonic Gonads	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; STEM-CELLS; ESTROGEN-RECEPTOR; GENE-EXPRESSION; PITX2; AROMATASE; OVARY; DIFFERENTIATION; ORIGIN; BIRDS	Female birds develop asymmetric gonads: a functional ovary develops on the left, whereas the right gonad regresses. In males, however, testes develop on both sides. We examined the distribution of germ cells using Vasa/Cvh as a marker. Expression is asymmetric in both sexes: at stage 35 the left gonad contains significantly more germ cells than the right. A similar expression pattern is seen for expression of ERNI (Ens1), a gene expressed in chick embryonic stem cells while they self-renew, but downregulated upon differentiation. Other pluripotency-associated markers (PouV/Oct3/4, Nanog and Sox2) also show asymmetric expression (more expressing cells on the left) in both sexes, but this asymmetry is at least partly due to expression in stromal cells of the developing gonad, and the pattern is different for all the genes. Therefore germ cell and pluripotency-associated genes show both sex-dependent and independent left-right asymmetry and a complex pattern of expression.	[Intarapat, Sittipon] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; [Intarapat, Sittipon; Stern, Claudio D.] UCL, Dept Cell & Dev Biol, London, England; [Intarapat, Sittipon; Stern, Claudio D.] UCL, UCL Ctr Stem Cells & Regenerat Med, London, England	Mahidol University; University of London; University College London; University of London; University College London	Stern, CD (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	c.stern@ucl.ac.uk	Intarapat, Sittipon/N-4468-2019; Intarapat, Sittipon/P-9947-2016; Stern, Claudio/AAZ-7381-2021; Stern, Claudio D/C-6265-2008	Intarapat, Sittipon/0000-0002-5134-1441; Stern, Claudio/0000-0002-9907-889X; Stern, Claudio D/0000-0002-9907-889X	Medical Research Council (MRC) [G0400559]; Thailand's Commission on Higher Education (CHE-SFR), Royal Thai Government; Medical Research Council [G0400559] Funding Source: researchfish; MRC [G0400559] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Thailand's Commission on Higher Education (CHE-SFR), Royal Thai Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by programme grant G0400559 from the Medical Research Council (MRC) and a Ph.D. scholarship from the programme 'Strategic Scholarships for Frontier Research Network' of Thailand's Commission on Higher Education (CHE-SFR), Royal Thai Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2004, NUCLEIC ACIDS RES, V32, P2259, DOI 10.1093/nar/gkh545; Acloque H, 2001, MECH DEVELOP, V103, P79, DOI 10.1016/S0925-4773(01)00336-7; Andrews JE, 1997, GEN COMP ENDOCR, V108, P182, DOI 10.1006/gcen.1997.6978; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; DUBOIS R, 1978, CR ACAD SCI D NAT, V286, P535; DUBOIS R, 1979, CR ACAD SCI D NAT, V288, P895; DUBOIS R, 1978, CR ACAD SCI D NAT, V286, P1613; FUJIMOTO T, 1976, ANAT REC, V185, P139, DOI 10.1002/ar.1091850203; Fuyuta M, 1974, Okajimas Folia Anat Jpn, V51, P251; Gage PJ, 1999, MAMM GENOME, V10, P197, DOI 10.1007/s003359900970; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Guioli S, 2007, DEVELOPMENT, V134, P4199, DOI 10.1242/dev.010249; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hoshino A, 2005, DEV GROWTH DIFFER, V47, P65, DOI 10.1111/j.1440-169x.2004.00783.x; Hudson QJ, 2005, DEV DYNAM, V233, P1052, DOI 10.1002/dvdy.20388; Ishimaru Y, 2008, DEVELOPMENT, V135, P677, DOI 10.1242/dev.012856; Kent J, 1996, DEVELOPMENT, V122, P2813; Kerr CL, 2008, HUM REPROD, V23, P589, DOI 10.1093/humrep/dem411; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Lavial F, 2009, DEV BIOL, V330, P73, DOI 10.1016/j.ydbio.2009.03.012; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 1997, MED HYPOTHESES, V49, P429, DOI 10.1016/S0306-9877(97)90092-X; Levin M, 1997, BIOESSAYS, V19, P287, DOI 10.1002/bies.950190406; Levin M, 1997, DEV BIOL, V189, P57, DOI 10.1006/dbio.1997.8662; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Nakabayashi O, 1998, J MOL ENDOCRINOL, V20, P193, DOI 10.1677/jme.0.0200193; Pain B, 1996, DEVELOPMENT, V122, P2339; Park TS, 2000, MOL REPROD DEV, V56, P475, DOI 10.1002/1098-2795(200008)56:4&lt;475::AID-MRD5&gt;3.0.CO;2-M; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Raya A, 2004, MECH DEVELOP, V121, P1043, DOI 10.1016/j.mod.2004.05.005; Reed KJ, 2002, MECH DEVELOP, V119, pS87, DOI 10.1016/S0925-4773(03)00097-2; Rex M, 1997, MECH DEVELOP, V66, P39, DOI 10.1016/S0925-4773(97)00086-5; REX M, 1994, GENE, V149, P381, DOI 10.1016/0378-1119(94)90183-X; Rodriguez-Leon J, 2008, P NATL ACAD SCI USA, V105, P11242, DOI 10.1073/pnas.0804904105; Romanoff A.L., 1960, AVIAN EMBRYO STRUCTU; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Smith CA, 2007, CYTOGENET GENOME RES, V117, P165, DOI 10.1159/000103177; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Smith CA, 2003, BIOL REPROD, V68, P560, DOI 10.1095/biolreprod.102.007294; Smith CA, 1997, J STEROID BIOCHEM, V60, P295, DOI 10.1016/S0960-0760(96)00196-3; Smith CA, 2001, J EXP ZOOL, V290, P691, DOI 10.1002/jez.1119; Smith CA, 2007, SEX DEV, V1, P279, DOI 10.1159/000108934; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Smith CA, 2009, INT J DEV BIOL, V53, P59, DOI 10.1387/ijdb.082742cs; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; SWARTZ WJ, 1972, AM J ANAT, V135, P51, DOI 10.1002/aja.1001350106; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; van de Lavoir MC, 2006, METHOD ENZYMOL, V418, P38, DOI 10.1016/S0076-6879(06)18003-9; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; van de Lavoir MC, 2006, MECH DEVELOP, V123, P31, DOI 10.1016/j.mod.2005.10.002; Witschi E, 1935, AM J ANAT, V56, P119, DOI 10.1002/aja.1000560107; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; ZACCANTI F, 1990, DIFFERENTIATION, V43, P71, DOI 10.1111/j.1432-0436.1990.tb00432.x; Zhu L, 1999, CURR BIOL, V9, P931, DOI 10.1016/S0960-9822(99)80419-9	58	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69893	10.1371/journal.pone.0069893	http://dx.doi.org/10.1371/journal.pone.0069893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894556	gold, Green Published, Green Submitted			2022-12-25	WOS:000322391400073
J	Aberg, CH; Antonoglou, G; Haubek, D; Kwamin, F; Claesson, R; Johansson, A				Aberg, Carola Hoglund; Antonoglou, Georgios; Haubek, Dorte; Kwamin, Francis; Claesson, Rolf; Johansson, Anders			Cytolethal Distending Toxin in Isolates of Aggregatibacter actinomycetemcomitans from Ghanaian Adolescents and Association with Serotype and Disease Progression	PLOS ONE			English	Article							HUMAN GINGIVAL FIBROBLASTS; CELL-CYCLE PROGRESSION; LEUKOTOXIC JP2 CLONE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; SUBGINGIVAL PLAQUE; IMMUNE-RESPONSE; PREVALENCE; GENES; EXPRESSION	Background and Objectives: The cytolethal distending toxin (Cdt) is a highly conserved exotoxin that are produced by a number of Gram negative bacteria, including Aggregatibacter actinomycetemcomitans, and affects mammalian cells by inhibiting cell division and causing apoptosis. A complete cdt-operon is present in the majority of A. actinomycetemcomitans, but the proportion of isolates that lack cdt-encoding genes (A, B and C) varies according to the population studied. The objectives of this study were to examine serotype, Cdt-genotype, and Cdt-activity in isolates of A. actinomycetemcomitans collected from an adolescent West African population and to examine the association between the carrier status of A. actinomycetemcomitans and the progression of attachment loss (AL). Materials and Methods: A total of 249 A. actinomycetemcomitans isolates from 200 Ghanaian adolescents were examined for serotype and cdt-genotype by PCR. The activity of the Cdt-toxin was examined by DNA-staining of exposed cultured cells and documented with flow cytometry. The periodontal status of the participants was examined at baseline and at a two-year follow-up. Results: Presence of all three cdt-encoding genes was detected in 79% of the examined A. actinomycetemcomitans isolates. All these isolates showed a substantial Cdt-activity. The two different cdt-genotypes (with and without presence of all three cdt-encoding genes) showed a serotype-dependent distribution pattern. Presence of A. actinomycetemcomitans was significantly associated with progression of AL (OR = 5.126; 95% CI = [2.994-8.779], p<0.001). Conclusion: A. actinomycetemcomitans isolated from the Ghanaian adolescents showed a distribution of serotype and cdt-genotype in line with results based on other previously studied populations. Presence of A. actinomycetemcomitans was significantly associated with disease progression, in particular the b serotype, whereas the association with disease progression was not particularly related to cdt-genotype, and Cdt-activity.	[Aberg, Carola Hoglund; Antonoglou, Georgios; Johansson, Anders] Umea Univ, Fac Med, Dept Odontol, Div Mol Periodontol, Umea, Sweden; [Haubek, Dorte] Aarhus Univ, Dept Dent, Sect Pediat Dent, Aarhus, Denmark; [Kwamin, Francis] Univ Ghana, Sch Dent, Accra, Ghana; [Claesson, Rolf] Umea Univ, Fac Med, Dept Odontol, Div Oral Microbiol, Umea, Sweden	Umea University; Aarhus University; University of Ghana; Umea University	Johansson, A (corresponding author), Umea Univ, Fac Med, Dept Odontol, Div Mol Periodontol, Umea, Sweden.	anders.johansson@odont.umu.se			Swedish National Graduate School in Odontological Science; Research Fund (TUA), County of Vasterbotten, Sweden; Swedish Dental Association, Sweden; Ingeborg and Leo Dannins Foundation; Aarhus University Research Foundation [F-2009-SUN-1-57]; Danish Dental Association (KOF); Danish Dental Association (CALCIN); Danish Dental Association (the dentists Kai O. Mehlsen and Espen Leth Esbensens Foundation)	Swedish National Graduate School in Odontological Science; Research Fund (TUA), County of Vasterbotten, Sweden; Swedish Dental Association, Sweden; Ingeborg and Leo Dannins Foundation; Aarhus University Research Foundation; Danish Dental Association (KOF); Danish Dental Association (CALCIN); Danish Dental Association (the dentists Kai O. Mehlsen and Espen Leth Esbensens Foundation)	This study was supported by the Swedish National Graduate School in Odontological Science, the Research Fund (TUA), County of Vasterbotten, Sweden, the Swedish Dental Association, Sweden, Ingeborg and Leo Dannins Foundation, Aarhus University Research Foundation (F-2009-SUN-1-57), funds from the Danish Dental Association (KOF and CALCIN and the dentists Kai O. Mehlsen and Espen Leth Esbensens Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg CH, 2012, J PERIODONTOL, V83, P1520, DOI 10.1902/jop.2012.110699; Ahmed HJ, 2001, J MED MICROBIOL, V50, P860, DOI 10.1099/0022-1317-50-10-860; Ando ES, 2010, J PERIODONTAL RES, V45, P471, DOI 10.1111/j.1600-0765.2009.01260.x; Belibasakis GN, 2008, APMIS, V116, P499, DOI 10.1111/j.1600-0463.2008.01017.x; Belibasakis GN, 2004, APMIS, V112, P674, DOI 10.1111/j.1600-0463.2004.apm1121006.x; Belibasakis GN, 2005, INFECT IMMUN, V73, P342, DOI 10.1128/IAI.73.1.342-351.2005; Brage M, 2011, J PERIODONTAL RES, V46, P170, DOI 10.1111/j.1600-0765.2010.01325.x; Chen C, 2010, MOL ORAL MICROBIOL, V25, P207, DOI 10.1111/j.2041-1014.2010.00567.x; Damek-Poprawa M, 2011, J DENT RES, V90, P874, DOI 10.1177/0022034511403743; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Elamin AM, 2010, J PERIODONTOL, V81, P891, DOI 10.1902/jop.2010.090709; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Fabris AS, 2002, ORAL MICROBIOL IMMUN, V17, P231, DOI 10.1034/j.1399-302X.2002.170405.x; Fine DH, 2007, J CLIN MICROBIOL, V45, P3859, DOI 10.1128/JCM.00653-07; HAUBEK D, 1995, J CLIN MICROBIOL, V33, P395, DOI 10.1128/JCM.33.2.395-401.1995; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Haubek D, 2007, INFECT IMMUN, V75, P3080, DOI 10.1128/IAI.01734-06; Haubek D, 2010, APMIS, V118, P1, DOI 10.1111/j.1600-0463.2010.02665.x; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Jentsch H, 2012, CLIN ORAL INVEST, V16, P1589, DOI 10.1007/s00784-012-0672-x; Jinadasa RN, 2011, MICROBIOL-SGM, V157, P1851, DOI 10.1099/mic.0.049536-0; Johansson A, 2005, EUR J ORAL SCI, V113, P197, DOI 10.1111/j.1600-0722.2005.00218.x; Johansson A, 2011, TOXINS, V3, P242, DOI 10.3390/toxins3030242; Kaplan JB, 2001, INFECT IMMUN, V69, P5375, DOI 10.1128/IAI.69.9.5375-5384.2001; Kawamoto D, 2009, ORAL MICROBIOL IMMUN, V24, P493, DOI 10.1111/j.1399-302X.2009.00547.x; Kilian M, 2006, PERIODONTOL 2000, V42, P158, DOI 10.1111/j.1600-0757.2006.00159.x; Kim TS, 2009, J PERIODONTOL, V80, P2020, DOI 10.1902/jop.2009.090241; Kittichotirat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022420; Lakio L, 2002, EUR J ORAL SCI, V110, P212, DOI 10.1034/j.1600-0447.2002.201238.x; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Leung WK, 2005, J PERIODONTAL RES, V40, P258, DOI 10.1111/j.1600-0765.2005.00805.x; Nishihara T, 2004, PERIODONTOL 2000, V36, P14, DOI 10.1111/j.1600-0757.2004.03671.x; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pinheiro ET, 2011, J PERIODONTAL RES, V46, P310, DOI 10.1111/j.1600-0765.2011.01344.x; Poulsen K, 2003, J CLIN MICROBIOL, V41, P4829, DOI 10.1128/JCM.41.10.4829-4832.2003; POULSEN K, 1994, MICROBIOL-UK, V140, P2049, DOI 10.1099/13500872-140-8-2049; SAARELA M, 1992, ORAL MICROBIOL IMMUN, V7, P277, DOI 10.1111/j.1399-302X.1992.tb00588.x; Schenkein HA, 2006, PERIODONTOL 2000, V40, P77, DOI 10.1111/j.1600-0757.2005.00144.x; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; Suzuki N, 2001, J CLIN MICROBIOL, V39, P2002, DOI 10.1128/JCM.39.5.2002-2005.2001; Takada K, 2010, MOL ORAL MICROBIOL, V25, P200, DOI 10.1111/j.2041-1014.2010.00572.x; Tan KS, 2002, J PERIODONTAL RES, V37, P268, DOI 10.1034/j.1600-0765.2002.01618.x; Van der Velden U, 2006, J CLIN PERIODONTOL, V33, P540, DOI 10.1111/j.1600-051X.2006.00953.x; Yamano R, 2003, J CLIN MICROBIOL, V41, P1391, DOI 10.1128/JCM.41.4.1391-1398.2003; Yang HW, 2004, J PERIODONTOL, V75, P592, DOI 10.1902/jop.2004.75.4.592; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x; ZAMBON JJ, 1983, INFECT IMMUN, V41, P19, DOI 10.1128/IAI.41.1.19-27.1983	49	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65781	10.1371/journal.pone.0065781	http://dx.doi.org/10.1371/journal.pone.0065781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23922633	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300043
J	Pluvinage, B; Hehemann, JH; Boraston, AB				Pluvinage, Benjamin; Hehemann, Jan-Hendrik; Boraston, Alisdair B.			Substrate Recognition and Hydrolysis by a Family 50 exo-beta-Agarase, Aga50D, from the Marine Bacterium Saccharophagus degradans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; AGARIVORANS SP NOV.; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; PSEUDOMONAS-ATLANTICA; STRUCTURE VALIDATION; CELLOBIOHYDROLASE-I; TRICHODERMA-REESEI; ENZYME	The bacteria that metabolize agarose use multiple enzymes of complementary specificities to hydrolyze the glycosidic linkages in agarose, a linear polymer comprising the repeating disaccharide subunit of neoagarobiose (3,6-anhydro-L-galactose-alpha-(1,3)-D-galactose) that are beta-(1,4)-linked. Here we present the crystal structure of a glycoside hydrolase family 50 exo-beta-agarase, Aga50D, from the marine microbe Saccharophagus degradans. This enzyme catalyzes a critical step in the metabolism of agarose by S. degradans through cleaving agarose oligomers into neoagarobiose products that can be further processed into monomers. The crystal structure of Aga50D to 1.9 angstrom resolution reveals a (beta/alpha)(8)-barrel fold that is elaborated with a beta-sandwich domain and extensive loops. The structures of catalytically inactivated Aga50D in complex with non-hydrolyzed neoagarotetraose (2.05 angstrom resolution) and neoagarooctaose (2.30 angstrom resolution) provide views of Michaelis complexes for a beta-agarase. In these structures, the D-galactose residue in the -1 subsite is distorted into a S-1(3) skew boat conformation. The relative positioning of the putative catalytic residues are most consistent with a retaining catalytic mechanism. Additionally, the neoagarooctaose complex showed that this extended substrate made substantial interactions with the beta-sandwich domain, which resembles a carbohydrate-binding module, thus creating additional plus (+) subsites and funneling the polymeric substrate through the tunnel-shaped active site. A synthesis of these results in combination with an additional neoagarobiose product complex suggests a potential exo-processive mode of action of Aga50D on the agarose double helix.	[Pluvinage, Benjamin; Hehemann, Jan-Hendrik; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Hehemann, Jan-Hendrik] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	University of Victoria; Massachusetts Institute of Technology (MIT)	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca		Hehemann, Jan-Hendrik/0000-0002-8700-2564; Boraston, Alisdair/0000-0001-6417-0592	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Discovery Accelerator Supplement; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Accelerator Supplement(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant and an NSERC Discovery Accelerator Supplement. The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Allouch J, 2004, STRUCTURE, V12, P623, DOI 10.1016/j.str.2004.02.020; Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731; ARNOTT S, 1974, J MOL BIOL, V90, P269, DOI 10.1016/0022-2836(74)90372-6; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; BEZUKLADNIKOV PW, 1986, CARBOHYD RES, V152, P261, DOI 10.1016/S0008-6215(00)90306-9; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chi WJ, 2012, APPL MICROBIOL BIOT, V94, P917, DOI 10.1007/s00253-012-4023-2; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Czjzek M, 2012, METHOD ENZYMOL, V510, P183, DOI 10.1016/B978-0-12-415931-0.00010-0; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Davies GJ, 2002, BIOCHEM SOC T, V30, P291, DOI 10.1042/BST0300291; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P1926, DOI 10.1021/bi972162m; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Ruiter GA, 1997, TRENDS FOOD SCI TECH, V8, P389, DOI 10.1016/S0924-2244(97)01091-1; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Ekborg NA, 2006, APPL ENVIRON MICROB, V72, P3396, DOI 10.1128/AEM.72.5.3396-3405.2006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu XT, 2010, MAR DRUGS, V8, P200, DOI 10.3390/md8010200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Genta FA, 2007, BBA-PROTEINS PROTEOM, V1774, P1079, DOI 10.1016/j.bbapap.2007.07.006; Goncalves AMD, 2012, ACTA CRYSTALLOGR D, V68, P1468, DOI 10.1107/S0907444912034646; Gregg KJ, 2011, J BIOL CHEM, V286, P15586, DOI 10.1074/jbc.M111.223172; Ha SC, 2011, BIOCHEM BIOPH RES CO, V412, P238, DOI 10.1016/j.bbrc.2011.07.073; Hehemann JH, 2012, P NATL ACAD SCI USA, V109, P19786, DOI 10.1073/pnas.1211002109; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Hehemann JH, 2012, J BIOL CHEM, V287, P13985, DOI 10.1074/jbc.M112.345645; Hosoya S, 2009, INT J SYST EVOL MICR, V59, P1262, DOI 10.1099/ijs.0.003244-0; Hu Z, 2009, J APPL MICROBIOL, V106, P181, DOI 10.1111/j.1365-2672.2008.03990.x; Jean WD, 2006, INT J SYST EVOL MICR, V56, P1245, DOI 10.1099/ijs.0.64130-0; Kim HT, 2010, APPL MICROBIOL BIOT, V86, P227, DOI 10.1007/s00253-009-2256-5; Kirimura K, 1999, J BIOSCI BIOENG, V87, P436, DOI 10.1016/S1389-1723(99)80091-7; KNUTSEN SH, 1994, BOT MAR, V37, P163, DOI 10.1515/botm.1994.37.2.163; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee DG, 2006, BIOTECHNOL LETT, V28, P1925, DOI 10.1007/s10529-006-9171-y; Letts JA, 2006, J BIOL CHEM, V281, P3625, DOI 10.1074/jbc.M507620200; Liao L, 2011, APPL ENVIRON MICROB, V77, P7077, DOI 10.1128/AEM.05364-11; Lin BK, 2012, WORLD J MICROB BIOT, V28, P1691, DOI 10.1007/s11274-011-0977-y; Mandelman D, 2003, J BACTERIOL, V185, P4127, DOI 10.1128/JB.185.14.4127-4135.2003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Michel G, 2003, J MOL BIOL, V334, P421, DOI 10.1016/j.jmb.2003.09.056; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; MORRICE LM, 1983, EUR J BIOCHEM, V137, P149, DOI 10.1111/j.1432-1033.1983.tb07808.x; MORRICE LM, 1983, EUR J BIOCHEM, V135, P553, DOI 10.1111/j.1432-1033.1983.tb07688.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikapitiya C, 2010, FISH AQUA SCI, V13, P36; Ohta Y, 2005, BIOTECHNOL APPL BIOC, V41, P183, DOI 10.1042/BA20040083; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rebuffet E, 2011, ENVIRON MICROBIOL, V13, P1253, DOI 10.1111/j.1462-2920.2011.02426.x; ROBYT JF, 1967, ARCH BIOCHEM BIOPHYS, V122, P8, DOI 10.1016/0003-9861(67)90118-X; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Sorbotten A, 2005, FEBS J, V272, P538, DOI 10.1111/j.1742-4658.2004.04495.x; SUGANO Y, 1993, APPL ENVIRON MICROB, V59, P1549; SUGANO Y, 1994, BBA-GENE STRUCT EXPR, V1218, P105, DOI 10.1016/0167-4781(94)90109-0; Temuujin U, 2011, APPL MICROBIOL BIOT, V92, P749, DOI 10.1007/s00253-011-3347-7; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Bueren AL, 2011, STRUCTURE, V19, P640, DOI 10.1016/j.str.2011.03.001; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vijayaraghavan R, 2012, J BASIC MICROB, V52, P705, DOI 10.1002/jobm.201100315; Vincent F, 2004, CHEMBIOCHEM, V5, P1596, DOI 10.1002/cbic.200400169; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zhang WW, 2007, APPL ENVIRON MICROB, V73, P2825, DOI 10.1128/AEM.02872-06; Ziervogel K, 2008, ENVIRON MICROBIOL, V10, P289, DOI 10.1111/j.1462-2920.2007.01451.x	77	47	51	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28078	28088		10.1074/jbc.M113.491068	http://dx.doi.org/10.1074/jbc.M113.491068			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23921382	Green Published, hybrid			2022-12-25	WOS:000330612800033
J	Block, A; Fristedt, R; Rogers, S; Kumar, J; Barnes, B; Barnes, J; Elowsky, CG; Wamboldt, Y; Mackenzie, SA; Redding, K; Merchant, SS; Basset, GJ				Block, Anna; Fristedt, Rikard; Rogers, Sara; Kumar, Jyothi; Barnes, Brian; Barnes, Joshua; Elowsky, Christian G.; Wamboldt, Yashitola; Mackenzie, Sally A.; Redding, Kevin; Merchant, Sabeeha S.; Basset, Gilles J.			Functional Modeling Identifies Paralogous Solanesyl-diphosphate Synthases That Assemble the Side Chain of Plastoquinone-9 in Plastids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-E; THYLAKOID MEMBRANES; PHOTOSYSTEM-II; ARABIDOPSIS; CHLOROPLAST; TOCOPHEROL; PLASTOCHROMANOL; LOCALIZATION; PLASTOGLOBULES; ACCUMULATION	It is a little known fact that plastoquinone-9, a vital redox cofactor of photosynthesis, doubles as a precursor for the biosynthesis of a vitamin E analog called plastochromanol-8, the physiological significance of which has remained elusive. Gene network reconstruction, GFP fusion experiments, and targeted metabolite profiling of insertion mutants indicated that Arabidopsis possesses two paralogous solanesyl-diphosphate synthases, AtSPS1 (At1g78510) and AtSPS2 (At1g17050), that assemble the side chain of plastoquinone-9 in plastids. Similar paralogous pairs were detected throughout terrestrial plant lineages but were not distinguished in the literature and genomic databases from mitochondrial homologs involved in the biosynthesis of ubiquinone. The leaves of the atsps2 knock-out were devoid of plastochromanol-8 and displayed severe losses of both non-photoactive and photoactive plastoquinone-9, resulting in near complete photoinhibition at high light intensity. Such a photoinhibition was paralleled by significant damage to photosystem II but not to photosystem I. In contrast, in the atsps1 knock-out, a small loss of plastoquinone-9, restricted to the non-photoactive pool, was sufficient to eliminate half of the plastochromanol-8 content of the leaves. Taken together, these results demonstrate that plastochromanol-8 originates from a subfraction of the non-photoactive pool of plastoquinone-9. In contrast to other plastochromanol-8 biosynthetic mutants, neither the single atsps knock-outs nor the atsps1 atsps2 double knock-out displayed any defects in tocopherols accumulation or germination.	[Block, Anna; Rogers, Sara; Kumar, Jyothi; Barnes, Brian; Barnes, Joshua; Elowsky, Christian G.; Wamboldt, Yashitola; Mackenzie, Sally A.; Basset, Gilles J.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA; [Fristedt, Rikard; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Redding, Kevin] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe	Basset, GJ (corresponding author), Univ Nebraska, Ctr Plant Sci Innovat, Beadle Ctr Genet Res, Lincoln, NE 68588 USA.	gbasset2@unl.edu	Block, Anna/AAF-2556-2020	Block, Anna/0000-0003-1689-4005; Redding, Kevin/0000-0003-2819-4022; Basset, Gilles/0000-0001-5275-9797	National Science Foundation [MCB-0918258, MCB-1148968]; United States Department of Energy [DE-FC02-02ER63421, DE-FG02-12ER16189]; Wenner-Gren Foundation; Center for Plant Science Innovation; Department of Biochemistry at the University of Nebraska-Lincoln; Direct For Biological Sciences [1148968] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Wenner-Gren Foundation; Center for Plant Science Innovation; Department of Biochemistry at the University of Nebraska-Lincoln; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was made possible in part by National Science Foundation Grants MCB-0918258 and MCB-1148968 (to G. J. B.), United States Department of Energy Cooperative Agreements DE-FC02-02ER63421 (to S. S. M.) and DE-FG02-12ER16189 (to S. A. M.), and a Wenner-Gren Foundation grant (to R. F.). This work was also supported by the Center for Plant Science Innovation and the Department of Biochemistry at the University of Nebraska-Lincoln.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ASAI K, 1994, BIOCHEM BIOPH RES CO, V202, P340, DOI 10.1006/bbrc.1994.1933; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Cheng ZG, 2003, PLANT CELL, V15, P2343, DOI 10.1105/tpc.013656; Christensen AC, 2005, PLANT CELL, V17, P2805, DOI 10.1105/tpc.105.035287; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cooley JW, 2001, J BACTERIOL, V183, P4251, DOI 10.1128/JB.183.14.4251-4258.2001; Dawson R. M. C., 1986, DATA BIOCH RES, p[132, 138]; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ducluzeau AL, 2012, PLANT J, V69, P366, DOI 10.1111/j.1365-313X.2011.04796.x; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Hirooka K, 2005, BIOSCI BIOTECH BIOCH, V69, P592, DOI 10.1271/bbb.69.592; Hirooka K, 2003, BIOCHEM J, V370, P679, DOI 10.1042/BJ20021311; Hsieh FL, 2011, PLANT PHYSIOL, V155, P1079, DOI 10.1104/pp.110.168799; Hundal T, 1995, ARCH BIOCHEM BIOPHYS, V324, P117, DOI 10.1006/abbi.1995.9920; Jones MO, 2013, BIOCHEM J, V449, P729, DOI 10.1042/BJ20120988; Jun L, 2004, PLANT CELL PHYSIOL, V45, P1882, DOI 10.1093/pcp/pch211; Karamoko M, 2011, PLANT CELL, V23, P4462, DOI 10.1105/tpc.111.089680; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; LEERBECK E, 1967, ACTA CHEM SCAND, V21, P2582, DOI 10.3891/acta.chem.scand.21-2582; Lichtenthaler HK, 1997, TRENDS PLANT SCI, V2, P316, DOI 10.1016/S1360-1385(97)89954-2; Lundquist PK, 2013, PLANT CELL, V25, P1818, DOI 10.1105/tpc.113.111120; Maeda H, 2007, CURR OPIN PLANT BIOL, V10, P260, DOI 10.1016/j.pbi.2007.04.006; Martinis J, 2013, PLANT PHYSIOL, V162, P652, DOI 10.1104/pp.113.218644; Mene-Saffrane L, 2010, P NATL ACAD SCI USA, V107, P17815, DOI 10.1073/pnas.1006971107; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Mullineaux CW, 2005, J EXP BOT, V56, P389, DOI 10.1093/jxb/eri064; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Norris SR, 1998, PLANT PHYSIOL, V117, P1317, DOI 10.1104/pp.117.4.1317; Ohara K, 2010, J EXP BOT, V61, P2683, DOI 10.1093/jxb/erq103; Piller LE, 2012, J EXP BOT, V63, P1609, DOI 10.1093/jxb/ers016; Piller LE, 2011, P NATL ACAD SCI USA, V108, P14354, DOI 10.1073/pnas.1104790108; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Rochaix JD, 2013, ANTIOXID REDOX SIGN, V18, P2184, DOI 10.1089/ars.2012.5110; Sadre R, 2010, J BIOL CHEM, V285, P18191, DOI 10.1074/jbc.M110.117929; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Szymanska R, 2010, PLANT CELL PHYSIOL, V51, P537, DOI 10.1093/pcp/pcq017; Szymanska R, 2010, ACTA BIOCHIM POL, V57, P105; Tian L, 2007, PLANTA, V226, P1067, DOI 10.1007/s00425-007-0564-5; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zbierzak AM, 2010, BIOCHEM J, V425, P389, DOI 10.1042/BJ20090704; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	47	37	39	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27594	27606		10.1074/jbc.M113.492769	http://dx.doi.org/10.1074/jbc.M113.492769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23913686	Green Published, hybrid			2022-12-25	WOS:000330597300054
J	Dacks, AM; Reale, V; Pi, YL; Zhang, WJ; Dacks, JB; Nighorn, AJ; Evans, PD				Dacks, Andrew M.; Reale, Vincenzina; Pi, Yeli; Zhang, Wujie; Dacks, Joel B.; Nighorn, Alan J.; Evans, Peter D.			A Characterization of the Manduca sexta Serotonin Receptors in the Context of Olfactory Neuromodulation	PLOS ONE			English	Article							ANTENNAL LOBE NEURONS; RAT-PREFRONTAL CORTEX; LOCAL INTERNEURONS; DROSOPHILA-MELANOGASTER; IMMUNOREACTIVE NEURON; BRAIN-SEROTONIN; IN-VITRO; MOTH; 5-HYDROXYTRYPTAMINE; GLUTAMATE	Neuromodulation, the alteration of individual neuron response properties, has dramatic consequences for neural network function and is a phenomenon observed across all brain regions and taxa. However, the mechanisms underlying neuromodulation are made complex by the diversity of neuromodulatory receptors expressed within a neural network. In this study we begin to examine the receptor basis for serotonergic neuromodulation in the antennal lobe of Manduca sexta. To this end we cloned all four known insect serotonin receptor types from Manduca (the Ms5HTRs). We used phylogenetic analyses to classify the Ms5HTRs and to establish their relationships to other insect serotonin receptors, other insect amine receptors and the vertebrate serotonin receptors. Pharmacological assays demonstrated that each Ms5HTR was selective for serotonin over other endogenous amines and that serotonin had a similar potency at all four Ms5HTRs. The pharmacological assays also identified several agonists and antagonists of the different Ms5HTRs. Finally, we found that the Ms5HT1A receptor was expressed in a subpopulation of GABAergic local interneurons suggesting that the Ms5HTRs are likely expressed heterogeneously within the antennal lobe based on functional neuronal subtype.	[Dacks, Andrew M.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Dacks, Andrew M.; Zhang, Wujie; Nighorn, Alan J.] Univ Arizona, Dept Neurosci, Tucson, AZ USA; [Reale, Vincenzina; Evans, Peter D.] Babraham Inst, Inositide Lab, Cambridge, England; [Pi, Yeli; Dacks, Joel B.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada	West Virginia University; University of Arizona; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Alberta	Dacks, AM (corresponding author), W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	adacks@gmail.com	Dacks, Joel/AAE-3308-2021	Dacks, Joel/0000-0003-4520-5694	NIH [DC-42092, 1 K12 Gm00708]; NSERC [372638-09]; BBSRC via the Babraham Institute; BBSRC [BBS/E/B/0000C194] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C194] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BBSRC via the Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant DC-42092 to AJN, a NIH Training Grant #1 K12 Gm00708 to AMD and NSERC Discovery grant 372638-09 to JBD. PDE and VR were funded by the BBSRC via the Babraham Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Aghajanian GK, 2000, BRAIN RES REV, V31, P302, DOI 10.1016/S0165-0173(99)00046-6; Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; Andrade R, 2011, NEUROPHARMACOLOGY, V61, P382, DOI 10.1016/j.neuropharm.2011.01.015; ARANEDA R, 1991, NEUROSCIENCE, V40, P399, DOI 10.1016/0306-4522(91)90128-B; Barrozo RB, 2010, J EXP BIOL, V213, P1100, DOI 10.1242/jeb.040139; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Becnel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020800; Beique JC, 2004, J NEUROSCI, V24, P4807, DOI 10.1523/JNEUROSCI.5113-03.2004; Beique JC, 2007, P NATL ACAD SCI USA, V104, P9870, DOI 10.1073/pnas.0700436104; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; COLPAERT FC, 1979, EUR J PHARMACOL, V58, P505, DOI 10.1016/0014-2999(79)90326-1; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dacks AM, 2008, J NEUROPHYSIOL, V99, P2077, DOI 10.1152/jn.01372.2007; Dacks AM, 2006, INSECT BIOCHEM MOLEC, V36, P741, DOI 10.1016/j.ibmb.2006.07.002; Dacks AM, 2006, J COMP NEUROL, V498, P727, DOI 10.1002/cne.21076; Dacks AM, 2012, J NEUROPHYSIOL, V108, P539, DOI 10.1152/jn.00159.2012; Dacks AM, 2010, J COMP NEUROL, V518, P2917, DOI 10.1002/cne.22371; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Feng GP, 1996, J NEUROSCI, V16, P3925; Gibson NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033828; Hardy A, 2005, NEUROSCIENCE, V131, P717, DOI 10.1016/j.neuroscience.2004.10.034; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hill ES, 2003, J EXP BIOL, V206, P345, DOI 10.1242/jeb.00080; JACOBS BL, 1991, PHARMACOL REV, V43, P563; JACOBS BL, 1990, ANN NY ACAD SCI, V600, P260, DOI 10.1111/j.1749-6632.1990.tb16888.x; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; JACOBS BL, 1990, NEUROPSYCHOPHARMACOL, V3, P473; Johnson O, 2011, NEUROSCIENCE, V192, P372, DOI 10.1016/j.neuroscience.2011.06.058; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Kahsai L, 2012, NEUROSCIENCE, V208, P11, DOI 10.1016/j.neuroscience.2012.02.007; KENT KS, 1987, J NEUROBIOL, V18, P451, DOI 10.1002/neu.480180506; Kloppenburg P, 2000, J EXP BIOL, V203, P1701; KLOPPENBURG P, 1995, J EXP BIOL, V198, P603; Kloppenburg P, 1999, J NEUROSCI, V19, P8172; KUPFERMANN I, 1979, ANNU REV NEUROSCI, V2, P447, DOI 10.1146/annurev.ne.02.030179.002311; Lambe EK, 2001, J NEUROSCI, V21, P9955, DOI 10.1523/JNEUROSCI.21-24-09955.2001; Lambe EK, 2006, NEUROPSYCHOPHARMACOL, V31, P1682, DOI 10.1038/sj.npp.1300944; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Liu SL, 2012, J NEUROPHYSIOL, V107, P473, DOI 10.1152/jn.00741.2011; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Mapara S, 2008, J EXP BIOL, V211, P900, DOI 10.1242/jeb.013953; MAXWELL GD, 1978, COMP BIOCHEM PHYS C, V61, P109, DOI 10.1016/0306-4492(78)90120-X; MERCER AR, 1995, J EXP BIOL, V198, P613; Mercer AR, 1996, J COMP PHYSIOL A, V178, P21, DOI 10.1007/BF00189587; Mercer AR, 1996, J NEUROBIOL, V29, P49, DOI 10.1002/(SICI)1097-4695(199601)29:1<49::AID-NEU4>3.0.CO;2-7; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; Nagakura I, 2010, J NEUROCHEM, V115, P994, DOI 10.1111/j.1471-4159.2010.06986.x; Nichols CD, 2007, DEV NEUROBIOL, V67, P752, DOI 10.1002/dneu.20370; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Petzold GC, 2009, NAT NEUROSCI, V12, P784, DOI 10.1038/nn.2335; Reisenman CE, 2011, J COMP PHYSIOL A, V197, P653, DOI 10.1007/s00359-011-0625-x; ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x; Roser C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049459; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Schlenstedt J, 2006, J NEUROCHEM, V98, P1985, DOI 10.1111/j.1471-4159.2006.04012.x; Seki Y, 2008, J COMP NEUROL, V506, P93, DOI 10.1002/cne.21528; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; SMITH K, 2007, RANGIFER         APR, P7; Steinbusch H W, 1981, Adv Exp Med Biol, V133, P7; Thamm M, 2010, CELL MOL LIFE SCI, V67, P2467, DOI 10.1007/s00018-010-0350-6; Trinquet E, 2011, EXPERT OPIN DRUG DIS, V6, P981, DOI 10.1517/17460441.2011.608658; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; VANRENTERGHEM C, 1987, BRAIN RES, V388, P21; Vazquez-Acevedo N, 2009, J COMP NEUROL, V513, P399, DOI 10.1002/cne.21979; Villalobos C, 2005, EUR J NEUROSCI, V22, P1120, DOI 10.1111/j.1460-9568.2005.04307.x; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032	77	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69422	10.1371/journal.pone.0069422	http://dx.doi.org/10.1371/journal.pone.0069422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922709	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700028
J	Falagas, ME; Karageorgopoulos, DE; Leptidis, J; Korbila, IP				Falagas, Matthew E.; Karageorgopoulos, Drosos E.; Leptidis, John; Korbila, Ioanna P.			MRSA in Africa: Filling the Global Map of Antimicrobial Resistance	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BACTEREMIA; PANTON-VALENTINE-LEUKOCIDIN; SOFT-TISSUE INFECTIONS; SUSCEPTIBILITY PROFILE; HIGH PREVALENCE; COMMUNITY; HOSPITALS; EPIDEMIOLOGY; EMERGENCE; EVOLUTION	We sought to assess the prevalence of methicillin-resistance among Staphylococcus aureus isolates in Africa. We included articles published in 2005 or later reporting for the prevalence of MRSA among S. aureus clinical isolates. Thirty-two studies were included. In Tunisia, the prevalence of MRSA increased from 16% to 41% between 2002-2007, while in Libya it was 31% in 2007. In South Africa, the prevalence decreased from 36% in 2006 to 24% during 2007-2011. In Botswana, the prevalence varied from 23-44% between 2000-2007. In Algeria and Egypt, the prevalence was 45% and 52% between 2003-2005, respectively. In Nigeria, the prevalence was greater in the northern than the southern part. In Ethiopia and the Ivory Coast, the prevalence was 55% and 39%, respectively. The prevalence of MRSA was lower than 50% in most of the African countries, although it appears to have risen since 2000 in many African countries, except for South Africa.	[Falagas, Matthew E.; Karageorgopoulos, Drosos E.; Leptidis, John; Korbila, Ioanna P.] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.; Korbila, Ioanna P.] Hygeia Grp, Mitera Hosp, Dept Internal Med Infect Dis, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Karageorgopoulos, Drosos/K-9241-2018	Karageorgopoulos, Drosos/0000-0002-9959-9978				Abera B, ETHIOP MED J, V46, P149; Adesida S, 2005, MICROB DRUG RESIST, V11, P115, DOI 10.1089/mdr.2005.11.115; Alli OAT, 2012, INDIAN J MED MICROBI, V30, P159, DOI 10.4103/0255-0857.96675; Amazian K, 2006, EUR J CLIN MICROBIOL, V25, P340, DOI 10.1007/s10096-006-0125-z; Antri K, 2011, CLIN MICROBIOL INFEC, V17, P526, DOI 10.1111/j.1469-0691.2010.03273.x; Antri K, 2010, Pathol Biol (Paris), V58, pe15, DOI 10.1016/j.patbio.2009.07.017; Ashour HM, 2007, J CLIN ONCOL, V25, P5763, DOI 10.1200/JCO.2007.14.0947; BARBER M, 1961, J CLIN PATHOL, V14, P385, DOI 10.1136/jcp.14.4.385; Ben Ayed S, 2006, PATHOL BIOL, V54, P435, DOI 10.1016/j.patbio.2006.07.010; Ben Saida N, 2005, MED MALADIES INFECT, V35, P363, DOI 10.1016/j.medmal.2005.02.014; BENNETT NM, 1985, MED J AUSTRALIA, V142, P138, DOI 10.5694/j.1326-5377.1985.tb133054.x; Biber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042864; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Borg MA, 2007, J ANTIMICROB CHEMOTH, V60, P1310, DOI 10.1093/jac/dkm365; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P160, DOI 10.1111/j.1469-0691.2010.03219.x; Brink A, 2007, SAMJ S AFR MED J, V97, P273; Buzaid N, 2011, J INFECT DEV COUNTR, V5, P723, DOI 10.3855/jidc.1701; David MZ, 2012, INFECT CONT HOSP EP, V33, P782, DOI 10.1086/666640; Elhamzaoui S, 2009, MED MALADIES INFECT, V39, P891, DOI 10.1016/j.medmal.2009.01.004; FAOAGALI JL, 1992, J HOSP INFECT, V20, P113, DOI 10.1016/0195-6701(92)90113-Z; Fayomi O. D, 2011, INTERNET J LAB MED, V4; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Ghamba P., 2012, J MED MED SCI, V3, P506; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Groome MJ, 2012, PAEDIATR INT CHILD H, V32, P140, DOI 10.1179/1465328111Y.0000000044; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; JACOBS MR, 1978, NEW ENGL J MED, V299, P735, DOI 10.1056/NEJM197810052991402; JEVONS MP, 1964, J CLIN PATHOL, V17, P243, DOI 10.1136/jcp.17.3.243; Kesah C, 2003, CLIN MICROBIOL INFEC, V9, P153, DOI 10.1046/j.1469-0691.2003.00531.x; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Makgotlho PE, 2009, FEMS IMMUNOL MED MIC, V57, P104, DOI 10.1111/j.1574-695X.2009.00585.x; MASON PR, 1991, CENT AFR J MED, V37, P56; Mastouri M, 2006, PATHOL BIOL, V54, P33, DOI 10.1016/j.patbio.2004.10.009; Mesrati I, 2010, J HOSP INFECT, V75, P265, DOI 10.1016/j.jhin.2010.03.015; Moremi N, 2012, J INFECT DEV COUNTR, V6, P620, DOI 10.3855/jidc.2093; Mshana S. S., 2009, Tanzania Journal of Health Research, V11, P59; Naik D, 2009, PAN AFR MED J, V3; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nations U, 2011, HUM DEV REP; Nichol KA, 2011, DIAGN MICR INFEC DIS, V69, P320, DOI 10.1016/j.diagmicrobio.2010.10.028; Nwankwo Emmanuel Onwubiko, 2011, Pan Afr Med J, V8, P4; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Park C, 1989, Nurs RSA, V4, P37; Perovic O, 2006, SAMJ S AFR MED J, V96, P714; Peterson AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038354; Randrianirina Frederique, 2007, Ann Clin Microbiol Antimicrob, V6, P5, DOI 10.1186/1476-0711-6-5; Rebiahi SA, 2011, MED MALADIES INFECT, V41, P646, DOI 10.1016/j.medmal.2011.09.010; Schaumburg F, 2011, CLIN MICROBIOL INFEC, V17, P1507, DOI 10.1111/j.1469-0691.2011.03534.x; Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150; SCRAGG JN, 1978, T ROY SOC TROP MED H, V72, P325, DOI 10.1016/0035-9203(78)90118-9; Shittu A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-286; Shittu AO, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-125; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Sung JY, 2012, DIAGN MICR INFEC DIS, V74, P28, DOI 10.1016/j.diagmicrobio.2012.05.018; Taiwo S S, 2005, West Afr J Med, V24, P100; Thabet Lamia, 2008, Tunis Med, V86, P992; The Center for Disease Dynamics Economics & Policy (CDDEP), METH RES STAPH AUR; Truong H, 2011, SAMJ S AFR MED J, V101, P413; van Rensburg MJJ, 2011, CLIN MICROBIOL INFEC, V17, P785, DOI 10.1111/j.1469-0691.2010.03373.x; van Rensburg MJJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-46; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wallin TR, 2008, EMERG MED CLIN N AM, V26, P431, DOI 10.1016/j.emc.2008.01.010; Wood SM, 2009, INFECT CONT HOSP EP, V30, P782, DOI 10.1086/599003; World Health Organization, 2006, HLTH PEOPL AFR REG H; Zinzendorf N Y, 2008, Dakar Med, V53, P176	66	94	96	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68024	10.1371/journal.pone.0068024	http://dx.doi.org/10.1371/journal.pone.0068024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922652	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700004
J	Liu, TL; Tsai, CH; Lee, WB; Chiang, JH				Liu, Tsunglin; Tsai, Cheng-Hung; Lee, Wen-Bin; Chiang, Jung-Hsien			Optimizing Information in Next-Generation-Sequencing (NGS) Reads for Improving De Novo Genome Assembly	PLOS ONE			English	Article							COMPUTATIONAL CHALLENGES; DNA; TOOL; ALIGNMENT; REPEATS	Next-Generation-Sequencing is advantageous because of its much higher data throughput and much lower cost compared with the traditional Sanger method. However, NGS reads are shorter than Sanger reads, making de novo genome assembly very challenging. Because genome assembly is essential for all downstream biological studies, great efforts have been made to enhance the completeness of genome assembly, which requires the presence of long reads or long distance information. To improve de novo genome assembly, we develop a computational program, ARF-PE, to increase the length of Illumina reads. ARF-PE takes as input Illumina paired-end (PE) reads and recovers the original DNA fragments from which two ends the paired reads are obtained. On the PE data of four bacteria, ARF-PE recovered >87% of the DNA fragments and achieved >98% of perfect DNA fragment recovery. Using Velvet, SOAPdenovo, Newbler, and CABOG, we evaluated the benefits of recovered DNA fragments to genome assembly. For all four bacteria, the recovered DNA fragments increased the assembly contiguity. For example, the N50 lengths of the P. brasiliensis contigs assembled by SOAPdenovo and Newbler increased from 80,524 bp to 166,573 bp and from 80,655 bp to 193,388 bp, respectively. ARF-PE also increased assembly accuracy in many cases. On the PE data of two fungi and a human chromosome, ARF-PE doubled and tripled the N50 length. However, the assembly accuracies dropped, but still remained >91%. In general, ARF-PE can increase both assembly contiguity and accuracy for bacterial genomes. For complex eukaryotic genomes, ARF-PE is promising because it raises assembly contiguity. But future error correction is needed for ARF-PE to also increase the assembly accuracy. ARF-PE is freely available at http://140.116.235.124/similar to tliu/arf-pe/.	[Liu, Tsunglin; Lee, Wen-Bin] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Tsai, Cheng-Hung; Chiang, Jung-Hsien] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Chiang, JH (corresponding author), Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan.	jchiang@mail.ncku.edu.tw		Chiang, Jung-Hsien/0000-0002-4657-6705	National Science Council, Taiwan [NSC 101-2672-B-006-007, NSC 100-2627-B-006-011]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by National Science Council, Taiwan (NSC 101-2672-B-006-007 and NSC 100-2627-B-006-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Chen Y, UNPUB; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Hu XS, 2012, BIOINFORMATICS, V28, P1533, DOI 10.1093/bioinformatics/bts187; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu BH, 2012, BIOINFORMATICS, V28, P2870, DOI 10.1093/bioinformatics/bts563; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Ronen R, 2012, BIOINFORMATICS, V28, pI188, DOI 10.1093/bioinformatics/bts219; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schadt EE, 2010, HUM MOL GENET, V19, pR227, DOI 10.1093/hmg/ddq416; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117	26	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69503	10.1371/journal.pone.0069503	http://dx.doi.org/10.1371/journal.pone.0069503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922726	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700035
J	Rao, VB; Schellenberg, D; Ghani, AC				Rao, V. Bhargavi; Schellenberg, David; Ghani, Azra C.			The Potential Impact of Improving Appropriate Treatment for Fever on Malaria and Non-Malarial Febrile Illness Management in Under-5s: A Decision-Tree Modelling Approach	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; PUBLIC-HEALTH FACILITIES; LUMEFANTRINE TREATMENT POLICY; ANTIMALARIAL-DRUG RESISTANCE; ARTEMETHER-LUMEFANTRINE; COMMUNITY EFFECTIVENESS; UNCOMPLICATED MALARIA; TRANSMISSION SETTINGS; PRESUMPTIVE TREATMENT; COMBINATION THERAPY	Background: As international funding for malaria programmes plateaus, limited resources must be rationally managed for malaria and non-malarial febrile illnesses (NMFI). Given widespread unnecessary treatment of NMFI with first-line antimalarial Artemisinin Combination Therapies (ACTs), our aim was to estimate the effect of health-systems factors on rates of appropriate treatment for fever and on use of ACTs. Methods: A decision-tree tool was developed to investigate the impact of improving aspects of the fever care-pathway and also evaluate the impact in Tanzania of the revised WHO malaria guidelines advocating diagnostic-led management Results: Model outputs using baseline parameters suggest 49% malaria cases attending a clinic would receive ACTs (95% Uncertainty Interval:40.6-59.2%) but that 44% (95% UI:35-54.8%) NMFI cases would also receive ACTs. Provision of 100% ACT stock predicted a 28.9% increase in malaria cases treated with ACT, but also an increase in overtreatment of NMFI, with 70% NMFI cases (95% UI:56.4-79.2%) projected to receive ACTs, and thus an overall 13% reduction (95% UI:5-21.6%) in correct management of febrile cases. Modelling increased availability or use of diagnostics had little effect on malaria management outputs, but may significantly reduce NMFI overtreatment. The model predicts the early rollout of revised WHO guidelines in Tanzania may have led to a 35% decrease (95% UI:31.2-39.8%) in NMFI overtreatment, but also a 19.5% reduction (95% UI:11-27.2%), in malaria cases receiving ACTs, due to a potential fourfold decrease in cases that were untested or tested false-negative (42.5% vs. 8.9%) and so untreated. Discussion: Modelling multi-pronged intervention strategies proved most effective to improve malaria treatment without increasing NMFI overtreatment. As malaria transmission declines, health system interventions must be guided by whether the management priority is an increase in malaria cases receiving ACTs (reducing the treatment gap), reducing ACT waste through unnecessary treatment of NMFI or expanding appropriate treatment of all febrile illness.	[Rao, V. Bhargavi; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England; [Schellenberg, David] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, London WC1E 7HT, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Rao, VB (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England.	bhargavi.rao@imperial.ac.uk	Ghani, Azra/B-8560-2009	Schellenberg, David/0000-0001-8222-0186; Ghani, Azra/0000-0002-0007-4910; Rao, V. Bhargavi/0000-0002-4406-1636	Wellcome Trust; MRC [G0600719, MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, G0600719, MR/K010174/1B, G0600719B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Wellcome Trust PhD fellowship for VBR. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgader TM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-11; Abeku TA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-202; Al-Taiar A, 2008, TROP MED INT HEALTH, V13, P762, DOI 10.1111/j.1365-3156.2008.02066.x; Amin AA, 2003, TROP MED INT HEALTH, V8, P1143, DOI 10.1046/j.1360-2276.2003.01140.x; [Anonymous], 2012, IND EV PHAS 1 AFF ME; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Baiden F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034073; Bastiaens GJH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-76; Binka F, 2012, MODELING BENEFITS IM; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Bjorkman A, 2010, CLIN INFECT DIS, V51, P512, DOI 10.1086/655689; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Byakika-Kibwika P, 2009, Afr Health Sci, V9, P206; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandler CIR, 2012, SOC SCI MED, V74, P1528, DOI 10.1016/j.socscimed.2012.01.025; Chandler CIR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-95; Chuma J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-144; Chuma J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-243; D'Acremont V, MALAR J, V10, P107; D'Acremont V, MALAR J, V9, P240; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Garrett L, 2012, NATURE, V482, P7, DOI 10.1038/482007a; Graz B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-136; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-317; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Krause G, 2000, ANN TROP PAEDIATR, V20, P273, DOI 10.1080/02724936.2000.11748147; Kyabayinze DJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-200; Leslie T, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4389; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Mangham LJ, 2012, TROP MED INT HEALTH, V17, P330, DOI 10.1111/j.1365-3156.2011.02918.x; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Masanja IM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-221; Masanja IM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-322; Masanja MI, 2010, AM J TROP MED HYG, V83, P1238, DOI 10.4269/ajtmh.2010.10-0194; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Mumba M, 2003, TROP MED INT HEALTH, V8, P544, DOI 10.1046/j.1365-3156.2003.01064.x; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Nicastri E, 2009, AM J TROP MED HYG, V80, P712, DOI 10.4269/ajtmh.2009.80.712; Njogu J, 2008, East Afr Med J, V85, P213; Noor AM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-100; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; O'Connell KA, 2011, MALARIA J, V10, P327; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okebe JU, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-180; Pongtavornpinyo W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-229; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Skarbinski J, 2009, AM J TROP MED HYG, V80, P919; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Sudoi RK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-37; Sumba PO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-245; TACAIDS ZAC NBS OCGS ICF, 2013, TANZ HIV AIDS MAL IN; TANNER M, 1993, T ROY SOC TROP MED H, V87, P518, DOI 10.1016/0035-9203(93)90070-7; Tipke M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-266; Uzochukwu BSC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-486; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, GUID TREATM MAL, V2nd; Yeung S, 2004, AM J TROP MED HYG, V71, P179, DOI 10.4269/ajtmh.2004.71.179; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x; Zurovac D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-31; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	78	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69654	10.1371/journal.pone.0069654	http://dx.doi.org/10.1371/journal.pone.0069654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922770	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700060
J	Weiss, A; Mirelman, A; Buchman, AS; Bennett, DA; Hausdorff, JM				Weiss, Aner; Mirelman, Anat; Buchman, Aron S.; Bennett, David A.; Hausdorff, Jeffrey M.			Using a Body-Fixed Sensor to Identify Subclinical Gait Difficulties in Older Adults with IADL Disability: Maximizing the Output of the Timed Up and Go	PLOS ONE			English	Article							TO-STAND TEST; PHYSICAL PERFORMANCE; RUSH MEMORY; FALL RISK; SIT; MOBILITY; WALKING; ACCELEROMETER; BALANCE; PEOPLE	Objective: The identification and documentation of subclinical gait impairments in older adults may facilitate the appropriate use of interventions for preventing or delaying mobility disability. We tested whether measures derived from a single body-fixed sensor worn during traditional Timed Up and Go (TUG) testing could identify subclinical gait impairments in community dwelling older adults without mobility disability. Methods: We used data from 432 older adults without dementia (mean age 83.30+/-7.04 yrs, 76.62% female) participating in the Rush Memory and Aging Project. The traditional TUG was conducted while subjects wore a body-fixed sensor. We derived measures of overall TUG performance and different subtasks including transitions (sit-to-stand, stand-to-sit), walking, and turning. Multivariate analysis was used to compare persons with and without mobility disability and to compare individuals with and without Instrumental Activities of Daily Living disability (IADL-disability), all of whom did not have mobility disability. Results: As expected, individuals with mobility disability performed worse on all TUG subtasks (p<0.03), compared to those who had no mobility disability. Individuals without mobility disability but with IADL disability had difficulties with turns, had lower yaw amplitude (p<0.004) during turns, were slower (p<0.001), and had less consistent gait (p<0.02). Conclusions: A single body-worn sensor can be employed in the community-setting to complement conventional gait testing. It provides a wide range of quantitative gait measures that appear to help to identify subclinical gait impairments in older adults.	[Weiss, Aner; Mirelman, Anat; Hausdorff, Jeffrey M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, Lab Gait & Neurodynam,Movement Disorders Unit, IL-69978 Tel Aviv, Israel; [Buchman, Aron S.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Harvard Univ, Sch Med, Boston, MA USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Rush University; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Harvard Medical School	Hausdorff, JM (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, Lab Gait & Neurodynam,Movement Disorders Unit, IL-69978 Tel Aviv, Israel.	jhausdor@tasmc.health.gov.il			NIH [R01AG17917, R01NS078009]; Illinois Department of Public Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Department of Public Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants R01AG17917, R01NS078009, and the Illinois Department of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean JF, 2011, PHYS THER, V91, P1804, DOI 10.2522/ptj.20100417; Bean JF, 2008, ARCH PHYS MED REHAB, V89, P2278, DOI 10.1016/j.apmr.2008.04.029; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bernardi M, 2004, J ELECTROMYOGR KINES, V14, P401, DOI 10.1016/j.jelekin.2003.09.001; Bossers WJR, 2012, DEMENT GER COGN D EX, V2, P589, DOI 10.1159/000345038; Brach JS, 2007, J GERONTOL A-BIOL, V62, P983, DOI 10.1093/gerona/62.9.983; Brach JS, 2002, PHYS THER, V82, P752, DOI 10.1093/ptj/82.8.752; Doheny EP, 2011, IEEE ENG MED BIO, P3063, DOI 10.1109/IEMBS.2011.6090837; Donoghue OA, 2012, J AM GERIATR SOC, V60, P1681, DOI 10.1111/j.1532-5415.2012.04120.x; Grillner S, 2011, SCIENCE, V334, P912, DOI 10.1126/science.1214778; Herman T, 2011, GERONTOLOGY, V57, P203, DOI 10.1159/000314963; Huang WNW, 2010, J AM GERIATR SOC, V58, P844, DOI 10.1111/j.1532-5415.2010.02820.x; Idland G, 2013, SCAND J PUBLIC HEALT, V41, P102, DOI 10.1177/1403494812466460; Ishigaki N, 2011, J BIOMECH, V44, P1788, DOI 10.1016/j.jbiomech.2011.04.016; Ivanenko YP, 2006, NEUROSCIENTIST, V12, P339, DOI 10.1177/1073858406287987; Janssen WGM, 2008, IEEE T NEUR SYS REH, V16, P479, DOI 10.1109/TNSRE.2008.2003386; Landgraff NC, 2010, J NEUROL, V257, P982, DOI 10.1007/s00415-009-5449-z; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lowry KA, 2012, ARCH PHYS MED REHAB, V93, P802, DOI 10.1016/j.apmr.2011.12.007; Moe-Nilssen R, 2004, J BIOMECH, V37, P121, DOI 10.1016/S0021-9290(03)00233-1; Najafi B, 2002, IEEE T BIO-MED ENG, V49, P843, DOI 10.1109/TBME.2002.800763; Odonkor CA, 2013, J GERONTOL A, DOI 10.1093/gerona/glt060; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; ROSOW I, 1966, J GERONTOL, V21, P556, DOI 10.1093/geronj/21.4.556; Rouhani H, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006674; Salarian A, 2007, IEEE T BIO-MED ENG, V54, P2296, DOI 10.1109/TBME.2007.896591; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Salarian A, 2009, IEEE ENG MED BIO, P224, DOI 10.1109/IEMBS.2009.5333970; Segal NA, 2012, ARCH PHYS MED REHABI; Spain RI, 2012, GAIT POSTURE, V35, P573, DOI 10.1016/j.gaitpost.2011.11.026; Takai Yohei, 2009, Journal of Physiological Anthropology, V28, P123, DOI 10.2114/jpa2.28.123; Tangen GG, 2012, DEMENT GER COGN D EX, V2, P622, DOI 10.1159/000345782; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Verghese J, 2011, GAIT POSTURE, V33, P98, DOI 10.1016/j.gaitpost.2010.10.004; Viccaro LJ, 2011, J AM GERIATR SOC, V59, P887, DOI 10.1111/j.1532-5415.2011.03336.x; Weiss A, 2011, PHYSIOL MEAS, V32, P2003, DOI 10.1088/0967-3334/32/12/009; Weiss A, 2010, MED ENG PHYS, V32, P119, DOI 10.1016/j.medengphy.2009.10.015; Zampieri C, 2011, PARKINSONISM RELAT D, V17, P277, DOI 10.1016/j.parkreldis.2010.08.001; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740; Zijlstra A, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-75; Zijlstra W, 2010, GAIT POSTURE, V31, P272, DOI 10.1016/j.gaitpost.2009.11.003	44	49	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e68885	10.1371/journal.pone.0068885	http://dx.doi.org/10.1371/journal.pone.0068885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922665	Green Published, gold, Green Submitted			2022-12-25	WOS:000323369700014
J	Agampodi, SB; Agampodi, TC				Agampodi, Suneth Buddhika; Agampodi, Thilini Chanchala			Antenatal Depression in Anuradhapura, Sri Lanka and the Factor Structure of the Sinhalese Version of Edinburgh Post Partum Depression Scale among Pregnant Women	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; POSTNATAL DEPRESSION; RISK-FACTORS; VALIDATION; EPDS; ANXIETY; TRANSLATION; PREVALENCE; SAMPLE; COMMUNITY	Background: Mental health problems among women of reproductive age group contribute to 7% of Global Burden of Diseases of women of all ages. Purpose of this study was to determine the prevalence and correlates of antenatal depression among pregnant women in Anuradhapura, Sri Lanka, and to explore the factor structure of EPDS. Methods: Pregnant women with gestational age of 24-36 weeks and residing in Anuradhapura district, Sri Lanka were recruited to the study using a two stage cluster sampling procedure. Sinhalese version of Edinburgh Post Partum Depression Scale (EPDS) and an interviewer administered questionnaire was use to collect data. A cut off value of 9 was used for the Sinhalese version of EPDS. Results: A total of 376 pregnant women were studied. Median EPDS score among pregnant women was 5 (IQR 2-8). Prevalence of antenatal depression in this study sample was 16.2% (n = 61). Thought of self harming (item number 10) was reported by 26 pregnant women (6.9%). None of the socio-demographic factors were associated with depression in this study sample. Having heart burn was significantly associated with depressive symptoms (p = 0.041). Sri Lankan version of EPDS showed a two factor solution. Anxiety was not emerged as a separate factor in this analysis. Conclusions: Prevalence of antenatal depression in Anuradhapura, Sri Lanka was relatively low. Anxiety was not emerged as a separate factor in the Sinhalese version of the EPDS.	[Agampodi, Suneth Buddhika; Agampodi, Thilini Chanchala] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Maternal & Child Hlth Res Unit, Saliyapura, Sri Lanka	Rajarata University of Sri Lanka	Agampodi, SB (corresponding author), Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Maternal & Child Hlth Res Unit, Saliyapura, Sri Lanka.	sunethagampodi@yahoo.com	Agampodi, Thilini/AAN-5396-2021; Agampodi, Suneth/G-3320-2012	Agampodi, Thilini/0000-0002-7977-6578; Agampodi, Suneth/0000-0001-7810-1774	Maternal Health Task Force of EngenderHealth	Maternal Health Task Force of EngenderHealth	This study was funded by the Maternal Health Task Force of EngenderHealth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2006, J PSYCHOSOM OBST GYN, V27, P267, DOI 10.1080/01674820600915478; Adouard F, 2005, ARCH WOMEN MENT HLTH, V8, P89, DOI 10.1007/s00737-005-0077-9; Agampodi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042333; Agampodi T C, 2011, Ceylon Med J, V56, P183, DOI 10.4038/cmj.v56i4.3907; Andersson L, 2004, OBSTET GYNECOL, V104, P467, DOI 10.1097/01.AOG.0000135277.04565.e9; [Anonymous], DEPR; Bowen Angela, 2006, Can Nurse, V102, P26; Dhillon N, 2010, MIDWIFERY, V26, P286, DOI 10.1016/j.midw.2008.09.001; Gausia K, 2009, ARCH WOMEN MENT HLTH, V12, P351, DOI 10.1007/s00737-009-0080-7; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Hartley M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-9; King PAL, 2012, ARCH WOMEN MENT HLTH, V15, P77, DOI 10.1007/s00737-012-0260-8; Lau Y, 2010, INT J NURS STUD, V47, P1139, DOI 10.1016/j.ijnurstu.2010.02.005; Lau Y, 2010, ARCH WOMEN MENT HLTH, V13, P153, DOI 10.1007/s00737-009-0134-x; Lee DTS, 2004, J AFFECT DISORDERS, V82, P93, DOI 10.1016/j.jad.2003.10.003; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Logsdon MC, 2009, ARCH WOMEN MENT HLTH, V12, P433, DOI 10.1007/s00737-009-0096-z; Luke S, 2009, J WOMENS HEALTH, V18, P1841, DOI 10.1089/jwh.2008.1261; Montazeri A, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-11; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rahman A, 2007, J AFFECT DISORDERS, V100, P115, DOI 10.1016/j.jad.2006.10.004; Reichenheim ME, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-93; Roomruangwong C, 2011, ASIAN BIOMED, V5, P179, DOI 10.5372/1905-7415.0502.024; Rowel Dhammica, 2008, Ceylon Medical Journal, V53, P10; Rubertsson C, 2011, NORD J PSYCHIAT, V65, P414, DOI 10.3109/08039488.2011.590606; Shah SMA, 2011, J PAK MED ASSOC, V61, P242; Swalm D, 2010, ARCH WOMEN MENT HLTH, V13, P515, DOI 10.1007/s00737-010-0170-6; Tuohy A, 2008, BRIT J CLIN PSYCHOL, V47, P153, DOI 10.1111/j.2044-8260.2008.tb00463.x; Vivilaki VG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-329; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2008, MAT MENT HLTH CHILD	32	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69708	10.1371/journal.pone.0069708	http://dx.doi.org/10.1371/journal.pone.0069708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922781	Green Published, gold			2022-12-25	WOS:000322838900072
J	Li, Y; Pan, YJ; Wang, R; Sun, YH; Hu, HC; Shen, XX; Lu, YM; Shen, L; Zhu, XZ; Chen, HQ				Li, Yuan; Pan, Yunjian; Wang, Rui; Sun, Yihua; Hu, Haichuan; Shen, Xuxia; Lu, Yongming; Shen, Lei; Zhu, Xiongzeng; Chen, Haiquan			ALK-Rearranged Lung Cancer in Chinese: A Comprehensive Assessment of Clinicopathology, IHC, FISH and RT-PCR	PLOS ONE			English	Article							GENE REARRANGEMENT; EML4-ALK; ADENOCARCINOMAS; FEATURES; TRANSCRIPTS	Approximately 3-7% of non-small cell lung cancers harbor an anaplastic lymphoma kinase (ALK) gene fusion, constituting a new molecular subtype of lung cancer that responds to crizotinib, an ALK inhibitor. Although previous studies have evaluated ALK-rearranged lung cancers, the comprehensive analysis of lung cancer in Chinese has not well assessed. Herein, we identified 44 cases of ALK-rearranged samples by fluorescent in-situ hybridization (FISH), immunohistochemistry (IHC), and reverse transcription polymerase chain reaction (RT-PCR) in a large number of surgically resected lung cancers. All 44 ALK-rearranged lung cancers were adenocarcinomas, with 2 cases having additional focal squamous components. The goal was to analyse the clinicopathological features of ALK-rearranged lung adenocarcinomas. Our data showed that a cribriform structure, prominent extracellular mucus and any type of mucous cell pattern may be either sensitive or specific to predict an ALK rearrangement. We used FISH as the standard detection method. We compared the ALK rearrangement accuracy of FISH, RT-PCR and IHC. RT-PCR could define both the ALK fusion partner and the fusion variant, but seemed unable to detect all translocations involving the ALK gene. It is noteworthy that IHC using the D5F3 antibody (Cell Signaling Technology) showed higher sensitivity and specificity than the ALK1 antibody (Dako). Therefore, we conclude that IHC remains a cost-effective and efficient technique for diagnosing ALK rearrangements and that D5F3 can be the optimal screening antibody in clinical practice.	[Li, Yuan; Shen, Xuxia; Lu, Yongming; Shen, Lei; Zhu, Xiongzeng] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Pan, Yunjian; Wang, Rui; Sun, Yihua; Hu, Haichuan; Chen, Haiquan] Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, Shanghai 200433, Peoples R China; [Li, Yuan; Pan, Yunjian; Wang, Rui; Sun, Yihua; Hu, Haichuan; Shen, Xuxia; Lu, Yongming; Shen, Lei; Zhu, Xiongzeng; Chen, Haiquan] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Zhu, XZ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China.	Xiongzengzhu@yahoo.com.cn; hqchen1@yahoo.com		Li, Yuan/0000-0001-5651-819X	National Natural Science Foundation of China [81101761, 81172218]; Key Construction Program of the National "985" Project [985-YFX0102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Construction Program of the National "985" Project	This work was supported by the funds from National Natural Science Foundation of China (81101761, 81172218); Key Construction Program of the National "985" Project (985-YFX0102) URL: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Kim H, 2011, J THORAC ONCOL, V6, P1359, DOI 10.1097/JTO.0b013e31821cfc73; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Nishino M, 2012, MODERN PATHOL, V25, P1462, DOI 10.1038/modpathol.2012.109; Paik JH, 2011, J THORAC ONCOL, V6, P466, DOI 10.1097/JTO.0b013e31820b82e8; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sasaki T, 2010, EUR J CANCER, V46, P1773, DOI 10.1016/j.ejca.2010.04.002; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Sica G, 2010, AM J SURG PATHOL, V34, P1155, DOI 10.1097/PAS.0b013e3181e4ee32; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wang R, 2012, CLIN CANCER RES, V18, P4725, DOI 10.1158/1078-0432.CCR-12-0677; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06	17	15	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69016	10.1371/journal.pone.0069016	http://dx.doi.org/10.1371/journal.pone.0069016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922677	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900018
J	Pedrotti, L; Mueller, MJ; Waller, F				Pedrotti, Lorenzo; Mueller, Martin J.; Waller, Frank			Piriformospora indica Root Colonization Triggers Local and Systemic Root Responses and Inhibits Secondary Colonization of Distal Roots	PLOS ONE			English	Article							INDUCED RESISTANCE; ARABIDOPSIS ROOTS; INNATE IMMUNITY; PLANT-GROWTH; BARLEY; COMPATIBILITY; SYMBIOSIS; FUNGI	Piriformospora indica is a basidiomycete fungus colonizing roots of a wide range of higher plants, including crop plants and the model plant Arabidopsis thaliana. Previous studies have shown that P. indica improves growth, and enhances systemic pathogen resistance in leaves of host plants. To investigate systemic effects within the root system, we established a hydroponic split-root cultivation system for Arabidopsis. Using quantitative real-time PCR, we show that initial P. indica colonization triggers a local, transient response of several defense-related transcripts, of which some were also induced in shoots and in distal, non-colonized roots of the same plant. Systemic effects on distal roots included the inhibition of secondary P. indica colonization. Faster and stronger induction of defense-related transcripts during secondary inoculation revealed that a P. indica pretreatment triggers root-wide priming of defense responses, which could cause the observed reduction of secondary colonization levels. Secondary P. indica colonization also induced defense responses in distant, already colonized parts of the root. Endophytic fungi therefore trigger a spatially specific response in directly colonized and in systemic root tissues of host plants.	[Pedrotti, Lorenzo; Mueller, Martin J.; Waller, Frank] Univ Wurzburg, Bioctr, Julius von Sachs Inst Biosci, D-97070 Wurzburg, Germany	University of Wurzburg	Waller, F (corresponding author), Univ Wurzburg, Bioctr, Julius von Sachs Inst Biosci, D-97070 Wurzburg, Germany.	Frank.Waller@uni-wuerzburg.de	mueller, martin j/C-7616-2019		German Research Foundation (DFG); University of Wuerzburg; European Union LLP-ERASMUS mobility scholarship	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; European Union LLP-ERASMUS mobility scholarship	This study is supported by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing. Lorenzo Pedrotti was funded by a European Union LLP-ERASMUS mobility scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achatz B, 2010, PLANT SOIL, V333, P59, DOI 10.1007/s11104-010-0319-0; Beckers GJM, 2009, PLANT CELL, V21, P944, DOI 10.1105/tpc.108.062158; Borowicz VA, 2001, ECOLOGY, V82, P3057; Camehl I, 2010, NEW PHYTOL, V185, P1062, DOI 10.1111/j.1469-8137.2009.03149.x; Chauvin A, 2013, NEW PHYTOL, V197, P566, DOI 10.1111/nph.12029; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Felle HH, 2009, MOL PLANT MICROBE IN, V22, P1179, DOI 10.1094/MPMI-22-9-1179; Franken P, 2012, APPL MICROBIOL BIOT, V96, P1455, DOI 10.1007/s00253-012-4506-1; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Lee YC, 2011, MOL PLANT MICROBE IN, V24, P421, DOI 10.1094/MPMI-05-10-0110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Molitor A, 2011, MOL PLANT MICROBE IN, V24, P1427, DOI 10.1094/MPMI-06-11-0177; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NEWMAN EI, 1987, NEW PHYTOL, V106, P745, DOI 10.1111/j.1469-8137.1987.tb00175.x; Pham GH, 2004, PLANT SURFACE MICROBIOLOGY, P593; Qiang XY, 2012, PLANT CELL, V24, P794, DOI 10.1105/tpc.111.093260; Schafer P, 2009, PLANT J, V59, P461, DOI 10.1111/j.1365-313X.2009.03887.x; Schikora A, 2011, PLANT PHYSIOL, V157, P1407, DOI 10.1104/pp.111.180604; Sharma M, 2008, CELL MICROBIOL, V10, P2235, DOI 10.1111/j.1462-5822.2008.01202.x; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; SMITH SE, 1997, MYCORRHIZAL SYMBIOSI, P605; Stein E, 2008, PLANT CELL PHYSIOL, V49, P1747, DOI 10.1093/pcp/pcn147; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Vadassery J, 2008, MOL PLANT MICROBE IN, V21, P1371, DOI 10.1094/MPMI-21-10-1371; Vadassery J, 2009, PLANT J, V59, P193, DOI 10.1111/j.1365-313X.2009.03867.x; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Verma S, 1998, MYCOLOGIA, V90, P896, DOI 10.2307/3761331; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Weiss M, 2001, MYCOL RES, V105, P403, DOI 10.1017/S095375620100363X; Weiss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016793	34	19	22	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69352	10.1371/journal.pone.0069352	http://dx.doi.org/10.1371/journal.pone.0069352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922705	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900037
J	Schrodt, C; McHugh, EE; Gawinowicz, MA; DuPont, HL; Brown, EL				Schrodt, Caroline; McHugh, Erin E.; Gawinowicz, Mary Ann; DuPont, Herbert L.; Brown, Eric L.			Rifaximin-Mediated Changes to the Epithelial Cell Proteome: 2-D Gel Analysis	PLOS ONE			English	Article							INTESTINAL ALKALINE-PHOSPHATASE; ENTEROHEMORRHAGIC ESCHERICHIA-COLI; INFLAMMATORY-BOWEL-DISEASE; HEAT-SHOCK PROTEINS; NEGATIVE REGULATION; TRAVELERS DIARRHEA; APAF-1 APOPTOSOME; GUT MICROBIOTA; HISTONE H2A; ACTIVATION	Rifaximin is a semi-synthetic rifamycin derivative that is used to treat different conditions including bacterial diarrhea and hepatic encephalopathy. Rifaximin is of particular interest because it is poorly adsorbed in the intestines and has minimal effect on colonic microflora. We previously demonstrated that rifaximin affected epithelial cell physiology by altering infectivity by enteric pathogens and baseline inflammation suggesting that rifaximin conferred cytoprotection against colonization and infection. Effects of rifaximin on epithelial cells were further examined by comparing the protein expression profile of cells pretreated with rifaximin, rifampin (control antibiotic), or media (untreated). Two-dimensional (2-D) gel electrophoresis identified 36 protein spots that were up-or down-regulated by over 1.7-fold in rifaximin treated cells compared to controls. 15 of these spots were down-regulated, including annexin A5, intestinal-type alkaline phosphatase, histone H4, and histone-binding protein RbbP4. 21 spots were up-regulated, including heat shock protein (HSP) 90 alpha and fascin. Many of the identified proteins are associated with cell structure and cytoskeleton, transcription and translation, and cellular metabolism. These data suggested that in addition to its antimicrobial properties, rifaximin may alter host cell physiology that provides cytoprotective effects against bacterial pathogens.	[Schrodt, Caroline; McHugh, Erin E.; DuPont, Herbert L.; Brown, Eric L.] Univ Texas Houston, Sch Publ Hlth, Ctr Infect Dis, Houston, TX 77030 USA; [Gawinowicz, Mary Ann] Columbia Univ Coll, Prot Core Facil, New York, NY USA; [DuPont, Herbert L.] Baylor Coll Med, St Lukes Episcopal Hosp, Internal Med Serv, Houston, TX 77030 USA; [DuPont, Herbert L.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Columbia University; Baylor College of Medicine; Saint Lukes Episcopal Hospital; Baylor College of Medicine	Brown, EL (corresponding author), Univ Texas Houston, Sch Publ Hlth, Ctr Infect Dis, Houston, TX 77030 USA.	eric.l.brown@uth.tmc.edu	DuPont, Herbert/AAH-6776-2021	Schrodt, Caroline/0000-0002-6900-745X	Salix Pharmaceuticals	Salix Pharmaceuticals	This work was funded by a commercial source, Salix Pharmaceuticals. Salix Pharmaceuticals had no role in the design of the experiments, interpretation of the data, writing of the manuscript, nor in deciding whether the data should be published. In the past, HLD has received honoraria for speaking and consulting fees from Salix Pharamaceuticals but in the context of the study described, none of the authors were paid a consultant fee nor were any patents relating to this work filed. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adachi JA, 2006, CLIN INFECT DIS, V42, P541, DOI 10.1086/499950; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Brest P, 2004, INFECT IMMUN, V72, P5741, DOI 10.1128/IAI.72.10.5741-5749.2004; Brown EL, 2010, ANTIMICROB AGENTS CH, V54, P388, DOI 10.1128/AAC.00691-09; Chen KT, 2010, AM J PHYSIOL-GASTR L, V299, pG467, DOI 10.1152/ajpgi.00364.2009; DuPont HL, 2007, J TRAVEL MED, V14, P16, DOI 10.1111/j.1708-8305.2006.00084.x; DuPont HL, 2011, EXPERT OPIN PHARMACO, V12, P293, DOI 10.1517/14656566.2011.546347; DuPont HL, 2004, CLIN MICROBIOL INFEC, V10, P1009, DOI 10.1111/j.1469-0691.2004.00997.x; Fernandes JMO, 2002, BIOCHEM J, V368, P611, DOI 10.1042/BJ20020980; Fernandez-Prada C, 1998, INFECT IMMUN, V66, P3918, DOI 10.1128/IAI.66.8.3918-3924.1998; Figueiredo PMS, 2007, LETT APPL MICROBIOL, V45, P358, DOI 10.1111/j.1472-765X.2007.02154.x; Fumi AL, 2008, ANN PHARMACOTHER, V42, P408, DOI 10.1345/aph.1K345; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Geddes K, 2008, GASTROENTEROLOGY, V135, P8, DOI 10.1053/j.gastro.2008.06.006; Gerard Laura, 2005, Expert Rev Anti Infect Ther, V3, P201, DOI 10.1586/14787210.3.2.201; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Guslandi M, 2011, WORLD J GASTROENTERO, V17, P4643, DOI 10.3748/wjg.v17.i42.4643; HIRSCH JG, 1958, J EXP MED, V108, P925, DOI 10.1084/jem.108.6.925; Infante RM, 2004, CLIN GASTROENTEROL H, V2, P135, DOI 10.1016/S1542-3565(03)00322-7; Isaacs KL, 2007, INFLAMM BOWEL DIS, V13, P1250, DOI 10.1002/ibd.20187; Jolley J, 2011, CLIN EXP GASTROENTER, V4, P43, DOI 10.2147/CEG.S18051; Kim HS, 2000, J IMMUNOL, V165, P3268, DOI 10.4049/jimmunol.165.6.3268; Leevy CB, 2007, DIGEST DIS SCI, V52, P737, DOI 10.1007/s10620-006-9442-4; Lemaire S, 2008, FEBS J, V275, P5286, DOI 10.1111/j.1742-4658.2008.06659.x; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Li GH, 2007, J PEPT SCI, V13, P368, DOI 10.1002/psc.851; Logue SE, 2009, NAT PROTOC, V4, P1383, DOI 10.1038/nprot.2009.143; Loguercio C, 2003, Minerva Gastroenterol Dietol, V49, P53; Loukiadis E, 2008, J BACTERIOL, V190, P275, DOI 10.1128/JB.00844-07; Malo MS, 2010, GUT, V59, P1476, DOI 10.1136/gut.2010.211706; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Nicolas E, 2000, J BIOL CHEM, V275, P9797, DOI 10.1074/jbc.275.13.9797; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Qualtrough D, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-14; Richards RC, 2001, BIOCHEM BIOPH RES CO, V284, P549, DOI 10.1006/bbrc.2001.5020; Rose FRAJ, 1998, INFECT IMMUN, V66, P3255, DOI 10.1128/IAI.66.7.3255-3263.1998; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Samba-Louaka A, 2009, INFECT IMMUN, V77, P5471, DOI 10.1128/IAI.00860-09; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scuto A, 2007, CANCER RES, V67, P10317, DOI 10.1158/0008-5472.CAN-06-3313; Steffen R, 2003, AM J GASTROENTEROL, V98, P1073, DOI [10.1016/S0002-9270(02)06005-7, 10.1111/j.1572-0241.2003.07283.x]; Takada M, 2010, LIFE SCI, V86, P499, DOI 10.1016/j.lfs.2010.02.010; Tuin A, 2009, GUT, V58, P379, DOI 10.1136/gut.2007.128868; Zheng LM, 2004, J IMMUNOL, V173, P6319, DOI 10.4049/jimmunol.173.10.6319	46	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e68550	10.1371/journal.pone.0068550	http://dx.doi.org/10.1371/journal.pone.0068550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922656	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900007
J	Wang, SJ; Wang, ZW				Wang, Sijie Jason; Wang, Zhao-Wen			Track-A-Worm, An Open-Source System for Quantitative Assessment of C. elegans Locomotory and Bending Behavior	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; NEURONS	A major challenge of neuroscience is to understand the circuit and gene bases of behavior. C. elegans is commonly used as a model system to investigate how various gene products function at specific tissue, cellular, and synaptic foci to produce complicated locomotory and bending behavior. The investigation generally requires quantitative behavioral analyses using an automated single-worm tracker, which constantly records and analyzes the position and body shape of a freely moving worm at a high magnification. Many single-worm trackers have been developed to meet lab-specific needs, but none has been widely implemented for various reasons, such as hardware difficult to assemble, and software lacking sufficient functionality, having closed source code, or using a programming language that is not broadly accessible. The lack of a versatile system convenient for wide implementation makes data comparisons difficult and compels other labs to develop new worm trackers. Here we describe Track-A-Worm, a system rich in functionality, open in source code, and easy to use. The system includes plug-and-play hardware (a stereomicroscope, a digital camera and a motorized stage), custom software written to run with Matlab in Windows 7, and a detailed user manual. Grayscale images are automatically converted to binary images followed by head identification and placement of 13 markers along a deduced spline. The software can extract and quantify a variety of parameters, including distance traveled, average speed, distance/time/speed of forward and backward locomotion, frequency and amplitude of dominant bends, overall bending activities measured as root mean square, and sum of all bends. It also plots worm travel path, bend trace, and bend frequency spectrum. All functionality is performed through graphical user interfaces and data is exported to clearly-annotated and documented Excel files. These features make Track-A-Worm a good candidate for implementation in other labs.	[Wang, Sijie Jason] Univ Connecticut, Ctr Hlth, Farmington, CT USA; [Wang, Zhao-Wen] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Wang, ZW (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA.	zwwang@uchc.edu			National Institutes of Health [5R01GM083049, 1R01MH085927]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants 5R01GM083049 and 1R01MH085927 (to ZWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht DR, 2011, NAT METHODS, V8, P599, DOI [10.1038/NMETH.1630, 10.1038/nmeth.1630]; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; Chen BJ, 2011, J NEUROSCI, V31, P17338, DOI 10.1523/JNEUROSCI.3638-11.2011; Chen BJ, 2010, J NEUROSCI, V30, P16651, DOI 10.1523/JNEUROSCI.3211-10.2010; Chen BJ, 2010, EMBO J, V29, P3184, DOI 10.1038/emboj.2010.194; Contreras EQ, 2013, ENVIRON SCI TECHNOL, V47, P1148, DOI 10.1021/es3036785; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; Faumont S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024666; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Kawano T, 2011, NEURON, V72, P572, DOI 10.1016/j.neuron.2011.09.005; Kim H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000780; Kwon N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057484; Lee JR, 2005, CALLALOO, V28, P25, DOI 10.1353/cal.2005.0023; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Rivera LI, 2008, P SOC PHOTO-OPT INS, V7266; Sellings L, 2013, EUR J NEUROSCI, V37, P743, DOI 10.1111/ejn.12099; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Tsibidis GD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-86; Wen Q, 2012, NEURON, V76, P750, DOI 10.1016/j.neuron.2012.08.039; Yemini Eviatar, 2011, Cold Spring Harb Protoc, V2011, P1483, DOI 10.1101/pdb.prot067025	28	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69653	10.1371/journal.pone.0069653	http://dx.doi.org/10.1371/journal.pone.0069653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922769	Green Submitted, gold, Green Published			2022-12-25	WOS:000322838900069
J	Polidori, C; Garcia, AJ; Nieves-Aldrey, JL				Polidori, Carlo; Garcia, Alberto Jorge; Nieves-Aldrey, Jose L.			Breaking up the Wall: Metal-Enrichment in Ovipositors, but Not in Mandibles, Co-Varies with Substrate Hardness in Gall-Wasps and Their Associates	PLOS ONE			English	Article							CYNIPID OAK GALLS; PHYLOGENETIC-RELATIONSHIPS; HYMENOPTERA; ZINC; EVOLUTION; MANGANESE; MICROANALYSIS; PARASITOIDS; NEREIS; ADULT	The cuticle of certain insect body parts can be hardened by the addition of metals, and because niche separation may require morphological adaptations, inclusion of such metals may be linked to life history traits. Here, we analysed the distribution and enrichment of metals in the mandibles and ovipositors of a large family of gall-inducing wasps (Cynipidae, or Gall-Wasps) (plus one gall-inducing Chalcidoidea), and their associated wasps (gall-parasitoids and gall-inquilines) (Cynipidae, Chalcidoidea and Ichneumonoidea). Both plant types/organs where galls are induced, as well as galls themselves, vary considerably in hardness, thus making this group of wasps an ideal model to test if substrate hardness can predict metal enrichment. Non-galler, parasitic Cynipoidea attacking unconcealed hosts were used as ecological "outgroup". With varying occurrence and concentration, Zn, Mn and Cu were detected in mandibles and ovipositors of the studied species. Zn tends be exclusively concentrated at the distal parts of the organs, while Mn and Cu showed a linear increase from the proximal to the distal parts of the organs. In general, we found that most of species having metal-enriched ovipositors (independently of metal type and concentration) were gall-invaders. Among gall-inducers, metals in the ovipositors were more likely to be found in species inducing galls in woody plants. Overall, a clear positive effect of substrate hardness on metal concentration was detected for all the three metals. Phylogenetic relationships among species, as suggested by the most recent estimates, seemed to have a weak role in explaining metal variation. On the other hand, no relationships were found between substrate hardness or gall-association type and concentration of metals in mandibles. We suggest that ecological pressures related to oviposition were sufficiently strong to drive changes in ovipositor elemental structure in these gall-associated Hymenoptera.	[Polidori, Carlo; Nieves-Aldrey, Jose L.] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, E-28006 Madrid, Spain; [Garcia, Alberto Jorge] CSIC, Museo Nacl Ciencias Nat, Lab Microscopia, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Polidori, C (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, E-28006 Madrid, Spain.	cpolidori@mncn.csic.es	García, Alberto/HDO-5321-2022; JORGE, ALBERTO/K-2922-2017; Polidori, Carlo/G-4382-2010; Nieves-Aldrey, Jose Luis/K-2544-2012	JORGE, ALBERTO/0000-0002-5178-4912; Polidori, Carlo/0000-0003-4834-0752; Nieves-Aldrey, Jose Luis/0000-0002-4711-7455	Ministry of Science and Innovation [CGL2009-10111, CGL-2010]; programme "Ayudas para la realizacion de estancias de investigacion en el centro cientifico de la Fundacion Huinay" (CSIC-Endesa); Program JAE-Doc "Junta para la Ampliacion de Estudios"; Spanish Research Council (CSIC); FSE	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); programme "Ayudas para la realizacion de estancias de investigacion en el centro cientifico de la Fundacion Huinay" (CSIC-Endesa); Program JAE-Doc "Junta para la Ampliacion de Estudios"; Spanish Research Council (CSIC); FSE(European Social Fund (ESF))	Financial support was provided by the research projects funded by the Ministry of Science and Innovation (subprogram BOS) CGL2009-10111 and CGL-2010 to JLNA, and by the programme "Ayudas para la realizacion de estancias de investigacion en el centro cientifico de la Fundacion Huinay" (CSIC-Endesa) to JLNA and CP. CP was funded by a post-doctoral contract (Program JAE-Doc "Junta para la Ampliacion de Estudios" funded by the Spanish Research Council (CSIC) and the FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs Z, 2010, MOL PHYLOGENET EVOL, V55, P210, DOI 10.1016/j.ympev.2009.12.004; Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; Askew R. R., 1961, Transactions of the Society for British Entomology, V14, P237; Askew R.R., 1984, P223; Askew Richard R., 2006, Zootaxa, V1301, P1; Askew RR, 2013, ZOOTAXA, V3643, P1; Birkedal H, 2006, CHEMBIOCHEM, V7, P1392, DOI 10.1002/cbic.200600160; Buffington ML, 2007, CLADISTICS, V23, P403, DOI 10.1111/j.1096-0031.2007.00153.x; Buffington ML, 2007, J NAT HIST, V41, P2267, DOI 10.1080/00222930701579732; Csoka Gyorgy, 2005, P573; Donovan JJ., 1996, MICROSC MICROANAL, V2, P1, DOI [10.1017/S1431927696210013, DOI 10.1017/S1431927696210013]; DUNCUMB P, 1994, MIKROCHIM ACTA, V114, P3, DOI 10.1007/BF01244530; FONTAINE A R, 1991, Journal of the Entomological Society of British Columbia, V88, P45; Garcia-Guinea J, 2011, THESCIENTIFICWORLDJO, V11, P186, DOI [10.1100/tsw.2011.9, 10.1100/tsw.2011.8]; Gauld I.D., 1991, MEMOIRS AM ENTOMOLOG, V47, P1; Ghara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023642; Gordon AD, 1999, CLASSIFICATION; HAWKINS BA, 1988, ECOL ENTOMOL, V13, P473, DOI 10.1111/j.1365-2311.1988.tb00381.x; Heraty JM, 2003, J NAT HIST, V37, P1751, DOI 10.1080/00222930210130320; Heraty JM, 2013, CLADISTICS, V29, P466, DOI 10.1111/cla.12006; HILLERTON JE, 1984, J STORED PROD RES, V20, P133, DOI 10.1016/0022-474X(84)90020-1; Lichtenegger HC, 2003, P NATL ACAD SCI USA, V100, P9144, DOI 10.1073/pnas.1632658100; Liljeblad J, 2008, ZOOTAXA, P1; Nieves-Aldrey JL, 2009, ZOOTAXA, P1; Nieves-Aldrey J. L., 2001, HYMENOPTERA CYNIPIDA, V16; NYLANDER JAA, 2004, BAYESIAN PHYLOGENETI; PACKWOOD R, 1991, ELECTRON PROBE QUANTITATION, P83; POUCHOU JL, 1991, ELECTRON PROBE QUANTITATION, P31; QUICKE DLJ, 1994, J NAT HIST, V28, P635, DOI 10.1080/00222939400770301; Quicke DLJ, 1998, ZOOL J LINN SOC-LOND, V124, P387, DOI 10.1006/zjls.1997.0146; Quicke Donald L.J., 2000, Atti della Accademia Nazionale Italiana di Entomologia Rendiconti, V47, P197; Ronquist F, 1995, SYST ENTOMOL, V20, P309, DOI 10.1111/j.1365-3113.1995.tb00099.x; RONQUIST F, 1994, EVOLUTION, V48, P241, DOI 10.1111/j.1558-5646.1994.tb01310.x; Ronquist F, 1999, ZOOL SCR, V28, P139, DOI 10.1046/j.1463-6409.1999.00022.x; ROOMANS GM, 1988, J ELECTRON MICR TECH, V9, P19, DOI 10.1002/jemt.1060090104; SCHOFIELD R, 1989, J EXP BIOL, V144, P577; Schofield RMS, 2002, NATURWISSENSCHAFTEN, V89, P579, DOI 10.1007/s00114-002-0381-4; Schofield RMS, 1997, J EXP BIOL, V200, P3235; Schofield RMS, 2001, SCORPION BIOLOGY AND RESEARCH, P234; Schofield Robert M. S., 2005, American Entomologist, V51, P45; Sharkey MJ, 2012, CLADISTICS, V28, P80, DOI 10.1111/j.1096-0031.2011.00366.x; Stewart AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027578; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; Stone GN, 1998, P ROY SOC B-BIOL SCI, V265, P979, DOI 10.1098/rspb.1998.0387; Stone GN, 2002, ANNU REV ENTOMOL, V47, P633, DOI 10.1146/annurev.ento.47.091201.145247; Stone GN, 2009, EVOLUTION, V63, P854, DOI 10.1111/j.1558-5646.2008.00604.x; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII	49	26	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70529	10.1371/journal.pone.0070529	http://dx.doi.org/10.1371/journal.pone.0070529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894668	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900132
J	Schutkowski, A; Kramer, J; Kluge, H; Hirche, F; Krombholz, A; Theumer, T; Stangl, GI				Schutkowski, Alexandra; Kraemer, Julia; Kluge, Holger; Hirche, Frank; Krombholz, Andreas; Theumer, Torsten; Stangl, Gabriele I.			UVB Exposure of Farm Animals: Study on a Food-Based Strategy to Bridge the Gap between Current Vitamin D Intakes and Dietary Targets	PLOS ONE			English	Article							FOLIC-ACID; EGG-YOLK; 5-METHYLTETRAHYDROFOLATE; PHOTODEGRADATION; CANCER; CHOLECALCIFEROL; DEFICIENCY; PREVENTION; DISEASE; FOLATE	Vitamin D deficiency is a global health problem. This study aimed to investigate the efficacy of ultraviolet (UV) B radiation for improving vitamin D-3 content of eggs and meat. In a two-factorial design hens that received diets with 0 (-D-3) or 3,000 IU (+D-3) vitamin D-3/kg were non-exposed (-UVB) or exposed to UVB radiation (+UVB) for 3 h daily over 4 weeks. Data show that UVB radiation was very effective in raising the vitamin D-3 content of egg yolk and meat. Egg yolk from +UVB/-D-3 hens had a higher vitamin D-3 content (17.5 +/- 7.2 mu g/100 g dry matter (DM)) than those from the -UVB/+D-3 group (5.2 +/- 2.4 mu g/100 g DM, p<0.01). Vitamin D-3 content in egg yolk of vitamin D-3-supplemented hens could be further increased by UVB radiation (32.4 +/- 10.9 mg/100 g DM). The content of 25-hydroxyvitamin D-3 (25(OH)D-3) in the egg yolk also increased in response to UVB, although less pronounced than vitamin D-3. Meat revealed about 4-fold higher vitamin D-3 contents in response to UVB than to dietary vitamin D-3 (p<0.001). In conclusion, exposure of hens to UVB is an efficient approach to provide consumers with vitamin D-3-enriched foods from animal sources.	[Schutkowski, Alexandra; Kraemer, Julia; Kluge, Holger; Hirche, Frank; Stangl, Gabriele I.] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany; [Krombholz, Andreas; Theumer, Torsten] Fraunhofer Inst Mech Mat IWM, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Fraunhofer Gesellschaft	Stangl, GI (corresponding author), Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany.	gabriele.stangl@landw.uni-halle.de		Schutkowski, Alexandra/0000-0002-9387-7869	Federal Ministry of Education and Research of Gemany [0315668A]	Federal Ministry of Education and Research of Gemany	Vitamin D analysis of this study was supported by a grant 0315668A from the Federal Ministry of Education and Research of Gemany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for the remaining parts of this study.	Bundesamt fur Strahlenschutz, 2013, SOL BOD UV STRAHL DE; CARSON JR, 1955, POULTRY SCI, V34, P256, DOI 10.3382/ps.0340256; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Dittmer KE, 2011, VET PATHOL, V48, P389, DOI 10.1177/0300985810375240; Doets EL, 2008, EUR J NUTR, V47, P17, DOI [10.1007/s00394-008-1003-5, 10.1007/s00394-007-0691-6]; Duthie SJ, 1999, BRIT MED BULL, V55, P578, DOI 10.1258/0007142991902646; Ferder M, 2013, AM J PHYSL IN PRESS; Ferguson Gary W., 2005, Journal of Herpetological Medicine and Surgery, V15, P9; FRASER DR, 1976, BIOCHEM J, V160, P671, DOI 10.1042/bj1600671; Gesellschaft fur Ernahrungsphysiologie, 1999, EMPF EN NAHRST LEG M, V1st; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Higashi T, 2008, ANAL BIOANAL CHEM, V391, P229, DOI 10.1007/s00216-007-1780-3; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Institute of Medicine FaNB, 2010, DIETARY REFERENCE IN; Ko JA, 2008, J AGR FOOD CHEM, V56, P3671, DOI 10.1021/jf073398s; KURMANN A, 1994, FOOD CHEM, V50, P75, DOI 10.1016/0308-8146(94)90096-5; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; Leeson S, 2003, J APPL POULTRY RES, V12, P24, DOI 10.1093/japr/12.1.24; Lewis PD, 2009, WORLD POULTRY SCI J, V65, P499, DOI 10.1017/S0043933909000361; Lietzow J, 2012, J AGR FOOD CHEM, V60, P799, DOI 10.1021/jf204273n; Lucock M, 2011, J EVID-BASED INTEGR, V16, P102, DOI 10.1177/1533210110392950; Mattila P, 1999, J AGR FOOD CHEM, V47, P4089, DOI 10.1021/jf990183c; MATTILA PH, 1995, J AGR FOOD CHEM, V43, P2394, DOI 10.1021/jf00057a015; Off MK, 2005, J PHOTOCH PHOTOBIO B, V80, P47, DOI 10.1016/j.jphotobiol.2005.03.001; Pilz S, 2010, MOL NUTR FOOD RES, V54, P1103, DOI 10.1002/mnfr.200900474; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Vinas BR, 2011, ANN NUTR METAB, V59, P84, DOI 10.1159/000332762; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Stanger O, 2002, CURR DRUG METAB, V3, P211, DOI 10.2174/1389200024605163; Steindal AH, 2008, PHOTOCH PHOTOBIO SCI, V7, P814, DOI 10.1039/b718907a; Steindal AH, 2006, PHOTOCHEM PHOTOBIOL, V82, P1651, DOI 10.1562/2006-06-09-RA-915; Tam TTT, 2009, J PHOTOCH PHOTOBIO B, V94, P201, DOI 10.1016/j.jphotobiol.2008.12.003; TIAN XQ, 1994, ENDOCRINOLOGY, V135, P655, DOI 10.1210/en.135.2.655; Tremezaygues L, 2009, DERM-ENDOCRINOL, V1, P239, DOI 10.4161/derm.1.4.9705; US Department of Agriculture ARS, 2011, USDA NAT NUTR DAT ST; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Williams JD, 2010, J PHOTOCH PHOTOBIO B, V99, P49, DOI 10.1016/j.jphotobiol.2010.02.003; Yao LX, 2013, J FOOD SCI, V78, pC178, DOI 10.1111/1750-3841.12032; Zhu JG, 2012, ARCH BIOCHEM BIOPHYS, V523, P30, DOI 10.1016/j.abb.2012.01.013	41	24	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69418	10.1371/journal.pone.0069418	http://dx.doi.org/10.1371/journal.pone.0069418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894475	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900067
J	Brydges, CR; Anderson, M; Reid, CL; Fox, AM				Brydges, Christopher R.; Anderson, Mike; Reid, Corinne L.; Fox, Allison M.			Maturation of Cognitive Control: Delineating Response Inhibition and Interference Suppression	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; LATENT-VARIABLE ANALYSIS; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; FRONTAL-LOBE; PREFRONTAL CORTEX; FUNCTIONAL MRI; CHILDREN; PERFORMANCE; CONFLICT	Cognitive control is integral to the ability to attend to a relevant task whilst suppressing distracting information or inhibiting prepotent responses. The current study examined the development of these two subprocesses by examining electrophysiological indices elicited during each process. Thirteen 18 year-old adults and thirteen children aged 8-11 years (mean = 9.77 years) completed a hybrid Go/Nogo flanker task while continuous EEG data were recorded. The N2 topography for both response inhibition and interference suppression changed with increasing age. The neural activation associated with response inhibition became increasingly frontally distributed with age, and showed decreases of both amplitude and peak latency from childhood to adulthood, possibly due to reduced cognitive demands and myelination respectively occurring during this period. Interestingly, a significant N2 effect was apparent in adults, but not observed in children during trials requiring interference suppression. This could be due to more diffuse activation in children, which would require smaller levels of activation over a larger region of the brain than is reported in adults. Overall, these results provide evidence of distinct maturational processes occurring throughout late childhood and adolescence, highlighting the separability of response inhibition and interference suppression.	[Brydges, Christopher R.; Anderson, Mike; Reid, Corinne L.; Fox, Allison M.] Univ Western Australia, Sch Psychol, Neurocognit Dev Unit, Perth, WA 6009, Australia; [Anderson, Mike; Reid, Corinne L.] Murdoch Univ, Sch Psychol, Perth, WA, Australia	University of Western Australia; Murdoch University	Brydges, CR (corresponding author), Univ Western Australia, Sch Psychol, Neurocognit Dev Unit, Perth, WA 6009, Australia.	brydgc01@student.uwa.edu.au	Fox, Allison M/H-9218-2014	Fox, Allison M/0000-0001-5189-6271; reid, corinne/0000-0001-5252-041X; Brydges, Christopher/0000-0001-5901-638X	Australian Postgraduate Award; Princess Margaret Hospital [EP1910]; Channel 7-Telethon Trust	Australian Postgraduate Award(Australian Government); Princess Margaret Hospital(University of Toronto); Channel 7-Telethon Trust	Funding support was provided for by an Australian Postgraduate Award scholarship for Christopher Brydges. The child research was supported by grants from Princess Margaret Hospital grant EP1910 and the Channel 7-Telethon Trust. The adult research was funded by the School of Psychology at the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayless S, 2007, EARLY HUM DEV, V83, P247, DOI 10.1016/j.earlhumdev.2006.05.021; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brouwer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032316; Brydges CR, 2012, INTELLIGENCE, V40, P458, DOI 10.1016/j.intell.2012.05.006; Brydges CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034482; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Cardenas VA, 2005, HUM BRAIN MAPP, V25, P317, DOI 10.1002/hbm.20103; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Cooke RWI, 1999, ARCH DIS CHILD-FETAL, V81, pF116, DOI 10.1136/fn.81.2.F116; Cragg L, 2009, DEV PSYCHOBIOL, V51, P533, DOI 10.1002/dev.20391; DEMPSTER FN, 1991, INTELLIGENCE, V15, P157, DOI 10.1016/0160-2896(91)90028-C; Dempster FN, 1993, EMERGING THEMES COGN, V1, P3; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DIAMOND A, 1988, CHILD DEV, V59, P523, DOI 10.1111/j.1467-8624.1988.tb01486.x; Duan X., 2010, PSYCHOL TEST ASSESSM, V52, P419, DOI DOI 10.1044/2F2016_JSLHR-L-15-0310; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Harnishfeger Katherine Kipp, 1995, P175, DOI 10.1016/B978-012208930-5/50007-6; Hershey T, 2010, BRAIN, V133, P3625, DOI 10.1093/brain/awq256; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; Johnstone SJ, 2005, J PSYCHOPHYSIOL, V19, P11, DOI 10.1027/0269-8803.19.1.11; Jonkman LM, 2007, CLIN NEUROPHYSIOL, V118, P1069, DOI 10.1016/j.clinph.2007.01.017; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Leon-Carrion J, 2004, INT J NEUROSCI, V114, P1291, DOI 10.1080/00207450490476066; LOGAN GD, 1986, J EXP PSYCHOL HUMAN, V12, P549, DOI 10.1037/0096-1523.12.4.549; Michel F, 2009, DEVELOPMENTAL SCI, V12, P272, DOI 10.1111/j.1467-7687.2008.00759.x; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Obonsawin MC, 2002, NEUROPSYCHOLOGIA, V40, P970, DOI 10.1016/S0028-3932(01)00171-3; Picton TW, 2007, DEV NEUROPSYCHOL, V31, P249, DOI 10.1080/87565640701228732; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Rueda MR, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-39; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Tillman CM, 2011, PSYCHOPHYSIOLOGY, V48, P1405, DOI 10.1111/j.1469-8986.2011.01203.x; van Boxtel GJM, 2001, BIOL PSYCHOL, V58, P229, DOI 10.1016/S0301-0511(01)00117-X	56	53	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69826	10.1371/journal.pone.0069826	http://dx.doi.org/10.1371/journal.pone.0069826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228SX	23894548	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000325211000161
J	Legrand, LB; Del Zotto, M; Tyrand, R; Pegna, AJ				Legrand, Lore B.; Del Zotto, Marzia; Tyrand, Remi; Pegna, Alan J.			Basic Instinct Undressed: Early Spatiotemporal Processing for Primary Sexual Characteristics	PLOS ONE			English	Article							HUMAN ORBITOFRONTAL CORTEX; HUMAN BRAIN; FACIAL EXPRESSIONS; HUMAN AMYGDALA; FEARFUL FACES; HEALTHY-MEN; HUMAN-BODY; ACTIVATION; STIMULI; PERCEPTION	This study investigates the spatiotemporal dynamics associated with conscious and non-conscious processing of naked and dressed human bodies. To this effect, stimuli of naked men and women with visible primary sexual characteristics, as well as dressed bodies, were presented to 20 heterosexual male and female participants while acquiring high resolution EEG data. The stimuli were either consciously detectable (supraliminal presentations) or were rendered non-conscious through backward masking (subliminal presentations). The N1 event-related potential component was significantly enhanced in participants when they viewed naked compared to dressed bodies under supraliminal viewing conditions. More importantly, naked bodies of the opposite sex produced a significantly greater N1 component compared to dressed bodies during subliminal presentations, when participants were not aware of the stimulus presented. A source localization algorithm computed on the N1 showed that the response for naked bodies in the supraliminal viewing condition was stronger in body processing areas, primary visual areas and additional structures related to emotion processing. By contrast, in the subliminal viewing condition, only visual and body processing areas were found to be activated. These results suggest that naked bodies and primary sexual characteristics are processed early in time (i.e., <200 ms) and activate key brain structures even when they are not consciously detected. It appears that, similarly to what has been reported for emotional faces, sexual features benefit from automatic and rapid processing, most likely due to their high relevance for the individual and their importance for the species in terms of reproductive success.	[Legrand, Lore B.; Del Zotto, Marzia; Pegna, Alan J.] Univ Hosp Geneva, Neurol Clin, Neuropsychol Unit, Lab Expt Neuropsychol, Geneva, Switzerland; [Legrand, Lore B.; Del Zotto, Marzia; Pegna, Alan J.] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland; [Tyrand, Remi] Univ Hosp Geneva, Neurol Clin, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Pegna, AJ (corresponding author), Univ Hosp Geneva, Neurol Clin, Neuropsychol Unit, Lab Expt Neuropsychol, Geneva, Switzerland.	alan.pegna@hcuge.ch	Del Zotto, Marzia/Y-1052-2019; Pegna, A J/D-1297-2017	Pegna, A J/0000-0001-9920-9290; Del Zotto, Marzia/0000-0003-3174-2798	Swiss National Science Foundation for Scientific Research [320030-144187, 320030-133080]	Swiss National Science Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This investigation was supported by the Swiss National Science Foundation for Scientific Research (Grants no. #320030-144187 and 320030-133080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokhin AP, 2006, BRAIN RES, V1093, P167, DOI 10.1016/j.brainres.2006.03.108; Bindemann M, 2010, J EXP PSYCHOL HUMAN, V36, P1477, DOI 10.1037/a0019057; Buhler M, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-30; Childress AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001506; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Georgiadis JR, 2012, PROG NEUROBIOL, V98, P49, DOI 10.1016/j.pneurobio.2012.05.004; Georgiadis JR, 2012, NAT REV UROL, V9, P486, DOI 10.1038/nrurol.2012.151; Gillath O, 2012, SOC COGN AFFECT NEUR, V7, P924, DOI 10.1093/scan/nsr065; Gliga T, 2005, J COGNITIVE NEUROSCI, V17, P1328, DOI 10.1162/0898929055002481; Grezes J, 2004, J NEUROSCI, V24, P5500, DOI 10.1523/JNEUROSCI.0219-04.2004; Gschwind M, 2012, CEREB CORTEX, V22, P1564, DOI 10.1093/cercor/bhr226; Hietanen JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024408; Janssen E, 2000, J SEX RES, V37, P8, DOI 10.1080/00224490009552016; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Kinsey AC, 2003, AM J PUBLIC HEALTH, V93, P894, DOI 10.2105/AJPH.93.6.894; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P318, DOI 10.1111/j.1469-8986.2007.00634.x; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; LeDoux J. E., 1996, EMOTIONAL BRAIN; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Masters WH., 1966, HUMAN SEXUAL RESPONS; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Moulier V, 2006, NEUROIMAGE, V33, P689, DOI 10.1016/j.neuroimage.2006.06.037; Mouras H, 2008, NEUROIMAGE, V42, P1142, DOI 10.1016/j.neuroimage.2008.05.051; Mouras H, 2003, NEUROIMAGE, V20, P855, DOI 10.1016/S1053-8119(03)00408-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Peelen MV, 2007, SOC COGN AFFECT NEUR, V2, P274, DOI 10.1093/scan/nsm023; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; Pegna AJ, 2008, INT J PSYCHOPHYSIOL, V70, P127, DOI 10.1016/j.ijpsycho.2008.08.007; Platek SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009042; Redoute J, 2005, PSYCHONEUROENDOCRINO, V30, P461, DOI 10.1016/j.psyneuen.2004.12.003; Rotshtein P, 2010, HUM BRAIN MAPP, V31, P1089, DOI 10.1002/hbm.20921; Sakaki M, 2012, COGN AFFECT BEHAV NE, V12, P115, DOI 10.3758/s13415-011-0062-x; Schmalzl L, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00108; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; Sinke CBA, 2010, NEUROIMAGE, V49, P1717, DOI 10.1016/j.neuroimage.2009.09.065; Spiering M, 2003, J SEX RES, V40, P134, DOI 10.1080/00224490309552175; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Stoleru S, 2012, NEUROSCI BIOBEHAV R, V36, P1481, DOI 10.1016/j.neubiorev.2012.03.006; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Thierry G, 2006, NEUROIMAGE, V32, P871, DOI 10.1016/j.neuroimage.2006.03.060; van Heijnsbergen CCRJ, 2007, BRAIN RES, V1186, P233, DOI 10.1016/j.brainres.2007.09.093; van Lankveld JJDM, 2008, BIOL PSYCHOL, V79, P200, DOI 10.1016/j.biopsycho.2008.04.016; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341	58	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69726	10.1371/journal.pone.0069726	http://dx.doi.org/10.1371/journal.pone.0069726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191CY	23894532	Green Published, Green Submitted, gold			2022-12-25	WOS:000322391400068
J	Sun, YY; Lin, SH; Lin, HC; Hung, CC; Wang, CY; Lin, YC; Hung, KS; Lien, CC; Kuan, CY; Lee, YH				Sun, Yu-Yo; Lin, Shang-Hsuan; Lin, Hung-Cheng; Hung, Chia-Chi; Wang, Chen-Yu; Lin, Yen-Chu; Hung, Kuo-Sheng; Lien, Cheng-Chang; Kuan, Chia-Yi; Lee, Yi-Hsuan			Cell Type-Specific Dependency on the PI3K/Akt Signaling Pathway for the Endogenous Epo and VEGF Induction by Baicalein in Neurons versus Astrocytes	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; ISCHEMIC BRAIN-INJURY; DOWN-REGULATION; ERYTHROPOIETIN; EXPRESSION; 12/15-LIPOXYGENASE; MECHANISMS; INHIBITION; NEUROPROTECTION; RAT	The neuroprotective effect of baicalein is generally attributed to inhibition of 12/15-lipoxygenase (12/15-LOX) and suppression of oxidative stress, but recent studies showed that baicalein also activates hypoxia-inducible factor-alpha (HIF1 alpha) through inhibition of prolyl hydrolase 2 (PHD2) and activation of the phosphatidylinositide-3 kinase (PI3K)/Akt signaling pathway. Yet, the significance and regulation of prosurvival cytokines erythropoietin (Epo) and vascular endothelial growth factor (VEGF), two transcriptional targets of HIF1 alpha, in baicalein-mediated neuroprotection in neurons and astrocytes remains unknown. Here we investigated the causal relationship between the PI3K/Akt signaling pathway and Epo/VEGF expression in baicalein-mediated neuroprotection in primary rat cortical neurons and astrocytes. Our results show that baicalein induced Epo and VEGF expression in a HIF1 alpha- and PI3K/Akt-dependent manner in neurons. Baicalein also protected neurons against excitotoxicity in a PI3K- and Epo/VEGF-dependent manner without affecting neuronal excitability. In contrast, at least a 10-fold higher concentration of baicalein was needed to induce Epo/VEGF production and PI3K/Akt activity in astrocytes for protection of neurons. Moreover, only baicalein-induced astrocytic VEGF, but not Epo expression requires HIF1 alpha, while PI3K/Akt signaling had little role in baicalein-induced astrocytic Epo/VEGF expression. These results suggest distinct mechanisms of baicalein-mediated Epo/VEGF production in neurons and astrocytes for neuroprotection, and provide new insights into the mechanisms and potential of baicalein in treating brain injury in vivo.	[Sun, Yu-Yo; Kuan, Chia-Yi] Emory Univ, Sch Med, Dept Pediat, Div Neurol,Ctr Neurodegenerat Dis, Atlanta, GA USA; [Lin, Shang-Hsuan; Wang, Chen-Yu; Lee, Yi-Hsuan] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan; [Lin, Hung-Cheng; Hung, Chia-Chi] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Wang, Chen-Yu; Lien, Cheng-Chang; Lee, Yi-Hsuan] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Lin, Yen-Chu; Lien, Cheng-Chang] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Hung, Kuo-Sheng] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan	Emory University; National Yang Ming Chiao Tung University; Taipei Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Municipal WanFang Hospital	Lee, YH (corresponding author), Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan.	yhlee3@ym.edu.tw	Lien, Cheng-Chang/AAO-6249-2020	Lien, Cheng-Chang/0000-0002-6692-9942; Hung, Chia-Chi/0000-0002-0914-6896; Lee, Yi-Hsuan/0000-0002-3213-827X; Sun, Yu-Yo/0000-0002-6608-1347	Top University Plan from Ministry of Education in Taiwan from National Science Council in Taiwan [NSC96-2628-B-038-010-MY3, NSC96-2320-B-038-025-MY3, NSC 101-2320-B-010 -041 -MY3]; National Institutes of Health from National Institute of Health in United States of America [NS074559]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074559] Funding Source: NIH RePORTER	Top University Plan from Ministry of Education in Taiwan from National Science Council in Taiwan; National Institutes of Health from National Institute of Health in United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Top University Plan from Ministry of Education in Taiwan (http://english.moe.gov.tw/), grants NSC96-2628-B-038-010-MY3 (YHL), NSC96-2320-B-038-025-MY3 (YHL), NSC 101-2320-B-010 -041 -MY3 (YHL) from National Science Council in Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7), and National Institutes of Health NS074559 (CYK) from National Institute of Health in United States of America (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Chan CB, 2011, J NEUROSCI, V31, P8083, DOI 10.1523/JNEUROSCI.1129-11.2011; Chao CC, 2011, BRAIN PATHOL, V21, P150, DOI 10.1111/j.1750-3639.2010.00431.x; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Cho H, 2008, MOL PHARMACOL, V74, P70, DOI 10.1124/mol.107.040162; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Gunnarson E, 2009, P NATL ACAD SCI USA, V106, P1602, DOI 10.1073/pnas.0812708106; Hwang KY, 2008, NEUROSCI LETT, V444, P264, DOI 10.1016/j.neulet.2008.08.057; Iwai M, 2010, STROKE, V41, P1032, DOI 10.1161/STROKEAHA.109.570325; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jin G, 2008, STROKE, V39, P2538, DOI 10.1161/STROKEAHA.108.514927; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kong DX, 2010, BIOL PHARM BULL, V33, P1600, DOI 10.1248/bpb.33.1600; Kunze R, 2012, STROKE, V43, P2748, DOI 10.1161/STROKEAHA.112.669598; Lapchak PA, 2007, NEUROSCIENCE, V150, P585, DOI 10.1016/j.neuroscience.2007.09.033; Lee HH, 2003, BRAIN RES, V986, P103, DOI 10.1016/S0006-8993(03)03197-4; Lee YH, 2000, J NEUROCHEM, V74, P2401, DOI 10.1046/j.1471-4159.2000.0742401.x; Liao JF, 2003, EUR J PHARMACOL, V464, P141, DOI 10.1016/S0014-2999(03)01422-5; Lin CH, 2009, J NEUROCHEM, V111, P777, DOI 10.1111/j.1471-4159.2009.06364.x; Lin MS, 2011, J NEUROTRAUM, V28, P1259, DOI 10.1089/neu.2011.1768; Lin MS, 2011, PROG NEURO-PSYCHOPH, V35, P931, DOI 10.1016/j.pnpbp.2010.12.022; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Mowat FM, 2012, AM J PATHOL, V180, P1726, DOI 10.1016/j.ajpath.2011.12.033; Mowat FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011103; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Pallast S, 2009, J NEUROCHEM, V111, P882, DOI 10.1111/j.1471-4159.2009.06379.x; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Pidgeon GP, 2002, CANCER RES, V62, P2721; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Spinella F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011241; Sun FY, 2005, J NEUROSCI RES, V79, P180, DOI 10.1002/jnr.20321; Sun YY, 2010, J NEUROSCI, V30, P9621, DOI 10.1523/JNEUROSCI.2295-10.2010; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Tang Y, 2009, INT J CANCER, V124, P1545, DOI 10.1002/ijc.24118; Tsai TH, 2002, BRIT J PHARMACOL, V137, P1314, DOI 10.1038/sj.bjp.0704959; van Leyen K, 2006, STROKE, V37, P3014, DOI 10.1161/01.STR.0000249004.25444.a5; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Viita H, 2008, CIRC RES, V102, P177, DOI 10.1161/CIRCRESAHA.107.155556; Wang W, 2011, BRIT J PHARMACOL, V162, P1364, DOI 10.1111/j.1476-5381.2010.01143.x; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Williams RJ, 2012, FREE RADICAL BIO MED, V52, P35, DOI 10.1016/j.freeradbiomed.2011.09.010; Wu XF, 2010, BIOCHEM BIOPH RES CO, V393, P514, DOI 10.1016/j.bbrc.2010.02.038; ZALESKA MM, 1989, J NEUROCHEM, V52, P255, DOI 10.1111/j.1471-4159.1989.tb10925.x	50	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69019	10.1371/journal.pone.0069019	http://dx.doi.org/10.1371/journal.pone.0069019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23904909	Green Published, Green Submitted, gold			2022-12-25	WOS:000322391400034
J	Tan, MK; Koval, J; Ghalayini, A				Tan, Mui-Keng; Koval, Jason; Ghalayini, Aida			Novel Genetic Variants of GA-Insensitive Rht-1 Genes in Hexaploid Wheat and Their Potential Agronomic Value	PLOS ONE			English	Article							MATURITY ALPHA-AMYLASE; DWARFING GENES; SIGNAL-TRANSDUCTION; GREEN-REVOLUTION; NEXT-GENERATION; FALLING NUMBER; GRAIN-YIELD; GIBBERELLIN; PATHWAY; DNA	This study has found numerous novel genetic variants of GA-insensitive dwarfing genes with potential agricultural value for crop improvement. The cultivar, Spica is a tall genotype and possesses the wild-type genes of Rht-A1a, Rht-B1a and Rht-D1a. The cultivar Quarrion possesses a null mutant in the DELLA motif in each of the 3 genomes. This is a first report of a null mutant of Rht-A1. In addition, novel null mutants which differ from reported null alleles of Rht-B1b, Rht-B1e and Rht-D1b have been found in Quarrion, Carnamah and Whistler. The accession, Aus1408 has an allele of Rht-B1 with a mutation in the conserved 'TVHYNP' N-terminal signal binding domain with possible implications on its sensitivity to GA. Mutations in the conserved C-terminal GRAS domain of Rht-A1 alleles with possible effects on expression have been found in WW1842, Quarrion and Drysdale. Genetic variants with putative spliceosomal introns in the GRAS domain have been found in all accessions except Spica. Genome-specific cis-sequences about 124 bp upstream of the start codon of the Rht-1 gene have been identified for each of the three genomes.	[Tan, Mui-Keng; Ghalayini, Aida] Elizabeth Macarthur Agr Inst, New South Wales NSW Dept Primary Ind, Menangle, NSW, Australia; [Koval, Jason] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia	NSW Department of Primary Industries; University of New South Wales Sydney	Tan, MK (corresponding author), Elizabeth Macarthur Agr Inst, New South Wales NSW Dept Primary Ind, Menangle, NSW, Australia.	mui-keng.tan@dpi.nsw.gov.au		Koval, Jason/0000-0003-4270-0534	Value-Added Wheat CRC, Australia	Value-Added Wheat CRC, Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The authors gratefully acknowledge financial support from Value-Added Wheat CRC, Australia (now terminated). University of New South Wales contributed half of the sequencing costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 2009, MOL GENET GENOMICS, V281, P223, DOI 10.1007/s00438-008-0406-6; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Delseny M, 2010, PLANT SCI, V179, P407, DOI 10.1016/j.plantsci.2010.07.019; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V129, P371, DOI 10.1017/S0021859697004899; Futschik A, 2010, GENETICS, V186, P207, DOI 10.1534/genetics.110.114397; Gooding MJ, 2012, J CEREAL SCI, V55, P305, DOI 10.1016/j.jcs.2012.01.003; Gooding MJ, 1999, BIOL AGRIC HORTIC, V16, P335, DOI 10.1080/01448765.1999.9755237; Gubler F, 2002, PLANT PHYSIOL, V129, P191, DOI 10.1104/pp.010918; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; KOORNNEEF M, 1985, PHYSIOL PLANTARUM, V65, P33, DOI 10.1111/j.1399-3054.1985.tb02355.x; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Mares D, 2008, J CEREAL SCI, V47, P6, DOI 10.1016/j.jcs.2007.01.005; Marroni F, 2011, PLANT J, V67, P736, DOI 10.1111/j.1365-313X.2011.04627.x; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Munkvold JD, 2009, THEOR APPL GENET, V119, P1223, DOI 10.1007/s00122-009-1123-1; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Rebetzke GJ, 2012, FIELD CROP RES, V127, P17, DOI 10.1016/j.fcr.2011.11.003; Rebetzke GJ, 2001, AUST J AGR RES, V52, P1221, DOI 10.1071/AR01042; Richards RA, 2004, P 4 INT CROP SCI C N; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tan MK, 2010, CROP PASTURE SCI, V61, P153, DOI 10.1071/CP09239	33	8	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69690	10.1371/journal.pone.0069690	http://dx.doi.org/10.1371/journal.pone.0069690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894524	gold, Green Published, Green Submitted			2022-12-25	WOS:000322391400066
J	Guo, H; Gao, M; Lu, Y; Liang, J; Lorenzi, PL; Bai, S; Hawke, DH; Li, J; Dogruluk, T; Scott, KL; Jonasch, E; Mills, GB; Ding, Z				Guo, H.; Gao, M.; Lu, Y.; Liang, J.; Lorenzi, P. L.; Bai, S.; Hawke, D. H.; Li, J.; Dogruluk, T.; Scott, K. L.; Jonasch, E.; Mills, G. B.; Ding, Z.			Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules	ONCOGENE			English	Article						AKT; phosphorylation; NIA	PROTEIN-KINASE-B; RICTOR-MTOR COMPLEX; MEMBRANE LOCALIZATION; CANCER CELLS; ACTIVATION; AKT/PKB; GROWTH; ROLES; DOWNSTREAM; STABILITY	Aberrant AKT activation is prevalent across multiple human cancer lineages providing an important new target for therapy. Twenty-two independent phosphorylation sites have been identified on specific AKT isoforms likely contributing to differential isoform regulation. However, the mechanisms regulating phosphorylation of individual AKT isoform molecules have not been elucidated because of the lack of robust approaches able to assess phosphorylation of multiple sites on a single AKT molecule. Using a nanofluidic proteomic immunoassay (NIA), consisting of isoelectric focusing followed by sensitive chemiluminescence detection, we demonstrate that under basal and ligand-induced conditions that the pattern of phosphorylation events is markedly different between AKT1 and AKT2. Indeed, there are at least 12 AKT1 peaks and at least 5 AKT2 peaks consistent with complex combinations of phosphorylation of different sites on individual AKT molecules. Following insulin stimulation, AKT1 was phosphorylated at Thr308 in the T-loop and Ser473 in the hydrophobic domain. In contrast, AKT2 was only phosphorylated at the equivalent sites (Thr309 and Ser474) at low levels. Further, Thr308 and Ser473 phosphorylation occurred predominantly on the same AKT1 molecules, whereas Thr309 and Ser474 were phosphorylated primarily on different AKT2 molecules. Although basal AKT2 phosphorylation was sensitive to inhibition of phosphatidylinositol 3-kinase (PI3K), basal AKT1 phosphorylation was essentially resistant. PI3K inhibition decreased pThr451 on AKT2 but not pThr450 on AKT1. Thus, NIA technology provides an ability to characterize coordinate phosphorylation of individual AKT molecules providing important information about AKT isoform-specific phosphorylation, which is required for optimal development and implementation of drugs targeting aberrant AKT activation.	[Guo, H.; Gao, M.; Lu, Y.; Liang, J.; Li, J.; Mills, G. B.; Ding, Z.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Lorenzi, P. L.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Bai, S.; Jonasch, E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Hawke, D. H.] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Dogruluk, T.; Scott, K. L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Mills, GB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gmills@mdanderson.org; zding@mdanderson.org		Dogruluk, Turgut/0000-0002-9212-9471	National Institutes of Health (NIH) [5R21CA126700]; University of Texas MD Anderson Cancer Center Kidney Cancer Multidisciplinary Research Program; AstraZeneca; Clinical Proteomic Tumor Analysis Consortium (CPTAC) [U24 CA126477, U24 CA126479, U54 CA112970]; NCI CCSG [P30 CA016672]; NATIONAL CANCER INSTITUTE [R21CA126700, U24CA126477, P30CA016672, U24CA126479, U54CA112970, U01CA168394] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center Kidney Cancer Multidisciplinary Research Program; AstraZeneca(AstraZeneca); Clinical Proteomic Tumor Analysis Consortium (CPTAC); NCI CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Bert Vogelstein for providing HCT116 wt and knockout cell lines. The work is supported by National Institutes of Health (NIH) grant 5R21CA126700, a grant from the University of Texas MD Anderson Cancer Center Kidney Cancer Multidisciplinary Research Program, and research support from AstraZeneca to ZD, and the Clinical Proteomic Tumor Analysis Consortium (CPTAC) grants (U24 CA126477, U24 CA126479, and U54 CA112970) to GBM and NCI CCSG grant (P30 CA016672).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Bouzakri K, 2006, CELL METAB, V4, P89, DOI 10.1016/j.cmet.2006.04.008; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Ding ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009910; Endersby R, 2011, CANCER RES, V71, P4106, DOI 10.1158/0008-5472.CAN-10-3597; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fan AC, 2009, NAT MED, V15, P566, DOI 10.1038/nm.1903; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao ML, 2000, BIOCHEM J, V352, P475, DOI 10.1042/0264-6021:3520475; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	28	31	34	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 26	2014	33	26					3463	3472		10.1038/onc.2013.301	http://dx.doi.org/10.1038/onc.2013.301			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK9WM	23912456	Green Accepted			2022-12-25	WOS:000338779300013
J	Randak, CO; Dong, Q; Heul, ARV; Elcock, AH; Welsh, MJ				Randak, Christoph O.; Dong, Qian; Heul, Amanda R. Ver; Elcock, Adrian H.; Welsh, Michael J.			ATP and AMP Mutually Influence Their Interaction with the ATP-binding Cassette (ABC) Adenylate Kinase Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) at Separate Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MOLECULAR-BASIS; BAKERS-YEAST; SWISS-MODEL; NUCLEOTIDE; TRANSPORTER; DOMAIN; CHANNEL; PROTEIN; PHOSPHOTRANSFERASE	Cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel in the ATP-binding cassette (ABC) transporter protein family. In the presence of ATP and physiologically relevant concentrations of AMP, CFTR exhibits adenylate kinase activity (ATP + AMP reversible arrow 2 ADP). Previous studies suggested that the interaction of nucleotide triphosphate with CFTR at ATP-binding site 2 is required for this activity. Two other ABC proteins, Rad50 and a structural maintenance of chromosome protein, also have adenylate kinase activity. All three ABC adenylate kinases bind and hydrolyze ATP in the absence of other nucleotides. However, little is known about how an ABC adenylate kinase interacts with ATP and AMP when both are present. Based on data from non-ABC adenylate kinases, we hypothesized that ATP and AMP mutually influence their interaction with CFTR at separate binding sites. We further hypothesized that only one of the two CFTR ATP-binding sites is involved in the adenylate kinase reaction. We found that 8-azidoadenosine 5'-triphosphate (8-N-3-ATP) and 8-azidoadenosine 5'-monophosphate (8-N-3-AMP) photolabeled separate sites in CFTR. Labeling of the AMP-binding site with 8-N-3-AMP required the presence of ATP. Conversely, AMP enhanced photolabeling with 8-N-3-ATP at ATP-binding site 2. The adenylate kinase active center probe P-1,P-5-di(adenosine-5') pentaphosphate interacted simultaneously with an AMP-binding site and ATP-binding site 2. These results show that ATP and AMP interact with separate binding sites but mutually influence their interaction with the ABC adenylate kinase CFTR. They further indicate that the active center of the adenylate kinase comprises ATP-binding site 2.	[Randak, Christoph O.; Dong, Qian; Heul, Amanda R. Ver] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Elcock, Adrian H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Randak, CO (corresponding author), Univ Iowa, Dept Pediat, 500 EMRB, Iowa City, IA 52242 USA.	chris-toph-randak@uiowa.edu		Randak, Christoph/0000-0003-3264-4137; Welsh, Michael/0000-0002-1646-6206; Elcock, Adrian/0000-0003-2820-1376	National Institutes of Health [K08HL097071, HL51670, HL091842]; Cystic Fibrosis Foundation [RANDAK09Q0]; Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842, K08HL097071, P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants K08HL097071 (to C. O. R.) and HL51670 and HL091842 (to M. J. W.). This work was also supported by Cystic Fibrosis Foundation Grant RANDAK09Q0.; The recipient of a Harry Shwachman Cystic Fibrosis Clinical Investigator Award and of a Parker B. Francis Fellowship.	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Berry MB, 2006, PROTEINS, V62, P555, DOI 10.1002/prot.20699; BERRY MB, 1994, PROTEINS, V19, P183, DOI 10.1002/prot.340190304; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bianchet MA, 1997, J BIOENERG BIOMEMBR, V29, P503, DOI 10.1023/A:1022443209010; Bilderback T, 1996, BIOCHEMISTRY-US, V35, P6100, DOI 10.1021/bi951833i; Brandt BW, 2008, NUCLEIC ACIDS RES, V36, pW255, DOI 10.1093/nar/gkn237; Callebaut I, 2004, CELL MOL LIFE SCI, V61, P230, DOI 10.1007/s00018-003-3386-z; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cheung JC, 2008, ARCH BIOCHEM BIOPHYS, V476, P95, DOI 10.1016/j.abb.2008.03.033; CHUAN H, 1989, J BIOL CHEM, V264, P7981; Criswell AR, 2003, J MOL BIOL, V330, P1087, DOI 10.1016/S0022-2836(03)00655-7; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dong Q, 2008, BIOPHYS J, V95, P5178, DOI 10.1529/biophysj.108.140897; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Gross CH, 2006, J BIOL CHEM, V281, P4058, DOI 10.1074/jbc.M511113200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hanrahan JW, 2003, ABC PROTEINS BACTERI, P589; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; ITO Y, 1980, EUR J BIOCHEM, V105, P85, DOI 10.1111/j.1432-1033.1980.tb04477.x; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Lammens A, 2010, J MOL BIOL, V401, P265, DOI 10.1016/j.jmb.2010.06.029; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; OSTEDGAARD LS, 1992, J BIOL CHEM, V267, P26142; Polshakov D, 2005, BIOCHEMISTRY-US, V44, P11241, DOI 10.1021/bi050859z; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; Randak C, 2003, CELL, V115, P837, DOI 10.1016/S0092-8674(03)00983-8; Randak CO, 2012, J BIOL CHEM, V287, P36105, DOI 10.1074/jbc.M112.408450; Randak CO, 2005, P NATL ACAD SCI USA, V102, P2216, DOI 10.1073/pnas.0409787102; SALVUCCI ME, 1992, BIOCHEMISTRY-US, V31, P4479, DOI 10.1021/bi00133a014; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schulz G. E., 1992, FARADAY DISCUSS, V93, P858; SHYAMALA V, 1991, J BIOL CHEM, V266, P18714; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Szabo K, 1999, J BIOL CHEM, V274, P12209, DOI 10.1074/jbc.274.18.12209; TOMASSELLI AG, 1980, EUR J BIOCHEM, V103, P481, DOI 10.1111/j.1432-1033.1980.tb05972.x; TOMASSELLI AG, 1979, EUR J BIOCHEM, V93, P263, DOI 10.1111/j.1432-1033.1979.tb12819.x; TOMASSELLI AG, 1983, EUR J BIOCHEM, V132, P109, DOI 10.1111/j.1432-1033.1983.tb07333.x; TRAVIS SM, 1993, J BIOL CHEM, V268, P15336; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; YAZAWA M, 1976, J BIOL CHEM, V251, P3021	62	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27692	27701		10.1074/jbc.M113.479675	http://dx.doi.org/10.1074/jbc.M113.479675			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921386	Green Published, hybrid			2022-12-25	WOS:000330597300062
J	Haniu, AECJ; Maricato, JT; Mathias, PPM; Castilho, DG; Miguel, RB; Monteiro, HP; Puccia, R; Batista, WL				Coronel Janu Haniu, Ana Eliza; Maricato, Juliana Terzi; Moraes Mathias, Pedro Paulo; Castilho, Daniele Goncalves; Miguel, Rodrigo Bernardi; Monteiro, Hugo Pequeno; Puccia, Rosana; Batista, Wagner Luiz			Low Concentrations of Hydrogen Peroxide or Nitrite Induced of Paracoccidioides brasiliensis Cell Proliferation in a Ras-Dependent Manner	PLOS ONE			English	Article							PROTEIN S-NITROSYLATION; CRYPTOCOCCUS-NEOFORMANS; MYCOBACTERIUM-TUBERCULOSIS; TYROSINE PHOSPHORYLATION; TRANSCRIPTIONAL RESPONSE; STRUCTURAL BASIS; REACTIVE OXYGEN; MAP KINASE; OXIDE; ACTIVATION	Paracoccidioides brasiliensis, a causative agent of paracoccidioidomycosis (PCM), should be able to adapt to dramatic environmental changes inside the infected host after inhalation of air-borne conidia and transition to pathogenic yeasts. Proteins with antioxidant functions may protect fungal cells against reactive oxygen (ROS) and nitrogen (RNS) species generated by phagocytic cells, thus acting as potential virulence factors. Ras GTPases are involved in stress responses, cell morphology, and differentiation in a range of organisms. Ras, in its activated form, interacts with effector proteins and can initiate a kinase cascade. In lower eukaryotes, Byr2 kinase represents a Ras target. The present study investigated the role of Ras in P. brasiliensis after in vitro stimulus with ROS or RNS. We have demonstrated that low concentrations of H2O2 (0.1 mM) or NO2 (0.1-0.25 mu M) stimulated P. brasiliensis yeast cell proliferation and that was not observed when yeast cells were pre-incubated with farnesyltransferase inhibitor. We constructed an expression plasmid containing the Byr2 Ras-binding domain (RBD) fused with GST (RBD-Byr2-GST) to detect the Ras active form. After stimulation with low concentrations of H2O2 or NO2, the Ras active form was observed in fungal extracts. Besides, NO2 induced a rapid increase in S-nitrosylated Ras levels. This alternative posttranslational modification of Ras, probably in residue Cys123, would lead to an exchange of GDP for GTP and consequent GTPase activation in P. brasiliensis. In conclusion, low concentrations of H2O2 or NO2 stimulated P. brasiliensis proliferation through Ras activation.	[Coronel Janu Haniu, Ana Eliza; Maricato, Juliana Terzi; Castilho, Daniele Goncalves; Puccia, Rosana; Batista, Wagner Luiz] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Moraes Mathias, Pedro Paulo; Miguel, Rodrigo Bernardi; Monteiro, Hugo Pequeno] Univ Fed Sao Paulo, Ctr Terapia Celular & Mol CTCMol, Dept Bioquim Biol Mol, Sao Paulo, Brazil; [Batista, Wagner Luiz] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Batista, WL (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	batista@unifesp.br	Puccia, Rosana/D-7303-2012; Maricato, Juliana/F-1608-2012; Batista, Wagner L./C-8204-2012	Puccia, Rosana/0000-0002-3332-0487; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/14392-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [477764/2009-6]; Coordenacao Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao Aperfeicoamento de Pessoal de Nivel Superior	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant 2011/14392-2) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant 477764/2009-6) to WLB; and Coordenacao Aperfeicoamento de Pessoal de Nivel Superior (scholarship to AECJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Batista WL, 2013, ANTIOXID REDOX SIGN, V18, P221, DOI 10.1089/ars.2011.4455; Batista WL, 2006, EUKARYOT CELL, V5, P379, DOI 10.1128/EC.5.2.379-390.2006; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Bhunia AK, 1997, J BIOL CHEM, V272, P15642, DOI 10.1074/jbc.272.25.15642; BRUMMER E, 1989, INFECT IMMUN, V57, P2289, DOI 10.1128/IAI.57.8.2289-2294.1989; Calvi SA, 2003, MICROBES INFECT, V5, P107, DOI 10.1016/S1286-4579(02)00078-3; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Caponigro F, 2003, EXPERT OPIN INV DRUG, V12, P943, DOI 10.1517/eoid.12.6.943.21785; Chang EC, 2006, CELL CYCLE, V5, P1936, DOI 10.4161/cc.5.17.3187; Colombo S, 2004, J BIOL CHEM, V279, P46715, DOI 10.1074/jbc.M405136200; Cullen PJ, 2012, GENETICS, V190, P23, DOI 10.1534/genetics.111.127456; Davis MF, 2011, FREE RADICAL BIO MED, V51, P565, DOI 10.1016/j.freeradbiomed.2011.05.003; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Evangelista AM, 2013, ANTIOXID RE IN PRESS; Tavares AHFP, 2007, MICROBES INFECT, V9, P583, DOI 10.1016/j.micinf.2007.01.024; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Feldmesser M, 2001, MICROBIOL-SGM, V147, P2355, DOI 10.1099/00221287-147-8-2355; Fernandes L, 2008, FEMS YEAST RES, V8, P300, DOI 10.1111/j.1567-1364.2007.00317.x; Forrester MT, 2011, FREE RADIC BIOL MED, V46, P119; Fortwendel JR, 2005, EUKARYOT CELL, V4, P1982, DOI 10.1128/EC.4.12.1982-1989.2005; Calich VLG, 2008, MYCOPATHOLOGIA, V165, P223, DOI 10.1007/s11046-007-9048-1; Heo J, 2005, J MOL BIOL, V346, P1423, DOI 10.1016/j.jmb.2004.12.050; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Lander HM, 1996, J BIOL CHEM, V271, P19705, DOI 10.1074/jbc.271.33.19705; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; Lee TY, 2012, BIOINFORMATICS, V28, P2293, DOI 10.1093/bioinformatics/bts436; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Matute DR, 2006, J CLIN MICROBIOL, V44, P2153, DOI 10.1128/JCM.02540-05; Mitchell L, 2013, ANTIOXID REDOX SIGN, V18, P250, DOI 10.1089/ars.2012.4687; Monteiro HP, 1996, FREE RADICAL BIO MED, V21, P323, DOI 10.1016/0891-5849(96)00051-2; Monteiro HP, 2008, ANTIOXID REDOX SIGN, V10, P843, DOI 10.1089/ars.2007.1853; Nascimento FRF, 2002, J IMMUNOL, V168, P4593, DOI 10.4049/jimmunol.168.9.4593; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nichols CB, 2009, EUKARYOT CELL, V8, P181, DOI 10.1128/EC.00351-08; Oliveira CJR, 2008, NITRIC OXIDE-BIOL CH, V18, P241, DOI 10.1016/j.niox.2008.02.001; Onken B, 2006, P NATL ACAD SCI USA, V103, P9045, DOI 10.1073/pnas.0603318103; Pervin S, 2007, CANCER RES, V67, P289, DOI 10.1158/0008-5472.CAN-05-4623; Pina A, 2008, J LEUKOCYTE BIOL, V83, P1088, DOI 10.1189/jlb.1107738; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Raines KW, 2007, CARDIOVASC RES, V75, P229, DOI 10.1016/j.cardiores.2007.04.013; Randhawa PK, 2011, CIRC RES, V108, P1199, DOI 10.1161/CIRCRESAHA.110.230888; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Rudoni S, 2001, BBA-MOL CELL RES, V1538, P181, DOI 10.1016/S0167-4889(01)00067-2; Santibanez JF, 2010, CARCINOGENESIS, V31, P2145, DOI 10.1093/carcin/bgq199; Scheffzek K, 2001, STRUCTURE, V9, P1043, DOI 10.1016/S0969-2126(01)00674-8; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Snelgrove RJ, 2006, J IMMUNOL, V177, P5509, DOI 10.4049/jimmunol.177.8.5509; Srinivasa K, 2012, MOL CELLS, V33, P183, DOI 10.1007/s10059-012-2244-y; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tamanoi Fuyuhiko, 2011, Genes Cancer, V2, P210, DOI 10.1177/1947601911407322; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Tu H, 1997, MOL CELL BIOL, V17, P5876, DOI 10.1128/MCB.17.10.5876; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Waugh MS, 2002, MICROBIOL-SGM, V148, P191, DOI 10.1099/00221287-148-1-191; Xie XQ, 2013, ENVIRON MICROBIOL, V15, P447, DOI 10.1111/j.1462-2920.2012.02871.x; Zhang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048786	68	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69590	10.1371/journal.pone.0069590	http://dx.doi.org/10.1371/journal.pone.0069590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922749	Green Submitted, Green Published, gold			2022-12-25	WOS:000323369700051
J	Gaudin, R; Berre, S; de Alencar, BC; Decalf, J; Schindler, M; Gobert, FX; Jouve, M; Benaroch, P				Gaudin, Raphael; Berre, Stefano; de Alencar, Bruna Cunha; Decalf, Jeremie; Schindler, Michael; Gobert, Francois-Xavier; Jouve, Mabel; Benaroch, Philippe			Dynamics of HIV-Containing Compartments in Macrophages Reveal Sequestration of Virions and Transient Surface Connections	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PLASMA-MEMBRANE; MONOCYTES; INFECTION; ENDOSOMES; ASSEMBLES; DOMAIN; BUDS	During HIV pathogenesis, infected macrophages behave as `"viral reservoirs" that accumulate and retain virions within dedicated internal Virus-Containing Compartments (VCCs). The nature of VCCs remains ill characterized and controversial. Using wild-type HIV-1 and a replication-competent HIV-1 carrying GFP internal to the Gag precursor, we analyzed the biogenesis and evolution of VCCs in primary human macrophages. VCCs appear roughly 14 hours after viral protein synthesis is detected, initially contain few motile viral particles, and then mature to fill up with virions that become packed and immobile. The amount of intracellular Gag, the proportion of dense VCCs, and the density of viral particles in their lumen increased with time post-infection. In contrast, the secretion of virions, their infectivity and their transmission to T cells decreased overtime, suggesting that HIV-infected macrophages tend to pack and retain newly formed virions into dense compartments. A minor proportion of VCCs remains connected to the plasma membrane overtime. Surprisingly, live cell imaging combined with correlative light and electron microscopy revealed that such connections can be transient, highlighting their dynamic nature. Together, our results shed light on the late phases of the HIV-1 cycle and reveal some of its macrophage specific features.	[Gaudin, Raphael; Berre, Stefano; de Alencar, Bruna Cunha; Decalf, Jeremie; Gobert, Francois-Xavier; Jouve, Mabel; Benaroch, Philippe] Ctr Rech, Inst Curie, Paris, France; [Gaudin, Raphael; Berre, Stefano; de Alencar, Bruna Cunha; Decalf, Jeremie; Gobert, Francois-Xavier; Benaroch, Philippe] INSERM, U932, Paris, France; [Jouve, Mabel] CNRS, INSERM, U934, UMR 3215, Paris, France; [Schindler, Michael] Helmholtz Zentrum Munich, Inst Virol, Munich, Germany	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Benaroch, P (corresponding author), Ctr Rech, Inst Curie, Paris, France.	benaroch@curie.fr	Schindler, Michael/C-1647-2015; Alencar, Bruna/J-5089-2014; decalf, jeremie/AAE-2939-2020; Alencar, Bruna/AGB-5949-2022; Gaudin, Raphael/G-6716-2017	Schindler, Michael/0000-0001-8989-5813; Alencar, Bruna/0000-0002-7711-1054; Jouve San Roman, Mabel Juana/0000-0002-3115-4681; Benaroch, Philippe/0000-0002-2655-0129; Gobert, Francois-Xavier/0000-0002-6085-6295; BERRE, Stefano/0000-0001-8427-759X; gaudin, raphael/0000-0002-8558-8143	Ensemble contre le SIDA; Agence Nationale de Recherche contre le SIDA; Institut Curie	Ensemble contre le SIDA; Agence Nationale de Recherche contre le SIDA(French National Research Agency (ANR)); Institut Curie	This study was supported by grants from " Ensemble contre le SIDA " and "Agence Nationale de Recherche contre le SIDA'' to PB and fellowships to BCdA and RG, respectively. SB was supported by a fellowship from the Institut Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Arfi V, 2008, J VIROL, V82, P6557, DOI 10.1128/JVI.02321-07; Benaroch P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-29; Bennett AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000591; Chu H, 2012, CELL HOST MICROBE, V12, P360, DOI 10.1016/j.chom.2012.07.011; Chu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035297; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Gaudin R, 2012, J CELL BIOL, V199, P467, DOI 10.1083/jcb.201201144; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Koppensteiner H, 2012, J VIROL, V86, P2826, DOI 10.1128/JVI.05915-11; Kramer B, 2005, BLOOD CELL MOL DIS, V35, P136, DOI 10.1016/j.bcmd.2005.06.006; Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Marsh M, 2009, BIOCHEM SOC T, V37, P185, DOI 10.1042/BST0370185; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; ORENSTEIN JM, 1988, J VIROL, V62, P2578, DOI 10.1128/JVI.62.8.2578-2586.1988; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pelchen-Matthews A, 2012, TRAFFIC, V13, P273, DOI 10.1111/j.1600-0854.2011.01306.x; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; SCHUITEMAKER H, 1991, J VIROL, V65, P356, DOI 10.1128/JVI.65.1.356-363.1991; SCHURMANN W, 1983, ANTIVIR RES, V3, P25, DOI 10.1016/0166-3542(83)90012-8; Terpstra FG, 2007, J HOSP INFECT, V66, P332, DOI 10.1016/j.jhin.2007.05.005; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Welsch S, 2011, J VIROL, V85, P7922, DOI 10.1128/JVI.00834-11	31	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69450	10.1371/journal.pone.0069450	http://dx.doi.org/10.1371/journal.pone.0069450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922713	Green Published, Green Submitted, gold			2022-12-25	WOS:000323369700031
J	Reynes, G; Vila, V; Fleitas, T; Reganon, E; de Mora, JF; Jorda, M; Martinez-Sales, V				Reynes, Gaspar; Vila, Virtudes; Fleitas, Tania; Reganon, Edelmiro; de Mora, Jaime Font; Jorda, Maria; Martinez-Sales, Vicenta			Circulating Endothelial Cells and Procoagulant Microparticles in Patients with Glioblastoma: Prognostic Value	PLOS ONE			English	Article							CANCER-PATIENTS; COLORECTAL-CANCER; CHEMOTHERAPY; TEMOZOLOMIDE; BEVACIZUMAB; GLIOMAS; ANGIOGENESIS; ENUMERATION; DYSFUNCTION; HEMOSTASIS	Aim: Circulating endothelial cells and microparticles are prognostic factors in cancer. However, their prognostic and predictive value in patients with glioblastoma is unclear. The objective of this study was to investigate the potential prognostic value of circulating endothelial cells and microparticles in patients with newly diagnosed glioblastoma treated with standard radiotherapy and concomitant temozolomide. In addition, we have analyzed the methylation status of the MGMT promoter. Methods: Peripheral blood samples were obtained before and at the end of the concomitant treatment. Blood samples from healthy volunteers were also obtained as controls. Endothelial cells were measured by an immunomagnetic technique and immunofluorescence microscopy. Microparticles were quantified by flow cytometry. Microparticle-mediated procoagulant activity was measured by endogen thrombin generation and by phospholipid-dependent clotting time. Methylation status of MGMT promoter was determined by multiplex ligation-dependent probe amplification. Results: Pretreatment levels of circulating endothelial cells and microparticles were higher in patients than in controls (p<0.001). After treatment, levels of microparticles and thrombin generation decreased, and phospholipid-dependent clotting time increased significantly. A high pretreatment endothelial cell count, corresponding to the 99th percentile in controls, was associated with poor overall survival. MGMT promoter methylation was present in 27% of tumor samples and was associated to a higher overall survival (66 weeks vs 30 weeks, p<0.004). Conclusion: Levels of circulating endothelial cells may have prognostic value in patients with glioblastoma.	[Reynes, Gaspar] Hosp Univ & Politecn La Fe, Serv Oncol Med, Valencia, Spain; [Vila, Virtudes; Reganon, Edelmiro; Martinez-Sales, Vicenta] Hosp Univ & Politecn La Fe, Ctr Invest, Valencia, Spain; [Fleitas, Tania] Hosp Clin Univ, Serv Hematol & Oncol Med, Valencia, Spain; [de Mora, Jaime Font] Sanitaria Hosp La Fe, Inst Invest, Valencia, Spain; [Jorda, Maria] Hosp Univ & Politecn La Fe, Serv Anat Patol, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Clinic Universitari de Valencia; Hospital Universitari i Politecnic La Fe	Reynes, G (corresponding author), Hosp Univ & Politecn La Fe, Serv Oncol Med, Valencia, Spain.	greynesm@gmail.com	de Mora, Jaime Font/H-6304-2015; de Mora, Jaime Font/AAK-7591-2021	de Mora, Jaime Font/0000-0002-6816-2095; de Mora, Jaime Font/0000-0002-6816-2095; Fleitas kanonnikoff, Tania/0000-0002-2789-9082; Reynes, Gaspar/0000-0001-8636-6094	Spanish Ministry of Economy and Competitiveness [SAF2012-37330]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported in part by SAF2012-37330 grant from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia FM, 2011, ARCH PATHOL LAB MED, V135, P1482, DOI 10.5858/arpa.2010-0731-OA; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Beerepoot LV, 2004, ANN ONCOL, V15, P139, DOI 10.1093/annonc/mdh017; Boos CJ, 2006, J AM COLL CARDIOL, V48, P1538, DOI 10.1016/j.jacc.2006.02.078; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Browder T, 2000, CANCER RES, V60, P1878; Calleri A, 2009, CLIN CANCER RES, V15, P7652, DOI 10.1158/1078-0432.CCR-09-1493; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Erdbruegger U, 2010, CURR STEM CELL RES T, V5, P294, DOI 10.2174/157488810793351721; Fleitas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047365; Gruenwald V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-695; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Helley D, 2009, EUR UROL, V56, P479, DOI 10.1016/j.eururo.2008.06.038; Kargiotis O, 2006, J NEURO-ONCOL, V78, P281, DOI 10.1007/s11060-005-9097-6; Kawaishi M, 2009, J THORAC ONCOL, V4, P208, DOI 10.1097/JTO.0b013e318193030d; Kim JT, 2006, ONCOL REP, V16, P33; Lacroix R, 2010, J THROMB HAEMOST, V8, P2571, DOI 10.1111/j.1538-7836.2010.04047.x; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Malka D, 2012, ANN ONCOL, V23, P919, DOI 10.1093/annonc/mdr365; Mancuso P, 2001, BLOOD, V97, P3658, DOI 10.1182/blood.V97.11.3658; Mancuso P, 2006, BLOOD, V108, P452, DOI 10.1182/blood-2005-11-4570; Mancuso Patrizia, 2012, Recent Results Cancer Res, V195, P163, DOI 10.1007/978-3-642-28160-0_14; Manzoni M, 2012, J CANCER RES CLIN, V138, P1187, DOI 10.1007/s00432-012-1190-6; Martinez-Sales V, 2011, DIS MARKERS, V31, P75, DOI [10.1155/2011/757840, 10.3233/DMA-2011-0801]; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Muntunga M, 2001, AM J RESP CRIT CARE, V163, P195; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Sartori MT, 2011, J NEURO-ONCOL, V104, P225, DOI 10.1007/s11060-010-0462-8; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2010, J CLIN ONCOL, V28, P2712, DOI 10.1200/JCO.2009.26.6650; Thaler J, 2011, ANN HEMATOL, V90, P447, DOI 10.1007/s00277-010-1111-1; Vroling L, 2009, ANGIOGENESIS, V12, P69, DOI 10.1007/s10456-009-9133-9; Woywodt A, 2006, J THROMB HAEMOST, V4, P671, DOI 10.1111/j.1538-7836.2006.01794.x	35	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69034	10.1371/journal.pone.0069034	http://dx.doi.org/10.1371/journal.pone.0069034			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922679	gold, Green Submitted, Green Published			2022-12-25	WOS:000323369700019
J	Lei, YP; Zhu, HP; Duhon, C; Yang, W; Ross, ME; Shaw, GM; Finnell, RH				Lei, Yunping; Zhu, Huiping; Duhon, Cody; Yang, Wei; Ross, M. Elizabeth; Shaw, Gary M.; Finnell, Richard H.			Mutations in Planar Cell Polarity Gene SCRIB Are Associated with Spina Bifida	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; TUMOR-SUPPRESSOR SCRIBBLE; VANGL2 MUTATIONS; LOOP-TAIL; MOUSE; DOMAINS; IDENTIFICATION; LOCALIZATION; PROTEINS; HOMOLOG	Neural tube defects (NTDs) (OMIM #182940) including anencephaly, spina bifida and craniorachischisis, are severe congenital malformations that affect 0.5-1 in 1,000 live births in the United States, with varying prevalence around the world. Mutations in planar cell polarity (PCP) genes are believed to cause a variety of NTDs in both mice and humans. SCRIB is a PCP-associated gene. Mice that are homozygous for the Scrib p.I285K and circletail (Crc) mutations, present with the most severe form of NTDs, namely craniorachischisis. A recent study reported that mutations in SCRIB were associated with craniorachischisis in humans, but whether SCRIB mutations contribute to increased spina bifida risk is still unknown. We sequenced the SCRIB gene in 192 infants with spina bifida and 190 healthy controls. Among the spina bifida patients, we identified five novel missense mutations that were predicted-to-be-deleterious by the PolyPhen software. Of these five mutations, three of them (p.P1043L, p.P1332L, p.L1520R) significantly affected the subcellular localization of SCRIB. In addition, we demonstrated that the craniorachischisis mouse line-90 mutation I285K, also affected SCRIB subcellular localization. In contrast, only one novel missense mutation (p.A1257T) was detected in control samples, and it was predicted to be benign. This study demonstrated that rare deleterious mutations of SCRIB may contribute to the multifactorial risk for human spina bifida.	[Lei, Yunping; Zhu, Huiping; Duhon, Cody; Finnell, Richard H.] Univ Texas Austin, Dept Nutr Sci, Dell Pediat Res Inst, Austin, TX 78712 USA; [Finnell, Richard H.] Univ Texas Austin, Coll Nat Sci, Dept Chem & Biochem, Austin, TX 78712 USA; [Yang, Wei; Shaw, Gary M.] Stanford Univ, Dept Pediat, Sch Med, Div Neonatol, Stanford, CA 94305 USA; [Ross, M. Elizabeth] Weill Cornell Med Coll, Brain & Mind Res Inst, Ctr Neurogenet, New York, NY USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Stanford University; Cornell University	Finnell, RH (corresponding author), Univ Texas Austin, Dept Nutr Sci, Dell Pediat Res Inst, Austin, TX 78712 USA.	rfinnell@austin.utexas.edu	Lei, Yunping/B-6322-2009; Finnell, Richard/D-8174-2018	Lei, Yunping/0000-0003-1504-0884; Shaw, Gary/0000-0001-7438-4914; Finnell, Richard/0000-0002-5962-8754	National Institute of Health [R01-NS050249, NS076465, HD067244]; National Institute of Health [Centers for Disease Control and Prevention, Center of Excellence Award] [U01/DD000491]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244] Funding Source: NIH RePORTER; National Center on Birth Defects and Developmental Disabilities [U01DD000491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050249, R01NS076465] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health [Centers for Disease Control and Prevention, Center of Excellence Award]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center on Birth Defects and Developmental Disabilities(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institute of Health [grant numbers R01-NS050249, NS076465, and HD067244]; and the Centers for Disease Control and Prevention, Center of Excellence Award [grant number U01/DD000491]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson R, 2004, J CELL SCI, V117, P6061, DOI 10.1242/jcs.01525; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Bryant PJ, 2000, NAT CELL BIOL, V2, pE141, DOI 10.1038/35019616; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Croen L A, 1991, Paediatr Perinat Epidemiol, V5, P423, DOI 10.1111/j.1365-3016.1991.tb00728.x; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Harris MJ, 2010, BIRTH DEFECTS RES A, V88, P653, DOI 10.1002/bdra.20676; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Juriloff DM, 2012, BIRTH DEFECTS RES A, V94, P824, DOI 10.1002/bdra.23079; Kallay LM, 2006, J CELL BIOCHEM, V99, P647, DOI 10.1002/jcb.20992; Kibar Z, 2011, CLIN GENET, V80, P76, DOI 10.1111/j.1399-0004.2010.01515.x; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Nagasaka K, 2006, CANCER SCI, V97, P1217, DOI 10.1111/j.1349-7006.2006.00315.x; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Robinson A, 2012, HUM MUTAT, V33, P440, DOI 10.1002/humu.21662; Santoni MJ, 2002, TRENDS GENET, V18, P494, DOI 10.1016/S0168-9525(02)02738-5; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158	25	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69262	10.1371/journal.pone.0069262	http://dx.doi.org/10.1371/journal.pone.0069262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922697	gold, Green Submitted, Green Published			2022-12-25	WOS:000322838900029
J	Yuan, F; Xu, ZG; Yang, MZ; Wei, QF; Zhang, Y; Yu, J; Zhi, Y; Liu, Y; Chen, ZW; Yang, J				Yuan, Fang; Xu, Zhigang; Yang, Mingzhen; Wei, Quanfang; Zhang, Yi; Yu, Jin; Zhi, Yi; Liu, Yang; Chen, Zhiwen; Yang, Jin			Overexpressed DNA Polymerase Iota Regulated by JNK/c-Jun Contributes to Hypermutagenesis in Bladder Cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; C-JUN; MAMMALIAN-CELLS; NH2-TERMINAL KINASE; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; MUTATION SPECTRA; GENOTOXIC STRESS; URINARY-BLADDER; PROTEIN-KINASE	Human DNA polymerase iota (pol iota) possesses high error-prone DNA replication features and performs translesion DNA synthesis. It may be specialized and strictly regulated in normal mammalian cells. Dysregulation of pol i may contribute to the acquisition of a mutator phenotype. However, there are few reports describing the transcription regulatory mechanism of pol iota, and there is controversy regarding its role in carcinogenesis. In this study, we performed the deletion and point-mutation experiment, EMSA, ChIP, RNA interference and western blot assay to prove that c-Jun activated by c-Jun N-terminal kinase (JNK) regulates the transcription of pol iota in normal and cancer cells. Xeroderma pigmentosum group C protein (XPC) and ataxia-telangiectasia mutated related protein (ATR) promote early JNK activation in response to DNA damage and consequently enhance the expression of pol iota, indicating that the novel role of JNK signal pathway is involved in DNA damage response. Furthermore, associated with elevated c-Jun activity, the overexpression of pol iota is positively correlated with the clinical tumor grade in 97 bladder cancer samples and may contribute to the hypermutagenesis. The overexpressed pol iota-involved mutagenesis is dependent on JNK/c-Jun pathway in bladder cancer cells identifying by the special mutation spectra. Our results support the conclusion that dysregulation of pol iota by JNK/c-Jun is involved in carcinogenesis and offer a novel understanding of the role of pol iota or c-Jun in mutagenesis.	[Yuan, Fang; Xu, Zhigang; Zhi, Yi; Liu, Yang; Chen, Zhiwen] Third Mil Med Univ, Southwest Hosp, Urol Inst People Liberat Army, Chongqing, Peoples R China; [Yang, Mingzhen] Third Mil Med Univ, Dept Clin Biochem, Chongqing, Peoples R China; [Wei, Quanfang; Zhang, Yi; Yu, Jin; Yang, Jin] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Chen, ZW (corresponding author), Third Mil Med Univ, Southwest Hosp, Urol Inst People Liberat Army, Chongqing, Peoples R China.	zhiwen@tmmu.edu.cn; jinyang@tmmu.edu.cn	Zhang, Yufeng/GZL-1973-2022; Zhang, Yong/H-1774-2012; Zhang, Yiming/HGB-7344-2022	Zhang, Yong/0000-0002-5831-637X; 	National Nature Science Foundation of China [30770460]; Army Nature Science Foundation of China [06H026]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Army Nature Science Foundation of China	This work was supported by the National Nature Science Foundation of China (30770460) and Army Nature Science Foundation of China (06H026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Biard DSF, 2007, NUCLEIC ACIDS RES, V35, P3535, DOI 10.1093/nar/gkm195; Canella KA, 2000, MUTAT RES-FUND MOL M, V450, P61, DOI 10.1016/S0027-5107(00)00016-6; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen ZW, 2007, CANCER RES, V67, P4578, DOI 10.1158/0008-5472.CAN-06-0877; Chen ZW, 2003, CARCINOGENESIS, V24, P1111, DOI 10.1093/carcin/bgg051; Choi JH, 2006, MUTAT RES-FUND MOL M, V599, P58, DOI 10.1016/j.mrfmmm.2006.01.003; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Damrot J, 2009, J MOL BIOL, V385, P1409, DOI 10.1016/j.jmb.2008.12.015; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dohrmann PR, 2006, GENETICS, V174, P87, DOI 10.1534/genetics.106.060236; Endo H, 2009, GUT, V58, P1637, DOI 10.1136/gut.2009.183624; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Fritz G, 2006, MOL BIOL CELL, V17, P851, DOI 10.1091/mbc.E05-07-0606; Goodman MF, 2000, CURR OPIN GENET DEV, V10, P162, DOI 10.1016/S0959-437X(00)00057-5; Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Hamdi M, 2005, ONCOGENE, V24, P7135, DOI 10.1038/sj.onc.1208875; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Helbig L, 2011, J BIOL CHEM, V286, P12991, DOI 10.1074/jbc.M110.190645; Im Hogune, 2004, Methods Mol Biol, V284, P129; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim BW, 2008, BMB REP, V41, P604, DOI 10.5483/BMBRep.2008.41.8.604; Kirouac KN, 2009, EMBO J, V28, P1644, DOI 10.1038/emboj.2009.122; Kitagawa D, 2002, J BIOL CHEM, V277, P366, DOI 10.1074/jbc.M107110200; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; MacLachan TK, 2002, P NATL ACAD SCI USA, V99, P9492, DOI 10.1073/pnas.132241599; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; McDonald JP, 2001, PHILOS T R SOC B, V356, P53, DOI 10.1098/rstb.2000.0748; McGregor WG, 1999, MOL CELL BIOL, V19, P147; Nehme A, 1997, CANCER RES, V57, P3253; Ohkumo T, 2006, MOL CELL BIOL, V26, P7696, DOI 10.1128/MCB.01076-06; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; SEIDMAN MM, 1985, GENE, V38, P233, DOI 10.1016/0378-1119(85)90222-7; Skopelitou A, 1997, EUR UROL, V31, P464; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; TINIAKOS DG, 1994, BRIT J UROL, V74, P757, DOI 10.1111/j.1464-410X.1994.tb07121.x; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; Vasilevskaya I, 2003, DRUG RESIST UPDATE, V6, P147, DOI 10.1016/S1368-7646(03)00043-8; Vidal AE, 2009, DNA REPAIR, V8, P420, DOI 10.1016/j.dnarep.2008.12.007; Vivas-Mejia P, 2010, CLIN CANCER RES, V16, P184, DOI 10.1158/1078-0432.CCR-09-1180; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang G, 2004, NUCLEIC ACIDS RES, V32, P2231, DOI 10.1093/nar/gkh541; WANG G, 1995, MOL CELL BIOL, V15, P1759; Wang Y, 2007, CANCER RES, V67, P3018, DOI 10.1158/0008-5472.CAN-06-3073; Yang J, 2004, CANCER RES, V64, P5597, DOI 10.1158/0008-5472.CAN-04-0603; Zhang YB, 2001, NUCLEIC ACIDS RES, V29, P928, DOI 10.1093/nar/29.4.928	53	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69317	10.1371/journal.pone.0069317	http://dx.doi.org/10.1371/journal.pone.0069317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922701	Green Submitted, Green Published, gold			2022-12-25	WOS:000322838900033
J	Chen, YW; Chu, HC; Lin, ZS; Shiah, WJ; Chou, CP; Klimstra, DS; Lewis, BC				Chen, Ya-Wen; Chu, Hsiao-Chien; Lin, Ze-Shiang; Shiah, Wei-Jyh; Chou, Chen-Pin; Klimstra, David S.; Lewis, Brian C.			p16 Stimulates CDC42-Dependent Migration of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							BREAST-CANCER; CYCLE INHIBITOR; GENE; EXPRESSION; OVEREXPRESSION; P16(INK4A); INK4A/ARF; PROTEIN; RAC; PATHOGENESIS	Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. Tumor dissemination to the extra-hepatic region of the portal vein, lymph nodes, lungs or bones contributes to the high mortality seen in HCC; yet, the molecular mechanisms responsible for HCC metastasis remain unclear. Prior studies have suggested a potential link between accumulated cytoplasm-localized p16 and tumor progression. Here we report that p16 enhances metastasis-associated phenotypes in HCC cells - ectopic p16 expression increased cell migration in vitro, and lung colonization after intravenous injection, whereas knockdown of endogenous p16 reduced cell migration. Interestingly, analysis of p16 mutants indicated that the Cdk4 interaction domain is required for stimulation of HCC cell migration; however, knockdown of Cdk4 and Cdk6 showed that these proteins are dispensable for this phenomenon. Intriguingly, we found that in p16-positive HCC samples, p16 protein is predominantly localized in the cytoplasm. In addition, we identified a potential role for nuclear-cytoplasmic shuttling in p16-stimulated migration, consistent with the predominantly cytoplasmic localization of p16 in IHC-positive HCC samples. Finally, we determined that p16-stimulated cell migration requires the Cdc42 GTPase. Our results demonstrate for the first time a pro-migratory role for p16, and suggest a potential mechanism for the observed association between cytoplasmic p16 and tumor progression in diverse tumor types.	[Chen, Ya-Wen; Chu, Hsiao-Chien; Lin, Ze-Shiang; Shiah, Wei-Jyh] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Chen, Ya-Wen] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chen, Ya-Wen; Lewis, Brian C.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Chou, Chen-Pin] Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung, Taiwan; [Klimstra, David S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Lewis, Brian C.] Univ Massachusetts, Program Mol Med, Sch Med, Worcester, MA 01605 USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA	National Health Research Institutes - Taiwan; China Medical University Taiwan; University of Massachusetts System; University of Massachusetts Worcester; Kaohsiung Veterans General Hospital; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Chen, YW (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan.	ywc@nhri.org.tw; Brian.Lewis@umassmed.edu	Chen, Ya-Wen/B-1100-2010; Chen, Ya-Wen/AAG-7549-2019	Chen, Ya-Wen/0000-0002-6080-8859	NIH [CA121171]; National Science Council [NSC97-3112-B-001-016, NSC 99-2320-B-400-001, NSC 100-2320-B-400-008, DOH101 TD-C-111-004]; NATIONAL CANCER INSTITUTE [R01CA121171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by an NIH grant CA121171 to BCL and National Science Council grants NSC97-3112-B-001-016, NSC 99-2320-B-400-001, NSC 100-2320-B-400-008 and DOH101 TD-C-111-004 to YWC. BCL is a member of the University of Massachusetts DERC (DK32520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifin MT, 2006, J NEURO-ONCOL, V77, P273, DOI 10.1007/s11060-005-9037-5; Benard V, 2002, METHOD ENZYMOL, V345, P349; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Chen YW, 2008, CANCER RES, V68, P476, DOI 10.1158/0008-5472.CAN-07-1960; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Chintala SK, 1997, ONCOGENE, V15, P2049, DOI 10.1038/sj.onc.1201382; Emig R, 1998, BRIT J CANCER, V78, P1661, DOI 10.1038/bjc.1998.739; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fahraeus R, 1999, EMBO J, V18, P2106, DOI 10.1093/emboj/18.8.2106; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Henshall SM, 2001, CLIN CANCER RES, V7, P544; Hui AM, 1996, HEPATOLOGY, V24, P575, DOI 10.1002/hep.510240319; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Lee CT, 1999, CLIN CANCER RES, V5, P977; Lewis BC, 2005, MOL CELL BIOL, V25, P1228, DOI 10.1128/MCB.25.4.1228-1237.2005; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Li LY, 2010, J CANCER, V1, P126; Liew CT, 1999, ONCOGENE, V18, P789, DOI 10.1038/sj.onc.1202359; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuda Y, 1999, GASTROENTEROLOGY, V116, P394, DOI 10.1016/S0016-5085(99)70137-X; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Milde-Langosch K, 2001, BREAST CANCER RES TR, V67, P61, DOI 10.1023/A:1010623308275; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; QUELLE DE, 1995, CELL, V83, P993; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; ROBINSON WS, 1994, ANNU REV MED, V45, P297; Sano T, 1998, AM J PATHOL, V153, P1741, DOI 10.1016/S0002-9440(10)65689-1; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Souza-Rodrigues E, 2007, PROTEOMICS, V7, P4102, DOI 10.1002/pmic.200700133; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Ward SC, 2010, MODERN PATHOL, V23, P1180, DOI 10.1038/modpathol.2010.105	44	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69389	10.1371/journal.pone.0069389	http://dx.doi.org/10.1371/journal.pone.0069389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894465	Green Published, Green Submitted, gold			2022-12-25	WOS:000322167900062
J	Gameiro, SR; Higgins, JP; Dreher, MR; Woods, DL; Reddy, G; Wood, BJ; Guha, C; Hodge, JW				Gameiro, Sofia R.; Higgins, Jack P.; Dreher, Matthew R.; Woods, David L.; Reddy, Goutham; Wood, Bradford J.; Guha, Chandan; Hodge, James W.			Combination Therapy with Local Radiofrequency Ablation and Systemic Vaccine Enhances Antitumor Immunity and Mediates Local and Distal Tumor Regression	PLOS ONE			English	Article							COLORECTAL LIVER METASTASES; CARCINOEMBRYONIC ANTIGEN GENE; FOCUSED ULTRASOUND; T-CELLS; CANCER; RADIATION; HEAT-SHOCK-PROTEIN-70; EXPRESSION; PHENOTYPE; CARCINOMA	Purpose: Radiofrequency ablation (RFA) is a minimally invasive energy delivery technique increasingly used for focal therapy to eradicate localized disease. RFA-induced tumor-cell necrosis generates an immunogenic source of tumor antigens known to induce antitumor immune responses. However, RFA-induced antitumor immunity is insufficient to control metastatic progression. We sought to characterize (a) the role of RFA dose on immunogenic modulation of tumor and generation of immune responses and (b) the potential synergy between vaccine immunotherapy and RFA aimed at local tumor control and decreased systemic progression. Experimental Design: Murine colon carcinoma cells expressing the tumor-associated (TAA) carcinoembryonic antigen (CEA) (MC38-CEA(+)) were studied to examine the effect of sublethal hyperthermia in vitro on the cells' phenotype and sensitivity to CTL-mediated killing. The effect of RFA dose was investigated in vivo impacting (a) the phenotype and growth of MC38-CEA(+) tumors and (b) the induction of tumor-specific immune responses. Finally, the molecular signature was evaluated as well as the potential synergy between RFA and poxviral vaccines expressing CEA and a TRIad of COstimulatory Molecules (CEA/TRICOM). Results: In vitro, sublethal hyperthermia of MC38-CEA(+) cells (a) increased cell-surface expression of CEA, Fas, and MHC class I molecules and (b) rendered tumor cells more susceptible to CTL-mediated lysis. In vivo, RFA induced (a) immunogenic modulation on the surface of tumor cells and (b) increased T-cell responses to CEA and additional TAAs. Combination therapy with RFA and vaccine in CEA-transgenic mice induced a synergistic increase in CD4(+) T-cell immune responses to CEA and eradicated both primary CEA(+) and distal CEA(-) s.c. tumors. Sequential administration of low-dose and high-dose RFA with vaccine decreased tumor recurrence compared to RFA alone. These studies suggest a potential clinical benefit in combining RFA with vaccine in cancer patients, and augment support for this novel translational paradigm.	[Gameiro, Sofia R.; Higgins, Jack P.; Hodge, James W.] NCI, Lab Tumor Immunol & Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Dreher, Matthew R.; Woods, David L.; Reddy, Goutham; Wood, Bradford J.] NIH, Ctr Intervent Oncol Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Guha, Chandan] Albert Einstein Coll Med, Dept Radiat Oncol, Montefiore Med Ctr, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Montefiore Medical Center; Yeshiva University	Hodge, JW (corresponding author), NCI, Lab Tumor Immunol & Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	jh241d@nih.gov	Wood, Bradford J/M-7995-2017	Wood, Bradford J/0000-0002-4297-0051; gameiro, sofia/0000-0002-2392-8122	Center for Cancer Research, National Cancer Institute, National Institutes of Health; CLINICAL CENTER [ZIACL040015, ZIACL040011, ZIACL040012] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This research was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya P, 2011, INT J ONCOL, V39, P311, DOI 10.3892/ijo.2011.1043; Bendz H, 2007, J BIOL CHEM, V282, P31688, DOI 10.1074/jbc.M704129200; Chakraborty M, 2004, CANCER RES, V64, P4328, DOI 10.1158/0008-5472.CAN-04-0073; Chakraborty M, 2008, CLIN CANCER RES, V14, P4241, DOI 10.1158/1078-0432.CCR-08-0335; Ciesielski MJ, 2008, CANCER IMMUNOL IMMUN, V57, P1827, DOI 10.1007/s00262-008-0510-9; den Brok MHMGM, 2004, CANCER RES, V64, P4024, DOI 10.1158/0008-5472.CAN-03-3949; Dromi SA, 2009, RADIOLOGY, V251, P58, DOI 10.1148/radiol.2511072175; EADESPERNER AM, 1994, CANCER RES, V54, P4169; Figueiredo C, 2009, BLOOD, V113, P3008, DOI 10.1182/blood-2008-06-162727; Garnett CT, 2004, CANCER RES, V64, P7985, DOI 10.1158/0008-5472.CAN-04-1525; Gelbard A, 2006, CLIN CANCER RES, V12, P1897, DOI 10.1158/1078-0432.CCR-05-1761; Gervais DA, 2009, J VASC INTERV RADIOL, V20, pS342, DOI 10.1016/j.jvir.2009.04.029; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Gravante G, 2009, LIVER INT, V29, P18, DOI 10.1111/j.1478-3231.2008.01915.x; Haen SP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/160250; Hiroishi K, 2010, J GASTROENTEROL, V45, P451, DOI 10.1007/s00535-009-0155-2; Hodge JW, 2012, SEMIN ONCOL, V39, P323, DOI 10.1053/j.seminoncol.2012.02.006; Hodge JW, 2012, CANCER BIOTHER RADIO, V27, P12, DOI 10.1089/cbr.2012.1202; Hodge JW, 2003, CANCER RES, V63, P7942; Hodge JW, 2013, INT J CANC; Hu MH, 2010, DIGEST DIS SCI, V55, P2365, DOI 10.1007/s10620-009-1008-9; Hulf T, 2012, ONCOGENE; Hundt W, 2007, ACAD RADIOL, V14, P859, DOI 10.1016/j.acra.2007.04.008; John-Aryankalayil M, 2012, RADIAT RES, V178, P105, DOI [10.1667/RR2703.1, 10.1667/RR2703]; Kass E, 2001, CANCER RES, V61, P206; KOJIMA H, 1994, IMMUNITY, V1, P357, DOI 10.1016/1074-7613(94)90066-3; Kudo-Saito C, 2005, CLIN CANCER RES, V11, P2416, DOI 10.1158/1078-0432.CCR-04-1380; Law KS, 2007, ANTICANCER RES, V27, P841; Liu LX, 2012, FEBS J, V279, P3800, DOI 10.1111/j.1742-4658.2012.08741.x; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Madan RA, 2012, SEMIN ONCOL, V39, P296, DOI 10.1053/j.seminoncol.2012.02.010; Makinde AY, 2013, MOL CANCER RES, V11, P5, DOI 10.1158/1541-7786.MCR-12-0492; Modrak DE, 2003, TUMOR BIOL, V24, P32, DOI 10.1159/000070658; Mulier S, 2008, ANN SURG ONCOL, V15, P144, DOI 10.1245/s10434-007-9478-5; Mulier S, 2008, DIGEST SURG, V25, P445, DOI 10.1159/000184736; MURARO R, 1985, CANCER RES, V45, P5769; Napoletano C, 2008, INT J ONCOL, V32, P481; Otto G, 2010, ANN SURG, V251, P796, DOI 10.1097/SLA.0b013e3181bc9fae; Park KH, 2013, J IMMUNOLOGY; Pathak S, 2011, COLORECTAL DIS, V13, pE252, DOI 10.1111/j.1463-1318.2011.02695.x; Rempp H, 2012, EUR RADIOL, V22, P1091, DOI 10.1007/s00330-011-2335-8; ROBBINS PF, 1991, CANCER RES, V51, P3657; Ruers T, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3526; Ryan MH, 2001, CANCER IMMUNOL IMMUN, V49, P603, DOI 10.1007/s002620000156; Sakaguchi Y, 2005, INTERVIROLOGY, V48, P64, DOI 10.1159/000082097; Schmid TE, 2012, CURR MED CHEM, V19, P1765; Schmitz J, 2002, CANCER RES, V62, P5058; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Siler Kathleen, 1993, Biotechnology Therapeutics, V4, P163; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Teng LS, 2010, HEPATOB PANCREAT DIS, V9, P361; Thaker AA, 2012, INT J HYPERTHER, V28, P766, DOI 10.3109/02656736.2012.724517; TSANG KY, 1995, J NATL CANCER I, V87, P982, DOI 10.1093/jnci/87.13.982; Tsang KY, 1997, CLIN CANCER RES, V3, P2439; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Waitz R, 2009, RADIOLOGY, V251, P1, DOI 10.1148/radiol.2511082215; Wang C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-58; Wansley EK, 2008, CLIN CANCER RES, V14, P4316, DOI 10.1158/1078-0432.CCR-08-0393; Weng DS, 2008, J IMMUNOTHER, V31, P63, DOI 10.1097/CJI.0b013e31815a121b; Widenmeyer M, 2011, INT J CANCER, V128, P2653, DOI 10.1002/ijc.25601; Wood BJ, 2002, CANCER-AM CANCER SOC, V94, P443, DOI 10.1002/cncr.10234; Xia JZ, 2012, ULTRASOUND MED BIOL, V38, P1363, DOI 10.1016/j.ultrasmedbio.2012.03.009; Yang WL, 2004, ANN SURG ONCOL, V11, P399, DOI 10.1245/ASO.2004.08.013; Zerbini A, 2006, CANCER RES, V66, P1139, DOI 10.1158/0008-5472.CAN-05-2244	64	52	56	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70417	10.1371/journal.pone.0070417	http://dx.doi.org/10.1371/journal.pone.0070417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894654	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900127
J	Packer, RMA; Hendricks, A; Volk, HA; Shihab, NK; Burn, CC				Packer, Rowena M. A.; Hendricks, Anke; Volk, Holger A.; Shihab, Nadia K.; Burn, Charlotte C.			How Long and Low Can You Go? Effect of Conformation on the Risk of Thoracolumbar Intervertebral Disc Extrusion in Domestic Dogs	PLOS ONE			English	Article							CHONDRODYSTROPHIC DOGS; SPINAL-CORD; NUCLEUS PULPOSUS; SURGICAL DECOMPRESSION; NOTOCHORDAL CELL; PART 2; DISEASE; HERNIATION; RECURRENCE; FENESTRATION	Intervertebral disc extrusion (IVDE) is a common neurological disorder in certain dog breeds, resulting in spinal cord compression and injury that can cause pain and neurological deficits. Most disc extrusions are reported in chondrodystrophic breeds (e.g. Dachshunds, Basset Hounds, Pekingese), where selection for 'long and low' morphologies is linked with intervertebral discs abnormalities that predispose dogs to IVDe. The aim of this study was to quantify the relationship between relative thoracolumbar vertebral column length and IVDE risk in diverse breeds. A 14 month cross-sectional study of dogs entering a UK small animal referral hospital for diverse disorders including IVDE was carried out. Dogs were measured on breed-defining morphometrics, including back length (BL) and height at the withers (HW). Of 700 dogs recruited from this referral population, measured and clinically examined, 79 were diagnosed with thoracolumbar IVDE following diagnostic imaging +/- surgery. The BL: HW ratio was positively associated with IVDE risk, indicating that relatively longer dogs were at increased risk, e.g. the probability of IVDE was 0.30 for Miniature Dachshunds when BL: HW ratio equalled 1.1, compared to 0.68 when BL: HW ratio equalled 1.5. Additionally, both being overweight and skeletally smaller significantly increased IVDE risk. Therefore, selection for longer backs and miniaturisation should be discouraged in high-risk breeds to reduce IVDE risk. In higher risk individuals, maintaining a lean body shape is particularly important to reduce the risk of IVDe. Results are reported as probabilities to aid decision-making regarding breed standards and screening programmes reflecting the degree of risk acceptable to stakeholders.	[Shihab, Nadia K.] Southern Counties Vet Specialists, Unit 6, Forest Corner Farm, Ringwood, Hants, England			cburn@rvc.ac.uk	Volk, Holger Andreas/B-9965-2011	Volk, Holger Andreas/0000-0002-7312-638X; Packer, Rowena/0000-0002-9988-9828; Burn, Charlotte/0000-0002-8734-8610	UFAW; BBSRC/RVC doctoral studentship	UFAW; BBSRC/RVC doctoral studentship	This study was funded by UFAW (www.ufaw.org.uk), while the primary author was supported by a joint BBSRC/RVC doctoral studentship (www.bbsrc.ac.uk; www.rvc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL MU, 1982, J AM VET MED ASSOC, V180, P519; BAUER M, 1992, J AM VET MED ASSOC, V200, P1809; Bergknut N, 2013, VET J, V195, P156, DOI 10.1016/j.tvjl.2012.05.027; Bergknut N, 2012, JAVMA-J AM VET MED A, V240, P1300, DOI 10.2460/javma.240.11.1300; Bergknut N, 2012, SPINE, V37, P351, DOI 10.1097/BRS.0b013e31821e5665; BRAUND K.G., 1993, DIS MECH SMALL ANIMA, P960; BRAUND KG, 1975, RES VET SCI, V19, P167, DOI 10.1016/S0034-5288(18)33527-6; Bray JP, 1998, J AM ANIM HOSP ASSOC, V34, P135, DOI 10.5326/15473317-34-2-135; Brisson BA, 2004, JAVMA-J AM VET MED A, V224, P1808, DOI 10.2460/javma.2004.224.1808; Brisson BA, 2011, JAVMA-J AM VET MED A, V238, P1593, DOI 10.2460/javma.238.12.1593; Brisson BA, 2010, VET CLIN N AM-SMALL, V40, P829, DOI 10.1016/j.cvsm.2010.06.001; Cappello R, 2006, SPINE, V31, P873, DOI 10.1097/01.brs.0000209302.00820.fd; *COUNC EUR, 1995, 1259529 CONS COUNC E; Dachshund Breed Council, 2012, DACHS LIF 2012 REP D; Degorska Beata, 2009, Vet Comp Orthop Traumatol, V22, P336; Erwin WM, 2008, J CELL COMMUN SIGNAL, V2, P59, DOI 10.1007/s12079-008-0031-5; Federation Cynologique Internationale, 2001, 14813072001GB FCI; Forterre F, 2010, SCHWEIZ ARCH TIERH, V152, P109, DOI 10.1024/0036-7281/a000027; Forterre F, 2008, VET SURG, V37, P399, DOI 10.1111/j.1532-950X.2008.00394.x; Forterre F, 2011, VET SURG, V40, P34, DOI 10.1111/j.1532-950X.2010.00780.x; Freeman PM, 2012, 25 S ESVN ECVN GHENT; Gage E. D., 1975, Journal of the American Animal Hospital Association, V11, P167; HANSEN H J, 1952, Acta Orthop Scand Suppl, V11, P1; Havranek-Balzaretti B, 1980, THESIS U ZURICH ZURI; Hecht S, 2009, VET RADIOL ULTRASOUN, V50, P353, DOI 10.1111/j.1740-8261.2009.01549.x; Itoh H, 2008, J VET MED SCI, V70, P701, DOI 10.1292/jvms.70.701; Itoho H, 2008, J VET MED SCI, V70, P37, DOI 10.1292/jvms.70.37; Jensen VF, 2000, J VET MED A, V47, P283, DOI 10.1046/j.1439-0442.2000.00296.x; Jensen VF, 2008, JAVMA-J AM VET MED A, V233, P1090, DOI 10.2460/javma.233.7.1090; Johnson JA, 2010, J VET INTERN MED, V24, P1343, DOI 10.1111/j.1939-1676.2010.0613.x; Kennelklubben Svenska, 2010, SPEC BREED SPEC INST; King JB, 2009, J VET SCI, V10, P225, DOI 10.4142/jvs.2009.10.3.225; Kranenburg HJC, 2013, VET J, V195, P164, DOI 10.1016/j.tvjl.2012.06.001; Levine JM, 2008, JAVMA-J AM VET MED A, V233, P931, DOI 10.2460/javma.233.6.931; Levine JM, 2006, JAVMA-J AM VET MED A, V229, P370, DOI 10.2460/javma.229.3.370; Lim C, 2010, J VET SCI, V11, P73, DOI 10.4142/jvs.2010.11.1.73; Malik Y, 2009, VET SURG, V38, P457, DOI 10.1111/j.1532-950X.2009.00529.x; Mateo I, 2011, VET RADIOL ULTRASOUN, V52, P17, DOI 10.1111/j.1740-8261.2010.01746.x; Mayhew PD, 2004, JAVMA-J AM VET MED A, V225, P1231, DOI 10.2460/javma.2004.225.1231; Mogensen MS, 2011, J HERED, V102, pS81, DOI 10.1093/jhered/esr021; Olby N, 2003, J AM VET MED ASSOC, V222, P762, DOI 10.2460/javma.2003.222.762; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Priester WA, 1976, THERIOGENOLOGY, V6, P293, DOI DOI 10.1016/0093-691X(76)90021-2; Probst A, 2008, VET J, V177, P63, DOI 10.1016/j.tvjl.2007.03.018; Purina, 2012, ASS YOUR DOGS BOD CO; Roach WJ, 2012, VET COMP ORTHOPAED, V25, P109, DOI 10.3415/VCOT-11-05-0075; Roberts T, 2010, VET J, V183, P266, DOI 10.1016/j.tvjl.2009.11.005; Rohdin C, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-24; Ryan TM, 2008, VET REC, V163, P11, DOI 10.1136/vr.163.1.11; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Scott HW, 1999, J SMALL ANIM PRACT, V40, P417, DOI 10.1111/j.1748-5827.1999.tb03114.x; Sharp NJH, 2005, SMALL ANIMAL SPINAL, P106; Smolders LA, 2013, VET J, V195, P292, DOI 10.1016/j.tvjl.2012.10.011; Sterna J, 2008, POL J VET SCI, V11, P55; Sterna J, 2007, POL J VET SCI, V10, P89; Stigen O, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-10; Sutter NB, 2008, MAMM GENOME, V19, P713, DOI 10.1007/s00335-008-9153-6; The Kennel Club, 2011, CEL HANDB DOG RES SO; The Kennel Club, 2000, DAND DINM TERR BREED; The Kennel Club, 2010, BASS HOUND BREED STA; The Kennel Club, 2012, BREED INF CTR DACHSH; The Kennel Club, 2009, DACHSH LONG HAIR BRE; Trebacz P, 2011, MED WETER, V67, P634; VERHEIJEN J, 1982, VET QUART, V4, P125, DOI 10.1080/01652176.1982.9693852	65	25	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69650	10.1371/journal.pone.0069650	http://dx.doi.org/10.1371/journal.pone.0069650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894518	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000322167900087
J	Speller, CF; Burley, DV; Woodward, RP; Yang, DY				Speller, Camilla F.; Burley, David V.; Woodward, Robyn P.; Yang, Dongya Y.			Ancient mtDNA Analysis of Early 16th Century Caribbean Cattle Provides Insight into Founding Populations of New World Creole Cattle Breeds	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; BOS-TAURUS; AFRICAN; DIVERSITY; ANCESTRY; SEQUENCE; ORIGINS; DOMESTICATION; MATRILINEAGES; COMPLEXITY	The Columbian Exchange resulted in a widespread movement of humans, plants and animals between the Old and New Worlds. The late 15th to early 16th century transfer of cattle from the Iberian Peninsula and Canary Islands to the Caribbean laid the foundation for the development of American creole cattle (Bos taurus) breeds. Genetic analyses of modern cattle from the Americas reveal a mixed ancestry of European, African and Indian origins. Recent debate in the genetic literature centers on the 'African' haplogroup T1 and its subhaplogroups, alternatively tying their origins to the initial Spanish herds, and/or from subsequent movements of taurine cattle through the African slave trade. We examine this problem through ancient DNA analysis of early 16 th century cattle bone from Sevilla la Nueva, the first Spanish colony in Jamaica. In spite of poor DNA preservation, both T3 and T1 haplogroups were identified in the cattle remains, confirming the presence of T1 in the earliest Spanish herds. The absence, however, of "African-derived American'' haplotypes (AA/T1c1a1) in the Sevilla la Nueva sample, leaves open the origins of this sub-haplogroup in contemporary Caribbean cattle.	[Speller, Camilla F.] Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England; [Speller, Camilla F.; Burley, David V.; Woodward, Robyn P.; Yang, Dongya Y.] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada	University of York - UK; Simon Fraser University	Speller, CF (corresponding author), Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England.	camilla.speller@york.ac.uk; burley@sfu.ca	Speller, Camilla/GLV-4769-2022; Speller, Camilla/D-2830-2014	Speller, Camilla/0000-0001-7128-9903	SFU/Social Sciences and Humanities Research Council; National Geographic Society [8522-08]	SFU/Social Sciences and Humanities Research Council; National Geographic Society(National Geographic Society)	This research was supported in part by 2004 and 2009 SFU/Social Sciences and Humanities Research Council grants to DVB with additional funding in 2009 to DVB/RPW from National Geographic Society (#8522-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Anderung C, 2005, P NATL ACAD SCI USA, V102, P8431, DOI 10.1073/pnas.0503396102; Beja-Pereira A, 2003, J HERED, V94, P243, DOI 10.1093/jhered/esg055; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bishko C. J., 1952, HISPANIC AM HIST REV, V32, P491; Bonfiglio S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038601; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Carney JA, 2009, IN THE SHADOW OF SLAVERY: AFRICA'S BOTANICAL LEGACY IN THE ATLANTIC WORLD, P1; Cortes O, 2008, ANIM GENET, V39, P649, DOI 10.1111/j.1365-2052.2008.01782.x; Crosby A.W., 1986, ECOLOGICAL IMPERIALI, DOI DOI 10.1017/CBO9780511805554; Cymbron T, 1999, P ROY SOC B-BIOL SCI, V266, P597, DOI 10.1098/rspb.1999.0678; Dadi H, 2009, ANIM GENET, V40, P556, DOI 10.1111/j.1365-2052.2009.01866.x; de France S. D., 2003, INT J HIST ARCHAEOL, V7, P99, DOI DOI 10.1023/A:1025184117208; de Oviedo VGF, 1959, HISTORIA GENERAL Y N; ELTIS D, 1987, HISPANIC AM HIST REV, V67, P109, DOI 10.2307/2515205; Ginja C, 2010, ANIM GENET, V41, P128, DOI 10.1111/j.1365-2052.2009.01976.x; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Lari M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-32; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Liron JP, 2006, ANIM GENET, V37, P379, DOI 10.1111/j.1365-2052.2006.01452.x; Lucero C, 2010, REV MED VET-TOULOUSE, V161, P485; Magee DA, 2002, J HERED, V93, P429, DOI 10.1093/jhered/93.6.429; Martinez AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049066; McTavish EJ, 2013, P NATL ACAD SCI USA, V110, pE1398, DOI 10.1073/pnas.1303367110; Meirelles FV, 1999, GENET MOL BIOL, V22, P543, DOI 10.1590/S1415-47571999000400013; Miretti MM, 2004, J HERED, V95, P450, DOI 10.1093/jhered/esh070; Miretti MM, 2002, J HERED, V93, P323, DOI 10.1093/jhered/93.5.323; Mirol PM, 2003, HEREDITY, V91, P248, DOI 10.1038/sj.hdy.6800312; Morales Padron Francisco, 2003, SPANISH JAMAICA; Nunn N, 2010, J ECON PERSPECT, V24, P163, DOI 10.1257/jep.24.2.163; Poinar HN, 1999, ACTA PAEDIATR, V88, P133, DOI 10.1111/j.1651-2227.1999.tb14423.x; Reitz E.J., 1995, PUERTO REAL ARCHAEOL, P287; REITZ Elizabeth J., 1992, HIST ARCHAEOL, V26, P84, DOI DOI 10.1007/BF03374163; Rodero E., 1995, ARCHIVOS DE ZOOTECNI, V41, P383; Rouse JE, 1977, THE CRIOLLO SPANISH; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Speller CF, 2010, P NATL ACAD SCI USA, V107, P2807, DOI 10.1073/pnas.0909724107; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Woodward RP, 2009, XAYMACA LIFE IN SPAN, P32; Wright Irene A., 1921, THE ENGLISH HISTORIC, V36, P70; Yang DY, 2008, J ARCHAEOL SCI, V35, P2778, DOI 10.1016/j.jas.2008.05.010; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	45	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69584	10.1371/journal.pone.0069584	http://dx.doi.org/10.1371/journal.pone.0069584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	188BY	23894505	Green Published, gold, Green Submitted			2022-12-25	WOS:000322167900081
J	Taboada, A; von Wehrden, H; Assmann, T				Taboada, Angela; von Wehrden, Henrik; Assmann, Thorsten			Integrating Life Stages into Ecological Niche Models: A Case Study on Tiger Beetles	PLOS ONE			English	Article							DIFFERENT SPATIAL SCALES; RIPARIAN CARABID BEETLE; CLIMATE-CHANGE; STRUCTURED POPULATIONS; SPECIES DISTRIBUTIONS; BIOTIC INTERACTIONS; GLOBAL CHANGE; HABITAT; RANGE; CONSERVATION	Detailed understanding of a species' natural history and environmental needs across spatial scales is a primary requisite for effective conservation planning, particularly for species with complex life cycles in which different life stages occupy different niches and respond to the environment at different scales. However, niche models applied to conservation often neglect early life stages and are mostly performed at broad spatial scales. Using the endangered heath tiger beetle (Cicindela sylvatica) as a model species, we relate presence/absence and abundance data of locally dispersing adults and sedentary larvae to abiotic and biotic variables measured in a multiscale approach within the geographic extent relevant to active conservation management. At the scale of hundreds of meters, fine-grained abiotic conditions (i.e., vegetation structure) are fundamental determinants of the occurrence of both life stages, whereas the effect of biotic factors is mostly contained in the abiotic signature. The combination of dense heath vegetation and bare ground areas is thus the first requirement for the species' preservation, provided that accessibility to the suitable habitat is ensured. At a smaller scale (centimetres), the influence of abiotic factors on larval occurrence becomes negligible, suggesting the existence of important additional variables acting within larval proximity. Sustained significant correlations between neighbouring larvae in the models provide an indication of the potential impact of neighbourhood crowding on the larval niche within a few centimetres. Since the species spends the majority of its life cycle in the larval stage, it is essential to consider the hierarchical abiotic and biotic processes affecting the larvae when designing practical conservation guidelines for the species. This underlines the necessity for a more critical evaluation of the consequences of disregarding niche variation between life stages when estimating niches and addressing effective conservation measures for species with complex life cycles.	[Taboada, Angela; von Wehrden, Henrik; Assmann, Thorsten] Univ Luneburg, Inst Ecol, D-21335 Luneburg, Germany; [Taboada, Angela] Univ Leon, Dept Biodivers & Environm Management, Area Ecol, E-24071 Leon, Spain; [von Wehrden, Henrik] Univ Luneburg, Ctr Methods, D-21335 Luneburg, Germany; [von Wehrden, Henrik] Res Inst Wildlife Ecol, Vienna, Austria	Leuphana University Luneburg; Universidad de Leon; Leuphana University Luneburg	Taboada, A (corresponding author), Univ Luneburg, Inst Ecol, D-21335 Luneburg, Germany.	angela.taboada@leuphana.de	Assmann, Thorsten/Q-9304-2017; Taboada, Angela/K-1744-2014	Assmann, Thorsten/0000-0002-9203-769X; Taboada, Angela/0000-0002-3494-4806; Taboada, Angela/0000-0002-1782-3148	Ministerio de Educacion, Cultura y Deporte, Spain [EX2009-0989]	Ministerio de Educacion, Cultura y Deporte, Spain	AT is funded by Ministerio de Educacion, Cultura y Deporte, Spain (Postdoctoral Fellowship EX2009-0989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Bjornstad O., 2009, NCF SPATIAL NONPARAM; Brewer AM, 2003, J ANIM ECOL, V72, P82, DOI 10.1046/j.1365-2656.2003.00682.x; Brust ML, 2010, COLEOPTS BULL, V64, P313, DOI 10.1649/0010-065X-64.4.313; Bullock JM, 2000, ECOGRAPHY, V23, P257, DOI 10.1111/j.1600-0587.2000.tb00281.x; Cabeza M, 2010, ECOGRAPHY, V33, P54, DOI 10.1111/j.1600-0587.2009.06040.x; Cornelisse TM, 2013, J INSECT CONSERV, V17, P17, DOI 10.1007/s10841-012-9482-3; Cornelisse TM, 2009, ECOL ENTOMOL, V34, P495, DOI 10.1111/j.1365-2311.2009.01093.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dieker P, 2011, BIOL CONSERV, V144, P2810, DOI 10.1016/j.biocon.2011.07.018; Dodd SG, 2011, THESIS U BIRMINGHAN; Elton C. S., 1927, ANIMAL ECOLOGY; Ficetola GF, 2011, DIVERS DISTRIB, V17, P1141, DOI 10.1111/j.1472-4642.2011.00797.x; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Gillingham PK, 2012, ECOGRAPHY, V35, P831, DOI 10.1111/j.1600-0587.2011.07434.x; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hartley S, 2010, ECOGRAPHY, V33, P83, DOI 10.1111/j.1600-0587.2009.06037.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Hoback WW, 2000, ECOL ENTOMOL, V25, P180, DOI 10.1046/j.1365-2311.2000.00256.x; Hori M., 1982, Physiology and Ecology Japan, V19, P77; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Kingsolver JG, 2011, INTEGR COMP BIOL, V51, P719, DOI 10.1093/icb/icr015; Kleinwachter M, 2008, ECOL ENTOMOL, V33, P286, DOI 10.1111/j.1365-2311.2007.00963.x; Kleinwaechter M, 2007, BIODIVERS CONSERV, V16, P3067, DOI 10.1007/s10531-007-9163-9; Knisley CB, 2005, ANN ENTOMOL SOC AM, V98, P552, DOI 10.1603/0013-8746(2005)098[0552:TOTTBC]2.0.CO;2; KNISLEY CB, 1988, ECOLOGY, V69, P1983, DOI 10.2307/1941176; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Leathwick JR, 2002, BIODIVERS CONSERV, V11, P2177, DOI 10.1023/A:1021394628607; Lindroth C.H., 1985, CARABIDAE COLEOPTERA; Lobo JM, 2001, BIOL J LINN SOC, V73, P233, DOI 10.1111/j.1095-8312.2001.tb01360.x; Luff ML, 1993, FAUNA ENTOMOLOGICA S, V27; Macfadyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040313; Matern A, 2007, BIOL CONSERV, V136, P618, DOI 10.1016/j.biocon.2007.01.006; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; Miller TEX, 2011, TRENDS ECOL EVOL, V26, P457, DOI 10.1016/j.tree.2011.05.005; Nakazawa M., 2011, FMSB FUNCTIONS MED S; NCAR-Research Application Program, 2010, VER FOR VER UT R PAC; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Omland KS, 2002, NORTHEAST NAT, V9, P433; Pearman PB, 2010, ECOGRAPHY, V33, P990, DOI 10.1111/j.1600-0587.2010.06443.x; PEARSON DL, 1988, ANNU REV ENTOMOL, V33, P123, DOI 10.1146/annurev.en.33.010188.001011; PEARSON DL, 1991, OIKOS, V61, P223, DOI 10.2307/3545340; Prinzing A, 2002, ECOGRAPHY, V25, P721, DOI 10.1034/j.1600-0587.2002.250608.x; R Development Core Team, 2011, R LANG ENV STAT COMP; Radchuk V, 2013, J ANIM ECOL, V82, P275, DOI 10.1111/j.1365-2656.2012.02029.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Russo D, 2011, J INSECT CONSERV, V15, P685, DOI 10.1007/s10841-010-9366-3; Satoh A, 2005, ECOL RES, V20, P143, DOI 10.1007/s11284-004-0028-3; Saupe EE, 2012, ECOL MODEL, V237, P11, DOI 10.1016/j.ecolmodel.2012.04.001; Schofield A, 2002, HEATH TIGER BEETLES; Schreiber S, 2008, ECOL LETT, V11, P576, DOI 10.1111/j.1461-0248.2008.01171.x; Schweiger O, 2012, GLOBAL ECOL BIOGEOGR, V21, P88, DOI 10.1111/j.1466-8238.2010.00607.x; Serrano J., 2003, CATALOGO CARABIDAE C; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x; Taboada A, 2012, ENTOMOL EXP APPL, V145, P82, DOI 10.1111/j.1570-7458.2012.01316.x; Takeuchi Y, 2007, POPUL ECOL, V49, P305, DOI 10.1007/s10144-007-0047-3; Turlure C, 2011, J THERM BIOL, V36, P173, DOI 10.1016/j.jtherbio.2011.02.001; Turlure C, 2009, OIKOS, V118, P950, DOI 10.1111/j.1600-0706.2009.17269.x; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wellenreuther M, 2012, ECOLOGY, V93, P1353; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; Wilson RJ, 2010, ECOGRAPHY, V33, P73, DOI 10.1111/j.1600-0587.2009.06038.x; ZAR JH, 1972, J AM STAT ASSOC, V67, P578, DOI 10.2307/2284441; Zimmermann NE, 2007, J APPL ECOL, V44, P1057, DOI 10.1111/j.1365-2664.2007.01348.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	75	10	10	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70038	10.1371/journal.pone.0070038	http://dx.doi.org/10.1371/journal.pone.0070038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894582	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000178
J	Chew, TG; Peaston, A; Lim, AK; Lorthongpanich, C; Knowles, BB; Solter, D				Chew, Ting Gang; Peaston, Anne; Lim, Ai Khim; Lorthongpanich, Chanchao; Knowles, Barbara B.; Solter, Davor			A Tudor Domain Protein SPINDLIN1 Interacts with the mRNA-Binding Protein SERBP1 and Is Involved in Mouse Oocyte Meiotic Resumption	PLOS ONE			English	Article							CYTOPLASMIC POLYADENYLATION; TRANSLATIONAL CONTROL; CYCLIC-GMP; MEIOSIS; ARREST; OVEREXPRESSION; METHYLATION; EXPRESSION; MATURATION; CPEB	Mammalian oocytes are arrested at prophase I of meiosis, and resume meiosis prior to ovulation. Coordination of meiotic arrest and resumption is partly dependent on the post-transcriptional regulation of maternal transcripts. Here, we report that, SPINDLIN1 (SPIN1), a maternal protein containing Tudor-like domains, interacts with a known mRNA-binding protein SERBP1, and is involved in regulating maternal transcripts to control meiotic resumption. Mouse oocytes deficient for Spin1 undergo normal folliculogenesis, but are defective in resuming meiosis. SPIN1, via its Tudor-like domain, forms a ribonucleoprotein complex with SERBP1, and regulating mRNA stability and/or translation. The mRNA for the cAMP-degrading enzyme, PDE3A, is reduced in Spin1 mutant oocytes, possibly contributing to meiotic arrest. Our study demonstrates that Spin1 regulates maternal transcripts post-transcriptionally and is involved in meiotic resumption.	[Chew, Ting Gang; Lim, Ai Khim; Lorthongpanich, Chanchao; Knowles, Barbara B.; Solter, Davor] ASTAR, Inst Med Biol, Mammalian Dev Lab, Singapore, Singapore; [Peaston, Anne] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, Australia; [Solter, Davor] Duke NUS Grad Med Sch, Singapore, Singapore; [Knowles, Barbara B.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Adelaide; National University of Singapore; National University of Singapore	Chew, TG (corresponding author), ASTAR, Inst Med Biol, Mammalian Dev Lab, Singapore, Singapore.	tinggang80@gmail.com	Solter, Davor/Q-5476-2019; Peaston, Anne E/H-7158-2013	Peaston, Anne/0000-0002-7501-2415; Knowles, Barbara B./0000-0002-2597-5619	Agency for Science, Technology and Research (A*STAR) Singapore	Agency for Science, Technology and Research (A*STAR) Singapore(Agency for Science Technology & Research (A*STAR))	This work is supported by research funds from the Agency for Science, Technology and Research (A*STAR) Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkov AL, 2010, TRENDS CELL BIOL, V20, P482, DOI 10.1016/j.tcb.2010.05.004; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Gaffre M, 2011, DEVELOPMENT, V138, P3735, DOI 10.1242/dev.063974; Ge WZ, 2005, MOL BIOL CELL, V16, P4124, DOI 10.1091/mbc.e04-11-0976; GEBAUER F, 1994, EMBO J, V13, P5712, DOI 10.1002/j.1460-2075.1994.tb06909.x; Gershon E, 2006, REPRODUCTION, V132, P21, DOI 10.1530/rep.1.01093; Goncalves KD, 2011, FEBS LETT, V585, P2556, DOI 10.1016/j.febslet.2011.07.010; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Heaton JH, 2001, J BIOL CHEM, V276, P3341, DOI 10.1074/jbc.M006538200; Lasko P, 2010, CURR BIOL, V20, pR666, DOI 10.1016/j.cub.2010.05.056; Lazar S, 2002, MOL ENDOCRINOL, V16, P331, DOI 10.1210/me.16.2.331; Lee YJ, 2012, J CELL BIOCH; Levesque JT, 1996, BIOL REPROD, V55, P1427, DOI 10.1095/biolreprod55.6.1427; Lowther KM, 2011, REPRODUCTION, V141, P737, DOI 10.1530/REP-10-0461; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; MOORE GPM, 1974, J CELL BIOL, V60, P416, DOI 10.1083/jcb.60.2.416; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Oh B, 2000, DEVELOPMENT, V127, P3795; Oh B, 1997, DEVELOPMENT, V124, P493; Passos DO, 2006, FEBS J, V273, P3946, DOI 10.1111/j.1742-4658.2006.05399.x; Robinson JW, 2012, DEV BIOL, V366, P308, DOI 10.1016/j.ydbio.2012.04.019; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Solc P, 2010, MOL HUM REPROD, V16, P654, DOI 10.1093/molehr/gaq034; Solter D, 2003, MANIPULATING MOUSE E, P274; Standart N, 2008, BIOCHEM SOC T, V36, P671, DOI 10.1042/BST0360671; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Wang SF, 2010, P NATL ACAD SCI USA, V107, P17639, DOI 10.1073/pnas.1013185107; Wang WX, 2011, EMBO REP, V12, P1160, DOI 10.1038/embor.2011.184; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yu Michael C, 2011, Mol Biol Int, V2011, P163827, DOI 10.4061/2011/163827; Yuan HF, 2008, GENE, V410, P67, DOI 10.1016/j.gene.2007.11.019; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573; Zhang P, 2008, J CELL PHYSIOL, V217, P400, DOI 10.1002/jcp.21515; Zhao Q, 2007, J BIOL CHEM, V282, P647, DOI 10.1074/jbc.M604029200	39	20	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69764	10.1371/journal.pone.0069764	http://dx.doi.org/10.1371/journal.pone.0069764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894536	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100080
J	Xu, J; Vanderlick, TK; Beales, PA				Xu, Jian; Vanderlick, T. Kyle; Beales, Paul A.			Lytic and Non-Lytic Permeabilization of Cardiolipin-Containing Lipid Bilayers Induced by Cytochrome c	PLOS ONE			English	Article							CAUSES PORE FORMATION; MEMBRANE-STRUCTURE; TRANSITION PORE; BAX; MITOCHONDRIA; APOPTOSIS; CHANNEL; RELEASE; SURFACE; SIZE	The release of cytochrome c (cyt c) from mitochondria is an important early step during cellular apoptosis, however the precise mechanism by which the outer mitochondrial membrane becomes permeable to these proteins is as yet unclear. Inspired by our previous observation of cyt c crossing the membrane barrier of giant unilamellar vesicle model systems, we investigate the interaction of cyt c with cardiolipin (CL)-containing membranes using the innovative droplet bilayer system that permits electrochemical measurements with simultaneous microscopy observation. We find that cyt c can permeabilize CL-containing membranes by induction of lipid pores in a dose-dependent manner, with membrane lysis eventually observed at relatively high (mu M) cyt c concentrations due to widespread pore formation in the membrane destabilizing its bilayer structure. Surprisingly, as cyt c concentration is further increased, we find a regime with exceptionally high permeability where a stable membrane barrier is still maintained between droplet compartments. This unusual non-lytic state has a long lifetime (>20 h) and can be reversibly formed by mechanically separating the droplets before reforming the contact area between them. The transitions between behavioural regimes are electrostatically driven, demonstrated by their suppression with increasing ionic concentrations and their dependence on CL composition. While membrane permeability could also be induced by cationic PAMAM dendrimers, the non-lytic, highly permeable membrane state could not be reproduced using these synthetic polymers, indicating that details in the structure of cyt c beyond simply possessing a cationic net charge are important for the emergence of this unconventional membrane state. These unexpected findings may hold significance for the mechanism by which cyt c escapes into the cytosol of cells during apoptosis.	[Xu, Jian; Vanderlick, T. Kyle] Yale Univ, Dept Chem & Environm Engn, New Haven, CT USA; [Beales, Paul A.] Univ Leeds, Sch Chem, Ctr Mol Nanosci, Leeds LS2 9JT, W Yorkshire, England	Yale University; University of Leeds	Beales, PA (corresponding author), Univ Leeds, Sch Chem, Ctr Mol Nanosci, Leeds LS2 9JT, W Yorkshire, England.	p.a.beales@leeds.ac.uk	Beales, Paul/E-2194-2013	Beales, Paul/0000-0001-9076-9793	Yale University	Yale University	This work was funded by Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidor I. G., 1979, J ELECTROANAL CHEM, V104, P37, DOI DOI 10.1016/S0022-0728(79)81006-2; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Atanasov V, 2005, BIOPHYS J, V89, P1780, DOI 10.1529/biophysj.105.061374; Banerjee J, 2004, BIOCHEM BIOPH RES CO, V323, P310, DOI 10.1016/j.bbrc.2004.08.094; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Beales PA, 2011, LANGMUIR, V27, P6107, DOI 10.1021/la104924c; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Bergstrom CL, 2013, P NATL ACAD SCI USA, V110, P6269, DOI 10.1073/pnas.1303819110; Bezrukov SM, 2000, CURR OPIN COLLOID IN, V5, P237, DOI 10.1016/S1359-0294(00)00061-3; Bockris J. O. M., 2000, MODERN ELECTROCHEMIS; Castellana ET, 2006, SURF SCI REP, V61, P429, DOI 10.1016/j.surfrep.2006.06.001; CHERNOMORDIK L, 1994, J VIROL, V68, P7115, DOI 10.1128/JVI.68.11.7115-7123.1994; Crompton M, 2000, CURR OPIN CELL BIOL, V12, P414, DOI 10.1016/S0955-0674(00)00110-1; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; DEKRUIJFF B, 1980, BIOCHIM BIOPHYS ACTA, V602, P477, DOI 10.1016/0005-2736(80)90327-2; DeMeulenaer B, 1997, J COLLOID INTERF SCI, V189, P254, DOI 10.1006/jcis.1997.4789; Deng YR, 1999, J STRUCT BIOL, V127, P231, DOI 10.1006/jsbi.1999.4147; Devarakonda B, 2004, INT J PHARMACEUT, V284, P133, DOI 10.1016/j.ijpharm.2004.07.006; Diederich A, 1998, PHYS REV E, V58, P4883, DOI 10.1103/PhysRevE.58.4883; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Fernandez MG, 2002, CELL GROWTH DIFFER, V13, P449; Gallaher J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061925; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gorbenko GP, 2006, BIOPHYS J, V90, P4093, DOI 10.1529/biophysj.105.080150; Gray J. R., 2005, ENV INSTRUMENTATION, P491; Guo L, 2004, AM J PHYSIOL-CELL PH, V286, pC1109, DOI 10.1152/ajpcell.00183.2003; GUPTE SS, 1988, J BIOL CHEM, V263, P5241; Hanke W., 1993, METHODS APPL; Heimburg T, 1999, BIOPHYS J, V76, P2575, DOI 10.1016/S0006-3495(99)77410-2; Hemmler R, 2005, BIOPHYS J, V88, P4000, DOI 10.1529/biophysj.104.058255; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holden MA, 2007, J AM CHEM SOC, V129, P8650, DOI 10.1021/ja072292a; Hristova K, 2001, BIOPHYS J, V80, P801, DOI 10.1016/S0006-3495(01)76059-6; HUMPHRIES G M K, 1975, Proceedings of the National Academy of Sciences of the United States of America, V72, P2483, DOI 10.1073/pnas.72.7.2483; Hung WC, 2000, BBA-BIOMEMBRANES, V1467, P198, DOI 10.1016/S0005-2736(00)00221-2; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kitano T, 2003, CHEM PHYS LIPIDS, V126, P225, DOI 10.1016/j.chemphyslip.2003.08.006; Kitchens KM, 2005, ADV DRUG DELIVER REV, V57, P2163, DOI 10.1016/j.addr.2005.09.013; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kwong J, 1999, CELL TISSUE RES, V298, P123, DOI 10.1007/s004419900057; LESTER HA, 1975, J GEN PHYSIOL, V65, P797, DOI 10.1085/jgp.65.6.797; LINDSEY H, 1979, BIOCHIM BIOPHYS ACTA, V555, P147, DOI 10.1016/0005-2736(79)90079-8; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; POWELL GL, 1990, BIOCHEMISTRY-US, V29, P5127, DOI 10.1021/bi00473a018; Renner S, 2010, SMALL, V6, P190, DOI 10.1002/smll.200901435; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; RYTOMAA M, 1992, J BIOL CHEM, V267, P22243; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Sarles SA, 2010, LAB CHIP, V10, P710, DOI 10.1039/b916736f; Sarles SA, 2010, ANAL CHEM, V82, P959, DOI 10.1021/ac902555z; Schuster B, 2002, BIOELECTROCHEMISTRY, V55, P5, DOI 10.1016/S1567-5394(01)00148-7; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shearman GC, 2007, BIOCHEM SOC T, V35, P498, DOI 10.1042/BST0350498; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Sung W, 1997, BIOPHYS J, V73, P1797, DOI 10.1016/S0006-3495(97)78210-9; Tien HT, 2001, J MEMBRANE SCI, V189, P83, DOI 10.1016/S0376-7388(01)00394-5; Tien HT, 2003, PLANAR LIPID BILAYER; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Veatch SL, 2006, BIOPHYS J, V90, P4428, DOI 10.1529/biophysj.105.080283; WINTERHALTER M, 1987, PHYS REV A, V36, P5874, DOI 10.1103/PhysRevA.36.5874; Winterhalter M, 2000, CURR OPIN COLLOID IN, V5, P250, DOI 10.1016/S1359-0294(00)00063-7; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	75	12	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69492	10.1371/journal.pone.0069492	http://dx.doi.org/10.1371/journal.pone.0069492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894494	gold, Green Published			2022-12-25	WOS:000322132100064
J	Zhang, Y; Shan, L; Hua, YP; Wang, D; Zeng, HW; Liu, RH; Zhang, WD; Hu, ZL				Zhang, Yan; Shan, Lei; Hua, Yaping; Wang, Dan; Zeng, Huawu; Liu, Runhui; Zhang, Weidong; Hu, Zhenlin			Baicalein Selectively Induces Apoptosis in Activated Lymphocytes and Ameliorates Concanavalin A-Induced Hepatitis in Mice	PLOS ONE			English	Article							AUTOIMMUNE HEPATITIS; CANCER CELLS; T-CELLS; CYCLOOXYGENASE-2 EXPRESSION; CYCLOSPORINE-A; LIVER-INJURY; IN-VITRO; INHIBITION; MECHANISMS; INDUCTION	Background: Insufficient apoptosis in activated lymphocytes contributes to the development of autoimmune hepatitis (AIH). Baicalein (BE), a flavonoid originally isolated from the root of Scutellaria baicalensis Georgi, possesses anti-inflammatory properties. However, whether BE can selectively induce apoptosis in activated lymphocytes and exert therapeutic effect on AIH has not been studied. Methodology/Principal Findings: The pro-apoptotic properties of BE were evaluated in vitro on different types of immune cells, and in vivo effects of BE were examined in a murine model of Concanavalin A (Con A)-induced hepatitis. In vitro treatment with BE resulted in a higher increase in the level of apoptosis in Con A-stimulated murine splenocytes, Con A-stimulated CD3(+) splenocytes, lipopolysaccharide (LPS)-stimulated CD19(+) splenocytes, and phorbol 12-myristate 13-acetate/ionomycin-stimulated Jurkat T cells, compared with that in unstimulated naive ones. Murine bone marrow-derived dentritic cells, peritoneal macrophages, and RAW264.7 cells, either stimulated with LPS or unstimulated, were all insensitive to the BE-induced apoptosis. BE treatment also led to a loss of mitochondrial membrane potential, an increase of cytochrome c release from mitochondria to the cytosol, a decrease in the ratio of Bcl-2/Bax, and activation of caspase-9,-3 in Con A-stimulated CD3(+) splenocytes and LPS-stimulated CD19(+) splenocytes, while showing no impact on Fas/FasL expressions and caspase-8 activation. In vivo administration of BE alleviated Con A-induced liver injury, suppressed serum level of TNF-alpha and IFN-gamma, and reduced liver infiltration of mononuclear cells (MNCs). Furthermore, BE treatment increased the incidences of apoptosis in liver-infiltrating MNCs and splenocytes, as well as in CD3(+) and CD19(+) splenocytes. When liver MNCs and splenocytes from BE-treated mice were cultured in vitro for 24 h, they exhibited marked increase in apoptosis compared to vehicle-treated control. Conclusions/Significance: The present study demonstrates the ability of BE to promote apoptosis in activated lymphocytes through mitochondrial pathway and its potential use in the treatment of AIH.	[Zhang, Yan; Shan, Lei; Wang, Dan; Zeng, Huawu; Liu, Runhui; Zhang, Weidong; Hu, Zhenlin] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Hua, Yaping] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China	Naval Medical University; Shanghai Jiao Tong University	Zhang, WD (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	wdzhangy@hotmail.com; zhenlinhu@hotmail.com	Zhang, Weidong/E-6563-2016; 花, 亚萍/AHE-6466-2022	Zhang, Weidong/0000-0002-2433-6823; hua, yaping/0000-0002-5756-3563	NCET Foundation; NSFC [30725045, 81072653]; Global Research Network for Medicinal Plants (GRNMP); Shanghai Leading Academic Discipline Project [B906]; Key laboratory of drug research for special environments; PLA; Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products [10DZ2251300]; Scientific Foundation of Shanghai China [09DZ1975700, 09DZ1971500, 10DZ1971700]; National Major Project of China [2011ZX09307-002-03]; National Key Technology R&D Program of China [2012BAI29B06]; King Saud University	NCET Foundation; NSFC(National Natural Science Foundation of China (NSFC)); Global Research Network for Medicinal Plants (GRNMP); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Key laboratory of drug research for special environments; PLA; Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products; Scientific Foundation of Shanghai China; National Major Project of China; National Key Technology R&D Program of China(National Key Technology R&D Program); King Saud University(King Saud University)	The work was supported by program NCET Foundation, NSFC (30725045), and NSFC (81072653), partially supported by Global Research Network for Medicinal Plants (GRNMP) and King Saud University, Shanghai Leading Academic Discipline Project(B906), FP7-PEOPLE-IRSES-2008 (TCMCANCER Project 230232), Key laboratory of drug research for special environments, PLA, Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products(10DZ2251300) and the Scientific Foundation of Shanghai China (09DZ1975700, 09DZ1971500, 10DZ1971700), National Major Project of China (2011ZX09307-002-03). National Key Technology R&D Program of China (2012BAI29B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Agarwal K, 2007, TISSUE ANTIGENS, V69, P227, DOI 10.1111/j.1399-0039.2006.00794.x; BRUNETTI M, 1995, BLOOD, V86, P4199, DOI 10.1182/blood.V86.11.4199.bloodjournal86114199; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chen CJ, 2004, BIOCHEM PHARMACOL, V67, P957, DOI 10.1016/j.bcp.2003.10.010; Chen DW, 2001, J IMMUNOL, V166, P5889, DOI 10.4049/jimmunol.166.10.5889; Chen FL, 2008, DIGEST DIS SCI, V53, P181, DOI 10.1007/s10620-007-9841-1; Chen TY, 2004, BLOOD, V103, P413, DOI 10.1182/blood-2003-07-2412; Cheng PY, 2007, BIOCHEM PHARMACOL, V73, P793, DOI 10.1016/j.bcp.2006.11.025; Chow JM, 2006, APOPTOSIS, V11, P1999, DOI 10.1007/s10495-006-0085-x; Di Carlo G, 2001, TRENDS PHARMACOL SCI, V22, P292, DOI 10.1016/S0165-6147(00)01716-8; Ding XZ, 1999, BIOCHEM BIOPH RES CO, V261, P218, DOI 10.1006/bbrc.1999.1012; Dou W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036075; GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1002/hep.1840210131; Geske FJ, 2002, INT J HEMATOL, V76, P16, DOI 10.1007/BF02982714; Gilbert K. M, 2010, HEPAT RES TREAT, V2010, DOI DOI 10.1155/2010/248157]; GILLIS S, 1979, J IMMUNOL, V123, P1624; Giovannetti A, 2008, CURR PHARM DESIGN, V14, P253; Heneghan MA, 2002, HEPATOLOGY, V35, P7, DOI 10.1053/jhep.2002.30991; Hildeman D, 2007, CURR OPIN IMMUNOL, V19, P516, DOI 10.1016/j.coi.2007.05.005; Hiraide A, 2005, AM J GASTROENTEROL, V100, P1322, DOI 10.1111/j.1572-0241.2005.41053.x; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; KUBO M, 1984, CHEM PHARM BULL, V32, P2724; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Li CR, 2011, BIOPHARM DRUG DISPOS, V32, P427, DOI 10.1002/bdd.771; Liu J, 2006, INT J PHARMACEUT, V312, P137, DOI 10.1016/j.ijpharm.2006.01.011; Liu WL, 2012, FITOTERAPIA, V83, P1532, DOI 10.1016/j.fitote.2012.08.021; Liu ZL, 2002, BIOL PHARM BULL, V25, P37, DOI 10.1248/bpb.25.37; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Mansour MK, 2006, J IMMUNOL, V176, P3053, DOI 10.4049/jimmunol.176.5.3053; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Peter ME, 1998, CURR OPIN IMMUNOL, V10, P545, DOI 10.1016/S0952-7915(98)80222-7; Pidgeon GP, 2002, CANCER RES, V62, P2721; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; SEKIYA K, 1982, BIOCHEM BIOPH RES CO, V105, P1090, DOI 10.1016/0006-291X(82)91081-6; Shen YC, 2003, EUR J PHARMACOL, V465, P171, DOI 10.1016/S0014-2999(03)01378-5; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; Strauss G, 2002, CLIN EXP IMMUNOL, V128, P255, DOI 10.1046/j.1365-2249.2002.01777.x; Sun Y, 2009, BIOCHEM PHARMACOL, V77, P1717, DOI 10.1016/j.bcp.2009.03.002; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tong WG, 2002, BIOCHEM BIOPH RES CO, V296, P942, DOI 10.1016/S0006-291X(02)02014-4; Volarevic V, 2012, HEPATOLOGY, V55, P1954, DOI 10.1002/hep.25542; Volarevic V, 2012, J HEPATOL, V56, P26, DOI 10.1016/j.jhep.2011.03.022; Wang ZJ, 2007, J IMMUNOL, V179, P5958, DOI 10.4049/jimmunol.179.9.5958; Woo KJ, 2006, IMMUNOBIOLOGY, V211, P359, DOI 10.1016/j.imbio.2006.02.002; Yachida M, 1999, CLIN EXP IMMUNOL, V116, P140; Yang LP, 2009, INVEST OPHTH VIS SCI, V50, P2319, DOI 10.1167/iovs.08-2642; Yun MY, 2010, INT IMMUNOPHARMACOL, V10, P1142, DOI 10.1016/j.intimp.2010.06.020; Zhang JJ, 2011, INT J PHARMACEUT, V420, P180, DOI 10.1016/j.ijpharm.2011.08.023; Zhou T, 1999, NAT MED, V5, P42, DOI 10.1038/4723	51	25	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69592	10.1371/journal.pone.0069592	http://dx.doi.org/10.1371/journal.pone.0069592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894507	gold, Green Published, Green Submitted			2022-12-25	WOS:000322132100071
J	Gupta, N; LeGoff, J; Chamat, S; Mercier-Delarue, S; Touzelet, O; Power, UF; Kazatchkine, MD; Simon, F; Lacroix-Desmazes, S; Bayry, J; Kaveri, SV				Gupta, Nimesh; LeGoff, Jerome; Chamat, Soulaima; Mercier-Delarue, Severine; Touzelet, Olivier; Power, Ultan F.; Kazatchkine, Michel D.; Simon, Francois; Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.			Affinity-Purified Respiratory Syncytial Virus Antibodies from Intravenous Immunoglobulin Exert Potent Antibody-Dependent Cellular Cytotoxicity	PLOS ONE			English	Article							INFECTIOUS-DISEASES; G-PROTEIN; IMMUNE GLOBULIN; GLYCOPROTEIN; ENHANCEMENT; THERAPY; INFANTS; MICE; RSV	Mixed infections are one of the major therapeutic challenges, as the current strategies have had limited success. One of the most common and widespread conditions of mixed infection is respiratory syncytial virus-mediated pathology of the respiratory tract in children. There is a dire need for the development of novel therapeutic approaches during mixed infections. Therapeutic intravenous immunoglobulin preparations, obtained from plasma pools of healthy donors have been used in immune deficiencies. This study was thus designed to characterize the functional efficacy of RSV-specific antibodies in IVIg. To explore the functional ability of these affinity-purified RSV-specific antibodies, the antibody-dependent and complement dependent cytotoxicity was determined using peripheral cells of healthy donors. This study demonstrates the existence of highly potent RSV-specific antibodies in IVIg preparations and provides the basis for the use of IVIg as broad-spectrum protective shield to RSV-infected children during mixed infections.	[Gupta, Nimesh; Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.] Inst Natl Sante & Rech Med, Unite 872, Paris, France; [Gupta, Nimesh; Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.] Ctr Rech Cordeliers, Equipe Immunopathol & Therapeut Immunointervent 1, Paris, France; [Gupta, Nimesh; Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.] Univ Paris 05, Univ Paris 06, UMR S 872, Paris, France; [LeGoff, Jerome; Simon, Francois] Univ Paris Diderot, Pres Sorbone Paris Cite, Paris, France; [LeGoff, Jerome; Mercier-Delarue, Severine; Simon, Francois] Hop St Louis, AP HP, Microbiol Lab, St Louis, France; [Chamat, Soulaima] Lebanese Univ, Fac Publ Hlth, Immunol Lab, Fanar, Lebanon; [Touzelet, Olivier; Power, Ultan F.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Kazatchkine, Michel D.] United Nation Secretary Gen Special Envoy HIV AID, Geneva, Switzerland; [Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.] Inst Natl Sante & Rech Med France, Int Associated Lab, Bombay, Maharashtra, India; [Lacroix-Desmazes, Sebastien; Bayry, Jagadeesh; Kaveri, Srinivas V.] Indian Council Med Res, Bombay, Maharashtra, India	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Lebanese University; Queens University Belfast; Institut National de la Sante et de la Recherche Medicale (Inserm); Indian Council of Medical Research (ICMR)	Kaveri, SV (corresponding author), Inst Natl Sante & Rech Med, Unite 872, Paris, France.	srini.kaveri@crc.jussieu.fr	Bayry, Jagadeesh/A-6589-2011; le goff, jerome/B-3447-2016; Gupta, Nimesh/C-3590-2017; LeGoff, jerome/AAP-7880-2021	Bayry, Jagadeesh/0000-0003-0498-9808; le goff, jerome/0000-0001-7111-1865; Gupta, Nimesh/0000-0001-9433-8448; Kaveri, Srini/0000-0002-0837-4053; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447; Power, Ultan/0000-0003-3246-3774	Institut National de la Sante et de la Recherche Medicale, Universite Pierre et Marie Curie, Universite Paris Descartes; Centre National de la Recherche Scientifique; European Community [[FP7-2007-2013]-HEALTH-F2-2010-260338-ALLFUN]	Institut National de la Sante et de la Recherche Medicale, Universite Pierre et Marie Curie, Universite Paris Descartes; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Community(European Commission)	This study was Supported by Institut National de la Sante et de la Recherche Medicale, Universite Pierre et Marie Curie, Universite Paris Descartes; Centre National de la Recherche Scientifique; European Community's Seventh Framework Programme [FP7-2007-2013]-HEALTH-F2-2010-260338-ALLFUN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bayry J, 2004, TRENDS PHARMACOL SCI, V25, P306, DOI 10.1016/j.tips.2004.04.002; Bayry J, 2003, J INFECT DIS, V188, P1610, DOI 10.1086/379335; Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61; Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870; Bukreyev A, 2012, J VIROL, V86, P10880, DOI 10.1128/JVI.01162-12; Caidi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051485; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; Collarini EJ, 2009, J IMMUNOL, V183, P6338, DOI 10.4049/jimmunol.0901373; FALSEY AR, 1995, J INFECT DIS, V172, P389, DOI 10.1093/infdis/172.2.389; GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Haynes LM, 2009, J INFECT DIS, V200, P439, DOI 10.1086/600108; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; KAUL TN, 1982, INFECT IMMUN, V37, P492, DOI 10.1128/IAI.37.2.492-498.1982; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Krause I, 2002, TRANSFUSION MED, V12, P133, DOI 10.1046/j.1365-3148.2002.00360.x; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Mao CR, 2009, J GEN VIROL, V90, P1119, DOI 10.1099/vir.0.009308-0; Nguyen QH, 1998, CLIN DIAGN LAB IMMUN, V5, P98, DOI 10.1128/CDLI.5.1.98-104.1998; Panitch HB, 2001, CURR OPIN PEDIATR, V13, P256, DOI 10.1097/00008480-200106000-00008; Rabel PO, 2012, CLIN VACCINE IMMUNOL, V19, P623, DOI 10.1128/CVI.05705-11; SIBER GR, 1994, J INFECT DIS, V169, P1368, DOI 10.1093/infdis/169.6.1368; Spycher M, 2009, VOX SANG, V97, P348, DOI 10.1111/j.1423-0410.2009.01217.x; STIEHM ER, 1994, CLIN DIAGN LAB IMMUN, V1, P342, DOI 10.1128/CDLI.1.3.342-347.1994; Sung CC, 2011, J MICROBIOL IMMUNOL, V44, P184, DOI 10.1016/j.jmii.2011.01.025; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675	26	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69390	10.1371/journal.pone.0069390	http://dx.doi.org/10.1371/journal.pone.0069390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894466	Green Published, gold, Green Submitted			2022-12-25	WOS:000322391400057
J	Hsiao, KC; Shih, NY; Fang, HL; Huang, TS; Kuo, CC; Chu, PY; Hung, YM; Chou, SW; Yang, YY; Chang, GC; Liu, KJ				Hsiao, Kuan-Chung; Shih, Neng-Yao; Fang, Hsun-Lang; Huang, Tze-Sing; Kuo, Ching-Chuan; Chu, Pei-Yi; Hung, Yi-Mei; Chou, Shao-Wen; Yang, Yi-Yuan; Chang, Gee-Chen; Liu, Ko-Jiunn			Surface alpha-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target	PLOS ONE			English	Article							UROKINASE PLASMINOGEN-ACTIVATOR; LUNG-CANCER; PANCREATIC-CANCER; IDENTIFICATION; SYSTEM; MECHANISM; RECEPTOR; PROTEIN; AUTOANTIBODIES; AUTOIMMUNITY	In previous research, we found alpha-enolase to be inversely correlated with progression-free and overall survival in lung cancer patients and detected alpha-enolase on the surface of lung cancer cells. Based on these findings, we hypothesized that surface alpha-enolase has a significant role in cancer metastasis and tested this hypothesis in the current study. We found that alpha-enolase was co-immunoprecipitated with urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen in lung cancer cells and interacted with these proteins in a cell-free dot blotting assay, which can be interrupted by alpha-enolase-specific antibody. alpha-Enolase in lung cancer cells co-localized with these proteins and was present at the site of pericellular degradation of extracellular matrix components. Treatment with antibody against alpha-enolase in vitro suppressed cell-associated plasminogen and matrix metalloproteinase activation, collagen and gelatin degradation, and cell invasion. Examination of the effect of treatment with shRNA plasmids revealed that down regulation of alpha-enolase decreases extracellular matrix degradation by and the invasion capacity of lung cancer cells. Adoptive transfer of alpha-enolase-specific antibody to mice resulted in accumulation of antibody in subcutaneous tumor and inhibited the formation of tumor metastasis in lung and bone. This study demonstrated that surface alpha-enolase promotes extracellular matrix degradation and invasion of cancer cells and that targeting surface alpha-enolase is a promising approach to suppress tumor metastasis.	[Hsiao, Kuan-Chung; Kuo, Ching-Chuan; Liu, Ko-Jiunn] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Shih, Neng-Yao; Huang, Tze-Sing; Kuo, Ching-Chuan; Hung, Yi-Mei; Chou, Shao-Wen; Liu, Ko-Jiunn] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Fang, Hsun-Lang] Min Hwei Coll Hlth Care Management, Dept Cosmetol & Hlth Care, Tainan, Taiwan; [Chu, Pei-Yi] St Martin De Porres Hosp, Dept Pathol, Chiayi, Taiwan; [Yang, Yi-Yuan; Liu, Ko-Jiunn] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Chang, Gee-Chen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chang, Gee-Chen] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chang, Gee-Chen] China Med Univ, Sch Med, Taichung, Taiwan	National Cheng Kung University; National Health Research Institutes - Taiwan; Taipei Medical University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Hsing University; China Medical University Taiwan	Chang, GC (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan.	august@vghtc.gov.tw; kojiunn@nhri.org.tw	Shih, Neng-Yao/D-2086-2010; Kuo, Ching-Chuan/C-1201-2010; Huang, Tze-Sing/C-9361-2013; Huang, Tze-Sing/E-3667-2010; Liu, Ko-Jiunn/D-2098-2010	Huang, Tze-Sing/0000-0001-8736-4330; Chu, Pei-Yi/0000-0001-7336-2465	Department of Health, Taiwan [DOH100-TD-C-111-005, DOH99-TD-G-111-009, DOH100-TD-C-111-004]; National Science Council, Taiwan [NSC98-3112-B-400-012, 99-3112-B-400-004, 100-3112-B-400-014, NSC98-2320-B-400-003-MY3]; VGHTC grant [TCVGH-963205C]	Department of Health, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); VGHTC grant	This work was supported by grants from the Department of Health, Taiwan, to G.-C. Chang (China Medical University Hospital Cancer Research Center of Excellence, DOH100-TD-C-111-005), N.-Y. Shih (DOH99-TD-G-111-009), and C.-C. Kuo (DOH100-TD-C-111-004) and grants from the National Science Council, Taiwan, to K.-J. Liu (NSC98-3112-B-400-012, 99-3112-B-400-004, and 100-3112-B-400-014), and C.-C. Kuo (NSC98-2320-B-400-003-MY3). G.-C. Chang was supported by a VGHTC grant (TCVGH-963205C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Husaini H, 2009, J THORAC ONCOL, V4, P251, DOI 10.1097/JTO.0b013e31819518fc; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; ARGUELLO F, 1992, CANCER RES, V52, P2304; Bae S, 2012, J IMMUNOL, V189, P365, DOI 10.4049/jimmunol.1102073; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Cappello P, 2009, INT J CANCER, V125, P639, DOI 10.1002/ijc.24355; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; Chang GC, 2006, CLIN CANCER RES, V12, P5746, DOI 10.1158/1078-0432.CCR-06-0324; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; Cozzi PJ, 2006, HUM PATHOL, V37, P1442, DOI 10.1016/j.humpath.2006.05.002; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Dowling P, 2007, BBA-PROTEINS PROTEOM, V1774, P93, DOI 10.1016/j.bbapap.2006.09.014; Fisher BAC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3740; Han B, 2005, ONCOL REP, V14, P105; He P, 2007, CANCER SCI, V98, P1234, DOI 10.1111/j.1349-7006.2007.00509.x; Ho JAA, 2010, ANAL CHEM, V82, P5944, DOI 10.1021/ac1001959; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Kagohashi K, 2003, MED ONCOL, V20, P25, DOI 10.1385/MO:20:1:25; Kawano K, 2012, EXP THER MED, V4, P61, DOI 10.3892/etm.2012.564; Kinloch AJ, 2011, ARTHRITIS RHEUM-US, V63, P3818, DOI 10.1002/art.30639; Kolberg J, 2006, MICROBIOL-SGM, V152, P1307, DOI 10.1099/mic.0.28747-0; Le DM, 2003, J NEUROSCI, V23, P4034; Leu SJ, 2010, VET IMMUNOL IMMUNOP, V137, P251, DOI 10.1016/j.vetimm.2010.06.001; Liu K.-J., 2007, J CANC MOL, V3, P45; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lokman NA, 2011, CANCER MICROENVIRON, V4, P199, DOI 10.1007/s12307-011-0064-9; Lopez-Alemany R, 2003, AM J HEMATOL, V72, P234, DOI 10.1002/ajh.10299; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mendes O, 2007, CLIN EXP METASTAS, V24, P341, DOI 10.1007/s10585-007-9071-0; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x; Romer J, 2004, CURR PHARM DESIGN, V10, P2359, DOI 10.2174/1381612043383962; Saldanha RG, 2007, J PROTEOME RES, V6, P1016, DOI 10.1021/pr060518n; Sanchez-Sweatman Otto H., 1998, Invasion and Metastasis, V18, P297, DOI 10.1159/000024522; Sato Hiroshi, 2006, Clin Calcium, V16, P621; Saulot V, 2002, ARTHRITIS RHEUM, V46, P1196, DOI 10.1002/art.10252; Schayowitz A, 2008, MOL CANCER THER, V7, P121, DOI 10.1158/1535-7163.MCT-07-0581; Shih NY, 2010, JPN J CLIN ONCOL, V40, P663, DOI 10.1093/jjco/hyq028; SMITH RE, 1980, THROMB RES, V17, P393, DOI 10.1016/0049-3848(80)90074-2; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sone S, 2007, CANCER METAST REV, V26, P685, DOI 10.1007/s10555-007-9081-z; Tan XD, 2006, INT J ONCOL, V28, P369; Tomaino B, 2011, J PROTEOME RES, V10, P105, DOI 10.1021/pr100213b; Tsai ST, 2010, EUR J CANCER, V46, P1712, DOI 10.1016/j.ejca.2010.03.018; WALSH JL, 1989, BIOCHIM BIOPHYS ACTA, V999, P64, DOI 10.1016/0167-4838(89)90031-9; Wang J, 2006, INT J MOL MED, V17, P849; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837	53	79	83	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e69354	10.1371/journal.pone.0069354	http://dx.doi.org/10.1371/journal.pone.0069354			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894455	Green Submitted, Green Published, gold			2022-12-25	WOS:000322391400051
J	Wu, C; Gong, FM; Pang, PF; Shen, M; Zhu, KS; Cheng, D; Liu, ZH; Shan, H				Wu, Chun; Gong, Faming; Pang, Pengfei; Shen, Min; Zhu, Kangshun; Cheng, Du; Liu, Zhihao; Shan, Hong			An RGD-Modified MRI-Visible Polymeric Vector for Targeted siRNA Delivery to Hepatocellular Carcinoma in Nude Mice	PLOS ONE			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; GENE-THERAPY; CANCER; CELLS; SURVIVIN; ANGIOGENESIS; APOPTOSIS	RNA interference (RNAi) has significant therapeutic promise for the genetic treatment of hepatocellular carcinoma (HCC). Targeted vectors are able to deliver small interfering RNA (siRNA) into HCC cells with high transfection efficiency and stability. The tripeptide arginine glycine aspartic acid (RGD)-modified non-viral vector, polyethylene glycol-grafted polyethylenimine functionalized with superparamagnetic iron oxide nanoparticles (RGD-PEG-g-PEI-SPION), was constructed as a magnetic resonance imaging (MRI)-visible nanocarrier for the delivery of Survivin siRNA targeting the human HCC cell line Bel-7402. The biophysical characterization of the RGD-PEG-g-PEI-SPION was performed. The RGD-modified complexes exhibited a higher transfection efficiency in transferring Survivin siRNA into Bel-7402 cells compared with a non-targeted delivery system, which resulted in more significant gene suppression at both the Survivin mRNA and protein expression levels. Then, the level of caspase-3 activation was significantly elevated, and a remarkable level of tumor cell apoptosis was induced. As a result, the tumor growth in the nude mice Bel-7402 hepatoma model was significantly inhibited. The targeting ability of the RGD-PEG-g-PEI-SPION was successfully imaged by MRI scans performed in vitro and in vivo. Our results strongly indicated that the RGD-PEG-g-PEI-SPION can potentially be used as a targeted non-viral vector for altering gene expression in the treatment of hepatocellular carcinoma and for detecting the tumor in vivo as an effective MRI probe.	[Wu, Chun; Pang, Pengfei; Shen, Min; Zhu, Kangshun; Shan, Hong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Radiol, Mol Imaging Lab, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Chun; Pang, Pengfei; Shen, Min; Zhu, Kangshun; Shan, Hong] Sun Yat Sen Univ, Intervent Radiol Inst, Guangzhou 510275, Guangdong, Peoples R China; [Gong, Faming; Cheng, Du] Sun Yat Sen Univ, Sch Chem & Chem Engn, Minist Educ, PCFM Lab, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Zhihao] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gastroenterol, Mol Digest Lab, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Shan, H (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Radiol, Mol Imaging Lab, Guangzhou 510275, Guangdong, Peoples R China.	shanhong@mail.sysu.edu.cn	cheng, du/GPK-2264-2022	cheng, du/0000-0001-5105-7777	NSFC-Guangdong Joint Foundation Key Project [U1032002]; National Natural Science Foundation of China [81071206, 81070349, 81101097, 81201090, 50830107]; Clinical Key Program of Ministry of Public Health of China [164]; China postdoctoral science foundation [20100470962]; Doctoral Foundation of Ministry of Education of China [20110171120084]; natural Science Foundation Project of Guangdong Province, China [10151008901000188]	NSFC-Guangdong Joint Foundation Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Key Program of Ministry of Public Health of China; China postdoctoral science foundation(China Postdoctoral Science Foundation); Doctoral Foundation of Ministry of Education of China(Ministry of Education, China); natural Science Foundation Project of Guangdong Province, China	This work was supported by the NSFC-Guangdong Joint Foundation Key Project (Grant No. U1032002), the National Natural Science Foundation of China (Grant Nos. 81071206, 81070349, 81101097, 81201090 and 50830107), the 2010-2012 Clinical Key Program of Ministry of Public Health of China (Grant No. 164), the China postdoctoral science foundation (Grant No. 20100470962), the Doctoral Foundation of Ministry of Education of China (Grant No. 20110171120084), and the natural Science Foundation Project of Guangdong Province, China (Grant No. 10151008901000188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2006, MOL CANCER THER, V5, P478, DOI 10.1158/1535-7163.MCT-05-0436; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; BELLIN MF, 1994, RADIOLOGY, V193, P657, DOI 10.1148/radiology.193.3.7972804; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Cai LL, 2011, INT J NANOMED, V6, P3499, DOI 10.2147/IJN.S26670; Chen GH, 2009, BIOMATERIALS, V30, P1962, DOI 10.1016/j.biomaterials.2008.12.043; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; El-Aneed A, 2004, J CONTROL RELEASE, V94, P1, DOI 10.1016/j.jconrel.2003.09.013; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fuke H, 2007, BIOCHEM BIOPH RES CO, V363, P738, DOI 10.1016/j.bbrc.2007.09.049; Green JJ, 2007, NANO LETT, V7, P874, DOI 10.1021/nl062395b; Huang MT, 2010, ANN SURG ONCOL, V17, P3379, DOI 10.1245/s10434-010-1163-4; Ito T, 2000, HEPATOLOGY, V31, P1080, DOI 10.1053/he.2000.6496; Kim SH, 2008, J CONTROL RELEASE, V129, P107, DOI 10.1016/j.jconrel.2008.03.008; Kumar CC, 2003, CURR DRUG TARGETS, V4, P123, DOI 10.2174/1389450033346830; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Merkel OM, 2009, J CONTROL RELEASE, V138, P148, DOI 10.1016/j.jconrel.2009.05.016; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Peer D, 2011, GENE THER, V18, P1127, DOI 10.1038/gt.2011.56; Shen M, 2012, INT J NANOMED, V7, P3319, DOI 10.2147/IJN.S32900; Thomas M, 2003, APPL MICROBIOL BIOT, V62, P27, DOI 10.1007/s00253-003-1321-8; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wu Y, 2010, INT J NANOMED, V5, P129	24	28	30	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66416	10.1371/journal.pone.0066416	http://dx.doi.org/10.1371/journal.pone.0066416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23922634	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800098
J	Jakobsson, ME; Moen, A; Bousset, L; Egge-Jacobsen, W; Kernstock, S; Melki, R; Falnes, PO				Jakobsson, Magnus E.; Moen, Anders; Bousset, Luc; Egge-Jacobsen, Wolfgang; Kernstock, Stefan; Melki, Ronald; Falnes, Pal O.			Identification and Characterization of a Novel Human Methyltransferase Modulating Hsp70 Protein Function through Lysine Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; ALPHA-SYNUCLEIN; BINDING; SET; HEAT-SHOCK-PROTEIN-70; PHOSPHORYLATION; ACTIVATION; SUBSTRATE; DISEASE; HSC70	Hsp70 proteins constitute an evolutionarily conserved protein family of ATP-dependent molecular chaperones involved in a wide range of biological processes. Mammalian Hsp70 proteins are subject to various post-translational modifications, including methylation, but for most of these, a functional role has not been attributed. In this study, we identified the methyltransferase METTL21A as the enzyme responsible for trimethylation of a conserved lysine residue found in several human Hsp70 (HSPA) proteins. This enzyme, denoted by us as HSPA lysine (K) methyltransferase (HSPA-KMT), was found to catalyze trimethylation of various Hsp70 family members both in vitro and in vivo, and the reaction was stimulated by ATP. Furthermore, we show that HSPA-KMT exclusively methylates 70-kDa proteins in mammalian protein extracts, demonstrating that it is a highly specific enzyme. Finally, we show that trimethylation of HSPA8 (Hsc70) has functional consequences, as it alters the affinity of the chaperone for both the monomeric and fibrillar forms of the Parkinson disease-associated protein alpha-synuclein.	[Jakobsson, Magnus E.; Moen, Anders; Egge-Jacobsen, Wolfgang; Kernstock, Stefan; Falnes, Pal O.] Univ Oslo, Dept Biosci, Fac Math & Nat Sci, N-0316 Oslo, Norway; [Bousset, Luc; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	University of Oslo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Falnes, PO (corresponding author), Univ Oslo, Dept Biosci, Fac Math & Nat Sci, N-0316 Oslo, Norway.	pal.falnes@ibv.uio.no	Falnes, Pål Ø./AAA-4581-2020	bousset, luc/0000-0002-0433-4337; Falnes, Pal/0000-0001-8114-6025	University of Oslo; Norwegian Cancer Society; Research Council of Norway; Agence Nationale pour la Recherche [ANR-09-MNPS-013-01]; CNRS; Human Frontier Science Program; Fondation Bettencourt Schueller	University of Oslo; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Agence Nationale pour la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Human Frontier Science Program(Human Frontier Science Program); Fondation Bettencourt Schueller	The work performed in the Falnes laboratory was supported by the University of Oslo and by grants from the Norwegian Cancer Society and the Research Council of Norway.; Supported by Agence Nationale pour la Recherche Grant ANR-09-MNPS-013-01, CNRS, the Human Frontier Science Program, and the Fondation Bettencourt Schueller.	Abe Miyako, 2004, Clin Prostate Cancer, V3, P49, DOI 10.3816/CGC.2004.n.013; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Birtas-Atesoglu E, 2008, CLIN EXP RHEUMATOL, V26, pS96; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dakappagari N, 2010, BIOMARKERS, V15, P31, DOI 10.3109/13547500903261347; Del Rizzo PA, 2011, EPIGENETICS-US, V6, P1059, DOI 10.4161/epi.6.9.16069; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Gao XC, 2012, J BIOL CHEM, V287, P6044, DOI 10.1074/jbc.M111.294728; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gribaldo S, 1999, J BACTERIOL, V181, P434, DOI 10.1128/JB.181.2.434-443.1999; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Kahali S, 2010, NEOPLASIA, V12, P80, DOI 10.1593/neo.91422; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Knowlton AA, 2000, AM J PHYSIOL-HEART C, V278, pH2143, DOI 10.1152/ajpheart.2000.278.6.H2143; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Pehar M, 2012, J BIOL CHEM, V287, P22436, DOI 10.1074/jbc.C112.362871; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Redeker V, 2012, J BIOL CHEM, V287, P32630, DOI 10.1074/jbc.M112.387530; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; WANG C, 1982, J BIOL CHEM, V257, P8356; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	41	82	96	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27752	27763		10.1074/jbc.M113.483248	http://dx.doi.org/10.1074/jbc.M113.483248			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23921388	Green Published, hybrid			2022-12-25	WOS:000330612800005
J	Boslem, E; Weir, JM; MacIntosh, G; Sue, N; Cantley, J; Meikle, PJ; Biden, TJ				Boslem, Ebru; Weir, Jacquelyn M.; MacIntosh, Gemma; Sue, Nancy; Cantley, James; Meikle, Peter J.; Biden, Trevor J.			Alteration of Endoplasmic Reticulum Lipid Rafts Contributes to Lipotoxicity in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; FREE FATTY-ACIDS; ER-STRESS; NEUTRAL SPHINGOMYELINASE; CERAMIDE ACCUMULATION; INDUCED APOPTOSIS; GOLGI TRANSPORT; CHOLESTEROL; PALMITATE; DEATH	Chronic saturated fatty acid exposure causes beta-cell apoptosis and, thus, contributes to type 2 diabetes. Although endoplasmic reticulum (ER) stress and reduced ER-to-Golgi protein trafficking have been implicated, the exact mechanisms whereby saturated fatty acids trigger beta-cell death remain elusive. Using mass spectroscopic lipidomics and subcellular fractionation, we demonstrate that palmitate pretreatment of MIN6 beta-cells promoted ER remodeling of both phospholipids and sphingolipids, but only the latter was causally linked to lipotoxic ER stress. Thus, overexpression of glucosylceramide synthase, previously shown to protect against defective protein trafficking and ER stress, partially reversed lipotoxic reductions in ER sphingomyelin (SM) content and aggregation of ER lipid rafts, as visualized using Erlin1-GFP. Using both lipidomics and a sterol response element reporter assay, we confirmed that free cholesterol in the ER was also reciprocally modulated by chronic palmitate and glucosylceramide synthase overexpression. This is consistent with the known coregulation and association of SM and free cholesterol in lipid rafts. Inhibition of SM hydrolysis partially protected against ATF4/C/EBP homology protein induction because of palmitate. Our results suggest that loss of SM in the ER is a key event for initiating beta-cell lipotoxicity, which leads to disruption of ER lipid rafts, perturbation of protein trafficking, and initiation of ER stress.	[Boslem, Ebru; Sue, Nancy; Cantley, James; Biden, Trevor J.] St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Program, Darlinghurst, NSW 2010, Australia; [Weir, Jacquelyn M.; MacIntosh, Gemma; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Baker Heart and Diabetes Institute	Biden, TJ (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Program, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	t.biden@garvan.org.au	Meikle, Peter J/B-4023-2009; Biden, Trevor/AAW-2829-2021	Boslem, Ebru/0000-0001-6123-4108; Biden, Trevor/0000-0001-5211-0234; Meikle, Peter/0000-0002-2593-4665; Cantley, James/0000-0003-2509-1271	National Health and Medical Research Council; Young Garvan Fellowship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Young Garvan Fellowship	This work was supported by a National Health and Medical Research Council project grant (to T. J. B.), by research fellowships (to T. J. B. and P. J. M.), and by the Young Garvan Fellowship (to E. B.).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Beeharry N, 2004, APOPTOSIS, V9, P599, DOI 10.1023/B:APPT.0000038039.82506.0c; Bonifacino J. S., 2003, CURRENT PROTOCOLS CE; Boslem E, 2012, ISLETS, V4, P177, DOI 10.4161/isl.20102; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; Epstein S, 2012, J LIPID RES, V53, P412, DOI 10.1194/jlr.M022186; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Gonzalez-Pertusa JA, 2010, ENDOCRINOLOGY, V151, P1487, DOI 10.1210/en.2009-0975; Gouaze-Andersson V, 2007, BBA-MOL CELL BIOL L, V1771, P1407, DOI 10.1016/j.bbalip.2007.09.005; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kockx M, 2012, BIOCHEM J, V447, P51, DOI 10.1042/BJ20111891; Krokowski D, 2013, J BIOL CHEM, V288, P17202, DOI 10.1074/jbc.M113.466920; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Maceyka M, 1997, J CELL BIOL, V139, P1411, DOI 10.1083/jcb.139.6.1411; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Petremand J, 2012, DIABETES, V61, P1100, DOI 10.2337/db11-1221; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Preston AM, 2009, DIABETOLOGIA, V52, P2369, DOI 10.1007/s00125-009-1506-5; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; Ridsdale A, 2006, MOL BIOL CELL, V17, P1593, DOI 10.1091/mbc.E05-02-0100; ROSENWALD AG, 1992, BIOCHEMISTRY-US, V31, P3581, DOI 10.1021/bi00129a005; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Runz H, 2006, EMBO J, V25, P2953, DOI 10.1038/sj.emboj.7601205; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003; Subathra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023644; Thorn K, 2010, J CELL BIOCHEM, V111, P497, DOI 10.1002/jcb.22734; Veret J, 2011, BIOCHEM J, V438, P177, DOI 10.1042/BJ20101386; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Worgall TS, 2011, ADV EXP MED BIOL, V721, P139, DOI 10.1007/978-1-4614-0650-1_9; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433	66	88	89	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26569	26582		10.1074/jbc.M113.489310	http://dx.doi.org/10.1074/jbc.M113.489310			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23897822	Green Published, hybrid			2022-12-25	WOS:000330594500023
J	Hinkofer, LC; Seidel, SAI; Korkmaz, B; Silva, F; Hummel, AM; Braun, D; Jenne, DE; Specks, U				Hinkofer, Lisa C.; Seidel, Susanne A. I.; Korkmaz, Brice; Silva, Francisco; Hummel, Amber M.; Braun, Dieter; Jenne, Dieter E.; Specks, Ulrich			A Monoclonal Antibody (MCPR3-7) Interfering with the Activity of Proteinase 3 by an Allosteric Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; WEGENERS-GRANULOMATOSIS; SERINE PROTEASES; NEUTROPHIL ELASTASE; CRYSTAL-STRUCTURE; IMMUNE-SYSTEM; CATHEPSIN-G; PR3; AUTOANTIGEN; DISTINCT	Proteinase 3 (PR3) is an abundant serine protease of neutrophil granules and a major target of autoantibodies (PR3 antineutrophil cytoplasmic antibodies) in granulomatosis with polyangiitis. Some of the PR3 synthesized by promyelocytes in the bone marrow escapes the targeting to granules and occurs on the plasma membrane of naive and primed neutrophils. This membrane-associated PR3 antigen may represent pro-PR3, mature PR3, or both forms. To discriminate between mature PR3 and its inactive zymogen, which have different conformations, we generated and identified a monoclonal antibody called MCPR3-7. It bound much better to pro-PR3 than to mature PR3. This monoclonal antibody greatly reduced the catalytic activity of mature PR3 toward extended peptide substrates. Using diverse techniques and multiple recombinant PR3 variants, we characterized its binding properties and found that MCPR3-7 preferentially bound to the so-called activation domain of the zymogen and changed the conformation of mature PR3, resulting in impaired catalysis and inactivation by alpha(1)-proteinase inhibitor (alpha(1)-antitrypsin). Noncovalent as well as covalent complexation between PR3 and alpha(1)-proteinase inhibitor was delayed in the presence of MCPR3-7, but cleavage of certain thioester and paranitroanilide substrates with small residues in the P1 position was not inhibited. We conclude that MCPR3-7 reduces PR3 activity by an allosteric mechanism affecting the S1' pocket and further prime side interactions with substrates. In addition, MCPR3-7 prevents binding of PR3 to cellular membranes. Inhibitory antibodies targeting the activation domain of PR3 could be exploited as highly selective inhibitors of PR3, scavengers, and clearers of the PR3 autoantigen in granulomatosis with polyangiitis.	[Hinkofer, Lisa C.; Korkmaz, Brice; Jenne, Dieter E.] Univ Munich, Univ Hosp, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Hinkofer, Lisa C.; Korkmaz, Brice; Jenne, Dieter E.] Ctr Lung Res DZL, Helmholtz Zentrum Munchen, D-81377 Munich, Germany; [Seidel, Susanne A. I.; Braun, Dieter] Univ Munich, D-80799 Munich, Germany; [Korkmaz, Brice] INSERM, U1100, Ctr Etud Pathol Resp, EA 6305, F-37032 Tours, France; [Silva, Francisco; Hummel, Amber M.; Specks, Ulrich] Mayo Clin & Mayo Fdn, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Rochester, MN 55905 USA; [Silva, Francisco] Pontificia Univ Catolica Chile, Fac Med, Dept Inmunol Clin & Reumatol, Santiago 8330033, Chile; [Jenne, Dieter E.] Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); Mayo Clinic; Pontificia Universidad Catolica de Chile; Max Planck Society	Jenne, DE (corresponding author), Univ Munich, Univ Hosp, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, Max Lebsche Pl 31, D-81377 Munich, Germany.	dieter.jenne@helmholtz-muenchen.de	Jenne, Dieter Erich/AAP-1414-2020; Seidel, Susanne A. I./AAI-2811-2020	KORKMAZ, BRICE/0000-0002-5159-8706	National Institutes of Health [RO1-AR49806, RC1-AR58303]; Vasculitis Clinical Research Consortium [U54-RR019497]; European Union [261382]; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [JE194/4-1, BR2152/2-1]; NanoSystems Initiative Munich; Center for NanoScience; Ludwig-Maximilians-Universitat Munich Initiative Functional Nanosystems; Mayo Clinic Monoclonal Antibody Core Facility; Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049806, RC1AR058303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vasculitis Clinical Research Consortium; European Union(European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NanoSystems Initiative Munich; Center for NanoScience; Ludwig-Maximilians-Universitat Munich Initiative Functional Nanosystems; Mayo Clinic Monoclonal Antibody Core Facility; Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-AR49806 and RC1-AR58303 (to U. S.) and U54-RR019497 from the Vasculitis Clinical Research Consortium (to F. S.). This work was also supported by European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 261382 (INTRICATE), the Alexander von Humboldt Foundation, a joint grant from the Deutsche Forschungsgemeinschaft (JE194/4-1; BR2152/2-1), the NanoSystems Initiative Munich, the Center for NanoScience, the Ludwig-Maximilians-Universitat Munich Initiative Functional Nanosystems, and the Mayo Clinic Monoclonal Antibody Core Facility.; Supported in part by funds from The Mayo Foundation.	CAMPANELLI D, 1990, J EXP MED, V172, P1709, DOI 10.1084/jem.172.6.1709; Capizzi SA, 2003, KIDNEY INT, V63, P756, DOI 10.1046/j.1523-1755.2003.00765.x; CSERNOK E, 1994, CLIN EXP IMMUNOL, V95, P244; CSERNOK E, 1990, AM J PATHOL, V137, P1113; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Fujinaga M, 1996, J MOL BIOL, V261, P267, DOI 10.1006/jmbi.1996.0458; Ganesan R, 2010, BIOCHEM J, V430, P179, DOI 10.1042/BJ20100634; Garwicz D, 1997, J LEUKOCYTE BIOL, V61, P113, DOI 10.1002/jlb.61.1.113; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Hoffman GS, 1998, ARTHRITIS RHEUM-US, V41, P1521, DOI 10.1002/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jenne DE, 2006, CLIN NEPHROL, V66, P153; Kallenberg CGM, 2011, CLIN REV ALLERG IMMU, V41, P224, DOI 10.1007/s12016-011-8258-y; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Korkmaz B, 2008, J BIOL CHEM, V283, P35976, DOI 10.1074/jbc.M806754200; Kuhl A, 2010, J IMMUNOL, V185, P387, DOI 10.4049/jimmunol.0903887; LINDLEY H, 1972, BIOCHEM J, V126, P683, DOI 10.1042/bj1260683; Lone AM, 2010, AAPS J, V12, P483, DOI 10.1208/s12248-010-9208-y; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; Perera NC, 2012, EXPERT REV CLIN IMMU, V8, P501, DOI 10.1586/ECI.12.39; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Rao NV, 1996, J BIOL CHEM, V271, P2972, DOI 10.1074/jbc.271.6.2972; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Seidel SAI, 2012, ANGEW CHEM INT EDIT, V51, P10656, DOI 10.1002/anie.201204268; Silva F, 2010, J AUTOIMMUN, V35, P299, DOI 10.1016/j.jaut.2010.06.021; Specks U, 1996, FEBS LETT, V390, P265, DOI 10.1016/0014-5793(96)00669-2; Sun J, 1998, CLIN EXP IMMUNOL, V114, P320; Sun JY, 1998, J IMMUNOL METHODS, V211, P111, DOI 10.1016/S0022-1759(97)00203-2; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; Wysocka M, 2008, ANAL BIOCHEM, V378, P208, DOI 10.1016/j.ab.2008.04.003; ZIMMER M, 1992, P NATL ACAD SCI USA, V89, P8215, DOI 10.1073/pnas.89.17.8215	38	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26635	26648		10.1074/jbc.M113.495770	http://dx.doi.org/10.1074/jbc.M113.495770			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23902773	hybrid, Green Published			2022-12-25	WOS:000330594500029
J	Kanjarawi, R; Dy, M; Bardel, E; Sparwasser, T; Dubois, B; Mecheri, S; Kaiserlian, D				Kanjarawi, Reem; Dy, Michel; Bardel, Emilie; Sparwasser, Tim; Dubois, Bertrand; Mecheri, Salah; Kaiserlian, Dominique			Regulatory CD4(+)Foxp3(+) T Cells Control the Severity of Anaphylaxis	PLOS ONE			English	Article							IGE RECEPTOR EXPRESSION; IN-VIVO; SELECTIVE DEPLETION; AIRWAY INFLAMMATION; MAST-CELLS; FOXP3(+); MOUSE; MICE; HISTAMINE; INTERLEUKIN-10	Objective: Anaphylaxis is a life-threatening outcome of immediate-type hypersensitivity to allergen, consecutive to mast cell degranulation by allergen-specific IgE. Regulatory T cells (Treg) can control allergic sensitization and mast cell degranulation, yet their clinical benefit on anaphylactic symptoms is poorly documented. Here we investigated whether Treg action during the effector arm of the allergic response alleviates anaphylaxis. Methods: We used a validated model of IgE-mediated passive systemic anaphylaxis, induced by intravenous challenge with DNP-HSA in mice passively sensitized with DNP-specific IgE. Anaphylaxis was monitored by the drop in body temperature as well as plasma histamine and serum mMCP1 levels. The role of Treg was analyzed using MHC class II-deficient (A beta(%)) mice, treatment with anti-CD25 or anti-CD4 mAbs and conditional ablation of Foxp3(+) Treg in DEREG mice. Therapeutic efficacy of Treg was also evaluated by transfer experiments using FoxP3-eGFP knock-in mice. Results: Anaphylaxis did not occur in mast cell-deficient W/W-v mutant mice and was only moderate and transient in mice deficient for histamine receptor-1. Defects in constitutive Treg, either genetic or induced by antibody or toxin treatment resulted in a more severe and/or sustained hypothermia, associated with a rise in serum mMCP1, but not histamine. Adoptive transfer of Foxp3(+) Treg from either naive or DNP-sensitized donors similarly alleviated body temperature loss in Treg-deficient DEREG mice. Conclusion: Constitutive Foxp3(+) Treg can control the symptomatic phase of mast cell and IgE-dependent anaphylaxis in mice. This might open up new therapeutic avenues using constitutive rather than Ag-specific Treg for inducing tolerance in allergic patients.	[Kanjarawi, Reem; Bardel, Emilie; Dubois, Bertrand; Kaiserlian, Dominique] Univ Lyon, Mucosal Immun Vaccinat & Biotherapies Team, Int Ctr Infectiol Res, CIRI, Lyon, France; [Kanjarawi, Reem; Bardel, Emilie; Dubois, Bertrand; Kaiserlian, Dominique] INSERM, U1111, F-69008 Lyon, France; [Kanjarawi, Reem; Bardel, Emilie; Dubois, Bertrand; Kaiserlian, Dominique] Ecole Normale Super Lyon, F-69364 Lyon, France; [Kanjarawi, Reem; Bardel, Emilie; Dubois, Bertrand; Kaiserlian, Dominique] Univ Lyon 1, Ctr Int Rech Infectiol, F-69365 Lyon, France; [Kanjarawi, Reem; Bardel, Emilie; Dubois, Bertrand; Kaiserlian, Dominique] CNRS, UMR5308, Lyon, France; [Dy, Michel] Univ Paris 05, CNRS, Hop Necker, UMR 8147, F-75270 Paris, France; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, Hannover, Germany; [Mecheri, Salah] Inst Pasteur, Unite Biol Interact Hote Parasites, Paris, France; [Mecheri, Salah] CNRS, Unite Rech Associee 2581, Paris, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; Helmholtz-Center for Infection Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Kaiserlian, D (corresponding author), Univ Lyon, Mucosal Immun Vaccinat & Biotherapies Team, Int Ctr Infectiol Res, CIRI, Lyon, France.	dominique.kaiserlian@inserm.fr	Dubois, Bertrand/D-4446-2013; Sparwasser, Tim/AAF-7085-2019; Sparwasser, Tim D/AAA-4306-2022; Mecheri, Salah/M-8315-2013; KAISERLIAN, Dominique/G-3325-2013	Dubois, Bertrand/0000-0002-7859-4975; Sparwasser, Tim/0000-0001-5645-902X; KAISERLIAN, Dominique/0000-0001-6252-4916	"Societe Francaise d'allergologie" (SFA); Fondation pour la Recherche Medicale (FRM); Syrian Ministry of High Education; INSERM; Hospices Civils de Lyon	"Societe Francaise d'allergologie" (SFA); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Syrian Ministry of High Education; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Hospices Civils de Lyon	This work was supported by a grant from "Societe Francaise d'allergologie" (SFA) and from Fondation pour la Recherche Medicale (FRM). Reem Kanjarawi is a recipient of a scholarship from the Syrian Ministry of High Education and post-doctoral fellowships from 'INSERM' and 'Hospices Civils de Lyon'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Baru AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047102; Baru AM, 2010, EUR J IMMUNOL, V40, P2259, DOI 10.1002/eji.200939972; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; Duarte J, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00056; Ganeshan K, 2012, J IMMUNOL, V188, P594, DOI 10.4049/jimmunol.1102389; Gri G, 2008, IMMUNITY, V29, P771, DOI 10.1016/j.immuni.2008.08.018; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; Kanjarawi R, 2011, INT ARCH ALLERGY IMM, V156, P387, DOI 10.1159/000323940; Kashyap M, 2008, J IMMUNOL, V180, P2039, DOI 10.4049/jimmunol.180.4.2039; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kim J, 2009, J IMMUNOL, V183, P7631, DOI 10.4049/jimmunol.0804308; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Makabe-Kobayashi Y, 2002, J ALLERGY CLIN IMMUN, V110, P298, DOI 10.1067/mai.2002.125977; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Meiler F, 2008, ALLERGY, V63, P1455, DOI 10.1111/j.1398-9995.2008.01774.x; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Norton SK, 2008, J IMMUNOL, V180, P2848, DOI 10.4049/jimmunol.180.5.2848; Ozdemir C, 2009, CLIN EXP ALLERGY, V39, P626, DOI 10.1111/j.1365-2222.2009.03242.x; Peavy RD, 2008, CURR OPIN ALLERGY CL, V8, P310, DOI 10.1097/ACI.0b013e3283036a90; Pemberton AD, 2006, J IMMUNOL, V176, P899, DOI 10.4049/jimmunol.176.2.899; Ring S, 2006, EUR J IMMUNOL, V36, P2981, DOI 10.1002/eji.200636207; Satoguina JS, 2005, J IMMUNOL, V174, P4718, DOI 10.4049/jimmunol.174.8.4718; Simons FER, 2009, J ALLERGY CLIN IMMUN, V124, P625, DOI 10.1016/j.jaci.2009.08.025; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; VAZ NM, 1977, INT ARCH ALLER A IMM, V53, P545, DOI 10.1159/000231796; Vocanson M, 2010, J ALLERGY CLIN IMMUN, V126, P280, DOI 10.1016/j.jaci.2010.05.022; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Winbery Stephen L, 2002, Clin Allergy Immunol, V17, P287	36	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69183	10.1371/journal.pone.0069183	http://dx.doi.org/10.1371/journal.pone.0069183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922690	Green Submitted, Green Published, gold			2022-12-25	WOS:000322838900028
J	Roskos, K; Hickerson, AI; Lu, HW; Ferguson, TM; Shinde, DN; Klaue, Y; Niemz, A				Roskos, Kristina; Hickerson, Anna I.; Lu, Hsiang-Wei; Ferguson, Tanya M.; Shinde, Deepali N.; Klaue, Yvonne; Niemz, Angelika			Simple System for Isothermal DNA Amplification Coupled to Lateral Flow Detection	PLOS ONE			English	Article							REAL-TIME PCR; POINT-OF-CARE; TOXIGENIC CLOSTRIDIUM-DIFFICILE; MYCOBACTERIUM-TUBERCULOSIS; STAPHYLOCOCCUS-AUREUS; RAPID DETECTION; DIAGNOSTICS; DEVICE; IDENTIFICATION; FEASIBILITY	Infectious disease diagnosis in point-of-care settings can be greatly improved through integrated, automated nucleic acid testing devices. We have developed an early prototype for a low-cost system which executes isothermal DNA amplification coupled to nucleic acid lateral flow (NALF) detection in a mesofluidic cartridge attached to a portable instrument. Fluid handling inside the cartridge is facilitated through one-way passive valves, flexible pouches, and electrolysis-driven pumps, which promotes a compact and inexpensive instrument design. The closed-system disposable prevents workspace amplicon contamination. The cartridge design is based on standard scalable manufacturing techniques such as injection molding. Nucleic acid amplification occurs in a two-layer pouch that enables efficient heat transfer. We have demonstrated as proof of principle the amplification and detection of Mycobacterium tuberculosis (M.tb) genomic DNA in the cartridge, using either Loop Mediated Amplification (LAMP) or the Exponential Amplification Reaction (EXPAR), both coupled to NALF detection. We envision that a refined version of this cartridge, including upstream sample preparation coupled to amplification and detection, will enable fully-automated sample-in to answer-out infectious disease diagnosis in primary care settings of low-resource countries with high disease burden.	[Roskos, Kristina; Hickerson, Anna I.; Lu, Hsiang-Wei; Shinde, Deepali N.; Klaue, Yvonne; Niemz, Angelika] Keck Grad Inst Appl Life Sci, Claremont, CA USA; [Ferguson, Tanya M.] Claremont BioSolut, Upland, CA USA	Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of Applied Life Sciences	Niemz, A (corresponding author), Keck Grad Inst Appl Life Sci, Claremont, CA USA.	aniemz@kgi.edu		Niemz, Angelika/0000-0001-7385-1541	National Institutes of Health [R01AI076247, R01AI090831]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090831, R01AI076247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this project was provided by the National Institutes of Health through awards R01AI076247 and R01AI090831. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bohm S, 1999, BIOMED MICRODEVICES, V1, P121, DOI 10.1023/A:1009996407848; Boyanton BL, 2012, J CLIN MICROBIOL, V50, P640, DOI 10.1128/JCM.01014-11; Brenwald NP, 2010, J HOSP INFECT, V74, P245, DOI 10.1016/j.jhin.2009.09.007; de Tejada BM, 2010, GYNECOL OBSTET INVES, V70, P250, DOI 10.1159/000314014; Dineva MA, 2005, J CLIN MICROBIOL, V43, P4015, DOI 10.1128/JCM.43.8.4015-4021.2005; Fang RD, 2009, J CLIN MICROBIOL, V47, P845, DOI 10.1128/JCM.01528-08; Goldmeyer J, 2008, J CLIN MICROBIOL, V46, P1534, DOI 10.1128/JCM.02234-07; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hicke B, 2012, J CLIN MICROBIOL, V50, P2681, DOI 10.1128/JCM.00621-12; Ince J, 2009, EXPERT REV MED DEVIC, V6, P641, DOI 10.1586/ERD.09.46; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; Kaltenboeck B, 2005, ADV CLIN CHEM, V40, P219, DOI 10.1016/S0065-2423(05)40006-2; Kim HJ, 2011, J CLIN VIROL, V50, P26, DOI 10.1016/j.jcv.2010.09.006; Lee HH, 2010, J INFECT DIS, V201, pS65, DOI 10.1086/650385; Liu RH, 2006, ANAL CHEM, V78, P1980, DOI 10.1021/ac0518553; Liu RH, 2004, ANAL CHEM, V76, P1824, DOI 10.1021/ac0353029; Liu RH, 2006, ANAL CHEM, V78, P4184, DOI 10.1021/ac060450v; Lu HW, 2013, PROC SPIE, V8615, DOI 10.1117/12.2005164; Mahalanabis M, 2010, BIOMED MICRODEVICES, V12, P353, DOI 10.1007/s10544-009-9391-8; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Mugasa CM, 2009, J CLIN MICROBIOL, V47, P630, DOI 10.1128/JCM.01430-08; Mwaba P, 2011, TROP MED INT HEALTH, V16, P819, DOI 10.1111/j.1365-3156.2011.02777.x; Niemz A, 2012, EXPERT REV MOL DIAGN, V12, P687, DOI [10.1586/ERM.12.71, 10.1586/erm.12.71]; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047; Puren A, 2010, J INFECT DIS, V201, pS27, DOI 10.1086/650390; Puthawibool T, 2009, J VIROL METHODS, V156, P27, DOI 10.1016/j.jviromet.2008.10.018; Raja S, 2005, CLIN CHEM, V51, P882, DOI 10.1373/clinchem.2004.046474; Rand KH, 2011, J CLIN MICROBIOL, V49, P2449, DOI 10.1128/JCM.02582-10; Stevens WS, 2010, J INFECT DIS, V201, pS78, DOI 10.1086/650383; Tan E, 2005, ANAL CHEM, V77, P7984, DOI 10.1021/ac051364i; Tan E, 2007, CLIN CHEM, V53, P2017, DOI 10.1373/clinchem.2007.091116; Tanriverdi S, 2010, J INFECT DIS, V201, pS52, DOI 10.1086/650387; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Vandeventer PE, 2011, J CLIN MICROBIOL, V49, P2533, DOI 10.1128/JCM.02171-10; Wang CH, 2011, LAB CHIP, V11, P1521, DOI 10.1039/c0lc00430h; Wolk DM, 2009, J CLIN MICROBIOL, V47, P3933, DOI 10.1128/JCM.00601-09; Wu QQ, 2011, ANAL CHEM, V83, P3336, DOI 10.1021/ac103129e; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Zhou P, 2010, BIOMED MICRODEVICES, V12, P821, DOI 10.1007/s10544-010-9436-z	45	60	68	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69355	10.1371/journal.pone.0069355	http://dx.doi.org/10.1371/journal.pone.0069355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922706	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900038
J	Leahy, SM; Kingsford, MJ; Steinberg, CR				Leahy, Susannah M.; Kingsford, Michael J.; Steinberg, Craig R.			Do Clouds Save the Great Barrier Reef? Satellite Imagery Elucidates the Cloud-SST Relationship at the Local Scale	PLOS ONE			English	Article							PHOTOSYNTHETICALLY-ACTIVE RADIATION; SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; SOLAR-RADIATION; CORAL-REEFS; PATTERNS; OCEAN; VARIABILITY; SENSITIVITY; MECHANISMS	Evidence of global climate change and rising sea surface temperatures (SSTs) is now well documented in the scientific literature. With corals already living close to their thermal maxima, increases in SSTs are of great concern for the survival of coral reefs. Cloud feedback processes may have the potential to constrain SSTs, serving to enforce an "ocean thermostat" and promoting the survival of coral reefs. In this study, it was hypothesized that cloud cover can affect summer SSTs in the tropics. Detailed direct and lagged relationships between cloud cover and SST across the central Great Barrier Reef (GBR) shelf were investigated using data from satellite imagery and in situ temperature and light loggers during two relatively hot summers (2005 and 2006) and two relatively cool summers (2007 and 2008). Across all study summers and shelf positions, SSTs exhibited distinct drops during periods of high cloud cover, and conversely, SST increases during periods of low cloud cover, with a three-day temporal lag between a change in cloud cover and a subsequent change in SST. Cloud cover alone was responsible for up to 32.1% of the variation in SSTs three days later. The relationship was strongest in both El Nino (2005) and La Nina (2008) study summers and at the inner-shelf position in those summers. SST effects on subsequent cloud cover were weaker and more variable among study summers, with rising SSTs explaining up to 21.6% of the increase in cloud cover three days later. This work quantifies the often observed cloud cooling effect on coral reefs. It highlights the importance of incorporating local-scale processes into bleaching forecasting models, and encourages the use of remote sensing imagery to value-add to coral bleaching field studies and to more accurately predict risks to coral reefs.	[Leahy, Susannah M.; Kingsford, Michael J.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Leahy, Susannah M.; Kingsford, Michael J.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld 4811, Australia; [Steinberg, Craig R.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	James Cook University; James Cook University; Australian Institute of Marine Science	Leahy, SM (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	Susannah.Leahy@my.jcu.edu.au	Kingsford, Michael J/C-2015-2008	Kingsford, Michael J/0000-0003-1704-6198; Leahy, Susannah/0000-0001-8517-201X	Australian Research Council Centre of Excellence for Coral Reef Studies; CRS' relationship; Australian Government's National Collaborative Research Infrastructure Strategy; Super Science Initiative; Australian Institute of Marine Science; Queensland State Government	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); CRS' relationship; Australian Government's National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Super Science Initiative; Australian Institute of Marine Science; Queensland State Government	Work supported by:-Australian Research Council Centre of Excellence for Coral Reef Studies, funding to MJK-Q-IMOS Satellite Remote Sensing funding via CRS' relationship with the Australian Government's National Collaborative Research Infrastructure Strategy, the Super Science Initiative, the Australian Institute of Marine Science, and the Queensland State Government The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Barry R.G., 2003, ATMOSPHERE WEATHER C; BARTON IJ, 1979, AUSTRALAS J DERMATOL, V20, P68; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Bony S, 1997, J CLIMATE, V10, P2055, DOI 10.1175/1520-0442(1997)010<2055:SSTALS>2.0.CO;2; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Broadbent AD, 2002, ESTUAR COAST SHELF S, V55, P547, DOI 10.1006/ecss.2002.1021; Causey BD, 2001, P WORKSH MIT COR BLE, P60; Celliers L, 2002, MAR POLLUT BULL, V44, P1380, DOI 10.1016/S0025-326X(02)00302-8; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Chatfield C, 1980, ANAL TIME SERIES INT; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Deschaseaux E., 2012, P 12 INT COR REEF S; DINESEN Z D, 1983, Coral Reefs, V1, P229, DOI 10.1007/BF00304420; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Eakin CM, 2012, 2012 OC SCI M SALT L; Fischer E, 2012, BIOGEOCHEMISTRY, V110, P31, DOI 10.1007/s10533-012-9719-y; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; FROUIN R, 1995, REMOTE SENS ENVIRON, V51, P98, DOI 10.1016/0034-4257(94)00068-X; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Grant RH, 1996, AGR FOREST METEOROL, V82, P267, DOI 10.1016/0168-1923(95)02327-5; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Jokiel PL, 2004, CORAL HEALTH AND DISEASE, P401; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; Jokiel PL, 1997, LIMNOL OCEANOGR, V42, P1468, DOI 10.4319/lo.1997.42.6.1468; Jones G.B., 1994, RECENT ADV MARINE SC, P183; Jones RN, 2000, CLIMATIC CHANGE, V45, P403, DOI 10.1023/A:1005551626280; King M. D., 1997, ATBDMOD05; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Lau KM, 1997, J CLIMATE, V10, P465, DOI 10.1175/1520-0442(1997)010<0465:MOSTSS>2.0.CO;2; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Liu G, 2006, P 10 INT COR REEF S; Lough J., 2007, CLIMATE CHANGE GREAT, P15; LOUGH JM, 1994, CORAL REEFS, V13, P181, DOI 10.1007/BF00301197; Lough JM, 1999, SEA SURFACE TEMPERAT; Mann KH, 2006, DYNAMICS MARINE ECOS; Masiri I, 2008, INT J REMOTE SENS, V29, P4443, DOI 10.1080/01431160801930255; Maynard JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032175; McClanahan TR, 2007, CORAL REEFS, V26, P695, DOI 10.1007/s00338-006-0193-7; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Modini RL, 2009, ATMOS CHEM PHYS, V9, P7607, DOI 10.5194/acp-9-7607-2009; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; NEWELL RE, 1979, AM SCI, V67, P405; Obura DO, 2005, ESTUAR COAST SHELF S, V63, P353, DOI 10.1016/j.ecss.2004.11.010; Oliver J. K., 2009, V205, P21; Quinn GP, 2003, EXPT DESIGN DATA ANA; RAMANATHAN V, 1991, NATURE, V351, P27, DOI 10.1038/351027a0; Redondo-Rodriguez A, 2012, MAR FRESHWATER RES, V63, P34, DOI 10.1071/MF11151; RUSS G, 1984, MAR ECOL PROG SER, V20, P23, DOI 10.3354/meps020023; Skirving W, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P301; Steinberg C., 2007, CLIMATE CHANGE GREAT, P51; Stephens GL, 2005, J CLIMATE, V18, P237, DOI 10.1175/JCLI-3243.1; Swan H. B., 2012, P 12 INT COR REEF S; Takahashi Y, 2010, ATMOS CHEM PHYS, V10, P1577, DOI 10.5194/acp-10-1577-2010; Tompkins AM, 2001, J CLIMATE, V14, P633, DOI 10.1175/1520-0442(2001)014<0633:OTRBTC>2.0.CO;2; Turner J, 2000, REEFS MAURITIUS; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Underwood AJ, 1997, LANDSCAPE URBAN PLAN, V37, P137, DOI 10.1016/S0169-2046(97)80000-X; Vallina SM, 2007, ENVIRON CHEM, V4, P384, DOI 10.1071/EN07055; Vallina SM, 2007, SCIENCE, V315, P506, DOI 10.1126/science.1133680; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Webb MJ, 2006, CLIM DYNAM, V27, P17, DOI 10.1007/s00382-006-0111-2; Wilkinson C, 1999, AMBIO, V28, P188; WILKINSON CR, 1989, CORAL REEFS, V8, P127, DOI 10.1007/BF00338268; Wilkinson CR, 1999, MAR FRESHWATER RES, V50, P867, DOI 10.1071/MF99121; Williams IN, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039849; Wolanski E., 1994, PHYS OCEANOGRAPHIC P	71	36	36	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70400	10.1371/journal.pone.0070400	http://dx.doi.org/10.1371/journal.pone.0070400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894649	gold, Green Published, Green Accepted			2022-12-25	WOS:000322167900124
J	Thubaut, J; Corbari, L; Gros, O; Duperron, S; Couloux, A; Samadi, S				Thubaut, Justine; Corbari, Laure; Gros, Olivier; Duperron, Sebastien; Couloux, Arnaud; Samadi, Sarah			Integrative Biology of Idas iwaotakii (Habe, 1958), a 'Model Species' Associated with Sunken Organic Substrates	PLOS ONE			English	Article							MUSSEL BATHYMODIOLUS-AZORICUS; NORTH FIJI BASIN; DEEP-SEA; HYDROTHERMAL VENT; GENE FLOW; DUAL SYMBIOSIS; MYTILIDAE; ATLANTIC; BIVALVIA; SEEP	The giant bathymodioline mussels from vents have been studied as models to understand the adaptation of organisms to deep-sea chemosynthetic environments. These mussels are closely related to minute mussels associated to organic remains decaying on the deep-sea floor. Whereas biological data accumulate for the giant mussels, the small mussels remain poorly studied. Despite this lack of data for species living on organic remains it has been hypothesized that during evolution, contrary to their relatives from vents or seeps, they did not acquire highly specialized biological features. We aim at testing this hypothesis by providing new biological data for species associated with organic falls. Within Bathymodiolinae a close phylogenetic relationship was revealed between the Bathymodiolus sensu stricto lineage (i.e. "thermophilus'' lineage) which includes exclusively vent and seep species, and a diversified lineage of small mussels, attributed to the genus Idas, that includes mostly species from organic falls. We selected Idas iwaotakii (Habe, 1958) from this latter lineage to analyse population structure and to document biological features. Mitochondrial and nuclear markers reveal a north-south genetic structure at an oceanic scale in the Western Pacific but no structure was revealed at a regional scale or as correlated with the kind of substrate or depth. The morphology of larval shells suggests substantial dispersal abilities. Nutritional features were assessed by examining bacterial diversity coupled by a microscopic analysis of the digestive tract. Molecular data demonstrated the presence of sulphur-oxidizing bacteria resembling those identified in other Bathymodiolinae. In contrast with most Bathymodiolus s.s. species the digestive tract of I. iwaotakii is not reduced. Combining data from literature with the present data shows that most of the important biological features are shared between Bathymodiolus s.s. species and its sister-lineage. However Bathymodiolus s.s. species are ecologically more restricted and also display a lower species richness than Idas species.	[Thubaut, Justine; Corbari, Laure; Samadi, Sarah] Museum Natl Hist Nat, UPMC IRD MNHN CNRS, UMR 7138, Dept Systemat & Evolut, F-75231 Paris, France; [Gros, Olivier] Univ Antilles Guyane, UMR CNRS 7138, Dept Biol, Pointe a Pitre, Guadeloupe, France; [Duperron, Sebastien] Univ Paris 06, UPMC IRD MNHN CNRS, UMR 7138, Paris, France; [Couloux, Arnaud] Ctr Natl Sequencage, Genoscope, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); Universite des Antilles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Thubaut, J (corresponding author), Museum Natl Hist Nat, UPMC IRD MNHN CNRS, UMR 7138, Dept Systemat & Evolut, F-75231 Paris, France.	thubaut@mnhn.fr	samadi, sarah/G-5011-2010; Duperron, Sebastien/C-4712-2011	samadi, sarah/0000-0003-0725-9368; Corbari, Laure/0000-0002-3323-6162; duperron, sebastien/0000-0002-6422-6821	Fondation pour la Recherche sur la Biodiversite [BioWood AAP-IN-2009-009]; ANR TF-DeepEvo [ANR-12-ISV7-0005-01]	Fondation pour la Recherche sur la Biodiversite; ANR TF-DeepEvo(French National Research Agency (ANR))	This work was developed in the framework of the European research network DiWood (GDRE-CNRS 225), in collaboration with N. Lebris, was supported by a grant of Fondation pour la Recherche sur la Biodiversite (BioWood AAP-IN-2009-009) and by the ANR TF-DeepEvo (ANR-12-ISV7-0005-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Baco-Taylor A., 2002, THESIS; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berger MS, 2006, MAR BIOL, V149, P1397, DOI 10.1007/s00227-006-0310-8; Bettencourt R, 2011, ICES J MAR SCI, V68, P357, DOI 10.1093/icesjms/fsq119; Bouchet Philippe, 2008, P9; CAVANAUGH CM, 1992, APPL ENVIRON MICROB, V58, P3799, DOI 10.1128/AEM.58.12.3799-3803.1992; CRADDOCK C, 1995, MAR BIOL, V124, P137, DOI 10.1007/BF00349155; DEAN HK, 1993, MALACOLOGIA, V35, P21; Deming JW, 1997, MICROSC RES TECHNIQ, V37, P162, DOI 10.1002/(SICI)1097-0029(19970415)37:2<162::AID-JEMT4>3.0.CO;2-Q; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Dixon DR, 2006, J MAR BIOL ASSOC UK, V86, P1363, DOI 10.1017/S0025315406014391; Dubilier N, 1998, MAR ECOL PROG SER, V165, P187, DOI 10.3354/meps165187; Duperron S, 2005, APPL ENVIRON MICROB, V71, P1694, DOI 10.1128/AEM.71.4.1694-1700.2005; Duperron S, 2008, FEMS MICROBIOL ECOL, V63, P338, DOI 10.1111/j.1574-6941.2008.00438.x; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; Duperron S, 2006, ENVIRON MICROBIOL, V8, P1441, DOI 10.1111/j.1462-2920.2006.01038.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faure B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006485; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiala-Medioni A, 2002, MAR BIOL, V141, P1035, DOI 10.1007/s00227-002-0903-9; FISHER CR, 1987, MAR BIOL, V96, P59, DOI 10.1007/BF00394838; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FU YX, 1993, GENETICS, V133, P693; Fujita Yuko, 2009, Venus (Tokyo), V67, P123; Fujiwara Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011808; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Genio L, 2008, J SHELLFISH RES, V27, P53, DOI 10.2983/0730-8000(2008)27[53:NROBMC]2.0.CO;2; Glauert AM, 1975, FIXATION DEHYDRATION; Gros O, 2007, ZOOMORPHOLOGY, V126, P163, DOI 10.1007/s00435-007-0035-3; Gros O, 2007, CAH BIOL MAR, V48, P103; Gustafson RG, 1998, MALACOLOGIA, V40, P63; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hashimoto Jun, 1994, Venus the Japanese Journal of Malacology, V53, P61; HILY A, 1986, CAH BIOL MAR, V27, P235; Hottinger L, 2006, CARNETS GEOLOGIE NOT; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KENK VC, 1985, MALACOLOGIA, V26, P253; LEPENNEC M, 1984, CR ACAD SCI III-VIE, V298, P493; Lorion J, 2012, CAH BIOL MAR, V53, P77; Lorion J, 2010, MOL PHYLOGENET EVOL, V57, P71, DOI 10.1016/j.ympev.2010.05.027; Lorion J, 2009, P ROY SOC B-BIOL SCI, V276, P177, DOI 10.1098/rspb.2008.1101; LUTZ RA, 1984, SCIENCE, V226, P1451, DOI 10.1126/science.226.4681.1451; LUTZ RA, 1980, MAR BIOL, V57, P127, DOI 10.1007/BF00387378; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; Miyazaki JI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010363; O'Mullan GD, 2001, MOL ECOL, V10, P2819, DOI 10.1046/j.1365-294X.2001.t01-1-01401.x; Olu-Le Roy K, 2004, DEEP-SEA RES PT I, V51, P1915, DOI 10.1016/j.dsr.2004.07.004; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; PAGE HM, 1990, MAR BIOL, V104, P251, DOI 10.1007/BF01313266; Pailleret M, 2007, MAR ECOL-EVOL PERSP, V28, P233, DOI 10.1111/j.1439-0485.2006.00149.x; Petersen JM, 2011, NATURE, V476, P176, DOI 10.1038/nature10325; Pile AJ, 1999, LIMNOL OCEANOGR, V44, P1833, DOI 10.4319/lo.1999.44.7.1833; Plouviez S, 2009, MOL ECOL, V18, P3903, DOI 10.1111/j.1365-294X.2009.04325.x; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salerno JL, 2005, BIOL BULL-US, V208, P145, DOI 10.2307/3593123; Samadi S, 2010, CAH BIOL MAR, V51, P459; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Spurr AR, 1969, J ULTRASTRUCT RES, V26, P1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Tregoning P, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000406; Von Cosel R, 1999, VELIGER, V42, P218; von Cosel R, 1998, CR ACAD SCI III-VIE, V321, P655, DOI 10.1016/S0764-4469(98)80005-X; von Cosel Rudo, 2002, Zoosystema, V24, P259; VONCOSEL R, 1994, VELIGER, V37, P374; Vrijenhoek RC, 1997, J HERED, V88, P285, DOI 10.1093/oxfordjournals.jhered.a023106; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Won YJ, 2008, J SHELLFISH RES, V27, P129, DOI 10.2983/0730-8000(2008)27[129:AOCBDM]2.0.CO;2	76	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e69680	10.1371/journal.pone.0069680	http://dx.doi.org/10.1371/journal.pone.0069680			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23894520	Green Published, gold			2022-12-25	WOS:000322167900089
J	Hedrera, MI; Galdames, JA; Jimenez-Reyes, MF; Reyes, AE; Avendano-Herrera, R; Romero, J; Feijoo, CG				Hedrera, Manuel I.; Galdames, Jorge A.; Jimenez-Reyes, Maria F.; Reyes, Ariel E.; Avendano-Herrera, Ruben; Romero, Jaime; Feijoo, Carmen G.			Soybean Meal Induces Intestinal Inflammation in Zebrafish Larvae	PLOS ONE			English	Article							SALMON SALMO-SALAR; TROUT ONCORHYNCHUS-MYKISS; ATLANTIC SALMON; DISTAL INTESTINE; RAINBOW-TROUT; INDUCED ENTERITIS; MODEL; L.; EXPRESSION; RESPONSES	The necessary replacement of fish meal with other protein source in diets of commercially important fish has prompted the study of the effect of the inclusion of different vegetable proteins sources on growth performance and on the gastro-intestinal tract. Currently, soybean meal is the primary protein source as a fish meal replacement because of its low price and high availability. Likewise, it is been documented that the ingestion of soybean meal by several fish species, such as salmonids and carp, triggers a type of intestinal inflammation called enteritis. In this paper, we analyzed the effects of the ingestion of soybean meal and two of its components, soy protein and soy saponin, on zebrafish to establish the basis for using zebrafish larvae as a model for fish nutrition. We took advantage of the existence of different transgenic lines, which allowed us to perform in vivo analysis. Our results indicated that larvae that were feed with soybean meal developed a clear intestinal inflammation as early as two day after beginning the diet. Moreover, we determined that is not the soy protein present in the diet but the soy saponin that is primarily responsible for triggering the immune response. These findings support the use of zebrafish screening assays to identify novel ingredients that would to improved current fish diets or would formulate new ones.	[Hedrera, Manuel I.; Galdames, Jorge A.; Reyes, Ariel E.; Avendano-Herrera, Ruben; Feijoo, Carmen G.] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile; [Jimenez-Reyes, Maria F.; Romero, Jaime] Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago, Chile; [Reyes, Ariel E.; Avendano-Herrera, Ruben] Interdisciplinary Ctr Aquiculture Res INCAR, Concepcion, Chile	Universidad Andres Bello; Universidad de Chile	Feijoo, CG (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile.	cfeijoo@unab.cl	Avendaño-Herrera, Ruben/H-2368-2015; Feijoo, Carmen G/AAF-9003-2019; Romero, Jaime/I-2816-2013	Romero, Jaime/0000-0001-9614-2393; Feijoo, Carmen G/0000-0003-1128-403X; Avendano-Herrera, Ruben/0000-0001-5368-4475	Fondecyt [11090102, 1110253]; Conicyt [79090006]; Fondap-INCAR [15110027]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondap-INCAR(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	Grants for C. G. Feijoo: Fondecyt 11090102; Conicyt 79090006. Grants for J. Romero: Fondecyt 1110253. Grants for A. E. Reyes: Fondap-INCAR 15110027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alestrom P, 2006, TRENDS BIOTECHNOL, V24, P15, DOI 10.1016/j.tibtech.2005.11.004; Alvarez MC, 2007, MAR BIOTECHNOL, V9, P117, DOI 10.1007/s10126-006-6034-4; Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; Bakke-McKellep AM, 2000, J FISH DIS, V23, P115, DOI 10.1046/j.1365-2761.2000.00218.x; Bakke-McKellep AM, 2007, BRIT J NUTR, V97, P699, DOI 10.1017/S0007114507381397; Burrells C, 1999, VET IMMUNOL IMMUNOP, V72, P277, DOI 10.1016/S0165-2427(99)00143-9; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; Feijoo CG, 2009, DEV DYNAM, V238, P2034, DOI 10.1002/dvdy.22006; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; Fleming A, 2010, INFLAMM BOWEL DIS, V16, P1162, DOI 10.1002/ibd.21200; Haffter P, 1996, DEVELOPMENT, V123, P1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knudsen D, 2008, BRIT J NUTR, V100, P120, DOI 10.1017/S0007114507886338; Knudsen D, 2007, J AGR FOOD CHEM, V55, P2261, DOI 10.1021/jf0626967; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Lilleeng E, 2009, FISH SHELLFISH IMMUN, V27, P65, DOI 10.1016/j.fsi.2009.04.007; Liu S, 2011, ANNU REV PATHOL-MECH, V6, P71, DOI 10.1146/annurev-pathol-011110-130330; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; NEW MB, 2002, 975 FAO FISH; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Nordrum S, 2000, COMP BIOCHEM PHYS B, V125, P317, DOI 10.1016/S0305-0491(99)00190-X; Oehlers SH, 2011, DEV DYNAM, V240, P288, DOI 10.1002/dvdy.22519; Panzica-Kelly Julieta M, 2012, Methods Mol Biol, V889, P25, DOI 10.1007/978-1-61779-867-2_4; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Refstie S, 1997, AQUACULTURE, V153, P263, DOI 10.1016/S0044-8486(97)00025-2; Refstie S, 2000, AQUACULTURE, V190, P49, DOI 10.1016/S0044-8486(00)00382-3; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Renshaw SA, 2012, DIS MODEL MECH, V5, P38, DOI 10.1242/dmm.007138; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Sahlmann C, 2013, FISH SHELLFISH IMMUN, V34, P599, DOI 10.1016/j.fsi.2012.11.031; Sukardi H, 2010, ZEBRAFISH, V7, P41, DOI 10.1089/zeb.2009.0636; TACON AJ, 2003, 886 FAO FISH; Uran PA, 2008, AQUACULT NUTR, V14, P324, DOI 10.1111/j.1365-2095.2007.00534.x; Uran PA, 2009, J FISH DIS, V32, P733, DOI 10.1111/j.1365-2761.2009.01049.x; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; vandenIngh TSGAM, 1996, J FISH DIS, V19, P47; VANDENINGH TSGAM, 1991, AQUACULTURE, V94, P297, DOI 10.1016/0044-8486(91)90174-6; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	43	117	122	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69983	10.1371/journal.pone.0069983	http://dx.doi.org/10.1371/journal.pone.0069983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894568	gold, Green Published, Green Submitted			2022-12-25	WOS:000325211000169
J	Pinto, A; Jacobsen, M; Geoghegan, PA; Cangelosi, A; Cejudo, ML; Tironi-Farinati, C; Goldstein, J				Pinto, Alipio; Jacobsen, Mariana; Geoghegan, Patricia A.; Cangelosi, Adriana; Laura Cejudo, Maria; Tironi-Farinati, Carla; Goldstein, Jorge			Dexamethasone Rescues Neurovascular Unit Integrity from Cell Damage Caused by Systemic Administration of Shiga Toxin 2 and Lipopolysaccharide in Mice Motor Cortex	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; ESCHERICHIA-COLI; RISK-FACTORS; MANIFESTATIONS; INFECTION; OUTBREAK; EXPRESSION; DEATH	Shiga toxin 2 (Stx2)-producing Escherichia coli (STEC) causes hemorrhagic colitis and hemolytic uremic syndrome (HUS) that can lead to fatal encephalopathies. Neurological abnormalities may occur before or after the onset of systemic pathological symptoms and motor disorders are frequently observed in affected patients and in studies with animal models. As Stx2 succeeds in crossing the blood-brain barrier (BBB) and invading the brain parenchyma, it is highly probable that the observed neurological alterations are based on the possibility that the toxin may trigger the impairment of the neurovascular unit and/or cell damage in the parenchyma. Also, lipopolysaccharide (LPS) produced and secreted by enterohemorrhagic Escherichia coli (EHEC) may aggravate the deleterious effects of Stx2 in the brain. Therefore, this study aimed to determine (i) whether Stx2 affects the neurovascular unit and parenchymal cells, (ii) whether the contribution of LPS aggravates these effects, and (iii) whether an inflammatory event underlies the pathophysiological mechanisms that lead to the observed injury. The administration of a sublethal dose of Stx2 was employed to study in detail the motor cortex obtained from a translational murine model of encephalopathy. In the present paper we report that Stx2 damaged microvasculature, caused astrocyte reaction and neuronal degeneration, and that this was aggravated by LPS. Dexamethasone, an anti-inflammatory, reversed the pathologic effects and proved to be an important drug in the treatment of acute encephalopathies.	[Pinto, Alipio; Jacobsen, Mariana; Laura Cejudo, Maria; Tironi-Farinati, Carla; Goldstein, Jorge] Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Neurofisiopatol, RA-1425 Buenos Aires, DF, Argentina; [Geoghegan, Patricia A.; Cangelosi, Adriana] ANLIS Dr Carlos G Malbran, CNCCB, Buenos Aires, DF, Argentina	University of Buenos Aires	Goldstein, J (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Neurofisiopatol, Ciudad Autonoma, RA-1425 Buenos Aires, DF, Argentina.	jogol@fmed.uba.ar	Jacobsen, Mariana/N-7059-2016	Jacobsen, Mariana/0000-0002-1736-1107; Goldstein, Jorge/0000-0002-9488-0074	CONICET (National Research Council, Argentina) [PIP114-200801-00497, PIP 112-201101-00901]	CONICET (National Research Council, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	These studies were supported by CONICET (National Research Council, Argentina) Grant PIP114-200801-00497 and PIP 112-201101-00901 (http://www.conicet.gov.ar/web/conicet/) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALE JF, 1980, AM J DIS CHILD, V134, P869, DOI 10.1001/archpedi.1980.02130210053014; Bell BP, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e12; Benderro GF, 2012, BRAIN RES, V1471, P46, DOI 10.1016/j.brainres.2012.06.055; BITZAN M, 1991, J PEDIATR-US, V119, P380, DOI 10.1016/S0022-3476(05)82049-9; Boccoli J, 2008, BRAIN RES, V1230, P320, DOI 10.1016/j.brainres.2008.07.052; BRASHER C, 1981, WESTERN J MED, V134, P193; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; CIMOLAI N, 1992, PEDIATRICS, V90, P616; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; Eriksson KJ, 2001, ARCH DIS CHILD, V84, P434, DOI 10.1136/adc.84.5.434; Exeni R., 2001, ARCH LATIN NEFR PED, V1, P35; Forster C, 2006, J PHYSIOL-LONDON, V573, P413, DOI 10.1113/jphysiol.2006.106385; Fujii J, 1996, INFECT IMMUN, V64, P5053, DOI 10.1128/IAI.64.12.5053-5060.1996; GIANANTONIO CA, 1973, NEPHRON, V11, P174; Goldstein J, 2007, BRAIN RES, V1161, P106, DOI 10.1016/j.brainres.2007.05.067; Grisaru S, 2011, PAED CHILD HEALT-CAN, V16, P337, DOI 10.1093/pch/16.6.337; HAHN JS, 1989, J CHILD NEUROL, V4, P108, DOI 10.1177/088307388900400206; HAMANO S, 1993, ACTA PAEDIATR, V82, P454, DOI 10.1111/j.1651-2227.1993.tb12721.x; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Jacob A, 2007, LAB INVEST, V87, P1186, DOI 10.1038/labinvest.3700686; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; KATZ J, 1971, J PEDIATR-US, V78, P426, DOI 10.1016/S0022-3476(71)80222-6; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khaibullina AA, 2004, DEV BRAIN RES, V148, P59, DOI 10.1016/j.devbrainres.2003.09.022; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; Kita E, 2000, INFECT IMMUN, V68, P1207, DOI 10.1128/IAI.68.3.1207-1214.2000; KOSTER F, 1978, NEW ENGL J MED, V298, P927, DOI 10.1056/NEJM197804272981702; Lindauer ML, 2009, J IMMUNOL, V183, P1419, DOI 10.4049/jimmunol.0901119; Little AR, 2001, NEUROTOXICOLOGY, V22, P607, DOI 10.1016/S0161-813X(01)00032-8; Liu CC, 2000, J PHYSIOL-LONDON, V527, P333, DOI 10.1111/j.1469-7793.2000.t01-1-00333.x; LOUISE CB, 1992, INFECT IMMUN, V60, P1536, DOI 10.1128/IAI.60.4.1536-1543.1992; Mazzetti S, 2004, EUR J HISTOCHEM, V48, P423; Mizuguchi M, 2001, ACTA NEUROPATHOL, V102, P306; Murray CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-50; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; O'Brien AD, 1998, ESCHERICHIA COLI O15, P1; Oakes RS, 2006, PEDIATRICS, V117, P1656, DOI 10.1542/peds.2005-0785; Obata F, 2008, J INFECT DIS, V198, P1398, DOI 10.1086/591911; Obata F, 2010, ADV APPL MICROBIOL, V71, P1, DOI 10.1016/S0065-2164(10)71001-7; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Proulx F, 2001, PEDIATR RES, V50, P163, DOI 10.1203/00006450-200108000-00002; Psotka MA, 2009, INFECT IMMUN, V77, P959, DOI 10.1128/IAI.00679-08; Rivas M, 2003, EMERG INFECT DIS, V9, P1184; Rivas M, 2010, PATHOGENIC ESCHERICH, P142; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROONEY J C, 1971, Proceedings of the Australian Association of Neurologists, V8, P67; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; SAXENA SK, 1989, J BIOL CHEM, V264, P596; SHETH KJ, 1986, ANN NEUROL, V19, P90, DOI 10.1002/ana.410190120; SIEGLER RL, 1994, PEDIATRICS, V94, P35; Siegler RL, 2001, AM J NEPHROL, V21, P420, DOI 10.1159/000046288; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sugatani J, 2000, THROMB RES, V100, P61, DOI 10.1016/S0049-3848(00)00305-4; TAPPER D, 1995, J PEDIATR SURG, V30, P158, DOI 10.1016/0022-3468(95)90554-5; TAYLOR CM, 1986, BRIT MED J, V292, P1513, DOI 10.1136/bmj.292.6534.1513; Tironi-Farinati C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055812; Tironi-Farinati C, 2010, J NEUROIMMUNOL, V222, P48, DOI 10.1016/j.jneuroim.2010.03.001; Ueno M, 2009, CURR NEUROPHARMACOL, V7, P142, DOI 10.2174/157015909788848901; UPADHYAYA K, 1980, PEDIATRICS, V65, P115; Verweyen HM, 1999, INFECTION, V27, P341, DOI 10.1007/s150100050040; Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285; VOYER LE, 1998, TEMAS ZOONOSIS ENFER, P46; Weissenborn K, 2012, NEUROLOGY, V79, P1466, DOI 10.1212/WNL.0b013e31826d5f26; Winter KRK, 2004, INFECT IMMUN, V72, P6680, DOI 10.1128/IAI.72.11.6680-6684.2004; Xing B, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-84; Zhang HW, 1997, J IMMUNOL, V159, P4868; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	71	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70020	10.1371/journal.pone.0070020	http://dx.doi.org/10.1371/journal.pone.0070020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894578	Green Published, gold, Green Submitted			2022-12-25	WOS:000325211000175
J	Driver, AM; Huang, W; Kropp, J; Penagaricano, F; Khatib, H				Driver, Ashley M.; Huang, Wen; Kropp, Jenna; Penagaricano, Francisco; Khatib, Hasan			Knockdown of CDKN1C (p57(kip2)) and PHLDA2 Results in Developmental Changes in Bovine Pre-implantation Embryos	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; IN-VITRO FERTILIZATION; IMPRINTED GENES; GROWTH-RETARDATION; DNA METHYLATION; RNA; EXPRESSION; APOPTOSIS; DIFFERENTIATION; SURVIVAL	Imprinted genes have been implicated in early embryonic, placental, and neonatal development and alterations in expression levels of these genes can lead to growth abnormalities and embryonic lethality. However, little is known about the functions of bovine imprinted genes during the pre-implantation period. Therefore, the objective of this study was to assess the influence of altered expression of imprinted genes on developmental progress of embryos using small interfering RNA (siRNA). Expression levels of 18 imprinted genes (MAGEL2, UBE3A, IGF2R, NAP1L5, TSSC4, PEG3, NDN, CDKN1C, PHLDA2, MKRN3, USP29, NNAT, PEG10, RTL1, IGF2, H19, MIM1, and XIST) were compared between embryos reaching the blastocyst stage and growth-arrested embryos (degenerates) using quantitative real-time PCR (qRT-PCR). Ten genes were found to be differentially expressed between blastocysts and degenerates. The CDKN1C gene showed the highest upregulation in blastocysts whereas PHLDA2 was highly expressed in degenerates. To assess whether the observed differential gene expression was causative or resultant of embryo degeneration, these genes were selected for functional analysis using siRNA. Injection of siRNA specific to PHLDA2 into one-cell zygotes resulted in a substantial increase in blastocyst development, whereas injection of CDKN1C-specific siRNA resulted in a 45% reduction (P = 0.0006) in blastocyst development. RNA-Seq analysis of CDKN1C-siRNA-injected vs. non-injected embryos revealed 51 differentially expressed genes with functions in apoptosis, lipid metabolism, differentiation, and cell cycle regulation. Gene ontology analysis revealed nine pathways related to cell signaling, metabolism, and nucleic acid processing. Overall, our results show that proper expression levels of the imprinted genes CDKN1C and PHLDA2 are critical for embryo development, which suggests that these genes can be used as markers for normal blastocyst formation.	[Driver, Ashley M.; Huang, Wen] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Huang, Wen] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Kropp, Jenna; Penagaricano, Francisco; Khatib, Hasan] Univ Wisconsin, Dept Anim Sci, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; North Carolina State University; University of Wisconsin System; University of Wisconsin Madison	Khatib, H (corresponding author), Univ Wisconsin, Dept Anim Sci, Madison, WI 53715 USA.	hkhatib@wisc.edu	Peñagaricano, Francisco/C-8083-2015; Huang, Wen/B-5005-2011; Khatib, Hasan/AAA-2693-2021	Peñagaricano, Francisco/0000-0001-6661-3991; Huang, Wen/0000-0001-6788-8364	USDA Hatch grant from the University of Wisconsin-Madison [PRJ16JH]	USDA Hatch grant from the University of Wisconsin-Madison	This research was funded by USDA Hatch grant No. PRJ16JH from the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-53; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bobetsis YA, 2010, J REPROD IMMUNOL, V85, P140, DOI 10.1016/j.jri.2010.04.001; Bressan FF, 2009, PLACENTA, V30, P823, DOI 10.1016/j.placenta.2009.07.007; Chen CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033538; Cheriyath V, 2011, J INTERF CYTOK RES, V31, P173, DOI 10.1089/jir.2010.0105; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Driver AM, 2009, J DAIRY SCI, V92, P4082, DOI 10.3168/jds.2009-2013; Driver AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-118; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Fauque P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-116; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gicquel C, 2006, HORM RES, V65, P28, DOI 10.1159/000091503; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Hansen PJ, 2007, THERIOGENOLOGY, V68, pS242, DOI 10.1016/j.theriogenology.2007.04.008; Harvey AJ, 2002, REPRODUCTION, V123, P479, DOI 10.1530/rep.0.1230479; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Huang E, 2010, NAT CELL BIOL, V12, P563, DOI 10.1038/ncb2058; Huang W, 2010, ANIM GENET, V41, P570, DOI 10.1111/j.1365-2052.2010.02046.x; HUANG W, 2010, BMC GENOMICS, V11; Huang W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-711; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; Kawamura C, 2002, LEUKEMIA LYMPHOMA, V43, P635, DOI 10.1080/10428190290012182; Khatib H, 2008, J DAIRY SCI, V91, P784, DOI 10.3168/jds.2007-0669; Khatib H, 2009, J DAIRY SCI, V92, P2238, DOI 10.3168/jds.2008-1767; Kues WA, 2008, PNAS, V106, P1679; Lee KB, 2009, ENDOCRINOLOGY, V150, P2463, DOI 10.1210/en.2008-1574; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Liu JH, 2008, MOL REPROD DEV, V75, P598, DOI 10.1002/mrd.20803; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manrique C, 2009, J BIOTECHNOL, V142, P185, DOI 10.1016/j.jbiotec.2009.05.009; Morton KM, 2007, MOL REPROD DEV, V74, P931, DOI 10.1002/mrd.20573; Nganvongpanit K, 2006, REPRODUCTION, V131, P861, DOI 10.1530/rep.1.01040; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; O'Meara CM, 2011, REPROD FERT DEVELOP, V23, P534, DOI 10.1071/RD10175; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Pateras IS, 2009, MOL CANCER RES, V7, P1902, DOI 10.1158/1541-7786.MCR-09-0317; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Roth Z, 2004, BIOL REPROD, V71, P1898, DOI 10.1095/biolreprod.104.031690; Salas M, 2004, MECH DEVELOP, V121, P1199, DOI 10.1016/j.mod.2004.05.017; Sartori R, 2002, J DAIRY SCI, V85, P2803, DOI 10.3168/jds.S0022-0302(02)74367-1; Sasaki H, 2010, DEV GROWTH DIFFER, V52, P263, DOI 10.1111/j.1440-169X.2009.01158.x; Schrock GE, 2007, J DAIRY SCI, V90, P4297, DOI 10.3168/jds.2007-0002; Seweryn Ewa, 2007, Postepy Hig Med Dosw (Online), V61, P672; Stein M, 2010, MOL BIOSYST, V6, P162, DOI 10.1039/b912398a; Sudheer Smita, 2007, Briefings in Functional Genomics & Proteomics, V6, P120, DOI 10.1093/bfgp/elm012; Suteevun-Phermthai T, 2009, ANIM REPROD SCI, V116, P19, DOI 10.1016/j.anireprosci.2009.01.003; Tesfaye D, 2010, REPRODUCTION, V139, P857, DOI 10.1530/REP-09-0312; Thurston A, 2008, REPRODUCTION, V135, P29, DOI 10.1530/REP-07-0211; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripurani SK, 2011, ENDOCRINOLOGY, V152, P1013, DOI 10.1210/en.2010-1134; Tunster SJ, 2010, MOL CELL BIOL, V30, P295, DOI 10.1128/MCB.00662-09; Tury A, 2011, CEREB CORTEX, V21, P1840, DOI 10.1093/cercor/bhq254; Tveden-Nyborg PY, 2008, THERIOGENOLOGY, V70, P1119, DOI 10.1016/j.theriogenology.2008.06.033; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; Williams CA, 2005, BRAIN DEV-JPN, V27, P88, DOI 10.1016/j.braindev.2003.09.014; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yang L, 2005, MOL REPROD DEV, V71, P431, DOI 10.1002/mrd.20311; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	67	18	19	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69490	10.1371/journal.pone.0069490	http://dx.doi.org/10.1371/journal.pone.0069490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894493	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100063
J	Pamphlett, R; Cheong, PL; Trent, RJ; Yu, B				Pamphlett, Roger; Cheong, Pak Leng; Trent, Ronald J.; Yu, Bing			Can ALS-Associated C9orf72 Repeat Expansions Be Diagnosed on a Blood DNA Test Alone?	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GGGGCC HEXANUCLEOTIDE REPEAT; FRONTOTEMPORAL DEMENTIA; MUTATIONS; DISEASE; BRAIN; MOSAICISM; NUMBER; GENES; ONSET	Gene mutations that preferentially affect the CNS have been implicated in a number of neurological disorders. This leads to the possibility that a disease-causing mutation present only in CNS tissues could be missed if it were tested in a blood DNA sample only. The commonest mutation in amyotrophic lateral sclerosis (ALS) is an expansion of the hexanucleotide repeats of C9orf72. To find out if CNS-specific mutations of this gene could cause some cases of ALS we looked for differences in the size of C9orf72 repeats between DNA from the CNS and from white blood cells (WBCs) of 38 sporadic ALS patients, using a repeat-primed PCR screening test. We also looked for differences in C9orf72 repeats in WBC DNA from 6 ALS-discordant and 1 ALS-concordant monozygotic twins. Abnormally expanded C9orf72 repeats were found in 13% of the ALS CNS samples, as well as in their paired WBC DNA. The 87% of ALS CNS samples with normal-sized C9orf72 repeats had the same number of repeats in paired WBC samples. All ALS-discordant twins had the same normal numbers of WBC C9orf72 repeats. Although previous work suggests some tissue mosaicism in C9orf72 repeat size is probably present, this study indicates that this is not likely to be of sufficient magnitude to result in a normal C9orf72 repeat length in blood but an abnormally expanded repeat length in the CNS. This suggests that a blood DNA test alone will usually be sufficient to make a diagnosis of C9orf72 repeat-related ALS.	[Pamphlett, Roger] Univ Sydney, Sydney Med Sch, Dept Pathol, Stacey Motor Neuron Dis Lab, Sydney, NSW 2006, Australia; [Cheong, Pak Leng; Trent, Ronald J.; Yu, Bing] Univ Sydney, Royal Prince Alfred Hosp, Dept Mol & Clin Genet, Sydney, NSW 2006, Australia; [Cheong, Pak Leng; Trent, Ronald J.; Yu, Bing] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Pamphlett, R (corresponding author), Univ Sydney, Sydney Med Sch, Dept Pathol, Stacey Motor Neuron Dis Lab, Sydney, NSW 2006, Australia.	roger.pamphlett@sydney.edu.au	Cheong, Pak Leng/D-3603-2013	Cheong, Pak Leng/0000-0002-0095-4459; Yu, Bing/0000-0001-6013-5220	MND Research Institute of Australia; Aimee Stacey and Burnett bequests	MND Research Institute of Australia; Aimee Stacey and Burnett bequests	This work was supported by the MND Research Institute of Australia and the Aimee Stacey and Burnett bequests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464; Beck JA, 2004, HUM MOL GENET, V13, P1219, DOI 10.1093/hmg/ddh134; Belzil VV, 2012, J NEUROL NEUROSUR PS, V83, P1133, DOI 10.1136/jnnp-2012-303127; Boeve BF, 2012, BRAIN, V135, P765, DOI 10.1093/brain/aws004; Buchman VL, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-12; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; Chio A, 2012, NEUROLOGY, V79, P1983, DOI 10.1212/WNL.0b013e3182735d36; Chio A, 2012, BRAIN, V135, P784, DOI 10.1093/brain/awr366; Conte A, 2012, J NEUROL NEUROSUR PS, V83, P1201, DOI 10.1136/jnnp-2012-302897; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Fogh I, 2007, NEUROGENETICS, V8, P235, DOI 10.1007/s10048-007-0092-2; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Hashida H, 1997, ANN NEUROL, V41, P505, DOI 10.1002/ana.410410414; Luquin N, 2008, NEUROMUSCULAR DISORD, V18, P545, DOI 10.1016/j.nmd.2008.04.013; Luquin N, 2010, AMYOTROPH LATERAL SC, V11, P76, DOI 10.3109/17482960802572699; Luquin N, 2009, NEUROMUSCULAR DISORD, V19, P696, DOI 10.1016/j.nmd.2009.07.005; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Mitchell JD, 2000, AMYOTROPH LATERAL SC, V1, P235, DOI 10.1080/14660820050515061; Morahan JM, 2009, AMYOTROPH LATERAL SC, V10, P418, DOI 10.3109/17482960802635397; Pamphlett R, 2004, MED HYPOTHESES, V62, P679, DOI 10.1016/j.mehy.2003.11.023; Pamphlett R, 2012, NEUROREPORT, V23, P556, DOI 10.1097/WNR.0b013e3283544718; Pamphlett R, 2011, J CLIN NEUROSCI, V18, P1231, DOI 10.1016/j.jocn.2010.12.049; Pamphlett R, 2011, MUSCLE NERVE, V44, P492, DOI 10.1002/mus.22095; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Saunderson RB, 2008, J NEUROL SCI, V267, P125, DOI 10.1016/j.jns.2007.10.006; Shaw PJ, 1997, NEUROREPORT, V8, P3923, DOI 10.1097/00001756-199712220-00016; SORIANO P, 1986, CELL, V46, P19, DOI 10.1016/0092-8674(86)90856-1; Tan QH, 2010, FUNCT INTEGR GENOMIC, V10, P321, DOI 10.1007/s10142-010-0160-9; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Vadlamudi L, 2010, NEW ENGL J MED, V363, P1335, DOI 10.1056/NEJMoa0910752; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	32	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2013	8	7							e70007	10.1371/journal.pone.0070007	http://dx.doi.org/10.1371/journal.pone.0070007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191CY	23894576	gold, Green Submitted, Green Published			2022-12-25	WOS:000322391400076
J	Lu, HD; Lv, LL; Dai, YH; Wu, G; Zhao, HQ; Zhang, FC				Lu, Huading; Lv, Lulu; Dai, Yuhu; Wu, Gang; Zhao, Huiqing; Zhang, Fucheng			Porous Chitosan Scaffolds with Embedded Hyaluronic Acid/Chitosan/Plasmid-DNA Nanoparticles Encoding TGF-beta 1 Induce DNA Controlled Release, Transfected Chondrocytes, and Promoted Cell Proliferation	PLOS ONE			English	Article							NONVIRAL GENE DELIVERY; MESENCHYMAL STEM-CELLS; IN-VITRO; PLASMID DNA; TRANSFORMING GROWTH-FACTOR-BETA-1; ACTIVATED MATRIX; MOLECULAR-WEIGHT; CARTILAGE; REGENERATION; EFFICIENCY	Cartilage defects resulting from traumatic injury or degenerative diseases have very limited spontaneous healing ability. Recent progress in tissue engineering and local therapeutic gene delivery systems has led to promising new strategies for successful regeneration of hyaline cartilage. In the present study, tissue engineering and local therapeutic gene delivery systems are combined with the design of a novel gene-activated matrix (GAM) embedded with hybrid hyaluronic acid(HA)/chitosan(CS)/plasmid-DNA nanoparticles encoding transforming growth factor (TGF)-beta 1. A chitosan scaffold functioned as the three-dimensional carrier for the nanoparticles. Results demonstrated that scaffold-entrapped plasmid DNA was released in a sustained and steady manner over 120 days, and was effectively protected in the HA/CS/pDNA nanoparticles. Culture results demonstrated that chondrocytes grown in the novel GAM were highly proliferative and capable of filling scaffold micropores with cells and extracellular matrix. Confocal laser scanning microscopy indicated that chondrocytes seeded in the GAM expressed exogenous transgenes labeled with green fluorescent protein. ELISA results demonstrated detectable TGF-beta 1 expression in the supernatant of GAM cultures, which peaked at the sixth day of culture and afterwards showed a moderate decline. Histological results and biochemical assays confirmed promotion of chondrocyte proliferation. Cell culture indicated no affects on phenotypic expression of ECM molecules, such as GAG. The results of this study indicate the suitability of this novel GAM for enhanced in vitro cartilage tissue engineering.	[Lu, Huading; Lv, Lulu; Dai, Yuhu; Zhao, Huiqing] Sun Yat Sen Univ, Dept Orthoped, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Gang] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Zhang, Fucheng] Sun Yat Sen Univ, Cent Lab, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; South China University of Technology; Sun Yat Sen University	Lu, HD (corresponding author), Sun Yat Sen Univ, Dept Orthoped, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	johnniehuading@163.com	Wu, Gang/A-1149-2009	Wu, Gang/0000-0002-4730-4971; ZHU, Chao-Dong/0000-0002-9347-3178	National Natural Science Foundation of China [30600632]; Basic Research Project of China [2012CB619105]; Natural Science Foundation of Guangdong Province, China [S2011010004808]; Science and Technology Projects of Guangdong Province, China [2010B060900029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of China; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Projects of Guangdong Province, China	This work was supported by grants from the National Natural Science Foundation of China (No. 30600632); the Basic Research Project of China (No. 2012CB619105); the Natural Science Foundation of Guangdong Province, China (No. S2011010004808); and the Science and Technology Projects of Guangdong Province, China (No. 2010B060900029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnaghi MA, 2009, BIOMATERIALS, V30, P5260, DOI 10.1016/j.biomaterials.2009.07.018; Bachmann G, 2004, RADIOLOGE, V44, P773, DOI 10.1007/s00117-004-1084-y; Bachrach G, 2006, J BIOMED MATER RES A, V77A, P811, DOI 10.1002/jbm.a.30675; Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; de la Fuente M, 2008, INVEST OPHTH VIS SCI, V49, P2016, DOI 10.1167/iovs.07-1077; Diao HJ, 2009, TISSUE ENG PT A, V15, P2687, DOI [10.1089/ten.tea.2008.0621, 10.1089/ten.TEA.2008.0621]; Duceppe N, 2009, BIOMATERIALS, V30, P2625, DOI 10.1016/j.biomaterials.2009.01.017; Elder SH, 2003, METH MOL B, V238, P41; Elisseeff J, 2001, J ORTHOP RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7; Endo M, 2006, TISSUE ENG, V12, P489, DOI 10.1089/ten.2006.12.489; Gao Y, 2008, INT J PHARMACEUT, V359, P241, DOI 10.1016/j.ijpharm.2008.03.037; Guo CA, 2007, J BIOSCI BIOENG, V103, P547, DOI 10.1263/jbb.103.547; Guo T, 2006, BIOMATERIALS, V27, P1095, DOI 10.1016/j.biomaterials.2005.08.015; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kumar MNVR, 2004, EXPERT OPIN BIOL TH, V4, P1213, DOI 10.1517/14712598.4.8.1213; Kuo YC, 2011, COLLOID SURFACE B, V84, P63, DOI 10.1016/j.colsurfb.2010.12.021; Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029; Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057; Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6; Lu HD, 2011, INT J PHARMACEUT, V420, P358, DOI 10.1016/j.ijpharm.2011.08.046; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004; Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083; Peng L, 2009, J BIOMED MATER RES A, V90A, P564, DOI 10.1002/jbm.a.32117; Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3; Rex TS, 2004, HUM GENE THER, V15, P960, DOI 10.1089/hum.2004.15.960; Sezer AD, 2009, AAPS PHARMSCITECH, V10, P1193, DOI 10.1208/s12249-009-9324-0; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; Shi DH, 2005, CHINESE MED J-PEKING, V118, P1436; Storrie H, 2006, ADV DRUG DELIVER REV, V58, P500, DOI 10.1016/j.addr.2006.03.004; Suh JKF, 2000, BIOMATERIALS, V21, P2589; Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080; Trentin D, 2005, J CONTROL RELEASE, V102, P263, DOI 10.1016/j.jconrel.2004.09.029; Ueno H, 2001, BIOMATERIALS, V22, P2125, DOI 10.1016/S0142-9612(00)00401-4; Wang S, 2000, J DENT RES, V79, P701, DOI 10.1177/00220345000790020201; Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013; Zhang XL, 2006, BIOCHEM BIOPH RES CO, V341, P202, DOI 10.1016/j.bbrc.2005.12.171; Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106; Zhao QQ, 2009, BIOL PHARM BULL, V32, P706, DOI 10.1248/bpb.32.706; Zhao X, 2006, J CONTROL RELEASE, V112, P223, DOI 10.1016/j.jconrel.2006.01.016; Zheng F, 2007, LIFE SCI, V80, P388, DOI 10.1016/j.lfs.2006.09.040	42	80	85	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69950	10.1371/journal.pone.0069950	http://dx.doi.org/10.1371/journal.pone.0069950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23894564	Green Submitted, Green Published, gold			2022-12-25	WOS:000325211000167
J	Lin, YT; Wu, YH; Tseng, CK; Lin, CK; Chen, WC; Hsu, YC; Lee, JC				Lin, Ying-Ting; Wu, Yu-Hsuan; Tseng, Chin-Kai; Lin, Chun-Kuang; Chen, Wei-Chun; Hsu, Yao-Chin; Lee, Jin-Ching			Green Tea Phenolic Epicatechins Inhibit Hepatitis C Virus Replication via Cycloxygenase-2 and Attenuate Virus-Induced Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; (-)-EPIGALLOCATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; RNA REPLICATION; CELL-CULTURE; INFECTION; EXPRESSION; CYCLOOXYGENASE-2; CATECHINS; SYSTEM	Chronic hepatitis C virus (HCV) infection is the leading risk factor for hepatocellular carcinoma (HCC) and chronic liver disease worldwide. Green tea, in addition to being consumed as a healthy beverage, contains phenolic catechins that have been used as medicinal substances. In the present study, we illustrated that the epicatechin isomers (+)-epicatechin and (-)-epicatechin concentration-dependently inhibited HCV replication at nontoxic concentrations by using in vitro cell-based HCV replicon and JFH-1 infectious systems. In addition to significantly suppressing virus-induced cyclooxygenase-2 (COX-2) expression, our results revealed that the anti-HCV activity of the epicatechin isomers occurred through the down-regulation of COX-2. Furthermore, both the epicatechin isomers additively inhibited HCV replication in combination with either interferon-alpha or viral enzyme inhibitors [2'-C-methylcytidine (NM-107) or telaprevir]. They also had prominent anti-inflammatory effects by inhibiting the gene expression of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, and inducible nitrite oxide synthase as well as the COX-2 in viral protein-expressing hepatoma Huh-7 cells. Collectively, (+)-epicatechin and (-)-epicatechin may serve as therapeutic supplements for treating HCV-related diseases.	[Lin, Ying-Ting; Wu, Yu-Hsuan; Tseng, Chin-Kai; Lin, Chun-Kuang; Chen, Wei-Chun; Lee, Jin-Ching] Kaohsiung Med Univ, Dept Biotechnol, Coll Life Sci, Kaohsiung, Taiwan; [Hsu, Yao-Chin] ChiMei Med Ctr, Dept Chinese Med, Tainan, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University	Hsu, YC (corresponding author), ChiMei Med Ctr, Dept Chinese Med, Tainan, Taiwan.	cmh7100@mail.chimei.org.tw; jclee@kmu.edu.tw	Putra, Dedi Fazriansyah/E-3111-2017; Zabidii, Wan/AAB-3381-2020	Putra, Dedi Fazriansyah/0000-0003-2896-1949; Lee, Jin-Ching/0000-0003-0729-9589; Wu, Yu-Hsuan/0000-0002-2175-3867; Morni, Wan Zabidii Wan/0000-0002-5595-7964	 [NSC 101-2113-M-037-010];  [NSC 101-2311-B-037-002-MY3];  [KMUER014];  [97CM-KMU-13]	; ; ; 	NSC 101-2113-M-037-010, NSC 101-2311-B-037-002-MY3 (http://web1.nsc.gov.tw/), KMUER014, 97CM-KMU-13 (http://www2.kmu.edu.tw/index.phtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Bassit Leda, 2008, Antiviral Chemistry & Chemotherapy, V19, P25; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Chang LK, 2003, BIOCHEM BIOPH RES CO, V301, P1062, DOI 10.1016/S0006-291X(03)00067-6; Chen C, 2012, ARCH VIROL; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Corbeil CR, 2008, J CHEM INF MODEL, V48, P902, DOI 10.1021/ci700398h; Dong-rui Ma, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P914; Friedman M, 2007, MOL NUTR FOOD RES, V51, P116, DOI 10.1002/mnfr.200600173; Gee J, 2008, UROL ONCOL-SEMIN ORI, V26, P641, DOI 10.1016/j.urolonc.2007.05.015; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gretton S, 2010, J GEN VIROL, V91, P671, DOI 10.1099/vir.0.016899-0; Halfon P, 2012, LIVER INT, V32, P79, DOI 10.1111/j.1478-3231.2011.02716.x; Hamza A, 2006, J PHYS CHEM B, V110, P2910, DOI 10.1021/jp0550762; Ho HY, 2009, J AGR FOOD CHEM, V57, P6140, DOI 10.1021/jf901128u; Hou DX, 2007, ARCH BIOCHEM BIOPHYS, V460, P67, DOI 10.1016/j.abb.2007.01.009; Ikeda M, 2007, ADV DRUG DELIVER REV, V59, P1277, DOI 10.1016/j.addr.2007.03.021; Isaacs CE, 2011, ANTIMICROB AGENTS CH, V55, P5646, DOI 10.1128/AAC.05531-11; Jesudian Arun B, 2012, Gastroenterol Hepatol (N Y), V8, P91; Jiang YF, 2011, CELL BIOL INT, V35, P1225, DOI 10.1042/CBI20110102; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Laurie SA, 2005, CANCER CHEMOTH PHARM, V55, P33, DOI 10.1007/s00280-004-0859-1; Lee JC, 2011, J VIRAL HEPATITIS, V18, pE315, DOI 10.1111/j.1365-2893.2010.01424.x; Lee JC, 2003, ANAL BIOCHEM, V316, P162, DOI 10.1016/S0003-2697(03)00053-8; Lee JC, 2011, ANTIVIR RES, V89, P35, DOI 10.1016/j.antiviral.2010.11.003; Lee JC, 2010, ANAL BIOCHEM, V403, P52, DOI 10.1016/j.ab.2010.04.004; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li Jianxiang, 2001, Zhonghua Yufang Yixue Zazhi, V35, P404; Li Shenwei, 2010, Antiviral Chemistry & Chemotherapy, V20, P239, DOI 10.3851/IMP1597; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Matthews Carolyn M, 2010, Proc (Bayl Univ Med Cent), V23, P142; Morinaga S, 2007, J GASTROEN HEPATOL, V22, P1249, DOI 10.1111/j.1440-1746.2006.04367.x; Nunez O, 2004, GUT, V53, P1665, DOI 10.1136/gut.2003.038364; Okamoto Mika, 2009, Antivir Chem Chemother, V20, P47, DOI 10.3851/IMP1372; Pan KL, 2009, ANTIMICROB AGENTS CH, V53, P4825, DOI 10.1128/AAC.00601-09; Park CM, 2010, FOOD CHEM TOXICOL, V48, P1255, DOI 10.1016/j.fct.2010.02.019; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Roh C, 2011, TALANTA, V85, P2639, DOI 10.1016/j.talanta.2011.08.035; Sakaki M, 2010, HEPATOL RES, V40, P1219, DOI 10.1111/j.1872-034X.2010.00727.x; Salloum S, 2012, TRANSL RES, V159, P421, DOI 10.1016/j.trsl.2011.12.007; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schaefer Martin, 2008, Curr Drug Abuse Rev, V1, P177; Shanafelt TD, 2012, CANCER; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; TAZAWA R, 1994, BIOCHEM BIOPH RES CO, V203, P190, DOI 10.1006/bbrc.1994.2167; Trujillo-Murillo K, 2007, J VIRAL HEPATITIS, V14, P608, DOI 10.1111/j.1365-2893.2006.00837.x; Trujillo-Murillo K, 2008, HEPATOLOGY, V47, P1462, DOI 10.1002/hep.22215; Tseng CK, 2011, ANAL BIOCHEM, V418, P50, DOI 10.1016/j.ab.2011.06.042; Weber JM, 2003, ANTIVIR RES, V58, P167, DOI 10.1016/S0166-3542(02)00212-7; Wohlfarth C, 2009, ACTA PHARMACOL SIN, V30, P25, DOI 10.1038/aps.2008.5; Wu KM, 2010, REGUL TOXICOL PHARM, V56, P1, DOI 10.1016/j.yrtph.2009.09.012; Zuo GY, 2007, ANTIVIR RES, V76, P86, DOI 10.1016/j.antiviral.2007.06.001	55	138	142	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54466	10.1371/journal.pone.0054466	http://dx.doi.org/10.1371/journal.pone.0054466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365670	Green Submitted, Green Published, gold			2022-12-25	WOS:000314023600058
J	Kjellberg, MA; Mattjus, P				Kjellberg, Matti A.; Mattjus, Peter			Glycolipid Transfer Protein Expression Is Affected by Glycosphingolipid Synthesis	PLOS ONE			English	Article							BREFELDIN-A; CERAMIDE GALACTOSYLTRANSFERASE; MEMBRANE-PROTEIN; STRUCTURAL BASIS; GOLGI-APPARATUS; PDMP BLOCKS; FFAT MOTIF; GLUCOSYLCERAMIDE; TRANSPORT; ER	Members of the glycolipid transfer protein superfamily (GLTP) are found from animals and fungi to plants and red microalga. Eukaryotes that encode the glucosylceramide synthase responsible for the synthesis of glucosylceramide, the precursor for most glycosphingolipids, also produce GLTPs. Cells that does not synthesize glucosylceramide neither express GLTPs. Based on this genetic relationship there must be a strong correlation between the synthesis of glucosylceramide and GLTPs. To regulate the levels of glycolipids we have used inhibitors of intracellular trafficking, glycosphingolipid synthesis and degradation, and small interfering RNA to down-regulate the activity of glucosylceramide synthase activity. We found that GLTP expression, both at the mRNA and protein levels, is elevated in cells that accumulate glucosylceramide. Monensin and brefeldin A block intracellular vesicular transport mechanisms. Brefeldin A treatment leads to accumulation of newly synthesized glucosylceramide, galactosylceramide and lactosylceramide in a fused endoplasmic reticulum-Golgi complex. On the other hand, inhibiting glycosphingolipid degradation with conduritol-B-epoxide, that generates glucosylceramide accumulation in the lysosomes, did not affect the levels of GLTP. However, glycosphingolipid synthesis inhibitors like PDMP, NB-DNJ and myriocin, all decreased glucosylceramide and GLTP below normal levels. We also found that an 80% loss of glucosylceramide due to glucosylceramide synthase knockdown resulted in a significant reduction in the expression of GLTP. We show here that interfering with membrane trafficking events and simple neutral glycosphingolipid synthesis will affect the expression of GLTP. We postulate that a change in the glucosylceramide balance causes a response in the GLTP expression, and put forward that GLTP might play a role in lipid directing and sensing of glucosylceramide at the ER-Golgi interface.	[Kjellberg, Matti A.; Mattjus, Peter] Abo Akad Univ, Dept Biosci, Turku, Finland	Abo Akademi University	Mattjus, P (corresponding author), Abo Akad Univ, Dept Biosci, Turku, Finland.	Peter.Mattjus@abo.fi	Mattjus, Peter/ABE-3596-2021; Mattjus, Peter/AAQ-7531-2021	Mattjus, Peter/0000-0001-8991-5933; 	Academy of Finland; Sigrid Juselius Foundation; Abo Akademi University; Magnus Ehrnrooths stiftelse; Medicinska Understodsforeningen Liv och Halsa r.f.	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Abo Akademi University; Magnus Ehrnrooths stiftelse; Medicinska Understodsforeningen Liv och Halsa r.f.	This work was supported by the Academy of Finland, Sigrid Juselius Foundation, Abo Akademi University, Magnus Ehrnrooths stiftelse and Medicinska Understodsforeningen Liv och Halsa r.f. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Allende ML, 2000, GLYCOBIOLOGY, V10, P1025, DOI 10.1093/glycob/10.10.1025; BASU S, 1973, J BIOL CHEM, V248, P1388; Bosio A, 1996, GENOMICS, V34, P69, DOI 10.1006/geno.1996.0242; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; BROWN RE, 1985, CHEM PHYS LIPIDS, V38, P79, DOI 10.1016/0009-3084(85)90059-3; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Burger KNJ, 1996, J CELL BIOL, V133, P15, DOI 10.1083/jcb.133.1.15; CHATTERJEE S, 1987, BIOCHIM BIOPHYS ACTA, V923, P136, DOI 10.1016/0304-4165(87)90136-X; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; De Matteis MA, 1999, FEBS LETT, V459, P310, DOI 10.1016/S0014-5793(99)01269-7; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; DUKSIN D, 1982, J BIOL CHEM, V257, P3105; FARRER RG, 1995, J NEUROCHEM, V65, P1865; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 2010, P JPN ACAD B-PHYS, V86, P426, DOI 10.2183/pjab.86.426; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; KALLEN KJ, 1993, BIOCHEM J, V289, P307, DOI 10.1042/bj2890307; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kok JW, 1998, J CELL BIOL, V142, P25, DOI 10.1083/jcb.142.1.25; Lannert H, 1998, J BIOL CHEM, V273, P2939, DOI 10.1074/jbc.273.5.2939; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maccioni HJF, 1999, BBA-MOL CELL BIOL L, V1437, P101, DOI 10.1016/S1388-1981(99)00002-5; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; Mikitova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030455; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; NEWBURG DS, 1986, BIOCHIM BIOPHYS ACTA, V877, P121, DOI 10.1016/0005-2760(86)90126-8; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Saito K, 2006, APPL MICROBIOL BIOT, V71, P515, DOI 10.1007/s00253-005-0187-3; SASAKI T, 1990, EXPERIENTIA, V46, P611, DOI 10.1007/BF01939700; SAUPE S, 1994, P NATL ACAD SCI USA, V91, P5927, DOI 10.1073/pnas.91.13.5927; SCHWARZMANN G, 1990, BIOCHEMISTRY-US, V29, P10865, DOI 10.1021/bi00501a001; Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; TRINCHERA M, 1989, J BIOL CHEM, V264, P15766; Tuuf J, 2007, BBA-MOL CELL BIOL L, V1771, P1353, DOI 10.1016/j.bbalip.2007.09.001; Tuuf J, 2009, BIOCHEM BIOPH RES CO, V388, P395, DOI 10.1016/j.bbrc.2009.08.023; van Meer G, 2002, J BIOL CHEM, V277, P25855, DOI 10.1074/jbc.R200010200; VANECHTEN G, 1990, EUR J CELL BIOL, V51, P135; WARNOCK DE, 1994, P NATL ACAD SCI USA, V91, P2708, DOI 10.1073/pnas.91.7.2708; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; West G, 2008, FEBS J, V275, P3421, DOI 10.1111/j.1742-4658.2008.06498.x; YAMADA K, 1986, BIOCHIM BIOPHYS ACTA, V879, P345; Zou X, 2010, J BIOL CHEM IN PRESS	52	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70283	10.1371/journal.pone.0070283	http://dx.doi.org/10.1371/journal.pone.0070283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	29220844	Green Submitted, gold, Green Published			2022-12-25	WOS:000322167900115
J	Li, YJ; Kakinami, C; Li, Q; Yang, BJ; Li, HW				Li, Yujia; Kakinami, Cherie; Li, Qi; Yang, Baojun; Li, Hongwei			Human Apolipoprotein A-I Is Associated with Dengue Virus and Enhances Virus Infection through SR-BI	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HIGH-DENSITY-LIPOPROTEINS; ACUTE-PHASE RESPONSE; HEMORRHAGIC-FEVER; CHOLESTEROL EFFLUX; ENTRY; RECEPTOR; CELLS; PROTEIN; SERUM	Diseases caused by dengue virus (DV) infection vary in severity, with symptoms ranging from mild fever to life threatening dengue hemorrhage fever (DHF) and dengue shock syndrome (DSS). Clinical studies have shown that significant decrease in the level of lipoproteins is correlated with severe illness in DHF/DSS patients. Available evidence also indicates that lipoproteins including high-density lipoprotein (HDL) and low-density lipoprotein (LDL) are able to facilitate cell entry of HCV or other flaviviruses via corresponding lipoprotein receptors. In this study, we found that pre-incubation of DV with human serum leads to an enhanced DV infectivity in various types of cells. Such enhancement could be due to interactions between serum components and DV particles. Through co-immunoprecipitation we revealed that apolipoprotein A-I (ApoAI), the major protein component in HDL, is associated with DV particles and is able to promote DV infection. Based on that observation, we further found that siRNA knockdown of the scavenger receptor class B type I (SR-BI), the cell receptor of ApoA-I, abolished the activity of ApoA-I in enhancement of DV infection. This suggests that ApoA-I bridges DV particles and cell receptor SR-BI and facilitates entry of DV into cells. FACS analysis of cell surface dengue antigen after virus absorption further confirmed that ApoA-I enhances DV infection via promoting initial attachment of the virus to cells. These findings illustrate a novel entry route of DV into cells, which may provide insights into the functional importance of lipoproteins in dengue pathogenesis.	[Li, Yujia; Kakinami, Cherie; Li, Qi; Yang, Baojun; Li, Hongwei] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Li, HW (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.	hli@hawaii.edu			National Institute of General Medical Sciences of the National Institutes of Health [P20GM103516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by grant number P20GM103516 from the National Institute of General Medical Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Albuquerque LM, 2009, J PROTEOME RES, V8, P5431, DOI 10.1021/pr900236f; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andreo U, 2007, CELL MICROBIOL, V9, P2445, DOI 10.1111/j.1462-5822.2007.00972.x; Burger Danielle, 2002, Autoimmunity Reviews, V1, P111, DOI 10.1016/S1568-9972(01)00018-0; Cabana VG, 1997, PEDIATR RES, V42, P651, DOI 10.1203/00006450-199711000-00017; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Frank PG, 2000, J LIPID RES, V41, P853; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HASE T, 1989, ARCH VIROL, V104, P129, DOI 10.1007/BF01313814; Hidari Kazuya I P J, 2011, Trop Med Health, V39, P37, DOI 10.2149/tmh.2011-S03; Kelley JF, 2012, VIROLOGY, V422, P326, DOI 10.1016/j.virol.2011.10.030; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Kiss RS, 2005, J LIPID RES, V46, P1877, DOI 10.1194/jlr.M400482-JLR200; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Lim HY, 1999, ARCH VIROL, V144, P989, DOI 10.1007/s007050050561; Liu SF, 2012, HEPATOLOGY, V56, P484, DOI 10.1002/hep.25665; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Marcel YL, 2003, CURR OPIN LIPIDOL, V14, P151, DOI 10.1097/00041433-200304000-00006; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Salas-Benito J, 2007, AM J TROP MED HYG, V77, P283, DOI 10.4269/ajtmh.2007.77.283; Schmitz J, 2011, VACCINE, V29, P7276, DOI 10.1016/j.vaccine.2011.07.017; Se-Thoe SY, 2000, J MED VIROL, V62, P364, DOI 10.1002/1096-9071(200011)62:3&lt;364::AID-JMV9&gt;3.0.CO;2-S; Singh IP, 1999, ANTIVIR RES, V42, P211, DOI 10.1016/S0166-3542(99)00032-7; van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539; Van Lenten BJ, 2006, ARTERIOSCL THROM VAS, V26, P1687, DOI 10.1161/01.ATV.0000232522.47018.a6; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Voisset C, 2006, J GEN VIROL, V87, P2577, DOI 10.1099/vir.0.81932-0; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; Zhu XW, 2012, ANNU REV NUTR, V32, P161, DOI 10.1146/annurev-nutr-071811-150709	38	423	429	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70390	10.1371/journal.pone.0070390	http://dx.doi.org/10.1371/journal.pone.0070390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	24260400	gold, Green Submitted, Green Published			2022-12-25	WOS:000322167900123
J	Goblirsch, M; Huang, ZY; Spivak, M				Goblirsch, Mike; Huang, Zachary Y.; Spivak, Marla			Physiological and Behavioral Changes in Honey Bees (Apis mellifera) Induced by Nosema ceranae Infection	PLOS ONE			English	Article							DIVISION-OF-LABOR; JUVENILE-HORMONE; HYPOPHARYNGEAL GLANDS; WORKER HONEYBEES; EUSOCIAL INSECT; LIFE-SPAN; COLONIES; MICROSPORIDIA; VITELLOGENIN; PHEROMONE	Persistent exposure to mite pests, poor nutrition, pesticides, and pathogens threaten honey bee survival. In healthy colonies, the interaction of the yolk precursor protein, vitellogenin (Vg), and endocrine factor, juvenile hormone (JH), functions as a pacemaker driving the sequence of behaviors that workers perform throughout their lives. Young bees perform nursing duties within the hive and have high Vg and low JH; as older bees transition to foraging, this trend reverses. Pathogens and parasites can alter this regulatory network. For example, infection with the microsporidian, Nosema apis, has been shown to advance behavioral maturation in workers. We investigated the effects of infection with a recent honey bee pathogen on physiological factors underlying the division of labor in workers. Bees infected with N. ceranae were nearly twice as likely to engage in precocious foraging and lived 9 days less, on average, compared to controls. We also show that Vg transcript was low, while JH titer spiked, in infected nurse-aged bees in cages. This pattern of expression is atypical and the reverse of what would be expected for healthy, non-infected bees. Disruption of the basic underpinnings of temporal polyethism due to infection may be a contributing factor to recent high colony mortality, as workers may lose flexibility in their response to colony demands.	[Goblirsch, Mike; Spivak, Marla] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	University of Minnesota System; University of Minnesota Twin Cities; Michigan State University	Goblirsch, M (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	goblirmj@umn.edu	Huang, Zachary/D-5485-2011; Spivak, Marla/AAI-5088-2020	Huang, Zachary/0000-0001-5354-5547; 	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)-Coordinated Agricultural Project (CAP); North Central Region Sustainable Agriculture Research and Education (NCR-SARE); Eastern Apicultural Society	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)-Coordinated Agricultural Project (CAP); North Central Region Sustainable Agriculture Research and Education (NCR-SARE); Eastern Apicultural Society	This research was supported by a United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)-Coordinated Agricultural Project (CAP) grant awarded to MS and ZH and research grants from North Central Region Sustainable Agriculture Research and Education (NCR-SARE) and the Eastern Apicultural Society awarded to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Amdam GV, 2011, NEUROBIOLOGY BEHAV H, P17; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Ares AM, 2012, J CHROMATOGR B, V899, P146, DOI 10.1016/j.jchromb.2012.05.016; Aronstein KA, 2011, J APICULT RES, V50, P145, DOI 10.3896/IBRA.1.50.2.06; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Blaser M, 2005, J INVERTEBR PATHOL, V89, P251, DOI 10.1016/j.jip.2005.04.004; Botias C, 2012, J INVERTEBR PATHOL, V110, P108, DOI 10.1016/j.jip.2012.02.014; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; HASSANEIN MH, 1953, ANN APPL BIOL, V40, P418, DOI 10.1111/j.1744-7348.1953.tb01093.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Hurd H, 2001, P ROY SOC B-BIOL SCI, V268, P1749, DOI 10.1098/rspb.2001.1729; KAATZ HH, 1992, J COMP PHYSIOL B, V162, P588, DOI 10.1007/BF00296638; Medici SK, 2012, PARASITOL RES, V110, P859, DOI 10.1007/s00436-011-2566-2; LIU TP, 1990, TISSUE CELL, V22, P533, DOI 10.1016/0040-8166(90)90081-J; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; PAGE RE, 1992, BEHAV ECOL, V3, P173, DOI 10.1093/beheco/3.2.173; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sakagami SF, 1968, RES POPUL ECOL, V10; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; SEELEY TD, 1983, BEHAV ECOL SOCIOBIOL, V12, P253, DOI 10.1007/BF00290778; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; SOLTER LF, 1990, J INVERTEBR PATHOL, V55, P337, DOI 10.1016/0022-2011(90)90076-I; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Traver BE, 2012, J INVERTEBR PATHOL, V109, P187, DOI 10.1016/j.jip.2011.11.001; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; WANG DI, 1970, J ECON ENTOMOL, V63, P1539, DOI 10.1093/jee/63.5.1539; WANG DI, 1969, J INVERTEBR PATHOL, V14, P135, DOI 10.1016/0022-2011(69)90098-6; WINSTON ML, 1987, BIOL HONEY BEE, P89; Woyciechowski M, 2009, INSECT SOC, V56, P193, DOI 10.1007/s00040-009-0012-6	53	194	201	4	166	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58165	10.1371/journal.pone.0058165	http://dx.doi.org/10.1371/journal.pone.0058165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483987	Green Published, gold			2022-12-25	WOS:000316936100082
J	Petersen, JL; Mickelson, JR; Cothran, EG; Andersson, LS; Axelsson, J; Bailey, E; Bannasch, D; Binns, MM; Borges, AS; Brama, P; Machado, AD; Distl, O; Felicetti, M; Fox-Clipsham, L; Graves, KT; Guerin, G; Haase, B; Hasegawa, T; Hemmann, K; Hill, EW; Leeb, T; Lindgren, G; Lohi, H; Lopes, MS; McGivney, BA; Mikko, S; Orr, N; Penedo, MCT; Piercy, RJ; Raekallio, M; Rieder, S; Roed, KH; Silvestrelli, M; Swinburne, J; Tozaki, T; Vaudin, M; Wade, CM; McCue, ME				Petersen, Jessica L.; Mickelson, James R.; Cothran, E. Gus; Andersson, Lisa S.; Axelsson, Jeanette; Bailey, Ernie; Bannasch, Danika; Binns, Matthew M.; Borges, Alexandre S.; Brama, Pieter; Machado, Artur da Camara; Distl, Ottmar; Felicetti, Michela; Fox-Clipsham, Laura; Graves, Kathryn T.; Guerin, Gerard; Haase, Bianca; Hasegawa, Telhisa; Hemmann, Karin; Hill, Emmeline W.; Leeb, Tosso; Lindgren, Gabriella; Lohi, Hannes; Lopes, Maria Susana; McGivney, Beatrice A.; Mikko, Sofia; Orr, Nicholas; Penedo, M. Cecilia T.; Piercy, Richard J.; Raekallio, Marja; Rieder, Stefan; Roed, Knut H.; Silvestrelli, Maurizio; Swinburne, June; Tozaki, Teruaki; Vaudin, Mark; Wade, Claire M.; McCue, Molly E.			Genetic Diversity in the Modern Horse Illustrated from Genome-Wide SNP Data	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GENETICS; MICROSATELLITE DIVERSITY; LINKAGE DISEQUILIBRIUM; DOMESTICATION; PROGRAM; ORIGINS; INFERENCE; LINEAGES; NUMBER	Horses were domesticated from the Eurasian steppes 5,000-6,000 years ago. Since then, the use of horses for transportation, warfare, and agriculture, as well as selection for desired traits and fitness, has resulted in diverse populations distributed across the world, many of which have become or are in the process of becoming formally organized into closed, breeding populations (breeds). This report describes the use of a genome-wide set of autosomal SNPs and 814 horses from 36 breeds to provide the first detailed description of equine breed diversity. FST calculations, parsimony, and distance analysis demonstrated relationships among the breeds that largely reflect geographic origins and known breed histories. Low levels of population divergence were observed between breeds that are relatively early on in the process of breed development, and between those with high levels of within-breed diversity, whether due to large population size, ongoing outcrossing, or large within-breed phenotypic diversity. Populations with low within-breed diversity included those which have experienced population bottlenecks, have been under intense selective pressure, or are closed populations with long breed histories. These results provide new insights into the relationships among and the diversity within breeds of horses. In addition these results will facilitate future genome-wide association studies and investigations into genomic targets of selection.	[Petersen, Jessica L.; Mickelson, James R.; McCue, Molly E.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Cothran, E. Gus] Texas A&M Univ, Coll Vet Med & Biomed Sci, College Stn, TX USA; [Andersson, Lisa S.; Axelsson, Jeanette; Lindgren, Gabriella; Mikko, Sofia] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Bailey, Ernie; Graves, Kathryn T.] Univ Kentucky, Dept Vet Sci, Lexington, KY USA; [Bannasch, Danika; Penedo, M. Cecilia T.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Binns, Matthew M.] Equine Anal, Midway, KY USA; [Borges, Alexandre S.] Univ Estadual Paulista, Dept Vet Clin Sci, Botucatu, SP, Brazil; [Brama, Pieter] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Machado, Artur da Camara; Lopes, Maria Susana] Univ Azores, Inst Biotechnol & Bioengn, Biotechnol Ctr Azores, Angra Do Heroismo, Portugal; [Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Felicetti, Michela; Silvestrelli, Maurizio] Univ Perugia, Fac Vet Med, I-06100 Perugia, Italy; [Fox-Clipsham, Laura; Swinburne, June; Vaudin, Mark] Anim Hlth Trust, Newmarket, Suffolk, England; [Guerin, Gerard] French Natl Inst Agr Res, Anim Genet & Integrat Biol Unit, Jouy En Josas, France; [Haase, Bianca; Wade, Claire M.] Univ Sydney, Sydney, NSW 2006, Australia; [Hasegawa, Telhisa] Nihon Bioresource Coll, Koga, Ibaraki, Japan; [Hemmann, Karin; Lohi, Hannes; Raekallio, Marja] Univ Helsinki, Fac Vet Med, Helsinki, Finland; [Hill, Emmeline W.; McGivney, Beatrice A.] Univ Coll Dublin, Coll Agr Food Sci & Vet Med, Dublin 2, Ireland; [Leeb, Tosso] Univ Bern, Inst Genet, Bern, Switzerland; [Orr, Nicholas] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Piercy, Richard J.] Univ London Royal Vet Coll, Comparat Neuromuscular Dis Lab, London, England; [Rieder, Stefan] Swiss Natl Stud Farm, Agroscope Liebefeld Posieux Res Stn, Avenches, Switzerland; [Roed, Knut H.] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Swinburne, June] Anim DNA Diagnost Ltd, Cambridge, England; [Tozaki, Teruaki] Lab Racing Chem, Dept Mol Genet, Utsunomiya, Tochigi, Japan	University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Swedish University of Agricultural Sciences; University of Kentucky; University of California System; University of California Davis; Universidade Estadual Paulista; University College Dublin; Universidade dos Acores; University of Veterinary Medicine Hannover, Foundation; University of Perugia; Animal Health Trust; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Sydney; University of Helsinki; University College Dublin; University of Bern; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University of London Royal Veterinary College; Swiss Federal Research Station Agroscope; Norwegian University of Life Sciences	Petersen, JL (corresponding author), Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA.	jlpeters@umn.edu	da Câmara Machado, Artur/J-8668-2013; Raekallio, Marja/I-1606-2019; Lopes, Maria Susana/AAH-6614-2021; Bailey, Ernest/M-1859-2018; Borges, Alexandre S/B-5506-2013; Bannasch, Danika/GZL-8044-2022; Lopes, Maria/J-5379-2013; Mikko, Sofia/F-1347-2017; Leeb, Tosso/G-3187-2014; Tozaki, Teruaki/ABD-9286-2021; Petersen, Jessica/ABF-2462-2020; Lohi, Hannes/F-4596-2011	da Câmara Machado, Artur/0000-0002-6098-502X; Raekallio, Marja/0000-0002-2653-003X; Bailey, Ernest/0000-0001-8246-9117; Lopes, Maria/0000-0003-1170-9771; Mikko, Sofia/0000-0002-6375-1376; Leeb, Tosso/0000-0003-0553-4880; Tozaki, Teruaki/0000-0001-8797-6644; Petersen, Jessica/0000-0001-5438-8555; Lohi, Hannes/0000-0003-1087-5532; Waud, Bianca/0000-0001-6493-9808; Bannasch, Danika/0000-0002-7614-7207; Hill, Emmeline/0000-0002-1805-2250; McCue, Molly/0000-0002-6807-0318; Hemmann, Karin/0000-0003-3981-4231; Lindgren, Gabriella/0000-0001-6046-9669; Mickelson, James/0000-0001-6951-0234; Secorun Borges, Alexandre/0000-0001-6256-8089; Wade, Claire/0000-0003-3413-4771	National Research Initiative from the United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [2008-35205-18766, 2009-55205-05254, 2012-67015-19432]; Foundation for the Advancement of the Tennessee Walking Show Horse; Tennessee Walking Horse Foundation; National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIHNAIMS) [1K08AR055713-01A2, 2T32AR007612]; American Quarter Horse Foundation; Morris Animal Foundation [D07EQ-500]; Swedish Research Council FORMAS [221-2009-1631, 2008-617]; Swedish-Norwegian Foundation for Equine Research [H0847211, H0947256]; Carl Tryggers Stiftelse [CTS 08: 29]; FCT; DRCT; Science Foundation Ireland [04/Y11/B539]; Volkswagen Stiftung und Niedersa chsisches Ministerium fur Wissenschaft und Kultur, Germany [VWZN2012];  [FRCT/2011/317/005]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055713, T32AR007612] Funding Source: NIH RePORTER	National Research Initiative from the United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA); Foundation for the Advancement of the Tennessee Walking Show Horse; Tennessee Walking Horse Foundation; National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIHNAIMS); American Quarter Horse Foundation; Morris Animal Foundation; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish-Norwegian Foundation for Equine Research; Carl Tryggers Stiftelse; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); DRCT; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Volkswagen Stiftung und Niedersa chsisches Ministerium fur Wissenschaft und Kultur, Germany; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Research Initiative Competitive Grants 2008-35205-18766, 2009-55205-05254, and 2012-67015-19432 from the United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA); Foundation for the Advancement of the Tennessee Walking Show Horse and Tennessee Walking Horse Foundation; National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIHNAIMS) grant 1K08AR055713-01A2 (MEM salary support), and 2T32AR007612 (JLP salary support), American Quarter Horse Foundation grant "Selective Breeding Practices in the American Quarter Horse: Impact on Health and Disease 2011-2012''; Morris Animal Foundation Grant D07EQ-500; The Swedish Research Council FORMAS (Contract 221-2009-1631 and 2008-617); The Swedish-Norwegian Foundation for Equine Research (Contract H0847211 and H0947256); The Carl Tryggers Stiftelse (Contract CTS 08: 29); IBB-CBA-UAc, was supported by FCT and DRCT and MSL by FRCT/2011/317/005; Science Foundation Ireland Award (04/Y11/B539) to EWH; Volkswagen Stiftung und Niedersa chsisches Ministerium fur Wissenschaft und Kultur, Germany (VWZN2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle KS, 2004, ANIM GENET, V35, P270, DOI 10.1111/j.1365-2052.2004.01166.x; Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Achmann R, 2004, ANIM GENET, V35, P285, DOI 10.1111/j.1365-2052.2004.01157.x; Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Belkhir KP, 2001, GENTETIX LOGICIEL WI; Binns MM, 2012, ANIM GENET, V43, P340, DOI 10.1111/j.1365-2052.2011.02259.x; Bjornstad G, 2000, J ANIM BREED GENET, V117, P307, DOI 10.1046/j.1439-0388.2000.00264.x; Bjornstad G, 2003, ANIM GENET, V34, P55, DOI 10.1046/j.1365-2052.2003.00922.x; Bomcke E, 2011, GENET MOL BIOL, V34, P68, DOI 10.1590/S1415-47572010005000113; Bower MA, 2012, ARCHAEOMETRY, V54, P916, DOI 10.1111/j.1475-4754.2012.00666.x; Bower MA, 2011, BIOL LETTERS, V7, P316, DOI 10.1098/rsbl.2010.0800; Bowling AT, 2000, GENETICS HORSE, Vviii; Canon J, 2000, ANIM GENET, V31, P39, DOI 10.1046/j.1365-2052.2000.00591.x; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Conant EK, 2012, ANIM GENET, V43, P53, DOI 10.1111/j.1365-2052.2011.02210.x; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Corbin LJ, 2010, ANIM GENET, V41, P8, DOI 10.1111/j.1365-2052.2010.02092.x; Cothran EG, 2011, GENET MOL RES, V10, P2394, DOI 10.4238/2011.October.7.1; COTHRAN EG, 1987, ANIM GENET, V18, P285, DOI 10.1111/j.1365-2052.1987.tb00772.x; Cunningham EP, 2001, ANIM GENET, V32, P360, DOI 10.1046/j.1365-2052.2001.00785.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Felicetti M, 2010, ANIM GENET, V41, P53, DOI 10.1111/j.1365-2052.2010.02102.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Firouz L, 1969, BIOL CONSERV, V1, P1; FLETCHER JL, 1946, J HERED, V37, P369, DOI 10.1093/oxfordjournals.jhered.a105563; GATES S, 1979, MAMMAL REV, V9, P3, DOI 10.1111/j.1365-2907.1979.tb00228.x; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Glowatzki-Mullis ML, 2006, ANIM GENET, V37, P33, DOI 10.1111/j.1365-2052.2005.01376.x; Goloboff P., 2003, SYST BIOL, V54, P176; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Hendricks B., 2007, INT ENCY HORSE BREED; Hund A., 2008, PARASITE IMMUNOL, V20, P73; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Keyser-Tracqui C, 2005, ANIM GENET, V36, P203, DOI 10.1111/j.1365-2052.2005.01316.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lei CZ, 2009, ANIM GENET, V40, P933, DOI 10.1111/j.1365-2052.2009.01950.x; Leroy G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-5; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lindgren G, 2004, NAT GENET, V36, P335, DOI 10.1038/ng1326; Ling YH, 2010, J HERED, V101, P639, DOI 10.1093/jhered/esq047; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Lira J, 2010, MOL ECOL, V19, P64, DOI 10.1111/j.1365-294X.2009.04430.x; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Lopes MS, 2011, MOL TOOLS CHARACTERI; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; Luis C, 2007, ANIM GENET, V38, P20, DOI 10.1111/j.1365-2052.2006.01545.x; Lynghaug F, 2009, OFFICIAL HORSE BREED; MACCLUER JW, 1983, J HERED, V74, P394, DOI 10.1093/oxfordjournals.jhered.a109824; Mackay-Smith A, 2000, SPEED THOROUGHBRED C, Vxxvii; Marletta D, 2006, J ANIM BREED GENET, V123, P315, DOI 10.1111/j.1439-0388.2006.00603.x; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; McGahern A, 2006, ANIM GENET, V37, P494, DOI 10.1111/j.1365-2052.2006.01495.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Peilieu C, 1984, FAO ANIMAL PRODUCTIO, V46, P1; Petersen JL, 2012, PLOS GENET IN PRESS; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Shasavarani H, 2010, AFR J BIOTECHNOL, V9, P293; Silvestrelli M, 1991, ANIMAL GENETIC RESOU, V8, P74; Solis A, 2005, J HERED, V96, P670, DOI 10.1093/jhered/esi123; Ticklen M, 2006, GET KNOW FINNHORSE; Tozaki T, 2003, J HERED, V94, P374, DOI 10.1093/jhered/esg079; Tryon RC, 2009, JAVMA-J AM VET MED A, V234, P120, DOI 10.2460/javma.234.1.120; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Warmuth V, 2013, ANIM GENET, V44, P53, DOI 10.1111/j.1365-2052.2012.02371.x; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Weatherby and Sons, 1791, INTR GEN STUD BOOK; Weatherley L, 1978, GREAT HORSES BRITAIN, Vviii; WEIR BS, 1980, GENETICS, V95, P477; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245	81	165	176	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54997	10.1371/journal.pone.0054997	http://dx.doi.org/10.1371/journal.pone.0054997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383025	Green Published, gold, Green Accepted			2022-12-25	WOS:000315563800095
J	Wang, JF; Hu, MG; Xu, CD; Christakos, G; Zhao, Y				Wang, Jin-Feng; Hu, Mao-Gui; Xu, Cheng-Dong; Christakos, George; Zhao, Yu			Estimation of Citywide Air Pollution in Beijing	PLOS ONE			English	Article							PARTICULATE MATTER; SOURCE APPORTIONMENT; AMBIENT AIR; PM2.5; PM10; PARTICLES; QUALITY; ATMOSPHERE; ILLNESS	There has been discrepancies between the daily air quality reports of the Beijing municipal government, observations recorded at the U. S. Embassy in Beijing, and Beijing residents' perceptions of air quality. This study estimates Beijing's daily area PM2.5 mass concentration by means of a novel technique SPA (Single Point Areal Estimation) that uses data from the single PM2.5 observation station of the U. S Embassy and the 18 PM10 observation stations of the Beijing Municipal Environmental Protection Bureau. The proposed technique accounts for empirical relationships between different types of observations, and generates best linear unbiased pollution estimates (in a statistical sense). The technique extends the daily PM2.5 mass concentrations obtained at a single station (U. S. Embassy) to a citywide scale using physical relations between pollutant concentrations at the embassy PM2.5 monitoring station and at the 18 official PM10 stations that are evenly distributed across the city. Insight about the technique's spatial estimation accuracy (uncertainty) is gained by means of theoretical considerations and numerical validations involving real data. The technique was used to study citywide PM2.5 pollution during the 423-day period of interest (May 10, 2010 to December 6, 2011). Finally, a freely downloadable software library is provided that performs all relevant calculations of pollution estimation.	[Wang, Jin-Feng; Hu, Mao-Gui; Xu, Cheng-Dong; Zhao, Yu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Christakos, George] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Zhao, Yu] Cent S Univ, Sch Geosci & Infophys, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; California State University System; San Diego State University; Central South University	Wang, JF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	wangjf@lreis.ac.cn	Hu, Maogui/N-7105-2013; xu, chengdong/O-8200-2017	Hu, Maogui/0000-0002-7671-7863; xu, chengdong/0000-0002-9266-7309; Wang, Jinfeng/0000-0002-6687-9420; Christakos, George/0000-0002-1865-5764	NSFC [41023010, 41271404]; MOST [2012CB955503, 2011AA120305]; CAS [XDA05090102]; Yongqian Chair Professorship (Zhejiang University, China)	NSFC(National Natural Science Foundation of China (NSFC)); MOST; CAS(Chinese Academy of Sciences); Yongqian Chair Professorship (Zhejiang University, China)	This study was supported by the following grants: NSFC (41023010; 41271404), MOST (2012CB955503; 2011AA120305) and CAS (XDA05090102). George Christakos was supported by a Yongqian Chair Professorship (Zhejiang University, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Bayraktar H, 2010, STOCH ENV RES RISK A, V24, P57, DOI 10.1007/s00477-008-0299-2; BJ-EPB, 2011, BEIJ MUN ENV PROT BU; Brook JR, 1997, J AIR WASTE MANAGE, V47, P2, DOI 10.1080/10473289.1997.10464407; Christakos G, 1998, ATMOS ENVIRON, V32, P2845, DOI 10.1016/S1352-2310(98)00407-5; Fu BJ, 2008, SCIENCE, V321, P611, DOI 10.1126/science.1162213; Gomiscek B, 2004, ATMOS ENVIRON, V38, P3917, DOI 10.1016/j.atmosenv.2004.03.056; Guzman F, 1996, SCIENCE, V271, P1040, DOI 10.1126/science.271.5252.1040; Isaaks E.H., 1989, ISA; Jerrett M, 2007, STOCH ENV RES RISK A, V21, P511, DOI 10.1007/s00477-007-0133-2; Kaiser J, 2000, SCIENCE, V289, P22, DOI 10.1126/science.289.5476.22; Kaiser J, 1997, SCIENCE, V276, P33, DOI 10.1126/science.276.5309.33; Kumar N, 2009, ATMOS ENVIRON, V43, P1153, DOI 10.1016/j.atmosenv.2008.10.055; Kumar R, 2006, ENVIRON MONIT ASSESS, V119, P191, DOI 10.1007/s10661-005-9022-7; Lelieveld J, 2002, SCIENCE, V298, P794, DOI 10.1126/science.1075457; Li CS, 2002, AEROSOL SCI TECH, V36, P469, DOI 10.1080/027868202753571287; Lundgren DA, 1996, AEROSOL SCI TECH, V25, P353, DOI 10.1080/02786829608965401; Maraziotis E, 2008, GLOBAL NEST J, V10, P123; Marcazzan GM, 2001, ATMOS ENVIRON, V35, P4639, DOI 10.1016/S1352-2310(01)00124-8; Marshall JD, 2008, ATMOS ENVIRON, V42, P1359, DOI 10.1016/j.atmosenv.2007.08.012; MEP-PRC, 1996, GB30951996 MEPPRC, P2; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Ostro B., 2004, OUTDOOR AIR POLLUTIO; Pandey P, 2012, B ENVIRON CONTAM TOX, V88, P265, DOI 10.1007/s00128-011-0466-x; Pyne S, 2002, SCIENCE, V295, P1994; Reis BY, 2007, PLOS MED, V4, P1019, DOI 10.1371/journal.pmed.0040210; Song Y, 2007, J HAZARD MATER, V146, P124, DOI 10.1016/j.jhazmat.2006.11.058; Tiwari S, 2012, AEROSOL AIR QUAL RES, V12, P20, DOI 10.4209/aaqr.2011.06.0075; US-Embassy-in-Beijing, 2011, US EMB BEIJ AIR QUAL; van de Kassteele J, 2006, STOCH ENV RES RISK A, V21, P183, DOI 10.1007/s00477-006-0055-4; Wang HL, 2008, J ENVIRON SCI, V20, P1323, DOI 10.1016/S1001-0742(08)62228-7; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024498; Wang Y, 2005, ATMOS ENVIRON, V39, P3771, DOI 10.1016/j.atmosenv.2005.03.013; WHO-Europe, 2006, AIR QUAL GUID GLOB U; Wiwanitkit V, 2008, STOCH ENV RES RISK A, V22, P437, DOI 10.1007/s00477-007-0149-7; XinHuaNet, 2011, CHIN US EXP EXPL BEI; Zheng M, 2005, ATMOS ENVIRON, V39, P3967, DOI 10.1016/j.atmosenv.2005.03.036	37	139	148	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53400	10.1371/journal.pone.0053400	http://dx.doi.org/10.1371/journal.pone.0053400			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23894665	gold, Green Published			2022-12-25	WOS:000313429800046
J	Wong, MCS; Ching, JYL; Hirai, HH; Lam, TYT; Griffiths, SM; Chan, FKL; Sung, JJY				Wong, Martin C. S.; Ching, Jessica Y. L.; Hirai, Hoyee H.; Lam, Thomas Y. T.; Griffiths, Sian M.; Chan, Francis K. L.; Sung, Joseph J. Y.			Perceived Obstacles of Colorectal Cancer Screening and Their Associated Factors among 10,078 Chinese Participants	PLOS ONE			English	Article								Purpose: to evaluate the proportion of self-referred screening participants having various psychological barriers and the factors associated with these barriers. Methods: A territory-wide bowel cancer screening centre sent an invitation via the media to all Hong Kong residents aged 50-70 years who were asymptomatic of CRC to join a free screening programme. Upon attendance they were requested to complete self-administered surveys on their perceived barriers of screening. Binary logistic regression analyses were used to evaluate the factors associated with these barriers. Results: From 10,078 consecutive screening participants (mean age 57.5 years; female 56.4%) completed the surveys between May 2008 to September 2012. There were high proportions who agreed or strongly agreed with the following barriers: financial difficulty (86.0%), limited service accessibility (58.2%), screening-induced bodily discomfort (55.2%), physical harm (44.4%), embarrassment (40.1%), apprehension (38.8%) and time constraints (13.9%). From regression models, older participants (aged >= 56) were less likely to have these barriers (Adjusted odds ratio [AOR] ranged from 0.738 to 0.952) but they encountered more difficulties to access to screening services (AOR ranged from 1.141 to 1.371). Female subjects were more likely to encounter most of these barriers (AOR ranged from 1.188 to 2.179). Participants who were uncertain of the necessity of CRC screening for people aged >= 50 were more likely to report these barriers (AOR ranged from 1.151 to 1.671). Conclusion: The proportions of perceptual barriers of CRC screening were high among these participants. Those with these associated factors should receive more thorough explanation of the screening test procedures.	[Wong, Martin C. S.; Ching, Jessica Y. L.; Hirai, Hoyee H.; Lam, Thomas Y. T.; Chan, Francis K. L.; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Fac Med, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Wong, Martin C. S.; Griffiths, Sian M.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Fac Med, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Wong, Martin/L-4568-2014; Chan, Francis K. L./F-4851-2010; Sung, Joseph J. Y./R-3203-2018	Wong, Martin/0000-0001-7706-9370; Chan, Francis K. L./0000-0001-7388-2436; Sung, Joseph J. Y./0000-0003-3125-5199	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	The authors acknowledged the support of the Hong Kong Jockey Club Charities Trust for the full funding support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Comm Canc Prevention, 2000, EUR J CANCER, V36, P1473; Berkowitz Z, 2008, J AM GERIATR SOC, V56, P307, DOI 10.1111/j.1532-5415.2007.01547.x; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Champion V L, 1984, ANS Adv Nurs Sci, V6, P73; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goulard H., 2007, EVALUATION EPIDEMIOL; Guessous I, 2010, PREV MED, V50, P3, DOI 10.1016/j.ypmed.2009.12.005; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Katz MH, 2006, MULTIVARIABLE ANALYSIS: A PRACTICAL GUIDE FOR CLINICIANS, 2ND EDITION, P68; Klabunde CN, 2006, AM J PREV MED, V30, P313, DOI 10.1016/j.amepre.2005.11.006; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lewis SF, 1996, J GEN INTERN MED, V11, P542, DOI 10.1007/BF02599602; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; McCaffery K, 2001, SOC SCI MED, V53, P679, DOI 10.1016/S0277-9536(00)00375-0; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Rawl SM, 2000, CANCER PRACT, V8, P32, DOI 10.1046/j.1523-5394.2000.81006.x; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Saito H, 2006, J MED SCREEN, V13, pS6; Stacy R, 2008, J CANCER EDUC, V23, P238, DOI 10.1080/08858190802189030; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Sung JJY, 2008, AM J GASTROENTEROL, V103, P974, DOI 10.1111/j.1572-0241.2007.01649.x; Weller D, 2007, BRIT J CANCER, V97, P1601, DOI 10.1038/sj.bjc.6604089; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wong CKH, 2012, J EVAL CLIN PRACT, V18, P1203, DOI 10.1111/j.1365-2753.2011.01776.x; Wong MCS, 2010, ALIMENT PHARM THER, V32, P74, DOI 10.1111/j.1365-2036.2010.04312.x; Wong MCS, 2012, CANCER CAUSE CONTROL, V23, P1541, DOI 10.1007/s10552-012-0031-x	31	39	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e70209	10.1371/journal.pone.0070209	http://dx.doi.org/10.1371/journal.pone.0070209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V41SG	24386367	Green Submitted, gold, Green Published			2022-12-25	WOS:000209565300001
J	Morozov, A; Pasternak, AF; Arashkevich, EG				Morozov, Andrew; Pasternak, Anna F.; Arashkevich, Elena G.			Revisiting the Role of Individual Variability in Population Persistence and Stability	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; VISUAL PREDATION RISK; FUNCTIONAL-RESPONSE; ZOOPLANKTON; BEHAVIOR; PREY; PERSONALITIES; SELECTION; PARADOX; GROWTH	Populations often exhibit a pronounced degree of individual variability and this can be important when constructing ecological models. In this paper, we revisit the role of inter-individual variability in population persistence and stability under predation pressure. As a case study, we consider interactions between a structured population of zooplankton grazers and their predators. Unlike previous structured population models, which only consider variability of individuals according to the age or body size, we focus on physiological and behavioural structuring. We first experimentally demonstrate a high degree of variation of individual consumption rates in three dominant species of herbivorous copepods (Calanus finmarchicus, Calanus glacialis, Calanus euxinus) and show that this disparity implies a pronounced variation in the consumption capacities of individuals. Then we construct a parsimonious predator-prey model which takes into account the intra-population variability of prey individuals according to behavioural traits: effectively, each organism has a 'personality' of its own. Our modelling results show that structuring of prey according to their growth rate and vulnerability to predation can dampen predator-prey cycles and enhance persistence of a species, even if the resource stock for prey is unlimited. The main mechanism of efficient top-down regulation is shown to work by letting the prey population become dominated by less vulnerable individuals when predator densities are high, while the trait distribution recovers when the predator densities are low.	[Morozov, Andrew] Univ Leicester, Dept Math, Leicester, Leics, England; [Morozov, Andrew; Pasternak, Anna F.; Arashkevich, Elena G.] PP Shirshov Oceanol Inst, Lab Plankton Ecol, Moscow, Russia	University of Leicester; Russian Academy of Sciences; Shirshov Institute of Oceanology	Morozov, A (corresponding author), Univ Leicester, Dept Math, Leicester, Leics, England.	am379@leicester.ac.uk	Ashhab, Ashraf AL/AAF-4989-2019; Arashkevich, Elena/E-8175-2014; Pasternak, Anna F/E-6121-2014; Morozov, Andrew/AAI-6528-2020	Ashhab, Ashraf AL/0000-0002-3716-2279; Arashkevich, Elena/0000-0003-0374-3064; Pasternak, Anna F/0000-0003-0317-5861; Minz, Dror/0000-0001-6746-9151; Gillor, Osnat/0000-0003-0849-2241	EU [FP7-226248]; RFBR (Russian Federation) [10-04-00386]	EU(European Commission); RFBR (Russian Federation)(Russian Foundation for Basic Research (RFBR)Russian Federation)	The study was partially supported by EU grant Arctic Tipping Points (FP7-226248) and RFBR grant 10-04-00386 (Russian Federation) to AP. The funding was used to cover the expenses of zooplankton feeding experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, ECOLOGY, V77, P1125, DOI 10.2307/2265581; Allen L. J. S., 2007, INTRO MATH BIOL; ARMSTRONG RA, 1994, LIMNOL OCEANOGR, V39, P597, DOI 10.4319/lo.1994.39.3.0597; BAMSTEDT U, 1988, HYDROBIOLOGIA, V167, P43, DOI 10.1007/BF00026293; BOLLENS SM, 1989, J PLANKTON RES, V11, P1047, DOI 10.1093/plankt/11.5.1047; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; CHARLESWORTH B, 1972, THEOR POPUL BIOL, V3, P377, DOI 10.1016/0040-5809(72)90011-1; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; CULLEN JJ, 1992, J GEOPHYS RES-OCEANS, V97, P639, DOI 10.1029/91JC01320; Cushing J., 1998, J SOC IND APPL MATH; Dagg MJ, 1997, LIMNOL OCEANOGR, V42, P974, DOI 10.4319/lo.1997.42.5.0974; De Robertis A, 2002, LIMNOL OCEANOGR, V47, P925, DOI 10.4319/lo.2002.47.4.0925; De Robertis A, 2000, LIMNOL OCEANOGR, V45, P1838, DOI 10.4319/lo.2000.45.8.1838; Diekmann O, 2010, J MATH BIOL, V61, P277, DOI 10.1007/s00285-009-0299-y; DRITS AV, 1994, HYDROBIOLOGIA, V293, P201, DOI 10.1007/BF00229942; Edwards CA, 2000, J MAR RES, V58, P37, DOI 10.1357/002224000321511197; EHLINGER TJ, 1990, ECOLOGY, V71, P886, DOI 10.2307/1937360; FERNO A, 1995, AQUACULTURE, V132, P285, DOI 10.1016/0044-8486(94)00384-Z; Genkai-Kato M, 1999, P ROY SOC B-BIOL SCI, V266, P1215, DOI 10.1098/rspb.1999.0765; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; Gurney WSC, 2001, J ANIM ECOL, V70, P881, DOI 10.1046/j.0021-8790.2001.00549.x; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; Kooi BW, 2000, COMMENT THEOR BIOL, V8, P125; Lehtiniemi M, 2006, MAR BIOL, V149, P845, DOI 10.1007/s00227-006-0243-2; Leising AW, 2005, J PLANKTON RES, V27, P987, DOI 10.1093/plankt/fbi084; Magal P., 2008, LECT NOTES MATH, V1936; MATHER JA, 1993, J COMP PSYCHOL, V107, P336, DOI 10.1037/0735-7036.107.3.336; Metz J., 1986, LECT NOTES BIOMATHEM, DOI DOI 10.1007/978-3-662-13159-6; Morozov AY, 2010, J THEOR BIOL, V262, P346, DOI 10.1016/j.jtbi.2009.09.023; Morozov A, 2008, DEEP-SEA RES PT II, V55, P2285, DOI 10.1016/j.dsr2.2008.05.008; Nisbet R.M., 1997, STRUCTURED POPULATIO, V18, P89; OATEN A, 1975, AM NAT, V109, P289, DOI 10.1086/282998; OHMAN MD, 1990, ECOL MONOGR, V60, P257, DOI 10.2307/1943058; Paffenhofer GA, 1996, J PLANKTON RES, V18, P1699, DOI 10.1093/plankt/18.9.1699; PAFFENHOFER GA, 1994, J PLANKTON RES, V16, P617, DOI 10.1093/plankt/16.6.617; Pearre S, 2003, BIOL REV, V78, P1, DOI 10.1017/S146479310200595X; Petrovskii S, 2009, AM NAT, V173, P278, DOI 10.1086/595755; Petrovskii SV, 2003, ECOL LETT, V6, P455, DOI 10.1046/j.1461-0248.2003.00451.x; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Saiz E, 2007, LIMNOL OCEANOGR, V52, P668, DOI 10.4319/lo.2007.52.2.0668; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Sekino T, 1999, EVOL ECOL, V13, P267, DOI 10.1023/A:1006797101565; Seuront L, 2004, MAR ECOL PROG SER, V283, P199, DOI 10.3354/meps283199; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; Torgersen T, 2003, J PLANKTON RES, V25, P565, DOI 10.1093/plankt/25.5.565; Tuljapurkar S., 1997, STRUCTURED POPULATIO; Utne ACW, 1997, CAN J ZOOL, V75, P2027, DOI 10.1139/z97-836; van Oers K, 2005, BEHAV ECOL, V16, P716, DOI 10.1093/beheco/ari045; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	49	90	97	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e70576	10.1371/journal.pone.0070576	http://dx.doi.org/10.1371/journal.pone.0070576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936450	Green Published, Green Submitted, gold			2022-12-25	WOS:000324545800045
J	Park, M; Wetzler, M; Jardetzky, TS; Barron, AE				Park, Minyoung; Wetzler, Modi; Jardetzky, Theodore S.; Barron, Annelise E.			A Readily Applicable Strategy to Convert Peptides to Peptoid-based Therapeutics	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; SIDE-CHAIN; ANTIMICROBIAL PEPTIDES; SCANNING MUTAGENESIS; HIV-1 ENTRY; PROLINE; DESIGN; PROTEIN; RESIDUES; ANALOGS	Incorporation of unnatural amino acids and peptidomimetic residues into therapeutic peptides is highly efficacious and commonly employed, but generally requires laborious trial-and-error approaches. Previously, we demonstrated that C-20 peptide has the potential to be a potential antiviral agent. Herein we report our attempt to improve the biological properties of this peptide by introducing peptidomimetics. Through combined alanine, proline, and sarcosine scans coupled with a competitive fluorescence polarization assay developed for identifying antiviral peptides, we enabled to pinpoint peptoid-tolerant peptide residues within C-20 peptide. The synergistic benefits of combining these (and other) commonly employed methods could lead to a easily applicable strategy for designing and refining therapeutically-attractive peptidomimetics.	[Park, Minyoung] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Wetzler, Modi; Barron, Annelise E.] Stanford Univ, Dept Bioengn, Sch Engn, Stanford, CA 94305 USA; [Wetzler, Modi; Barron, Annelise E.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Jardetzky, Theodore S.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Barron, AE (corresponding author), Stanford Univ, Dept Bioengn, Sch Engn, Stanford, CA 94305 USA.	aebarron@stanford.edu	; Viner, Russell/A-1441-2009; Sovio, Ulla/H-8532-2019	Barron, Annelise/0000-0002-0735-6873; Viner, Russell/0000-0003-3047-2247; Sovio, Ulla/0000-0002-0799-1105; Park, Min Hae/0000-0002-2563-4910	National Institutes of Health [R01-GM61050, R01-AI072666]; Stanford University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University(Stanford University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants (R01-GM61050 to TSJ and R01-AI072666 to AEB) and the Bio-X Interdisciplinary Initiatives Program at Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antosova Z, 2009, TRENDS BIOTECHNOL, V27, P628, DOI 10.1016/j.tibtech.2009.07.009; Armand P, 1998, P NATL ACAD SCI USA, V95, P4309, DOI 10.1073/pnas.95.8.4309; Cantel S, 2008, J ORG CHEM, V73, P5663, DOI 10.1021/jo800142s; Caporale A, 2010, J PEPT SCI, V16, P480, DOI 10.1002/psc.1265; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Culf AS, 2010, MOLECULES, V15, P5282, DOI 10.3390/molecules15085282; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dohm MT, 2011, CURR PHARM DESIGN, V17, P2732; Eggenberger K, 2009, CHEMBIOCHEM, V10, P2504, DOI 10.1002/cbic.200900331; Eyles SJ, 2001, NAT STRUCT BIOL, V8, P380, DOI 10.1038/87524; Hoffmann B, 2006, PROTEIN PEPTIDE LETT, V13, P829, DOI 10.2174/092986606777841299; Isaad AL, 2009, J PEPT SCI, V15, P451, DOI 10.1002/psc.1141; Jagasia R, 2009, J ORG CHEM, V74, P2964, DOI 10.1021/jo802097m; Kodadek T, 2010, NAT CHEM BIOL, V6, P162, DOI 10.1038/nchembio.303; Kondo T, 2011, PLANT CELL PHYSIOL, V52, P30, DOI 10.1093/pcp/pcq146; Lee BC, 2011, ACS CHEM BIOL, V6, P1367, DOI 10.1021/cb200300w; Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n; Nguyen JT, 2000, CHEM BIOL, V7, P463, DOI 10.1016/S1074-5521(00)00130-7; Ni L, 2005, ANTIVIR THER, V10, P833; Otvos Laszlo Jr., 2008, V494, P1, DOI 10.1007/978-1-59745-419-3_1; Park M, 2011, ANAL BIOCHEM, V409, P195, DOI 10.1016/j.ab.2010.10.020; Parthasarathy R, 1995, PROG BIOPHYS MOL BIO, V64, P1, DOI 10.1016/0079-6107(95)00009-7; Punna S, 2004, SYNLETT, P99, DOI 10.1055/s-2003-43375; Reddy MM, 2011, CELL, V144, P132, DOI 10.1016/j.cell.2010.11.054; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Ruijtenbeek R, 2001, CHEMBIOCHEM, V2, P171, DOI 10.1002/1439-7633(20010302)2:3<171::AID-CBIC171>3.0.CO;2-B; Sato AK, 2006, CURR OPIN BIOTECH, V17, P638, DOI 10.1016/j.copbio.2006.10.002; Schulman BA, 1996, NAT STRUCT BIOL, V3, P682, DOI 10.1038/nsb0896-682; Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599; Uchida M, 2009, P NATL ACAD SCI USA, V106, P19375, DOI 10.1073/pnas.0906145106; Udugamasooriya DG, 2008, BIOORG MED CHEM LETT, V18, P5892, DOI 10.1016/j.bmcl.2008.07.023; Unciti-Broceta A, 2009, BIOORGAN MED CHEM, V17, P959, DOI 10.1016/j.bmc.2008.02.068; Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang EX, 2003, BIOCHEM BIOPH RES CO, V302, P469, DOI 10.1016/S0006-291X(03)00197-9; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572; Zhu WL, 2007, J PEPT SCI, V13, P529, DOI 10.1002/psc.882; Zhu WL, 2006, BIOCHEMISTRY-US, V45, P13007, DOI 10.1021/bi060487+; Zimmermann J, 2003, J BIOL CHEM, V278, P36810, DOI 10.1074/jbc.M305934200; ZUCKERMANN RN, 1992, J AM CHEM SOC, V114, P10646, DOI 10.1021/ja00052a076; Zuckermann RN, 2009, CURR OPIN MOL THER, V11, P299	44	42	48	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58874	10.1371/journal.pone.0058874	http://dx.doi.org/10.1371/journal.pone.0058874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555603	Green Published, gold, Green Submitted			2022-12-25	WOS:000316546400014
J	Lin, YC; Chen, JC; Morni, WZW; Putra, DF; Huang, CL; Li, CC; Hsieh, JF				Lin, Yong-Chin; Chen, Jiann-Chu; Morni, Wan Zabidii W.; Putra, Dedi Fazriansyah; Huang, Chien-Lun; Li, Chang-Che; Hsieh, Jen-Fang			Vaccination Enhances Early Immune Responses in White Shrimp Litopenaeus vannamei after Secondary Exposure to Vibrio alginolyticus	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; PROPHENOLOXIDASE-ACTIVATING SYSTEM; HOT-WATER EXTRACT; PENAEUS-MONODON; GRACILARIA-TENUISTIPITATA; RESISTANCE; HEMOCYTES; INNATE; CLASSIFICATION; CRUSTACEANS	Background: Recent work suggested that the presence of specific memory or some form of adaptive immunity occurs in insects and shrimp. Hypervariable pattern recognition molecules, known as Down syndrome cell adhesion molecules, are able to mount specific recognition, and immune priming in invertebrates. In the present study, we attempted to understand the immune response pattern of white shrimp Litopenaeus vannamei which received primary (PE) and secondary exposure (SE) to Vibrio alginolyticus. Methodology: Immune parameters and proliferation of haematopoietic tissues (HPTs) of shrimp which had received PE and SE to V. alginolyticus were measured. In the PE trial, the immune parameters and proliferation of HPTs of shrimp that received heat-killed V. alginolyticus (HVa) and formalin-inactivated V. alginolyticus (FVa) were measured. Mortality, immune parameters and proliferation of HPTs of 7-day-HVa-PE shrimp (shrimp that received primary exposure to HVa after 7 days) and 7-day-FVa-PE shrimp (shrimp that received primary exposure to FVa after 7 days) following SE to live V. alginolyticus (LVa) were measured. Phagocytic activity and clearance efficiency were examined for the 7 similar to 35-day-HVa-PE and FVa-PE shrimp. Results: HVa-receiving shrimp showed an earlier increase in the immune response on day 1, whereas FVa-receiving shrimp showed a late increase in the immune response on day 5. The 7-day-FVa-PE shrimp showed enhancement of immunity when encountering SE to LVa, whereas 7-day-HVa-PE shrimp showed a minor enhancement in immunity. 7-day-FVa-PE shrimp showed higher proliferation and an HPT mitotic index. Both phagocytic activity and clearance maintained higher for both HVa-PE and FVa-PE shrimp after 28 days. Conclusions: HVa-and FVa-receiving shrimp showed the bacteria agglutinated prior to being phagocytised. FVa functions as a vaccine, whereas HVa functions as an inducer and can be used as an immune adjuvant. A combined mixture of FVa and HVa can serve as a "vaccine component" to modulate the immunity of shrimp.	[Lin, Yong-Chin; Chen, Jiann-Chu; Morni, Wan Zabidii W.; Putra, Dedi Fazriansyah; Huang, Chien-Lun; Li, Chang-Che; Hsieh, Jen-Fang] Natl Taiwan Ocean Univ, Coll Life Sci, Dept Aquaculture, Keelung, Taiwan	National Taiwan Ocean University	Chen, JC (corresponding author), Natl Taiwan Ocean Univ, Coll Life Sci, Dept Aquaculture, Keelung, Taiwan.	jcchen@mail.ntou.edu.tw	Putra, Dedi Fazriansyah/E-3111-2017; Zabidii, Wan/AAB-3381-2020	Putra, Dedi Fazriansyah/0000-0003-2896-1949; Lee, Jin-Ching/0000-0003-0729-9589; Wu, Yu-Hsuan/0000-0002-2175-3867; Morni, Wan Zabidii Wan/0000-0002-5595-7964	National Science Council [NSC98-2313-B-019-002-MY3, NSC101-2313-B-019-002]; Center for Marine Bioenvironmental and Biotechnology, National Taiwan Ocean University	National Science Council(Ministry of Science and Technology, Taiwan); Center for Marine Bioenvironmental and Biotechnology, National Taiwan Ocean University	This paper was supported by grants from the National Science Council (NSC98-2313-B-019-002-MY3 and NSC101-2313-B-019-002), and the Center for Marine Bioenvironmental and Biotechnology, National Taiwan Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi AO, 1999, AQUACULTURE, V178, P1, DOI 10.1016/S0044-8486(99)00131-3; Arala-Chaves M, 2000, AQUACULTURE, V191, P247, DOI 10.1016/S0044-8486(00)00430-0; BELL KL, 1993, DEV COMP IMMUNOL, V17, P211, DOI 10.1016/0145-305X(93)90040-W; BIAGINI G, 1995, NEUROSCI LETT, V190, P212, DOI 10.1016/0304-3940(95)11529-6; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; CHAN SM, 1988, BIOL BULL, V175, P185, DOI 10.2307/1541558; Chang CC, 2008, FISH SHELLFISH IMMUN, V25, P672, DOI 10.1016/j.fsi.2008.09.004; Cheng WT, 2005, FISH SHELLFISH IMMUN, V18, P1, DOI 10.1016/j.fsi.2004.03.002; Chou PH, 2011, FISH SHELLFISH IMMUN, V30, P1109, DOI 10.1016/j.fsi.2011.02.009; Chou PH, 2009, DEV COMP IMMUNOL, V33, P1258, DOI 10.1016/j.dci.2009.07.006; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Eliss A. E., 1990, TECHNIQUES FISH IMMU, P101, DOI DOI 10.1016/S0145-305X(01)00038-6; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Hossain M. M. M., 2009, Journal of Biological Sciences, V9, P392, DOI 10.3923/jbs.2009.392.401; Hou WY, 2005, FISH SHELLFISH IMMUN, V19, P127, DOI 10.1016/j.fsi.2004.11.009; Humason G.L., 1979, ANIMAL TISSUE TECHNI, P661, DOI DOI 10.5962/BHL.TITLE.5890; ITAMI T, 1991, Journal of Aquatic Animal Health, V3, P151, DOI 10.1577/1548-8667(1991)003&lt;0151:SOLGTP&gt;2.3.CO;2; Itami T, 1989, J AQUAT ANIM HEALTH, V1, P234; Itami T, 1992, FISHERIES, V40, P139; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; KARUNASAGAR I, 1994, AQUACULTURE, V128, P203, DOI 10.1016/0044-8486(94)90309-3; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Kurtz J, 2004, MICROBES INFECT, V6, P1410, DOI 10.1016/j.micinf.2004.10.002; Lavilla-Pitogo CR, 1998, AQUACULTURE, V164, P337, DOI 10.1016/S0044-8486(98)00198-7; Li CC, 2010, FISH SHELLFISH IMMUN, V28, P121, DOI 10.1016/j.fsi.2009.10.003; Li CC, 2008, FISH SHELLFISH IMMUN, V25, P853, DOI 10.1016/j.fsi.2008.09.014; Lightner DV, 1998, AQUACULTURE, V164, P201, DOI 10.1016/S0044-8486(98)00187-2; Liu CH, 2004, DIS AQUAT ORGAN, V61, P169, DOI 10.3354/dao061169; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lorenzon S, 1999, FISH SHELLFISH IMMUN, V9, P31, DOI 10.1006/fsim.1998.0168; MARTIN GG, 1985, J MORPHOL, V185, P339, DOI 10.1002/jmor.1051850306; Namikoshi A, 2004, AQUACULTURE, V229, P25, DOI 10.1016/S0044-8486(03)00363-6; Pereira J. J., 2009, Tamilnadu Journal of Veterinary and Animal Sciences, V5, P246; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Pope EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020960; Powell A, 2011, J INVERTEBR PATHOL, V107, P95, DOI 10.1016/j.jip.2011.02.006; Rodriguez J, 2000, AQUACULTURE, V191, P109, DOI 10.1016/S0044-8486(00)00421-X; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Rowley AF, 2007, J IMMUNOL, V179, P7209, DOI 10.4049/jimmunol.179.11.7209; Sirirustananun N, 2011, FISH SHELLFISH IMMUN, V31, P848, DOI 10.1016/j.fsi.2011.07.025; SMITH VJ, 1983, CELL TISSUE RES, V233, P295; Smith VJ, 2003, FISH SHELLFISH IMMUN, V15, P71, DOI 10.1016/S1050-4648(02)00140-7; SODERHALL K, 1979, CAN J MICROBIOL, V25, P406, DOI 10.1139/m79-062; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Tayag CM, 2010, FISH SHELLFISH IMMUN, V28, P764, DOI 10.1016/j.fsi.2010.01.023; Teunissen OSP, 1998, AQUACULTURE, V164, P359, DOI 10.1016/S0044-8486(98)00200-2; van de Braak CBT, 2002, FISH SHELLFISH IMMUN, V12, P253, DOI 10.1006/fsim.2001.0369; Vaseeharan B, 2006, LETT APPL MICROBIOL, V43, P137, DOI 10.1111/j.1472-765X.2006.01941.x; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; Witteveldt J, 2004, FISH SHELLFISH IMMUN, V16, P571, DOI 10.1016/j.fsi.2003.09.006; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yeh ST, 2008, AQUACULTURE, V276, P22, DOI 10.1016/j.aquaculture.2008.01.034; Yeh ST, 2009, FISH SHELLFISH IMMUN, V26, P724, DOI 10.1016/j.fsi.2009.02.025; Zhang ZF, 2006, FISH SHELLFISH IMMUN, V21, P159, DOI 10.1016/j.fsi.2005.11.003	60	138	142	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69722	10.1371/journal.pone.0069722	http://dx.doi.org/10.1371/journal.pone.0069722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23365670	Green Published, Green Submitted, gold			2022-12-25	WOS:000322132100079
J	Zheng, YC; Lu, YL; Wang, JF; Yang, LF; Pan, CY; Huang, Y				Zheng, Yongchen; Lu, Yingli; Wang, Jinfeng; Yang, Longfei; Pan, Chenyu; Huang, Ying			Probiotic Properties of Lactobacillus Strains Isolated from Tibetan Kefir Grains	PLOS ONE			English	Article							BILE-SALT HYDROLASE; LACTIC-ACID BACTERIA; IN-VITRO; DAIRY-PRODUCTS; CACO-2 CELLS; MILK-KEFIR; RATS; PLANTARUM; ACIDOPHILUS; ADHESION	The objective of this study was to evaluate the functional properties of lactic acid bacteria (LAB) isolated from Tibetan kefir grains. Three Lactobacillus isolates identified as Lactobacillus acidophilus LA15, Lactobacillus plantarum B23 and Lactobacillus kefiri D17 that showed resistance to acid and bile salts were selected for further evaluation of their probiotic properties. The 3 selected strains expressed high in vitro adherence to Caco-2 cells. They were sensitive to gentamicin, erythromycin and chloramphenicol and resistant to vancomycin with MIC values of 26 mg/ml. All 3 strains showed potential bile salt hydrolase (BSH) activity, cholesterol assimilation and cholesterol co-precipitation ability. Additionally, the potential effect of these strains on plasma cholesterol levels was evaluated in Sprague-Dawley (SD) rats. Rats in 4 treatment groups were fed the following experimental diets for 4 weeks: a high-cholesterol diet, a high-cholesterol diet plus LA15, a high-cholesterol diet plus B23 or a high-cholesterol diet plus D17. The total cholesterol, triglyceride and low-density lipoprotein cholesterol levels in the serum were significantly (P<0.05) decreased in the LAB-treated rats compared with rats fed a high-cholesterol diet without LAB supplementation. The high-density lipoprotein cholesterol levels in groups B23 and D17 were significantly (P<0.05) higher than those in the control and LA15 groups. Additionally, both fecal cholesterol and bile acid levels were significantly (P<0.05) increased after LAB administration. Fecal lactobacilli counts were significantly (P<0.05) higher in the LAB treatment groups than in the control groups. Furthermore, the 3 strains were detected in the rat small intestine, colon and feces during the feeding trial. The bacteria levels remained high even after the LAB administration had been stopped for 2 weeks. These results suggest that these strains may be used in the future as probiotic starter cultures for manufacturing novel fermented foods.	[Zheng, Yongchen; Lu, Yingli; Wang, Jinfeng; Yang, Longfei; Pan, Chenyu; Huang, Ying] Jilin Univ, Hosp 2, Cent Res Lab, Changchun 130023, Peoples R China	Jilin University	Huang, Y (corresponding author), Jilin Univ, Hosp 2, Cent Res Lab, Changchun 130023, Peoples R China.	yinghuang@jlu.edu.cn	Yang, Longfei/B-4223-2018	Yang, Longfei/0000-0003-4153-9670; Ma, Aiguo/0000-0001-9507-8844	National Natural Science Foundation of China [31100022]; Program of Science and Technology Development Plan of Jilin Province [20110737]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Science and Technology Development Plan of Jilin Province	This work was supported by the National Natural Science Foundation of China (No. 31100022) and the Program of Science and Technology Development Plan of Jilin Province (No. 20110737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERBAEK M, 1995, EUR J CLIN NUTR, V49, P346; Alander M, 1999, APPL ENVIRON MICROB, V65, P351; ANGULO L, 1993, J DAIRY RES, V60, P263, DOI 10.1017/S002202990002759X; Bao Y, 2010, FOOD CONTROL, V21, P695, DOI 10.1016/j.foodcont.2009.10.010; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; BernetCamard MF, 1997, APPL ENVIRON MICROB, V63, P2747, DOI 10.1128/AEM.63.7.2747-2753.1997; Bories G, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.732; Charteris WP, 1998, J APPL MICROBIOL, V84, P759; Chen YP, 2012, J DAIRY SCI, V95, P63, DOI 10.3168/jds.2011-4696; COCONNIER MH, 1993, FEMS MICROBIOL LETT, V110, P299, DOI [10.1111/j.1574-6968.1993.tb06339.x, 10.1016/0378-1097(93)90119-M]; CROCIANI J, 1995, LETT APPL MICROBIOL, V21, P146, DOI 10.1111/j.1472-765X.1995.tb01027.x; DASHKEVICZ MP, 1989, APPL ENVIRON MICROB, V55, P11, DOI 10.1128/AEM.55.1.11-16.1989; Diniz RO, 2003, PHARMACOL RES, V47, P49, DOI 10.1016/S1043-6618(02)00240-2; DOWELL VR, 1998, MEDIA ISOLATION CHAR; Dunne C, 2001, AM J CLIN NUTR, V73, p386S, DOI 10.1093/ajcn/73.2.386s; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; EFSA-FEEDAP Panel,, 2005, EFSA J, V3, P1, DOI [10.2903/j.efsa.2005.223, DOI 10.2903/J.EFSA.2005.223]; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garrote GL, 2001, J DAIRY RES, V68, P639, DOI 10.1017/S0022029901005210; Gevers D, 2003, APPL ENVIRON MICROB, V69, P1270, DOI 10.1128/AEM.69.2.1270-1275.2003; GILLILAND SE, 1990, J DAIRY SCI, V73, P905, DOI 10.3168/jds.S0022-0302(90)78747-4; Hamon E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-63; Hashimoto Hideo, 1999, Animal Science Journal, V70, P90; Huang Y, 2013, J DAIRY SCI, V96, P2816, DOI 10.3168/jds.2012-6371; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; Klein G, 2000, J APPL MICROBIOL, V89, P815, DOI 10.1046/j.1365-2672.2000.01187.x; Klein G, 1998, INT J FOOD MICROBIOL, V41, P103, DOI 10.1016/S0168-1605(98)00049-X; Kratz M, 2002, EUR J LIPID SCI TECH, V104, P300, DOI 10.1002/1438-9312(200205)104:5<300::AID-EJLT300>3.0.CO;2-2; Kumar R, 2011, BRIT J NUTR, V105, P561, DOI 10.1017/S0007114510003740; Lambert JM, 2008, APPL ENVIRON MICROB, V74, P4719, DOI 10.1128/AEM.00137-08; Lardizabal JA, 2011, CARDIOL CLIN, V29, P87, DOI 10.1016/j.ccl.2010.10.002; Liong MT, 2006, J DAIRY SCI, V89, P1390, DOI 10.3168/jds.S0022-0302(06)72207-X; Liu JR, 2006, BRIT J NUTR, V95, P939, DOI 10.1079/BJN20061752; Maietti L, 2007, SYST APPL MICROBIOL, V30, P509, DOI 10.1016/j.syapm.2007.05.002; Mathara JM, 2008, INT J FOOD MICROBIOL, V126, P57, DOI 10.1016/j.ijfoodmicro.2008.04.027; Minelli EB, 2004, INT DAIRY J, V14, P723, DOI 10.1016/j.idairyj.2004.01.007; Ouwehand AC, 2001, INT J FOOD MICROBIOL, V64, P119, DOI 10.1016/S0168-1605(00)00440-2; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rossetti L, 2009, INT J FOOD MICROBIOL, V130, P70, DOI 10.1016/j.ijfoodmicro.2009.01.003; Sarkar S., 2003, Nutrition & Food Science, V33, P273, DOI 10.1108/00346650310507109; SCHIFFRIN EJ, 1995, J DAIRY SCI, V78, P491, DOI 10.3168/jds.S0022-0302(95)76659-0; Silva KR, 2009, APPL BIOCHEM BIOTECH, V152, P316, DOI 10.1007/s12010-008-8303-3; Tabuchi M, 2004, MILCHWISSENSCHAFT, V59, P249; Taranto MP, 1998, J DAIRY SCI, V81, P2336, DOI 10.3168/jds.S0022-0302(98)70123-7; Urdaneta E, 2007, NUTR RES, V27, P653, DOI 10.1016/j.nutres.2007.08.002; Vinderola CG, 2005, J DAIRY RES, V72, P195, DOI 10.1017/S0022029905000828; Wang J, 2012, J DAIRY SCI, V95, P1645, DOI 10.3168/jds.2011-4768; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zavaglia AG, 1998, J FOOD PROTECT, V61, P865, DOI 10.4315/0362-028X-61.7.865; Zhou JZ, 2009, FOOD MICROBIOL, V26, P770, DOI 10.1016/j.fm.2009.04.009	51	125	139	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69868	10.1371/journal.pone.0069868	http://dx.doi.org/10.1371/journal.pone.0069868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894554	Green Published, gold, Green Submitted			2022-12-25	WOS:000322132100083
J	Liu, KC; Ge, W				Liu, Ka-Cheuk; Ge, Wei			Evidence for Gating Roles of Protein Kinase A and Protein Kinase C in Estradiol-Induced Luteinizing Hormone Receptor (lhcgr) Expression in Zebrafish Ovarian Follicle Cells	PLOS ONE			English	Article							MEMBRANE ESTROGEN-RECEPTOR; BRAIN TYROSINE-HYDROXYLASE; NITRIC-OXIDE SYNTHASE; GONADOTROPIN RECEPTORS; GENE-EXPRESSION; MESSENGER-RNA; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL REGULATION; DOWN-REGULATION; UP-REGULATION	Estradiol (E2) stimulates luteinizing hormone receptor (lhcgr) expression in zebrafish follicle cells via nuclear estrogen receptors (nERs) that are likely expressed on the membrane, and lhcgr responds to E2 in a biphasic manner during 24-h treatment. These observations raise an interesting question on the signaling mechanism underlying E2 regulation, in particular the biphasic response of lhcgr expression. In the present study, we demonstrated that E2 regulation of lhcgr was significantly influenced by the activity of cAMP-PKA pathway. Activation of cAMP-PKA pathway by forskolin or db-cAMP suppressed E2-stimulated lhcgr expression in short-term (3 h) but enhanced its effect in long-term (24 h), suggesting differential roles of PKA at these two phases of lhcgr response. PKA inhibitor H89 showed reversed effects. In contrast, PKC pathway had consistent permissive effect on E2-induced lhcgr expression as evidenced by strong inhibition of E2 effect by PKC inhibitors GF109203X and Ro-31-8220 at both 3 and 24 h. One of the mechanisms by which PKA and PKC gated E2 effect might be through regulating nERs, particularly esr2a. Despite the strong influence of PKA and PKC, our data did not suggest direct mediating roles for these two pathways in E2 stimulation of lhcgr expression; yet they likely play critical gating roles in E2 signal transduction. As a follow-up study to our previous report on E2 regulation of gonadotropin receptors in the zebrafish ovary, the present study provides further evidence for the involvement of classical intracellular signal transduction pathways in E2 stimulation of lhcgr expression in the follicle cells.	[Ge, Wei] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Ctr Cell & Dev Biol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Ge, W (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	weige@cuhk.edu.hk	Ma, Miaojun/E-1320-2012	Ma, Miaojun/0000-0001-7046-9574; Liu, Kun/0000-0001-9127-053X; Liu, Ka Cheuk/0000-0001-6082-8801	Research Grants Council [CUHK464707, 464308, 464409]; Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	Research Grants Council(Hong Kong Research Grants Council); Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	The work was substantially supported by grants from the Research Grants Council (CUHK464707, 464308 and 464409) and the Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region to W.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's website: http://www.ugc.edu.hk/eng/rgc/grf/grf.htm	Amsterdam A, 2002, MOL CELL ENDOCRINOL, V187, P69, DOI 10.1016/S0303-7207(01)00701-8; Burns KH, 2002, ENDOCRINOLOGY, V143, P2823, DOI 10.1210/en.143.8.2823; Byers M, 1997, MOL ENDOCRINOL, V11, P172, DOI 10.1210/me.11.2.172; Caiazza F, 2007, BIOCHEM BIOPH RES CO, V359, P102, DOI 10.1016/j.bbrc.2007.05.059; CATT KJ, 1991, J BIOENERG BIOMEMBR, V23, P7; Chaube R, 2005, J NEUROENDOCRINOL, V17, P91, DOI 10.1111/j.1365-2826.2005.01282.x; Chaube R, 2005, GEN COMP ENDOCR, V141, P116, DOI 10.1016/j.ygcen.2004.12.010; Chen DB, 2004, ENDOCRINOLOGY, V145, P113, DOI 10.1210/en.2003-0547; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; Chen LH, 2011, CELL SIGNAL, V23, P497, DOI 10.1016/j.cellsig.2010.11.005; Chiang CH, 2000, J CLIN ENDOCR METAB, V85, P3828, DOI 10.1210/jc.85.10.3828; De Marinis YZ, 2010, DIABETOLOGIA, V53, P717, DOI 10.1007/s00125-009-1635-x; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; De Servi B, 2005, ONCOGENE, V24, P4946, DOI 10.1038/sj.onc.1208676; Dewing P, 2008, ENDOCRINOLOGY, V149, P5934, DOI 10.1210/en.2008-0847; Hatae J, 2009, J PHYSIOL SCI, V59, P181, DOI 10.1007/s12576-009-0023-0; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Jaubert AM, 2007, ENDOCRINOLOGY, V148, P2444, DOI 10.1210/en.2006-1329; Jeng SR, 2007, GEN COMP ENDOCR, V154, P161, DOI 10.1016/j.ygcen.2007.05.026; Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117; Kobayashi T, 2008, GEN COMP ENDOCR, V156, P595, DOI 10.1016/j.ygcen.2008.02.010; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; Le HH, 2010, ENDOCRINOLOGY, V151, P5689, DOI 10.1210/en.2010-0710; Lee MY, 2008, CELL RES, V18, P491, DOI 10.1038/cr.2008.42; LEUNG PCK, 1992, ENDOCR REV, V13, P476, DOI 10.1210/er.13.3.476; Levin ER, 2011, MOL ENDOCRINOL, V25, P377, DOI 10.1210/me.2010-0284; Li CW, 2012, GEN COMP ENDOCR, V176, P420, DOI 10.1016/j.ygcen.2011.12.032; Liu KC, 2013, GEN COMP ENDOCR, V181, P288, DOI 10.1016/j.ygcen.2012.07.032; Liu KC, 2011, ENDOCRINOLOGY, V152, P4418, DOI 10.1210/en.2011-1065; Liu XC, 2009, BIOL REPROD, V80, P1253, DOI 10.1095/biolreprod.108.070250; Longo M, 2006, J MOL ENDOCRINOL, V37, P489, DOI 10.1677/jme.1.02055; Lucas TF, 2008, BIOL REPROD, V78, P101; Luckenbach JA, 2011, GEN COMP ENDOCR, V171, P52, DOI 10.1016/j.ygcen.2010.12.016; Maharjan S, 2010, J NEUROCHEM, V112, P42, DOI 10.1111/j.1471-4159.2009.06430.x; Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013; Menon B, 2011, MOL ENDOCRINOL, V25, P282, DOI 10.1210/me.2010-0366; Menuet A, 2004, J MOL ENDOCRINOL, V32, P975, DOI 10.1677/jme.0.0320975; Mhyre AJ, 2006, ENDOCRINOLOGY, V147, P1796, DOI 10.1210/en.2005-1316; MIGLIACCIO S, 1993, MOL ENDOCRINOL, V7, P1133, DOI 10.1210/me.7.9.1133; Migliaccio S, 1998, STEROIDS, V63, P352, DOI 10.1016/S0039-128X(98)00040-3; Migliaccio S, 1998, ENDOCRINOLOGY, V139, P4598, DOI 10.1210/en.139.11.4598; Mize AL, 2002, NEUROENDOCRINOLOGY, V76, P339, DOI 10.1159/000067583; Nelson ER, 2007, MOL REPROD DEV, V74, P1105, DOI 10.1002/mrd.20634; Nelson ER, 2010, ENDOCRINOLOGY, V151, P1668, DOI 10.1210/en.2009-1447; Oba Y, 1999, BIOCHEM BIOPH RES CO, V263, P584, DOI 10.1006/bbrc.1999.1346; Oba Y, 1999, BIOCHEM BIOPH RES CO, V265, P366, DOI 10.1006/bbrc.1999.1700; Pang Y, 2008, ENDOCRINOLOGY, V149, P3410, DOI 10.1210/en.2007-1663; Pang YF, 2010, DEV BIOL, V342, P194, DOI 10.1016/j.ydbio.2010.03.027; Pang YF, 2009, GEN COMP ENDOCR, V161, P58, DOI 10.1016/j.ygcen.2008.10.003; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pinzone JJ, 2004, MOL CELL BIOL, V24, P4605, DOI 10.1128/MCB.24.11.4605-4612.2004; Qiu J, 2003, J NEUROSCI, V23, P9529; Radice S, 2004, CHEM-BIOL INTERACT, V147, P185, DOI 10.1016/j.cbi.2003.12.006; REE AH, 1992, ENDOCRINOLOGY, V131, P1810, DOI 10.1210/en.131.4.1810; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; SACEDA M, 1991, J BIOL CHEM, V266, P17809; Sheldahl LC, 2008, NEUROSCIENCE, V153, P751, DOI 10.1016/j.neuroscience.2008.02.035; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Soverchia L, 2005, TOXICOL APPL PHARM, V209, P236, DOI 10.1016/j.taap.2005.04.013; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Tischkau SA, 2000, J NEUROSCI, V20, P7830; Tonetti DA, 2000, BRIT J CANCER, V83, P782, DOI 10.1054/bjoc.2000.1326; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Zhang CG, 2010, ENDOCRINOLOGY, V151, P4477, DOI 10.1210/en.2010-0177; Zhang HH, 2010, ENDOCRINOLOGY, V151, P3874, DOI 10.1210/en.2009-1356; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031; Zhang ZG, 2002, BIOCHEM BIOPH RES CO, V294, P926, DOI 10.1016/S0006-291X(02)00348-0; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Zhou R, 2011, BIOL REPROD, V85, P615, DOI 10.1095/biolreprod.111.091884	75	26	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62524	10.1371/journal.pone.0062524	http://dx.doi.org/10.1371/journal.pone.0062524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658740	gold, Green Submitted, Green Published			2022-12-25	WOS:000321202100014
J	Pasternak, Z; Al-Ashhab, A; Gatica, J; Gafny, R; Avraham, S; Minz, D; Gillor, O; Jurkevitch, E				Pasternak, Zohar; Al-Ashhab, Ashraf; Gatica, Joao; Gafny, Ron; Avraham, Shlomit; Minz, Dror; Gillor, Osnat; Jurkevitch, Edouard			Spatial and Temporal Biogeography of Soil Microbial Communities in Arid and Semiarid Regions	PLOS ONE			English	Article							DISTANCE-DECAY; DIVERSITY; 16S	Microbial communities in soils may change in accordance with distance, season, climate, soil texture and other environmental parameters. Microbial diversity patterns have been extensively surveyed in temperate regions, but few such studies attempted to address them with respect to spatial and temporal scales and their correlations to environmental factors, especially in arid ecosystems. In order to fill this gap on a regional scale, the molecular fingerprints and abundance of three taxonomic groups - Bacteria, alpha-Proteobacteria and Actinobacteria - were sampled from soils 0.5-100 km apart in arid, semi-arid, dry Mediterranean and shoreline Mediterranean regions in Israel. Additionally, on a local scale, the molecular fingerprints of three taxonomic groups - Bacteria, Archaea and Fungi - were sampled from soils 1 cm-500 m apart in the semi-arid region, in both summer and winter. Fingerprints of the Bacteria differentiated between all regions (P<0.02), while those of the a-Proteobacteria differentiated between some of the regions (0.01<P<0.09), and actinobacterial fingerprints were similar among all regions (P>0.05). Locally, fingerprints of archaea and fungi did not display distance-decay relationships (P>0.13), that is, the dissimilarity between communities did not increase with geographic distance. Neither was this phenomenon evident in bacterial samples in summer (P>0.24); in winter, however, differences between bacterial communities significantly increased as the geographic distances between them grew (P<0.01). Microbial community structures, as well as microbial abundance, were both significantly correlated to precipitation and soil characteristics: texture, organic matter and water content (R-2>0.60, P<0.01). We conclude that on the whole, microbial biogeography in arid and semi-arid soils in Israel is determined more by specific environmental factors than geographic distances and spatial distribution patterns.	[Pasternak, Zohar; Gatica, Joao; Jurkevitch, Edouard] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Microbiol & Plant Dis, IL-76100 Rehovot, Israel; [Al-Ashhab, Ashraf; Gillor, Osnat] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Zuckerberg Inst Water Res, IL-84993 Sede Boqer, Israel; [Gafny, Ron; Avraham, Shlomit] Israel Police Natl Headquarters, DIFS, Forens Biol Lab, Jerusalem, Israel; [Minz, Dror] Agr Res Org, Volcani Ctr, Inst Soil Water & Environm Sci, IL-50250 Bet Dagan, Israel	Hebrew University of Jerusalem; Ben Gurion University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Pasternak, Z (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Microbiol & Plant Dis, IL-76100 Rehovot, Israel.	zpast@yahoo.com	Ashhab, Ashraf AL/AAF-4989-2019; Arashkevich, Elena/E-8175-2014; Pasternak, Anna F/E-6121-2014; Morozov, Andrew/AAI-6528-2020	Ashhab, Ashraf AL/0000-0002-3716-2279; Arashkevich, Elena/0000-0003-0374-3064; Pasternak, Anna F/0000-0003-0317-5861; Minz, Dror/0000-0001-6746-9151; Gillor, Osnat/0000-0003-0849-2241	Technical Support Working Group of the U.S. CTTSO (Combating Terrorism Technical Support Office)	Technical Support Working Group of the U.S. CTTSO (Combating Terrorism Technical Support Office)	Funding for this project was provided by the Technical Support Working Group of the U.S. CTTSO (Combating Terrorism Technical Support Office). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; Angel R, 2010, ISME J, V4, P553, DOI 10.1038/ismej.2009.136; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Bachar A, 2012, MICROB ECOL, V63, P694, DOI 10.1007/s00248-011-9957-x; Bachar A, 2010, MICROB ECOL, V60, P453, DOI 10.1007/s00248-010-9727-1; Bell CW, 2009, MICROB ECOL, V58, P827, DOI 10.1007/s00248-009-9529-5; Bell T, 2010, ISME J, V4, P1357, DOI 10.1038/ismej.2010.77; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Clark J, 2009, MICROB ECOL, V57, P248, DOI 10.1007/s00248-008-9475-7; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Egert M, 2003, APPL ENVIRON MICROB, V69, P2555, DOI 10.1128/AEM.69.5.2555-2562.2003; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Franklin RB, 2003, FEMS MICROBIOL ECOL, V44, P335, DOI 10.1016/S0168-6496(03)00074-6; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LeBlanc JC, 2008, APPL ENVIRON MICROB, V74, P2627, DOI 10.1128/AEM.02711-07; Mangan SA, 2004, OECOLOGIA, V141, P687, DOI 10.1007/s00442-004-1684-2; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mather P. M., 1976, COMPUTATIONAL METHOD; Mielke P., 1984, METEOROLOGICAL APPL, P813; Moore-Kucera J, 2008, MICROB ECOL, V55, P500, DOI 10.1007/s00248-007-9295-1; MOYER CL, 1994, APPL ENVIRON MICROB, V60, P871, DOI 10.1128/AEM.60.3.871-879.1994; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Pasternak Z, 2012, INT RES J MICROBIOL, V3, P363; Sensabaugh GF, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P49, DOI 10.1007/978-1-4020-9204-6_4; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Vetsigian K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001184; WILLIAMS S T, 1972, Soil Biology and Biochemistry, V4, P215, DOI 10.1016/0038-0717(72)90014-4	36	90	97	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69705	10.1371/journal.pone.0069705	http://dx.doi.org/10.1371/journal.pone.0069705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23936450	Green Published, Green Submitted, gold			2022-12-25	WOS:000322838900071
J	Ghosh, AK; Murphy, SB; Kishore, R; Vaughan, DE				Ghosh, Asish K.; Murphy, Sheila B.; Kishore, Raj; Vaughan, Douglas E.			Global Gene Expression Profiling in PAI-1 Knockout Murine Heart and Kidney: Molecular Basis of Cardiac-Selective Fibrosis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; GROWTH-FACTOR-BETA; ANKYRIN REPEAT PROTEIN; MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; DEFICIENT MICE; TGF-BETA; COMMON; EGR-1; FIBROBLASTS	Fibrosis is defined as an abnormal matrix remodeling due to excessive synthesis and accumulation of extracellular matrix proteins in tissues during wound healing or in response to chemical, mechanical and immunological stresses. At present, there is no effective therapy for organ fibrosis. Previous studies demonstrated that aged plasminogen activator inhibitor-1(PAI-1) knockout mice develop spontaneously cardiac-selective fibrosis without affecting any other organs. We hypothesized that differential expressions of profibrotic and antifibrotic genes in PAI-1 knockout hearts and unaffected organs lead to cardiac selective fibrosis. In order to address this prediction, we have used a genome-wide gene expression profiling of transcripts derived from aged PAI-1 knockout hearts and kidneys. The variations of global gene expression profiling were compared within four groups: wildtype heart vs. knockout heart; wildtype kidney vs. knockout kidney; knockout heart vs. knockout kidney and wildtype heart vs. wildtype kidney. Analysis of illumina-based microarray data revealed that several genes involved in different biological processes such as immune system processing, response to stress, cytokine signaling, cell proliferation, adhesion, migration, matrix organization and transcriptional regulation were affected in hearts and kidneys by the absence of PAI-1, a potent inhibitor of urokinase and tissue-type plasminogen activator. Importantly, the expressions of a number of genes, involved in profibrotic pathways including Ankrd1, Pi16, Egr1, Scx, Timp1, Timp2, Klf6, Loxl1 and Klotho, were deregulated in PAI-1 knockout hearts compared to wildtype hearts and PAI-1 knockout kidneys. While the levels of Ankrd1, Pi16 and Timp1 proteins were elevated during EndMT, the level of Timp4 protein was decreased. To our knowledge, this is the first comprehensive report on the influence of PAI-1 on global gene expression profiling in the heart and kidney and its implication in fibrogenesis and several other biological processes. The significance of these observations in the light of heart-specific profibrotic signaling and fibrogenesis are discussed.	[Ghosh, Asish K.; Murphy, Sheila B.; Kishore, Raj; Vaughan, Douglas E.] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Ghosh, AK (corresponding author), Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA.	a-ghosh2@northwestern.edu; d-vaughan@northwestern.edu	KUMAR, SUSHIL/T-8493-2017; Bhalla, Kuhulika/A-4297-2014	KUMAR, SUSHIL/0000-0001-8481-9221; Bhalla, Kuhulika/0000-0002-6608-2120; Khanna, Navin/0000-0003-1208-614X; SAMUCHIWAL, SACHIN/0000-0001-6232-5650; Tousif, Sultan/0000-0001-6174-6541	National Institutes of Health-National Heart, Lung, and Blood Institute (NIH-NHLBI) [1P01HL108795, HL051387, HL091983, HL105597, HL095874, HL053354]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051387, R01HL105597, R01HL091983, R01HL053354, P01HL108795, R01HL095874, R37HL053354] Funding Source: NIH RePORTER	National Institutes of Health-National Heart, Lung, and Blood Institute (NIH-NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from National Institutes of Health-National Heart, Lung, and Blood Institute (NIH-NHLBI) (1P01HL108795, HL051387, HL091983, HL105597, HL095874 and HL053354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Boengler K, 2003, CARDIOVASC RES, V59, P573, DOI 10.1016/S0008-6363(03)00511-X; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CARMELIET P, 1993, J CLIN INVEST, V92, P2756, DOI 10.1172/JCI116893; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Cho SJ, 2006, J BIOL CHEM, V281, P8161, DOI 10.1074/jbc.M506770200; Czubryt MP, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-19; De Taeye B, 2005, CURR OPIN PHARMACOL, V5, P149, DOI 10.1016/j.coph.2005.01.007; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Du P, 2013, USING LUMI PACKAGE P; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Ellmers LJ, 2010, CURR ENZYME INHIB, V6, P78; Frost RJA, 2007, CIRCULATION, V116, P1768, DOI 10.1161/CIRCULATIONAHA.107.696468; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; Ghosh AK, 2010, CURRENT ENZYME INHIB, V6, P54; Ghosh AK, 2012, CELL SIGNAL, V24, P1031, DOI 10.1016/j.cellsig.2011.12.024; Ghosh Asish K, 2012, Front Biosci (Elite Ed), V4, P1556; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Ghosh AK, 2010, CIRCULATION, V122, P1200, DOI 10.1161/CIRCULATIONAHA.110.955245; Heymans S, 2005, AM J PATHOL, V166, P15, DOI 10.1016/S0002-9440(10)62228-6; Hu BA, 2013, CURR OPIN RHEUMATOL, V25, P71, DOI 10.1097/BOR.0b013e32835b1352; Kardasinski M, 2009, J MOL CELL CARDIOL, V47, P174, DOI 10.1016/j.yjmcc.2009.05.006; Kishore P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000292; Leask A, 2010, CURR ENZYME INHIB, V6, P97; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Li YY, 2000, CARDIOVASC RES, V46, P214, DOI 10.1016/S0008-6363(00)00003-1; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mastuzaki K, 2010, CURR ENZYME INHIB, V6, P57; Mgbemena V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-409; Micutkova L, 2011, MECH AGEING DEV, V132, P468, DOI 10.1016/j.mad.2011.07.005; Miele L, 2008, GASTROENTEROLOGY, V135, P282, DOI 10.1053/j.gastro.2008.04.004; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Moriwaki H, 2004, CIRC RES, V95, P637, DOI 10.1161/01.RES.0000141427.61023.f4; Nakamura H, 2002, GENE THER, V9, P495, DOI 10.1038/sj.gt.3301681; Nie QH, 2004, WORLD J GASTROENTERO, V10, P86; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Oie E, 2010, SCAND CARDIOVASC J, V44, P359, DOI 10.3109/14017431.2010.511256; Pardo A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S9; PHAN SH, 1987, J LEUKOCYTE BIOL, V42, P106, DOI 10.1002/jlb.42.2.106; Phua YL, 2012, J PATHOL, DOI [10.1002/path.4155, DOI 10.1002/PATH.4155.[]; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Samaras SE, 2012, BIOCHEM BIOPH RES CO, V425, P830, DOI 10.1016/j.bbrc.2012.07.162; SethuNarayanan SR, 2011, INT J HUM GENET, V11, P135, DOI 10.1080/09723757.2011.11886136; Shi Y, 2005, AM J PATHOL, V166, P303, DOI 10.1016/S0002-9440(10)62254-7; Singh M, 2010, HEART FAIL REV, V15, P487, DOI 10.1007/s10741-010-9158-6; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK., 2013, LIMMA LINEAR MODELS; Starkel P, 2003, J HEPATOL, V39, P538, DOI 10.1016/S0168-8278(03)00360-X; Stoker AW, 1990, CURR OPIN CELL BIOL, V2, P864, DOI 10.1016/0955-0674(90)90085-S; Sugiura H, 2012, AM J PHYSIOL-RENAL, V302, pF1252, DOI 10.1152/ajprenal.00294.2011; Takahashi S, 2010, J ATHEROSCLER THROMB, V17, P73, DOI 10.5551/jat.2410; Torrado M, 2006, FEBS LETT, V580, P4182, DOI 10.1016/j.febslet.2006.06.073; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Velasco G, 1999, J BIOL CHEM, V274, P4570, DOI 10.1074/jbc.274.8.4570; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xiao Q, 2012, CANCER MICROENVIRON, V5, P261, DOI 10.1007/s12307-012-0105-z; Xu Z, 2010, BLOOD, V115, P2038, DOI 10.1182/blood-2009-09-244962; Yang H.-C., 2010, CURR ENZYM INHIB, V6, P87; Yue X., 2010, CURR ENZYM INHIB, V6, P67, DOI [10.2174/157340810791233033, DOI 10.2174/157340810791233033]; Zhang ZZ, 2007, THESIS; Zirlik A, 2009, THROMB HAEMOSTASIS, V101, P1060, DOI 10.1160/TH08-03-0164	66	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e63825	10.1371/journal.pone.0063825	http://dx.doi.org/10.1371/journal.pone.0063825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23724005	Green Submitted, Green Published, gold			2022-12-25	WOS:000319733000028
